PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Davis, I; Yang, Y; Wherritt, D; Liu, AM				Davis, Ian; Yang, Yu; Wherritt, Daniel; Liu, Aimin			Reassignment of the human aldehyde dehydrogenase ALDH8A1 (ALDH12) to the kynurenine pathway in tryptophan catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aldehyde dehydrogenase; 2-aminomuconate semialdehyde dehydrogenase; tryptophan catabolism; retinal metabolism; NAD biosynthesis; biodegradation; serotonin; neurological disease; kynurenine pathway; retinal dehydrogenase	SEMIALDEHYDE DECARBOXYLASE ACMSD; NAD BIOSYNTHESIS; IDENTIFICATION; DEGRADATION; EXPRESSION; MECHANISM; CATALYSIS; SEQUENCE; RING	The kynurenine pathway is the primary route for l-tryptophan degradation in mammals. Intermediates and side products of this pathway are involved in immune response and neurodegenerative diseases. This makes the study of enzymes, especially those from mammalian sources, of the kynurenine pathway worthwhile. Recent studies on a bacterial version of an enzyme of this pathway, 2-aminomuconate semialdehyde (2-AMS) dehydrogenase (AMSDH), have provided a detailed understanding of the catalytic mechanism and identified residues conserved for muconate semialdehyde recognition and activation. Findings from the bacterial enzyme have prompted the reconsideration of the function of a previously identified human aldehyde dehydrogenase, ALDH8A1 (or ALDH12), which was annotated as a retinal dehydrogenase based on its ability to preferentially oxidize 9-cis-retinal over trans-retinal. Here, we provide compelling bioinformatics and experimental evidence that human ALDH8A1 should be reassigned to the missing 2-AMS dehydrogenase of the kynurenine metabolic pathway. For the first time, the product of the semialdehyde oxidation by AMSDH is also revealed by NMR and high-resolution MS. We found that ALDH8A1 catalyzes the NAD(+)-dependent oxidation of 2-AMS with a catalytic efficiency equivalent to that of AMSDH from the bacterium Pseudomonas fluorescens. Substitution of active-site residues required for substrate recognition, binding, and isomerization in the bacterial enzyme resulted in human ALDH8A1 variants with 160-fold increased K-m or no detectable activity. In conclusion, this molecular study establishes an additional enzymatic step in an important human pathway for tryptophan catabolism.	[Davis, Ian; Yang, Yu; Wherritt, Daniel; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Davis, Ian] Univ Texas San Antonio, San Antonio, TX USA; [Davis, Ian] Georgia State Univ, Atlanta, GA 30303 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University System of Georgia; Georgia State University	Liu, AM (corresponding author), Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA.	Feradical@utsa.edu	Liu, Aimin/C-1572-2017; Wherritt, Daniel/AAY-6852-2020	Liu, Aimin/0000-0002-4182-8176; Wherritt, Daniel/0000-0002-8616-9864; Yang, Yu/0000-0001-5305-2435; Davis, Ian/0000-0002-1566-4972	National Institutes of Health [G12MD007591]; National Science Foundation [1625963]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108988, R01GM107529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107985] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER; Division Of Chemistry [1625963] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Dr. Wendell Griffith for assisting with MS analysis. The mass spectrometry facility was sponsored by National Institutes of Health Grant G12MD007591. The NMR spectrometer is a shared instrument sponsored by the National Science Foundation under Award 1625963.	Ananieva Elitsa, 2015, World J Biol Chem, V6, P281, DOI 10.4331/wjbc.v6.i4.281; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005; Colabroy KL, 2005, J AM CHEM SOC, V127, P840, DOI 10.1021/ja0446395; Davis I, 2015, EXPERT REV NEUROTHER, V15, P719, DOI 10.1586/14737175.2015.1049999; Fukuoka SI, 2002, J BIOL CHEM, V277, P35162, DOI 10.1074/jbc.M200819200; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; He ZQ, 1998, J BACTERIOL, V180, P4591, DOI 10.1128/JB.180.17.4591-4595.1998; Huo L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6935; Huo L, 2015, PROTEINS, V83, P178, DOI 10.1002/prot.24722; Huo L, 2013, J BIOL CHEM, V288, P30862, DOI 10.1074/jbc.M113.496869; Huo L, 2012, BIOCHEMISTRY-US, V51, P5811, DOI 10.1021/bi300635b; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Li TF, 2005, J AM CHEM SOC, V127, P12282, DOI 10.1021/ja0532234; Li TF, 2007, J AM CHEM SOC, V129, P9278, DOI 10.1021/ja073648l; Li TF, 2006, BIOCHEMISTRY-US, V45, P6628, DOI 10.1021/bi060108c; Lima WC, 2009, MOL BIOL EVOL, V26, P399, DOI 10.1093/molbev/msn261; Lin M, 2000, J BIOL CHEM, V275, P40106, DOI 10.1074/jbc.M008027200; Muraki T, 2003, APPL ENVIRON MICROB, V69, P1564, DOI 10.1128/AEM.69.3.1564-1572.2003; NISHINO SF, 1993, APPL ENVIRON MICROB, V59, P2520, DOI 10.1128/AEM.59.8.2520-2525.1993; NISHIZUKA Y, 1965, J BIOL CHEM, V240, P733; Park J, 2013, J BIOL CHEM, V288, P15760, DOI 10.1074/jbc.M113.460428; Pellicciari R, 2018, J MED CHEM, V61, P745, DOI 10.1021/acs.jmedchem.7b01254; Phillips RS, 2017, BIOORG MED CHEM LETT, V27, P1705, DOI 10.1016/j.bmcl.2017.02.080; Phillips RS, 2014, ARCH BIOCHEM BIOPHYS, V544, P69, DOI 10.1016/j.abb.2013.10.020; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; WHITMAN CP, 1991, J AM CHEM SOC, V113, P3154, DOI 10.1021/ja00008a052; Wogulis M, 2008, BIOCHEMISTRY-US, V47, P1608, DOI 10.1021/bi701172v; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang Y, 2016, J BIOL CHEM, V291, P26252, DOI 10.1074/jbc.M116.759712	34	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9594	9603		10.1074/jbc.RA118.003320	http://dx.doi.org/10.1074/jbc.RA118.003320			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29703752	hybrid, Green Published			2022-12-26	WOS:000436102300004
J	Iyer, GR; Singh, S; Kaur, I; Agarwal, S; Siddiqui, MA; Bansal, A; Kumar, G; Saini, E; Paul, G; Mohmmed, A; Chitnis, CE; Malhotra, P				Iyer, Gayatri R.; Singh, Shailja; Kaur, Inderjeet; Agarwal, Shalini; Siddiqui, Mansoor A.; Bansal, Abhisheka; Kumar, Gautam; Saini, Ekta; Paul, Gourab; Mohmmed, Asif; Chitnis, Chetan E.; Malhotra, Pawan			Calcium-dependent phosphorylation of Plasmodium falciparum serine repeat antigen 5 triggers merozoite egress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoproteomics; plasmodium; posttranslational modification (PTM); protein phosphorylation; malaria; CDPK1; merozoites egress; Plasmodium falciparum; SERA5	MALARIA PARASITE DEVELOPMENT; PROTEIN-KINASE; CYSTEINE PROTEASE; HOST ERYTHROCYTE; ARTEMISININ RESISTANCE; LIFE-CYCLE; SERA5; INHIBITION; EXPRESSION; IDENTIFICATION	The human malaria parasite Plasmodium falciparum proliferates in red blood cells following repeated cycles of invasion, multiplication, and egress. P. falciparum serine repeat antigen 5 (PfSERA5), a putative serine protease, plays an important role in merozoite egress. However, regulation of its activity leading to merozoite egress is poorly understood. In this study, we show that PfSERA5 undergoes phosphorylation prior to merozoite egress. Immunoprecipitation of parasite lysates using anti-PfSERA5 serum followed by MS analysis identified calcium-dependent protein kinase 1 (PfCDPK1) as an interacting kinase. Association of PfSERA5 with PfCDPK1 was corroborated by co-sedimentation, co-immunoprecipitation, and co-immunolocalization analyses. Interestingly, PfCDPK1 phosphorylated PfSERA5 in vitro in the presence of Ca2+ and enhanced its proteolytic activity. A PfCDPK1 inhibitor, purfalcamine, blocked the phosphorylation and activation of PfSERA5 both in vitroas well as in schizonts, which, in turn, blocked merozoite egress. Together, these results suggest that phosphorylation of PfSERA5 by PfCDPK1 following a rise in cytosolic Ca2+ levels activates its proteolytic activity to trigger merozoite egress.	[Iyer, Gayatri R.; Singh, Shailja; Kaur, Inderjeet; Agarwal, Shalini; Siddiqui, Mansoor A.; Bansal, Abhisheka; Kumar, Gautam; Saini, Ekta; Paul, Gourab; Mohmmed, Asif; Chitnis, Chetan E.; Malhotra, Pawan] Int Ctr Genet Engn & Biotechnol, Malaria Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Singh, Shailja; Chitnis, Chetan E.] Inst Pasteur, Dept Parasites & Insect Vectors, 25-28 Rue Doctor Roux, F-75015 Paris, France; [Singh, Shailja] Jawaharlal Nehru Univ, Special Ctr Mol Med, Delhi, India; [Agarwal, Shalini] Jawaharlal Nehru Univ, Sch Life Sci, Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Chitnis, CE; Malhotra, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.; Chitnis, CE (corresponding author), Inst Pasteur, Dept Parasites & Insect Vectors, 25-28 Rue Doctor Roux, F-75015 Paris, France.	chetan.chitnis@pasteur.fr; pawanmal@gmail.com	Bansal, Abhisheka/ABC-7871-2020	Bansal, Abhisheka/0000-0002-2959-8494; Chitnis, Chetan/0000-0002-8773-9865; Kaur, Inderjeet/0000-0001-8778-1396; Saini, Ekta/0000-0001-5701-6108; Agarwal, Shalini/0000-0002-5526-6872; Iyer, Gayatri/0000-0002-8100-0832	Department of Biotechnology, Government of India [BT/01/CEIB/11/V/01]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India (BT/01/CEIB/11/V/01). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal S, 2013, CELL MICROBIOL, V15, P910, DOI 10.1111/cmi.12086; Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Azevedo MF, 2013, BIOCHEM J, V452, P433, DOI 10.1042/BJ20130124; Bansal A, 2013, J BIOL CHEM, V288, P1590, DOI 10.1074/jbc.M112.411934; BZIK DJ, 1988, MOL BIOCHEM PARASIT, V30, P279, DOI 10.1016/0166-6851(88)90097-7; Collins CR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006453; Dua M, 2001, MOL BIOCHEM PARASIT, V116, P95, DOI 10.1016/S0166-6851(01)00306-1; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; HADLEY T, 1983, EXP PARASITOL, V55, P306, DOI 10.1016/0014-4894(83)90027-9; Hanspal M, 2002, BLOOD, V100, P1048, DOI 10.1182/blood-2002-01-0101; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; Kanodia S, 2014, BBA-GEN SUBJECTS, V1840, P2765, DOI 10.1016/j.bbagen.2014.04.013; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kaur I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35432; Kiefer MC, 1996, MOL BIOCHEM PARASIT, V78, P55, DOI 10.1016/S0166-6851(96)02607-2; Korde R, 2008, J MED CHEM, V51, P3116, DOI 10.1021/jm070735f; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Le Bonniec S, 1999, J BIOL CHEM, V274, P14218, DOI 10.1074/jbc.274.20.14218; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; LYON JA, 1986, J IMMUNOL, V136, P2245; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Palacpac NMQ, 2011, VACCINE, V29, P5837, DOI 10.1016/j.vaccine.2011.06.052; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Soni S, 2005, BLOOD CELL MOL DIS, V35, P201, DOI 10.1016/j.bcmd.2005.05.006; Stallmach R, 2015, MOL MICROBIOL, V96, P368, DOI 10.1111/mmi.12941; Stephens BJ, 2005, MOL CANCER THER, V4, P1653, DOI 10.1158/1535-7163.MCT-05-0248; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	41	17	18	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9736	9746		10.1074/jbc.RA117.001540	http://dx.doi.org/10.1074/jbc.RA117.001540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29716996	hybrid, Green Published			2022-12-26	WOS:000436102300018
J	Abe, K; Sunagawa, N; Terada, T; Takahashi, Y; Arakawa, T; Igarashi, K; Samejima, M; Nakai, H; Taguchi, H; Nakajima, M; Fushinobu, S				Abe, Koichi; Sunagawa, Naoki; Terada, Tohru; Takahashi, Yuta; Arakawa, Takatoshi; Igarashi, Kiyohiko; Samejima, Masahiro; Nakai, Hiroyuki; Taguchi, Hayao; Nakajima, Masahiro; Fushinobu, Shinya			Structural and thermodynamic insights into beta-1,2-glucooligosaccharide capture by a solute-binding protein in Listeria innocua	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; CYCLIC-BETA-GLUCANS; MOLECULAR-DYNAMICS; EVOLUTIONARY CONSERVATION; STRUCTURE VALIDATION; PERIPLASMIC GLUCANS; ACTIVE-TRANSPORT; MALTOSE; OLIGOSACCHARIDES; RECOGNITION	beta-1,2-Glucans are bacterial carbohydrates that exist in cyclic or linear forms and play an important role in infections and symbioses involving Gram-negative bacteria. Although several beta-1,2-glucan-associated enzymes have been characterized, little isknownabouthow beta-1,2-glucan and its shorter oligosaccharides (Sop n s) are captured and imported into the bacterial cell. Here, we report the biochemical and structural characteristics of the Sop n -binding protein (SO-BP, Lin1841) associated with the ATP-binding cassette (ABC) transporter from the Grampositive bacterium Listeria innocua. Calorimetric analysis revealed that SO-BP specifically binds to Sop n s with a degree of polymerization of 3 or more, with K d values in the micromolar range. The crystal structures of SO-BP in an unliganded open formandin closedcomplexeswithtri-, tetra-, andpentaoligosaccharides (Sop 3-5) were determined to a maximum resolution of 1.6 A. The binding site displayed shape complementarity to Sop n, which adopted a zigzag conformation. We noted that water-mediated hydrogen bonds and stacking interactions play a pivotal role in the recognition of Sop 3-5 by SO-BP, consistent with its binding thermodynamics. Computational free-energy calculations and a mutational analysis confirmed that interactions with the third glucose moiety of Sop n s are significantly responsible for ligand binding. A reduction in unfavorable changes in binding entropy that were in proportion to the lengths of the Sop n s was explained by conformational entropy changes. Phylogenetic and sequence analyses indicated that SO-BP ABC transporter homologs, glycoside hydrolases, and other related proteins are co-localized in the genomes of several bacteria. This study may improve our understanding of bacterial beta-1,2-glucan metabolism and promote the discovery of unidentified beta-1,2-glucan-associated proteins.	[Abe, Koichi; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Abe, Koichi; Terada, Tohru] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Sunagawa, Naoki; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Takahashi, Yuta; Nakai, Hiroyuki] Niigata Univ, Fac Agr, Niigata 9502181, Japan; [Igarashi, Kiyohiko] VTT Tech Res Ctr Finland, FI-02044 Espoo, Vtt, Finland; [Taguchi, Hayao; Nakajima, Masahiro] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, 2641 Yamazaki, Noda, Chiba 2788510, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Niigata University; VTT Technical Research Center Finland; Tokyo University of Science	Fushinobu, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Terada, Tohru/W-2956-2019; Nakajima, Masahiro/J-3566-2019; Igarashi, Kiyohiko/E-6799-2016; Arakawa, Takatoshi/K-9739-2013	Fushinobu, Shinya/0000-0003-1346-6435; Terada, Tohru/0000-0002-7091-0646; Nakajima, Masahiro/0000-0002-3182-0859; Igarashi, Kiyohiko/0000-0001-5152-7177; Arakawa, Takatoshi/0000-0001-6496-5440; Taguchi, Hayao/0000-0001-5270-581X; Sunagawa, Naoki/0000-0002-0382-6671	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED); JSPS-KAKENHI [15H02443, 26660083]	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS-KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED) and by JSPS-KAKENHI Grants 15H02443 and 26660083 (to S. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe K., 2015, J APPL GLYCOSCI, V62, P47, DOI [DOI 10.5458/JAG.JAG, 10.5458/jag.jag.JAG-2014_011, DOI 10.5458/JAG.JAG.JAG-2014_011]; Abe K, 2017, J BIOL CHEM, V292, P7487, DOI 10.1074/jbc.M116.762724; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; ANDRE I, 1995, NEW J CHEM, V19, P331; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; Barnett CB, 2008, J PHYS CHEM B, V112, P15450, DOI 10.1021/jp8067409; BENNETT CH, 1976, J COMPUT PHYS, V22, P245, DOI 10.1016/0021-9991(76)90078-4; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P6240, DOI 10.1021/bi0101695; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case D. A., 2017, AMBER 2017; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DOWD MK, 1992, CARBOHYD RES, V233, P15, DOI 10.1016/S0008-6215(00)90917-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ejby M, 2016, J BIOL CHEM, V291, P20220, DOI 10.1074/jbc.M116.746529; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Medrano FJ, 2014, ACTA CRYSTALLOGR F, V70, P564, DOI 10.1107/S2053230X14006578; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MANDELS M, 1962, J BACTERIOL, V83, P400, DOI 10.1128/JB.83.2.400-408.1962; MAO B, 1982, J BIOL CHEM, V257, P1131; Medintz IL, 2006, CURR OPIN BIOTECH, V17, P17, DOI 10.1016/j.copbio.2006.01.002; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakajima M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42671; Nakajima M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148870; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Notenboom V, 2001, J MOL BIOL, V314, P797, DOI 10.1006/jmbi.2001.5153; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pereira CS, 2006, BIOPHYS J, V90, P4337, DOI 10.1529/biophysj.106.081539; Peric-Hassler L, 2010, CARBOHYD RES, V345, P1781, DOI 10.1016/j.carres.2010.05.026; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Rahman O, 2008, WORLD J MICROB BIOT, V24, P2377, DOI 10.1007/s11274-008-9795-2; Rao V. S. R., 1998, CONFORMATION CARBOHY; Schmidt S, 2010, RAPID COMMUN MASS SP, V24, P2009, DOI 10.1002/rcm.4605; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; TALAGA P, 1994, J BACTERIOL, V176, P6538, DOI 10.1128/JB.176.21.6538-6544.1994; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Terada T, 2012, J PHYS CHEM B, V116, P6810, DOI 10.1021/jp2125558; Terwilliger TC, 2013, ACTA CRYSTALLOGR D, V69, P2244, DOI 10.1107/S0907444913017770; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Bogaert INA, 2007, APPL MICROBIOL BIOT, V76, P23, DOI 10.1007/s00253-007-0988-7; van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvf201; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101	68	15	15	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8812	8828		10.1074/jbc.RA117.001536	http://dx.doi.org/10.1074/jbc.RA117.001536			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29678880	Green Published, hybrid			2022-12-26	WOS:000434941900008
J	Dan, J; Zhou, QJ; Zhai, HL; Cheng, J; Wan, L; Ge, C; Xie, LX				Dan, Jing; Zhou, Qingjun; Zhai, Hualei; Cheng, Jun; Wan, Lei; Ge, Cheng; Xie, Lixin			Clinical analysis of fungal keratitis in patients with and without diabetes	PLOS ONE			English	Article							CORNEAL; KERATOPLASTY	We compared the clinical characteristics, treatments, and prognoses of fungal keratitis in patients with and without diabetes. Patients diagnosed with fungal keratitis at Shandong Eye Institute between January 2010 and December 2016 were retrospectively reviewed and classified as diabetic and nondiabetic groups. One-hundred-and-eleven patients (111 eyes) with diabetes and 740 patients (740 eyes) without diabetes were included. The diabetic patients showed significantly older (p< 0.05) and lower male: female ratio (p< 0.05). Plants trauma was the primary risk factor in both groups, and there was no significant difference of pathogen type (the most common was Fusarium genus, followed by Alternaria and Aspergillus genera). Multivariate logistic regression analyses revealed that diabetes and topical glucocorticoid use were the independent risk factors for the severity of fungal keratitis. The recurrent infection rate between the diabetic and nondiabetic patients during the follow-up (6 to 24 months) after penetrating keratoplasty (PKP) was not significantly different. Although the recurrent epithelial defect, rejection, and best-corrected visual acuity were similar between the patients with matched bed/graft size (7.75/8.0 mm) in the two groups 1 year after PKP, the incidence of delayed re-epithelialization (>7 days) was significantly higher in diabetic patients (3/10 versus 2/43 in nondiabetic patients, p< 0.05). More specially, the diabetic patients with the duration >= 10 years showed more significantly delayed re-epithelialization than those with the diabetic duration less than 10 years (3/5 versus 1/26, p< 0.05). In conclusion, the diabetes mellitus is an independent risk factor that affect the severity of fungal keratitis. Corneal re-epithelialization was significantly delayed after PKP in the diabetic patients, especially with the duration >= 10 years.	[Dan, Jing; Xie, Lixin] Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan, Hubei, Peoples R China; [Dan, Jing; Zhou, Qingjun; Zhai, Hualei; Cheng, Jun; Wan, Lei; Ge, Cheng; Xie, Lixin] Shandong Acad Med Sci, Qingdao Eye Hosp, Shandong Eye Inst, Qingdao, Shandong, Peoples R China	Wuhan University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Xie, LX (corresponding author), Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan, Hubei, Peoples R China.; Xie, LX (corresponding author), Shandong Acad Med Sci, Qingdao Eye Hosp, Shandong Eye Inst, Qingdao, Shandong, Peoples R China.	lixin_xie@hotmail.com	Cheng, Jun/AAV-9031-2021; Xie, li/HGE-6052-2022					Chen YM, 2010, AM J OPHTHALMOL, V150, P352, DOI 10.1016/j.ajo.2010.03.024; Christman AL, 2011, J INVEST DERMATOL, V131, P2121, DOI 10.1038/jid.2011.176; Gabir MM, 2000, DIABETES CARE, V23, P1108, DOI 10.2337/diacare.23.8.1108; Hine JL, 2017, DIABETIC MED, V34, P551, DOI 10.1111/dme.13205; Hiraoka T, 2007, CORNEA, V26, P336, DOI 10.1097/ICO.0b013e31802cd8a8; Keay LJ, 2011, OPHTHALMOLOGY, V118, P920, DOI 10.1016/j.ophtha.2010.09.011; Lagali NS, 2017, INVEST OPHTH VIS SCI, V58, P6318, DOI 10.1167/iovs.17-22257; Ljubimov AV, 2017, VISION RES, V139, P138, DOI 10.1016/j.visres.2017.03.002; Markoulli M, 2018, OCUL SURF, V16, P45, DOI 10.1016/j.jtos.2017.10.006; Poradzka A, 2013, ACTA POL PHARM, V70, P587; Prajna NV, 2017, JAMA OPHTHALMOL, V135, P987, DOI 10.1001/jamaophthalmol.2017.2914; St Leger AJ, 2017, IMMUNITY, V47, P148, DOI 10.1016/j.immuni.2017.06.014; STERN GA, 1991, OPHTHALMOLOGY, V98, P847; Suaya JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060057; Xie LX, 2008, OPHTHALMOLOGY, V115, P983, DOI 10.1016/j.ophtha.2007.07.034; Xie LX, 2006, OPHTHALMOLOGY, V113, P1943, DOI 10.1016/j.ophtha.2006.05.035	16	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196741	10.1371/journal.pone.0196741	http://dx.doi.org/10.1371/journal.pone.0196741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715322	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281100051
J	Yang, CM; Hung, CL; Su, HC; Lin, HJ; Chen, CH; Lin, CC; Hu, HH; Lin, SH; Sung, PS				Yang, Chun-Ming; Hung, Chien-Ling; Su, Hui-Chen; Lin, Huey-Juan; Chen, Chih-Hung; Lin, Chou-Ching; Hu, Han-Hwa; Lin, Sheng-Hsiang; Sung, Pi-Shan			Leukoaraiosis and risk of intracranial hemorrhage and outcome after stroke thrombolysis	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; SYMPTOMATIC INTRACEREBRAL HEMORRHAGE; TISSUE-PLASMINOGEN ACTIVATOR; WHITE-MATTER LESIONS; INTRAVENOUS THROMBOLYSIS; GUIDELINES; ALTEPLASE; THERAPY; TAIWAN; SCALE	Background The impact of leukoaraiosis on the risk of symptomatic intracerebral hemorrhage (SICH) after stroke thrombolysis is conflicting, and the data on Asian populations are lacking. Therefore, in this study, we assessed the association between leukoaraiosis and SICH, and the association between leukoaraiosis and the 90-day functional outcome in the Asian population. Methods Data were collected from a two-center prospective registry of acute ischemic stroke patients given intravenous tissue plasminogen activator between 2006 and 2014. A total of 614 pretreatment brain CT and 455 posttreatment MRI were retrospectively assessed using two different rating scales for the presence of leukoaraiosis. Outcome measures were the occurrence of SICH with three definitions and any hemorrhage after thrombolysis and functional outcome at 3 months. Results Of the 614 patients assessed, 30.3% showed severe leukoaraiosis on the baseline brain CT. The SICH rate was 4.6% -7.2% based on different definitions, and overall, 24.9% of patients showed any post-tPA hemorrhage. No association was observed between the severity of leukoaraiosis and SICH, regardless of having used different leukoaraiosis rating scales or as assessment using different imaging modalities. However, severe leukoaraiosis was independently associated with poor functional outcome at 3 months (OR 1.96, 95% C1 1.24-3.11, P = 0.004) after adjustment for confounders. Conclusions Our results showed no association between leukoaraiosis and the risk of SICH. Although the presence of severe leukoaraiosis predicted a poor functional outcome after stroke, IV thrombolysis might not be withheld in acute ischemic stroke patients solely based on the presence of severe leukoaraiosis on pre-thrombolytic CT scans.	[Yang, Chun-Ming; Lin, Huey-Juan] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Hung, Chien-Ling] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Surg, Tainan, Taiwan; [Hung, Chien-Ling; Lin, Sheng-Hsiang; Sung, Pi-Shan] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan, Taiwan; [Su, Hui-Chen; Chen, Chih-Hung; Lin, Chou-Ching; Sung, Pi-Shan] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Neurol, Tainan, Taiwan; [Hu, Han-Hwa] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Hu, Han-Hwa] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Sung, PS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan, Taiwan.; Sung, PS (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Neurol, Tainan, Taiwan.	pishansung@gmail.com	Lin, Chou-Ching K/I-1451-2019	Lin, Chou-Ching K/0000-0002-3070-5787; Sung, Pi-shan/0000-0003-2505-7583	Chi Mei Hospital [CMNCKU10416]	Chi Mei Hospital	The funding of this study is from Chi Mei Hospital (grant number: CMNCKU10416), but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2010, LANCET NEUROL, V9, P866, DOI 10.1016/S1474-4422(10)70165-4; Alvarez-Sabin J, 2013, LANCET NEUROL, V12, P689, DOI 10.1016/S1474-4422(13)70055-3; Aries MJH, 2010, EUR J NEUROL, V17, P866, DOI 10.1111/j.1468-1331.2010.02963.x; Chang Yeu-Jhy, 2008, Acta Neurol Taiwan, V17, P275; Chao AC, 2010, STROKE, V41, P885, DOI 10.1161/STROKEAHA.109.575605; Charidimou A, 2016, STROKE, V47, P2364, DOI 10.1161/STROKEAHA.116.014096; Choi JH, 2011, J KOREAN NEUROSURG S, V50, P75, DOI 10.3340/jkns.2011.50.2.75; Choi JC, 2015, J STROKE, V17, P7, DOI 10.5853/jos.2015.17.1.7; Costello CA, 2012, J CLIN NEUROSCI, V19, P360, DOI 10.1016/j.jocn.2011.08.014; Demchuk AM, 2008, CEREBROVASC DIS, V26, P120, DOI 10.1159/000139658; Derex L, 2008, J NEUROL NEUROSUR PS, V79, P1093, DOI 10.1136/jnnp.2007.133371; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Holmstedt CA, 2013, LANCET NEUROL, V12, P1106, DOI 10.1016/S1474-4422(13)70195-9; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; INZITARI D, 1990, STROKE, V21, P1419, DOI 10.1161/01.STR.21.10.1419; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kongbunkiat K, 2017, NEUROLOGY, V88, P638, DOI 10.1212/WNL.0000000000003605; Lee SJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-31; Lin QQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153486; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mehta RH, 2014, STROKE, V45, P2263, DOI 10.1161/STROKEAHA.114.005019; Neumann-Haefelin T, 2006, STROKE, V37, P2463, DOI 10.1161/01.STR.0000239321.53203.ea; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/089892906775990552; Ntaios G, 2015, NEUROLOGY, V84, P1213, DOI 10.1212/WNL.0000000000001402; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; O'Sullivan Mike, 2008, Pract Neurol, V8, P26, DOI 10.1136/jnnp.2007.139428; Palumbo V, 2007, NEUROLOGY, V68, P1020, DOI 10.1212/01.wnl.0000257817.29883.48; SCHMIDT R, 1992, ARCH NEUROL-CHICAGO, V49, P825, DOI 10.1001/archneur.1992.00530320049011; Seet RCS, 2012, CEREBROVASC DIS, V34, P106, DOI 10.1159/000339675; SELEKLER K, 1989, STROKE, V20, P1016, DOI 10.1161/01.STR.20.8.1016; Smith EE, 2002, NEUROLOGY, V59, P193, DOI 10.1212/WNL.59.2.193; Sung SF, 2013, STROKE, V44, P1561, DOI 10.1161/STROKEAHA.111.000651; TSIVQOULIS G, 2008, LANCET, V372; VANSWIETEN JC, 1991, ANN NEUROL, V30, P825, DOI 10.1002/ana.410300612; VANSWIETEN JC, 1990, J NEUROL NEUROSUR PS, V53, P1080, DOI 10.1136/jnnp.53.12.1080; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Willer L, 2015, J STROKE CEREBROVASC, V24, P1126, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.018; Xiong Yun Yun, 2011, J Aging Res, V2011, P617927, DOI 10.4061/2011/617927	40	13	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196505	10.1371/journal.pone.0196505	http://dx.doi.org/10.1371/journal.pone.0196505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715283	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100027
J	Kaczmarek, R; Szymczak-Kulus, K; Bereznicka, A; Mikolajczyk, K; Duk, M; Majorczyk, E; Krop-Watorek, A; Klausa, E; Skowronska, J; Michalewska, B; Brojer, E; Czerwinski, M				Kaczmarek, Radoslaw; Szymczak-Kulus, Katarzyna; Bereznicka, Anna; Mikolajczyk, Krzysztof; Duk, Maria; Majorczyk, Edyta; Krop-Watorek, Anna; Klausa, Elzbieta; Skowronska, Joanna; Michalewska, Bogumila; Brojer, Ewa; Czerwinski, Marcin			Single nucleotide polymorphisms in A4GALT spur extra products of the human Gb3/CD77 synthase and underlie the P1PK blood group system	PLOS ONE			English	Article							GENETIC-BASIS; AMINO-ACID; NOR; CHOLESTEROL; ANTIBODIES; ERYTHROCYTES; COMPLEX; CELLS; IDENTIFICATION; SPECIFICITY	Contrary to the mainstream blood group systems, P1PK continues to puzzle and generate controversies over its molecular background. The P1PK system comprises three glycosphingolipid antigens: P-k, P1 and NOR, all synthesised by a glycosyltransferase called Gb3/- CD77 synthase. The P-k antigen is present in most individuals, whereas P1 frequency is lesser and varies regionally, thus underlying two common phenotypes: P-1, if the P1 antigen is present, and P-2, when P1 is absent. Null and NOR phenotypes are extremely rare. To date, several single nucleotide polymorphisms (SNPs) have been proposed to predict the P-1/P-2 status, but it has not been clear how important they are in general and in relation to each other, nor has it been clear how synthesis of NOR affects the P-1 phenotype. Here, we quantitatively analysed the phenotypes and A4GALT transcription in relation to the previously proposed SNPs in a sample of 109 individuals, and addressed potential P1 antigen level confounders, most notably the red cell membrane cholesterol content. While all the SNPs were associated with the P-1/P-2 blood type and rs5751348 was the most reliable, we found large differences in P1 level within groups defined by their genotype and substantial intercohort overlaps, which shows that the P1PK blood group system still eludes full understanding.	[Kaczmarek, Radoslaw; Szymczak-Kulus, Katarzyna; Bereznicka, Anna; Mikolajczyk, Krzysztof; Duk, Maria; Czerwinski, Marcin] Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol, Wroclaw, Poland; [Majorczyk, Edyta; Czerwinski, Marcin] Opole Univ Technol, Fac Phys Educ & Physiotherapy, Opole, Poland; [Krop-Watorek, Anna] Univ Opole, Dept Biotechnol & Mol Biol, Opole, Poland; [Klausa, Elzbieta] Reg Ctr Transfus Med, Wroclaw, Poland; Blood Bank, Wroclaw, Poland; [Skowronska, Joanna] Reg Ctr Transfus Med, Katowice, Poland; Blood Bank, Katowice, Poland; [Michalewska, Bogumila; Brojer, Ewa] Inst Hematol & Blood Transfus, Dept Immunohaematol & Immunol Transfus Med, Warsaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Opole University of Technology; University of Opole; Institute of Hematology & Blood Transfusion	Kaczmarek, R (corresponding author), Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol, Wroclaw, Poland.	radoslaw.kaczmarek@iitd.pan.wroc.pl	Mikolajczyk, Krzysztof/AAX-1573-2020; Majorczyk, Edyta/P-3066-2019; Brojer, Ewa/V-6860-2018	Majorczyk, Edyta/0000-0001-7248-9544; Brojer, Ewa/0000-0003-1947-6888; Mikolajczyk, Krzysztof/0000-0003-1879-2205; Bereznicka, Anna/0000-0002-7228-0772; Nawrocka, Zofia Anna/0000-0001-8376-9218; Kaczmarek, Radoslaw/0000-0001-8084-1958; Szymczak-Kulus, Katarzyna/0000-0003-2660-3662; Czerwinski, Marcin/0000-0003-2859-3699	National Science Centre of Poland Opus Project [DEC-2014/13/B/NZ6/00227]; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	National Science Centre of Poland Opus Project; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This work was funded by National Science Centre of Poland Opus Project DEC-2014/13/B/NZ6/00227 (Prof. Marcin Czerwinski). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This publication was supported by the Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for the years 2014-2018.	BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Busse-Wicher M, 2014, MATRIX BIOL, V35, P25, DOI 10.1016/j.matbio.2013.10.001; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Daniels G., 2013, HUMAN BLOOD GROUPS, P259; Duk M, 2005, GLYCOBIOLOGY, V15, P109, DOI 10.1093/oxfordjournals.glycob.a034964; Duk M, 2001, J BIOL CHEM, V276, P40574, DOI 10.1074/jbc.M102711200; Duk M, 2007, GLYCOBIOLOGY, V17, P304, DOI 10.1093/glycob/cwl071; Eernstman J, 2017, VOX SANG, V112; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hellberg A, 2003, TRANSFUSION, V43, P899, DOI 10.1046/j.1537-2995.2003.00425.x; Hogerkorp CM, 2006, J IMMUNOL, V177, P4341, DOI 10.4049/jimmunol.177.7.4341; Hung KT, 2012, ARTERIOSCL THROM VAS, V32, P1460, DOI 10.1161/ATVBAHA.112.248971; Iwamura K, 2003, J BIOL CHEM, V278, P44429, DOI 10.1074/jbc.M301609200; Jacob F, 2014, BRIT J CANCER, V111, P1634, DOI 10.1038/bjc.2014.455; Kaczmarek R, 2013, FEBS J, V280, P530; Kaczmarek R, 2016, GLYCOCONJUGATE J, V33, P963, DOI 10.1007/s10719-016-9716-9; Kaczmarek R, 2016, BIOCHEM BIOPH RES CO, V470, P168, DOI 10.1016/j.bbrc.2016.01.017; Kaczmarek R, 2014, TRANSFUS MED REV, V28, P126, DOI 10.1016/j.tmrv.2014.04.007; Kusnierz-Alejska G, 1999, TRANSFUSION, V39, P32, DOI 10.1046/j.1537-2995.1999.39199116892.x; Lai YJ, 2014, TRANSFUSION, V54, P3222, DOI 10.1111/trf.12771; Landsteiner K, 1927, P SOC EXP BIOL MED, V24, P941; LANGE Y, 1983, J BIOL CHEM, V258, P6920; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Poole J, 2007, TRANSFUS MED REV, V21, P58, DOI 10.1016/j.tmrv.2006.08.003; Ramakrishnan B, 2001, J BIOL CHEM, V276, P37665, DOI 10.1074/jbc.M102458200; ROWE GP, 1992, ANN HUM GENET, V56, P267, DOI 10.1111/j.1469-1809.1992.tb01151.x; Samani FS, 2014, CYTOTECHNOLOGY, V66, P555, DOI 10.1007/s10616-013-9609-8; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; SHAW MA, 1984, ANN HUM GENET, V48, P229, DOI 10.1111/j.1469-1809.1984.tb01019.x; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Storry JR, 2011, VOX SANG, V101, P77, DOI 10.1111/j.1423-0410.2010.01462.x; Suchanowska A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408286; Takematsu H, 2011, J BIOL CHEM, V286, P27214, DOI 10.1074/jbc.M111.234526; Thuresson B, 2011, BLOOD, V117, P678, DOI 10.1182/blood-2010-08-301333; Tziakas DN, 2007, J AM COLL CARDIOL, V49, P2081, DOI 10.1016/j.jacc.2006.08.069; van Die I, 2010, GLYCOBIOLOGY, V20, P2, DOI 10.1093/glycob/cwp140; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Volynsky P, 2017, MOL IMMUNOL, V90, P87, DOI 10.1016/j.molimm.2017.06.247; Weissgerber TL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002128; Westman JS, 2018, BLOOD, V131, P1611, DOI 10.1182/blood-2017-08-803080; Yeh C-C, 2018, TRANSFUSION IN PRESS; Zhu GF, 1997, GLYCOBIOLOGY, V7, P987, DOI 10.1093/glycob/7.7.987	45	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196627	10.1371/journal.pone.0196627	http://dx.doi.org/10.1371/journal.pone.0196627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709005	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100045
J	Umair, M; Abbasi, BH; Sharif, S; Alam, MM; Rana, MS; Mujtaba, G; Arshad, Y; Fatmi, MQ; Zaidi, SZ				Umair, Massab; Abbasi, Bilal Haider; Sharif, Salmaan; Alam, Muhammad Masroor; Rana, Muhammad Suleman; Mujtaba, Ghulam; Arshad, Yasir; Fatmi, M. Qaiser; Zaidi, Sohail Zahoor			High prevalence of G3 rotavirus in hospitalized children in Rawalpindi, Pakistan during 2014	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; 1ST 2 YEARS; PHYLOGENETIC ANALYSIS; DOUBLE-BLIND; GASTROENTERITIS; DIARRHEA; STRAINS; INFANTS; CHINA; EPIDEMIOLOGY	Rotavirus A species (RVA) is the leading cause of severe diarrhea among children in both developed and developing countries. Among different RVA G types, humans are most commonly infected with G1, G2, G3, G4 and G9. During 2003-2004, G3 rotavirus termed as - "new variant G3" emerged in Japan that later disseminated to multiple countries across the world. Although G3 rotaviruses are now commonly detected globally, they have been rarely reported from Pakistan. We investigated the genetic diversity of G3 strains responsible RVA gastroenteritis in children hospitalized in Rawalpindi, Pakistan during 2014. G3P[8] (18.3%; n = 24) was detected as the most common genotype causing majority of infections in children less than 06 months. Phylogenetic analysis of Pakistani G3 strains showed high amino acid similarity to "new variant G3" and G3 strains reported from China, Russia, USA, Japan, Belgium and Hungary during 2007-2012. Pakistani G3 strains belonged to lineage 3 within sub-lineage 3d, containing an extra N-linked glycosylation site compared to the G3 strain of RotaTeq (TM). To our knowledge, this is the first report on the molecular epidemiology of G3 rotavirus strains from Pakistan and calls for immediate response measures to introduce RV vaccine in the routine immunization program of the country on priority.	[Umair, Massab; Abbasi, Bilal Haider] Quaid I Azam Univ, Dept Biotechnol, Islamabad, Pakistan; [Umair, Massab; Sharif, Salmaan; Alam, Muhammad Masroor; Rana, Muhammad Suleman; Mujtaba, Ghulam; Arshad, Yasir; Zaidi, Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan; [Fatmi, M. Qaiser] COMSATS Inst Informat Technol, Dept BioSci, Islamabad, Pakistan	Quaid I Azam University; COMSATS University Islamabad (CUI)	Umair, M (corresponding author), Quaid I Azam Univ, Dept Biotechnol, Islamabad, Pakistan.; Umair, M (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	massab.umair@yahoo.com	Rana, Dr. Muhammad Suleman/HCH-1540-2022; Abbasi, Bilal Haider/J-1810-2019	Abbasi, Bilal Haider/0000-0002-6529-2134				Alam MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067998; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Banyai K, 2017, INFECT GENET EVOL, V48, P19, DOI 10.1016/j.meegid.2016.12.002; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Cashman O, 2012, EPIDEMIOL INFECT, V140, P247, DOI 10.1017/S0950268811000306; Chan-It W, 2011, INFECT GENET EVOL, V11, P415, DOI 10.1016/j.meegid.2010.11.018; Chen Y, 2013, PEDIATR INFECT DIS J, V32, pE285, DOI 10.1097/INF.0b013e31828c3de4; Ciarlet M, 1997, J VIROL, V71, P8213, DOI 10.1128/JVI.71.11.8213-8220.1997; CIARLET M, 1994, J CLIN MICROBIOL, V32, P2609, DOI 10.1128/JCM.32.10.2609-2612.1994; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Dey SK, 2009, INFECT GENET EVOL, V9, P983, DOI 10.1016/j.meegid.2009.06.016; Diggle L., 2007, BRIT J NURSING, V16; Doro R, 2014, INFECT GENET EVOL, V28, P495, DOI 10.1016/j.meegid.2014.09.016; Duan ZJ, 2009, J INFECT DIS, V200, pS167, DOI 10.1086/605039; Estes M, 2013, FIELDS VIROLOGY; Fang ZY, 2002, J CLIN MICROBIOL, V40, P1875, DOI 10.1128/JCM.40.5.1875-1878.2002; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Iftikhar T, 2012, J MED VIROL, V84, P2003, DOI 10.1002/jmv.23402; Degiuseppe JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110341; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; Jin Y, 2008, WORLD J PEDIATR, V4, P197, DOI 10.1007/s12519-008-0036-4; Kawai K, 2012, VACCINE, V30, P1244, DOI 10.1016/j.vaccine.2011.12.092; Kazi AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108221; Lennon G, 2008, J MED VIROL, V80, P524, DOI 10.1002/jmv.21084; Li K, 2016, VIROLOGY, V494, P168, DOI 10.1016/j.virol.2016.04.017; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Martinez-Laso J, 2009, J GEN VIROL, V90, P935, DOI 10.1099/vir.0.007807-0; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Mitui MT, 2011, J CLIN VIROL, V50, P325, DOI 10.1016/j.jcv.2011.01.008; Ngo TC, 2009, VACCINE, V27, pF75, DOI 10.1016/j.vaccine.2009.08.074; Orenstein EW, 2007, VACCINE, V25, P406, DOI 10.1016/j.vaccine.2006.07.054; Palomo C, 2000, J MED VIROL, V60, P468, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;468::AID-JMV16&gt;3.0.CO;2-E; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan TG, 2007, CLIN LAB, V53, P41; Pietsch C, 2011, J CLIN VIROL, V50, P136, DOI 10.1016/j.jcv.2010.10.013; Qazi R, 2009, VACCINE, V27, pF25, DOI 10.1016/j.vaccine.2009.08.064; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; RCWG, 2017, NEWL ASS GEN; Rotavirus Classification Working Group (RCWG), 2016, NEWL ASS GEN; Sanchez-Fauquier A, 2006, EMERG INFECT DIS, V12, P1536, DOI 10.3201/eid1210.060384; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Seheri LM, 2010, J INFECT DIS, V202, pS139, DOI 10.1086/653559; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Stupka JA, 2009, INFECT GENET EVOL, V9, P1225, DOI 10.1016/j.meegid.2009.07.002; Tamim S, 2013, INFECT GENET EVOL, V14, P161, DOI 10.1016/j.meegid.2012.10.009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Thongprachum A, 2013, INFECT GENET EVOL, V13, P168, DOI 10.1016/j.meegid.2012.09.010; Utachee P, 2010, J VIROL, V84, P4311, DOI 10.1128/JVI.02619-09; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Wang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088850; Wang YH, 2009, J MED VIROL, V81, P382, DOI 10.1002/jmv.21387; World Health Organization, 2002, GEN PORT HOSP BAS SU; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zeller M, 2011, J CLIN MICROBIOL	59	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0195947	10.1371/journal.pone.0195947	http://dx.doi.org/10.1371/journal.pone.0195947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708975	gold, Green Submitted, Green Published			2022-12-26	WOS:000431130100010
J	Walsh, DMJ; Groarke, AM; Morrison, TG; Durkan, G; Rogers, E; Sullivan, FJ				Walsh, Deirdre M. J.; Groarke, Ann Marie; Morrison, Todd G.; Durkan, Garrett; Rogers, Eamonn; Sullivan, Francis J.			Measuring a new facet of post traumatic growth: Development of a scale of physical post traumatic growth in men with prostate cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC GROWTH; BREAST-CANCER; BODY-CONSCIOUSNESS; HOSPITAL ANXIETY; HEALTH; SURVIVORS; MINDFULNESS; EXPERIENCES; INVENTORY	Purpose This study developed a measure of physical post traumatic growth (physical post traumatic growth inventory; P-PTGI) in men with prostate cancer. Methods A pool of items was created from themes identified in a qualitative study. A quantitative study was then conducted to assess the psychometric properties of the P-PTGI in a sample of 693 prostate cancer survivors. Results Tests of dimensionality revealed that the 20-item P-PTGI contained two factors: Health Autonomy and Health Awareness. Results demonstrated that scale score reliability for the P-PTGI and its subscales was excellent. In support of the scale's convergent validity, scores on the P-PTGI correlated positively with mindfulness and quality of life, and correlated negatively with depression and anxiety. A statistically significant correlation between the P-PTGI and another robust indicator of post traumatic growth attests to its concurrent validity. Conclusions While further investigation of the P-PTGI's psychometric properties is required, preliminary findings are promising.	[Walsh, Deirdre M. J.; Groarke, Ann Marie] NUI Galway, Sch Psychol, Galway, Ireland; [Morrison, Todd G.] Univ Saskatchewan, Saskatoon, SK, Canada; [Durkan, Garrett; Rogers, Eamonn; Sullivan, Francis J.] Saolta Univ Healthcare Grp, Natl Canc Control Programme, Galway, Ireland; [Durkan, Garrett; Rogers, Eamonn; Sullivan, Francis J.] Galway Univ Hosp, Galway, Ireland; [Sullivan, Francis J.] NUI Galway, Prostate Canc Inst, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; University of Saskatchewan; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Walsh, DMJ (corresponding author), NUI Galway, Sch Psychol, Galway, Ireland.	Deirdre.m.walsh@nuigalway.ie		Sullivan, Francis J./0000-0001-5111-5383; Walsh, Deirdre/0000-0003-4255-299X; Morrison, Todd/0000-0001-8033-3822; Groarke, AnnMarie/0000-0003-3254-9279	College of Arts, Social Sciences and Celtic Studies at the National University of Ireland, Galway	College of Arts, Social Sciences and Celtic Studies at the National University of Ireland, Galway	This study was funded by a student PhD scholarship from the College of Arts, Social Sciences and Celtic Studies at the National University of Ireland, Galway to DMJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barskova T, 2009, DISABIL REHABIL, V31, P1709, DOI 10.1080/09638280902738441; Bellizzi KM, 2010, J HEALTH PSYCHOL, V15, P615, DOI 10.1177/1359105309356364; Bevan AL, 2014, PSYCHOL HEALTH, V29, P405, DOI 10.1080/08870446.2013.859258; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Byrne B., 2009, STRUCTURAL EQUATION, V2nd ed.; Christensen AJ, 1996, J CONSULT CLIN PSYCH, V64, P147, DOI 10.1037/0022-006X.64.1.147; Cohen LH, 1998, LEA SER PER CLIN PSY, P23; Connerty TJ, 2013, EUR J CANCER CARE, V22, P334, DOI 10.1111/ecc.12036; Crane-Okada R, 2012, CANC NURS, V35, P1; Davis L.L., 1992, APPL NURS RES, V5, P194, DOI [10.1016/S0897-1897(05)80008-4, DOI 10.1016/S0897-1897(05)80008-4]; Demark-Wahnefried W, 2000, CANCER-AM CANCER SOC, V88, P674, DOI 10.1002/(SICI)1097-0142(20000201)88:3&lt;674::AID-CNCR26&gt;3.0.CO;2-R; DEVELLIS RF, SCALE DEV THEORY APP; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Hefferon K., 2012, PSYCHOLOGY, V3, P1238, DOI [10.4236/psych.2012.312A183, DOI 10.4236/PSYCH.2012.312A183]; Hefferon K, 2013, QUAL RES SPORT EXERC, V5, P80, DOI 10.1080/2159676X.2012.712995; Hefferon K, 2010, J HUMANIST PSYCHOL, V50, P224, DOI 10.1177/0022167809341996; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Kampman H, 2015, CAN PSYCHOL, V56, P283, DOI 10.1037/cap0000031; King DB, 2014, CAN PSYCHOL, V55, P240, DOI 10.1037/a0038087; Kline R.B., 2011, PRINCIPLES PRACTICE; Kohls N, 2009, PERS INDIV DIFFER, V46, P224, DOI 10.1016/j.paid.2008.10.009; MILLER LC, 1981, J PERS SOC PSYCHOL, V41, P397, DOI 10.1037/0022-3514.41.2.397; Morse J. M., 2002, INT J QUAL METHODS, P13, DOI 10.1177/160940690200100202; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Park C. L., 2006, HDB POSTTRAUMATIC GR, P47; Park CL, 2010, PSYCHOL BULL, V136, P257, DOI 10.1037/a0018301; Pollard C, 2007, BRIT J HEALTH PSYCH, V12, P347, DOI 10.1348/135910707X197046; Ritvo P, 2005, J CLIN EPIDEMIOL, V58, P466, DOI 10.1016/j.jclinepi.2004.08.019; Rowan N, 2007, QUAL REP, V12, P450; Sabiston CM, 2007, J SPORT EXERCISE PSY, V29, P419, DOI 10.1123/jsep.29.4.419; Satia JA, 2009, CANCER NURS, V32, P107, DOI 10.1097/NCC.0b013e3181982d4c; Schmidt S, 2014, QUAL LIFE RES, V23, P2169, DOI 10.1007/s11136-014-0678-8; SKRINAR GS, 1986, PERCEPT MOTOR SKILL, V62, P483, DOI 10.2466/pms.1986.62.2.483; Stanton A. L., 2006, HDB POSTTRAUMATIC GR, P138; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tallman B, 2010, REHABIL PSYCHOL, V55, P204, DOI 10.1037/a0019541; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Thornton AA, 2006, PSYCHO-ONCOL, V15, P285, DOI 10.1002/pon.953; Urcuyo KR, 2005, PSYCHOL HEALTH, V20, P175, DOI 10.1080/08870440512331317634; Walach H, 2006, PERS INDIV DIFFER, V40, P1543, DOI 10.1016/j.paid.2005.11.025; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	6	6	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0195992	10.1371/journal.pone.0195992	http://dx.doi.org/10.1371/journal.pone.0195992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1YS	29702656	gold, Green Published, Green Submitted			2022-12-26	WOS:000431013300011
J	Namroodi, S; Shirazi, AS; Khaleghi, SR; Mills, JN; Kheirabady, V				Namroodi, Somayeh; Shirazi, Amir S.; Khaleghi, Seyyed Reza; Mills, James N.; Kheirabady, Vahid			Frequency of exposure of endangered Caspian seals to Canine distemper virus, Leptospira interrogans, and Toxoplasma gondii	PLOS ONE			English	Article							MORBILLIVIRUS ANTIBODY; MARINE MAMMALS; PHOCA-CASPICA; MORTALITY; INFECTION; ATLANTIC	Canine distemper virus (CDV), Leptospira interrogans, and Toxoplasma gondii are potentially lethal pathogens associated with decline in marine mammal populations. The Caspian Sea is home for the endangered Caspian seal (Pusa caspica). In the late 1990s and early 2000s, CDV caused a series of mortality events involving at least several thousand Caspian seals. To assess current infection status in Caspian seals, we surveyed for antibodies to three pathogens with potential to cause mortality in marine mammals. During 2015 +/- 2017, we tested serum samples from 36, apparently healthy, Caspian seals, accidentally caught in fishing nets in the Caspian Sea off Northern Iran, for antibodies to CDV, L. interrogans, and T. gondii, by virus neutralization, microscopic agglutination, and modified agglutination, respectively. Twelve (33%), 6 (17%), and 30 (83%) samples were positive for CDV, L. interrogans and T. gondii antibodies, respectively. The highest titers of CDV, L. interrogans, and T. gondii antibodies were 16, 400, and 50, respectively. Frequencies of antibody to these pathogens were higher in seals > 1 year old compared to seals < 1 year old. Two serovars of L. interrogans (Pomona and Canicola) were detected. Our results suggest a need for additional studies to clarify the impact of these pathogens on Caspian seal population decline and the improvement of management programs, including systematic screening to detect and protect the remaining population from disease outbreaks.	[Namroodi, Somayeh; Khaleghi, Seyyed Reza] Gorgan Univ Agr Sci & Nat Resources, Fac Vet Med, Dept Environm Sci, Gorgan, Golestan Provin, Iran; [Shirazi, Amir S.] Caspian Seal Treatment & Res Ctr, Gorgan, Golestan Provin, Iran; [Mills, James N.] Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA; [Kheirabady, Vahid] Dept Environm, Gorgan, Golestan Provin, Iran	Emory University	Namroodi, S (corresponding author), Gorgan Univ Agr Sci & Nat Resources, Fac Vet Med, Dept Environm Sci, Gorgan, Golestan Provin, Iran.	snamroodi2000@yahoo.com		namrudi, somaye/0000-0002-4292-4098	Gorgan University of Agricultural Sciences & Natural Resources [95-354-84]; Caspian Seal Treatment and Research Center	Gorgan University of Agricultural Sciences & Natural Resources; Caspian Seal Treatment and Research Center	This project was supported by Gorgan University of Agricultural Sciences & Natural Resources (Grant No. 95-354-84) to SN and Caspian Seal Treatment and Research Center which is under support of Lennie't Hart from the Netherlands to ASS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2003, J WILDLIFE DIS, V39, P145, DOI 10.7589/0090-3558-39.1.145; Aguirre A, 2003, 10 INT S VET EP EC; Alvarado-Esquivel C, 2012, VET PARASITOL, V184, P321, DOI 10.1016/j.vetpar.2011.08.036; Bolin C, 2000, EMERGING DISEASES OF ANIMALS, P185; Colagross-Schouten AM, 2002, J WILDLIFE DIS, V38, P7, DOI 10.7589/0090-3558-38.1.7; DIETZ R, 1989, NATURE, V338, P627, DOI 10.1038/338627a0; Dmitrieva L, 2016, MAR ECOL PROG SER, V554, P241, DOI 10.3354/meps11804; Dmitrieva L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067074; Dubey JP, 2003, VET PARASITOL, V116, P275, DOI 10.1016/S0304-4017(03)00263-2; Dubey JP, 1997, VET PARASITOL, V71, P307, DOI 10.1016/S0304-4017(97)00016-2; Duignan PJ, 1996, MAR MAMMAL SCI, V12, P499; Goodman S, 2016, IUCN RED LIST THREAT; Greene C.E., 2006, INFECT DIS DOG CAT; Gulland FMD, 1996, J WILDLIFE DIS, V32, P572, DOI 10.7589/0090-3558-32.4.572; Harkonen T, 2008, AMBIO, V37, P356, DOI 10.1579/07-R-345.1; Harkonen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043130; HEATH SE, 1994, J AM VET MED ASSOC, V205, P1518; Higgins R, 2000, CAN VET J, V41, P105; Issazadeh K., 2009, World Journal of Zoology, V4, P79; Kennedy S, 2000, EMERG INFECT DIS, V6, P637, DOI 10.3201/eid0606.000613; Kosarev AN, 2005, HANDB ENVIRON CHEM, V5, P5; Kreuder C, 2003, J WILDLIFE DIS, V39, P495, DOI 10.7589/0090-3558-39.3.495; Kuiken T, 2006, VET PATHOL, V43, P321, DOI 10.1354/vp.43-3-321; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Lynch Michael, 2007, P459, DOI 10.1002/9780470376478.ch40; Mackereth GF, 2005, NEW ZEAL VET J, V53, P428, DOI 10.1080/00480169.2005.36588; Miller MA, 2001, J PARASITOL, V87, P816, DOI 10.1645/0022-3395(2001)087[0816:IACOTP]2.0.CO;2; Nielsen O, 2000, J WILDLIFE DIS, V36, P508, DOI 10.7589/0090-3558-36.3.508; OSTERHAUS ADME, 1988, NATURE, V335, P20, DOI 10.1038/335020a0; OSTERHAUS ADME, 1989, NATURE, V338, P209, DOI 10.1038/338209b0; Rijks JM, 2005, EMERG INFECT DIS, V11, P1945, DOI 10.3201/eid1112.050596; Roe WD, 2013, VET PARASITOL, V192, P67, DOI 10.1016/j.vetpar.2012.11.001; Saliki JT, 2001, J CLIN MICROBIOL, V39, P1877, DOI 10.1128/JCM.39.5.1877-1881.2001; Sattari Tabrizi S, 2009, IRANIAN J VET MED, V3, P7; SMITH AW, 1977, J WILDLIFE DIS, V13, P144, DOI 10.7589/0090-3558-13.2.144; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Visser I. K. G., 1991, Reviews in Medical Microbiology, V2, P105; Wilson SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099265	38	9	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196070	10.1371/journal.pone.0196070	http://dx.doi.org/10.1371/journal.pone.0196070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698496	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600033
J	Rashidi, FB; AlQhatani, AD; Bashraheel, SS; Shaabani, S; Groves, MR; Domling, A; Goda, SK				Rashidi, Fatma B.; AlQhatani, Alanod D.; Bashraheel, Sara S.; Shaabani, Shabnam; Groves, Matthew R.; Domling, Alexander; Goda, Sayed K.			Isolation and molecular characterization of novel glucarpidases: Enzymes to improve the antibody directed enzyme pro-drug therapy for cancer treatment	PLOS ONE			English	Article							PRODRUG THERAPY; ESCHERICHIA-COLI; METHOTREXATE; PROTEIN; IMMUNOGENICITY; ASPARAGINASE; PURIFICATION; PHARMACOLOGY; EPITOPE; ADEPT	Repeated cycles of antibody-directed enzyme pro-drug therapy (ADEPT) and the use of glucarpidase in the detoxification of cytotoxic methotrexate (MTX) are highly desirable during cancer therapy but are hampered by the induced human antibody response to glucarpidase. Novel variants of glucarpidase (formal name: carboxypeptidase G2, CPG2) with epitopes not recognized by the immune system are likely to allow repeated cycles of ADEPT for effective cancer therapy. Towards this aim, over two thousand soil samples were collected and screened for folate hydrolyzing bacteria using folate as the sole carbon source. The work led to the isolation and the characterization of three new glucarpidase producing strains, which were designated as: Pseudomonas lubricans strain SF168, Stenotrophomonas sp SA and Xenophilus azovorans SN213. The CPG2 genes of Xenophilus azovorans SN213 (named Xen CPG2) and Stenotrophomonas sp SA (named Sten CPG2) were cloned and molecularly characterized. Both Xen CPG2 and Sten CPG2 share very close amino acid sequences (99%); we therefore, focused on the study of Xen CPG2. Finally, we demonstrated that a polyclonal antibody raised against our new CPG2, Xen CPG2, does not react with the CPG2 from Pseudomonas sp. strain RS-16 (Ps CPG2) that are currently in clinical use. The two enzymes, therefore could potentially be used consecutively in the ADEPT protocol to minimize the effect of the human antibody response that hampers current treatment with Ps CPG2. The identified novel CPG2 in this study will, therefore, pave the way for safer antibody directed enzyme pro-drug therapy for cancer treatment.	[Rashidi, Fatma B.; Goda, Sayed K.] Cairo Univ, Fac Sci, Giza, Egypt; [AlQhatani, Alanod D.; Bashraheel, Sara S.; Goda, Sayed K.] Antidoping Lab Qatar, Res Dept, Prot Engn Unit, Doha, Qatar; [AlQhatani, Alanod D.; Bashraheel, Sara S.; Shaabani, Shabnam; Groves, Matthew R.; Domling, Alexander] Univ Groningen, Dept Pharm, Drug Design Grp, Antonius Deusinglaan, Av Groningen, Netherlands	Egyptian Knowledge Bank (EKB); Cairo University; Anti Doping Laboratory (Qatar); University of Groningen	Goda, SK (corresponding author), Cairo Univ, Fac Sci, Giza, Egypt.; Goda, SK (corresponding author), Antidoping Lab Qatar, Res Dept, Prot Engn Unit, Doha, Qatar.	sgoda@adlqatar.qa	Goda, Sayed/Q-8251-2019; Dömling, Alexander S.S./E-6324-2019; Goda, Sayed K/AAU-9078-2020	Domling, Alexander/0000-0002-9923-8873; Groves, Matthew/0000-0001-9859-5177; Shaabani, Shabnam/0000-0001-5546-7140	Qatar national research fund (QNRF) [NPRP6-065-3-012]	Qatar national research fund (QNRF)(National Research Foundation of KoreaQatar National Research Fund (QNRF))	The presented work was funded by The Qatar national research fund (QNRF) research grant, grant number NPRP6-065-3-012 by SKG (lead PI) and AD (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGSHAWE KD, 1988, BRIT J CANCER, V58, P700, DOI 10.1038/bjc.1988.293; BAGSHAWE KD, 1995, MOL MED TODAY, V1, P424, DOI 10.1016/S1357-4310(95)90815-3; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BLEYER WA, 1978, CANCER-AM CANCER SOC, V41, P36, DOI 10.1002/1097-0142(197801)41:1<36::AID-CNCR2820410108>3.0.CO;2-I; Calvert Alan Hilary, 2004, Oncology (Williston Park), V18, P13; Cheng TL, 1999, BRIT J CANCER, V79, P1378, DOI 10.1038/sj.bjc.6690221; Chirino AJ, 2004, DRUG DISCOV TODAY, V9, P82, DOI 10.1016/S1359-6446(03)02953-2; Coelho V, 2007, INT J ONCOL, V31, P951; Dasgupta S, 2011, INDIAN J PHARMACOL, V43, P512, DOI 10.4103/0253-7613.84955; Denny WA, 2004, CANCER INVEST, V22, P604, DOI 10.1081/CNV-200027148; Goda SK, 2009, PROTEIN J, V28, P435, DOI 10.1007/s10930-009-9211-2; Gustavsson B, 2015, INVEST NEW DRUG, V33, P1078, DOI 10.1007/s10637-015-0272-0; Hu X.S., 2017, J MATER SCI-MATER EL, V1, P1; JOLIVET J, 1983, NEW ENGL J MED, V309, P1094, DOI 10.1056/NEJM198311033091805; Jung M., 2001, Mini-Reviews in Medicinal Chemistry, V1, P399, DOI 10.2174/1389557013406747; Kalghatgi KK BJ, 1981, ENZYMES DRUGS, pP77; Kisliuk RL, 2003, CURR PHARM DESIGN, V9, P2615, DOI 10.2174/1381612033453695; Lansiaux A, 2007, B CANCER, V94, pS134; Martin J, 1997, CANCER CHEMOTH PHARM, V40, P189, DOI 10.1007/s002800050646; Mayer A, 2004, BRIT J CANCER, V90, P2402, DOI 10.1038/sj.bjc.6601888; MCCULLOUGH JL, 1971, J BIOL CHEM, V246, P7207; McGuire JJ, 2003, BIOCHEM PHARMACOL, V65, P315, DOI 10.1016/S0006-2952(02)01602-7; Mehta RK, 2014, J BIOL CHEM, V289, P3555, DOI [10.1074/jbc.M113.486530, 10.4331/wjbc.v5.i3.355]; MINTON NP, 1983, J BACTERIOL, V156, P1222, DOI 10.1128/JB.156.3.1222-1227.1983; MOOLA ZB, 1994, BIOCHEM J, V302, P921, DOI 10.1042/bj3020921; PINEDO HM, 1976, CANCER RES, V36, P4418; Rekedal LR, 2010, ARTHRITIS RHEUM-US, V62, P3569, DOI 10.1002/art.27703; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sharma Surinder K, 2005, Curr Opin Investig Drugs, V6, P611; Sharma SK, 2017, EXPERT OPIN BIOL TH, V17, P1, DOI 10.1080/14712598.2017.1247802; SHERWOOD RF, 1985, EUR J BIOCHEM, V148, P447, DOI 10.1111/j.1432-1033.1985.tb08860.x; Syrigos KN, 1999, ANTICANCER RES, V19, P605; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THOMPSON R, 1994, J ANIM BREED GENET, V111, P102, DOI 10.1111/j.1439-0388.1994.tb00443.x; Turra KM, 2012, J MOL MODEL, V18, P1867, DOI 10.1007/s00894-011-1196-z; Zhang Q, 2007, CANCER IMMUNOL IMMUN, V56, P477, DOI 10.1007/s00262-006-0202-2	37	11	12	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196254	10.1371/journal.pone.0196254	http://dx.doi.org/10.1371/journal.pone.0196254			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698433	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600052
J	Yousef, A; Hibbert, B; Feder, J; Bernick, J; Russo, J; MacDonald, Z; Glover, C; Dick, A; Boodhwani, M; Lam, BK; Ruel, M; Labinaz, M; Burwash, IG				Yousef, Altayyeb; Hibbert, Benjamin; Feder, Joshua; Bernick, Jordan; Russo, Juan; MacDonald, Zachary; Glover, Christopher; Dick, Alexander; Boodhwani, Munir; Buu-Khanh Lam; Ruel, Marc; Labinaz, Marino; Burwash, Ian G.			A novel echocardiographic hemodynamic index for predicting outcome of aortic stenosis patients following transcatheter aortic valve replacement	PLOS ONE			English	Article							VALVULOARTERIAL IMPEDANCE; LOW-FLOW; EJECTION FRACTION; RISK STRATIFICATION; PROGNOSTIC IMPACT; STROKE VOLUME; GRADIENT; SEVERITY; AREA; IMPLANTATION	Objective Transcatheter aortic valve replacement (TAVR) reduces left ventricular (LV) afterload and improves prognosis in aortic stenosis (AS) patients. However, LV afterload consists of both valvular and arterial loads, and the benefits of TAVR may be attenuated if the arterial load dominates. We proposed a new hemodynamic index, the Relative Valve Load (RVL), a ratio of mean gradient (MG) and valvuloarterial impedance (Zva), to describe the relative contribution of the valvular load to the global LV load, and examined whether RVL predicted patient outcome following TAVR. Methods A total of 258 patients with symptomatic severe AS (indexed aortic valve area (AVA) <0.6cm(2)/m(2), AR <= 2+) underwent successful TAVR at the University of Ottawa Heart Institute and had clinical follow-up to 1-year post-TAVR. Pre-TAVR MG, AVA, percent stroke work loss (%SWL), Zva and RVL were measured by echocardiography. The primary endpoint was all cause mortality at 1-year post TAVR. Results There were 53 deaths (20.5%) at 1-year. RVL <= 7.95ml/m(2) had a sensitivity of 60.4% and specificity of 75.1% for identifying all cause mortality at 1-year post-TAVR and provided better specificity than MG<40 mmHg, AVA>0.75cm(2), % SWL <= 25% and Zva>5mmHg/ml/m(2) despite equivalent or better sensitivity. In multivariable Cox analysis, RVL <= 7.95ml/m(2) was an independent predictor of all cause mortality (HR 3.2, CI 1.8-5.9; p<0.0001). RVL <= 7.95ml/m(2) was predictive of all cause mortality in both low flow and normal flow severe AS. Conclusions RVL is a strong predictor of all-cause mortality in severe AS patients undergoing TAVR. A pre-procedural RVL <= 7.95ml/m(2) identifies AS patients at increased risk of death despite TAVR and may assist with decision making on the benefits of TAVR.	[Yousef, Altayyeb; Hibbert, Benjamin; Feder, Joshua; Bernick, Jordan; Russo, Juan; MacDonald, Zachary; Glover, Christopher; Dick, Alexander; Labinaz, Marino; Burwash, Ian G.] Univ Ottawa, Univ Ottawa Heart Inst, Div Cardiol, Ottawa, ON, Canada; [Boodhwani, Munir; Buu-Khanh Lam; Ruel, Marc] Univ Ottawa, Univ Ottawa Heart Inst, Div Cardiac Surg, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa Heart Institute	Burwash, IG (corresponding author), Univ Ottawa, Univ Ottawa Heart Inst, Div Cardiol, Ottawa, ON, Canada.	iburwash@ottawaheart.ca						Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Bermejo J, 2003, J AM COLL CARDIOL, V41, P142, DOI 10.1016/S0735-1097(02)02627-X; Blais C, 2006, CIRCULATION, V113, P711, DOI 10.1161/CIRCULATIONAHA.105.557678; Briand M, 2005, J AM COLL CARDIOL, V46, P291, DOI 10.1016/j.jacc.2004.10.081; Burwash IG, 2002, J AM SOC ECHOCARDIOG, V15, P814, DOI 10.1067/mje.2002.120287; BURWASH IG, 1993, AM J PHYSIOL, V265, pH1734, DOI 10.1152/ajpheart.1993.265.5.H1734; Clavel MA, 2017, JACC-CARDIOVASC IMAG, V10, P185, DOI 10.1016/j.jcmg.2017.01.002; Eleid MF, 2015, EUR HEART J-CARD IMG, V16, P1270, DOI 10.1093/ehjci/jev091; Eleid MF, 2015, AM J CARDIOL, V116, P989, DOI 10.1016/j.amjcard.2015.06.027; Eleid MF, 2015, HEART, V101, P23, DOI 10.1136/heartjnl-2014-306151; Eleid MF, 2013, CIRCULATION, V128, P1781, DOI 10.1161/CIRCULATIONAHA.113.003695; Giannini C, 2012, J AM SOC ECHOCARDIOG, V25, P444, DOI 10.1016/j.echo.2011.12.008; Hachicha Z, 2009, J AM COLL CARDIOL, V54, P1003, DOI 10.1016/j.jacc.2009.04.079; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Herrmann HC, 2013, CIRCULATION, V127, P2316, DOI 10.1161/CIRCULATIONAHA.112.001290; Kadem L, 2005, HEART, V91, P354, DOI 10.1136/hrt.2003.030601; Katsanos S, 2013, J AM SOC ECHOCARDIOG, V26, P691, DOI 10.1016/j.echo.2013.04.003; Lancellotti P, 2005, CIRCULATION, V112, pI377, DOI 10.1161/CIRCULATIONAHA.104.523274; Lancellotti P, 2012, J AM COLL CARDIOL, V59, P235, DOI 10.1016/j.jacc.2011.08.072; Lancellotti P, 2010, HEART, V96, P1364, DOI 10.1136/hrt.2009.190942; Le Ven F, 2015, HEART, V101, P1196, DOI 10.1136/heartjnl-2014-307067; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Levy F, 2011, EUR J ECHOCARDIOGR, V12, P358, DOI 10.1093/ejechocard/jer022; Little SH, 2007, HEART, V93, P848, DOI 10.1136/hrt.2006.098392; Muratori M, 2018, EUR HEART J-CARD IMG, V19, P389, DOI 10.1093/ehjci/jex046; Mylotte D, 2015, EUR HEART J, V36, P1306, DOI 10.1093/eurheartj/ehu388; OTTO CM, 1986, J AM COLL CARDIOL, V7, P509, DOI 10.1016/S0735-1097(86)80460-0; Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Yousef A, 2016, CAN J CARDIOL, V32, P266, DOI 10.1016/j.cjca.2015.04.033	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195641	10.1371/journal.pone.0195641	http://dx.doi.org/10.1371/journal.pone.0195641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698407	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600015
J	Chiu, YM; Lai, MS; Chan, KA				Chiu, Ying-Ming; Lai, Mei-Shu; Chan, K. Arnold			Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS PATIENTS; IMMUNOSUPPRESSIVE THERAPY; HBV REACTIVATION; OCCULT CARRIERS; C VIRUS; DISEASE; TAIWAN; SAFETY; AGENTS; RISK	Background and objective Potential hepatoxicity is an important clinical concern when administering immunosuppressive therapies to patients infected by hepatitis B virus (HBV). Tumor necrosis factor inhibitors (anti-TNF) increase the likelihood of hepatitis consequent to HBV reactivation, but reported risks and outcomes vary. We determined the risks of liver enzyme elevation in antirheumatic drug users from an HBV-endemic region with differing HBV serostatus. Methods We established retrospective cohorts with rheumatoid arthritis, ankylosing spondylitis, or psoriasis/psoriatic arthritis who: 1) received anti-TNF agents from 1 January 2004 to 30 June 2013; 2) received care from 1 June 2011 to 30 June 2013 but only ever used conventional disease-modifying anti-rheumatic drugs (DMARDs). Serology results defined three subgroups: HBV surface antigen positive (HBsAg+), HBsAg negative/HBV core antibody positive (HBsAg-/HBcAb+), or uninfected. We compared incidences of serum alanine aminotransferase (ALT) exceeding twice the upper reference limit between HBV serostatus subgroups in each treatment cohort. Results Among 783 patients treated with anti-TNF (n = 472) or DMARDs only (n = 311), HBsAg -/HBcAb+ anti-TNF users had incidence of ALT elevation commensurate with uninfected counterparts (6.1 vs. 6.0/100 person-years), compared to 19.6/100 person-years in HBsAg + patients (standardized rate ratio 3.3, 95% CI 1.3 +/- 8.2); none effected had severe or fatal hepatitis and ALT levels in all HBsAg-/HBcAb+ patients remained stable, mostly normalizing spontaneously, or after moderating treatment. Patterns of of ALT elevation associated with differing HBV serostatus in the DMARD cohort, resembled those in anti-TNF users. Conclusions In this large HBV-endemic cohort, the absolute incidence of ALT elevation in anti-TNF users was more than three-fold higher in HBsAg+ patients than in uninfected counterparts; however, no such association was evident in patients with HBsAg-/HBcAb+ serotype, whose risk and outcomes of liver enzyme elevation were similar to uninfected patients, suggesting that anti-TNF use by HBsAg-/HBcAb+ patients is probably safe.	[Chiu, Ying-Ming] Changhua Christian Hosp, Div Allergy Immunol & Rheumatol, Changhua, Taiwan; [Chiu, Ying-Ming] Hungkuang Univ, Coll Med & Nursing, Dept Nursing, Taichung, Taiwan; [Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Chan, K. Arnold] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Chan, K. Arnold] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan	Changhua Christian Hospital; Hungkuang University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chiu, YM (corresponding author), Changhua Christian Hosp, Div Allergy Immunol & Rheumatol, Changhua, Taiwan.; Chiu, YM (corresponding author), Hungkuang Univ, Coll Med & Nursing, Dept Nursing, Taichung, Taiwan.	129273@cch.org.tw		Chiu, Ying-Ming/0000-0003-4548-5331; Chan, Kinwei/0000-0001-8161-1986	Taiwan Tanabe Seiyaku Co., Ltd.	Taiwan Tanabe Seiyaku Co., Ltd.	The authors received no specific funding from any funding bodies in the public, commercial or not-for-profit sectors to carry out the research described in this manuscript. Medical writing was funded by Taiwan Tanabe Seiyaku Co., Ltd.; however, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 2011, NAT REV RHEUMATOL, V7, P139, DOI 10.1038/nrrheum.2010.214; Caporali R, 2010, ARTHRIT CARE RES, V62, P749, DOI 10.1002/acr.20130; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Chen MH, 2017, J INFECT DIS, V215, P566, DOI 10.1093/infdis/jiw606; Chen YH, 2012, FORMOS J RHEUMATOL, V26, P1; Cho YT, 2012, J DERMATOL, V39, P269, DOI 10.1111/j.1346-8138.2011.01434.x; Chung SJ, 2009, J RHEUMATOL, V36, P2416, DOI 10.3899/jrheum.081324; Curtis JR, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2008.101378; Fukuda W, 2017, ANN RHEUM DIS, V76, P1051, DOI 10.1136/annrheumdis-2016-209973; Giannitti C, 2011, J RHEUMATOL, V38, P781, DOI 10.3899/jrheum.101157; Greenland S, 2008, MODERN EPIDEMIOLOGY, P258; HSU HY, 1986, J MED VIROL, V18, P301, DOI 10.1002/jmv.1890180402; Kato M, 2011, J RHEUMATOL, V38, P2209, DOI 10.3899/jrheum.110289; Lan JL, 2011, ANN RHEUM DIS, V70, P1719, DOI 10.1136/ard.2010.148783; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Lee YH, 2013, CLIN EXP RHEUMATOL, V31, P118; Madonia S, 2007, INFLAMM BOWEL DIS, V13, P508, DOI 10.1002/ibd.20035; MARINOS G, 1995, GASTROENTEROLOGY, V108, P1453, DOI 10.1016/0016-5085(95)90694-0; Matsumoto T, 2010, LIVER INT, V30, P1241, DOI 10.1111/j.1478-3231.2010.02238.x; Mochida S, 2016, J GASTROENTEROL, V51, P999, DOI 10.1007/s00535-016-1168-2; Mok MY, 2000, CLIN EXP RHEUMATOL, V18, P363; Mori S, 2011, MOD RHEUMATOL, V21, P621, DOI 10.1007/s10165-011-0458-z; Nakamura J, 2016, INT J RHEUM DIS, V19, P470, DOI 10.1111/1756-185X.12359; Perez-Alvarez R, 2011, MEDICINE, V90, P359, DOI 10.1097/MD.0b013e3182380a76; Perrillo RP, 2015, GASTROENTEROLOGY, V148, P221, DOI 10.1053/j.gastro.2014.10.038; Perrillo RP, 2001, GASTROENTEROLOGY, V120, P1009, DOI 10.1053/gast.2001.22461; Ryu HH, 2012, CLIN RHEUMATOL, V31, P931, DOI 10.1007/s10067-012-1960-1; Sokolove J, 2010, ANN RHEUM DIS, V69, P1612, DOI 10.1136/ard.2009.112136; SUNG JL, 1984, CHINESE J GASTROENTE, V1, P1; Tan J, 2012, CLIN RHEUMATOL, V31, P1169, DOI 10.1007/s10067-012-1988-2; Tsai FC, 2006, DIGEST DIS SCI, V51, P1627, DOI 10.1007/s10620-006-9074-8; Urata Y, 2011, MOD RHEUMATOL, V21, P16, DOI 10.1007/s10165-010-0337-z; Vento S, 2002, LANCET ONCOL, V3, P333, DOI 10.1016/S1470-2045(02)00773-8; Vigano M, 2012, EXPERT OPIN BIOL TH, V12, P193, DOI 10.1517/14712598.2012.646986; WONG GHW, 1986, NATURE, V323, P819, DOI 10.1038/323819a0	35	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196210	10.1371/journal.pone.0196210	http://dx.doi.org/10.1371/journal.pone.0196210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694398	Green Published, Green Submitted, gold			2022-12-26	WOS:000430802400075
J	Masenga, GG; Shayo, BC; Reach, V				Masenga, Gileard G.; Shayo, Benjamin C.; Reach, Vibeke			Prevalence and risk factors for pelvic organ prolapse in Kilimanjaro, Tanzania: A population based study in Tanzanian rural community	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; GENITAL PROLAPSE; FLOOR DISORDERS; WOMEN; EPIDEMIOLOGY; SUPPORT; NEPAL	Introduction The prevalence and risk-factors of pelvic organ prolapse (POP) in Tanzania are unknown. To help elucidate the problem, we assessed POP and associated risk-factors among Tanzanian women by deploying the POP-Q classification system. Method A cross sectional community based study conducted in Hai, Rombo and Same Districts, Kilimanjaro Region, Tanzania. Women aged 18-90 were recruited through multi-stage random sampling from January to May 2015. Home-based questionnaire interviews were performed and the women were subsequently invited to the nearest health clinic for pelvic examination. Trained physicians used the POP-Q classification system to assess the POP stage. Results A total of 1195 women were interviewed and invited for pelvic examination; 1063(89%) women presented at the clinic of whom 1047(88%) accepted a clinical examination. Of 1047 examined women, 64.6% had an anatomical POP stage II-IV and 6.7% had a severe POP that descended 1 cm or more below the hymen. POP stage II-IV was associated with being aged 35+years, being a farmer, doing petty trading and having delivered 3 times or more. Severe POP was associated with carrying heavy objects for >= 5 hours (OR 4.70; 1.67-13.2), having delivered 5 times or more (OR 10.2; 2.22-48.6) and having delivered at home (OR 2.40; 1.36-4.22). Conclusion POP is a common condition among rural Tanzanian women where 64.6% are having POP grade II-IV and 6.7% are having a severe POP descending 1 cm or more below the hymen. Risk-factors are increasing age, heavy lifting, high parity and home-delivery.	[Masenga, Gileard G.] Kilimanjaro Christian Med Univ Coll, Moshi, Kilimanjaro, Tanzania; [Masenga, Gileard G.; Shayo, Benjamin C.] Kilimanjaro Christian Med Ctr, Dept Obstet & Gynecol, Moshi, Kilimanjaro, Tanzania; [Reach, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Reach, Vibeke] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	Kilimanjaro Christian Medical Centre; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Masenga, GG (corresponding author), Kilimanjaro Christian Med Univ Coll, Moshi, Kilimanjaro, Tanzania.; Masenga, GG (corresponding author), Kilimanjaro Christian Med Ctr, Dept Obstet & Gynecol, Moshi, Kilimanjaro, Tanzania.	drgmasenga@yahoo.com	Rasch, Vibeke/G-9393-2019	Rasch, Vibeke/0000-0001-6557-0985; Shayo, Benjamin C/0000-0001-8544-437X	Building Stronger University (BSU) - DANIDA (the Danish International Development Agency)	Building Stronger University (BSU) - DANIDA (the Danish International Development Agency)	This research was conducted under the auspices of the Building Stronger University (BSU), which is funded by DANIDA (the Danish International Development Agency). The funders had no role in study design, data collection and analysis, manuscript preparation or decision to publish.	Abrams P, 2002, AM J OBSTET GYNECOL, V187, P126, DOI 10.1067/mob.2002.125704; [Anonymous], TITLE ERROR; Ballard K, 2016, INT UROGYNECOL J, V27, P1063, DOI 10.1007/s00192-015-2933-0; Barber MD, 2005, AM J OBSTET GYNECOL, V193, P103, DOI 10.1016/j.ajog.2004.12.025; Bodner-Adler B, 2007, INT UROGYNECOL J, V18, P1343, DOI 10.1007/s00192-007-0331-y; Bonetti TR, 2004, REPROD HEALTH MATTER, V12, P166, DOI 10.1016/S0968-8080(04)23110-X; Giri A, 2017, AM J OBSTET GYNECOL, V217, P11, DOI 10.1016/j.ajog.2017.01.039; Gumanga S K, 2014, Ghana Med J, V48, P208, DOI 10.4314/gmj.v48i4.7; Gunasekera P, 2007, LANCET, V369, P1789, DOI 10.1016/S0140-6736(07)60814-9; Harmanli O, 2014, INT UROGYNECOL J, V25, P447, DOI 10.1007/s00192-013-2252-2; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Machin Sarah Elizabeth, 2011, Menopause Int, V17, P132, DOI 10.1258/mi.2011.011108; Maher C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub5; Mant J, 1997, BRIT J OBSTET GYNAEC, V104, P579, DOI 10.1111/j.1471-0528.1997.tb11536.x; Megabiaw B, 2013, INT UROGYNECOL J, V24, P1135, DOI 10.1007/s00192-012-1981-y; National Bureau of Statistics, 2016, KEY FIND 2015 16 TAN; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Persu C, 2011, J Med Life, V4, P75; Rortveit G, 2007, OBSTET GYNECOL, V109, P1396, DOI 10.1097/01.AOG.0000263469.68106.90; Scherf C, 2002, BJOG-INT J OBSTET GY, V109, P431, DOI 10.1111/j.1471-0528.2002.01109.x; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Swift SE, 2003, AM J OBSTET GYNECOL, V189, P372, DOI 10.1067/S0002-9378(03)00698-7; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walker GJA, 2011, INT UROGYNECOL J, V22, P127, DOI 10.1007/s00192-010-1215-0; Wusu-Ansah OK, 2008, INT J GYNECOL OBSTET, V103, P121, DOI 10.1016/j.ijgo.2008.06.014	25	37	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195910	10.1371/journal.pone.0195910	http://dx.doi.org/10.1371/journal.pone.0195910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694427	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400050
J	Yamamoto, T; Kaku, M; Sumi, H; Yashima, Y; Izumino, J; Tanimoto, K				Yamamoto, Taeko; Kaku, Masato; Sumi, Hiromi; Yashima, Yuka; Izumino, Jin; Tanimoto, Kotaro			Effects of loxoprofen on the apical root resorption during orthodontic tooth movement in rats	PLOS ONE			English	Article							PULP TISSUES; INHIBITION; LIGAND; CELLS; OSTEOCLASTS; PERMANENT; INCISORS; DRUGS; TEETH	Studies have revealed that severe apical root resorption during tooth movement is caused by the noninfective inflammatory reaction of apical root tissues. We hypothesized that loxoprofen can suppress apical root resorption during tooth movement. Cyclic tensile force (CTF) of 10 kPa was applied to the human pulp cells for 48 hours by the Flexcell Strain Unit. Loxoprofen (10 and 100 mu M) was added to the culture cells, and expression of cyclooxygenase (COX)-1, COX-2, interleukin (IL)-1 beta, receptor activator of nuclear factor kappa-B ligand (RANKL), tumor necrosis factor (TNF)-alpha, and macrophage colony-stimulating factor (MCSF) were examined. To determine the effects of loxoprofen sodium on apical root reabsorption during tooth movement, the upper first molars of 7-week-old rats were subjected to mesial movement by 10g force for 30 days with or without the oral administration of loxoprofen. Gene expression and protein concentration of COX-1, COX-2, IL-1 beta, TNF-alpha, RANKL and M-CSF were significantly higher in the CTF group than in the control group. However, these levels were decreased by loxoprofen administration. After orthodontic tooth movement, the expression of IL-1 beta, TNF-alpha, RANKL and M-CSF decreased in the loxoprofen group than in the control group by immunohistochemical staining. In comparison to control group, less number of odontoclasts and a decrease in the amount of apical root resorption was observed in the loxoprofen group. Many osteoclasts became visible on the pressure side of the alveolar bone in the both groups, and the amount of tooth movement did not show a significant difference. These findings demonstrate that severe apical root resorption may be suppressed by loxoprofen administration, without a disturbance of tooth movement.	[Yamamoto, Taeko; Kaku, Masato; Sumi, Hiromi; Yashima, Yuka; Izumino, Jin; Tanimoto, Kotaro] Hiroshima Univ, Dept Orthodont & Craniofacial Dev Biol, Grad Sch Biomed Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan	Hiroshima University	Kaku, M (corresponding author), Hiroshima Univ, Dept Orthodont & Craniofacial Dev Biol, Grad Sch Biomed Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan.	mkaku@hiroshima-u.ac.jp	Kaku, Masato/AAY-1945-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan [903534]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by a Grant-in-Aid (No. 903534) for Basic Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to TY.	Abedini S, 2011, CRYOBIOLOGY, V62, P181, DOI 10.1016/j.cryobiol.2011.03.001; Alexander SA, 1996, AM J ORTHOD DENTOFAC, V110, P321, DOI 10.1016/S0889-5406(96)80017-5; Baek KH, 2010, CALCIFIED TISSUE INT, V87, P226, DOI 10.1007/s00223-010-9393-9; Bender IB, 1997, J ENDODONT, V23, P768, DOI 10.1016/S0099-2399(97)80353-6; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chan E, 2005, AM J ORTHOD DENTOFAC, V127, P186, DOI 10.1016/j.ajodo.2003.11.026; de Boer TN, 2009, OSTEOARTHR CARTILAGE, V17, P482, DOI 10.1016/j.joca.2008.09.002; GOLDIE RS, 1984, AM J ORTHOD DENTOFAC, V85, P424, DOI 10.1016/0002-9416(84)90163-5; Gonzales C, 2008, ANGLE ORTHOD, V78, P502, DOI 10.2319/052007-240.1; Graber TM, 1967, ORTHODONTICS PRINCIP; HARRIS EF, 1992, AM J ORTHOD DENTOFAC, V101, P112, DOI 10.1016/0889-5406(92)70002-R; Heider U, 2004, J CANCER RES CLIN, V130, P469, DOI 10.1007/s00432-004-0578-3; Jerome John, 2005, J Calif Dent Assoc, V33, P951; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Kaku M, 2014, J ENDODONT, V40, P372, DOI 10.1016/j.joen.2013.11.027; KALEY J, 1991, ANGLE ORTHOD, V61, P125; KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269; Kohno T, 2002, J Orthod, V29, P129, DOI 10.1093/ortho/29.2.129; Kurihara S., 2004, BIOL MECH TOOTH MOVE, P113; Levander E, 1998, EUR J ORTHODONT, V20, P427, DOI 10.1093/ejo/20.4.427; Li Xiaohua, 2009, Am J Biomed Sci, V1, P352; LINGE BO, 1983, EUR J ORTHODONT, V5, P173, DOI 10.1093/ejo/5.3.173; MCDONALD F, 1994, EUR J ORTHODONT, V16, P1; MIDGETT RJ, 1981, AM J ORTHOD DENTOFAC, V80, P256, DOI 10.1016/0002-9416(81)90289-X; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Miura F, 1973, T 3 INT ORTH C LOND, P35; Reitan K, 1970, SSO Schweiz Monatsschr Zahnheilkd, V80, P579; REMINGTON DN, 1989, AM J ORTHOD DENTOFAC, V96, P43, DOI 10.1016/0889-5406(89)90227-8; SPURRIER SW, 1990, AM J ORTHOD DENTOFAC, V97, P130, DOI 10.1016/0889-5406(90)70086-R; SUGIMOTO M, 1991, BIOCHEM PHARMACOL, V42, P2363, DOI 10.1016/0006-2952(91)90242-W; Sumi H, 2017, BIOMED RES-INDIA, V28, P2617; Taner T, 1999, EUR J ORTHODONT, V21, P491, DOI 10.1093/ejo/21.5.491; Tomoyasu Y, 2009, ORTHOD WAVES, V68, P152, DOI 10.1016/j.odw.2009.05.002; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	35	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0194453	10.1371/journal.pone.0194453	http://dx.doi.org/10.1371/journal.pone.0194453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694352	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400012
J	Chang, X; DeFries, RS; Liu, LM; Davis, K				Chang, Xiao; DeFries, Ruth S.; Liu, Liming; Davis, Kyle			Understanding dietary and staple food transitions in China from multiple scales	PLOS ONE			English	Article							NUTRITION TRANSITION; PRODUCTION DIVERSITY; INCOME; SECURITY; QUALITY; AGRICULTURE; ASSOCIATION; URBANICITY; DYNAMICS; VARIETY	China is facing both non-communicable diseases (NCDs) and micronutrient deficiency, which have been largely related to transitions within Chinese diets, for example, the over-consumption of vegetable oils and animal-source products and decreasing consumption of coarse staple foods. In this study, we use three metrics-dietary diversity score (DDS), staple diversity score (SDS) and the proportion of coarse staple consumption (PoCS)-to investigate overall dietary transitions as well as trends in staple food consumption for nine provinces in China from 1997 to 2009. We also investigated how household characteristics, community urbanicity, and provincial conditions have affected household diets and the relationship between overall diet and staple diet across socio-economic gradients. Overall dietary diversity (DDS) showed consistent growth across all the provinces and subpopulations and was strongly associated with a household's socio-economic status. However, staple indicators (SDS and PoCS) showed notable difference both geographically and socio-economically. The relationship between overall dietary indicator (DDS) and staple indicators (SDS, PoCS) across SES gradients revealed that education is a more important influence than income in ensuring dietary balance and nutritional quality. Our findings show that programs aimed at promoting dietary balance and healthy staple diets must account for differences between provinces in terms of agronomic, nutritional, social, and economic conditions. By identifying the socio-economic characteristics and locations of the most nutritionally vulnerable populations, this study also points toward the need for policies that incorporate nutritional considerations into grain production systems and provide a strategy for enhancing China's national food security.	[Chang, Xiao; Liu, Liming] China Agr Univ, Dept Land Resources Management, Beijing, Peoples R China; [DeFries, Ruth S.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Davis, Kyle] Columbia Univ, Earth Inst, New York, NY USA; [Davis, Kyle] Nature Conservancy, New York, NY USA	China Agricultural University; Columbia University; Columbia University; Nature Conservancy	Liu, LM (corresponding author), China Agr Univ, Dept Land Resources Management, Beijing, Peoples R China.	liulm@cau.edu.en		Davis, Kyle/0000-0003-4504-1407; Liu, Liming/0000-0002-8021-533X	National Natural Science Foundation of China [41130526]; Chinese Scholarship Council; Nature Conservancy's NatureNet Science Fellows program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council); Nature Conservancy's NatureNet Science Fellows program	LL received funding from the National Natural Science Foundation of China (grant number 41130526) (http://www.nsfc.gov.cn/publish/portal1/) for this research. XC received financial support from the Chinese Scholarship Council (http://en.csc.edu.cn/) to do the research as a visiting Ph.D. student at Columbia University. Kyle Davis was supported by The Nature Conservancy's NatureNet Science Fellows program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkerwi A, 2015, NUTRIENTS, V7, P2823, DOI 10.3390/nu7042823; Anderman TL, 2014, FOOD SECUR, V6, P541, DOI 10.1007/s12571-014-0360-6; [Anonymous], 2006, MODERN EC RES, P87; [Anonymous], 2013, THESIS; [Anonymous], 1999, RUR RES GET OUT POV; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; DeFries R, 2015, SCIENCE, V349, P238, DOI 10.1126/science.aaa5766; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Du SF, 2014, OBES REV, V15, P8, DOI 10.1111/obr.12122; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Fransen HP, 2008, CURR OPIN CLIN NUTR, V11, P559, DOI 10.1097/MCO.0b013e32830a49db; Furst T, 1996, APPETITE, V26, P247, DOI 10.1006/appe.1996.0019; Gardner H., 2016, FORGET RICE NOODLES; Gronau R, 2001, DEMAND VARIETY HOUSE; Groth MV, 2001, EUR J CLIN NUTR, V55, P959, DOI 10.1038/sj.ejcn.1601251; HAINES PS, 1988, AM J AGR ECON, V70, P543, DOI 10.2307/1241492; Hawkesworth S, 2010, PHILOS T R SOC B, V365, P3083, DOI 10.1098/rstb.2010.0122; Jones AD, 2014, FOOD POLICY, V46, P1, DOI 10.1016/j.foodpol.2014.02.001; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Kennedy ET, 1987, INCOME NUTR EFFECTS; Kennedy G., 2011, GUID MEAS HOUS IND D; Kennedy GL, 2009, EVALUATION DIETARY D, DOI [10.1007/s12571-014-0360-6, DOI 10.1007/S12571-014-0360-6]; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Kutner M. H., 2004, APPL LINEAR REGRESSI; Li Yuqin Z H., 2013, J AGROTECHNICAL, P100; Liu J, 2014, FOOD POLICY, V49, P323, DOI 10.1016/j.foodpol.2014.09.007; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Murphy SP, 2006, J AM DIET ASSOC, V106, P425, DOI 10.1016/j.jada.2005.12.003; Negin J, 2009, FOOD SECUR, V1, P351, DOI 10.1007/s12571-009-0025-z; Paquette MC, 2005, CAN J PUBLIC HEALTH, V96, pS15, DOI 10.1007/BF03405196; Pellegrini L, 2014, CAN J DEV STUD, V35, P211, DOI 10.1080/02255189.2014.898580; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Popkin BM, 2014, OBES REV, V15, P60, DOI 10.1111/obr.12120; Popkin B. M., 2003, Development Policy Review, V21, P581, DOI 10.1111/j.1467-8659.2003.00225.x; Popkin BM, 2009, NESTLE NUTR WORKS SE, V63, P1, DOI 10.1159/000209967; Popkin BM, 2006, FOOD POLICY, V31, P554, DOI 10.1016/j.foodpol.2006.02.008; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; Popkin BM, 2002, PUBLIC HEALTH NUTR, V5, P205, DOI 10.1079/PHN2001295; POPKIN BM, 1993, EUR J CLIN NUTR, V47, P333; Remans R, 2014, GLOB FOOD SECUR-AGR, V3, P174, DOI 10.1016/j.gfs.2014.07.001; Ruel MT, 2003, J NUTR, V133, p3911S, DOI 10.1093/jn/133.11.3911S; SHACK KW, 1990, SOC SCI MED, V31, P61, DOI 10.1016/0277-9536(90)90010-P; Shannon J, 2007, PUBLIC HEALTH NUTR, V10, P810, DOI 10.1017/S1368980007258604; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Swindale A., 2006, FHI 360FANTA; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; Wang H, 2016, ASIA PACIFIC J CLIN; Wang HC, 2013, BIOMED ENG-APP BAS C, V25, DOI 10.4015/S1016237213500592; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wu BB C Y, 2012, J AGR MANAGEMENT I M, P11; Zhai FY, 2014, OBES REV, V15, P16, DOI 10.1111/obr.12124; Zhang Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172406; Zhang Y., 2016, CONSUMPTION ATTITUDE; Zuur Alain F., 2009, P1	55	33	36	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0195775	10.1371/journal.pone.0195775	http://dx.doi.org/10.1371/journal.pone.0195775			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7GN	29689066	Green Published, Green Submitted, gold			2022-12-26	WOS:000430678800013
J	Doran, RC; Tatsuno, GP; O'Rourke, SM; Yu, B; Alexander, DL; Mesa, KA; Berman, PW				Doran, Rachel C.; Tatsuno, Gwen P.; O'Rourke, Sara M.; Yu, Bin; Alexander, David L.; Mesa, Kathryn A.; Berman, Phillip W.			Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1 ENVELOPE TRIMER; POTENT NEUTRALIZATION; GLYCOPROTEIN GP120; CLEAVAGE SITES; HUMANIZED MICE; EFFICACY TRIAL; UNITED-STATES; SIALIC-ACID; DESIGN	To date, the RV144 HIV vaccine trial has been the only study to show that immunization can confer protection from HIV infection. While encouraging, the modest 31.2% (P=0.04) efficacy achieved in this study left significant room for improvement, and created an incentive to optimize the AIDSVAX B/E vaccine immunogens to increase the level of vaccine efficacy. Since the completion of the RV144 trial, our understanding of the antigenic structure of the HIV envelope protein, gp120, and of the specificity of broadly neutralizing monoclonal antibodies (bN-mAbs) that bind to it, has significantly improved. In particular, we have learned that multiple families of bN-mAbs require specific oligomannose glycans for binding. Both of the monomeric gp120 immunogens (MN-and A244-rgp120) in the AIDSVAX B/E vaccine used in the RV144 trial were enriched for glycans containing high levels of sialic acid, and lacked critical N-linked glycosylation sites required for binding by several families of bNmAbs. The absence of these epitopes may have contributed to the low level of efficacy achieved in this study. In this report, we describe our efforts to improve the antigenic structure of the rgp120 immunogens used in the vaccine by optimizing glycan-dependent epitopes recognized by multiple bN-mAbs. Our results demonstrated that by shifting the location of one PNGS in A244-rgp120, and by adding two PNGS to MN-rgp120, in conjunction with the production of both proteins in a cell line that favors the incorporation of oligomannose glycans, we could significantly improve the binding by three major families of bNmAbs. The immunogens described here represent a second generation of gp120-based vaccine immunogens that exhibit potential for use in RV144 follow-up studies.	[Doran, Rachel C.; Tatsuno, Gwen P.; O'Rourke, Sara M.; Yu, Bin; Alexander, David L.; Mesa, Kathryn A.; Berman, Phillip W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Doran, Rachel C.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Berman, Phillip W.] Gladstone Inst Virol & Immunol, San Francisco, CA USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; The J David Gladstone Institutes	Doran, RC (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.; Doran, RC (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	racdoran@soe.ucsc.edu			National Institutes of Health [R01AI113893]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institutes of Health (R01AI113893 - awarded to Phillip W. Berman). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee K, 2012, AIDS RES HUM RETROV, V28, P206, DOI 10.1089/aid.2011.0101; Barouch DH, 2014, NAT REV MICROBIOL, V12, P765, DOI 10.1038/nrmicro3360; Berman PW, 1999, VIROLOGY, V265, P1, DOI 10.1006/viro.1999.0031; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; CLEMENTS GJ, 1991, AIDS RES HUM RETROV, V7, P3, DOI 10.1089/aid.1991.7.3; CONLEY AJ, 1994, P NATL ACAD SCI USA, V91, P3348, DOI 10.1073/pnas.91.8.3348; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; de Bruyn G, 2004, VACCINE, V22, P704, DOI 10.1016/j.vaccine.2003.08.023; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; de Vries RP, 2012, J VIROL, V86, P11735, DOI 10.1128/JVI.01084-12; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Gorman J, 2016, NAT STRUCT MOL BIOL, V23, P81, DOI 10.1038/nsmb.3144; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; GURGO C, 1988, VIROLOGY, V164, P531, DOI 10.1016/0042-6822(88)90568-5; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Julg B, 2017, PROTECTION MIXED SHI, DOI [10.1126/scitranslmed.aao4235, DOI 10.1126/SCITRANSLMED.AAO4235]; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kong L, 2010, J MOL BIOL, V403, P131, DOI 10.1016/j.jmb.2010.08.033; Krumm SA, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0241-5; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; MCCUTCHAN FE, 1992, AIDS RES HUM RETROV, V8, P1887, DOI 10.1089/aid.1992.8.1887; Medlock J, 2017, P NATL ACAD SCI USA, V114, P4017, DOI 10.1073/pnas.1620788114; Morales JF, 2014, J BIOL CHEM, V289, P20526, DOI 10.1074/jbc.M114.554089; MORELL AG, 1971, J BIOL CHEM, V246, P1461; MORELL AG, 1968, J BIOL CHEM, V243, P155; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Nitschke L, 2009, IMMUNOL REV, V230, P128, DOI 10.1111/j.1600-065X.2009.00801.x; Pancera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055701; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rothenberg, 2001, CORNING INCORPORATED, V1; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Stephenson KE, 2016, CURR OPIN IMMUNOL, V41, P39, DOI 10.1016/j.coi.2016.05.011; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903; Yu B, 2010, J VIROL, V84, P1513, DOI 10.1128/JVI.01765-09; Zhou TQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099881; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	67	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196370	10.1371/journal.pone.0196370	http://dx.doi.org/10.1371/journal.pone.0196370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689099	Green Published, Green Submitted, gold			2022-12-26	WOS:000430678800049
J	Wang, YL; Li, HH; Zheng, M; Wu, YB; Zeng, T; Fu, JJ; Zeng, DY				Wang, Yuanliu; Li, Honghui; Zheng, Min; Wu, Yubi; Zeng, Ting; Fu, Jinjian; Zeng, Dingyuan			Maternal vitamin D deficiency increases the risk of adverse neonatal outcomes in the Chinese population: A prospective cohort study	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; 25-HYDROXYVITAMIN D; D SUPPLEMENTATION; PREGNANCY OUTCOMES; FETAL-GROWTH; DOUBLE-BLIND; BIRTH; WOMEN; METAANALYSIS; PREVALENCE	Background Although vitamin D (vitD) deficiency is a common problem in pregnant women, in China, few studies have focused on the relationship between maternal vitD deficiency throughout the three trimesters and subsequent neonatal outcomes in China. Methods Between 2015 and 2016, maternal serum and neonate cord blood samples were collected from 1978 mother-neonate pairs from Liuzhou city. Results The mean concentrations of 25-hydroxy vitD (25(OH) D) were 16.17 +/- 6.27 and 15.23 +/- 5.43 ng/ml in the mother and neonate groups, respectively, and the prevalence values of vitD deficiency in the two groups were 78.18% and 83.27%, respectively. Logistic regression showed that maternal vitD deficiency independently increased the risk of gestational diabetes mellitus (GDM) (adjust OR, aOR 1.08; P = 0.026). A relatively lower risk of vitD deficiency was observed in the third trimester than in the first and second trimester (aOR 0.80; P = 0.004). VitD-calcium cosupplementation during pregnancy improves the vitD deficiency in both the maternal and neonatal groups (aOR 0.56, 0.66; P<0.001 and 0.021, respectively). Maternal vitD deficiency significantly increased the risk of neonatal low birth weight (LBW) (aOR 2.83; P = 0.005) and small-for-gestational-age (SGA) (aOR 1.17; P = 0.015). There was a positive correlation between maternal and neonatal vitD deficiency (r = 0.879, P<0.001). VitD supplementation during pregnancy significantly reduced the risk of giving birth to LBW infants (OR = 0.47, 95% CI = 0.33-0.68, P<0.001). Conclusions Further research focusing on the consumption of vitD with calcium during pregnancy and the consequential clinical outcomes in Chinese pregnant women is warranted.	[Wang, Yuanliu; Wu, Yubi; Zeng, Dingyuan] Liuzhou Matern & Child Hlth Care Hosp, Dept Obstet & Gynecol, Liuzhou, Guangxi, Peoples R China; [Li, Honghui; Zeng, Ting] Liuzhou Maternal & Child Hlth Care Hosp, Liuzhou Key Lab Children Dev Disorders, Liuzhou, Guangxi, Peoples R China; [Zheng, Min] Liuzhou Matern & Child Hlth Care Hosp, Dept Pediat, Liuzhou, Guangxi, Peoples R China; [Fu, Jinjian] Liuzhou Matern & Child Hlth Care Hosp, Dept Lab Med, Liuzhou, Guangxi, Peoples R China		Zeng, DY (corresponding author), Liuzhou Matern & Child Hlth Care Hosp, Dept Obstet & Gynecol, Liuzhou, Guangxi, Peoples R China.	zdylzsfy@126.com		Zeng, Dingyuan/0000-0002-4271-5632	Guangxi Natural Science Foundation [2017GXNSFAA198312, 2017AB49005]; Guangxi Medical and Health Self-funding Project [Z2013609, Z2012520, Z20170473, Z20170516]; Liuzhou Science and Technology Bureau Project [2014J030421, 2017BD20201]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Medical and Health Self-funding Project; Liuzhou Science and Technology Bureau Project	This study was funded by the Guangxi Natural Science Foundation (2017GXNSFAA198312 and 2017AB49005); Guangxi Medical and Health Self-funding Project (No Z2013609, Z2012520, Z20170473, Z20170516) and the Liuzhou Science and Technology Bureau Project (No 2014J030421, No 2017BD20201). The funding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Al Nozha OM, 2016, INT J HEALTH SCI-IJH, V10, P443; Al-Shaikh GK, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0901-4; Andersen LB, 2015, AM J CLIN NUTR, V102, P633, DOI 10.3945/ajcn.114.103655; Baca KM, 2016, ANN EPIDEMIOL, V26, P853, DOI 10.1016/j.annepidem.2016.09.015; Barebring L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152198; Bellavia Daniele, 2016, Curr Osteoporos Rep; Chen YH, 2015, J CLIN ENDOCR METAB, V100, P1912, DOI 10.1210/jc.2014-4407; Cortes M, 2016, CELL REP, V17, P458, DOI 10.1016/j.celrep.2016.09.012; Cox SM, 2001, INT J GYNECOL OBSTET, V72, P85; Gernand AD, 2014, OBSTET GYNECOL, V123, P40, DOI 10.1097/AOG.0000000000000049; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P176, DOI 10.1016/j.diabres.2013.11.003; Hanieh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099005; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Karamali M, 2016, PUBLIC HEALTH NUTR, V19, P156, DOI 10.1017/S1368980015000609; Khalessi Nasrin, 2015, J Family Reprod Health, V9, P113; Kiely ME, 2016, AM J CLIN NUTR, V104, P354, DOI 10.3945/ajcn.116.130419; Lansing AH, 2015, SOUTH MED J, V108, P164, DOI 10.14423/SMJ.0000000000000254; Li XH, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0378-4; Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292; Miliku K, 2016, AM J CLIN NUTR, V103, P1514, DOI 10.3945/ajcn.115.123752; Obi Y, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/868961; Palacios C, 2016, J STEROID BIOCHEM, V164, P148, DOI 10.1016/j.jsbmb.2016.02.008; Park H, 2017, BONE, V95, P183, DOI 10.1016/j.bone.2016.12.002; Parlea L, 2012, DIABETIC MED, V29, pE25, DOI 10.1111/j.1464-5491.2011.03550.x; Pereira-Santos M, 2015, OBES REV, V16, P341, DOI 10.1111/obr.12239; Perez-Lopez FR, 2015, FERTIL STERIL, V103, P1278, DOI 10.1016/j.fertnstert.2015.02.019; Qin LL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050301; Sahoo SK, 2017, J BONE MINER METAB, V35, P464, DOI 10.1007/s00774-016-0777-4; Song SJ, 2013, PUBLIC HEALTH NUTR, V16, P687, DOI 10.1017/S1368980012003084; Toko EN, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120794; Wei SQ, 2014, CURR OPIN OBSTET GYN, V26, P438, DOI 10.1097/GCO.0000000000000117; Wei SQ, 2013, J MATERN-FETAL NEO M, V26, P889, DOI 10.3109/14767058.2013.765849; Weinert LS, 2015, MATERN CHILD HLTH J, V19, P94, DOI 10.1007/s10995-014-1499-7; Yu XD, 2014, NUTRIENTS, V6, P5600, DOI 10.3390/nu6125600; Yun CF, 2017, PUBLIC HEALTH NUTR, V20, P1746, DOI [10.1017/s1368980015002980, 10.1017/S1368980015002980]; Zhang CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003753; Zhou J, 2014, EUR J CLIN NUTR, V68, P925, DOI 10.1038/ejcn.2014.99; Zhu P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14930; Zhu T, 2015, INT J CLIN EXP PATHO, V8, P1459	40	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0195700	10.1371/journal.pone.0195700	http://dx.doi.org/10.1371/journal.pone.0195700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689109	Green Submitted, Green Published, gold			2022-12-26	WOS:000430678800011
J	Sampayo-Escobar, V; Green, R; Cheung, MB; Bedi, R; Mohapatra, S; Mohapatra, SS				Sampayo-Escobar, Viviana; Green, Ryan; Cheung, Michael B.; Bedi, Raminder; Mohapatra, Subhra; Mohapatra, Shyam S.			Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection	PLOS ONE			English	Article							SERUM OSTEOPONTIN; RSV INFECTION; EXPRESSION; INFANTS; AIRWAY; INFLAMMATION; RESPONSES; DISEASE; PROTEIN; HOST	The molecular mechanisms underlying susceptibility to severe respiratory syncytial virus (RSV) infection remain poorly understood. Herein, we report on the role of osteopontin (OPN) in regulation of RSV infection in human epithelial cells and how interleukin-1 beta (IL-1 beta), a cytokine secreted soon after RSV infection, when persistently expressed can induce OPN expression leading to increased viral infection. We first compared OPN expression in two human epithelial cell lines: HEK-293 and HEp-2. In contrast to HEp-2, HEK-293 expresses low levels of pro-caspase-1 resulting in decreased IL-1 beta expression in response to RSV infection. We found a correlation between low IL-1 beta levels and a delay in induction of OPN expression in RSV-infected HEK-293 cells compared to HEp-2. This phenomenon could partially explain the high susceptibility of HEp-2 cells to RSV infection versus the moderate susceptibility of HEK-293 cells. Also, HEK-293 cells expressing low levels of pro-caspase-1 exhibit decreased IL-1 beta expression and delayed OPN expression in response to RSV infection. HEK-293 cells incubated with human rIL-1 beta showed a dose-dependent increase in OPN expression upon RSV infection. Also, incubation with rOPN increased RSV viral load. Moreover, HEp-2 cells or mice infected with a mucogenic RSV strain RSV-L19F showed elevated levels of OPN in contrast to mice infected with the laboratory RSV strain rA2. This correlated with elevated levels of OPN following infection with RSV-L19F compared to rA2. Together, these results demonstrate that increased OPN expression is regulated in part by IL-1 beta, and the interplay between IL-1 beta and OPN signaling may play a pivotal role in the spread of RSV infection.	[Sampayo-Escobar, Viviana; Cheung, Michael B.; Bedi, Raminder; Mohapatra, Subhra; Mohapatra, Shyam S.] James A Haley Vet Affairs Hosp, Tampa, FL 33612 USA; [Sampayo-Escobar, Viviana; Cheung, Michael B.; Bedi, Raminder; Mohapatra, Shyam S.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Dept Internal Med, Tampa, FL 33620 USA; [Green, Ryan; Mohapatra, Subhra] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Mohapatra, S; Mohapatra, SS (corresponding author), James A Haley Vet Affairs Hosp, Tampa, FL 33612 USA.; Mohapatra, SS (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Dept Internal Med, Tampa, FL 33620 USA.; Mohapatra, S (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA.	smohapa2@health.usf.edu; smohapat@health.usf.edu	Cheung, Michael/G-5459-2011	Cheung, Michael/0000-0002-0021-3802	VA Merit Review Awards [BX003685, BX003413]; Research Career Scientist Awards [IK6 BX003778, IK6BX004212]; Fulbright Scholarship (Becas Caldas COLCIENCIAS); Helen Hoxeng Fund; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; Veterans Affairs [I01BX003413] Funding Source: NIH RePORTER	VA Merit Review Awards(US Department of Veterans Affairs); Research Career Scientist Awards; Fulbright Scholarship (Becas Caldas COLCIENCIAS); Helen Hoxeng Fund; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by a VA Merit Review Awards #BX003685 and BX003413, and Research Career Scientist Awards to Dr. Shyam Mohapatra (IK6 BX003778) and Dr. Subhra Mohapatra (IK6BX004212). Viviana Sampayo was supported by Fulbright Scholarship (Becas Caldas 2011-COLCIENCIAS) and the Helen Hoxeng Fund. Though this report is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, the contents of this report do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abel B, 2005, J IMMUNOL, V175, P6006, DOI 10.4049/jimmunol.175.9.6006; Akelma AZ, 2014, ALLERGOL IMMUNOPATH, V42, P275, DOI 10.1016/j.aller.2013.01.009; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; BARDIN PG, 1992, CLIN EXP ALLERGY, V22, P809, DOI 10.1111/j.1365-2222.1992.tb02825.x; Bertrand P, 2015, CYTOKINE, V76, P417, DOI 10.1016/j.cyto.2015.07.017; Blanco JCG, 2002, J INFECT DIS, V185, P1780, DOI 10.1086/340823; Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9; Boyapalle S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029386; Chen MY, 2009, EUR J IMMUNOL, V39, P2525, DOI 10.1002/eji.200838879; Cheung MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163709; Coclet-Ninin J, 1997, EUR CYTOKINE NETW, V8, P345; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; DeVincenzo JP, 2007, J INFECT DIS, V195, P1084, DOI 10.1086/512622; Falsey AR, 2005, DRUG AGING, V22, P577, DOI 10.2165/00002512-200522070-00004; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Han J, 2011, PULM MED, V2011, DOI 10.1155/2011/748038; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; Kahles F, 2014, MOL METAB, V3, P384, DOI 10.1016/j.molmet.2014.03.004; Kang CG, 2017, BIOORG MED CHEM LETT, V27, P1914, DOI 10.1016/j.bmcl.2017.03.047; Konno S, 2011, CLIN EXP ALLERGY, V41, P1360, DOI 10.1111/j.1365-2222.2011.03775.x; Lee JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175384; Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08; Liu WL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9471215; Liu WL, 2012, J ALLERGY CLIN IMMUN, V130, P1416, DOI 10.1016/j.jaci.2012.06.010; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Lu X, 2009, ALLERGY, V64, P104, DOI 10.1111/j.1398-9995.2008.01829.x; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Matsuse H, 2000, J IMMUNOL, V164, P6583, DOI 10.4049/jimmunol.164.12.6583; McCurdy LH, 2003, J VIROL, V77, P1747, DOI 10.1128/JVI.77.3.1747-1756.2003; Mejias A, 2004, ANTIMICROB AGENTS CH, V48, P1811, DOI 10.1128/AAC.48.5.1811-1822.2004; Mohapatra SS, 2008, CLIN MICROBIOL REV, V21, P495, DOI 10.1128/CMR.00054-07; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Murray Clare S, 2004, Proc Am Thorac Soc, V1, P99, DOI 10.1513/pats.2306027; Oh K, 2015, IMMUNE NETW, V15, P142, DOI 10.4110/in.2015.15.3.142; Openshaw Peter J M, 2005, Proc Am Thorac Soc, V2, P121, DOI 10.1513/pats.200504-032AW; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Pagel CN, 2014, J CELL COMMUN SIGNAL, V8, P95, DOI 10.1007/s12079-013-0217-3; Piedimonte G, 2014, CURR OPIN PHARMACOL, V16, P82, DOI 10.1016/j.coph.2014.03.008; Riccetto Adriana Gut Lopes, 2006, Braz J Infect Dis, V10, P357, DOI 10.1590/S1413-86702006000500011; Rittling SR, 1999, EXP NEPHROL, V7, P103; Rosenberg HF, 2012, CURR MED CHEM, V19, P1424; Samitas K, 2011, EUR RESPIR J, V37, P331, DOI 10.1183/09031936.00017810; Schlender J, 2005, J VIROL, V79, P5507, DOI 10.1128/JVI.79.9.5507-5515.2005; Schwarze J, 2004, AM J RESP CRIT CARE, V169, P801, DOI 10.1164/rccm.200308-1203OC; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; Segovia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029695; Senbanjo LT, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00018; Serlin DM, 2006, J CELL BIOCHEM, V97, P519, DOI 10.1002/jcb.20661; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Szabo SM, 2012, PAEDIATR RESPIR REV, V13, pS9; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Triantafilou K, 2013, THORAX, V68, P66, DOI 10.1136/thoraxjnl-2012-202182; van der Windt GJW, 2010, EUR RESPIR J, V36, P1337, DOI 10.1183/09031936.00002710; Varga SM, 2002, VIROLOGY, V295, P203, DOI 10.1006/viro.2002.1382; Wang J, 2014, J ETHNOPHARMACOL, V154, P131, DOI 10.1016/j.jep.2014.03.041; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weber GF, 2001, BBA-REV CANCER, V1552, P61, DOI 10.1016/S0304-419X(01)00037-3; West CE, 2017, PEDIATR RES, V82, P63, DOI 10.1038/pr.2017.77; Willson DF, 2003, J PEDIATR-US, V143, pS142, DOI 10.1067/S0022-3476(03)00514-6; Wong TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088764; Wu PS, 2011, EXPERT REV ANTI-INFE, V9, P731, DOI [10.1586/eri.11.92, 10.1586/ERI.11.92]; Xanthou G, 2007, NAT MED, V13, P570, DOI 10.1038/nm1580; Zhu YA, 2015, JPN J INFECT DIS, V68, P467, DOI 10.7883/yoken.JJID.2014.467	71	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0192709	10.1371/journal.pone.0192709	http://dx.doi.org/10.1371/journal.pone.0192709			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677209	Green Published, Green Submitted, gold			2022-12-26	WOS:000430638900003
J	Imamaki, R; Ogawa, K; Kizuka, Y; Komi, Y; Kojima, S; Kotani, N; Honke, K; Honda, T; Taniguchi, N; Kitazume, S				Imamaki, Rie; Ogawa, Kazuko; Kizuka, Yasuhiko; Komi, Yusuke; Kojima, Soichi; Kotani, Norihiro; Honke, Koichi; Honda, Takashi; Taniguchi, Naoyuki; Kitazume, Shinobu			Glycosylation controls cooperative PECAM-VEGFR2-beta 3 integrin functions at the endothelial surface for tumor angiogenesis	ONCOGENE			English	Article							CELL ADHESION MOLECULE; PRECURSOR PROTEIN 770; HOMOPHILIC INTERACTIONS; PLATELET; CANCER; SIALYLATION; RECEPTOR; PECAM-1; GLYCANS; APOPTOSIS	Most of the angiogenesis inhibitors clinically used in cancer treatment target the vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) pathway. However, the current strategies for treating angiogenesis have limited efficacy. The issue of how to treat angiogenesis and endothelial dysfunction in cancer remains a matter of substantial debate. Here we demonstrate a glycosylation-dependent regulatory mechanism for tumor angiogenesis. St6gal1(-/-) mice, lacking the alpha 2,6-sialylation enzyme, were shown to exhibit impaired tumor angiogenesis through enhanced endothelial apoptosis. In a previous study, St6gal1(-/-) endothelial cells exhibited a reduction in the cell surface residency of platelet endothelial cell adhesion molecule (PECAM). In this study, we found that cooperative functionality of PECAM-VEGFR2-integrin beta 3 was disturbed in St6gal1(-/-) mice. First, cell surface PECAM-VEGFR2 complexes were lost, and both VEGFR2 internalization and the VEGFR-dependent signaling pathway were enhanced. Second, enhanced anoikis was observed, suggesting that the absence of alpha 2,6-sialic acid leads to dysregulated integrin signaling. Notably, ectopic expression of PECAM increased cell surface integrin-beta 3, indicating that the reduction of cell surface integrin-beta 3 involves loss-of-endothelial PECAM. The results suggest that the cell surface stability of these glycoproteins is significantly reduced by the lack of alpha 2,6-sialic acid, leading to abnormal signal transduction. The present findings highlight that alpha 2,6-sialylation is critically involved in endothelial survival by controlling the cell surface stability and signal transduction of angiogenic molecules, and could be a novel target for anti-angiogenesis therapy.	[Imamaki, Rie; Ogawa, Kazuko; Kizuka, Yasuhiko; Taniguchi, Naoyuki; Kitazume, Shinobu] RIKEN, Dis Glyc Team, Syst Glycobiol Res Grp, Saitama 3510198, Japan; [Komi, Yusuke; Kojima, Soichi] RIKEN, Mol Ligand Biol Res Team, Wako, Saitama 3510198, Japan; [Kotani, Norihiro] Saitama Med Univ, Dept Biochem, Saitama 3500495, Japan; [Honke, Koichi] Kochi Univ, Dept Biochem, Med Sch, Kochi 7838505, Japan; [Honda, Takashi] Fukushima Med Univ, Sch Nursing, Dept Human Life Sci, Fukushima 9601295, Japan; [Kitazume, Shinobu] Fukushima Med Univ, Preparing Sect New Fac Med Sci, Fukushima 9601295, Japan	RIKEN; RIKEN; Saitama Medical University; Kochi University; Fukushima Medical University; Fukushima Medical University	Kitazume, S (corresponding author), RIKEN, Dis Glyc Team, Syst Glycobiol Res Grp, Saitama 3510198, Japan.; Kitazume, S (corresponding author), Fukushima Med Univ, Preparing Sect New Fac Med Sci, Fukushima 9601295, Japan.	shinobuk@fmu.ac.jp	Taniguchi, Naoyuki/I-4182-2014; Kojima, Soichi/N-7104-2015	Taniguchi, Naoyuki/0000-0001-5889-5968; Kotani, Norihiro/0000-0003-3739-6478; Kojima, Soichi/0000-0002-5252-1612; Kizuka, Yasuhiko/0000-0002-3181-9743	Systems Glycobiology Research Project; Strategic Programs for RD of RIKEN; MEXT/JSPS KAKENHI grant [16K08601, 25430122]; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [16K08601] Funding Source: KAKEN	Systems Glycobiology Research Project; Strategic Programs for RD of RIKEN; MEXT/JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Systems Glycobiology Research Project and the Strategic Programs for R&D of RIKEN (to N.T.), MEXT/JSPS KAKENHI grant numbers 16K08601 and 25430122 (to S.K.), and a grant from the Mitsubishi Foundation (to S.K.). The authors would like to acknowledge Dr. Jamey D. Marth for providing the St6gal1<SUP>-/-</SUP> mice and the RIKEN BSI-Olympus Collaboration Center for technical support.	Abe Y, 1999, J IMMUNOL, V163, P2867; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bird IN, 1999, J CELL SCI, V112, P1989; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Croci DO, 2014, GLYCOBIOLOGY, V24, P1283, DOI 10.1093/glycob/cwu083; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Domingues I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025668; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frentzas S, 2016, NAT MED, V22, P1294, DOI 10.1038/nm.4197; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao CJ, 2003, BLOOD, V102, P169, DOI 10.1182/blood-2003-01-0003; HANASAKI K, 1994, J BIOL CHEM, V269, P10637; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kitazume S, 2014, GLYCOBIOLOGY, V24, P1260, DOI 10.1093/glycob/cwu094; Kitazume S, 2014, J BIOL CHEM, V289, P27604, DOI 10.1074/jbc.M114.563585; Kitazume S, 2012, J BIOL CHEM, V287, P40817, DOI 10.1074/jbc.M112.398578; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Komi Y, 2007, JPN J CLIN ONCOL, V37, P867, DOI 10.1093/jjco/hym115; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee C, 2014, J BIOL CHEM, V289, P9121, DOI 10.1074/jbc.M114.555888; Lertkiatmongkol P, 2016, J BIOL CHEM, V291, P26216, DOI 10.1074/jbc.M116.756502; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; McIntyre A, 2015, EMBO MOL MED, V7, P368, DOI 10.15252/emmm.201404271; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Paddock C, 2016, BLOOD, V127, P1052, DOI 10.1182/blood-2015-07-660092; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Sata M, 2000, ARTERIOSCL THROM VAS, V20, P309, DOI 10.1161/01.ATV.20.2.309; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Ungewiss C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18652; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	50	22	23	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 2	2018	37	31					4287	4299		10.1038/s41388-018-0271-7	http://dx.doi.org/10.1038/s41388-018-0271-7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP1HN	29717262	Green Published			2022-12-26	WOS:000440566100007
J	Bright, T; Kuper, H; Macleod, D; Musendo, D; Irunga, P; Yip, JLY				Bright, Tess; Kuper, Hannah; Macleod, David; Musendo, David; Irunga, Peter; Yip, Jennifer L. Y.			Population need for primary eye care in Rwanda: A national survey	PLOS ONE			English	Article							VISUAL IMPAIRMENT; UNCORRECTED PRESBYOPIA; SPECTACLE COVERAGE; REFRACTIVE ERROR; RAPID ASSESSMENT; AFRICA; BLINDNESS	Background Universal access to Primary Eye Care (PEC) is a key global initiative to reduce and prevent avoidable causes of visual impairment (VI). PEC can address minor eye conditions, simple forms of uncorrected refractive error (URE) and create a referral pathway for specialist eye care, thus offering a potential solution to a lack of eye health specialists in low-income countries. However, there is little information on the population need for PEC, including prevalence of URE in all ages in Sub-Saharan Africa. Methods A national survey was conducted of people aged 7 and over in Rwanda in September-December 2016. Participants were selected through two-stage probability proportional to size sampling and compact segment sampling. VI (visual acuity<6/12) was assessed using Portable Eye Examination Kit (PEEK); URE was detected using a pinhole and presbyopia using local near vision test. We also used validated questionnaires to collect socio-demographic and minor eye symptoms information. Prevalence estimates for VI, URE and need for PEC (URE, presbyopia with good distance vision, need for referrals and minor eye conditions) were age and sex standardized to the Rwandan population. Associations between age, sex, socio-economic status and the key outcomes were examined using logistic regression. Results 4618 participants were examined and interviewed out of 5361 enumerated (86% response rate). The adjusted population prevalence of VI was 3.7% (95%CI = 3.0 +/- 4.5%), URE was 2.2% (95%CI = 1.7-2.8%) and overall need for PEC was 34.0% (95%CI = 31.8-36.4%). Women and older people were more likely to need PEC and require a referral. Conclusions Nearly a third of the population in Rwanda has the potential to benefit from PEC, with greater need identified in older people and women. Universal access to PEC can address unmet eye health needs and public health planning needs to ensure equitable access to older people and women.	[Bright, Tess; Kuper, Hannah; Yip, Jennifer L. Y.] London Sch Hyg & Trop Med, Fac Infect Dis & Trop Dis, Int Ctr Eye Hlth, Keppel St, London, England; [Bright, Tess; Kuper, Hannah; Musendo, David; Yip, Jennifer L. Y.] London Sch Hyg & Trop Med, Fac Infect Dis & Trop Dis, Int Ctr Evidence Disabil, Keppel St, London, England; [Macleod, David] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, Keppel St, London, England; [Musendo, David; Irunga, Peter] Lifetime Consultants, Kigali, Rwanda	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Bright, T (corresponding author), London Sch Hyg & Trop Med, Fac Infect Dis & Trop Dis, Int Ctr Eye Hlth, Keppel St, London, England.; Bright, T (corresponding author), London Sch Hyg & Trop Med, Fac Infect Dis & Trop Dis, Int Ctr Evidence Disabil, Keppel St, London, England.	tess.bright@lshtm.ac.uk		Macleod, David/0000-0002-2371-5709	Vision for A Nation	Vision for A Nation	This research was funded by Vision for A Nation and carried out through a partnership between London School of Hygiene & Tropical Medicine and Lifetime Consultants. The funder provided support in the form of salaries for authors TB, JLYY, HK, D. Macleod, D. Musendo, and PI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section	Aboobaker S, 2016, MIDDLE EAST AFR J OP, V23, P145, DOI 10.4103/0974-9233.164615; [Anonymous], 2016, ECONOMIST; Bastawrous A, 2015, JAMA OPHTHALMOL, V133, P930, DOI 10.1001/jamaophthalmol.2015.1468; Ben Kumah D, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0053-8; Binagwaho A, 2015, B WORLD HEALTH ORGAN, V93, P429, DOI 10.2471/BLT.14.143149; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Burke AG, 2006, OPHTHALMOLOGY, V113, P723, DOI 10.1016/j.ophtha.2006.01.030; Chan VF, 2013, OPHTHAL EPIDEMIOL, V20, P131, DOI 10.3109/09286586.2013.783082; COURTRIGHT P, 1995, BRIT J OPHTHALMOL, V79, P506, DOI 10.1136/bjo.79.5.506-a; Courtright P, 2010, ANN TROP MED PARASIT, V104, P361, DOI 10.1179/136485910X12743554760225; Courtright P, 2010, TROP MED INT HEALTH, V15, P692, DOI 10.1111/j.1365-3156.2010.02530.x; De Smedt S, 2011, AM J TROP MED HYG, V85, P711, DOI 10.4269/ajtmh.2011.11-0291; Demographic and Health Survey, 2016, RWAND DEM HLTH SURV; Holden BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1731, DOI 10.1001/archopht.126.12.1731; International Agency for the Prevention of Blindness, 2017, SPECT COV REP 2017; International Agency for the Prevention of Blindness, 2017, VIS 2020 RIGHT SIGHT; Juniper EF, 1996, J ALLERGY CLIN IMMUN, V98, P843, DOI 10.1016/S0091-6749(96)70135-5; Kuper H, 2008, PLOS MED, V5, P1716, DOI 10.1371/journal.pmed.0050244; Laviers H, 2011, BRIT J OPHTHALMOL, V95, P783, DOI 10.1136/bjo.2010.186890; Laviers HR, 2010, INVEST OPHTH VIS SCI, V51, P1234, DOI 10.1167/iovs.08-3154; Lewallen S, 2001, BRIT J OPHTHALMOL, V85, P897, DOI 10.1136/bjo.85.8.897; Mafwiri MM, 2014, BMC NURS, V13, DOI 10.1186/1472-6955-13-15; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Naidoo Kovin, 2014, Community Eye Health, V27, P74; Naidoo KS, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-361; National Institute of Statistics of Rwanda, INT HOUS LIV COND SU; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Patel Ilesh, 2007, Community Eye Health, V20, P40; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Senyonjo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104128; Sherwin JC, 2008, CLIN EXP OPHTHALMOL, V36, P245, DOI 10.1111/j.1442-9071.2008.01711.x; Sherwin JC, 2012, BRIT J OPHTHALMOL, V96, P927, DOI 10.1136/bjophthalmol-2011-300426; The World Bank, RWAND 2017; Thylefors B, 1998, Community Eye Health, V11, P1; World Health Organization, 2013, UN EYE HLTH GLOB ACT; Zhu MJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-311	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0193817	10.1371/journal.pone.0193817	http://dx.doi.org/10.1371/journal.pone.0193817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715288	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000431281100003
J	Dumontet, C; Couray-Targe, S; Teisseire, M; Karlin, L; Maucort-Boulch, D				Dumontet, Charles; Couray-Targe, Sandrine; Teisseire, Marion; Karlin, Lionel; Maucort-Boulch, Delphine			Real life management of patients hospitalized with multiple myeloma in France	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; POPULATION; BORTEZOMIB; PATTERNS; LENALIDOMIDE; SURVIVAL; AGE	Background Patients with multiple myeloma included in prospective clinical trials are highly selected and therefore are expected not to be representative of the entire patient population. Additionally recommendations based on literature data and randomized trials are not systematically implemented in all patients. We sought to determine how patients hospitalized with a diagnosis of multiple myeloma are currently treated in France. Methods and findings We performed a nation-wide search using the Programme de Medicalisation des Systemes d'Information (PMSI) database which includes anonymous data for all patients hospitalized in France. We identified newly diagnosed cases in 2012 and analyzed the number and duration of hospital stays, coexisting conditions and treatment modalities with data available until the end of 2015. A diagnosis of multiple myeloma was determined for the first time during a hospitalization in France in 2012 in 6,282 patients (3,234 males and 3,048 females). The median age at diagnosis was 74 years (72 in males and 76 in females). A majority (55.3%) of patients were diagnosed and treated in a single heath center, including 37% in a university hospital and 52% in a non-university public hospital. Comorbidities potentially impacting on myeloma treatment were present in 57.5% of patients at diagnosis, and 15% had an associated diagnosis of another neoplasia. Intensive therapies with stem cell transplants were performed in 1033 patients (16% of total), the majority of which were aged less than 65 (881 patients, 85.3%). Stem cell transplants were performed more frequently in males while the distance between the site of residence and the transplant center had no impact on likelihood of receiving a transplant. Only 60% of patients less than 65 years old who were treated for their disease underwent intensification with stem cell transplant within the 4-year follow-up period. Conclusions A large majority of patients hospitalized with a diagnosis of multiple myeloma are elderly, in particular females, and not eligible for transplants. Among the patients aged less than 65 and receiving therapy for their disease, 40% do not undergo transplants. These data emphasize the need for alternative therapies.	[Dumontet, Charles; Karlin, Lionel] Hosp Civils Lyon, Hematol Dept, Pierre Benite, France; [Dumontet, Charles; Maucort-Boulch, Delphine] Univ Lyon 1, Villeurbanne, France; [Couray-Targe, Sandrine; Teisseire, Marion] Hosp Civils Lyon, DIM, Lyon, France; [Maucort-Boulch, Delphine] Hosp Civils Lyon, Serv Biostat, Lyon, France; [Maucort-Boulch, Delphine] CNRS, UMR 5558, Equipe Biostat Sante, Pierre Benite, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Dumontet, C (corresponding author), Hosp Civils Lyon, Hematol Dept, Pierre Benite, France.; Dumontet, C (corresponding author), Univ Lyon 1, Villeurbanne, France.	charles.dumontet@chu-lyon.fr		Dumontet, Charles/0000-0003-1875-134X				Benboubker L, 2014, NEW ENGL J MED, V371, P906, DOI 10.1056/NEJMoa1402551; Blommestein HM, 2016, EUR J HAEMATOL, V96, P198, DOI 10.1111/ejh.12571; Fourrier-Reglat A, 2014, LEUKEMIA LYMPHOMA, V55, P848, DOI 10.3109/10428194.2013.806801; Grelaud A, 2016, LEUKEMIA LYMPHOMA, V57, P1349, DOI 10.3109/10428194.2015.1096354; Leleu X, 2013, THROMB HAEMOSTASIS, V110, P844, DOI 10.1160/TH13-02-0140; Mateos MV, 2015, BLOOD REV, V29, P387, DOI 10.1016/j.blre.2015.06.001; Mian M, 2016, ANTICANCER RES, V36, P1059; Moulis G, 2015, REV MED INTERNE, V36, P411, DOI 10.1016/j.revmed.2014.11.009; Offidani M, 2012, CL LYMPH MYELOM LEUK, V12, P423, DOI 10.1016/j.clml.2012.06.008; Palmaro A, 2017, PHARMACOEPIDEM DR S, V26, P578, DOI 10.1002/pds.4180; Palmaro A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006189; Quach H, 2009, INTERN MED J, V39, P290, DOI 10.1111/j.1445-5994.2008.01738.x; Rios-Tamayo R, 2016, AM J HEMATOL, V91, P700, DOI 10.1002/ajh.24389; Rios-Tamayo R, 2015, CANCER EPIDEMIOL, V39, P693, DOI 10.1016/j.canep.2015.08.002; Touzeau C, 2017, LEUKEMIA, V31, P1039, DOI 10.1038/leu.2017.60; Turesson I, 2010, MAYO CLIN PROC, V85, P225, DOI 10.4065/mcp.2009.0426; Velez R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009584; Waxman AJ, 2010, BLOOD, V116, P5501, DOI 10.1182/blood-2010-07-298760; Winn AN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv139	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196596	10.1371/journal.pone.0196596	http://dx.doi.org/10.1371/journal.pone.0196596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715281	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281100036
J	Teichman, J; Dodbiba, L; Thai, H; Fleet, A; Morey, T; Liu, L; McGregor, M; Cheng, DX; Chen, Z; Darling, G; Brhane, Y; Song, YY; Espin-Garcia, O; Xu, W; Girgis, H; Schwock, J; MacKay, H; Bristow, R; Ailles, L; Liu, G				Teichman, Jennifer; Dodbiba, Lorin; Thai, Henry; Fleet, Andrew; Morey, Trevor; Liu, Lucy; McGregor, Madison; Cheng, Dangxiao; Chen, Zhuo; Darling, Gail; Brhane, Yonathan; Song, Yuyao; Espin-Garcia, Osvaldo; Xu, Wei; Girgis, Hala; Schwock, Joerg; MacKay, Helen; Bristow, Robert; Ailles, Laurie; Liu, Geoffrey			Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma	PLOS ONE			English	Article							BARRETTS METAPLASIA; STEM-CELLS; GASTROESOPHAGEAL JUNCTION; GASTROINTESTINAL-TRACT; SMOOTHENED INHIBITOR; PANCREATIC-CANCER; IN-VIVO; PATHWAY; PROLIFERATION; ACTIVATION	Background The Hedgehog (Hh) signaling pathway is active in esophageal adenocarcinoma (EAC). We used a patient-derived murine xenograft (PDX) model of EAC to evaluate tumour response to conventional treatment with radiation/chemoradiation with or without Hh inhibition. Our goal was to determine the potential radioresistance effects of Hh signaling and radiosensitization by Hh inhibitors. Methods PDX models were treated with radiation, chemotherapy or combined chemoradiation. Tumour response was measured by growth delay. Hh transcript levels (qRT-PCR) were compared among frozen tumours from treated and control mice. 5E1, a monoclonal SHH antibody, or LDE225, a clinical SMO inhibitor (Novartis (R)) inhibited Hh signaling. Results Precision irradiation significantly delayed xenograft tumour growth in all 7 PDX models. Combined chemoradiation further delayed growth relative to either modality alone in three of six PDX models. Following irradiation, two of three PDX models demonstrated sustained up-regulation of Hh transcripts. Combined LDE225 and radiation, and 5E1 alone delayed growth relative to either treatment alone in a Hh-responsive PDX model, but not in a non-responsive model. Conclusion Hh signaling mediates the radiation response in some EAC PDX models, and inhibition of this pathway may augment the efficacy of radiation in tumours that are Hh dependent.	[Teichman, Jennifer; Morey, Trevor] Univ Toronto, Postgrad Med Educ, Toronto, ON, Canada; [Teichman, Jennifer; Dodbiba, Lorin; Liu, Lucy; Bristow, Robert; Ailles, Laurie; Liu, Geoffrey] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Thai, Henry; Fleet, Andrew; Liu, Lucy; McGregor, Madison; Cheng, Dangxiao; Chen, Zhuo; Xu, Wei; Bristow, Robert; Ailles, Laurie; Liu, Geoffrey] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Darling, Gail] Univ Hlth Network, Dept Thorac Surg, Toronto, ON, Canada; [Brhane, Yonathan; Song, Yuyao; Espin-Garcia, Osvaldo; Xu, Wei] Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada; [Xu, Wei; Liu, Geoffrey] Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Girgis, Hala; Schwock, Joerg] Dept Lab Med & Pathobiol, Toronto, ON, Canada; [MacKay, Helen] Sunnybrook Hlth Sci Ctr, Div Med Oncol, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Liu, G (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.; Liu, G (corresponding author), Princess Margaret Canc Ctr, Toronto, ON, Canada.; Liu, G (corresponding author), Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	Geoffrey.liu@uhn.ca	Teichman, Jennifer/AHE-5052-2022	Teichman, Jennifer/0000-0002-7538-5772; Bristow, Robert/0000-0002-8553-9544	Ontario Graduate Scholarship	Ontario Graduate Scholarship(Ontario Graduate Scholarship)	The work was supported by an Ontario Graduate Scholarship, and by institutional funding held by the principle investigator. LDE 225 was supplied by Novartis. Novartis had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Beachy PA, 2004, NATURE, V431, P402, DOI 10.1038/431402a; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Boonstra JJ, 2010, JNCI-J NATL CANCER I, V102, P271, DOI 10.1093/jnci/djp499; Catenacci DVT, 2015, J CLIN ONCOL, V33, P4284, DOI 10.1200/JCO.2015.62.8719; Chaudary N, 2012, CANCER-AM CANCER SOC, V118, P3105, DOI 10.1002/cncr.26635; Chen Y.F., 2011, INT J ROCK MECH MIN, V03, P1, DOI DOI 10.1016/J.IJR0BP.2011.01.003; Chung CH, 2011, J CLIN ONCOL, V29, P1326, DOI 10.1200/JCO.2010.32.3295; Clemons NJ, 2013, CANCER BIOL THER, V14, P782, DOI 10.4161/cbt.25362; Dallas VA Medical Center, 2000, FEAS ITR TARG THER I; Damhofer H, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0469-1; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Dodbiba L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121872; Dodbiba L, 2013, LAB INVEST, V93, P397, DOI 10.1038/labinvest.2013.8; Fernandez A, 2012, ONCOGENE, V31, P1923, DOI 10.1038/onc.2011.379; Gibson MK, 2013, ANN SURG, V258, P82, DOI 10.1097/SLA.0b013e318270500d; Kebenko M, 2015, CELL SIGNAL, V27, P373, DOI 10.1016/j.cellsig.2014.11.022; Kim R, 1997, CANCER EPIDEM BIOMAR, V6, P369; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Ma XL, 2006, INT J CANCER, V118, P139, DOI 10.1002/ijc.21295; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Polednak AP, 2003, INT J CANCER, V105, P98, DOI 10.1002/ijc.11029; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Rodon J, 2014, CLIN CANCER RES, V20, P1900, DOI 10.1158/1078-0432.CCR-13-1710; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Shirai K, 2011, J RADIAT RES, V52, P264, DOI 10.1269/jrr.10166; Shridhar Ravi, 2013, J Gastrointest Cancer, V44, P375, DOI 10.1007/s12029-013-9511-9; Sidney Kimmel Comprehensive Cancer Center, 2000, PHAS 2 STUD GEMC NAB; Sims-Mourtada J, 2006, CLIN CANCER RES, V12, P6565, DOI 10.1158/1078-0432.CCR-06-0176; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Souza RF, 2016, DIGEST DIS, V34, P483, DOI 10.1159/000445225; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Wadhwa R, 2017, BRIT J CANCER, V117, P648, DOI 10.1038/bjc.2017.225; Wang DH, 2014, J CLIN INVEST, V124, P3767, DOI 10.1172/JCI66603; Wang DH, 2010, GASTROENTEROLOGY, V138, P1810, DOI 10.1053/j.gastro.2010.01.048; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Yang Ling, 2012, Int J Biochem Mol Biol, V3, P46; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yoon C, 2014, CLIN CANCER RES, V20, P3974, DOI 10.1158/1078-0432.CCR-14-0011; Yoshikawa R, 2008, BRIT J CANCER, V98, P1670, DOI 10.1038/sj.bjc.6604361; Zaidi AH, 2013, CANCER INVEST, V31, P480, DOI 10.3109/07357907.2013.820317; Zeng J, 2013, INT J RADIAT ONCOL, V86, P143, DOI 10.1016/j.ijrobp.2012.10.014; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	54	12	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0194809	10.1371/journal.pone.0194809	http://dx.doi.org/10.1371/journal.pone.0194809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715275	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281100004
J	Silva, JMD; Alabarse, PVG; Teixeira, VDN; Freitas, EC; de Oliveira, FH; Chakr, RMD; Xavier, RM				de Souza Silva, Jordana Miranda; Gil Alabarse, Paulo Vinicius; Nunes Teixeira, Vivian de Oliveira; Freitas, Eduarda Correa; de Oliveira, Francine Hehn; da Silva Chakr, Rafael Mendonca; Xavier, Ricardo Machado			Muscle wasting in osteoarthritis model induced by anterior cruciate ligament transection	PLOS ONE			English	Article							GROWTH-FACTOR-I; RADIOGRAPHIC KNEE OSTEOARTHRITIS; DOWNSTREAM ACTIVATION SIGNALS; CROSS-SECTIONAL AREA; C-REACTIVE PROTEIN; SKELETAL-MUSCLE; DISUSE ATROPHY; INFLAMMATORY MARKERS; QUADRICEPS STRENGTH; HIP OSTEOARTHRITIS	This study aimed to investigate the molecular pathways involved in muscle wasting in an animal model of osteoarthritis (OA) induced by anterior cruciate ligament transection (ACLT) in rats. Reduction of protein syntheses, increased proteolysis and impaired muscle regeneration are important pathways related to muscle wasting, and myogenin, MyoD, myostatin and MuRF-1 are some of their markers. Female Wistar rats were allocated into two groups: OA (submitted to the ACLT) and SFIAM (submitted to surgery without ACLT). Nociception, spontaneous exploratory locomotion and body weight of animals were evaluated weekly. Twelve weeks after the disease induction, animals were euthanized, and the right knee joints were collected. Gastrocnemius muscle of the right hind paw were dissected and weighed. Gastrocnemius was used for evaluation of muscle atrophy and expression of IL-1 beta, TNF-alpha, Pax7, myogenin, MyoD, myostatin and MuRF-1. Histopathology of the knee confirmed the development of the disease in animals of OA group. Gastrocnemius of OA animals showed a reduction of about 10% in area and an increased IL-1 beta expression compared to animals of SHAM group. Expression of myostatin was increased in OA group, while myogenin expression was decreased. TNF-alpha, Pax7, MuRF-1 and MyoD expression was similar in both OA and SHAM groups. Nociception was significantly elevated in OA animals in the last two weeks of experimental period. Spontaneous exploratory locomotion, body weight and weight of gastrocnemius showed no difference between OA and SHAM groups. Gastrocnemius atrophy in OA induced by ACLT involves elevated expression of IL-1 beta within the muscle, as well as increased expression of myostatin and decreased expression of myogenin. Therefore, muscle wasting may be linked to impaired muscle regeneration.	[de Souza Silva, Jordana Miranda; Freitas, Eduarda Correa; da Silva Chakr, Rafael Mendonca; Xavier, Ricardo Machado] Univ Fed Rio Grande do Sul, Programa Posgrad Med, Ciencias Med, Porto Alegre, RS, Brazil; [de Souza Silva, Jordana Miranda; Gil Alabarse, Paulo Vinicius; Nunes Teixeira, Vivian de Oliveira; Freitas, Eduarda Correa; Xavier, Ricardo Machado] Hosp Clin Porto Alegre, Lab Doencas Autoimunes, Porto Alegre, RS, Brazil; [de Oliveira, Francine Hehn] Hosp Clin Porto Alegre, Serv Patol, Porto Alegre, RS, Brazil; [da Silva Chakr, Rafael Mendonca; Xavier, Ricardo Machado] Hosp Clin Porto Alegre, Serv Reumatol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Silva, JMD (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Med, Ciencias Med, Porto Alegre, RS, Brazil.; Silva, JMD (corresponding author), Hosp Clin Porto Alegre, Lab Doencas Autoimunes, Porto Alegre, RS, Brazil.	jo-msouza@hotmail.com	; Chakr, Rafael/C-6963-2014	Gil Alabarse, Paulo Vinicius/0000-0002-9721-9302; Chakr, Rafael/0000-0002-8677-2479; Miranda de Souza Silva, Jordana/0000-0002-0357-4638	Fundo de Incentivo a Pesquisa e Eventos (FIPE) do Hospital de Clinicas de Porto Alegre [120040]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundo de Incentivo a Pesquisa e Eventos (FIPE) do Hospital de Clinicas de Porto Alegre; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundo de Incentivo a Pesquisa e Eventos (FIPE) do Hospital de Clinicas de Porto Alegre provided financial support for the study (grant 120040). Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided support fora research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Argiles JM, 2012, DRUG DISCOV TODAY, V17, P702, DOI 10.1016/j.drudis.2012.02.001; Arokoski MH, 2002, J RHEUMATOL, V29, P2185; Aversa Z, 2012, ANN SURG ONCOL, V19, P1350, DOI 10.1245/s10434-011-1720-5; Bennell KL, 2013, RHEUM DIS CLIN N AM, V39, P145, DOI 10.1016/j.rdc.2012.11.003; Broussard SR, 2004, J IMMUNOL, V172, P7713, DOI 10.4049/jimmunol.172.12.7713; Broussard SR, 2003, ENDOCRINOLOGY, V144, P2988, DOI 10.1210/en.2003-0087; Chacon-Cabrera A, 2017, J CELL PHYSL; Chacon-Cabrera A, 2014, J CELL PHYSIOL, V229, P1660, DOI 10.1002/jcp.24611; Cheung WW, 2010, PEDIATR NEPHROL, V25, P711, DOI 10.1007/s00467-009-1427-z; Coelho CW, 2013, CLINICS, V68, P107, DOI 10.6061/clinics/2013(01)OA17; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Crul T, 2007, EUR J CLIN INVEST, V37, P897, DOI 10.1111/j.1365-2362.2007.01867.x; Dumon NA, 2015, DEVELOPMENT, V142, P1572, DOI 10.1242/dev.114223; Filippin LI, 2013, J CACHEXIA SARCOPENI, V4, P231, DOI 10.1007/s13539-013-0102-1; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Holla JFM, 2012, ANN BEHAV MED, V44, P33, DOI 10.1007/s12160-012-9353-x; Ikeda S, 2005, J ORTHOP SCI, V10, P121, DOI 10.1007/s00776-004-0876-2; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Klimek MEB, 2010, BIOCHEM BIOPH RES CO, V391, P1548, DOI 10.1016/j.bbrc.2009.12.123; Kunz RI, 2014, BRAZ J MED BIOL RES, V47, P842, DOI 10.1590/1414-431X20143795; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Latres E, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0060-8; Levinger I, 2011, ARTHRITIS RHEUM-US, V63, P1343, DOI 10.1002/art.30287; Levinger P, 2011, ARTHRIT CARE RES, V63, P1715, DOI 10.1002/acr.20625; Liikavainio T, 2008, ARCH PHYS MED REHAB, V89, P2185, DOI 10.1016/j.apmr.2008.04.012; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Myer A, 2001, DEV BIOL, V229, P340, DOI 10.1006/dbio.2000.9985; Teixeira VDN, 2013, EXP BIOL MED, V238, P1421, DOI 10.1177/1535370213505961; Teixeira VDN, 2012, REV BRAS REUMATOL, V52, P247; Palmieri-Smith RM, 2010, AM J PHYS MED REHAB, V89, P541, DOI 10.1097/PHM.0b013e3181ddd5c3; Pearle AD, 2007, OSTEOARTHR CARTILAGE, V15, P516, DOI 10.1016/j.joca.2006.10.010; Penninx BWJH, 2004, J RHEUMATOL, V31, P2027; Pisters MF, 2014, OSTEOARTHR CARTILAGE, V22, P171, DOI 10.1016/j.joca.2013.12.007; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Ramamoorthy S, 2009, AM J PHYSIOL-ENDOC M, V297, pE392, DOI 10.1152/ajpendo.90529.2008; Rasch A, 2007, ACTA ORTHOP, V78, P505, DOI 10.1080/17453670710014158; Reardon KA, 2001, MUSCLE NERVE, V24, P893, DOI 10.1002/mus.1086.abs; Ruan MZC, 2013, OSTEOARTHR CARTILAGE, V21, P1355, DOI 10.1016/j.joca.2013.06.016; Sanchez-Ramirez DC, 2013, RHEUMATOLOGY, V52, P727, DOI 10.1093/rheumatology/kes366; Slemenda C, 1998, ARTHRITIS RHEUM, V41, P1951, DOI 10.1002/1529-0131(199811)41:11<1951::AID-ART9>3.0.CO;2-9; Slimani L, 2015, J CACHEXIA SARCOPENI, V6, P73, DOI 10.1002/jcsm.12011; Snijders T, 2014, CLIN SCI, V126, P557, DOI 10.1042/CS20130295; Taniguchi M, 2015, ULTRASOUND MED BIOL, V41, P2567, DOI 10.1016/j.ultrasmedbio.2015.05.014; Thorstensson CA, 2004, ANN RHEUM DIS, V63, P402, DOI 10.1136/ard.2003.007583; Toledo M, 2011, J CACHEXIA SARCOPENI, V2, P57, DOI 10.1007/s13539-011-0018-6; VanderVeen BN, 2017, OXID MED CELL LONGEV, V2017, P1, DOI 10.1155/2017/3292087; Wall BT, 2014, ACTA PHYSIOL, V210, P600, DOI 10.1111/apha.12190; Yang W, 2006, CANCER RES, V66, P1320, DOI 10.1158/0008-5472.CAN-05-3060; Zanou N, 2013, CELL MOL LIFE SCI, V70, P4117, DOI 10.1007/s00018-013-1330-4	53	15	16	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196682	10.1371/journal.pone.0196682	http://dx.doi.org/10.1371/journal.pone.0196682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709011	Green Submitted, Green Published, gold			2022-12-26	WOS:000431130100052
J	Lohumi, S; Lee, H; Kim, MS; Qin, JW; Kandpal, LM; Bee, H; Rahman, A; Cho, BK				Lohumi, Santosh; Lee, Hoonsoo; Kim, Moon S.; Qin, Jianwei; Kandpal, Lalit Mohan; Bee, Hyungjin; Rahman, Anisur; Cho, Byoung-Kwan			Calibration and testing of a Raman hyperspectral imaging system to reveal powdered food adulteration	PLOS ONE			English	Article							WHEAT-FLOUR; BENZOYL PEROXIDE; SPECTROSCOPY; SAFETY	The potential adulteration of foodstuffs has led to increasing concern regarding food safety and security, in particular for powdered food products where cheap ground materials or hazardous chemicals can be added to increase the quantity of powder or to obtain the desired aesthetic quality. Due to the resulting potential health threat to consumers, the development of a fast, label-free, and non-invasive technique for the detection of adulteration over a wide range of food products is necessary. We therefore report the development of a rapid Raman hyperspectral imaging technique for the detection of food adulteration and for authenticity analysis. The Raman hyperspectral imaging system comprises of a custom designed laser illumination system, sensing module, and a software interface. Laser illumination system generates a 785 nm laser line of high power, and the Gaussian like intensity distribution of laser beam is shaped by incorporating an engineered diffuser. The sensing module utilize Rayleigh filters, imaging spectrometer, and detector for collection of the Raman scattering signals along the laser line. A custom-built software to acquire Raman hyperspectral images which also facilitate the real time visualization of Raman chemical images of scanned samples. The developed system was employed for the simultaneous detection of Sudan dye and Congo red dye adulteration in paprika powder, and benzoyl peroxide and alloxan mono-hydrate adulteration in wheat flour at six different concentrations (w/w) from 0.05 to 1%. The collected Raman imaging data of the adulterated samples were analyzed to visualize and detect the adulterant concentrations by generating a binary image for each individual adulterant material. The results obtained based on the Raman chemical images of adulterants showed a strong correlation (R>0.98) between added and pixel based calculated concentration of adulterant materials. This developed Raman imaging system thus, can be considered as a powerful analytical technique for the quality and authenticity analysis of food products.	[Lohumi, Santosh; Kandpal, Lalit Mohan; Bee, Hyungjin; Rahman, Anisur; Cho, Byoung-Kwan] Chungnam Natl Univ, Dept Biosyst Machinery Engn, Coll Agr & Life Sci, 99 Daehak Ro, Daejeon, South Korea; [Lee, Hoonsoo; Kim, Moon S.; Qin, Jianwei] ARS, Environm Microbiol & Food Safety Lab, USDA, Beltsville, MD USA	Chungnam National University; United States Department of Agriculture (USDA)	Cho, BK (corresponding author), Chungnam Natl Univ, Dept Biosyst Machinery Engn, Coll Agr & Life Sci, 99 Daehak Ro, Daejeon, South Korea.	chobk@cnu.ac.kr	Rahman, Anisur/N-2151-2019; Qin, Jianwei/C-9871-2014; Kandpal, Lalit Mohan/AAP-7350-2020; Rahman, Anisur/D-9737-2011; Cho, Byoung-Kwan/AAB-7558-2022	Rahman, Anisur/0000-0003-1466-4310; Qin, Jianwei/0000-0002-8061-4373; Kandpal, Lalit Mohan/0000-0002-1377-5361; Cho, Byoung-Kwan/0000-0002-8397-9853	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(IPET) through Agriculture, Food and Rural Affairs Research Center Support Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of [717001071WT111]; Golden Seed Project, Ministry of Ocean and Fisheries; Rural Development Administration; Korea Forest Services	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(IPET) through Agriculture, Food and Rural Affairs Research Center Support Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of; Golden Seed Project, Ministry of Ocean and Fisheries; Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Korea Forest Services	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(IPET) through Agriculture, Food and Rural Affairs Research Center Support Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of Korea (No. 717001071WT111) and partly by research funds from the Golden Seed Project, Ministry of Ocean and Fisheries, Rural Development Administration, and Korea Forest Services.	[ASTA] American Spice Trade Association, 2005, SUD RED REL DYES WHI; Baranska M, 2005, J AGR FOOD CHEM, V53, P6565, DOI 10.1021/jf0510440; Bocklitz TW, 2016, ANAL CHEM, V88, P133, DOI 10.1021/acs.analchem.5b04665; Branigan T., 2008, GUARDIAN NEWS MEDIA; Chen W, 2011, ANAL CHIM ACTA, V708, P84, DOI 10.1016/j.aca.2011.10.002; Dhakal S, 2016, J FOOD MEAS CHARACT, V10, P374, DOI 10.1007/s11694-016-9316-1; Everstine K., 2013, THESIS; Liu YL, 2009, APPL SPECTROSC, V63, P477, DOI 10.1366/000370209787944398; Lohumi S, 2017, FOOD ADDIT CONTAM A, V34, p1 ; Lohumi S, 2015, TRENDS FOOD SCI TECH, V46, P85, DOI 10.1016/j.tifs.2015.08.003; Mishra KK, 2007, INT J FOOD SCI TECH, V42, P1363, DOI 10.1111/j.1365-2621.2006.01356.x; Mishra P, 2016, J FOOD ENG, V168, P7, DOI 10.1016/j.jfoodeng.2015.07.008; Mishra P, 2015, J NEAR INFRARED SPEC, V23, P15, DOI 10.1255/jnirs.1141; Nida Saleem, 2013, Journal of Tropical Life Science, V3, P1; Ponhong K, 2015, J FOOD DRUG ANAL, V23, P652, DOI 10.1016/j.jfda.2015.03.006; Qin J, 2014, T ASABE, V57, P1783; Qin J, 2010, T ASABE, V53, P1873; Qin J, APPL SCI, V201, P1; Qin Jianwei, 2017, Journal of Biosystems Engineering, V42, P170, DOI 10.5307/JBE.2017.42.3.170; Qin JW, 2017, APPL SPECTROSC, V71, P2469, DOI 10.1177/0003702817706690; Qin JW, 2017, FOOD ADDIT CONTAM A, V34, P152, DOI 10.1080/19440049.2016.1263880; ShakilaBanu M., 2012, INT J ADV INNOVATIVE, V2278, P204; Smith GPS, 2015, ADV DRUG DELIVER REV, V89, P21, DOI 10.1016/j.addr.2015.01.005; Veracity D., 2005, NATURAL NEWS; Wang CY, 2014, LASER ENG, V27, P373; Wang XB, 2017, EUR FOOD RES TECHNOL, V243, P2265, DOI 10.1007/s00217-017-2928-9; Weglarz-Tomczak E, 2012, CHEMIK, V66, P1300; Yeun Mo Chang, 2017, Journal of Biosystems Engineering, V42, P293, DOI 10.5307/JBE.2017.42.4.293; Zhang ZM, 2010, ANALYST, V135, P1138, DOI 10.1039/b922045c; Zhao J, 2015, PROC SPIE, V9488, DOI 10.1117/12.2176830	30	20	21	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0195253	10.1371/journal.pone.0195253	http://dx.doi.org/10.1371/journal.pone.0195253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708973	gold, Green Published, Green Submitted			2022-12-26	WOS:000431130100008
J	Ortega-Mayagoitia, E; Hernandez-Martinez, O; Ciros-Perez, J				Ortega-Mayagoitia, Elizabeth; Hernandez-Martinez, Osvaldo; Ciros-Perez, Jorge			Phenotypic plasticity of life-history traits of a calanoid copepod in a tropical lake: Is the magnitude of thermal plasticity related to thermal variability?	PLOS ONE			English	Article							TEMPERATURE-SIZE RESPONSES; REPRODUCTIVE-BIOLOGY; BODY-SIZE; DYNAMICS; FOOD; ZOOPLANKTON; STRATEGIES; CRUSTACEA; GROWTH; PHYLOGEOGRAPHY	According to the Climatic Variability Hypothesis [CVH], thermal plasticity should be wider in organisms from temperate environments, but is unlikely to occur in tropical latitudes where temperature fluctuations are narrow. In copepods, food availability has been suggested as the main driver of phenotypic variability in adult size if the range of temperature change is less than 14 degrees C. Leptodiaptomus garciai is a calanoid copepod inhabiting Lake Alchichica, a monomictic, tropical lake in Mexico that experiences regular, narrow temperature fluctuations but wide changes in phytoplankton availability. We investigated whether the seasonal fluctuations of temperature and food produce phenotypic variation in the life-history traits of this tropical species. We sampled L. garcia throughout a year and measured female size, egg size and number, and hatching success, along with temperature and phytoplankton biomass. The amplitude of the plastic responses was estimated with the Phenotypic Plasticity Index. This index was also computed for a published dataset of 84 copepod populations to look if there is a relationship between the amplitude of the phenotypic plasticity of adult size and seasonal change in temperature. The temperature annual range in Lake Alchichica was 3.2 degrees C, whereas phytoplankton abundance varied 17-fold. A strong pattern of thermal plasticity in egg size and adult female size followed the inverse relationship with temperature commonly observed in temperate environments, although its adaptive value was not demonstrated. Egg number, relative reproductive effort and number of nauplii per female were clearly plastic to food availability, allowing organisms to increase their fitness. When comparing copepod species from different latitudes, we found that the magnitude of thermal plasticity of adult size is not related to the range of temperature variation; furthermore, thermal plasticity exists even in environments of limited temperature variation, where the response is more intense compared to temperate populations.	[Ortega-Mayagoitia, Elizabeth; Ciros-Perez, Jorge] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Div Invest & Posgrad, Grp Invest Limnol Trop, Tlalnepantla De Baz, Edo De Mexico, Mexico; [Hernandez-Martinez, Osvaldo] Univ Nacl Autonoma Mexico, Posgrad Ciencias Mar & Limnol, Tlalnepantla De Baz, Edo De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ortega-Mayagoitia, E (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Div Invest & Posgrad, Grp Invest Limnol Trop, Tlalnepantla De Baz, Edo De Mexico, Mexico.	eortega@unam.mx	Ortega-Mayagoitia, Elizabeth/AAF-8441-2020; Ciros, Jorge/G-5958-2018	Ortega-Mayagoitia, Elizabeth/0000-0002-8892-1888; Ciros, Jorge/0000-0002-4292-7539	Direccion General de Asuntos del Personal Academic, Universidad Nacional Autonoma de Mexico [PAPIIT-DGAPA UNAM IN222916]; Facultad de Estudios Superiores Iztacala, Universidad Nacional Autonoma de Mexico (PAPCA-FES Iztacala, UNAM); Consejo Nacional de Ciencia y Tecnologia [255788]	Direccion General de Asuntos del Personal Academic, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Facultad de Estudios Superiores Iztacala, Universidad Nacional Autonoma de Mexico (PAPCA-FES Iztacala, UNAM); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was financed by Direccion General de Asuntos del Personal Academic, Universidad Nacional Autonoma de Mexico (grants PAPIIT-DGAPA UNAM IN222916 received by EOM and JCP) (http://dgapa.unam.mx/index.php/impulso-a-la-investigacion/papiit); Facultad de Estudios Superiores Iztacala, Universidad Nacional Autonoma de Mexico (PAPCA-FES Iztacala, UNAM 2007-2008 received by EOM); and Consejo Nacional de Ciencia y Tecnologia (255788 received by JCP) (http://www.conacyt.gob.mx/index.php/fondos-y-apoyos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2010, MOL PHYLOGENET EVOL, V55, P418, DOI 10.1016/j.ympev.2009.12.008; Afanasyeva EL, 1998, J MARINE SYST, V15, P351, DOI 10.1016/S0924-7963(97)00086-9; Aguilar-Kirigin AJ, 2013, OECOLOGIA, V173, P745, DOI 10.1007/s00442-013-2682-z; Alcocer J, 2009, ENVIRON BIOL FISH, V85, P317, DOI 10.1007/s10641-009-9505-4; Alonso C, 2004, LIMNOL OCEANOGR, V49, P225, DOI 10.4319/lo.2004.49.1.0225; Angilletta MJ, 2006, AM NAT, V168, pE123, DOI 10.1086/507880; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Ardiles V, 2012, HYDROBIOLOGIA, V679, P77, DOI 10.1007/s10750-011-0853-7; Atkinson D, 2001, EXPTL BIOL REV, P269; Bailey J, 2016, DEEP-SEA RES PT II, V134, P173, DOI 10.1016/j.dsr2.2015.04.017; Berger I, 2001, FRESHWATER BIOL, V46, P787, DOI 10.1046/j.1365-2427.2001.00717.x; BOLLENS SM, 1991, OECOLOGIA, V87, P155, DOI 10.1007/BF00325252; Bradford-Grieve JM, 2010, INVERTEBR SYST, V24, P291, DOI 10.1071/IS10007; Brito S.L., 2009, Acta Limnologica Brasiliensia, V21, P409; Caley MJ, 2001, EVOLUTION, V55, P1245; Caudill CC, 2004, HYDROBIOLOGIA, V511, P91, DOI 10.1023/B:HYDR.0000014032.05680.9d; Ciros-Perez J, 2015, LIMNOL OCEANOGR, V60, P2158, DOI 10.1002/lno.10157; Compton TJ, 2007, J EXP MAR BIOL ECOL, V352, P200, DOI 10.1016/j.jembe.2007.07.010; Cornils A, 2017, MOL PHYLOGENET EVOL, V107, P473, DOI 10.1016/j.ympev.2016.12.019; Cornils A, 2013, MOL PHYLOGENET EVOL, V69, P861, DOI 10.1016/j.ympev.2013.06.018; DAM HG, 1991, MAR ECOL PROG SER, V71, P113, DOI 10.3354/meps071113; Hernandez MD, 2014, J LIMNOL, V73, P387, DOI 10.4081/jlimnol.2014.910; DeWitt T.J., 2004, PHENOTYPIC PLASTICIT; Dumont H.J., 1975, Oecologia, V19, P75, DOI 10.1007/BF00377592; Edler L, 2010, IOC MANUALS GUIDES, P13; ESCRIBANO R, 1992, J EXP MAR BIOL ECOL, V159, P77, DOI 10.1016/0022-0981(92)90259-D; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Adame MF, 2008, FRESHWATER BIOL, V53, P22, DOI 10.1111/j.1365-2427.2007.01864.x; Forster J, 2011, FUNCT ECOL, V25, P1024, DOI 10.1111/j.1365-2435.2011.01852.x; Gerking SD., 1994, FEEDING ECOLOGY FISH; Gianoli E, 2012, BIOL J LINN SOC, V105, P1, DOI 10.1111/j.1095-8312.2011.01793.x; Guisande C, 1996, MAR ECOL PROG SER, V143, P37, DOI 10.3354/meps143037; Hairston NG, 1998, J MARINE SYST, V15, P23, DOI 10.1016/S0924-7963(97)00046-8; Halsband C, 2001, MAR ECOL PROG SER, V209, P219, DOI 10.3354/meps209219; Hart RC, 2011, HYDROBIOLOGIA, V668, P61, DOI 10.1007/s10750-010-0400-y; Hastie T., 1986, STAT SCI, V1, P297; Horne CR, 2016, GLOBAL ECOL BIOGEOGR, V25, P988, DOI 10.1111/geb.12460; Horne CR, 2015, ECOL LETT, V18, P327, DOI 10.1111/ele.12413; Ianora A, 2003, PHYCOLOGIA, V42, P351, DOI 10.2216/i0031-8884-42-4-351.1; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; JAMIESON C, 1988, HYDROBIOLOGIA, V164, P235, DOI 10.1007/BF00005943; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jimenez-Melero R, 2005, J PLANKTON RES, V27, P1175, DOI 10.1093/plankt/fbi083; Khodami S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06656-4; Kozlowski J, 2004, INTEGR COMP BIOL, V44, P480, DOI 10.1093/icb/44.6.480; Lewis Jr WM, 2010, VERH INT VEREIN LIMN, V30, P1596; Liang D, 1997, MAR BIOL, V128, P409, DOI 10.1007/s002270050106; Macek M, 2009, J LIMNOL, V68, P183, DOI 10.4081/jlimnol.2009.183; McKinnon AD, 1996, LIMNOL OCEANOGR, V41, P1438, DOI 10.4319/lo.1996.41.7.1438; Molina-Montenegro MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047620; Montiel-Martinez A, 2008, J PLANKTON RES, V30, P1079, DOI 10.1093/plankt/fbn067; MYERS RA, 1983, MAR ECOL PROG SER, V11, P189, DOI 10.3354/meps011189; Niehoff B, 2000, ICES J MAR SCI, V57, P1764, DOI 10.1006/jmsc.2000.0971; Niehoff B, 2007, PROG OCEANOGR, V74, P1, DOI 10.1016/j.pocean.2006.05.005; Oliva MG, 2006, DIATOM RES, V21, P81; Oliva MG, 2001, HYDROBIOLOGIA, V466, P299, DOI 10.1023/A:1014578024049; Orme D, 2013, COMP ANAL PHYLOGENET; Ortega-Mayagoitia E, 2000, WETLANDS, V20, P629, DOI 10.1672/0277-5212(2000)020[0629:SADOZI]2.0.CO;2; Ortega-Mayagoitia E, 2011, J PLANKTON RES, V33, P1574, DOI 10.1093/plankt/fbr045; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; R Core Team, 2021, R LANGUAGE ENV STAT; Reid JW, 2010, AQUAT ECOL-SAN DIEGO, P829, DOI 10.1016/B978-0-12-374855-3.00021-2; Riccardi Nicoletta, 2000, Aquatic Ecology, V34, P243, DOI 10.1023/A:1009971507797; Stearns S.C., 1992, pi; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thum RA, 2004, HYDROBIOLOGIA, V519, P135, DOI 10.1023/B:HYDR.0000026500.27949.e9; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; West-Eberhard Mary Jane, 2003, pi; Willmer P, 2005, ENV PHYSL ANIMALS; Zagoskin MV, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/926342; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	74	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196496	10.1371/journal.pone.0196496	http://dx.doi.org/10.1371/journal.pone.0196496			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708999	Green Published, gold, Green Submitted			2022-12-26	WOS:000431130100033
J	Salat, H; Murcio, R; Yano, K; Arcaute, E				Salat, Hadrien; Murcio, Roberto; Yano, Keiji; Arcaute, Elsa			Uncovering inequality through multifractality of land prices: 1912 and contemporary Kyoto	PLOS ONE			English	Article							ORDINAL VARIATION; SEGREGATION; CITIES; SPACE; AREAS	Multifractal analysis offers a number of advantages to measure spatial economic segregation and inequality, as it is free of categories and boundaries definition problems and is insensitive to some shape-preserving changes in the variable distribution. We use two datasets describing Kyoto land prices in 1912 and 2012 and derive city models from this data to show that multifractal analysis is suitable to describe the heterogeneity of land prices. We found in particular a sharp decrease in multifractality, characteristic of homogenisation, between older Kyoto and present Kyoto, and similarities both between present Kyoto and present London, and between Kyoto and Manhattan as they were a century ago. In addition, we enlighten the preponderance of spatial distribution over variable distribution in shaping the multifractal spectrum. The results were tested against the classical segregation and inequality indicators, and found to offer an improvement over those.	[Salat, Hadrien; Arcaute, Elsa] UCL, Ctr Adv Spatial Anal, London, England; [Murcio, Roberto] UCL, Consumer Res Data Ctr, London, England; [Yano, Keiji] Ritsumeikan Univ, Dept Geog, Kyoto, Japan	University of London; University College London; University of London; University College London; Ritsumeikan University	Salat, H (corresponding author), UCL, Ctr Adv Spatial Anal, London, England.	hadrien.salat@ucl.ac.uk	Salat, Hadrien/K-9708-2019	Salat, Hadrien/0000-0003-0958-9715	ERC [249393-ERC-2009-AdG]; UK ESRC Consumer Data Research Centre (CDRC) [ES/L011840/1]; EPSRC Digital Economy Phase 2: UK Regions Digital Research Facility (UK RDRF) [EP/M023583/1]; EPSRC [EP/M023583/1] Funding Source: UKRI; ESRC [ES/L011840/1] Funding Source: UKRI	ERC(European Research Council (ERC)European Commission); UK ESRC Consumer Data Research Centre (CDRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); EPSRC Digital Economy Phase 2: UK Regions Digital Research Facility (UK RDRF)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	R.M. was supported by ERC Grant [249393-ERC-2009-AdG] and also acknowledges the support of UK ESRC Consumer Data Research Centre (CDRC) [ES/L011840/1]. E.A. was supported by EPSRC Digital Economy Phase 2: UK Regions Digital Research Facility (UK RDRF) [EP/M023583/1, 2015-2020]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apparicio P, 2014, SOC SCI COMPUT REV, V32, P117, DOI 10.1177/0894439313504539; Ariza-Villaverde AB, 2013, COMPUT ENVIRON URBAN, V38, P1, DOI 10.1016/j.compenvurbsys.2012.11.001; ATMANSPACHER H, 1989, PHYS REV A, V40, P3954, DOI 10.1103/PhysRevA.40.3954; Batty M., 1994, FRACTAL CITIES; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; BERRY KJ, 1992, PERCEPT MOTOR SKILL, V74, P576, DOI 10.2466/PMS.74.2.576-578; Chakravorty S, 1996, URBAN STUD, V33, P1671, DOI 10.1080/0042098966556; Chen QM, 1999, COMPUT GEOSCI, V25, P1073, DOI 10.1016/S0098-3004(99)00068-0; CHHABRA AB, 1991, PHYS REV A, V43, P1114, DOI 10.1103/PhysRevA.43.1114; Dawkins CJ, 2007, J REGIONAL SCI, V47, P255, DOI 10.1111/j.1467-9787.2007.00508.x; Evertsz CJ, 1992, MULTIFRACTAL MEASURE, P849; Falconer K., 2003, FRACTAL GEOMETRY; Fielding AJ, 2004, T I BRIT GEOGR, V29, P64, DOI 10.1111/j.0020-2754.2004.00114.x; Frankhauser P., 1994, FRACTALITE STRUCTURE; Frisch U, 1983, P VAR SUMM SCH 88, VLXXXVIII; Fujita K, 1997, THE JAPANESE CITY, P106; HALSEY TC, 1986, PHYS REV A, V33, P1141, DOI 10.1103/PhysRevA.33.1141; Hu SG, 2013, LANDSCAPE URBAN PLAN, V110, P25, DOI 10.1016/j.landurbplan.2012.09.008; Hu SG, 2012, APPL GEOGR, V34, P161, DOI 10.1016/j.apgeog.2011.10.016; Huang YX, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016208; Huang YX, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026319; Jargowsky PA, 1996, AM SOCIOL REV, V61, P984, DOI 10.2307/2096304; Jargowsky PA, 2005, 053 NPC; KVALSETH TO, 1995, PERCEPT MOTOR SKILL, V80, P843, DOI 10.2466/pms.1995.80.3.843; KVALSETH TO, 1995, PERCEPT MOTOR SKILL, V81, P621, DOI 10.2466/pms.1995.81.2.621; Louf R, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.198702; McMillen DP, 2003, J URBAN ECON, V53, P321, DOI 10.1016/S0094-1190(03)00026-3; Murcio R, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062130; Murcio R, 2009, PHYSICA A, V388, P2689, DOI 10.1016/j.physa.2009.03.021; Nie Q, 2015, EARTH SCI INFORM, V8, P381, DOI 10.1007/s12145-014-0159-1; ODLAND J, 1978, ECON GEOGR, V54, P234, DOI 10.2307/142837; Reardon S., 2006, 29 GEN C INT ASS RES; Reardon SF, 2004, SOCIOL METHODOL, V34, P121, DOI 10.1111/j.0081-1750.2004.00150.x; Rodriguez-Romo S, 2014, CHAOS SOLITON FRACT, V66, P31, DOI 10.1016/j.chaos.2014.05.006; Salat H, 2017, PHYSICA A, V473, P467, DOI 10.1016/j.physa.2017.01.041; Sen A., 1973, EC INEQUALITY; VICSEK T, 1990, EUROPHYS LETT, V12, P217, DOI 10.1209/0295-5075/12/3/005; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; Yano K, 2011, HIST GIS KYOTO; Yano K, 2009, VIRTUAL GEOGRAPHIC E, P69; Yano K, 2007, VIRTUAL KYOTO EXPLOR, P48; Yano K, 2008, J GEOGR-TOKYO, V117, P464	42	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196737	10.1371/journal.pone.0196737	http://dx.doi.org/10.1371/journal.pone.0196737			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE3RI	29709024	Green Submitted, Green Published, gold			2022-12-26	WOS:000431130100055
J	Hallit, S; Leynaert, B; Delmas, MC; Rocchi, S; De Blic, J; Marguet, C; Scherer, E; Dufourg, MN; Bois, C; Reboux, G; Millon, L; Charles, MA; Raherison, C				Hallit, Souheil; Leynaert, Benedicte; Delmas, Marie Christine; Rocchi, Steffi; De Blic, Jacques; Marguet, Christophe; Scherer, Emeline; Dufourg, Marie Noelle; Bois, Corinne; Reboux, Gabriel; Millon, Laurence; Charles, Marie Aline; Raherison, Chantal			Wheezing phenotypes and risk factors in early life: The ELFE cohort	PLOS ONE			English	Article							1ST 6 YEARS; RESPIRATORY SYNCYTIAL VIRUS; CHILDHOOD WHEEZE; GASTROESOPHAGEAL-REFLUX; BIRTH COHORTS; LUNG-FUNCTION; ASTHMA; CHILDREN; ALLERGIES; PATTERNS	Objective Different phenotypes of wheezing have been described to date but not in early life. We aim to describe wheezing phenotypes between the ages of two months and one year, and assess risk factors associated with these wheezing phenotypes in a large birth cohort. Methods We studied 18,041 infants from the ELFE (French Longitudinal Study of Children) birth cohort. Parents reported wheezing and respiratory symptoms at two and 12 months, and answered a complete questionnaire (exposure during pregnancy, parental allergy). Results Children with no symptoms (controls) accounted for 77.2%, 2.1% had had wheezing at two months but no wheezing at one year (intermittent), 2.4% had persistent wheezing, while 18.3% had incident wheezing at one year. Comparing persistent wheezing to controls showed that having one sibling (ORa = 2.19) or 2 siblings (ORa = 2.23) compared to none, nocturnal cough (OR = 5.2), respiratory distress (OR = 4.1) and excess bronchial secretions (OR = 3.47) at two months, reflux in the child at 2 months (OR = 1.55), maternal history of asthma (OR = 1.46) and maternal smoking during pregnancy (OR = 1.57) were significantly associated with persistent wheezing. These same factors, along with cutaneous rash in the child at 2 months (OR = 1.13) and paternal history of asthma (OR = 1.32) were significantly associated with increased odds of incident wheezing. Having one sibling (ORa = 1.9) compared to none, nocturnal cough at 2 months (OR = 1.76) and excess bronchial secretions at 2 months (OR = 1.65) were significantly associated with persistent compared to intermittent wheezing. Conclusion Respiratory symptoms (cough, respiratory distress, and excessive bronchial secretion) were significantly associated with a high risk of persistent wheezing at one year. Smoking exposure during pregnancy was also a risk factor for persistent and incident wheezing.	[Hallit, Souheil; Raherison, Chantal] Bordeaux Univ, ISPED, INSERM, U1219, Bordeaux, France; [Leynaert, Benedicte] INSERM, U1152, Paris, France; [Leynaert, Benedicte] Univ Paris Dederot, Paris, France; [Delmas, Marie Christine] Sante Publ France, St Maurice, France; [Rocchi, Steffi; Scherer, Emeline; Reboux, Gabriel; Millon, Laurence] Univ Hosp, Parasitol Mycol Dept, Besancon, France; [Rocchi, Steffi; Scherer, Emeline; Reboux, Gabriel; Millon, Laurence] Bourgogne Franche Comte Univ, Chronoenvironnement, CNRS, UMR 6249, Besancon, France; [De Blic, Jacques] CHU Necker Enfants Malades, Pediat Allergy & Pulmonol, Paris, France; [Marguet, Christophe] CHU Rouen, Pediat & Pulmonol, Rouen, France; [Dufourg, Marie Noelle; Bois, Corinne; Charles, Marie Aline] INSERM, Unite Mixte, INED, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institute of Public Health Surveillance; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hallit, S (corresponding author), Bordeaux Univ, ISPED, INSERM, U1219, Bordeaux, France.	souheilhallit@hotmail.com	Raherison, Chantal/T-3556-2019; Charles, Marie Aline/S-1866-2019; Charles, Marie Aline/F-8567-2017; Leynaert, Benedicte/N-5251-2018; Millon, laurence/AAK-5980-2020; Hallit, Souheil/R-6727-2018	Charles, Marie Aline/0000-0003-4025-4390; Charles, Marie Aline/0000-0003-4025-4390; Leynaert, Benedicte/0000-0001-5045-2492; Hallit, Souheil/0000-0001-6918-5689; Rocchi, steffi/0000-0001-9262-1127	Ministry of Research, Comite de Concertation pour les Donnees en Sciences Humaines et Sociales (CCDSHS); Ministry of Culture (Departement des etudes, de la prospective et des statistiques [DEPS]); ANR [ANR-11-EQPX-0038]	Ministry of Research, Comite de Concertation pour les Donnees en Sciences Humaines et Sociales (CCDSHS); Ministry of Culture (Departement des etudes, de la prospective et des statistiques [DEPS]); ANR(French National Research Agency (ANR))	The ELFE survey is a joint project between the Institut National d'Etudes Demographiques (INED), Institut National de la Sante et de la Recherche Medicale (INSERM), Etablissement Francais du Sang (EFS), Institut de Veille Sanitaire (InVS), Institut National de la Statistique et des Etudes Economiques (INSEE), the Ministry of Health (Direction Generale de la Sante [DGS]), the Ministry of Environment (Direction Generale de la Prevention des Risques [DGPR]), the Ministries of Health and Employment (Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques [DREES]), and the Caisse Nationale des Allocations Familiales (CNAF), with the support the Ministry of Research, Comite de Concertation pour les Donnees en Sciences Humaines et Sociales (CCDSHS), and the Ministry of Culture (Departement des etudes, de la prospective et des statistiques [DEPS]). As part of the RECONAI platform, the study received state funding from the ANR within the framework of the Future Investments program (reference: ANR-11-EQPX-0038). We would also like to thank the scientific coordinators (B. Geay, H. Leridon, C. Bois, M.-N. Dufourg, J.L. Lanoe, X. Thierry, and C. Zaros), IT and data managers, and statistician (A. Rakotonirina, R. Kugel, R. Borges-Panhino, M. Cheminat, H. Juillard), administrative and family communication staff, study technician (C. Guevel, M. Zoubiri, L. Gravier, I. Milan, R. Popa) of the ELFE coordination team, as well as the families that gave time to the study. The funders had no role in the study design, collection, analysis and interpretation of data, nor in the writing of the report or the decision to submit the paper for publication.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Blake K, 2013, CURR OPIN PULM MED, V19, P24, DOI 10.1097/MCP.0b013e32835b582b; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Bousquet J, 2014, J ALLERGY CLIN IMMUN, V133, P1535, DOI 10.1016/j.jaci.2014.01.018; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Carroll KN, 2008, IMMUNOL ALLERGY CLIN, V28, P539, DOI 10.1016/j.iac.2008.03.001; Caudri D, 2009, J ALLERGY CLIN IMMUN, V124, P903, DOI 10.1016/j.jaci.2009.06.045; Chen QX, 2012, ANN ALLERG ASTHMA IM, V108, P311, DOI 10.1016/j.anai.2012.02.016; Chipps BE, 2011, J PEDIATR-US, V158, P878, DOI 10.1016/j.jpeds.2011.01.057; de Jong PA, 2006, AM J RESP CRIT CARE, V173, P199, DOI 10.1164/rccm.200505-810OC; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Gabet S, 2016, PEDIAT ALLERG IMM-UK, V27, P831, DOI 10.1111/pai.12622; Garcia-Aymerich J, 2015, ALLERGY, V70, P973, DOI 10.1111/all.12640; Global Initiative for Asthma (GINA), 2017, GINA REP GLOB STRAT; Grad R, 2012, J ALLERGY CLIN IMMUN, V130, P299, DOI 10.1016/j.jaci.2012.05.022; Grazuleviciene R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/240757; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Herr M, 2012, J ALLERGY CLIN IMMUN, V130, P389, DOI 10.1016/j.jaci.2012.05.054; JENKINS MA, 1994, BRIT MED J, V309, P90, DOI 10.1136/bmj.309.6947.90; Litonjua AA, 1998, AM J RESP CRIT CARE, V158, P176, DOI 10.1164/ajrccm.158.1.9710014; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Paaso EMS, 2013, AM J RESP CRIT CARE, V188, P624, DOI 10.1164/rccm.201212-2236LE; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Smits HH, 2016, CURR OPIN IMMUNOL, V42, P41, DOI 10.1016/j.coi.2016.05.009; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Spycher B, 2013, J ALLERGY CLIN IMMUN, V132, P1058, DOI 10.1016/j.jaci.2013.08.002; Stensballe LG, 2006, PEDIATRICS, V118, pE1360, DOI 10.1542/peds.2006-0907; Thakkar K, 2010, PEDIATRICS, V125, pE925, DOI 10.1542/peds.2009-2382; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Tromp IIM, 2012, EUR RESPIR J, V40, P681, DOI 10.1183/09031936.00119111; Vandentorren S, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-58; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8	40	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196711	10.1371/journal.pone.0196711	http://dx.doi.org/10.1371/journal.pone.0196711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702689	Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300045
J	Morris, S; Subramanian, J; Gel, E; Runger, G; Thompson, E; Mallery, D; Weiss, G				Morris, Scott; Subramanian, Janakiraman; Gel, Esma; Runger, George; Thompson, Eric; Mallery, David; Weiss, Glen			Performance of next-generation sequencing on small tumor specimens and/or low tumor content samples using a commercially available platform	PLOS ONE			English	Article							CELL LUNG-CANCER	Background Next generation sequencing tests (NGS) are usually performed on relatively small core biopsy or fine needle aspiration (FNA) samples. Data is limited on what amount of tumor by volume or minimum number of FNA passes are needed to yield sufficient material for running NGS. We sought to identify the amount of tumor for running the PCDx NGS platform. Methods 2,723 consecutive tumor tissues of all cancer types were queried and reviewed for inclusion. Information on tumor volume, success of performing NGS, and results of NGS were compiled. Assessment of sequence analysis, mutation calling and sensitivity, quality control, drug associations, and data aggregation and analysis were performed. Results 6.4% of samples were rejected from all testing due to insufficient tumor quantity. The number of genes with insufficient sensitivity make definitive mutation calls increased as the percentage of tumor decreased, reaching statistical significance below 5% tumor content. The number of drug associations also decreased with a lower percentage of tumor, but this difference only became significant between 1-3%. The number of drug associations did decrease with smaller tissue size as expected. Neither specimen size or percentage of tumor affected the ability to pass mRNA quality control. A tumor area of 10 mm(2) provides a good margin of error for specimens to yield adequate drug association results. Conclusions Specimen suitability remains a major obstacle to clinical NGS testing. We determined that PCR-based library creation methods allow the use of smaller specimens, and those with a lower percentage of tumor cells to be run on the PCDx NGS platform.	[Morris, Scott; Thompson, Eric; Mallery, David] Paradigm Diagnost, Phoenix, AZ 85004 USA; [Subramanian, Janakiraman] St Lukes Hlth Syst, Kansas City, MO USA; [Gel, Esma] Arizona State Univ, Coll Comp Informat & Decis Syst Engn, Tempe, AZ USA; [Runger, George] Arizona State Univ, Dept Biomed Informat, Phoenix, AZ USA; [Weiss, Glen] Univ Arizona, Coll Med Phoenix, Phoenix, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Downtown Phoenix; University of Arizona	Morris, S (corresponding author), Paradigm Diagnost, Phoenix, AZ 85004 USA.	smorris@paradigmdx.com	Gel, Esma/AAM-2969-2020	Gel, Esma/0000-0003-0472-4762; weiss, glen/0000-0002-6067-597X	Paradigm Diagnostics	Paradigm Diagnostics	Paradigm Diagnostics funded this work (SM, DM and ET are all employed by Paradigm Diagnostics; GW was a consultant for Paradigm Diagnostics). The specific roles of these authors are articulated in the 'author contributions' section. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CH, 2012, J CANCER, V3, P7, DOI 10.7150/jca.3.7; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gutierrez ME, 2017, CLIN LUNG CANCER, V18, P651, DOI 10.1016/j.cllc.2017.04.004; Hagemann IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/cncr.29089; Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Mantripragada KC, 2016, J ONCOL PRACT, V12, pE396, DOI 10.1200/JOP.2015.008433; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Radovich M, 2016, ONCOTARGET, V7, P56491, DOI 10.18632/oncotarget.10606; Rangachari Deepa, 2016, Cancer Treat Commun, V9, P41, DOI 10.1016/j.ctarc.2016.07.001; Squillace RM, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S88908; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Weiss GJ, 2015, ONCOTARGETS THER, V8, P959, DOI 10.2147/OTT.S81995	14	19	19	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196556	10.1371/journal.pone.0196556	http://dx.doi.org/10.1371/journal.pone.0196556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702695	Green Published, gold			2022-12-26	WOS:000431013300038
J	Voysey, M; Pollard, AJ; Perera, R; Shrestha, S; Thorson, S; Fanshawe, TR				Voysey, Merryn; Pollard, Andrew J.; Perera, Rafael; Shrestha, Shrijana; Thorson, Stephen; Fanshawe, Thomas R.			Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; INVASIVE-DISEASE; CARRIAGE; RATES	Background Many vaccines contain multiple components. Licensed pneumococcal conjugate vaccines (PCV) contain polysaccharides from 7, 10, or 13 different serotypes of Streptococcus pneumoniae. The main outcomes in randomised trials of pneumococcal vaccines are serotype-specific antibody measures. Comparisons are made between groups for each serotype, resulting in multiple separate comparisons of treatment effects which can be complicated to interpret. We investigated methods for computing the overall difference between vaccine groups across all serotypes. Methods Pneumococcal antibody concentrations were obtained from a randomised controlled trial of ten-valent pneumococcal vaccine, conducted in Kathmandu, Nepal. Infants received either 2 priming doses of vaccine at 6 and 14 weeks of age followed by a booster (2+1), or 3 priming doses at 6, 10, and 14 weeks of age with no booster (3+0). The overall difference between vaccine schedules across all serotypes was computed at each visit using a multi-variate linear model with equal weights for each serotype. Alternative weights were derived from invasive pneumococcal disease cases in Nepal, Bangladesh and Pakistan, and from estimates of the relative invasiveness of each serotype and used in sensitivity analyses. Results When 10 separate estimates of treatment differences were computed the ratio of antibody responses for each serotype in the 2+1 group compared with the 3+0 group at 10 months of age varied greatly, with serotype-specific GMRs ranging from 2.80 for serotype 14, to 9.14 for serotype 18C. Using equal weights for each serotype, the overall geometric mean ratio (GMR) was 5.02 (95% CI 4.06-6.22) at 10 months of age, and 1.46 (95% CI 1.14-1.88) at 3 years of age. Using weights based on disease incidence gave GMRs ranging from 5.15 to 6.63 at 10 months of age, and 1.47 to 1.78 at 3 years of age. Using weights based on relative invasiveness gave estimates of 6.81 and 1.59, at 10 months and 3 years respectively. Conclusion PCV clinical trial data have a multivariate structure with correlated outcomes for different serotypes. When analysing each serotype separately, the multiple estimates of the treatment effect can complicate the interpretation of trial results. Reporting a single overall estimate which accounts for the correlation between outcomes can simplify such interpretation. Treatment effects can be weighted equally or alternative weights derived from independent data can be used. Many modern vaccines have multiple components, such as quadrivalent meningococcal group ACWY vaccine or four-component group B meningococcal vaccine, thus these methods are widely applicable.	[Voysey, Merryn; Perera, Rafael; Fanshawe, Thomas R.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Voysey, Merryn; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Pollard, Andrew J.] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England; [Shrestha, Shrijana; Thorson, Stephen] Patan Acad Hlth Sci, Paediat Res Unit, Kathmandu, Nepal	University of Oxford; University of Oxford; University of Oxford	Voysey, M (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.; Voysey, M (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.	merryn.voysey@phc.ox.ac.uk		Shrestha, Shrijana/0000-0001-9484-0227; Perera, Rafael/0000-0003-2418-2091; Voysey, Merryn/0000-0001-6324-6559	National Institute of Health Research Doctoral Research Fellowship [DRF-2015-08-048]	National Institute of Health Research Doctoral Research Fellowship	MV is funded by a National Institute of Health Research Doctoral Research Fellowship (DRF-2015-08-048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Di Fabio JL, 2001, PEDIATR INFECT DIS J, V20, P959, DOI 10.1097/00006454-200110000-00009; Fox J., 2014, R COMPANION APPL REG; Hamaluba M, 2015, LANCET INFECT DIS, V15, P405, DOI 10.1016/S1473-3099(15)70007-1; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Jobson J D, 2012, APPL MULTIVARIATE DA; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kandasamy R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114286; Kelly DF, 2011, INT J INFECT DIS, V15, pE17, DOI 10.1016/j.ijid.2010.05.021; Lee LH, 2003, VACCINE, V21, P2190, DOI 10.1016/S0264-410X(03)00025-2; R Core Team, 2013, R LANG ENV STAT COMP; Saha SK, 2015, PED INFECT DIS J; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Schuerman L, 2011, CLIN VACCINE IMMUNOL, V18, P2161, DOI 10.1128/CVI.05313-11; Shah AS, 2009, CLIN INFECT DIS, V48, pS123, DOI 10.1086/596490; Shakoor S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098796; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008; Truck J, 2016, PED INFECT DIS J	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196200	10.1371/journal.pone.0196200	http://dx.doi.org/10.1371/journal.pone.0196200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702658	Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300022
J	Boscutti, F; Casolo, V; Beraldo, P; Braidot, E; Zancani, M; Rixen, C				Boscutti, Francesco; Casolo, Valentino; Beraldo, Paola; Braidot, Enrico; Zancani, Marco; Rixen, Christian			Shrub growth and plant diversity along an elevation gradient: Evidence of indirect effects of climate on alpine ecosystems	PLOS ONE			English	Article							SPECIES RICHNESS; VACCINIUM-MYRTILLUS; DWARF SHRUBS; CYCLICAL PROCESSES; HEATH COMMUNITY; ARCTIC TUNDRA; LAND-USE; VEGETATION; EXPANSION; RESPONSES	Enhanced shrub growth and expansion are widespread responses to climate warming in many arctic and alpine ecosystems. Warmer temperatures and shrub expansion could cause major changes in plant community structure, affecting both species composition and diversity. To improve our understanding of the ongoing changes in plant communities in alpine tundra, we studied interrelations among climate, shrub growth, shrub cover and plant diversity, using an elevation gradient as a proxy for climate conditions. Specifically, we analyzed growth of bilberry (Vaccinium myrtillus L.) and its associated plant communities along an elevation gradient of ca. 600 vertical meters in the eastern European Alps. We assessed the ramet age, ring width and shoot length of V. myrtillus, and the shrub cover and plant diversity of the community. At higher elevation, ramets of V. myrtillus were younger, with shorter shoots and narrower growth rings. Shoot length was positively related to shrub cover, but shrub cover did not show a direct relationship with elevation. A greater shrub cover had a negative effect on species richness, also affecting species composition (beta-diversity), but these variables were not influenced by elevation. Our findings suggest that changes in plant diversity are driven directly by shrub cover and only indirectly by climate, here represented by changes in elevation.	[Boscutti, Francesco; Casolo, Valentino; Beraldo, Paola; Braidot, Enrico; Zancani, Marco] Univ Udine, Dept Agr Food Environm & Anim Sci, Plant Biol Unit, Udine, Italy; [Rixen, Christian] Alpine Ecosyst, WSL Inst Forest Snow & Landscape Res SLF, Unit Ecosyst Boundaries, Davos, Switzerland	University of Udine; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Boscutti, F (corresponding author), Univ Udine, Dept Agr Food Environm & Anim Sci, Plant Biol Unit, Udine, Italy.	francesco.boscutti@uniud.it	Boscutti, Francesco/M-4297-2015; Beraldo, Paola/AGG-0926-2022	Boscutti, Francesco/0000-0002-4969-2752; BRAIDOT, Enrico/0000-0002-5415-3657; Beraldo, Paola/0000-0002-5806-4109	Provincia di Udine	Provincia di Udine	This research was funded by a grant of the "Provincia di Udine" to FB.; We thank Michela D'Ambrogio and Fabiola Salzillo for support during field surveys and ramet cross-section processing, and Carla Calligaro for supervising the laboratory activities. We thank Mellissa Dawes and Prof. Angelo Vianello for their support during the writing of this manuscript and for their critical revision. We further thank Michele Fabro, Silvano Fior and Andrea Marini, of the "Provincia di Udine", and the staff of the "Corpo forestale della Regione Friuli Venezia Giulia" for logistic support during field surveys. This research was funded by a grant of the "Provincia di Udine" which supervised all the field surveys.	Aeschimann D, 2004, FLORA ALPINA; Anadon-Rosell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100577; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Bar A, 2008, J BIOGEOGR, V35, P625, DOI 10.1111/j.1365-2699.2007.01804.x; Bar A., 2006, Dendrochronologia, V24, P17, DOI 10.1016/j.dendro.2006.05.001; BARCLAYESTRUP P, 1969, J ECOL, V57, P737, DOI 10.2307/2258496; BARCLAYESTRUP P, 1970, J ECOL, V58, P243, DOI 10.2307/2258179; Blok D., 2011, BIOGEOSCIENCES, V8, P1169, DOI [10.5194/bg-8-1169-2011, DOI 10.5194/bg-8-1169-2011]; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Bruun HH, 2006, J VEG SCI, V17, P37, DOI 10.1111/j.1654-1103.2006.tb02421.x; Buntgen U, 2015, J ECOL, V103, P489, DOI 10.1111/1365-2745.12361; Chang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123499; Christie KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101716; Dial RJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000453; Dirnbock T, 2003, J BIOGEOGR, V30, P401, DOI 10.1046/j.1365-2699.2003.00839.x; Ellenberg H., 1988, VEGETATION ECOLOGY C; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Fernandez-Calvo IC, 2004, FORESTRY, V77, P213, DOI 10.1093/forestry/77.3.213; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Hallinger M, 2010, NEW PHYTOL, V186, P890, DOI 10.1111/j.1469-8137.2010.03223.x; Klanderud K, 2003, HOLOCENE, V13, P1, DOI 10.1191/0959683603hl589ft; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Kullman L, 2002, J ECOL, V90, P68, DOI 10.1046/j.0022-0477.2001.00630.x; Kumordzi BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157136; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lutz C, 2012, PLANTS ALPINE REGION; Mucina L, 1993, PFLANZENGESELLSCHA 2, VII; Mucina L., 1993, PFLANZENGESELLSCHA 3; Mucina L, 1993, PFLANZENGESELLSCHA 1, V1; Myers-Smith IH, 2015, NAT CLIM CHANGE, V5, P887, DOI [10.1038/nclimate2697, 10.1038/NCLIMATE2697]; Myers-Smith IH, 2015, EARTH-SCI REV, V140, P1, DOI 10.1016/j.earscirev.2014.10.004; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Odland A, 1999, ECOGRAPHY, V22, P548, DOI 10.1111/j.1600-0587.1999.tb01285.x; Olofsson J, 2009, GLOBAL CHANGE BIOL, V15, P2681, DOI 10.1111/j.1365-2486.2009.01935.x; PARSONS AN, 1994, J ECOL, V82, P307, DOI 10.2307/2261298; Pearson RG, 2013, NAT CLIM CHANGE, V3, P673, DOI [10.1038/NCLIMATE1858, 10.1038/nclimate1858]; Pellissier L, 2010, PLANT ECOL, V211, P351, DOI 10.1007/s11258-010-9794-x; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Poldini L, 2004, PLANT BIOSYST, V138, P53, DOI 10.1080/11263500410001684125; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; PYRKE AF, 1994, J VEG SCI, V5, P13, DOI 10.2307/3235633; R Core Team, 2017, LANG ENV STAT COMP; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Raich JW, 1997, ECOLOGY, V78, P707; Rixen C, 2004, BOT HELV, V114, P127, DOI 10.1007/s00035-004-0692-5; Rixen C, 2010, POLAR RES, V29, P85, DOI 10.1111/j.1751-8369.2010.00155.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sedlacek J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122395; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Stohlgren TJ, 1999, ECOL APPL, V9, P45, DOI 10.1890/1051-0761(1999)009[0045:HGASQA]2.0.CO;2; Strengbom J, 2003, OIKOS, V103, P133, DOI 10.1034/j.1600-0706.2003.12680.x; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Tape KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152636; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Tommervik H, 2009, FOREST ECOL MANAG, V257, P244, DOI 10.1016/j.foreco.2008.08.038; Venturini C., 2006, EVOLUZIONE GEOLOGICA; von Arx G, 2006, ECOLOGY, V87, P665, DOI 10.1890/05-1041; Wahren CHA, 2005, GLOBAL CHANGE BIOL, V11, P537, DOI 10.1111/j.1365-2486.2005.00927.x; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; WALKER MD, 1995, ECOL STU AN, V113, P3; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; WHITTAKER RH, 1975, ECOLOGY, V56, P771, DOI 10.2307/1936291; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Wilson SD, 2009, GLOBAL CHANGE BIOL, V15, P1676, DOI 10.1111/j.1365-2486.2009.01896.x; Wipf S, 2006, GLOBAL CHANGE BIOL, V12, P1496, DOI 10.1111/j.1365-2486.2006.01185.x; WOODWARD FI, 1986, OECOLOGIA, V70, P580, DOI 10.1007/BF00379908; ZISKA LH, 1992, AM J BOT, V79, P863, DOI 10.2307/2444995	80	33	34	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196653	10.1371/journal.pone.0196653	http://dx.doi.org/10.1371/journal.pone.0196653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698464	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600113
J	Peng, B; Peng, SH; Qu, RM; Xu, LH; Jiang, ZL				Peng, Bin; Peng, Shun-Hua; Qu, Run-Ming; Xu, Li-Hua; Jiang, Zheng-Lin			Nitrogen narcosis induced by repetitive hyperbaric nitrogen oxygen mixture exposure impairs long-term cognitive function in newborn mice	PLOS ONE			English	Article							INERT-GAS NARCOSIS; CENTRAL-NERVOUS-SYSTEM; APOPTOTIC NEURODEGENERATION; GENERAL-ANESTHESIA; DEVELOPING BRAIN; MEMORY; ISOFLURANE; HELIUM; DIVERS; IMPACT	Human beings are exposed to compressed air or a nitrogen-oxygen mixture, they will produce signs and symptoms of nitrogen narcosis such as amnesia or even loss of memory, which may be disappeared once back to the normobaric environment. This study was designed to investigate the effect of nitrogen narcosis induced by repetitive hyperbaric nitrogen-oxygen mixture exposure on long-term cognitive function in newborn mice and the underlying mechanisms. The electroencephalogram frequency was decreased while the amplitude was increased in a pressure-dependent manner during 0.6, 1.2, 1.8 MPa (million pascal) nitrogen-oxygen mixture exposures in adult mice. Nitrogen narcosis in postnatal days 7-9 mice but not in adult mice induced by repetitive hyperbaric exposure prolonged the latency to find the platform and decreased the number of platform-site crossovers during Morris water maze tests, and reduced the time in the center during the open field tests. An increase in the expression of cleaved caspase-3 in the hippocampus and cortex were observed immediately on the first day after hyperbaric exposure, and this lasted for seven days. Additionally, nitrogen narcosis induced loss of the dendritic spines but not of the neurons, which may mainly account for the cognitive dysfunction. Nitrogen narcosis induced long-term cognitive and emotional dysfunction in the postnatal mice but not in the adult mice, which may result from neuronal apoptosis and especially reduction of dendritic spines of neurons.	[Jiang, Zheng-Lin] Nantong Univ, Inst Naut Med, Dept Neurophysiol & Neuropharmacol, Nantong, Jiangsu, Peoples R China; Nantong Univ, Co innovat Ctr Neuroregenerat, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Jiang, ZL (corresponding author), Nantong Univ, Inst Naut Med, Dept Neurophysiol & Neuropharmacol, Nantong, Jiangsu, Peoples R China.	jiangzl@ntu.edu.cn	xu, li/GNH-3667-2022	Peng, Bin/0000-0002-4422-5637; Jiang, Zheng-Lin/0000-0002-7134-5511	Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China [81372131, 81671859, 81601639]; Natural Science Fund for Colleges and Universities in Jiangsu Province [17KJB340001]	Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund for Colleges and Universities in Jiangsu Province	This work was partly supported by a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, and the authors were also supported by grants obtained from the National Natural Science Foundation of China (81372131, 81671859 and 81601639) and Natural Science Fund for Colleges and Universities in Jiangsu Province (17KJB340001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraini JH, 1998, BRAIN RES, V808, P300, DOI 10.1016/S0006-8993(98)00760-4; Balestra C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00696; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Briner A, 2011, ANESTHESIOLOGY, V115, P282, DOI 10.1097/ALN.0b013e318221fbbd; Buchanan TW, 2009, HORM BEHAV, V56, P44, DOI 10.1016/j.yhbeh.2009.02.011; Clark JE, 2015, EXTREME PHYSIOL MED, V4, DOI 10.1186/s13728-014-0020-7; Coleman K, 2017, ANESTHESIOLOGY, V126, P74, DOI 10.1097/ALN.0000000000001383; ECKENHOFF JE, 1953, AMA AM J DIS CHILD, V86, P587, DOI 10.1001/archpedi.1953.02050080600004; Freiberger JJ, 2016, J APPL PHYSIOL, V121, P953, DOI 10.1152/japplphysiol.00534.2016; Gronli J, 2016, J SLEEP RES, V25, P103; Hemelryck W, 2014, SCAND J MED SCI SPOR, V24, P928, DOI 10.1111/sms.12100; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hobbs M, 2009, UNDERSEA HYPERBAR M, V36, P73; Hobbs M, 2015, PHYSIOL BEHAV, V144, P46, DOI 10.1016/j.physbeh.2015.02.043; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Istaphanous GK, 2013, ANESTH ANALG, V116, P845, DOI 10.1213/ANE.0b013e318281e988; Jenniches I, 2016, BIOL PSYCHIAT, V79, P858, DOI 10.1016/j.biopsych.2015.03.033; Kirkland PJ, 2018, DIVING NITROGEN NARC; Loepke AW, 2008, ANESTH ANALG, V106, P1681, DOI 10.1213/ane.0b013e318167ad77; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Pastena L, 2005, AVIAT SPACE ENVIR MD, V76, P1031; Platholi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102978; Raper J, 2015, ANESTHESIOLOGY, V123, P1084, DOI 10.1097/ALN.0000000000000851; Rostain JC, 2011, UNDERSEA HYPERBAR M, V38, P49; Rostain JC, 2016, COMPR PHYSIOL, V6, P1579, DOI 10.1002/cphy.c150024; Schmidt M, 2016, BEHAV BRAIN RES, V296, P7, DOI 10.1016/j.bbr.2015.08.005; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; TOWNSEND RE, 1971, AEROSPACE MED, V42, P843; Vallee N, 2009, NEUROCHEM RES, V34, P835, DOI 10.1007/s11064-008-9827-1; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vutskits L, 2016, NAT REV NEUROSCI, V17, P705, DOI 10.1038/nrn.2016.128; Wlodarczyk A, 2006, CHEM SOC REV, V35, P890, DOI 10.1039/b517771p; Zhang YY, 2012, ANN NEUROL, V72, P630, DOI 10.1002/ana.23683	34	1	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196611	10.1371/journal.pone.0196611	http://dx.doi.org/10.1371/journal.pone.0196611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698458	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600109
J	Qin, BL; Hu, HL; Lu, YC; Wang, YF; Yu, Y; Zhang, JQ; Zhang, ZB; Gao, HB; Wang, Q; Wang, SG				Qin, Baolong; Hu, Henglong; Lu, Yuchao; Wang, Yufeng; Yu, Yang; Zhang, Jiaqiao; Zhang, Zhongbiao; Gao, Hongbin; Wang, Qing; Wang, Shaogang			Intraoperative ultrasonography in laparoscopic partial nephrectomy for intrarenal tumors	PLOS ONE			English	Article							RADICAL NEPHRECTOMY; SPARING SURGERY; RENAL TUMORS; ULTRASOUND	Objective To evaluate the feasibility and efficacy of intraoperative ultrasonography in laparoscopic partial nephrectomy (LPN) for intrarenal tumors. Patients and methods All patients who underwent LPN for renal tumors in our institution from January 2010 to October 2016 were assessed retrospectively. Patients were divided into two groups, the first with totally intrarenal tumors (TIT group), defined as a solid renal mass with no exophytic element on both preoperative and intraoperative evaluations, and the second with exophytic tumors (control group). General information and perioperative data of the two groups were compared, including tumor characteristics, operative time, estimated blood loss, warm ischemia time and pathological findings. Intraoperative laparoscopic ultrasonography (ILUS) was used to precisely locate and delineate the TIT border, as well as seeking for other suspected lesions. Results We identified 583 patients who underwent LPN in our center, including 46 in the TIT and 537 in the control group. All patients in the TIT group were evaluated by ILUS, and all TIT procedures were successfully performed with only one conversion to open surgery. The mean tumor sizes in the TIT and control groups were 2.42 +/- 0.46 cm and 3.29 +/- 1.43 cm (p < 0.001), respectively. The TIT group's R.E.N.A.L. nephrometry score was higher than that of the control group (median 8.5 vs 6.0, p < 0.001), and their mean operation times were 127.2 +/- 16.0 min and 120.1 +/- 19.2 min, respectively. Mean estimated blood loss was higher in the TIT than in the control group (161.3 ml vs 136.6 ml, p = 0.003). Mean warm ischemia time differed in the TIT and control groups (22.2 +/- 6.4 vs 20.6 +/- 4.7 min, p = 0.105), but not significantly. Rates of open conversion and positive margins, as well as rates of major postoperative complications, pathological findings, and 1-month changes in renal function, were similar in the two groups. Conclusion Intraoperative ultrasonography is technically feasible in patients undergoing LPN for TITs. This method may reduce the need for radical nephrectomy in patients with endogenic renal masses.	[Qin, Baolong; Hu, Henglong; Lu, Yuchao; Wang, Yufeng; Zhang, Jiaqiao; Zhang, Zhongbiao; Gao, Hongbin; Wang, Qing; Wang, Shaogang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan, Hubei, Peoples R China; [Yu, Yang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Ultrasonog, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, SG (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan, Hubei, Peoples R China.	sgwangtjm@163.com	Wang, Shaogang/AGO-4944-2022; Zhang, Jiaqiao/GMX-0790-2022	Wang, Shaogang/0000-0002-3206-1495; Wang, Qing/0000-0001-6540-1858; Zhang, Jiaqiao/0000-0001-6747-0654; Hu, Henglong/0000-0002-3618-7036	National Natural Science Foundation of China [81570631]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81570631). The URLs of National Natural Science Foundation of China is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YB, 2014, WORLD J UROL, V32, P1493, DOI 10.1007/s00345-013-1222-0; Chung BI, 2011, J UROLOGY, V186, P2182, DOI 10.1016/j.juro.2011.07.106; Drachenberg DE, 2004, J UROLOGY, V172, P49, DOI 10.1097/01.ju.0000130930.70356.28; Gwinn EC, 2013, SURGERY, V154, P909, DOI 10.1016/j.surg.2013.04.041; Haber GP, 2006, EUR UROL, V49, P660, DOI 10.1016/j.eururo.2006.02.001; Kolecki R, 1998, SURG CLIN N AM, V78, P251, DOI 10.1016/S0039-6109(05)70312-1; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Marszalek M, 2009, EUR UROL, V55, P1171, DOI 10.1016/j.eururo.2009.01.042; Nadu A, 2013, BJU INT, V112, pE82, DOI 10.1111/bju.12168; Olweny EO, 2012, BJU INT, V109, P906, DOI 10.1111/j.1464-410X.2011.10547.x; Porpiglia F, 2014, EUR UROL, V66, P778, DOI 10.1016/j.eururo.2014.06.001; Ren T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091978; SCHLEGEL JU, 1961, J UROLOGY, V86, P367, DOI 10.1016/S0022-5347(17)65180-2; Scosyrev E, 2014, EUR UROL, V65, P372, DOI 10.1016/j.eururo.2013.06.044; SIGEL B, 1980, RADIOLOGY, V137, P531, DOI 10.1148/radiology.137.2.7433687; SIGEL B, 1984, ANN SURG, V200, P486, DOI 10.1097/00000658-198410000-00010; Tan HJ, 2012, JAMA-J AM MED ASSOC, V307, P1629, DOI 10.1001/jama.2012.475; Volpe A, 2015, EUR UROL, V68, P61, DOI 10.1016/j.eururo.2015.01.025; Wang YB, 2016, BJU INT, V117, P126, DOI 10.1111/bju.13214; Wright JL, 2005, J UROLOGY, V174, P841, DOI 10.1097/01.ju.0000169423.94253.46	21	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195911	10.1371/journal.pone.0195911	http://dx.doi.org/10.1371/journal.pone.0195911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698427	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600022
J	Haider, MSH; Khan, WH; Deeba, F; Ali, S; Ahmed, A; Naqvi, IH; Dohare, R; Alsenaidy, HA; Alsenaidy, AM; Broor, S; Parveen, S				Haider, Md Shakir Hussain; Khan, Wajihul Hasan; Deeba, Farah; Ali, Sher; Ahmed, Anwar; Naqvi, Irshad H.; Dohare, Ravins; Alsenaidy, Hytham A.; Alsenaidy, Abdulrahman M.; Broor, Shobha; Parveen, Shama			BA9 lineage of respiratory syncytial virus from across the globe and its evolutionary dynamics	PLOS ONE			English	Article							GLYCOPROTEIN G GENE; G-PROTEIN GENE; B GENOTYPE BA; MOLECULAR EPIDEMIOLOGY; SUBGROUP-B; PHYLOGENETIC ANALYSIS; CIRCULATION PATTERNS; GROUP-A; SOUTHWESTERN CHINA; ON1 GENOTYPE	Respiratory syncytial virus (RSV) is an important pathogen of global significance. The BA9 is one of the most predominant lineages of the BA genotype of group B RSV that has acquired a 60bp duplication in its G protein gene. We describe the local and global evolutionary dynamics of the second hyper variable region in the C-terminal of the G protein gene of the BA9 lineage. A total of 418 sequences (including 31 study and 387 GenBank strains) from 29 different countries were used for phylogenetic analysis. This analysis showed that the study strains clustered with BA (BA9 and BA8) and SAB4 genotype of group B RSV. We performed time-scaled evolutionary clock analyses using Bayesian Markov chain Monte Carlo methods. We also carried out glycosylation, selection pressure, mutational, entropy and Network analyses of the BA9 lineage. The time to the most recent common ancestor (tMRCA) of the BA genotype and BA9 lineage were estimated to be the years 1995 (95% HPD; 1987-1997) and 2000 (95% HPD; 1998-2001), respectively. The nucleotide substitution rate of the BA genotype [(4.58 x 10(-3) (95% HPD; 3.89-5.29 x 10(-3)) substitution/site/year] was slightly faster than the BA9 lineage [4.03 x 10(-3) (95% HPD; 4.65-5.2492 x 10(-3))]. The BA9 lineage was categorized into 3 sub lineages (I, II and III) based on the Bayesian and Network analyses. The local transmission pattern suggested that BA9 is the predominant lineage of BA viruses that has been circulating in India since 2002 though showing fluctuations in its effective population size. The BA9 lineage established its global distribution with report from 23 different countries over the past 16 years. The present study augments our understanding of RSV infection, its epidemiological dynamics warranting steps towards its overall global surveillance.	[Haider, Md Shakir Hussain; Khan, Wajihul Hasan; Deeba, Farah; Ali, Sher; Dohare, Ravins; Parveen, Shama] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India; [Khan, Wajihul Hasan] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, New Delhi, India; [Ahmed, Anwar; Alsenaidy, Abdulrahman M.] King Saud Univ, Dept Biochem, Coll Sci, Riyadh, Saudi Arabia; [Ahmed, Anwar] King Saud Univ, Dept Biochem, Coll Sci, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia; [Naqvi, Irshad H.] Jamia Millia Islamia, Dr MA Ansari Hlth Ctr, New Delhi, India; [Alsenaidy, Hytham A.] Shaqra Univ, Coll Med, Shaqra, Saudi Arabia; [Broor, Shobha] Shree Guru Gobind Singh Tricentenary Univ, Dept Microbiol, Fac Med & Hlth Sci, Gurgaon, Haryana, India	Jamia Millia Islamia; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; King Saud University; King Saud University; Jamia Millia Islamia; Shaqra University	Parveen, S (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India.	sparveen2@jmi.ac.in	Dohare, Ravins/AAN-6883-2020; Khan, Wajihul/AAT-2889-2021; Ahmed, Anwar/AAL-7789-2021; Broor, Shobha/AAX-4163-2021; Ahmed, Anwar/ADH-1445-2022	Dohare, Ravins/0000-0002-0602-3719; Khan, Wajihul/0000-0002-8544-2638; Broor, Shobha/0000-0001-9679-4180; Ahmed, Anwar/0000-0001-8147-714X	Council of Scientific and Industrial Research and Indian Council of Medical Research, Government of India; DST-SERB, New Delhi, India; King Saud University, College of Science Research Centre; Research fellowship by Council of Scientific and Industrial Research and Indian Council of Medical Research, Government of India; King Saud University, Deanship of Scientific Research, College of Science Research Centre	Council of Scientific and Industrial Research and Indian Council of Medical Research, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaIndian Council of Medical Research (ICMR)); DST-SERB, New Delhi, India; King Saud University, College of Science Research Centre(King Saud University); Research fellowship by Council of Scientific and Industrial Research and Indian Council of Medical Research, Government of India; King Saud University, Deanship of Scientific Research, College of Science Research Centre(King Saud University)	Md Shakir Hussain Haider is supported by Research fellowship by Council of Scientific and Industrial Research and Indian Council of Medical Research, Government of India. S Ali acknowledges the award of J.C. Bose National fellowship from DST-SERB, New Delhi, India. We thank Centre for Development of Advanced Computing (C-DAC) Pune, for providing Bioinformatics Resources and Applications Facility (BRAF) server. This study was supported by King Saud University, Deanship of Scientific research, College of Science Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Md Shakir Hussain Haider is supported by Research fellowship by Council of Scientific and Industrial Research and Indian Council of Medical Research, Government of India. S Ali acknowledges the award of J.C. Bose National fellowship from DST-SERB, New Delhi, India). We thank Centre for Development of Advanced Computing (C-DAC) Pune, for providing Bioinformatics Resources and Applications Facility (BRAF) server. This study was supported by King Saud University, Deanship of Scientific Research, College of Science Research Centre.	Agrawal AS, 2009, J CLIN VIROL, V45, P358, DOI 10.1016/j.jcv.2009.05.013; Ahmed A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166145; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bharaj P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-89; Bose ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120098; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Choudhary ML, 2013, INFECT GENET EVOL, V20, P369, DOI 10.1016/j.meegid.2013.09.025; Cui GL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.19; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Luna LKD, 2007, J INFECT DIS, V195, P675, DOI 10.1086/511432; Tran DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045436; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Esposito S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129369; Etemadi MR, 2013, EVOL BIOINFORM, V9, DOI 10.4137/EBO.S10999; Faghihloo E, 2011, ACTA VIROL, V55, P81, DOI 10.4149/av_2011_01_81; Faghihloo E, 2014, INFECT GENET EVOL, V22, P130, DOI 10.1016/j.meegid.2014.01.009; Forcic D, 2012, J MED VIROL, V84, P1985, DOI 10.1002/jmv.23425; Fujitsuka A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-168; Geis S, 2013, J CLIN MICROBIOL, V51, P155, DOI 10.1128/JCM.02151-12; Gimferrer L, 2015, J CLIN VIROL, V66, P27, DOI 10.1016/j.jcv.2015.02.018; Haider MSH, 2018, INFECT GENET EVOL, V60, P140, DOI 10.1016/j.meegid.2018.02.010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hirano E, 2014, INFECT GENET EVOL, V28, P183, DOI 10.1016/j.meegid.2014.09.030; Hirsh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090515; Houspie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060416; Jaureguiberry S, 2012, J TRAVEL MED, V19, P22, DOI 10.1111/j.1708-8305.2011.00570.x; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Kimura H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11648; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kushibuchi I, 2013, INFECT GENET EVOL, V18, P168, DOI 10.1016/j.meegid.2013.05.010; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Do LAH, 2015, J GEN VIROL, V96, P3470, DOI 10.1099/jgv.0.000298; Malasao R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142192; Martinelli M, 2014, VIRUS RES, V189, P293, DOI 10.1016/j.virusres.2014.06.006; Morrison DA, 2005, INT J PARASITOL, V35, P567, DOI 10.1016/j.ijpara.2005.02.007; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Nagasawa K, 2015, INFECT GENET EVOL, V36, P217, DOI 10.1016/j.meegid.2015.09.020; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; Olvera A, 2010, VET J, V184, P130, DOI 10.1016/j.tvjl.2009.02.015; Organization W. H, 2005, MAK AN MOTH CHILD CO; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Pybus OG, 2000, GENETICS, V155, P1429; Qin X, 2013, ARCH VIROL, V158, P1487, DOI 10.1007/s00705-012-1552-z; Raghuram V. L. N. S., 2015, VirusDisease, V26, P276, DOI 10.1007/s13337-015-0283-7; Salter A, 2011, J MED VIROL, V83, P337, DOI 10.1002/jmv.21957; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Singh AK, 2014, INDIAN J MED MICROBI, V32, P13, DOI 10.4103/0255-0857.124288; Sullender WM, 1991, J VIROL; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan L, 2013, J VIROL, V87, P8213, DOI 10.1128/JVI.03278-12; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; van Niekerk S, 2011, J VIROL, V85, P8789, DOI 10.1128/JVI.02623-10; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Visser A, 2008, J MED VIROL, V80, P724, DOI 10.1002/jmv.21128; WERTZ GW, 1985, P NATL ACAD SCI USA, V82, P4075, DOI 10.1073/pnas.82.12.4075; Yamaguchi M, 2011, J CLIN MICROBIOL, V49, P1034, DOI 10.1128/JCM.02132-10; Yoshida A, 2012, J MED MICROBIOL, V61, P820, DOI 10.1099/jmm.0.041137-0; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	81	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0193525	10.1371/journal.pone.0193525	http://dx.doi.org/10.1371/journal.pone.0193525			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694383	gold, Green Submitted, Green Published			2022-12-26	WOS:000430802400004
J	Hoffman, KL; Hutchinson, DS; Fowler, J; Smith, DP; Ajami, NJ; Zhao, H; Scheet, P; Chow, WH; Petrosino, JF; Daniel, CR				Hoffman, Kristi L.; Hutchinson, Diane S.; Fowler, Jerry; Smith, Daniel P.; Ajami, Nadim J.; Zhao, Hua; Scheet, Paul; Chow, Wong-Ho; Petrosino, Joseph F.; Daniel, Carrie R.			Oral microbiota reveals signs of acculturation in Mexican American women	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PERIODONTAL-DISEASE; UNITED-STATES; CANCER-RISK; DIVERSITY; HEALTH; PREVALENCE; HISPANICS; RESIDENCE; SEQUENCES	The oral microbiome has been linked to a number of chronic inflammatory conditions, including obesity, diabetes, periodontitis, and cancers of the stomach and liver. These conditions disproportionately affect Mexican American women, yet few studies have examined the oral microbiota in this at-risk group. We characterized the 16S rDNA oral microbiome in 369 non-smoking women enrolled in the MD Anderson Mano a Mano Mexican American Cohort Study. Lower bacterial diversity, a potential indicator of oral health, was associated with increased age and length of US residency among recent immigrants. Grouping women by overarching bacterial community type (e.g., "Streptococcus," "Fusobacterium," and "Prevotella" clusters), we observed differences across a number of acculturation-related variables, including nativity, age at immigration, time in the US, country of longest residence, and a multi-dimensional acculturation scale. Participants in the cluster typified by higher abundance of Streptococcus spp. exhibited the lowest bacterial diversity and appeared the most acculturated as compared to women in the "Prevotella" group. Computationally-predicted functional analysis suggested the Streptococcus-dominated bacterial community had greater potential for carbohydrate metabolism while biosynthesis of essential amino acids and nitrogen metabolism prevailed among the Prevotella-high group. Findings suggest immigration and adaption to life in the US, a well-established mediator of disease risk, is associated with differences in oral microbial profiles in Mexican American women. These results warrant further investigation into the joint and modifying effects of acculturation and oral bacteria on the health of Mexican American women and other immigrant populations. The oral microbiome presents an easily accessible biomarker of disease risk, spanning biological, behavioral, and environmental factors.	[Hoffman, Kristi L.; Fowler, Jerry; Zhao, Hua; Scheet, Paul; Chow, Wong-Ho; Daniel, Carrie R.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Hutchinson, Diane S.; Smith, Daniel P.; Ajami, Nadim J.; Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Hoffman, KL; Daniel, CR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA.	khoffman2@mdanderson.org; cdaniel@mdanderson.org	Smith, Daniel/L-6827-2019; Petrosino, Joseph F./AAF-1621-2019	Smith, Daniel/0000-0002-2479-2044; 	National Cancer Institute at the National Institutes of Health [CA016672, R25CA057730]	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute at the National Institutes of Health [CA016672 to Ronald Depinho, MD; R25CA057730 to Shine Chang, PhD]. The Cohort additionally receives funds collected pursuant to the Comprehensive Tobacco Settlement of 1998 and appropriated by the 76th Legislature to the University of Texas MD Anderson Cancer Center; from the Caroline W Law Fund for Cancer Prevention; and from the Dan Duncan Family Institute for Risk Assessment and Cancer Prevention. Study content is solely the responsibility of the authors and does not necessarily represent the official views of any funding agency. Funders did not contribute to the design or conduct of the study; the collection, analysis, or interpretation of data; or the preparation, review, or approval of the manuscript	Albrecht SS, 2013, INT J PUBLIC HEALTH, V58, P573, DOI 10.1007/s00038-012-0414-5; Alkek Center for Metagenomics and Microbiome Research Baylor College of Medicine, 2015, SAG MICR EXPL; American Cancer Society, 2015, 862315 AM CANC SOC; Anderson C, 2016, AM J PUBLIC HEALTH, V106, P547, DOI 10.2105/AJPH.2015.303008; [Anonymous], 2004, 7054 PEW HISP CTR; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Barcenas CH, 2007, OBESITY, V15, P1043, DOI 10.1038/oby.2007.537; Belstrom D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147472; Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cheung BY, 2011, PSYCHOL SCI, V22, P147, DOI 10.1177/0956797610394661; Chow WH, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv016; Corby PMA, 2008, J PERIODONTOL, V79, P1426, DOI [10.1902/jop.2008.070585, 10.1902/jop.2008.070585 ]; Corby PM, 2005, J CLIN MICROBIOL, V43, P5753, DOI 10.1128/JCM.43.11.5753-5759.2005; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Daviglus ML, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003929; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Flores G, 2008, PEDIATRICS, V121, pE1703, DOI 10.1542/peds.2007-2906; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Garcia L, 2012, ETHNIC DIS, V22, P58; Graham MA, 2005, J AM DENT ASSOC, V136, P1572, DOI 10.14219/jada.archive.2005.0092; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Kanasi E, 2010, CARIES RES, V44, P485, DOI 10.1159/000320158; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kato I, 2017, J AM COLL NUTR, V36, P88, DOI 10.1080/07315724.2016.1185386; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li J, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0316-1; Mai PL, 2007, CANCER EPIDEM BIOMAR, V16, P517, DOI 10.1158/1055-9965.EPI-06-0747; Marin G, 1996, HISPANIC J BEHAV SCI, V18, P297, DOI 10.1177/07399863960183002; Mason MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077287; MENDOZA RH, 1989, J CROSS CULT PSYCHOL, V20, P372, DOI 10.1177/0022022189204003; Mercado F, 2000, J CLIN PERIODONTOL, V27, P267, DOI 10.1034/j.1600-051x.2000.027004267.x; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; Miranda A. O., 2000, J MENTAL HLTH COUNSE, V22, P306; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; National Center for Health Statistics, 2016, 20161232 US DEP HLTH; O'Brien MJ, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140142; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; R Core Team, 2021, R LANGUAGE ENV STAT; Riley JL, 2008, J PAIN, V9, P750, DOI 10.1016/j.jpain.2008.03.007; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Takeshita T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06990; U. S. Census Bureau, 2016, POP DIV ANN EST RES; U.S. Census Bureau, 2019, 2019 AM COMM SURV 1; Wu J, 2016, ISME J, V10, P2435, DOI 10.1038/ismej.2016.37; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zaura E, 2015, MBIO, V6, DOI 10.1128/mBio.01693-15; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	59	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0194100	10.1371/journal.pone.0194100	http://dx.doi.org/10.1371/journal.pone.0194100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	29694348	Green Submitted, gold, Green Published			2022-12-26	WOS:000430802400007
J	Mendler, M; Falk, J; Drossel, B				Mendler, Marc; Falk, Johannes; Drossel, Barbara			Analysis of stochastic bifurcations with phase portraits	PLOS ONE			English	Article							CHEMICAL-REACTION; MODELS; SYSTEM	We propose a method to obtain phase portraits for stochastic systems. Starting from the Fokker-Planck equation, we separate the dynamics into a convective and a diffusive part. We show that stable and unstable fixed points of the convective field correspond to maxima and minima of the stationary probability distribution if the probability current vanishes at these points. Stochastic phase portraits, which are vector plots of the convective field, therefore indicate the extrema of the stationary distribution and can be used to identify stochastic bifurcations that change the number and stability of these extrema. We show that limit cycles in stochastic phase portraits can indicate ridges of the probability distribution, and we identify a novel type of stochastic bifurcation, where the probability maximum moves to the edge of the system through a gap between the two nullclines of the convective field.	[Mendler, Marc; Falk, Johannes; Drossel, Barbara] Tech Univ Darmstadt, Inst Festkorperphys, Hsch Str 6, D-64289 Darmstadt, Germany	Technical University of Darmstadt	Mendler, M (corresponding author), Tech Univ Darmstadt, Inst Festkorperphys, Hsch Str 6, D-64289 Darmstadt, Germany.	marcm@fkp.tu-darmstadt.de		Falk, Johannes/0000-0001-8496-6221; Mendler, Marc/0000-0001-8492-1760	Hessen State Ministry of Higher Education, Research and the Arts (HMWK) via the "LOEWE CompuGene" project; German Research Foundation; Open Access Publishing Fund of Technische Universitat Darmstadt	Hessen State Ministry of Higher Education, Research and the Arts (HMWK) via the "LOEWE CompuGene" project; German Research Foundation(German Research Foundation (DFG)); Open Access Publishing Fund of Technische Universitat Darmstadt	JF acknowledges funding by the Hessen State Ministry of Higher Education, Research and the Arts (HMWK) via the "LOEWE CompuGene" project (http://www.compugene.tu-darmstadt.de). We acknowledge support by the German Research Foundation and the Open Access Publishing Fund of Technische Universitat Darmstadt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, THERMODYNAMICS, DOI [10.1007/3-540-36217-7_3, DOI 10.1007/3-540-36217-7_3]; [Anonymous], 2016, COMM, DOI DOI 10.1016/J.CNSNS.2016.05.001; Arnold L, 1996, INT J BIFURCAT CHAOS, V6, P1947, DOI 10.1142/S0218127496001272; Arnold L, 2013, RANDOM DYNAMICAL SYS; Bazykin AD, 1998, NONLINEAR DYNAMICS O, V11; Biancalani T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.038101; Bokes P, 2016, GENE EXPRESSION NOIS; CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953; Cheng Z, 2015, MOST PROBABLE DYNAMI, V30; DAVIS MHA, 1984, J ROY STAT SOC B MET, V46, P353; Duncan A, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042111; Falk J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176410; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gardiner C.W., 1985, HANDBOOK OF STOCHAST, V3; GILLESPIE DT, 1991, MARKOV PROCESSES AN; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grima R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3625958; Hirsch MW, 2013, DIFFERENTIAL EQUATIONS, DYNAMICAL SYSTEMS, AND AN INTRODUCTION TO CHAOS, 3RD EDITION, P1; Lin YT, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0772; Lotka A.J., 1926, SCI PROGR 20 CENTURY, V21, P341; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; Moon W, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/055017; Nolte DD, 2010, PHYS TODAY, V63, P33, DOI 10.1063/1.3397041; Perko L, 2013, DIFFERENTIAL EQUATIO, V7; Qian H, 2002, P NATL ACAD SCI USA, V99, P10376, DOI 10.1073/pnas.152007599; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ramsey Stephen, 2005, Journal of Bioinformatics and Computational Biology, V3, P415, DOI 10.1142/S0219720005001132; Risken PDH, 1984, SPRINGER SERIES IN S; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Sandefur CI, 2013, MOL BIOSYST, V9, P2189, DOI 10.1039/c3mb70052f; SchenkHoppe KR, 1996, NONLINEAR DYNAM, V11, P255, DOI 10.1007/BF00120720; SCHLOGL F, 1972, Z PHYS, V253, P147, DOI 10.1007/BF01379769; Schmitt CK, 2014, THEOR ECOL-NETH, V7, P115, DOI 10.1007/s12080-013-0204-6; Schnoerr D, 2017, J PHYS A-MATH THEOR, V50, P1, DOI 10.1088/1751-8121/aa54d9; Scott M, 2007, P NATL ACAD SCI USA, V104, P7402, DOI 10.1073/pnas.0610468104; Tsimring LS, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026601; Van Kampen N., 2011, STOCHASTIC PROCESSES; Vellela M, 2007, B MATH BIOL, V69, P1727, DOI 10.1007/s11538-006-9188-3; Yang YG, 2017, COMMUN NONLINEAR SCI, V42, P62, DOI 10.1016/j.cnsns.2016.05.004; Zakharova A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011106	40	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196126	10.1371/journal.pone.0196126	http://dx.doi.org/10.1371/journal.pone.0196126			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689108	gold, Green Published, Green Submitted			2022-12-26	WOS:000430678800027
J	Ito, T; Ishida, S; Takahashi, Y				Ito, Takeshi; Ishida, Sarahmi; Takahashi, Yohsuke			Autophosphorylation of Ser-6 via an intermolecular mechanism is important for the rapid reduction of NtCDPK1 kinase activity for substrate RSG	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASES; BZIP TRANSCRIPTIONAL ACTIVATOR; REPRESSION OFSHOOT GROWTH; SHOOT GROWTH; CALCIUM; GIBBERELLINS; CALMODULIN; BINDING; DOMAIN; PHOSPHORYLATION	Tobacco (Nicotiana tabacum) Ca2+-dependent protein kinase 1 (NtCDPK1) is involved in feedback regulation of the plant hormone gibberellin through the phosphorylation of the transcription factor, REPRESSION OF SHOOT GROWTH (RSG). Previously, Ser-6 and Thr-21 were identified as autophosphorylation sites in NtCDPK1. Autophosphorylation of Ser-6 and Thr-21 not only decreases the binding affinity of NtCDPK1 for RSG, but also inhibits the homodimerization of NtCDPK1. Furthermore, autophosphorylation decreases the phosphorylation efficiency of RSG. We demonstrated that Ser-6 and Thr-21 of NtCDPK1 are phosphorylated in response to GAs in plants. The substitution of these autophosphorylation sites with Ala enhances the NtCDPK1 overexpression-induced sensitization of seeds to a GA biosynthetic inhibitor during germination. These findings suggested that autophosphorylation of Ser-6 and Thr-21 prevents excessive phosphorylation of RSG. In this study, we attempted to determine which autophosphorylation site is responsible for the functional regulation of NtCDPK1. Ser-6 was autophosphorylated within 1 min, whereas Thr-21 required over 5 min to be completely autophosphorylated. Furthermore, we found that Ser-6 and Thr21 were autophosphorylated by inter- and intramolecular mechanisms, respectively, which may be reflected in the faster autophosphorylation of Ser-6. Although both autophosphorylation sites were involved in the reduction of the binding affinity of NtCDPK1 for RSG and the inhibition of NtCDPK1 homodimerization, autophosphorylation of Ser-6 alone was sufficient to decrease the kinase activity of NtCDPK1 for RSG. These results suggest that autophosphorylation of Ser-6 is important for the rapid reduction of NtCDPK1 kinase activity for RSG, whereas that of Thr-21 may play an auxiliary role.	[Ito, Takeshi; Takahashi, Yohsuke] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Japan; [Ishida, Sarahmi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan	Hiroshima University; University of Tokyo	Ito, T (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Japan.	itotakes@hiroshima-u.ac.jp	Ito, Takeshi/R-5064-2016	Ito, Takeshi/0000-0002-5648-1371; Takahashi, Yohsuke/0000-0002-3851-8783	Japan Society for the Promotion of Science [15K18555, 15H04392]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24118004]; Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (grant no. 15K18555 to TI and 15H04392 to YT), and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant no. 24118004 to YT); Japan Society for the Promotion of Science, http://www.jsps.go.jp/, Ministry of Education, Culture, Sports, Science, and Technology of Japan, http://www.mext.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenstock J, 2016, TRENDS BIOCHEM SCI, V41, P938, DOI 10.1016/j.tibs.2016.08.006; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Fukazawa J, 2010, PLANT J, V62, P1035, DOI 10.1111/j.1365-313X.2010.04215.x; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1991, SCIENCE, V252, P951, DOI 10.1126/science.1852075; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Ishida S, 2004, PLANT CELL, V16, P2641, DOI 10.1105/tpc.104.024604; Ishida S, 2008, PLANT CELL, V20, P3273, DOI 10.1105/tpc.107.057489; Ito T, 2017, PLANT PHYSIOL, V174, P2457, DOI 10.1104/pp.17.00515; Ito T, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.977721; Ito T, 2014, PLANT PHYSIOL, V165, P1737, DOI 10.1104/pp.114.236448; Ito T, 2011, PLANT SIGNAL BEHAV, V6, P924, DOI 10.4161/psb.6.7.15604; Ito T, 2010, PLANT CELL, V22, P1592, DOI 10.1105/tpc.109.073577; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kinoshita-Kikuta E, 2014, PROTEOMICS, V14, P2437, DOI 10.1002/pmic.201400380; Lavoie H, 2014, TRENDS BIOCHEM SCI, V39, P475, DOI 10.1016/j.tibs.2014.08.004; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; McCubbin AG, 2004, PLANT J, V39, P206, DOI 10.1111/j.1365-313X.2004.02121.x; Okegawa Yuki, 2015, Biochem Biophys Rep, V4, P148, DOI 10.1016/j.bbrep.2015.09.005; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sanyal SK, 2015, PHYSIOL PLANTARUM, V155, P89, DOI 10.1111/ppl.12344; Schulz P, 2013, PLANT PHYSIOL, V163, P523, DOI 10.1104/pp.113.222539; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Simeunovic A, 2016, J EXP BOT, V67, P3855, DOI 10.1093/jxb/erw157; SUEN KL, 1991, PLANT MOL BIOL, V17, P581, DOI 10.1007/BF00037045; Swatek KN, 2014, BIOCHEM J, V459, P15, DOI 10.1042/BJ20130035; Takahashi Y, 2011, SIGNAL COMMUN PLANTS, P129, DOI 10.1007/978-3-642-20829-4_9; TREWAVAS A, 1994, PLANT MOL BIOL, V26, P1329, DOI 10.1007/BF00016478; Wernimont AK, 2011, PROTEINS, V79, P803, DOI 10.1002/prot.22919; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Witte CP, 2010, J BIOL CHEM, V285, P9740, DOI 10.1074/jbc.M109.052126	41	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196357	10.1371/journal.pone.0196357	http://dx.doi.org/10.1371/journal.pone.0196357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684069	gold, Green Submitted, Green Published			2022-12-26	WOS:000430660600056
J	Lifshitz, H; Verkuilen, J; Shnitzer-Meirovich, S; Altman, C				Lifshitz, Hefziba; Verkuilen, Jay; Shnitzer-Meirovich, Shlomit; Altman, Carmit			Crystallized and fluid intelligence of university students with intellectual disability who are fully integrated versus those who studied in adapted enrichment courses	PLOS ONE			English	Article							ADULTS; ADOLESCENTS; YOUNG; INDIVIDUALS; PERFORMANCE; CHILDREN; PEOPLE	Background & para;& para;Inclusion of people with intellectual disability (ID) in higher postsecondary academic education is on the rise. However, there are no scientific criteria for determining the eligibility for full inclusion of students with ID in university courses. This study focuses on two models of academic inclusion for students with ID: (a) separate adapted enrichment model: students with ID study in separate enrichment courses adapted to their level; (b) full inclusion model: students with ID are included in undergraduate courses, receive academic credits and are expected to accumulate the amount of credits for a B.A.& para;& para;Aim & para;& para;(a) To examine whether crystallized and fluid intelligence and cognitive tests can serve as screening tests for determining the appropriate placement of students with ID for the adapted enrichment model versus the full inclusion model. (b) To examine the attitudes towards the program of students with ID in the inclusion model.& para;& para;Method/Procedure & para;& para;The sample included 31 adults with ID: students with ID who were fully included (N= 10) and students with ID who participated in the adapted enrichment model (N= 21). Crystallized and fluid intelligence were examined (WAIS-III, Wechsler, 1997) and Hebrew abstract verbal tests (Glanz, 1989). Semi-structured interviews were conducted in order to examine the attitudes of students in the inclusion model towards the program.& para;& para;Outcomes and results & para;& para;The ANOVAs indicate that the most prominent difference between the groups was in vocabulary, knowledge and working memory. ROC analysis, a fundamental tool for diagnostic test evaluation, was used to determine the students' eligibility for appropriate placement in the two models. Seven tests distinguished between the groups in terms of sensitivity and specificity. The interviews were analyzed according to three phases.& para;& para;Conclusions/Implications & para;& para;The results indicate that students with ID are able to participate in undergraduate courses and achieve academic goals. The general IQ and idioms test seem to be best determiners for appropriate placement of students with ID to one of the two models. The included students with ID are motivated and self-determined in continuing in the program.	[Lifshitz, Hefziba] Bar Ilan Univ, Sch Educ, Dept Special Educ, ID Majoring Program, Ramat Gan, Israel; [Verkuilen, Jay] CUNY, Grad Ctr, Educ Psychol & Publ Hlth, New York, NY USA; [Shnitzer-Meirovich, Shlomit] Levinsky Coll, Tel Aviv, Israel; [Altman, Carmit] Bar Ilan Univ, Sch Educ, Ramat Gan, Israel	Bar Ilan University; City University of New York (CUNY) System; Bar Ilan University	Lifshitz, H (corresponding author), Bar Ilan Univ, Sch Educ, Dept Special Educ, ID Majoring Program, Ramat Gan, Israel.	hefziba@013net.net	Verkuilen, Jay/V-4362-2019					Ackerman P. L., 2000, J GERONTOL, V55B, P69, DOI DOI 10.1093/GER0NB/55.2.P69; Allport G, 1975, NATURE PERSONALITY S; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Canivez GL, 2009, SCHOOL PSYCHOL QUART, V24, P252, DOI 10.1037/a0018030; Cohen L., 2011, RES METHODS ED; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Devenny DA, 1996, J INTELL DISABIL RES, V40, P208, DOI 10.1046/j.1365-2788.1996.761761.x; Facon B, 2008, RES DEV DISABIL, V29, P29, DOI 10.1016/j.ridd.2006.10.003; Feuerstein R., 2003, ED PSYCHOL PRACTITIO, P59; Feuerstein R, 1974, J INT COUNCIL PSYCHO, V9-10, P7; Glanz Y, 1989, HACHASHIVA KETIFKUD; Grossman H. J., 1983, CLASSIFICATION MENTA; Health Service Executive, 2010, INFORM PEOPLE DIABET; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; Israel Board of Education, 2011, SPEC ED STUD ISR; Iwamoto A., 2005, SYNDROME NEWS UPDATE, V4, P129; Karmiloff-Smith A, 1998, TRENDS COGN SCI, V2, P389, DOI 10.1016/S1364-6613(98)01230-3; Kaufman AS, 2001, INTELLIGENCE, V29, P131, DOI 10.1016/S0160-2896(00)00046-5; Kave G., 2006, DEV NEUROPSYCHOL, V16, P549; Kittler P, 2004, J INTELL DISABIL RES, V48, P114, DOI 10.1111/j.1365-2788.2004.00500.x; Lifshitz H, 1999, MENT RETARD, V37, P125, DOI 10.1352/0047-6765(1999)037<0125:CMIAAO>2.0.CO;2; Lifshitz H, 2016, ACTA PSYCHOPATHOL, V2, P34; Lifshitz H, 2011, RES DEV DISABIL, V32, P326, DOI 10.1016/j.ridd.2010.10.010; Lifshitz H, 2005, J COGN EDUC PSYCHOL, V5, P144, DOI 10.1891/194589505787382504; Lifshitz-Vahav H, 2016, AGING MENT HEALTH, V20, P955, DOI 10.1080/13607863.2015.1047322; Lifshitz-Vahav H, 2015, EDUC TRAIN AUTISM DE, V50, P142; Luckasson R, 2002, MENTAL RETARDATION D; Luftig RL, 1987, TEACHING MENTALLY RE; Maehr M. L., 1996, TRANSFORMING SCH CUL; Mashal N, 2011, RES DEV DISABIL, V32, P2045, DOI 10.1016/j.ridd.2011.08.012; Maslow A. H., 2013, THEORY HUMAN MOTIVAT; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; McGrew KS, 2009, INTELLIGENCE, V37, P1, DOI 10.1016/j.intell.2008.08.004; Niesz T, 2008, WORK, V31, P113; O'Connor B, 2012, J POLICY PRACT INTEL, V9, P247, DOI 10.1111/jppi.12009; Pelatti CY, 2015, SEMIN SPEECH LANG, V36, P50, DOI 10.1055/s-0034-1396446; Pineda P., 2009, SYNDROME IS NOT DIS; Plotner AJ, 2015, INTELLECT DEV DISAB, V53, P58, DOI 10.1352/1934-9556-53.1.58; Quartz SR, 1997, BEHAV BRAIN SCI, V20, P537; Rose D. H., 2006, PRACTICAL READER UNI; Rubin H.J., 1995, QUALITATIVE INTERVIE; Schalock R., 2010, INTELLECTUAL DISABIL, V11; Sheppard-Jones K, 2015, INTELLECT DEV DISAB, V53, P120, DOI 10.1352/1934-9556-53.2.120; Shkedi A., 2003, WORDS MEANING QUALIT; Shnitzer-Meirovich S, 2017, EDUC TRAIN AUTISM DE, V52, P252; Spearman C.E., 1927, ABILITIES MAN THEIR; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Temple V, 2010, J INTELL DISABIL RES, V54, P573, DOI 10.1111/j.1365-2788.2010.01282.x; Uditsky B, 2012, J POLICY PRACT INTEL, V9, P298, DOI 10.1111/jppi.12005; Vicari S, 2005, DEV MED CHILD NEUROL, V47, P305, DOI 10.1017/S0012162205000599; Vogel T., 2014, ATTITUDES ATTITUDE C; WANG PP, 1994, J CLIN EXP NEUROPSYC, V16, P317, DOI 10.1080/01688639408402641; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D, 2001, WAIS 3 HEB MAN ADM S; Wechsler D, 1997, WAIS 3 ADM SOCRING M; Wechsler D., 1989, ECHELLE INTELLIGENCE; Wolfensberger W., 2005, NEW GENOCIDE HANDICA; Ziegler M, 2012, J RES PERS, V46, P173, DOI 10.1016/j.jrp.2012.01.002; ZWEIG MH, 1993, CLIN CHEM, V39, P561	59	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0193351	10.1371/journal.pone.0193351	http://dx.doi.org/10.1371/journal.pone.0193351			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7AK	29684024	Green Submitted, gold, Green Published			2022-12-26	WOS:000430660600002
J	Schatz, E; Knight, L				Schatz, Enid; Knight, Lucia			"I was referred from the other side": Gender and HIV testing among older South Africans living with HIV	PLOS ONE			English	Article							RURAL MALAWI; HEALTH-CARE; LIFE-COURSE; RISK; MEN; BEHAVIORS; ACCESS; ADULTS; TRANSMISSION; PERSPECTIVES	South Africa has a Universal Test and Treat (UTT) policy in place to ensure that everyone tests for HIV and can access treatment if they test positive. The aim of this study is to document the pathways that older South Africans who are living with HIV take to access testing and treatment in this context. Despite the aging of the HIV epidemic in South Africa and clear evidence that testing older persons (over age 50) is necessary, very little is known about the circumstances under which older persons test for HIV or their motivations for doing so. In this study, we analyze 21 qualitative, in-depth interviews with women and men aged 50 and over who are living with HIV from two townships outside of Cape Town. Using grounded theory to specify emerging themes, we find similarities and differences between older men and women in their pathways to testing. Men primarily test for HIV when their spouse is diagnosed or in connection with TB testing and treatment. Older women, who are more likely to be widowed or divorced, often test for HIV only when they are symptomatic or not responding appropriately to care for non-communicable diseases. Most importantly, we find that older South Africans do not seek testing as a response to risk. Instead, older men and women test only once they are symptomatic and referred by a provider, or as a result of a partner's status. Our respondents, particularly the women, expressed "shock" and confusion at learning they were HIV-positive because they do not see themselves as at risk of acquiring HIV. Because the benefits of UTT are greatest with early detection and treatment, older persons' tendency to test at such a late stage of illness decreases the individual and population level advantages of UTT. More research is needed to understand older persons' risk and testing behavior so that policy and programs include HIV testing messages that reach this population.	[Schatz, Enid] Univ Missouri, Dept Hlth Sci, Columbia, MO 65211 USA; [Schatz, Enid] Univ Missouri, Dept Womens & Gender Studies, Columbia, MO 65211 USA; [Knight, Lucia] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of the Western Cape	Schatz, E (corresponding author), Univ Missouri, Dept Hlth Sci, Columbia, MO 65211 USA.; Schatz, E (corresponding author), Univ Missouri, Dept Womens & Gender Studies, Columbia, MO 65211 USA.	schatzej@health.missouri.edu		Knight, Lucia/0000-0001-9938-6887; Schatz, Enid/0000-0003-3963-2745	University of Missouri - South Africa Education Program	University of Missouri - South Africa Education Program	Funded by University of Missouri - South Africa Education Program (https://www.umsystem.edu/president/southafrica). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato M, 2012, SOCIAL PROTECTION CA; Akers A, 2007, J WOMENS HEALTH, V16, P842, DOI 10.1089/jwh.2006.0028; Akers AY, 2008, SEX TRANSM DIS, V35, P420, DOI 10.1097/OLQ.0b013e3181644b39; Akullian A, 2017, AIDS, V31, P1755, DOI [10.1097/QAD.0000000000001553, 10.1097/qad.0000000000001553]; Ameh S, 2017, HEALTH POLICY PLANN, V32, P257, DOI 10.1093/heapol/czw118; Angotti N, 2017, CULT HLTH S IN PRESS; Angotti N, 2011, HEALTH POLICY PLANN, V26, P307, DOI 10.1093/heapol/czq066; [Anonymous], PROGR REP 2011 GLOB; Belli Robert F., 2009, CALENDAR TIME DIARY; Calasanti T, 2010, GERONTOLOGIST, V50, P720, DOI 10.1093/geront/gnq085; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Choko AT, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2093-2; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Connell R, 2012, SOC SCI MED, V74, P1675, DOI 10.1016/j.socscimed.2011.06.006; Conserve D, 2013, AM J MENS HEALTH, V7, P450, DOI 10.1177/1557988312468146; de Oliveira T, 2017, LANCET HIV, V4, pE41, DOI 10.1016/S2352-3018(16)30186-2; Dovel K, 2015, AIDS, V29, P1123, DOI 10.1097/QAD.0000000000000655; ELDER GH, 1994, SOC PSYCHOL QUART, V57, P4; Freeman E, 2012, INT J STD AIDS, V23, P490, DOI 10.1258/ijsa.2011.011340; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Hensen B, 2012, TROP MED INT HEALTH, V17, P59, DOI 10.1111/j.1365-3156.2011.02893.x; Houle B, 2017, SEXUAL BEHAV HIV RIS; Jewkes R, 2005, SOC SCI MED, V61, P1809, DOI 10.1016/j.socscimed.2005.03.022; Langen Tabitha T, 2005, Afr Health Sci, V5, P188; Lawn SD, 2011, SAMJ S AFR MED J, V101, P258, DOI 10.7196/SAMJ.4392; Leichliter JS, 2011, SAHARA J-J SOC ASP H, V8, P82, DOI 10.1080/17290376.2011.9724989; Lekalakala-Mokgele E, 2014, SAHARA J-J SOC ASP H, V11, P67, DOI 10.1080/17290376.2014.931816; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mojola SA, 2015, SOC SCI MED, V143, P204, DOI 10.1016/j.socscimed.2015.08.023; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; Nakray K., 2013, GENDER BASED VIOLENC; Negin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162967; Negin J, 2012, AIDS BEHAV, V16, P63, DOI 10.1007/s10461-011-9994-y; Njozing BN, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-6; Oni T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0750-1; Rosenberg MS, 2017, JAIDS-J ACQ IMM DEF, V74, pE9, DOI 10.1097/QAI.0000000000001173; Schatz E, 2017, J AGING HLT IN PRESS; Schatz E, 2015, GLOB PUBLIC HEALTH, V10, P1185, DOI 10.1080/17441692.2015.1035664; Seeley J., 2008, 110 CPRC; Shisana O, 2012, S AFRICAN NATL HIV P; Siegel K, 1999, AIDS CARE, V11, P525, DOI 10.1080/09540129947686; Sikweyiya Y, 2011, CULT HEALTH SEX, V13, P1091, DOI 10.1080/13691058.2011.604429; Snow RC, 2010, AIDS CARE, V22, P1060, DOI 10.1080/09540120903193641; South African National Department of Health, 2015, NAT ANT SENT HIV PRE; Strauss A., 1990, BASICS QUALITATIVE R; Strauss A. L, 1994, HDB QUALITATIVE RES, V1st, P273, DOI DOI 10.1007/BF00988593; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2014, THE GAP REP; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS221, DOI 10.1097/QAI.0b013e318299c3f4; Vollmer S, 2017, AIDS BEHAV, V21, pS101, DOI 10.1007/s10461-016-1591-7; World Health Organization, 2015, GUID START ANT THER	53	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196158	10.1371/journal.pone.0196158	http://dx.doi.org/10.1371/journal.pone.0196158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7AK	29684054	Green Published, gold, Green Submitted			2022-12-26	WOS:000430660600040
J	Tomasini, MD; Johnson, DS; Mincer, JS; Simon, SM				Tomasini, Michael D.; Johnson, Daniel S.; Mincer, Joshua S.; Simon, Sanford M.			Modeling the dynamics and kinetics of HIV-1 Gag during viral assembly	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ESCRT PROTEIN RECRUITMENT; CAPSID PROTEIN; CRYOELECTRON MICROSCOPY; MOLECULAR-DYNAMICS; LATTICE FORMATION; REVEALS; MORPHOGENESIS; SUFFICIENT; SIMULATION	We report a computational model for the assembly of HIV-1 Gag into immature viral particles at the plasma membrane. To reproduce experimental structural and kinetic properties of assembly, a process occurring on the order of minutes, a coarse-grained representation consisting of a single particle per Gag molecule is developed. The model uses information relating the functional interfaces implicated in Gag assembly, results from cryo electrontomography, and biophysical measurements from fluorescence microscopy, such as the dynamics of Gag assembly at single virions. These experimental constraints eliminated many classes of potential interactions, and narrowed the model to a single interaction scheme with two non-equivalent interfaces acting to form Gags into a hexamer, and a third interface acting to link hexamers together. This model was able to form into a hexameric structure with correct lattice spacing and reproduced biologically relevant growth rates. We explored the effect of genomic RNA seeding punctum growth, finding that RNA may be a factor in locally concentrating Gags to initiate assembly. The simulation results infer that completion of assembly cannot be governed simply by Gag binding kinetics. However the addition of membrane curvature suggests that budding of the virion from the plasma membrane could factor into slowing incorporation of Gag at an assembly site resulting in virions of the same size and number of Gag molecules independent of Gag concentration or the time taken to complete assembly. To corroborate the results of our simulation model, we developed an analytic model for Gag assembly finding good agreement with the simulation results.	[Tomasini, Michael D.; Johnson, Daniel S.; Mincer, Joshua S.; Simon, Sanford M.] Rockefeller Univ, Lab Cellular Biophys, 1230 York Ave, New York, NY 10021 USA; [Johnson, Daniel S.] Hofstra Univ, Dept Phys & Astron, 151 Hofstra Univ, Hempstead, NY 11550 USA; [Mincer, Joshua S.] Icahn Sch Med Mt Sinai, Dept Anesthesiol, New York, NY 10029 USA; [Mincer, Joshua S.] Mem Sloan Kettering Canc Ctr, Dept Anestheosol & Crit Care Med, New York, NY 10021 USA	Rockefeller University; Hofstra University; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center	Simon, SM (corresponding author), Rockefeller Univ, Lab Cellular Biophys, 1230 York Ave, New York, NY 10021 USA.	simon@rockefeller.edu	Tomasini, Michael/AGF-2299-2022; Mincer, Joshua/B-4785-2008	Mincer, Joshua/0000-0002-2482-3154; Simon, Sanford/0000-0002-8615-4224; Johnson, Daniel/0000-0001-8906-0509	National Science Foundation (NSF) [MCB1121172]; National Institutes of Health (NIH) [5R01GM119585]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119585] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (NSF) grant MCB1121172 and National Institutes of Health (NIH grants) 5R01GM119585 to SMS. This work was supported in part through the computational resources and staff expertise provided by Scientific Computing at the Icahn School of Medicine at Mount Sinai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Ayton GS, 2010, BIOPHYS J, V99, P2757, DOI 10.1016/j.bpj.2010.08.018; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bharat TAM, 2014, P NATL ACAD SCI USA, V111, P8233, DOI 10.1073/pnas.1401455111; Bleck M, 2014, P NATL ACAD SCI USA, V111, P12211, DOI 10.1073/pnas.1321655111; Borsetti A, 1998, J VIROL, V72, P9313, DOI 10.1128/JVI.72.11.9313-9317.1998; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Bulacu M, 2013, J CHEM THEORY COMPUT, V9, P3282, DOI 10.1021/ct400219n; Campbell EM, 2015, NAT REV MICROBIOL, V13, P471, DOI 10.1038/nrmicro3503; Carlson LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001173; Carlson LA, 2008, CELL HOST MICROBE, V4, P592, DOI 10.1016/j.chom.2008.10.013; Chen B, 2011, BIOPHYS J, V100, P3035, DOI 10.1016/j.bpj.2011.05.025; Datta SAK, 2016, J VIROL, V90, P1773, DOI 10.1128/JVI.02061-15; Datta SAK, 2011, J VIROL, V85, P4111, DOI 10.1128/JVI.00006-11; ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761; Fogarty KH, 2014, J MOL BIOL, V426, P1611, DOI 10.1016/j.jmb.2013.11.025; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Goh BC, 2015, STRUCTURE, V23, P1414, DOI 10.1016/j.str.2015.05.017; Grime JMA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11568; Grime JMA, 2012, BIOPHYS J, V103, P1774, DOI 10.1016/j.bpj.2012.09.007; Grover JR, 2013, J VIROL, V87, P4650, DOI 10.1128/JVI.03526-12; Hendrix J, 2015, J CELL BIOL, V210, P629, DOI 10.1083/jcb.201504006; Hogue Ian B, 2012, Mol Biol Int, V2012, P979765, DOI 10.1155/2012/979765; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; Liu C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10714; MAMMANO F, 1994, J VIROL, V68, P4927, DOI 10.1128/JVI.68.8.4927-4936.1994; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Mercenne G, 2015, ELIFE, V4, DOI 10.7554/eLife.03778; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Ruiz-Herrero T, 2015, BIOPHYS J, V108, P585, DOI 10.1016/j.bpj.2014.12.017; Schur FKM, 2016, SCIENCE, V353, P506, DOI 10.1126/science.aaf9620; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tsiang M, 2012, BIOCHEMISTRY-US, V51, P4416, DOI 10.1021/bi300052h; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Yu ZH, 2013, J MOL BIOL, V425, P112, DOI 10.1016/j.jmb.2012.10.006; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	44	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0196133	10.1371/journal.pone.0196133	http://dx.doi.org/10.1371/journal.pone.0196133			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677208	Green Submitted, gold, Green Published			2022-12-26	WOS:000430638900025
J	Lima, FDE; Willmitzer, L; Nikoloski, Z				de Abreu e Lima, Francisco; Willmitzer, Lothar; Nikoloski, Zoran			Classification-driven framework to predict maize hybrid field performance from metabolic profiles of young parental roots	PLOS ONE			English	Article							GENOMIC PREDICTION; INHERITANCE; MODELS	Maize (Zea mays L.) is a staple food whose production relies on seed stocks that largely comprise hybrid varieties. Therefore, knowledge about the molecular determinants of hybrid performance (HP) in the field can be used to devise better performing hybrids to address the demands for sustainable increase in yield. Here, we propose and test a classification-driven framework that uses metabolic profiles from in vitro grown young roots of parental lines from the Dent x Flint maize heterotic pattern to predict field HP. We identify parental analytes that best predict the metabolic inheritance patterns in 328 hybrids. We then demonstrate that these analytes are also predictive of field HP (0.64 >= r >= 0.79) and discriminate hybrids of good performance (accuracy of 87.50%). Therefore, our approach provides a cost-effective solution for hybrid selection programs.	[de Abreu e Lima, Francisco; Willmitzer, Lothar; Nikoloski, Zoran] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Nikoloski, Zoran] Univ Potsdam, Inst Biochem & Biol, Bioinformat Grp, Potsdam, Germany	Max Planck Society; University of Potsdam	Nikoloski, Z (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.; Nikoloski, Z (corresponding author), Univ Potsdam, Inst Biochem & Biol, Bioinformat Grp, Potsdam, Germany.	nikoloski@mpimp-golm.mpg.de		Nikoloski, Zoran/0000-0003-2671-6763	German Federal Ministry of Education and Research (BMBF) within the project PLANT 2030 OPTIMAL [FKZ: 0315958B]	German Federal Ministry of Education and Research (BMBF) within the project PLANT 2030 OPTIMAL(Federal Ministry of Education & Research (BMBF))	This work has been supported by the German Federal Ministry of Education and Research (BMBF) within the project PLANT 2030 OPTIMAL (FKZ: 0315958B) to L.W.	BERNTSSON P, 1986, QUANT STRUCT-ACT REL, V5, P45, DOI 10.1002/qsar.19860050202; Birchler JA, 2010, PLANT CELL, V22, P2105, DOI 10.1105/tpc.110.076133; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dan Z, 2016, SCI REPORTS, P6; Darwin C, 1877, EFFECTS CROSS SELF F; Lima FDE, 2017, PLANT J, V90, P319, DOI 10.1111/tpj.13495; Drucker H, 1997, ADV NEUR IN, V9, P155; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; East EM, 1936, GENETICS, V21, P375; Falconer D. S., 1996, Introduction to quantitative genetics.; Feher K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085435; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Frisch M, 2010, TAG THEORETICAL APPL, P120; Gartner T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005220; HUANG BQ, 1992, INT REV CYTOL, V140, P233, DOI 10.1016/S0074-7696(08)61099-2; Jiang Y, 2017, NAT GENET, V49, P1741, DOI 10.1038/ng.3974; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lisec J, 2011, PLANT J, V68, P326, DOI 10.1111/j.1365-313X.2011.04689.x; REBOUD X, 1994, HEREDITY, V72, P132, DOI 10.1038/hdy.1994.19; Reif JC, 2013, PLANT BREEDING, V132, P107, DOI 10.1111/pbr.12007; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Seymour DK, 2016, P NATL ACAD SCI USA, V113, pE7317, DOI 10.1073/pnas.1615268113; SHULL G.H., 1908, J HERED, V4, P296; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Technow F, 2012, THEOR APPL GENET, V125, P1181, DOI 10.1007/s00122-012-1905-8; Westhues M, 2017, TAG THEORETICAL APPL, V24; WOLD H., 1966, MULTIVARIATE ANAL, P391, DOI DOI 10.1007/S00423-022-02505-9; Xu S, 2016, PLANT J; Xu SH, 2014, P NATL ACAD SCI USA, V111, P12456, DOI 10.1073/pnas.1413750111; Zenke-Philippi C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2580-y; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	35	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196038	10.1371/journal.pone.0196038	http://dx.doi.org/10.1371/journal.pone.0196038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698533	Green Submitted, gold, Green Published			2022-12-26	WOS:000431007600029
J	Franco, J; Ferreira, C; Sobreira, TJP; Sundberg, JP; HogenEsch, H				Franco, Jackeline; Ferreira, Christina; Sobreira, Tiago J. Paschoal; Sundberg, John P.; HogenEsch, Harm			Profiling of epidermal lipids in a mouse model of dermatitis: Identification of potential biomarkers	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CHRONIC PROLIFERATIVE DERMATITIS; CHILDHOOD ATOPIC-DERMATITIS; CHAIN-LENGTH DISTRIBUTION; STRATUM-CORNEUM LIPIDS; SKIN BARRIER; HIGH-THROUGHPUT; FATTY-ACID; QUANTITATIVE-ANALYSIS; SHOTGUN LIPIDOMICS	Lipids are important structural and functional components of the skin. Alterations in the lipid composition of the epidermis are associated with inflammation and can affect the barrier function of the skin. SHARPIN-deficient cpdm mice develop a chronic dermatitis with similarities to atopic dermatitis in humans. Here, we used a recently-developed approach named multiple reaction monitoring (MRM)-profiling and single ion monitoring to rapidly identify discriminative lipid ions. Shorter fatty acyl residues and increased relative amounts of sphingosine ceramides were observed in cpdm epidermis compared to wild type mice. These changes were accompanied by downregulation of the Fasn gene which encodes fatty acid synthase. A profile of diverse lipids was generated by fast screening of over 300 transitions (ion pairs). Tentative attribution of the most significant transitions was confirmed by product ion scan (MS/MS), and the MRM-profiling linear intensity response was validated with a C17-ceramide lipid standard. Relative quantification of sphingosine ceramides CerAS (d18:1/24:0)2OH, CerAS(d18:1/16:0)2OH and CerNS(d18:1/16:0) discriminated between the two groups with 100% accuracy, while the free fatty acids cerotic acid, 16-hydroxy palmitic acid, and docosahexaenoic acid (DHA) had 96.4% of accuracy. Validation by liquid chromatography tandem mass spectrometry (LC-MS/MS) of the above-mentioned ceramides was in agreement with MRM-profiling results. Identification and rapid monitoring of these lipids represent a tool to assess therapeutic outcomes in SHARPIN-deficient mice and other mouse models of dermatitis and may have diagnostic utility in atopic dermatitis.	[Franco, Jackeline; HogenEsch, Harm] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Ferreira, Christina; Sobreira, Tiago J. Paschoal] Purdue Univ, Bindley Biosci Ctr, Metabolite Profiling Facil, W Lafayette, IN 47907 USA; [Sundberg, John P.; HogenEsch, Harm] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [HogenEsch, Harm] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Jackson Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus	HogenEsch, H (corresponding author), Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.; HogenEsch, H (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.; HogenEsch, H (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	hogenesch@purdue.edu	Ferreira, Christina Ramires/F-4744-2012; Franco, Jackeline/GNM-9489-2022	Ferreira, Christina Ramires/0000-0003-3988-6454; Franco, Jackeline/0000-0002-0737-4764; HogenEsch, Harm/0000-0002-2738-9189	National Institutes of Health [AR049288]; Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D); Colciencias fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D); Colciencias fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported in part by grants from the National Institutes of Health (AR049288) and the Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D). JF was supported in part by a Colciencias fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal K, 2017, J LIPID RES, V58, P188, DOI 10.1194/jlr.M071738; Ardern-Jones MR, 2014, BRIT J DERMATOL, V171, P207, DOI 10.1111/bjd.13210; Bieber T, 2016, ALLERGY, V71, P588, DOI 10.1111/all.12857; Bleck O, 1999, J INVEST DERMATOL, V113, P894, DOI 10.1046/j.1523-1747.1999.00809.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Breiden B, 2014, BBA-MOL CELL BIOL L, V1841, P441, DOI 10.1016/j.bbalip.2013.08.010; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Chowdhury S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165214; Cole C, 2014, J ALLERGY CLIN IMMUN, V134, P82, DOI 10.1016/j.jaci.2014.04.021; Colsch B, 2004, J LIPID RES, V45, P281, DOI 10.1194/jlr.M300331-JLR200; Cordeiro Fernanda B, 2017, Rapid Commun Mass Spectrom, V31, P1462, DOI 10.1002/rcm.7927; Danso M, 2017, J DERMATOL SCI, V88, P57, DOI 10.1016/j.jdermsci.2017.05.005; Danso MO, 2014, J INVEST DERMATOL, V134, P1941, DOI 10.1038/jid.2014.83; Elias PM, 2014, BBA-MOL CELL BIOL L, V1841, P323, DOI 10.1016/j.bbalip.2013.10.001; Elias PM, 2009, CURR OPIN ALLERGY CL, V9, P437, DOI 10.1097/ACI.0b013e32832e7d36; Ferreira CR, 2016, ANALYST, V141, P5252, DOI 10.1039/c6an01618a; Fischer CL, 2014, BBA-MOL CELL BIOL L, V1841, P319, DOI 10.1016/j.bbalip.2013.08.012; Flohr C, 2014, ALLERGY, V69, P3, DOI 10.1111/all.12270; GERMAIN L, 1993, BURNS, V19, P99, DOI 10.1016/0305-4179(93)90028-7; Gil A, 2002, BIOMED PHARMACOTHER, V56, P388, DOI 10.1016/S0753-3322(02)00256-1; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harris IR, 1997, J INVEST DERMATOL, V109, P783, DOI 10.1111/1523-1747.ep12340962; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; HogenEsch H, 2006, EXP DERMATOL, V15, P808, DOI 10.1111/j.1600-0625.2006.00483.x; Janssens M, 2012, J LIPID RES, V53, P2755, DOI 10.1194/jlr.P030338; Kelleher M, 2015, J ALLERGY CLIN IMMUN, V135, P930, DOI 10.1016/j.jaci.2014.12.013; Kendall AC, 2013, PROG LIPID RES, V52, P141, DOI 10.1016/j.plipres.2012.10.003; Koberlin MS, 2015, CELL, V162, P170, DOI 10.1016/j.cell.2015.05.051; Krause L, 2016, J ALLERGY CLIN IMMUN, V138, P1207, DOI 10.1016/j.jaci.2016.04.018; Li MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06581; Li S, 2017, BRIT J DERMATOL, V177, pE125, DOI 10.1111/bjd.15409; Li S, 2016, EXPERT REV PROTEOMIC, V13, P451, DOI 10.1080/14789450.2016.1177462; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loiseau N, 2013, J DERMATOL SCI, V72, P296, DOI 10.1016/j.jdermsci.2013.08.003; Macheleidt O, 2002, J INVEST DERMATOL, V119, P166, DOI 10.1046/j.1523-1747.2002.01833.x; Maksimovic N, 2012, J DERMATOL, V39, P42, DOI 10.1111/j.1346-8138.2011.01295.x; Mansouri Y, 2015, J CLIN MED, V4, P858, DOI 10.3390/jcm4050858; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Mojumdar EH, 2014, BBA-BIOMEMBRANES, V1838, P2473, DOI 10.1016/j.bbamem.2014.05.023; Nygaard U, 2016, J EUR ACAD DERMATOL, V30, P1930, DOI 10.1111/jdv.13679; Opalka L, 2016, LANGMUIR, V32, P12894, DOI 10.1021/acs.langmuir.6b03082; Paternoster L, 2015, NAT GENET, V47, P1449, DOI 10.1038/ng.3424; Potter CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085666; Renninger ML, 2010, EXP DERMATOL, V19, P252, DOI 10.1111/j.1600-0625.2009.00944.x; Rutkowsky JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1378, DOI 10.1152/ajpendo.00656.2013; Sadowski T, 2017, SCI REP-UK, V7, DOI 10.1038/srep43761; Schwudke D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004614; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Tata A, 2013, J MASS SPECTROM, V48, P844, DOI 10.1002/jms.3231; Tawada C, 2014, J INVEST DERMATOL, V134, P712, DOI 10.1038/jid.2013.364; Thijs JL, 2015, J CLIN MED, V4, P479, DOI 10.3390/jcm4030479; Uchiyama M, 2016, BBA-BIOMEMBRANES, V1858, P2050, DOI 10.1016/j.bbamem.2016.06.001; Uchiyama N, 2000, J DERMATOL SCI, V24, P134, DOI 10.1016/S0923-1811(00)00088-8; van Smeden J, 2014, BBA-MOL CELL BIOL L, V1841, P295, DOI 10.1016/j.bbalip.2013.11.006; van Smeden J, 2014, J INVEST DERMATOL, V134, P1238, DOI 10.1038/jid.2013.517; van Smeden J, 2014, EXP DERMATOL, V23, P45, DOI 10.1111/exd.12293; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Wang M, 2016, PROG LIPID RES, V61, P83, DOI 10.1016/j.plipres.2015.12.002; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; YAMAMOTO A, 1991, ARCH DERMATOL RES, V283, P219, DOI 10.1007/BF01106105; Yokouchi M, 2015, J DERMATOL SCI, V77, P28, DOI 10.1016/j.jdermsci.2014.11.007	72	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196595	10.1371/journal.pone.0196595	http://dx.doi.org/10.1371/journal.pone.0196595			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698466	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600105
J	Gago-Arias, A; Sanchez-Nieto, B; Espinoza, I; Karger, CP; Pardo-Montero, J				Gago-Arias, Araceli; Sanchez-Nieto, Beatriz; Espinoza, Ignacio; Karger, Christian P.; Pardo-Montero, Juan			Impact of different biologically-adapted radiotherapy strategies on tumor control evaluated with a tumor response model	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; POSITRON-EMISSION-TOMOGRAPHY; ENDOTHELIAL-CELL-PROLIFERATION; PHASE-II TRIAL; NECK-CANCER; RADIATION-THERAPY; PROSTATE-CANCER; DOSE-ESCALATION; FRACTIONATED RADIOTHERAPY; HETEROGENEOUS TUMORS	Motivated by the capabilities of modern radiotherapy techniques and by the recent developments of functional imaging techniques, dose painting by numbers (DPBN) was proposed to treat tumors with heterogeneous biological characteristics. This work studies different DPBN optimization techniques for virtual head and neck tumors assessing tumor response in terms of cell survival and tumor control probability with a previously published tumor response model (TRM). Uniform doses of 2 Gy are redistributed according to the microscopic oxygen distribution and the density distribution of tumor cells in four virtual tumors with different biological characteristics. In addition, two different optimization objective functions are investigated, which: i) minimize tumor cell survival (OFsurv) or; ii) maximize the homogeneity of the density of surviving tumor cells (OFstd). Several adaptive schemes, ranging from single to daily dose optimization, are studied and the treatment response is compared to that of the uniform dose. The results show that the benefit of DPBN treatments depends on the tumor reoxygenation capability, which strongly differed among the set of virtual tumors investigated. The difference between daily (fraction by fraction) and three weekly optimizations (at the beginning of weeks 1, 3 and 4) was found to be small, and higher benefit was observed for the treatments optimized using OFsurv. This in silico study corroborates the hypothesis that DPBN may be beneficial for treatments of tumors which show reoxygenation during treatment, and that a few optimizations may be sufficient to achieve this therapeutic benefit.	[Gago-Arias, Araceli; Sanchez-Nieto, Beatriz; Espinoza, Ignacio] Pontificia Univ Catolica Chile, Inst Fis, Santiago, Chile; [Karger, Christian P.] HIRO, Natl Ctr Radiat Res Oncol NCRO, Heidelberg, Germany; [Pardo-Montero, Juan] Inst Invest Sanitaria IDIS, Grp Imaxe Mol, Santiago De Compostela, Spain; [Pardo-Montero, Juan] Univ Santiago de Compostela, Complexo Hosp, Serv Radiofis & Protecc Radiol, Santiago De Compostela, Spain	Pontificia Universidad Catolica de Chile; Universidade de Santiago de Compostela	Gago-Arias, A (corresponding author), Pontificia Univ Catolica Chile, Inst Fis, Santiago, Chile.	magagoa@uc.cl	nieto, Beatriz Sanchez/AAA-4310-2021; Gago-Arias, Araceli/ABE-7910-2020; Pardo-Montero, Juan/A-4459-2017	Gago-Arias, Maria Araceli/0000-0002-1999-2340; Sanchez-Nieto, Beatriz/0000-0003-0713-3108; Pardo-Montero, Juan/0000-0001-7990-3971	FONDECYT [3150333, 11170575, 111505601]; Institute de Salud Carlos III (Miguel Servet research grant) [CP12/03162, CPII17/00028]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Institute de Salud Carlos III (Miguel Servet research grant)	A.G-A., J.P-M and I.E. acknowledge the support of FONDECYT 2015 Postdoctoral 3150333 and FONDECYT 2017 Iniciacion 11170575, Institute de Salud Carlos III (Miguel Servet research grant CP12/03162 and CPII17/00028), and FONDECYT 2015 Iniciacion 111505601, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2003, PHYS MED BIOL, V48, pN31, DOI 10.1088/0031-9155/48/2/404; Banerjee H., 2010, THESIS; Bentzen SM, 2005, LANCET ONCOL, V6, P112, DOI 10.1016/S1470-2045(05)01737-7; Bentzen SM, 2011, SEMIN RADIAT ONCOL, V21, P101, DOI 10.1016/j.semradonc.2010.10.001; Berwouts D, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0629-3; Berwouts D, 2015, RADIOTHER ONCOL, V115, P272, DOI 10.1016/j.radonc.2015.04.022; Berwouts D, 2013, RADIOTHER ONCOL, V107, P310, DOI 10.1016/j.radonc.2013.04.002; Bowen SR, 2009, PHYS MED BIOL, V54, P1483, DOI 10.1088/0031-9155/54/6/007; BRAHME A, 1987, ACTA ONCOL, V26, P377, DOI 10.3109/02841868709104364; Brahme A., 1996, IAEATECDOC896, P49; Bremer C, 2003, RADIOLOGY, V226, P214, DOI 10.1148/radiol.2261012140; Chang JH, 2013, ACTA ONCOL, V52, P1723, DOI 10.3109/0284186X.2012.759273; Chao KSC, 2001, INT J RADIAT ONCOL, V49, P1171, DOI 10.1016/S0360-3016(00)01433-4; Choi W, 2010, RADIOTHER ONCOL, V97, P176, DOI 10.1016/j.radonc.2010.04.012; Cox JD, 2012, INT J RADIAT ONCOL, V82, P1042, DOI 10.1016/j.ijrobp.2011.12.032; Czyzyk J, 1998, IEEE COMPUT SCI ENG, V5, P68, DOI 10.1109/99.714603; Das SK, 2011, SEMIN RADIAT ONCOL, V21, P111, DOI 10.1016/j.semradonc.2010.10.002; Das SK, 2004, MED PHYS, V31, P1452, DOI 10.1118/1.1750991; DENEKAMP J, 1982, BRIT J CANCER, V45, P136, DOI 10.1038/bjc.1982.16; DENEKAMP J, 1982, BRIT J CANCER, V46, P711, DOI 10.1038/bjc.1982.263; Dirscher T, 2012, Z MED PHYS, V22, P48, DOI 10.1016/j.zemedi.2011.09.006; Duprez F, 2011, INT J RADIAT ONCOL, V80, P1045, DOI 10.1016/j.ijrobp.2010.03.028; Ebert MA, 1996, PHYS MED BIOL, V41, P2125, DOI 10.1088/0031-9155/41/10/019; El Naqa I, 2006, INT J RADIAT ONCOL, V64, P1275, DOI 10.1016/j.ijrobp.2005.11.022; Espinoza I, 2015, MED PHYS, V42, P90, DOI 10.1118/1.4903298; Espinoza I, 2013, MED PHYS, V40, DOI 10.1118/1.4812431; Fleckenstein J, 2011, INT J RADIAT ONCOL, V81, pE283, DOI 10.1016/j.ijrobp.2011.01.020; Flynn R, 2007, MED PHYS, V34, P2522, DOI 10.1118/1.2761242; Fowler JF, 2008, CLIN ONCOL-UK, V20, P113, DOI 10.1016/j.clon.2007.11.003; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; Gago-Arias A, 2016, PHYS MED BIOL, V61, P1204, DOI 10.1088/0031-9155/61/3/1204; GATENBY RA, 1988, INT J RADIAT ONCOL, V14, P831, DOI 10.1016/0360-3016(88)90002-8; Gronlund E, 2017, RADIOTHER ONCOL, V122, P236, DOI 10.1016/j.radonc.2016.09.007; Gropp W., 1997, APPROXIMATION THEORY, P167; Harriss-Phillips WM, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/363564; Harting C, 2007, PHYS MED BIOL, V52, P4775, DOI 10.1088/0031-9155/52/16/005; Heukelom J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-84; HOCKEL M, 1993, RADIOTHER ONCOL, V26, P45, DOI 10.1016/0167-8140(93)90025-4; Huang ZB, 2010, CANCER RES, V70, P463, DOI 10.1158/0008-5472.CAN-09-2501; Jeraj R, 2015, J NUCL MED, V56, P1752, DOI 10.2967/jnumed.114.141424; Kachnic LA, 2013, INT J RADIAT ONCOL, V86, P27, DOI 10.1016/j.ijrobp.2012.09.023; Kong F, 2013, J CLIN ONCOL, V31, P7522; Kong FM, 2017, JAMA ONCOLOGY, DOI [10.1001/jameoneol.2017.0982, DOI 10.1001/JAMEONEOL.2017.0982]; Lee NY, 2008, INT J RADIAT ONCOL, V70, P2, DOI 10.1016/j.ijrobp.2007.06.039; Ling CC, 2000, INT J RADIAT ONCOL, V47, P551, DOI 10.1016/S0360-3016(00)00467-3; Madani I, 2007, INT J RADIAT ONCOL, V68, P126, DOI 10.1016/j.ijrobp.2006.12.070; Madani I, 2011, RADIOTHER ONCOL, V101, P351, DOI 10.1016/j.radonc.2011.06.020; Malinen E, 2006, PHYS MED BIOL, V51, P4903, DOI 10.1088/0031-9155/51/19/012; Marcu L, 2004, PHYS MED BIOL, V49, P3767, DOI 10.1088/0031-9155/49/16/021; Monnich D, 2011, PHYS MED BIOL, V56, P2045, DOI 10.1088/0031-9155/56/7/009; Moiseenko V, 2004, ACTA ONCOL, V43, P499, DOI 10.1080/02841860410032777; Movsas B, 2002, UROLOGY, V60, P634, DOI 10.1016/S0090-4295(02)01858-7; Nahum AE, 2003, INT J RADIAT ONCOL, V57, P391, DOI 10.1016/S0360-3016(03)00534-0; Nutting CM, 2002, BRIT J RADIOL, V75, P151, DOI 10.1259/bjr.75.890.750151; Onjukka E, 2017, CLIN ONCOL-UK, V29, P6, DOI 10.1016/j.clon.2016.09.009; Pedicini P, 2013, INT J RADIAT ONCOL, V85, pE231, DOI 10.1016/j.ijrobp.2012.11.033; Petit SF, 2009, PHYS MED BIOL, V54, P2179, DOI 10.1088/0031-9155/54/7/022; Sanchez-Nieto B, INT J RADIAT ONCOL, V44, P369, DOI [10.1016/60360-3016(99)000292, DOI 10.1016/60360-3016(99)000292]; SCHWACHOFER JHM, 1989, INT J RADIAT ONCOL, V17, P1015, DOI 10.1016/0360-3016(89)90149-1; Shi XR, 2014, CANCER LETT, V355, P169, DOI 10.1016/j.canlet.2014.07.042; Steel GG, 2002, BASIC CLIN RADIOBIOL; Thorwarth D, 2005, PHYS MED BIOL, V50, P2209, DOI 10.1088/0031-9155/50/10/002; Thorwarth D, 2007, INT J RADIAT ONCOL, V68, P291, DOI 10.1016/j.ijrobp.2006.11.061; Toma-Dasu I, 2009, ACTA ONCOL, V48, P1181, DOI 10.3109/02841860903188643; Trani D, 2015, CLIN CANCER RES, V21, P5511, DOI 10.1158/1078-0432.CCR-15-0290; Troost EGC, 2010, J NUCL MED, V51, P866, DOI 10.2967/jnumed.109.069310; Vanderstraeten B, 2006, RADIOTHER ONCOL, V79, P249, DOI 10.1016/j.radonc.2006.03.003; WITHERS HR, 1988, ACTA ONCOL, V27, P131, DOI 10.3109/02841868809090333; Wouters BG, 1997, RADIAT RES, V147, P541, DOI 10.2307/3579620; Yang Y, 2005, MED PHYS, V32, P1473, DOI 10.1118/1.1924312; Yaromina A, 2011, INT J RADIAT ONCOL, V80, P1205, DOI 10.1016/j.ijrobp.2011.02.015; ZAGARS GK, 1987, RADIOTHER ONCOL, V8, P353, DOI 10.1016/S0167-8140(87)80186-X; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V70, P1124, DOI 10.1016/j.ijrobp.2007.11.044; Zhang C., 2014, QUANT BIOL, V2, P85, DOI [10.1007/s40484-014-0032-8, DOI 10.1007/S40484-014-0032-8]; Zhang QH, 2015, PHYS MEDICA, V31, P1060, DOI 10.1016/j.ejmp.2015.07.145	75	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196310	10.1371/journal.pone.0196310	http://dx.doi.org/10.1371/journal.pone.0196310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698534	gold, Green Submitted, Green Published			2022-12-26	WOS:000431007600061
J	Garcia, S; Alberich, S; Martinez-Cengotitabengoa, M; Arango, C; Castro-Fornieles, J; Parellada, M; Baeza, I; Moreno, C; Mico, JA; Berrocoso, E; Graell, M; Otero, S; Simal, T; Gonzalez-Pinto, A				Garcia, Sainza; Alberich, Susana; Martinez-Cengotitabengoa, Monica; Arango, Celso; Castro-Fornieles, Josefina; Parellada, Mara; Baeza, Inmaculada; Moreno, Carmen; Antonio Mico, Juan; Berrocoso, Esther; Graell, Montserrat; Otero, Soraya; Simal, Tatiana; Gonzalez-Pinto, Ana			The complex association between the antioxidant defense system and clinical status in early psychosis	PLOS ONE			English	Article							OXIDATIVE STRESS; PSYCHIATRIC-DISORDERS; IN-VIVO; SCHIZOPHRENIA; PLASMA; PATHOPHYSIOLOGY; INFLAMMATION; MARKERS; BIPOLAR; SCALE	Oxidative stress is a pathophysiological mechanism potentially involved in psychiatric disorders. The objective of this study was to assess the relationship between total antioxidant status (TAS) and the functional status of patients with a first episode of psychosis at the onset of the disease. For this purpose, a sample of 70 patients aged between 9 and 17 years with a first episode of psychosis were followed up for a period of two years. Blood samples were drawn to measure TAS levels at three time points: at baseline, at one year, and at two years. Clinical symptoms and functioning were also assessed at the same time points using various scales. Linear regression analysis was performed to investigate the relationship between TAS and clinical status at each assessment, adjusting for potential confounding factors. The distribution of clinical variables was grouped in different percentiles to assess the dose-response in the relation between clinical variables and TAS. At baseline, patient's score on Children's Global Assessment Scale (CGAS) was directly and significantly associated with TAS with a monotonic increase in percentiles, and surprising this association was reversed after one and two years of follow-up with a monotonic decrease. In summary at the onset of the illness, TAS is positively related to clinical status, whereas as the illness progresses this correlation is reversed and becomes negative. This may be the result of an adaptive response.	[Garcia, Sainza; Alberich, Susana; Martinez-Cengotitabengoa, Monica; Arango, Celso; Castro-Fornieles, Josefina; Parellada, Mara; Baeza, Inmaculada; Moreno, Carmen; Antonio Mico, Juan; Berrocoso, Esther; Graell, Montserrat; Otero, Soraya; Gonzalez-Pinto, Ana] Ctr Biomed Res Mental Hlth Network CIBERSAM, Madrid, Spain; [Garcia, Sainza; Alberich, Susana; Martinez-Cengotitabengoa, Monica; Gonzalez-Pinto, Ana] Araba Univ Hosp, BioAraba Res Inst, Dept Psychiat, OSI Araba, Vitoria, Spain; [Garcia, Sainza; Martinez-Cengotitabengoa, Monica; Gonzalez-Pinto, Ana] Univ Basque Country, Vitoria, Spain; [Martinez-Cengotitabengoa, Monica] Natl Distance Educ Univ UNED, Psychobiol Dept, Vitoria, Spain; [Arango, Celso; Parellada, Mara; Moreno, Carmen] Gregorio Maranon Gen Univ Hosp, Child & Adolescent Psychiat Dept, IiSGM, Madrid, Spain; [Arango, Celso; Parellada, Mara; Moreno, Carmen] Univ Complutense Madrid, Sch Med, Madrid, Spain; [Castro-Fornieles, Josefina; Baeza, Inmaculada] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Castro-Fornieles, Josefina; Baeza, Inmaculada] Hosp Clin Barcelona, Inst Neurosci, Dept Child & Adolescent Psychiat & Psychol, SGR489, Barcelona, Spain; [Castro-Fornieles, Josefina] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Antonio Mico, Juan; Berrocoso, Esther] Univ Cadiz, Neuropsychopharmacol & Psychobiol Res Grp, Cadiz, Spain; [Antonio Mico, Juan; Berrocoso, Esther] NiBICA, Inst Res & Innovat Biomed Sci, Cadiz, Spain; [Graell, Montserrat] Nino Jesus Univ, La Princesa Inst Hlth Res, Child & Adolescent Psychiat & Psychol Dept, Childrens Hosp, Madrid, Spain; [Otero, Soraya] Marques De Valdecilla Univ Hosp, Dept Psychiat, IDIVAL, Santander, Spain; [Otero, Soraya] Marques De Valdecilla Univ Hosp, Child & Adolescent Psychiat Unit, Santander, Spain; [Otero, Soraya] Univ Cantabria, Sch Med, Santander, Spain; [Simal, Tatiana] Miguel Servet Univ Hosp, Dept Psychiat, Zaragoza, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Bioaraba Health Research Institute; University Hospital of Araba; University of Basque Country; Universidad Nacional de Educacion a Distancia (UNED); General University Gregorio Maranon Hospital; Complutense University of Madrid; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Universidad de Cadiz; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Miguel Servet University Hospital	Gonzalez-Pinto, A (corresponding author), Ctr Biomed Res Mental Hlth Network CIBERSAM, Madrid, Spain.; Gonzalez-Pinto, A (corresponding author), Araba Univ Hosp, BioAraba Res Inst, Dept Psychiat, OSI Araba, Vitoria, Spain.; Gonzalez-Pinto, A (corresponding author), Univ Basque Country, Vitoria, Spain.	anamaria.gonzalez-pintoarrllaga@osakidetza.eus	MICO, JUAN ANTONIO/E-1527-2013; Arango, Celso/AAZ-8314-2021; Berrocoso, Esther/H-9958-2015; Baeza, Inmaculada/GQI-3365-2022; Moreno, Carmen/AAQ-1079-2021; Parellada, Mara/GQH-7619-2022; Parellada, Mara/AAQ-1272-2021	MICO, JUAN ANTONIO/0000-0001-8905-8484; Arango, Celso/0000-0003-3382-4754; Berrocoso, Esther/0000-0003-0208-7472; Moreno, Carmen/0000-0003-0541-4846; Parellada, Mara/0000-0001-7977-3601; Alberich, Susana/0000-0002-4945-3428; Gonzalez-Pinto, Ana Maria/0000-0002-2568-5179	Instituto de Salud Carlos III (European Regional Development Fund/European Social Fund, "Investing in your future") [PI14/01900, PI16/01164]; Basque Foundation for Health Innovation and Research (BIOEF); Networking Center for Biomedical Research in Mental Health (CIBERSAM); University of the Basque Country [GIC12/84]; Stanley Research Foundation [03-RC-003]; University of the Basque Country	Instituto de Salud Carlos III (European Regional Development Fund/European Social Fund, "Investing in your future"); Basque Foundation for Health Innovation and Research (BIOEF); Networking Center for Biomedical Research in Mental Health (CIBERSAM); University of the Basque Country; Stanley Research Foundation; University of the Basque Country	This study has been funded by Instituto de Salud Carlos III through the projects PI14/01900, PI16/01164 (Co-funded by European Regional Development Fund/European Social Fund, "Investing in your future"); the Basque Foundation for Health Innovation and Research (BIOEF); Networking Center for Biomedical Research in Mental Health (CIBERSAM) and the University of the Basque Country (GIC12/84). The psychiatric research department in University Hospital Araba is supported by the Stanley Research Foundation (03-RC-003). Sainza Garcia has a PhD fellowship from the University of the Basque Country. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Mico JA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-26; Bartolini D, 2016, J CHROMATOGR B, V1019, P29, DOI 10.1016/j.jchromb.2016.02.002; Bitanihirwe BKY, 2011, NEUROSCI BIOBEHAV R, V35, P878, DOI 10.1016/j.neubiorev.2010.10.008; Castro-Fornieles J, 2007, SCHIZOPHR RES, V91, P226, DOI 10.1016/j.schres.2006.12.004; Coughlin JM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.40; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; Fendri C, 2006, ENCEPHALE, V32, P244; Fernandes BS, 2016, MOL PSYCHIATR, V21, P554, DOI 10.1038/mp.2015.87; Gama CS, 2007, NEUROSCI LETT, V420, P45, DOI 10.1016/j.neulet.2007.04.001; Gama CS, 2006, PROG NEURO-PSYCHOPH, V30, P512, DOI 10.1016/j.pnpbp.2005.11.009; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Harris LW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046368; Jiang S, 2017, MOL NEUROBIOL, V54, P1440, DOI 10.1007/s12035-016-9707-7; Khandaker GM, 2015, LANCET PSYCHIAT, V2, P258, DOI 10.1016/S2215-0366(14)00122-9; Kolosova NG, 2006, NEUROBIOL AGING, V27, P1289, DOI 10.1016/j.neurobiolaging.2005.07.022; Martinez-Cengotitabengoa M, 2016, SCHIZOPHRENIA BULL, V42, P142, DOI 10.1093/schbul/sbv078; Martinez-Cengotitabengoa M, 2014, SCHIZOPHR RES, V156, P23, DOI 10.1016/j.schres.2014.03.025; Mauerhofer C, 2016, MOL ASPECTS MED, V49, P78, DOI 10.1016/j.mam.2016.02.003; Mendoza-Nunez VM, 2001, MECH AGEING DEV, V122, P835, DOI 10.1016/S0047-6374(01)00240-8; Miyaoka T, 2005, EUR NEUROPSYCHOPHARM, V15, P249, DOI 10.1016/j.euroneuro.2004.11.002; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Peralta Martin V, 1994, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V22, P171; Raffa M, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-124; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Sanchez-Rodriguez MA, 2006, LIFE SCI, V78, P1682, DOI 10.1016/j.lfs.2005.08.007; Sawa A, 2016, SCHIZOPHR RES, V176, P1, DOI 10.1016/j.schres.2016.06.014; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Summergrad P, 2016, LANCET PSYCHIAT, V3, P390, DOI 10.1016/S2215-0366(16)30031-1; Tuncel OK, 2015, PSYCHIAT RES, V228, P688, DOI 10.1016/j.psychres.2015.04.046; Yao JK, 1998, SCHIZOPHR RES, V32, P1, DOI 10.1016/S0920-9964(98)00030-9; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zhang XY, 2012, SCHIZOPHR RES, V139, P66, DOI 10.1016/j.schres.2012.04.009; Zhao XR, 2013, TRANSL STROKE RES, V4, P71, DOI 10.1007/s12975-012-0245-y	33	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0194685	10.1371/journal.pone.0194685	http://dx.doi.org/10.1371/journal.pone.0194685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1WN	29698400	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600006
J	Lu, ZX; Ma, YF; Gao, LY; Li, YJ; Li, Q; Qiang, M				Lu, Zhaoxu; Ma, Yufeng; Gao, Linying; Li, Yingjun; Li, Qiang; Qiang, Mei			Urine mercury levels correlate with DNA methylation of imprinting gene H19 in the sperm of reproductive-aged men	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; EXPOSURE; CADMIUM; EPIGENETICS; LEAD; SPERMATOGENESIS; METHYLMERCURY; PREGNANCY; BEHAVIOR; GROWTH	Background Mercury (Hg) is a well-recognized environmental pollutant known by its toxicity of development and neurotoxicity, which results in adverse health outcomes. However, the mechanisms underlying the teratogenic effects of Hg are not well understood. Imprinting genes are emerging regulators for fetal development subjecting to environmental pollutants impacts. In this study, we examined the association between preconceptional Hg exposure and the alteration of DNA methylation of imprinting genes H19, Meg3, and Peg3 in human sperm DNA. Methods A total of 616 men, aged from 22 to 59, were recruited from Reproductive Medicine Clinic of Maternal and Child Care Service Center and the Urologic Surgery Clinic of Shanxi Academy of Medical Sciences during April 2015 and March 2016. Demographic information was collected through questionnaires. Urine was collected and urinary Hg concentrations were measured using a fully-automatic double-channel hydride generation atomic fluorescence spectrometer. Methylation of imprinting genes H19, Meg3 and Peg3 of sperm DNA from 242 participants were examined by bisulfite pyrosequencing. Spearman's rank and multivariate regression analysis were used for correlation analysis between sperm DNA methylation status of imprinting genes and urinary Hg levels. Results The median concentration of Hg for 616 participants was 9.14 mu g/l (IQR: 5.56 +/- 12.52 mu g/l; ranging 0.16 +/- 71.35 mu g/l). A total of 42.7% of the participants are beyond normal level for non-occupational exposure according to the criterion of Hg poisoning (>= 10 mu g/L). Spearman's rank analysis indicated a negative correlation between urinary Hg concentrations and average DNA methylation levels of imprinted genes H19 (r(s) = -0.346, p < 0.05), but there was no such a correlation for Peg3 and Meg3. Further, we analyzed the correlation between methylation level at individual CpG site of H19 and urinary Hg level. The results showed a negative correlation between urinary Hg concentrations and three out of seven CpG sites on H19 DMR, namely CpG2 (r(s) = -0.137, p < 0.05), CpG4 (r(s) = -0.380, p < 0.05) and CpG6 (r(s) = -0.228, p < 0.05). After adjusting age, smoking, drinking, intake of aquatic products and education by multivariate regression analysis, the results have confirmed the correlation as mentioned above. Conclusions Mercury non-occupational environmental exposure in reproductive-aged men was associated with altered DNA methylation outcomes at imprinting gene H19 in sperm, implicating the susceptibility of the developing sperm for environmental insults.	[Lu, Zhaoxu; Ma, Yufeng; Li, Yingjun; Qiang, Mei] Shanxi Med Univ, Sch Publ Hlth, Dept Child & Adolescence Hlth, Taiyuan, Shanxi, Peoples R China; [Gao, Linying] Shanxi Med Univ, Sch Publ Hlth, Dept Sanit Inspect, Taiyuan, Shanxi, Peoples R China; [Li, Qiang] Childrens Hosp, Dept Androl, Taiyuan, Shanxi, Peoples R China; [Li, Qiang] Women Hlth Ctr Shanxi, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University	Qiang, M (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Dept Child & Adolescence Hlth, Taiyuan, Shanxi, Peoples R China.	qiang5858@sxmu.edu.cn			National Natural Science Foundation of China (CN) [81673185]; Shanxi Scholarship Council of China [2015-051]; fund for Shanxi key subjects construction (FSKSC) [1331]	National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC)); Shanxi Scholarship Council of China; fund for Shanxi key subjects construction (FSKSC)	This work was supported by the National Natural Science Foundation of China (CN): 81673185: Dr. Mei Qiang Shanxi Scholarship Council of China: 2015-051: Dr. Mei Qiang Sponsored by the fund for Shanxi key subjects construction (FSKSC): 1331: Dr. Mei Qiang The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Benchaib M, 2005, HUM REPROD, V20, P768, DOI 10.1093/humrep/deh684; Berglund Marika, 2005, Environ Health, V4, P20, DOI 10.1186/1476-069X-4-20; Boujbiha MA, 2009, REPROD TOXICOL, V28, P81, DOI 10.1016/j.reprotox.2009.03.011; Brender JD, 2006, ENVIRON RES, V101, P132, DOI 10.1016/j.envres.2005.08.003; Chow ESH, 2008, AQUAT TOXICOL, V87, P157, DOI 10.1016/j.aquatox.2008.01.019; CORDIER S, 1991, BRIT J IND MED, V48, P375; CORNS WT, 1994, ANALYST, V119, P2481, DOI 10.1039/an9941902481; El-Maarri O, 2003, HUM MOL GENET, V12, P1405, DOI 10.1093/hmg/ddg152; Fang LanYun, 2013, Journal of Environmental & Occupational Medicine, V30, P56; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; GROSSMAN J, 1951, J CLIN INVEST, V30, P1208, DOI 10.1172/JCI102540; Haertle L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184030; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hoyo C, 2014, EPIGENETICS-US, V9, P1120, DOI 10.4161/epi.29332; Jin L, 2013, REPROD TOXICOL, V35, P25, DOI 10.1016/j.reprotox.2012.10.015; [金明华 Jin Minghua], 2005, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V31, P522; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kelly TLJ, 2003, J ANDROL, V24, P822; Keverne EB, 2008, FRONT NEUROENDOCRIN, V29, P398, DOI 10.1016/j.yfrne.2008.03.001; Knezovich Jaysen Gregory, 2012, Frontiers in Genetics, V3, P10, DOI 10.3389/fgene.2012.00010; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liang F, 2015, ASIAN J ANDROL, V17, P985, DOI 10.4103/1008-682X.160267; Maroziene Ligita, 2002, Environ Health, V1, P6, DOI 10.1186/1476-069X-1-6; Masemola ML, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00085; Mathers JC, 2008, P NUTR SOC, V67, P390, DOI 10.1017/S0029665108008744; Miyaso H, 2017, ENVIRON RES, V157, P1, DOI 10.1016/j.envres.2017.05.006; Nye MD, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvv009; Papaconstantinou AD, 2003, BIRTH DEFECTS RES B, V68, P456, DOI 10.1002/bdrb.10044; Perera F, 2011, REPROD TOXICOL, V31, P363, DOI 10.1016/j.reprotox.2010.12.055; Pruss-Ustun A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-9; Radford EJ, 2011, FEBS LETT, V585, P2059, DOI 10.1016/j.febslet.2011.05.063; Reik W, 2003, J PHYSIOL-LONDON, V547, P35, DOI 10.1113/jphysiol.2002.033274; Scheuhammer A, 2015, SCI TOTAL ENVIRON, V509, P91, DOI 10.1016/j.scitotenv.2014.05.142; Smeester L, 2014, GENES-BASEL, V5, P477, DOI 10.3390/genes5020477; Smith LE, 2010, NEUROTOXICOL TERATOL, V32, P246, DOI 10.1016/j.ntt.2009.09.004; Soubry A, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0217-2; Stouder C, 2011, REPROD TOXICOL, V31, P507, DOI 10.1016/j.reprotox.2011.02.009; SU MQ, 1976, TOXICOL APPL PHARM, V38, P207, DOI 10.1016/0041-008X(76)90174-5; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Tsuji JS, 2003, ENVIRON HEALTH PERSP, V111, P623, DOI 10.1289/ehp.5717; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Yorifuji T, 2015, ARCH ENVIRON OCCUP H, V70, P297, DOI 10.1080/19338244.2014.904268; Yuan HF, 2015, J HUAZHONG U SCI-MED, V35, P938, DOI 10.1007/s11596-015-1532-0	46	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196314	10.1371/journal.pone.0196314	http://dx.doi.org/10.1371/journal.pone.0196314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698523	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600062
J	Melguizo-Rodriguez, L; Ramos-Torrecillas, J; Manzano-Moreno, FJ; Illescas-Montes, R; Rivas, A; Ruiz, C; De Luna-Bertos, E; Garcia-Martinez, O				Melguizo-Rodriguez, Lucia; Ramos-Torrecillas, Javier; Javier Manzano-Moreno, Francisco; Illescas-Montes, Rebeca; Rivas, Ana; Ruiz, Concepcion; De Luna-Bertos, Elvira; Garcia-Martinez, Olga			Effect of phenolic extracts from different extra-virgin olive oil varieties on osteoblast-like cells	PLOS ONE			English	Article							ANTIGENIC PHENOTYPE; MEDITERRANEAN DIET; ARBEQUINA; QUALITY; GROWTH; CLASSIFICATION; HYDROXYTYROSOL; MODULATION; CANCER	The reported incidence of osteoporosis is lower in countries in which the Mediterranean diet predominates, and this apparent relationship may be mediated by the phenolic compounds present in olive oil. The objective of this study was to determine the effect of phenolic extracts from different varieties of extra-virgin olive oil (Picual, Arbequina, Picudo, and Hojiblanca) on the differentiation, antigenic expression, and phagocytic capacity of osteoblast-like MG-63 cells. At 24 h of treatment a significant increase in phosphatase alkaline activity and significant reductions in CD54, CD80, and HLA-DR expression and in phagocytic activity were observed in comparison to untreated controls. The in vitro study performed has demonstrated that phenolic compounds from different extra virgin olive oil varieties can modulate different parameters related to osteoblast differentiation and function.	[Melguizo-Rodriguez, Lucia; Ramos-Torrecillas, Javier; Ruiz, Concepcion; De Luna-Bertos, Elvira; Garcia-Martinez, Olga] Univ Granada, Fac Hlth Sci, Dept Nursing, Biomed Grp BIO277, Granada, Spain; [Melguizo-Rodriguez, Lucia; Ramos-Torrecillas, Javier; Javier Manzano-Moreno, Francisco; Illescas-Montes, Rebeca; Rivas, Ana; Ruiz, Concepcion; De Luna-Bertos, Elvira; Garcia-Martinez, Olga] Inst Invest Biosanitaria, Ibs Granada, Granada, Spain; [Javier Manzano-Moreno, Francisco] Univ Granada, Sch Dent, Dept Stomatol, Biomed Grp BIO277, Granada, Spain; [Illescas-Montes, Rebeca] Univ Granada, Fac Hlth Sci Melilla, Dept Nursing, Biomed Grp BIO277, Melilla, Spain; [Rivas, Ana] Univ Granada, Fac Pharm, Dept Nutr & Food Sci, AGR Grp 255, Granada, Spain; [Ruiz, Concepcion] Univ Granada, Inst Neurosci Federico Oloriz, Granada, Spain	University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; University of Granada; University of Granada; University of Granada	De Luna-Bertos, E (corresponding author), Univ Granada, Fac Hlth Sci, Dept Nursing, Biomed Grp BIO277, Granada, Spain.; De Luna-Bertos, E (corresponding author), Inst Invest Biosanitaria, Ibs Granada, Granada, Spain.	elviradlb@ugr.es	Rivas, Ana/D-7841-2018; Ruiz, Concepcion/L-2808-2014; Ramos-Torrecillas, Javier/U-5789-2019; Illescas-Montes, Rebeca/F-8700-2016; Illescas-Montes, Rebeca/AAC-4437-2019; Ramos-Torrecillas, Javier/F-3746-2012; De Luna-Bertos, Elvira/F-8544-2016; Melguizo-Rodríguez, Lucía/F-4683-2018; Garcia-Martinez, Olga/L-2782-2014	Rivas, Ana/0000-0002-2143-0750; Ruiz, Concepcion/0000-0003-4332-6812; Ramos-Torrecillas, Javier/0000-0002-6631-7866; Illescas-Montes, Rebeca/0000-0001-9795-8159; Illescas-Montes, Rebeca/0000-0001-9795-8159; Ramos-Torrecillas, Javier/0000-0002-6631-7866; De Luna-Bertos, Elvira/0000-0002-4381-5942; Garcia-Martinez, Olga/0000-0003-1912-4639	research group (Junta de Andalucia) [BIO277]; Department of Nursing (University of Granada); Ministerio de Educacion, Cultura y Deporte [FPU15-05635]	research group (Junta de Andalucia)(Junta de Andalucia); Department of Nursing (University of Granada); Ministerio de Educacion, Cultura y Deporte	This study was supported by the research group BIO277 (Junta de Andalucia) and Department of Nursing (University of Granada).	Bakhouche A, 2013, FOOD RES INT, V50, P401, DOI 10.1016/j.foodres.2012.11.001; Caruso G, 2014, AGR WATER MANAGE, V134, P94, DOI 10.1016/j.agwat.2013.12.003; Cauley JA, 2017, CURR OPIN RHEUMATOL, V29, P150, DOI 10.1097/BOR.0000000000000365; Chin KY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080755; Dabbou S, 2010, SCI HORTIC-AMSTERDAM, V124, P122, DOI 10.1016/j.scienta.2009.12.017; Diaz-Rodriguez L, 2009, ANN NY ACAD SCI, V1173, pE46, DOI 10.1111/j.1749-6632.2009.04950.x; Diaz-Rodriguez L, 2012, BIOL RES NURS, V14, P98, DOI 10.1177/1099800411398933; Farinelli D, 2015, SCI HORTIC-AMSTERDAM, V192, P97, DOI 10.1016/j.scienta.2015.04.035; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Garcia JM, 2013, IRRIGATION SCI, V31, P359, DOI 10.1007/s00271-011-0315-z; Garcia-Martinez O, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.0111141; Garcia-Martinez O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150045; Garcia-Martinez O, 2012, J ORAL MAXIL SURG, V70, P1558, DOI 10.1016/j.joms.2011.06.199; Hagiwara K, 2011, EUR J PHARMACOL, V662, P78, DOI 10.1016/j.ejphar.2011.04.023; *IOOC, 1984, 6 IOOC; Manzano-Moreno FJ, 2013, CLIN ORAL INVEST, V17, P1349, DOI 10.1007/s00784-012-0811-4; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Fernandez-Real JM, 2012, J CLIN ENDOCR METAB, V97, P3792, DOI 10.1210/jc.2012-2221; Martinez F, 1999, GRASAS ACEITES, V50, P122, DOI 10.3989/gya.1999.v50.i2.646; Martinez-Gonzalez MA, 2015, PROG CARDIOVASC DIS, V58, P50, DOI 10.1016/j.pcad.2015.04.003; McLean Robert R, 2009, Curr Osteoporos Rep, V7, P134; Melguizo-Rodriguez L, 2018, EUR J CLIN IN PRESS; Perez E, 2006, BIOSCIENCE REP, V26, P281, DOI 10.1007/s10540-006-9022-z; Puel C, 2008, J AGR FOOD CHEM, V56, P9417, DOI 10.1021/jf801794q; Reyes-Botella C, 2002, CELL PHYSIOL BIOCHEM, V12, P359, DOI 10.1159/000067906; Rotelli MT, 2015, SURG ONCOL, V24, P145, DOI 10.1016/j.suronc.2015.08.001; Ruiz C, 2007, J BONE MINER METAB, V25, P286, DOI 10.1007/s00774-007-0767-7; Ruiz C, 2003, CELL PHYSIOL BIOCHEM, V13, P309, DOI 10.1159/000074546; Saleh NK, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-10; Sandrini E, 2005, J BIOMED MATER RES B, V73B, P392, DOI 10.1002/jbm.b.30241; Santiago-Mora R, 2011, OSTEOPOROSIS INT, V22, P675, DOI 10.1007/s00198-010-1270-x; Servili M, 2014, ANTIOXIDANTS-BASEL, V3, P1, DOI 10.3390/antiox3010001; Taamalli A, 2012, FOOD CHEM, V132, P561, DOI 10.1016/j.foodchem.2011.10.070; Taamalli A, 2010, EUR FOOD RES TECHNOL, V231, P965, DOI 10.1007/s00217-010-1350-3; Terzuoli E, 2016, MOL NUTR FOOD RES, V60, P519, DOI 10.1002/mnfr.201500498; Visioli F, 2011, CURR PHARM DESIGN, V17, P786, DOI 10.2174/138161211795428885	36	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196530	10.1371/journal.pone.0196530	http://dx.doi.org/10.1371/journal.pone.0196530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698527	Green Submitted, Green Published, gold			2022-12-26	WOS:000431007600094
J	Ramaiah, A; Koralur, MC; Dasch, GA				Ramaiah, Arunachalam; Koralur, Munegowda C.; Dasch, Gregory A.			Complexity of type-specific 56 kDa antigen CD4 T-cell epitopes of Orientia tsutsugamushi strains causing scrub typhus in India	PLOS ONE			English	Article							RICKETTSIA-TSUTSUGAMUSHI; SEQUENCE; GENE; DIVERSITY; EPIDEMIOLOGY; RODENTS; PATIENT	Orientia tsutsugamushi (Ots) is an obligate, intracellular, mite-transmitted human pathogen which causes scrub typhus. Understanding the diversity of Ots antigens is essential for designing specific diagnostic assays and efficient vaccines. The protective immunodominant type-specific 56 kDa antigen (TSA) of Ots varies locally and across its geographic distribution. TSA contains four hypervariable domains. We bioinformatically analyzed 345 partial sequences of TSA available from India, most of which contain only the three variable domains (VDI-III) and three spacer conserved domains (SVDI, SVDII/III, SVDIII). The total number (152) of antigenic types (amino acid variants) varied from 14-36 in the six domains of TSA that we studied. Notably, 55% (787/1435) of the predicted CD4 T-cell epitopes (TCEs) from all the six domains had high binding affinities (HBA) to at least one of the prevalent Indian human leukocyte antigen (HLA) alleles. A surprisingly high proportion (61%) of such TCEs were from spacer domains; indeed 100% of the CD4 TCEs in the SVDI were HBA. TSA sequences from India had more antigenic types (AT) than TSA from Korea. Overall, >90% of predicted CD4 TCEs from spacer domains were predicted to have HBA against one or more prevalent HLA types from Indian, Korean, Asia-Pacific region or global population data sets, while only <50% of CD4 TCEs in variable domains exhibited such HBA. The phylogenetically and immunologically important amino acids in the conserved spacer domains were identified. Our results suggest that the conserved spacer domains are predicted to be functionally more important than previously appreciated in immune responses to Ots infections. Changes occurring at the TCE level of TSA may contribute to the wide range of pathogenicity of Ots in humans and mouse models. CD4 T-cell functional experiments are needed to assess the immunological significance of these HBA spacer domains and their role in clearance of Ots from Indian patients.	[Ramaiah, Arunachalam; Koralur, Munegowda C.; Dasch, Gregory A.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Dasch, GA (corresponding author), Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA 30333 USA.	ged4@cdc.gov	Koralur, Munegowda/G-8802-2015	Koralur, Munegowda/0000-0001-6347-3890	Centers for Disease Control and Prevention (CDC) [1U600E000103, 93.322]; ASM/CDC Postdoctoral Fellowship	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ASM/CDC Postdoctoral Fellowship	A.R. is supported by an appointment to the Postdoctoral Bioinformatics Fellowship Program administrated by the Association of Public Health Laboratories (APHL) and funded by the Centers for Disease Control and Prevention (CDC) as part of the Cooperative Agreement 1U600E000103 (CFDA No. 93.322). M.C.K. is supported by an ASM/CDC Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this study are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Bhate R, 2017, VECTOR-BORNE ZOONOT, V17, P749, DOI 10.1089/vbz.2017.2159; Blacksell SD, 2008, FEMS IMMUNOL MED MIC, V52, P335, DOI 10.1111/j.1574-695X.2007.00375.x; CHONG Y, 1989, Yonsei Medical Journal, V30, P111; Chu H, 2013, J MICROBIOL BIOTECHN, V23, P1159, DOI 10.4014/jmb.1303.03019; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; CURRIE B, 1993, MED J AUSTRALIA, V158, P609, DOI 10.5694/j.1326-5377.1993.tb137630.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELISBERG BL, 1968, J HYG EPID MICROB IM, V12, P18; Feng HM, 1997, J IMMUNOL, V158, P5314; Graves S, 1999, AM J TROP MED HYG, V60, P786, DOI 10.4269/ajtmh.1999.60.786; HANSON B, 1991, INFECT IMMUN, V59, P4134, DOI 10.1128/IAI.59.11.4134-4141.1991; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kim G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005408; KODAMA K, 1987, INFECT IMMUN, V55, P2490, DOI 10.1128/IAI.55.10.2490-2495.1987; Kollars TM, 2003, AM J TROP MED HYG, V68, P299, DOI 10.4269/ajtmh.2003.68.299; Lee JH, 2008, J INFECT DIS, V198, P250, DOI 10.1086/589284; Lin PR, 2011, APPL ENVIRON MICROB, V77, P3398, DOI 10.1128/AEM.02796-10; Ogawa M, 2002, AM J TROP MED HYG, V67, P162, DOI 10.4269/ajtmh.2002.67.162; OHASHI N, 1990, J CLIN MICROBIOL, V28, P2111, DOI 10.1128/JCM.28.9.2111-2113.1990; OHASHI N, 1992, J BIOL CHEM, V267, P12728; Paris DH, 2015, MOL MED MICROBIOLOGY, P2057, DOI DOI 10.1016/B978-0-12-397169-2.00112-8; Qiang Y, 2003, MICROBIOL IMMUNOL, V47, P577, DOI 10.1111/j.1348-0421.2003.tb03420.x; Rakshit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10773-5; SHIRAI A, 1975, AM J TROP MED HYG, V24, P145, DOI 10.4269/ajtmh.1975.24.145; Singhsilarak T, 2005, AM J TROP MED HYG, V72, P640, DOI 10.4269/ajtmh.2005.72.640; STOVER CK, 1990, INFECT IMMUN, V58, P2076, DOI 10.1128/IAI.58.7.2076-2084.1990; Takhampunya R, 2016, VECTOR-BORNE ZOONOT, V16, P33, DOI 10.1089/vbz.2014.1753; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Varghese GM, 2015, EMERG INFECT DIS, V21, P64, DOI 10.3201/eid2101.140580; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Xu G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006062; Xu G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005763; YAMAMOTO S, 1986, MICROBIOL IMMUNOL, V30, P611, DOI 10.1111/j.1348-0421.1986.tb02988.x; Yang HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046997; YI KS, 1993, MIL MED, V158, P269, DOI 10.1093/milmed/158.4.269	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196240	10.1371/journal.pone.0196240	http://dx.doi.org/10.1371/journal.pone.0196240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698425	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600048
J	Zhang, X; Chen, X; Wang, XY; Zhou, XT				Zhang, Xi; Chen, Xun; Wang, Xiaoying; Zhou, Xingtao			Iridociliary cysts do not impact on posterior phakic intraocular lens implantation for high myopia correction: A prospective cohort study in 1569 eyes	PLOS ONE			English	Article							CILIARY BODY CYSTS; 3-YEAR FOLLOW-UP; COLLAMER LENS; ULTRASOUND BIOMICROSCOPY; ANGLE-CLOSURE; MODERATE; ASTIGMATISM; GLAUCOMA; IRIS	Purpose To investigate the clinical characters and effect of iridociliary cysts among patients who had undergone posterior phakic intraocular lens implantation. Methods A total 1569 eyes of 866 high myopia patients, who underwent phakic intraocular lens implantation from 1 September 2011 to 31 August 2016, was included in this prospective cohort study. These patients were followed up for more than 12 months postoperatively. Results During the study period, 218 eyes (14%) of 154 patients were diagnosed with iridociliary cysts by ultrasound biomicroscopy. There were 74.3% patients with unilateral cysts and the cysts tended to have occurred in patients ages 20 to 30 years old (22%). The location of the cysts varied with temporal position as the most (50%) and superior position as the least (9.6%). After 1 week postoperative follow-up, there were no significant differences in clinical outcomes between the cysts group and no cysts group, but the proportion of 20/20 or better uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), and the 2 types of vector astigmatism. Intraocular pressure (IOP), refraction, and vault remained stable at different time points of the follow-up period, while vault of cysts patients tend to be lower than patients without cysts at more than 12 months. Conclusions Iridociliary cysts were more common than estimated and it had no impact on Phakic Intraocular Lens implantation because there was no clue to show significantly difference on postoperative clinical outcomes between the patients with and without iridociliary cysts in this study.	[Zhang, Xi; Chen, Xun; Wang, Xiaoying; Zhou, Xingtao] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Zhang, Xi; Chen, Xun; Wang, Xiaoying; Zhou, Xingtao] Hlth Minist, Myopia Key Lab, Dept Ophthalmol, Shanghai, Peoples R China	Fudan University	Wang, XY (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai, Peoples R China.; Wang, XY (corresponding author), Hlth Minist, Myopia Key Lab, Dept Ophthalmol, Shanghai, Peoples R China.	doctxiaoyingwang@163.com	zhou, xt/GWZ-9212-2022; zhou, xing/GQP-4516-2022		Shanghai Shenkang Hospital Development Center [SHDC12016207]; Health and Family Planning Committee of Pudong New District of Shanghai [PW2014D-1]	Shanghai Shenkang Hospital Development Center; Health and Family Planning Committee of Pudong New District of Shanghai	This work was supported by the Shanghai Shenkang Hospital Development Center (Grant No. SHDC12016207) and the Health and Family Planning Committee of Pudong New District of Shanghai (Grant No. PW2014D-1) to Xiaoying Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman-Ullah Muhammad, 2012, Ophthalmic Surg Lasers Imaging, V43 Online, pe18, DOI 10.3928/15428877-20120223-01; Chang JS, 2007, J REFRACT SURG, V23, P17; Cornut PL, 2010, J FR OPHTALMOL, V33, P680, DOI 10.1016/j.jfo.2010.06.017; Cronemberger Sebastião, 2006, Arq. Bras. Oftalmol., V69, P471, DOI 10.1590/S0004-27492006000400003; Gao J, 2013, J CATARACT REFR SURG, V39, P1011, DOI 10.1016/j.jcrs.2013.01.040; Gonvers M, 2003, J CATARACT REFR SURG, V29, P918, DOI 10.1016/S0886-3350(03)00065-8; Kamiya K, 2009, J REFRACT SURG, V25, P259, DOI 10.3928/1081597X-20090301-04; Kunimatsu S, 1999, AM J OPHTHALMOL, V127, P48, DOI 10.1016/S0002-9394(98)00308-0; Marigo FA, 1999, OPHTHALMOLOGY, V106, P2131, DOI 10.1016/S0161-6420(99)90495-5; McWhae JA, 2007, CAN J OPHTHALMOL, V42, P268, DOI 10.3129/canjophthalmol.i07-017; Ritch R, 2003, OPHTHALMOLOGY, V110, P1880, DOI 10.1016/S0161-6420(03)00563-3; Sanders DR, 2008, J REFRACT SURG, V24, P773, DOI 10.3928/1081597X-20081001-02; Sanders DR, 2007, OPHTHALMOLOGY, V114, P54, DOI 10.1016/j.ophtha.2006.08.049; Sanders DR, 2004, OPHTHALMOLOGY, V111, P1683, DOI 10.1016/j.ophtha.2004.03.026; Sari ES, 2013, GRAEF ARCH CLIN EXP, V251, P1413, DOI 10.1007/s00417-012-2172-8; Seki M, 2014, J GLAUCOMA, V23, P477, DOI 10.1097/IJG.0b013e31827a088c; Shi M, 2015, EYE, V29, P499, DOI 10.1038/eye.2014.336; SHIELDS JA, 1984, BRIT J OPHTHALMOL, V68, P152, DOI 10.1136/bjo.68.3.152; THOMAS R, 1989, AUST NZ J OPHTHALMOL, V17, P317, DOI 10.1111/j.1442-9071.1989.tb00541.x; Vukich JA, 2003, OPHTHALMOLOGY, V110, P255, DOI 10.1016/S0161-6420(02)01771-2	20	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196460	10.1371/journal.pone.0196460	http://dx.doi.org/10.1371/journal.pone.0196460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698452	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600084
J	Mu, XP; Wang, PF; Du, JJ; Gao, YG; Zhang, JC				Mu, Xiaopeng; Wang, Pengfei; Du, Junjie; Gao, Yu Gary; Zhang, Jiancheng			The chloroplast genome of Cerasus humilis: Genomic characterization and phylogenetic analysis	PLOS ONE			English	Article							SEQUENCE; MITOCHONDRIAL; ALIGNMENT; STRESS; TOOLS	Cerasus humilis is endemic to China and is a new fruit tree species with economic and environmental benefits, with potential developmental and utilization applications. We report the first complete chloroplast genome sequence of C. humilis. Its genome is 158,084 bp in size, and the overall GC content is 36.8%. An inverted repeats (IR) of 52,672 bp in size is separated by a large single-copy (LSC) region of 86,374 bp and a small single-copy (SSC) region of 19,038 bp. The chloroplast genome of C. humilis contains 131 genes including 90 protein-coding genes, 33 transfer RNA genes, and 8 ribosomal RNA genes. The genome has a total 510 simple sequence repeats (SSRs). Of these, 306, 149, and 55 were found in the LSC, IR, and SSC regions, respectively. In addition, a comparison of the boundaries of the LSC, SSC, and IR regions of ten other Prunus species exhibited an overall high degree of sequence similarity, with slight variations in the IR boundary region which included gene deletions, insertions, expansions, and contractions. C. humilis lost the ycf1 gene at the IRA/SSC border and it has the largest ycf1 gene at the IRB/SSC border among these Prunus species, whereas the rps19 gene was inserted at the IRB/LSC junction. Furthermore, phylogenetic reconstruction using 61 conserved coding-protein genes clustered C. humilis with Prunus tomentosa. Thus, the complete chloroplast genome sequence of C. humilis provides a rich source of genetic information for studies on Prunus taxonomy, phylogeny, and evolution, as well as lays the foundation for further development and utilization of C. humilis.	[Mu, Xiaopeng; Wang, Pengfei; Du, Junjie; Zhang, Jiancheng] Shanxi Agr Univ, Coll Hort, Jinzhong, Shanxi, Peoples R China; [Du, Junjie] Shanxi Key Lab Germplasm Improvement & Utilizat P, Jinzhong, Shanxi, Peoples R China; [Gao, Yu Gary] Ohio State Univ, Coll Food Agr & Environm Sci, OSU South Ctr, Shyville Rd, Piketon, OH USA	Shanxi Agricultural University; University System of Ohio; Ohio State University	Du, JJ (corresponding author), Shanxi Agr Univ, Coll Hort, Jinzhong, Shanxi, Peoples R China.; Du, JJ (corresponding author), Shanxi Key Lab Germplasm Improvement & Utilizat P, Jinzhong, Shanxi, Peoples R China.	djj738@163.com	Gao, Yu "Gary"/D-6587-2018	Gao, Yu "Gary"/0000-0002-9901-8790	Major Subject of Shanxi Science and Technology Research [20121101010]; Doctoral Research Fund of Shanxi Agriculture University [2015ZZ19]; China Postdoctoral Science Foundation [2017M621106]	Major Subject of Shanxi Science and Technology Research; Doctoral Research Fund of Shanxi Agriculture University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was performed with the support of the Major Subject of Shanxi Science and Technology Research (Grant No. 20121101010), the Doctoral Research Fund of Shanxi Agriculture University (Grant No. 2015ZZ19) and China Postdoctoral Science Foundation (Grant No.2017M621106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NO HORTICULTURE; [Anonymous], 1993, CROP VARIETY RESOURC; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Howe C. J., 2016, CHLOROPLAST GENOME, DOI [10.1038/npg.els.0002016, DOI 10.1038/NPG.ELS.0002016]; Kaila T, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01847; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Leese F, 2008, LIMNOL OCEANOGR-METH, V6, P412, DOI 10.4319/lom.2008.6.412; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WD, 2014, SCI HORTIC-AMSTERDAM, V175, P208, DOI 10.1016/j.scienta.2014.06.015; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu RS, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02054; Mu XP, 2015, J HORTIC SCI BIOTECH, V90, P525, DOI 10.1080/14620316.2015.11668709; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Park S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0432-6; Raman G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141329; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Silva SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165176; Song X, 2011, PHOTOSYNTHETICA, V49, P523, DOI 10.1007/s11099-011-0065-4; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Williams AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125768; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yin ZP, 2014, PLANT GROWTH REGUL, V74, P209, DOI 10.1007/s10725-014-9912-1; Yu DJ., 1979, CHINESE FRUIT TAXONO; Zhang L, 1994, ACTA HORTICULTURAE S, V1, P94; Zuo LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171264	38	11	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196473	10.1371/journal.pone.0196473	http://dx.doi.org/10.1371/journal.pone.0196473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694421	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400092
J	Naderi, M; Farashi, A; Erdi, MA				Naderi, Morteza; Farashi, Azita; Erdi, Mehdi Alipour			Persian leopard's (Panthera pardus saxicolor) unnatural mortality factors analysis in Iran	PLOS ONE			English	Article							SURVIVAL RATES; NATIONAL-PARK; CONSERVATION; KILLS	Due to the relatively low offspring survival rate, surviving adult leopards play a critical role in the species' viability. The unnatural mortality of leopards, caused by human activities can seriously compromise the species' long-term population survival. An analysis of spatial distribution and sex ratio of unnatural mortality of 147 recorded Persian leopard (Panthera pardus saxicolor) carcasses during a fifteen-year period (from 2000-2015) in Iran indicated that road mortality is the second most frequent cause of unnatural mortality of Persian leopards' after illegal hunting (or prey poisoning, such as poisoned meat) by villagers, shepherds and military forces. The greatest percent of unnatural mortality events were recorded in the Golestan provinc in the north of Iran and eastern most parts of the Hyrcanian forests. Using distribution models of species, based on road accident locations as species data, we mapped the species' distribution and critical areas of unnatural mortality of Persian leopard that can be used in prioritizing leopard-human conflicts management. Our results showed that mortality records were significantly higher in non-protected compared to protected areas. Males constituted 65 percent of the records used in the study as males dispersed more widely compared to the females. This imbalance can have severe demographic effects. A large proportion of leopards' activity, occurrence area, and habitat lies in non-protected areas, which is mirrored by the greater number of unnatural mortality outside protected areas. Most of the incidents were due to human factors, thus management interventions such as traffic speed limitations, signs, cameras, and faunal bridges as well as increasing public participation and awareness (especially among rural communities) will positively affect the species' conservation programs. This research aimed to produce unnatural mortality of leopards' risk map throughout Iran and discuss the different aspects of this phenomenon, major human-caused threats and the efficiency of the legal protected areas in satisfying the species' ecological requirements. We propose management interventions such as traffic speed limitations, signs, cameras, and faunal bridges as well as increasing public awareness and participation, especially among rural communities, to support the species' conservation.	[Naderi, Morteza] Arak Univ, Fac Agr & Nat Resources, Dept Environm Sci, Arak, Iran; [Farashi, Azita] Ferdowsi Univ Mashhad, Fac Nat Resource & Environm, Dept Environm Sci, Mashhad, Iran; [Erdi, Mehdi Alipour] Univ Tehran, Grad Fac Environm, Environm Planning & Management, Tehran, Iran	Arak University; Ferdowsi University Mashhad; University of Tehran	Naderi, M (corresponding author), Arak Univ, Fac Agr & Nat Resources, Dept Environm Sci, Arak, Iran.	ghnadery@yahoo.com	Farashi, Azita/AAE-6892-2021; Naderi, Morteza/K-8868-2013	Farashi, Azita/0000-0002-5536-2311; Naderi, Morteza/0000-0002-7578-4159				Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; Balme G.A., 2004, ECOL J, V6, P1; BASKARAN N., 2010, J THREAT TAXA, V2, P753, DOI DOI 10.11609/J0TT.02101.753-9; Cheung WWL, 2005, BIOL CONSERV, V124, P97, DOI 10.1016/j.biocon.2005.01.017; Dalerum F, 2008, J WILDLIFE MANAGE, V72, P1125, DOI 10.2193/2007-336; Darvishsefat A. A., 2006, ATLAS PROTECTED AREA; DREWS C, 1995, AFR J ECOL, V33, P89, DOI 10.1111/j.1365-2028.1995.tb00785.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Erfanian B, 2013, WILDLIFE BIOL, V19, P170, DOI 10.2981/12-045; Farhadinia Mohammad, 2007, Cat News, V46, P34; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Ghafaripour S., 2017, J WILDLIFE BIODIVERS, V1, P47; Ghoddousi Arash, 2008, Cat News, V49, P10; Ghoddusi H, 2010, SCOT J POLIT ECON, V57, P359, DOI 10.1111/j.1467-9485.2009.00522.x; Gubbi Sanjay, 2014, Cat News, V60, P30; Hemami MR, 2016, ENVIRON RES, V7, P215; Hoskin CJ, 2010, ECOL SOC, V15, DOI 10.5751/es-03272-150315; Jackson P., 1996, BIOL CONSERVATION; Khaleghi MR, 2014, SOIL WATER RES, V9, P25, DOI 10.17221/33/2012-SWR; Khorozyan Igor, 2005, Endangered Species Update, V22, P51; Kiabi Bahram H., 2002, Zoology in the Middle East, V26, P41; KITCHENER A., 1991, NATURAL HIST WILD CA; Krebs J, 2004, J WILDLIFE MANAGE, V68, P493, DOI 10.2193/0022-541X(2004)068[0493:SOSRAC]2.0.CO;2; Lin HX, 1995, FUZZY SETS FUZZY DEC; Odden M, 2005, WILDLIFE BIOL, V11, P145, DOI 10.2981/0909-6396(2005)11[145:SAAPOL]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ree VDR, 2011, ECOL SOC, V16, P48; Rostro-Garcia S, 2016, LANDSCAPE ECOL, V31, P1277, DOI 10.1007/s10980-015-0335-9; Sanei A., 2012, UTM 11 INT S SUST SC; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Sunquist ME, 2002, WILD CATS WORLD; Swanepoel L. H., 2016, RED LIST MAMMALS S A; Swanepoel LH, 2015, WILDLIFE BIOL, V21, P263, DOI 10.2981/wlb.00108; Swanepoel LH, 2015, ORYX, V49, P595, DOI 10.1017/S0030605313001282; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Switalski TA, 2011, BIOL CONSERV, V144, P2666, DOI 10.1016/j.biocon.2011.07.026; Taghdisi M, 2013, TURK J ZOOL, V37, P554, DOI 10.3906/zoo-1301-20; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; ZADEH LA, 1988, COMPUTER, V21, P83, DOI 10.1109/2.53; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	41	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195387	10.1371/journal.pone.0195387	http://dx.doi.org/10.1371/journal.pone.0195387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694391	Green Submitted, gold, Green Published			2022-12-26	WOS:000430802400027
J	Ma, X; Wang, B; Wang, XF; Luo, YJ; Fan, WF				Ma, Xia; Wang, Bei; Wang, Xiaofang; Luo, Yujiao; Fan, Wufang			NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SIGNALING PATHWAY; WNT/BETA-CATENIN; EXPRESSION; PROMOTES; OCT4; GENE; PROLIFERATION; MAINTENANCE; LEUKEMIA	Background Accumulating evidence demonstrated that NANOG1, the key transcription factor for embryonic stem cells, is associated with human cancers. NANOGP8, one of the pseudogenes in NANOG gene family, contains an intact open reading frame and also said to be expressed in cancer tissues. Therefore, a systematic study is greatly needed to address the following questions: among NANOG1 and NANOGP8, which gene is the main contributor for NANOG expression in cancer cells and which one is the key regulator responsible for stemness, epithelial-mesenchymal transition (EMT), metastasis, chemoresistance and other malignant phenotypes. Here we try to explore these issues with gastric adenocarcinoma cell lines in vitro using variety of molecular and cellular techniques. Methods Special primers were designed to distinguish PCR products from NANOG1 and NANOGP8. Sphere-forming cells were cultured with serum-free and selective medium. A stable cell line was established with infection of lentivirus containing NANOGP8. qPCR was performed to measure NANOGP8 expression and its association with stemness, EMT and CSC markers in adherent cells and sphere-forming cells. Western blot analysis was deployed to confirm results of the transcript analysis. Experiments of cell proliferation, migration, invasion, clonogenic assay, sphere cell growth assays, cell cycle analysis, beta-catenin accumulation and translocation in nucleus, and drug resistance were conducted to measure the impact of NANOGP8 on malignant statuses of gastric cancer cells. Immunofluorescence staining was used to analyze cell subpopulations with different markers. Results NANOGP8 is mainly responsible for NANOG expression in sphere-forming (stem cell-like) cells derived from gastric cancer cell lines regardless their differentiation status. Ectopic expression of NANOGP8 significantly up-regulates stemness transcription factors, EMT inducers, and cancer stem cell markers (CSC) including Lgr5. NANOGP8 also promotes expression of the signature genes vimentin and N-caderin for mesenchymal cells and down-regulates the signature gene E-caderin for epithelial cells whereby confer the cells with mesenchymal cell phenotype. In NANOGP8 over-expressed adherent and sphere-forming cells, Lgr5+ cells are significantly increased. Ectopic expression of NANOGP8 endows gastric cells with enhanced proliferation, migration, invasion, sphere-forming and clonogenic capacity, and chemoresistance. NANOGP8 expression also enhances beta-catenin accumulation in nucleus and strengthens Wnt signal transduction. Conclusion NANOGP8 is the main regulator of gastric cancer stem cells. It is closely associated with EMT, stemness, and CSC marker as well as Wnt signal pathway. NANOGP8 is correlated with cell proliferation, migration, invasion, clonogenic capacity, beta-catenin accumulation in nucleus, and chemoresistance in gastric cancer. NANOGP8 is a promising molecular target for clinical intervention of gastric cancer.	[Ma, Xia; Wang, Bei; Wang, Xiaofang; Luo, Yujiao; Fan, Wufang] Hebei Univ, Sch Life Sci, Mol Biol Lab Gastr Canc, Baoding, Hebei, Peoples R China; [Ma, Xia; Wang, Bei; Wang, Xiaofang; Luo, Yujiao; Fan, Wufang] Hebei Univ, Minist Educ, Key Lab Med Chem & Mol Diag, Baoding, Hebei, Peoples R China	Hebei University; Hebei University	Fan, WF (corresponding author), Hebei Univ, Sch Life Sci, Mol Biol Lab Gastr Canc, Baoding, Hebei, Peoples R China.; Fan, WF (corresponding author), Hebei Univ, Minist Educ, Key Lab Med Chem & Mol Diag, Baoding, Hebei, Peoples R China.	wfan6888@yahoo.com		Fan, Wufang/0000-0002-4354-0328	Hebei Province from Fund of the Hundred Talents Program [E2012100011]	Hebei Province from Fund of the Hundred Talents Program	Funded by Hebei Province from Fund of the Hundred Talents Program; E2012100011; Wufang Fan.	Abell Amy N, 2014, Curr Pathobiol Rep, V2, P21; Bharti R, 2016, CANCER LETT, V375, P51, DOI 10.1016/j.canlet.2016.02.048; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cao J, 2013, LEUKEMIA RES, V37, P1170, DOI 10.1016/j.leukres.2013.04.021; Choi HW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13559; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Duan XH, 2016, ACTA BIOCH BIOPH SIN, V48, P1042, DOI 10.1093/abbs/gmw099; Eberle I, 2010, NUCLEIC ACIDS RES, V38, P5384, DOI 10.1093/nar/gkq307; Ejendal KFK, 2002, CURR PROTEIN PEPT SC, V3, P503, DOI 10.2174/1389203023380521; Elaskalani O, 2017, WORLD J GASTRO ONCOL, V9, P37, DOI 10.4251/wjgo.v9.i1.37; Feng SY, 2017, CELL CYCLE, V16, P869, DOI 10.1080/15384101.2017.1308617; Feng ST, 2016, ONCOL REP, V36, P3207, DOI 10.3892/or.2016.5154; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gomceli I, 2012, WORLD J GASTROENTERO, V18, P5164, DOI 10.3748/wjg.v18.i37.5164; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Higgins DM, 2013, ONCOTARGET, V4, P792, DOI 10.18632/oncotarget.1059; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ibrahim EE, 2012, STEM CELLS, V30, P2076, DOI 10.1002/stem.1182; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ke Yang, 1994, Zhonghua Zhongliu Zazhi, V16, P7; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Khazaei Salman, 2016, Asian Pac J Cancer Prev, V17, P1701; Lin T, 2012, MED ONCOL, V29, P878, DOI 10.1007/s12032-011-9860-9; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; Lu YH, 2013, CANCER LETT, V340, P113, DOI 10.1016/j.canlet.2013.07.009; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Migita T, 2017, LAB INVEST; Miyazawa K, 2014, ONCOL LETT, V8, P985, DOI 10.3892/ol.2014.2274; Nirasawa S, 2009, ONCOL REP, V22, P587, DOI 10.3892/or_00000476; Santaliz-Ruiz LEIV, 2014, INT J CANCER, V135, P2741, DOI 10.1002/ijc.28690; Scerbo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085104; Spears E, 2011, J BIOL CHEM, V286, P4946, DOI 10.1074/jbc.C110.205922; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uchino K, 2012, EXP CELL RES, V318, P1799, DOI 10.1016/j.yexcr.2012.04.011; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Wang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168904; Wang ZJ, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/475389; Wu YY, 2012, MOL CANCER RES, V10, P1597, DOI 10.1158/1541-7786.MCR-12-0155-T; Yao C, 2016, STEM CELLS, V34, P820, DOI 10.1002/stem.2320; Yin X, 2012, ANN SURG ONCOL, V19, P2877, DOI 10.1245/s10434-012-2314-6; Yong X, 2016, CANCER LETT, V374, P292, DOI 10.1016/j.canlet.2016.02.032; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JY, 2010, ONCOL LETT, V1, P457, DOI 10.3892/ol_00000081; Zhang W, 2016, INT J BIOL SCI, V12, P1372, DOI 10.7150/ijbs.16349; Zhao HQ, 2017, J CELL MOL MED, V21, P2055, DOI 10.1111/jcmm.13126; Zhao XZ, 2016, ONCOL LETT, V11, P442, DOI 10.3892/ol.2015.3884; Zhou Y, 2017, ONCOTARGET, V8, P33110, DOI 10.18632/oncotarget.16145	48	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0192436	10.1371/journal.pone.0192436	http://dx.doi.org/10.1371/journal.pone.0192436			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689047	Green Published, gold, Green Submitted			2022-12-26	WOS:000430678800003
J	Lamina, C; Braga, D; Castro, R; Guimaraes, C; de Castilho, LVA; Freire, DMG; Barrientos, L				Lamina, Claudio; Braga, Douglas; Castro, Rui; Guimaraes, Carolina; de Castilho, Livia V. A.; Freire, Denise M. G.; Barrientos, Leticia			& IT;Streptomyces luridus & IT; So3.2 from Antarctic soil as a novel producer of compounds with bioemulsification potential	PLOS ONE			English	Article							NEIGHBOR-JOINING METHOD; STREPTOMYCES SP; BIOSURFACTANT PRODUCTION; MARINE ACTINOBACTERIA; BACTERIA; METABOLITES; MICROORGANISM; SURFACTANTS; PHYLOGENIES; DIVERSITY	The present study aimed to identify novel microbial producers of bioemulsificant compounds from Antarctic soils. Fifty-nine microbial strains were isolated from five different locations at South Shetland Islands, Antarctica, and screened for biosurfactant production by beta-hemolytic activity. Strain So 3.2 was determined as bioemulsifier-producer and identified by phenotypic and molecular characterization as Streptomyces luridus. Emulsification activity, oil displacement method and drop-collapsing test were performed to evaluate the biosurfactant activity with different oils and hydrocarbons using two different culture media (Luria Bertani and Bushnell Haas in the presence of different carbon sources: glucose, glycerol, olive oil and n-Hexadecane). Cell free supernatant of Bushnell Haas culture supplemented with n-Hexadecane showed the best results for all tests. Emulsification of hydrocarbons exceeded 60%, reaching up to 90% on oil with high API grade, while displacement tests ranged from 8 cm to 4 cm in diameter according the culture media and tested oils. Our results revealed that Streptomyces luridus So3.2 is able to produce bioemulsifiers capable of emulsifying hydrocarbons and oils, which could be used in different biotechnological applications, particularly for bioremediation of environments contaminated by oil leaks.	[Lamina, Claudio; Barrientos, Leticia] Ctr Excellence Translat Med, Lab Appl Mol Biol, Temuco, Chile; [Lamina, Claudio; Barrientos, Leticia] Univ La Frontera, Sci & Technol Bioresource Nucleus BIOREN, Temuco, Chile; [Braga, Douglas; Castro, Rui; Guimaraes, Carolina; de Castilho, Livia V. A.; Freire, Denise M. G.] Univ Fed Rio de Janeiro, Ctr Tecnol, Inst Quim, Dept Bioquim,Lab Biotecnol Microbiana, Av Athos Silveira Ramos,Cidade Univ, Rio De Janeiro, RJ, Brazil	Universidad de La Frontera; Universidade Federal do Rio de Janeiro	Barrientos, L (corresponding author), Ctr Excellence Translat Med, Lab Appl Mol Biol, Temuco, Chile.; Barrientos, L (corresponding author), Univ La Frontera, Sci & Technol Bioresource Nucleus BIOREN, Temuco, Chile.; Freire, DMG (corresponding author), Univ Fed Rio de Janeiro, Ctr Tecnol, Inst Quim, Dept Bioquim,Lab Biotecnol Microbiana, Av Athos Silveira Ramos,Cidade Univ, Rio De Janeiro, RJ, Brazil.	freire@iq.ufrj.br; leticia.barrientos@ufrontera.cl	de Castilho, Lívia V A/I-6256-2017; de Castilho, Lívia Vieira Araujo/S-3944-2019; Barrientos, Leticia/R-6205-2017	de Castilho, Lívia V A/0000-0001-5719-9629; de Castilho, Lívia Vieira Araujo/0000-0001-5719-9629; Barrientos, Leticia/0000-0002-5344-054X; Lamilla, Claudio Andres/0000-0003-0490-6945; de Paula Vieira de Castro, Rui/0000-0002-7641-8724	Instituto Antartico Chileno, Ministerio de Relaciones Exteriores de Chile [INACH DT_05-15 CL, INACH RT_14-12, INACH DT_05-15, RT_14-12]; Universidad de La Frontera/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ [FPJ15-0009]; Universidade Federal do Rio de Janeiro/ Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ; Direccion de Investigacion Universidad de La Frontera [DI17-0116]; Consejo Nacional de Ciencia y Tecnologia CONICYT [21140691]; Universidad de La Frontera/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ; Universidad de La Frontera [DI17-0116]; Conicyt [21140691]	Instituto Antartico Chileno, Ministerio de Relaciones Exteriores de Chile; Universidad de La Frontera/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ; Universidade Federal do Rio de Janeiro/ Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ; Direccion de Investigacion Universidad de La Frontera; Consejo Nacional de Ciencia y Tecnologia CONICYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad de La Frontera/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ; Universidad de La Frontera; Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by the Instituto Antartico Chileno, Ministerio de Relaciones Exteriores de Chile (http://www.inach.cl/inach/) Grants INACH DT_05-15 CL and Grant INACH RT_14-12 to LB and had a role in Data collection and logistical support. This was also funded by Universidad de La Frontera/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ, (http://www.ufro.cl/) Grant FPJ15-0009 to LB and provided data analysis; Universidade Federal do Rio de Janeiro/ Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ (https://ufrj.br) D.F; R.C.; C.A.; L.A and provided data analysis; Direccion de Investigacion Universidad de La Frontera (http://www.ufro.cl/) Grant DI17-0116 to LB and provided data analysis and the Consejo Nacional de Ciencia y Tecnologia CONICYT (http://www.conicyt.cl/becasconicyt/2014/03/11/doctorado-en-chile-2014/) Grant No 21140691 to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Judith Hoffman (Northern Light Translations & Editing) for her revision of the English manuscript. The authors gratefully acknowledge Grants INACH DT_05-15 and RT_14-12 from the Instituto Antartico Chileno, Ministerio de Relaciones Exteriores de Chile; Grant FPJ15-0009 from Universidad de La Frontera/Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro FAPERJ, and Grant DI17-0116 from Universidad de La Frontera -for logistical support. Claudio Lamilla is grateful for Conicyt Grant No 21140691.	Abouseoud M, 2008, DESALINATION, V223, P143, DOI 10.1016/j.desal.2007.01.198; Amena S, 2010, BRAZ J MICROBIOL, V41, P173, DOI [10.1590/S1517-83822010000100025, 10.1590/S1517-838220100001000025]; Antony R, 2012, MICROBIOL RES, V167, P372, DOI 10.1016/j.micres.2012.03.003; Banat IM, 2014, FRONTIERS MICROBIOLO; BENAVIDES J., 2006, PUBL CIENT, V4, P82; Calvo C, 2009, SCI TOTAL ENVIRON, V407, P3634, DOI 10.1016/j.scitotenv.2008.07.008; Canals MV, 2005, MICROBIOL MADRID, V352; Chakraborty S, 2015, INT J BIOL MACROMOL, V79, P405, DOI 10.1016/j.ijbiomac.2015.04.068; COOPER DG, 1987, APPL ENVIRON MICROB, V53, P224, DOI 10.1128/AEM.53.2.224-229.1987; Cox RA, 2004, MICROBIOL-SGM, V150, P1413, DOI 10.1099/mic.0.26560-0; Deepa R, 2015, SCREENING BIOEMULSIF, V4, P687; Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47, DOI 10.1128/.61.1.47-64.1997; Elsayed EA, 2015, BRAZ ARCH BIOL TECHN, V58, P676, DOI 10.1590/S1516-89132015050184; Encheva-Malinova M, 2014, BIOTECHNOL BIOTEC EQ, V28, P721, DOI 10.1080/13102818.2014.947066; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gandhimathi R, 2009, BIOPROC BIOSYST ENG, V32, P825, DOI 10.1007/s00449-009-0309-x; Gentile G, 2003, J APPL MICROBIOL, V95, P1124, DOI 10.1046/j.1365-2672.2003.02077.x; Gesheva V, 2012, POLAR BIOL, V35, P291, DOI 10.1007/s00300-011-1052-8; Gesheva V, 2010, CURR MICROBIOL, V61, P112, DOI 10.1007/s00284-010-9584-7; Haba E, 2014, BBA-BIOMEMBRANES, V1838, P776, DOI 10.1016/j.bbamem.2013.11.004; Hanada Y, 2014, FEBS J, V281, P3576, DOI 10.1111/febs.12878; Hua ZZ, 2003, WATER RES, V37, P4143, DOI 10.1016/S0043-1354(03)00380-4; Jagtap S, 2010, INDIAN J EXP BIOL, V48, P70; Jayatilake GS, 1996, J NAT PROD, V59, P293, DOI 10.1021/np960095b; Karthik L., 2010, ENV BIOTECHNOL, V1, P34; Khopade A, 2012, J COLLOID INTERF SCI, V367, P311, DOI 10.1016/j.jcis.2011.11.009; Kokare C. R., 2007, Indian Journal of Biotechnology, V6, P78; Kronemberger FD, 2008, APPL BIOCHEM BIOTECH, V147, P33, DOI 10.1007/s12010-007-8057-3; Kugler JH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00212; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lamilla C, 2017, POLAR BIOL, V40, P719, DOI 10.1007/s00300-016-1977-z; Lee LH, 2012, WORLD J MICROB BIOT, V28, P2125, DOI 10.1007/s11274-012-1018-1; Colin VL, 2017, WATER AIR SOIL POLL, V228, DOI 10.1007/s11270-017-3623-y; Colin VL, 2013, CHEMOSPHERE, V90, P1372, DOI 10.1016/j.chemosphere.2012.08.002; Lo Giudice A, 2007, FEMS MICROBIOL ECOL, V60, P383, DOI 10.1111/j.1574-6941.2007.00300.x; Manivasagan P, 2014, MICROBIOL RES, V169, P262, DOI 10.1016/j.micres.2013.07.014; Maniyar JP, 2011, INDIAN J EXP BIOL, V49, P293; Marchant R, 2012, TRENDS BIOTECHNOL, V30, P558, DOI 10.1016/j.tibtech.2012.07.003; Medina D, 2013, ACTINOMICETOS ANTAGO; Monteiro AS, 2010, BIORESOURCE TECHNOL, V101, P5186, DOI 10.1016/j.biortech.2010.02.041; Moran AC, 2002, BIOTECHNOL LETT, V24, P177, DOI 10.1023/A:1014140820207; Mulligan CN, 2005, ENVIRON POLLUT, V133, P183, DOI 10.1016/j.envpol.2004.06.009; Muthusamy K, 2008, CURR SCI INDIA, V94, P736; Nguyen TT, 2011, INT J MOL SCI, V12, P1232, DOI 10.3390/ijms12021232; Nichols D, 1999, CURR OPIN BIOTECH, V10, P240, DOI 10.1016/S0958-1669(99)80042-1; Nitschke M, 2006, BIORESOURCE TECHNOL, V97, P336, DOI 10.1016/j.biortech.2005.02.044; Papaleo MC, 2013, NEW BIOTECHNOL, V30, P824, DOI 10.1016/j.nbt.2013.03.011; Patil JR, 2001, J APPL MICROBIOL, V91, P290, DOI 10.1046/j.1365-2672.2001.01382.x; Raju R, 2010, ORG LETT, V12, P5158, DOI 10.1021/ol102162d; Richter M, 1998, FEMS MICROBIOL LETT, V163, P165, DOI 10.1111/j.1574-6968.1998.tb13041.x; Rizzo C, 2015, ECOTOXICOLOGY, V24, P1294, DOI 10.1007/s10646-015-1504-y; Rodrigues LR, 2010, ADV EXPT MED BIOL BI; Ruberto L, 2004, BIORREMEDIACION SUEL; Sachdev DP, 2013, APPL MICROBIOL BIOT, V97, P1005, DOI 10.1007/s00253-012-4641-8; Safary A., 2010, Biotechnology, V9, P378, DOI 10.3923/biotech.2010.378.382; Saharan BS., 2011, GENETIC ENG BIOTECHN, V2011, P1; Saisivam S, 2008, INDIAN J BIOTECHNOL, V7, P349; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shete AM, 2006, J SCI IND RES INDIA, V65, P91; Sjoling, 2003, EXTREMOPHILES, V7, P107; Song BH, 1996, J COLLOID INTERF SCI, V184, P77, DOI 10.1006/jcis.1996.0598; Su SS, 2013, J ASIAN NAT PROD RES, V15, P265, DOI 10.1080/10286020.2012.762764; Subramani R, 2012, MICROBIOL RES, V167, P571, DOI 10.1016/j.micres.2012.06.005; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tugrul T, 2005, WORLD J MICROB BIOT, V21, P851, DOI 10.1007/s11274-004-5958-y; Uzoigwe C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00245; Viramontes-Ramos S, 2010, BRAZ J MICROBIOL, V41, P668, DOI 10.1590/S1517-83822010000300017; Ward AC, 2006, CURR OPIN MICROBIOL, V9, P279, DOI 10.1016/j.mib.2006.04.004; Willumsen PA, 1997, BIODEGRADATION, V7, P415, DOI 10.1007/BF00056425; Yan X, 2014, BIOCHEM SYST ECOL, V55, P292, DOI 10.1016/j.bse.2014.03.015; Yu H, 2011, SOIL SEDIMENT CONTAM, V20, P274, DOI 10.1080/15320383.2011.560981; Zambry NS, 2017, BIOPROC BIOSYST ENG, V40, P1007, DOI 10.1007/s00449-017-1764-4; Zaragoza A, 2010, LANGMUIR, V26, P8567, DOI 10.1021/la904637k	74	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196054	10.1371/journal.pone.0196054	http://dx.doi.org/10.1371/journal.pone.0196054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684071	gold, Green Submitted, Green Published			2022-12-26	WOS:000430660600035
J	Solati, Z; Edel, AL; Shang, Y; Karmin, O; Ravandi, A				Solati, Zahra; Edel, Andrea L.; Shang, Yue; Karmin, O.; Ravandi, Amir			Oxidized phosphatidylcholines are produced in renal ischemia reperfusion injury	PLOS ONE			English	Article							OXIDATION-SPECIFIC BIOMARKERS; ACUTE KIDNEY INJURY; LOW-DENSITY-LIPOPROTEIN; PHOSPHOLIPASE-A2 ACTIVITY; PERCUTANEOUS CORONARY; LIPID-METABOLISM; RAT-KIDNEY; DISEASE; ACCUMULATION; INHIBITION	Background & para;& para;The aim of this study was to determine the individual oxidized phosphatidylcholine (OxPC) molecules generated during renal ischemia/reperfusion (I/R) injury.& para;& para;Methods & para;& para;Kidney ischemia was induced in male Sprague-Dawley rats by clamping the left renal pedicle for 45 min followed by reperfusion for either 6h or 24h. Kidney tissue was subjected to lipid extraction. Phospholipids and OxPC species were identified and quantitated using liquid chromatography coupled to electrospray ionization tandem mass spectrometry using internal standards.& para;& para;Result & para;& para;We identified fifty-five distinct OxPC in rat kidney following I/R injury. These included a variety of fragmented (aldehyde and carboxylic acid containing species) and non-fragmented products. 1-stearoyl-2-linoleoyl-phosphatidylcholine (SLPC-OH), which is a non-fragmented OxPC and 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine (PAzPC), which is a fragmented OxPC, were the most abundant OxPC species after 6h and 24 h I/R respectively. Total fragmented aldehyde OxPC were significantly higher in 6h and 24h I/R groups compared to sham operated groups (P= 0.03, 0.001 respectively). Moreover, levels of aldehyde OxPC at 24h I/R were significantly greater than those in 6h I/R (P= 0.007). Fragmented carboxylic acid increased significantly in 24h I/R group compared with sham and 6h I/R groups (P= 0.001, 0.001). Moreover, levels of fragmented OxPC were significantly correlated with creatinine levels (r = 0.885, P= 0.001). Among non-fragmented OxPC, only isoprostanes were elevated significantly in 6h I/R group compared with sham group but not in 24h I/R group (P = 0.01). No significant changes were observed in other non-fragmented OxPC including long chain products and terminal furans.& para;& para;Conclusion & para;& para;We have shown for the first time that bioactive OxPC species are produced in renal I/R and their levels increase with increasing time of reperfusion in a kidney model of I/R and correlate with severity of I/R injury. Given the pathological activity of fragmented OxPCs, therapies focused on their reduction may be a mechanism to attenuate renal I/R injury.	[Solati, Zahra; Edel, Andrea L.; Ravandi, Amir] Univ Manitoba, St Boniface Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB, Canada; [Solati, Zahra; Shang, Yue; Karmin, O.; Ravandi, Amir] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Shang, Yue; Karmin, O.] Univ Manitoba, Dept Anim Sci, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba	Ravandi, A (corresponding author), Univ Manitoba, St Boniface Hosp, Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB, Canada.; Ravandi, A (corresponding author), Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada.	aravandi@sbgh.mb.ca	Ravandi, Amir/O-7552-2019	O, Karmin/0000-0002-2163-9458; Shang, Yue/0000-0002-8576-4338; /0000-0001-6663-1225	Heart and Stroke Foundation of Canada; Research Manitoba	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Research Manitoba	This study was supported by Heart and Stroke Foundation of Canada and Research Manitoba (to Amir Ravandi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoia ML, 2013, J AM COLL CARDIOL, V61, P2169, DOI 10.1016/j.jacc.2013.02.047; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bretscher P, 2015, EMBO MOL MED, V7, P593, DOI 10.15252/emmm.201404702; CAPLAN MJ, 1986, CELL, V46, P623, DOI 10.1016/0092-8674(86)90888-3; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Folch J, SIMPLE METHOD ISOLAT; Friedli O, 2017, BBA-MOL CELL BIOL L, V1862, P382, DOI 10.1016/j.bbalip.2016.07.006; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Ganguly R, 2018, MOL CELL BIOCHEM, V437, P163, DOI 10.1007/s11010-017-3104-z; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Hartvigsen K, 2009, J LIPID RES, V50, pS388, DOI 10.1194/jlr.R800100-JLR200; Hasanally D, 2014, EUROPEAN HEART J; Hasanally D, 2017, LIPIDS, V52, P11, DOI 10.1007/s11745-016-4217-y; Hasanally D, 2014, ADV BIOCHEM HEALTH D, V10, P55, DOI 10.1007/978-1-4939-0464-8_3; Hashiguchi H, 2005, ANESTH ANALG, V101, P1584, DOI [10.1213/01.ANE.0000184044.517549.B8, 10.1213/01.ANE.0000184044.51749.B8]; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Jimi S, 1999, ARTERIOSCL THROM VAS, V19, P794, DOI 10.1161/01.ATV.19.3.794; Johnson ACM, 2005, KIDNEY INT, V67, P2196, DOI 10.1111/j.1523-1755.2005.00325.x; Kadl A, 2011, FREE RADICAL BIO MED, V51, P1903, DOI 10.1016/j.freeradbiomed.2011.08.026; Kiechl S, 2007, ARTERIOSCL THROM VAS, V27, P1788, DOI 10.1161/ATVBAHA.107.145805; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Liu Y, 2012, KIDNEY BLOOD PRESS R, V35, P373, DOI 10.1159/000336171; Loidl A, 2003, J BIOL CHEM, V278, P32921, DOI 10.1074/jbc.M306088200; Lv J, 2015, PATHOL BIOL, V63, P236, DOI 10.1016/j.patbio.2015.07.010; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; MOLITORIS BA, 1985, J CLIN INVEST, V76, P2097, DOI 10.1172/JCI112214; Naito M, 2009, AM J PATHOL, V174, P54, DOI 10.2353/ajpath.2009.080602; NAKAMURA H, 1991, J CLIN INVEST, V87, P1810, DOI 10.1172/JCI115202; Rao S, 2016, AM J PHYSIOL-RENAL, V310, pF1136, DOI 10.1152/ajprenal.00100.2016; Ravandi A, 2014, J AM COLL CARDIOL, V63, P1961, DOI 10.1016/j.jacc.2014.01.055; Rovcanin B, 2016, CURR MED CHEM, V23, P1965, DOI 10.2174/0929867323666160112122858; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Stemmer U, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-110; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Torzewski Michael, 2017, JACC Basic Transl Sci, V2, P229, DOI 10.1016/j.jacbts.2017.02.004; Tsimikas S, 2004, CIRCULATION, V109, P3164, DOI 10.1161/01.CIR.0000130844.01174.55; Tsimikas S, 2006, J AM COLL CARDIOL, V47, P2219, DOI 10.1016/j.jacc.2006.03.001; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P2218, DOI 10.1016/j.jacc.2012.08.979; Tsimikas S, 2011, J AM COLL CARDIOL, V58, P1715, DOI 10.1016/j.jacc.2011.07.017; Tsimikas S, 2010, J AM COLL CARDIOL, V56, P946, DOI 10.1016/j.jacc.2010.04.048; Uderhardt S, 2011, J TRANSL MED, V9, pP5; Wei QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106647; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Zager RA, 2001, AM J PATHOL, V159, P743, DOI 10.1016/S0002-9440(10)61745-2; Zhao YY, 2015, ADV CLIN CHEM, V68, P153, DOI 10.1016/bs.acc.2014.11.002; Zhao YY, 2013, CLIN CHIM ACTA, V422, P59, DOI 10.1016/j.cca.2013.03.033	50	15	16	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195172	10.1371/journal.pone.0195172	http://dx.doi.org/10.1371/journal.pone.0195172			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684044	Green Published, Green Submitted, gold			2022-12-26	WOS:000430660600011
J	Shewade, HD; Kokane, AM; Singh, AR; Parmar, M; Verma, M; Desikan, P; Khans, SN; Kumar, AMV				Shewade, Hemant Deepak; Kokane, Arun M.; Singh, Akash Ranjan; Parmar, Malik; Verma, Manoj; Desikan, Prabha; Khans, Sheeba Naz; Kumar, Ajay M. V.			Provider reported barriers and solutions to improve testing among tuberculosis patients 'eligible for drug susceptibility test': A qualitative study from programmatic setting in India	PLOS ONE			English	Article							HIGH BURDEN COUNTRIES; MDR-TB; DIAGNOSIS; DISTRICT; CULTURE	Background In a study conducted in Bhopal district (a setting with facility for molecular drug susceptibility testing (DST)) located in central India in 2014-15, we found high levels of pre-diagnosis attrition among patients with presumptive multi drug-resistant tuberculosis (MDR-TB)-meaning TB patients who were eligible for DST, were not being tested. Objectives In this study, we explored the health care provider perspectives into barriers and suggested solutions for improving DST. Methods This was a descriptive qualitative study. One to one interviews (n = 10) and focus group discussions (n = 2) with experienced key informants involved in programmatic management of DR-TB were conducted in April 2017. Manual descriptive thematic analysis was performed. Results The key barriers reported were a) lack of or delay in identification of patients eligible for DST because of using treatment register as the source for identifying patients b) lack of assured specimen transport after patient identification and c) lack of tracking. Extra pulmonary TB patients were not getting identified as eligible for DST. Solutions suggested by the health care providers were i) generation of unique identifier at identification in designated micros-copy center (DMC), immediate intimation of unique identifier to district and regular monitoring by senior TB laboratory and senior treatment supervisors of patients eligible for DST that were missed; ii) documentation of unique identifier at each step of cascade; iii) use of human carriers/couriers to transport specimen from DMCs especially in rural areas; and iv) routine entry of all presumptive extra-pulmonary TB specimen, as far as possible, in DMC laboratory register. Conclusion Lack of assured specimen transport and lack of accountability for tracking patient after identification and referral were the key barriers. The identification of patients eligible for DST among microbiologically confirmed TB at the time of diagnosis and among clinically confirmed TB at the time of treatment initiation is the key. Use of unique identifier at identification and its use to ensure cohort wise tracking has to be complemented with specimen transport support and prompt feedback to the DMC. The study has implications to improve detection of MDR-TB among diagnosed/notified TB patients.	[Shewade, Hemant Deepak; Kumar, Ajay M. V.] Int Union TB & Lung Dis Union, New Delhi, India; [Shewade, Hemant Deepak; Kumar, Ajay M. V.] Int Union TB & Lung Dis Union, Paris, France; [Kokane, Arun M.; Singh, Akash Ranjan] All India Inst Med Sci, Dept Community Med & Family Med, Bhopal, Madhya Pradesh, India; [Parmar, Malik] Country Off India, WHO, New Delhi, India; [Verma, Manoj; Khans, Sheeba Naz] State TB Cell, Dept Hlth & Family Welf, Bhopal, Madhya Pradesh, India; [Desikan, Prabha] Bhopal Mem Hosp & Res Ctr, Bhopal, Madhya Pradesh, India	All India Institute of Medical Sciences (AIIMS) Bhopal; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - Bhopal Memorial Hospital & Research Center (BMHRC)	Shewade, HD (corresponding author), Int Union TB & Lung Dis Union, New Delhi, India.; Shewade, HD (corresponding author), Int Union TB & Lung Dis Union, Paris, France.	hemantjipmer@gmail.com	Shewade MD PhD, Hemant Deepak/J-3907-2019; Kokane, Arun/GOV-6535-2022	Shewade MD PhD, Hemant Deepak/0000-0002-8242-1911; Kokane, Arun/0000-0003-0250-5494; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Singh, Akash Ranjan/0000-0003-0553-1559	Department for International Development (DFID), UK; La Fondation Veuve Emile Metr-Tesch (Luxembourg)	Department for International Development (DFID), UK; La Fondation Veuve Emile Metr-Tesch (Luxembourg)	We thank the Department for International Development (DFID), UK, and La Fondation Veuve Emile Metr-Tesch (Luxembourg) for funding this open access publication. The funders had no role in the design or conduct of the study.	Abeygunawardena SC, 2014, PUBLIC HEALTH ACTION, V4, P105, DOI 10.5588/pha.13.0111; [Anonymous], 2009, CODING MANUAL QUALIT; Barnabishvili M, 2016, ACTA TROP, V161, P106, DOI 10.1016/j.actatropica.2016.06.014; Cazabon D, 2017, INT J INFECT DIS, V56, P111, DOI 10.1016/j.ijid.2016.10.016; Central TB Division, 2012, GUID PROGR MAN DRUG; Central TB Division Ministry of Health and Family Welfare, 2017, GUID PROGR MAN DRUG; Chadha SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026659; Creswell J.W., 2007, DESIGNING CONDUCTING; Das J, 2015, LANCET INFECT DIS, V15, P1305, DOI 10.1016/S1473-3099(15)00077-8; Harries AD, 2004, INT J TUBERC LUNG D, V8, P204; Khann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059903; Kilale AM, 2013, PUBLIC HEALTH ACTION, V3, P156, DOI 10.5588/pha.12.0103; Kvale S., 2012, DOING INTERVIEWS; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088330; Liamputtong D. E, 2005, QUALITATIVE RES METH, DOI [10.1016/j.ymeth.2005.03.001, DOI 10.1016/J.YMETH.2005.03.001]; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Naidoo P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1145-0; Qi W, 2011, INT J TUBERC LUNG D, V15, P137; Revised National Tuberculosis Control Programme (RNTCP), 2017, TB INDIA 2017; Revised National Tuberculosis Control Programme (RNTCP), 2016, ANNUAL STATUS REPORT; Revised National Tuberculosis Control Programme (RNTCP); Central TB Division, 2017, NATIONAL STRATEGIC P; Revised national tuberculosis control programme (RNTCP); Central TB division; Ministry of Health and Family Welfare; Government of India, NISHAY WEB BAS SOL M; RNTCP, 2016, IND TB REP 2021; Shewade D, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2191-6; Shewade HD, 2016, PUBLIC HEALTH ACTION, V6, P242, DOI 10.5588/pha.16.0075; Shewade HD, 2015, PUBLIC HEALTH ACTION, V5, P132, DOI 10.5588/pha.14.0098; Shewade HD, 2017, J TUBERC RES, V5, P237, DOI [10.4236/jtr.2017.54025, DOI 10.4236/JTR.2017.54025]; Subbaraman R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002149; Hoang TTT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2338-5; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2017, WHOHTMTB201723; Yagui M, 2006, INT J TUBERC LUNG D, V10, P838; Yellappa V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4627-7; Yellappa V, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1545-9	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0196162	10.1371/journal.pone.0196162	http://dx.doi.org/10.1371/journal.pone.0196162			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677210	Green Submitted, Green Published, gold			2022-12-26	WOS:000430638900026
J	Schmidt, A; Bauknecht, P; Williams, EA; Augustinowski, K; Grunder, S; Jekely, G				Schmidt, Axel; Bauknecht, Philipp; Williams, Elizabeth A.; Augustinowski, Katrin; Gruender, Stefan; Jekely, Gaspar			Dual signaling of Wamide myoinhibitory peptides through a peptide-gated channel and a GPCR in Platynereis	FASEB JOURNAL			English	Article						peptide-gated ion channel; helix; FaNaC; neuropeptide; degenerin	3 HOMOLOGOUS SUBUNITS; ION-CHANNEL; NA+ CHANNEL; FUNCTIONAL-CHARACTERIZATION; NERVOUS-SYSTEM; HYDRA; NEUROPEPTIDE; RECEPTORS; AMILORIDE; PROTEIN	Neuropeptides commonly signal by metabotropic GPCRs. In some mollusks and cnidarians, RFamide neuropeptides mediate fast ionotropic signaling by peptide-gated ion channels that belong to the DEG/ENaC family. Here we describe a neuropeptide system with a dual mode of signaling by both a peptide-gated ion channel and a GPCR. We identified and characterized a peptide-gated channel in the marine annelid Platynereis dumerilii that is specifically activated by Wamide myoinhibitory peptides derived from the same proneuropeptide. The myoinhibitory peptide-gated ion channel (MGIC) belongs to the DEG/ENaC family and is paralogous to RFamide-gated ion channels. Platynereis myoinhibitory peptides also activate a previously described GPCR, MAG. We measured the potency of all Wamides on both MGIC and MAG and identified peptides that preferentially activate one or the other receptor. Analysis of a single-cell transcriptome resource indicates that MGIC and MAG signal in distinct target neurons. The identification of a Wamide-gated ion channel suggests that peptide-gated channels are more diverse and widespread in animals than previously appreciated. The possibility of neuropeptide signaling by both ionotropic and metabotropic receptors to different target cells in the same organism highlights an additional level of complexity in peptidergic signaling networks.Schmidt, A., Bauknecht, P., Williams, E. A., Augustinowski, K., Grunder, S., Jekely, G. Dual signaling of Wamide myoinhibitory peptides through a peptide-gated channel and a GPCR in Platynereis.	[Schmidt, Axel; Augustinowski, Katrin; Gruender, Stefan] Rhein Westfal Tech Hsch RWTH Aachen Univ, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany; [Bauknecht, Philipp] Max Planck Inst Dev Biol, Tubingen, Germany; [Williams, Elizabeth A.; Jekely, Gaspar] Univ Exeter, Living Syst Inst, Exeter, Devon, England	RWTH Aachen University; Max Planck Society; University of Exeter	Grunder, S (corresponding author), Rhein Westfal Tech Hsch RWTH Aachen Univ, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.; Jekely, G (corresponding author), Univ Exeter, Stocker Rd, Exeter EX4 4QD, Devon, England.	sgruender@ukaachen.de; g.jekely@exeter.ac.uk	Schmidt, Axel/GLR-2893-2022; Gründer, Stefan/I-2495-2019; Jékely, Gáspár/I-8708-2012	Schmidt, Axel/0000-0002-9780-7243; Gründer, Stefan/0000-0002-7635-9883; Jékely, Gáspár/0000-0001-8496-9836; Bauknecht, Philipp/0000-0003-0423-8158; Williams, Elizabeth/0000-0003-3067-3137	International Max Planck Research School (IMPRS) "From Molecules to Organisms"; Deutsche Forschungsgemeinschaft [JE 777/1-1]	International Max Planck Research School (IMPRS) "From Molecules to Organisms"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank P. Lenzig [Rheinisch-Westfalische Technische Hochschule (RWTH) Aachen] for expert technical assistance, and E. Lingueglia (Universite Cote d'Azur, Valbonne, France) for providing H. aspersa FaNaC. P.B. was supported by the International Max Planck Research School (IMPRS) "From Molecules to Organisms." E.A.W. was supported by a grant from Deutsche Forschungsgemeinschaft (JE 777/1-1). The authors declare no conflicts of interest.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Assmann M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0084-2; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Bauknecht P, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0341-7; Bauknecht P, 2015, CELL REP, V12, P684, DOI 10.1016/j.celrep.2015.06.052; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen XM, 2010, NEUROPHARMACOLOGY, V58, P1045, DOI 10.1016/j.neuropharm.2010.01.011; Conzelmann M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-906; Conzelmann M, 2013, P NATL ACAD SCI USA, V110, P8224, DOI 10.1073/pnas.1220285110; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; COTTRELL GA, 1990, PFLUG ARCH EUR J PHY, V416, P612, DOI 10.1007/BF00382698; Durrnagel S, 2012, J GEN PHYSIOL, V140, P391, DOI 10.1085/jgp.201210798; Durrnagel S, 2010, J BIOL CHEM, V285, P11958, DOI 10.1074/jbc.M109.059998; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Furukawa Y, 2006, PFLUG ARCH EUR J PHY, V451, P646, DOI 10.1007/s00424-005-1498-z; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Grunder S, 2015, J EXP BIOL, V218, P551, DOI 10.1242/jeb.111666; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jekely G, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.166710; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Kim YJ, 2010, P NATL ACAD SCI USA, V107, P6520, DOI 10.1073/pnas.0914764107; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Krishnan A, 2015, J EXP BIOL, V218, P562, DOI 10.1242/jeb.110312; Leng TD, 2016, CNS NEUROSCI THER, V22, P468, DOI 10.1111/cns.12524; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Nikitin M, 2015, GEN COMP ENDOCR, V212, P145, DOI 10.1016/j.ygcen.2014.03.049; Nusbaum MP, 2017, NAT REV NEUROSCI, V18, P389, DOI 10.1038/nrn.2017.56; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Schmidt A, 2017, MOL PHARMACOL, V92, P665, DOI 10.1124/mol.117.110064; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Thiel D, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170136; Tunaru S, 2005, MOL PHARMACOL, V68, P1271, DOI 10.1124/mol.105.015750; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wiemuth D, 2010, J BIOL CHEM, V285, P30404, DOI 10.1074/jbc.M110.153064; Williams EA, 2017, ELIFE, V6, DOI 10.7554/eLife.26349; Williams EA, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-014-0093-6	41	12	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5338	5349		10.1096/fj.201800274R	http://dx.doi.org/10.1096/fj.201800274R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688813	Bronze, Green Submitted			2022-12-26	WOS:000447972500012
J	Heukers, R; Fan, TS; de Wit, RH; van Senten, JR; De Groof, TWM; Bebelman, MP; Lagerweij, T; Vieira, J; de Munnik, SM; Smits-de Vries, L; van Offenbeek, J; Rahbar, A; van Hoorick, D; Soderberg-Naucler, C; Wurdinger, T; Leurs, R; Siderius, M; Vischer, HF; Smit, MJ				Heukers, Raimond; Fan, Tian Shu; de Wit, Raymond H.; van Senten, Jeffrey R.; De Groof, Timo W. M.; Bebelman, Maarten P.; Lagerweij, Tonny; Vieira, Joao; de Munnik, Sabrina M.; Smits-de Vries, Laura; van Offenbeek, Jody; Rahbar, Afsar; van Hoorick, Diane; Soderberg-Naucler, Cecilia; Wurdinger, Thomas; Leurs, Rob; Siderius, Marco; Vischer, Henry F.; Smit, Martine J.			The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth	ONCOGENE			English	Article							PROTEIN-COUPLED RECEPTOR; HUMAN CYTOMEGALOVIRUS US28; IN-VIVO; NERVOUS-SYSTEM; NECK-CANCER; NANOBODIES; CELLS; PROMOTES; INFECTION; THERAPY	Glioblastoma (GBM) is the most aggressive and an incurable type of brain cancer. Human cytomegalovirus (HCMV) DNA and encoded proteins, including the chemokine receptor US28, have been detected in GBM tumors. US28 displays constitutive activity and is able to bind several human chemokines, leading to the activation of various proliferative and inflammatory signaling pathways. Here we show that HCMV, through the expression of US28, significantly enhanced the growth of 3D spheroids of U251- and neurospheres of primary glioblastoma cells. Moreover, US28 expression accelerated the growth of glioblastoma cells in an orthotopic intracranial GBM-model in mice. We developed highly potent and selective US28-targeting nanobodies, which bind to the extracellular domain of US28 and detect US28 in GBM tissue. The nanobodies inhibited chemokine binding and reduced the constitutive US28-mediated signaling with nanomolar potencies and significantly impaired HCMV/US28-mediated tumor growth in vitro and in vivo. This study emphasizes the oncomodulatory role of HCMV-encoded US28 and provides a potential therapeutic approach for HCMV-positive tumors using the nanobody technology.	[Heukers, Raimond; Fan, Tian Shu; de Wit, Raymond H.; van Senten, Jeffrey R.; De Groof, Timo W. M.; Bebelman, Maarten P.; de Munnik, Sabrina M.; Smits-de Vries, Laura; van Offenbeek, Jody; Leurs, Rob; Siderius, Marco; Vischer, Henry F.; Smit, Martine J.] Vrije Univ, Fac Sci, Div Med Chem, AIMMS, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands; [Lagerweij, Tonny; Wurdinger, Thomas] Vrije Univ Amsterdam Med Ctr, Canc Ctr Amsterdam, Neurooncol Res Grp, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Vieira, Joao; van Hoorick, Diane] Ablynx NV, Technol Pk 21, B-9052 Zwijnaarde, Belgium; [Rahbar, Afsar; Soderberg-Naucler, Cecilia] Karolinska Inst, Dept Med Solna, Ctr Mol Med, Expt Cardiovasc Res Unit, S-17177 Stockholm, Sweden; [Rahbar, Afsar; Soderberg-Naucler, Cecilia] Karolinska Inst, Ctr Mol Med, Dept Med & Neurol, S-17177 Stockholm, Sweden	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Karolinska Institutet; Karolinska Institutet	Smit, MJ (corresponding author), Vrije Univ, Fac Sci, Div Med Chem, AIMMS, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands.	mj.smit@vu.nl	Leurs, Rob/ABB-4299-2021; Leurs, Rob/AAC-8508-2022; Wurdinger, Thomas/AAA-5645-2022; van Senten, Jeffrey/AAH-4348-2021; Lagerweij, Tonny/AAY-7128-2020; Heukers, Raimond/H-9403-2013	Leurs, Rob/0000-0003-1354-2848; Rahbar, Afsar/0000-0003-1158-2512; Smit, Martine/0000-0003-2713-0238; van Senten, Jeffrey Roy/0000-0002-1096-6891; Heukers, Raimond/0000-0003-4498-7751; Bebelman, Maarten/0000-0003-4007-5093; De Groof, Timo/0000-0001-6918-2955	Netherlands Organization for Scientific Research (NWO: Vici grant) [016.140.657]; Dutch Technology Foundation (STW) [11462]	Netherlands Organization for Scientific Research (NWO: Vici grant)(Netherlands Organization for Scientific Research (NWO)); Dutch Technology Foundation (STW)(Technologiestichting STW)	This work was supported by the Netherlands Organization for Scientific Research (NWO: Vici grant 016.140.657) and the Dutch Technology Foundation (STW, 11462).	Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Bhattacharjee B, 2012, J VIROL, V86, P6815, DOI 10.1128/JVI.00015-12; Bongers G, 2010, J CLIN INVEST, V120, P3969, DOI 10.1172/JCI42563; Bradley ME, 2015, MOL PHARMACOL, V87, P251, DOI 10.1124/mol.114.094821; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Burger M, 1999, J IMMUNOL, V163, P2017; Bush NAO, 2017, NEUROSURG REV, V40, P1, DOI 10.1007/s10143-016-0709-8; Caretti V, 2014, ACTA NEUROPATHOL, V127, P897, DOI 10.1007/s00401-014-1272-4; Casarosa P, 2003, J BIOL CHEM, V278, P5172, DOI 10.1074/jbc.M210033200; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Cobbs C, 2014, NEURO-ONCOLOGY, V16, P1435, DOI 10.1093/neuonc/nou295; Cobbs CS, 2002, CANCER RES, V62, P3347; De Tavernier E, 2016, J BIOL CHEM, V291, P15243, DOI 10.1074/jbc.M115.684241; de Wit RH, 2017, J PHARMACOL EXP THER, V363, P35, DOI 10.1124/jpet.117.242735; de Wit RH, 2016, ONCOTARGET, V7, P67966, DOI 10.18632/oncotarget.11817; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; GAO JL, 1994, J BIOL CHEM, V269, P28539; Hadaczek P, 2013, CLIN CANCER RES, V19, P6473, DOI 10.1158/1078-0432.CCR-13-1121; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Humby MS, 2016, J VIROL, V90, P2959, DOI 10.1128/JVI.02507-15; Jahnichen S, 2010, P NATL ACAD SCI USA, V107, P20565, DOI 10.1073/pnas.1012865107; Jansen MHA, 2016, MOL CANCER THER, V15, P2166, DOI 10.1158/1535-7163.MCT-15-0558; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Krishna BA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14321; Lamszus K, 2003, CLIN CANCER RES, V9, P1399; Langemeijer EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048935; Li YM, 2010, TOXINS, V2, P2645, DOI 10.3390/toxins2112645; Lollinga WT, 2017, TRANSPLANTATION, V101, P531, DOI 10.1097/TP.0000000000001289; Manglik A, 2017, ANNU REV PHARMACOL, V57, P19, DOI 10.1146/annurev-pharmtox-010716-104710; Mason GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003635; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; Maussang D, 2013, J BIOL CHEM, V288, P29562, DOI 10.1074/jbc.M113.498436; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Mitchell DA, 2015, NATURE, V519, P366, DOI 10.1038/nature14320; Mujic-Delic A, 2014, TRENDS PHARMACOL SCI, V35, P247, DOI 10.1016/j.tips.2014.03.003; Noriega VM, 2014, VIRUSES-BASEL, V6, P1202, DOI 10.3390/v6031202; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Peng CW, 2016, MOL CLIN ONCOL, V4, P154, DOI 10.3892/mco.2015.692; Rahbar Afsar, 2012, Herpesviridae, V3, P3, DOI 10.1186/2042-4280-3-3; Sinclair JH, 2013, VIRUSES-BASEL, V5, P2803, DOI 10.3390/v5112803; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; SoderbergNaucler C, 1997, CELL, V91, P119, DOI 10.1016/S0092-8674(01)80014-3; Soderberg-Naucler C, 2013, NEW ENGL J MED, V369, P985, DOI 10.1056/NEJMc1302145; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; STEENSGAARD J, 1977, IMMUNOLOGY, V32, P445; Stragliotto G, 2013, INT J CANCER, V133, P1204, DOI 10.1002/ijc.28111; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Taha MS, 2016, BRIT J NEUROSURG, V30, P307, DOI 10.3109/02688697.2015.1119241; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; van Driel PBAA, 2016, J CONTROL RELEASE, V229, P93, DOI 10.1016/j.jconrel.2016.03.014; Vischer HF, 2014, NAT REV DRUG DISCOV, V13, P123, DOI 10.1038/nrd4189; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177	55	40	41	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 26	2018	37	30					4110	4121		10.1038/s41388-018-0255-7	http://dx.doi.org/10.1038/s41388-018-0255-7			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GO2YI	29706656	hybrid, Green Published			2022-12-26	WOS:000439847000005
J	Kolsch, A; Hejazi, M; Stieger, KR; Feifel, SC; Kern, JF; Muh, F; Lisdat, F; Lokstein, H; Zouni, A				Koelsch, Adrian; Hejazi, Mahdi; Stieger, Kai R.; Feifel, Sven C.; Kern, Jan F.; Mueh, Frank; Lisdat, Fred; Lokstein, Heiko; Zouni, Athina			Insights into the binding behavior of native and non-native cytochromes to photosystem I from Thermosynechococcus elongatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC REACTION-CENTER; FLASH KINETIC-ANALYSIS; FAST-ELECTRON TRANSFER; PLASTOCYANIN; PROTEIN; C(6); ELECTROSTATICS; COMPLEX; PEROXIDASE; CRYSTALLIZATION	The binding of photosystem I (PS I) from Thermosynechococcus elongatus to the native cytochrome (cyt) c(6) and cyt c from horse heart (cyt c(HH)) was analyzed by oxygen consumption measurements, isothermal titration calorimetry (ITC), and rigid body docking combined with electrostatic computations of binding energies. Although PS I has a higher affinity for cyt c(HH) than for cyt c(6), the influence of ionic strength and pH on binding is different in the two cases. ITC and theoretical computations revealed the existence of unspecific binding sites for cyt c(HH) besides one specific binding site close to P 700. Binding to PS I was found to be the same for reduced and oxidized cyt c(HH). Based on this information, suitable conditions for cocrystallization of cyt c(HH) with PS I were found, resulting in crystals with a PS I: cyt c(HH) ratio of 1: 1. A crystal structure at 3.4-angstrom resolution was obtained, but cyt c(HH) cannot be identified in the electron density map because of unspecific binding sites and/or high flexibility at the specific binding site. Modeling the binding of cyt c 6 to PS I revealed a specific binding site where the distance and orientation of cyt c(6) relative to P-700 are comparable with cyt c 2 from purple bacteria relative to P-870. This work provides new insights into the binding modes of different cytochromes to PS I, thus facilitating steps toward solving the PS I-cyt c costructure and a more detailed understanding of natural electron transport processes.	[Koelsch, Adrian; Hejazi, Mahdi; Zouni, Athina] Humboldt Univ, Biophys Photosynth, Inst Biol, Philippstr 13, D-10115 Berlin, Germany; [Stieger, Kai R.; Feifel, Sven C.; Lisdat, Fred] Univ Appl Sci Wildau, Inst Appl Life Sci, Biosyst Technol, Hochschulring 1, D-15745 Wildau, Germany; [Kern, Jan F.] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Mueh, Frank] Johannes Kepler Univ Linz, Dept Theoret Biophys, Inst Theoret Phys, Altenberger Str 69, A-4040 Linz, Austria; [Lokstein, Heiko] Charles Univ Prague, Dept Chem Phys & Opt, Ke Karlovu 3, CZ-12116 Prague 2, Czech Republic	Humboldt University of Berlin; University of Applied Sciences Wildau; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Johannes Kepler University Linz; Charles University Prague	Kolsch, A; Zouni, A (corresponding author), Humboldt Univ, Biophys Photosynth, Inst Biol, Philippstr 13, D-10115 Berlin, Germany.	koelscha@hu-berlin.de; athina.zouni@hu-berlin.de	Lokstein, Heiko/AAK-1930-2021; Lokstein, Heiko/P-2788-2019; Kern, Jan/G-2586-2013	Lokstein, Heiko/0000-0001-6739-4612; Kern, Jan/0000-0002-7272-1603	Bundesministerium fur Bildung and Forschung (BMBF), Germany [031A154B]; Deutsche Forschungsgemeinschaft through the cluster of excellence "Unifying Concepts in Catalysis" [E2/E3]; Czech Science Foundation (Grantova Agentura Ceske Republiky) [P501/12/G055]	Bundesministerium fur Bildung and Forschung (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft through the cluster of excellence "Unifying Concepts in Catalysis"(German Research Foundation (DFG)); Czech Science Foundation (Grantova Agentura Ceske Republiky)	This work was supported in part by the Bundesministerium fur Bildung and Forschung (BMBF), Germany (Biotechnologie 2020+, Project 031A154B) and the Deutsche Forschungsgemeinschaft through the cluster of excellence "Unifying Concepts in Catalysis" coordinated by the Technische Universitat Berlin (Project E2/E3). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Czech Science Foundation (Grantova Agentura Ceske Republiky) Grant P501/12/G055.	Arslan E, 1998, BIOCHEM BIOPH RES CO, V251, P744, DOI 10.1006/bbrc.1998.9549; Axelrod HL, 2002, J MOL BIOL, V319, P501, DOI 10.1016/S0022-2836(02)00168-7; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bernal-Bayard P, 2015, BBA-BIOENERGETICS, V1847, P1549, DOI 10.1016/j.bbabio.2015.09.006; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Diaz-Moreno I, 2005, J BIOL CHEM, V280, P7925, DOI 10.1074/jbc.M412422200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Drepper F, 1996, BIOCHEMISTRY-US, V35, P1282, DOI 10.1021/bi951471e; El-Mohsnawy E, 2010, BIOCHEMISTRY-US, V49, P4740, DOI 10.1021/bi901807p; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fromme P, 1998, BBA-BIOENERGETICS, V1365, P175, DOI 10.1016/S0005-2728(98)00059-0; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Golub M, 2017, PHOTOSYNTH RES, V133, P163, DOI 10.1007/s11120-017-0342-6; Guergova-Kuras M, 2001, P NATL ACAD SCI USA, V98, P4437, DOI 10.1073/pnas.081078898; HAEHNEL W, 1989, J CELL BIOL, V108, P1397, DOI 10.1083/jcb.108.4.1397; HATANAKA H, 1993, BIOCHIM BIOPHYS ACTA, V1141, P45, DOI 10.1016/0005-2728(93)90187-K; HERVAS M, 1994, BBA-BIOENERGETICS, V1184, P235, DOI 10.1016/0005-2728(94)90228-3; HERVAS M, 1992, EUR J BIOCHEM, V203, P115, DOI 10.1111/j.1432-1033.1992.tb19835.x; HERVAS M, 1995, BIOCHEMISTRY-US, V34, P11321, DOI 10.1021/bi00036a004; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lubner CE, 2011, P NATL ACAD SCI USA, V108, P20988, DOI 10.1073/pnas.1114660108; MALMGREN L, 1978, BRAIN RES, V153, P477, DOI 10.1016/0006-8993(78)90333-5; Mazor Y, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.14; MOSER CC, 1988, BIOCHEMISTRY-US, V27, P2450, DOI 10.1021/bi00407a031; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Muh F, 2005, BBA-BIOENERGETICS, V1708, P219, DOI 10.1016/j.bbabio.2005.03.005; Mukherjee D, 2011, J COLLOID INTERF SCI, V358, P477, DOI 10.1016/j.jcis.2011.03.070; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Navarro JA, 2000, PHOTOSYNTH RES, V65, P63, DOI 10.1023/A:1006404621724; Nguyen K, 2017, PHOTOSYNTH RES, V131, P79, DOI 10.1007/s11120-016-0300-8; Nowaczyk MM, 2016, NAT CHEM BIOL, V12, P990, DOI 10.1038/nchembio.2240; PELLETIER H, 1992, SCIENCE, V258, P1748, DOI 10.1126/science.1334573; Pettigrew GW, 2003, BIOCHEMISTRY-US, V42, P2046, DOI 10.1021/bi027125w; POULOS TL, 1987, J BIOL CHEM, V262, P13881; Proux-Delrouyre V, 2003, J AM CHEM SOC, V125, P13686, DOI 10.1021/ja0363819; Scheuermann TH, 2015, METHODS, V76, P87, DOI 10.1016/j.ymeth.2014.11.024; Shimada S, 2017, EMBO J, V36, P291, DOI 10.15252/embj.201695021; Sommer F, 2004, J BIOL CHEM, V279, P20009, DOI 10.1074/jbc.M313986200; Sommer F, 2002, J BIOL CHEM, V277, P6573, DOI 10.1074/jbc.M110633200; Stieger KR, 2016, J MATER CHEM A, V4, P17009, DOI 10.1039/c6ta07141d; Stieger KR, 2016, NANOSCALE, V8, P10695, DOI 10.1039/c6nr00097e; Stieger KR, 2014, PHYS CHEM CHEM PHYS, V16, P15667, DOI 10.1039/c4cp00935e; Utschig LM, 2011, J AM CHEM SOC, V133, P16334, DOI 10.1021/ja206012r; van Thor JJ, 1999, BIOCHEMISTRY-US, V38, P12735, DOI 10.1021/bi9903502; VANGELDER BF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593, DOI 10.1016/0006-3002(62)90073-2; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; Zygadlo A, 2005, BBA-BIOENERGETICS, V1708, P154, DOI 10.1016/j.bbabio.2005.02.003	59	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9090	9100		10.1074/jbc.RA117.000953	http://dx.doi.org/10.1074/jbc.RA117.000953			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29695502	Green Published, hybrid			2022-12-26	WOS:000434941900030
J	Panahi, G; Pasalar, P; Zare, M; Rizzuto, R; Meshkani, R				Panahi, Ghodratollah; Pasalar, Parvin; Zare, Mina; Rizzuto, Rosario; Meshkani, Reza			MCU-knockdown attenuates high glucose-induced inflammation through regulating MAPKs/NF-kappa B pathways and ROS production in HepG2 cells	PLOS ONE			English	Article							MITOCHONDRIAL CALCIUM UNIPORTER; INSULIN-RESISTANCE; MUSCLE-CELLS; KEY ROLE; ACTIVATION; STRESS; APOPTOSIS; PALMITATE; PROTEIN; HYPERGLYCEMIA	Mitochondrial Ca2+ is a key regulator of organelle physiology and the excessive increase in mitochondrial calcium is associated with the oxidative stress. In the present study, we investigated the molecular mechanisms linking mitochondrial calcium to inflammatory and coagulative responses in hepatocytes exposed to high glucose (HG) (33mM glucose). Treatment of HepG2 cells with HG for 24 h induced insulin resistance, as demonstrated by an impairment of insulin-stimulated Akt phosphorylation. HepG2 treatment with HG led to an increase in mitochondrial Ca2+ uptake, while cytosolic calcium remained unchanged. Inhibition of MCU by lentiviral-mediated shRNA prevented mitochondrial calcium uptake and downregulated the inflammatory (TNF-alpha, IL-6) and coagulative (PAI-1 and FGA) mRNA expression in HepG2 cells exposed to HG. The protection from HG-induced inflammation by MCU inhibition was accompanied by a decrease in the generation of reactive oxygen species (ROS). Importantly, MCU inhibition in HepG2 cells abrogated the phosphorylation of p38, JNK and IKK alpha/IKK beta in HG treated cells. Taken together, these data suggest that MCU inhibition may represent a promising therapy for prevention of deleterious effects of obesity and metabolic diseases.	[Panahi, Ghodratollah; Pasalar, Parvin; Meshkani, Reza] Univ Tehran Med Sci, Fac Med, Dept Biochem, Tehran, Iran; [Zare, Mina] Shiraz Univ Med Sci, Dept Biochem, Recombinant Prot Lab, Shiraz, Iran; [Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, Padua, Italy	Tehran University of Medical Sciences; Shiraz University of Medical Science; University of Padua	Meshkani, R (corresponding author), Univ Tehran Med Sci, Fac Med, Dept Biochem, Tehran, Iran.	rmeshkani@tums.ac.ir	panahi, shahriyar/W-3772-2019; Zare, Mina/ABG-8610-2020	panahi, shahriyar/0000-0001-8338-4633; Zare, Mina/0000-0003-1061-4439; Rizzuto, Rosario/0000-0001-7044-5097	Tehran University of Medical Sciences [93-01-30-25164]	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This work was financially supported by a grant (93-01-30-25164) from the Deputy of Research, Tehran University of Medical Sciences.	Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BOUMA ME, 1989, IN VITRO CELL DEV B, V25, P267; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Di Paolo S, 2006, J AM SOC NEPHROL, V17, P2236, DOI 10.1681/ASN.2006030196; Dong WM, 1998, J INTERF CYTOK RES, V18, P629, DOI 10.1089/jir.1998.18.629; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; EVERSON GT, 1986, J BIOL CHEM, V261, P2197; Gaitanaki C, 2003, J EXP BIOL, V206, P2759, DOI 10.1242/jeb.00483; Gautier-Stein A, 2012, DIABETES, V61, P2451, DOI 10.2337/db11-0986; Hara T, 2014, ENDOCRINOLOGY, V155, P758, DOI 10.1210/en.2013-1519; Hardbower DM, 2013, GUT MICROBES, V4, P475, DOI 10.4161/gmic.25583; HOEG JM, 1985, ARTERIOSCLEROSIS, V5, P228, DOI 10.1161/01.ATV.5.3.228; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kumar S, 2012, BBA-GEN SUBJECTS, V1820, P907, DOI 10.1016/j.bbagen.2012.02.010; Lagoudakis L, 2010, HEPATOLOGY, V52, P602, DOI 10.1002/hep.23673; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Malhotra JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004424; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Meshkani R, 2016, CLIN CHIM ACTA, V462, P77, DOI 10.1016/j.cca.2016.08.015; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Park GB, 2014, INT J ONCOL, V44, P977, DOI 10.3892/ijo.2014.2252; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Ramana KV, 2004, DIABETES, V53, P2910, DOI 10.2337/diabetes.53.11.2910; Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3; Romagnoli A, 2007, ENDOPLASMIC RETICULU; Rowell DL, 1997, AM J PHYSIOL-GASTR L, V273, pG322, DOI 10.1152/ajpgi.1997.273.2.G322; Sheth K, 2001, Curr Opin Crit Care, V7, P99, DOI 10.1097/00075198-200104000-00008; Spellman CW, 2010, J AM OSTEOPATH ASSOC, V110, pS2; Suarez J, 2008, AM J PHYSIOL-CELL PH, V295, pC1561, DOI 10.1152/ajpcell.00076.2008; Taheripak G, 2013, FREE RADICAL BIO MED, V65, P1435, DOI 10.1016/j.freeradbiomed.2013.09.019; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Tsai C-W, 2017, P NATL ACAD SCI USA; Vakili S, 2013, MOL MED REP, V7, P211, DOI 10.3892/mmr.2012.1172; Wang SL, 2009, BIOMED ENVIRON SCI, V22, P32, DOI 10.1016/S0895-3988(09)60019-2; Wright LE, 2017, AM J PHYSL ENDOCRINO	44	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196580	10.1371/journal.pone.0196580	http://dx.doi.org/10.1371/journal.pone.0196580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709004	Green Submitted, gold, Green Published			2022-12-26	WOS:000431130100041
J	Hayton, K; Moirogiannis, D; Magnasco, M				Hayton, Keith; Moirogiannis, Dimitrios; Magnasco, Marcelo			Adaptive scales of integration and response latencies in a critically-balanced model of the primary visual cortex	PLOS ONE			English	Article							RECEPTIVE-FIELD; STRIATE CORTEX; NATURAL IMAGES; FUNCTIONAL ARCHITECTURE; NEURONAL AVALANCHES; RECURRENT NETWORK; SPATIAL SUMMATION; NEURAL-NETWORKS; ALERT MONKEYS; DYNAMICS	The primary visual cortex (V1) integrates information over scales in visual space, which have been shown to vary, in an input-dependent manner, as a function of contrast and other visual parameters. Which algorithms the brain uses to achieve this feat are largely unknown and an open problem in visual neuroscience. We demonstrate that a simple dynamical mechanism can account for this contrast-dependent scale of integration in visuotopic space as well as connect this property to two other stimulus-dependent features of V1: extents of lateral integration on the cortical surface and response latencies.	[Hayton, Keith; Moirogiannis, Dimitrios; Magnasco, Marcelo] Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Hayton, K (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	khayt86@gmail.com						Albrecht DG, 2002, J NEUROPHYSIOL, V88, P888, DOI 10.1152/jn.2002.88.2.888; Bauer U, 1999, VISION RES, V39, P613, DOI 10.1016/S0042-6989(98)00172-2; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bienenstock E., 1998, ADV COMPLEX SYST, V1, P361, DOI [10.1142/S0219525998000223, DOI 10.1142/S0219525998000223]; Bressloff PC, 2000, NEURAL COMPUT, V12, P2473, DOI 10.1162/089976600300014809; Bressloff PC, 2001, PHILOS T R SOC B, V356, P299, DOI 10.1098/rstb.2000.0769; Camalet S, 2000, P NATL ACAD SCI USA, V97, P3183, DOI 10.1073/pnas.97.7.3183; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Choe Y, 1998, P NATL ACAD SCI USA, V95, P15321, DOI 10.1073/pnas.95.26.15321; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; da Silva L, 1998, PHYS LETT A, V242, P343, DOI 10.1016/S0375-9601(98)00232-1; Dayan P, 2001, COMPUTATIONAL NEUROS; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Ermentrout B, 1998, REP PROG PHYS, V61, P353, DOI 10.1088/0034-4885/61/4/002; Ermentrout GB, 2010, MATH FDN NEUROSCIENC; Fechner G, 1966, 1966 ELEMENTS PSYCHO; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fraiman D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061922; Freeman WJ, 2005, NEURAL NETWORKS, V18, P497, DOI 10.1016/j.neunet.2005.06.014; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Hansel D, 13 MODELING FEATURE; Hoppensteadt F., 2012, WEAKLY CONNECTED NEU; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kanders K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09854-2; Kanders K, 2017, CHAOS, V27, DOI 10.1063/1.4978998; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kern A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.128101; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Lochmann T, 2012, J NEUROSCI, V32, P4179, DOI 10.1523/JNEUROSCI.0817-11.2012; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Magnasco MO, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258102; Mora T, 2011, J STAT PHYS, V144, P268, DOI 10.1007/s10955-011-0229-4; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Rosenblatt F., 1961, PRINCIPLES NEURODYNA; Rubin DB, 2015, NEURON, V85, P402, DOI 10.1016/j.neuron.2014.12.026; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Schwabe L, 2006, J NEUROSCI, V26, P9117, DOI 10.1523/JNEUROSCI.1253-06.2006; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Seung HS, 1998, NEURAL NETWORKS, V11, P1253, DOI 10.1016/S0893-6080(98)00064-1; Shriki O, 2003, NEURAL COMPUT, V15, P1809, DOI 10.1162/08997660360675053; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Solovey G, 2015, J NEUROSCI, V35, P10866, DOI 10.1523/JNEUROSCI.4895-14.2015; von der Malsburg C, 1999, NEURON, V24, P95, DOI 10.1016/S0896-6273(00)80825-9; Wiggins S, 2003, INTRO APPL NONLINEAR, pIntroduction; Yan XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041419; Zhu MC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003191; Zipser K, 1996, J NEUROSCI, V16, P7376	63	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196566	10.1371/journal.pone.0196566	http://dx.doi.org/10.1371/journal.pone.0196566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702661	Green Submitted, Green Published, gold			2022-12-26	WOS:000431013300039
J	Christ, R; Guevar, J; Poyade, M; Rea, PM				Christ, Roxie; Guevar, Julien; Poyade, Matthieu; Rea, Paul M.			Proof of concept of a workflow methodology for the creation of basic canine head anatomy veterinary education tool using augmented reality	PLOS ONE			English	Article								Neuroanatomy can be challenging to both teach and learn within the undergraduate veterinary medicine and surgery curriculum. Traditional techniques have been used for many years, but there has now been a progression to move towards alternative digital models and interactive 3D models to engage the learner. However, digital innovations in the curriculum have typically involved the medical curriculum rather than the veterinary curriculum. Therefore, we aimed to create a simple workflow methodology to highlight the simplicity there is in creating a mobile augmented reality application of basic canine head anatomy. Using canine CT and MRI scans and widely available software programs, we demonstrate how to create an interactive model of head anatomy. This was applied to augmented reality for a popular Android mobile device to demonstrate the user-friendly interface. Here we present the processes, challenges and resolutions for the creation of a highly accurate, data based anatomical model that could potentially be used in the veterinary curriculum. This proof of concept study provides an excellent framework for the creation of augmented reality training products for veterinary education. The lack of similar resources within this field provides the ideal platform to extend this into other areas of veterinary education and beyond.	[Christ, Roxie; Rea, Paul M.] Univ Glasgow, Anat Facil, Sch Life Sci, Coll Med Vet & Life Sci, Thomson Bldg, Glasgow, Lanark, Scotland; [Christ, Roxie; Poyade, Matthieu] Glasgow Sch Art, Sch Simulat & Visualisat, Glasgow, Lanark, Scotland; [Guevar, Julien] North Carolina State Univ, Dept Clin Sci, Coll Vet Med, Raleigh, NC USA	University of Glasgow; Glasgow School of Art; University of North Carolina; North Carolina State University	Rea, PM (corresponding author), Univ Glasgow, Anat Facil, Sch Life Sci, Coll Med Vet & Life Sci, Thomson Bldg, Glasgow, Lanark, Scotland.	Paul.Rea@glasgow.ac.uk		REA, PAUL/0000-0002-8486-373X				[Anonymous], 2015, ORTHOP J HARVARD MED; Ashwell KWS, 2004, MED EDUC, V38, P1185, DOI 10.1111/j.1365-2929.2004.01990.x; Barsom EZ, 2016, SURG ENDOSC, V30, P4174, DOI 10.1007/s00464-016-4800-6; Boon JM, 2002, CLIN ANAT, V15, P45, DOI 10.1002/ca.1091; Borden N.M., 2007, 3D ANGIOGRAPHIC ATLA; Bottcher P, 1999, VET RADIOL ULTRASOUN, V40, P611, DOI 10.1111/j.1740-8261.1999.tb00887.x; Burdea G.C., 2003, VIRTUAL REALITY TECH; Chien CH, 2010, LECT NOTES ENG COMP, P370; Clark RC, 2011, E-Learning and the Science of Instruction: Proven Guidelines for Consumers and Designers of Multimedia Learning, 3rd Edition, P1, DOI 10.1002/9781118255971; Dale V., 1949, THESIS; Elizondo-Omana Rodrigo E., 2005, Anatomical Record Part B:The New Anatomist, V285, P11; Holmes MA, 1996, VET REC, V138, P199, DOI 10.1136/vr.138.9.199; Jamali SS, 2015, PROCD SOC BEHV, V197, P659, DOI 10.1016/j.sbspro.2015.07.054; Jastrow Holger, 2004, Anatomical Record Part B:The New Anatomist, V280, P20, DOI 10.1002/ar.b.20027; Kamphuis C, 2014, PERSPECT MED EDUC, V3, P300, DOI 10.1007/s40037-013-0107-7; Khot Z, 2013, ANAT SCI EDUC, V6, P211, DOI 10.1002/ase.1355; Linton A, 2005, J VET MED EDUC, V32, P249, DOI 10.3138/jvme.32.2.249; Ma M, 2016, CLIN ANAT, V29, P446, DOI 10.1002/ca.22675; Martinelli MJ, 1997, VET RADIOL ULTRASOUN, V38, P193, DOI 10.1111/j.1740-8261.1997.tb00840.x; Mayer RE, 2014, COMPUTER GAMES FOR LEARNING: AN EVIDENCE-BASED APPROACH, P1; Parkes R, 2009, STUD HEALTH TECHNOL, V142, P244, DOI 10.3233/978-1-58603-964-6-244; Patel KM, 2008, CLIN ANAT, V21, P182, DOI 10.1002/ca.20584; Raffan H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168911; Ramos RL, 2008, J UNDERGRADUATE NEUR, V6, P53; Robertson D, 1994, 2 INT WWW C 1994; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; Spitzer V M, 1998, ATLAS VISIBLE HUMAN; Sugand K, 2010, ANAT SCI EDUC, V3, P83, DOI 10.1002/ase.139; TOGA AW, 1995, BRAIN RES BULL, V38, P77, DOI 10.1016/0361-9230(95)00074-O; Turney BW, 2007, ANN ROY COLL SURG, V89, P104, DOI 10.1308/003588407X168244; Verhoeven BH, 2002, MED EDUC, V36, P711, DOI 10.1046/j.1365-2923.2002.01268.x; Zhu EG, 2014, PEERJ, V2, DOI 10.7717/peerj.469	32	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195866	10.1371/journal.pone.0195866	http://dx.doi.org/10.1371/journal.pone.0195866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698413	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000431007600020
J	Liao, PC; Boldogh, IR; Siegmund, SE; Freyberg, Z; Pon, LA				Liao, Pin-Chao; Boldogh, Istvan R.; Siegmund, Stephanie E.; Freyberg, Zachary; Pon, Liza A.			Isolation of mitochondria from Saccharomyces cerevisiae using magnetic bead affinity purification	PLOS ONE			English	Article							FLUORESCENT PROTEIN INDICATORS; YEAST MITOCHONDRIA; BUDDING YEAST; TOMOGRAPHIC RECONSTRUCTION; QUALITY-CONTROL; OUTER-MEMBRANE; ATP SYNTHASE; LIFE-SPAN; IMPORT; SEPARATION	Isolated mitochondria are widely used to study the function of the organelle. Typically, mitochondria are prepared using differential centrifugation alone or in conjunction with density gradient ultracentrifugation. However, mitochondria isolated using differential centrifugation contain membrane or organelle contaminants, and further purification of crude mitochondria by density gradient ultracentrifugation requires large amounts of starting material, and is time-consuming. Mitochondria have also been isolated by irreversible binding to antibody-coated magnetic beads. We developed a method to prepare mitochondria from budding yeast that overcomes many of the limitations of other methods. Mitochondria are tagged by insertion of 6 histidines (6xHis) into the TOM70 (Translocase of outer membrane 70) gene at its chromosomal locus, isolated using Ni-NTA (nickel (II) nitrilotriacetic acid) paramagnetic beads and released from the magnetic beads by washing with imidazole. Mitochondria prepared using this method contain fewer contaminants, and are similar in ultrastructure as well as protein import and cytochrome c oxidase complex activity compared to mitochondria isolated by differential centrifugation. Moreover, this isolation method is amenable to small samples, faster than purification by differential and density gradient centrifugation, and more cost-effective than purification using antibody-coated magnetic beads. Importantly, this method can be applied to any cell type where the genetic modification can be introduced by CRISPR or other methods.	[Liao, Pin-Chao; Boldogh, Istvan R.; Pon, Liza A.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Siegmund, Stephanie E.] Columbia Univ, Dept Neurol, New York, NY USA; [Freyberg, Zachary] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Freyberg, Zachary] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA	Columbia University; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pon, LA (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	lap5@cumc.columbia.edu	Freyberg, Zachary/L-4927-2018; Liao, Pin-chao/Z-2825-2019	Freyberg, Zachary/0000-0001-6460-0118; Siegmund, Stephanie/0000-0003-1848-2389; Liao, Pin-Chao/0000-0002-1969-5565	National Institutes of Health (NIH) [GM45735, GM122589, AG051047, NS093798]; John F. and Nancy A. Emmerling Fund of The Pittsburgh Foundation; Simons Foundation [349247]; NYSTAR; NIH [GM103310]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122589, P41GM103310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS093798] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John F. and Nancy A. Emmerling Fund of The Pittsburgh Foundation; Simons Foundation; NYSTAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH; https://www.nih.gov) (GM45735, GM122589 and AG051047) to LP and to SS (F30-NS093798) and from the John F. and Nancy A. Emmerling Fund of The Pittsburgh Foundation (www.pittsburghtoundation.org) to ZF. The Simons Electron Microscopy Center and National Resource for Automated Molecular Microscopy located at the New York Structural Biology Center were supported by grants from the Simons Foundation (www.simonsfoundation.org) (349247), NYSTAR, and the NIH (GM103310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Banik Bhabatosh, 2017, Curr Protoc Cell Biol, V76, DOI 10.1002/cpcb.26; Banik B, 2016, NANOSCALE, V8, P19581, DOI 10.1039/c6nr05882e; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Boldogh I, 1998, J CELL BIOL, V141, P1371, DOI 10.1083/jcb.141.6.1371; Boldogh IR, 2007, METHOD CELL BIOL, V80, P45, DOI 10.1016/S0091-679X(06)80002-6; Cui TZ, 2014, J BIOL CHEM, V289, P6133, DOI 10.1074/jbc.M113.523688; DAUM G, 1982, J BIOL CHEM, V257, P3028; Davies KM, 2012, P NATL ACAD SCI USA, V109, P13602, DOI 10.1073/pnas.1204593109; Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Franko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082392; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hasson SA, 2010, P NATL ACAD SCI USA, V107, P9578, DOI 10.1073/pnas.0914387107; Higuchi R, 2013, CURR BIOL, V23, P2417, DOI 10.1016/j.cub.2013.10.022; Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040; Khattar NK, 2016, J NEUROSCI METH, V263, P1, DOI 10.1016/j.jneumeth.2016.01.017; Lackner DH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10237; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Peleh Valentina, 2015, Methods Mol Biol, V1270, P37, DOI 10.1007/978-1-4939-2309-0_3; Pernice WM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10595; PFANNER N, 1987, EMBO J, V6, P3449, DOI 10.1002/j.1460-2075.1987.tb02668.x; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Savic D, 2015, GENOME RES, V25, P1581, DOI 10.1101/gr.193540.115; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; SMITH MD, 1995, J BIOL CHEM, V270, P28331; Stuart Rosemary A, 2007, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1119s34; Vevea JD, 2015, DEV CELL, V35, P584, DOI 10.1016/j.devcel.2015.11.010; Vevea JD, 2013, JOVE-J VIS EXP, DOI 10.3791/50633	41	9	9	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196632	10.1371/journal.pone.0196632	http://dx.doi.org/10.1371/journal.pone.0196632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698455	gold, Green Submitted, Green Published			2022-12-26	WOS:000431007600111
J	Parise, C; Caggiano, V				Parise, Carol; Caggiano, Vincent			The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; SOCIAL SUPPORT; RADIATION-THERAPY; AFRICAN-AMERICAN; SURVIVAL; WOMEN; RACE; DISPARITIES; CALIFORNIA; STAGE	Purpose To assess the effect of marital status and the role of race/ethnicity on breast cancer specific mortality in women with triple negative breast cancer (TNBC). Methods The study utilized the California Cancer Registry to identify 22,812 cases of first primary female TNBC. Unadjusted Kaplan-Meier breast cancer specific survival was computed. Cox Proportional Hazards modeling was used to compute the adjusted risk of breast cancer specific mortality for women who were single, separated, divorced, and widowed when compared with women who were married. Models were adjusted for age, stage, tumor grade, SES, and treatment with surgery, chemotherapy, hormone therapy, and radiation therapy. Hazard ratios (HR) and 95% confidence intervals (CI) were reported. Results Separated (HR: 1.45; 95% CI: 1.14 +/- 2.01) and widowed (HR: 1.39; 95% CI: 1.23 +/- 1.57) white women had a higher risk of mortality than white married women whereas single and divorced white women had the same risk of mortality. For Asian/Pacific Islanders (API), only single (HR: 1.55; 95% CI: 1.17 +/- 2.06) and divorced (HR: 1.81; 95% CI: 1.26 +/- 2.60) women had a higher risk of mortality than married women. Marital status had no influence on risk of mortality for either black or Hispanic women. Conclusions The risk of mortality associated with marital status is dependent on race/ethnicity. Only white and API women with TNBC have a marital advantage.	[Parise, Carol; Caggiano, Vincent] Sutter Inst Med Res, Sacramento, CA 95816 USA		Parise, C (corresponding author), Sutter Inst Med Res, Sacramento, CA 95816 USA.	parisec@sutterhealth.org		Parise, Carol/0000-0002-3098-6160	Sutter Medical Center Sacramento Foundation [947110-1107555]	Sutter Medical Center Sacramento Foundation	This study was funded by grant 947110-1107555 from the Sutter Medical Center Sacramento Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Aizer AA, 2012, J CLIN ONCOL, V30, P3071, DOI 10.1200/JCO.2012.42.8466; [Anonymous], 2002, PATHVISION HER 2 DNA; [Anonymous], 2016, AM COMMUNITY SURVEY; [Anonymous], 2012, IBM SPSS STAT WINDOW, V21; [Anonymous], 2008, CAL CANC REP SYST ST, VI; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; BROMAN CL, 1993, J MARRIAGE FAM, V55, P724, DOI 10.2307/353352; Brown M, 2008, CANCER-AM CANCER SOC, V112, P737, DOI 10.1002/cncr.23243; Bryant CM, 2008, FAM RELAT, V57, P239, DOI 10.1111/j.1741-3729.2008.00497.x; Chang SM, 2005, CANCER-AM CANCER SOC, V104, P1975, DOI 10.1002/cncr.21399; Clarke CA, 2005, CANCER EPIDEM BIOMAR, V14, P1441, DOI 10.1158/1055-9965.EPI-04-0567; DAKO HERCEPTest&REG;, 2003, SUMM PROC; Dawood S, 2009, J CLIN ONCOL, V27, P220, DOI 10.1200/JCO.2008.17.9952; Delgado D J, 1995, P R Health Sci J, V14, P103; Dillaway H, 2001, J FAM ISSUES, V22, P309, DOI 10.1177/019251301022003003; Du KL, 2012, SUPPORT CARE CANCER, V20, P1317, DOI 10.1007/s00520-011-1219-4; Elefteriou F, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.61; ERNSTER VL, 1979, J NATL CANCER I, V63, P567, DOI 10.1093/jnci/63.3.567; Eskander MF, 2016, AM J SURG, V212, P691, DOI 10.1016/j.amjsurg.2016.07.004; Fritz AG., 2000, INT CLASSIFICATION D, p[vi, 239]; FUNCH DP, 1983, J PSYCHOSOM RES, V27, P77, DOI 10.1016/0022-3999(83)90112-5; Gomez SL, 2016, CANCER-AM CANCER SOC, V122, P1618, DOI 10.1002/cncr.29885; GOODWIN JS, 1987, JAMA-J AM MED ASSOC, V258, P3125, DOI 10.1001/jama.258.21.3125; Hanske J, 2016, PREV MED, V89, P140, DOI 10.1016/j.ypmed.2016.05.017; Hines LM, 2011, J WOMENS HEALTH, V20, P1543, DOI 10.1089/jwh.2010.2558; Hinyard L, 2017, BREAST, V32, P13, DOI 10.1016/j.breast.2016.12.008; Iqbal J, 2015, JAMA-J AM MED ASSOC, V313, P165, DOI 10.1001/jama.2014.17322; KATO I, 1989, JPN J CANCER RES, V80, P306, DOI 10.1111/j.1349-7006.1989.tb02311.x; Kravdal H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-804; Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846; Lara-Medina F, 2011, CANCER-AM CANCER SOC, V117, P3658, DOI 10.1002/cncr.25961; Leung J, 2016, PSYCHO-ONCOLOGY, V25, P1222, DOI 10.1002/pon.4131; Li XX, 2017, BREAST CANCER RES TR, V161, P279, DOI 10.1007/s10549-016-4059-6; Marcus AF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173370; Martinez ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175515; Martinez ME, 2016, CANCER-AM CANCER SOC, V122, P1570, DOI 10.1002/cncr.29886; Bender PFM, 2017, J CANCER RES CLIN, V143, P563, DOI 10.1007/s00432-016-2311-4; MAUNSELL E, 1995, CANCER, V76, P631, DOI 10.1002/1097-0142(19950815)76:4<631::AID-CNCR2820760414>3.0.CO;2-9; Merrill RM, 2017, J CANCER SURVIV, V11, P578, DOI 10.1007/s11764-017-0627-y; Napoles-Springer Anna M, 2007, J Cancer Surviv, V1, P193, DOI 10.1007/s11764-007-0029-7; NEALE AV, 1994, J CLIN EPIDEMIOL, V47, P475, DOI 10.1016/0895-4356(94)90294-1; O'Brien B, 2015, CLIN BREAST CANCER, V15, pE177, DOI 10.1016/j.clbc.2014.12.010; Osborne C, 2005, BREAST CANCER RES TR, V93, P41, DOI 10.1007/s10549-005-3702-4; Ou SHI, 2008, CANCER-AM CANCER SOC, V112, P2011, DOI 10.1002/cncr.23397; Parikh-Patel A, 2006, CANCER-AM CANCER SOC, V107, P1189, DOI 10.1002/cncr.22016; Parise C, 2016, J BREAST CANCER, V19, P112, DOI 10.4048/jbc.2016.19.2.112; Parise C, 2014, CANCER EPIDEMIOL, V38, P556, DOI 10.1016/j.canep.2014.08.001; Parise CA, 2017, BREAST CANCER RES TR, V165, P743, DOI 10.1007/s10549-017-4383-5; Parise CA, 2017, J RACIAL ETHN HEALTH, V4, P706, DOI 10.1007/s40615-016-0274-4; Parise CA, 2017, BREAST CANCER RES TR, V163, P151, DOI 10.1007/s10549-017-4159-y; Parise CA, 2015, J CANCER EPIDEMIOL, V2015, DOI 10.1155/2015/813456; Parise CA, 2012, CANCER-AM CANCER SOC, V118, P2516, DOI 10.1002/cncr.26542; Parise CA, 2010, CRIT REV ONCOL HEMAT, V76, P44, DOI 10.1016/j.critrevonc.2009.09.002; Parise CA, 2009, BREAST J, V15, P593, DOI 10.1111/j.1524-4741.2009.00822.x; Pinquart M, 2010, CRIT REV ONCOL HEMAT, V75, P122, DOI 10.1016/j.critrevonc.2009.06.003; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Shavers VL, 2003, CANCER-AM CANCER SOC, V97, P134, DOI 10.1002/cncr.11051; Silber JH, 2013, JAMA-J AM MED ASSOC, V310, P389, DOI 10.1001/jama.2013.8272; Simon MS, 1996, CANCER, V77, P308, DOI 10.1002/(SICI)1097-0142(19960115)77:2<308::AID-CNCR13>3.3.CO;2-V; Soler-Vila H, 2003, CANCER, V98, P1299, DOI 10.1002/cncr.11670; SPIEGEL D, 1989, LANCET, V2, P888; SWANSON GM, 1985, CANCER RES, V45, P5883; Tannenbaum SL, 2013, CANCER CAUSE CONTROL, V24, P1705, DOI 10.1007/s10552-013-0246-5; Telli ML, 2011, BREAST CANCER RES TR, V127, P471, DOI 10.1007/s10549-010-1173-8; Vona-Davis L, 2008, CANCER EPIDEM BIOMAR, V17, P3319, DOI 10.1158/1055-9965.EPI-08-0544; Wieder R, 2016, J CANCER, V7, P1587, DOI 10.7150/jca.16012; Yang HC, 2009, CANCER-AM CANCER SOC, V115, P217, DOI 10.1002/cncr.23964; Yin DX, 2010, CANCER CAUSE CONTROL, V21, P1721, DOI 10.1007/s10552-010-9601-y; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516; Zell JA, 2007, CANCER EPIDEM BIOMAR, V16, P546, DOI 10.1158/1055-9965.EPI-06-0893	71	15	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196134	10.1371/journal.pone.0196134	http://dx.doi.org/10.1371/journal.pone.0196134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1WN	29698415	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600038
J	Imbach, P; Chou, SC; Lyra, A; Rodrigues, D; Rodriguez, D; Latinovic, D; Siqueira, G; Silva, A; Garofolo, L; Georgiou, S				Imbach, Pablo; Chou, Sin Chan; Lyra, Andre; Rodrigues, Daniela; Rodriguez, Daniel; Latinovic, Dragan; Siqueira, Gracielle; Silva, Adan; Garofolo, Lucas; Georgiou, Selena			Future climate change scenarios in Central America at high spatial resolution	PLOS ONE			English	Article							MIDSUMMER DROUGHT; SOUTH-AMERICA; PRECIPITATION; MODEL; VARIABILITY; EXTREMES; DATASET; MEXICO	The objective of this work is to assess the downscaling projections of climate change over Central America at 8-km resolution using the Eta Regional Climate Model, driven by the HadGEM2-ES simulations of RCP4.5 emission scenario. The narrow characteristic of continent supports the use of numerical simulations at very high-horizontal resolution. Prior to assessing climate change, the 30-year baseline period 1961-1990 is evaluated against different sources of observations of precipitation and temperature. The mean seasonal precipitation and temperature distribution show reasonable agreement with observations. Spatial correlation of the Eta, 8-km resolution, simulations against observations show clear advantage over the driver coarse global model simulations. Seasonal cycle of precipitation confirms the added value of the Eta at 8-km over coarser resolution simulations. The Eta simulations show a systematic cold bias in the region. Climate features of the Mid-Summer Drought and the Caribbean Low-Level Jet are well simulated by the Eta model at 8-km resolution. The assessment of the future climate change is based on the 30-year period 2021-2050, under RCP4.5 scenario. Precipitation is generally reduced, in particular during the JJA and SON, the rainy season. Warming is expected over the region, but stronger in the northern portion of the continent. The Mid-Summer Drought may develop in regions that do not occur during the baseline period, and where it occurs the strength may increase in the future scenario. The Caribbean Low-Level Jet shows little change in the future. Extreme temperatures have positive trend within the period 2021-2050, whereas extreme precipitation, measured by R50mm and R90p, shows positive trend in the eastern coast, around Costa Rica, and negative trends in the northern part of the continent. Negative trend in the duration of dry spell, which is an estimate based on evapotranspiration, is projected in most part of the continent. Annual mean water excess has negative trends in most part of the continent, which suggests decreasing water availability in the future scenario.	[Imbach, Pablo] Int Ctr Trop Agr, Climate Change Agr & Food Secur Program, Hanoi, Vietnam; [Imbach, Pablo; Georgiou, Selena] Trop Agr Res & Higher Educ Ctr, Turrialba, Costa Rica; [Chou, Sin Chan; Lyra, Andre; Rodrigues, Daniela; Latinovic, Dragan; Siqueira, Gracielle; Silva, Adan; Garofolo, Lucas] Natl Inst Space Res, Cachoeira Paulista, SP, Brazil; [Rodriguez, Daniel] Alberto Luiz Coimbra Inst Grad Studies & Res Engn, Rio De Janeiro, RJ, Brazil	Alliance; International Center for Tropical Agriculture - CIAT; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; Instituto Nacional de Pesquisas Espaciais (INPE)	Imbach, P (corresponding author), Int Ctr Trop Agr, Climate Change Agr & Food Secur Program, Hanoi, Vietnam.; Imbach, P (corresponding author), Trop Agr Res & Higher Educ Ctr, Turrialba, Costa Rica.	P.Imbach@cgiar.org	Rodriguez, Daniel Andres/AAB-1422-2021; Garofolo, Lucas/GMW-8049-2022; RODRIGUEZ, Daniel/GWC-3563-2022; Rodriguez, Daniel Andres/AAN-2381-2021; Chou, Sin Chan/F-6364-2012; Rodriguez, Daniel Andres A/F-5581-2012; Lyra, Andre/O-8656-2016	Rodriguez, Daniel Andres/0000-0002-1054-1252; Chou, Sin Chan/0000-0002-8973-1808; Rodriguez, Daniel Andres A/0000-0002-1054-1252; Imbach, Pablo/0000-0003-4078-6063; Lyra, Andre/0000-0001-6834-6081	AC3 project from the International Development Research Centre (IDRC) Canada; CGIAR Fund Donors; Brazilian Council for Research and Technological Development, CNPq [308035/20135]	AC3 project from the International Development Research Centre (IDRC) Canada(CGIAR); CGIAR Fund Donors(CGIAR); Brazilian Council for Research and Technological Development, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The first author, PI, received financial support from AC3 project from the International Development Research Centre (IDRC) Canada. First author work was also partially implemented as part of the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), which is carried out with support from CGIAR Fund Donors and through bilateral funding agreements. For details please visit https://ccafs.cgiar.org/donors. The views expressed in this document cannot be taken to reflect the official opinions of these organisations. The second author, SCC, would like to thank Brazilian Council for Research and Technological Development, CNPq, for the grant number 308035/20135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author, PI, received financial support from AC3 project from the International Development Research Centre (IDRC) Canada. First author work was also partially implemented as part of the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), which is carried out with support from CGIAR Fund Donors and through bilateral funding agreements. For details please visit https://ccafs.cgiar.org/donors. The views expressed in this document cannot be taken to reflect the official opinions of these organisations. The second author, SCC, would like to thank Brazilian Council for Research and Technological Development, CNPq, for the grant number 308035/20135. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006119; Alfaro E.J., 2000, TOPICOS METEOROLOGIC, V7, P99; Amador Astua JA., 1998, METEOROL OCEANOGR TO, V15, P1; [Anonymous], 1986, 87802 NASA; Barron J, 2003, AGR FOREST METEOROL, V117, P23, DOI 10.1016/S0168-1923(03)00037-6; Campbell JD, 2011, INT J CLIMATOL, V31, P1866, DOI 10.1002/joc.2200; Chou S.C., 2014, AM J CLIM CHANG, V3, P512, DOI DOI 10.4236/AJCC.2014.35043; Chou SC, 2005, NONLINEAR PROC GEOPH, V12, P537, DOI 10.5194/npg-12-537-2005; Chou SC., 2014, AM J CLIM CHANGE, V3, P438, DOI [10.4236/ajcc.2014.35039, DOI 10.4236/AJCC.2014.35039]; Chou SC, 2012, CLIM DYNAM, V38, P635, DOI 10.1007/s00382-011-1002-8; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; DORMAN JL, 1989, J APPL METEOROL, V28, P833, DOI 10.1175/1520-0450(1989)028<0833:AGCOAR>2.0.CO;2; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.50; Hastenrath S., 1967, THEOR APPL CLIMATOL, V15, P201, DOI DOI 10.1007/BF02243853; Hidalgo HG, 2017, CLIMATIC CHANGE, V141, P13, DOI 10.1007/s10584-016-1786-y; Hidalgo HG, 2015, INT J CLIMATOL, V35, P3397, DOI 10.1002/joc.4216; Imbach P, 2017, CLIMATIC CHANGE, V141, P1, DOI 10.1007/s10584-017-1920-5; Imbach P, 2012, J HYDROMETEOROL, V13, P665, DOI 10.1175/JHM-D-11-023.1; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Kamiguchi K, 2006, SOLA, V2, P64, DOI 10.2151/sola.2006-017; Karmalkar AV, 2011, CLIM DYNAM, V37, P605, DOI 10.1007/s00382-011-1099-9; Karnauskas KB, 2013, ATMOSFERA, V26, P261, DOI 10.1016/S0187-6236(13)71075-0; Kreft S., 2016, GLOBAL CLIMATE RISK; Magana V, 1999, J CLIMATE, V12, P1577, DOI 10.1175/1520-0442(1999)012<1577:TMDOMA>2.0.CO;2; Magana V, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021033; Maloney ED, 2014, J CLIMATE, V27, P2230, DOI 10.1175/JCLI-D-13-00273.1; Marengo JA, 2012, CLIM DYNAM, V38, P1829, DOI 10.1007/s00382-011-1155-5; MESINGER F, 1984, RIV METEOROL AERONAU, V44, P195; Mesinger F, 2012, METEOROL ATMOS PHYS, V116, P63, DOI 10.1007/s00703-012-0182-z; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mosino A.P., 1966, P C REG LAT UN GEOGR, V3, P500; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mourao C., 2016, ATMOS CLIM SCI, V6, P62493, DOI [10.4236/acs.2016.61001, DOI 10.4236/ACS.2016.61001]; Munoz E, 2008, J CLIMATE, V21, P1260, DOI 10.1175/2007JCLI1855.1; Nakaegawa T, 2014, THEOR APPL CLIMATOL, V116, P155, DOI 10.1007/s00704-013-0934-9; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Pesquero JF, 2010, THEOR APPL CLIMATOL, V99, P75, DOI 10.1007/s00704-009-0123-z; Rauscher SA, 2008, CLIM DYNAM, V31, P551, DOI 10.1007/s00382-007-0359-1; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Seluchi ME, 2003, WEATHER FORECAST, V18, P481, DOI 10.1175/1520-0434(2003)18<481:AOTSOT>2.0.CO;2; Sheffield J, 2013, J CLIMATE, V26, P9247, DOI 10.1175/JCLI-D-12-00593.1; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Taylor MA, 2013, INT J CLIMATOLOGY, V32, P119, DOI [10.1002/joc.346, DOI 10.1002/JOC.346]; Tebaldi C, 2006, CLIMATIC CHANGE, V79, P185, DOI 10.1007/s10584-006-9051-4; van Oldenborgh GJ, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1311; Wang CZ, 2007, CLIM DYNAM, V29, P411, DOI 10.1007/s00382-007-0243-z; Xie PP, 2003, J CLIMATE, V16, P2197, DOI 10.1175/2769.1	48	40	41	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0193570	10.1371/journal.pone.0193570	http://dx.doi.org/10.1371/journal.pone.0193570			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694355	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400005
J	Niizato, T; Murakami, H				Niizato, Takayuki; Murakami, Hisashi			Entangled time in flocking: Multi-time-scale interaction reveals emergence of inherent noise	PLOS ONE			English	Article							NATURAL FLOCKS; LEVY WALK; FISH; PATTERNS; DISTRIBUTIONS; SIMULATIONS; SCHOOLS	Collective behaviors that seem highly ordered and result in collective alignment, such as schooling by fish and flocking by birds, arise from seamless shuffling (such as super-diffusion) and bustling inside groups (such as Levy walks). However, such noisy behavior inside groups appears to preclude the collective behavior: intuitively, we expect that noisy behavior would lead to the group being destabilized and broken into small sub groups, and high alignment seems to preclude shuffling of neighbors. Although statistical modeling approaches with extrinsic noise, such as the maximum entropy approach, have provided some reasonable descriptions, they ignore the cognitive perspective of the individuals. In this paper, we try to explain how the group tendency, that is, high alignment, and highly noisy individual behavior can coexist in a single framework. The key aspect of our approach is multi-time-scale interaction emerging from the existence of an interaction radius that reflects shortterm and long-term predictions. This multi-time-scale interaction is a natural extension of the attraction and alignment concept in many flocking models. When we apply this method in a two-dimensional model, various flocking behaviors, such as swarming, milling, and schooling, emerge. The approach also explains the appearance of super-diffusion, the Levy walk in groups, and local equilibria. At the end of this paper, we discuss future developments, including extending our model to three dimensions.	[Niizato, Takayuki] Tsukuba Univ, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan; [Murakami, Hisashi] Univ Tokyo, Res Ctr Adv Sci & Technol, Megro, Tokyo, Japan	University of Tsukuba; University of Tokyo	Niizato, T (corresponding author), Tsukuba Univ, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan.	t_niizato@yahoo.co.jp						AOKI I, 1982, B JPN SOC SCI FISH, V48, P1081; Ariel G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9396; Attanasi A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.238102; Attanasi A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003697; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bialek W, 2014, P NATL ACAD SCI USA, V111, P7212, DOI 10.1073/pnas.1324045111; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Bode NWF, 2011, J R SOC INTERFACE, V8, P301, DOI 10.1098/rsif.2010.0397; Bode NWF, 2010, P ROY SOC B-BIOL SCI, V277, P3065, DOI 10.1098/rspb.2010.0855; Calovi DS, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1362; Calovi DS, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/1/015026; Cavagna A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2484; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Collignon B, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150473; Couzin I, 2007, NATURE, V445, P715, DOI 10.1038/445715a; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Gautrais J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002678; Gautrais J, 2008, ANN ZOOL FENN, V45, P415, DOI 10.5735/086.045.0505; Goldstone RL, 2009, TOP COGN SCI, V1, P412, DOI 10.1111/j.1756-8765.2009.01038.x; Gunji Yukio-Pegio, 2012, International Journal of Artificial Life Research, V3, P45, DOI 10.4018/jalr.2012010105; Haken H, 1996, PHYSICA D, V97, P95, DOI 10.1016/0167-2789(96)00080-2; Haken H., 1978, SYNERGETICS INTRO; Hemelrijk CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126913; Hemelrijk CK, 2012, INTERFACE FOCUS, V2, P726, DOI 10.1098/rsfs.2012.0025; Hemelrijk CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022479; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Kunz H, 2012, APPL ANIM BEHAV SCI, V138, P142, DOI 10.1016/j.applanim.2012.02.002; Mateo D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09830-w; Mora T, 2016, NAT PHYS, V12, P1153, DOI [10.1038/NPHYS3846, 10.1038/nphys3846]; Morin A, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.012134; Murakami Hisashi, 2012, International Journal of Artificial Life Research, V3, P34, DOI 10.4018/jalr.2012010104; Murakami H, 2014, PLOS ONE, V9; Murakami H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10605; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Niizato T, 2014, BIOSYSTEMS, V119, P62, DOI 10.1016/j.biosystems.2014.03.001; Niizato T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035615; Pita D, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160377; Pita D, 2015, PEERJ, V3, DOI 10.7717/peerj.1113; Raichlen DA, 2014, P NATL ACAD SCI USA, V111, P728, DOI 10.1073/pnas.1318616111; Shang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04184; Sonoda K, 2016, ARTIF LIFE ROBOT, V21, P379, DOI 10.1007/s10015-016-0314-5; Strandburg-Peshkin A, 2013, CURR BIOL, V23; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sumpter DJT, 2012, INTERFACE FOCUS, V2, P764, DOI 10.1098/rsfs.2012.0031; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; Viswanathan GM, 2010, NATURE, V465, P1018, DOI 10.1038/4651018a; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106; Young GF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002894; Zaburdaev V, 2015, REV MOD PHYS, V87, P483, DOI 10.1103/RevModPhys.87.483	54	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0195988	10.1371/journal.pone.0195988	http://dx.doi.org/10.1371/journal.pone.0195988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689074	Green Published, Green Submitted, gold			2022-12-26	WOS:000430678800020
J	Brogaard, L; Larsen, LE; Heegaard, PMH; Anthon, C; Gorodkin, J; Durrwald, R; Skovgaard, K				Brogaard, Louise; Larsen, Lars E.; Heegaard, Peter M. H.; Anthon, Christian; Gorodkin, Jan; Duerrwald, Ralf; Skovgaard, Kerstin			IFN-lambda and microRNAs are important modulators of the pulmonary innate immune response against influenza A (H1N2) infection in pigs	PLOS ONE			English	Article							ANTIVIRAL PROTECTION; VIRUS-INFECTION; SWINE; EXPRESSION; MODEL; GENES; HOST; H3N2; VIRULENCE; GENOMES	The innate immune system is paramount in the response to and clearance of influenza A virus (IAV) infection in non-immune individuals. Known factors include type I and III interferons and antiviral pathogen recognition receptors, and the cascades of antiviral and pro- and anti-inflammatory gene expression they induce. MicroRNAs (miRNAs) are increasingly recognized to participate in post-transcriptional modulation of these responses, but the temporal dynamics of how these players of the antiviral innate immune response collaborate to combat infection remain poorly characterized. We quantified the expression of miRNAs and protein coding genes in the lungs of pigs 1, 3, and 14 days after challenge with swine IAV (H1N2). Through RT-qPCR we observed a 400-fold relative increase in IFN-lambda 3 gene expression on day 1 after challenge, and a strong interferon-mediated antiviral response was observed on days 1 and 3 accompanied by up-regulation of genes related to the pro-inflammatory response and apoptosis. Using small RNA sequencing and qPCR validation we found 27 miRNAs that were differentially expressed after challenge, with the highest number of regulated miRNAs observed on day 3. In contrast, the number of protein coding genes found to be regulated due to IAV infection peaked on day 1. Pulmonary miRNAs may thus be aimed at fine-tuning the initial rapid inflammatory response after IAV infection. Specifically, we found five miRNAs (ssc-miR-15a, ssc-miR-18a, ssc-miR-21, ssc-miR-29b, and hsa-miR-590-3p)-four known porcine miRNAs and one novel porcine miRNA candidate-to be potential modulators of viral pathogen recognition and apoptosis. A total of 11 miRNAs remained differentially expressed 14 days after challenge, at which point the infection had cleared. In conclusion, the results suggested a role for miRNAs both during acute infection as well as later, with the potential to influence lung homeostasis and susceptibility to secondary infections in the lungs of pigs after IAV infection.	[Brogaard, Louise; Heegaard, Peter M. H.; Skovgaard, Kerstin] Tech Univ Denmark, Dept Biotechnol & Biomed, Sect Prot Sci & Signaling Biol, Lyngby, Denmark; [Larsen, Lars E.] Tech Univ Denmark, Natl Vet Inst, Div Diagnost & Sci Advice Virol, Lyngby, Denmark; [Anthon, Christian; Gorodkin, Jan] Univ Copenhagen, Dept Vet & Anim Sci, Ctr Noncoding RNA Technol & Hlth RTH, Frederiksberg, Denmark; [Duerrwald, Ralf] Robert Koch Inst, Dept Infect Dis, Berlin, Germany	Technical University of Denmark; Technical University of Denmark; University of Copenhagen; Robert Koch Institute	Brogaard, L (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Sect Prot Sci & Signaling Biol, Lyngby, Denmark.	loun@vet.dtu.dk	; Heegaard, Peter/E-9794-2015; Larsen, Lars Erik/G-3827-2015	skovgaard, kerstin/0000-0001-5663-4879; Heegaard, Peter/0000-0003-4506-4932; Gorodkin, Jan/0000-0001-5823-4000; Anthon, Christian/0000-0002-4336-1688; Larsen, Lars Erik/0000-0003-0730-5555; Brogaard, Louise/0000-0003-4571-6822	Independent Research Fund Denmark [4005-00443, 1337-00014]; Innovation Fund Denmark [0603-00320B]; Bundesministerium fur Bildung and Forschung [01KI1006L]	Independent Research Fund Denmark; Innovation Fund Denmark; Bundesministerium fur Bildung and Forschung(Federal Ministry of Education & Research (BMBF))	LB, LEL, PMHH, and KS recieved no specific funding for this work. CA and JG were supported by the Independent Research Fund Denmark (4005-00443) (http://ufm.dk/forskningog-innovatien/rad-og-udvalgidff) and Innovation Fund Denmark (0603-00320B) (https://innevatonsfonden.dk/en). RD was supported by the Bundesministerium fur Bildung and Forschung (01KI1006L) (https://www.bmbf.de/). Laboratory reagents and disposable labware were partially funded by Independent Research Fund Denmark (1337-00014) (http://ufm.dk/forskn ing-og-innovation/rad-og-udvalg/dff).	Alipoor SD, 2016, EUR J PHARMACOL, V791, P395, DOI 10.1016/j.ejphar.2016.09.015; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arora S, 2016, CELL DEATH DIFFER, V23, P1243, DOI 10.1038/cdd.2016.19; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Barbe F, 2011, VET J, V187, P48, DOI 10.1016/j.tvjl.2009.12.012; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Blondal T, 2017, METHODS MOL BIOL, V1580, P21, DOI 10.1007/978-1-4939-6866-4_3; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Brogaard L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21812; Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413; Dawson HD, 2017, VET MICROBIOL, V202, P2, DOI 10.1016/j.vetmic.2016.05.013; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Forero A, 2017, TRENDS IMMUNOL; Foster PS, 2013, IMMUNOL REV, V253, P198, DOI 10.1111/imr.12058; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Iwatsuki-Horimoto K, 2017, J VIROL, V91, DOI [10.1128/jvi.01716-16, 10.1128/JVI.01716-16]; Janke BH, 2014, VET PATHOL, V51, P410, DOI 10.1177/0300985813513043; Junge A, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw167; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kash JC, 2015, AM J PATHOL, V185, P1528, DOI 10.1016/j.ajpath.2014.08.030; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li YK, 2013, CELL MOL IMMUNOL, V10, P65, DOI 10.1038/cmi.2012.55; Li Y, 2011, VIROLOGY, V421, P105, DOI 10.1016/j.virol.2011.09.011; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Ma WJ, 2011, J VIROL, V85, P11626, DOI 10.1128/JVI.05705-11; Makkoch J, 2016, EXP BIOL MED, V241, P409, DOI 10.1177/1535370215611764; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mauskopf Josephine, 2013, J Med Econ, V16, P264, DOI 10.3111/13696998.2012.752376; Mayank AK, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.360; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Nassirpour R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-485; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Oglesby IK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-148; Oulas A, 2015, METHODS MOL BIOL, V1269, P207, DOI 10.1007/978-1-4939-2291-8_13; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pociask DA, 2017, AM J PATHOL, V187, P851, DOI 10.1016/j.ajpath.2016.12.012; Podolska A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-459; Pomorska-Mol M, 2014, ARCH VIROL, V159, P2605, DOI 10.1007/s00705-014-2116-1; Pomorska-Mol M, 2014, INFLUENZA OTHER RESP, V8, P228, DOI 10.1111/irv.12186; Pomorska-Mol M, 2012, FEMS IMMUNOL MED MIC, V66, P334, DOI 10.1111/j.1574-695X.2012.01026.x; R Core Team, 2017, R PROJ STAT COMP; Rajao DS, 2015, ILAR J, V56, P44, DOI 10.1093/ilar/ilv002; Samir M, 2016, FRONT VET SCI, V3, P1, DOI [10.3389/fvets.2016.00001, DOI 10.3389/FVETS.2016.00001]; Sedger LM, 2013, MOL IMMUNOL, V56, P781, DOI 10.1016/j.molimm.2013.07.009; Skovgaard K, 2013, INNATE IMMUN-LONDON, V19, P531, DOI 10.1177/1753425912473668; Skovgaard K, 2009, VET RES, V40, DOI 10.1051/vetres/2009006; Syedbasha M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00119; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Terrier O, 2013, J GEN VIROL, V94, P985, DOI 10.1099/vir.0.049528-0; Trebbien R, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-290; Trebbien R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-434; Tripathi S, 2015, INNATE IMMUN-LONDON, V21, P73, DOI 10.1177/1753425913508992; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vela EM, 2014, J MED MICROBIOL, V63, P1131, DOI 10.1099/jmm.0.067959-0; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wiersma LCM, 2015, VACCINES, V3, P239, DOI 10.3390/vaccines3020239; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074190; Ye RD, 2015, J LEUKOCYTE BIOL, V98, P923, DOI 10.1189/jlb.3VMR0315-080R	74	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0194765	10.1371/journal.pone.0194765	http://dx.doi.org/10.1371/journal.pone.0194765			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677213	gold, Green Published, Green Submitted			2022-12-26	WOS:000430638900006
J	Goldstone, DC; Baker, EN				Goldstone, David C.; Baker, Edward N.			Stress control for a well-structured life	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							TYPHIMURIUM	Aerobic life brings with it a need to respond to external redox stress in ways that preserve key processes. Suppressor of copper sensitivity (Scs) proteins contribute to this response in some bacteria, but have poorly defined molecular functions. Furlong et al. now demonstrate that two Scs proteins from Proteus mirabilis provide a redox relay functionally equivalent to, but structurally distinct from, the Dsb proteins that orchestrate disulfide bonding in Escherichia coli, emphasizing the wide prevalence of this mechanism in bacteria.	[Goldstone, David C.; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand	University of Auckland	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz		Goldstone, David/0000-0003-0069-9408				Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Furlong EJ, 2018, J BIOL CHEM, V293, P5793, DOI 10.1074/jbc.RA118.001860; Furlong EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16065; Goldstone DC, 2016, ACTA CRYSTALLOGR D, V72, P40, DOI 10.1107/S2059798315021488; Gupta SD, 1997, J BACTERIOL, V179, P4977, DOI 10.1128/jb.179.16.4977-4984.1997; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Heller WT, 2010, ACTA CRYSTALLOGR D, V66, P1213, DOI [10.1107/S0907444910017658, 10.1107/S090744491001]; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Shepherd M, 2013, ANTIOXID REDOX SIGN, V19, P1494, DOI 10.1089/ars.2012.4939; Williamson JA, 2015, NAT STRUCT MOL BIOL, V22, P809, DOI 10.1038/nsmb.3099	10	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2018	293	16					5806	5807		10.1074/jbc.H118.002699	http://dx.doi.org/10.1074/jbc.H118.002699			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD4UE	29678889	hybrid, Green Published			2022-12-26	WOS:000430497300005
J	Sun, WJ; Li, XJ; Niu, BB				Sun, Wenjuan; Li, Xinju; Niu, Beibei			Prediction of soil organic carbon in a coal mining area by Vis-NIR spectroscopy	PLOS ONE			English	Article							MATTER; SPECTRA; MODEL	Coal mining has led to increasingly serious land subsidence, and the reclamation of the subsided land has become a hot topic of concern for governments and scholars. Soil quality of reclaimed land is the key indicator to the evaluation of the reclamation effect; hence, rapid monitoring and evaluation of reclaimed land is of great significance. Visible-near infrared (Vis-NIR) spectroscopy has been shown to be a rapid, timely and efficient tool for the prediction of soil organic carbon (SOC). In this study, 104 soil samples were collected from the Baodian mining area of Shandong province. Vis-NIR reflectance spectra and soil organic carbon content were then measured under laboratory conditions. The spectral data were first denoised using the Savitzky-Golay (SG) convolution smoothing method or the multiple scattering correction (MSC) method, after which the spectral reflectance (R) was subjected to reciprocal, reciprocal logarithm and differential transformations to improve spectral sensitivity. Finally, regression models for estimating the SOC content by the spectral data were constructed using partial least squares regression (PLSR). The results showed that: (1) The SOC content in the mining area was generally low (at the below-average level) and exhibited great variability. (2) The spectral reflectance increased with the decrease of soil organic carbon content. In addition, the sensitivity of the spectrum to the change in SOC content, especially that in the near-infrared band of the original reflectance, decreased when the SOC content was low. (3) The modeling results performed best when the spectral reflectance was preprocessed by Savitzky-Golay (SG) smoothing coupled with multiple scattering correction (MSC) and first-order differential transformation (modeling R-2 = 0.86, RMSE = 2.00 g/kg, verification R-2 = 0.78, RMSE = 1.81 g/kg, and RPD = 2.69). In addition, the first-order differential of R combined with SG, MSC with R, SG together with MSC and R also produced better modeling results than other pretreatment combinations. Vis-NIR modeling with specific spectral preprocessing methods could predict SOC content effectively.	[Sun, Wenjuan; Li, Xinju; Niu, Beibei] Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Li, XJ (corresponding author), Shandong Agr Univ, Coll Resources & Environm, Tai An, Shandong, Peoples R China.	lxj0911@126.com	Niu, Beibei/AAA-2144-2020	Niu, Beibei/0000-0002-0197-5454	Natural Science Foundation of China (NSFC) [41771324]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was funded by the Natural Science Foundation of China (NSFC) (41771324). The funder has supported my work in data acquisition and analysis.	Aichi H, 2009, BIOSYST ENG, V104, P442, DOI 10.1016/j.biosystemseng.2009.08.002; Bao NS, 2017, GEODERMA, V288, P47, DOI 10.1016/j.geoderma.2016.10.033; Bartholomeus HM, 2008, GEODERMA, V145, P28, DOI 10.1016/j.geoderma.2008.01.010; Bodlak L, 2012, ECOL ENG, V43, P53, DOI 10.1016/j.ecoleng.2011.07.013; [陈华舟 Chen Huazhou], 2011, [计算机与应用化学, Computers and Applied Chemistry], V28, P518; China Soil Census Office, 1998, CHIN SOIL; Conforti M, 2013, CATENA, V110, P44, DOI 10.1016/j.catena.2013.06.013; Fajardo M, 2016, GEODERMA, V263, P244, DOI 10.1016/j.geoderma.2015.05.010; Febrero-Bande M, 2017, INT STAT REV, V85, P61, DOI 10.1111/insr.12116; Guo DouDou, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P192; Guo L, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6100308; He DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099251; HENDERSON TL, 1992, SOIL SCI SOC AM J, V56, P865, DOI 10.2136/sssaj1992.03615995005600030031x; [侯燕平 Hou Yanping], 2015, [土壤通报, Chinese Journal of Soil Science], V46, P287; Leone AP, 2013, FRESEN ENVIRON BULL, V22, P1230; Li Peisheng, 2005, Journal of Huazhong University of Science and Technology, V33, P61; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140688; Morellos A, 2016, BIOSYST ENG, V152, P104, DOI 10.1016/j.biosystemseng.2016.04.018; Mouazen A M, 2011, ADV BIOMEDICAL ENG P; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Srivastava R, 2015, J INDIAN SOC REMOTE, V43, P751, DOI 10.1007/s12524-015-0458-0; Tan K, 2014, SPECTROSC SPECT ANAL, V34, P3317, DOI 10.3964/j.issn.1000-0593(2014)12-3317-06; Wang HT, 2014, PREDICTING FOREST SO; Wang SQ, 2008, SPECTROSC SPECT ANAL, V28, P808; Wang X, 2016, TILLAGE CULTIVATION, P80; Yang AiXia, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P162; Yang D. J., 2016, ENVIRON EARTH SCI, V75, P1, DOI DOI 10.1007/s12665-015-4873-x	27	15	16	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0196198	10.1371/journal.pone.0196198	http://dx.doi.org/10.1371/journal.pone.0196198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677214	gold, Green Published, Green Submitted			2022-12-26	WOS:000430638900028
J	Li, JJ; Xie, JG; Liu, SS; Li, X; Zhang, DL; Wang, XQ; Jiang, JQ; Hu, W; Zhang, Y; Jin, BQ; Zhuang, R; Yin, W				Li, Junjie; Xie, Jiangang; Liu, Shanshou; Li, Xiao; Zhang, Dongliang; Wang, Xianqi; Jiang, Jinquan; Hu, Wei; Zhang, Yuan; Jin, Boquan; Zhuang, Ran; Yin, Wen			ADAR1 attenuates allogeneic graft rejection by suppressing miR-21 biogenesis in macrophages and promoting M2 polarization	FASEB JOURNAL			English	Article						microRNA; RNA edit; transplantation rejection	ADENOSINE-DEAMINASE ADAR1; PROTEIN-KINASE PKR; M-1/M-2 MACROPHAGES; RNA; RECEPTOR; ACTIVATION; EXPRESSION; VIRUS; ROLES; GENE	ADAR1 (adenosine deaminase acting on double-stranded RNA 1) is an RNA-editing enzyme that mediates adenosine-to-inosine RNA editing events, an important post-transcriptional modification mechanism that can alter the coding properties of mRNA or regulate microRNA biogenesis. ADAR1 also regulates the innate immune response. Here, we have demonstrated that ADAR1 expression increased in LPS-stimulated macrophages. Silencing ADAR1 by using small interfering RNA in macrophages resulted in the pronounced polarization of macrophages to M1, whereas ADAR1 overexpression promoted M2 polarization, which indicated that ADAR1 can inhibit macrophage hyperpolarization and prevent immune hyperactivity. The RNA-RNP immunoprecipitation binding assay demonstrated a direct interaction between ADAR1 and miR-21 precursor. Significant up-regulation in IL-10 and down-regulation in miR-21 were observed in ADAR1-overexpressing macrophages. We evaluated miR-21 target mRNAs and macrophage polarization signaling pathways and found that forkhead box protein O1 (Foxo1) was up-regulated in cells that overexpressed ADAR1. In a mouse allogeneic skin transplantation model, grafts in the ADAR1-overexpressed group survived longer and suffered less immune cell infiltration. In ADAR1-overexpressed recipients, splenic macrophages were significantly polarized to M2, and levels of sera IL-10 were markedly higher than those in the control group. In summary, ADAR1 modulates macrophage M2 polarization via the ADAR1-miR-21-Foxo1-IL-10 axis, thereby suppressing allogeneic graft rejection.Li, J., Xie, J., Liu, S., Li, X., Zhang, D., Wang, X., Jiang, J., Hu, W., Zhang, Y., Jin, B., Zhuang, R., Yin, W. ADAR1 attenuates allogeneic graft rejection by suppressing miR-21 biogenesis in macrophages and promoting M2 polarization.	[Li, Junjie; Xie, Jiangang; Liu, Shanshou; Wang, Xianqi; Jiang, Jinquan; Yin, Wen] Fourth Mil Med Univ, Xijing Hosp, Dept Emergency, Xian 710032, Shaanxi, Peoples R China; [Li, Xiao] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Zhang, Dongliang] Fourth Mil Med Univ, Xijing Hosp, Dept Plast Surg, Xian, Shaanxi, Peoples R China; [Xie, Jiangang; Zhang, Dongliang; Hu, Wei; Zhang, Yuan; Zhuang, Ran] Fourth Mil Med Univ, Sch Basic Med Sci, Transplant Immunol Lab, Xian, Shaanxi, Peoples R China; [Hu, Wei; Jin, Boquan; Zhuang, Ran] Fourth Mil Med Univ, Sch Basic Med Sci, Dept Immunol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yin, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Emergency, Xian 710032, Shaanxi, Peoples R China.; Zhuang, R (corresponding author), Fourth Mil Med Univ, Dept Immunol, 169 Changlexilu Rd, Xian 710032, Shaanxi, Peoples R China.	fmmuzhr@fmmu.edu.cn; xjyyyw@fmmu.edu.cn	Zhuang, Ran/I-7336-2019	Zhuang, Ran/0000-0002-3614-0422	National Natural Science Foundation of China [81500492, 81671575, 91442105, 81370388]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Prof. Shuzhong Guo (Xijing Hospital) for academic vision and advice. This work was supported by the National Natural Science Foundation of China (Grants 81500492, 81671575, 91442105, and 81370388). The authors declare no conflicts of interest.	Ahluwalia PK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00107; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Boesten LSM, 2006, FASEB J, V20, P953, DOI 10.1096/fj.05-4530fje; Cachat A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0093-9; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; Chawla G, 2014, NUCLEIC ACIDS RES, V42, P5245, DOI 10.1093/nar/gku145; Chen T, 2015, CELL RES, V25, P459, DOI 10.1038/cr.2015.24; Chen Y, 2017, EXP HEMATOL ONCOL, V6, DOI 10.1186/s40164-017-0083-4; Cho CJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040799; Chung S, 2015, J LEUKOCYTE BIOL, V97, P327, DOI 10.1189/jlb.3A0514-251R; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Cunha C, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6986175; Galore-Haskel G, 2015, ONCOTARGET, V6, P28999, DOI 10.18632/oncotarget.4905; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; HANCOCK WW, 1983, TRANSPLANTATION, V35, P458, DOI 10.1097/00007890-198305000-00013; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; He X, 2016, EBIOMEDICINE, V13, P339, DOI 10.1016/j.ebiom.2016.10.024; Hood JL, 2012, CURR TOP MICROBIOL, V353, P61, DOI 10.1007/82_2011_157; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Mannon RB, 2012, CURR OPIN ORGAN TRAN, V17, P20, DOI 10.1097/MOT.0b013e32834ee5b6; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2017, J IMMUNOL, V199, P2194, DOI 10.4049/jimmunol.1701141; Muhlberg L, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1160181; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakano M, 2016, J BIOL CHEM, V291, P894, DOI 10.1074/jbc.M115.699363; Narayanan M, 2013, TRANSPLANTATION, V95, P566, DOI 10.1097/TP.0b013e318277438f; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; Nie YZ, 2007, J VIROL, V81, P917, DOI 10.1128/JVI.01527-06; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ohman M, 2007, BIOCHIMIE, V89, P1171, DOI 10.1016/j.biochi.2007.06.002; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Pfaller CK, 2011, CURR OPIN IMMUNOL, V23, P573, DOI 10.1016/j.coi.2011.08.009; Salehi S, 2015, CURR OPIN ORGAN TRAN, V20, P446, DOI 10.1097/MOT.0000000000000209; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Shoshan E, 2015, NAT CELL BIOL, V17, P311, DOI 10.1038/ncb3110; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Song C, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120129; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115855; Weiden MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108476; Zhao HQ, 2015, GENOME RES, V25, P66, DOI 10.1101/gr.176107.114; Zhuang R, 2013, NUCLEIC ACIDS RES, V41, P7905, DOI 10.1093/nar/gkt565; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004	50	13	14	1	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5162	5173		10.1096/fj.201701449R	http://dx.doi.org/10.1096/fj.201701449R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29694248	Bronze			2022-12-26	WOS:000443817700043
J	Dite, TA; Langendorf, CG; Hoque, A; Galic, S; Rebello, RJ; Ovens, AJ; Lindqvist, LM; Ngoei, KRW; Ling, NXY; Furic, L; Kemp, BE; Scott, JW; Oakhill, JS				Dite, Toby A.; Langendorf, Christopher G.; Hoque, Ashfaqul; Galic, Sandra; Rebello, Richard J.; Ovens, Ashley J.; Lindqvist, Lisa M.; Ngoei, Kevin R. W.; Ling, Naomi X. Y.; Furic, Luc; Kemp, Bruce E.; Scott, John W.; Oakhill, Jonathan S.			AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; RATIONAL DESIGN; CANCER; AUTOPHAGY; SUBUNIT; ULK1; PHOSPHORYLATION; METABOLISM; COMPLEXES; MECHANISM	Inhibition of the metabolic regulator AMP-activated protein kinase (AMPK) is increasingly being investigated for its therapeutic potential in diseases where AMPK hyperactivity results in poor prognoses, as in established cancers and neurodegeneration. However, AMPK-inhibitory tool compounds are largely limited to compound C, which has a poor selectivity profile. Here we identify the pyrimidine derivative SBI-0206965 as a direct AMPK inhibitor. SBI-0206965 inhibits AMPK with 40-fold greater potency and markedly lower kinase promiscuity than compound C and inhibits cellular AMPK signaling. Biochemical characterization reveals that SBI-0206965 is a mixed-type inhibitor. A co-crystal structure of the AMPK kinase domain/SBI-0206965 complex shows that the drug occupies a pocket that partially overlaps the ATP active site in a type IIb inhibitor manner. SBI-0206965 has utility as a tool compound for investigating physiological roles for AMPK and provides fresh impetus to small-molecule AMPK inhibitor therapeutic development.	[Dite, Toby A.; Hoque, Ashfaqul; Ovens, Ashley J.; Ling, Naomi X. Y.; Oakhill, Jonathan S.] Univ Melbourne, St Vincents Inst Med Res, Metab Signalling Lab, Fitzroy, Vic 3065, Australia; [Langendorf, Christopher G.; Galic, Sandra; Ngoei, Kevin R. W.; Kemp, Bruce E.; Scott, John W.] Univ Melbourne, St Vincents Inst Med Res, Prot Chem & Metab Unit, Fitzroy, Vic 3065, Australia; [Rebello, Richard J.; Furic, Luc] Peter MacCallum Canc Ctr, Prostate Canc Translat Res Lab, Melbourne, Vic 3000, Australia; [Rebello, Richard J.; Furic, Luc] Monash Univ, Biomed Discovery Inst, Canc Program, Clayton, Vic 3800, Australia; [Rebello, Richard J.; Furic, Luc] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Lindqvist, Lisa M.] Walter & Eliza Hall Inst Med Res, Cell Signalling & Cell Death Div, Parkville, Vic 3052, Australia; [Furic, Luc] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Kemp, Bruce E.; Scott, John W.; Oakhill, Jonathan S.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic 3000, Australia	St. Vincent's Institute of Medical Research; University of Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; Peter Maccallum Cancer Center; Monash University; Monash University; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center; University of Melbourne; Australian Catholic University	Oakhill, JS (corresponding author), St Vincents Inst Med Res, Metab Signalling Lab, Fitzroy, Vic 3065, Australia.	joakhill@svi.edu.au	Kemp, Bruce/G-9602-2019; Furic, Luc/F-4886-2012; Oakhill, Jonathan S/F-5724-2011; Scott, John W/AAA-2676-2021; Rebello, Richard/W-4687-2019; Scott, John W/P-1170-2018; Galic, Sandra/C-6098-2014; Hoque, Ashfaqul/AAL-8462-2020	Kemp, Bruce/0000-0001-6735-5082; Furic, Luc/0000-0002-1893-9812; Oakhill, Jonathan S/0000-0002-9475-1440; Scott, John W/0000-0002-1896-9798; Rebello, Richard/0000-0001-6271-6678; Scott, John W/0000-0002-1896-9798; Galic, Sandra/0000-0002-7611-5619; Hoque, Ashfaqul/0000-0003-2384-2983; Langendorf, Christopher/0000-0002-9049-5283; Ling, Naomi/0000-0001-6240-4092; Ovens, Ashley/0000-0001-5711-6555	Australian Research Council (ARC); Cancer Australia; National Health and Medical Research Council (NHMRC); Jack Brockhoff foundation [JBF-4206]; Victorian Government's Operational Infrastructure Support Program; Department of Health and Human Services acting through the Victorian Cancer Agency [MCRF16007]	Australian Research Council (ARC)(Australian Research Council); Cancer Australia; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Jack Brockhoff foundation; Victorian Government's Operational Infrastructure Support Program; Department of Health and Human Services acting through the Victorian Cancer Agency	This work was supported by grants from the Australian Research Council (ARC), Cancer Australia, the National Health and Medical Research Council (NHMRC), and the Jack Brockhoff foundation (Grant JBF-4206, 2016). The authors declare that they have no conflicts of interest with the contents of this article.; An NHMRC Early Career Research Fellow. Supported in part by the Victorian Government's Operational Infrastructure Support Program.; Supported by the Department of Health and Human Services acting through the Victorian Cancer Agency (MCRF16007).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BDOLAH A, 1968, J BACTERIOL, V96, P1144, DOI 10.1128/JB.96.4.1144-1149.1968; Blanc J, 2013, ANTI-CANCER AGENT ME, V13, P731, DOI 10.2174/1871520611313050008; Bricogne G., 2011, BUSTER VERSION 2 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P173, DOI 10.1016/0926-6569(63)90226-8; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Davidson W, 2004, BIOCHEMISTRY-US, V43, P11658, DOI 10.1021/bi0495073; Dessauer CW, 1999, TRENDS PHARMACOL SCI, V20, P205, DOI 10.1016/S0165-6147(99)01310-3; Dite TA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00628-y; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fryer LGD, 2002, FEBS LETT, V531, P189, DOI 10.1016/S0014-5793(02)03501-9; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Ghani U, 2010, BIOORGAN MED CHEM, V18, P4042, DOI 10.1016/j.bmc.2010.04.021; Handa N, 2011, ACTA CRYSTALLOGR D, V67, P480, DOI 10.1107/S0907444911010201; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Jeon SM, 2015, ARCH PHARM RES, V38, P346, DOI 10.1007/s12272-015-0549-z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kovalenko M, 1997, BIOCHEMISTRY-US, V36, P6260, DOI 10.1021/bi962553l; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Langendorf CG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10912; Lee Y, 2016, BIOCHEM BIOPH RES CO, V469, P515, DOI 10.1016/j.bbrc.2015.12.015; Lesuisse D, 2011, BIOORG MED CHEM LETT, V21, P2224, DOI 10.1016/j.bmcl.2011.03.003; Liang JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8926; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Liu YJ, 2015, J NEUROGENET, V29, P50, DOI 10.3109/01677063.2015.1067203; Marmor S, 2001, BIOCHEMISTRY-US, V40, P12207, DOI 10.1021/bi015567m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; PATEL MS, 1972, BIOCHEM J, V128, P677, DOI 10.1042/bj1280677; Popovics P, 2015, EXPERT OPIN THER TAR, V19, P617, DOI 10.1517/14728222.2015.1005603; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Ross FA, 2017, CELL CHEM BIOL, V24, P813, DOI 10.1016/j.chembiol.2017.05.021; Ross FA, 2016, BIOCHEM J, V473, P189, DOI 10.1042/BJ20150910; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott JW, 2015, CHEM BIOL, V22, P705, DOI 10.1016/j.chembiol.2015.05.011; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Tang F, 2017, ONCOL REP, V37, P3449, DOI 10.3892/or.2017.5635; Thomson JM, 2007, ANTIMICROB AGENTS CH, V51, P1577, DOI 10.1128/AAC.01293-06; Vijayan RSK, 2015, J MED CHEM, V58, P466, DOI 10.1021/jm501603h; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; WESTMARK PR, 1993, J AM CHEM SOC, V115, P3416, DOI 10.1021/ja00062a003; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	64	66	66	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8874	8885		10.1074/jbc.RA118.003547	http://dx.doi.org/10.1074/jbc.RA118.003547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29695504	Green Published, hybrid			2022-12-26	WOS:000434941900012
J	Li, X; Hu, SG; Fan, WB; Deng, K				Li, Xin; Hu, Sangen; Fan, Wenbo; Deng, Kai			Modeling an enhanced ridesharing system with meet points and time windows	PLOS ONE			English	Article							A-RIDE PROBLEM; VEHICLE-ROUTING PROBLEM; TABU SEARCH; HEURISTIC ALGORITHMS; TRAFFIC INFORMATION; TRANSPORT-SERVICES; DELIVERY PROBLEM; PICKUP; PARATRANSIT; BRANCH	With the rising of e-hailing services in urban areas, ride sharing is becoming a common mode of transportation. This paper presents a mathematical model to design an enhanced ridesharing system with meet points and users' preferable time windows. The introduction of meet points allows ridesharing operators to trade off the benefits of saving en-route delays and the cost of additional walking for some passengers to be collectively picked up or dropped off. This extension to the traditional door-to-door ridesharing problem brings more operation flexibility in urban areas (where potential requests may be densely distributed in neighborhood), and thus could achieve better system performance in terms of reducing the total travel time and increasing the served passengers. We design and implement a Tabu-based meta-heuristic algorithm to solve the proposed mixed integer linear program (MILP). To evaluate the validation and effectiveness of the proposed model and solution algorithm, several scenarios are designed and also resolved to optimality by CPLEX. Results demonstrate that (i) detailed route plan associated with passenger assignment to meet points can be obtained with en-route delay savings; (ii) as compared to CPLEX, the meta-heuristic algorithm bears the advantage of higher computation efficiency and produces good quality solutions with 8%similar to 15% difference from the global optima; and (iii) introducing meet points to ridesharing system saves the total travel time by 2.7%-3.8% for small-scale ridesharing systems. More benefits are expected for ridesharing systems with large size of fleet. This study provides a new tool to efficiently operate the ridesharing system, particularly when the ride sharing vehicles are in short supply during peak hours. Traffic congestion mitigation will also be expected.	[Li, Xin] Hong Kong Polytech Univ, Dept Elect Engn, Hong Kong, Peoples R China; [Hu, Sangen] Guangdong Univ Technol, Sch Civil & Transportat Engn, Guangzhou, Guangdong, Peoples R China; [Fan, Wenbo] Southwest Jiaotong Univ, Sch Transportat & Logist, Chengdu, Sichuan, Peoples R China; [Deng, Kai] Univ Sci & Technol China, Sch Gifted Young, Hefei, Anhui, Peoples R China	Hong Kong Polytechnic University; Guangdong University of Technology; Southwest Jiaotong University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Fan, WB (corresponding author), Southwest Jiaotong Univ, Sch Transportat & Logist, Chengdu, Sichuan, Peoples R China.	wbfan@swjtu.edu.cn		Fan, Wenbo/0000-0002-4525-9812	National Natural Science Foundation of China [51608455]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Project No. 51608455).	AbdelAty MA, 1997, TRANSPORT RES C-EMER, V5, P39, DOI 10.1016/S0968-090X(96)00023-X; Agatz N, 2012, EUR J OPER RES, V223, P295, DOI 10.1016/j.ejor.2012.05.028; Attanasio A, 2004, PARALLEL COMPUT, V30, P377, DOI 10.1016/j.parco.2004.12.001; Berbeglia G, 2012, INFORMS J COMPUT, V24, P343, DOI 10.1287/ijoc.1110.0454; Borndorfer R, 1999, LECT NOTES ECON MATH, V471, P391; Brake J, 2007, TRANSPORT POLICY, V14, P458, DOI 10.1016/j.tranpol.2007.09.001; BRAMEL J, 1995, OPER RES, V43, P649, DOI 10.1287/opre.43.4.649; Cordeau JF, 2006, OPER RES, V54, P573, DOI 10.1287/opre.1060.0283; Cordeau JF, 2003, 4OR-Q J OPER RES, V1, P89, DOI 10.1007/s10288-002-0009-8; Cordeau JF, 2003, TRANSPORT RES B-METH, V37, P579, DOI 10.1016/S0191-2615(02)00045-0; Cordeau JF, 2001, J OPER RES SOC, V52, P928, DOI 10.1057/palgrave.jors.2601163; DAGANZO CF, 1984, TRANSPORT RES B-METH, V18, P315, DOI 10.1016/0191-2615(84)90014-6; Desaulniers G, 2002, SIAM MONOG DISCR MAT, P225; Desrosiers J., 1986, American Journal of Mathematical and Management Sciences, V6, P301; Diana M, 2004, TRANSPORT RES B-METH, V38, P539, DOI 10.1016/j.trb.2003.07.001; Diana M, 2006, TRANSPORT RES B-METH, V40, P651, DOI 10.1016/j.trb.2005.09.005; DUMAS Y, 1991, EUR J OPER RES, V54, P7, DOI 10.1016/0377-2217(91)90319-Q; Feuerstein E, 2001, THEOR COMPUT SCI, V268, P91, DOI 10.1016/S0304-3975(00)00261-9; Fleischmann B, 2004, TRANSPORT SCI, V38, P420, DOI 10.1287/trsc.1030.0074; Fu LP, 2002, TRANSPORT RES B-METH, V36, P485, DOI 10.1016/S0191-2615(01)00014-5; GLOVER F, 1986, COMPUT OPER RES, V13, P533, DOI 10.1016/0305-0548(86)90048-1; Ho SC, 2006, J HEURISTICS, V12, P55, DOI 10.1007/s10732-006-4192-1; IOACHIM I, 1995, TRANSPORT SCI, V29, P63, DOI 10.1287/trsc.29.1.63; JAW JJ, 1986, TRANSPORT RES B-METH, V20, P243, DOI 10.1016/0191-2615(86)90020-2; Karabuk S, 2009, TRANSPORT RES B-METH, V43, P448, DOI 10.1016/j.trb.2008.08.002; Kim T, 2011, TRANSPORT RES REC, P68, DOI 10.3141/2218-08; Kirchler D, 2013, TRANSPORT RES B-METH, V56, P120, DOI 10.1016/j.trb.2013.07.014; Lai DSW, 2016, TRANSPORT RES E-LOG, V86, P32, DOI 10.1016/j.tre.2015.12.001; Lois A., 2007, P 87 TRANSP RES BOAR, P1; Luo Y, 2011, TRANSPORT RES REC, P59, DOI 10.3141/2218-07; Ma XL, 2018, J CLEAN PROD, V170, P1052, DOI 10.1016/j.jclepro.2017.09.182; Ma XL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040818; Ma XL, 2013, TRANSPORT RES C-EMER, V36, P1, DOI 10.1016/j.trc.2013.07.010; Mahmoudi M, 2016, TRANSPORT RES B-METH, V89, P19, DOI 10.1016/j.trb.2016.03.009; MALANDRAKI C, 1992, TRANSPORT SCI, V26, P185, DOI 10.1287/trsc.26.3.185; Masmoudi MA, 2017, COMPUT OPER RES, V81, P1, DOI 10.1016/j.cor.2016.12.008; Masson R, 2014, COMPUT OPER RES, V41, P12, DOI 10.1016/j.cor.2013.07.020; Molenbruch Y., 2017, ANN OPER RES, P1; Nzouonta J, 2009, IEEE T VEH TECHNOL, V58, P3609, DOI 10.1109/TVT.2009.2014455; PSARAFTIS HN, 1980, TRANSPORT SCI, V14, P130, DOI 10.1287/trsc.14.2.130; PSARAFTIS HN, 1983, TRANSPORT SCI, V17, P351, DOI 10.1287/trsc.17.3.351; Rappoport H. K., 1994, Annals of Operations Research, V50, P505, DOI 10.1007/BF02085656; RAPPOPORT HK, 1992, INTERFACES, V22, P73, DOI 10.1287/inte.22.3.73; Ropke S, 2009, TRANSPORT SCI, V43, P267, DOI 10.1287/trsc.1090.0272; Savelsbergh M. W. P., 1985, Annals of Operations Research, V4, P285, DOI 10.1007/BF02022044; SOLOMON M, 1992, INTERFACES, V22, P88, DOI 10.1287/inte.22.3.88; Stiglic M, 2015, TRANSPORT RES B-METH, V82, P36, DOI 10.1016/j.trb.2015.07.025; Swersey A., 1983, MANAGE SCI, V30, P844; Tangphaisankun A., 2009, P E ASIA SOC TRANSPO, V7, P236; Toth P, 1997, TRANSPORT SCI, V31, P60, DOI 10.1287/trsc.31.1.60; Wong KI, 2014, TRANSPORTMETRICA A, V10, P55, DOI 10.1080/18128602.2012.694491; Zachariadis EE, 2015, TRANSPORT RES B-METH, V71, P158, DOI 10.1016/j.trb.2014.11.004; Zhao J, 2016, J ADV TRANSPORT, V50, P1090, DOI 10.1002/atr.1391; Ziliaskopoulos A., 2006, 85 ANN M TRANSP RES, P1	54	15	16	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0195927	10.1371/journal.pone.0195927	http://dx.doi.org/10.1371/journal.pone.0195927			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5RZ	29715302	gold, Green Submitted, Green Published			2022-12-26	WOS:000431281100007
J	Lee, U; Chang, S; Putra, GA; Kim, H; Kim, DH				Lee, Unseok; Chang, Sungyul; Putra, Gian Anantrio; Kim, Hyoungseok; Kim, Dong Hwan			An automated, high-throughput plant phenotyping system using machine learning based plant segmentation and image analysis	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GROWTH; RESPONSES	A high-throughput plant phenotyping system automatically observes and grows many plant samples. Many plant sample images are acquired by the system to determine the characteristics of the plants (populations). Stable image acquisition and processing is very important to accurately determine the characteristics. However, hardware for acquiring plant images rapidly and stably, while minimizing plant stress, is lacking. Moreover, most software cannot adequately handle large-scale plant imaging. To address these problems, we developed a new, automated, high-throughput plant phenotyping system using simple and robust hardware, and an automated plant-imaging-analysis pipeline consisting of machine-learning based plant segmentation. Our hardware acquires images reliably and quickly and minimizes plant stress. Furthermore, the images are processed automatically. In particular, large-scale plant-image datasets can be segmented precisely using a classifier developed using a superpixel-based machine-learning algorithm (Random Forest), and variations in plant parameters (such as area) over time can be assessed using the segmented images. We performed comparative evaluations to identify an appropriate learning algorithm for our proposed system, and tested three robust learning algorithms. We developed not only an automatic analysis pipeline but also a convenient means of plant-growth analysis that provides a learning data interface and visualization of plant growth trends. Thus, our system allows end-users such as plant biologists to analyze plant growth via large-scale plant image data easily.	[Lee, Unseok; Chang, Sungyul; Putra, Gian Anantrio; Kim, Hyoungseok] Korea Inst Sci & Technol, Convergence Res Ctr Smart Farm Solut, Kangnung, Gangwon Do, South Korea; [Kim, Dong Hwan] Korea Inst Sci & Technol, Ctr Intelligent & Interact Robot, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST)	Kim, DH (corresponding author), Korea Inst Sci & Technol, Ctr Intelligent & Interact Robot, Seoul, South Korea.	gregorykim@kist.re.kr		Putra, Gian Anantrio/0000-0002-4628-0904; Kim, Dong Hwan/0000-0002-4345-8308	National Research Council of Science & Technology (NST) grant by the Korea government (MSIP) [CRC-15-01-KIST]	National Research Council of Science & Technology (NST) grant by the Korea government (MSIP)(National Research Council of Science & Technology (NST), Republic of Korea)	This work was supported by National Research Council of Science & Technology (NST) grant by the Korea government (MSIP) (No. CRC-15-01-KIST), URL: http://www.nst.re.kr/nst_en/, authors who received the funding: H. Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Council of Science & Technology (NST) grant by the Korea government (MSIP) (No. CRC-15-01-KIST).	Abadi M., 2016, TENSORFLOW LARGE SCA; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; An DK, 2010, SENSOR LETT, V8, P56, DOI 10.1166/sl.2010.1201; An N, 2016, COMPUT ELECTRON AGR, V127, P376, DOI 10.1016/j.compag.2016.04.002; Arvidsson S, 2011, NEW PHYTOL, V191, P895, DOI 10.1111/j.1469-8137.2011.03756.x; Bai G, 2016, COMPUT ELECTRON AGR, V128, P181, DOI 10.1016/j.compag.2016.08.021; Barker J, 2016, COMPUT ELECTRON AGR, V122, P74, DOI 10.1016/j.compag.2016.01.017; Berger Bettina, 2012, Methods Mol Biol, V918, P9, DOI 10.1007/978-1-61779-995-2_2; Cai J., 2011, INT J INFORM ELECT E, V1, P79; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chen DJ, 2014, PLANT CELL, V26, P4636, DOI 10.1105/tpc.114.129601; Chene Y, 2012, COMPUT ELECTRON AGR, V82, P122, DOI 10.1016/j.compag.2011.12.007; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crimmins MA, 2008, ENVIRON MANAGE, V41, P949, DOI 10.1007/s00267-008-9086-6; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Gardner MW, 1998, ATMOS ENVIRON, V32, P2627, DOI 10.1016/S1352-2310(97)00447-0; Hartmann A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-148; Humplik JF, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0072-8; Ispiryan R, 2013, FUNCT PLANT BIOL, V40, P1065, DOI 10.1071/FP12323; Jiang Y, 2016, COMPUT ELECTRON AGR, V130, P57, DOI 10.1016/j.compag.2016.09.017; Leister D, 1999, PLANT PHYSIOL BIOCH, V37, P671, DOI 10.1016/S0981-9428(00)80097-2; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Madden S, 2012, IEEE INTERNET COMPUT, V16, P4, DOI 10.1109/MIC.2012.50; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Navarro PJ, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16050641; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Singh A, 2016, TRENDS PLANT SCI, V21, P110, DOI 10.1016/j.tplants.2015.10.015; Sonnentag O, 2012, AGR FOREST METEOROL, V152, P159, DOI 10.1016/j.agrformet.2011.09.009; Tian XL, 2015, J VIS COMMUN IMAGE R, V26, P146, DOI 10.1016/j.jvcir.2014.11.005; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Tisne S, 2013, PLANT J, V74, P534, DOI 10.1111/tpj.12131; Valliammal N., 2012, INT J COMPUT APPL, V44, P10, DOI DOI 10.5120/6322-8669; Woelker W, 1996, P SOC PHOTO-OPT INS, V2727, P1197, DOI 10.1117/12.233192; Yazdanbakhsh N, 2009, FUNCT PLANT BIOL, V36, P938, DOI 10.1071/FP09167	37	52	54	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196615	10.1371/journal.pone.0196615	http://dx.doi.org/10.1371/journal.pone.0196615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702690	Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300044
J	Portnoy, S; Maayan, C; Tsenter, J; Ofran, Y; Goldman, V; Hiller, N; Karniel, N; Schwartz, I				Portnoy, Sigal; Maayan, Channa; Tsenter, Jeanna; Ofran, Yonah; Goldman, Vladimir; Hiller, Nurit; Karniel, Naama; Schwartz, Isabella			Characteristics of ataxic gait in familial dysautonomia patients	PLOS ONE			English	Article							RELIABILITY; KNEE; PATTERNS; STRENGTH; SYMMETRY; LENGTH; SEMG	Introduction and objectives Progressive ataxic gait is a common symptom in individuals with Familial Dysautonomia (FD). At least 50% of adults with FD require assistance with walking. Our aims were to describe the medical condition of individuals with FD (ii) compare their gait characteristics to healthy individuals, and (iii) assess correlations between gait measures, presence of unstable gait pattern and frequency of falls. Methods Twelve subjects with FD (7 males, age 25.3 +/- 10.6 years) and 16 healthy participants (6 males, age 35.9 +/- 11.9 years) were recruited. Gait kinematics, gait symmetry, dynamic muscle activity, and foot deep vibration sensation were recorded. Results Ataxic gait degrees were: severe (6 out of 12), moderate (4 out of 12) and low (2 out of 12). The number of falls correlated with base width asymmetry. Crouch gait was noted in 3 out of 12 of the subjects. Conclusions In-depth quantitative gait analysis of individuals with FD revealed ataxic gait. The ataxic pattern might be a result of combined neurological deficiencies and osseous deformities. Increasing the base of support of patients with FD might increase the symmetry of the base width during gait and decrease the number of falls. Additionally, perturbation treatment and dynamic balance exercises may be recommended in order to improve compensatory strategies. Future investigation of this population should include quantification of osseous rotations of the lower limb in order to fully understand its effect on their gait pattern and falls.	[Portnoy, Sigal; Tsenter, Jeanna; Ofran, Yonah; Karniel, Naama; Schwartz, Isabella] Hebrew Univ Jerusalem, Hadassah Med Sch, Hadassah Med Ctr, Dept Phys Med & Rehabil, Jerusalem, Israel; [Portnoy, Sigal] Tel Aviv Univ, Sackler Fac Med, Dept Occupat Therapy, Tel Aviv, Israel; [Maayan, Channa] Hebrew Univ Jerusalem, Hadassah Med Sch, Hadassah Med Ctr, Familial Dysauton Ctr,Pediat Dept, Jerusalem, Israel; [Goldman, Vladimir] Hebrew Univ Jerusalem, Hadassah Med Sch, Hadassah Med Ctr, Dept Orthoped Surg, Jerusalem, Israel; [Hiller, Nurit] Hebrew Univ Jerusalem, Hadassah Med Sch, Hadassah Med Ctr, Dept Radiol, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Portnoy, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Hadassah Med Ctr, Dept Phys Med & Rehabil, Jerusalem, Israel.; Portnoy, S (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Occupat Therapy, Tel Aviv, Israel.	portnoys@post.tau.ac.il		Karniel, Naama/0000-0003-1214-2930				Amin S, 2014, J BONE MINER RES, V29, P581, DOI 10.1002/jbmr.2072; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2010, J NEUROL, V257, P198, DOI 10.1007/s00415-009-5293-1; Bader J, 2011, VALIDATION DYNAMIC C; Bar-On E, 2000, J BONE JOINT SURG AM, V82A, P1563, DOI 10.2106/00004623-200011000-00008; Black Laura, 2016, Pediatr Neurol Briefs, V30, P42; Blazkiewicz M, 2014, ACTA BIOENG BIOMECH, V16, P29, DOI 10.5277/abb140104; BLOOM S, 1984, BRIT MED J, V288, P1793, DOI 10.1136/bmj.288.6433.1793; Bongers KTJ, 2015, AGE AGEING, V44, P294, DOI 10.1093/ageing/afu151; Carriero A, 2009, J PEDIATR ORTHOPED, V29, P73, DOI 10.1097/BPO.0b013e31819224d; Dietrich P, 2016, GENET MOL BIOL, V39, P497, DOI [10.1590/1678-4685-GMB-2015-0335, 10.1590/1678-4685-gmb-2015-0335]; Frigo C, 2009, CLIN BIOMECH, V24, P236, DOI 10.1016/j.clinbiomech.2008.07.012; Gage Jr, 2004, CLIN DEV MED, P382; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hicks JL, 2008, J BIOMECH, V41, P960, DOI 10.1016/j.jbiomech.2008.01.002; Hilz MJ, 2000, CLIN AUTON RES, V10, P177, DOI 10.1007/BF02291353; Ilg W, 2013, MOVEMENT DISORD, V28, P1566, DOI 10.1002/mds.25558; Kaufman K, 2016, GAIT POSTURE, V49, P375, DOI 10.1016/j.gaitpost.2016.07.075; Kedem P, 2016, CURR OPIN PEDIATR, V28, P55, DOI 10.1097/MOP.0000000000000316; Kim CM, 2003, GAIT POSTURE, V18, P23, DOI 10.1016/S0966-6362(02)00122-4; Lee KM, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-56; Maayan C, 2002, OSTEOPOROSIS INT, V13, P429, DOI 10.1007/s001980200050; MAAYAN C, 1987, CLIN GENET, V32, P106; Macefield VG, 2013, MOVEMENT DISORD, V28, P823, DOI 10.1002/mds.25482; Macefield VG, 2011, BRAIN, V134, P3198, DOI 10.1093/brain/awr168; Marsh AP, 2011, J GERONTOL A-BIOL, V66, P1376, DOI 10.1093/gerona/glr158; Martorell R, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035320500495563; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Meldrum D, 2014, GAIT POSTURE, V39, P265, DOI 10.1016/j.gaitpost.2013.07.130; MURRAY MP, 1978, AM J PHYS MED REHAB, V57, P278; Norcliffe-Kaufmann L, 2016, PROG NEUROBIOL; Opheim A, 2013, GAIT POSTURE, V37, P165, DOI 10.1016/j.gaitpost.2012.06.032; Palma JA, 2014, EXPERT OPIN PHARMACO, V15, P2653, DOI 10.1517/14656566.2014.970530; Pau M, 2015, J NEUROL SCI, V358, P339, DOI 10.1016/j.jns.2015.09.352; Portnoy S., 2013, Annals of Physical and Rehabilitation Medicine, V56, P527, DOI 10.1016/j.rehab.2013.06.005; Portnoy S, 2015, PM&R, V7, P1042, DOI 10.1016/j.pmrj.2015.04.007; Rota V, 2011, INT J REHABIL RES, V34, P265, DOI 10.1097/MRR.0b013e328347be02; Rozumalski A, 2009, GAIT POSTURE, V30, P155, DOI 10.1016/j.gaitpost.2009.05.010; Schniepp R, 2014, J NEUROL, V261, P213, DOI 10.1007/s00415-013-7189-3; Shohat M, 2014, GENE REV FAMILIAL DY; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Steele KM, 2012, J PEDIATR REHAB MED, V5, P99, DOI 10.3233/PRM-2012-0201; Stief F, 2013, J APPL BIOMECH, V29, P105, DOI 10.1123/jab.29.1.105; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Suzuki K, 1999, AM J PHYS MED REHAB, V78, P147, DOI 10.1097/00002060-199903000-00012; Temlett JA, 2009, J CLIN NEUROSCI, V16, P1435, DOI 10.1016/j.jocn.2009.03.010; TOKITA N, 1978, ANN OTO RHINOL LARYN, V87, P1	47	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196599	10.1371/journal.pone.0196599	http://dx.doi.org/10.1371/journal.pone.0196599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698477	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600106
J	Alderman, H; Headey, D				Alderman, Harold; Headey, Derek			The timing of growth faltering has important implications for observational analyses of the underlying determinants of nutrition outcomes	PLOS ONE			English	Article							CHILD GROWTH; HEALTH; SANITATION; COUNTRIES; EDUCATION; PROGRAMS; DRIVERS	Background Growth faltering largely occurs in the first 23 months after birth and is thought to be largely determined by various harmful or protective socioeconomic conditions. Children 23 months or younger, however, have only been partially exposed to these conditions, implying that statistical associations between these conditions and child growth may be substantially smaller in samples that include younger children. Objectives To test the prediction that associations between child anthropometric outcomes and various socioeconomic conditions are systematically different for older and younger children. Methods We analyzed data for 699,421 children aged 0-59 months, drawn from 125 DHS implemented between 1992 and 2014 in 57 countries. The outcome variables were height-forage Z scores (HAZ) and stunting (HAZ<-2), and weight-for-height z scores (WHZ) and wasting (WHZ<-2). Independent variables included household wealth, parental education, maternal height, demographic factors, and exposure to WASH and health services. We used age-disaggregated regressions to examine how the associations between dependent and independent variables vary across different child age ranges. Results Non-parametric regression results reaffirmed that most linear growth faltering and wasting takes place prior to 23 months of age. Estimates of the magnitude of association with wealth, education and improved toilet use from HAZ regressions are systematically larger in the sample of children 24-59 months than in the 0-23 month or 0-59 month samples; the reverse is true for WHZ regressions. Conclusions Previous observational analyses appear to substantially underestimate the protective impacts of a wide range of underlying determinants on stunting. Conversely, wasting rates are typically low for children 24-59 months, implying that associations between underlying conditions and wasting may be stronger for children 0-23 months of age. Such analyses should pay closer attention to age disaggregation; researchers should be aware of the age effect reported in the current study and present analysis stratified by age.	[Alderman, Harold; Headey, Derek] Int Food Policy Res Inst, Washington, DC 20036 USA	CGIAR; International Food Policy Research Institute (IFPRI)	Alderman, H (corresponding author), Int Food Policy Res Inst, Washington, DC 20036 USA.	H.alderman@cgiar.org		Alderman, Harold/0000-0001-8019-6397	Bill and Malinda Gates Foundation [OPP1112307]	Bill and Malinda Gates Foundation	Funded by Bill and Malinda Gates Foundation Grant Agreement Investment ID OPP1112307.	Alderman H, 2017, WORLD DEV, V94, P448, DOI 10.1016/j.worlddev.2017.02.007; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Corsi DJ, 2012, INT J EPIDEMIOLOGY; Dearden KA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4033-1; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Fabic MS, 2012, B WORLD HEALTH ORGAN, V90, P604, DOI 10.2471/BLT.11.095513; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Haddad L, 2003, WORLD BANK ECON REV, V17, P107, DOI 10.1093/wber/lhg012; Headey D.D., 2017, 1695 IFPRI; Headey D, 2016, MATERN CHILD NUTR, V12, P210, DOI 10.1111/mcn.12274; Headey D, 2016, LANCET GLOB HEALTH, V4, pE159, DOI 10.1016/S2214-109X(15)00295-8; Headey D, 2015, WORLD DEV, V66, P749, DOI 10.1016/j.worlddev.2014.09.022; Headey DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145738; Headey DD, 2013, WORLD DEV, V42, P76, DOI 10.1016/j.worlddev.2012.07.002; Jensen R, 2012, CESIFO ECON STUD, V58, P322, DOI 10.1093/cesifo/ifs014; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Larsen AF, 2017, 1617 IFPRI; Leroy JL, 2014, J NUTR, V144, P1460, DOI 10.3945/jn.114.191981; Linnemayr S, 2011, J DEV ECON, V96, P106, DOI 10.1016/j.jdeveco.2010.06.002; Menon P, 2013, FOOD NUTR BULL, V34, pS195, DOI 10.1177/15648265130343S206; Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8; Richard SA, 2012, J NUTR, V142, P1291, DOI 10.3945/jn.111.154922; Rieger M, 2016, DEMOGRAPHY, V53, P241, DOI 10.1007/s13524-015-0449-3; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, P26; Schott WB, 2013, SOC SCI MED, V97, P278, DOI 10.1016/j.socscimed.2013.05.016; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Spears D., 2013, WORLD BANK POLICY RE; Spears D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073784; Tumilowicz A, 2015, AM J CLIN NUTR, V102, P1249, DOI 10.3945/ajcn.114.100776; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Vollmer S, 2017, INT J EPIDEMIOL, V46, P312, DOI 10.1093/ije/dyw133; Vollmer S, 2014, LANCET GLOB HEALTH, V2, pE225, DOI 10.1016/S2214-109X(14)70025-7; Zanello G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162668	35	57	57	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195904	10.1371/journal.pone.0195904	http://dx.doi.org/10.1371/journal.pone.0195904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	29694431	Green Published, Green Submitted, gold			2022-12-26	WOS:000430802400049
J	Maier, IL; Becker, JC; Leyhe, JR; Schnieder, M; Behme, D; Psychogios, MN; Liman, J				Maier, Ilko L.; Becker, Johannes C.; Leyhe, Johanna Rosemarie; Schnieder, Marlene; Behme, Daniel; Psychogios, Marios-Nikos; Liman, Jan			Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; ISCHEMIC-STROKE; POSTSTROKE INFECTION; PNEUMONIA; ACTIVATION; DIAGNOSIS; LATERALIZATION; COMPLICATIONS; PREDICTORS; DYSPHAGIA	Background Stroke-induced immunodepression is a well characterized complication of acute ischemic stroke. In experimental studies beta-blocker therapy reversed stroke-induced immunodepression, reduced infection rates and mortality. Recent, heterogeneous studies in stroke patients could not provide evidence of a protective effect of beta-blocker therapy. Aim of this study is to investigate the potential preventive effect of beta-blockers in subgroups of patients at high risk for stroke-induced immunodepression. Methods Data from a prospectively derived registry of major stroke patients receiving endovascular therapy between 2011 +/- 2017 in a tertiary stroke center (University Medical Center Go E ttingen. Germany) was used. The effect of beta-blocker therapy on pneumonia, urinary tract infection, sepsis and mortality was assessed using multivariate logistic regression analysis. Results Three hundred six patients with a mean age of 72 +/- 13 years and a median NIHSS of 16 (IQR 10.75 +/- 20) were included. 158 patients (51.6%) had pre-stroke-and continued betablocker therapy. Beta-blocker therapy did not reduce the incidence of pneumonia (OR 0.78, 95% CI 0.31 +/- 1.92, p = 0.584), urinary tract infections (OR 1.51, 0.88 +/- 2.60, p = 0.135), sepsis (OR 0.57, 0.18 +/- 1.80, p = 0.334) or mortality (OR 0.59, 0.16 +/- 2.17, p = 0.429). Strokes involving the insula and anterio-medial cortex increased the risk for pneumonia (OR 4.55, 2.41 +/- 8.56, p< 0.001) and sepsis (OR 4.13, 1.81 +/- 9.43, p = 0.001), while right hemispheric strokes increased the risk for pneumonia (OR 1.60, 0.92 +/- 2.77, p = 0.096). There was a nonsignificantly increased risk for urinary tract infections in patients with beta-blocker therapy and insula/anterio-medial cortex strokes (OR 3.12, 95% CI 0.88 +/- 11.05, p = 0.077) with no effect of beta-blocker therapy on pneumonia, sepsis or mortality in both subgroups. Conclusions In major ischemic stroke patients, beta- blocker therapy did not lower post-stroke infection rates and was associated with urinary tract infections in a subgroup with insula/anteriomedial strokes.	[Maier, Ilko L.; Schnieder, Marlene; Liman, Jan] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Becker, Johannes C.] St Bernward Hosp Hildesheim, Dept Neurol, Hildesheim, Germany; [Leyhe, Johanna Rosemarie; Behme, Daniel; Psychogios, Marios-Nikos] Univ Med Ctr Gottingen, Dept Neuroradiol, Gottingen, Germany	University of Gottingen; University of Gottingen	Maier, IL (corresponding author), Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany.	ilko.maier@med.uni-goettingen.de	Behme, Daniel/H-4551-2019		Gottinger Kolleg fur Translationale Medizin; Niedersachsisches Ministerium fur Wissenschaft and Kultur [11-76251-99-52/14]	Gottinger Kolleg fur Translationale Medizin; Niedersachsisches Ministerium fur Wissenschaft and Kultur	This study was supported with a grant provided by the "Gottinger Kolleg fur Translationale Medizin" and the "Niedersachsisches Ministerium fur Wissenschaft and Kultur" to ILM (grant number 11-76251-99-52/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bae HJ, 2005, STROKE, V36, P2441, DOI 10.1161/01.STR.0000185721.73445.fd; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Brogan E, 2014, DYSPHAGIA, V29, P340, DOI 10.1007/s00455-013-9514-5; Choe HS, 2017, INT J UROL, DOI [10.1001/jama.2016.0287, DOI 10.1001/JAMA.2016.0287]; Dalhoff K, 2013, DTSCH ARZTEBL INT, V110, P634, DOI 10.3238/arztebl.2013.0634; De Raedt S, 2012, EUR J NEUROL, V19, P234, DOI 10.1111/j.1468-1331.2011.03475.x; Dziedzic T, 2007, J NEUROL SCI, V252, P53, DOI 10.1016/j.jns.2006.10.007; Harms H, 2011, CEREBROVASC DIS, V32, P552, DOI 10.1159/000331922; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hug A, 2011, STROKE, V42, P3580, DOI 10.1161/STROKEAHA.111.620948; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Kohm AP, 2001, PHARMACOL REV, V53, P487; Lv H, 2016, OSTEOPOROSIS INT, V27, P3001, DOI 10.1007/s00198-016-3624-5; Maier IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116836; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Meyer S, 2004, NEUROREPORT, V15, P357, DOI 10.1097/00001756-200402090-00029; Phelan C, 2015, J STROKE CEREBROVASC, V24, P1998, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.035; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; SANDER D, 1995, J NEUROL, V242, P313, DOI 10.1007/BF00878874; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smith CJ, 2015, STROKE, V46, P2335, DOI 10.1161/STROKEAHA.115.009617; Starr JB, 2017, STROKE, V48, P2693, DOI 10.1161/STROKEAHA.117.017230; Starr JB, 2017, NEUROL SCI, V38, P967, DOI 10.1007/s10072-017-2877-x; Sykora M, 2015, STROKE, V46, P1269, DOI 10.1161/STROKEAHA.114.008260; Vogelgesang A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008718; Walter U, 2013, EUR J NEUROL, V20, P153, DOI 10.1111/j.1468-1331.2012.03818.x; Westendorp WF, 2016, CEREBROVASC DIS, V42, P506, DOI 10.1159/000450926; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	30	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196174	10.1371/journal.pone.0196174	http://dx.doi.org/10.1371/journal.pone.0196174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694433	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400070
J	Morillas-de-Laguno, P; Vargas-Hitos, JA; Rosales-Castillo, A; Siez-Uran, LM; Montalban-Mendez, C; Gavilan-Carrera, B; Navarro-Mateos, C; Acosta-Manzano, P; Delgado-Fernandez, M; Sabio, JM; Ortego-Centeno, N; Callejas-Rubio, JL; Soriano-Maldonado, A				Morillas-de-Laguno, Pablo; Vargas-Hitos, Jose A.; Rosales-Castillo, Antonio; Manuel Siez-Uran, Luis; Montalban-Mendez, Cristina; Gavilan-Carrera, Blanca; Navarro-Mateos, Carmen; Acosta-Manzano, Pedro; Delgado-Fernandez, Manuel; Sabio, Jose M.; Ortego-Centeno, Norberto; Callejas-Rubio, Jose L.; Soriano-Maldonado, Alberto			Association of objectively measured physical activity and sedentary time with arterial stiffness in women with systemic lupus erythematosus with mild disease activity	PLOS ONE			English	Article							PRESSURE MEASURING DEVICES; HYPERTENSION-SOCIETY PROTOCOL; PULSE-WAVE VELOCITY; BLOOD-PRESSURE; SUBCLINICAL ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; ALL-CAUSE; ADULTS; VALIDATION; MORTALITY	Objectives To examine the association of objectively measured physical activity (PA) intensity levels and sedentary time with arterial stiffness in women with systemic lupus erythematosus (SLE) with mild disease activity and to analyze whether participants meeting the international PA guidelines have lower arterial stiffness than those not meeting the PA guidelines. Methods The study comprised 47 women with SLE (average age 41.2 [standard deviation 13.9]) years, with clinical and treatment stability during the 6 months prior to the study. PA intensity levels and sedentary time were objectively measured with triaxial accelerometry. Arterial stiffness was assessed through pulse wave velocity, evaluated by Mobil-O-Graph (R) 24h pulse wave analysis monitor. Results The average time in moderate to vigorous PA in bouts of >= 10 consecutive minutes was 135.1 +/- 151.8 minutes per week. There was no association of PA intensity levels and sedentary time with arterial stiffness, either in crude analyses or after adjusting for potential confounders. Participants who met the international PA guidelines did not show lower pulse wave velocity than those not meeting them (b = -0.169; 95% CI: -0.480 to 0.143; P = 0.280). Conclusions Our results suggest that PA intensity levels and sedentary time are not associated with arterial stiffness in patients with SLE. Further analyses revealed that patients with SLE meeting international PA guidelines did not present lower arterial stiffness than those not meeting the PA guidelines. Future prospective research is needed to better understand the association of PA and sedentary time with arterial stiffness in patients with SLE.	[Morillas-de-Laguno, Pablo; Gavilan-Carrera, Blanca; Navarro-Mateos, Carmen; Acosta-Manzano, Pedro; Delgado-Fernandez, Manuel] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Vargas-Hitos, Jose A.; Sabio, Jose M.] Virgen de las Nieves Univ Hosp, Dept Internal Med, System Autoimmune Dis Unit, Granada, Spain; [Rosales-Castillo, Antonio; Manuel Siez-Uran, Luis; Montalban-Mendez, Cristina] Virgen de las Nieves Univ Hosp, Dept Internal Med, Fellows System Autoimmune Dis Unit, Granada, Spain; [Ortego-Centeno, Norberto; Callejas-Rubio, Jose L.] San Cecilio Univ Hosp, Dept Internal Med, System Autoimmune Dis Unit, Granada, Spain; [Soriano-Maldonado, Alberto] Univ Almeria, Fac Educ Sci, Dept Educ, Almeria, Spain; [Soriano-Maldonado, Alberto] Univ Almeria, CERNEP Res Ctr, SPORT Res Grp CTS 1024, Almeria, Spain	University of Granada; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; Hospital Universitario San Cecilio; Universidad de Almeria; Universidad de Almeria	Morillas-de-Laguno, P (corresponding author), Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain.	pmorillasdelaguno@correo.ugr.es	Soriano-Maldonado, Alberto/I-6379-2015; Rosales, Antonio/AAV-4775-2021; Gavilán-Carrera, Blanca/AAB-5424-2021; Manzano, Pedro Acosta/AAN-5114-2020; Delgado-Fernández, Manuel/N-2990-2013; Vargas-Hitos, José Antonio/ABG-4532-2020; Ortego-Centeno, Norberto/C-4793-2019	Soriano-Maldonado, Alberto/0000-0002-4626-420X; Rosales, Antonio/0000-0001-9637-2025; Delgado-Fernández, Manuel/0000-0003-0636-9258; Vargas-Hitos, José Antonio/0000-0002-0596-8710; callejas, jose luis/0000-0002-1653-0087; Navarro-Mateos, Carmen/0000-0002-0757-7975; Ortego-Centeno, Norberto/0000-0003-2325-0937; Gavilan Carrera, Blanca/0000-0002-9223-7181; Morillas de Laguno, Pablo/0000-0002-7838-3625	Fundacion para la Investigacion Biosanitaria de Andalucia Oriental [PI-0525-2016]	Fundacion para la Investigacion Biosanitaria de Andalucia Oriental	This work was supported by Fundacion para la Investigacion Biosanitaria de Andalucia Oriental, Grant numbers: PI-0525-2016 (http://www.fibao.es/; http://www.ibsgranada.es/) to JAVH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Farias N, 2014, J SCI MED SPORT, V17, P293, DOI 10.1016/j.jsams.2013.07.002; Ahn GE, 2015, ARTHRIT CARE RES, V67, P701, DOI 10.1002/acr.22480; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; Bjarnegard N, 2006, LUPUS, V15, P644, DOI 10.1177/0961203306071402; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Choi L, 2012, MED SCI SPORT EXER, V44, P2009, DOI 10.1249/MSS.0b013e318258cb36; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dassouki T, 2016, LUPUS, V26, P1; Eriksson K, 2012, SCAND J RHEUMATOL, V41, P290, DOI 10.3109/03009742.2011.624117; Garcia-Hermoso A, 2015, ATHEROSCLEROSIS, V243, P516, DOI 10.1016/j.atherosclerosis.2015.10.004; Gladman DD, 2003, J RHEUMATOL, V30, P1955; Glazer NL, 2013, MED SCI SPORT EXER, V45, P109, DOI 10.1249/MSS.0b013e31826beae5; Griffiths B, 2005, BEST PRACT RES CL RH, V19, P685, DOI 10.1016/j.berh.2005.03.010; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kerekes G, 2012, NAT REV RHEUMATOL, V8, P224, DOI 10.1038/nrrheum.2012.16; Kim Y, 2013, INT J EPIDEMIOL, V42, P1040, DOI 10.1093/ije/dyt108; Kruse NT, 2017, SPORT MED, P1; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Luzardo L, 2012, HYPERTENS RES, V35, P980, DOI 10.1038/hr.2012.78; Mahieu MA, 2016, LUPUS, V25, P1; Sabio JM, 2009, J RHEUMATOL, V36, P2204, DOI 10.3899/jrheum.081253; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Migueles J. H., 2017, SPORTS MED; Montalban-Mendez C, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12885; Nieves CEF, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0571-2; Nikpour M, 2005, RHEUM DIS CLIN N AM, V31, P329, DOI 10.1016/j.rdc.2005.01.001; O'Brien E, 2002, BLOOD PRESS MONIT, V7, P3, DOI 10.1097/00126097-200202000-00002; OBRIEN E, 1993, J HYPERTENS, V11, P677, DOI 10.1097/00004872-199306000-00013; OBRIEN E, 1990, J HYPERTENS, V8, P607, DOI 10.1097/00004872-199007000-00004; Parsons TJ, 2016, PREV MED, V89, P194, DOI 10.1016/j.ypmed.2016.05.031; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Sacre K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094511; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Volkmann ER, 2010, ARTHRIT CARE RES, V62, P258, DOI 10.1002/acr.20076; Weber T, 2011, HYPERTENSION, V58, P825, DOI 10.1161/HYPERTENSIONAHA.111.176313; Weiss W, 2012, BLOOD PRESS MONIT, V17, P128, DOI 10.1097/MBP.0b013e328353ff63; Weiss W, 2010, BLOOD PRESS MONIT, V15, P225, DOI 10.1097/MBP.0b013e328338892f; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Wu GC, 2016, AUTOIMMUN REV, V15, P22, DOI 10.1016/j.autrev.2015.10.002	41	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196111	10.1371/journal.pone.0196111	http://dx.doi.org/10.1371/journal.pone.0196111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694382	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400064
J	Tuzov, N				Tuzov, Nik			A framework for the estimation of the proportion of true discoveries in single nucleotide variant detection studies for human data	PLOS ONE			English	Article							SEQUENCING DATA; QUALITY-CONTROL	Any single nucleotide variant detection study could benefit from a fast and cheap method of measuring the quality of variant call list. It is advantageous to be able to see how the call list quality is affected by different variant filtering thresholds and other adjustments to the study parameters. Here we look into a possibility of estimating the proportion of true positives in a single nucleotide variant call list for human data. Using whole-exome and whole-genome gold standard data sets for training, we focus on building a generic model that only relies on information available from any variant caller. We assess and compare the performance of different candidate models based on their practical accuracy. We find that the generic model delivers decent accuracy most of the time. Further, we conclude that its performance could be improved substantially by leveraging the variant quality metrics that are specific to each variant calling tool.	[Tuzov, Nik] Partek Inc, St Louis, MO 63005 USA		Tuzov, N (corresponding author), Partek Inc, St Louis, MO 63005 USA.	ntuzav@partek.com		Tuzov, Nik/0000-0002-2015-7537	Partek Incorporated	Partek Incorporated	Nik Tuzov is a full-time employee of Partek Incorporated, which funded his work on the manuscript and allowed him to use Partek's commercial software ("Partek Flow" and "Partek Genomics Suite"). The funder provided support in the form of salary for author Nik Tuzov, but did not have any additional role in the study design, data collection and analysis, and preparation of the manuscript. However, the author assumed he could not go through with his decision to publish without first presenting the results to his superiors at Partek Inc and obtain their approval to publish the findings. The specific roles of the author are articulated in the "Author contributions" section.	Anderson D. R., 2013, MODEL SELECTION MULT; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Cleary J. G., 2015, BIOINFORMATICS, DOI [10.1101/023754, DOI 10.1101/023754]; Cornish A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/456479; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Goldfeder RL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0269-0; Guo Y, 2014, GENOMICS, V103, P323, DOI 10.1016/j.ygeno.2014.03.006; Hasmats J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084785; Highnam G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7275; Koire A, 2016, BIOCOMPUT-PAC SYM, P207; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Liu XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075619; Meynert AM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-195; Pirooznia M, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-14; PREGIBON D, 1981, ANN STAT, V9, P705, DOI 10.1214/aos/1176345513; Tuzov N, 2017, FRAMEWORK ESTIMATION, DOI [10.6084/m9.figshare.5326876.v1, DOI 10.6084/M9.FIGSHARE.5326876.V1]; Wang J, 2015, BIOINFORMATICS, V31, P318, DOI 10.1093/bioinformatics/btu668; Yi M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku392; Zhu QQ, 2015, CANCER EPIDEM BIOMAR, V24, P1207, DOI 10.1158/1055-9965.EPI-15-0205; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	21	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196058	10.1371/journal.pone.0196058	http://dx.doi.org/10.1371/journal.pone.0196058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694377	Green Published, Green Submitted, gold			2022-12-26	WOS:000430802400058
J	Wang, WL; Teng, F; Lin, YH; Ji, DH; Xu, Y; Chen, CS; Xie, CT				Wang, Wenlei; Teng, Fei; Lin, Yinghui; Ji, Dehua; Xu, Yan; Chen, Changsheng; Xie, Chaotian			Transcriptomic study to understand thermal adaptation in a high temperature-tolerant strain of Pyropia haitanensis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; II ELECTRON-TRANSPORT; STRESS TOLERANCE; PLANT-RESPONSES; MOLECULAR CHAPERONES; GENE-EXPRESSION; HSP90; THERMOTOLERANCE; PHOTOSYNTHESIS; ACCLIMATION	Pyropia haitanensis, a high-yield commercial seaweed in China, is currently undergoing increasing levels of high-temperature stress due to gradual global warming. The mechanisms of plant responses to high temperature stress vary with not only plant type but also the degree and duration of high temperature. To understand the mechanism underlying thermal tolerance in P. haitanensis, gene expression and regulation in response to short- and long-term temperature stresses (SHS and LHS) was investigated by performing genome-wide high-throughput transcriptomic sequencing for a high temperature tolerant strain (HTT). A total of 14,164 differential expression genes were identified to be high temperature- responsive in at least one time point by high-temperature treatment, representing 41.10% of the total number of unigenes. The present data indicated a decrease in the photosynthetic and energy metabolic rates in HTT to reduce unnecessary energy consumption, which in turn facilitated in the rapid establishment of acclimatory homeostasis in its transcriptome during SHS. On the other hand, an increase in energy consumption and antioxidant substance activity was observed with LHS, which apparently facilitates in the development of resistance against severe oxidative stress. Meanwhile, ubiquitin-mediated proteolysis, brassinosteroids, and heat shock proteins also play a vital role in HTT. The effects of SHS and LHS on the mechanism of HTT to resist heat stress were relatively different. The findings may facilitate further studies on gene discovery and the molecular mechanisms underlying high-temperature tolerance in P. haitanensis, as well as allow improvement of breeding schemes for high temperature-tolerant macroalgae that can resist global warming.	[Wang, Wenlei; Teng, Fei; Lin, Yinghui; Ji, Dehua; Xu, Yan; Chen, Changsheng; Xie, Chaotian] Jimei Univ, Fisheries Coll, Xiamen, Peoples R China; [Wang, Wenlei; Teng, Fei; Lin, Yinghui; Ji, Dehua; Xu, Yan; Chen, Changsheng; Xie, Chaotian] Minist Agr, Key Lab Hlth Mariculture East China Sea, Xiamen, Peoples R China	Jimei University; Ministry of Agriculture & Rural Affairs	Xie, CT (corresponding author), Jimei Univ, Fisheries Coll, Xiamen, Peoples R China.; Xie, CT (corresponding author), Minist Agr, Key Lab Hlth Mariculture East China Sea, Xiamen, Peoples R China.	ctxie@jmu.edu.cn		Xie, Chaotian/0000-0001-7735-1640	China Agriculture Research System [CARS-50]; National Natural Science Foundation of China [41276177]; Natural Science Foundation of Fujian, China [2014J07006, 2014J05041]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian, China(Natural Science Foundation of Fujian Province)	This work was supported by China Agriculture Research System (CARS-50) to CX, the National Natural Science Foundation of China (Grant No: 41276177) to CX and the Natural Science Foundation of Fujian, China (Grant Nos. 2014J07006 to CX and 2014J05041 to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; [陈昌生 CHEN Changsheng], 2008, [海洋学报, Acta Oceanologica Sinica], V30, P100; Choi S, 2013, J APPL PHYCOL, V25, P1237, DOI 10.1007/s10811-012-9921-2; Cooper KF, 1999, MOL CELL BIOL, V19, P3338; Cramer GR, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-163; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; Dutta S, 2009, PLANT PHYSIOL, V150, P1050, DOI 10.1104/pp.109.137265; FAO, 2010, STAT WORLD FISH AQ; Fernandes J, 2008, PLANT BIOTECHNOL J, V6, P782, DOI 10.1111/j.1467-7652.2008.00360.x; Fishery Bureau Ministry of Agriculture, 2021, CHINA FISHERY STAT Y, P22; Fragkostefanakis S, 2015, PLANT CELL ENVIRON, V38, P693, DOI 10.1111/pce.12426; Gao S, 2013, PHOTOSYNTH RES, V116, P45, DOI 10.1007/s11120-013-9892-4; Haldimann P, 2005, PLANT CELL ENVIRON, V28, P302, DOI 10.1111/j.1365-3040.2005.01289.x; Hardtke CS, 2007, TRENDS CELL BIOL, V17, P485, DOI 10.1016/j.tcb.2007.08.003; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HAVAUX M, 1993, PLANT CELL ENVIRON, V16, P461, DOI 10.1111/j.1365-3040.1993.tb00893.x; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Hu T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1147; Huang BR, 2008, J INTEGR PLANT BIOL, V50, P1230, DOI 10.1111/j.1744-7909.2008.00735.x; Ji DH, 2015, J APPL PHYCOL, V27, P499, DOI 10.1007/s10811-014-0314-6; Jin SH, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv009; Kassahn KS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-358; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Lee JH, 2011, MOL CELLS, V31, P201, DOI 10.1007/s10059-011-0031-9; Li B, 2014, ACTA OCEANOL SIN, V33, P152, DOI 10.1007/s13131-014-0526-2; Lin WH, 2004, CELL RES, V14, P34, DOI 10.1038/sj.cr.7290200; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu FL, 2014, J APPL PHYCOL, V26, P1585, DOI 10.1007/s10811-013-0188-z; Lu XP, 2016, PHYSIOL PLANTARUM, V156, P397, DOI 10.1111/ppl.12383; Luo QJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094354; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Mathur S, 2014, J PHOTOCH PHOTOBIO B, V137, P116, DOI 10.1016/j.jphotobiol.2014.01.010; Mishkind M, 2009, PLANT J, V60, P10, DOI 10.1111/j.1365-313X.2009.03933.x; Mohanty S, 2006, PLANTA, V224, P692, DOI 10.1007/s00425-006-0248-6; Munnik T, 1998, BBA-LIPID LIPID MET, V1389, P222, DOI 10.1016/S0005-2760(97)00158-6; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Pachauri RK, 2014, SYNTHESIS REPORT, P151; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Qin J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-409; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Sairam RK, 2000, BIOL PLANTARUM, V43, P245, DOI 10.1023/A:1002756311146; Sgobba A, 2015, PHYSIOL PLANTARUM, V153, P68, DOI 10.1111/ppl.12220; Sun PP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1586-1; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Tewari AK, 1998, PLANT PHYSIOL, V117, P851, DOI 10.1104/pp.117.3.851; Thussagunpanit J, 2015, J PLANT GROWTH REGUL, V34, P320, DOI 10.1007/s00344-014-9467-4; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2226-5; Wang RH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10269; Wang WL, 2018, ALGAL RES, V29, P104, DOI 10.1016/j.algal.2017.11.026; Wang WL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17099; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Wu X, 2013, ACTA PHYSIOL PLANT, V36, P251; Xie CT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-107; Xu K, 2016, ALGAL RES, V19, P198, DOI 10.1016/j.algal.2016.08.010; Xu Y, 2014, J APPL PHYCOL, V26, P607, DOI 10.1007/s10811-013-0066-8; Yamasaki T, 2002, PLANT PHYSIOL, V128, P1087, DOI 10.1104/pp.010919; Yan J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19473; Yan XH, 2010, J APPL PHYCOL, V22, P511, DOI 10.1007/s10811-009-9486-x; Yang R, 2013, BOT MAR, V56, P249, DOI 10.1515/bot-2012-0178; Yeh CH, 2012, PLANT SCI, V195, P10, DOI 10.1016/j.plantsci.2012.06.004; Yin H, 2008, PLANT GROWTH REGUL, V54, P45, DOI 10.1007/s10725-007-9227-6; YORDANOV I, 1986, PHOTOBIOCH PHOTOBIOP, V12, P147; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang XW, 2013, GENE, V530, P185, DOI 10.1016/j.gene.2013.08.048; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049652	76	41	45	9	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195842	10.1371/journal.pone.0195842	http://dx.doi.org/10.1371/journal.pone.0195842			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694388	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400046
J	Mang, CS; Whitten, TA; Cosh, MS; Scott, SH; Wiley, JP; Debert, CT; Dukelow, SP; Benson, BW				Mang, Cameron S.; Whitten, Tara A.; Cosh, Madeline S.; Scott, Stephen H.; Wiley, J. Preston; Debert, Chantel T.; Dukelow, Sean P.; Benson, Brian W.			Test-retest reliability of the KINARM end-point robot for assessment of sensory, motor and neurocognitive function in young adult athletes	PLOS ONE			English	Article							CONCUSSION ASSESSMENT; VALIDITY; SENSORIMOTOR; SYMPTOMS; TRAIL; SPORT; AGE; IMPACT; SEX	Background Current assessment tools for sport-related concussion are limited by a reliance on subjective interpretation and patient symptom reporting. Robotic assessments may provide more objective and precise measures of neurological function than traditional clinical tests. Objective To determine the reliability of assessments of sensory, motor and cognitive function conducted with the KINARM end-point robotic device in young adult elite athletes. Methods Sixty-four randomly selected healthy, young adult elite athletes participated. Twenty-five individuals (25 M, mean age +/- SD, 20.2 +/- 2.1 years) participated in a within-season study, where three assessments were conducted within a single season (assessments labeled by session: S1, S2, S3). An additional 39 individuals (28M; 22.8 +/- 6.0 years) participated in a year-to-year study, where annual pre-season assessments were conducted for three consecutive seasons (assessments labeled by year: Y1, Y2, Y3). Forty-four parameters from five robotic tasks (Visually Guided Reaching, Position Matching, Object Hit, Object Hit and Avoid, and Trail Making B) and overall Task Scores describing performance on each task were quantified. Results Test-retest reliability was determined by intra-class correlation coefficients (ICCs) between the first and second, and second and third assessments. In the within-season study, ICCs were >= 0.50 for 68% of parameters between S1 and S2, 80% of parameters between S2 and S3, and for three of the five Task Scores both between S1 and S2, and S2 and S3. In the year-to-year study, ICCs were >= 0.50 for 64% of parameters between Y1 and Y2, 82% of parameters between Y2 and Y3, and for four of the five Task Scores both between Y1 and Y2, and Y2 and Y3. Conclusions Overall, the results suggest moderate-to-good test-retest reliability for the majority of parameters measured by the KINARM robot in healthy young adult elite athletes. Future work will consider the potential use of this information for clinical assessment of concussion-related neurological deficits.	[Mang, Cameron S.; Whitten, Tara A.; Debert, Chantel T.; Dukelow, Sean P.; Benson, Brian W.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Mang, Cameron S.; Whitten, Tara A.; Debert, Chantel T.; Dukelow, Sean P.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Cosh, Madeline S.; Benson, Brian W.] Winter Sport Inst, WinSport Med Clin, Calgary, AB, Canada; [Scott, Stephen H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Wiley, J. Preston; Dukelow, Sean P.; Benson, Brian W.] Univ Calgary, Sport Med Ctr, Fac Kinesiol, Calgary, AB, Canada; [Benson, Brian W.] Canadian Sport Inst Calgary, Calgary, AB, Canada	University of Calgary; Queens University - Canada; University of Calgary	Mang, CS (corresponding author), Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada.; Mang, CS (corresponding author), Hotchkiss Brain Inst, Calgary, AB, Canada.	cameron.mang@ucalgary.ca		Mang, Cameron/0000-0002-3376-5355; Dukelow, Sean/0000-0002-0609-981X; Debert, Chantel/0000-0002-2704-0438	Own the Podium Canada; Canadian Academy of Sport and Exercise Medicine Research Fund; Canadian Sport Institute Calgary; Calgary, Alberta; Canadian Institutes of Health Research; Alberta Innovates Health Solutions; Mitacs fellowship; Alberta Innovates [201500083] Funding Source: researchfish	Own the Podium Canada; Canadian Academy of Sport and Exercise Medicine Research Fund; Canadian Sport Institute Calgary; Calgary, Alberta; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Mitacs fellowship; Alberta Innovates	This work was funded by Own the Podium Canada, the Canadian Academy of Sport and Exercise Medicine Research Fund, the Canadian Sport Institute Calgary and Jim Smith of Calgary, Alberta (BWB). CSM was funded by post-doctoral fellowships from the Canadian Institutes of Health Research and Alberta Innovates Health Solutions. TAW was funded by a Mitacs fellowship in partnership with Own the Podium Canada.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; BLEECKER ML, 1987, DEV NEUROPSYCHOL, V3, P165, DOI 10.1080/87565648709540372; Bourke TC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0201-2; Brett BL, 2016, ARCH CLIN NEUROPSYCH; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Cohen J.E., 1988, STAT POWER ANAL BEHA; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; Dukelow SP, 2017, INT J STROKE, V12, P7, DOI 10.1177/1747493016654483; Dukelow SP, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-72; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Herter TM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-43; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kane M, 2004, APPL MEAS EDUC, V17, P221, DOI 10.1207/s15324818ame1703_1; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Kenzie JM, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0329-8; Little CE, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0195-9; Little CE, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0070-0; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McCrory P, 2017, BRIT J SPORT MED, DOI [10.1109/JTEHM.2015.2424224, DOI 10.1109/JTEHM.2015.2424224]; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLean D, 2016, DEXTERIT E 3 6 USER; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Otaka E, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0059-8; Portney LG, 2009, FDN CLIN RES APPL PR; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI [10.1136/BMJSEM-2015-000012, DOI 10.1136/BMJSEM-2015-000012]; Salarian A., 2008, MATLAB CENTRAL FILE; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 2011, J REHABIL RES DEV, V48, P335, DOI 10.1682/JRRD.2010.04.0057; Simmatis L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188786; Subbian V, 2016, ACAD EMERG MED, V23, P382, DOI 10.1111/acem.12906; Subbian V, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2424224; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	47	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196205	10.1371/journal.pone.0196205	http://dx.doi.org/10.1371/journal.pone.0196205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7GN	29689075	Green Submitted, gold, Green Published			2022-12-26	WOS:000430678800031
J	Ostadal, P; Mlcek, M; Gorhan, H; Simundic, I; Strunina, S; Hrachovina, M; Kruger, A; Vondrakova, D; Janotka, M; Hala, P; Mates, M; Ostadal, M; Leiters, JC; Kittnar, O; Neuzil, P				Ostadal, Petr; Mlcek, Mikulas; Gorhan, Holger; Simundic, Ivo; Strunina, Svitlana; Hrachovina, Matej; Kruger, Andreas; Vondrakova, Dagmar; Janotka, Marek; Hala, Pavel; Mates, Martin; Ostadal, Martin; Leiters, James C.; Kittnar, Otomar; Neuzil, Petr			Electrocardiogram-synchronized pulsatile extracorporeal life support preserves left ventricular function and coronary flow in a porcine model of cardiogenic shock	PLOS ONE			English	Article							MEMBRANE-OXYGENATION; CIRCULATORY SUPPORT; HEMODYNAMIC ENERGY; ASSIST DEVICE; SWINE MODEL; NONPULSATILE; PERFORMANCE; DYSFUNCTION; SYSTEMS; DISTENSION	Introduction Veno-arterial extracorporeal life support (ECLS) is increasingly being used to treat rapidly progressing or severe cardiogenic shock. However, it has been repeatedly shown that increased afterload associated with ECLS significantly diminishes left ventricular (LV) performance. The objective of the present study was to compare LV function and coronary flow during standard continuous-flow ECLS support and electrocardiogram (ECG)-synchronized pulsatile ECLS flow in a porcine model of cardiogenic shock. Methods Sixteen female swine (mean body weight 45 kg) underwent ECLS implantation under general anesthesia and artificial ventilation. Subsequently, acute cardiogenic shock, with documented signs of tissue hypoperfusion, was induced by initiating global myocardial hypoxia. Hemodynamic cardiac performance variables and coronary flow were then measured at different rates of continuous or pulsatile ECLS flow (ranging from 1 L/min to 4 L/min) using arterial and venous catheters, a pulmonary artery catheter, an LV pressure-volume loop catheter, and a Doppler coronary guide-wire. Results Myocardial hypoxia resulted in declines in mean cardiac output to 1.7 +/- 0.7 L/min, systolic blood pressure to 64 +/- 22 mmHg, and LV ejection fraction (LVEF) to 22 +/- 7%. Synchronized pulsatile flow was associated with a significant reduction in LV end-systolic volume by 6.2 mL (6.7%), an increase in LV stroke volume by 5.0 mL (17.4%), higher LVEF by 4.5% 18.8% relative), cardiac output by 0.37 L/min (17.1%), and mean arterial pressure by 3.0 mmHg (5.5%) when compared with continuous ECLS flow at all ECLS flow rates (P<0.05). At selected ECLS flow rates, pulsatile flow also reduced LV end-diastolic pressure, end-diastolic volume, and systolic pressure. ECG-synchronized pulsatile flow was also associated with significantly increased (7% to 22%) coronary flow at all ECLS flow rates. Conclusion ECG-synchronized pulsatile ECLS flow preserved LV function and coronary flow compared with standard continuous-flow ECLS in a porcine model of cardiogenic shock.	[Ostadal, Petr; Kruger, Andreas; Vondrakova, Dagmar; Janotka, Marek; Hala, Pavel; Mates, Martin; Neuzil, Petr] Na Homolce Hosp, Cardiovasc Ctr, Prague, Czech Republic; [Mlcek, Mikulas; Hrachovina, Matej; Kittnar, Otomar] Charles Univ Prague, Fac Med 1, Dept Physiol, Prague, Czech Republic; [Gorhan, Holger; Simundic, Ivo] Xenios AG, Heilbronn, Germany; [Strunina, Svitlana] Czech Tech Univ, Fac Biomed Engn, Prague, Czech Republic; [Ostadal, Martin] Na Bulovce Hosp, Dept Orthoped, Prague, Czech Republic; [Leiters, James C.] Geisel Sch Med Dartmouth, Dept Mol & Integrat Biol, Lebanon, NH USA	Na Homolce Hospital; Charles University Prague; Czech Technical University Prague; Bulovka University Hospital; Dartmouth College	Ostadal, P (corresponding author), Na Homolce Hosp, Cardiovasc Ctr, Prague, Czech Republic.	ostadal.petr@gmail.com	Ostadal, 9@/G-5352-2015	Ostadal, Petr/0000-0001-9550-222X	Xenios AG (Heilbronn, Germany); MH CZ - DRO [IG 150501]; MH CZ - DRO (Nemocnice Na Homolce - NNH) [00023884]; Xenios AG;  [SW260147/2015]	Xenios AG (Heilbronn, Germany); MH CZ - DRO; MH CZ - DRO (Nemocnice Na Homolce - NNH); Xenios AG; 	This study was supported by Xenios AG (Heilbronn, Germany). Additionally, the study was supported by an Institutional grant MH CZ - DRO (IG 150501, Nemocnice Na Homolce - NNH, 00023884) to PO and by SW260147/2015 to M. Mlcek. Xenios AG provided support in the form of salaries for authors [HG, IS, JCL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrams D, 2014, J AM COLL CARDIOL, V63, P2769, DOI 10.1016/j.jacc.2014.03.046; Aissaoui N, 2012, J AM SOC ECHOCARDIOG, V25, P632, DOI 10.1016/j.echo.2012.02.009; Barbone A, 2011, INTERACT CARDIOV TH, V13, P293, DOI 10.1510/icvts.2011.269795; Belohlavek J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-163; BERDJIS F, 1992, PEDIATR CARDIOL, V13, P141; Beurtheret S, 2013, EUR HEART J, V34, P112, DOI 10.1093/eurheartj/ehs081; Broome M, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0760-1; Combes A, 2008, CRIT CARE MED, V36, P1404, DOI 10.1097/CCM.0b013e31816f7cf7; Cremers B, 2015, ARTIF ORGANS, V39, P77, DOI 10.1111/aor.12413; ECMO, 2012, EXTRACORPOREAL CARDI, V4th; Fuhrman BP, 1999, ARTIF ORGANS, V23, P966, DOI 10.1046/j.1525-1594.1999.06484.x; HIRSCHL RB, 1992, J PEDIATR SURG, V27, P48, DOI 10.1016/0022-3468(92)90103-E; Itoh H, 2016, ARTIF ORGANS, V40, P19, DOI 10.1111/aor.12588; Karaci AR, 2011, ARTIF ORGANS, V35, P1010, DOI 10.1111/j.1525-1594.2011.01378.x; KIMBALL TR, 1991, J PEDIATR-US, V118, P431, DOI 10.1016/S0022-3476(05)82163-8; Ostadal, 2016, CURR RES CARDIOL, V3, P5, DOI DOI 10.4172/2368-0512.1000054; Ostadal P, 2016, PHYSIOL RES, V65, P711, DOI 10.33549/physiolres.933294; Ostadal P, 2017, EUR J HEART FAIL, V19, P124, DOI 10.1002/ejhf.857; Ostadal P, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0634-6; Ostadal P, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1202, DOI 10.1161/CIRCEP.112.973123; Poss J, 2015, EUR HEART J-ACUTE CA, V4, P475, DOI 10.1177/2048872614561481; Pranikoff T, 1994, ASAIO J, V40, pM339, DOI 10.1097/00002480-199407000-00020; Pyles LA, 2010, J CARDIOVASC TRANSL, V3, P625, DOI 10.1007/s12265-010-9215-5; Shen I, 2001, ANN THORAC SURG, V71, P862, DOI 10.1016/S0003-4975(00)02280-3; Shen I, 2001, ANN THORAC SURG, V71, P868, DOI 10.1016/S0003-4975(00)02281-5; Sidebotham D, 2012, ANAESTH INTENS CARE, V40, P568; Soleimani B, 2012, PERFUSION-UK, V27, P326, DOI 10.1177/0267659112443722; Wang SG, 2015, ARTIF ORGANS, V39, P774, DOI 10.1111/aor.12466; Wang SG, 2015, ARTIF ORGANS, V39, pE90, DOI 10.1111/aor.12482; Werdan K, 2014, EUR HEART J, V35, P156, DOI 10.1093/eurheartj/eht248; Wolfe R, 2015, ARTIF ORGANS, V39, pE127, DOI 10.1111/aor.12484	31	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196321	10.1371/journal.pone.0196321	http://dx.doi.org/10.1371/journal.pone.0196321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689088	Green Submitted, gold, Green Published			2022-12-26	WOS:000430678800044
J	Dow, A; Prisic, S				Dow, Allexa; Prisic, Sladjana			Alternative ribosomal proteins are required for growth and morphogenesis of & IT;Mycobacterium smegmatis & IT; under zinc limiting conditions	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CELL-DIVISION; STRINGENT RESPONSE; ESCHERICHIA-COLI; SENSITIVITY; ADAPTATION; EXPRESSION; TRANSPORT; DEPLETION; REGULONS	Zinc is an essential micronutrient required for proper structure and function of many proteins. Bacteria regularly encounter zinc depletion and have evolved diverse mechanisms to continue growth when zinc is limited, including the expression of zinc-independent paralogs of zinc-binding proteins. Mycobacteria have a conserved operon encoding four zinc-independent alternative ribosomal proteins (AltRPs) that are expressed when zinc is depleted. It is unknown if mycobacterial AltRPs replace their primary paralogs in the ribosome and maintain protein synthesis under zinc-limited conditions, and if such replacements contribute to their physiology. This study shows that AltRPs from Mycobacterium smegmatis are essential for growth when zinc ion is scarce. Specifically, the deletion mutant of this operon (Delta altRP) is unable to grow in media containing a high-affinity zinc chelator, while growth of the wild type strain is unaffected under the same conditions. However, when zinc is gradually depleted during growth in zinc-limited medium, the Delta altRP mutant maintains the same growth rate as seen for the wild type strain. In contrast to M. smegmatis grown with sufficient zinc supplementation that forms shorter cells when transitioning from logarithmic to stationary phase, M. smegmatis deficient for zinc elongates after the expression of AltRPs in late logarithmic phase. These zinc-depleted bacteria also exhibit a remarkable morphology characterized by a condensed chromosome, increased number of polyphosphate granules, and distinct appearance of lipid bodies and the cell wall compared to the zinc-replete cells. However, the Delta altRP cells fail to elongate and transition into the zinc-limited morphotype, resembling the wild type zinc-replete bacteria instead. Therefore, the altRP operon in M. smegmatis has a vital role in continuation of growth when zinc is scarce and in triggering specific morphogenesis during the adaptation to zinc limitation, suggesting that AltRPs can functionally replace their zinc-dependent paralogs, but also contribute to mycobacterial physiology in a unique way.	[Dow, Allexa; Prisic, Sladjana] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Prisic, S (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.	prisic@hawaii.edu		Prisic, Sladjana/0000-0003-3137-4358	National Institute of Allergy and Infectious Diseases [R21AI109293]; National Institute of General Medical Sciences [P30GM114737]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114737] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007601] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institute of Allergy and Infectious Diseases grant R21AI109293 and the National Institute of General Medical Sciences grant P30GM114737 www.nih.gov (National Institute of Health) to S.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; Akanuma G, 2006, J BACTERIOL, V188, P2715, DOI 10.1128/JB.188.7.2715-2720.2006; Arenz S, 2016, NUCLEIC ACIDS RES, V44, P6471, DOI 10.1093/nar/gkw470; Chen K, 2005, ANTIMICROB AGENTS CH, V49, P1002, DOI 10.1128/AAC.49.3.1002-1009.2005; Chuang YM, 2016, ANTIMICROB AGENTS CH, V60, P6460, DOI 10.1128/AAC.01139-16; Chuang YM, 2013, MBIO, V4, DOI 10.1128/mBio.00039-13; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dahl JL, 2005, J BACTERIOL, V187, P2439, DOI 10.1128/JB.187.7.2439-2447.2005; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Gabriel SE, 2009, J BACTERIOL, V191, P6116, DOI 10.1128/JB.00802-09; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Golovine K, 2008, PROSTATE, V68, P1443, DOI 10.1002/pros.20810; Graham AI, 2009, J BIOL CHEM, V284, P18377, DOI 10.1074/jbc.M109.001503; Gupta KR, 2016, J BACTERIOL, V198, P1414, DOI 10.1128/JB.00126-16; Hentschel J, 2017, CELL REP, V20, P149, DOI 10.1016/j.celrep.2017.06.029; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Keren I, 2011, MOL BIOL, P2, DOI [10.1128/mBio.00100-11.Editor, DOI 10.1128/MBIO.00100-11.EDITOR]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Little RH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005837; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Makarova KS, 2001, GENOME BIOL, V2; Merchant SS, 2012, ADV MICROB PHYSIOL, V60, P91, DOI 10.1016/B978-0-12-398264-3.00002-4; Nanamiya H, 2004, MOL MICROBIOL, V52, P273, DOI 10.1111/j.1365-2958.2003.03972.x; Natori Y, 2007, MOL MICROBIOL, V63, P294, DOI 10.1111/j.1365-2958.2006.05513.x; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Owen GA, 2007, J BACTERIOL, V189, P4078, DOI 10.1128/JB.01901-06; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Prisic S, 2015, MOL MICROBIOL, V97, P263, DOI 10.1111/mmi.13022; Provvedi R, 2008, J BACTERIOL, V190, P7859, DOI 10.1128/JB.00714-08; Raman S, 2004, J BACTERIOL, V186, P6605, DOI 10.1128/JB.186.19.6605-6616.2004; Reisner BS, 1997, INT J TUBERC LUNG D, V1, P270; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider C., 2012, NAT METHODS; SCHREIBER G, 1995, CURR MICROBIOL, V30, P27, DOI 10.1007/BF00294520; Seki Y, 2014, PLANT BIOLOGY, V16, P258, DOI 10.1111/plb.12008; Sharma AK, 2016, J BIOL CHEM, V291, P24215, DOI 10.1074/jbc.M116.754531; Shi Z, 2015, ANNU REV CELL DEV BI, V31, P31, DOI 10.1146/annurev-cellbio-100814-125346; Shin JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12612; Sigdel TK, 2006, J BACTERIOL, V188, P6709, DOI 10.1128/JB.00680-06; Singh R, 2013, J BACTERIOL, V195, P2839, DOI 10.1128/JB.00038-13; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Ward SK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00063; WINDER FG, 1964, BIOCHEM J, V90, P122, DOI 10.1042/bj0900122; Wolf YI, 2001, GENOME RES, V11, P356, DOI 10.1101/gr.GR-1619R; Wu M-L, 2016, FRONT MICROBIOL, V7, P1, DOI [10.3389/fmicb.2016.00001, DOI 10.3389/FMICB.2016.00001]; Yutin N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036972; Zuckerkandl E, 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	52	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196300	10.1371/journal.pone.0196300	http://dx.doi.org/10.1371/journal.pone.0196300			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684089	Green Published, gold, Green Submitted			2022-12-26	WOS:000430660600051
J	St-Laurent, GP; Hagerman, S; Kozak, R; Hoberg, G				St-Laurent, Guillaume Peterson; Hagerman, Shannon; Kozak, Robert; Hoberg, George			Public perceptions about climate change mitigation in British Columbia's forest sector	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; ENVIRONMENTAL ACTIVISM; RISK PERCEPTIONS; MANAGEMENT; CARBON; POLICY; TRUST; PREFERENCES; ATTITUDES; VALUES	The role of forest management in mitigating climate change is a central concern for the Canadian province of British Columbia. The successful implementation of forest management activities to achieve climate change mitigation in British Columbia will be strongly influenced by public support or opposition. While we now have increasingly clear ideas of the management opportunities associated with forest mitigation and some insight into public support for climate change mitigation in the context of sustainable forest management, very little is known with respect to the levels and basis of public support for potential forest management strategies to mitigate climate change. This paper, by describing the results of a web-based survey, documents levels of public support for the implementation of eight forest carbon mitigation strategies in British Columbia's forest sector, and examines and quantifies the influence of the factors that shape this support. Overall, respondents ascribed a high level of importance to forest carbon mitigation and supported all of the eight proposed strategies, indicating that the British Columbia public is inclined to consider alternative practices in managing forests and wood products to mitigate climate change. That said, we found differences in levels of support for the mitigation strategies. In general, we found greater levels of support for a rehabilitation strategy (e.g. reforestation of unproductive forest land), and to a lesser extent for conservation strategies (e.g. old growth conservation, reduced harvest) over enhanced forest management strategies (e.g. improved harvesting and silvicultural techniques). We also highlighted multiple variables within the British Columbia population that appear to play a role in predicting levels of support for conservation and/or enhanced forest management strategies, including environmental values, risk perception, trust in groups of actors, prioritized objectives of forest management and socio-demographic factors.	[St-Laurent, Guillaume Peterson] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada; [Hagerman, Shannon; Kozak, Robert] Univ British Columbia, Fac Forestry, Vancouver, BC, Canada; [Hoberg, George] Univ British Columbia, Liu Inst Global Issues, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	St-Laurent, GP (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada.	peterson.guil@gmail.com	St-Laurent, Guillaume Peterson/AAU-3089-2020	St-Laurent, Guillaume Peterson/0000-0002-1329-0954	Forest Carbon Management Project of the Pacific Institute for Climate Solutions (PICS); Social Sciences and Humanities Research Council of Canada; PICS	Forest Carbon Management Project of the Pacific Institute for Climate Solutions (PICS); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); PICS	Funding for this study was provided by the Forest Carbon Management Project of the Pacific Institute for Climate Solutions (PICS): http://www.pics.uvic.ca. The work of the first author was supported both by the Social Sciences and Humanities Research Council of Canada (http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx) and PICS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; Akerlof K, 2013, GLOBAL ENVIRON CHANG, V23, P81, DOI 10.1016/j.gloenvcha.2012.07.006; Angelsen A., 2012, ANAL REDD CHALLENGES, P31; Aubin I, 2011, FOREST CHRON, V87, P755, DOI 10.5558/tfc2011-092; BC MFLNRO, 2013, CLIM MIT POT BRIT CO; BC MOE, 2014, BRIT COL GREENH GAS; Blair J, 2013, DESIGNING SURVEYS GU; Brody SD, 2008, ENVIRON BEHAV, V40, P72, DOI 10.1177/0013916506298800; Canadian Parks and Wilderness Society (CRAWS), 2016, NAT CLIM CHANG; Carlson M, 2010, FOREST CHRON, V86, P434, DOI 10.5558/tfc86434-4; Cashore Benjamin, 2001, SEARCH SUSTAINABILIT; Clason D.L., 1994, J AGR ED, V35, P31, DOI DOI 10.5032/JAE.1994.04031; Clement JM, 2011, APPL GEOGR, V31, P393, DOI 10.1016/j.apgeog.2010.10.001; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Dunlap RE, 2008, J ENVIRON EDUC, V40, P3, DOI 10.3200/JOEE.40.1.3-18; Durant RF, 2005, EUR UNION POLIT, V6, P181, DOI 10.1177/1465116505051982; Dymond Caren C, 2012, Carbon Balance Manag, V7, P8, DOI 10.1186/1750-0680-7-8; Dymond CC, 2009, 92 MIN FOR RANG FOR; FAO, 2016, 117 FAO; ForestEthics, 2007, ROBB CARB BANK GLOB; Forsyth J, 2013, SEARCH CERTAINTY DEC, P299; Government of BC, 2016, BRIT COL CLIM LEAD P; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Hajjar R, 2015, FOREST POLICY ECON, V61, P59, DOI 10.1016/j.forpol.2015.08.004; Harshaw H. W., 2009, J ECOSYST MANAG, V10, P81; Harshaw HW, 2005, J LEISURE RES, V37, P426, DOI 10.1080/00222216.2005.11950061; Hoberg G, 2016, FOREST POLICY ECON, V69, P73, DOI 10.1016/j.forpol.2016.05.005; Howlett M., 2001, CANADIAN FOREST POLI; Jung A, 2015, GLOBAL NEWS     0827; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kasperson RE, 2006, GLOBAL ENVIRON CHANG, V16, P320, DOI 10.1016/j.gloenvcha.2006.08.002; Kasperson RE, 2013, DAEDALUS-US, V142, P90, DOI 10.1162/DAED_a_00187; Kellstedt PM, 2008, RISK ANAL, V28, P113, DOI 10.1111/j.1539-6924.2008.01010.x; Kozak RA, 2008, CAN J FOREST RES, V38, P3071, DOI 10.1139/X08-146; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Kurz WA, 2013, ENVIRON REV, V21, P260, DOI 10.1139/er-2013-0041; Kurz W.A., 1998, MITIGATION ADAPTATIO, V2, P405, DOI [10.1023/B:MITI.0000004486.62808.29, DOI 10.1023/B:MITI.0000004486.62808.29]; Kurz W. A., 2016, UNASYLVA, V246, P61; Lachapelle E, 2014, 2013 CANADA US COMP; Lamers P, 2014, GCB BIOENERGY, V6, P44, DOI 10.1111/gcbb.12055; Leiserowitz A., 2016, CLIMATE CHANGE AM MI; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Lempriere TC, 2013, ENVIRON REV, V21, P293, DOI 10.1139/er-2013-0039; Lempriere TC, 2017, CANADIAN J FOREST RE; Leopold Aldo, 1949, SAND COUNTY ALMANAC; Lippke B, 2011, CARBON MANAG, V2, P303, DOI 10.4155/CMT.11.24; Lorenzoni I, 2006, CLIMATIC CHANGE, V77, P73, DOI 10.1007/s10584-006-9072-z; Luckert M, 2011, POLICIES SUSTAINABLY; Malmsheimer RW, 2011, J FOREST, V109, pS7; McFarlane BL, 1996, FOREST CHRON, V72, P623, DOI 10.5558/tfc72623-6; McFarlane BL, 2000, SOC NATUR RESOUR, V13, P649, DOI 10.1080/08941920050121927; McFarlane BL, 2006, ENVIRON BEHAV, V38, P266, DOI 10.1177/0013916505277999; McFarlane BL, 2005, RISK ANAL, V25, P543, DOI 10.1111/j.1539-6924.2005.00623.x; McFarlane BL, 2003, J ENVIRON PSYCHOL, V23, P79, DOI 10.1016/S0272-4944(02)00080-4; McFarlane BL, 2006, BIOL CONSERV, V130, P340, DOI 10.1016/j.biocon.2005.12.029; McFarlane BL, 2012, CAN J FOREST RES, V42, P710, DOI [10.1139/X2012-030, 10.1139/x2012-030]; Menny C, 2011, SSRN ELECT J, DOI [10.2139/ssrn.1960516, DOI 10.2139/SSRN.1960516]; Mildenberger M., 2016, DISTRIBUTION CLIMATE; Milfont TL, 2012, RISK ANAL, V32, P1003, DOI 10.1111/j.1539-6924.2012.01800.x; NRCan, 2016, STAT DAT EMPL; O'Connor RE, 1999, RISK ANAL, V19, P461, DOI 10.1111/j.1539-6924.1999.tb00421.x; Olsen CS, 2010, INT J WILDLAND FIRE, V19, P137, DOI 10.1071/WF08168; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Parfitt B, 2010, MANAGING BCS FORESTS; Parkins JR, 2007, GLOBAL ENVIRON CHANG, V17, P460, DOI 10.1016/j.gloenvcha.2007.01.003; Pedlar JH, 2012, BIOSCIENCE, V62, P835, DOI 10.1525/bio.2012.62.9.10; Pistorius T, 2012, CURR OPIN ENV SUST, V4, P638, DOI 10.1016/j.cosust.2012.07.002; Poortinga W, 2003, RISK ANAL, V23, P961, DOI 10.1111/1539-6924.00373; Pralle Sarah, 2006, ENV ADVOCACY AGENDA; Price K, 2009, FOREST ECOL MANAG, V258, P495, DOI 10.1016/j.foreco.2008.10.010; Proctor J., 2015, CBC NEWS; Renn O, 2006, LAND USE POLICY, V23, P34, DOI 10.1016/j.landusepol.2004.08.005; Sathre R, 2010, ENVIRON SCI POLICY, V13, P104, DOI 10.1016/j.envsci.2009.12.005; Semenza JC, 2008, AM J PREV MED, V35, P479, DOI 10.1016/j.amepre.2008.08.020; Sheppard SRJ, 2005, FOREST ECOL MANAG, V207, P171, DOI 10.1016/j.foreco.2004.10.032; Smith JW, 2011, LANDSCAPE URBAN PLAN, V101, P359, DOI 10.1016/j.landurbplan.2011.03.002; Smith M, 2007, CONFLICT COLLABORATI; Smyth CE, 2014, BIOGEOSCIENCES, V11, P3515, DOI 10.5194/bg-11-3515-2014; Smyth C, 2017, GCB BIOENERGY, V9, P817, DOI 10.1111/gcbb.12387; Smyth C, 2017, GCB BIOENERGY, V9, P1071, DOI 10.1111/gcbb.12389; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Spence A, 2009, ENVIRONMENT, V51, P8, DOI 10.1080/00139150903337217; St-Laurent GP, 2017, LAND USE POLICY, V60, P169, DOI 10.1016/j.landusepol.2016.10.025; STEEL BS, 1994, SOC NATUR RESOUR, V7, P137, DOI 10.1080/08941929409380852; Steg L, 2000, ENVIRON BEHAV, V32, P250, DOI 10.1177/00139160021972513; STINSON G, 2001, MITIGATION ADAPTATIO, V6, P1, DOI [DOI 10.1023/A%3A1011396115488, DOI 10.1023/A:1011396115488]; Ter-Mikaelian MT, 2008, FOREST CHRON, V84, P166, DOI 10.5558/tfc84166-2; Tindall DB, 2010, FOREST CHRON, V86, P709, DOI 10.5558/tfc86709-6; Tindall DB, 2013, ABORIGINAL PEOPLES AND FOREST LANDS IN CANADA, P1; van der Linden S, 2015, J ENVIRON PSYCHOL, V41, P112, DOI 10.1016/j.jenvp.2014.11.012; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; Vaske JJ, 1999, SOC NATUR RESOUR, V12, P523, DOI 10.1080/089419299279425; Vining J., 1999, HUM ECOL REV, V6, P21; WEAVER AA, 2002, INT J SOCIOLOGY, V0032; Whitmarsh L, 2008, J RISK RES, V11, P351, DOI 10.1080/13669870701552235; Wieting J., 2013, CARBON RISK BCS UNPR; Winter G, 2004, J FOREST, V102, P8; [徐中 Xu Zhong], 2017, [现代制造工程, Modern Manufacturing Engineering], P1	98	14	14	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195999	10.1371/journal.pone.0195999	http://dx.doi.org/10.1371/journal.pone.0195999			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7AK	29684041	Green Published, gold, Green Submitted			2022-12-26	WOS:000430660600029
J	Stowell, JAW; Wagstaff, JL; Hill, CH; Yu, MM; McLaughlin, SH; Freund, SMV; Passmore, LA				Stowell, James A. W.; Wagstaff, Jane L.; Hill, Chris H.; Yu, Minmin; McLaughlin, Stephen H.; Freund, Stefan M. V.; Passmore, Lori A.			A low-complexity region in the YTH domain protein Mmi1 enhances RNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; intrinsically disordered protein; mRNA decay; meiosis; protein-nucleic acid interaction; nuclear magnetic resonance (NMR); deadenylation; exosome specificity factor; YT521-B homology; YTH domain	MESSENGER-RNA; STRUCTURAL BASIS; M(6)A RNA; RECOGNITION; ELIMINATION; SYSTEM; MECHANISM; PROMOTES; REVEALS; PROGRAM	Mmi1 is an essential RNA-binding protein in the fission yeast Schizosaccharomyces pombe that eliminates meiotic transcripts during normal vegetative growth. Mmi1 contains a YTH domain that binds specific RNA sequences, targeting mRNAs for degradation. The YTH domain of Mmi1 uses a noncanonical RNA-binding surface that includes contacts outside the conserved fold. Here, we report that an N-terminal extension that is proximal to the YTH domain enhances RNA binding. Using X-ray crystallography, NMR, and biophysical methods, we show that this low-complexity region becomes more ordered upon RNA binding. This enhances the affinity of the interaction of the Mmi1 YTH domain with specific RNAs by reducing the dissociation rate of the Mmi1-RNA complex. We propose that the low-complexity region influences RNA binding indirectly by reducing dynamic motions of the RNA-binding groove and stabilizing a conformation of the YTH domain that binds to RNA with high affinity. Taken together, our work reveals how a low-complexity region proximal to a conserved folded domain can adopt an ordered structure to aid nucleic acid binding.	[Stowell, James A. W.; Wagstaff, Jane L.; Hill, Chris H.; Yu, Minmin; McLaughlin, Stephen H.; Freund, Stefan M. V.; Passmore, Lori A.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Freund, SMV; Passmore, LA (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	smvf@mrc-lmb.cam.ac.uk; passmore@mrc-lmb.cam.ac.uk		Hill, Chris H/0000-0001-7037-0611; Passmore, Lori/0000-0003-1815-3710	European Research Council under the European Union's Seventh Framework Programme/ERC [261151]; Medical Research Council [MC_U105192715]; MRC [MC_U105192715] Funding Source: UKRI	European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Starting Grant Agreement 261151 (to L. A. P.) and Medical Research Council Grant MC_U105192715 (to L. A. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Calabretta S, 2015, TRENDS BIOCHEM SCI, V40, P662, DOI 10.1016/j.tibs.2015.08.012; Chatterjee D, 2016, RNA, V22, P1011, DOI 10.1261/rna.056515.116; Clery A, 2017, METHODS, V118, P137, DOI 10.1016/j.ymeth.2017.03.004; Coey CT, 2016, NUCLEIC ACIDS RES, V44, P10248, DOI 10.1093/nar/gkw768; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cremona N, 2011, MOL BIOL CELL, V22, P66, DOI 10.1091/mbc.E10-05-0448; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Flock T, 2014, CURR OPIN STRUC BIOL, V26, P62, DOI 10.1016/j.sbi.2014.05.007; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hautbergue GM, 2008, P NATL ACAD SCI USA, V105, P5154, DOI 10.1073/pnas.0709167105; Haynes C, 2006, NUCLEIC ACIDS RES, V34, P305, DOI 10.1093/nar/gkj424; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hiriart E, 2012, EMBO J, V31, P2296, DOI 10.1038/emboj.2012.105; Jarvelin AI, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0132-3; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Keating KS, 2012, ACTA CRYSTALLOGR D, V68, P985, DOI 10.1107/S0907444912018549; Keating KS, 2010, P NATL ACAD SCI USA, V107, P8177, DOI 10.1073/pnas.0911888107; Kilchert C, 2015, CELL REP, V13, P2504, DOI 10.1016/j.celrep.2015.11.026; Langer A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3099; Li J, 2017, ELIFE, V6, DOI 10.7554/eLife.30688; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPheeters DS, 2009, NAT STRUCT MOL BIOL, V16, P255, DOI 10.1038/nsmb.1556; Monaco S, 2013, J APPL CRYSTALLOGR, V46, P804, DOI 10.1107/S0021889813006195; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Neelamraju Y, 2015, J PROTEOMICS, V127, P61, DOI 10.1016/j.jprot.2015.04.031; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Shen HH, 2007, NAT STRUCT MOL BIOL, V14, P597, DOI 10.1038/nsmb1263; Shichino Y, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140022; Smet-Nocca C, 2008, BIOCHEMISTRY-US, V47, P6519, DOI 10.1021/bi7022283; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; Stowell JAW, 2016, CELL REP, V17, P1978, DOI 10.1016/j.celrep.2016.10.066; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Theler D, 2014, NUCLEIC ACIDS RES, V42, P13911, DOI 10.1093/nar/gku1116; Ukleja M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10433; Vassilenko KS, 2002, BBA-PROTEIN STRUCT M, V1594, P168, DOI 10.1016/S0167-4838(01)00303-X; Wang CY, 2016, NUCLEIC ACIDS RES, V44, P969, DOI 10.1093/nar/gkv1382; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Welte T, 2014, BIOPHYS J, V106, p18A, DOI 10.1016/j.bpj.2013.11.156; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	62	9	9	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9210	9222		10.1074/jbc.RA118.002291	http://dx.doi.org/10.1074/jbc.RA118.002291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29695507	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000435441400007
J	Choi, H; Chaiyamongkol, W; Doolittle, AC; Johnson, ZI; Gogate, SS; Schoepflin, ZR; Shapiro, IM; Risbud, MV				Choi, Hyowon; Chaiyamongkol, Weera; Doolittle, Alexandra C.; Johnson, Zariel I.; Gogate, Shilpa S.; Schoepflin, Zachary R.; Shapiro, Irving M.; Risbud, Makarand V.			COX-2 expression mediated by calcium-TonEBP signaling axis under hyperosmotic conditions serves osmoprotective function in nucleus pulposus cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MEDULLARY INTERSTITIAL-CELLS; ELEMENT-BINDING PROTEIN; INTERVERTEBRAL DISC; CYCLOOXYGENASE-2 EXPRESSION; TRANSCRIPTION FACTOR; HYPERTONIC STRESS; EPITHELIAL-CELLS; CONTRIBUTES; SURVIVAL	The nucleus pulposus (NP) of intervertebral discs experiences dynamic changes in tissue osmolarity because of diurnal loading of the spine. TonEBP/NFAT5 is a transcription factor that is critical in osmoregulation as well as survival of NP cells in the hyperosmotic milieu. The goal of this study was to investigate whether cyclooxygenase-2 (COX-2) expression is osmoresponsive and dependent on TonEBP, and whether it serves an osmoprotective role. NP cells up-regulated COX-2 expression in hyperosmotic media. The induction of COX-2 depended on elevation of intracellular calcium levels and p38 MAPK pathway, but independent of calcineurin signaling as well as MEK/ERK and JNK pathways. Under hyperosmotic conditions, both COX-2 mRNA stability and its proximal promoter activity were increased. The proximal COX-2 promoter (-1840/+123 bp) contained predicted binding sites for TonEBP, AP-1, NF-kappa B, and C/EBP-beta. While COX-2 promoter activity was positively regulated by both AP-1 and NF-kappa B, AP-1 had no effect and NF-kappa B negatively regulated COX-2 protein levels under hyperosmotic conditions. Onthe other hand, TonEBPwas necessary for both COX-2 promoter activity and protein up-regulation in response to hyperosmotic stimuli. Ex vivo disc organ culture studies using hypomorphic TonEBP(+/-) mice confirmed that TonEBP is required for hyperosmotic induction of COX-2. Importantly, the inhibition of COX-2 activity under hyperosmotic conditions resulted in decreased cell viability, suggesting that COX-2 plays a cytoprotectiveandhomeostatic role inNPcells for their adaptation to dynamically loaded hyperosmotic niches.	[Choi, Hyowon; Chaiyamongkol, Weera; Doolittle, Alexandra C.; Johnson, Zariel I.; Gogate, Shilpa S.; Schoepflin, Zachary R.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Choi, Hyowon; Chaiyamongkol, Weera; Doolittle, Alexandra C.; Johnson, Zariel I.; Gogate, Shilpa S.; Schoepflin, Zachary R.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell Biol & Regenerat Med, Philadelphia, PA 19107 USA; [Chaiyamongkol, Weera] Prince Songkla Univ, Dept Orthopaed Surg, Fac Med, Hat Yai 90110, Thailand	Jefferson University; Jefferson University; Prince of Songkla University	Risbud, MV (corresponding author), Thomas Jefferson Univ, 1025 Walnut St,Ste 511 Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu		Choi, Hyowon/0000-0003-4935-4849	NIAMS, National Institutes of Health [R01AR055655, R01AR064733, T32AR052273, F30AR066506]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064733, F30AR066506, R01AR055655, T32AR052273] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by NIAMS, National Institutes of Health Grants R01AR055655 and R01AR064733, and T32AR052273 (to Z. I. J. and A. C. D.), and F30AR066506 (to Z. R. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Binch ALA, 2016, MATRIX BIOL, V52-54, P355, DOI 10.1016/j.matbio.2016.01.005; Breyer MD, 2001, CURR OPIN NEPHROL HY, V10, P89, DOI 10.1097/00041552-200101000-00014; Chen J, 2005, J BIOL CHEM, V280, P16354, DOI 10.1074/jbc.M411134200; Cheng HF, 2002, J BIOL CHEM, V277, P45638, DOI 10.1074/JBC.m206040200; Cheng HF, 2000, J CLIN INVEST, V106, P681, DOI 10.1172/JCI10318; Choi H., 2018, MATRIX BIOL; Coon D, 2007, J ENDODONT, V33, P432, DOI 10.1016/j.joen.2006.12.001; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Favale NO, 2009, BIOCHEM BIOPH RES CO, V381, P301, DOI 10.1016/j.bbrc.2008.12.189; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Gajghate S, 2009, J BONE MINER RES, V24, P992, DOI [10.1359/JBMR.090103, 10.1359/jbmr.090103]; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Gogate SS, 2012, J BONE MINER RES, V27, P1106, DOI 10.1002/jbmr.1571; Hao CM, 1999, AM J PHYSIOL-RENAL, V277, pF352, DOI 10.1152/ajprenal.1999.277.3.F352; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Hiyama A, 2009, J BIOL CHEM, V284, P9824, DOI 10.1074/jbc.M807081200; Irarrazabal CE, 2008, J BIOL CHEM, V283, P2554, DOI 10.1074/jbc.M703490200; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Johnson ZI, 2017, J BIOL CHEM, V292, P17561, DOI 10.1074/jbc.M117.790378; Johnson ZI, 2016, J BIOL CHEM, V291, P26686, DOI 10.1074/jbc.M116.757732; Johnson ZI, 2014, MATRIX BIOL, V40, P10, DOI 10.1016/j.matbio.2014.08.014; Kim NH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.61; Kim SH, 2009, CARCINOGENESIS, V30, P753, DOI 10.1093/carcin/bgp066; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Ko BCB, 1997, J BIOL CHEM, V272, P16431, DOI 10.1074/jbc.272.26.16431; Kusama K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132017; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lee YS, 2013, FREE RADICAL RES, V47, P422, DOI 10.3109/10715762.2013.784965; Libert S, 2016, MOL VIS, V22, P100; Madonna R, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0342-4; Miyakawa H, 1998, AM J PHYSIOL-RENAL, V274, pF753, DOI 10.1152/ajprenal.1998.274.4.F753; Moeckel GW, 2003, J BIOL CHEM, V278, P19352, DOI 10.1074/jbc.M302209200; Nahm O, 2002, AM J PHYSIOL-CELL PH, V282, pC49, DOI 10.1152/ajpcell.00267.2001; Norregaard R, 2015, KIDNEY RES CLIN PRAC, V34, P194, DOI 10.1016/j.krcp.2015.10.004; Ogata S, 2006, BIOCHEM BIOPH RES CO, V351, P808, DOI 10.1016/j.bbrc.2006.10.098; Peskar BM, 2001, J PHYSIOLOGY-PARIS, V95, P3, DOI 10.1016/S0928-4257(01)00003-1; Rim JS, 1998, J BIOL CHEM, V273, P20615, DOI 10.1074/jbc.273.32.20615; Risbud MV, 2014, NAT REV RHEUMATOL, V10, P44, DOI 10.1038/nrrheum.2013.160; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Rishud M. V., 2018, MATRIX BIOL; Shehzad A, 2015, BMB REP, V48, P109, DOI 10.5483/BMBRep.2015.48.2.081; Shin HJ, 2014, CELL DEATH DIFFER, V21, P1095, DOI 10.1038/cdd.2014.29; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Tian Y, 2016, MATRIX BIOL, V50, P39, DOI 10.1016/j.matbio.2015.11.008; Tsai TT, 2007, J BONE MINER RES, V22, P965, DOI 10.1359/JBMR.070322; Tsai TT, 2006, J BIOL CHEM, V281, P25416, DOI 10.1074/jbc.M601969200; van Dijk B, 2015, J ORTHOP RES, V33, P1724, DOI 10.1002/jor.22946; Wang H, 2015, AM J PHYSIOL-RENAL, V308, pF140, DOI 10.1152/ajprenal.00471.2014; Yan Y, 2006, J CELL SCI, V119, P2985, DOI 10.1242/jcs.03014; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Zhang DY, 2008, MOL CANCER RES, V6, P165, DOI 10.1158/1541-7786.MCR-07-0181	53	21	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8969	8981		10.1074/jbc.RA117.001167	http://dx.doi.org/10.1074/jbc.RA117.001167			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29700115	Green Published, hybrid			2022-12-26	WOS:000434941900020
J	Ren, WT; Ji, DQ; Xu, XL				Ren, Weitong; Ji, Dongqing; Xu, Xiulian			Metal cofactor modulated folding and target recognition of HIV-1 NCp7	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUCLEIC-ACID CHAPERONE; TYPE-1 NUCLEOCAPSID PROTEIN; TERMINAL ZINC-FINGER; INTRINSICALLY DISORDERED PROTEINS; ENERGY LANDSCAPE; BINDING; RNA; DOMAINS; P53	The HIV-1 nucleocapsid 7 (NCp7) plays crucial roles in multiple stages of HIV-1 life cycle, and its biological functions rely on the binding of zinc ions. Understanding the molecular mechanism of how the zinc ions modulate the conformational dynamics and functions of the NCp7 is essential for the drug development and HIV-1 treatment. In this work, using a structure-based coarse-grained model, we studied the effects of zinc cofactors on the folding and target RNA(SL3) recognition of the NCp7 by molecular dynamics simulations. After reproducing some key properties of the zinc binding and folding of the NCp7 observed in previous experiments, our simulations revealed several interesting features in the metal ion modulated folding and target recognition. Firstly, we showed that the zinc binding makes the folding transition states of the two zinc fingers less structured, which is in line with the Hammond effect observed typically in mutation, temperature or denaturant induced perturbations to protein structure and stability. Secondly, We showed that there exists mutual interplay between the zinc ion binding and NCp7-target recognition. Binding of zinc ions enhances the affinity between the NCp7 and the target RNA, whereas the formation of the NCp7-RNA complex reshapes the intrinsic energy landscape of the NCp7 and increases the stability and zinc affinity of the two zinc fingers. Thirdly, by characterizing the effects of salt concentrations on the target RNA recognition, we showed that the NCp7 achieves optimal balance between the affinity and binding kinetics near the physiologically relevant salt concentrations. In addition, the effects of zinc binding on the inter-domain conformational flexibility and folding cooperativity of the NCp7 were also discussed.	[Ren, Weitong; Ji, Dongqing] Nanjing Univ, Sch Phys, Nanjing 210093, Jiangsu, Peoples R China; [Xu, Xiulian] Yangzhou Univ, Sch Phys Sci & Technol, Yangzhou 225002, Jiangsu, Peoples R China	Nanjing University; Yangzhou University	Xu, XL (corresponding author), Yangzhou Univ, Sch Phys Sci & Technol, Yangzhou 225002, Jiangsu, Peoples R China.	xuxl@yzu.edu.cn			National Natural Science Foundation of China [11147178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this research was provided by the National Natural Science Foundation of China (No. 11147178) to XX.	ALDOVINI A, 1990, J VIROL, V64, P1920, DOI 10.1128/JVI.64.5.1920-1926.1990; Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; BERG JM, 1986, SCIENCE, V232, P485, DOI 10.1126/science.2421409; Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; BESS JW, 1992, J VIROL, V66, P840, DOI 10.1128/JVI.66.2.840-847.1992; Best RB, 2009, SCIENCE, V323, P593, DOI 10.1126/science.1169555; Case DA, 2014, AMBER 14; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Cruceanu M, 2006, NUCLEIC ACIDS RES, V34, P593, DOI 10.1093/nar/gkj458; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; Darlix JL, 2016, BIOCHEM SOC T, V44, P1427, DOI 10.1042/BST20160101-T; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; DARLIX JL, 1995, J MOL BIOL, V254, P523, DOI 10.1006/jmbi.1995.0635; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Deshmukh L, 2018, ANGEW CHEM INT EDIT, V57, P2687, DOI 10.1002/anie.201713172; Deshmukh L, 2016, CHEMPHYSCHEM, V17, P1548, DOI 10.1002/cphc.201600212; DORFMAN T, 1993, J VIROL, V67, P6159, DOI 10.1128/JVI.67.10.6159-6169.1993; Dyson HJ, 2016, BIOPHYS J, V110, P1013, DOI 10.1016/j.bpj.2016.01.030; Fox SJ, 2017, PROG BIOPHYS MOL BIO, V128, P57, DOI 10.1016/j.pbiomolbio.2017.05.008; Garg D, 2014, VIRUS RES, V193, P135, DOI 10.1016/j.virusres.2014.07.004; Godet J, 2010, RNA BIOL, V7, P687, DOI 10.4161/rna.7.6.13616; Goldschmidt Valerie, 2010, HIV Therapy, V4, P179, DOI 10.2217/HIV.10.3; Guo JH, 2002, J VIROL, V76, P4370, DOI 10.1128/JVI.76.9.4370-4378.2002; Hayashi T, 2015, J PHYS CHEM B, V119, P14120, DOI 10.1021/acs.jpcb.5b08513; Hori N, 2012, J CHEM THEORY COMPUT, V8, P3384, DOI 10.1021/ct300361j; Iraci N, 2018, DRUG DISCOV TODAY, V23, P687, DOI 10.1016/j.drudis.2018.01.022; Jenkins LMM, 2005, J MED CHEM, V48, P2847, DOI 10.1021/jm0492195; Kannan S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23750; Kenzaki H, 2011, J CHEM THEORY COMPUT, V7, P1979, DOI 10.1021/ct2001045; Kmiecik S, 2016, CHEM REV, V116, P7898, DOI 10.1021/acs.chemrev.6b00163; Lee BM, 1998, J MOL BIOL, V279, P633, DOI 10.1006/jmbi.1998.1766; LEVER A, 1989, J VIROL, V63, P4085, DOI 10.1128/JVI.63.9.4085-4087.1989; Li W., 2014, BIOMED RES INT, V2014, P11, DOI DOI 10.1016/J.SBI.2014.11.006; Li WF, 2008, J AM CHEM SOC, V130, P892, DOI 10.1021/ja075302g; Li WF, 2014, P NATL ACAD SCI USA, V111, P10550, DOI 10.1073/pnas.1402768111; Li WF, 2012, P NATL ACAD SCI USA, V109, P17789, DOI 10.1073/pnas.1201807109; Li WF, 2011, P NATL ACAD SCI USA, V108, P3504, DOI 10.1073/pnas.1018983108; Li WF, 2010, BIOPHYS J, V99, P3029, DOI 10.1016/j.bpj.2010.08.041; Li WF, 2010, METHODS, V52, P106, DOI 10.1016/j.ymeth.2010.04.014; Liu F, 2017, P NATL ACAD SCI USA, V114, pE3927, DOI 10.1073/pnas.1615949114; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Maynard AT, 2001, J AM CHEM SOC, V123, P1047, DOI 10.1021/ja0011616; MELY Y, 1994, BIOCHEMISTRY-US, V33, P12085, DOI 10.1021/bi00206a011; Mely Y, 1996, BIOCHEMISTRY-US, V35, P5175, DOI 10.1021/bi952587d; Mitra M, 2013, BIOCHEMISTRY-US, V52, P8226, DOI 10.1021/bi401250a; MORELLET N, 1992, EMBO J, V11, P3059, DOI 10.1002/j.1460-2075.1992.tb05377.x; MORELLET N, 1994, J MOL BIOL, V235, P287, DOI 10.1016/S0022-2836(05)80033-6; Muriaux D, 2010, RNA BIOL, V7, P744, DOI 10.4161/rna.7.6.14065; Musah RA, 2004, CURR TOP MED CHEM, V4, P1605, DOI 10.2174/1568026043387331; Naganathan AN, 2010, P NATL ACAD SCI USA, V107, P8611, DOI 10.1073/pnas.1000988107; Narayanan N, 2006, BIOCHEMISTRY-US, V45, P12617, DOI 10.1021/bi060925c; Okazaki KI, 2008, P NATL ACAD SCI USA, V105, P11182, DOI 10.1073/pnas.0802524105; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Quintal S, 2012, BIOCHEMISTRY-US, V51, P1752, DOI 10.1021/bi201834g; Ravikumar KM, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4774148; Sancineto L, 2018, DRUG DISCOV TODAY, V23, P260, DOI 10.1016/j.drudis.2017.10.017; Shin JS, 2015, CELL CYCLE, V14, P533, DOI 10.1080/15384101.2014.998056; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Spell SR, 2017, CHEM COMMUN, V53, P91, DOI 10.1039/c6cc07970a; SUMMERS MF, 1992, PROTEIN SCI, V1, P563, DOI 10.1002/pro.5560010502; Takada S, 2015, ACCOUNTS CHEM RES, V48, P3026, DOI 10.1021/acs.accounts.5b00338; Terakawa T, 2011, BIOPHYS J, V101, P1450, DOI 10.1016/j.bpj.2011.08.003; Urbaneja MA, 2002, J MOL BIOL, V318, P749, DOI 10.1016/S0022-2836(02)00043-8; Wang Q, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002114; Weinkam P, 2010, PROTEIN FOLDING META, P247; Weinkam P, 2010, ACCOUNTS CHEM RES, V43, P652, DOI 10.1021/ar9002703; Weinkam P, 2009, BIOCHEMISTRY-US, V48, P2394, DOI 10.1021/bi802293m; Weinkam P, 2008, BIOCHEMISTRY-US, V47, P13470, DOI 10.1021/bi801223n; Williams MC, 2001, P NATL ACAD SCI USA, V98, P6121, DOI 10.1073/pnas.101033198; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu H, 2014, VIRUS RES, V193, P39, DOI 10.1016/j.virusres.2014.06.002; Wu H, 2014, NUCLEIC ACIDS RES, V42, P2525, DOI 10.1093/nar/gkt1227; Yiu CPB, 2000, CHEMBIOCHEM, V1, P49, DOI 10.1002/1439-7633(20000703)1:1<49::AID-CBIC49>3.0.CO;2-A; Zargarian L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102150; Zhang PZ, 2017, BIOPHYS J, V112, P1105, DOI 10.1016/j.bpj.2017.01.020	75	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196662	10.1371/journal.pone.0196662	http://dx.doi.org/10.1371/journal.pone.0196662			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715277	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281100042
J	Chen, LZ; Wang, L; Wang, HR; Sun, RH; You, LL; Zheng, YS; Yuan, YJ; Li, DD				Chen, Lizhi; Wang, Lei; Wang, Herong; Sun, Ruhao; You, Lili; Zheng, Yusheng; Yuan, Yijun; Li, Dongdong			Identification and characterization of a plastidial omega-3 fatty acid desaturase EgFAD8 from oil palm (Elaeis guineensis Jacq.) and its promoter response to light and low temperature	PLOS ONE			English	Article							FATTY-ACID DESATURASES; LINOLENIC ACID; COMPARATIVE TRANSCRIPTOME; OMEGA-3 DESATURASE; GENE-EXPRESSION; COLD; TISSUES; CLONING; DIFFER; LEVEL	In higher plants, omega-3 fatty acid desaturases are the key enzymes in the biosynthesis of alpha-linolenic acid (18:3), which plays key roles in plant metabolism as a structural component of both storage and membrane lipids. Here, the first omega-3 fatty acid desaturase gene was identified and characterized from oil palm. The bioinformatic analysis indicated it encodes a temperature-sensitive chloroplast omega-3 fatty acid desaturase, designated as EgFAD8. The expression analysis revealed that EgFAD8 is highly expressed in the oil palm leaves, when compared with the expression in the mesocarp. The heterologous expression of EgFAD8 in yeast resulted in the production of a novel fatty acid 18:3 (about 0.27%), when fed with 18:2 in the induction culture. Furthermore, to detect whether EgFAD8 could be induced by the environment stress, we detected the expression efficiency of the EgFAD8 promoter in transgenic Arabidopsis treated with low temperature and darkness, respectively. The results indicated that the promoter of EgFAD8 gene could be significantly induced by low temperature and slightly induced by darkness. These results reveal the function of EgFAD8 and the feature of its promoter from oil palm fruits, which will be useful for understanding the fuction and regulation of plastidial omega-3 fatty acid desaturases in higher plants.	[Chen, Lizhi; Wang, Lei; Wang, Herong; Sun, Ruhao; Zheng, Yusheng; Yuan, Yijun; Li, Dongdong] Minist Educ, Key Lab Adv Mat Trop Isl Resources, Haikou, Hainan, Peoples R China; [Chen, Lizhi; Wang, Lei; Wang, Herong; Sun, Ruhao; Zheng, Yusheng; Yuan, Yijun; Li, Dongdong] Hainan Univ, Coll Mat & Chem Engn, Dept Bioengn, Haikou, Hainan, Peoples R China; [You, Lili] Hainan Univ, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China	Hainan University; Hainan University	Yuan, YJ; Li, DD (corresponding author), Minist Educ, Key Lab Adv Mat Trop Isl Resources, Haikou, Hainan, Peoples R China.; Yuan, YJ; Li, DD (corresponding author), Hainan Univ, Coll Mat & Chem Engn, Dept Bioengn, Haikou, Hainan, Peoples R China.	yijun.yuan@hainu.edu.cn; liddfym@hotmail.com	xiao, wife/AAU-5469-2020; 游, 丽君/Q-4596-2019	游, 丽君/0000-0001-7873-3894; LI, Dongdong/0000-0003-4006-3551	National Natural Science Foundation of China [31360476, 31660222, 31460213]; Hainan Natural Science Foundation [20163138]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hainan Natural Science Foundation	This research was supported by the National Natural Science Foundation of China (to DL: 31360476 and 31660222; to YZ: 31460213) and Hainan Natural Science Foundation(to LY: 20163138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu V, 2010, J EXP BOT, V61, P3371, DOI 10.1093/jxb/erq158; Baker EJ, 2016, PROG LIPID RES, V64, P30, DOI 10.1016/j.plipres.2016.07.002; Banilas G, 2007, TREE PHYSIOL, V27, P481, DOI 10.1093/treephys/27.4.481; Bazmi AA, 2011, RENEW SUST ENERG REV, V15, P574, DOI 10.1016/j.rser.2010.09.031; Berberich T, 1998, 2 MAIZE GENES ENCODI, P297; Bilyeu KD, 2003, CROP SCI, V43, P1833, DOI 10.2135/cropsci2003.1833; Bourgis F, 2011, P NATL ACAD SCI USA, V108, P12527, DOI 10.1073/pnas.1106502108; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; Calder PC, 2003, LIPIDS, V38, P343, DOI 10.1007/s11745-003-1068-y; Corley R., 2003, OIL PALM, P287, DOI [10.1002/9780470750971.ch4/summary, DOI 10.1002/9780470750971]; CRAWFORD MA, 1980, POSTGRAD MED J, V56, P557, DOI 10.1136/pgmj.56.658.557; D'Angeli S, 2016, PLANTA, V243, P1279, DOI 10.1007/s00425-016-2490-x; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Dislich C, 2017, BIOL REV, V92, P1539, DOI 10.1111/brv.12295; Dominguez T, 2010, PLANT PHYSIOL, V153, P655, DOI 10.1104/pp.110.154815; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; Ebong PE, 1999, PLANT FOOD HUM NUTR, V53, P209, DOI 10.1023/A:1008089715153; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Guan LL, 2014, GENET MOL RES, V13, P6623, DOI [10.4238/2014.August.28.7, 10.4238/2014]; Guo Liang, 2008, Chinese Journal of Applied and Environmental Biology, V14, P469, DOI 10.3724/SP.J.1145.2009.00469; Hamilton ML, 2014, METAB ENG, V22, P3, DOI 10.1016/j.ymben.2013.12.003; Hernandez ML, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv159; IBA K, 1993, J BIOL CHEM, V268, P24099; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jin YH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01791; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; KODAMA H, 1994, PLANT PHYSIOL, V105, P601, DOI 10.1104/pp.105.2.601; Lagunas B, 2013, PHYTOCHEMISTRY, V95, P158, DOI 10.1016/j.phytochem.2013.07.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee KR, 2016, PLANT CELL REP, V35, P2523, DOI 10.1007/s00299-016-2053-4; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; [李东栋 Li Dongdong], 2007, [分子植物育种, Molecular Plant Breeding], V5, P883; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Murphy D., 1998, FATTY ACID DESATURAS, V1th; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Rajwade AV, 2014, PHYTOCHEMISTRY, V98, P41, DOI 10.1016/j.phytochem.2013.12.002; Roman Chiappetta A, 2012, J EXP BOT, V63, P695; Shahidi F, 2015, J FUNCT FOODS, V19, P797, DOI 10.1016/j.jff.2015.09.038; Simon E, 2011, EXP EYE RES, V93, P628, DOI 10.1016/j.exer.2011.07.016; Sun RH, 2016, GENE, V591, P21, DOI 10.1016/j.gene.2016.06.039; Szymanski J, 2014, PLANT CELL, V26, P915, DOI 10.1105/tpc.113.118919; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teixeira MC, 2010, J AGR FOOD CHEM, V58, P1870, DOI 10.1021/jf902684v; Vrinten P, 2005, PLANT PHYSIOL, V139, P79, DOI 10.1104/pp.105.064451; [王雷 Wang Lei], 2016, [分子植物育种, Molecular Plant Breeding], V14, P570; YADAV NS, 1993, PLANT PHYSIOL, V103, P467, DOI 10.1104/pp.103.2.467	51	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196693	10.1371/journal.pone.0196693	http://dx.doi.org/10.1371/journal.pone.0196693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698515	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600119
J	Kreilinger, A; Georgi, T; Pregartner, G; Ivastinovic, D; Pichler, T; Berghold, A; Velikay-Parel, M				Kreilinger, Alex; Georgi, Thomas; Pregartner, Gudrun; Ivastinovic, Domagoj; Pichler, Tamara; Berghold, Andrea; Velikay-Parel, Michaels			Quantifying the impact on navigation performance in visually impaired: Auditory information loss versus information gain enabled through electronic travel aids	PLOS ONE			English	Article							QUALITY-OF-LIFE; RETINITIS-PIGMENTOSA; SENSORY IMPAIRMENT; MOBILITY PERFORMANCE; VISION IMPAIRMENT; EVERYDAY COMPETENCE; BLIND INDIVIDUALS; FUNCTIONAL STATUS; OLDER PERSONS; HEARING-LOSS	This study's purpose was to analyze and quantify the impact of auditory information loss versus information gain provided by electronic travel aids (ETAs) on navigation performance in people with low vision. Navigation performance of ten subjects (age: 54.9 +/- 11.2 years) with visual acuities >1.0 LogMAR was assessed via the Graz Mobility Test (GMT). Subjects passed through a maze in three different modalities: 'Normal' with visual and auditory information available, 'Auditory Information Loss' with artificially reduced hearing (leaving only visual information), and 'ETA' with a vibrating ETA based on ultrasonic waves, thereby facilitating visual, auditory, and tactile information. Main performance measures comprised passage time and number of contacts. Additionally, head tracking was used to relate head movements to motion direction. When comparing 'Auditory Information Loss' to 'Normal', subjects needed significantly more time (p<0.001), made more contacts (p<0.001), had higher relative viewing angles (p = 0.002), and a higher percentage of orientation losses (p = 0.011). The only significant difference when comparing 'ETA' to 'Normal' was a reduced number of contacts (p<0.001). Our study provides objective, quantifiable measures of the impact of reduced hearing on the navigation performance in low vision subjects. Significant effects of 'Auditory Information Loss' were found for all measures; for example, passage time increased by 17.4%. These findings show that low vision subjects rely on auditory information for navigation. In contrast, the impact of the ETA was not significant but further analysis of head movements revealed two different coping strategies: half of the subjects used the ETA to increase speed, whereas the other half aimed at avoiding contacts.	[Kreilinger, Alex; Georgi, Thomas; Ivastinovic, Domagoj; Pichler, Tamara; Velikay-Parel, Michaels] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Pregartner, Gudrun; Berghold, Andrea] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Graz	Kreilinger, A (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.	alex.kreilinger@medunigraz.at						Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bailey IL, 2012, OPTOMETRY VISION SCI, V89, P1257, DOI 10.1097/OPX.0b013e318264e85a; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Bittner AK, 2011, INVEST OPHTH VIS SCI, V52, P8042, DOI 10.1167/iovs.11-8321; Bittner AK, 2011, OPTOMETRY VISION SCI, V88, P1153, DOI 10.1097/OPX.0b013e3182271638; Brennan M, 2005, GERONTOLOGIST, V45, P337, DOI 10.1093/geront/45.3.337; Brennan M, 2006, J REHABIL RES DEV, V43, P777, DOI 10.1682/JRRD.2005.06.0109; BROWN B, 1986, AM J OPTOM PHYS OPT, V63, P733; CARABELLESE C, 1993, J AM GERIATR SOC, V41, P401, DOI 10.1111/j.1532-5415.1993.tb06948.x; Chebat DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126307; Chebat DR, 2011, NEUROREPORT, V22, P342, DOI 10.1097/WNR.0b013e3283462def; Colenbrander A, 2010, ACTA OPHTHALMOL, V88, P163, DOI 10.1111/j.1755-3768.2009.01670.x; CRAIG JC, 1988, INT J REHABIL RES, V11, P167, DOI 10.1097/00004356-198806000-00007; Crews JE, 2004, AM J PUBLIC HEALTH, V94, P823, DOI 10.2105/AJPH.94.5.823; DAKOPOULOS D, 2010, T SYS MAN CYBER C, V40, P25, DOI DOI 10.1109/TSMCC.2009.2021255; David P, 2004, INT J COMPUT VISION, V59, P259, DOI 10.1023/B:VISI.0000025800.10423.1f; Diderot Denis, 2011, BLINDNESS ENLIGHTENM; EDWARDS AS, 1946, J EXP PSYCHOL, V36, P526, DOI 10.1037/h0059909; Fischer ME, 2009, OPHTHAL EPIDEMIOL, V16, P346, DOI 10.3109/09286580903312236; Ganz A, 2012, INT J TELEMED APPL, V2012, DOI 10.1155/2012/894869; Georgi T, 2008, INVEST OPHTH VIS SCI, V49, P1781; Geruschat DR, 1998, OPTOMETRY VISION SCI, V75, P525, DOI 10.1097/00006324-199807000-00022; Grant AC, 2000, PERCEPT PSYCHOPHYS, V62, P301, DOI 10.3758/BF03205550; Haymes S, 1996, OPTOMETRY VISION SCI, V73, P621, DOI 10.1097/00006324-199610000-00001; Haymes SA, 2002, OPHTHAL PHYSL OPT, V22, P79, DOI 10.1046/j.1475-1313.2002.00016.x; Hicheur H, 2005, NEUROSCI LETT, V383, P87, DOI 10.1016/j.neulet.2005.03.046; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Keller BK, 1999, J AM GERIATR SOC, V47, P1319, DOI 10.1111/j.1532-5415.1999.tb07432.x; Kolarik AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175750; Kolarik AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160872; Kolarik AJ, 2016, EXP BRAIN RES, V234, P1725, DOI 10.1007/s00221-016-4567-y; Kuyk T, 1998, OPTOMETRY VISION SCI, V75, P174, DOI 10.1097/00006324-199803000-00022; Laforge R.G., 1992, J AGING HEALTH, V4, P126, DOI [10.1177/089826439200400108, DOI 10.1177/089826439200400108]; Latham K, 2010, OPHTHAL PHYSL OPT, V30, P55, DOI 10.1111/j.1475-1313.2009.00693.x; Leat SJ, 2006, CLIN EXP OPTOM, V89, P215, DOI 10.1111/j.1444-0938.2006.00050.x; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; Lee P, 1999, AM J OPHTHALMOL, V127, P447, DOI 10.1016/S0002-9394(98)00418-8; Legge GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076783; Lovie-Kitchin JE, 2010, OPTOMETRY VISION SCI, V87, P948, DOI 10.1097/OPX.0b013e3181ff99be; McAnally KI, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00210; Postma A, 2007, PERCEPTION, V36, P1253, DOI 10.1068/p5441; Reuben DB, 1999, J AM GERIATR SOC, V47, P930, DOI 10.1111/j.1532-5415.1999.tb01286.x; Reuben DB, 1998, J AM GERIATR SOC, V46, P1008, DOI 10.1111/j.1532-5415.1998.tb02758.x; Soong GP, 2001, OPTOMETRY VISION SCI, V78, P657, DOI 10.1097/00006324-200109000-00011; Supa M, 1944, AM J PSYCHOL, V57, P133, DOI 10.2307/1416946; Turano KA, 1999, INVEST OPHTH VIS SCI, V40, P865; Velikay-Parel M, 2007, J NEURAL ENG, V4, pS102, DOI 10.1088/1741-2560/4/1/S12; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Wallhagen MI, 2001, J AM GERIATR SOC, V49, P1086, DOI 10.1046/j.1532-5415.2001.49213.x; Wallmeier L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1428; West SK, 2002, ARCH OPHTHALMOL-CHIC, V120, P774	52	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196156	10.1371/journal.pone.0196156	http://dx.doi.org/10.1371/journal.pone.0196156			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1WN	29698428	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600041
J	Speed, JDM; Bendiksby, M; Finstad, AG; Hassel, K; Kolstad, AL; Presto, T				Speed, James D. M.; Bendiksby, Mika; Finstad, Anders G.; Hassel, Kristian; Kolstad, Anders L.; Presto, Tommy			Contrasting spatial, temporal and environmental patterns in observation and specimen based species occurrence data	PLOS ONE			English	Article							BIOLOGICAL COLLECTIONS; DISTRIBUTION MODELS; BIODIVERSITY DATA; CITIZEN SCIENCE; CLIMATE-CHANGE; DISTRIBUTIONS; CONSERVATION; DIVERSITY; DATABASES; ECOLOGY	Species occurrence data records the location and time of an encounter with a species, and is valuable for many aspects of ecological and evolutionary analyses. A key distinction within species occurrence data is between (1) collected and preserved specimens that can be taxonomically validated (i.e., natural history collections), and (2) observations, which are more error prone but richer in terms of number and spread of observations. In this study we analyse the distribution in temporal, spatial, taxonomic and environmental coverage of specimen- and observation based species occurrence data for land plants in Norway, a region with strong climatic and human population density gradients. Of 4.8 million species occurrence records, the majority (78%) were observations. However, there was a greater species richness in the specimen record (N = 4691) than in the observation record (N = 3193) and most species were recorded more as specimens than observations. Specimen data was on average older, and collected later during the year. Both record types were highly influenced by a small number of prolific contributors. The species most highly represented in the observation data set were widespread or invasive, while in the specimen records, taxonomically challenging species were overrepresented. Species occurrence records were unevenly spatially distributed. Both specimen and observation records were concentrated in regions of Norway with high human population density and with high temperatures and precipitation, but in different regions within Norway. Observation and specimen records thus differ in taxonomic, temporal, spatial and environmental coverage for a well-sampled group and study region, potentially influencing the ecological inferences made from studies utilizing species occurrence data. The distribution of observation data dominates the dataset, so inferences of species diversity and distributions do not correspond to the evolutionary or physiological knowledge of species, which is based on specimen data. We make recommendations for users of biodiversity data, and collectors to better exploit the complementary strengths of these distinct biodiversity data types.	[Speed, James D. M.; Bendiksby, Mika; Finstad, Anders G.; Hassel, Kristian; Kolstad, Anders L.; Presto, Tommy] Norwegian Univ Sci & Technol, NTNU Univ Museum, Dept Nat Hist, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Speed, JDM (corresponding author), Norwegian Univ Sci & Technol, NTNU Univ Museum, Dept Nat Hist, Trondheim, Norway.	james.spned@ntou.no	Speed, James D. M./C-1099-2009; Hassel, Kristian/AAD-7241-2022; Kolstad, Anders/N-7538-2019; Finstad, Anders Gravbrot/H-6519-2015	Speed, James D. M./0000-0002-0633-5595; Hassel, Kristian/0000-0002-1906-8166; Kolstad, Anders/0000-0002-9623-9491; Finstad, Anders Gravbrot/0000-0003-4529-6266				[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Araujo MB, 2000, BIOL CONSERV, V96, P331, DOI 10.1016/S0006-3207(00)00074-4; Asase A., 2016, BIODIVERS INFORM, V11, P1, DOI [10.17161/bi.v11i0.5860, DOI 10.17161/BI.V11I0.5860]; Beck J, 2014, ECOL INFORM, V19, P10, DOI 10.1016/j.ecoinf.2013.11.002; Belbin L, 2013, ZOOKEYS, P67, DOI 10.3897/zookeys.305.5438; Berendsohn WG, 2010, SUMMARY RECOMMENDATI, V7; Bird TJ, 2014, BIOL CONSERV, V173, P144, DOI 10.1016/j.biocon.2013.07.037; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Costello MJ, 2013, TRENDS ECOL EVOL, V28, P454, DOI 10.1016/j.tree.2013.05.002; Culley TM, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300076; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elven H, 2016, KUNNSKAPSSTATUS ARTS; Elven Reidar, 2007, Blyttia, V65, P238; Feeley KJ, 2010, J BIOGEOGR, V37, P733, DOI 10.1111/j.1365-2699.2009.02240.x; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Fortin MJ, 2005, OIKOS, V108, P7, DOI 10.1111/j.0030-1299.2005.13146.x; Funk VA, 1999, BIODIVERS CONSERV, V8, P727, DOI 10.1023/A:1008877222842; Gaston KJ, 2011, BIOSCIENCE, V61, P354, DOI 10.1525/bio.2011.61.5.4; GBIF.org, 2017, GBIF OCC DOWNL, DOI [10.15468/dl.f2guqo.2017, DOI 10.15468/DL.F2GUQO.2017]; GBIF Secretariat, 2021, GBIF BACKBONE TAXONO, DOI [10.15468/39omei, DOI 10.15468/39OMEI, 10.15468/39OMEI]; Gederaas L, 2012, ALIEN SPECIES NORWAY; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Grootaert P., 2010, MANUAL FIELD RECORDI, P377, DOI 10.1128/AEM.00759-10; Guillera-Arroita G, 2017, ECOGRAPHY, V40, DOI 10.1111/ecog.02445; Hart R, 2014, P NATL ACAD SCI USA, V111, P10615, DOI 10.1073/pnas.1403376111; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2000, CONSERV BIOL, V14, P1755, DOI [10.1046/j.1523-1739.2000.98543.x, 10.1111/j.1523-1739.2000.98543.x]; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Lavoie C, 2013, PERSPECT PLANT ECOL, V15, P68, DOI 10.1016/j.ppees.2012.10.002; Lister AM, 2011, TRENDS ECOL EVOL, V26, P153, DOI 10.1016/j.tree.2010.12.009; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Mair L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147796; Maldonado C, 2015, GLOBAL ECOL BIOGEOGR, V24, P973, DOI 10.1111/geb.12326; Martin MD, 2014, MOL ECOL, V23, P1701, DOI 10.1111/mec.12675; Mesibov R, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.293.5111; Miller DAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065808; Newbold T, 2010, PROG PHYS GEOG, V34, P3, DOI 10.1177/0309133309355630; Otegui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055144; Pocock MJO, 2015, BIOL J LINN SOC, V115, P475, DOI 10.1111/bij.12548; Primack D, 2004, AM J BOT, V91, P1260, DOI 10.3732/ajb.91.8.1260; Pyke GH, 2010, BIOL REV, V85, P247, DOI 10.1111/j.1469-185X.2009.00098.x; Reichman OJ, 2011, SCIENCE, V331, P703, DOI 10.1126/science.1197962; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Smith BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151232; Soberon J, 2004, PHILOS T R SOC B, V359, P689, DOI 10.1098/rstb.2003.1439; Soberon JM, 2000, BIODIVERS CONSERV, V9, P1441, DOI 10.1023/A:1008987010383; Speed JDM, 2017, BIOL CONSERV, V205, P77, DOI 10.1016/j.biocon.2016.11.030; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Sutherland WJ, 2015, BIOL J LINN SOC, V115, P779, DOI 10.1111/bij.12576; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Tye CA, 2016, J APPL ECOL; van der Wal R, 2015, AMBIO, V44, pS584, DOI 10.1007/s13280-015-0709-x; Waeber PO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183903; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0	58	21	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196417	10.1371/journal.pone.0196417	http://dx.doi.org/10.1371/journal.pone.0196417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698441	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000431007600077
J	Niihata, K; Fukuma, S; Hiratsuka, Y; Ono, K; Yamada, M; Sekiguchi, M; Otani, K; Kikuchi, S; Konno, S; Fukuhara, S				Niihata, Kakuya; Fukuma, Shingo; Hiratsuka, Yoshimune; Ono, Koichi; Yamada, Masakazu; Sekiguchi, Miho; Otani, Koji; Kikuchi, Shinichi; Konno, Shinichi; Fukuhara, Shunichi			Association between vision-specific quality of life and falls in community-dwelling older adults: LOHAS	PLOS ONE			English	Article							BEAVER DAM EYE; RISK-FACTORS; VISUAL FUNCTION; POPULATION; IMPAIRMENT; LIMITATIONS; PREDICTORS; FRACTURES; OUTCOMES	Background Falls and fall-related fractures are a major public health problem among the older adults. Although objective measures of poor vision have been reported to be associated with falls, the association of self-reported visual function and vision-specific quality of life (QOL) with falls has been inconsistent across several studies. We investigated the association of self-reported visual function and vision specific QOL with falls in community-dwelling older adults. Methods We conducted a cross-sectional analysis using the baseline data from participants of the Locomotive Syndrome and Health Outcome in Aizu Cohort Study (LOHAS), which is an ongoing population-based cohort study to evaluate the association of physical dysfunction with the clinical outcomes in community-dwelling people. In the present study, the participants aged over 65 years in 2010 were eligible. The exposure variable was the composite score of the VFQ-J11, which was newly developed using item response theory to evaluate vision specific QOL, and the self-reported outcomes were any fall and frequent falls (>= 2) over a 1-month period. We estimated odds ratios using separate logistic regression models adjusted for relevant confounding factors. Results Among 1624 participants, the median (interquartile range) composite score of VFQ-J11 was 86.8 (76.0-95.9). Any fall and frequent falls were reported by 13.9% and 5.4% of participants, respectively. The composite score of the VFQ-J11 was significantly associated with both frequent falls (adjusted ORs per 10 points, 0.80; 95% CI, 0.68-0.93) and any fall (adjusted ORs per 10 points, 0.84; 95% CI, 0.76-0.94). Conclusions We found that the composite score of the VFQ-J11 was associated with falls in community-dwelling older adults. Detecting individuals with visual impairments associated with falls using the VFQ-J11 and improvement in the score by interventions could prevent falls. We may consider adding self-reported visual function and vision-specific QOL to conventional risk factors for fall among older adults.	[Niihata, Kakuya] Fukushima Med Univ, Div Clin Epidemiol, Fukushima, Japan; [Niihata, Kakuya; Fukuma, Shingo; Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Commun & Clin Excellence CiRC2LE, Fukushima, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Fukuma, Shingo] Inst Hlth Outcomes & Proc Evaluat Res iHope Int, Kyoto, Japan; [Fukuma, Shingo] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Hiratsuka, Yoshimune] Juntendo Univ, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Ono, Koichi] Juntendo Tokyo Koto Geriatr Med Ctr, Dept Ophthalmol, Tokyo, Japan; [Yamada, Masakazu] Kyorin Univ, Dept Ophthalmol, Tokyo, Japan; [Sekiguchi, Miho; Otani, Koji; Konno, Shinichi] Fukushima Med Univ, Sch Med, Dept Orthoped Surg, Fukushima, Japan; [Kikuchi, Shinichi] Fukushima Med Univ, Fukushima Global Med Sci Ctr, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University; Kyoto University; Kyoto University; Juntendo University; Juntendo University; Kyorin University; Fukushima Medical University; Fukushima Medical University	Fukuma, S (corresponding author), Fukushima Med Univ, Ctr Innovat Res Commun & Clin Excellence CiRC2LE, Fukushima, Japan.; Fukuma, S (corresponding author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan.; Fukuma, S (corresponding author), Inst Hlth Outcomes & Proc Evaluat Res iHope Int, Kyoto, Japan.; Fukuma, S (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan.	fukuma.shingo.3m@kyoto-u.ac.jp	Otani, Koji/ABF-8564-2020	Otani, Koji/0000-0001-8409-9623; Fukuma, Shingo/0000-0002-8379-8761				Black Alex, 2005, Clin Exp Optom, V88, P212; de Boer MR, 2004, J BONE MINER RES, V19, P1539, DOI 10.1359/JBMR.040504; Fukuhara S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073084; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Hiratsuka Y, 2014, JPN J OPHTHALMOL, V58, P415, DOI 10.1007/s10384-014-0335-3; Inouye SK, 1998, J GERIATR PSYCH NEUR, V11, P118, DOI 10.1177/089198879801100302; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; Jacomb PA, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-4; Jaffee EG, 2016, J HEALTH COMMUN, V21, P135, DOI 10.1080/10810730.2016.1179371; Kallstrand-Eriksson J, 2013, SCAND J CARING SCI, V27, P433, DOI 10.1111/j.1471-6712.2012.01053.x; Klein BEK, 2003, OPHTHALMOLOGY, V110, P644, DOI 10.1016/S0161-6420(02)01935-8; Klein BEK, 1998, OPHTHALMOLOGY, V105, P160, DOI 10.1016/S0161-6420(98)91911-X; Kurita N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002413; LORD SR, 1991, AGE AGEING, V20, P175, DOI 10.1093/ageing/20.3.175; Morris M, 2004, AUST J PHYSIOTHER, V50, P153, DOI 10.1016/S0004-9514(14)60153-7; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Otani K, 2012, J ORTHOP SCI, V17, P261, DOI 10.1007/s00776-012-0200-5; Ramrattan RS, 2001, ARCH OPHTHALMOL-CHIC, V119, P1788, DOI 10.1001/archopht.119.12.1788; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Steinman BA, 2015, J AGING HEALTH, V27, P158, DOI 10.1177/0898264314543473; Suzukamo Yoshimi, 2005, Health Qual Life Outcomes, V3, P65, DOI 10.1186/1477-7525-3-65; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; Yamazaki Shin, 2005, Health Qual Life Outcomes, V3, P48	25	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0195806	10.1371/journal.pone.0195806	http://dx.doi.org/10.1371/journal.pone.0195806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7GN	29689064	Green Published, Green Submitted, gold			2022-12-26	WOS:000430678800015
J	Statello, L; Maugeri, M; Garre, E; Nawaz, M; Wahlgren, J; Papadimitriou, A; Lundqvist, C; Lindfors, L; Collen, A; Sunnerhagen, P; Ragusa, M; Purrello, M; Di Pietro, C; Tigue, N; Valadi, H				Statello, Luisa; Maugeri, Marco; Garre, Elena; Nawaz, Muhammad; Wahlgren, Jessica; Papadimitriou, Alexandros; Lundqvist, Christina; Lindfors, Lennart; Collen, Anna; Sunnerhagen, Per; Ragusa, Marco; Purrello, Michele; Di Pietro, Cinzia; Tigue, Natalie; Valadi, Hadi			Identification of RNA-binding proteins in exosomes capable of interacting with different types of RNA: RBP-facilitated transport of RNAs into exosomes	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; MESSENGER-RNA; PROTEOMIC ANALYSIS; EMERGING ROLE; CELLS; MICROVESICLES; MICRORNAS; EXPRESSION; BIOMARKERS; NUCLEOLIN	The RNA that is packaged into exosomes is termed as exosomal-shuttle RNA (esRNA); however, the players, which take this subset of RNA (esRNA) into exosomes, remain largely unknown. We hypothesized that RNA binding proteins (RBPs) could serve as key players in this mechanism, by making complexes with RNAs and transporting them into exosomes during the biosynthesis of exosomes. Here, we demonstrate the presence of 30 RBPs in exosomes that were shown to form RNA-RBP complexes with both cellular RNA and exosomal-RNA species. To assess the involvement of these RBPs in RNA-transfer into exosomes, the gene transcripts encoding six of the proteins identified in exosomes (HSP90AB1, XPO5, hnRNPH1, hnRNPM, hnRNPA2B1, and MVP) were silenced by siRNA and subsequent effect on esRNA was assessed. A significant reduction of total esRNA was observed by post-transcriptional silencing of MVP, compared to other RBPs. Furthermore, to confirm the binding of MVP with esRNA, a biotinylated-MVP was transiently expressed in HEK293F cells. Higher levels of esRNA were recovered from MVP that was eluted from exosomes of transfected cells, as compared to those of non-transfected cells. Our data indicate that these RBPs could end up in exosomes together with RNA molecules in the form of RNA-ribonu-cleoprotein complexes, which could be important for the transport of RNAs into exosomes and the maintenance of RNAs inside exosomes. This type of maintenance may favor the shuttling of RNAs from exosomes to recipient cells in the form of stable complexes.	[Statello, Luisa; Maugeri, Marco; Garre, Elena; Nawaz, Muhammad; Wahlgren, Jessica; Papadimitriou, Alexandros; Lundqvist, Christina; Valadi, Hadi] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Lindfors, Lennart] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Collen, Anna] AstraZeneca AB, Dept Pharmaceut Sci, Innovat Med, Gothenburg, Sweden; [Sunnerhagen, Per] Univ Gothenburg, Lundberg Lab, Dept Chem & Mol Biol, Gothenburg, Sweden; [Ragusa, Marco; Purrello, Michele; Di Pietro, Cinzia] Univ Catania, Dept Biomed & Biotechnol Sci, Sect Biol & Genet G Sichel, BioMol Genome & Complex Syst BioMed Unit BMGS, Catania, Italy; [Tigue, Natalie] MedImmune Ltd, Dept Antibody Discovery & Prot Engn, Granta Pk, Cambridge, England	University of Gothenburg; University of Gothenburg; AstraZeneca; University of Gothenburg; University of Catania; AstraZeneca; Medimmune	Valadi, H (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	hadi.valadi@gu.se	Ragusa, Marco/D-7691-2010; Sunnerhagen, Per/G-1696-2012; Nawaz, Muhammad/B-6596-2014; Statello, Luisa/AAU-5115-2021; Statello, Luisa/ABG-9166-2020; Valadi, Hadi/ABH-9766-2020; Maugeri, Marco/AAF-6569-2020	Ragusa, Marco/0000-0002-4282-920X; Sunnerhagen, Per/0000-0002-0967-8729; Nawaz, Muhammad/0000-0002-0792-8296; Statello, Luisa/0000-0001-8261-4214; Valadi, Hadi/0000-0003-3482-2451; Maugeri, Marco/0000-0003-2157-1542; Tigue, Natalie/0000-0001-9916-0255; Collen, Anna/0000-0002-3220-7247; Lundqvist, Christina/0000-0002-2256-4072	Swedish research council (VR); Swedish Foundation of Strategic Research in the Industrial Research Centre; FoRmulaEx - Nucleotide Functional Drug Delivery [IRC15-0065]; Aroseniusfonden; Magnus Bergvalls Stiftelse; IngaBritt och Arne Lundbergs Forskningsstiftelse; Sao Paulo Research Foundation (FAPESP) [12/24574-3]; Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil [99999.007057/2015-06]	Swedish research council (VR)(Swedish Research Council); Swedish Foundation of Strategic Research in the Industrial Research Centre(Swedish Foundation for Strategic Research); FoRmulaEx - Nucleotide Functional Drug Delivery; Aroseniusfonden; Magnus Bergvalls Stiftelse; IngaBritt och Arne Lundbergs Forskningsstiftelse; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work has been financially, supported by grants from the Swedish research council (VR), the Swedish Foundation of Strategic Research in the Industrial Research Centre, FoRmulaEx - Nucleotide Functional Drug Delivery (IRC15-0065), Aroseniusfonden, Magnus Bergvalls Stiftelse, and IngaBritt och Arne Lundbergs Forskningsstiftelse. We also acknowledge Sao Paulo Research Foundation (FAPESP), Proc. No. 12/24574-3), and the Coordination for the Improvement of Higher Education Personnel (CAPES, Proc. No. 99999.007057/2015-06), Brazil. The funding agencies had no influence on the study design, data collection and analysis, or writing and submission of the report.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bellingham SA, 2012, NUCL ACIDS RES; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Bolukbasi MF, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2011.2; Bomsztyk K, 1997, FEBS LETT, V403, P113, DOI 10.1016/S0014-5793(97)00041-0; Bouvet P, 2001, J MOL BIOL, V309, P763, DOI 10.1006/jmbi.2001.4691; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Ekstrom K, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18389; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fatima F, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00161; Fatima F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00545; Fatima Farah, 2017, Non-Coding RNA, V3, P10, DOI 10.3390/ncrna3010010; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Folk P, 2004, CELL MOL LIFE SCI, V61, P629, DOI 10.1007/s00018-003-3215-4; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Gourzones C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-119; Guduric-Fuchs J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-357; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Iavello A, 2016, INT J MOL MED, V37, P958, DOI 10.3892/ijmm.2016.2488; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Jannot G, 2011, EMBO REP, V12, P581, DOI 10.1038/embor.2011.66; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Kanada M, 2015, P NATL ACAD SCI USA, V112, pE1433, DOI 10.1073/pnas.1418401112; Katsuda T, 2013, PROTEOMICS; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Li JM, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/9853070; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mateescu B, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1286095; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McKenzie AJ, 2016, CELL REP, V15, P978, DOI 10.1016/j.celrep.2016.03.085; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Nawaz M, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00050; Nawaz M, 2014, NAT REV UROL, V11, P688, DOI 10.1038/nrurol.2014.301; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Nolte-tHoen EN, 2012, NUCLEIC ACIDS RES, DOI [10.1038/embor.2011.66, DOI 10.1038/EMBOR.2011.66]; Olver Christine, 2007, V43, P99, DOI 10.1007/978-1-4020-5943-8_7; Tosar JP, 2015, NUCLEIC ACIDS RES, V43, P5601, DOI 10.1093/nar/gkv432; Parchure A, 2017, NEURON, V96, P604, DOI 10.1016/j.neuron.2017.10.020; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Patton JG, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27494; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Principe S, 2013, PROTEOMICS, V13, P1667, DOI 10.1002/pmic.201200561; Ragusa Marco, 2014, Oncoscience, V1, P132; Ramirez MI, 2018, NANOSCALE; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Santangelo L, 2016, CELL REP, V17, P799, DOI 10.1016/j.celrep.2016.09.031; Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; Squadrito ML, 2014, CELL REP, V8, P1432, DOI 10.1016/j.celrep.2014.07.035; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Teng Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14448; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Tominaga K, 2011, MOL CELL BIOL, V31, P4219, DOI 10.1128/MCB.05955-11; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Balkom BWM, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26760; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Volk N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019391; Wahlgren J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks463; Wani S, 2018, CELL BIOCHEM FUNCT, V36, P106, DOI 10.1002/cbf.3323; Welton JL, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31209; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251	90	114	118	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0195969	10.1371/journal.pone.0195969	http://dx.doi.org/10.1371/journal.pone.0195969			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689087	Green Published, gold			2022-12-26	WOS:000430678800019
J	Al-Saffar, A; Awang, S; Tao, H; Omar, N; Al-Saiagh, W; Al-bared, M				Al-Saffar, Ahmed; Awang, Suryanti; Tao, Hai; Omar, Nazlia; Al-Saiagh, Wafaa; Al-bared, Mohammed			Malay sentiment analysis based on combined classification approaches and Senti-lexicon algorithm	PLOS ONE			English	Article							OPINION	Sentiment analysis techniques are increasingly exploited to categorize the opinion text to one or more predefined sentiment classes for the creation and automated maintenance of review-aggregation websites. In this paper, a Malay sentiment analysis classification model is proposed to improve classification performances based on the semantic orientation and machine learning approaches. First, a total of 2,478 Malay sentiment-lexicon phrases and words are assigned with a synonym and stored with the help of more than one Malay native speaker, and the polarity is manually allotted with a score. In addition, the supervised machine learning approaches and lexicon knowledge method are combined for Malay sentiment classification with evaluating thirteen features. Finally, three individual classifiers and a combined classifier are used to evaluate the classification accuracy. In experimental results, a wide-range of comparative experiments is conducted on a Malay Reviews Corpus (MRC), and it demonstrates that the feature extraction improves the performance of Malay sentiment analysis based on the combined classification. However, the results depend on three factors, the features, the number of features and the classification approach.	[Al-Saffar, Ahmed; Awang, Suryanti; Tao, Hai] Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Pahang, Malaysia; [Omar, Nazlia; Al-Saiagh, Wafaa; Al-bared, Mohammed] Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Bangi, Selangor, Malaysia	Universiti Malaysia Pahang; Universiti Kebangsaan Malaysia	Al-Saffar, A (corresponding author), Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Pahang, Malaysia.	ahmed_saffar5@siswa.ukm.edu.my	Awang, Suryanti/L-8747-2016; HAI, TAO/D-9580-2011; Hai, Tao/AFU-5851-2022; Omar, Nazlia/L-9901-2019	Omar, Nazlia/0000-0002-8173-8933; Awang, Suryanti/0000-0002-5468-1150	Universiti Malaysia Pahang (UMP) [RDU1603102]	Universiti Malaysia Pahang (UMP)	The authors would like to express their deep gratitude to Universiti Malaysia Pahang (UMP) for provided the financial support under project no. RDU1603102. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2008, ACM T INFORM SYST, V26, DOI [10.1145/1344411.1344413, 10.1145/1361684.1361685]; Alfred  R., 2016, INT C SOFT COMP DAT, V652, P289; [Anonymous], 2015, J COMPUTER SCI; Asghar MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140204; Bahrainian SA, 2013, 2013 IEEE/WIC/ACM INTERNATIONAL JOINT CONFERENCE ON WEB INTELLIGENCE AND INTELLIGENT AGENT TECHNOLOGY - WORKSHOPS (WI-IAT), VOL 3, P26, DOI 10.1109/WI-IAT.2013.145; Cambria E, 2017, IEEE INTELL SYST, V32, P74, DOI 10.1109/MIS.2017.4531228; Cambria E, 2016, KNOWL-BASED SYST, V108, P1, DOI 10.1016/j.knosys.2016.07.025; Cambria E, 2016, IEEE COMPUT INTELL M, V11, P9, DOI 10.1109/MCI.2016.2572481; Cambria E, 2016, IEEE INTELL SYST, V31, P102, DOI 10.1109/MIS.2016.31; Chaovalit Pimwadee, 2005, P 38 ANN HAW INT C S, p112c; Chaturvedi I, 2017, INFORM FUSION, P65; DASARATHY BV, 1979, P IEEE, V67, P708, DOI 10.1109/PROC.1979.11321; Dehkharghani R, 2012, INT CONF DAT MIN WOR, P669, DOI 10.1109/ICDMW.2012.121; Diez-Pastor JF, 2015, INFORM SCIENCES, V325, P98, DOI 10.1016/j.ins.2015.07.025; Dzeroski S, 2004, MACH LEARN, V54, P255, DOI 10.1023/B.MAC.0000015881.36452.6e; Esuli A., 2005, P CIKM 05 P 14 ACM I, P617; Gang Li, 2010, Proceedings 2010 IEEE International Conference on Intelligent Systems and Knowledge Engineering (ISKE 2010), P331, DOI 10.1109/ISKE.2010.5680859; Gezici G., 2012, WORKSH SENT AN SDAD, P5; HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871; Hasbullah S., 2016, P 10 INT C UB INF MA; Hollander JB, 2016, SHORT HIST SOCIAL ME, P15; Isa D, 2008, IEEE T KNOWL DATA EN, V20, P1264, DOI 10.1109/TKDE.2008.76; Isa N, 2013, LECT NOTES ENG COMP, P1543; Joachims T., 2001, P 24 ANN INT ACM SIG, P128, DOI DOI 10.1145/383952.383974; Kamps Jaap, 2004, P 4 INT C LANG RES E, P1115; Kang H, 2012, EXPERT SYST APPL, V39, P6000, DOI 10.1016/j.eswa.2011.11.107; Karanasou M, 2016, INT CONF DAT MIN WOR, P944, DOI [10.1109/ICDMW.2016.0138, 10.1109/ICDMW.2016.74]; Keshavarz H, 2017, KNOWL-BASED SYST, V122, P1, DOI 10.1016/j.knosys.2017.01.028; Li SS, 2007, PROCEEDINGS OF THE 2007 IEEE INTERNATIONAL CONFERENCE ON NATURAL LANGUAGE PROCESSING AND KNOWLEDGE ENGINEERING (NLP-KE'07), P135; Li XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124672; Liu B, 2012, MINING TEXT DATA, P415, DOI [10.1007/978-1-4614-3223-4_13, DOI 10.1007/978-1-4614-3223-4_13]; Liu L, 2009, ENCY DATABASE SYSTEM, V6, P1543; Lo SL, 2017, ARTIF INTELL REV, V48, P499, DOI 10.1007/s10462-016-9508-4; Mahafdah Rund, 2014, Journal of Computer Science, V10, P1865, DOI 10.3844/jcssp.2014.1865.1873; Medhat W, 2014, AIN SHAMS ENG J, V5, P1093, DOI 10.1016/j.asej.2014.04.011; Mudinas A., 2012, P 1 INT WORKSH ISS S, P5; Muhammad A, 2016, KNOWL-BASED SYST, V108, P92, DOI 10.1016/j.knosys.2016.05.032; Omar Nazlia, 2013, International Journal of Advancements in Computing Technology, V5, P77; Onan A, 2016, ADV INTELL SYST, V464, P167, DOI 10.1007/978-3-319-33625-1_16; Pang Bo, 2002, P ACL 02 C EMP METH, V10; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Poria S., 2015, P 2015 C EMP METH NA, P2539; Poria S, 2016, KNOWL-BASED SYST, V108, P42, DOI 10.1016/j.knosys.2016.06.009; Puteh M, 2013, LECT NOTES ENG COMP, P1498; Qin P, 2009, WISM: 2009 INTERNATIONAL CONFERENCE ON WEB INFORMATION SYSTEMS AND MINING, PROCEEDINGS, P181, DOI 10.1109/WISM.2009.44; Rana T.A., 2016, ARTIF INTELL REV, P1; Samsudin N, 2013, INT J ADV COMPUT SC, V4, P19; Samsudin N, 2013, LECT NOTES ENG COMP, P1520; Samsudin N, 2011, IEEE DATA MINING, P38, DOI 10.1109/DMO.2011.5976502; Taboada M, 2011, COMPUT LINGUIST, V37, P267, DOI 10.1162/COLI_a_00049; Ting-Chun Peng, 2010, Proceedings of the 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology - Workshops (WI-IAT 2010), P243, DOI 10.1109/WI-IAT.2010.229; Wang G, 2015, INFORM PROCESS MANAG, V51, P458, DOI 10.1016/j.ipm.2014.09.004; Wilson T, 2005, P HLTEMNLP INTERACTI, P34, DOI DOI 10.3115/1225733.1225751; Ye Q, 2009, EXPERT SYST APPL, V36, P6527, DOI 10.1016/j.eswa.2008.07.035; Zhou Z.-H., 2012, ENSEMBLE METHODS FDN, P15	56	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0194852	10.1371/journal.pone.0194852	http://dx.doi.org/10.1371/journal.pone.0194852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684036	Green Submitted, gold, Green Published			2022-12-26	WOS:000430660600007
J	Moore, KL; Patel, K; Boscardin, WJ; Steinman, MA; Ritchie, C; Schwartz, JB				Moore, Kelly L.; Patel, Kanan; Boscardin, W. John; Steinman, Michael A.; Ritchie, Christine; Schwartz, Janice B.			Medication burden attributable to chronic co-morbid conditions in the very old and vulnerable	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; NURSING-HOME; UNITED-STATES; POLYPHARMACY; RESIDENTS; QUALITY; ADULTS; CARE; MULTIMORBIDITY; PREVALENCE	Objective & para;& para;Polypharmacy is common in older patients but relationships between polypharmacy and common co-morbid conditions have not been elucidated. Our goal was to determine relationships between daily oral medication use and common co-morbid disease dyads and triads using comprehensive medication and diagnostic data from a national sample of nursing homes (NH).& para;& para;Design & para;& para;Retrospective, cross-sectional study.& para;& para;Setting & para;& para;Nationally representative sample of U.S. Nursing Homes.& para;& para;Participants & para;& para;Nationally representative sample of long-term stay residents (n = 11734, 75% women) aged 65 years or older.& para;& para;Measurements & para;& para;Diagnosis and medication data were analyzed. Proportion of daily oral medication intake attributed to treatment of common two-(dyads) and three-disease (triad) combinations and "health maintenance" agents (vitamins, dietary supplements, stool softeners without related diagnoses) was determined.& para;& para;Results & para;& para;Older NH residents received slightly >8 oral medications/day with the number related to number of medical diagnoses (p < .0001). One third of chronic oral medication intake/day (excluding health maintenance agents) could be attributed to dyad combinations and about half to triad combinations despite an average of 5 other diagnoses. Triads were comprised of hypertension +/- arthritis +/- vascular disease, +/-depression, +/- osteoporosis +/- gastroesophageal reflux disease and +/- diabetes. Health maintenance agents accounted for 15-17% of daily oral medication intake (1.4 medications) such that almost two-thirds of daily oral medications were attributable to disease triads plus health maintenance. Fewer medications were prescribed for NH residents over age 85 (decreased ACE inhibitor and HMG CoA reductase inhibitor USE (p < .001)) while use of Alzheimer medications was higher (p < .01).& para;& para;Conclusions & para;& para;A large fraction of daily oral medications were attributed to management of common co-morbid disease dyads and triads. Efforts to reduce polypharmacy and unwanted medication interactions could focus on regimens for common co-morbid dyads and triads in varying populations.	[Moore, Kelly L.; Patel, Kanan; Ritchie, Christine; Schwartz, Janice B.] Ctr Res Aging Jewish Home, San Francisco, CA 94112 USA; [Patel, Kanan; Boscardin, W. John; Steinman, Michael A.; Ritchie, Christine; Schwartz, Janice B.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Boscardin, W. John] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Steinman, Michael A.] San Francisco VA Med Ctr, San Francisco, CA USA; [Schwartz, Janice B.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Schwartz, JB (corresponding author), Ctr Res Aging Jewish Home, San Francisco, CA 94112 USA.; Schwartz, JB (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Schwartz, JB (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	Janice.schwartz@ucsf.edu	Schwartz, Janice/K-6354-2019		National Institute for Aging [RC1 AG 036377, K24AG049057]; Jewish Home of San Francisco; NIA [RC1 AG 036377, K24AG049057]	National Institute for Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Jewish Home of San Francisco; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded in part by National Institute for Aging (https://www.nia.nih.gov) grants RC1 AG 036377 (JBS, MS) and K24AG049057 (MS), and with funds from the Jewish Home of San Francisco (JBS, CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded in part by NIA grants RC1 AG 036377 and K24AG049057, and with funds from the Jewish Home of San Francisco. The authors report no conflicts of interest in relation to this work.	[Anonymous], 2009, NAT NURS HOM SURV 20; Arnett DK, 2014, J AM COLL CARDIOL, V64, P1851, DOI 10.1016/j.jacc.2014.07.012; Aronow WS, 2011, J AM SOC HYPERTENS, V5, P259, DOI 10.1016/j.jash.2011.06.001; Bach PB, 2006, NEW ENGL J MED, V354, P2312, DOI 10.1056/NEJMp068108; Beers MH, 1997, ARCH INTERN MED, V157, P1531, DOI 10.1001/archinte.157.14.1531; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd CM, 2010, PUBLIC HEALTH REV, V32, P451, DOI 10.1007/BF03391611; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Calderon-Larranaga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084967; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; CARBONIN P, 1991, J AM GERIATR SOC, V39, P1093, DOI 10.1111/j.1532-5415.1991.tb02875.x; CMS, 2017, MED FEE SERV PROV UT; Cms.gov, NURS HOM DAT COMP 20; Dwyer Lisa L, 2009, Vital Health Stat 1, P1; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; Gurwitz JH, 2005, AM J MED, V118, P251, DOI 10.1016/j.amjmed.2004.09.018; Gurwitz JH, 2002, ARCH INTERN MED, V162, P1670, DOI 10.1001/archinte.162.15.1670; GURWITZ JH, 1991, ANN INTERN MED, V114, P956, DOI 10.7326/0003-4819-114-11-956; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; HELLING DK, 1987, J AM GERIATR SOC, V35, P4, DOI 10.1111/j.1532-5415.1987.tb01312.x; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Jokanovic N, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.03.003; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Karkare SU, 2011, AM J GERIATR PHARMAC, V9, P109, DOI 10.1016/j.amjopharm.2011.03.001; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Moore KL, 2014, J NUTR HEALTH AGING, V18, P429, DOI 10.1007/s12603-014-0001-y; Moore KL, 2012, J AM GERIATR SOC, V60, P756, DOI 10.1111/j.1532-5415.2012.03909.x; National Action Plan for Adverse Drug Event Prevention, 2014, OFF DIS PREV HLTH PR; National Nursing Home Survey Data, DRUG EST CHAR P FIL; NOLAN L, 1989, AGE AGEING, V18, P52, DOI 10.1093/ageing/18.1.52; NOLAN L, 1988, J AM GERIATR SOC, V36, P142, DOI 10.1111/j.1532-5415.1988.tb01785.x; Onder G, 2012, J GERONTOL A-BIOL, V67, P698, DOI 10.1093/gerona/glr233; Schwartz JB, 2016, J AM GERIATR SOC, V64, P1996, DOI 10.1111/jgs.14288; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Sharma M, 2015, CIRCULATION, V132, P194, DOI 10.1161/CIRCULATIONAHA.114.013267; Steinman MA, 2014, J GEN INTERN MED, V29, P1379, DOI 10.1007/s11606-014-2924-8	39	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196109	10.1371/journal.pone.0196109	http://dx.doi.org/10.1371/journal.pone.0196109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7AK	29684077	Green Published, gold, Green Submitted			2022-12-26	WOS:000430660600038
J	Zhong, H; Guan, W; Zhang, WY; Jiang, SX; Fan, LL				Zhong, Han; Guan, Wei; Zhang, Wenyi; Jiang, Shixiong; Fan, Lingling			A bi-objective integer programming model for partly-restricted flight departure scheduling	PLOS ONE			English	Article							LONDON-HEATHROW-AIRPORT; DEPENDENT PROCESSING TIMES; AIRCRAFT LANDINGS; OPTIMIZATION; ALGORITHMS	The normal studies on air traffic departure scheduling problem (DSP) mainly deal with an independent airport in which the departure traffic is not affected by surrounded airports, which, however, is not a consistent case. In reality, there still exist cases where several commercial airports are closely located and one of them possesses a higher priority. During the peak hours, the departure activities of the lower-priority airports are usually required to give way to those of higher-priority airport. These giving-way requirements can inflict a set of changes on the modeling of departure scheduling problem with respect to the lower-priority airports. To the best of our knowledge, studies on DSP under this condition are scarce. Accordingly, this paper develops a bi-objective integer programming model to address the flight departure scheduling of the partly-restricted (e.g., lower-priority) one among several adjacent airports. An adapted tabu search algorithm is designed to solve the current problem. It is demonstrated from the case study of Tianjin Binhai International Airport in China that the proposed method can obviously improve the operation efficiency, while still realizing superior equity and regularity among restricted flows.	[Zhong, Han; Guan, Wei; Zhang, Wenyi; Jiang, Shixiong; Fan, Lingling] Beijing Jiaotong Univ, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China	Beijing Jiaotong University	Guan, W (corresponding author), Beijing Jiaotong Univ, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China.	weig@bjtu.edu.cn	Jiang, Shixiong/ABE-4715-2020	Zhang, Wenyi/0000-0002-4752-9994	National Natural Science Foundation of China [71621001, 71501013, 71601015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is jointly supported by the National Natural Science Foundation of China under Grant Nos. 71621001 to WG, 71501013 to LF, and 71601015 to WZ. There was no additional external funding received for this study.	Atkin JAD, 2008, J SCHEDULING, V11, P323, DOI 10.1007/s10951-008-0065-9; Atkin JAD, 2007, TRANSPORT SCI, V41, P90, DOI 10.1287/trsc.1060.0163; Atkin JAD, 2008, LECT NOTES ECON MATH, V600, P235; Balakrishnan H., 2007, 7 US EUR AIR TRAFF M; Beasley JE, 2000, TRANSPORT SCI, V34, P180, DOI 10.1287/trsc.34.2.180.12302; Bianco L, 1999, ANN OPER RES, V86, P393, DOI 10.1023/A:1018975323093; BIANCO L, 1988, NAV RES LOG, V35, P177, DOI 10.1002/1520-6750(198804)35:2<177::AID-NAV3220350203>3.0.CO;2-V; Bolender M.A., 2000, SCHEDULING CONTROL S; CAAC, 2015, NAT CIV AV FLIGHT OP; Dear RG, 1978, TRANSPORT RES, V12, P216; Ernst AT, 1999, NETWORKS, V34, P229, DOI 10.1002/(SICI)1097-0037(199910)34:3<229::AID-NET8>3.0.CO;2-W; Eun Y, 2010, IEEE T INTELL TRANSP, V11, P359, DOI 10.1109/TITS.2010.2044791; Fricke H., 2009, P ATM SEM, P1; GLOVER F, 1986, COMPUT OPER RES, V13, P533, DOI 10.1016/0305-0548(86)90048-1; Gotteland JB, 2003, IEEE C EVOL COMPUTAT, P544, DOI 10.1109/CEC.2003.1299623; Gupta G, 2009, 9 AIAA AV TECHN INT, P1; Hoffman R, 2005, AIAA GUID NAV CONTR, P1; Hu XB, 2005, ENG APPL ARTIF INTEL, V18, P633, DOI 10.1016/j.engappai.2004.11.012; Hu XB, 2008, IEEE T INTELL TRANSP, V9, P301, DOI 10.1109/TITS.2008.922884; Krichen S, 2014, EXPERT SYST APPL, V41, P6483, DOI 10.1016/j.eswa.2014.03.028; Leeuwen PV, 2002, ELECT NOTES THEORETI, V76, P252, DOI [10.1016/S1571-0661(04)80797-7, DOI 10.1016/S1571-0661(04)80797-7]; Lieder A, 2015, EUR J OPER RES, V243, P61, DOI 10.1016/j.ejor.2014.11.027; Psaraftis Harilaos N., 1978, DYNAMIC PROGRAMMING; Rathinam S, 2009, AIAA GUID NAV CONTR, P6250; Sina-Finance& Economy, 2014, ATM CHALL; Su WY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/801374; Takeichi N, 2017, TRANSPORT RES C-EMER, V77, P433, DOI 10.1016/j.trc.2017.01.025; Tian JG, 2012, PHYSCS PROC, V33, P348, DOI 10.1016/j.phpro.2012.05.073; [尹嘉男 Yin Jia'nan], 2015, [航空学报, Acta Aeronautica et Astronautica Sinica], V36, P1574; Zhan ZH, 2010, IEEE T INTELL TRANSP, V11, P399, DOI 10.1109/TITS.2010.2044793; Zhang ZN, 2015, J AIR TRANSP MANAG, V42, P15, DOI 10.1016/j.jairtraman.2014.07.007	31	3	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196146	10.1371/journal.pone.0196146	http://dx.doi.org/10.1371/journal.pone.0196146			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715299	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281100011
J	Schneider, C; Feller, M; Bauer, DC; Collet, TH; da Costa, BR; Auer, R; Peeters, RP; Brown, SJ; Bremner, AP; O'Leary, PC; Feddema, P; Leedman, PJ; Aujesky, D; Walsh, JP; Rodondi, N				Schneider, Claudio; Feller, Martin; Bauer, Douglas C.; Collet, Tinh-Hai; da Costa, Bruno R.; Auer, Reto; Peeters, Robin P.; Brown, Suzanne J.; Bremner, Alexandra P.; O'Leary, Peter C.; Feddema, Peter; Leedman, Peter J.; Aujesky, Drahomir; Walsh, John P.; Rodondi, Nicolas			Initial evaluation of thyroid dysfunction - Are simultaneous TSH and fT4 tests necessary?	PLOS ONE			English	Article							THYROTROPIN REFERENCE RANGE; PARTICIPANT DATA-ANALYSIS; SERVICES TASK-FORCE; SUBCLINICAL HYPOTHYROIDISM; ASSOCIATION GUIDELINES; SENSITIVE THYROTROPIN; HORMONE; DISEASE; RISK; POPULATION	Objective Guidelines for thyroid function evaluation recommend testing TSH first, then assessing fT4 only if TSH is out of the reference range (two-step), but many clinicians initially request both TSH and fT4 (one-step). Given limitations of previous studies, we aimed to compare the two-step with the one-step approach in an unselected community-dwelling study population, and develop a prediction score based on clinical parameters that could identify at-risk patients for thyroid dysfunction. Design Cross-sectional analysis of the population-based Busselton Health Study. Methods We compared the two-step with the one-step approach, focusing on cases that would be missed by the two-step approach, i.e. those with normal TSH, but out-of-range fT4. We used likelihood ratio tests to identify demographic and clinical parameters associated with thyroid dysfunction and developed a clinical prediction score by using a beta-coefficient based scoring method. Results Following the two-step approach, 93.0% of all 4471 participants had normal TSH and would not need further testing. The two-step approach would have missed 3.8% of all participants (169 of 4471) with a normal TSH, but a fT4 outside the reference range. In 85% (144 of 169) of these cases, fT4 fell within 2 pmol/l of fT4 reference range limits, consistent with healthy outliers. The clinical prediction score that performed best excluded only 22.5% of participants from TSH testing. Conclusion The two-step approach may avoid measuring fT4 in as many as 93% of individuals with a very small risk of missing thyroid dysfunction. Our findings do not support the simultaneous initial measurement of both TSH and fT4.	[Schneider, Claudio; Feller, Martin; Aujesky, Drahomir; Rodondi, Nicolas] Univ Bern, Bern Univ Hosp, Inselspital, Dept Gen Internal Med, Bern, Switzerland; [Feller, Martin; Auer, Reto; Rodondi, Nicolas] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Collet, Tinh-Hai; da Costa, Bruno R.] Lausanne Univ Hosp, Serv Endocrinol Diabet & Metab, Lausanne, Switzerland; [da Costa, Bruno R.] Univ Toronto, St Michaels Hosp, Inst Hlth Policy Management & Evaluat, Appl Hlth Res Ctr,Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Peeters, Robin P.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Brown, Suzanne J.; Walsh, John P.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA, Australia; [Bremner, Alexandra P.] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [O'Leary, Peter C.] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, WA, Australia; [Feddema, Peter] Diagnost Stago, Doncaster, Vic, Australia; [Leedman, Peter J.; Walsh, John P.] Univ Western Australia, Med Sch, Crawley, WA, Australia; [Leedman, Peter J.] Harry Perkins Inst Med Res, UWA Ctr Med Res, Perth, WA, Australia	University of Bern; University Hospital of Bern; University of Bern; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Erasmus University Rotterdam; Erasmus MC; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Harry Perkins Institute of Medical Research	Rodondi, N (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Gen Internal Med, Bern, Switzerland.; Rodondi, N (corresponding author), Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland.	nicolas.rodondi@insel.ch	Walsh, John/GQI-2785-2022; Auer, Reto/AAG-9597-2020; Collet, Tinh-Hai/I-4462-2019; Feller, Martin/I-7852-2016	Auer, Reto/0000-0003-4222-4849; Collet, Tinh-Hai/0000-0002-3243-1222; Walsh, John/0000-0002-1766-2612; Bremner, Alexandra/0000-0002-4068-4860; Peeters, Robin/0000-0001-7732-9371; Rodondi, Nicolas/0000-0001-9083-6896; BROWN, SUZANNE/0000-0002-8413-561X; Feller, Martin/0000-0003-2519-836X	Health Promotion Foundation of Western Australia; Swiss National Science Foundation [SNSF 320030-150025, 320030_172676, P3SMP3-155318, PZ00P3-167826]; Diagnostic Stago	Health Promotion Foundation of Western Australia; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Diagnostic Stago	The 1994/1995 Busselton Health Survey was funded by the Health Promotion Foundation of Western Australia. The current work was supported by grants from the Swiss National Science Foundation (SNSF 320030-150025 and 320030_172676 to Prof. N. Rodondi, P3SMP3-155318 and PZ00P3-167826 to Dr. T.-H. Collet). One commercial company (Diagnostic Stago) provided support in the form of salaries to Dr. P. Feddema, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is detailed in the 'author contributions' section.	[Anonymous], 2003, THYROID, V13, P3; Bauer DC, 1996, ARCH INTERN MED, V156, P2333, DOI 10.1001/archinte.156.20.2333; Baumgartner C, 2017, CIRCULATION, V136, P2100, DOI 10.1161/CIRCULATIONAHA.117.028753; BILLEWICZ WZ, 1969, Q J MED, V38, P255; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Biondi B, 2015, EUR THYROID J, V4, P149, DOI 10.1159/000438750; Blum MR, 2015, JAMA-J AM MED ASSOC, V313, P2055, DOI 10.1001/jama.2015.5161; Brabant G, 2006, EUR J ENDOCRINOL, V154, P633, DOI 10.1530/eje.1.02136; Brown SJ, 2016, CLIN ENDOCRINOL, V85, P789, DOI 10.1111/cen.13107; Brucker-Davis F, 1999, J CLIN ENDOCR METAB, V84, P476, DOI 10.1210/jc.84.2.476; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Carle A, 2016, AM J MED, V129, P1082, DOI 10.1016/j.amjmed.2016.06.013; Chaker L, 2015, J CLIN ENDOCR METAB, V100, P2181, DOI 10.1210/jc.2015-1438; Chopra IJ, 1997, J CLIN ENDOCR METAB, V82, P329, DOI 10.1210/jc.82.2.329; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; CostHelper I, 2016, COSTH WHAT PEOPL PAY; Daucourt V, 2003, MED CARE, V41, P432; Emerson JF, 2001, AM J CLIN PATHOL, V116, P879; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Gibbons V, 2009, NEW ZEAL MED J, V122, P25; Gurnell M, 2011, CLIN ENDOCRINOL, V74, P673, DOI 10.1111/j.1365-2265.2011.04023.x; Hadlow NC, 2013, J CLIN ENDOCR METAB, V98, P2936, DOI 10.1210/jc.2012-4223; Helfand M, 2004, ANN INTERN MED, V140, P128, DOI 10.7326/0003-4819-140-2-200401200-00015; Jabbar A, 2017, NAT REV CARDIOL, V14, P39, DOI 10.1038/nrcardio.2016.174; Kende M., 2002, Papua New Guinea Medical Journal, V45, P197; Khandelwal D, 2012, DRUGS, V72, P17, DOI 10.2165/11598070-000000000-00000; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Ladenson PW, 2000, ARCH INTERN MED, V160, P1573, DOI 10.1001/archinte.160.11.1573; LeFevre ML, 2015, ANN INTERN MED, V162, P641, DOI 10.7326/M15-0483; Manji N, 2006, J CLIN ENDOCR METAB, V91, P4873, DOI 10.1210/jc.2006-1402; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; MURRAY I P, 1964, Med J Aust, V1, P827; O'Leary PC, 2006, CLIN ENDOCRINOL, V64, P97, DOI 10.1111/j.1365-2265.2005.02424.x; Olateju TO, 2006, ANN CLIN BIOCHEM, V43, P431, DOI 10.1258/000456306778904678; Pearce SHS, 2013, EUR THYROID J, V2, P215, DOI 10.1159/000356507; Persani L, 2012, J CLIN ENDOCR METAB, V97, P3068, DOI 10.1210/jc.2012-1616; Refetoff S, 2014, J CLIN ENDOCR METAB, V99, P768, DOI 10.1210/jc.2013-3393; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; SESHADRI MS, 1989, J GEN INTERN MED, V4, P490, DOI 10.1007/BF02599546; SPENCER CA, 1990, J CLIN ENDOCR METAB, V70, P453, DOI 10.1210/jcem-70-2-453; Surks MI, 2005, J CLIN ENDOCR METAB, V90, P5489, DOI 10.1210/jc.2005-0170; SURKS MI, 1990, JAMA-J AM MED ASSOC, V263, P1529, DOI 10.1001/jama.263.11.1529; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; The Association for Clinical Biochemistry BT Foundation AaBT, 2006, UK GUID US THYR FUNC; Tomlin A, 2011, BMJ QUAL SAF, V20, P282, DOI 10.1136/bmjqs.2010.048124; Toubert ME, 2000, EUR J ENDOCRINOL, V142, P605, DOI 10.1530/eje.0.1420605; Vaidya Bijay, 2013, Qual Prim Care, V21, P143; Viera AJ, 2003, FAM MED, V35, P408; Wartofsky L, 2005, J CLIN ENDOCR METAB, V90, P5483, DOI 10.1210/jc.2005-0455; Willis EA, 2013, ANN CLIN BIOCHEM, V50, P166, DOI 10.1258/acb.2012.012100	51	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196631	10.1371/journal.pone.0196631	http://dx.doi.org/10.1371/journal.pone.0196631			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709030	Green Published, gold			2022-12-26	WOS:000431130100047
J	Belfroid, E; Mollers, M; Smit, PW; Hulscher, M; Koopmans, M; Reusken, C; Timen, A				Belfroid, Evelien; Mollers, Madelief; Smit, Pieter W.; Hulscher, Marlies; Koopmans, Marion; Reusken, Chantal; Timen, Aura			Positive experiences of volunteers working in deployable laboratories in West Africa during the Ebola outbreak	PLOS ONE			English	Article							HEALTH-CARE WORKERS; LEGACY; SARS	The largest outbreak of Ebola virus disease ever started in West Africa in December 2013; it created a pressing need to expand the workforce dealing with it. The aim of this study was to gain insight into the experiences of volunteers from the European Union who worked in deployable laboratories in West Africa during the outbreak. This study is part of the EMERGE project. We assessed the experiences of 251 volunteers with a 19-item online questionnaire. The questions asked about positive aspects of volunteering such as learning new skills, establishing a new path in life, and changing life values. Other questionnaire subjects were the compliance to follow-up measures, the extent to which volunteers felt these measures restricted their daily activities, the fear of stigmatization, and worries about becoming infected or infecting their families. The volunteers reported positive effects that reached far beyond their daily work, such as changes in life priorities and a greater appreciation of the value of their own lives. Although the volunteers did not feel that temperature monitoring restricted their daily activities, full compliance to temperature monitoring and reporting it to the authorities was low. The volunteers did not fear Ebola infection for themselves or their families and were not afraid of stigmatization. With respect to the burden on the families, 50% reported that their family members were worried that the volunteer would be infected with Ebola virus. Altogether, the positive experiences of the volunteers in this study far outweigh the negative implications and constitute an important argument for inspiring people who intend to join such missions and for motivating the hesitant ones.	[Belfroid, Evelien; Mollers, Madelief; Timen, Aura] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Preparedness & Response Unit, Antonie van Leeuwenhoeklaan 9, Bilthoven, Netherlands; [Belfroid, Evelien; Hulscher, Marlies] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, IQ Healthcare, Nijmegen, Netherlands; [Smit, Pieter W.; Koopmans, Marion; Reusken, Chantal] Erasmus MC, WHO, Collaborating Ctr Arbovirus & Hemorrhag Fever Ref, Dept Virol, Rotterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; World Health Organization	Belfroid, E (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Preparedness & Response Unit, Antonie van Leeuwenhoeklaan 9, Bilthoven, Netherlands.; Belfroid, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, IQ Healthcare, Nijmegen, Netherlands.; Reusken, C (corresponding author), Erasmus MC, WHO, Collaborating Ctr Arbovirus & Hemorrhag Fever Ref, Dept Virol, Rotterdam, Netherlands.	Evelien.belfroid@rivm.nl; c.reusken@erasmusmc.nl	Belfroid, Evelien/AAB-8868-2019; Reusken, Chantal/ABD-5168-2021; Timen, Aura/GLV-4130-2022; Koopmans, Marion/Y-9170-2019; Hulscher, Marlies/B-1229-2014; Belfroid, Evelien/I-2780-2015	Reusken, Chantal/0000-0003-4605-9174; Koopmans, Marion/0000-0002-5204-2312; Hulscher, Marlies/0000-0002-2160-4810; Belfroid, Evelien/0000-0002-6432-2880	European Commission's Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) [677066]; Dutch Ministry of Health, Welfare and Sport (VWS); Dutch Ministry of Health, Welfare and Sport	European Commission's Consumers, Health, Agriculture and Food Executive Agency (CHAFEA); Dutch Ministry of Health, Welfare and Sport (VWS); Dutch Ministry of Health, Welfare and Sport	This publication has been produced with the support of the European Commission's Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) (http://ec.europa.eu/chafea/) for the EMERGE Joint Action (grant agreement no. 677066) to MK and support from the Dutch Ministry of Health, Welfare and Sport (VWS) to AT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank all the volunteers who participated in the questionnaire. We also thank their deploying organizations, namely, Public Health England, EU Mobile Laboratories, Dutch Mobile Ebola Laboratories, the Italian mobile laboratory, the Belgium mobile laboratory, and the French Minstere des Armees (Centre de Traitement des Soignants de Conakry) for facilitating this investigation. This publication has been produced with the support of the European Commission's Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) for the EMERGE Joint Action (grant agreement no. 677066) and support from the Dutch Ministry of Health, Welfare and Sport. Its content is the sole responsibility of the authors, and can in no way be taken to reflect the views of the CHAFEA or any other body of the European Union.	Belfroid E., 2017, J HOSP INFECT; Evans DK, 2015, LANCET GLOB HEALTH, V3, pE439, DOI 10.1016/S2214-109X(15)00065-0; Gulland A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5485; Haussig J. M., 2017, EURO SURVEILL, V22; Koh D, 2005, MED CARE, V43, P676, DOI 10.1097/01.mlr.0000167181.36730.cc; Maunder R, 2004, PHILOS T R SOC B, V359, P1117, DOI 10.1098/rstb.2004.1483; Mollers M, 2015, EMERG INFECT DIS, V21, P1667, DOI 10.3201/eid2109.150560; Rexroth U, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.12.21070; Smith MW, 2017, HEALTH SECUR, V15, P104, DOI 10.1089/hs.2016.0068; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Timen A, 2012, EMERG INFECT DIS, V18, P1107, DOI 10.3201/eid1807.101638; Turtle L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120013; Wang N., 2016, J PARTY SCH CORPS, V3, P23; World Health Organization, 2016, BUILD GLOB HLTH EM W; World Health Organization, 2016, SIT REP EB VIR DIS 1, P2	15	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196320	10.1371/journal.pone.0196320	http://dx.doi.org/10.1371/journal.pone.0196320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698521	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600063
J	Nespoli, E; Rizzo, F; Boeckers, T; Schulze, U; Hengerer, B				Nespoli, Ester; Rizzo, Francesca; Boeckers, Tobias; Schulze, Ulrike; Hengerer, Bastian			Altered dopaminergic regulation of the dorsal striatum is able to induce tic-like movements in juvenile rats	PLOS ONE			English	Article							LA-TOURETTE-SYNDROME; OBSESSIVE-COMPULSIVE DISORDER; FAST-SPIKING INTERNEURONS; MEDIAL PREOPTIC AREA; BASAL GANGLIA; D2 RECEPTORS; POSTNATAL-DEVELOPMENT; GLUTAMATE ANTAGONIST; PROJECTION NEURONS; NUCLEUS-ACCUMBENS	Motor tics are sudden, repetitive, involuntary movements representing the hallmark behaviors of the neurodevelopmental disease Tourette's syndrome (TS). The primary cause of TS remains unclear. The initial observation that dopaminergic antagonists alleviate tics led to the development of a dopaminergic theory of TS etiology which is supported by post mortem and in vivo studies indicating that non-physiological activation of the striatum could generate tics. The striatum controls movement execution through the balanced activity of dopamine receptor D1 and D2-expressing medium spiny neurons of the direct and indirect pathway, respectively. Different neurotransmitters can activate or repress striatal activity and among them, dopamine plays a major role. In this study we introduced a chronic dopaminergic alteration in juvenile rats, in order to modify the delicate balance between direct and indirect pathway. This manipulation was done in the dorsal striatum, that had been associated with tic-like movements generation in animal models. The results were movements resembling tics, which were categorized and scored according to a newly developed rating scale and were reduced by clonidine and riluzole treatment. Finally, post mortem analyses revealed altered RNA expression of dopaminergic receptors D1 and D2, suggesting an imbalanced dopaminergic regulation of medium spiny neuron activity as being causally related to the observed phenotype.	[Nespoli, Ester; Hengerer, Bastian] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Dept, Biberach, Germany; [Nespoli, Ester; Rizzo, Francesca; Schulze, Ulrike] Univ Ulm, Dept Child & Adolescent Psychiat Psychotherapy, Ulm, Germany; [Rizzo, Francesca; Boeckers, Tobias] Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany; [Nespoli, Ester] Ulm Univ, Dept Neurol, Mol & Translat Neurosci, Ulm, Germany	Boehringer Ingelheim; Ulm University; Ulm University; Ulm University	Nespoli, E; Hengerer, B (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, CNS Dept, Biberach, Germany.; Nespoli, E (corresponding author), Univ Ulm, Dept Child & Adolescent Psychiat Psychotherapy, Ulm, Germany.; Nespoli, E (corresponding author), Ulm Univ, Dept Neurol, Mol & Translat Neurosci, Ulm, Germany.	ester.nespoli@uni-ulm.de; bastian.hengerer@boehringer-ingelheirm.com	Schulze, Ulrike/AAV-6618-2021	Hengerer, Bastian/0000-0002-7811-9795	International Graduate School of molecular medicine of Ulm University; TS-EUROTRAIN community; European Community's Seventh Framework Programme TS-EUROTRAIN [316978]; Boehringer Ingelheim Pharma GmbH Co.	International Graduate School of molecular medicine of Ulm University; TS-EUROTRAIN community; European Community's Seventh Framework Programme TS-EUROTRAIN; Boehringer Ingelheim Pharma GmbH Co.(Boehringer Ingelheim)	Authors are very thankful to the International Graduate School of molecular medicine of Ulm University and the TS-EUROTRAIN community for their support to this work.	Abi-Jaoude E, 2015, HUM BRAIN MAPP, V36, P2592, DOI 10.1002/hbm.22793; AKIYAMA H, 1989, BRAIN RES, V489, P247, DOI 10.1016/0006-8993(89)90857-3; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bortolato M, 2017, J NEUROSCI METH, V292, P12, DOI 10.1016/j.jneumeth.2017.02.007; Bratcher NA, 2005, J EXP ANAL BEHAV, V84, P371, DOI 10.1901/jeab.2005.82-04; Bronfeld M, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00050; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Caligiore D, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005395; Cazorla M, 2014, NEURON, V81, P153, DOI 10.1016/j.neuron.2013.10.041; Charntikov S, 2011, NEUROSCIENCE, V183, P121, DOI 10.1016/j.neuroscience.2011.03.037; Chen GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135368; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Delfino MA, 2004, BEHAV BRAIN RES, V152, P297, DOI 10.1016/j.bbr.2003.10.009; Dhawan JK, 1998, BRAIN RES BULL, V45, P333, DOI 10.1016/S0361-9230(97)00404-8; Diaz-Anzaldua A, 2004, MOL PSYCHIATR, V9, P272, DOI 10.1038/sj.mp.4001411; Eddy Clare M, 2011, Ther Adv Neurol Disord, V4, P25, DOI 10.1177/1756285610390261; Ford CP, 2014, NEUROSCIENCE, V282, P13, DOI 10.1016/j.neuroscience.2014.01.025; Freeze BS, 2013, J NEUROSCI, V33, P18531, DOI 10.1523/JNEUROSCI.1278-13.2013; Gagnon D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41432; Ganos C, 2015, NEUROL CLIN, V33, P115, DOI 10.1016/j.ncl.2014.09.008; GELBARD HA, 1989, DEV BRAIN RES, V49, P123, DOI 10.1016/0165-3806(89)90065-5; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gilbert DL, 2006, NEUROLOGY, V67, P1695, DOI 10.1212/01.wnl.0000242733.18534.2c; Gittis AH, 2011, J NEUROSCI, V31, P15727, DOI 10.1523/JNEUROSCI.3875-11.2011; Grant P, 2007, J CHILD ADOL PSYCHOP, V17, P761, DOI 10.1089/cap.2007.0021; Grant P, 2010, J CHILD ADOL PSYCHOP, V20, P309, DOI 10.1089/cap.2010.0009; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Herzberg I, 2010, PSYCHIAT GENET, V20, P179, DOI 10.1097/YPG.0b013e32833a215a; HOFFMAN DC, 1995, PSYCHOPHARMACOLOGY, V120, P128, DOI 10.1007/BF02246184; HYDE TM, 1995, NEUROLOGY, V45, P1176, DOI 10.1212/WNL.45.6.1176; JANKOVIC J, 1991, MOVEMENT DISORD, V6, P248, DOI 10.1002/mds.870060309; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Kalueff AV, 2007, NAT PROTOC, V2, P2538, DOI 10.1038/nprot.2007.367; Kanaan AS, 2017, BRAIN, V140, P218, DOI 10.1093/brain/aww285; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Konradi C, 2004, NEUROBIOL DIS, V17, P219, DOI 10.1016/j.nbd.2004.07.005; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Kumar VM, 1996, NEUROSCI RES, V24, P207, DOI 10.1016/0168-0102(95)00995-7; Lemmon ME, 2015, PEDIATR NEUROL, V52, P629, DOI 10.1016/j.pediatrneurol.2015.02.002; Lennington JB, 2016, BIOL PSYCHIAT, V79, P372, DOI 10.1016/j.biopsych.2014.07.018; Mahone EM, 2018, PSYCHIAT RES-NEUROIM, V273, P46, DOI 10.1016/j.pscychresns.2017.12.005; MARSHALL JF, 1989, BRAIN RES, V493, P247, DOI 10.1016/0006-8993(89)91160-8; McCairn KW, 2016, NEURON, V89, P300, DOI 10.1016/j.neuron.2015.12.025; Miller AM, 2010, ARCH GEN PSYCHIAT, V67, P955, DOI 10.1001/archgenpsychiatry.2010.102; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Minzer K, 2004, J NEUROL SCI, V219, P55, DOI 10.1016/j.jns.2003.12.006; Muller-Vahl KR, 2017, J PSYCHIATR RES, V86, P1, DOI 10.1016/j.jpsychires.2016.11.004; Muller-Vahl KR, 2000, ACTA NEUROL SCAND, V101, P165, DOI 10.1034/j.1600-0404.2000.101003165.x; Naaijen J, 2017, NEUROIMAGE-CLIN, V13, P16, DOI 10.1016/j.nicl.2016.11.013; NEAL BS, 1992, SYNAPSE, V11, P35, DOI 10.1002/syn.890110106; Nordstrom EJ, 2015, BRAIN RES, V1629, P38, DOI 10.1016/j.brainres.2015.09.032; Peterson BS, 2003, ARCH GEN PSYCHIAT, V60, P415, DOI 10.1001/archpsyc.60.4.415; Pogorelov V, 2015, EXP NEUROL, V265, P122, DOI 10.1016/j.expneurol.2015.01.001; Pringsheim T, 2007, J NEUROL NEUROSUR PS, V78, P544, DOI 10.1136/jnnp.2006.102442; RADJA F, 1993, NEUROSCIENCE, V57, P635, DOI 10.1016/0306-4522(93)90011-4; Rizzo F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00059; Rizzo R, 2013, EUR J PAEDIATR NEURO, V17, P421, DOI 10.1016/j.ejpn.2013.01.005; Robertson MM, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2016.97; SAVASTA M, 1988, NEUROSCI LETT, V85, P119, DOI 10.1016/0304-3940(88)90440-5; Scahill Lawrence, 2006, NeuroRx, V3, P192, DOI 10.1007/BF03207049; Scharf JM, 2015, MOVEMENT DISORD, V30, P221, DOI 10.1002/mds.26089; SHAPIRO E, 1989, ARCH GEN PSYCHIAT, V46, P722; Singer Harvey S, 2011, Handb Clin Neurol, V100, P641, DOI 10.1016/B978-0-444-52014-2.00046-X; Singer HS, 2010, CURR TREAT OPTION NE, V12, P539, DOI 10.1007/s11940-010-0095-4; Singer HS, 2010, MED HYPOTHESES, V74, P862, DOI 10.1016/j.mehy.2009.11.028; SINGER HS, 1995, PEDIATRICS, V95, P74; Soiza-Reilly M, 2011, INT J DEV NEUROSCI, V29, P855, DOI 10.1016/j.ijdevneu.2011.08.001; Sowell ER, 2008, NAT NEUROSCI, V11, P637, DOI 10.1038/nn.2121; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Tarazi FI, 2000, INT J DEV NEUROSCI, V18, P29, DOI 10.1016/S0736-5748(99)00108-2; TEICHER MH, 1995, DEV BRAIN RES, V89, P167, DOI 10.1016/0165-3806(95)00109-Q; Thomas WS, 1998, DEV BRAIN RES, V111, P99, DOI 10.1016/S0165-3806(98)00126-6; Wink LK, 2011, J CHILD ADOL PSYCHOP, V21, P375, DOI 10.1089/cap.2010.0154; Worbe Y, 2013, CORTEX, V49, P1126, DOI 10.1016/j.cortex.2012.08.020; Worbe Y, 2009, CEREB CORTEX, V19, P1844, DOI 10.1093/cercor/bhn214; Xu M, 2016, NEUROSCIENCE, V324, P321, DOI 10.1016/j.neuroscience.2016.02.074; Yael D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00132	80	10	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196515	10.1371/journal.pone.0196515	http://dx.doi.org/10.1371/journal.pone.0196515			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698507	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600091
J	Borges, MB; Marchevsky, RS; Mendes, YS; Mendes, LG; Duarte, AC; Cruz, M; de Filippis, AMB; Vasconcelos, PFC; Freire, M; Homma, A; Mossman, S; Lepine, E; Vanloubbeeck, Y; Lorin, C; Malice, MP; Caride, E; Warter, L				Borges, Maria Beatriz; Marchevsky, Renato Sergio; Mendes, Ygara S.; Mendes, Luiz Gustavo; Duarte, Ana Claudia; Cruz, Michael; Bispo de Filippis, Ana Maria; Vasconcelos, Pedro Fernando C.; Freire, Marcos; Homma, Akira; Mossman, Sally; Lepine, Edith; Vanloubbeeck, Yannick; Lorin, Clarisse; Malice, Marie-Pierre; Caride, Elena; Warter, Lucile			Characterization of recent and minimally passaged Brazilian dengue viruses inducing robust infection in rhesus macaques	PLOS ONE			English	Article							NONHUMAN-PRIMATES; VACCINE FORMULATIONS; ANTIBODY-RESPONSE; IMMUNE-RESPONSES; GROWTH-FACTOR; SERUM-LEVELS; EFFICACY; SEVERITY; VIREMIA; VERTEBRATE	The macaque is widely accepted as a suitable model for preclinical characterization of dengue vaccine candidates. However, the only vaccine for which both preclinical and clinical efficacy results were reported so far showed efficacy levels that were substantially different between macaques and humans. We hypothesized that this model's predictive capacity may be improved using recent and minimally passaged dengue virus isolates, and by assessing vaccine efficacy by characterizing not only the post-dengue virus challenge viremia/RNAemia but also the associated-cytokine profile. Ten recent and minimally passaged Brazilian clinical isolates from the four dengue virus serotypes were tested for their infectivity in rhesus macaques. For the strains showing robust replication capacity, the associated-changes in soluble mediator levels, and the elicited dengue virus-neutralizing antibody responses, were also characterized. Three isolates from dengue virus serotypes 1, 2 and 4 induced viremia of high magnitude and longer duration relative to previously reported viremia kinetics in this model, and robust dengue virus-neutralizing antibody responses. Consistent with observations in humans, increased MCP-1, IFN-gamma and VEGF-A levels, and transiently decreased IL-8 levels were detected after infection with the selected isolates. These results may contribute to establishing a dengue macaque model showing a higher predictability for vaccine efficacy in humans.	[Borges, Maria Beatriz; Marchevsky, Renato Sergio; Mendes, Ygara S.; Mendes, Luiz Gustavo; Duarte, Ana Claudia; Bispo de Filippis, Ana Maria; Freire, Marcos; Homma, Akira; Caride, Elena] Fiocruz MS, Rio De Janeiro, Brazil; [Cruz, Michael; Mossman, Sally; Lepine, Edith] GSK, Rockville, MD USA; [Vasconcelos, Pedro Fernando C.] MoH, Inst Evandro Chagas, Ananindeua, Brazil; [Vanloubbeeck, Yannick; Lorin, Clarisse; Malice, Marie-Pierre; Warter, Lucile] GSK, Rixensart, Belgium	Fundacao Oswaldo Cruz; GlaxoSmithKline; Instituto Evandro Chagas; GlaxoSmithKline	Warter, L (corresponding author), GSK, Rixensart, Belgium.	lucile.x.warter@gsk.com	Vasconcelos, Pedro/AAH-3142-2019	Marchevsky, Renato/0000-0003-1174-3902; Cruz, Michael/0000-0001-9334-1979	GlaxoSmithKline Biologicals S.A. (Rixensart, Belgium); MoH; CNPq [457664/2013-4, 303999/2016-0]; Fiocruz (Rio de Janeiro, Brazil)	GlaxoSmithKline Biologicals S.A. (Rixensart, Belgium); MoH; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fiocruz (Rio de Janeiro, Brazil)	This work was funded by GlaxoSmithKline Biologicals S.A. (Rixensart, Belgium) under a Cooperative Research and Development Agreement with Fiocruz (Rio de Janeiro, Brazil). GlaxoSmithKline Biologicals S.A. was involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript. PFCV was partially supported by MoH and CNPq (457664/2013-4 and 303999/2016-0) grants.	Althouse BM, 2014, VIROLOGY, V452, P237, DOI 10.1016/j.virol.2014.01.015; Appanna R, 2012, AM J TROP MED HYG, V87, P936, DOI 10.4269/ajtmh.2012.11-0606; Badawy AAG, 2015, APMIS, V123, P823, DOI 10.1111/apm.12431; Blaney JE, 2005, J VIROL, V79, P5516, DOI 10.1128/JVI.79.9.5516-5528.2005; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Clark KB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00305; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Endy TP, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00183; Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268; Ferreira MS, 2014, IMMUNOL LETT, V158, P126, DOI 10.1016/j.imlet.2013.12.008; Freire MS, 2007, MEM I OSWALDO CRUZ, V102, P203, DOI 10.1590/S0074-02762007005000011; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P146, DOI 10.4269/ajtmh.1976.25.146; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; HALSTEAD SB, 1973, J INFECT DIS, V128, P7, DOI 10.1093/infdis/128.1.7; Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494; Hickey AC, 2013, AM J TROP MED HYG, V89, P1043, DOI 10.4269/ajtmh.13-0145; Koraka P, 2007, MICROBES INFECT, V9, P940, DOI 10.1016/j.micinf.2007.03.012; Koraka P, 2007, VACCINE, V25, P5409, DOI 10.1016/j.vaccine.2007.04.079; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Larsen CP, 2015, VACCINE, V33, P7075, DOI 10.1016/j.vaccine.2015.09.052; Lee YH, 2016, J GEN VIROL, V97, P3103, DOI 10.1099/jgv.0.000637; Miagostovich Marize P., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P17, DOI 10.1590/S0036-46652003000100004; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0; Osorio JE, 2011, AM J TROP MED HYG, V84, P978, DOI 10.4269/ajtmh.2011.10-0592; Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6; Raghupathy R, 1998, J MED VIROL, V56, P280, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;280::AID-JMV18&gt;3.0.CO;2-I; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Sariol CA, 2007, CLIN VACCINE IMMUNOL, V14, P756, DOI 10.1128/CVI.00052-07; Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452; Srikiatkhachorn A, 2017, SEMIN IMMUNOPATHOL, V39, P563, DOI 10.1007/s00281-017-0625-1; St John AL, 2013, NAT REV MICROBIOL, V11, P420, DOI 10.1038/nrmicro3030; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; WEAVER SC, 1992, CURR TOP MICROBIOL, V176, P99; Yoshida T, 2012, ARCH VIROL, V157, P363, DOI 10.1007/s00705-011-1178-6	46	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196311	10.1371/journal.pone.0196311	http://dx.doi.org/10.1371/journal.pone.0196311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694440	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400081
J	Garris, HW; Baldwin, SA; Taylor, J; Gurr, DB; Denesiuk, DR; Van Hamme, JD; Fraser, LH				Garris, Heath W.; Baldwin, Susan A.; Taylor, Jon; Gurr, David B.; Denesiuk, Daniel R.; Van Hamme, Jonathan D.; Fraser, Lauchlan H.			Short-term microbial effects of a large-scale mine-tailing storage facility collapse on the local natural environment	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; EVOLUTIONARY HISTORY; SOIL; DIVERSITY; COMMUNITIES; REMOVAL; BIOGEOGRAPHY; REMEDIATION; DRAINAGE; INSIGHTS	We investigated the impacts of the Mount Polley tailings impoundment failure on chemical, physical, and microbial properties of substrates within the affected watershed, comprised of 70 hectares of riparian wetlands and 40 km of stream and lake shore. We established a bio-monitoring network in October of 2014, two months following the disturbance, and evaluated riparian and wetland substrates for microbial community composition and function via 16S and full metagenome sequencing. A total of 234 samples were collected from substrates at 3 depths and 1,650,752 sequences were recorded in a geodatabase framework. These data revealed a wealth of information regarding watershed-scale distribution of microbial community members, as well as community composition, structure, and response to disturbance. Substrates associated with the impact zone were distinct chemically as indicated by elevated pH, nitrate, and sulphate. The microbial community exhibited elevated metabolic capacity for selenate and sulfate reduction and an abundance of chemolithoautotrophs in the Thiobacillus thiophilus/T. denitrificans/T. thioparus clade that may contribute to nitrate attenuation within the affected watershed. The most impacted area (a 6 km stream connecting two lakes) exhibited 30% lower microbial diversity relative to the remaining sites. The tailings impoundment failure at Mount Polley Mine has provided a unique opportunity to evaluate functional and compositional diversity soon after a major catastrophic disturbance to assess metabolic potential for ecosystem recovery.	[Garris, Heath W.; Denesiuk, Daniel R.; Van Hamme, Jonathan D.; Fraser, Lauchlan H.] Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada; [Garris, Heath W.; Denesiuk, Daniel R.; Van Hamme, Jonathan D.; Fraser, Lauchlan H.] Thompson Rivers Univ, Dept Biol Sci, Kamloops, BC, Canada; [Baldwin, Susan A.; Taylor, Jon; Gurr, David B.] Univ British Columbia, Dept Chem & Biol Engn, Vancouver, BC, Canada; [Garris, Heath W.] Covenant Coll, Dept Biol, Lookout Mt, GA 30750 USA	University of British Columbia	Garris, HW (corresponding author), Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada.; Garris, HW (corresponding author), Thompson Rivers Univ, Dept Biol Sci, Kamloops, BC, Canada.; Garris, HW (corresponding author), Covenant Coll, Dept Biol, Lookout Mt, GA 30750 USA.	heath.garris@covenant.edu		Van Hamme, Jonathan/0000-0001-9471-7616	Mitacs Accelerate/Elevate Post-doctoral Fellowship for Heath Garris; Mount Polley Mining Corp; NSERC; Mitacs; Genome BC; Genome Canada; Mount Polley Mine; Genome Canada Emerging Opportunity Program; Natural Sciences and Engineering Research Council of Canada Engage Program; Mitacs Accelerate Program; Mitacs Elevate Program	Mitacs Accelerate/Elevate Post-doctoral Fellowship for Heath Garris; Mount Polley Mining Corp; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mitacs; Genome BC; Genome Canada(Genome Canada); Mount Polley Mine; Genome Canada Emerging Opportunity Program(Genome Canada); Natural Sciences and Engineering Research Council of Canada Engage Program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mitacs Accelerate Program; Mitacs Elevate Program	This project was supported by a Mitacs Accelerate/Elevate Post-doctoral Fellowship for Heath Garris, where professional development seminars/training were provided with little/no input into the content of the research proposal/execution. This program was co-funded by a partner industry (Mount Polley Mining Corp) that contributed substantially to the development of the project (in the form of site access, feasibility assessment, material support, and manuscript review). Additional funding from NSERC was awarded to support an initial (pre-breach) water quality project. NSERC monitored changes in the proposed project scope by requesting reports, but did not contribute to the content of the study directly. Finally, Genome BC and Genome Canada supported the project through funding and consultation on project scope/applicability/suitability with respect to the use of genomics technologies and accomplishment of project goals, which served to improve project precisions/outcomes. Project funding web references: Mitacs (https://www.mitacs.ca/en/impact/postdoctoral-fellows-share-program-benefits-mitacs-elevate-retreat); Genome BC (https://www.genomecanada.ca/en/metagenomics-assess-impacts-mount-polley-mine-taillings-dam-breach-associated-ecosystems); Genome Canada (https://www.genomecanada.ca/en/metagenomics-assess-impacts-mount-polley-mine-taillings-dam-breach-associated-ecosystems); Mount Polley Mine (https://www.imperialmetals.com/assets/docs/mt-polley/2015-02-23_MPFN.pdf).; We would like to thank Genome BC and Genome Canada Emerging Opportunity Program, Natural Sciences and Engineering Research Council of Canada Engage Program, and Mitacs Accelerate and Mitacs Elevate Programs for funding. We also are grateful to Mount Polley Mine Corporation and particularly Katie McMahen, Colleen Hughes, Luke Moger, Art Frye, and 'Lyn Anglin for their partnership in this project. We are also grateful to two anonymous reviewers for comments on an earlier version of this manuscript.	Amils Ricardo, 2014, Life-Basel, V4, P511, DOI 10.3390/life4030511; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], TITLE ERROR; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Baldwin SA, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00027; Banning NC, 2011, APPL ENVIRON MICROB, V77, P6158, DOI 10.1128/AEM.00764-11; Barnes S, 2013, MOUNT POLLEY WATER M; Berga M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036959; Butler CS, 2012, BIOCHEM SOC T, V40, P1239, DOI 10.1042/BST20120087; Castenholz R, 2011, BERGEYS MANUAL SYSTE, V3, P1698; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Crump BC, 2007, ECOLOGY, V88, P1365, DOI 10.1890/06-0387; Degens BP, 2001, SOIL BIOL BIOCHEM, V33, P1143, DOI 10.1016/S0038-0717(01)00018-9; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Eaton A. D., 2005, STANDARD METHODS EXA; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elshahed MS, 2003, APPL ENVIRON MICROB, V69, P5609, DOI 10.1128/AEM.69.9.5609-5621.2003; Eswayah AS, 2016, APPL ENVIRON MICROB, V82, P4848, DOI 10.1128/AEM.00877-16; EXCOFFIER L, 1992, GENETICS, V131, P479; Faulwetter JL, 2009, ECOL ENG, V35, P987, DOI 10.1016/j.ecoleng.2008.12.030; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fillol M, 2016, ISME J, V10, P665, DOI 10.1038/ismej.2015.143; Findlay RH, 2008, APPL ENVIRON MICROB, V74, P3014, DOI 10.1128/AEM.01809-07; Freckman DW, 1997, AMBIO, V26, P556; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Golder Associates Ltd, 2015, MOUNT POLL MIN CORP; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Harris JA, 2003, EUR J SOIL SCI, V54, P801, DOI 10.1046/j.1351-0754.2003.0559.x; Hudson-Edwards K, 2016, SCIENCE, V352, P288, DOI 10.1126/science.aaf3354; Illumina, 2017, 16S MET SEQ LIB PREP, P1; Jalali K, 2000, WATER RES, V34, P797, DOI 10.1016/S0043-1354(99)00194-3; Johnson DB, 2008, BIOTECHNOL LETT, V30, P445, DOI 10.1007/s10529-007-9574-4; Johnson DB, 2005, SCI TOTAL ENVIRON, V338, P3, DOI 10.1016/j.scitotenv.2004.09.002; Jong T, 2003, WATER RES, V37, P3379, DOI 10.1016/S0043-1354(03)00165-9; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Kennedy C.B., 2016, PROCEEDING TAILINGS, P857; Khoshnoodi M, 2013, MINERALS-BASEL, V3, P427, DOI 10.3390/min3040427; Kleinsteuber S, 2008, FEMS MICROBIOL ECOL, V63, P107, DOI 10.1111/j.1574-6941.2007.00402.x; Konopka A, 2015, ISME J, V9, P1488, DOI 10.1038/ismej.2014.251; Konwar KM, 2015, BIOINFORMATICS, V31, P3345, DOI 10.1093/bioinformatics/btv361; Kossoff D, 2014, APPL GEOCHEM, V51, P229, DOI 10.1016/j.apgeochem.2014.09.010; Kuroda M, 2011, J BACTERIOL, V193, P2141, DOI 10.1128/JB.01197-10; Leiva ED, 2014, SCI TOTAL ENVIRON, V466, P490, DOI 10.1016/j.scitotenv.2013.07.009; Liang B, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0117-4; Lottermoser B.G., 2010, MINE WASTES; Loy A, 2005, APPL ENVIRON MICROB, V71, P1373, DOI 10.1128/AEM.71.3.1373-1386.2005; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; McEwan AG, 2002, GEOMICROBIOL J, V19, P3, DOI 10.1080/014904502317246138; Morgenstern N.R., 2015, REPORT MOUNT POLLEY; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Neculita CM, 2007, J ENVIRON QUAL, V36, P1, DOI 10.2134/jeq2006.0066; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Nikl L., 2016, P TAILINGS MINE WAST, P845; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ren Z, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02319; Rico M, 2008, J HAZARD MATER, V152, P846, DOI 10.1016/j.jhazmat.2007.07.050; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidtova J, 2011, WATER RES, V45, P1115, DOI 10.1016/j.watres.2010.10.038; Shade A, 2012, ISME J, V6, P2153, DOI 10.1038/ismej.2012.56; Song Y, 2001, WATER ENVIRON RES, V73, P37, DOI 10.2175/106143001X138660; Stoltz E, 2002, ENVIRON EXP BOT, V47, P271, DOI 10.1016/S0098-8472(02)00002-3; Teng Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00032; Torrento C, 2010, CHEM GEOL, V278, P80, DOI 10.1016/j.chemgeo.2010.09.003; USGS, 2011, 6 MILL LANDS SCEN DO; van Kessel MAHJ, 2015, NATURE, V528, P555, DOI 10.1038/nature16459; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wang A, 2004, J HARBIN I TECHNOL, P2004; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433	70	8	8	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196032	10.1371/journal.pone.0196032	http://dx.doi.org/10.1371/journal.pone.0196032			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694379	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400055
J	Halina, M; Liebal, K; Tomasello, M				Halina, Marta; Liebal, Katja; Tomasello, Michael			The goal of ape pointing	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; ORANGUTANS PONGO-PYGMAEUS; GESTURAL COMMUNICATION; ATTENTIONAL STATUS; SHARED EXPERIENCE; YOUNG CHIMPANZEES; DIFFERENTIAL USE; INFANTS USE; BEHAVIOR; HAND	Captive great apes regularly use pointing gestures in their interactions with humans. However, the precise function of this gesture is unknown. One possibility is that apes use pointing primarily to direct attention (as in "please look at that"); another is that they point mainly as an action request (such as "can you give that to me?"). We investigated these two possibilities here by examining how the looking behavior of recipients affects pointing in chimpanzees (Pan troglodytes) and bonobos (Pan paniscus). Upon pointing to food, subjects were faced with a recipient who either looked at the indicated object (successful-look) or failed to look at the indicated object (failed-look). We predicted that, if apes point primarily to direct attention, subjects would spend more time pointing in the failed-look condition because the goal of their gesture had not been met. Alternatively, we expected that, if apes point primarily to request an object, subjects would not differ in their pointing behavior between the successful-look and failed-look conditions because these conditions differed only in the looking behavior of the recipient. We found that subjects did differ in their pointing behavior across the successful-look and failed-look conditions, but contrary to our prediction subjects spent more time pointing in the successful-look condition. These results suggest that apes are sensitive to the attentional states of gestural recipients, but their adjustments are aimed at multiple goals. We also found a greater number of individuals with a strong right-hand than left-hand preference for pointing.	[Halina, Marta] Univ Cambridge, Dept Hist & Philosophy Sci, Free Sch Lane, Cambridge, England; [Liebal, Katja] Free Univ Berlin, Dept Educ & Psychol, Cluster Languages Emot, Evolutionary Psychol, Berlin, Germany; [Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Tomasello, Michael] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	University of Cambridge; Free University of Berlin; Max Planck Society; Duke University	Halina, M (corresponding author), Univ Cambridge, Dept Hist & Philosophy Sci, Free Sch Lane, Cambridge, England.	mh801@cam.ac.uk	Liebal, Katja/AAQ-7910-2020	Liebal, Katja/0000-0003-2447-8327; Halina, Marta/0000-0002-3482-4281	MH: German-American Fulbright Full Grant; Leverhulme Centre for the Future of Intelligence; KL: Volkswagen-Stiftung, Germany	MH: German-American Fulbright Full Grant; Leverhulme Centre for the Future of Intelligence; KL: Volkswagen-Stiftung, Germany	MH: German-American Fulbright Full Grant (http://www.fulbright.de/commission/about-the-program/desbription-of-the-program/< http://www.fulbright.de/commission/about-the-program/description-of-the-program/>) and Leverhulme Centre for the Future of Intelligence (http://Icfi.ac.uk/ < http://Icfi.ac.uk/>). KL: Volkswagen-Stiftung, Germany (https://www.volkswagenstiftung.de/en/foundation < http://www.volkswagenstiftung.de/en/foundation >). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard KA, 2014, ANNU REV ANTHROPOL, V43, P183, DOI 10.1146/annurev-anthro-102313-030223; Brauer J, 2007, ANIM COGN, V10, P439, DOI 10.1007/s10071-007-0088-1; Bullinger AF, 2010, DEVELOPMENTAL SCI, V14, P58; CALL J, 1994, J COMP PSYCHOL, V108, P307, DOI 10.1037/0735-7036.108.4.307; Call J., 2007, GESTURAL COMMUNICATI; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Cartmill EA, 2007, CURR BIOL, V17, P1345, DOI 10.1016/j.cub.2007.06.069; Cartmill EA, 2010, ANIM COGN, V13, P793, DOI 10.1007/s10071-010-0328-7; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Gomez J.C., 1990, P333, DOI 10.1017/CBO9780511665486.014; Gomez Juan Carlos, 1996, P131; Halina M, 2017, ROUTLEDGE HDB PHILOS, P238; Halina M, 2015, PHILOS SCI, V82, P473, DOI 10.1086/681627; Hare B, 2000, ANIM BEHAV, V59, P771, DOI 10.1006/anbe.1999.1377; Hare B, 2006, COGNITION, V101, P495, DOI 10.1016/j.cognition.2005.01.011; Hobaiter C, 2014, CURR BIOL, V24, P1596, DOI 10.1016/j.cub.2014.05.066; Hobaiter C, 2014, J COMP PSYCHOL, V128, P82, DOI 10.1037/a0033757; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; HOPKINS WD, 1993, DEV PSYCHOBIOL, V26, P219, DOI 10.1002/dev.420260405; HOPKINS WD, 1995, BEHAV NEUROSCI, V109, P808, DOI 10.1037/0735-7044.109.4.808; Hopkins WD, 2003, DEVELOPMENTAL SCI, V6, P55, DOI 10.1111/1467-7687.00254; Hopkins WD, 1999, INT J PRIMATOL, V20, P851, DOI 10.1023/A:1020822401195; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Hostetter AB, 2007, ANIM COGN, V10, P55, DOI 10.1007/s10071-006-0031-x; InoueNakamura N, 1997, J COMP PSYCHOL, V111, P159, DOI 10.1037/0735-7036.111.2.159; Kaminski J, 2004, ANIM COGN, V7, P216, DOI 10.1007/s10071-004-0214-2; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; Kendon A., 1980, RELATIONSHIP VERBAL, P207, DOI [10.1515/9783110813098.207, DOI 10.1515/9783110813098.207]; Leavens DA, 1996, J COMP PSYCHOL, V110, P346, DOI 10.1037/0735-7036.110.4.346; Leavens DA, 2005, CURR DIR PSYCHOL SCI, V14, P185, DOI 10.1111/j.0963-7214.2005.00361.x; Leavens DA, 2005, CHILD DEV, V76, P291, DOI 10.1111/j.1467-8624.2005.00845.x; Leavens DA, 2004, J COMP PSYCHOL, V118, P48, DOI 10.1037/0735-7036.118.1.48; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Leavens DA, 1999, J COMP PSYCHOL, V113, P417, DOI 10.1037/0735-7036.113.4.417; Leavens DA, 1998, DEV PSYCHOL, V34, P813, DOI 10.1037/0012-1649.34.5.813; Leavens David A., 2004, Interaction Studies, V5, P387, DOI 10.1075/is.5.3.05lea; Leavens DA, 2010, ANIM COGN, V13, P33, DOI 10.1007/s10071-009-0242-z; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Liebal K, 2004, INTERACT STUD, V5, P199, DOI 10.1075/is.5.2.03lie; Liebal K, 2012, PHILOS T R SOC B, V367, P118, DOI 10.1098/rstb.2011.0044; Liebal Katja, 2006, GESTURE, V6, P1, DOI [10.1075/gest.6.1.02lie, DOI 10.1075/GEST.6.1.02LIE]; Liebal K, 2010, INFANCY, V15, P545, DOI 10.1111/j.1532-7078.2009.00028.x; Liebal K, 2009, DEVELOPMENTAL SCI, V12, P264, DOI 10.1111/j.1467-7687.2008.00758.x; Lurz R, 2018, ANIM BEHAV, V135, P239, DOI 10.1016/j.anbehav.2017.11.014; McNeill D., 1992, HAND MIND WHAT GESTU; Melis AP, 2006, J COMP PSYCHOL, V120, P154, DOI 10.1037/0735-7036.120.2.154; Meunier H, 2013, ANIM COGN, V16, P155, DOI 10.1007/s10071-012-0558-y; Moore R, 2014, CURR BIOL, V24, pR645, DOI 10.1016/j.cub.2014.05.072; Pika S, 2006, CURR BIOL, V16, pR191, DOI 10.1016/j.cub.2006.02.037; Pika S, 2005, AM J PRIMATOL, V65, P39, DOI 10.1002/ajp.20096; Pika S, 2009, PREHISTORY LANGUAGE, P166, DOI [10.1093/acprof:oso/9780199545872.003.0009, DOI 10.1093/ACPROF:OSO/9780199545872.003.0009]; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; Poss SR, 2006, AM J PRIMATOL, V68, P978, DOI 10.1002/ajp.20304; Roberts AI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4088; Roberts AI, 2013, ANIM COGN, V16, P187, DOI 10.1007/s10071-012-0563-1; Russell CL, 1997, J COMP PSYCHOL, V111, P185, DOI 10.1037/0735-7036.111.2.185; Savage-Rumbaugh S., 1988, P224; Tempelmann S, 2011, ANIM COGN, V14, P433, DOI 10.1007/s10071-011-0378-5; TOMASELLO M, 1989, PRIMATES, V30, P35, DOI 10.1007/BF02381209; TOMASELLO M, 1994, PRIMATES, V35, P137, DOI 10.1007/BF02382050; Tomasello M, 2005, MONOGR SOC RES CHILD, V70, P1; TOMASELLO M, 1985, J HUM EVOL, V14, P175, DOI 10.1016/S0047-2484(85)80005-1; Tomasello M, 2008, JEAN NICOD LECT, P1; Vea JJ, 1998, FOLIA PRIMATOL, V69, P289, DOI 10.1159/000021640; Zimmermann F, 2009, ANIM COGN, V12, P347, DOI 10.1007/s10071-008-0194-8	66	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195182	10.1371/journal.pone.0195182	http://dx.doi.org/10.1371/journal.pone.0195182			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	29694358	Green Published, gold			2022-12-26	WOS:000430802400023
J	Jayawickrama, GS; Nematollahi, A; Sun, GC; Church, WB				Jayawickrama, Gayan S.; Nematollahi, Alireza; Sun, Guanchen; Church, William Bret			Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ACID; SCHIZOPHRENIA; METABOLISM; GLUTAMATE; PROTECTION; TRYPTOPHAN; REDUCTION; CARBIDOPA; PATHWAY	The mammalian kynurenine aminotransferase (KAT) enzymes are a family of related iso-forms that are pyridoxal 5'-phosphate-dependent, responsible for the irreversible transamination of kynurenine to kynurenic acid. Kynurenic acid is implicated in human diseases such as schizophrenia where it is found in elevated levels and consequently KAT-II, as the isoform predominantly responsible for kynurenic acid production in the brain, has been targeted for the development of specific inhibitors. One class of compounds that have also shown inhibitory activity towards the KAT enzymes are estrogens and their sulfate esters. Estradiol disulfate in particular is very strongly inhibitory and it appears that the 17-sulfate makes a significant contribution to its potency. The work here demonstrates that the effect of this moiety can be mirrored in existing KAT-II inhibitors, from the development of two novel inhibitors, JN-01 and JN-02. Both inhibitors were based on NS-1502 (IC50: 315 mu M), but the deliberate placement of a sulfonamide group significantly improved the potency of JN-01 (IC50: 73.8 mu M) and JN-02 (IC50: 112.8 mu M) in comparison to the parent compound. This 3-4 fold increase in potency shows the potential of these moieties to be accommodated in the KAT-II active site and the effect they can have on improving inhibitors, and the environments in the KAT-II have been suitably modelled using docking calculations.	[Jayawickrama, Gayan S.; Nematollahi, Alireza; Sun, Guanchen; Church, William Bret] Univ Sydney, Grp Biomol Struct & Informat, Fac Pharm, Sydney, NSW, Australia; [Sun, Guanchen] Fountain Biotech, Sydney, NSW, Australia	University of Sydney	Church, WB (corresponding author), Univ Sydney, Grp Biomol Struct & Informat, Fac Pharm, Sydney, NSW, Australia.	bret.church@sydney.edu.au	; Church, William/H-6040-2013	Nematollahi, Alireza/0000-0002-2971-7377; Church, William/0000-0002-8033-5518	University of Sydney; Australian Postgraduate Research Awards; Australian Research Council; Rebecca L. Cooper Medical Research Foundation; Fountain Biotech	University of Sydney(University of Sydney); Australian Postgraduate Research Awards; Australian Research Council(Australian Research Council); Rebecca L. Cooper Medical Research Foundation; Fountain Biotech	Authors A.N., G.S., G.S.J. received support from the University of Sydney and Australian Postgraduate Research Awards, and W.B.C. was supported by funding from the Australian Research Council and The Rebecca L. Cooper Medical Research Foundation. GS is currently employed by Fountain Biotech. Fountain Biotech provides support for author GS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	AKAHANE K, 1993, ANTIMICROB AGENTS CH, V37, P1764, DOI 10.1128/AAC.37.9.1764; Albuquerque EX, 2013, BIOCHEM PHARMACOL, V85, P1027, DOI 10.1016/j.bcp.2012.12.014; Amori L, 2009, NEUROSCIENCE, V159, P196, DOI 10.1016/j.neuroscience.2008.11.055; [Anonymous], 2015, SCHROD REL GLID; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Beggiato S, 2014, NEUROPHARMACOLOGY, V82, P11, DOI 10.1016/j.neuropharm.2014.02.019; Bellocchi D, 2009, BBA-PROTEINS PROTEOM, V1794, P1802, DOI 10.1016/j.bbapap.2009.08.016; CARPENEDO R, 1994, NEUROSCIENCE, V61, P237, DOI 10.1016/0306-4522(94)90227-5; DANYSZ W, 1989, NEUROSCI LETT, V96, P340, DOI 10.1016/0304-3940(89)90402-3; DECASTRO FT, 1957, J BIOL CHEM, V228, P777; Dounay AB, 2012, ACS MED CHEM LETT, V3, P187, DOI 10.1021/ml200204m; ELMSLIE KS, 1985, BRAIN RES, V330, P265, DOI 10.1016/0006-8993(85)90685-7; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GraphPad Prism, 2016, GRAPHPAD PRISM VERS; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; Han Q, 2008, J BIOL CHEM, V283, P3567, DOI 10.1074/jbc.M708358200; Han Q, 2010, CELL MOL LIFE SCI, V67, P353, DOI 10.1007/s00018-009-0166-4; Hinz M, 2014, CLIN PHARMACOL-ADV A, V6, P189, DOI 10.2147/CPAA.S72234; Hinz M, 2014, CLIN PHARMACOL-ADV A, V6, P161, DOI 10.2147/CPAA.S70707; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jayawickrama GS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17979-7; Jayawickrama GS, 2015, CURR MED CHEM, V22, P2902, DOI 10.2174/0929867322666150608094054; Jensen RA, 1996, J BACTERIOL, V178, P2161, DOI 10.1128/jb.178.8.2161-2171.1996; Kozak R, 2014, J NEUROSCI, V34, P10592, DOI 10.1523/JNEUROSCI.1107-14.2014; Lugo-Huitron R, 2011, NEUROTOXICOL TERATOL, V33, P538, DOI 10.1016/j.ntt.2011.07.002; MASON M, 1969, ANN NY ACAD SCI, V166, P170, DOI 10.1111/j.1749-6632.1969.tb46385.x; MASON M, 1960, J BIOL CHEM, V235, P1312; Nadvi NA, 2017, PROTEIN SCI, V26, P727, DOI 10.1002/pro.3119; Nematollahi A, 2016, MOLECULES, V21, DOI 10.3390/molecules21070856; Nematollahi A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040446; Pellicciari R, 2006, CHEMMEDCHEM, V1, P528, DOI 10.1002/cmdc.200500095; Pocivavsek A, 2011, NEUROPSYCHOPHARMACOL, V36, P2357, DOI 10.1038/npp.2011.127; Potter MC, 2010, NEUROPSYCHOPHARMACOL, V35, P1734, DOI 10.1038/npp.2010.39; Prescott C, 2006, NEUROSCI LETT, V402, P108, DOI 10.1016/j.neulet.2006.03.051; Release S., 2015, LIGPREP VERSION 3 3; Rossi F, 2010, J MED CHEM, V53, P5684, DOI 10.1021/jm100464k; Rossi F, 2008, CURR OPIN STRUC BIOL, V18, P748, DOI 10.1016/j.sbi.2008.09.009; SCARDI V, 1962, BIOCHEM J, V83, P413, DOI 10.1042/bj0830413; Schomburg I, 2002, TRENDS BIOCHEM SCI, V27, P54, DOI 10.1016/S0968-0004(01)02027-8; Schrodinger LLC., 2015, PYMOL MOL GRAPH SYST; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Stone TW, 2013, BR J PHARM; Wu HQ, 2014, SCHIZOPHRENIA BULL, V40, pS152, DOI 10.1093/schbul/sbt157; Zmarowski A, 2009, EUR J NEUROSCI, V29, P529, DOI 10.1111/j.1460-9568.2008.06594.x	46	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196404	10.1371/journal.pone.0196404	http://dx.doi.org/10.1371/journal.pone.0196404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689093	gold, Green Published, Green Submitted			2022-12-26	WOS:000430678800052
J	Hwang, JS; Dahms, HU; Huang, KL; Huang, MY; Liu, XJ; Khim, JS; Wong, CK				Hwang, Jiang-Shiou; Dahms, Hans-Uwe; Huang, Ke Li; Huang, Mu-Yeh; Liu, Xue-Jun; Khim, Jong Seong; Wong, Chong Kim			Bioaccumulation of trace metals in octocorals depends on age and tissue compartmentalization	PLOS ONE			English	Article							ATOMIC-ABSORPTION-SPECTROMETRY; WATER-QUALITY ASSESSMENT; NORTHERN TAIWAN COAST; GREAT-BARRIER-REEF; HEAVY-METALS; CORAL-REEF; RED-SEA; TAMIRAPARANI RIVER; TAKIFUGU-OBSCURUS; PORITES CORALS	Trace metal dynamics have not been studied with respect to growth increments in octocorals. It is particularly unknown whether ontogenetic compartmentalization of trace metal accumulation is species-specific. We studied here for the first time the intracolonial distribution and concentrations of 18 trace metals in the octocorals Subergorgia suberosa, Echinogorgia complexa and E. reticulata that were retrieved from the northern coast of Taiwan. Levels of trace metals were considerably elevated in corals collected at these particular coral habitats as a result of diverse anthropogenic inputs. There was a significant difference in the concentration of metals among octocorals except for Sn. Both species of Echinogorgia contained significantly higher concentrations of Cu, Zn and Al than Subergorgia suberosa. We used for the first time exponential growth curves that describe an age-specific relationship of octocoral trace metal concentrations of Cu, Zn, Cd, Cr and Pb where the distance from the grip point was reflecting younger age as linear regressions. The larger colony (C7) had a lower accumulation rate constant than the smaller one (C6) for Cu, Zn, Cd, Cr and Pb, while other trace metals showed an opposite trend. The Cu concentration declined exponentially from the grip point, whereas the concentrations of Zn, Cd, Cr and Pb increased exponentially. In S. suberosa and E. reticulata, Zn occurred primarily in coenosarc tissues and Zn concentrations increased with distance from the grip point in both skeletal and coenosarc tissues. Metals which appeared at high concentrations (e.g. Ca, Zn and Fe) generally tended to accumulate in the outer coenosarc tissues, while metals with low concentrations (e.g. V) tended to accumulate in the soft tissues of the inner	[Hwang, Jiang-Shiou; Huang, Ke Li] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Dahms, Hans-Uwe] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Dahms, Hans-Uwe] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Huang, Mu-Yeh] Yu Da Coll Business, Dept Mkt & Logist Management, Miaoli, Taiwan; [Liu, Xue-Jun; Wong, Chong Kim] Chinese Univ Hong Kong, Dept Biol, Shatin, Hong Kong, Peoples R China; [Khim, Jong Seong] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Khim, Jong Seong] Seoul Natl Univ, Res Inst Oceanog, Seoul, South Korea	National Taiwan Ocean University; Kaohsiung Medical University; National Sun Yat Sen University; Chinese University of Hong Kong; Seoul National University (SNU); Seoul National University (SNU)	Dahms, HU (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.; Dahms, HU (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan.	hansudahms@yahoo.com	Khim, Jong Seong/AAD-3054-2020	Khim, Jong Seong/0000-0001-7977-0929; Dahms, Hans-Uwe/0000-0002-0352-2715	Ministry of Science and Technology, Taiwan [MOST 103-2611-M-019-002, MOST 104-2621-M-019-002, MOST 104-2611-M-019-004, MOST 105-2621-M-019-001, MOST 106-2621-M-019-001]; Center of Excellence for the Oceans, National Taiwan Ocean University, Taiwan; Research Center for Environmental Medicine, Kaohsiung Medical University (KMU) [MOST104-2621-M-037-001, MOST105-2621-M-037-001]; Research Center for Environmental Medicine, Kaohsiung Medical University [KMU-TP105A27]; Ministry of Oceans and Fisheries, Republic of Korea	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Center of Excellence for the Oceans, National Taiwan Ocean University, Taiwan; Research Center for Environmental Medicine, Kaohsiung Medical University (KMU); Research Center for Environmental Medicine, Kaohsiung Medical University; Ministry of Oceans and Fisheries, Republic of Korea	We are grateful to the Ministry of Science and Technology, Taiwan (MOST 103-2611-M-019-002; MOST 104-2621-M-019-002; MOST 104-2611-M-019-004; MOST 105-2621-M-019-001 and MOST 106-2621-M-019-001), and Center of Excellence for the Oceans, National Taiwan Ocean University, Taiwan for their financial support to J. S. Hwang. H.U. Dahms acknowledges the support of a grant from the Research Center for Environmental Medicine, Kaohsiung Medical University (KMU), MOST104-2621-M-037-001, and MOST105-2621-M-037-001 to T.H. SHIH. This work was partly supported by a grant from the Research Center for Environmental Medicine, Kaohsiung Medical University (KMU-TP105A27) to H.U.D. J.S.K. was supported by the projects entitled "Integrated management of marine environment and ecosystems around Saemangeum" and "Development of integrated estuarine management system" funded by the Ministry of Oceans and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AHAM, 2011, HELGOLAND MAR RES, V65, P67, DOI 10.1007/s10152-010-0202-7; Anu G., 2008, Toxicological and Environmental Chemistry, V90, P1135, DOI 10.1080/02772240701877627; Anu G, 2007, ENVIRON MONIT ASSESS, V128, P195, DOI 10.1007/s10661-006-9305-7; Bastidas C, 2004, MAR ECOL PROG SER, V267, P133, DOI 10.3354/meps267133; Bielmyer GK, 2010, AQUAT TOXICOL, V97, P125, DOI 10.1016/j.aquatox.2009.12.021; Birkeland CR, 1997, LIFE DEATH CORAL REE, P1; Browne NK, 2015, MAR ENVIRON RES, V105, P39, DOI 10.1016/j.marenvres.2015.02.002; Bureau of Environmental Protection, 1999, MON PLAN WAT QUAL NO; Chan I, 2014, MAR POLLUT BULL, V85, P648, DOI 10.1016/j.marpolbul.2013.11.015; Chen C-T, 2004, J MARINE SCI TECHNOL, V12, P355, DOI [DOI 10.1080/02757549808037625V, 10.1080/02757549808037625v]; Chen CW, 2007, CHEMOSPHERE, V66, P1431, DOI 10.1016/j.chemosphere.2006.09.030; Chen CS, 2004, 10 INT COR REEF S OK; Chen TR, 2010, MAR ENVIRON RES, V70, P318, DOI 10.1016/j.marenvres.2010.06.004; Dai CF, 2002, P IUCN WCPA EA4 TAIP, P265; Dai CF, 1997, STATUS CORAL REEFS P, P123; DENTON GRW, 1986, MAR POLLUT BULL, V17, P209, DOI 10.1016/0025-326X(86)90602-8; DEPLEDGE MH, 1990, COMP BIOCHEM PHYS C, V97, P1, DOI 10.1016/0742-8413(90)90163-4; Doong RA, 2008, MAR POLLUT BULL, V57, P846, DOI 10.1016/j.marpolbul.2007.12.015; EPA-Taiwan, 2017, SURF WAT CLASS WAT Q; Esslemont G, 2000, MAR CHEM, V71, P215, DOI 10.1016/S0304-4203(00)00050-5; Esslemont G, 2000, MAR CHEM, V69, P69, DOI 10.1016/S0304-4203(99)00096-1; Esslemont G, 1999, MAR POLLUT BULL, V38, P1051, DOI 10.1016/S0025-326X(99)00183-6; Fang TH, 2006, MAR ENVIRON RES, V61, P224, DOI 10.1016/j.marenvres.2005.10.002; GOH B P L, 1991, Pacific Science, V45, P276; Grigg R.W., 1990, P439; GUZMAN HM, 1992, MAR POLLUT BULL, V24, P554, DOI 10.1016/0025-326X(92)90708-E; HOWARD LS, 1984, OCEANOGR MAR BIOL, V22, P195; Howard LS, 1986, CORAL REEF POPULATIO, P452; Hsiao SH, 2006, CRUSTACEANA, V79, P459, DOI 10.1163/156854006777554820; HUNG TC, 1992, SCI TOTAL ENVIRON, V125, P359, DOI 10.1016/0048-9697(92)90401-D; Hwang J-S, 2000, NATL TAIWAN MUSEUM S, V10, P199; Hwang JS, 2006, J PLANKTON RES, V28, P943, DOI 10.1093/plankt/fbl031; Hwang JS, 2005, J PLANKTON RES, V27, P205, DOI 10.1093/plankt/fbh162; Hwang JS, 2004, ZOOL STUD, V43; JAFFE R, 1992, TALANTA, V39, P113, DOI 10.1016/0039-9140(92)80004-W; Jeong SY, 2014, FISH PHYSIOL BIOCHEM, V40, P205, DOI 10.1007/s10695-013-9837-z; Johannes R.E., 1975, Elsevier oceanogr Ser, V12, P13; Kadukova J, 2005, ENVIRON INT, V31, P227, DOI 10.1016/j.envint.2004.09.020; Khaled A, 2003, B ENVIRON CONTAM TOX, V71, P577, DOI 10.1007/s00128-003-8751-y; Kim JH, 2013, AQUAC RES, V44, P985, DOI 10.1111/j.1365-2109.2012.03104.x; Kim JH, 2012, FISH PHYSIOL BIOCHEM, V38, P1331, DOI 10.1007/s10695-012-9621-5; Kim JH, 2010, COMP BIOCHEM PHYS C, V152, P473, DOI 10.1016/j.cbpc.2010.08.002; Kim JH, 2010, COMP BIOCHEM PHYS C, V151, P99, DOI 10.1016/j.cbpc.2009.09.001; Kimrua T, 2004, STATUS CORAL REEFS W, V1, P277; Knowlton N, 2013, ENCY BIODIVERSITY, DOI [10.1016/B978-0-12-384719-5.00237-9, DOI 10.1016/B978-0-12-384719-5.00237-9]; Kumarasamy P, 2014, ARAB J GEOSCI, V7, P5209, DOI 10.1007/s12517-013-1146-4; Kumarasamy P, 2014, ENVIRON EARTH SCI, V71, P2441, DOI 10.1007/s12665-013-2644-0; Lee CL, 1996, CHEMOSPHERE, V33, P2505, DOI 10.1016/S0045-6535(96)00344-X; Lenore S, 1998, STANDARD METHODS EXA, pi; Lin MC, 1991, THESIS, P1; Lin S, 1999, MAR POLLUT BULL, V38, P960, DOI 10.1016/S0025-326X(99)00108-3; LUOMA SN, 1983, SCI TOTAL ENVIRON, V28, P1, DOI 10.1016/S0048-9697(83)80004-7; Mason AZ, 1995, METAL SPECIATION BIO, P679; Mitchelmore CL, 2007, AQUAT TOXICOL, V85, P48, DOI 10.1016/j.aquatox.2007.07.015; Morrison RJ, 2015, MAR POLLUT BULL, V96, P41, DOI 10.1016/j.marpolbul.2015.05.049; Pekey H, 2006, MAR POLLUT BULL, V52, P1197, DOI 10.1016/j.marpolbul.2006.02.012; Peng SH, 2006, CRUSTACEANA, V79, P263, DOI 10.1163/156854006776759617; Pohl T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04250; Rainbow PS, 2002, ENVIRON POLLUT, V120, P497, DOI 10.1016/S0269-7491(02)00238-5; Ramos AA, 2004, MAR POLLUT BULL, V48, P281, DOI 10.1016/j.marpolbul.2003.08.003; Reichelt-Brushett AJ, 1999, MAR POLLUT BULL, V38, P182, DOI 10.1016/S0025-326X(98)00183-0; Saunders MG, 1997, J RADIOANAL NUCL CH, V219, P135; SHEN GT, 1987, EARTH PLANET SC LETT, V82, P289, DOI 10.1016/0012-821X(87)90203-2; Tseng LC, 2011, MAR BIOL, V158, P1301, DOI 10.1007/s00227-011-1649-z; Wielgus J, 2004, MAR POLLUT BULL, V48, P248, DOI 10.1016/j.marpolbul.2003.08.008; Wilkinson C., 1998, GLOBAL CORAL REEF MO, P184; Xu XR, 2013, AQUAT BIOL, V18, P293, DOI 10.3354/ab00502; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077569	68	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196222	10.1371/journal.pone.0196222	http://dx.doi.org/10.1371/journal.pone.0196222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684058	gold, Green Published, Green Submitted			2022-12-26	WOS:000430660600044
J	Sceneay, J; Griessinger, CM; Hoffmann, SHL; Wen, SW; Wong, CSF; Krumeich, S; Kneilling, M; Pichler, BJ; Moller, A				Sceneay, Jaclyn; Griessinger, Christoph M.; Hoffmann, Sabrina H. L.; Wen, Shu Wen; Wong, Christina S. F.; Krumeich, Sophie; Kneilling, Manfred; Pichler, Bernd J.; Moeller, Andreas			Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; IN-VIVO TRACKING; BEARING MICE; IMMUNE SUPPRESSION; DENDRITIC CELLS; GM-CSF; CANCER; DIFFERENTIATION; INFLAMMATION; ANGIOGENESIS	Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid progenitor cells that are expanded in cancer and act as potent suppressors of the anti-tumor immune response. MDSCs consist of two major subsets, namely monocytic (M-) MDSCs and granulocytic (G-) MDSCs that differ with respect to their phenotype, morphology and mechanisms of suppression. Here, we cultured bone marrow cells with IL-6 and GM-CSF in vitro to generate a population of bone marrow MDSCs (BM-MDSCs) similar to G-MDSCs from tumor-bearing mice in regards to phenotype, morphology and suppressive-function. Through fluorescent labeling of these BM-MDSCs and optical imaging, we could visualize the recruitment and localization of BM-MDSCs in breast tumor-bearing mice in vivo. Furthermore, we were able to demonstrate that BM-MDSCs home to primary and metastatic breast tumors, but have no significant effect on tumor growth or progression. Ex vivo flow cytometry characterization of BM-MDSCs after adoptive transfer demonstrated both organ-and tumor-specific effects on their phenotype and differentiation, demonstrating the importance of the local microenvironment on MDSC fate and function. In this study, we have developed a method to generate, visualize and detect BM-MDSCs in vivo and ex vivo through optical imaging and flow cytometry, in order to understand the organ-specific changes rendered to MDSCs in breast cancer.	[Sceneay, Jaclyn; Griessinger, Christoph M.; Wen, Shu Wen; Wong, Christina S. F.; Krumeich, Sophie; Moeller, Andreas] QIMR Berghofer Med Res Inst, Tumor Microenvironm Lab, Herston, Qld, Australia; [Griessinger, Christoph M.; Hoffmann, Sabrina H. L.; Kneilling, Manfred; Pichler, Bernd J.] Eberhard Karls Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Tubingen, Germany; [Kneilling, Manfred] Eberhard Karls Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Moeller, Andreas] Univ Queensland, Sch Med, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; Eberhard Karls University of Tubingen; Siemens AG; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Queensland	Moller, A (corresponding author), QIMR Berghofer Med Res Inst, Tumor Microenvironm Lab, Herston, Qld, Australia.; Moller, A (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld, Australia.	Andreas.moller@qjmrberghofer.edu.au	Möller, Andreas/O-1063-2015	Möller, Andreas/0000-0002-8618-6998	German Research Foundation [GR4017/1-1]; Fortune-Junior Grant of the Medical Faculty [2309-0-0]; University of Tubingen; Swiss Werner Siemens Foundation; National Health and Medical Research Council Australia (NHMRC) [APP1068510]; Cancer Council Queensland [APP1045620]; Rio-Tinto-Ride-To-Conquer-Cancer [6156]; National Breast Cancer Foundation (Australia) [ECF-11-09, NC-13-26]; National Breast Cancer Foundation [NC-13-26] Funding Source: researchfish	German Research Foundation(German Research Foundation (DFG)); Fortune-Junior Grant of the Medical Faculty; University of Tubingen; Swiss Werner Siemens Foundation; National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Rio-Tinto-Ride-To-Conquer-Cancer; National Breast Cancer Foundation (Australia); National Breast Cancer Foundation	This work was supported by the Research Fellowship of the German Research Foundation (GR4017/1-1) and a Fortune-Junior Grant (2309-0-0) of the Medical Faculty for CMG; the University of Tubingen and the Swiss Werner Siemens Foundation for BJP; the National Health and Medical Research Council Australia (NHMRC, APP1068510), Cancer Council Queensland (APP1045620) Rio-Tinto-Ride-To-Conquer-Cancer (6156), and National Breast Cancer Foundation (Australia) fellowship and grant to AM (ECF-11-09, NC-13-26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2013, NAT REV IMMUNOL, V13, P755, DOI 10.1038/nri3531; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bronte V, 1999, J IMMUNOL, V162, P5728; Bronte V, 1998, J IMMUNOL, V161, P5313; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Chioda M, 2011, CANCER METAST REV, V30, P27, DOI 10.1007/s10555-011-9268-1; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Elpek KG, 2014, CANCER IMMUNOL RES, V2, P655, DOI 10.1158/2326-6066.CIR-13-0209; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Griessinger CM, 2015, P NATL ACAD SCI USA, V112, P1161, DOI 10.1073/pnas.1418391112; Griessinger CM, 2014, J NUCL MED, V55, P301, DOI 10.2967/jnumed.113.126318; Hammami I, 2012, BIOCHEM BIOPH RES CO, V425, P724, DOI 10.1016/j.bbrc.2012.07.139; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Iclozan C, 2013, CANCER IMMUNOL IMMUN, V62, P909, DOI 10.1007/s00262-013-1396-8; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Kusmartsev S, 2002, CANCER IMMUNOL IMMUN, V51, P293, DOI 10.1007/s00262-002-0280-8; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Lassailly F, 2010, BLOOD, V115, P5347, DOI 10.1182/blood-2009-05-224030; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Morales JK, 2010, BREAST CANCER RES TR, V123, P39, DOI 10.1007/s10549-009-0622-8; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Narita Y, 2009, BIOMED RES-TOKYO, V30, P7, DOI 10.2220/biomedres.30.7; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; Qin H, 2014, NAT MED, V20, P676, DOI 10.1038/nm.3560; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Sceneay J, 2012, CANCER RES, V72, P3906, DOI 10.1158/0008-5472.CAN-11-3873; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sutton EJ, 2008, EUR RADIOL, V18, P2021, DOI 10.1007/s00330-008-0984-z; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Wong CSF, 2012, CANCER RES, V72, P1694, DOI 10.1158/0008-5472.CAN-11-3310; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zhong H, 2014, INT J CANCER, V134, P2633, DOI 10.1002/ijc.28590	48	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0196040	10.1371/journal.pone.0196040	http://dx.doi.org/10.1371/journal.pone.0196040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677215	Green Published, gold			2022-12-26	WOS:000430638900022
J	Handler, J; Cullis, J; Avanzi, A; Vucic, EA; Bar-Sagi, D				Handler, Jesse; Cullis, Jane; Avanzi, Antonina; Vucic, Emily A.; Bar-Sagi, Dafna			Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-beta exposure	ONCOGENE			English	Article							STEM-CELL; EXPRESSION; CANCER; ADENOCARCINOMA; GENERATION; TRANSDIFFERENTIATION; DISSEMINATION; ACTIVATION; PLASTICITY; PROMOTES	Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease and a major health problem in the United States. While the cytokine TGF-beta has been implicated in PDAC development, it can exert both pro-tumorigenic and anti-tumorigenic effects that are highly context dependent and incompletely understood. Using three-dimensional (3D) cultures of Kras(G12D)-expressing mouse pancreatic epithelial cells we demonstrated that while exposure to exogenous TGF-beta induced growth arrest of the Kras(G12D) cells, its subsequent removal allowed the cells to enter a hyper-proliferative, partially mesenchymal (PM), and progenitor-like state. This state was highly stable and was maintained by autocrine TGF-beta signaling. While untreated Kras(G12D) cells formed cystic lesions in vivo, PM cells formed ductal structures resembling human PanINs, suggesting that they had attained increased oncogenic potential. Supporting this hypothesis, we determined that the PM cells share salient molecular and phenotypic features with the quasi-mesenchymal/squamous subtype of human PDAC, which has the worst prognosis of any of the recently identified subtypes. Transient pulses of TGF-beta have been observed during pancreatitis, a major risk factor for PDAC. Our data suggest that transient TGF-beta exposure is sufficient to induce the acquisition of stable PDAC-associated phenotypes in pre-neoplastic Kras(G12D) cells, providing novel molecular insight into the complex role of TGF-beta in tumorigenesis.	[Handler, Jesse; Cullis, Jane; Avanzi, Antonina; Vucic, Emily A.; Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	New York University	Bar-Sagi, D (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	dafna.bar-sagi@nyumc.org		Bar-Sagi, Dafna/0000-0003-2597-8948; Handler, Jesse/0000-0001-5444-3905	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center [P30CA016087]; NIH/NCI grant [CA210263]; NIH [T32GM007308, 5-T32 CA 009161-39, 5-T32AI100853-04]; Canadian Institutes of Health Research postdoctoral fellowship [146792]; NATIONAL CANCER INSTITUTE [R35CA210263, T32CA009161, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI100853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER	Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L.J. Taylor for discussions and help with article preparation and the members of the Bar-Sagi laboratory for comments. The authors also thank the New York University School of Medicine Genome Technology Center (GTC), especially Adriana Heguy and Igor Dolgalev, for help designing, performing, and analyzing RNA sequencing experiments. The GTC is partially supported by the Cancer Center Support Grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. This work was further supported by NIH/NCI grant CA210263 (D. Bar-Sagi). J. Handler was supported by NIH grant T32GM007308. J. Cullis was supported by NIH grants 5-T32 CA 009161-39 and 5-T32AI100853-04. E.A. Vucic is supported by a Canadian Institutes of Health Research postdoctoral fellowship (146792).	American Cancer Society, 2017, CANC FACTS FIG 2017; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Cullis J, 2017, CANCER IMMUNOL RES, V5, P182, DOI 10.1158/2326-6066.CIR-16-0125; Desgrosellier JS, 2014, DEV CELL, V30, P295, DOI 10.1016/j.devcel.2014.06.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ellenrieder V, 2001, CANCER RES, V61, P4222; FRIESS H, 1993, GASTROENTEROLOGY, V105, P1846, DOI 10.1016/0016-5085(93)91084-U; Goonesekere NCW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093046; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Handra-Luca A, 2011, BRIT J CANCER, V104, P1296, DOI 10.1038/bjc.2011.93; Harper KL, 2016, NATURE, V540, P588, DOI 10.1038/nature20609; Hezel AF, 2012, CANCER RES, V72, P4840, DOI 10.1158/0008-5472.CAN-12-0634; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Principe DR, 2016, CANCER RES, V76, P2525, DOI 10.1158/0008-5472.CAN-15-1293; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Riesle E, 1997, GUT, V40, P73, DOI 10.1136/gut.40.1.73; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sadler TW., 2015, LANGMANS MEDICAL EMB, V13; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takadate T, 2013, INT J CANCER, V132, P1368, DOI 10.1002/ijc.27797; Whittle MC, 2015, CELL, V161, P1345, DOI 10.1016/j.cell.2015.04.048; Wilentz RE, 2000, CANCER RES, V60, P2002; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744	44	12	12	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 2	2018	37	31					4334	4342		10.1038/s41388-018-0264-6	http://dx.doi.org/10.1038/s41388-018-0264-6			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP1HN	29713060	Green Accepted			2022-12-26	WOS:000440566100010
J	Klose, R; Adam, MG; Weis, EM; Moll, I; Wustehube-Lausch, J; Tetzlaff, F; Oka, C; Ehrmann, M; Fischer, A				Klose, Ralph; Adam, M. Gordian; Weis, Eva-Maria; Moll, Iris; Wustehube-Lausch, Joycelyn; Tetzlaff, Fabian; Oka, Chio; Ehrmann, Michael; Fischer, Andreas			Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis	ONCOGENE			English	Article							SMALL-VESSEL DISEASE; NOTCH LIGAND; DLL4; SUSCEPTIBILITY; DEFICIENCY; EXPRESSION; REPRESSION; MUTATIONS	The serine protease HTRA1 is involved in several vascular diseases and its expression is often deregulated in cancer. We aimed at identifying how HTRA1 in the vasculature affects tumor growth. Here we report that silencing of HTRA1 in cultured endothelial cells increased migration rate and tube formation, whereas forced HTRA1 expression impaired sprouting angiogenesis. Mechanistically, endothelial HTRA1 expression enhanced Delta/Notch signaling by reducing the amount of the weak Notch ligand JAG1. HTRA1 physically interacted with JAG1 and cleaved it within the intracellular domain, leading to protein degradation. Expression of a constitutive active Notch1 prevented the hypersprouting phenotype upon silencing of HTRA1. In HtrA1-deficient mice, endothelial Notch signaling was diminished and isolated endothelial cells had increased expression of VEGF receptor-2. Growth of syngeneic tumors was strongly impaired in HtrA1(-/-) mice. The tumor vasculature was much denser in HtrA1(-/-) mice and less covered with mural cells. This chaotic and immature vascular network was poorly functional as indicated by large hypoxic tumor areas and low tumor cell proliferation rates. In summary, inhibition of HTRA1 in the tumor stroma impaired tumor progression by deregulating angiogenesis.	[Klose, Ralph; Adam, M. Gordian; Weis, Eva-Maria; Moll, Iris; Wustehube-Lausch, Joycelyn; Tetzlaff, Fabian; Fischer, Andreas] German Canc Res Ctr, Div Vasc Signaling & Canc A270, D-69120 Heidelberg, Germany; [Wustehube-Lausch, Joycelyn; Fischer, Andreas] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci, D-68167 Mannheim, Germany; [Oka, Chio] Nara Inst Sci & Technol, Lab Gene Funct Anim, 8916-5 Takayama, Ikoma, Nara 6300192, Japan; [Ehrmann, Michael] Univ Duisburg Essen, Ctr Med Biotechnol, Fac Biol, D-45117 Essen, Germany; [Fischer, Andreas] Heidelberg Univ Hosp, Med Clin 1, Endocrinol & Clin Chem, D-69120 Heidelberg, Germany; [Adam, M. Gordian] Metan Hlth GmbH, Berlin, Germany; [Wustehube-Lausch, Joycelyn] BioNTech AG, Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Nara Institute of Science & Technology; University of Duisburg Essen; Ruprecht Karls University Heidelberg; BioNTech SE	Fischer, A (corresponding author), German Canc Res Ctr, Div Vasc Signaling & Canc A270, D-69120 Heidelberg, Germany.; Fischer, A (corresponding author), Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci, D-68167 Mannheim, Germany.; Fischer, A (corresponding author), Heidelberg Univ Hosp, Med Clin 1, Endocrinol & Clin Chem, D-69120 Heidelberg, Germany.	a.fischer@dkfz.de	Ehrmann, Michael/A-7307-2012	Ehrmann, Michael/0000-0002-1927-260X; Fischer, Andreas/0000-0002-4889-0909	Fritz-Thyssen Foundation [10.13.1.160]; Deutsche Forschungsgemeinschaft [SFB-TR23]; Deutsche Krebshilfe [110638]; Helmholtz Society	Fritz-Thyssen Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Helmholtz Society(Helmholtz Association)	This work was supported by the Fritz-Thyssen Foundation (10.13.1.160), the Deutsche Forschungsgemeinschaft (SFB-TR23, project A7), the Deutsche Krebshilfe (110638), and the Helmholtz Society to AF.	Altobelli E, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4041-2; Beaufort N, 2014, P NATL ACAD SCI USA, V111, P16496, DOI 10.1073/pnas.1418087111; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Catrein I, 2005, FEBS J, V272, P2892, DOI 10.1111/j.1742-4658.2005.04710.x; De Luca A, 2003, J HISTOCHEM CYTOCHEM, V51, P1279, DOI 10.1177/002215540305101004; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Friedrich U, 2015, HUM MOL GENET, V24, P6361, DOI 10.1093/hmg/ddv346; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hasan MZ, 2015, DEV BIOL, V397, P89, DOI 10.1016/j.ydbio.2014.10.015; He XP, 2010, CANCER RES, V70, P3109, DOI 10.1158/0008-5472.CAN-09-3557; Jabs M, 2018, CIRCULATION, V137, P2592, DOI 10.1161/CIRCULATIONAHA.117.029733; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klose R, 2015, CARDIOVASC RES, V107, P153, DOI 10.1093/cvr/cvv151; Kofler NM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16449; Limbourg A, 2007, CIRC RES, V100, P363, DOI 10.1161/01.RES.0000258174.77370.2c; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Outtz HH, 2010, J IMMUNOL, V185, P4363, DOI 10.4049/jimmunol.1000720; Poepsel S, 2015, NAT CHEM BIOL, V11, P862, DOI [10.1038/NCHEMBIO.1931, 10.1038/nchembio.1931]; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Shiga A, 2011, HUM MOL GENET, V20, P1800, DOI 10.1093/hmg/ddr063; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Teoh SSY, 2015, PLACENTA, V36, P990, DOI 10.1016/j.placenta.2015.07.001; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Verdura E, 2015, BRAIN, V138, P2347, DOI 10.1093/brain/awv155; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Zhang L, 2012, J BIOL CHEM, V287, P1520, DOI 10.1074/jbc.M111.275990	31	17	17	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 2	2018	37	31					4260	4272		10.1038/s41388-018-0258-4	http://dx.doi.org/10.1038/s41388-018-0258-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP1HN	29713059				2022-12-26	WOS:000440566100005
J	Morris, SM; Mhyre, AJ; Carmack, SS; Myers, CH; Burns, C; Ye, WJ; Ferrer, M; Olson, JM; Klinghoffer, RA				Morris, Shelli M.; Mhyre, Andrew J.; Carmack, Savanna S.; Myers, Carrie H.; Burns, Connor; Ye, Wenjuan; Ferrer, Marc; Olson, James M.; Klinghoffer, Richard A.			A modified gene trap approach for improved high-throughput cancer drug discovery	ONCOGENE			English	Article							TYROSINE KINASE INHIBITOR; EMBRYONIC STEM-CELLS; EXPRESSION SIGNATURE; PROMOTER TRAPS; MELANOMA; BRAF; MUTAGENESIS; LEUKEMIA; TAK-632; DESIGN	While advances in laboratory automation has dramatically increased throughout of compound screening efforts, development of robust cell-based assays in relevant disease models remain resource-intensive and time-consuming, presenting a bottleneck to drug discovery campaigns. To address this issue, we present a modified gene trap approach to efficiently generate pathway-specific reporters that result in a robust "on" signal when the pathway of interest is inhibited. In this proof-of-concept study, we used vemurafenib and trametinib to identify traps that specifically detect inhibition of the mitogen-activated protein kinase (MAPK) pathway in a model of BRAFV600E driven human malignant melanoma. We demonstrate that insertion of our trap into particular loci results in remarkably specific detection of MAPK pathway inhibitors over compounds targeting any other pathway or cellular function. The accuracy of our approach was highlighted in a pilot screen of similar to 6000 compounds where 40 actives were detected, including 18 MEK, 10 RAF, and 3 ERK inhibitors along with a few compounds representing previously under-characterized inhibitors of the MAPK pathway. One such compound, bafetinib, a second generation BCR/ABL inhibitor, reduced phosphorylation of ERK and when combined with trametinib, both in vitro and in vivo, reduced growth of vemurafenib resistant melanoma cells. While piloted in a model of BRAF-driven melanoma, our results set the stage for using this approach to rapidly generate reporters against any transcriptionally active pathway across a wide variety of disease-relevant cell-based models to expedite drug discovery efforts.	[Morris, Shelli M.; Mhyre, Andrew J.; Carmack, Savanna S.; Myers, Carrie H.; Olson, James M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Burns, Connor; Klinghoffer, Richard A.] Presage Biosci, Seattle, WA 98109 USA; [Ye, Wenjuan; Ferrer, Marc] NIH NCATS, Rockville, MD USA; [Olson, James M.] Univ Washington, Sch Med, Div Pediat Hematol Oncol, Seattle, WA 98195 USA; [Olson, James M.] Seattle Childrens Hosp, Seattle, WA 98105 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Olson, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.; Klinghoffer, RA (corresponding author), Presage Biosci, Seattle, WA 98109 USA.; Olson, JM (corresponding author), Univ Washington, Sch Med, Div Pediat Hematol Oncol, Seattle, WA 98195 USA.; Olson, JM (corresponding author), Seattle Childrens Hosp, Seattle, WA 98105 USA.	jolson@fredhutch.org; Rich.Klinghoffer@presagebio.com			National Cancer Institute of the National Institutes of Health [R43CA171366, RO1CA193841, RO1CA155360]; Seattle Children's Brain Tumor Research Endowment; NATIONAL CANCER INSTITUTE [R01CA155360, R43CA171366, R01CA114567, R01CA193841] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000363] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Seattle Children's Brain Tumor Research Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We would like to thank Jason Frazier, Robert Finney, Emily J. Girard, Madison W. Nakamoto and the staff of the Genomics Shared Resource and the Comparative Medicine Shared Resource at the Fred Hutchinson Cancer Research Center. This research was supported by the National Cancer Institute of the National Institutes of Health under Award Numbers R43CA171366 (R.A.K.), RO1CA193841 (A.J.M. and J.M.O.), RO1CA155360 and the Seattle Children's Brain Tumor Research Endowment (J.M.O.).	Abe H, 2011, ACS MED CHEM LETT, V2, P320, DOI 10.1021/ml200004g; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dang CV, 2017, NAT REV CANCER, V17, P502, DOI 10.1038/nrc.2017.36; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Friedel RH, 2010, METHOD ENZYMOL, V477, P243, DOI 10.1016/S0076-6879(10)77013-0; FRIEDRICH G, 1993, METHOD ENZYMOL, V225, P681; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Griner LAM, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.360; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Kaelin WG, 2017, NAT REV CANCER, V17, P441, DOI 10.1038/nrc.2017.32; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kannengiesser C, 2008, MOL ONCOL, V1, P425, DOI 10.1016/j.molonc.2008.01.002; Kimura S, 2005, BLOOD, V106, P3948, DOI 10.1182/blood-2005-06-2209; Li YJ, 2015, INT J CLIN EXP PATHO, V8, P7818; Loboda A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-26; Luke JJ, 2017, NAT REV CLIN ONCOL, V14, P463, DOI 10.1038/nrclinonc.2017.43; Medico E, 2001, NAT BIOTECHNOL, V19, P579, DOI 10.1038/89343; Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464; Nakamura A, 2013, CANCER RES, V73, P7043, DOI 10.1158/0008-5472.CAN-13-1825; Okaniwa M, 2013, J MED CHEM, V56, P6478, DOI 10.1021/jm400778d; Okaniwa M, 2012, J MED CHEM, V55, P3452, DOI 10.1021/jm300126x; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santos FPS, 2010, CURR OPIN INVEST DR, V11, P1450; Southall N. A., 2009, HDB DRUG SCREENING, P442; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Yuhong, 2010, Curr Chem Genomics, V4, P57, DOI 10.2174/1875397301004010057; Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125	35	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 2	2018	37	31					4226	4238		10.1038/s41388-018-0274-4	http://dx.doi.org/10.1038/s41388-018-0274-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP1HN	29717260	hybrid, Green Accepted			2022-12-26	WOS:000440566100003
J	Stival, C; Ritagliati, C; Xu, XR; Gervasi, MG; Luque, GM; Graf, CB; De la Vega-Beltran, JL; Torres, N; Darszon, A; Krapf, D; Buffone, MG; Visconti, PE; Krapf, D				Stival, Cintia; Ritagliati, Carla; Xu, Xinran; Gervasi, Maria G.; Luque, Guillermina M.; Baro Graf, Carolina; Luis De la Vega-Beltran, Jose; Torres, Nicolas; Darszon, Alberto; Krapf, Diego; Buffone, Mariano G.; Visconti, Pablo E.; Krapf, Dario			Disruption of protein kinase A localization induces acrosomal exocytosis in capacitated mouse sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sperm; fertilization; reproduction; protein kinase A (PKA); signal transduction	OPTICAL RECONSTRUCTION MICROSCOPY; MALE-FERTILITY; TYROSINE PHOSPHORYLATION; ANCHORING PROTEIN; MAMMALIAN SPERM; SRC KINASE; EGG WATER; MOTILITY; PKA; CAMP	Protein kinase A (PKA) is a broad-spectrum Ser/Thr kinase involved in the regulation of several cellular activities. Thus, its precise activation relies on being localized at specific subcellular places known as discrete PKA signalosomes. A-Kinase anchoring proteins (AKAPs) form scaffolding assemblies that play a pivotal role in PKA regulation by restricting its activity to specific microdomains. Because one of the first signaling events observed during mammalian sperm capacitation is PKA activation, understanding how PKA activity is restricted in space and time is crucial to decipher the critical steps of sperm capacitation. Here, we demonstrate that the anchoring of PKA to AKAP is not only necessary but also actively regulated during sperm capacitation. However, we find that once capacitated, the release of PKA from AKAP promotes a sudden Ca2+ influx through the sperm-specific Ca2+ channel CatSper, starting a tail-to-head Ca2+ propagation that triggers the acrosome reaction. Three-dimensional super-resolution imaging confirmed a redistribution of PKA within the flagellar structure throughout the capacitation process, which depends on anchoring to AKAP. These results represent a new signaling event that involves CatSper Ca2+ channels in the acrosome reaction, sensitive to PKA stimulation upon release from AKAP.	[Stival, Cintia; Ritagliati, Carla; Baro Graf, Carolina; Krapf, Dario] CONICET UNR, Lab Cell Signal Transduct Networks, Inst Biol Mol & Celular Rosario IBR, RA-2000 Rosario, Santa Fe, Argentina; [Xu, Xinran; Krapf, Diego] Colorado State Univ, Dept Elect & Comp Engn, Ft Collins, CO 80523 USA; [Gervasi, Maria G.; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Luque, Guillermina M.; Torres, Nicolas; Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Biol & Med Expt IBYME, C1428ADN, Buenos Aires, DF, Argentina; [Luis De la Vega-Beltran, Jose; Darszon, Alberto] UNAM, Inst Biotecnol IBT, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico; [Krapf, Diego] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Colorado State University; University of Massachusetts System; University of Massachusetts Amherst; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Universidad Nacional Autonoma de Mexico; Colorado State University	Krapf, D (corresponding author), Inst Biol Mol & Celular Rosario CONICET UNR, RA-2000 Rosario, SF, Argentina.; Krapf, D (corresponding author), UNR, Lab Especialidades Reprod, Fac Ciencias Bioquim & Farmaceut, Ocampo & Esmeralda, RA-2000 Rosario, SF, Argentina.	krapf@ibr-conicet.gov.ar	Luque, Guillermina/M-9237-2019; Stival, Cintia/AAM-2069-2021; torres, nicolas/AAE-4849-2019; Krapf, Diego/Y-2087-2019	Luque, Guillermina/0000-0002-2745-8236; Krapf, Diego/0000-0002-2833-5553; Torres, Nicolas/0000-0001-6501-185X; Darszon, Alberto/0000-0002-2502-0505; Baro Graf, Carolina/0000-0003-4490-9083; Gervasi, Maria Gracia/0000-0002-5468-2700; Krapf, Dario/0000-0001-7607-1954	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2014-2702, PICT 2015-3164, PICT 2015-2294]; Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico [IN205516]; Consejo Nacional de Ciencia y Tecnologia Fronteras [71]; National Science Foundation [1401432]; Eunice Kennedy Shriver National Institutes of Health, NICHD Grants [RO1 HD38082, HD44044]; National Institutes of Health [RO1TW008662]; Division Of Physics [1401432] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038082, R01HD044044] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW008662] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia Fronteras; National Science Foundation(National Science Foundation (NSF)); Eunice Kennedy Shriver National Institutes of Health, NICHD Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grants PICT 2014-2702 and PICT 2015-3164 (to Dario Krapf) and PICT 2015-2294 (to M.G.B.), Direccion General de Asuntos del Personal Academico/Universidad Nacional Autonoma de Mexico Grant IN205516 and Consejo Nacional de Ciencia y Tecnologia Fronteras 71 (to A.D.), National Science Foundation Grant 1401432 (to Diego Krapf), Eunice Kennedy Shriver National Institutes of Health, NICHD Grants RO1 HD38082 and HD44044 (to P.E.V.), and National Institutes of Health Grant RO1TW008662 (to M.G.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvau A, 2016, DEVELOPMENT, V143, P2325, DOI 10.1242/dev.136499; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; Buffone MG, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117911; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chavez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060578; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; Clouvel G, 2013, PROC SPIE, V8590, DOI 10.1117/12.2001986; Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Ernesto JI, 2015, J CELL BIOL, V210, P1213, DOI 10.1083/jcb.201412041; Escoffier J, 2007, J CELL PHYSIOL, V212, P753, DOI 10.1002/jcp.21075; Escoffier J, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.127266; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Greenwald EC, 2011, J CARDIOVASC PHARM, V58, P462, DOI 10.1097/FJC.0b013e31822001e3; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Hereng TH, 2012, J STRUCT BIOL, V178, P300, DOI 10.1016/j.jsb.2012.03.013; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hino T, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140400; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Izeddin I, 2012, OPT EXPRESS, V20, P4957, DOI 10.1364/OE.20.004957; Krapf D, 2007, DEV BIOL, V306, P516, DOI 10.1016/j.ydbio.2007.03.030; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; Krapf D, 2009, BIOL REPROD, V80, P311, DOI 10.1095/biolreprod.108.071076; Krapf D, 2016, PHYS CHEM CHEM PHYS, V18, P12633, DOI 10.1039/c6cp00937a; La Spina FA, 2016, DEV BIOL, V411, P172, DOI 10.1016/j.ydbio.2016.02.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XY, 2013, IUBMB LIFE, V65, P2, DOI 10.1002/iub.1111; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Marbouty M, 2015, MOL CELL, V59, P588, DOI 10.1016/j.molcel.2015.07.020; Muro Y, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.135368; Newell AEH, 2008, CELL MOTIL CYTOSKEL, V65, P539, DOI 10.1002/cm.20279; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Romarowski A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136085; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Stival C, 2016, ADV ANAT EMBRYOL CEL, V220, P93, DOI 10.1007/978-3-319-30567-7_5; Stival C, 2015, J BIOL CHEM, V290, P18855, DOI 10.1074/jbc.M115.640326; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Torres-Flores V, 2011, HUM REPROD, V26, P2626, DOI 10.1093/humrep/der237; Torres-Quesada O, 2017, CELL SIGNAL, V37, P1, DOI 10.1016/j.cellsig.2017.05.012; Weigel AV, 2011, P NATL ACAD SCI USA, V108, P6438, DOI 10.1073/pnas.1016325108; Wertheimer E, 2013, J BIOL CHEM, V288, P35307, DOI 10.1074/jbc.M113.489476; Wojtal KA, 2006, MOL BIOL CELL, V17, P3638, DOI 10.1091/mbc.E06-03-0230	49	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9435	9447		10.1074/jbc.RA118.002286	http://dx.doi.org/10.1074/jbc.RA118.002286			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29700114	Green Published, hybrid			2022-12-26	WOS:000435441400027
J	Tretter, JY; Schorpp, K; Luxenburger, E; Trambauer, J; Steiner, H; Hadian, K; Gires, O; Niessing, D				Tretter, Jana Ylva; Schorpp, Kenji; Luxenburger, Elke; Trambauer, Johannes; Steiner, Harald; Hadian, Kamyar; Gires, Olivier; Niessing, Dierk			A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; EP-CAM; MONOCLONAL-ANTIBODY; COLON-CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; ANTIGEN GA733-2; POOR-PROGNOSIS; EXPRESSION; GENE	Epithelial cell-adhesion molecule (EpCAM) is a transmembrane protein that regulates cell cycle progression and differentiation and is overexpressed in many carcinomas. The EpCAMinduced mitogenic cascade is activated via regulated intramembrane proteolysis (RIP) of EpCAM by ADAM and gamma-secretases, generating the signaling-active intracellular domain EpICD. Because of its expression pattern and molecular function, EpCAM is a valuable target in prognostic and therapeutic approaches for various carcinomas. So far, several immunotherapeutic strategies have targeted the extracellular domain of EpCAM. However, targeting the intracellular signaling cascade of EpCAM holds promise for specifically interfering with EpCAM's proliferation- stimulating signaling cascade. Here, using a yellow fluorescence protein-tagged version of the C-terminal fragment of EpCAM, we established a high-content screening (HCS) of a small-molecule compound library (n = 27,280) and characterized validated hits that target EpCAM signaling. In total, 128 potential inhibitors were initially identified, of which one compound with robust inhibitory effects on RIP of EpCAM was analyzed in greater detail. In summary, our study demonstrates that the development of an HCS for small-molecule inhibitors of the EpCAM signaling pathway is feasible. We propose that this approach may also be useful for identifying chemical compounds targeting other disorders involving membrane cleavagedependent signaling pathways.	[Tretter, Jana Ylva; Niessing, Dierk] German Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Struct Biol, D-85764 Neuherberg, Germany; [Schorpp, Kenji; Hadian, Kamyar] German Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Toxicol & Pharmacol, Assay Dev & Screening Platform, D-85764 Neuherberg, Germany; [Luxenburger, Elke; Gires, Olivier] Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, D-80539 Munich, Germany; [Trambauer, Johannes; Steiner, Harald] Ludwig Maximilians Univ Munchen, Biomed Ctr, Metab Biochem, D-80539 Munich, Germany; [Steiner, Harald] German Ctr Neurodegenerat Dis, D-81377 Munich, Germany; [Niessing, Dierk] Ulm Univ, Inst Pharmaceut Biotechnol, D-89081 Ulm, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Ulm University	Niessing, D (corresponding author), German Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Struct Biol, D-85764 Neuherberg, Germany.; Gires, O (corresponding author), Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol Head & Neck Surg, Grosshadern Med Ctr, D-80539 Munich, Germany.; Niessing, D (corresponding author), Ulm Univ, Inst Pharmaceut Biotechnol, D-89081 Ulm, Germany.	Olivier.Gires@med.uni-muenchen.de; niessing@helmholtz-muenchen.de	Niessing, Dierk/M-4619-2014; Niessing, Dierk/AAE-4936-2022; Hadian, Kamyar/B-6314-2013	Niessing, Dierk/0000-0002-5589-369X; Niessing, Dierk/0000-0002-5589-369X; Hadian, Kamyar/0000-0001-8727-2575; Trambauer, Johannes/0000-0002-7173-1180	Wilhelm Sander Foundation [2015.019.1]	Wilhelm Sander Foundation	This work was supported by Wilhelm Sander Foundation Grant 2015.019.1. The authors declare that they have no conflicts of interest with the contents of this article.	ALBERTI S, 1994, P NATL ACAD SCI USA, V91, P5833, DOI 10.1073/pnas.91.13.5833; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Brunner A, 2008, J CLIN PATHOL, V61, P307, DOI 10.1136/jcp.2007.049460; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Chong JM, 2001, J BIOL CHEM, V276, P5804, DOI 10.1074/jbc.M008839200; Denzel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-402; Dolle L, 2015, AM J PHYSIOL-GASTR L, V308, pG233, DOI 10.1152/ajpgi.00069.2014; Du WQ, 2009, J CANCER RES CLIN, V135, P1277, DOI 10.1007/s00432-009-0569-5; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fields ALA, 2009, J CLIN ONCOL, V27, P1941, DOI 10.1200/JCO.2008.18.5710; Fong D., 2006, J CLIN PATHOL; Gerlach JC, 2018, J CELL PHYSIOL, V233, P4841, DOI 10.1002/jcp.26286; Gires O, 2008, ATLAS GENET CYTOGENE; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gosens MJEM, 2007, MODERN PATHOL, V20, P221, DOI 10.1038/modpathol.3800733; Groth A, 2012, CLIN CANCER RES, V18, P1028, DOI 10.1158/1078-0432.CCR-11-2767; Hachmeister M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071836; Imrich S, 2012, CELL ADHES MIGR, V6, P30, DOI 10.4161/cam.18953; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kuan II, 2017, SCI REP-UK, V7, DOI 10.1038/srep41852; Liao MY, 2015, ONCOTARGET, V6, P24947, DOI 10.18632/oncotarget.4453; Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Lund K, 2014, MABS-AUSTIN, V6, P1038, DOI 10.4161/mabs.28207; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Massoner P, 2014, BRIT J CANCER, V111, P955, DOI 10.1038/bjc.2014.366; Molina F, 1996, EUR J BIOCHEM, V240, P125, DOI 10.1111/j.1432-1033.1996.0125h.x; Munz M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-44; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Neighbors M, 2008, J IMMUNOTHER, V31, P644, DOI 10.1097/CJI.0b013e3181826d89; Ng CF, 2011, GENE, V481, P41, DOI 10.1016/j.gene.2011.04.005; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Oishi N, 2014, LIVER CANCER, V3, P71, DOI 10.1159/000343863; Park SY, 2016, ONCOL REP, V36, P197, DOI 10.3892/or.2016.4789; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ralhan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014130; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Riesenberg R, 2001, J HISTOCHEM CYTOCHEM, V49, P911, DOI 10.1177/002215540104900711; Sankpal NV, 2017, ONCOGENE, V36, P3706, DOI 10.1038/onc.2016.504; Sankpal NV, 2013, MOL CANCER RES, V11, P418, DOI 10.1158/1541-7786.MCR-12-0518; Sarrach S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20131-8; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schmohl JU, 2016, ONCOTARGET, V7, P73830, DOI 10.18632/oncotarget.12073; Schmoll HJ, 2009, J CLIN ONCOL, V27, P1926, DOI 10.1200/JCO.2008.20.6284; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; SEARS HF, 1982, LANCET, V1, P762; SEARS HF, 1984, J BIOL RESP MODIF, V3, P138; Spater D, 2014, DEVELOPMENT, V141, P4418, DOI 10.1242/dev.091538; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Spizzo G, 2002, INT J CANCER, V98, P883, DOI 10.1002/ijc.10270; STRNAD J, 1989, CANCER RES, V49, P314; SZALA S, 1990, P NATL ACAD SCI USA, V87, P3542, DOI 10.1073/pnas.87.9.3542; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Tsaktanis T, 2015, J BIOL CHEM, V290, P24574, DOI 10.1074/jbc.M115.662700; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Varga M, 2004, CLIN CANCER RES, V10, P3131, DOI 10.1158/1078-0432.CCR-03-0528; Waldron NN, 2014, TARGET ONCOL, V9, P239, DOI 10.1007/s11523-013-0290-9; Went P, 2005, AM J SURG PATHOL, V29, P83, DOI 10.1097/01.pas.0000.146028.70868.7a; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Yanamoto S, 2007, ORAL ONCOL, V43, P869, DOI 10.1016/j.oraloncology.2006.10.010; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng XH, 2017, CANCER RES, V77, P482, DOI 10.1158/0008-5472.CAN-16-0842	71	2	2	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8994	9005		10.1074/jbc.RA118.002776	http://dx.doi.org/10.1074/jbc.RA118.002776			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29700109	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000434941900022
J	Chicaiza-Ayala, W; Henriquez-Trujillo, AR; Ortiz-Prado, E; Douce, RW; Coral-Almeida, M				Chicaiza-Ayala, Wilson; Henriquez-Trujillo, Aquiles R.; Ortiz-Prado, Esteban; Douce, Richard W.; Coral-Almeida, Marco			The burden of acute respiratory infections in Ecuador 2011-2015	PLOS ONE			English	Article							GLOBAL BURDEN; DISEASE; INFLUENZA; CHILDREN; COST	Background Burden of disease studies intend to improve public health decision-making and to measure social and economic impact in population. The objective of this study was to describe the burden of acute respiratory infections (ARI) in Ecuador between 2011 and 2015. Methods Five-year period morbidity and mortality data available from national agencies of statistics was analyzed to estimate the burden of disease attributable to acute respiratory infections. Cases and deaths registered were grouped according to their ICD-10 code into three diagnostic groups: Acute upper respiratory infections (J00-J06), Influenza and pneumonia (J09-J18), and Bronchitis and other acute lower respiratory infections (J20-J22, J85, J86). Disability-adjusted life years stratified by diagnostic and age group were calculated using the "DALY" package for R. The productivity loss in monetary terms was estimated using the human capital method. Results Over the 5-year period studied there were a total of 14.84 million cases of acute respiratory infections, with 17 757 deaths reported (0.12%). The yearly burden of disease ranged between 98 944 to 118 651 disability-adjusted life years, with an estimated average loss of productivity of US$152.16 million (+/- 19.6) per year. Approximately 99% of the burden can be attributed to years life lost due to premature mortality in population under 5 years old and over 60 years-old. Conclusions The burden of acute respiratory infections remained steady during the analyzed period. Evidence-based prevention and control policies to tackle acute respiratory infections in Ecuador should focus on the population at extreme ages of life.	[Chicaiza-Ayala, Wilson; Henriquez-Trujillo, Aquiles R.; Ortiz-Prado, Esteban; Coral-Almeida, Marco] Univ Amer, Fac Hlth Sci, Hlth Res Grp 1, Quito, Ecuador; [Ortiz-Prado, Esteban] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Ortiz-Prado, Esteban] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA; [Douce, Richard W.] Lakeland Hlth Care, Dept Internal Med, St Joseph, MI USA; [Coral-Almeida, Marco] Univ Amer, Fac Hlth Sci, Via Nayon S-N, Quito, Ecuador	Universidad de Las Americas - Ecuador; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Universidad de Las Americas - Ecuador	Coral-Almeida, M (corresponding author), Univ Amer, Fac Hlth Sci, Hlth Res Grp 1, Quito, Ecuador.; Coral-Almeida, M (corresponding author), Univ Amer, Fac Hlth Sci, Via Nayon S-N, Quito, Ecuador.	marco.coral@udla.edu.ec	Henriquez-Trujillo, Aquiles R./G-3645-2011; Ortiz-Prado, Esteban/C-9550-2014	Henriquez-Trujillo, Aquiles R./0000-0002-3094-4438; Ortiz-Prado, Esteban/0000-0002-1895-7498; Douce, Richard/0000-0002-8675-7658; Coral, Marco/0000-0003-0211-2906; Chicaiza-Ayala, Wilson/0000-0001-8639-698X	Universidad de las Americas Quito [VET.MC.17.03]	Universidad de las Americas Quito	This work was financially supported by the Universidad de las Americas Quito grant number (VET.MC.17.03). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Corrêa Ricardo de Amorim, 2017, Rev. bras. epidemiol., V20, P171, DOI 10.1590/1980-5497201700050014; Devleesschauwer Brecht, 2014, DALY DALY CALCULATOR; Douce RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022206; Ferkol Thomas, 2014, Ann Am Thorac Soc, V11, P404, DOI 10.1513/AnnalsATS.201311-405PS; Forum of International Respiratory Societies, 2013, RESP DIS WORLD REAL, V1st; Hirve S, INFLUENZA SEASONALIT; Institute for Health Metrics and Evaluation, GBD RES TOOL GHDX; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Jonnalagadda S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171687; Lara-Oliveros Carlos A, 2016, Rev. salud pública, V18, P568, DOI 10.15446/rsap.v18n4.45485; McDonald SA, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0116-y; Ministerio de Salud Publica del Ecuador, 2015, ESQ VAC FAM EC 2015; Ministerio de Salud Publica del Ecuador, 2007, LIN TECN OP VAC INFL; Ministerio de Salud Publica del Ecuador, 2017, EV ESTR NAC IMM; Ministerio del Trabajo de Ecuador, 2016, AC MIN NO MDT 2016 0, P2; Mulholland K, 2007, VACCINE, V25, P2394, DOI 10.1016/j.vaccine.2006.09.007; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; National Institute for Health and Clinical Excellence, 2008, RESP TRACT INF ANT P, V69, P1; Ortiz-Prado E., 2017, GLOB J HLTH SCI, V9, DOI [10.5539/gjhs.v9n1p201, DOI 10.5539/GJHS.V9N1P201]; Ortiz-Prado E, 2014, REV PANAM SALUD PUBL, V36, P57; Peasah SK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1685-6; Reed C., 2015, PLOS ONE, V10; Repository GHO data, 2016, REP GHO DAT LIF TABL; Saha S, 2016, INFLUENZA OTHER RESP; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Savy V, 2013, INFLUENZA OTHER RESP, V7, P1017, DOI 10.1111/irv.12036; Thompson M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7027; Tromme I, 2016, EUR J CANCER, V53, P33, DOI 10.1016/j.ejca.2015.09.016; Undurraga EA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002056; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization, 2016, INT STAT CLASS DIS R, V2017	35	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196650	10.1371/journal.pone.0196650	http://dx.doi.org/10.1371/journal.pone.0196650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715314	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281100039
J	Diaz-Perez, S; Kane, N; Kurmis, AA; Yang, F; Kummer, NT; Dervan, PB; Nickols, NG				Diaz-Perez, Silvia; Kane, Nathanael; Kurmis, Alexis A.; Yang, Fei; Kummer, Nicolas T.; Dervan, Peter B.; Nickols, Nicholas G.			Interference with DNA repair after ionizing radiation by a pyrrole-imidazole polyamide	PLOS ONE			English	Article							SINGLE-STRAND BREAKS; MINOR-GROOVE; RECOGNITION; CANCER; DAMAGE; CELLS; INHIBITION; OLAPARIB	Pyrrole-imidazole (Py-lm) polyamides are synthetic non-genotoxic minor groove-binding small molecules. We hypothesized that Py-lm polyamides can modulate the cellular response to ionizing radiation. Pre-treatment of cells with a Py-Im polyamide prior to exposure to ionizing radiation resulted in a delay in resolution of phosphorylated.-H2AX foci, increase in XRCC1 foci, and reduced cellular replication potential. RNA-sequencing of cell lines exposed to the polyamide showed induction of genes related to the ultraviolet radiation response. We observed that the polyamide is almost 10-fold more toxic to a cell line deficient in DNA ligase 3 as compared to the parental cell line. Alkaline single cell gel electrophoresis reveals that the polyamide induces genomic fragmentation in the ligase 3 deficient cell line but not the corresponding parental line. The polyamide interferes directly with DNA ligation in vitro. We conclude that Py-Im polyamides may be further explored as sensitizers to genotoxic therapies.	[Diaz-Perez, Silvia; Kane, Nathanael; Kummer, Nicolas T.; Nickols, Nicholas G.] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA; [Kurmis, Alexis A.; Yang, Fei; Dervan, Peter B.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Nickols, Nicholas G.] VA Greater Los Angeles Healthcare Syst, Dept Radiat Oncol, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; California Institute of Technology; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Nickols, NG (corresponding author), Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA.; Nickols, NG (corresponding author), VA Greater Los Angeles Healthcare Syst, Dept Radiat Oncol, Los Angeles, CA 90073 USA.	nnickols@mednet.ucla.edu			Prostate Cancer Foundation Young Investigator Award; Stop Cancer Career Development Award; National Institute of General Medical Sciences [R01GM27681]; Jonsson Cancer Center Foundation Seed Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027681] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002520] Funding Source: NIH RePORTER	Prostate Cancer Foundation Young Investigator Award; Stop Cancer Career Development Award; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Jonsson Cancer Center Foundation Seed Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by Prostate Cancer Foundation Young Investigator Award to Dr Nicholas George Nickols, Stop Cancer Career Development Award to Dr Nicholas George Nickols, National Institute of General Medical Sciences grant R01GM27681 to Peter B Dervan, Jonsson Cancer Center Foundation Seed Grant to Dr Nicholas George Nickols. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2015, GENES-BASEL, V6, P385, DOI 10.3390/genes6020385; Cheng HH, 2016, EUR UROL, V69, P992, DOI 10.1016/j.eururo.2015.11.022; Chenoweth DM, 2009, P NATL ACAD SCI USA, V106, P13175, DOI 10.1073/pnas.0906532106; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Kielkopf CL, 1998, NAT STRUCT BIOL, V5, P104, DOI 10.1038/nsb0298-104; Konecny GE, 2016, BRIT J CANCER, V115, P1157, DOI 10.1038/bjc.2016.311; Kuo LJ, 2008, IN VIVO, V22, P305; Kurmis AA, 2017, CANCER RES, V77, P2207, DOI 10.1158/0008-5472.CAN-16-2503; Lawrence TS, 2003, SEMIN RADIAT ONCOL, V13, P13, DOI 10.1053/srao.2003.50002; Martinez TF, 2014, NUCLEIC ACIDS RES, V42, P11546, DOI 10.1093/nar/gku866; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Nickols NG, 2007, ACS CHEM BIOL, V2, P561, DOI 10.1021/cb700110z; Nickols NG, 2007, NUCLEIC ACIDS RES, V35, P363, DOI 10.1093/nar/gkl1042; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Olenyuk BZ, 2004, P NATL ACAD SCI USA, V101, P16768, DOI 10.1073/pnas.0407617101; OLIVE PL, 1995, EXP CELL RES, V221, P19, DOI 10.1006/excr.1995.1348; PAINTER RB, 1974, GENETICS, V78, P139; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Pearl LH, 2015, NAT REV CANCER, V15, P166, DOI 10.1038/nrc3891; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; ROOTS R, 1985, INT J RADIAT ONCOL, V11, P259, DOI 10.1016/0360-3016(85)90147-6; Schaue D, 2015, NAT REV CLIN ONCOL; Seiwert TY, 2007, NAT CLIN PRACT ONCOL, V4, P86, DOI 10.1038/ncponc0714; White S, 1998, NATURE, V391, P468, DOI 10.1038/35106; Xu L, 2016, P NATL ACAD SCI USA, V113, P12426, DOI 10.1073/pnas.1612745113; Yang F, 2003, BIOCHEMISTRY-US, V42, P6249, DOI 10.1021/bi034177s; Yang F, 2013, J MED CHEM, V56, P7449, DOI 10.1021/jm401100s; Yang F, 2013, P NATL ACAD SCI USA, V110, P1863, DOI 10.1073/pnas.1222035110	31	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196803	10.1371/journal.pone.019680	http://dx.doi.org/10.1371/journal.pone.019680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715291				2022-12-26	WOS:000431281100055
J	Kim, TY; Kofron, CM; King, ME; Markes, AR; Okundaye, AO; Qu, ZL; Mende, U; Choi, BR				Kim, Tae Yun; Kofron, Celinda M.; King, Michelle E.; Markes, Alexander R.; Okundaye, Amenawon O.; Qu, Zhilin; Mende, Ulrike; Choi, Bum-Rak			Directed fusion of cardiac spheroids into larger heterocellular microtissues enables investigation of cardiac action potential propagation via cardiac fibroblasts	PLOS ONE			English	Article							IN-VITRO MODELS; CELL-CULTURE; MYOCARDIAL MICROTISSUES; VENTRICULAR MYOCYTES; ELECTRICAL-ACTIVITY; IMPULSE CONDUCTION; SODIUM-CHANNELS; TISSUE FUSION; HEART-DISEASE; MYOFIBROBLASTS	Multicellular spheroids generated through cellular self-assembly provide cytoarchitectural complexities of native tissue including three-dimensionality, extensive cell-cell contacts, and appropriate cell-extracellular matrix interactions. They are increasingly suggested as building blocks for larger engineered tissues to achieve shapes, organization, heterogeneity, and other biomimetic complexities. Application of these tissue culture platforms is of particular importance in cardiac research as the myocardium is comprised of distinct but intermingled cell types. Here, we generated scaffold-free 3D cardiac microtissue spheroids comprised of cardiac myocytes (CMs) and/or cardiac fibroblasts (CFs) and used them as building blocks to form larger microtissues with different spatial distributions of CMs and CFs. Characterization of fusing homotypic and heterotypic spheroid pairs revealed an important influence of CFs on fusion kinetics, but most strikingly showed rapid fusion kinetics between heterotypic pairs consisting of one CF and one CM spheroid, indicating that CMs and CFs self-sort in vitro into the intermixed morphology found in the healthy myocardium. We then examined electrophysiological integration of fused homotypic and heterotypic microtissues by mapping action potential propagation. Heterocellular elongated microtissues which recapitulate the disproportionate CF spatial distribution seen in the infarcted myocardium showed that action potentials propagate through CF volumes albeit with significant delay. Complementary computational modeling revealed an important role of CF sodium currents and the spatial distribution of the CM-CF boundary in action potential conduction through CF volumes. Taken together, this study provides useful insights for the development of complex, heterocellular engineered 3D tissue constructs and their engraftment via tissue fusion and has implications for arrhythmogenesis in cardiac disease and repair.	[Kim, Tae Yun; Kofron, Celinda M.; King, Michelle E.; Markes, Alexander R.; Okundaye, Amenawon O.; Mende, Ulrike; Choi, Bum-Rak] Rhode Isl Hosp, Cardiovasc Res Ctr, Cardiovasc Inst, Providence, RI 02903 USA; [Kim, Tae Yun; Kofron, Celinda M.; King, Michelle E.; Markes, Alexander R.; Okundaye, Amenawon O.; Mende, Ulrike; Choi, Bum-Rak] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Kofron, Celinda M.] Brown Univ, Sch Engn, Ctr Biomed Engn, Providence, RI 02912 USA; [Markes, Alexander R.] Brown Univ, Div Biol & Med, Providence, RI 02912 USA; [Okundaye, Amenawon O.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Qu, Zhilin] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Brown University; Brown University; University of California System; University of California Los Angeles	Mende, U; Choi, BR (corresponding author), Rhode Isl Hosp, Cardiovasc Res Ctr, Cardiovasc Inst, Providence, RI 02903 USA.; Mende, U; Choi, BR (corresponding author), Brown Univ, Alpert Med Sch, Providence, RI 02912 USA.	ulrike_mende@brown.edu; bum-rak_choi@brown.edu	Kim, Tae Yun/AFU-8071-2022	Kim, Tae Yun/0000-0003-0605-9575	National Institutes of Health [T32HL094300, F32HL126311, R21HL113918, R01HL114784]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL113918, T32HL094300, F32HL126311, R01HL114784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (https://www.nih.gov) in the form of postdoctoral fellowships (to CMK, T32HL094300 and F32HL126311) and grants (to UM, R21HL113918 and R01HL114784). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Antzelevitch Charles, 2011, Card Electrophysiol Clin, V3, P23, DOI 10.1016/j.ccep.2010.10.012; ARMSTRONG MT, 1978, J CELL SCI, V33, P37; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Beachley V, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414556561; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; Blakely AM, 2015, TISSUE ENG PART C-ME, V21, P737, DOI [10.1089/ten.tec.2014.0439, 10.1089/ten.TEC.2014.0439]; Bratt-Leal AM, 2011, INTEGR BIOL-UK, V3, P1224, DOI 10.1039/c1ib00064k; CABO C, 1992, CIRC RES, V71, P260, DOI 10.1161/01.RES.71.2.260; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chang MG, 2009, CIRC RES, V105, P1062, DOI 10.1161/CIRCRESAHA.108.176248; Chatelier A, 2012, J PHYSIOL-LONDON, V590, P4307, DOI 10.1113/jphysiol.2012.233593; Chilton L, 2007, J PHYSIOL-LONDON, V583, P225, DOI 10.1113/jphysiol.2007.135038; Chimenti I, 2017, J CARDIOVASC TRANSL, V10, P150, DOI 10.1007/s12265-017-9741-5; Czajka CA, 2014, ANN BIOMED ENG, V42, P1049, DOI 10.1007/s10439-014-0986-8; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Denyer MCT, 1999, IN VITRO CELL DEV-AN, V35, P352; Desroches BR, 2012, AM J PHYSIOL-HEART C, V302, pH2031, DOI 10.1152/ajpheart.00743.2011; Dingle YTL, 2015, TISSUE ENG PART C-ME, V21, P1274, DOI [10.1089/ten.tec.2015.0135, 10.1089/ten.TEC.2015.0135]; Duan B, 2017, ANN BIOMED ENG, V45, P195, DOI 10.1007/s10439-016-1607-5; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Fleming PA, 2010, DEV DYNAM, V239, P398, DOI 10.1002/dvdy.22161; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; GAIL MH, 1971, EXP CELL RES, V64, P156, DOI 10.1016/0014-4827(71)90206-0; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Gerbin KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131446; Gourdie RG, 2016, NAT REV DRUG DISCOV, V15, P620, DOI 10.1038/nrd.2016.89; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Gunter J, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9098523; Hajdu Z, 2010, J TISSUE ENG REGEN M, V4, P659, DOI 10.1002/term.291; He KM, 2011, CARDIOVASC RES, V92, P39, DOI 10.1093/cvr/cvr189; Ho VHB, 2010, BIOMATERIALS, V31, P3095, DOI 10.1016/j.biomaterials.2009.12.047; Horvath P, 2016, NAT REV DRUG DISCOV, V15, P751, DOI 10.1038/nrd.2016.175; Jacquemet V, 2008, AM J PHYSIOL-HEART C, V294, pH2040, DOI 10.1152/ajpheart.01298.2007; Jakab K, 2008, DEV DYNAM, V237, P2438, DOI 10.1002/dvdy.21684; Jousset F, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00496; Kelm JM, 2006, TISSUE ENG, V12, P2541, DOI 10.1089/ten.2006.12.2541; Kelm JM, 2004, TISSUE ENG, V10, P201, DOI 10.1089/107632704322791853; Kim JA, 2013, BIOMATERIALS, V34, P8555, DOI 10.1016/j.biomaterials.2013.07.056; Knight E, 2015, J ANAT, V227, P746, DOI 10.1111/joa.12257; Kofron CM, 2017, AM J PHYSIOL-HEART C, V313, pH810, DOI 10.1152/ajpheart.00181.2017; Kofron CM, 2017, J PHYSIOL-LONDON, V595, P3891, DOI 10.1113/JP273100; Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096; Kohl P, 2014, J MOL CELL CARDIOL, V70, P37, DOI 10.1016/j.yjmcc.2013.12.024; Koivumaki JT, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00275; Laschke MW, 2017, TRENDS BIOTECHNOL, V35, P133, DOI 10.1016/j.tibtech.2016.08.004; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lehmann M, 2013, EUR J HISTOCHEM, V57, P205, DOI 10.4081/ejh.2013.e31; Li GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007307; Li YZ, 2017, ACTA BIOMATER, V55, P120, DOI 10.1016/j.actbio.2017.04.027; Lin HS, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa663b; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; MacCannell KA, 2007, BIOPHYS J, V92, P4121, DOI 10.1529/biophysj.106.101410; Mahoney VM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26744; Mahoney VM, 2016, PROG BIOPHYS MOL BIO, V120, P128, DOI 10.1016/j.pbiomolbio.2015.12.006; Mathur A, 2016, ADV DRUG DELIVER REV, V96, P203, DOI 10.1016/j.addr.2015.09.011; McCune M, 2014, SOFT MATTER, V10, P1790, DOI 10.1039/c3sm52806e; McSpadden LC, 2012, CIRC-ARRHYTHMIA ELEC, V5, P821, DOI 10.1161/CIRCEP.111.969329; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Munaz A, 2016, LAB CHIP, V16, P2946, DOI 10.1039/c6lc00815a; Nath S, 2016, PHARMACOL THERAPEUT, V163, P94, DOI 10.1016/j.pharmthera.2016.03.013; Nayak AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072950; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034; Ong CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05018-4; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pampaloni F, 2010, BIOTECHNOL GENET ENG, V26, P117; Patterson E, 2017, J CARDIOVASC ELECTR, V28, P1203, DOI 10.1111/jce.13300; Perez-Pomares JM, 2006, BIOESSAYS, V28, P809, DOI 10.1002/bies.20442; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Polonchuk L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06385-8; Quinn TA, 2016, P NATL ACAD SCI USA, V113, P14852, DOI 10.1073/pnas.1611184114; Rago AP, 2009, BIOTECHNOL BIOENG, V102, P1231, DOI 10.1002/bit.22162; Robinson EE, 2003, J CELL SCI, V116, P377, DOI 10.1242/jcs.00231; Rog-Zielinska EA, 2016, TRENDS MOL MED, V22, P99, DOI 10.1016/j.molmed.2015.12.006; Rohr S, 1997, SCIENCE, V275, P841, DOI 10.1126/science.275.5301.841; Rohr S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P442, DOI 10.1161/CIRCEP.110.957647; Sant Shilpa, 2017, Drug Discov Today Technol, V23, P27, DOI 10.1016/j.ddtec.2017.03.002; Souders CA, 2012, AM J PATHOL, V181, P1226, DOI 10.1016/j.ajpath.2012.06.015; Spach MS, 1997, PACE, V20, P397, DOI 10.1111/j.1540-8159.1997.tb06199.x; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Stevenson William G, 2009, Trans Am Clin Climatol Assoc, V120, P403; Stuart SDF, 2016, J MOL CELL CARDIOL, V91, P114, DOI 10.1016/j.yjmcc.2015.12.024; Susienka MJ, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/4/045003; Tallquist MD, 2017, NAT REV CARDIOL, V14, P484, DOI 10.1038/nrcardio.2017.57; Tian Y, 2012, CIRC RES, V110, P1023, DOI 10.1161/CIRCRESAHA.111.243899; Valiunas V, 2009, J PHYSIOL-LONDON, V587, P5211, DOI 10.1113/jphysiol.2009.180505; van Putten S, 2016, J MOL CELL CARDIOL, V93, P133, DOI 10.1016/j.yjmcc.2015.11.025; Vasquez C, 2011, J CARDIOVASC PHARM, V57, P380, DOI 10.1097/FJC.0b013e31820cda19; Vasquez C, 2010, CIRC RES, V107, P1011, DOI 10.1161/CIRCRESAHA.110.227421; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; Walker NL, 2007, J CARDIOVASC ELECTR, V18, P862, DOI 10.1111/j.1540-8167.2007.00858.x; Wei OY, 2007, ANESTHESIOLOGY, V107, P91, DOI 10.1097/01.anes.0000268390.28362.4a; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Xie YF, 2009, HEART RHYTHM, V6, P1641, DOI 10.1016/j.hrthm.2009.08.003; Xie YF, 2009, AM J PHYSIOL-HEART C, V297, pH775, DOI 10.1152/ajpheart.00341.2009; Xu QH, 2007, AM J PHYSIOL-RENAL, V293, pF631, DOI 10.1152/ajprenal.00379.2006; Yue LX, 2011, CARDIOVASC RES, V89, P744, DOI 10.1093/cvr/cvq329; Zhang H, 2000, AM J PHYSIOL-HEART C, V279, pH397, DOI 10.1152/ajpheart.2000.279.1.H397; Zhang P, 2012, AM J PHYSIOL-HEART C, V303, pH1385, DOI 10.1152/ajpheart.01167.2011; Zhou PZ, 2016, CIRC RES, V118, P368, DOI 10.1161/CIRCRESAHA.116.308139; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	108	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196714	10.1371/journal.pone.0196714	http://dx.doi.org/10.1371/journal.pone.0196714			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715271	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100048
J	Shafian, S; Rajan, N; Schnell, R; Bagavathiannan, M; Valasek, J; Shi, YY; Olsenholler, J				Shafian, Sanaz; Rajan, Nithya; Schnell, Ronnie; Bagavathiannan, Muthukumar; Valasek, John; Shi, Yeyin; Olsenholler, Jeff			Unmanned aerial systems-based remote sensing for monitoring sorghum growth and development	PLOS ONE			English	Article							VEGETATION INDEXES; SPECTRAL REFLECTANCE; PLANT-DENSITY; GRAIN MOLD; GREEN LAI; IMAGERY; COTTON; CROPS; WHEAT; LEAF	Unmanned Aerial Vehicles and Systems (UAV or UAS) have become increasingly popular in recent years for agricultural research applications. UAS are capable of acquiring images with high spatial and temporal resolutions that are ideal for applications in agriculture. The objective of this study was to evaluate the performance of a UAS-based remote sensing system for quantification of crop growth parameters of sorghum (Sorghum bicolor L.) including leaf area index (LAI), fractional vegetation cover (f(c)) and yield. The study was conducted at the Texas A&M Research Farm near College Station, Texas, United States. A fixed-wing UAS equipped with a multispectral sensor was used to collect image data during the 2016 growing season (April-October). Flight missions were successfully carried out at 50 days after planting (DAP; 25 May), 66 DAP (10 June) and 74 DAP (18 June). These flight missions provided image data covering the middle growth period of sorghum with a spatial resolution of approximately 6.5 cm. Field measurements of LAI and f(c) were also collected. Four vegetation indices were calculated using the UAS images. Among those indices, the normalized difference vegetation index (NDVI) showed the highest correlation with LAI, f(c) and yield with R-2 values of 0.91, 0.89 and 0.58 respectively. Empirical relationships between NDVI and LAI and between NDVI and f(c) were validated and proved to be accurate for estimating LAI and f(c) from UAS-derived NDVI values. NDVI determined from UAS imagery acquired during the flowering stage (74 DAP) was found to be the most highly correlated with final grain yield. The observed high correlations between UAS-derived NDVI and the crop growth parameters (f(c), LAI and grain yield) suggests the applicability of UAS for within-season data collection of agricultural crops such as sorghum.	[Shafian, Sanaz; Rajan, Nithya; Schnell, Ronnie; Bagavathiannan, Muthukumar] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Valasek, John] Texas A&M Univ, Dept Aerosp Engn, College Stn, TX 77843 USA; [Shi, Yeyin] Texas A&M Univ, Dept Biol & Agr Engn, College Stn, TX USA; [Olsenholler, Jeff] Texas A&M Univ, Dept Geog, College Stn, TX USA; [Shafian, Sanaz] Univ Idaho, Parma Res & Extens Ctr, Parma, ID USA; [Shi, Yeyin] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Idaho; University of Idaho; University of Nebraska System; University of Nebraska Lincoln	Rajan, N (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	nrajan@tamu.edu	Schnell, Ronnie/AAP-3749-2021	Schnell, Ronnie/0000-0001-6174-9953	Texas A&M AgriLife Research Cropping Systems Seed Grant program	Texas A&M AgriLife Research Cropping Systems Seed Grant program	This research was funded by the Texas A&M AgriLife Research Cropping Systems Seed Grant program.	Vega FA, 2015, BIOSYST ENG, V132, P19, DOI 10.1016/j.biosystemseng.2015.01.008; Arnall DB, 2006, J PLANT NUTR, V29, P1983, DOI 10.1080/01904160600927997; Attia A, 2015, AGRON J, V107, P1355, DOI 10.2134/agronj14.0502; BOREL CC, 1994, REMOTE SENS ENVIRON, V47, P403, DOI 10.1016/0034-4257(94)90107-4; BRENNER AJ, 1995, PLANT CELL ENVIRON, V18, P1332, DOI 10.1111/j.1365-3040.1995.tb00193.x; Campos I, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083562; Chen GH, 2011, AGRON J, V103, P32, DOI 10.2134/agronj2010.0153; Elarab M, 2015, INT J APPL EARTH OBS, V43, P32, DOI 10.1016/j.jag.2015.03.017; GERIK TJ, 1987, CROP SCI, V27, P1225, DOI 10.2135/cropsci1987.0011183X002700060027x; Gitelson AA, 2014, REMOTE SENS ENVIRON, V144, P65, DOI 10.1016/j.rse.2014.01.004; Glenn EP, 2008, SENSORS-BASEL, V8, P2136, DOI 10.3390/s8042136; Gonzalez-Dugo V, 2013, PRECIS AGRIC, V14, P660, DOI 10.1007/s11119-013-9322-9; Hilker T, 2013, REMOTE SENS ENVIRON, V137, P31, DOI 10.1016/j.rse.2013.05.023; Hunt ER, 2014, IEEE J-STARS, V7, P4566, DOI 10.1109/JSTARS.2014.2317876; Jenkins D., 2013, EC IMP UNM AIRCR SYS; Jiang ZY, 2008, REMOTE SENS ENVIRON, V112, P3833, DOI 10.1016/j.rse.2008.06.006; Ko JH, 2005, AGRON J, V97, P1374, DOI 10.2134/agronj2004.0267; Kross A, 2015, INT J APPL EARTH OBS, V34, P235, DOI 10.1016/j.jag.2014.08.002; Lelong CCD, 2008, SENSORS-BASEL, V8, P3557, DOI 10.3390/s8053557; Levy PE, 1999, AGR FOREST METEOROL, V97, P199, DOI 10.1016/S0168-1923(98)00092-6; Maas SJ, 2010, REMOTE SENS-BASEL, V2, P1644, DOI 10.3390/rs2071644; Murray SC, 2016, HIGH CLEARANCE PHENO, V9866, DOI [10.1117/12.2228323, DOI 10.1117/12.2228323]; Nguy-Robertson AL, 2014, AGR FOREST METEOROL, V192, P140, DOI 10.1016/j.agrformet.2014.03.004; Rajan N, 2014, AGRON J, V106, P1358, DOI 10.2134/agronj13.0532; Rajan N, 2009, PRECIS AGRIC, V10, P304, DOI 10.1007/s11119-009-9116-2; Sharma R, 2010, PLANT DIS, V94, P439, DOI 10.1094/PDIS-94-4-0439; Shi Y, 2016, PROC SPIE, V9866, DOI 10.1117/12.2228737; Shi YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159781; Storlien JO, 2014, SOIL SCI SOC AM J, V78, P1694, DOI 10.2136/sssaj2014.04.0176; Swain KC, 2010, T ASABE, V53, P21; Tarekegn G, 2006, PLANT PATHOL, V55, P238, DOI 10.1111/j.1365-3059.2006.01333.x; Uto K, 2013, IEEE J-STARS, V6, P851, DOI 10.1109/JSTARS.2013.2250921; Valasek J, 2017, P 2017 INT C UNM AIR; Valasek J, 2016, PROC SPIE, V9866, DOI 10.1117/12.2228894; Xiang HT, 2011, BIOSYST ENG, V108, P174, DOI 10.1016/j.biosystemseng.2010.11.010; Zarco-Tejada PJ, 2012, REMOTE SENS ENVIRON, V117, P322, DOI 10.1016/j.rse.2011.10.007	36	57	59	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196605	10.1371/journal.pone.0196605	http://dx.doi.org/10.1371/journal.pone.0196605			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715311	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100037
J	Fischer, K; Diederich, S; Smith, G; Reiche, S; dos Reis, VP; Stroh, E; Groschup, MH; Weingartl, HM; Balkema-Buschmann, A				Fischer, Kerstin; Diederich, Sandra; Smith, Greg; Reiche, Sven; dos Reis, Vinicius Pinho; Stroh, Eileen; Groschup, Martin H.; Weingartl, Hana M.; Balkema-Buschmann, Anne			Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs	PLOS ONE			English	Article							EMERGENT DEADLY PARAMYXOVIRUS; NUCLEOCAPSID PROTEIN; ESCHERICHIA-COLI; LEISHMANIA-TARENTOLAE; SUBUNIT VACCINE; EQUINE MORBILLIVIRUS; MOLECULAR-BIOLOGY; G-GLYCOPROTEIN; GUINEA-PIGS; FRUIT BATS	Hendra virus (HeV) and Nipah virus (NiV) belong to the genus Henipavirus in the family Paramyxoviridae. Henipavirus infections were first reported in the 1990's causing severe and often fatal outbreaks in domestic animals and humans in Southeast Asia and Australia. NiV infections were observed in humans in Bangladesh, India and in the first outbreak in Malaysia, where pigs were also infected. HeV infections occurred in horses in the North-Eastern regions of Australia, with singular transmission events to humans. Bats of the genus Pteropus have been identified as the reservoir hosts for henipaviruses. Molecular and serological indications for the presence of henipa-like viruses in African fruit bats, pigs and humans have been published recently. In our study, truncated forms of HeV and NiV attachment (G) proteins as well as the full-length NiV nucleocapsid (N) protein were expressed using different expression systems. Based on these recombinant proteins, Enzyme-linked Immunosorbent Assays (ELISA) were developed for the detection of HeV or NiV specific antibodies in porcine serum samples. We used the NiV N ELISA for initial serum screening considering the general reactivity against henipaviruses. The G protein based ELISAs enabled the differentiation between HeV and NiV infections, since as expected, the sera displayed higher reactivity with the respective homologous antigens. In the future, these assays will present valuable tools for serosurveillance of swine and possibly other livestock or wildlife species in affected areas. Such studies will help assessing the potential risk for human and animal health worldwide by elucidating the distribution of henipaviruses.	[Fischer, Kerstin; dos Reis, Vinicius Pinho; Stroh, Eileen; Groschup, Martin H.; Balkema-Buschmann, Anne] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Novel & Emerging Infect Dis, Greifswald, Germany; [Diederich, Sandra; Smith, Greg; Weingartl, Hana M.] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Reiche, Sven] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany	Friedrich Loeffler Institute; Canadian Food Inspection Agency; Friedrich Loeffler Institute	Balkema-Buschmann, A (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Novel & Emerging Infect Dis, Greifswald, Germany.	anne.buschmann@fli.de		Reiche, Sven/0000-0001-7575-2483; Balkema-Buschmann, Anne/0000-0001-7613-9592				Baechlein C, 2013, J VIROL METHODS, V193, P238, DOI 10.1016/j.jviromet.2013.05.018; Basile G, 2009, MOL BIOTECHNOL, V43, P273, DOI 10.1007/s12033-009-9213-5; Berhane Y, 2008, TRANSBOUND EMERG DIS, V55, P165, DOI 10.1111/j.1865-1682.2008.01021.x; Berhane Y, 2006, J VIROL METHODS, V132, P59, DOI 10.1016/j.jviromet.2005.09.005; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Bossart KN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004241; Bossart KN, 2005, J VIROL, V79, P6690, DOI 10.1128/JVI.79.11.6690-6702.2005; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; Chen JM, 2006, J VIROL METHODS, V136, P273, DOI 10.1016/j.jviromet.2006.05.003; Chong HT, 2008, NEUROL ASIA, V13, P23; Chowdhury S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003302; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2003, J CLIN VIROL, V26, P265, DOI 10.1016/S1386-6532(02)00268-8; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Daniels P, 2001, MICROBES INFECT, V3, P289, DOI 10.1016/S1286-4579(01)01382-X; de Araujo J, 2017, VECTOR-BORNE ZOONOT, V17, P271, DOI 10.1089/vbz.2016.2051; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Eshaghi M, 2005, J CLIN MICROBIOL, V43, P3172, DOI 10.1128/JCM.43.7.3172-3177.2005; Eshaghi M, 2004, VIRUS RES, V106, P71, DOI 10.1016/j.virusres.2004.06.011; Eshaghia M, 2005, J BIOTECHNOL, V116, P221, DOI 10.1016/j.jbiotec.2004.10.020; Fischer K, 2016, J VIROL METHODS, V228, P48, DOI 10.1016/j.jviromet.2015.11.006; Grzyb K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30627; Guillaume V, 2009, VIROLOGY, V387, P459, DOI 10.1016/j.virol.2009.03.001; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Han HJ, 2015, VIRUS RES, V205, P1, DOI 10.1016/j.virusres.2015.05.006; Hanna JN, 2006, MED J AUSTRALIA, V185, P562, DOI 10.5694/j.1326-5377.2006.tb00692.x; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Hayman DTS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025256; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Hooper PT, 1997, VET PATHOL, V34, P323, DOI 10.1177/030098589703400408; Hughes K, 2014, VET REC, V175, P533, DOI 10.1136/vr.g6836; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Kirkland PD, 2015, EMERG INFECT DIS, V21, P2182, DOI 10.3201/eid2112.151324; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kulkarni Diwakar D, 2016, J Immunoassay Immunochem, V37, P154, DOI 10.1080/15321819.2015.1074922; Li MY, 2010, VET RES, V41, DOI 10.1051/vetres/2010005; Lo MK, 2012, CURR TOP MICROBIOL, V359, P41, DOI 10.1007/82_2012_211; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; McEachern JA, 2008, VACCINE, V26, P3842, DOI 10.1016/j.vaccine.2008.05.016; McNabb L, 2014, J VIROL METHODS, V200, P22, DOI 10.1016/j.jviromet.2014.01.010; Middleton D, 2014, VET CLIN N AM-EQUINE, V30, P579, DOI 10.1016/j.cveq.2014.08.004; Mills JN, 2009, EMERG INFECT DIS, V15, P950, DOI 10.3201/eid1506.080453; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; Pallister J, 2011, VACCINE, V29, P5623, DOI 10.1016/j.vaccine.2011.06.015; Pallister JA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-237; Pearce LA, 2015, PROTEIN EXPRES PURIF, V116, P19, DOI 10.1016/j.pep.2015.07.008; Pernet O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6342; Pickering BS, 2016, VACCINE, V34, P4777, DOI 10.1016/j.vaccine.2016.08.028; Pion C, 2014, VACCINE, V32, P5570, DOI 10.1016/j.vaccine.2014.07.092; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; PONTECORVO G, 1975, SOMAT CELL GENET, V1, P397, DOI 10.1007/BF01538671; Rockx B, 2012, ANTIVIR RES, V95, P135, DOI 10.1016/j.antiviral.2012.05.008; Rockx B, 2010, J VIROL, V84, P9831, DOI 10.1128/JVI.01163-10; Tan WS, 2004, J MED VIROL, V73, P105, DOI 10.1002/jmv.20052; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8; Weingartl H, 2005, J VIROL, V79, P7528, DOI 10.1128/JVI.79.12.7528-7534.2005; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; Weingartl HM, 2009, VET J, V181, P211, DOI 10.1016/j.tvjl.2008.10.016; Westbury HA, 1996, AUST VET J, V74, P132, DOI 10.1111/j.1751-0813.1996.tb14813.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Yu FX, 2006, J CLIN MICROBIOL, V44, P3134, DOI 10.1128/JCM.00693-06	68	17	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0194385	10.1371/journal.pone.0194385	http://dx.doi.org/10.1371/journal.pone.0194385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708971	gold, Green Published, Green Submitted			2022-12-26	WOS:000431130100005
J	Lip, GYH; Pan, XY; Kamble, S; Kawabata, H; Mardekian, J; Masseria, C; Phatak, H				Lip, Gregory Y. H.; Pan, Xianying; Kamble, Shital; Kawabata, Hugh; Mardekian, Jack; Masseria, Cristina; Phatak, Hemant			Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; STROKE; THERAPY; OUTCOMES; PREVENTION; TRIAL	Discontinuation of oral anticoagulants may expose non-valvular atrial fibrillation (NVAF) patients to an increased risk of stroke. This study describes the real-world discontinuation rates and compared the risk of drug discontinuation among NVAF patients initiating apixaban, warfarin, dabigatran, or rivaroxaban. This retrospective cohort study evaluated newly-anticoagulated NVAF patients in the MarketScan((R)) data population from 01/01/2012 through 12/31/2014. Discontinuation was defined as a lack of subsequent prescription of the index drug within 30 days after the last supply day of the last prescription. A Cox model was used to estimate the hazard ratio (HR) of discontinuation, adjusted for age, sex, and comorbidities. Among 45,361 eligible NVAF patients, 15,461 (34.1%) initiated warfarin; 7,438 (16.4%) apixaban; 4,661 (10.3%) dabigatran; and 17,801 (39.2%) initiated rivaroxaban treatment. Compared to warfarin, patients who initiated dabigatran (adjusted HR [aHR]: 0.84, 95% confidence interval [Cl]: 0.80-0.87, P<0.001), rivaroxaban (aHR: 0.70, 95% Cl: 0.68-0.73, P<0.001), or apixaban (aHR: 0.57, 95% Cl: 0.55-0.60, P<0.001) were 16%, 30%, and 43% less likely to discontinue treatment, respectively. When compared to apixaban, patients who initiated dabigatran (aHR: 1.46, 95% Cl: 1.38-1.54, P<0.001) or rivaroxaban (aHR: 1.23, 95% Cl: 1.17-1.28, P<0.001) were more likely to discontinue treatment. Among newly-anticoagulated NVAF patients in the real-world setting, initiation on rivaroxaban, dabigatran, or apixaban was associated with a significantly lower risk of discontinuation compared to warfarin. When compared to apixaban, patients who initiated treatment with warfarin, dabigatran, or rivaroxaban were more likely to discontinue treatment.	[Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Pan, Xianying; Kawabata, Hugh] Bristol Myers Squibb Co BMS, Ctr Observat Res & Data Sci, Princeton, NJ USA; [Kamble, Shital; Phatak, Hemant] Bristol Myers Squibb Co BMS, Worldwide Hlth Econ & Outcomes Res, Princeton, NJ USA; [Mardekian, Jack; Masseria, Cristina] Pfizer Inc, Outcomes & Evidence Patient & Hlth Impact, New York, NY USA	University of Birmingham; Aalborg University; Bristol-Myers Squibb; Bristol-Myers Squibb; Pfizer	Lip, GYH (corresponding author), Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England.; Lip, GYH (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark.	g.y.h.lip@bham.ac.uk			Bristol-Myers Squibb Company, Princeton, NJ, USA; Pfizer Inc., New York, New York, USA	Bristol-Myers Squibb Company, Princeton, NJ, USA(Bristol-Myers Squibb); Pfizer Inc., New York, New York, USA(Pfizer)	This study was sponsored by Bristol-Myers Squibb Company, Princeton, NJ, USA and Pfizer Inc., New York, New York, USA. The funder provided support in the form of salaries for authors XP, SK, HK, JM, CM, HM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson D, 2008, HLTH RES DATA REAL W; Al-Khalili F, 2015, EUR SOC CARD ESC C A; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Deitelzweig SB, 2013, CLIN THER, V35, P1201, DOI 10.1016/j.clinthera.2013.06.005; Ewen E, 2012, VASC HEALTH RISK MAN, V8, P587, DOI 10.2147/VHRM.S34280; Forslund T, 2016, EUR J CLIN PHARMACOL, V72, P329, DOI 10.1007/s00228-015-1983-z; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Ho JCS, 2012, CLIN CARDIOL, V35, pE40, DOI 10.1002/clc.22069; Jacobs Ashley, 2014, Hosp Pharm, V49, P115, DOI 10.1310/hpj4902-115; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Lopes RD, 2010, AM HEART J, V159, P331, DOI 10.1016/j.ahj.2009.07.035; Mitchell SA, 2013, CLIN APPL THROMB-HEM, V19, P619, DOI 10.1177/1076029613486539; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Patel MR, 2013, J AM COLL CARDIOL, V61, P651, DOI 10.1016/j.jacc.2012.09.057; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Phatak HM, 2006, ANN PHARMACOTHER, V40, P1737, DOI 10.1345/aph.1H153; Shore S, 2014, AM HEART J, V167, P810, DOI 10.1016/j.ahj.2014.03.023; Spivey CA, 2015, CURR MED RES OPIN, V31, P2021, DOI 10.1185/03007995.2015.1082995; Zalesak M, 2013, CIRC-CARDIOVASC QUAL, V6, P567, DOI 10.1161/CIRCOUTCOMES.113.000192	25	40	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0195950	10.1371/journal.pone.0195950	http://dx.doi.org/10.1371/journal.pone.0195950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709012	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100011
J	Lassen, LB; Gregersen, E; Lsager, AK; Betzer, C; Kofoed, RH; Jensen, PH				Lassen, Louise Berkhoudt; Gregersen, Emil; lsager, Anne Kathrine; Betzer, Cristine; Kofoed, Rikke Hahn; Jensen, Poul Henning			ELISA method to detect alpha-synuclein oligomers in cell and animal models	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; LEWY BODIES; IN-VIVO; TRANSGENIC MICE; FILAMENTS; PROTEIN; ACCUMULATION; DEMENTIA; OCCURS	Soluble aggregates of alpha-synuclein, so-called oligomers, are hypothesized to act as neurotoxic species in Parkinson's disease, Lewy body dementia and multiple systems atrophy, but specific tools to detect these aggregated species are only slowly appearing. We have developed an a-synuclein oligomer ELISA that allows us to detect and compare a-synuclein oligomer levels in different in vivo and in vitro experiments. The ELISA is based on commercially available antibodies and the epitope of the capture antibody MJF14-6-4-2 is foldingand aggregate-dependent and not present on monomers.	[Jensen, Poul Henning] Univ Aarhus, DANDRITE Danish Res Inst Translat Neurosci, Aarhus, Denmark; Dept Biomed, Aarhus, Denmark	Aarhus University; Aarhus University	Jensen, PH (corresponding author), Univ Aarhus, DANDRITE Danish Res Inst Translat Neurosci, Aarhus, Denmark.	phj@biomed.au.dk	Kofoed, Rikke Hahn/S-7694-2017	Kofoed, Rikke Hahn/0000-0003-0177-0739; Betzer, Cristine/0000-0001-5429-3548	Lundbeck foundation [R192-2015-895, R248-2016-2518]; Postgraduate school at Health at Aarhus University; Lundbeck Foundation [R192-2015-895, R223-2015-4222, R248-2016-2518] Funding Source: researchfish	Lundbeck foundation(Lundbeckfonden); Postgraduate school at Health at Aarhus University; Lundbeck Foundation(Lundbeckfonden)	The project was financially supported by the Lundbeck foundation (R192-2015-895, R248-2016-2518) and by in-kind support to PHJ from Aarhus University. The Postgraduate school at Health at Aarhus University supported the PhD stipend of EG. The project was further supported by Dandrite, Aarhus University and The Michael J. Fox Foundation.	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Betemps D, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-29; Betzer C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116473; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brannstrom K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090857; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Fagerqvist T, 2013, J NEUROCHEM, V126, P131, DOI 10.1111/jnc.12175; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Jensen PH, 2000, J BIOL CHEM, V275, P21500, DOI 10.1074/jbc.M000099200; Kubo S, 2001, J NEUROCHEM, V78, P42, DOI 10.1046/j.1471-4159.2001.00364.x; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lassen LB, 2016, BRAIN PATHOL, V26, P389, DOI 10.1111/bpa.12374; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Lindersson EK, 2004, NEUROREPORT, V15, P2735; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Majbour NK, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0072-9; Mysling S, 2013, BIOCHEMISTRY-US, V52, P9097, DOI 10.1021/bi4009193; Neri D, 1996, TRENDS BIOTECHNOL, V14, P465, DOI 10.1016/S0167-7799(96)10067-6; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Paslawski W, 2014, BIOCHEMISTRY-US, V53, P6252, DOI 10.1021/bi5007833; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Rockenstein E, 2014, BRAIN, V137, P1496, DOI 10.1093/brain/awu057; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Spillantini MG, 1999, PARKINSONISM RELAT D, V5, P157, DOI 10.1016/S1353-8020(99)00031-0; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Vekrellis K, 2009, J NEUROCHEM, V109, P1348, DOI 10.1111/j.1471-4159.2009.06054.x; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108	33	37	37	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196056	10.1371/journal.pone.0196056	http://dx.doi.org/10.1371/journal.pone.0196056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698510	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600032
J	Liu, F; Morris, M; Hicklen, L; Izadi, H; Dawes, H				Liu, Francesca; Morris, Martyn; Hicklen, Lisa; Izadi, Hooshang; Dawes, Helen			The impact of high and low-intensity exercise in adolescents with movement impairment	PLOS ONE			English	Article							DEVELOPMENTAL COORDINATION DISORDER; PHYSICAL-ACTIVITY; SHUTTLE RUN; MOTOR SKILL; CHILDREN; FITNESS; PARTICIPATION; RELIABILITY; OXIDATION; FATIGUE	Five to six percent of young people have movement impairment (MI) associated with reduced exercise tolerance and physical activity levels which persist into adulthood. To better understand the exercise experience in MI, we determined the physiological and perceptual responses during and following a bout of exercise performed at different intensities typically experienced during sport in youth with MI. Thirty-eight adolescents (11 +/- 18 years) categorised on the Bruininks-Oseretsky Test of Motor Proficiency-2 Short-Form performed a peak oxygen uptake bike test (VO2peak) test at visit 1 (V1). At visits 2 (V2) and 3 (V3), participants were randomly assigned to both low-intensity (LI) 30min exercise at 50% peak power output (PPO50%) and high-intensity (HI) 30s cycling at PPO100%, interspersed with 30s rest, for 30min protocol (matched for total work). Heart rate (HR) and rating of perceived exertion (RPE) for legs, breathing and overall was measured before, during and at 1, 3 and 7-min post-exercise (P1, P3, P7). There was a significant difference in VO2peak between groups (MI:31.5 +/- 9.2 vs. NMI:40.0 +/- 9.5ml.kg(-1).min(-1), p<0.05). PPO was significantly lower in MI group (MI:157 +/- 61 vs. NMI:216 +/- 57 W)(p<0.05). HRavg during HI-cycling was reduced in MI (140 +/- 18 vs. 157 +/- 14bpm, p<0.05), but not LI (133 +/- 18 vs. 143 +/- 17bpm, p>0.05). Both groups experienced similar RPE for breathing and overall (MI:7.0 +/- 3.0 vs. NMI: 6.0 +/- 2.0, p>0.05) at both intensities, but reported higher legs RPE towards the end (p<0.01). Significant differences were found in HRrecovery at P1 post-HI (MI: 128 +/- 25.9 vs. NMI:154 +/- 20.2, p<0.05) but not for legs RPE. Perceived fatigue appears to limit exercise in youth with MI in both high and low-intensity exercise types. Our findings suggest interventions reducing perceived fatigue during exercise may improve exercise tolerance and positively impact on engagement in physical activities.	[Liu, Francesca; Morris, Martyn; Dawes, Helen] Oxford Brookes Univ, Dept Sport & Hlth Sci, Oxford, Oxon, England; [Morris, Martyn] Coventry Univ, Dept Biomol & Sport Sci, Coventry, W Midlands, England; [Hicklen, Lisa] Univ Texas Arlington, Dept Kinesiol, Arlington, TX 76019 USA; [Izadi, Hooshang] Oxford Brookes Univ, Dept Mech Engn & Math Sci, Oxford, Oxon, England; [Dawes, Helen] Oxford Brookes Univ, Oxford Inst Nursing & Allied Hlth Res OxINMAHR, Oxford, England; [Dawes, Helen] Univ Oxford, Dept Clin Neurol, Oxford, England; [Dawes, Helen] Cardiff Univ, Cardiff, S Glam, Wales	Oxford Brookes University; Coventry University; University of Texas System; University of Texas Arlington; Oxford Brookes University; Oxford Brookes University; University of Oxford; Cardiff University	Liu, F (corresponding author), Oxford Brookes Univ, Dept Sport & Hlth Sci, Oxford, Oxon, England.	francesca.liu-2013@brookes.ac.uk		Dawes, Helen/0000-0002-2933-5213	Parkinson's Fund (PF) Charitable Trust	Parkinson's Fund (PF) Charitable Trust	This research was supported by the Parkinson's Fund (PF) Charitable Trust, awarded to FKL, and members of the CLEAR Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly HAA, 2015, WHO TECH REP SER, V994, P1; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Association A.P., 2000, DIAGN STAT MAN MENT, VFourth; Balemans ACJ, 2013, MED SCI SPORT EXER, V45, P561, DOI 10.1249/MSS.0b013e3182732b2f; Barker AR, 2014, J SPORT SCI, V32, P757, DOI 10.1080/02640414.2013.853132; Barnett AL, 2013, CHILD CARE HLTH DEV, V39, P393, DOI 10.1111/j.1365-2214.2012.01376.x; Barnett LM, 2009, J ADOLESCENT HEALTH, V44, P252, DOI 10.1016/j.jadohealth.2008.07.004; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; Bruininks RH, 2005, BRUININKS OSERETSKY; Buchan DS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-498; Cairney J, 2010, RES DEV DISABIL, V31, P1332, DOI 10.1016/j.ridd.2010.07.008; Cantell M, 2008, HUM MOVEMENT SCI, V27, P344, DOI 10.1016/j.humov.2008.02.007; Carney J, 2005, J PEDIATR-US, V147, P515, DOI 10.1016/j.jpeds.2005.05.013; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Davis JM, 1997, MED SCI SPORT EXER, V29, P45, DOI 10.1097/00005768-199701000-00008; Davison, 2007, SPORT EXERCISE PHYSL, VI; Diefenthaeler F, 2007, RES BRAS MED ESPORTE, V13, p182e; Dobbins M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651; Eston RG, 2000, PEDIATR EXERC SCI, V12, P388, DOI 10.1123/pes.12.4.388; Eston RG, 2009, J EXERC SCI FIT, V7, pS11, DOI 10.1016/S1728-869X(09)60018-6; Faught BE, 2013, RES DEV DISABIL, V34, P4439, DOI 10.1016/j.ridd.2013.09.024; GODFREY S, 1971, CLIN SCI, V40, P419, DOI 10.1042/cs0400419; Hands B, 2008, J SCI MED SPORT, V11, P155, DOI 10.1016/j.jsams.2007.02.012; Hebestreit H, 2000, MED SCI SPORT EXER, V32, P1964, DOI 10.1097/00005768-200011000-00022; Kane KJ, 2016, PHYS OCCUP THER PEDI, V36, P28, DOI 10.3109/01942638.2014.978934; Kessler HS, 2012, SPORTS MED, V42, P489, DOI 10.2165/11630910-000000000-00000; Kirby A, 2010, RES DEV DISABIL, V31, P131, DOI 10.1016/j.ridd.2009.08.010; Li YC, 2018, PSYCHOL SPORT EXERC, V37, P244, DOI 10.1016/j.psychsport.2017.11.001; Maffeis C, 2005, J CLIN ENDOCR METAB, V90, P231, DOI 10.1210/jc.2004-0715; Morris M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002909; Overseas Development Institute, 2013, DIS STAT RES; Ratel S, 2006, SPORTS MED, V36, P1031, DOI 10.2165/00007256-200636120-00004; Riddell MC, 2008, J APPL PHYSIOL, V105, P742, DOI 10.1152/japplphysiol.01256.2007; Rivilis I, 2011, RES DEV DISABIL, V32, P894, DOI 10.1016/j.ridd.2011.01.017; Ruiz JR, 2007, PEDIATR RES, V61, P350, DOI 10.1203/pdr.0b013e318030d1bd; SCHULZENEICK IM, 1992, EUR J PEDIATR, V151, P160, DOI 10.1007/BF01954374; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; Tolfrey K, 2017, OXFORD TXB CHILDRENS, V3rd, P477, DOI DOI 10.1093/MED/9780198757672.003.0035; Ullenhag A, 2014, DISABIL REHABIL, V36, P464, DOI 10.3109/09638288.2013.798360; van der Niet AG, 2015, J SCI MED SPORT, V18, P673, DOI 10.1016/j.jsams.2014.09.006; Verschuren O, 2006, PHYS THER, V86, P1107, DOI 10.1093/ptj/86.8.1107; Wahi G, 2011, RES DEV DISABIL, V32, P2785, DOI 10.1016/j.ridd.2011.05.030; Wasserman K., 2012, PRINCIPLES EXERCISE, V1, P8; Weinger K, 2011, ARCH INTERN MED, V171, P1990, DOI 10.1001/archinternmed.2011.502; WEISER PC, 1973, MED SCI SPORT EXER, V5, P79	46	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195944	10.1371/journal.pone.0195944	http://dx.doi.org/10.1371/journal.pone.0195944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1WN	29698495	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600025
J	Miyamoto, J; Watanabe, K; Taira, S; Kasubuchi, M; Li, X; Irie, J; Itoh, H; Kimura, I				Miyamoto, Junki; Watanabe, Keita; Taira, Satsuki; Kasubuchi, Mayu; Li, Xuan; Irie, Junichiro; Itoh, Hiroshi; Kimura, Ikuo			Barley beta-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; INSULIN-RESISTANCE; GLYCEMIC RESPONSE; SOLUBLE FIBER; FOOD-INTAKE; CONSUMPTION; GLUCOSE; OBESITY; APPETITE; DISEASE	Dietary intake of barley beta-glucan (BG) is known to affect energy metabolism. However, its underlying mechanism remains poorly understood because studies have presented inconsistent results, with both positive and negative effects reported in terms of satiety, energy intake, weight loss, and glycemic control. The objective of this study was to clarify the physiological role underlying the metabolic benefits of barley BG using a mouse model of high fat diet (HFD)-induced obesity. Male 4-wk-old C57BL/6J mice were fed an HFD with 20% barley flour containing either high BG (HBG; 2% BG) or low BG (LBG; 0.6% BG) levels under conventional and germ-free (GF) conditions for 12 wks. In addition, mice were fed either an HFD with 5% cellulose (HFC; high fiber cellulose) or 5% barley BG (HFB; high fiber beta-glucan) for 12 wks. Then, metabolic parameters, gut microbial compositions, and the production of fecal short-chain fatty acids (SCFAs) were analyzed. The weight gain and fat mass of HBG-fed mice were lower than those of control mice at 16-wk-old. Moreover, the secretion of the gut hormones PYY and GLP-1 increased in HBG-fed mice, thereby reducing food intake and improving insulin sensitivity by changing the gut microbiota and increasing SCFAs (especially, butyrate) under conventional condition. These effects in HBG-fed mice were abolished under GF conditions. Moreover, the HFB diets also increased PYY and GLP-1 secretion, and decreased food intake compared with that in HFC-fed mice. These results suggest that the beneficial metabolic effects of barley BG are primary due to the suppression of appetite and improvement of insulin sensitivity, which are induced by gut hormone secretion promoted via gut microbiota-produced SCFAs.	[Miyamoto, Junki; Watanabe, Keita; Taira, Satsuki; Kasubuchi, Mayu; Li, Xuan; Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo, Japan; [Miyamoto, Junki; Li, Xuan; Irie, Junichiro; Itoh, Hiroshi; Kimura, Ikuo] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo, Japan; [Irie, Junichiro; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo, Japan	Tokyo University of Agriculture & Technology; Keio University	Kimura, I (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, Fuchu, Tokyo, Japan.; Kimura, I (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo, Japan.	ikimura@cc.tuat.ac.jp	Kimura, Ikuo/B-4193-2015; 宮本, 潤基/ABG-8169-2020; Irie, Junichiro/H-7795-2019	Irie, Junichiro/0000-0003-2662-4121	JSPS [JP15H05344]; AMED [17gm1010007h0001]; Foundation for Dietary Scientific Research; Uehara Memorial Foundation; Skylark Food Science Institute	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AMED(Japan Agency for Medical Research and Development (AMED)); Foundation for Dietary Scientific Research; Uehara Memorial Foundation(Uehara Memorial Foundation); Skylark Food Science Institute	This works was supported by research grants from the JSPS (JP15H05344), AMED (17gm1010007h0001), the Foundation for Dietary Scientific Research, the Uehara Memorial Foundation, and the Skylark Food Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoe S, 2017, CEREAL CHEM, V94, P956, DOI 10.1094/CCHEM-04-17-0083-R; Behall KM, 2006, DIABETES CARE, V29, P976, DOI 10.2337/dc05-2012; Behall KM, 2004, AM J CLIN NUTR, V80, P1185, DOI 10.1093/ajcn/80.5.1185; Belobrajdic DP, 2015, NUTR RES, V35, P162, DOI 10.1016/j.nutres.2014.12.006; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Bourdon I, 1999, AM J CLIN NUTR, V69, P55; Brockman DA, 2013, EUR J NUTR, V52, P1743, DOI 10.1007/s00394-012-0478-2; Casiraghi MC, 2006, J AM COLL NUTR, V25, P313, DOI 10.1080/07315724.2006.10719541; Chakraborti C. K., 2015, WORLD J GASTROINTEST, V6, P110, DOI [10.4291/wjgp.v6.i4.110, DOI 10.4291/WJGP.V6.I4.110]; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Choi JS, 2010, MOL NUTR FOOD RES, V54, P1004, DOI 10.1002/mnfr.200900127; De Silva A, 2011, CELL METAB, V14, P700, DOI 10.1016/j.cmet.2011.09.010; Delaney B, 2003, J NUTR, V133, P468, DOI 10.1093/jn/133.2.468; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Esmaillzadeh A, 2005, EUR J CLIN NUTR, V59, P353, DOI 10.1038/sj.ejcn.1602080; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Greenwood Hannah C, 2011, Rev Diabet Stud, V8, P355, DOI 10.1900/RDS.2011.8.355; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Isken F, 2010, J NUTR BIOCHEM, V21, P278, DOI 10.1016/j.jnutbio.2008.12.012; Jenkins DJA, 2000, CURR OPIN LIPIDOL, V11, P49, DOI 10.1097/00041433-200002000-00008; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kaplan RJ, 2002, INT J FOOD SCI NUTR, V53, P305, DOI 10.1080/09637480220138160; Kasubuchi M, 2015, NUTRIENTS, V7, P2839, DOI 10.3390/nu7042839; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; McRorie JW, 2017, J ACAD NUTR DIET, V117, P251, DOI 10.1016/j.jand.2016.09.021; Nakajima A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179696; Nakamura N, 2009, APPL ENVIRON MICROB, V75, P1121, DOI 10.1128/AEM.02359-07; Nilsson AC, 2015, BRIT J NUTR, V114, P899, DOI 10.1017/S0007114515002524; Poppitt SD, 2007, ASIA PAC J CLIN NUTR, V16, P16; Rytter E, 1996, ANN NUTR METAB, V40, P212, DOI 10.1159/000177921; Saltzman E, 2001, J AM COLL NUTR, V20, P50, DOI 10.1080/07315724.2001.10719014; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sanz Y, 2010, P NUTR SOC, V69, P434, DOI 10.1017/S0029665110001813; Shinoda K, 2015, CELL METAB, V22, P997, DOI 10.1016/j.cmet.2015.09.029; Singer K, 2015, J BIOL CHEM, V290, P13250, DOI 10.1074/jbc.M114.634568; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Theuwissen E, 2008, PHYSIOL BEHAV, V94, P285, DOI 10.1016/j.physbeh.2008.01.001; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; WOLEVER TMS, 1989, AM J GASTROENTEROL, V84, P1027	44	74	77	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196579	10.1371/journal.pone.0196579	http://dx.doi.org/10.1371/journal.pone.0196579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698465	Green Submitted, Green Published, gold			2022-12-26	WOS:000431007600102
J	Yoshida, T; Masani, K; Zabjek, K; Popovic, MR; Chen, R				Yoshida, Takashi; Masani, Kei; Zabjek, Karl; Popovic, Milos R.; Chen, Robert			Dynamic cortical participation during bilateral, cyclical ankle movements: Effects of Parkinson's disease	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; DEEP BRAIN-STIMULATION; CORTICOMUSCULAR COHERENCE; BASAL GANGLIA; PEDUNCULOPONTINE NUCLEUS; BIMANUAL COORDINATION; SUBSTANTIA-NIGRA; AUTOMATIC MOVEMENTS; VOLUNTARY MOVEMENTS; SUBTHALAMIC NUCLEI	Parkinson's disease (PD) is known to increase asymmetry and variability of bilateral movements. However, the mechanisms of such abnormalities are not fully understood. Here, we aimed to investigate whether kinematic abnormalities are related to cortical participation during bilateral, cyclical ankle movements, which required i) maintenance of a specific frequency and ii) bilateral coordination of the lower limbs in an anti-phasic manner. We analyzed electroencephalographic and electromyographic signals from nine men with PD and nine aged-matched healthy men while they sat and cyclically dorsi- and plantarflexed their feet. This movement was performed at a similar cadence to normal walking under two conditions: i) self-paced and ii) externally paced by a metronome. Participants with PD exhibited reduced range of motion and more variable bilateral coordination. However, participants with and without PD did not differ in the magnitude of corticomuscular coherence between the midline cortical areas and tibialis anterior and medial gastrocnemius muscles. This finding suggests that either the kinematic abnormalities were related to processes outside linear corticomuscular communication or PD-related changes in neural correlates maintained corticomuscular communication but not motor performance.	[Yoshida, Takashi; Masani, Kei; Popovic, Milos R.] Univ Hlth Network, Toronto Rehabil Inst, Rehabil Engn Lab, Toronto, ON, Canada; [Yoshida, Takashi; Masani, Kei; Popovic, Milos R.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Yoshida, Takashi] Univ Med Ctr Gottingen, Dept Trauma Surg Orthopaed & Plast Surg, Appl Surg & Rehabil Technol Lab, Gottingen, Lower Saxony, Germany; [Zabjek, Karl] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Chen, Robert] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; [Chen, Robert] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Chen, Robert] Univ Hlth Network, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Gottingen; University of Toronto; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Masani, K (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Rehabil Engn Lab, Toronto, ON, Canada.; Masani, K (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	k.masani@utoronto.ca	MUI, HOI LING/I-3220-2018; Masani, Kei/B-4991-2010	Masani, Kei/0000-0002-0207-3241; Popovic, Milos R/0000-0002-2837-2346	Toronto Rehabilitation Institute Student Scholarship from the University of Toronto; CREATE Academic Rehabilitation Engineering Fellowship from the Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [MOP 15128, OMH131582]; Toronto Rehabilitation Institute University Health Network; Natural Sciences and Engineering Research Council [249669]	Toronto Rehabilitation Institute Student Scholarship from the University of Toronto; CREATE Academic Rehabilitation Engineering Fellowship from the Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Toronto Rehabilitation Institute University Health Network; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	TY was supported by the Toronto Rehabilitation Institute Student Scholarship from the University of Toronto (https://www.utoronto.ca/) and the CREATE Academic Rehabilitation Engineering Fellowship from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). This work was partially supported by Canadian Institutes of Health Research (CA) (http://www.cihr-irsc.gc.ca/e/193.html) grants (MOP 15128, RC; OMH131582, KM). The authors also acknowledge the support from the Toronto Rehabilitation Institute University Health Network (http://www.uhn.ca/TorontoRehab), Dean Connor and Maris Uffelmann Donation, and Natural Sciences and Engineering Research Council Discovery Grant (#249669, MRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2003, BRAIN RES BULL, V61, P219, DOI 10.1016/S0361-9230(03)00119-9; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Almeida QJ, 2002, MOVEMENT DISORD, V17, P30, DOI 10.1002/mds.10030; [Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; Baltadjieva R, 2006, EUR J NEUROSCI, V24, P1815, DOI 10.1111/j.1460-9568.2006.05033.x; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; BROTCHIE P, 1991, BRAIN, V114, P1685, DOI 10.1093/brain/114.4.1685; BROUWER B, 1990, ELECTROEN CLIN NEURO, V76, P509, DOI 10.1016/0013-4694(90)90002-2; Byblow WD, 2000, HUM MOVEMENT SCI, V19, P223, DOI 10.1016/S0167-9457(00)00011-7; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Chakarov V, 2009, J NEUROPHYSIOL, V102, P1115, DOI 10.1152/jn.91095.2008; EIDELBERG E, 1981, BRAIN, V104, P647, DOI 10.1093/brain/104.4.647-a; Espay AJ, 2009, MOVEMENT DISORD, V24, P1001, DOI 10.1002/mds.22480; Farina D, 2014, J APPL PHYSIOL, V117, P1215, DOI 10.1152/japplphysiol.00162.2014; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; FREEMAN JS, 1993, J NEUROL NEUROSUR PS, V56, P1078, DOI 10.1136/jnnp.56.10.1078; Frenkel-Toledo S, 2005, JNEUROENGREHABIL, V2; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; GARCIARILL E, 1987, BRAIN RES BULL, V18, P731, DOI 10.1016/0361-9230(87)90208-5; GARCIARILL E, 1986, BRAIN RES REV, V11, P47, DOI 10.1016/0165-0173(86)90009-3; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Goetz L, 2016, J NEUROSCI, V36, P4917, DOI 10.1523/JNEUROSCI.2514-15.2016; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Gross J, 2000, J PHYSIOL-LONDON, V527, P623, DOI 10.1111/j.1469-7793.2000.00623.x; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Hunnicutt BJ, 2014, NAT NEUROSCI, V17, P1276, DOI 10.1038/nn.3780; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Johnson KA, 1998, BRAIN, V121, P743, DOI 10.1093/brain/121.4.743; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Kallio J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053425; Kato K, 2015, CLIN NEUROPHYSIOL, V126, P1941, DOI 10.1016/j.clinph.2014.12.007; Kilner JM, 2000, J NEUROSCI, V20, P8838; Kristeva R, 2007, NEUROIMAGE, V36, P785, DOI 10.1016/j.neuroimage.2007.03.025; Lanciego JL, 2012, COLD SPRING HARBOR P, V2; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Le Ray D, 2011, PROG BRAIN RES, V188, P51, DOI 10.1016/B978-0-444-53825-3.00009-7; Libenson MH., 2010, ELECTROENCEPHALOGRAP, P124; Masakado Yoshihisa, 2008, Keio Journal of Medicine, V57, P50, DOI 10.2302/kjm.57.50; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; McClelland VM, 2012, EXP BRAIN RES, V219, P275, DOI 10.1007/s00221-012-3087-7; MCGEER PL, 1988, ANN NEUROL, V24, P574, DOI 10.1002/ana.410240415; Mima T, 1999, J CLIN NEUROPHYSIOL, V16, P501, DOI 10.1097/00004691-199911000-00002; Mima T, 2001, STROKE, V32, P2597, DOI 10.1161/hs1101.098764; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; MURRAY MP, 1978, AM J PHYS MED REHAB, V57, P278; Myers LJ, 2003, J NEUROSCI METH, V124, P157, DOI 10.1016/S0165-0270(03)00004-9; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS8, DOI 10.1016/S1471-1931(00)00028-8; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; Omlor W, 2011, J NEUROSCI, V31, P8037, DOI 10.1523/JNEUROSCI.4153-10.2011; Perretti A, 2011, CLIN NEUROPHYSIOL, V122, P546, DOI 10.1016/j.clinph.2010.07.016; Plaha P, 2005, NEUROREPORT, V16, P1883, DOI 10.1097/01.wnr.0000187637.20771.a0; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Pollok B, 2012, J PHYSIOL-LONDON, V590, P3203, DOI 10.1113/jphysiol.2012.231316; RASCOL O, 1992, ARCH NEUROL-CHICAGO, V49, P144, DOI 10.1001/archneur.1992.00530260044017; Riddle CN, 2006, NEUROIMAGE, V33, P618, DOI 10.1016/j.neuroimage.2006.07.027; RINNE JO, 1989, ANN NEUROL, V26, P47, DOI 10.1002/ana.410260107; Riquelme I, 2014, J ELECTROMYOGR KINES, V24, P928, DOI 10.1016/j.jelekin.2014.07.004; Rossiter HE, 2013, NEUROIMAGE-CLIN, V2, P50, DOI 10.1016/j.nicl.2012.11.002; Ryczko D, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00295; Salenius S, 2002, BRAIN, V125, P491, DOI 10.1093/brain/awf042; Serrien DJ, 2000, NEUROPSYCHOLOGIA, V38, P1714; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/awl346; Thompson P D, 1986, Mov Disord, V1, P113, DOI 10.1002/mds.870010205; Trenado C, 2014, FRONTHUMAN NEUROSCI, V8; Trujillo-Ortiz A, ROYSTEST ROYSTONS MU; Tsang EW, 2010, NEUROLOGY, V75, P950, DOI 10.1212/WNL.0b013e3181f25b35; Ushiyama J, 2012, J APPL PHYSIOL, V112, P1258, DOI 10.1152/japplphysiol.01291.2011; Ushiyama J, 2011, J APPL PHYSIOL, V110, P1233, DOI 10.1152/japplphysiol.01194.2010; van den Berg C, 2000, EXP BRAIN RES, V134, P174, DOI 10.1007/s002210000441; Ward NJ, 2013, J NEUROPHYSIOL, V110, P1744, DOI 10.1152/jn.00296.2013; Wichmann T, 2013, PRINCIPLES NEURAL SC, P960; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2015, CEREB CORTEX, V25, P3330, DOI 10.1093/cercor/bhu135; Wu T, 2010, BRAIN, V133, P2394, DOI 10.1093/brain/awq151; Yang Y, 2018, EUR J NEUROSCI, V48, P2407, DOI 10.1111/ejn.13692; Yang Y, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00126; Yang Y, 2016, IEEE T BIO-MED ENG, V63, P2629, DOI 10.1109/TBME.2016.2585097; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yoshida T, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00155; Yoshida T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44658	95	6	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196177	10.1371/journal.pone.0196177	http://dx.doi.org/10.1371/journal.pone.0196177			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1WN	29698430	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600043
J	Belcher, JD; Chen, CS; Nguyen, J; Abdulla, F; Zhang, P; Nguyen, H; Nguyen, P; Killeen, T; Miescher, SM; Brinkman, N; Nath, KA; Steers, CJ; Vercellotti, GM				Belcher, John D.; Chen, Chunsheng; Nguyen, Julia; Abdulla, Fuad; Zhang, Ping; Nguyen, Hao; Nguyen, Phong; Killeen, Trevor; Miescher, Sylvia M.; Brinkman, Nathan; Nath, Karl A.; Steers, Clifford J.; Vercellotti, Gregory M.			Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction	PLOS ONE			English	Article							ACUTE CHEST SYNDROME; P-SELECTIN; MOUSE MODEL; HEMOGLOBIN; RECEPTOR; MICE; EXPRESSION; TOXICITY; PROTEIN; LIVER	During hemolysis, hemoglobin and heme released from red blood cells promote oxidative stress, inflammation and thrombosis. Plasma haptoglobin and hemopexin scavenge free hemoglobin and heme, respectively, but can be depleted in hemolytic states. Haptoglobin and hemopexin supplementation protect tissues, including the vasculature, liver and kidneys. It is widely assumed that these protective effects are due primarily to hemoglobin and heme clearance from the vasculature. However, this simple assumption does not account for the consequent cytoprotective adaptation seen in cells and organs. To further address the mechanism, we used a hyperhemolytic murine model (Townes-SS) of sickle cell disease to examine cellular responses to haptoglobin and hemopexin supplementation. A single infusion of haptoglobin or hemopexin (+/- equimolar hemoglobin) in SS-mice increased heme oxygenase-1 (HO-1) in the liver, kidney and skin several fold within 1 hour and decreased nuclear NF-kappa B phospho-p65, and vaso-occlusion for 48 hours after infusion. Plasma hemoglobin and heme levels were not significantly changed 1 hour after infusion of haptoglobin or hemopexin. Haptoglobin and hemopexin also inhibited hypoxia/reoxygenation and lipopolysaccharide-induced vaso-occlusion in SS-mice. Inhibition of HO-1 activity with tin protoporphyrin blocked the protections afforded by haptoglobin and hemopexin in SS-mice. The HO-1 reaction product carbon monoxide, fully restored the protection, in part by inhibiting Weibel-Palade body mobilization of P-selectin and von Willebrand factor to endothelial cell surfaces. Thus, the mechanism by which haptoglobin and hemopexin supplementation in hyperhemolytic SS-mice induces cytoprotective cellular responses is linked to increased HO-1 activity.	[Belcher, John D.; Chen, Chunsheng; Nguyen, Julia; Abdulla, Fuad; Zhang, Ping; Nguyen, Hao; Nguyen, Phong; Killeen, Trevor; Vercellotti, Gregory M.] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Vasc Biol Ctr, Box 736 UMHC, Minneapolis, MN 55455 USA; [Miescher, Sylvia M.] CSL Behring AG, Res & Dev, Bern, Switzerland; [Brinkman, Nathan] CSL Behring, Res & Dev, Kankakee, IL USA; [Nath, Karl A.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Steers, Clifford J.] Univ Minnesota, Dept Med, Div Gastroenterol Hepatol & Nutr, Box 736 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; CSL; CSL; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Belcher, JD (corresponding author), Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Vasc Biol Ctr, Box 736 UMHC, Minneapolis, MN 55455 USA.	belcher@umn.edu	Abdulla, Fuad/AHB-7032-2022	Belcher, John D/0000-0001-5536-2752	National Heart, Lung and Blood Institute [R01 HL114567-05]; CSL Behring; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047060] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CSL Behring; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by a grant from the National Heart, Lung and Blood Institute R01 HL114567-05 to GMV and JDB and a grant from CSL Behring to JDB and GMV. The funder (CSL Behring) provided support in the form of salaries for authors [SMM NB]. These authors [SMM NB] provided input on research aims and goals, provided hemopexin and haptoglobin, and assisted with writing, review and editing of the manuscript.	ALAM J, 1989, J BIOL CHEM, V264, P17637; Alayash AI, 2011, CLIN CHIM ACTA, V412, P493, DOI 10.1016/j.cca.2010.12.011; Arredouani MS, 2005, IMMUNOLOGY, V114, P263, DOI 10.1111/j.1365-2567.2004.02071.x; Ataga KI, 2017, NEW ENGL J MED, V376, P429, DOI 10.1056/NEJMoa1611770; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; BALLA G, 1992, J BIOL CHEM, V267, P18148; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Bean CJ, 2012, BLOOD, V120, P3822, DOI 10.1182/blood-2011-06-361642; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Belcher John D, 2013, ISRN Oxidative Med, V2013; Belcher JD, 2010, J MOL MED, V88, P665, DOI 10.1007/s00109-010-0613-6; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; BUNN HF, 1968, J BIOL CHEM, V243, P465; Camus SM, 2015, BLOOD, V125, P3805, DOI 10.1182/blood-2014-07-589283; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Chen LF, 2011, J NEUROSURG, V114, P1159, DOI 10.3171/2010.10.JNS10861; Chintagari NR, 2016, AM J RESP CELL MOL, V55, P288, DOI 10.1165/rcmb.2015-0197OC; Chintagari NR, 2015, BLOOD CELL MOL DIS, V54, P302, DOI 10.1016/j.bcmd.2014.12.001; Cooper CE, 2008, BBA-PROTEINS PROTEOM, V1784, P1415, DOI 10.1016/j.bbapap.2008.03.019; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2254, DOI 10.1089/ars.2012.4605; Fagoonee S, 2005, AM J PATHOL, V166, P973, DOI 10.1016/S0002-9440(10)62319-X; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Frenette PS, 2004, BLOOD, V103, P1979; Ghosh S, 2013, J CLIN INVEST, V123, P4809, DOI 10.1172/JCI64578; Graw JA, 2016, CIRCULATION, V134, P945, DOI 10.1161/CIRCULATIONAHA.115.019955; Hanson MS, 2011, BRIT J HAEMATOL, V154, P502, DOI 10.1111/j.1365-2141.2011.08738.x; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Kalambur VS, 2004, AM J HEMATOL, V77, P117, DOI 10.1002/ajh.20143; Kohli DR, 2010, BLOOD, V116, P456, DOI 10.1182/blood-2010-01-260372; Li RC, 2009, J CEREBR BLOOD F MET, V29, P953, DOI 10.1038/jcbfm.2009.19; Louie JE, 2018, TRANSFUSION, V58, P470, DOI 10.1111/trf.14407; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nielsen MJ, 2010, ANTIOXID REDOX SIGN, V12, P261, DOI 10.1089/ars.2009.2792; OKUDA M, 1992, BIOCHIM BIOPHYS ACTA, V1136, P143, DOI 10.1016/0167-4889(92)90249-B; Padilla A, 2004, BLOOD, V103, P2150, DOI 10.1182/blood-2003-08-2956; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Shi PA, 2016, BRIT J HAEMATOL, V175, P714, DOI 10.1111/bjh.14280; SMITH A, 1979, BIOCHEM J, V182, P47, DOI 10.1042/bj1820047; Smith A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00187; Thomsen JH, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/523652; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Vandegriff KD, 2003, TRANSFUSION, V43, P509, DOI 10.1046/j.1537-2995.2003.00341.x; Vercellotti GM, 2016, MOL MED, V22, P437, DOI 10.2119/molmed.2016.00063; Vinchi F, 2008, AM J PATHOL, V173, P289, DOI 10.2353/ajpath.2008.071130; Vinchi F, 2013, CIRCULATION, V127, P1317, DOI 10.1161/CIRCULATIONAHA.112.130179; Wagener FADTG, 1997, P SOC EXP BIOL MED, V216, P456; WINTERBOURN CC, 1990, METHOD ENZYMOL, V186, P265; Wu LC, 2006, BLOOD, V108, P1183, DOI 10.1182/blood-2006-02-004812; [No title captured]	58	65	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196455	10.1371/journal.pone.0196455	http://dx.doi.org/10.1371/journal.pone.0196455			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694434	gold, Green Published, Green Submitted			2022-12-26	WOS:000430802400091
J	Bridgeman, B; Morgan-Richards, M; Wheeler, D; Trewick, SA				Bridgeman, Benjamin; Morgan-Richards, Mary; Wheeler, David; Trewick, Steven A.			First detection of Wolbachia in the New Zealand biota	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; HORIZONTAL TRANSMISSION; DIVERSITY; PHYLOGENY; INFECTION; ENDOSYMBIONT; EVOLUTION; POPULATIONS; SUPERGROUP; ARTHROPOD	Wolbachia is one of the most widespread intracellular bacteria on earth, estimated to infect between 40 and 66% of arthropod species in most ecosystems that have been surveyed. Their significance rests not only in their vast distribution, but also in their ability to modify the reproductive biology of their hosts, which can ultimately affect genetic diversity and speciation of infected populations. Wolbachia has yet to be formally identified in the fauna of New Zealand which has high levels of endemic biodiversity and this represents a gap in our understanding of the global biology of Wolbachia. Using High Throughput Sequencing (HTS) of host DNA in conjunction with traditional molecular techniques we identified six endemic Orthoptera species that were positive for Wolbachia infection. In addition, short-sequence amplification with Wolbachia specific primers applied to New Zealand and introduced invertebrates detected a further 153 individuals positive for Wolbachia. From these short-range DNA amplification products sequence data was obtained for the ftsZ gene region from 86 individuals representing 10 host species. Phylogenetic analysis using the sequences obtained in this study reveals that there are two distinct Wolbachia bacteria lineages in New Zealand hosts belonging to recognised Wolbachia supergroups (A and B). These represent the first described instances of Wolbachia in the New Zealand native fauna, including detection in putative parasitoids of infected Orthoptera suggesting a possible transmission path. Our detection of Wolbachia infections of New Zealand species provides the opportunity to study local transmission of Wolbachia and explore their role in the evolution of New Zealand invertebrates.	[Bridgeman, Benjamin; Morgan-Richards, Mary; Trewick, Steven A.] Massey Univ, Coll Sci, Ecol Grp, Palmerston North, New Zealand; [Wheeler, David] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Massey University; Massey University	Bridgeman, B (corresponding author), Massey Univ, Coll Sci, Ecol Grp, Palmerston North, New Zealand.	b.bridgeman@outlook.com		Bridgeman, Benjamin/0000-0003-1620-5927; Wheeler, David/0000-0001-5538-8119; Trewick, Steven/0000-0002-4680-8457	National Science Foundation [SBE-1338614, SBE-1338626]; NZ Department of Conservation; Royal Society of New Zealand Te Aparangi Marsden Fund grant [MAU1201]; Department of Conservation Taxonomic Units Fund [4076]; Massey University Research Fund	National Science Foundation(National Science Foundation (NSF)); NZ Department of Conservation; Royal Society of New Zealand Te Aparangi Marsden Fund grant; Department of Conservation Taxonomic Units Fund; Massey University Research Fund	This research was supported by the National Science Foundation, Grant Nos. SBE-1338614 and SBE-1338626.; Briar Taylor-Smith provided DNA extractions of many Hemiandrus specimens. HTS datasets were generated as part of other studies supported by TIFBIS funding from the NZ Department of Conservation; Royal Society of New Zealand Te Aparangi Marsden Fund grant (MAU1201), Department of Conservation Taxonomic Units Fund (contract 4076), Massey University Research Fund ("What limits a weta?" to MMR). We thank John Early, Auckland War Memorial Museum for providing specimens of Archaeoteleia. This paper was improved by comments from two anonymous reviewers.	Ahmed MZ, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0660-x; Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792; [Anonymous], 2014, ILL HISEQ2000; Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bing XL, 2014, ECOL EVOL, V4, P2714, DOI 10.1002/ece3.1126; BREEUWER JAJ, 1993, GENETICS, V135, P565; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Early JW, 2007, ZOOTAXA, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fraser JE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006751; Glowska E, 2015, INFECT GENET EVOL, V30, P140, DOI 10.1016/j.meegid.2014.12.019; Goldberg J, 2008, PHILOS T R SOC B, V363, P3319, DOI 10.1098/rstb.2008.0114; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hernandez M, 2004, REV BIOL TROP, V52, P795; HERTIG M., 1936, Parasitology, V28, P453, DOI 10.1017/S0031182000022666; Hertig M, 1924, J MED RES, V44, P329; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1996, HEREDITY, V76, P1, DOI 10.1038/hdy.1996.1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes GL, 2011, APPL ENVIRON MICROB, V77, P2165, DOI 10.1128/AEM.02878-10; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Huson DH, 2014, BIOINFORMATICS, V30, P38, DOI 10.1093/bioinformatics/btt254; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jeong G, 2012, J ASIA-PAC ENTOMOL, V15, P563, DOI 10.1016/j.aspen.2012.07.002; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1423, DOI 10.1098/rspb.2001.1656; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Le Clec'h W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060232; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Li SJ, 2017, ISME J, V11, P1019, DOI 10.1038/ismej.2016.164; Lo N, 2002, MOL BIOL EVOL, V19, P341, DOI 10.1093/oxfordjournals.molbev.a004087; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Rokas A, 2002, MOL ECOL, V11, P1815, DOI 10.1046/j.1365-294X.2002.01556.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ros VID, 2009, APPL ENVIRON MICROB, V75, P1036, DOI 10.1128/AEM.01109-08; Sarasa J, 2013, CYTOGENET GENOME RES, V139, P36, DOI 10.1159/000341572; Sazama EJ, 2017, ECOL EVOL, V7, P1165, DOI 10.1002/ece3.2742; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; Sivyer L, 2018, INSECT CONSERV DIVER; Slatko BE, 2010, SYMBIOSIS, V51, P55, DOI 10.1007/s13199-010-0067-1; Taylor-Smith B, 2016, THESIS; Taylor-Smith BL, 2016, NEW ZEAL J ZOOL, V43, P363, DOI 10.1080/03014223.2016.1205109; Trewick S, 2009, NZ BIOL ENCY ISLANDS; Trewick SA, 2007, J BIOGEOGR, V34, P1, DOI 10.1111/j.1365-2699.2006.01643.x; Turner JD, 2017, P NATL ACAD SCI USA, V114, pE9712, DOI 10.1073/pnas.1710845114; Vaux F, 2017, MOL PHYLOGENET EVOL, V114, P367, DOI 10.1016/j.ympev.2017.06.018; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Watanabe M, 2013, J INVERTEBR PATHOL, V112, P83, DOI 10.1016/j.jip.2012.09.006; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zhang YK, 2013, MICROB ECOL, V65, P731, DOI 10.1007/s00248-013-0198-z; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	60	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195517	10.1371/journal.pone.0195517	http://dx.doi.org/10.1371/journal.pone.0195517			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694414	Green Published, gold			2022-12-26	WOS:000430802400033
J	Begum, S; Yiu, A; Stebbing, J; Castellano, L				Begum, S.; Yiu, A.; Stebbing, J.; Castellano, L.			Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas	ONCOGENE			English	Article								The previously unchartered gene expression territory governed by circular RNAs is becoming clearer with the onset of deeper sequencing technologies. The translation of circular RNAs remained a controversial theory until earlier this year, when two studies [1, 2] showed endogenous circular RNA translation in vitro and in vivo, and have further provided mechanistical evidence. In this edition of Oncogene, Zhang et al., provide evidence for the first circular RNA translated with relevance to cancer; a novel tumour suppressor protein, SHPRH-146aa, produced by circ-SHPRH driven by IRES elements. The novel tumour suppressor protein produced by the circular RNA was found to work in synergy with the full-length protein, behaving as a protective decoy molecule to decrease degradation, and thus increasing the tumour suppressive functionality of the gene. An extended patient survival time was seen in glioblastoma patients with elevated levels of SHPRH-146aa. This study also marks the discovery of the first circular RNA with an overlapping initiation and termination codon, resulting in the translation of the full circRNA, exploring a mechanism not previously found or seen.	[Begum, S.] Imperial Coll London, Dept Surg & Canc, Fac Med, Div Computat & Syst Med, South Kensington Campus,Exhibit Rd, London SW7 2AZ, England; [Yiu, A.; Stebbing, J.; Castellano, L.] Imperial Coll London, Fac Med, Div Canc, Dept Surg & Canc, Hammersmith Campus,Du Cane Rd, London W12 0NN, England; [Castellano, L.] Univ Sussex, Sch Life Sci, John Maynard Smith Bldg, Brighton BN1 9QG, E Sussex, England	Imperial College London; Imperial College London; University of Sussex	Castellano, L (corresponding author), Imperial Coll London, Fac Med, Div Canc, Dept Surg & Canc, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.; Castellano, L (corresponding author), Univ Sussex, Sch Life Sci, John Maynard Smith Bldg, Brighton BN1 9QG, E Sussex, England.	l.castellano@imperial.ac.uk	Castellano, Leandro/AAE-1366-2021	Castellano, Leandro/0000-0002-3059-4829; Begum, Sofina/0000-0001-7689-0087; Stebbing, Justin/0000-0002-1117-6947	Department of Health [NIHR-RP-011-053] Funding Source: Medline	Department of Health		CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32; Ebbesen KK, 2016, BBA-GENE REGUL MECH, V1859, P163, DOI 10.1016/j.bbagrm.2015.07.007; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Guarnerio J, 2016, CELL, V165, P289, DOI 10.1016/j.cell.2016.03.020; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hou LD, 2017, INT J IMMUNOPATH PH, V30, P1, DOI 10.1177/0394632016686985; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Kumar S, 2017, NATURE, V547, P40, DOI 10.1038/nature23085; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021; Qin ML, 2016, CANCER BIOMARK, V16, P161, DOI 10.3233/CBM-150552; Rasool Mahmood, 2016, Noncoding RNA Res, V1, P69, DOI 10.1016/j.ncrna.2016.11.001; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122	14	73	75	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 26	2018	37	30					4055	4057		10.1038/s41388-018-0230-3	http://dx.doi.org/10.1038/s41388-018-0230-3			3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GO2YI	29706655				2022-12-26	WOS:000439847000001
J	Gattelli, A; Sola, MEG; Roloff, TC; Cardiff, RD; Kordon, EC; Chodosh, LA; Hynes, NE				Gattelli, Albana; Garcia Sola, Martin E.; Roloff, Tim C.; Cardiff, Robert D.; Kordon, Edith C.; Chodosh, Lewis A.; Hynes, Nancy E.			Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition	ONCOGENE			English	Article							BREAST-CANCER CELLS; TRANSGENIC MICE; GENE; RESISTANCE; LANDSCAPE; FUSIONS; GROWTH	The receptor tyrosine kinase Ret, a key gain-of-function mutated oncoprotein in thyroid carcinomas, has recently been implicated in other cancer types. While Ret copy number gains and mutations have been reported at low frequencies in breast tumors, we and others have reported that Ret is overexpressed in about 40% of human tumors and this correlates with poor patient prognosis. Ret activation regulates numerous intracellular pathways related to proliferation and inflammation, but it is not known whether abnormal Ret expression is sufficient to induce mammary carcinomas. Using a novel doxycycline-inducible transgenic mouse model with the MMTV promoter controlling Ret expression, we show that overexpression of wild-type Ret in the mammary epithelium produces mammary tumors, displaying a morphology that recapitulates characteristics of human luminal breast tumors. Ret-evoked tumors are estrogen receptor positive and negative for progesterone receptor. Moreover, tumors rapidly regress after doxycycline withdrawal, indicating that Ret is the driving oncoprotein. Using next-generation sequencing, we examined the levels of transcripts in these tumors, confirming a luminal signature. Ret-evoked tumors have been passaged in mice and used to test novel therapeutic approaches. Importantly, we have determined that tumors are resistant to endocrine therapy, but respond successfully to treatment with a Ret kinase inhibitor. Our data provide the first compelling evidence for an oncogenic role of non-mutated Ret in the mammary gland and are an incentive for clinical development of Ret as a cancer biomarker and therapeutic target.	[Gattelli, Albana; Garcia Sola, Martin E.; Kordon, Edith C.] UBA, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Gattelli, Albana; Garcia Sola, Martin E.; Kordon, Edith C.] UBA, CONICET, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, RA-1428 CABA Buenos Aires, Argentina; [Gattelli, Albana; Roloff, Tim C.; Hynes, Nancy E.] Friedrich Miescher Inst Biomed Res FMI, Maulbeerstr 66, CH-4058 Basel, Switzerland; [Cardiff, Robert D.] UCD, Ctr Genom Pathol, Sch Med, Pathol & Lab Med, Cty Rd 98 & Hutchison Dr, Davis, CA USA; [Chodosh, Lewis A.] Univ Penn Upenn, Perelman Sch Med, Dept Canc Biol, 614 BRB II-III,421 Curie Blvd, Philadelphia, PA USA; [Hynes, Nancy E.] Univ Basel, CH-4002 Basel, Switzerland	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Friedrich Miescher Institute for Biomedical Research; University of Pennsylvania; Pennsylvania Medicine; University of Basel	Gattelli, A (corresponding author), UBA, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina.; Gattelli, A (corresponding author), UBA, CONICET, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, RA-1428 CABA Buenos Aires, Argentina.; Gattelli, A; Hynes, NE (corresponding author), Friedrich Miescher Inst Biomed Res FMI, Maulbeerstr 66, CH-4058 Basel, Switzerland.; Hynes, NE (corresponding author), Univ Basel, CH-4002 Basel, Switzerland.	albanaga@fbmc.fcen.uba.ar; Nancy.Hynes@fmi.ch		Gattelli, Albana/0000-0003-1260-5413; Garcia Sola, Martin E/0000-0002-0229-8870	Susan G. Komen for the Cure(R) [KG101234, SAC110041]; Fundacion para el Progreso de la Medicina Cordoba [02]; Krebsliga beider Basel [10-2030]; Novartis Research Foundation	Susan G. Komen for the Cure(R)(Susan G. Komen Breast Cancer Foundation); Fundacion para el Progreso de la Medicina Cordoba; Krebsliga beider Basel; Novartis Research Foundation	AG was supported by grant KG101234 from Susan G. Komen for the Cure (R) and grant GF No 02 from Fundacion para el Progreso de la Medicina Cordoba. NEH was supported by grants from Susan G. Komen for the Cure (R) SAC110041, from Krebsliga beider Basel 10-2030 and by the Novartis Research Foundation.	Akeno-Stuart N, 2007, CANCER RES, V67, P6956, DOI 10.1158/0008-5472.CAN-06-4605; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; Esseghir S, 2007, CANCER RES, V67, P11732, DOI 10.1158/0008-5472.CAN-07-2343; Gattelli A, 2013, EMBO MOL MED, V5, P1335, DOI 10.1002/emmm.201302625; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Hynes NE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003186; IWAMOTO T, 1990, ONCOGENE, V5, P535; Kang J, 2012, ONCOGENE, V31, P402, DOI 10.1038/onc.2011.553; Kohno T, 2013, CANCER SCI, V104, P1396, DOI 10.1111/cas.12275; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Morandi A, 2013, CANCER RES, V73, P3783, DOI 10.1158/0008-5472.CAN-12-4265; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Plaza-Menacho I, 2010, ONCOGENE, V29, P4648, DOI 10.1038/onc.2010.209; Rakha EA, 2007, J CLIN ONCOL, V25, P4772, DOI 10.1200/JCO.2007.12.2747; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Spanheimer PM, 2014, CLIN CANCER RES, V20, P2115, DOI 10.1158/1078-0432.CCR-13-2221; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807	25	10	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 19	2018	37	29					4046	4054		10.1038/s41388-018-0235-y	http://dx.doi.org/10.1038/s41388-018-0235-y			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GN5LP	29695833				2022-12-26	WOS:000439101300010
J	Punch, EK; Hover, S; Blest, HTW; Fuller, J; Hewson, R; Fontana, J; Mankouri, J; Barr, JN				Punch, Emma K.; Hover, Samantha; Blest, Henry T. W.; Fuller, Jack; Hewson, Roger; Fontana, Juan; Mankouri, Jamel; Barr, John N.			Potassium is a trigger for conformational change in the fusion spike of an enveloped RNA virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virus entry; fusion protein; electron tomography; conformational change; potassium transport; ion channel; virus structure	HEMORRHAGIC-FEVER VIRUS; CRYSTAL-STRUCTURE; CRYOELECTRON TOMOGRAPHY; ELECTRON-MICROSCOPY; GLYCOPROTEIN; ENTRY; PH; BUNYAVIRUSES; CLATHRIN; PROTEIN	Many enveloped viruses enter cells through the endocytic network, from which they must subsequently escape through fusion of viral and endosomal membranes. This membrane fusion is mediated by virus-encoded spikes that respond to the dynamic endosomal environment, which triggers conformational changes in the spikes that initiate the fusion process. Several fusion triggers have been identified and include pH, membrane composition, and endosome-resident proteins, and these cues dictate when and where viral fusion occurs. We recently reported that infection with an enveloped bunyavirus requires elevated potassium ion concentrations [K+], controlled by cellular K+ channels, that are encountered during viral transit through maturing endosomes. Here we reveal the molecular basis for the K+ requirement of bunyaviruses through the first direct visualization of a member of the Nairoviridae family, namely Hazara virus (HAZV), using cryo-EM. Using cryo-electron tomography, we observed HAZV spike glycoproteins within infectious HAZV particles exposed to both high and low [K+], which showed that exposure to K+ alone results in dramatic changes to the ultrastructural architecture of the virion surface. In low [K+], the spikes adopted a compact conformation arranged in locally ordered arrays, whereas, following exposure to high [K+], the spikes became extended, and spike-membrane interactions were observed. Viruses exposed to high [K+] also displayed enhanced infectivity, thus identifying K+ as a newly defined trigger that helps promote viral infection. Finally, we confirmed that K+ channel blockers are inhibitory to HAZV infection, highlighting the potential of K+ channels as anti-bunyavirus targets.	[Punch, Emma K.; Hover, Samantha; Blest, Henry T. W.; Fuller, Jack; Fontana, Juan; Mankouri, Jamel; Barr, John N.] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Fontana, Juan; Mankouri, Jamel; Barr, John N.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Fuller, Jack; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England	University of Leeds; University of Leeds; Public Health England	Barr, JN (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.; Barr, JN (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	j.n.barr@leeds.ac.uk	Fontana, Juan/A-9138-2009	Fontana, Juan/0000-0002-9084-2927; Hover, Samantha/0000-0001-9190-5670; barr, john/0000-0002-9035-2039; Mankouri, Jamel/0000-0002-4325-3687	Wellcome Trust [108466/Z/15/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Microscopes were funded by the Wellcome Trust (108466/Z/15/Z). We also thank Dr. Emma L. Hesketh and Dr. Rebecca F. Thompson of The University of Leeds for cryo-EM data acquisition.	Adams MJ, 2017, ARCH VIROL, V162, P1441, DOI 10.1007/s00705-016-3215-y; Apellaniz B, 2014, CHEM PHYS LIPIDS, V181, P40, DOI 10.1016/j.chemphyslip.2014.03.003; Battisti AJ, 2011, J VIROL, V85, P835, DOI 10.1128/JVI.01847-10; Bergeron E, 2007, J VIROL, V81, P13271, DOI 10.1128/JVI.01647-07; Bitto D, 2016, J BIOL CHEM, V291, P6412, DOI 10.1074/jbc.M115.691113; Bowden TA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003374; de Boer SM, 2012, J VIROL, V86, P13767, DOI 10.1128/JVI.01364-12; Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110; Dube M, 2016, J VIROL, V90, P6303, DOI 10.1128/JVI.00634-16; DuBois RM, 2013, NATURE, V493, P552, DOI 10.1038/nature11741; Estrada-Pena A, 2013, J APPL MICROBIOL, V114, P278, DOI 10.1111/jam.12039; Freiberg AN, 2008, J VIROL, V82, P10341, DOI 10.1128/JVI.01191-08; Garrison AR, 2013, VIROLOGY, V444, P45, DOI 10.1016/j.virol.2013.05.030; Guardado-Calvo P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005813; Halldorsson S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02789-2; Halldorsson S, 2016, P NATL ACAD SCI USA, V113, P7154, DOI 10.1073/pnas.1603827113; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hover S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006845; Hover S, 2016, J BIOL CHEM, V291, P3411, DOI 10.1074/jbc.M115.692673; Huiskonen JT, 2010, J VIROL, V84, P4889, DOI 10.1128/JVI.00057-10; Huiskonen JT, 2009, J VIROL, V83, P3762, DOI 10.1128/JVI.02483-08; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Li S, 2016, CELL REP, V16, P278, DOI 10.1016/j.celrep.2016.06.039; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Sherman MB, 2009, VIROLOGY, V387, P11, DOI 10.1016/j.virol.2009.02.038; Shtanko O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004390; Simon M, 2009, J GEN VIROL, V90, P210, DOI 10.1099/vir.0.006387-0; Stauffer S, 2014, J VIROL, V88, P13029, DOI 10.1128/JVI.01430-14; SULEIMAN MNEH, 1980, LANCET, V2, P939; Surtees R, 2015, BMC STRUCT BIOL, V15, DOI 10.1186/s12900-015-0051-3; TALMON Y, 1987, J VIROL, V61, P2319, DOI 10.1128/JVI.61.7.2319-2321.1987; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Wang WM, 2015, J VIROL, V89, P11740, DOI 10.1128/JVI.01680-15; Willensky S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005948; Xiong QR, 2009, J STRUCT BIOL, V168, P378, DOI 10.1016/j.jsb.2009.08.016; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhu Y., 2018, J VIROL, V92	43	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9937	9944		10.1074/jbc.RA118.002494	http://dx.doi.org/10.1074/jbc.RA118.002494			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29678879	Green Published, hybrid			2022-12-26	WOS:000437096700001
J	Macek, P; Cliff, MJ; Embrey, KJ; Holdgate, GA; Nissink, JWM; Panova, S; Waltho, JP; Davies, RA				Macek, Pavel; Cliff, Matthew J.; Embrey, Kevin J.; Holdgate, Geoffrey A.; Nissink, J. Willem M.; Panova, Stanislava; Waltho, Jonathan P.; Davies, Rick A.			Myc phosphorylation in its basic helix-loop-helix region destabilizes transient -helical structures, disrupting Max and DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered protein; Myc (c-Myc); protein phosphorylation; protein dynamic; protein-protein interaction; biophysics	PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; BURKITT-LYMPHOMA CELLS; COPY-NUMBER ALTERATION; C-MYC; TRANSCRIPTION FACTORS; GENE; KINASE; SET; THERMODYNAMICS	Myelocytomatosis proto-oncogene transcription factor (Myc) is an intrinsically disordered protein with critical roles in cellular homeostasis and neoplastic transformation. It is tightly regulated in the cell, with Myc phosphorylation playing a major role. In addition to the well-described tandem phosphorylation of Thr-52 and Ser-62 in the Myc transactivation domain linked to its degradation, P21 (RAC1)-activated kinase 2 (PAK2)-mediated phosphorylation of serine and threonine residues in the C-terminal basic helix-loop-helix leucine zipper (bHLH-LZ) region regulates Myc transcriptional activity. Here we report that PAK2 preferentially phosphorylates Myc twice, at Thr-358 and Ser-373, with only a minor fraction being modified at the previously identified Thr-400 site. For transcriptional activity, Myc binds E-box DNA elements, requiring its heterodimerization with Myc-associated factor X (Max) via the bHLH-LZ regions. Using isothermal calorimetry (ITC), we found that Myc phosphorylation destabilizes this ternary protein-DNA complex by decreasing Myc's affinity for Max by 2 orders of magnitude, suggesting a major effect of phosphorylation on this complex. Phosphomimetic substitutions revealed that Ser-373 dominates the effect on Myc-Max heterodimerization. Moreover, a T400D substitution disrupted Myc's affinity for Max. ITC, NMR, and CD analyses of several Myc variants suggested that the effect of phosphorylation on the Myc-Max interaction is caused by secondary structure disruption during heterodimerization rather than by a change in the structurally disordered state of Myc or by phosphorylation-induced electrostatic repulsion in the heterodimer. Our findings provide critical insights into the effects of PAK2-catalyzed phosphorylation of Myc on its interactions with Max and DNA.	[Macek, Pavel; Davies, Rick A.] AstraZeneca, IMED Discovery Sci, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [Embrey, Kevin J.; Holdgate, Geoffrey A.] AstraZeneca, IMED Discovery Sci, Cambridge CB4 0WG, England; [Nissink, J. Willem M.] AstraZeneca, IMED Oncol, Cambridge CB4 0WG, England; [Cliff, Matthew J.; Panova, Stanislava; Waltho, Jonathan P.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Cliff, Matthew J.; Panova, Stanislava; Waltho, Jonathan P.] Univ Manchester, Sch Chem, Manchester M1 7DN, Lancs, England; [Macek, Pavel] NMR Bio SAS, CS 10090, F-38044 Grenoble, France	AstraZeneca; AstraZeneca; AstraZeneca; University of Manchester; University of Manchester	Davies, RA (corresponding author), AstraZeneca, IMED Discovery Sci, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.; Macek, P (corresponding author), NMR Bio SAS, CS 10090, F-38044 Grenoble, France.	macek@nmr-bio.com; rick.davies@astrazeneca.com	Nissink, J. Willem M./C-1507-2010	Nissink, J. Willem M./0000-0003-2572-9140; Macek, Pavel/0000-0003-3774-7717; Cliff, Matthew/0000-0002-7482-0234; Panova, Stanislava/0000-0002-9331-5962; Waltho, Jonathan/0000-0002-7402-5492	Discovery Sciences grant from the AstraZeneca Post-Doctoral Programme; Bruker BioSpin; BBSRC [BB/K016245/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [974872, BB/K016245/1] Funding Source: researchfish	Discovery Sciences grant from the AstraZeneca Post-Doctoral Programme; Bruker BioSpin; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Discovery Sciences grant from the AstraZeneca Post-Doctoral Programme (to P. M.) and a student fellowship from Bruker BioSpin (to S. P.). The work described here was initiated as a project within AstraZeneca. K. J. E., R. A. D., G. A. H., and J. W. M. N. are current employees of AstraZeneca and may hold stock in the company. P. M. is a former employee of AstraZeneca and may hold stock in the company.	Andrew CD, 2002, BIOCHEMISTRY-US, V41, P1897, DOI 10.1021/bi0113216; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P2333, DOI 10.1021/bi0522551; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Dang CV, 1999, MOL CELL BIOL, V19, P1; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Fletcher JM, 2012, ACS SYNTH BIOL, V1, P240, DOI 10.1021/sb300028q; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Gundry Rebekah L, 2009, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1025s88; Hart JR, 2014, P NATL ACAD SCI USA, V111, P12556, DOI 10.1073/pnas.1319488111; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Huang ZD, 2004, MOL CELL BIOL, V24, P1582, DOI 10.1128/MCB.24.4.1582-1594.2004; Janes RW., 2009, MODERN TECHNIQUES CI, P183; Jung KC, 2005, BIOCHEM BIOPH RES CO, V334, P269, DOI 10.1016/j.bbrc.2005.06.088; Jung LA, 2017, ONCOGENE, V36, P1911, DOI 10.1038/onc.2016.354; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; Krylov D., 2001, ELS, DOI [10.1038/npg.els.0003001, DOI 10.1038/NPG.ELS.0003001]; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; LANG JC, 1988, BRIT J CANCER, V58, P62; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Lienin SF, 1998, J AM CHEM SOC, V120, P9870, DOI 10.1021/ja9810179; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Meier-Andrejszki L, 2007, BIOCHEMISTRY-US, V46, P12427, DOI 10.1021/bi701081q; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Noguchi K, 1999, J BIOL CHEM, V274, P32580, DOI 10.1074/jbc.274.46.32580; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Savino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022284; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Shi J, 2009, BIOORG MED CHEM LETT, V19, P6038, DOI 10.1016/j.bmcl.2009.09.044; Soucek L, 2002, CANCER RES, V62, P3507; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Uribesalgo I, 2011, NAT CELL BIOL, V13, P1443, DOI 10.1038/ncb2355; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wasylishen AR, 2013, CANCER RES, V73, P6504, DOI 10.1158/0008-5472.CAN-12-4063; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhao HT, 2015, J CO2 UTIL, V11, P10, DOI 10.1016/j.jcou.2014.11.004	55	11	13	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9301	9310		10.1074/jbc.RA118.002709	http://dx.doi.org/10.1074/jbc.RA118.002709			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29695509	Green Published, hybrid			2022-12-26	WOS:000435441400016
J	Li, HC; Zhang, PF; Zhang, QY; Li, CN; Zou, WG; Chang, ZJ; Cui, CP; Zhang, LQ				Li, Hongchang; Zhang, Pengfei; Zhang, Qiuyue; Li, Chaonan; Zou, Weiguo; Chang, Zhijie; Cui, Chun-Ping; Zhang, Lingqiang			WWP2 is a physiological ubiquitin ligase for phosphatase and tensin homolog (PTEN) in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMLINE MUTATIONS; TUMOR-SUPPRESSOR; AXON REGENERATION; COWDEN DISEASE; NUCLEAR PTEN; GENE; PTEN/MMAC1; BREAST; CANCER; STABILITY	The tumor suppressor phosphatase and tensin homolog (PTEN) plays a central role in regulating phosphatidylinositol 3-kinase (PI3K) signaling, and its gene is very frequently mutated in various human cancers. Numerous studies have revealed that PTEN levels are tightly regulated by both transcriptional and posttranslational modifications, with especially ubiquitylation significantly regulating PTEN protein levels. Although several ubiquitin ligases have been reported to mediate PTEN ubiquitylation in vitro, the ubiquitin ligase that promotes PTEN degradation in vivo has not been reported. Here we took advantage of specific knockout mouse models to demonstrate that WW domain-containing E3 ubiquitin protein ligase 2 (WWP2) promotes PTEN degradation under physiological conditions, whereas another ubiquitin ligase, carboxyl terminus of Hsp70-interacting protein (CHIP), had no such effect. WWP2 knockout mice exhibited reduced body size, elevated PTEN protein levels, and reduced phosphorylation levels of the serine/threonine kinase and PTEN target AKT. In contrast, we observed no elevation of PTEN protein levels in CHIP knockout tissues and mouse embryonic fibroblasts. Furthermore, PTEN protein levels in CHIP/WWP2 double knockout mice were very similar to those in WWP2 single knockout mice and significantly higher than in WT and CHIP knockout mice. Our results demonstrate that WWP2, rather than CHIP, is an ubiquitin ligase that promotes PTEN degradation in vivo. Considering PTEN's significant role in tumor development, we propose that WWP2 may be a potential target for fine-tuning PTEN levels in anticancer therapies.	[Li, Hongchang; Zhang, Pengfei; Zhang, Qiuyue; Li, Chaonan; Cui, Chun-Ping; Zhang, Lingqiang] Beijing Inst Life, Natl Ctr Prot Sci Beijing, State Key Lab Prote, Beijing 102206, Peoples R China; [Zhang, Lingqiang] Southern Med Univ, Shanghai Fengxian Cent Hosp Grad Training Base, Dept Gen Surg, Fengxian Hosp, Shanghai 201400, Peoples R China; [Zou, Weiguo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Chang, Zhijie] Tsinghua Univ, Sch Med, Dept Basic Med Sci, State Key Lab Membrane Biol, Beijing 100084, Peoples R China	Southern Medical University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tsinghua University	Cui, CP; Zhang, LQ (corresponding author), Beijing Inst Life, 27 Taiping Rd, Beijing 100850, Peoples R China.	cui_chunping2000@aliyun.com; zhanglq@nic.bmi.ac.cn	Chang, Zhijie/AAH-8109-2019	Chang, Zhijie/0000-0003-1567-3227	National Natural Science Foundation of China [31330021]; Beijing Natural Science Foundation Project [Z151100003915083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation Project(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (Grant 31330021) and Beijing Natural Science Foundation Project (Z151100003915083). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2000, CANCER RES, V60, P3605; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sutphen R, 1999, AM J MED GENET, V82, P290, DOI 10.1002/(SICI)1096-8628(19990212)82:4<290::AID-AJMG3>3.0.CO;2-0; Tawo R, 2017, CELL, V169, P470, DOI 10.1016/j.cell.2017.04.003; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Zou WG, 2011, NAT CELL BIOL, V13, P59, DOI 10.1038/ncb2134	27	16	18	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8886	8899		10.1074/jbc.RA117.001060	http://dx.doi.org/10.1074/jbc.RA117.001060			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29685889	Green Published, hybrid			2022-12-26	WOS:000434941900013
J	Wei, JY; Zhao, JH; Zhang, XL; Wang, D; Zhang, WJ; Wang, ZP; Zhou, JL				Wei, Jinyan; Zhao, Jianhong; Zhang, Xueling; Wang, Dan; Zhang, Wenjuan; Wang, Zhiping; Zhou, Junlin			Analysis of dual energy spectral CT and pathological grading of clear cell renal cell carcinoma (ccRCC)	PLOS ONE			English	Article							IODINE QUANTIFICATION; MULTIVARIATE-ANALYSIS; CLINICAL-APPLICATIONS; TUMOR; NECROSIS; MASSES; ENHANCEMENT; PREDICTION; NEOPLASMS; FEATURES	Objective To discuss the dual energy spectral computer tomography (CT) imaging features of the pathological grading of clear cell renal cell carcinoma (ccRCC) and the correlation between spectral CT imaging features and pathology. Materials and methods We performed analyses of 62 patients with confirmed diagnosis of ccRCC. All patients underwent non-enhanced CT and dual-phase (cortex phase, CP and parenchyma phase, PP) contrast-enhanced CT with dual energy spectral mode. The subjects were pathologically divided into two groups: low-grade group (Fuhrman 1/2) and high-grade group (Fuhrman 3/4). The CT value of each lesion was measured on the monochromatic image at 70 keV. The normalized iodine concentrations (NIC) and the slope of the spectrum curve were calculated. The qualitative morphological parameters, including tumor shape, calcification, pseudocapsule, necrosis, and enhancement mode, were compared between the two groups. The quantitative data were compared using Student's t-test, and the enumeration data were analyzed using the chi-square test between low-grade and high-grade ccRCC. Receiver operating characteristic curve was used to determine the sensitivity and specificity of the quantitative parameters in two groups. Results The CT value, NIC, and mean slope of the low-grade group were increased compared with the high-grade group during CP (P = 0.001, P = 0.043, and P<0.001, respectively). The CT did not differ significantly during PP (P = 0.134); however, the NIC and mean slope varied considerably in the low grade compared with the high-grade group (P = 0.048, P = 0.017, respectively). The CT threshold value, NIC, and slope had high sensitivity and specificity in differentiating low-grade ccRCC from high-grade ccRCC. The tumor shape, pseudocapsule, and necrosis differed significantly between the two groups (P<0.05). Conclusions Dual energy spectral CT with the quantitative analysis of iodine concentration and qualitative analysis of morphological characteristics increases the accuracy of diagnosing the pathological grade of ccRCC.	[Wei, Jinyan; Zhao, Jianhong; Zhang, Xueling; Wang, Dan; Zhang, Wenjuan; Zhou, Junlin] Lanzhou Univ, Hosp 2, Dept Radiol, Lanzhou, Gansu, Peoples R China; [Wang, Zhiping] Lanzhou Univ, Hosp 2, Key Lab Gansu Prov Urol Dis, Inst Urol,Clin Ctr Gansu Prov Nephrourol, Lanzhou, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Zhou, JL (corresponding author), Lanzhou Univ, Hosp 2, Dept Radiol, Lanzhou, Gansu, Peoples R China.	zjl601@163.com	Zhao, jianhong/AAM-3835-2021		Talent Innovation and Entrepreneurship Project of Lanzhou [2016-RC-58]	Talent Innovation and Entrepreneurship Project of Lanzhou	This research was supported by Talent Innovation and Entrepreneurship Project of Lanzhou (2016-RC-58). Junlin Zhou received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asayama Y, 2008, AM J ROENTGENOL, V190, pW28, DOI 10.2214/AJR.07.2117; Ascenti G, 2013, EUR RADIOL, V23, P2288, DOI 10.1007/s00330-013-2811-4; Becker A, 2016, EJSO-EUR J SURG ONC, V42, P419, DOI 10.1016/j.ejso.2015.09.023; Chandarana H, 2011, AM J ROENTGENOL, V196, pW693, DOI 10.2214/AJR.10.5541; Chang SG, 2001, UROLOGY, V58, P904, DOI 10.1016/S0090-4295(01)01375-9; Chang YH, 2011, KAOHSIUNG J MED SCI, V27, P59, DOI 10.1016/j.kjms.2010.12.004; Chen C, 2017, CLIN IMAG, V46, P14, DOI 10.1016/j.clinimag.2017.06.010; Ficarra V, 2001, UROL INT, V67, P130, DOI 10.1159/000050968; Frank I, 2002, J UROLOGY, V168, P2395, DOI 10.1016/S0022-5347(05)64153-5; Godley Paul A., 1999, Current Opinion in Oncology, V11, P213, DOI 10.1097/00001622-199905000-00014; Graser A, 2009, EUR RADIOL, V19, P13, DOI 10.1007/s00330-008-1122-7; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Jin HW, 2006, AM J ROENTGENOL, V186, P1423, DOI 10.2214/AJR.04.1408; Jinzaki M, 2000, J COMPUT ASSIST TOMO, V24, P835, DOI 10.1097/00004728-200011000-00002; Karcaaltincaba M, 2011, DIAGN INTERV RADIOL, V17, P181, DOI 10.4261/1305-3825.DIR.3860-10.0; Karlo CA, 2014, RADIOLOGY, V270, P464, DOI 10.1148/radiol.13130663; Kutikov A, 2011, EUR UROL, V60, P241, DOI 10.1016/j.eururo.2011.03.029; Lam JS, 2005, CANCER-AM CANCER SOC, V103, P2517, DOI 10.1002/cncr.21127; Lane BR, 2005, CURR OPIN UROL, V15, P289, DOI 10.1097/01.mou.0000178336.94991.17; Lee SE, 2006, J UROLOGY, V176, P1332, DOI 10.1016/j.juro.2006.06.021; Ljungberg B, 2007, EUR UROL, V51, P1502, DOI 10.1016/j.eururo.2007.03.035; McDonald DM, 2002, CANCER RES, V62, P5381; Mileto A, 2014, EUR RADIOL, V24, P353, DOI 10.1007/s00330-013-3030-8; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; Neville AM, 2011, RADIOLOGY, V259, P173, DOI 10.1148/radiol.10101170; Prasad SR, 2006, RADIOGRAPHICS, V26, P1795, DOI 10.1148/rg.266065010; Prasad SR, 2006, RADIOGRAPHICS, V26, P1809; Reiner CS, 2013, INVEST RADIOL, V48, P183, DOI 10.1097/RLI.0b013e31827c63a3; Reuter VE, 2006, SEMIN ONCOL, V33, P534, DOI 10.1053/j.seminoncol.2006.06.009; Thompson RH, 2009, J UROLOGY, V181, P2033, DOI 10.1016/j.juro.2009.01.027; Tsui KH, 2000, J UROLOGY, V163, P1090, DOI 10.1016/S0022-5347(05)67699-9; TSUI KH, 2000, J UROLOGY, V163, P1295; Zhu YH, 2014, AM J ROENTGENOL, V203, pW295, DOI 10.2214/AJR.13.12297	33	22	27	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0195699	10.1371/journal.pone.0195699	http://dx.doi.org/10.1371/journal.pone.0195699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715308	gold, Green Submitted, Green Published			2022-12-26	WOS:000431281100006
J	Shridhar, PB; Patel, IR; Gangiredla, J; Noll, LW; Shi, XR; Bai, JF; Elkins, CA; Strockbine, N; Nagaraja, TG				Shridhar, Pragathi B.; Patel, Isha R.; Gangiredla, Jayanthi; Noll, Lance W.; Shi, Xiaorong; Bai, Jianfa; Elkins, Christopher A.; Strockbine, Nancy; Nagaraja, T. G.			DNA microarray-based assessment of virulence potential of Shiga toxin gene-carrying Escherichia coli O104:H7 isolated from feedlot cattle feces	PLOS ONE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; TELLURITE RESISTANCE; STRAINS; OUTBREAK; O104/H4; IDENTIFICATION; HUMANS; GENOTYPES; ANIMALS; TARGET	Escherichia coli O104:H4, a hybrid pathotype reported in a large 2011 foodborne outbreak in Germany, has not been detected in cattle feces. However, cattle harbor and shed in the feces other O104 serotypes, particularly O104:H7, which has been associated with sporadic cases of diarrhea in humans. The objective of our study was to assess the virulence potential of Shiga toxin-producing E. coli (STEC) O104:H7 isolated from feces of feedlot cattle using DNA microarray. Six strains of STEC O104:H7 isolated from cattle feces were analyzed using FDA-E. coli Identification (ECID) DNA microarray to determine their virulence profiles and compare them to the human strains (clinical) of O104:H7, STEC O104:H4 (German outbreak strain), and O104:H21 (milk-associated Montana outbreak strain). Scatter plots were generated from the array data to visualize the gene-level differences between bovine and human O104 strains, and Pearson correlation coefficients (r) were determined. Splits tree was generated to analyze relatedness between the strains. All O104:H7 strains, both bovine and human, similar to O104:H4 and O104:H21 outbreak strains were negative for intimin (eae). The bovine strains were positive for Shiga toxin 1 subtype c (stx1c), enterohemolysin (ehxA), tellurite resistance gene (terD), IrgA homolog protein (iha), type 1 fimbriae (fimH), and negative for genes that code for effector proteins of type III secretory system. The six cattle O104 strains were closely related (r = 0.86-0.98) to each other, except for a few differences in phage related and non-annotated genes. One of the human clinical O104:H7 strains (2011C-3665) was more closely related to the bovine O104:H7 strains (r = 0.81-0.85) than the other four human clinical O104:H7 strains (r = 0.75-0.79). Montana outbreak strain (O104:H21) was more closely related to four of the human clinical O104:H7 strains than the bovine O104:H7 strains. None of the bovine E. coli O104 strains carried genes characteristic of E. coli O104:H4 German outbreak strain and unlike other human strains were also negative for Shiga toxin 2. Because cattle E. coli O104:H7 strains possess stx1c and genes that code for enterohemolysin and a variety of adhesins, the serotype has the potential to be a diarrheagenic foodborne pathogen in humans.	[Shridhar, Pragathi B.; Noll, Lance W.; Shi, Xiaorong; Nagaraja, T. G.] US FDA, Dept Diagnost Med & Pathobiol, Ctr Food Safety & Appl Nutr, Laurel, MD 20724 USA; [Patel, Isha R.; Gangiredla, Jayanthi; Elkins, Christopher A.] US FDA, Div Mol Biol, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Bai, Jianfa] Kansas State Univ, Vet Diagnost Lab, Manhattan, KS 66506 USA; [Strockbine, Nancy] CDC, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Kansas State University; Centers for Disease Control & Prevention - USA	Nagaraja, TG (corresponding author), US FDA, Dept Diagnost Med & Pathobiol, Ctr Food Safety & Appl Nutr, Laurel, MD 20724 USA.	tnagaraj@vet.k-state.edu	Bai, Jianfa/M-7830-2019	Bai, Jianfa/0000-0002-0021-3036; Nagaraja, T. G./0000-0002-0899-878X; Elkins, Christopher/0000-0002-6029-9812	National Institute of Food and Agriculture, U. S. Department of Agriculture [2012-68003-30155]	National Institute of Food and Agriculture, U. S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work that is supported by the National Institute of Food and Agriculture, U. S. Department of Agriculture, under award number 2012-68003-30155. The funders had no role in the study design, data collection and analyses, preparation of the manuscript or decision to publish.	Auvray F, 2012, VET MICROBIOL, V158, P443, DOI 10.1016/j.vetmic.2012.02.029; Baranzoni GM, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmich.2016.00574, 10.3389/fmicb.2016.00574]; Beutin L, 2013, INT J MED MICROBIOL, V303, P595, DOI 10.1016/j.ijmm.2013.08.001; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; Chen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039294; Cheng YL, 2015, IMMUNOLOGY, V145, P258, DOI 10.1111/imm.12442; Delannoy S, 2012, J CLIN MICROBIOL, V50, P3485, DOI 10.1128/JCM.01656-12; Feng P, 2001, J CLIN MICROBIOL, V39, P24, DOI 10.1128/JCM.39.1.24-28.2001; Girardeau JP, 2005, J CLIN MICROBIOL, V43, P6098, DOI 10.1128/JCM.43.12.6098-6107.2005; Jackson SA, 2012, APPL ENVIRON MICROB, V78, P1601, DOI 10.1128/AEM.07464-11; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Ju WT, 2012, J CLIN MICROBIOL, V50, P4123, DOI 10.1128/JCM.02262-12; Lacher DW, 2016, J FOOD PROTECT, V79, P1656, DOI 10.4315/0362-028X.JFP-16-176; Lacher DW, 2014, APPL ENVIRON MICROB, V80, P4677, DOI 10.1128/AEM.01049-14; Lienemann T, 2012, EMERG INFECT DIS, V18, P577, DOI 10.3201/eid1804.111310; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Miko A, 2013, INT J MED MICROBIOL, V303, P410, DOI 10.1016/j.ijmm.2013.05.006; Orth D, 2007, RES MICROBIOL, V158, P105, DOI 10.1016/j.resmic.2006.10.007; Paddock ZD, 2013, APPL ENVIRON MICROB, V79, P3522, DOI 10.1128/AEM.00246-13; Patel IR, 2016, APPL ENVIRON MICROB, V82, P3384, DOI 10.1128/AEM.04077-15; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Ross BN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141845; Rump LV, 2012, APPL ENVIRON MICROB, V78, P1615, DOI 10.1128/AEM.07533-11; Schmidt H, 1996, J CLIN MICROBIOL, V34, P2364, DOI 10.1128/JCM.34.10.2364-2367.1996; Shridhar PB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152101; Siegler RL, 2003, PEDIATR NEPHROL, V18, P92, DOI 10.1007/s00467-002-1035-7; Tarr PI, 2000, INFECT IMMUN, V68, P1400, DOI 10.1128/IAI.68.3.1400-1407.2000; Unno T, 2009, APPL ENVIRON MICROB, V75, P5659, DOI 10.1128/AEM.00443-09; Valkova D, 2007, CENT EUR J BIOL, V2, P182, DOI 10.2478/s11535-007-0019-9; Wieler LH, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-17; WOLD AE, 1988, INFECT IMMUN, V56, P2531, DOI 10.1128/IAI.56.10.2531-2537.1988; Zhang WL, 2002, J CLIN MICROBIOL, V40, P1441, DOI 10.1128/JCM.40.4.1441-1446.2002	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196490	10.1371/journal.pone.0196490	http://dx.doi.org/10.1371/journal.pone.0196490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708991	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100031
J	Adams, CF; Alade, LA; Legault, CM; O'Brien, L; Palmer, MC; Sosebee, KA; Traver, ML				Adams, Charles F.; Alade, Larry A.; Legault, Christopher M.; O'Brien, Loretta; Palmer, Michael C.; Sosebee, Katherine A.; Traver, Michele L.			Relative importance of population size, fishing pressure and temperature on the spatial distribution of nine Northwest Atlantic groundfish stocks	PLOS ONE			English	Article							DENSITY-DEPENDENT CHANGES; COD GADUS-MORHUA; CLIMATE-CHANGE; MARINE FISHES; INDICATORS; PATTERNS; ABUNDANCE; TRENDS; SALMON; ALASKA	The spatial distribution of nine Northwest Atlantic groundfish stocks was documented using spatial indicators based on Northeast Fisheries Science Center spring and fall bottom trawl survey data, 1963-2016. We then evaluated the relative importance of population size, fishing pressure and bottom temperature on spatial distribution with an information theoretic approach. Northward movement in the spring was generally consistent with prior analyses, whereas changes in depth distribution and area occupancy were not. Only two stocks exhibited the same changes in spatiotemporal distribution in the fall as compared with the spring. Fishing pressure was the most important predictor of the center of gravity (i.e., bivariate mean location of the population) for the majority of stocks in the spring, whereas in the fall this was restricted to the east-west component. Fishing pressure was also the most important predictor of the dispersion around the center of gravity in both spring and fall. In contrast, biomass was the most important predictor of area occupancy for the majority of stocks in both seasons. The relative importance of bottom temperature was ranked highest in the fewest number of cases. This study shows that fishing pressure, in addition to the previously established role of climate, influences the spatial distribution of groundfish in the Northwest Atlantic. More broadly, this study is one of a small but growing body of literature to demonstrate that fishing pressure has an effect on the spatial distribution of marine resources. Future work must consider both fishing pressure and climate when examining mechanisms underlying fish distribution shifts.	[Adams, Charles F.; Alade, Larry A.; Legault, Christopher M.; O'Brien, Loretta; Palmer, Michael C.; Sosebee, Katherine A.; Traver, Michele L.] Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, Woods Hole, MA 02543 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Adams, CF (corresponding author), Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, Woods Hole, MA 02543 USA.	charles.adams@noaa.gov		Adams, Charles/0000-0001-9979-5381; Legault, Christopher/0000-0002-0328-1376				Adams CF, 2017, ICES J MAR SCI, V74, P170, DOI 10.1093/icesjms/fsw128; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Atkinson DB, 1997, CAN J FISH AQUAT SCI, V54, P132, DOI 10.1139/f96-158; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bell RJ, 2015, ICES J MAR SCI, V72, P1311, DOI 10.1093/icesjms/fsu217; Bez N, 1997, QUANT GEO G, V8, P1316; Bez N., 2007, J SOC FR STAT, V148, P53; Brodie WB, 1998, J SEA RES, V39, P139, DOI 10.1016/S1385-1101(97)00056-7; Brooks EN, 2015, CAN J FISH AQUAT SCI, V72, P634, DOI 10.1139/cjfas-2014-0231; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carey MP, 2017, T AM FISH SOC, V146, P791, DOI 10.1080/00028487.2017.1302992; Dichmont CM, 2016, FISH RES, V183, P447, DOI 10.1016/j.fishres.2016.07.001; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Engelhard GH, 2014, GLOBAL CHANGE BIOL, V20, P2473, DOI 10.1111/gcb.12513; Engelhard GH, 2011, ICES J MAR SCI, V68, P1090, DOI 10.1093/icesjms/fsr031; Fairweather TP, 2006, AFR J MAR SCI, V28, P661, DOI 10.2989/18142320609504215; Faraj A, 2007, ICES J MAR SCI, V64, P1820, DOI 10.1093/icesjms/fsm160; Frank KT, 2016, P NATL ACAD SCI USA, V113, P8248, DOI 10.1073/pnas.1602325113; Hendrickson Lisa, 2005, Journal of Northwest Atlantic Fishery Science, V37, P53, DOI 10.2960/J.v37.m566; Hsieh CH, 2008, CAN J FISH AQUAT SCI, V65, P947, DOI 10.1139/F08-017; Johnston R., 2014, NW ATLANTIC FISHERIE, P14; KENDALL AW, 1990, FISH B-NOAA, V88, P133; Kleisner KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149220; Legendre P., 2012, NUMERICAL ECOLOGY; Link JS, 2011, FISH FISH, V12, P461, DOI 10.1111/j.1467-2979.2010.00398.x; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; Mauger S, 2017, CAN J FISH AQUAT SCI, V74, P702, DOI 10.1139/cjfas-2016-0076; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; MURAWSKI SA, 1988, CAN J FISH AQUAT SCI, V45, P1720, DOI 10.1139/f88-204; NEFSC (Northeast Fisheries Science Center), 2006, CRUIS RES NOAA SHIP, P6; Neter J., 1996, APPL LINEAR STAT MOD; Nye JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1420; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Palmer MC, 2017, 1702 NEFSC; Palmer MC., 2014, 1414 NEFSC; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Renard D, 2017, RGEOSTATS GEOSTATIST; Rindorf A, 2006, J APPL ECOL, V43, P445, DOI 10.1111/j.1365-2664.2006.01161.x; Rivoirard J., 2008, GEOSTATISTICS ESTIMA; Sinclair AF, 1998, CAN J FISH AQUAT SCI, V55, P1248, DOI 10.1139/cjfas-55-5-1248; SWAIN DP, 1994, CAN J FISH AQUAT SCI, V51, P1046, DOI 10.1139/f94-104; ter Hofstede R, 2011, ICES J MAR SCI, V68, P1189, DOI 10.1093/icesjms/fsr053; Thorson JT, 2017, FISH FISH, V18, P1073, DOI 10.1111/faf.12225; Thorson JT, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1853; Thorson JT, 2016, METHODS ECOL EVOL, V7, P990, DOI 10.1111/2041-210X.12567; Trenkel VM, 2005, MAR ECOL PROG SER, V299, P257, DOI 10.3354/meps299257; Walsh HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137382; Woillez M, 2007, ICES J MAR SCI, V64, P537, DOI 10.1093/icesjms/fsm025; Woillez M, 2009, AQUAT LIVING RESOUR, V22, P155, DOI 10.1051/alr/2009017	53	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196583	10.1371/journal.pone.0196583	http://dx.doi.org/10.1371/journal.pone.0196583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698454	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600103
J	Mu, XP; Wang, PF; Du, JJ; Gao, YG; Zhang, JC				Mu, Xiaopeng; Wang, Pengfei; Du, Junjie; Gao, Yu Gary; Zhang, Jiancheng			Comparison of fruit organic acids and metabolism-related gene expression between Cerasus humilis (Bge.) Sok and Cerasus glandulosa (Thunb.) Lois	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYLASE; MALATE-DEHYDROGENASE; MOLECULAR-CLONING; BERRY DEVELOPMENT; ENZYME; ACCUMULATION; PURIFICATION; PLANTS	Cerasus humilis (Bge.) Sok and Cerasus glandulosa (Thunb.) Lois are economically important fruit-producing shrubs. Although these two species have similar looking fruits, their fruit organic acid contents differ drastically. In this study, we focused on comparing the organic acid content, activity of enzymes gene expression involved in organic acid metabolism in both C. humilis and C. glandulosa fruits. To investigate the differences of organic acid metabolism in fruits of these two species, a comparative transcriptome analysis was performed. Our results showed that temporal changes of two main organic acids exhibited different trends in these two species. Transcriptome sequencing of developing C. humilis and C. glandulosa fruits systematically revealed 6,594 differentially expressed genes. Compared with C. humilis, the expression levels of 3,469 and 3,125 genes were up-and down-regulated in C. glandulosa, respectively, including one PEPC gene, 12 malic acid metabolism genes, 25 citric acid cycle genes, and 194 NAD/NADP metabolism genes. The correlation analysis and principal component analysis of gene expression, enzymatic activity and organic acid content showed that differences in the expression of genes encoding the NAD-malate dehydrogenase (NAD-MDH) and NADP-malate enzyme (NADP-ME) contributed substantially to the observed differences in organic acid accumulation of two species. Our results provide a solid foundation for future elucidation of key mechanisms regulating organic acid biosynthesis in C. humilis and C. glandulosa fruits and could lead to efficient and highly targeted generation of more commercially accepted cultivars.	[Mu, Xiaopeng; Wang, Pengfei; Du, Junjie; Zhang, Jiancheng] Shanxi Agr Univ, Coll Hort, Taigu, Shanxi, Peoples R China; [Du, Junjie] Shanxi Key Lab Germplasm Improvement & Utilizat P, Taigu, Shanxi, Peoples R China; [Gao, Yu Gary] Ohio State Univ, Coll Food Agr & Environm Sci, OSU South Ctr, Piketon, OH USA	Shanxi Agricultural University; University System of Ohio; Ohio State University	Du, JJ (corresponding author), Shanxi Agr Univ, Coll Hort, Taigu, Shanxi, Peoples R China.; Du, JJ (corresponding author), Shanxi Key Lab Germplasm Improvement & Utilizat P, Taigu, Shanxi, Peoples R China.	djj738@163.com	Gao, Yu "Gary"/D-6587-2018	Gao, Yu "Gary"/0000-0002-9901-8790	Major Subject of Shanxi Science and Technology Research [20121101010]; China Postdoctoral Science Foundation [2017M621106]; Doctoral Research Fund of Shanxi Agriculture University [2015ZZ19]	Major Subject of Shanxi Science and Technology Research; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Doctoral Research Fund of Shanxi Agriculture University	This work was supported by the Major Subject of Shanxi Science and Technology Research (Grant No. 20121101010), the China Postdoctoral Science Foundation (Grant No. 2017M621106) and the Doctoral Research Fund of Shanxi Agriculture University (Grant No. 2015ZZ19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, CROP VARIETY RESOURC; Benjamini Y, 2001, ANN STAT, V29, P1165; Chen MX, 2009, J FRUIT SCI, V02, P471; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Diakou P, 2000, AUST J PLANT PHYSIOL, V27, P221; Drincovich MF, 2001, FEBS LETT, V490, P1, DOI 10.1016/S0014-5793(00)02331-0; Etienne A, 2013, J EXP BOT, V64, P1451, DOI 10.1093/jxb/ert035; Etienne C, 2002, PHYSIOL PLANTARUM, V114, P259, DOI 10.1034/j.1399-3054.2002.1140212.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo RunZi, 2013, Jiangsu Journal of Agricultural Sciences, V29, P157; HIRAI M, 1977, PLANT CELL PHYSIOL, V18, P791; Huo YueQing, 2009, Scientia Agricultura Sinica, V42, P216; LAW RD, 1995, BIOCHEM J, V307, P807, DOI 10.1042/bj3070807; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Miller SS, 1998, PLANT J, V15, P173, DOI 10.1046/j.1365-313X.1998.00192.x; Moing A, 1998, ACTA HORTIC, P425, DOI 10.17660/ActaHortic.1998.465.53; Moing A, 2000, PHYSIOL PLANTARUM, V108, P1, DOI 10.1034/j.1399-3054.2000.108001001.x; Mu XP, 2016, J HORTIC SCI BIOTECH, V91, P71, DOI 10.1080/14620316.2015.1110994; Mu XP, 2015, J HORTIC SCI BIOTECH, V90, P525, DOI 10.1080/14620316.2015.11668709; Nergiz C, 2009, SCI HORTIC-AMSTERDAM, V122, P216, DOI 10.1016/j.scienta.2009.05.011; NOTTON BA, 1993, PHYTOCHEMISTRY, V33, P1333, DOI 10.1016/0031-9422(93)85085-6; Or E, 2000, J PLANT PHYSIOL, V157, P527, DOI 10.1016/S0176-1617(00)80108-X; Palomo J, 1998, PLANT PHYSIOL, V118, P617, DOI 10.1104/pp.118.2.617; Sadka A, 2000, PLANT SCI, V158, P173, DOI 10.1016/S0168-9452(00)00328-9; Saradhuldhat P, 2007, SCI HORTIC-AMSTERDAM, V112, P297, DOI 10.1016/j.scienta.2006.12.031; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wang J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186650; Wang PF, 2018, J FORESTRY RES, V29, P55, DOI 10.1007/s11676-017-0418-3; [王鹏飞 Wang Pengfei], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P4101; Wen TaO, 2001, Acta Horticulturae Sinica, V28, P161; Yao YX, 2009, SCI HORTIC-AMSTERDAM, V122, P404, DOI 10.1016/j.scienta.2009.05.033; YEN C R, 1990, SOCIAL HORTICULTURAE, V115, P815; Yin JX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122682; Zhang YZ, 2010, FOOD CHEM, V123, P1013, DOI 10.1016/j.foodchem.2010.05.053; [赵永红 ZHAO YongHong], 2007, [中国生态农业学报, Chinese Journal of Eco-Agriculture], V15, P87	36	12	13	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196537	10.1371/journal.pone.0196537	http://dx.doi.org/10.1371/journal.pone.0196537			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698526	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600096
J	Vitral, GLN; Aguiar, RAPL; de Souza, IMF; Rego, MAS; Guimaraes, RN; Reis, ZSN				Nogueira Vitral, Gabriela Luiza; Lopes Aguiar, Regina Amelia P.; Fonseca de Souza, Ingrid Michelle; Santiago Rego, Maria Albertina; Guimaraes, Rodney Nascimento; Nogueira Reis, Zilma Silveira			Skin thickness as a potential marker of gestational age at birth despite different fetal growth profiles: A feasibility study	PLOS ONE			English	Article							VALIDATION; WEIGHT; INTERGROWTH-21ST; ULTRASOUND	Background New methodologies to estimate gestational age (GA) at birth are demanded to face the limited access to obstetric ultrasonography and imprecision of postnatal scores. The study analyzed the correlation between neonatal skin thickness and pregnancy duration. Secondarily, it investigated the influence of fetal growth profiles on tissue layer dimensions. Methods and findings In a feasibility study, 222 infants selected at a term-to-preterm ratio of 1: 1 were assessed. Reliable information on GA was based on the early ultrasonography-based reference. The thicknesses of the epidermal and dermal skin layers were examined using high-frequency ultrasonography. We scanned the skin over the forearm and foot plantar surface of the new-borns. A multivariate regression model was adjusted to determine the correlation of GA with skin layer dimensions. The best model to correlate skin thickness with GA was fitted using the epidermal layer on the forearm site, adjusted to cofactors, as follows: Gestational age (weeks) = -28.0 + 12.8 Ln (Thickness) - 4.4 Incubator staying; R-2 = 0.604 (P<0.001). In this model, the constant value for the standard of fetal growth was statistically null. The dermal layer thickness on the forearm and plantar surfaces had a negative moderate linear correlation with GA (R = -0.370, P<0.001 and R = -0.421, P<0.001, respectively). The univariate statistical analyses revealed the influence of underweight and overweight profiles on neonatal skin thickness at birth. Of the 222 infants, 53 (23.9%) had inappropriate fetal growths expected for their GA. Epidermal thickness was not fetal growth standard dependent as follows: 172.2 (19.8) mu m for adequate for GA, 171.4 (20.6) mu m for SGA, and 177.7 (15.2) mu m for LGA (P = 0.525, mean [SD] on the forearm). Conclusions The analysis highlights a new opportunity to relate GA at birth to neonatal skin layer thickness. As this parameter was not influenced by the standard of fetal growth, skin maturity can contribute to clinical applications.	[Nogueira Vitral, Gabriela Luiza; Lopes Aguiar, Regina Amelia P.; Fonseca de Souza, Ingrid Michelle; Guimaraes, Rodney Nascimento; Nogueira Reis, Zilma Silveira] Univ Fed Minas Gerais, Fac Med, Postgrad Program Womens Hlth, Belo Horizonte, MG, Brazil; [Lopes Aguiar, Regina Amelia P.; Guimaraes, Rodney Nascimento; Nogueira Reis, Zilma Silveira] Univ Fed Minas Gerais, Fac Med, Dept Gynecol & Obstet, Belo Horizonte, MG, Brazil; [Santiago Rego, Maria Albertina] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil; [Nogueira Vitral, Gabriela Luiza; Lopes Aguiar, Regina Amelia P.; Fonseca de Souza, Ingrid Michelle; Santiago Rego, Maria Albertina; Guimaraes, Rodney Nascimento; Nogueira Reis, Zilma Silveira] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Postgrad Program Womens Hlth, Belo Horizonte, MG, Brazil.; Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Gynecol & Obstet, Belo Horizonte, MG, Brazil.; Reis, ZSN (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.	zilma@medicina.ufmg.br	Reis, Zilma/H-8105-2013	Reis, Zilma/0000-0001-6374-9295	Grand Challenges Exploration from the Bill & Melinda Gates Foundation [OPP1128907]; Fundacao de Amparo a Pesquisa de Minas Gerais, Brazil [AUC-00032-15]; Pro-Reitoria de Pesquisa of Universidade Federal de Minas Gerais, Brazil (PRPq Call) [02/2017]	Grand Challenges Exploration from the Bill & Melinda Gates Foundation; Fundacao de Amparo a Pesquisa de Minas Gerais, Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa of Universidade Federal de Minas Gerais, Brazil (PRPq Call)	This research was supported by the Grand Challenges Exploration from the Bill & Melinda Gates Foundation (Grant No. OPP1128907, http://www.gatesfoundation.org/) and Fundacao de Amparo a Pesquisa de Minas Gerais, Brazil (Grant No. AUC-00032-15, http://www.fapemig.br/en/). Revision of the manuscript written in English was supported by Pro-Reitoria de Pesquisa of Universidade Federal de Minas Gerais, Brazil (PRPq Call No. 02/2017, http://www.ufmg.br/prpq). The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adeyekun A A, 2014, East Afr Med J, V91, P138; AGACHE P, 1980, BRIT J DERMATOL, V103, P643, DOI 10.1111/j.1365-2133.1980.tb01686.x; [Anonymous], 2014, Obstet Gynecol, V124, P863, DOI 10.1097/01.AOG.0000454932.15177.be; Catov JM, 2015, OBESITY, V23, P1071, DOI 10.1002/oby.21006; Cortex Technology, 2015, SER SKINLAB USB INST; Crisan D, 2012, INDIAN J DERMATOL VE, V78, DOI 10.4103/0378-6323.98096; Currie J, 2007, J LABOR ECON, V25, P231, DOI 10.1086/511377; Ersch J, 1999, OBSTET GYNECOL, V94, P753, DOI 10.1016/S0029-7844(99)00379-8; Fluhr JW, 2012, BRIT J DERMATOL, V166, P483, DOI 10.1111/j.1365-2133.2011.10659.x; Graafmans WC, 2001, BRIT J OBSTET GYNAEC, V108, P1237, DOI 10.1111/j.1471-0528.2001.00291.x; Hardman MJ, 1999, J INVEST DERMATOL, V113, P1106, DOI 10.1046/j.1523-1747.1999.00800.x; Karl S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0124286, DOI 10.1371/JOURNAL.PONE.0124286.PMID:25945927]; Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095; Lee ACC, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1423; Lee ACC, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3303; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; Meyer N, 2014, BRIT J DERMATOL, V171, P799, DOI 10.1111/bjd.13129; MOLL I, 1986, J INVEST DERMATOL, V87, P779, DOI 10.1111/1523-1747.ep12458993; Reis ZSN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184734; Oranges T, 2015, ADV WOUND CARE, V4, P587, DOI 10.1089/wound.2015.0642; Pereira Ana Paula Esteves, 2013, BMC Res Notes, V6, P60, DOI 10.1186/1756-0500-6-60; Petersen J R, 1995, Skin Res Technol, V1, P86, DOI 10.1111/j.1600-0846.1995.tb00023.x; Ploin D, 2011, VACCINE, V29, P8438, DOI 10.1016/j.vaccine.2011.07.111; POLLACK RN, 1992, CLIN OBSTET GYNECOL, V35, P99, DOI 10.1097/00003081-199203000-00015; Rippon M G, 1998, Skin Res Technol, V4, P147, DOI 10.1111/j.1600-0846.1998.tb00101.x; ROBERT MF, 1976, NEW ENGL J MED, V294, P357, DOI 10.1056/NEJM197602122940702; Sattler E, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061224; Schou AJ, 2004, SKIN RES TECHNOL, V10, P200, DOI 10.1111/j.1600-0846.2004.00070.x; Seidenari S, 2000, DERMATOLOGY, V201, P218, DOI 10.1159/000018491; SMITH LT, 1982, J INVEST DERMATOL, V79, pS93, DOI 10.1111/1523-1747.ep12545877; TAN CY, 1982, BRIT J DERMATOL, V106, P657, DOI 10.1111/j.1365-2133.1982.tb14702.x; Telofski LS, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/198789; Veena SR, 2013, PUBLIC HEALTH NUTR, V16, P1656, DOI 10.1017/S1368980012003795; Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6; Villar J, 2014, LANCET DIABETES ENDO, V2, P781, DOI 10.1016/S2213-8587(14)70121-4; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Vitral G, 2016, SOC BRASILEIRA INFOR; Vyas S, 2015, COMPUT BIOL MED, V57, P173, DOI 10.1016/j.compbiomed.2014.12.010; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; Wingate MS, 2007, ANN EPIDEMIOL, V17, P425, DOI 10.1016/j.annepidem.2007.01.035; Young MF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170192	41	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196542	10.1371/journal.pone.0196542	http://dx.doi.org/10.1371/journal.pone.0196542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698511	Green Submitted, gold, Green Published			2022-12-26	WOS:000431007600097
J	Bilinski, SM; Jaglarz, MK; Halajian, A; Tworzydlo, W				Bilinski, Szczepan M.; Jaglarz, Mariusz K.; Halajian, Ali; Tworzydlo, Waclaw			Unusual morphological adaptations and processes associated with viviparity in an epizoic dermapteran	PLOS ONE			English	Article							INSECTA; EARWIGS	Matrotrophic viviparity is a reproductive pattern in which offspring develop inside a female's body which provides gas exchange and nutrients necessary for development. Besides placental mammals, structural and physiological aspects of matrotrophic viviparity are poorly characterized. In insects, the majority of species is oviparous, i.e. lay eggs, and viviparous reproduction has been reported only in 11 out of 44 orders, including earwigs (Dermaptera). Among dermapterans, matrotrophic viviparity has been reported in two epizoic subgroups: Arixeniidae and Hemimeridae. Here, we provide morphological evidence for distinct adaptations for this mode of viviparity in embryonic and maternal tissues in a representative of the latter subgroup, Hemimerus talpoides. Our study reveals a novel mechanism of maternal contribution to embryonic development which operates during oogenesis and involves characteristic modification of endoplasmic reticulum cisternae. Conspicuous and apparently inactive para-crystalline stacks of the endoplasmic reticulum are deposited in the oocyte cytoplasm and become activated during early embryonic development. Our analyses indicate additionally that in Hemimerus, transformed follicular/ovarian cells (on the mother's side) and an evagination of the dorsal vessel (on the embryo's side) converge to form a cephalic vesicle, structure analogous to a placenta. The cellular architecture of this unusual "cephalic placenta" points to its participation in an exchange of low molecular weight substances between a mother and developing embryo.	[Bilinski, Szczepan M.; Jaglarz, Mariusz K.; Tworzydlo, Waclaw] Jagiellonian Univ, Inst Zool & Biomed Res, Dept Dev Biol & Invertebrate Morphol, Gronostajowa 9, Krakow, Poland; [Halajian, Ali] Univ Limpopo, Dept Biodivers, Sovenga, South Africa	Jagiellonian University; University of Limpopo	Bilinski, SM (corresponding author), Jagiellonian Univ, Inst Zool & Biomed Res, Dept Dev Biol & Invertebrate Morphol, Gronostajowa 9, Krakow, Poland.	szczepan.bilinski@uj.edu.pl	Tworzydlo, Waclaw/AAJ-1343-2020; Halajian, Ali/G-3056-2011	Tworzydlo, Waclaw/0000-0003-1481-1050; Halajian, Ali/0000-0003-2279-940X; Bilinski, Szczepan/0000-0001-8969-2661	Narodowe Centrum Nauki (National Science Centre, Poland) [UMO-2016/21/B/NZ8/00560]	Narodowe Centrum Nauki (National Science Centre, Poland)	This study was funded by a research grant OPUS 11 (UMO-2016/21/B/NZ8/00560) from Narodowe Centrum Nauki (National Science Centre, Poland) to SMB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilinski SM, 2017, ZOOLOGY, V125, P32, DOI 10.1016/j.zool.2017.08.001; Blackburn DG, 2015, J MORPHOL, V276, P961, DOI 10.1002/jmor.20272; Haas F, 2001, EUR J ENTOMOL, V98, P445, DOI 10.14411/eje.2001.065; Haas Fabian, 2003, Entomologische Abhandlungen (Dresden), V61, P138; Hagan HR., 1951, EMBRYOLOGY VIVIPAROU; Heymons R., 1912, Zoologische Jahrbuecher Jena Supplement, V15; Heymons R, 1983, ENTWICKLUNG OHRWURMS; Jarvis KJ, 2005, SYST ENTOMOL, V30, P442, DOI 10.1111/j.1365-3113.2004.00276.x; NAKATA S, 1974, PAC INSECTS, V16, P307; NUSSLEINVOLHARD C, 1991, DEVELOPMENT, P1; Ostrovsky AN, 2016, BIOL REV, V91, P673, DOI 10.1111/brv.12189; Tworzydlo W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064087; Vrsansky PV, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1398-4; Wheeler DE, 2003, ENCY INSECTS, P991	14	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195647	10.1371/journal.pone.0195647	http://dx.doi.org/10.1371/journal.pone.0195647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694411	Green Published, Green Submitted, gold			2022-12-26	WOS:000430802400038
J	Yawata, Y; Makino, K; Ikegaya, Y				Yawata, Yosuke; Makino, Kenichi; Ikegaya, Yuji			Answering hastily retards learning	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; RATS; IMPULSIVITY; ACCURACY; STRESS	Appropriate decisions involve at least two aspects: the speed of the decision and the correctness of the decision. Although a quick and correct decision is generally believed to work favorably, these two aspects may be interdependent in terms of overall task performance. In this study, we scrutinized learning behaviors in an operant task in which rats were required to poke their noses into either of two holes by referring to a light cue. All 22 rats reached the learning criterion, an 80% correct rate, within 4 days of testing, but they were diverse in the number of sessions spent to reach the learning criterion. Individual analyses revealed that the mean latency for responding was negatively correlated with the number of sessions until learning, suggesting that the rats that responded more rapidly to the cues learned the task more slowly. For individual trials, the mean latency for responding in correct trials (L-C) was significantly longer than that in incorrect trials (L-I), suggesting that, on average, long deliberation times led to correct answers in the trials. The success ratio before learning was not correlated with the learning speed. Thus, deliberative decision-making, rather than overall correctness, is critical for learning.	[Yawata, Yosuke; Makino, Kenichi; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Ikegaya, Yuji] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan	University of Tokyo; National Institute of Information & Communications Technology (NICT) - Japan	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan.; Ikegaya, Y (corresponding author), Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan.	yuji@ikegaya.jp		Ikegaya, Yuji/0000-0003-2260-8191	 [26250003];  [25119004]; Grants-in-Aid for Scientific Research [17J10634] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in Aid for Scientific Research on Innovative Areas (26250003; 25119004, http://www.jsps.go.jp/englishie-gractsb). The funders had no role in stsudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Burnham KE, 2010, PSYCHOPHARMACOLOGY, V208, P13, DOI 10.1007/s00213-009-1701-6; Butts KA, 2013, BEHAV BRAIN RES, V252, P222, DOI 10.1016/j.bbr.2013.06.007; Floresco SB, 2006, NEUROPSYCHOPHARMACOL, V31, P297, DOI 10.1038/sj.npp.1300825; Floresco SB, 2008, BEHAV BRAIN RES, V190, P85, DOI 10.1016/j.bbr.2008.02.008; Franken IHA, 2008, PSYCHIAT RES, V158, P155, DOI 10.1016/j.psychres.2007.06.002; Heitz RP, 2012, NEURON, V76, P616, DOI 10.1016/j.neuron.2012.08.030; Igata H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21293; Iguchi Y, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00119; Klanker M, 2015, NEUROBIOL LEARN MEM, V125, P135, DOI 10.1016/j.nlm.2015.08.011; Nikiforuk A, 2012, BEHAV BRAIN RES, V226, P118, DOI 10.1016/j.bbr.2011.09.006; Nordgren LF, 2009, J CONSUM RES, V36, P39, DOI 10.1086/596306; Olshavsky ME, 2014, J EXP ANAL BEHAV, V102, P162, DOI 10.1002/jeab.104; Redish AD, 2016, NAT REV NEUROSCI, V17, P147, DOI 10.1038/nrn.2015.30; Reinagel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068505; SCHOUTEN JF, 1967, ACTA PSYCHOL, V27, P143, DOI 10.1016/0001-6918(67)90054-6; Thai CA, 2013, COGN AFFECT BEHAV NE, V13, P164, DOI 10.3758/s13415-012-0124-8	17	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195404	10.1371/journal.pone.0195404	http://dx.doi.org/10.1371/journal.pone.0195404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	29694374	Green Submitted, gold, Green Published			2022-12-26	WOS:000430802400028
J	Kuhn, JMM; Jakobsson, M; Gunther, T				Kuhn, Jose Manuel Monroy; Jakobsson, Mattias; Gunther, Torsten			Estimating genetic kin relationships in prehistoric populations	PLOS ONE			English	Article							IDENTITY-BY-DESCENT; ANCIENT DNA; ESTIMATING RELATEDNESS; STONE-AGE; GENOME; NEANDERTHAL; CONTAMINATION; FARMERS; KINSHIP; EUROPE	Archaeogenomic research has proven to be a valuable tool to trace migrations of historic and prehistoric individuals and groups, whereas relationships within a group or burial site have not been investigated to a large extent. Knowing the genetic kinship of historic and prehistoric individuals would give important insights into social structures of ancient and historic cultures. Most archaeogenetic research concerning kinship has been restricted to uniparental markers, while studies using genome-wide information were mainly focused on comparisons between populations. Applications which infer the degree of relationship based on modern-day DNA information typically require diploid genotype data. Low concentration of endogenous DNA, fragmentation and other post-mortem damage to ancient DNA (aDNA) makes the application of such tools unfeasible for most archaeological samples. To infer family relationships for degraded samples, we developed the software READ (Relationship Estimation from Ancient DNA). We show that our heuristic approach can successfully infer up to second degree relationships with as little as 0.1x shotgun coverage per genome for pairs of individuals. We uncover previously unknown relationships among prehistoric individuals by applying READ to published aDNA data from several human remains excavated from different cultural contexts. In particular, we find a group of five closely related males from the same Corded Ware culture site in modern-day Germany, suggesting patrilocality, which highlights the possibility to uncover social structures of ancient populations by applying READ to genome-wide aDNA data. READ is publicly available from https://bitbucket.org/tguenther/read.	[Kuhn, Jose Manuel Monroy; Jakobsson, Mattias; Gunther, Torsten] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Norbyvagen 18C, SE-75236 Uppsala, Sweden; [Jakobsson, Mattias] Uppsala Univ, SciLifeLab, Norbyvagen 18C, SE-75236 Uppsala, Sweden; [Kuhn, Jose Manuel Monroy] Univ Freiburg, Inst Biol Zool 1, Hauptstr 1, D-79104 Freiburg, Germany	Uppsala University; SciLifeLab; Uppsala University; University of Freiburg	Jakobsson, M; Gunther, T (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Norbyvagen 18C, SE-75236 Uppsala, Sweden.; Jakobsson, M (corresponding author), Uppsala Univ, SciLifeLab, Norbyvagen 18C, SE-75236 Uppsala, Sweden.	rnattias.jakobsson@ebc.uu.se; torsten.guenther@ebc.uu.se	Günther, Torsten/I-3355-2019; Jakobsson, Mattias/A-6116-2011	Günther, Torsten/0000-0001-9460-390X; Jakobsson, Mattias/0000-0001-7840-7853; Monroy Kuhn, Jose Manuel/0000-0002-4748-8854	Erasmus Mundus Master Programme in Evolutionary Biology (MEME); Consejo Nacional de Ciencia y Tecnologia (CONACYT); European Research Council [311413]; Swedish Research Council; Knut och Alice Wallenbergs Stiftelse; Vetenskapsradet; Wenner-Gren-Foundations fellowship; SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [b2013203, b2015094]	Erasmus Mundus Master Programme in Evolutionary Biology (MEME); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Vetenskapsradet(Swedish Research Council); Wenner-Gren-Foundations fellowship; SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX)	JMMK received scholarships from the Erasmus Mundus Master Programme in Evolutionary Biology (MEME) and the Consejo Nacional de Ciencia y Tecnologia (CONACYT). MJ was supported by an European Research Council starting grant (no. 311413), a Swedish Research Council grant, Knut och Alice Wallenbergs Stiftelse, Knut och Alice Wallenbergs Stiftelse, and Vetenskapsradet. TG was supported by a Wenner-Gren-Foundations fellowship. Computations were performed on resources provided by SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under projects b2013203 and b2015094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Federico Sanchez-Quinto, Jan Stora, Rita Peyroteo Stjerna, four anonymous reviewers, and those who commented on the preprint for constructive feedback on the manuscript as well as Gulsah Merve Dal Kilinc and Mehmet Somel for discussions on the approach. Computations were performed on resources provided by SNIC through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under projects b2013203 and b2015094.	Albrechtsen A, 2010, GENETICS, V186, P295, DOI 10.1534/genetics.110.113977; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2021, LANG ENV STAT COMP; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Browning SR, 2012, ANNU REV GENET, V46, P617, DOI 10.1146/annurev-genet-110711-155534; Canturk KM, 2014, GENET TEST MOL BIOMA, V18, P455, DOI 10.1089/gtmb.2013.0466; Cassidy LM, 2016, P NATL ACAD SCI USA, V113, P368, DOI 10.1073/pnas.1518445113; Cui YQ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0378; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Deguilloux MF, 2014, J ARCHAEOL SCI, V41, P399, DOI 10.1016/j.jas.2013.09.006; Ensor B. E., 2013, ARCHAEOLOGY KINSHIP; Fernandes D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41529; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Goldberg A, 2017, P NATL ACAD SCI USA, V114, P2657, DOI 10.1073/pnas.1616392114; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Gunther T, 2016, CURR OPIN GENET DEV, V41, P115, DOI 10.1016/j.gde.2016.09.004; Gunther T, 2015, P NATL ACAD SCI USA, V112, P11917, DOI 10.1073/pnas.1509851112; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hofmanova A Z, 2016, P NATL ACAD SCI USA; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Hughes-Stamm SR, 2011, INT J LEGAL MED, V125, P341, DOI 10.1007/s00414-010-0455-3; Jonsson H, 2013, BIOINFORMATICS; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Kennett DJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14115; King TE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6631; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Korneliussen TS, 2015, BIOINFORMATICS, V31, P4009, DOI 10.1093/bioinformatics/btv509; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Leinthaler B, 2006, ARCHAOLOGIE UBERHOLS, P59; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004144; Li H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085437; Lipatov M, 2015, BIORXIV; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Martin MD, 2017, MOL ECOL, V26, P4145, DOI 10.1111/mec.14188; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Moltke I, 2014, BIOINFORMATICS, V30, P1027, DOI 10.1093/bioinformatics/btt652; Oliehoek PA, 2006, GENETICS, V173, P483, DOI 10.1534/genetics.105.049940; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Palin K, 2011, GENET EPIDEMIOL, V35, P853, DOI 10.1002/gepi.20635; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Ralph P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001555; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Renaud G, 2017, BIOINFORMATICS, V33, P577, DOI 10.1093/bioinformatics/btw670; Renaud G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0776-0; Roberson EDO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006711; Saag L, 2017, CURR BIOL, V27, P2185, DOI 10.1016/j.cub.2017.06.022; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Seguin-Orlando A., 2017, SCIENCE; Sjogren KG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155083; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Slatkin M, 2016, P NATL ACAD SCI USA, V113, P6380, DOI 10.1073/pnas.1524306113; Theunert C, 2017, GENETICS, V206, P1025, DOI 10.1534/genetics.117.200600; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Van Rossum G., 2007, USENIX ANN TECHN C M, V41; Vieira FG, 2016, BIOINFORMATICS, V32, P2096, DOI 10.1093/bioinformatics/btw212; Vohr SH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2241-6; Waples RK, 2018, BIORXIV; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yang MA, 2017, CURR BIOL, V27, P3202, DOI 10.1016/j.cub.2017.09.030; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	77	86	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195491	10.1371/journal.pone.0195491	http://dx.doi.org/10.1371/journal.pone.0195491			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684051	Green Published, gold, Green Submitted			2022-12-26	WOS:000430660600015
J	Ladds, MJGW; Pastor-Fernandez, A; Popova, G; van Leeuwen, IMM; Eng, KE; Drummond, CJ; Johansson, L; Svensson, R; Westwood, NJ; McCarthy, AR; Tholander, F; Popa, M; Lane, DP; McCormack, E; McInerney, GM; Bhatia, R; Lain, S				Ladds, Marcus J. G. W.; Pastor-Fernandez, Andres; Popova, Gergana; van Leeuwen, Ingeborg M. M.; Eng, Kai Er; Drummond, Catherine J.; Johansson, Lars; Svensson, Richard; Westwood, Nicholas J.; McCarthy, Anna R.; Tholander, Fredrik; Popa, Mihaela; Lane, David P.; McCormack, Emmet; McInerney, Gerald M.; Bhatia, Ravi; Lain, Sonia			Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib	PLOS ONE			English	Article							LEUKEMIA STEM-CELLS; P53; INHIBITION; DRUG; CHLOROQUINE; CANCER; RESISTANCE; MECHANISM; MELANOMA; LC3	Tenovin-6 is the most studied member of a family of small molecules with antitumour activity in vivo. Previously, it has been determined that part of the effects of tenovin-6 associate with its ability to inhibit SirT1 and activate p53. However, tenovin-6 has also been shown to modulate autophagic flux. Here we show that blockage of autophagic flux occurs in a variety of cell lines in response to certain tenovins, that autophagy blockage occurs regardless of the effect of tenovins on SirT1 or p53, and that this blockage is dependent on the aliphatic tertiary amine side chain of these molecules. Additionally, we evaluate the contribution of this tertiary amine to the elimination of proliferating melanoma cells in culture. We also demonstrate that the presence of the tertiary amine is sufficient to lead to death of tumour cells arrested in G1 phase following vemurafenib treatment. We conclude that blockage of autophagic flux by tenovins is necessary to eliminate melanoma cells that survive B-Raf inhibition and achieve total tumour cell kill and that autophagy blockage can be achieved at a lower concentration than by chloroquine. This observation is of great relevance as relapse and resistance are frequently observed in cancer patients treated with B-Raf inhibitors.	[Ladds, Marcus J. G. W.; Pastor-Fernandez, Andres; Popova, Gergana; van Leeuwen, Ingeborg M. M.; Eng, Kai Er; Drummond, Catherine J.; McCarthy, Anna R.; Lane, David P.; McInerney, Gerald M.; Lain, Sonia] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Johansson, Lars] Karolinska Inst, Dept Med Biochem & Biophys, Chem Biol Consortium Sweden, Div Translat Med & Chem Biol,Sci Life Lab, Stockholm, Sweden; [Svensson, Richard] Uppsala Univ, Uppsala Univ Drug Optimizat & Pharmaceut Profilin, Dept Pharm, Uppsala, Sweden; [Westwood, Nicholas J.] Univ St Andrews, Sch Chem & Biomed Sci, Res Complex, St Andrews, Fife, Scotland; [Westwood, Nicholas J.] EaStCHEM, Res Complex, St Andrews, Fife, Scotland; [Tholander, Fredrik] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Popa, Mihaela; McCormack, Emmet] Univ Bergen, Dept Clin Sci, Bergen, Norway; [McCormack, Emmet] Haukeland Hosp, Dept Internal Med, Hematol Sect, Bergen, Norway; [Bhatia, Ravi] Univ Alabama Birmingham, Dept Hematol & Oncol, Birmingham, AL USA	Karolinska Institutet; Karolinska Institutet; Uppsala University; University of St Andrews; University of St Andrews; Karolinska Institutet; University of Bergen; University of Bergen; Haukeland University Hospital; University of Alabama System; University of Alabama Birmingham	Ladds, MJGW; Lain, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	marcus.lacicis@ki.se; sonia.lain@ki.se	Popova, Gergana/Q-4440-2019; Cormack, Emmet Mc/D-2922-2012; Lain, Sonia/B-6980-2014; McInerney, Gerald/G-5344-2012; Pastor Fernandez, Andres/C-2153-2018	Popova, Gergana/0000-0001-9804-4041; Cormack, Emmet Mc/0000-0002-7621-4625; Lain, Sonia/0000-0001-9693-5246; McInerney, Gerald/0000-0003-2257-7241; Westwood, Nicholas/0000-0003-0630-0138; Pastor Fernandez, Andres/0000-0002-8060-073X; Lane, David/0000-0003-0551-3545; Ladds, Marcus/0000-0002-9894-0169; Pastor Fernandez, Andres/0000-0002-5265-9013; Drummond, Catherine/0000-0002-7019-3173	Vetenskapsradet (VR) [521-2014-3341, 538-2013-8807, 621-2014-4718]; Cancerfonden (Swedish Cancer Society) [150393]; CAN [2014/702, 2015/751]; Association for International Cancer Research (AICR) [130086]; Barncancerfonden (Swedish Childhood Cancer Foundation) [TJ-2014-0038, PR-2014-0038]; Leukemia and Lymphoma Society (LLS) [6137-14]; NIH [R01 CA95684]; Karolinska Institute; Karolinska Institutet; Cancer Research UK [C21383, A6950]; Kreftforeningen [182735, 732200]; Halse Vest [911884, 911789]; NATIONAL CANCER INSTITUTE [R01CA095684] Funding Source: NIH RePORTER	Vetenskapsradet (VR)(Swedish Research Council); Cancerfonden (Swedish Cancer Society)(Swedish Cancer Society); CAN; Association for International Cancer Research (AICR); Barncancerfonden (Swedish Childhood Cancer Foundation); Leukemia and Lymphoma Society (LLS)(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karolinska Institute(Karolinska Institutet); Karolinska Institutet(Karolinska Institutet); Cancer Research UK(Cancer Research UK); Kreftforeningen; Halse Vest; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by five grants to Sonia Lain: Vetenskapsradet (VR) 521-2014-3341, Cancerfonden (Swedish Cancer Society) 150393, CAN 2014/702, Association for International Cancer Research (AICR) 130086, Barncancerfonden (Swedish Childhood Cancer Foundation) TJ-2014-0038, Barncancerfonden (Swedish Childhood Cancer Foundation) PR-2014-0038; two grants to Ravi Bhatia: Leukemia and Lymphoma Society (LLS) 6137-14 and NIH R01 CA95684; one grant to David P Lane: Vetenskapsradet (VR) 538-2013-8807; one grant to Marcus J G W Ladds: Karolinska Institute KID Doctoral Student Funding; one grant to Gergana Popova: Karolinska Institutet KID Doctoral Student Funding; two grants to Nicholas J Westwood: Cancer Research UK C21383 and Cancer Research UK A6950; two grants to Gerald McInerney: Vetenskapsradet (VR) 621-2014-4718 and Cancerfonden (Swedish Cancer Society) 150393, CAN 2015/751; and four grants to Emmet McCormack: Kreftforeningen 182735, Kreftforeningen 732200, Halse Vest 911884, Halse Vest 911789.	Avery-Kiejda KA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-203; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blaydes JP, 1997, ONCOGENE, V14, P1859, DOI 10.1038/sj.onc.1201018; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; Fisher Rosalie, 2012, Cancer Manag Res, V4, P243, DOI 10.2147/CMAR.S25284; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; Groves MJ, 2013, BRIT J CANCER, V109, P2434, DOI 10.1038/bjc.2013.601; Helgason GV, 2011, BLOOD, V118, P2035, DOI 10.1182/blood-2011-01-330621; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnson DB, 2013, CANCER IMMUNOL RES, V1, P373, DOI 10.1158/2326-6066.CIR-13-0092; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaufmann AM, 2007, J PHARM SCI-US, V96, P729, DOI 10.1002/jps.20792; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Li L, 2014, CELL STEM CELL, V15, P431, DOI 10.1016/j.stem.2014.08.001; Li L, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2685.2685; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Lloyd JB, 2000, ADV DRUG DELIVER REV, V41, P189, DOI 10.1016/S0169-409X(99)00065-4; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Ma L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.385; MacCallum SF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01275; Marceau F, 2009, DRUG METAB DISPOS, V37, P2271, DOI 10.1124/dmd.109.028480; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; McCarthy AR, 2013, MOL CANCER THER, V12, P352, DOI 10.1158/1535-7163.MCT-12-0900; McCarthy AR, 2012, BIOORGAN MED CHEM, V20, P1779, DOI 10.1016/j.bmc.2012.01.001; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morissette G, 2008, TOXICOL APPL PHARM, V228, P364, DOI 10.1016/j.taap.2007.12.031; Ndolo RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049366; Ribas A, 2013, NEW ENGL J MED, V368, P1365, DOI 10.1056/NEJMc1302338; Sharma A, 2012, DRUGS, V72, P2207, DOI 10.2165/11640870-000000000-00000; Shvets E, 2008, AUTOPHAGY, V4, P1054, DOI 10.4161/auto.6823; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Swampillai AL, 2012, CLIN ONCOL-UK, V24, P387, DOI 10.1016/j.clon.2011.09.010; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; TITUS EO, 1989, THER DRUG MONIT, V11, P369, DOI 10.1097/00007691-198911040-00001; van Leeuwen IMM, 2012, CELL CYCLE, V11, P1851, DOI 10.4161/cc.20254; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang Z, 2013, ONCOGENE, V32, P589, DOI 10.1038/onc.2012.83; WIESMANN UN, 1975, BIOCHEM BIOPH RES CO, V66, P1338, DOI 10.1016/0006-291X(75)90506-9; Wong KK, 2009, RECENT PAT ANTI-CANC, V4, P28, DOI 10.2174/157489209787002461; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Yuan HF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.25	54	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195956	10.1371/journal.pone.0195956	http://dx.doi.org/10.1371/journal.pone.0195956			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684045	gold, Green Published			2022-12-26	WOS:000430660600026
J	McCormick, AA; Shakeel, A; Yi, C; Kaur, H; Mansour, AM; Bakshi, CS				McCormick, Alison A.; Shakeel, Aisha; Yi, Chris; Kaur, Hardeep; Mansour, Ahd M.; Bakshi, Chandra Shekhar			Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge	PLOS ONE			English	Article							ANTIBODY-RESPONSE; IMMUNE-RESPONSES; TULAREMIA; LIVE; IMMUNIZATION; IDENTIFICATION; FORMULATIONS; EXPRESSION; SIGNATURES; DEFICIENT	Tularemia is a fatal human disease caused by Francisella tularensis, a Gram-negative encapsulated coccobacillus bacterium. Due to its low infectious dose, ease of aerosolized transmission, and lethal effects, the CDC lists F. tularensis as a Category A pathogen, the highest level for a potential biothreat agent. Previous vaccine studies have been conducted with live attenuated, inactivated, and subunit vaccines, which have achieved partial or full protection from F. tularensis live vaccine strain (LVS) challenge, but no vaccine has been approved for human use. We demonstrate the improved efficacy of a multi-antigen subunit vaccine by using Tobacco Mosaic virus (TMV) as an antigen carrier for the F. tularensis SchuS4 proteins DnaK, OmpA, SucB and Tul4 (DOST). The magnitude and quality of immune responses were compared after mice were immunized by subcutaneous or intranasal routes of administration with a TMV-DOST mixture, with or without four different adjuvants. Immune responses varied in magnitude and isotype profile, by antigen, by route of administration, and by protection in an F. tularensis LVS challenge model of disease. Interestingly, our analysis demonstrates an overwhelming IgG2 response to SucB after intranasal dosing, as well as a robust cellular response, which may account for the improved two dose survival imparted by the tetravalent vaccine, compared to a previous study that tested efficacy of TMV-DOT. Our study provides evidence that potent humoral, cellular and mucosal immunity can be achieved by optimal antigen combination, delivery, adjuvant and appropriate route of administration, to improve vaccine potency and provide protection from pathogen challenge.	[McCormick, Alison A.; Shakeel, Aisha; Yi, Chris; Kaur, Hardeep] Touro Univ Calif, Coll Pharm, Vallejo, CA 94592 USA; [Mansour, Ahd M.; Bakshi, Chandra Shekhar] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	Touro University California; New York Medical College	McCormick, AA (corresponding author), Touro Univ Calif, Coll Pharm, Vallejo, CA 94592 USA.	Alison.mccormick@tu.edu			Touro University Seed Grant; National Institute of Allergy and Infectious Disease (NIH) [R21 A1122108-01A1]	Touro University Seed Grant; National Institute of Allergy and Infectious Disease (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Touro University Seed Grant, 2015; SB and AM; https://www.touro.edu/ and by National Institute of Allergy and Infectious Disease (NIH) R21 A1122108-01A1; CSB, PI and AM, Key Investigator; https://www.naid.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman Gaylene Bouska, 2002, AAOHN J, V50, P373; Altman GB, 2002, AAOHN J, V50, P8; Arnaboldi PM, 2016, VACCINE, V34, P5768, DOI 10.1016/j.vaccine.2016.09.063; Ashtekar AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050460; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Banik S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130858; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Barry EM, 2009, HUM VACCINES, V5, P832, DOI 10.4161/hv.10297; Baxevanis CN, 2013, IMMUNOTHERAPY-UK, V5, P497, DOI [10.2217/IMT.13.24, 10.2217/imt.13.24]; Bitsaktsis C, 2009, J IMMUNOL, V182, P4899, DOI 10.4049/jimmunol.0803242; Blaauboer SM, 2015, ELIFE, V4, DOI 10.7554/eLife.06670; Chen L, 2016, P NATL ACAD SCI USA, V113, pE3609, DOI 10.1073/pnas.1518311113; Cutts FT, 1997, BIOLOGICALS, V25, P323, DOI 10.1006/biol.1997.0103; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985; Foshay L, 1942, AM J PUBLIC HEALTH N, V32, P1131, DOI 10.2105/AJPH.32.10.1131; Furuya Y, 2013, INFECT IMMUN, V81, P3434, DOI 10.1128/IAI.00408-13; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Havlasova J, 2005, PROTEOMICS, V5, P2090, DOI 10.1002/pmic.200401123; Hickey AJ, 2011, VACCINE, V29, P6941, DOI 10.1016/j.vaccine.2011.07.075; Holland SD, 2016, J PEDIATR-US, V178, P299, DOI 10.1016/j.jpeds.2016.07.023; Hong KJ, 2013, CLIN EXP VACCINE RES, V2, P34, DOI 10.7774/cevr.2013.2.1.34; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Huang XP, 2010, EXPERT OPIN THER TAR, V14, P787, DOI 10.1517/14728222.2010.501333; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; Janovska S, 2007, IMMUNOL LETT, V108, P151, DOI 10.1016/j.imlet.2006.12.004; Jia QM, 2016, VACCINE, V34, P4969, DOI 10.1016/j.vaccine.2016.08.041; Kaur R, 2012, CLIN VACCINE IMMUNOL, V19, P359, DOI 10.1128/CVI.05384-11; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Knudsen NPH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19570; Krieg AM, 2012, NUCLEIC ACID THER, V22, P77, DOI 10.1089/nat.2012.0340; LEBEDINSKY VA, 1979, ZH MIKROB EPID IMMUN, P11; Liu HM, 1998, BLOOD, V92, P3730, DOI 10.1182/blood.V92.10.3730.422k20_3730_3736; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Mallajosyula JK, 2014, HUM VACC IMMUNOTHER, V10, P586, DOI 10.4161/hv.27567; Mara-Koosham G, 2011, INFECT IMMUN, V79, P1770, DOI 10.1128/IAI.00605-10; McCormick AA, 1999, P NATL ACAD SCI USA, V96, P703, DOI 10.1073/pnas.96.2.703; McCormick AA, 2006, VACCINE, V24, P6414, DOI 10.1016/j.vaccine.2006.06.003; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Pires A, 2009, J PHARM PHARM SCI, V12, P288, DOI 10.18433/J3NC79; Post DMB, 2017, MBIO, V8, DOI [10.1128/mBio.01592-17, 10.1128/mbio.01592-17]; Putzova D, 2016, FOLIA MICROBIOL, V61, P495, DOI 10.1007/s12223-016-0461-z; Ramirez K, 2012, CLIN IMMUNOL, V144, P98, DOI 10.1016/j.clim.2012.05.006; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Reed DS, 2014, INFECT IMMUN, V82, P2098, DOI 10.1128/IAI.01498-14; Richard K, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00574-16; Riese P, 2014, EXPERT OPIN DRUG DEL, V11, P1619, DOI 10.1517/17425247.2014.931936; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Singh H, 2015, METHODS MOL BIOL, V1348, P327, DOI 10.1007/978-1-4939-2999-3_28; Stinson E, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw079; Sunagar Raju, 2016, Vaccine (Auckl), V6, P9; Sunagar R, 2016, VACCINE, V34, P3396, DOI 10.1016/j.vaccine.2016.04.054; Twine SM, 2006, BIOCHEM BIOPH RES CO, V346, P999, DOI 10.1016/j.bbrc.2006.06.008; Veazey RS, 2015, HUM VACC IMMUNOTHER, V11, P2913, DOI 10.1080/21645515.2015.1070998; Verma SK, 2012, WORLD J MICROB BIOT, V28, P2487, DOI 10.1007/s11274-012-1056-8; Walch M, 2015, CELL, V161, P1229, DOI 10.1016/j.cell.2015.05.021	58	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0194614	10.1371/journal.pone.0194614	http://dx.doi.org/10.1371/journal.pone.0194614			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684046	gold, Green Published, Green Submitted			2022-12-26	WOS:000430660600006
J	Hella, J; Cercamondi, CI; Mhimbira, F; Sasamalo, M; Stoffel, N; Zwahlen, M; Bodmer, T; Gagneux, S; Reither, K; Zimmermann, MB; Risch, L; Fenner, L				Hella, Jerry; Cercamondi, Colin I.; Mhimbira, Francis; Sasamalo, Mohamed; Stoffel, Nicole; Zwahlen, Marcel; Bodmer, Thomas; Gagneux, Sebastien; Reither, Klaus; Zimmermann, Michael B.; Risch, Lorenz; Fenner, Lukas			Anemia in tuberculosis cases and household controls from Tanzania: Contribution of disease, coinfections, and the role of hepcidin	PLOS ONE			English	Article							IRON-DEFICIENCY; INFLAMMATION; METABOLISM; BURDEN	Background Tuberculosis (TB) induces a systemic inflammatory state affecting iron homeostasis. Patients with TB often have additional comorbidities such as anemia which can result in poorer treat outcomes. We studied the contribution of anemia and the role of the iron regulatory hormone hepcidin among TB patients and household contacts. Methods We analyzed serum samples from 102 TB cases and 98 controls without TB, matched by age/sex, for hepcidin, iron, and inflammation parameters. Five controls developed TB within 12 months. We used linear regression to assess associations. Results Anemia of chronic disease (ACD) was more frequent among cases than controls (59.8% vs. 26.1%), but iron-deficiency anemia more frequent in controls (10% vs. 1%). The median hepcidin level was higher in cases than controls (63.7 vs. 14.2 ng/mL), but coinfections with HIV, helminths, and respiratory pathogens did not show cumulative effects. Hepcidin was associated with more severe TB symptom scoring (coefficient 0.8, 95% confidence interval [CI] 0.5-1.2) and higher mycobacterial load (0.7, 95% CI 0.4-1.0). Hepcidin was higher in TB cases and controls who developed TB compared to controls without TB (p<0.001), even when restricting to HIV-negative study participants. Conclusions ACD was the predominate etiology in TB patients suggesting limited benefit from iron supplementation. Increased hepcidin levels long before active disease, indicating altered iron metabolism, may be a marker for developing disease among TB-exposed individuals. Clinical management of anemia and nutrition interventions in TB patients need to be considered to improve the clinical course and outcomes.	[Hella, Jerry; Mhimbira, Francis; Sasamalo, Mohamed] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Hella, Jerry; Mhimbira, Francis; Sasamalo, Mohamed; Gagneux, Sebastien; Reither, Klaus] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Hella, Jerry; Mhimbira, Francis; Sasamalo, Mohamed; Gagneux, Sebastien; Reither, Klaus] Univ Basel, Basel, Switzerland; [Cercamondi, Colin I.; Stoffel, Nicole; Zimmermann, Michael B.] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Lab Human Nutr, Zurich, Switzerland; [Zwahlen, Marcel; Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Bodmer, Thomas; Risch, Lorenz] Labormed Zentrum Dr Risch, Liebefeld, Switzerland; [Fenner, Lukas] Gesundheitsamt, Kanton Solothurn, Switzerland	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern	Hella, J (corresponding author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.; Hella, J (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Hella, J (corresponding author), Univ Basel, Basel, Switzerland.; Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.; Fenner, L (corresponding author), Gesundheitsamt, Kanton Solothurn, Switzerland.	jhella@ihi.or.tz; lukas.fenner@ispm.unibe.ch	Zimmermann, Michael B/C-3062-2016; Stoffel, Nicole/AAG-2879-2021; Zwahlen, Marcel/AFF-8559-2022; Risch, Lorenz/D-4629-2011; Gagneux, Sebastien/ABE-7909-2020; Hella, Jerry/I-6738-2017	Stoffel, Nicole/0000-0001-5953-0610; Zwahlen, Marcel/0000-0002-6772-6346; Risch, Lorenz/0000-0003-2692-6699; Hella, Jerry/0000-0003-2392-8592; Gagneux, Sebastien/0000-0001-7783-9048; Reither, Klaus/0000-0001-6195-8237; Fenner, Lukas/0000-0003-3309-4835	Rudolf Geigy Foundation (Basel, Switzerland)	Rudolf Geigy Foundation (Basel, Switzerland)	This work was supported by the Rudolf Geigy Foundation (Basel, Switzerland). The funder provided support in the form of salaries for authors (JH, FM, MS and LF) and reagents (TB and LR). The funders did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrew KD, 2014, J ACQ IMMUN DEF SYND, V66, P33, DOI [10.1097/QAI.0000000000000091, DOI 10.1097/QAI.0000000000000091]; Armitage AE, 2014, P NATL ACAD SCI USA, V111, P12187, DOI 10.1073/pnas.1402351111; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; De Voss JJ, 1999, J BACTERIOL, V181, P4443, DOI 10.1128/JB.181.15.4443-4451.1999; Devi U, 2003, BRIT J NUTR, V90, P541, DOI 10.1079/BJN2003936; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112; Hiza H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2642-z; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Isanaka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037350; Isanaka S, 2012, J NUTR, V142, P350, DOI 10.3945/jn.111.144287; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kerkhoff AD, 2016, INT J TUBERC LUNG D, V20, P193, DOI 10.5588/ijtld.15.0558; Kerkhoff AD, 2016, J INFECT DIS, V213, P61, DOI 10.1093/infdis/jiv364; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; Knopp S, 2014, AM J TROP MED HYG, V90, P535, DOI 10.4269/ajtmh.13-0268; Koulaouzidis A, 2009, J GASTROINTEST LIVER, V18, P345; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Lumb R, 2013, SA PATHOLOGY; McDermid JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-48; Mhimbira F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005342; Mhimbira F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161171; Michels K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004998; Minchella PA, 2014, INT J TUBERC LUNG D, V18, P1337, DOI 10.5588/ijtld.14.0143; Minchella PA, 2015, TUBERCULOSIS, V95, P288, DOI 10.1016/j.tube.2015.02.042; Minchella PA, 2015, CLIN INFECT DIS, V60, P764, DOI 10.1093/cid/ciu945; Ministry of Health and Social Welfare, 2014, NAT TB LEPR 2013 ANN; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Rathod DA, 2007, AM J CLIN PATHOL, V128, P585, DOI 10.1309/R1YL4B4BT2WCQDGV; Rohner F, 2017, AM J CLIN NUTR, V106, p372S, DOI 10.3945/ajcn.116.142232; Said K, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0276-4; Shin Dong-Min, 2011, Immune Netw, V11, P245, DOI 10.4110/in.2011.11.5.245; Sow FB, 2011, TUBERCULOSIS, V91, P314, DOI 10.1016/j.tube.2011.03.003; Steiner A, 2016, J AM MED INFORM ASSN, V23, P916, DOI 10.1093/jamia/ocv185; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Wang CY, 2016, CURR OPIN HEMATOL, V23, P189, DOI 10.1097/MOH.0000000000000236; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; World Health Organization, 2001, IR DEF AN ASS PREV C; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P115	40	33	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195985	10.1371/journal.pone.0195985	http://dx.doi.org/10.1371/journal.pone.0195985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677205	Green Published, Green Accepted, gold			2022-12-26	WOS:000430638900020
J	Ng, BC; Kleinheyer, M; Smith, PA; Timms, D; Cohn, WE; Lim, E				Ng, Boon C.; Kleinheyer, Matthias; Smith, Peter A.; Timms, Daniel; Cohn, William E.; Lim, Einly			Pulsatile operation of a continuous-flow right ventricular assist device (RVAD) to improve vascular pulsatility	PLOS ONE			English	Article							PULMONARY-ARTERY PRESSURE; PULSE PRESSURE; HEART-FAILURE; NITRIC-OXIDE; BLOOD PUMP; HYPERTENSION; RESISTANCE; CIRCULATION; MODULATION; MECHANISMS	Despite the widespread acceptance of rotary blood pump (RBP) in clinical use over the past decades, the diminished flow pulsatility generated by a fixed speed RBP has been regarded as a potential factor that may lead to adverse events such as vasculature stiffening and hemorrhagic strokes. In this study, we investigate the feasibility of generating physiological pulse pressure in the pulmonary circulation by modulating the speed of a right ventricular assist device (RVAD) in a mock circulation loop. A rectangular pulse profile with predetermined pulse width has been implemented as the pump speed pattern with two different phase shifts (0% and 50%) with respect to the ventricular contraction. In addition, the performance of the speed modulation strategy has been assessed under different cardiovascular states, including variation in ventricular contractility and pulmonary arterial compliance. Our results indicated that the proposed pulse profile with optimised parameters (A(pulse) = 10000 rpm and omega(min) = 3000 rpm) was able to generate pulmonary arterial pulse pressure within the physiological range (9-15 mmHg) while avoiding undesirable pump backflow under both co- and counter-pulsation modes. As compared to co-pulsation, stroke work was reduced by over 44% under counter-pulsation, suggesting that mechanical workload of the right ventricle can be efficiently mitigated through counter-pulsing the pump speed. Furthermore, our results showed that improved ventricular contractility could potentially lead to higher risk of ventricular suction and pump backflow, while stiffening of the pulmonary artery resulted in increased pulse pressure. In conclusion, the proposed speed modulation strategy produces pulsatile hemodynamics, which is more physiologic than continuous blood flow. The findings also provide valuable insight into the interaction between RVAD speed modulation and the pulmonary circulation under various cardiovascular states.	[Ng, Boon C.; Lim, Einly] Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Ng, Boon C.; Smith, Peter A.; Cohn, William E.] Texas Heart Inst, Houston, TX 77025 USA; [Kleinheyer, Matthias; Timms, Daniel] BiVACOR Inc, Houston, TX USA	Universiti Malaya; Texas Heart Institute	Lim, E (corresponding author), Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia.	einly_lim@um.edu.my	LIM, EINLY/B-8861-2010; Smith, Alex/H-6986-2019	LIM, EINLY/0000-0003-2037-4213; 	Ministry of Higher Education of Malaysia [UM.C/HIR/MOHUENG/50]; Fundamental Research Grant Scheme [FP008-2016]; BiVACOR	Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); Fundamental Research Grant Scheme; BiVACOR	This research is mainly supported financially by Ministry of Higher Education of Malaysia (UM.C/HIR/MOHUENG/50-Dr Einly Lim) and Fundamental Research Grant Scheme (FP008-2016-Dr Einly Lim). BiVACOR Inc has provided support in the form of salaries for two co-authors (Daniel Timms and Matthias Kleinheyer), who are affiliated to the firm. Daniel Timms is currently the Chief Executive Officer and Chief Technical Officer of BiVACOR, while Matthias Kleinheyer is employed as a part time researcher in this firm. In term of research materials, the in-house built mock circulation loop study is fully funded by BiVACOR for this research. Apart from that, the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akimoto T, 2000, ASAIO J, V46, P596, DOI 10.1097/00002480-200009000-00018; Alfie J, 1999, HYPERTENSION, V34, P808, DOI 10.1161/01.HYP.34.4.808; Ando M, 2011, ARTIF ORGANS, V35, P941, DOI 10.1111/j.1525-1594.2011.01205.x; Bearnson GB, 1996, ASAIO J, V42, pM620, DOI 10.1097/00002480-199609000-00062; Burkhoff D, 2006, J CARD FAIL, V12, P227, DOI 10.1016/j.cardfail.2005.10.012; Castelain V, 2001, J AM COLL CARDIOL, V37, P1085, DOI 10.1016/S0735-1097(00)01212-2; Chemla D, 2004, CHEST, V126, P1313, DOI 10.1378/chest.126.4.1313; CHEN JM, 1995, J HEART LUNG TRANSPL, V14, P186; Cheng A, 2014, ANN CARDIOTHORAC SUR, V3, P573, DOI 10.3978/j.issn.2225-319X.2014.08.24; Cooper CJ, 1996, CIRCULATION, V93, P266, DOI 10.1161/01.CIR.93.2.266; Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1; Di Molfetta A, 2018, ARTIF ORGANS, V42, P386, DOI 10.1111/aor.13050; Eda K, 1999, Ann Thorac Cardiovasc Surg, V5, P365; FERGUSON JJ, 1986, CATHETER CARDIO DIAG, V12, P376, DOI 10.1002/ccd.1810120604; FURUSE A, 1972, J THORAC CARDIOV SUR, V63, P495, DOI 10.1016/S0022-5223(19)41919-3; Ghio S, 2017, PLOS ONE, P1; Goldstein DJ, 1998, NEW ENGL J MED, V339, P1522, DOI 10.1056/NEJM199811193392107; Grant BJB, 1988, J APPL PHYSIOL, V1988, P4, DOI [10.1177/0218492309338121, DOI 10.1177/0218492309338121]; Gregory SD, 2011, ANN C IEEE ENG MED B; Henaine R, 2013, J THORAC CARDIOV SUR, V146, P522, DOI 10.1016/j.jtcvs.2012.11.031; Ising M., 2011, CARDIOVASC ENG TECHN, V2, P90, DOI [10.1007/s13239-011-0042-x, DOI 10.1007/S13239-011-0042-X]; Jackson CE, 2015, EUR HEART J, V36, P1106, DOI 10.1093/eurheartj/ehu490; Jahren SE, 2014, ARTIF ORGANS, V38, P316, DOI 10.1111/aor.12139; Karimova A, 2014, J THORAC CARDIOV SUR, V147, P1691, DOI 10.1016/j.jtcvs.2013.11.012; Khalil HA, 2010, J HEART LUNG TRANSPL, V29, P568, DOI 10.1016/j.healun.2009.12.004; Khambadkone S, 2003, CIRCULATION, V107, P3204, DOI 10.1161/01.CIR.0000074210.49434.40; Klingensmith ME, 2011, WASHINGTON MANUAL SU; Kucuker SA, 2004, J HEART LUNG TRANSPL, V23, P28, DOI 10.1016/S1053-2498(03)00057-3; Lankhaar JW, 2008, EUR HEART J, V29, P1688, DOI 10.1093/eurheartj/ehn103; Li M, 2009, ANN BIOMED ENG, V37, P1082, DOI 10.1007/s10439-009-9684-3; Millar JA, 2000, HYPERTENSION, V36, P907, DOI 10.1161/01.HYP.36.5.907; MILNOR WR, 1969, CIRC RES, V25, P637, DOI 10.1161/01.RES.25.6.637; Mitchell GF, 2001, HYPERTENSION, V38, P1433, DOI 10.1161/hy1201.098298; Noor MR, 2016, ARTIF ORGANS, V40, P549, DOI 10.1111/aor.12593; Pirbodaghi T, 2013, EUR J CARDIO-THORAC, V43, P383, DOI 10.1093/ejcts/ezs299; Pirbodaghi T, 2012, J THORAC CARDIOV SUR, V144, P970, DOI 10.1016/j.jtcvs.2012.02.015; Qian KX, 1996, MED ENG PHYS, V18, P57, DOI 10.1016/1350-4533(95)00010-0; Rai JU, 1992, J APPL PHYSIOL, V72, P73, DOI [10.1152/jappl.1992.72.1.73, DOI 10.1152/JAPPL.1992.72.1.73]; Ramnarine KV, 1998, ULTRASOUND MED BIOL, V24, P451, DOI 10.1016/S0301-5629(97)00277-9; SAFAR ME, 1987, ARTERIOSCLEROSIS, V7, P232, DOI 10.1161/01.ATV.7.3.232; Saito S, 2012, J HEART LUNG TRANSPL, V31, P858, DOI 10.1016/j.healun.2012.03.002; Shi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092668; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Stergiopulos N, 1998, HYPERTENSION, V32, P556, DOI 10.1161/01.HYP.32.3.556; Sugiki Hiroshi, 2009, Asian Cardiovasc Thorac Ann, V17, P395, DOI 10.1177/0218492309338121; Syyed R, 2008, CHEST, V133, P633, DOI 10.1378/chest.07-1367; Taguchi S, 1988, ASAIO Trans, V34, P213; Thenappan T, 2016, ANN AM THORAC SOC, V13, P276, DOI 10.1513/AnnalsATS.201509-599FR; Timms DL, 2011, ARTIF ORGANS, V35, P384, DOI 10.1111/j.1525-1594.2010.01088.x; Vollkron M, 2002, ARTIF ORGANS, V26, P349, DOI 10.1046/j.1525-1594.2002.06870.x; Wang Zhijie, 2011, Pulm Circ, V1, P212, DOI 10.4103/2045-8932.83453; Yildiran T, 2010, TEX HEART I J, V37, P284	52	4	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195975	10.1371/journal.pone.0195975	http://dx.doi.org/10.1371/journal.pone.0195975			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677212	Green Published, Green Submitted, gold			2022-12-26	WOS:000430638900019
J	Fragiadaki, M; Zeidler, MP				Fragiadaki, Maria; Zeidler, Martin P.			Ankyrin repeat and single KH domain 1 (ANKHD1) drives renal cancer cell proliferation via binding to and altering a subset of miRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; cancer biology; microRNA (miRNA); microRNA mechanism; cell proliferation; ANKHD1; ccRCC; clear cell; miR-29a; miRNA-binding	MICRORNA EXPRESSION PROFILE; PROMOTES; HIPPO; MASK; IDENTIFICATION; MIGRATION; REVEALS; PATHWAY; BIOGENESIS; ACTIVATION	Clear cell renal cell carcinoma (ccRCC) represents the most common kidney cancer worldwide. Increased cell proliferation associated with abnormal microRNA (miRNA) regulation are hallmarks of carcinogenesis. Ankyrin repeat and single KH domain 1 (ANKHD1) is a highly conserved protein found to interact with core cancer pathways in Drosophila; however, its involvement in RCC is completely unexplored. Quantitative PCR studies coupled with large-scale genomics data sets demonstrated that ANKHD1 is significantly up-regulated in kidneys of RCC patients when compared with healthy controls. Cell cycle analysis revealed that ANKHD1 is an essential factor for RCC cell division. To understand the molecular mechanism(s) utilized by ANKHD1 to drive proliferation, we performed bioinformatics analyses that revealed that ANKHD1 contains a putative miRNA-binding motif. We screened 48 miRNAs with tumor-enhancing or -suppressing activities and found that ANKHD1 binds to and regulates three tumor-suppressing miRNAs (i.e. miR-29a, miR-205, and miR-196a). RNA-immunoprecipitation assays demonstrated that ANKHD1 physically interacts with its target miRNAs via a single K-homology domain, located in the C terminus of the protein. Functionally, we discovered that ANKHD1 positively drives ccRCC cell mitosis via binding to and suppressing mainly miR-29a and to a lesser degree via miR-196a/205, leading to up-regulation in proliferative genes such as CCDN1. Collectively, these data identify ANKHD1 as a new regulator of ccRCC proliferation via specific miRNA interactions.	[Fragiadaki, Maria] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Acad Nephrol Unit, Hallamshire Tower, Sheffield S10 2RX, S Yorkshire, England; [Fragiadaki, Maria; Zeidler, Martin P.] Univ Sheffield, Bateson Ctr, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Fragiadaki, M (corresponding author), Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Acad Nephrol Unit, Hallamshire Tower, Sheffield S10 2RX, S Yorkshire, England.	m.fragiadaki@sheffield.ac.uk		Zeidler, Martin/0000-0003-2942-1135; Fragiadaki, Maria/0000-0002-1587-5577	Kidney Research UK Fellowship; Thomas-Berry and Simpson Fellowship; Cancer Research UK Senior Fellowship	Kidney Research UK Fellowship(Kidney Research UK (KRUK)); Thomas-Berry and Simpson Fellowship; Cancer Research UK Senior Fellowship	This work was supported by a Kidney Research UK Fellowship and a Thomas-Berry and Simpson Fellowship (to M.F.) and a Cancer Research UK Senior Fellowship (to M.P.Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Avraham R, 2012, BIOCHEM SOC T, V40, P26, DOI 10.1042/BST20110623; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen JJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-169; Chen L, 2014, BMB REP, V47, P39, DOI 10.5483/BMBRep.2014.47.1.079; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Chen Z, 2014, ONCOL RES TREAT, V37, P658, DOI 10.1159/000368792; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dhyani A, 2015, EUR J CANCER, V51, P252, DOI 10.1016/j.ejca.2014.11.012; Fragiadaki M, 2017, KIDNEY INT, V91, P575, DOI 10.1016/j.kint.2016.10.039; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Mayoral MF, 2007, STRUCTURE, V15, P485, DOI 10.1016/j.str.2007.03.006; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; He HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125672; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Hollingworth D, 2012, NUCLEIC ACIDS RES, V40, P6873, DOI 10.1093/nar/gks368; Karlsson P, 2015, P NATL ACAD SCI USA, V112, P14096, DOI 10.1073/pnas.1512865112; Li YF, 2016, MOL MED REP, V14, P560, DOI 10.3892/mmr.2016.5251; Lin S, 2016, J BIOL CHEM, V291, P15342, DOI 10.1074/jbc.M116.726067; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Ma WB, 2012, J BIOL CHEM, V287, P10189, DOI 10.1074/jbc.M111.303636; Machado-Neto JA, 2014, EXP CELL RES, V324, P137, DOI 10.1016/j.yexcr.2014.04.004; Mamoori A, 2016, BIOL CELL, V108, P51, DOI 10.1111/boc.201500062; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nishikawa R, 2015, FEBS LETT, V589, P2136, DOI 10.1016/j.febslet.2015.06.005; Piazzon N, 2012, J MOL CELL BIOL, V4, P398, DOI 10.1093/jmcb/mjs027; Sansores-Garcia L, 2013, CURR BIOL, V23, P229, DOI 10.1016/j.cub.2012.12.033; Sidor CM, 2013, CURR BIOL, V23, P223, DOI 10.1016/j.cub.2012.11.061; Smith RK, 2002, DEVELOPMENT, V129, P71; Tang W, 2014, BRIT J CANCER, V110, P450, DOI 10.1038/bjc.2013.724; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Traina F, 2006, BBA-MOL BASIS DIS, V1762, P828, DOI 10.1016/j.bbadis.2006.07.010; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; White NMA, 2011, BRIT J CANCER, V105, P1741, DOI 10.1038/bjc.2011.401; Xu L, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-17; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhao ZJ, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0513-x; Zhu MW, 2015, HUM MOL GENET, V24, P3272, DOI 10.1093/hmg/ddv081	45	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9570	9579		10.1074/jbc.RA117.000975	http://dx.doi.org/10.1074/jbc.RA117.000975			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29695508	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000436102300002
J	Yamanaka, Y; Winardhi, RS; Yamauchi, E; Nishiyama, S; Sowa, Y; Yan, J; Kawagishi, I; Ishihama, A; Yamamoto, K				Yamanaka, Yuki; Winardhi, Ricksen S.; Yamauchi, Erika; Nishiyama, So-ichiro; Sowa, Yoshiyuki; Yan, Jie; Kawagishi, Ikuro; Ishihama, Akira; Yamamoto, Kaneyoshi			Dimerization site 2 of the bacterial DNA-binding protein H-NS is required for gene silencing and stiffened nucleoprotein filament formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); gene silencing; dimerization; transcription factor; gene regulation; bacterial chromatin; DNA compaction; H-NS; nucleoid-associated protein; transcription repression	NUCLEOID-STRUCTURING PROTEIN; ESCHERICHIA-COLI; FOREIGN DNA; TRANSCRIPTION FACTORS; IN-VITRO; DOMAIN; EXPRESSION; OLIGOMERIZATION; ORGANIZATION; RECOGNITION	The bacterial nucleoid-associated protein H-NS is a DNA-binding protein, playing a major role in gene regulation. To regulate transcription, H-NS silences genes, including horizontally acquired foreign genes. Escherichia coli H-NS is 137 residues long and consists of two discrete and independent structural domains: an N-terminal oligomerization domain and a C-terminal DNA-binding domain, joined by a flexible linker. The N-terminal oligomerization domain is composed of two dimerization sites, dimerization sites 1 and 2, which are both required for H-NS oligomerization, but the exact role of dimerization site 2 in gene silencing is unclear. To this end, we constructed a whole set of single amino acid substitution variants spanning residues 2 to 137. Using a well-characterized H-NS target, the slp promoter of the glutamic acid-dependent acid resistance (GAD) cluster promoters, we screened for any variants defective in gene silencing. Focusing on the function of dimerization site 2, we analyzed four variants, I70C/I70A and L75C/L75A, which all could actively bind DNA but are defective in gene silencing. Atomic force microscopy analysis of DNA-H-NS complexes revealed that all of these four variants formed condensed complexes on DNA, whereas WT H-NS formed rigid and extended nucleoprotein filaments, a conformation required for gene silencing. Single-molecule stretching experiments confirmed that the four variants had lost the ability to form stiffened filaments. We conclude that dimerization site 2 of H-NS plays a key role in the formation of rigid H-NS nucleoprotein filament structures required for gene silencing.	[Yamanaka, Yuki; Yamauchi, Erika; Nishiyama, So-ichiro; Sowa, Yoshiyuki; Kawagishi, Ikuro; Ishihama, Akira; Yamamoto, Kaneyoshi] Hosei Univ, Dept Frontier Biosci, 3-7-2 Kajino Cho, Tokyo 1848584, Japan; [Yamanaka, Yuki; Nishiyama, So-ichiro; Sowa, Yoshiyuki; Kawagishi, Ikuro; Ishihama, Akira; Yamamoto, Kaneyoshi] Hosei Univ, Res Ctr Micronano Technol, 3-11-15 Midori Cho, Tokyo 1840003, Japan; [Yamanaka, Yuki; Winardhi, Ricksen S.; Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, 5A Engn Dr 1, Singapore 117411, Singapore; [Winardhi, Ricksen S.; Yan, Jie] Natl Univ Singapore, Dept Phys, 2 Sci Dr 3, Singapore 117542, Singapore; [Nishiyama, So-ichiro] Niigata Univ Pharm & Appl Life Sci, Fac Appl Life Sci, Akiha Ku, 265-1 Higashijima, Niigata, Niigata 9568603, Japan	Hosei University; Hosei University; National University of Singapore; National University of Singapore; Niigata University	Yamamoto, K (corresponding author), Hosei Univ, Dept Frontier Biosci, 3-7-2 Kajino Cho, Tokyo 1848584, Japan.; Yamamoto, K (corresponding author), Hosei Univ, Res Ctr Micronano Technol, Tokyo 1848584, Japan.	kanyamam@hosei.ac.jp	Yamanaka, Yuki/AAV-3504-2020; Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291; Yamanaka, Yuki/0000-0003-3479-9896; Sowa, Yoshiyuki/0000-0002-1691-2018	RCE in Mechanobiology; Alcohol and Education Research Council; MEXT Supported Program for the Strategic Research Foundation at Private Universities; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2013-T2-1-154]; National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore; Cooperative Research Program of the Network Joint Research Center for Materials and Devices; National Institutes of Health	RCE in Mechanobiology; Alcohol and Education Research Council; MEXT Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore); National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore(National Research Foundation, Singapore); Cooperative Research Program of the Network Joint Research Center for Materials and Devices; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an RCE in Mechanobiology, the National Institutes of Health, and the Alcohol and Education Research Council. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the MEXT Supported Program for the Strategic Research Foundation at Private Universities, 2013-2017, to Hosei University.; Supported by the Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2013-T2-1-154) and the National Research Foundation of Singapore through the Mechanobiology Institute at National University of Singapore.; Supported by the Cooperative Research Program of the Network Joint Research Center for Materials and Devices.	Ali SS, 2013, J BIOL CHEM, V288, P13356, DOI 10.1074/jbc.M113.455378; Ali SS, 2012, CURR OPIN MICROBIOL, V15, P175, DOI 10.1016/j.mib.2011.12.014; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; BRACCO L, 1989, EMBO J, V8, P4289, DOI 10.1002/j.1460-2075.1989.tb08615.x; Burton NA, 2010, J MOL BIOL, V401, P726, DOI 10.1016/j.jmb.2010.06.054; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Caramel A, 2000, MOL MICROBIOL, V36, P85, DOI 10.1046/j.1365-2958.2000.01827.x; Cordeiro TN, 2015, J BIOL CHEM, V290, P21200, DOI 10.1074/jbc.M114.630400; Desai SK, 2016, ELIFE, V5, DOI 10.7554/eLife.10747; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Donato GM, 1999, J BACTERIOL, V181, P941, DOI 10.1128/JB.181.3.941-948.1999; Dorman CJ, 2009, FRONT BIOSCI-LANDMRK, V14, P4103, DOI 10.2741/3515; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Gao YF, 2017, P NATL ACAD SCI USA, V114, P12560, DOI 10.1073/pnas.1716721114; Giangrossi M, 2014, BBA-PROTEINS PROTEOM, V1844, P339, DOI 10.1016/j.bbapap.2013.11.010; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Ishihama A, 2016, NUCLEIC ACIDS RES, V44, P2058, DOI 10.1093/nar/gkw051; Ishihama A, 2014, J BACTERIOL, V196, P2718, DOI 10.1128/JB.01579-14; Jauregui R, 2003, NUCLEIC ACIDS RES, V31, P6770, DOI 10.1093/nar/gkg882; Krin E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-273; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Liu YJ, 2010, GENE DEV, V24, P339, DOI 10.1101/gad.1883510; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Qu Y, 2013, NUCLEIC ACIDS RES, V41, P5263, DOI 10.1093/nar/gkt249; Renault M, 2013, FEBS J, V280, P2916, DOI 10.1111/febs.12297; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; SHINDO H, 1995, FEBS LETT, V360, P125, DOI 10.1016/0014-5793(95)00079-O; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Ueda T, 2013, DNA RES, V20, P263, DOI 10.1093/dnares/dst008; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; van der Valk RA, 2017, ELIFE, V6, DOI 10.7554/eLife.27369; Walthers D, 2011, J BIOL CHEM, V286, P1895, DOI 10.1074/jbc.M110.164962; Williams RM, 1996, J BACTERIOL, V178, P4335, DOI 10.1128/jb.178.15.4335-4343.1996; Winardhi RS, 2015, BIOPHYS J, V109, P1321, DOI 10.1016/j.bpj.2015.08.016; Winardhi RS, 2014, J BIOL CHEM, V289, P13739, DOI 10.1074/jbc.M113.545954; Winardhi RS, 2012, NUCLEIC ACIDS RES, V40, P8942, DOI 10.1093/nar/gks669; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yamanaka Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111962	48	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9496	9505		10.1074/jbc.RA117.001425	http://dx.doi.org/10.1074/jbc.RA117.001425			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29695505	hybrid, Green Published			2022-12-26	WOS:000435441400032
J	Kudlacek, ST; Premkumar, L; Metz, SW; Tripathy, A; Bobkov, AA; Payne, AM; Graham, S; Brackbill, JA; Miley, MJ; de Silva, AM; Kuhlman, B				Kudlacek, Stephan T.; Premkumar, Lakshmanane; Metz, Stefan W.; Tripathy, Ashutosh; Bobkov, Andrey A.; Payne, Alexander Matthew; Graham, Stephen; Brackbill, James A.; Miley, Michael J.; de Silva, Aravinda M.; Kuhlman, Brian			Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ANTIBODY; NEUTRALIZING ANTIBODIES; CONFORMATIONAL-CHANGES; PROTECTIVE EFFICACY; CRYSTAL-STRUCTURE; HIGHLY POTENT; EPITOPES; DOMAIN; IMMUNOGENICITY; STABILITY	The spread of dengue (DENV) and Zika virus (ZIKV) is a major public health concern. The primary target of antibodies that neutralize DENV and ZIKV is the envelope (E) glycoprotein, and there is interest in using soluble recombinant E (sRecE) proteins as subunit vaccines. However, the most potent neutralizing antibodies against DENV and ZIKV recognize epitopes on the virion surface that span two or more E proteins. Therefore, to create effective DENV and ZIKV vaccines, presentation of these quaternary epitopes may be necessary. The sRecE proteins fromDENVand ZIKV crystallize as native-like dimers, but studies in solution suggest that these dimers are marginally stable. To better understand the challenges associated with creating stable sRecE dimers, we characterized the thermostability of sRecE proteins from ZIKV and three DENV serotypes, DENV2-4. All four proteins irreversibly unfolded at moderate temperatures (46-53 degrees C). At 23 degrees C and low micromolar concentrations, DENV2 and ZIKV were primarily dimeric, and DENV3-4 were primarily monomeric, whereas at 37 degrees C, all four proteins were predominantly monomeric. We further show that the dissociation constant for DENV2 dimerization is very temperature-sensitive, ranging from < 1 mu M at 25 degrees C to 50 mu M at 41 degrees C, due to a large exothermic enthalpy of binding of similar to 79 kcal/mol. We also found that quaternary epitope antibody binding to DENV2-4 and ZIKV sRecE is reduced at 37 degrees C. Our observation of reduced sRecE dimerization at physiological temperature highlights the need for stabilizing the dimer as part of its development as a subunit vaccine.	[Kudlacek, Stephan T.; Tripathy, Ashutosh; Payne, Alexander Matthew; Kuhlman, Brian] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Premkumar, Lakshmanane; Metz, Stefan W.; Graham, Stephen; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Bobkov, Andrey A.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Brackbill, James A.; Miley, Michael J.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Kuhlman, Brian] Univ N Carolina, Lineburger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Sanford Burnham Prebys Medical Discovery Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Kuhlman, B (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	bkuhlman@email.unc.edu	desilva, Aravinda/ABE-6260-2020; , PEP-MX Core/AGV-4051-2022; Metz, Stefan/J-1974-2019	desilva, Aravinda/0000-0003-3317-5950; Metz, Stefan/0000-0002-9249-2844; Kudlacek, Stephan/0000-0002-0029-9984; Payne, Alex/0000-0003-0947-0191	NIGMS, National Institutes of Health (NIH) [R01GM073960]; NIAID, NIH [U19 AI09784]; Centers for Disease Control and Prevention [00HVELJB-2017-04191]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570, R01GM073960] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health (NIH), Grant R01GM073960; NIAID, NIH Grant U19 AI09784; and Centers for Disease Control and Prevention Grant 00HVELJB-2017-04191. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5; Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439; COHEN J, 2017, SCIENCE, V80; Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021; Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058; DELENDA C, 1994, ARCH VIROL, V139, P197, DOI 10.1007/BF01309465; Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651; Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341; Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15; Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178; Govindarajan D, 2015, VACCINE, V33, P4105, DOI 10.1016/j.vaccine.2015.06.067; Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722; Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/mmbr.00055-16, 10.1128/MMBR.00055-16]; Hsieh SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100641; KOSLYUCHENKO VA, 2016, NATURE, V533, P425; Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhlman B, 1998, BIOCHEMISTRY-US, V37, P1025, DOI 10.1021/bi972352x; Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025; Li J, 2018, STRUCTURE, V26, P51, DOI 10.1016/j.str.2017.11.017; Lim XX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14339; Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74; Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004; Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11; Manoff SB, 2015, VACCINE, V33, P7126, DOI 10.1016/j.vaccine.2015.09.101; MCDIS Y, 2004, NATURE, V427, P313; Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6; Metz SW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005071; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464; Nivarthi UK, 2017, J VIROL, V91, DOI 10.1128/JVI.02041-16; Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302; Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Scheiblhofer S, 2017, EXPERT REV VACCINES, V16, P479, DOI 10.1080/14760584.2017.1306441; Sergeev YV, 2004, BIOCHEMISTRY-US, V43, P415, DOI 10.1021/bi034617f; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Wengler G, 1999, VIROLOGY, V257, P472, DOI 10.1006/viro.1999.9661; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, 2016, J WKLY EPIDEMIOL REC, V91, P349; Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2015, CURR OPIN VIROL, V12, P109, DOI 10.1016/j.coviro.2015.04.006; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	55	14	14	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8922	8933		10.1074/jbc.RA118.002658	http://dx.doi.org/10.1074/jbc.RA118.002658			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29678884	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000434941900016
J	Toledo, A; Grieger, E; Karram, K; Morrison, H; Baader, SL				Toledo, Andrea; Grieger, Elena; Karram, Khalad; Morrison, Helen; Baader, Stephan L.			Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation	PLOS ONE			English	Article							ALTERNATIVELY SPLICED TRANSCRIPTS; CENTRAL-NERVOUS-SYSTEM; GENE-PRODUCT; SCHWANN-CELLS; ERM PROTEINS; PLASMA-MEMBRANE; PRECURSOR CELLS; MERLIN PHOSPHORYLATION; CNS MYELINATION; RAT-BRAIN	The neurofibromatosis type 2 (NF2) tumor suppressor protein Merlin functions as a negative regulator of cell growth and actin dynamics in different cell types amongst which Schwann cells have been extensively studied. In contrast, the presence and the role of Merlin in oligo-dendrocytes, the myelin forming cells within the CNS, have not been elucidated. In this work, we demonstrate that Merlin immunoreactivity was broadly distributed in the white matter throughout the central nervous system. Following Merlin expression during development in the cerebellum, Merlin could be detected in the cerebellar white matter tract at early postnatal stages as shown by its co-localization with Olig2-positive cells as well as in adult brain sections where it was aligned with myelin basic protein containing fibers. This suggests that Merlin is expressed in immature and mature oligodendrocytes. Expression levels of Merlin were low in oligodendrocytes as compared to astrocytes and neurons throughout development. Expression of Merlin in oligodendroglia was further supported by its identification in either immortalized cell lines of oligodendroglial origin or in primary oligodendrocyte cultures. In these cultures, the two main splice variants of Nf2 could be detected. Merlin was localized in clusters within the nuclei and in the cytoplasm. Overexpressing Merlin in oligodendrocyte cell lines strengthened reduced impedance in XCELLigence measurements and Ki67 stainings in cultures over time. In addition, the initiation and elongation of cellular projections were reduced by Merlin overexpression. Consistently, cell migration was retarded in scratch assays done on Nf2-transfected oligodendrocyte cell lines. These data suggest that Merlin actively modulates process outgrowth and migration in oligodendrocytes.	[Toledo, Andrea; Grieger, Elena; Baader, Stephan L.] Inst Anat Anat & Cell Biol, Bonn, Germany; [Toledo, Andrea] UdelaR, Secc Biol Celular, Lab Cultivo Tejidos, Fac Ciencias, Montevideo, Uruguay; [Karram, Khalad] Johannes Gutenberg Univ Mainz, Inst Mol Med, Mainz, Germany; [Morrison, Helen] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany	University of Bonn; Universidad de la Republica, Uruguay; Johannes Gutenberg University of Mainz; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Baader, SL (corresponding author), Inst Anat Anat & Cell Biol, Bonn, Germany.	sbaader@uni-bonn.de	Morrison, Helen/F-9748-2014	Morrison, Helen/0000-0003-4938-1409; Toledo, Andrea/0000-0002-8310-8636; Baader, Stephan/0000-0001-8669-723X	Alexander von Humboldt foundation; BONFOR [0-0167.0017]	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); BONFOR	This work was supported by the Alexander von Humboldt foundation (https://www.humboldt-foundation.de/web/start.html, HERMES to AT), and by BONFOR (http://www.ukb.uni-bonn.de/quick2web/internet/internet.nsf/vwUNIDLookup/B72A5EAAF5CFF627C1257658002584DA, 0-0167.0017 to SLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANSAL R, 1987, J NEUROCHEM, V49, P1902, DOI 10.1111/j.1471-4159.1987.tb02453.x; BIANCHI AB, 1994, NAT GENET, V6, P185, DOI 10.1038/ng0294-185; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Chatterjee N, 2008, J BIOL CHEM, V283, P8310, DOI 10.1074/jbc.M706074200; Chen HB, 2011, INT J BIOCHEM CELL B, V43, P545, DOI 10.1016/j.biocel.2010.12.011; CLAUDIO JO, 1995, NEUROREPORT, V6, P1942, DOI 10.1097/00001756-199510020-00028; Cole BK, 2008, MOL CELL BIOL, V28, P1274, DOI 10.1128/MCB.01139-07; Cooper J, 2014, FEBS LETT, V588, P2743, DOI 10.1016/j.febslet.2014.04.001; Curto M, 2008, BRIT J CANCER, V98, P256, DOI 10.1038/sj.bjc.6604002; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; den Bakker MA, 1999, J HISTOCHEM CYTOCHEM, V47, P1471; Dowling CM, 2014, BIOSCIENCE REP, V34, P415, DOI 10.1042/BSR20140031; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Forrest AD, 2009, J NEUROSCI RES, V87, P3456, DOI 10.1002/jnr.22022; Gautreau A, 2002, J BIOL CHEM, V277, P31279, DOI 10.1074/jbc.C200125200; Gronholm M, 2005, MOL CELL NEUROSCI, V28, P683, DOI 10.1016/j.mcn.2004.11.014; Guerrero PA, 2015, ONCOGENE, V34, P2621, DOI 10.1038/onc.2014.185; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; Gusella JF, 1999, BBA-REV CANCER, V1423, pM29, DOI 10.1016/S0304-419X(99)00005-0; GUTMANN DH, 1995, HUM MOL GENET, V4, P471, DOI 10.1093/hmg/4.3.471; Hai M, 2002, J NEUROSCI RES, V69, P497, DOI 10.1002/jnr.10327; Hanemann CO, 2007, BRAIN PATHOL, V17, P371, DOI 10.1111/j.1750-3639.2007.00086.x; HARA T, 1994, CANCER RES, V54, P330; Harada T, 1996, J NEUROSURG, V84, P847, DOI 10.3171/jns.1996.84.5.0847; Hashimoto R, 2016, MECH DEVELOP, V140, P25, DOI 10.1016/j.mod.2016.02.004; Houshmandi SS, 2009, MOL CELL BIOL, V29, P1472, DOI 10.1128/MCB.01392-08; Huang WH, 2014, GLIA, V62, P896, DOI 10.1002/glia.22648; Huynh DP, 1996, ONCOGENE, V13, P73; Huynh DP, 1996, CELL GROWTH DIFFER, V7, P1551; Jannatipour M, 2001, J BIOL CHEM, V276, P33093, DOI 10.1074/jbc.M105792200; Josephson MP, 2017, GENETICS, V205, P737, DOI 10.1534/genetics.116.191957; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Luo ZL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9457; Lutchman M, 1996, TRENDS NEUROSCI, V19, P373, DOI 10.1016/S0166-2236(96)10044-8; Manent J, 2003, J NEUROSCI METH, V123, P167, DOI 10.1016/S0165-0270(02)00349-7; Manetti ME, 2012, BIOL OPEN, V1, P949, DOI 10.1242/bio.20122121; MANUELIDIS L, 1977, ACTA NEUROPATHOL, V38, P129, DOI 10.1007/BF00688559; McClatchey AI, 1997, GENE DEV, V11, P1253, DOI 10.1101/gad.11.10.1253; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Mei Y, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0189-7; Meng JJ, 2000, J NEUROSCI RES, V62, P491, DOI 10.1002/1097-4547(20001115)62:4<491::AID-JNR3>3.0.CO;2-D; MERRILL JE, 1988, J BIOL REG HOMEOS AG, V2, P77; MIRSKY R, 1980, J CELL BIOL, V84, P483, DOI 10.1083/jcb.84.3.483; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Morris ZS, 2009, P NATL ACAD SCI USA, V106, P9767, DOI 10.1073/pnas.0902031106; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Murray LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043295; O'Meara RW, 2013, J NEUROSCI, V33, P9781, DOI 10.1523/JNEUROSCI.5582-12.2013; Perez-Garcia EI, 2015, BIOCHEM BIOPH RES CO, V468, P594, DOI 10.1016/j.bbrc.2015.10.156; Petrilli AM, 2016, ONCOGENE, V35, P537, DOI 10.1038/onc.2015.125; PYKETT MJ, 1994, HUM MOL GENET, V3, P559, DOI 10.1093/hmg/3.4.559; R Core Team, 2018, R LANG ENV STAT COMP; Ramesh V, 2004, NAT REV NEUROSCI, V5, P462, DOI 10.1038/nrn1407; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; SAINZ J, 1994, HUM MOL GENET, V3, P885, DOI 10.1093/hmg/3.6.885; Schmucker B, 1999, HUM MOL GENET, V8, P1561, DOI 10.1093/hmg/8.8.1561; Schulz A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159718; Schulz A, 2014, BRAIN, V137, P420, DOI 10.1093/brain/awt327; Schulz A, 2013, NAT NEUROSCI, V16, P426, DOI 10.1038/nn.3348; Schulz A, 2010, J NEUROSCI, V30, P10177, DOI 10.1523/JNEUROSCI.0840-10.2010; Seo PS, 2009, EXP BIOL MED, V234, P255, DOI 10.3181/0809-RM-275; Serrano I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3976; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shimizu T, 2017, GLIA, V65, P360, DOI 10.1002/glia.23096; Steiner J, 2011, EUR ARCH PSY CLIN N, V261, P477, DOI 10.1007/s00406-011-0197-3; StemmerRachamimov AO, 1997, J NEUROPATH EXP NEUR, V56, P735; StemmerRachamimov AO, 1997, AM J PATHOL, V151, P1649; Surace EI, 2004, ONCOGENE, V23, P580, DOI 10.1038/sj.onc.1207142; Thaxton C, 2011, MOL CELL NEUROSCI, V47, P1, DOI 10.1016/j.mcn.2010.12.006; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zou Y, 2014, J NEUROSCI, V34, P15764, DOI 10.1523/JNEUROSCI.2267-14.2014	95	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196726	10.1371/journal.pone.0196726	http://dx.doi.org/10.1371/journal.pone.0196726			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715273	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281100049
J	Park, H; Jeong, D; Nguyen, P; Henry, L; Hoang, J; Kim, Y; Sheen, E; Nguyen, MH				Park, Haesuk; Jeong, Donghak; Nguyen, Pauline; Henry, Linda; Hoang, Joseph; Kim, Yoona; Sheen, Edward; Nguyen, Mindie H.			Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis	PLOS ONE			English	Article							NATURAL-HISTORY; HCV INFECTION; HEPATOCELLULAR-CARCINOMA; ASIAN PATIENTS; HBV INFECTION; UNITED-STATES; C INFECTION; DEATH; MORTALITY; COHORT	Background Economic burden of HBV and HCV infection are trending upwards. Aims Compare hepatitis B virus (HBV) and hepatitis C virus (HCV) related hospital admission rates, charges, mortality rates, causes of death in a US population-based study. Methods Retrospective cohort analysis of HBV and HCV patients from the California Office of Statewide Health Planning and Development (2006-2013) database. Results A total of 23,891 HBV and 148,229 HCV patients were identified. Across the 8-year period, the mean increase for all-cause ($1,863 vs $1,388) and liver-related hospitalization charges ($1,175 vs $675) were significantly higher for the HBV cohort compared to the HCV cohort. HBV patients had significantly higher liver-related hospital charges per person per year than HCV patients after controlling for covariates ($123,239 vs $111,837; p = 0.002). Compared to HCV patients, adjusted mortality hazard ratio was slightly lower in HBV patients (relative risk = 0.96; 95% CI 0.94-0.99). The major causes and places of death were different. The three major causes of death for HBV were: other malignant neoplasms (35%), cardiovascular disease/other circulatory disorders (17%), and liver-related disease (15%) whereas for HCV patients were: liver-related disease (22%), other malignant neoplasms (20%), and cardiovascular disease (16%). Regarding the place of death, 53% of HBV patients and 44% of HCV patients died in hospital inpatient, respectively. Conclusions HBV patients incurred higher liver-related hospital charges and higher mean increase for all-cause and liver-related hospitalization charges over the 8-year period compared to HCV patients. HBV patients had slightly lower mortality rate and their major causes and places of death were noticeably different from HCV patients.	[Park, Haesuk; Henry, Linda] Univ Florida, Coll Pharm, Pharmaceut Outcomes & Policy, Gainesville, FL 32611 USA; [Jeong, Donghak; Nguyen, Pauline; Hoang, Joseph; Kim, Yoona; Sheen, Edward; Nguyen, Mindie H.] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA	State University System of Florida; University of Florida; Stanford University	Nguyen, MH (corresponding author), Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA.	mindiehn@stanford.edu						Amin J, 2006, LANCET, V368, P938, DOI 10.1016/S0140-6736(06)69374-4; California Department of Public Health (COPH), 2016, CHRON HEP B INF CAL; California Department of Public Health (COPH), 2016, CHRON HEP C INF CAL; Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x; Chen G, 2005, INT J EPIDEMIOL, V34, P132, DOI 10.1093/ije/dyh339; Cholankeril G, 2016, DIGEST DIS SCI, V61, P2505, DOI 10.1007/s10620-016-4160-z; Devaki P, 2014, CANCER-AM CANCER SOC, V120, P1725, DOI 10.1002/cncr.28639; Duberg AS, 2008, J VIRAL HEPATITIS, V15, P538, DOI 10.1111/j.1365-2893.2008.00982.x; Gidding HF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-52; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Institute of Medicine (US) Committee on the Prevention and Control of Viral Hepatitis Infection, 2010, HEPATITIS LIVER CANC, DOI DOI 10.17226/12793; Kim N, 2018, CANCER IN PRESS, DOI [10.1002/cncr.31373, DOI 10.1002/CNCR.31373]; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Lin SY, 2007, HEPATOLOGY, V46, P1034, DOI 10.1002/hep.21784; Mitchell Tarissa, 2013, PLoS One, V8, DOI 10.1371/annotation/7f73ed17-709e-4d7f-9aae-aab1f4a34985; Montuclard C, 2015, J HEPATOL, V62, P1265, DOI 10.1016/j.jhep.2015.01.020; Nguyen LH, 2013, ALIMENT PHARM THER, V37, P921, DOI 10.1111/apt.12300; Office of Statewide Health Planning and Development, 2017, CAL INP DAT REP MAN; Rajbhandari R, 2015, ALIMENT PHARM THER, V41, P928, DOI 10.1111/apt.13162; Sie L, 2013, J VIRAL HEPATITIS, V20, P628, DOI 10.1111/jvh.12086; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Szpakowski JL, 2013, HEPATOLOGY, V58, P21, DOI 10.1002/hep.26110; Tran SA, 2018, BMJ OPEN GASTROENTER, V5, DOI 10.1136/bmjgast-2017-000192; Walter SR, 2011, J HEPATOL, V54, P879, DOI 10.1016/j.jhep.2010.08.035; WHO, 2016, HEP C; World Health Organization, 2016, HEP B; Yip B, 2014, DIGEST DIS SCI, V59, P192, DOI 10.1007/s10620-013-2948-7; Zingmond DS, 2004, J CLIN EPIDEMIOL, V57, P21, DOI 10.1016/S0895-4356(03)00250-6	28	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196452	10.1371/journal.pone.0196452	http://dx.doi.org/10.1371/journal.pone.0196452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708985	Green Submitted, Green Published, gold			2022-12-26	WOS:000431130100027
J	Bradley, ELP; Vidot, DC; Gaul, Z; Sutton, MY; Pereyra, M				Bradley, Erin L. P.; Vidot, Denise C.; Gaul, Zaneta; Sutton, Madeline Y.; Pereyra, Margaret			Acceptability of oral rapid HIV testing at dental clinics in communities with high HIV prevalence in South Florida	PLOS ONE			English	Article							CARE; WILLINGNESS; DIAGNOSIS; KNOWLEDGE; ATTITUDES; URBAN	Background Expanding HIV screening for populations at risk necessitates testing in nontraditional settings. We assessed HIV testing in dental clinics in South Florida, an urban area with the highest rates of HIV diagnoses in the United States in 2015. Aims We explored patients' acceptance of oral HIV rapid tests administered by dental providers and identified reasons for accepting or declining HIV testing. Methods During 2014 and 2015, dentists and hygienists at two federally qualified health center (FQHC) dental clinics who serve racial/ethnic minority patient populations in South Florida were trained to administer oral HIV rapid tests as a part of a routine dental visit. Patients presenting for dental services were offered a rapid HIV test and brief survey regarding their demographics, HIV testing history and behaviors. Results We enrolled 600 patients (median age = 43 years; IQR: 29-56 years), 45% non-Hispanic black and 35% Hispanic/Latino, 83% graduated high school, and 50% unemployed. Most (85%) accepted oral HIV rapid testing (none tested HIV-positive); 14% had never been tested for HIV. The most common reasons for testing were a desire to know HIV status (56%) and free testing (54%). Among 93 (15%) patients who declined testing, 58% were tested recently and 31% felt confident that they were HIV-negative; however, 74 (80%) who declined testing said they would feel comfortable discussing HIV prevention with their dentist. Additionally, 290 of 600 patients (48%) reported condomless vaginal or anal sex in the past 6 months. Further, among 119 patients who had condomless sex with an HIV-positive partner and/or one whose HIV status was unknown, 98 (82%) accepted the oral HIV test. Conclusion Dental clinics may provide expanded opportunities for oral HIV rapid testing and conversations about HIV prevention in high HIV prevalence communities.	[Bradley, Erin L. P.; Sutton, Madeline Y.] Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Vidot, Denise C.] Univ Miami, Sch Nursing & Hlth Studies, Miami, FL USA; [Gaul, Zaneta] ICF, Atlanta, GA USA; [Pereyra, Margaret] Columbia Univ, Med Ctr, Sociomed Sci, New York, NY USA	Centers for Disease Control & Prevention - USA; University of Miami; Columbia University	Bradley, ELP (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	ebradley3@cdc.gov		Gaul, Zaneta/0000-0001-5881-6449	Centers for Disease Control and Prevention, Program Announcement [PS11-003, 1U01PS003321]; ICF	Centers for Disease Control and Prevention, Program Announcement(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ICF	This study was supported by the Centers for Disease Control and Prevention, Program Announcement PS11-003; Award#1U01PS003321. The funding agency provided support for authors: ELPB, DCV, MYS, and MP; their roles are outlined in the author contribution section. ICF provided support in the form of salaries for author (ZG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Blackstock OJ, 2010, AIDS PATIENT CARE ST, V24, P781, DOI 10.1089/apc.2010.0159; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Centers for Disease Control and Prevention, 2015, HIV SURV REP DIAGN H; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dailey AF, 2017, MMWR-MORBID MORTAL W, V66, P1300, DOI 10.15585/mmwr.mm6647e1; Derigne L, 2012, J HIV-AIDS SOC SERV, V11, P388, DOI 10.1080/15381501.2012.737213; Dietz CA, 2008, AIDS PATIENT CARE ST, V22, P205, DOI 10.1089/apc.2007.0235; Durall PS, 2015, SPEC CARE DENT, V35, P29, DOI 10.1111/scd.12096; Haukoos JS, 2013, ANN EMERG MED, V61, P353, DOI 10.1016/j.annemergmed.2012.10.031; Hutchinson MK, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-11; Hutchinson Mary Katherine, 2012, Nurse Pract, V37, P20, DOI 10.1097/01.NPR.0000410281.60115.15; Leblanc NM, 2016, QUAL HEALTH RES, V26, P294, DOI 10.1177/1049732315616624; Lyons MS, 2013, JAIDS-J ACQ IMM DEF, V64, P315, DOI 10.1097/QAI.0b013e3182a21611; Manski RJ, DENT SERVICES USE EX; Nassry DD, 2012, J DENT EDUC, V76, P1150; National Association of Community Health Centers, MOD DENT CAR; Office of HIV/AIDS and Infectious Disease Policy, NAT HIV AIDS STRAT U; Parish CL, 2018, AIDS CARE, V30, P347, DOI 10.1080/09540121.2017.1367087; Patton Lauren L, 2002, J Dent Educ, V66, P1169; Pereyra M, 2011, AIDS CARE, V23, P98, DOI 10.1080/09540121.2010.498861; Pollack HA, 2014, AM J PUBLIC HEALTH, V104, P872, DOI 10.2105/AJPH.2013.301700; Pollack HA, 2010, AM J PUBLIC HEALTH, V100, P88, DOI 10.2105/AJPH.2008.157230; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Santella AJ, 2013, INT J DENT HYG, V11, P287, DOI 10.1111/idh.12022; Santella Anthony J, 2012, J Dent Hyg, V86, P265; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Siegel K, 2012, AM J PUBLIC HEALTH, V102, P625, DOI 10.2105/AJPH.2011.300509; Silveira Marushka Leanne, 2011, Ethics Biol Eng Med, V2, P115; Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180; VanDevanter N, 2012, NURS RES PRACT, V2012, DOI [10.1155/2012/803169, DOI 10.1155/2012/803169]; Vernillo AT, 2007, J DENT EDUC, V71, P1534; Wilson E, 2013, ORAL DIS, V19, P431, DOI 10.1111/odi.12047; Yehia BR, 2012, JAMA-J AM MED ASSOC, V308, P339, DOI 10.1001/jama.2012.5927	34	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196323	10.1371/journal.pone.0196323	http://dx.doi.org/10.1371/journal.pone.0196323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1YS	29702677	Green Published, gold, Green Submitted			2022-12-26	WOS:000431013300027
J	Rohman, A; van Oosterwijk, N; Puspaningsih, NNT; Dijkstra, BW				Rohman, Ali; van Oosterwijk, Niels; Puspaningsih, Ni Nyoman Tri; Dijkstra, Bauke W.			Structural basis of product inhibition by arabinose and xylose of the thermostable GH43 beta-1,4-xylosidase from Geobacillus thermoleovorans IT-08	PLOS ONE			English	Article							BETA-D-XYLOSIDASE; SELENOMONAS-RUMINANTIUM; INDUSTRIAL APPLICATIONS; L-ARABINOFURANOSIDASE; MICROBIAL XYLANASES; BIOTECHNOLOGY; BINDING; CLASSIFICATION; HYDROLASES; ENZYMES	Complete degradation of the xylan backbone of hemicellulosic plant cell walls requires the synergistic action of endo-xylanases and beta-1,4-xylosidases. While endo-xylanases produce xylooligosaccharides from xylan, beta-1,4-xylosidases degrade the xylooligosaccharides into xylose monomers. The glycoside hydrolase family 43 beta-1,4-xylosidase from Geobacillus thermoleovorans IT-08 is a promising, heat stable catalyst for the saccharification of hemicellulosic material into simple fermentable sugars, but it is competitively inhibited by its products arabinose and xylose. As a first step to help overcome this problem, we elucidated crystal structures of the enzyme in the unliganded form and with bound products, at 1.7-2.0 A resolution. The structures are very similar to those of other enzymes belonging to glycoside hydrolase family 43. Unexpectedly, the monosaccharides are bound in very different ways. Arabinose preferentially binds in subsite -1, while xylose exclusively interacts with subsite +1. These structures and sugar binding preferences suggest ways for improving the catalytic performance of the enzyme by rational mutational design.	[Rohman, Ali; Puspaningsih, Ni Nyoman Tri] Univ Airlangga, Fac Sci & Technol, Dept Chem, Surabaya, Indonesia; [Rohman, Ali; Puspaningsih, Ni Nyoman Tri] Univ Airlangga, Inst Trop Dis, Surabaya, Indonesia; [Rohman, Ali; van Oosterwijk, Niels; Dijkstra, Bauke W.] Univ Groningen, Lab Biophys Chem, Groningen, Netherlands	Airlangga University; Airlangga University; University of Groningen	Dijkstra, BW (corresponding author), Univ Groningen, Lab Biophys Chem, Groningen, Netherlands.	b.w.dijkstra@rug.nl	Dijkstra, Bauke W./H-4308-2019; Rohman, Ali/GWV-1736-2022; Puspaningsih, Ni Nyoman Tri/AAH-4928-2021	Dijkstra, Bauke W./0000-0001-9731-6586; Rohman, Ali/0000-0002-8177-5881	Universitas Airlangga [624/UN3.14/LT/2017]; Directorate General of Higher Education, the Ministry of Research, Technology, and Higher Education, Republic of Indonesia	Universitas Airlangga; Directorate General of Higher Education, the Ministry of Research, Technology, and Higher Education, Republic of Indonesia	This work was partly supported by Universitas Airlangga to AR and NNTP (Hibah Riset Mandat No. 624/UN3.14/LT/2017). AR was a recipient of a scholarship from the Directorate General of Higher Education, the Ministry of Research, Technology, and Higher Education, Republic of Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunzelle JS, 2008, ARCH BIOCHEM BIOPHYS, V474, P157, DOI 10.1016/j.abb.2008.03.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fan ZM, 2010, APPL MICROBIOL BIOT, V86, P1099, DOI 10.1007/s00253-009-2335-7; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Herrmann MC, 1997, BIOCHEM J, V321, P375, DOI 10.1042/bj3210375; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jordan DB, 2007, ARCH BIOCHEM BIOPHYS, V465, P231, DOI 10.1016/j.abb.2007.05.016; Jordan DB, 2011, J IND MICROBIOL BIOT, V38, P1821, DOI 10.1007/s10295-011-0971-2; Jordan DB, 2010, APPL MICROBIOL BIOT, V86, P1647, DOI 10.1007/s00253-010-2538-y; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KEITEL T, 1994, EUR J BIOCHEM, V222, P203, DOI 10.1111/j.1432-1033.1994.tb18858.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUHAD RC, 1993, CRIT REV BIOTECHNOL, V13, P151, DOI 10.3109/07388559309040630; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MARSHALL PJ, 1983, BIOCHEM J, V215, P67, DOI 10.1042/bj2150067; Matsuzawa T, 2017, J BIOCHEM, V162, P173, DOI 10.1093/jb/mvx012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olsson L, 1996, ENZYME MICROB TECH, V18, P312, DOI 10.1016/0141-0229(95)00157-3; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Prade RA, 1996, BIOTECHNOL GENET ENG, V13, P101, DOI 10.1080/02648725.1996.10647925; Rohman A, 2007, ACTA CRYSTALLOGR F, V63, P932, DOI 10.1107/S1744309107046015; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Subramaniyan S, 2002, CRIT REV BIOTECHNOL, V22, P33, DOI 10.1080/07388550290789450; Sunna A, 1997, CRIT REV BIOTECHNOL, V17, P39, DOI 10.3109/07388559709146606; TIMELL TE, 1982, WOOD SCI TECHNOL, V16, P83, DOI 10.1007/BF00351097; Wagschal K, 2009, APPL BIOCHEM BIOTECH, V155, P304, DOI 10.1007/s12010-008-8362-5; Williams SJ, 2000, J AM CHEM SOC, V122, P2223, DOI 10.1021/ja993805j; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshida S, 2010, J BACTERIOL, V192, P5424, DOI 10.1128/JB.00503-10	39	19	19	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196358	10.1371/journal.pone.0196358	http://dx.doi.org/10.1371/journal.pone.0196358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698436	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600068
J	Liu, H; Weber, A; Morse, J; Kodumudi, K; Scott, E; Mullinax, J; Sarnaik, AA; Pilon-Thomas, S				Liu, Hao; Weber, Amy; Morse, Jennifer; Kodumudi, Krithika; Scott, Ellen; Mullinax, John; Sarnaik, Amod A.; Pilon-Thomas, Shari			T cell mediated immunity after combination therapy with intralesional PV-10 and blockade of the PD-1/PD-L1 pathway in a murine melanoma model	PLOS ONE			English	Article							ANTI-PD-1	Intralesional (IL) injection of Rose Bengal (PV-10) induces regression of injected and uninjected lesions in several murine tumor models. In this study, we investigated the anti-tumor response of combining IL PV-10 with blockade of the PD-1/PD-L1 pathway and the role of immune cell populations in eliciting this response. To investigate the role of T cell subsets in mediating an immune response, B16 or M05 melanoma-bearing mice received combination therapy as well as CD8(+), CD4(+), or CD25(+) depleting antibodies. Tumor growth was measured. T cells were collected from spleens or tumors, and phenotype, activation markers, and reactivity were measured. Splenocytes from mice treated with combination therapy had increased OVA antigen-specific CD8(+) T cells in M05-tumor-bearing mice. Depletion of CD4(+) T cells or regulatory T cells (Tregs) in combination with IL PV-10 and anti-PD-1 antibody treatment resulted in an enhanced anti-tumor effect. Treatment with CD8(+) depleting antibody abrogated anti-tumor immunity. These results support a clinical study for the safety and anti-tumor immune responses with combination therapy of IL PV-10 and PD-1/PD-L1 blockade.	[Liu, Hao; Weber, Amy; Morse, Jennifer; Kodumudi, Krithika; Scott, Ellen; Mullinax, John; Sarnaik, Amod A.; Pilon-Thomas, Shari] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Mullinax, John] H Lee Moffitt Canc Ctr & Res Inst, Sarcoma Program, Tampa, FL USA; [Sarnaik, Amod A.; Pilon-Thomas, Shari] H Lee Moffitt Canc & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA; [Liu, Hao] Pfizer Worldwide Res & Dev, La Jolla Labs, San Diego, CA USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Pfizer	Pilon-Thomas, S (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.; Pilon-Thomas, S (corresponding author), H Lee Moffitt Canc & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA.	Shari.pilon-thomas@moffitt.org	Sarnaik, Amod/W-5536-2019	Scott, Ellen/0000-0003-1933-9779	Moffitt Cancer Center Flow Cytometry Core Facility; National Cancer Institute [P30 CA076292]; Provectus Biopharmaceuticals, Inc.; Miles; American Cancer Society - Leo and Anne Albert Charitable Foundation Research Scholar Grant [RSG-16-117-01-LIB];  [NCI-5K23CA178083]; NATIONAL CANCER INSTITUTE [K23CA178083] Funding Source: NIH RePORTER	Moffitt Cancer Center Flow Cytometry Core Facility; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Provectus Biopharmaceuticals, Inc.; Miles; American Cancer Society - Leo and Anne Albert Charitable Foundation Research Scholar Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the Moffitt Cancer Center Flow Cytometry Core Facility and the Support Grant P30 CA076292 from the National Cancer Institute. This study was supported by a sponsored research agreement from Provectus Biopharmaceuticals, Inc. and a Miles for Moffitt grant. MS was supported by NCI-5K23CA178083. SPT was supported by an American Cancer Society - Leo and Anne Albert Charitable Foundation Research Scholar Grant, (RSG-16-117-01-LIB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank M. Scott Kidd for his technical assistance and the Moffitt Cancer Center Flow Cytometry Core Facility (Support Grant P30 CA076292 from the National Cancer Institute).	Andtbacka RHI, 2015, J CLIN ONCOL, V33, P2780, DOI 10.1200/JCO.2014.58.3377; Coventry Brendon J, 2012, Cancer Manag Res, V4, P137, DOI 10.2147/CMAR.S31887; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kodumudi KN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153053; Liu H, 2016, ONCOTARGET, V7, P37893, DOI 10.18632/oncotarget.9247; MARSH RJ, 1976, ARCH OPHTHALMOL-CHIC, V94, P1899; Peng WY, 2012, CANCER RES, V72, P5209, DOI 10.1158/0008-5472.CAN-12-1187; Pilon-Thomas S, 2010, J IMMUNOL, V184, P3442, DOI 10.4049/jimmunol.0904114; Qin JZ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.473; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Sakuishi K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23849; Society AC, 2015, CANC FACTS FIG 2015; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Thompson JF, 2015, ANN SURG ONCOL, V22, P2135, DOI 10.1245/s10434-014-4169-5; Thompson JF, 2008, MELANOMA RES, V18, P405, DOI 10.1097/CMR.0b013e32831328c7; Toomey P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068561; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wachter E D C, 2002, P SPIE; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620	25	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196033	10.1371/journal.pone.0196033	http://dx.doi.org/10.1371/journal.pone.0196033			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694419	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400056
J	Seong, CS; Bin Gwag, H; Hwang, JK; Park, SJ; Park, KM; Kim, JS; On, YK				Seong, Choong Sil; Bin Gwag, Hye; Hwang, Jin Kyung; Park, Seung Jung; Park, Kyoung-Min; Kim, June Soo; On, Young Keun			Clinical significance of fragmented QRS complexes or J waves in patients with idiopathic ventricular arrhythmias	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; EARLY REPOLARIZATION; CARDIAC-ARREST; EVENTS; PREVALENCE; SURVIVORS; PREDICTS; FIBRILLATION; MORTALITY; MARKER	Background Idiopathic ventricular fibrillation (IVF) can cause sudden cardiac death. Previous studies have reported that J waves and fragmented QRS complexes (f-QRS) are arrhythmogenic markers and predictors of cardiac events. We evaluated the prevalence and clinical significance of J waves and f-QRS in patients with IVF. Methods We studied 81 patients who received an implantable cardioverter defibrillator (ICD) due to IVF between October 1999 and June 2015. We assessed the prevalence of J waves and fQRS using electrocardiograms (ECGs). Patients were classified into three groups: J wave group (n = 35), f-QRS group (n = 20), or normal ECG group (n = 26). The control group included 81 subjects without heart disease who were matched for age, sex, and race. We compared syncope, sudden cardiac arrest, and appropriate ICD shock between the three groups. Results The follow-up duration was 4.1 years. J waves and f-QRS were more frequent in patients with IVF than in control subjects (43.2%, 21% vs. 24.7%, 19.7%, P < 0.001). Out of the three groups, clinical cardiac events were most frequent in the f-QRS group (50% vs. 45.7% vs. 11.5%, P = 0.028). A comparison of the combined group of J wave and f-QRS versus the normal ECG group revealed that the combined group had a higher frequency of clinical cardiac events than the normal ECG group (47.3% vs. 11.5%, respectively, P = 0.009). Conclusions Patients with IVF had higher prevalence of f-QRS or J waves. And patients with f-QRS or J waves were at higher risk of recurrent ventricular fibrillation.	[Seong, Choong Sil; Bin Gwag, Hye; Hwang, Jin Kyung; Park, Seung Jung; Park, Kyoung-Min; Kim, June Soo; On, Young Keun] Sungkyunkwan Univ, Div Cardiol, Dept Internal Med, Heart Vasc & Stroke Inst,Samsung Med Ctr,Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	On, YK (corresponding author), Sungkyunkwan Univ, Div Cardiol, Dept Internal Med, Heart Vasc & Stroke Inst,Samsung Med Ctr,Sch Med, Seoul, South Korea.	oykmd123@gmail.com			Samsung Biomedical Research Institute [SMO1170431]	Samsung Biomedical Research Institute(Samsung)	This study was supported by an unrestricted research grant from the Samsung Biomedical Research Institute (grant no. SMO1170431) to YKO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Canpolat U, 2015, MED PRIN PRACT, V24, P200, DOI 10.1159/000369464; Canpolat U, 2013, J CARDIOVASC ELECTR, V24, P1260, DOI 10.1111/jce.12202; Cetin MS, 2016, AM J CARDIOL, V117, P1516, DOI 10.1016/j.amjcard.2016.02.022; Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONAHA.105.595892; Das MK, 2009, HEART RHYTHM, V6, pS8, DOI 10.1016/j.hrthm.2008.10.019; Das MK, 2010, HEART RHYTHM, V7, P74, DOI 10.1016/j.hrthm.2009.09.065; Das MK, 2007, HEART RHYTHM, V4, P1385, DOI 10.1016/j.hrthm.2007.06.024; Derval N, 2011, J AM COLL CARDIOL, V58, P722, DOI 10.1016/j.jacc.2011.04.022; Gussak I, 2000, J ELECTROCARDIOL, V33, P299, DOI 10.1054/jelc.2000.18106; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Macfarlane PW, 2015, J AM COLL CARDIOL, V66, P470, DOI 10.1016/j.jacc.2015.05.033; Morita H, 2008, CIRCULATION, V118, P1697, DOI 10.1161/CIRCULATIONAHA.108.770917; Myerburg RJ, 1997, AM J CARDIOL, V80, pF10, DOI 10.1016/S0002-9149(97)00477-3; Nakayama M, 2013, EUROPACE, V15, P109, DOI 10.1093/europace/eus259; Omar HR, 2016, HERZ, V41, P48, DOI 10.1007/s00059-015-4338-8; Ozcan F, 2014, ANN NONINVAS ELECTRO, V19, P454, DOI 10.1111/anec.12146; Ozcan F, 2014, ANN NONINVAS ELECTRO, V19, P351, DOI 10.1111/anec.12141; Peters S, 2008, HEART RHYTHM, V5, P1417, DOI 10.1016/j.hrthm.2008.07.012; Priori SG, 1997, CIRCULATION, V95, P265; Rosengarten JA, 2015, EUROPACE, V17, P969, DOI 10.1093/europace/euu279; Rosso R, 2008, J AM COLL CARDIOL, V52, P1231, DOI 10.1016/j.jacc.2008.07.010; Sinner MF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000314; Tang Yan-hong, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P930; Tian Y, 2017, INT J HEART RHYTHM, V2, P34, DOI DOI 10.4103/2352-4197; Tikkanen JT, 2009, NEW ENGL J MED, V361, P2529, DOI 10.1056/NEJMoa0907589; Wang J, 2012, J GERIATR CARDIOL, V9, P143, DOI 10.3724/SP.J.1263.2011.12121; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	27	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0194363	10.1371/journal.pone.0194363	http://dx.doi.org/10.1371/journal.pone.0194363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694354	Green Submitted, gold, Green Published			2022-12-26	WOS:000430802400011
J	Cai, J; Chen, HY; Peng, SJ; Meng, JL; Wang, Y; Zhou, Y; Qian, XP; Sun, XY; Pang, XW; Zhang, Y; Zhang, J				Cai, Juan; Chen, Hong-Yan; Peng, Shu-Jie; Meng, Jun-Ling; Wang, Yan; Zhou, Yu; Qian, Xiao-Ping; Sun, Xiu-Yuan; Pang, Xue-Wen; Zhang, Yu; Zhang, Jun			USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling	FASEB JOURNAL			English	Article						TBK1; ubiquitination; deubiquitination; degradation; innate immunity	E3 UBIQUITIN LIGASE; BINDING KINASE 1; SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; NF-KAPPA-B; RIG-I; INNATE IMMUNITY; PROTEASOMAL DEGRADATION; INTERFERON-PRODUCTION; SUMO DEUBIQUITINASE	Ubiquitination and deubiquitination are important post-translational regulatory mechanisms responsible for fine tuning the antiviral signaling. In this study, we identified a deubiquitinase, the ubiquitin-specific peptidase 7/herpes virus associated ubiquitin-specific protease (USP7/HAUSP) as an important negative modulator of virus-induced signaling. Overexpression of USP7 suppressed Sendai virus and polyinosinic-polycytidylic acid and poly(deoxyadenylic-deoxythymidylic)-induced ISRE and IFN- activation, and enhanced virus replication. Knockdown or knockout of endogenous USP7 expression had the opposite effect. Coimmunoprecipitation assays showed that USP7 physically interacted with tripartite motif (TRIM)27. This interaction was enhanced after SeV infection. In addition, TNF receptor-associated factor family member-associated NF-kappa-B-binding kinase (TBK)-1 was pulled down in the TRIM27-USP7 complex. Overexpression of USP7 promoted the ubiquitination and degradation of TBK1 through promoting the stability of TRIM27. Knockout of endogenous USP7 led to enhanced TRIM27 degradation and reduced TBK1 ubiquitination and degradation, resulting in enhanced type I IFN signaling. Our findings suggest that USP7 acts as a negative regulator in antiviral signaling by stabilizing TRIM27 and promoting the degradation of TBK1.Cai, J., Chen, H.-Y., Peng, S.-J., Meng, J.-L., Wang, Y., Zhou, Y., Qian, X.-P., Sun, X.-Y., Pang, X.-W., Zhang, Y., Zhang, J. USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling.	[Cai, Juan; Chen, Hong-Yan; Peng, Shu-Jie; Meng, Jun-Ling; Wang, Yan; Zhou, Yu; Qian, Xiao-Ping; Sun, Xiu-Yuan; Pang, Xue-Wen; Zhang, Yu; Zhang, Jun] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Key Lab Med Immunol,Minist Hlth,Dept Immunol, Beijing, Peoples R China	Peking University	Zhang, J (corresponding author), Peking Univ, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	junzhang@bjmu.edu.cn			National Natural Science Foundation of China [31470843]; Program for New Century Excellent Talents in University [NCET-13-0018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	The authors thank Drs. Takashi Fujita (Kyoto University, Kyoto, Japan), Tom Maniatis (Columbia University School of Medicine, New York, NY, USA), and Zhijian Chen (University of Texas Southwestern Medical Center, Dallas, TX, USA) for RIG-I-, TBK1-, IKK epsilon-, and MAVS-expressing vectors. The authors also thank Drs. Hong-Bing Shu (Wuhan University, Wuhan, China), Hong Tang (Institut Pasteur of Shanghai, Chinese Academy of Science, Shanghai, China), Zhengfan Jiang (Peking University, Peking, China), and Dan-Ying Chen (Peking University) for vectors or reagents. This work was supported by grants from the National Natural Science Foundation of China Grant 31470843, and Program for New Century Excellent Talents in University Grant NCET-13-0018 (to J.Z.). The authors declare no conflicts of interest.	Ali A, 2017, BIOCHEM J, V474, P1653, DOI 10.1042/BCJ20160304; An T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005179; Antrobus R, 2008, VIRUS RES, V137, P64, DOI 10.1016/j.virusres.2008.05.017; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Cui J, 2014, CELL RES, V24, P400, DOI 10.1038/cr.2013.170; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Daubeuf S, 2009, BLOOD, V113, P3264, DOI 10.1182/blood-2008-07-168203; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Gao LL, 2011, J BIOL CHEM, V286, P36592, DOI 10.1074/jbc.M111.283762; Gu MD, 2016, EMBO J, V35, P2553, DOI 10.15252/embj.201694060; Hao H, 2015, MOL CELL, V59, P956, DOI 10.1016/j.molcel.2015.07.033; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Jacq X, 2013, CELL BIOCHEM BIOPHYS, V67, P25, DOI 10.1007/s12013-013-9635-3; Kalamvoki M, 2012, J VIROL, V86, P12871, DOI 10.1128/JVI.01981-12; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Khoronenkova SV, 2012, CELL CYCLE, V11, P2409, DOI 10.4161/cc.20800; Khoronenkova SV, 2011, NUCLEIC ACIDS RES, V39, P2604, DOI 10.1093/nar/gkq1210; Lecona E, 2016, NAT STRUCT MOL BIOL, V23, P270, DOI 10.1038/nsmb.3185; Lee HR, 2011, NAT STRUCT MOL BIOL, V18, P1336, DOI 10.1038/nsmb.2142; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464; Li XL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aae0435; Lin M, 2016, MOL CELL, V64, P267, DOI 10.1016/j.molcel.2016.08.029; Liu D, 2015, MOL CELL BIOL, V35, P2400, DOI 10.1128/MCB.00090-15; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luo WW, 2016, NAT IMMUNOL, V17, P1057, DOI 10.1038/ni.3510; Morotti A, 2014, LEUKEMIA, V28, P1326, DOI 10.1038/leu.2013.370; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Panda S, 2015, IMMUNITY, V43, P647, DOI 10.1016/j.immuni.2015.09.010; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Paz S, 2006, CELL MOL BIOL, V52, P17, DOI 10.1170/T694; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Saul VV, 2015, BBA-MOL CELL RES, V1853, P136, DOI 10.1016/j.bbamcr.2014.10.008; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Smits VAJ, 2016, BIOESSAYS, V38, P863, DOI 10.1002/bies.201600096; Song GH, 2016, NAT IMMUNOL, V17, P1342, DOI 10.1038/ni.3588; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang LJ, 2013, J VIROL, V87, P4507, DOI 10.1128/JVI.00031-13; Wang LQ, 2016, EBIOMEDICINE, V13, P99, DOI 10.1016/j.ebiom.2016.10.018; Xiang WW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501889; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamaguchi L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00136-5; Yang Z, 2012, FEBS LETT, V586, P3013, DOI 10.1016/j.febslet.2012.06.025; Ye JS, 2014, J VIROL, V88, P12765, DOI 10.1128/JVI.02037-14; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zaman MMU, 2013, MOL CELL BIOL, V33, P4971, DOI 10.1128/MCB.00465-13; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zhan ZZ, 2015, J IMMUNOL, V195, P3849, DOI 10.4049/jimmunol.1403083; Zhang J, 2014, PROTEIN CELL, V5, P503, DOI 10.1007/s13238-014-0058-8; Zhang L, 2014, J IMMUNOL, V193, P2230, DOI 10.4049/jimmunol.1302634; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024; Zhao YL, 2012, CELL SIGNAL, V24, P2197, DOI 10.1016/j.cellsig.2012.06.017; Zheng QL, 2015, CELL RES, V25, P1121, DOI 10.1038/cr.2015.108; Zurek B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041255	78	32	32	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5238	5249		10.1096/fj.201700473RR	http://dx.doi.org/10.1096/fj.201700473RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688809	Bronze			2022-12-26	WOS:000447972500004
J	Etzl, S; Lindner, R; Nelson, MD; Winkler, A				Etzl, Stefan; Lindner, Robert; Nelson, Matthew D.; Winkler, Andreas			Structure-guided design and functional characterization of an artificial red light-regulated guanylate/adenylate cyclase for optogenetic applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; CRYSTAL-STRUCTURE; PHYTOCHROME; GENE; ELEGANS; BINDING; PHOTOACTIVATION; PHOTORECEPTORS; REARRANGEMENTS; TRANSDUCTION	Genetically targeting biological systems to control cellular processes with light is the concept of optogenetics. Despite impressive developments in this field, underlying molecular mechanisms of signal transduction of the employed photoreceptor modules are frequently not sufficiently understood to rationally design new optogenetic tools. Here, we investigate the requirements for functional coupling of red light-sensing phytochromes with non-natural enzymatic effectors by creating a series of constructs featuring the Deinococcus radiodurans bacteriophytochrome linked to a Synechocystis guanylate/adenylate cyclase. Incorporating characteristic structural elements important for cyclase regulation in our designs, we identified several red light-regulated fusions with promising properties. We provide details of one light-activated construct with low dark-state activity and high dynamic range that outperforms previous optogenetic tools in vitro and expands our in vivo toolkit, as demonstrated by manipulation of Caenorhabditis elegans locomotor activity. The full-length crystal structure of this phytochromelinked cyclase revealed molecular details of photoreceptoreffector coupling, highlighting the importance of the regulatory cyclase element. Analysis of conformationaldynamicsbyhydrogendeuterium exchange in different functional states enriched our understanding of phytochrome signaling and signal integration by effectors. We found that light-induced conformational changes in the phytochrome destabilize the coiled-coil sensoreffector linker, which releases the cyclase regulatory element from an inhibited conformation, increasing cyclase activity of this artificial system. Future designs of optogenetic functionalities may benefit from our work, indicating that rational considerations for the effector improve the rate of success of initial designs to obtain optogenetic tools with superior properties.	[Etzl, Stefan; Winkler, Andreas] Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria; [Lindner, Robert] Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany; [Nelson, Matthew D.] St Josephs Univ, Dept Biol, Philadelphia, PA 19131 USA	Graz University of Technology; Max Planck Society; Saint Joseph's University	Winkler, A (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	Andreas.Winkler@TUGraz.at	Nelson, Matthew/N-1462-2013	Nelson, Matthew/0000-0002-2085-8974; Winkler, Andreas/0000-0001-6221-9671	Austrian Science Fund (FWF) [P27124]; NAWI Graz; Austrian Science Fund Ph.D. program "DK Molecular Enzymology" Grant [W901]; NIGMS National Institutes of Health [R15GM122058]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM122058] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NAWI Graz; Austrian Science Fund Ph.D. program "DK Molecular Enzymology" Grant; NIGMS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Austrian Science Fund (FWF) Grant P27124 (to A. W.). This work was also supported by NAWI Graz. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Austrian Science Fund Ph.D. program "DK Molecular Enzymology" Grant W901.; Supported by the NIGMS National Institutes of Health Grant R15GM122058.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Anantharaman V, 2001, TRENDS BIOCHEM SCI, V26, P579, DOI 10.1016/S0968-0004(01)01968-5; Bhate MP, 2015, STRUCTURE, V23, P981, DOI 10.1016/j.str.2015.04.002; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Bjorling A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600920; Burgie ES, 2016, STRUCTURE, V24, P448, DOI 10.1016/j.str.2016.01.001; Burgie ES, 2014, J BIOL CHEM, V289, P24573, DOI 10.1074/jbc.M114.571661; Burkhardt A, 2016, EUR PHYS J PLUS, V131, P1, DOI 10.1140/epjp/i2016-16056-0; Churgin MA, 2017, ELIFE, V6, DOI [10.7554/elife.26652, 10.7554/eLife.26652]; Davis MW, 1995, J NEUROSCI, V15, P8408; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; de Alda JAGO, 2000, J BACTERIOL, V182, P3839, DOI 10.1128/JB.182.13.3839-3842.2000; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enomoto G, 2014, J BIOL CHEM, V289, P24801, DOI 10.1074/jbc.M114.583674; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Gourinchas G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602498; Gushchin I, 2017, SCIENCE, V356, DOI 10.1126/science.aah6345; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleinboelting S, 2016, J BIOL CHEM, V291, P9776, DOI 10.1074/jbc.M115.708255; Kleinboelting S, 2014, FEBS J, V281, P4151, DOI 10.1111/febs.12913; Kleinboelting S, 2014, P NATL ACAD SCI USA, V111, P3727, DOI 10.1073/pnas.1322778111; Lindner R, 2017, J MOL BIOL, V429, P1336, DOI 10.1016/j.jmb.2017.03.020; Lindner R, 2014, J AM SOC MASS SPECTR, V25, P1018, DOI 10.1007/s13361-014-0850-y; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lupas AN, 2017, TRENDS BIOCHEM SCI, V42, P130, DOI 10.1016/j.tibs.2016.10.007; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; Nelson M. D., 2011, OVERLAP EXTENSION PC, P459; Ohki M, 2016, P NATL ACAD SCI USA, V113, P6659, DOI 10.1073/pnas.1517520113; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ramos-Espiritu L, 2016, NAT CHEM BIOL, V12, P838, DOI [10.1038/NCHEMBIO.2151, 10.1038/nchembio.2151]; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Ryu MH, 2014, P NATL ACAD SCI USA, V111, P10167, DOI 10.1073/pnas.1324301111; Saalau-Bethell SM, 2014, CHEMMEDCHEM, V9, P823, DOI 10.1002/cmdc.201300480; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Shcherbakova DM, 2015, ANNU REV BIOCHEM, V84, P519, DOI 10.1146/annurev-biochem-060614-034411; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Vercellino I, 2017, P NATL ACAD SCI USA, V114, pE9821, DOI 10.1073/pnas.1712621114; Winkler A, 2015, ACS CHEM BIOL, V10, P502, DOI 10.1021/cb500744m; Ziegler M, 2017, FEBS J, V284, P1204, DOI 10.1111/febs.14047	45	34	34	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9078	9089		10.1074/jbc.RA118.003069	http://dx.doi.org/10.1074/jbc.RA118.003069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29695503	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000434941900029
J	Woutersen, K; van den Berg, AV; Boonstra, FN; Theelen, T; Goossens, J				Woutersen, Karlijn; van den Berg, Albert V.; Boonstra, F. Nienke; Theelen, Thomas; Goossens, Jeroen			Useful field of view test performance throughout adulthood in subjects without ocular disorders	PLOS ONE			English	Article							CONTRAST SENSITIVITY; OLDER DRIVERS; VISUAL-ATTENTION; ISCEV STANDARD; NORMATIVE DATA; PREDICTORS; AGE; VISION; ACUITY; RELIABILITY	Previous research has shown an age-related decline in Useful Field of View (UFOV) test performance, which measures the duration required to extract relevant information from a scene in three subtasks. However, these results are mostly based on data that may have been confounded by (age-related) ocular diseases. We examined UFOV performance in subjects aged 19.5 to 70.3 years to investigate how UFOV performance changes throughout adulthood. All subjects underwent a thorough ophthalmological examination to exclude ocular disorders. We also examined some elementary visual functions, i.e., near and far visual acuity, crowding and contrast sensitivity. We investigated whether these functions were related to age and whether they could explain a possible age-related decline in UFOV performance. The subjects (n = 41) performed very well on almost every measure and reached far better UFOV and visual acuity scores than those reported by other studies that relied on self-reported absence of ocular pathology. We did not find significant relationships between age and any of the elementary visual functions or the first two UFOV subtasks (R-UFOV1(2) = 0.03, p = 0.25; R-UFOV2(2) = 0.07, p = 0.10). However, we found an age-related decline in performance on the third UFOV subtask (R-UFOV3(3) = 0.36, p < 0.001), which was unrelated to performance on the elementary visual function tasks. Our results show that performance on the first two UFOV subtasks as well as central elementary visual functions may remain high in the absence of obvious ophthalmological pathology.	[Woutersen, Karlijn; van den Berg, Albert V.; Boonstra, F. Nienke; Goossens, Jeroen] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci,Sect Biophys, Nijmegen, Netherlands; [Boonstra, F. Nienke] Natl Fdn Visually Impaired & Blind, Royal Dutch Visio, Huizen, Netherlands; [Theelen, Thomas] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Woutersen, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci,Sect Biophys, Nijmegen, Netherlands.	k.woutersen@douders.ru.nl	Theelen, Thomas/A-3192-2012; Goossens, Jeroen/D-7311-2010	Theelen, Thomas/0000-0001-9067-1171; Goossens, Jeroen/0000-0001-5522-3437; van den Berg, Albert Victor/0000-0002-1543-5408	Radboud University Medical Center; European Union Program FP7-PEOPLE-ITN 'Health PAC' grant [604063 - IDP]	Radboud University Medical Center; European Union Program FP7-PEOPLE-ITN 'Health PAC' grant	This research was supported by the Radboud University Medical Center (www.radboudumc.nl; KW, AvdB, TT, JG) And the European Union Program FP7-PEOPLE-2013-ITN 'Health PAC' grant 604063 - IDP (https://ec.europa.eu/research/fp7/index_en.cfm; AvdB, JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089381; [Anonymous], 2014, R LANG ENV STAT COMP; Anstey KJ, 2012, ACCIDENT ANAL PREV, V45, P766, DOI 10.1016/j.aap.2011.10.006; Astle AT, 2014, INVEST OPHTH VIS SCI, V55, P5039, DOI 10.1167/iovs.14-14181; BALL K, 1990, CLIN VISION SCI, V5, P113; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Bennett DM, 2009, OPTOMETRY VISION SCI, V86, P717, DOI 10.1097/OPX.0b013e3181a7b3b9; Bentley SA, 2012, INVEST OPHTH VIS SCI, V53, P6763, DOI 10.1167/iovs.12-9718; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Broman AT, 2004, INVEST OPHTH VIS SCI, V45, P2955, DOI 10.1167/iovs.04-0219; Canty A., 2016, BOOT BOOTSTRAP R S P, P3; Champely S., 2018, PACKAGE PWR; Coates DR, 2013, OPTOMETRY VISION SCI, V90, P628, DOI 10.1097/OPX.0b013e31829908a4; Davison A. C., 1997, BOOTSTRAP METHODS TH, DOI [10.1017/CBO9780511802843, DOI 10.1017/CB09780511802843, 10. 1017/CBO9780511802843]; Dommes A, 2013, ACCIDENT ANAL PREV, V59, P135, DOI 10.1016/j.aap.2013.05.017; Donders FC, 1864, ANOMALITIES ACCOMMOD; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; Edwards JD, 2006, ARCH CLIN NEUROPSYCH, V21, P275, DOI 10.1016/j.acn.2006.03.001; ELLIOTT D, 1990, VISION RES, V30, P541, DOI 10.1016/0042-6989(90)90066-T; ELLIOTT DB, 1995, OPTOMETRY VISION SCI, V72, P186, DOI 10.1097/00006324-199503000-00006; Fraser ML, 2013, ACCIDENT ANAL PREV, V58, P10, DOI 10.1016/j.aap.2013.04.015; FRISEN L, 1981, A GRAEF ARCH KLIN EX, V215, P149, DOI 10.1007/BF00413146; GITTINGS NS, 1986, EXP GERONTOL, V21, P423, DOI 10.1016/0531-5565(86)90047-1; GREENE HA, 1987, AM J OPTOM PHYS OPT, V64, P749; Harrell F. E., 2016, HMISC HARRELL MISCEL; Henderson S, 2013, ACCIDENT ANAL PREV, V50, P103, DOI 10.1016/j.aap.2012.03.035; Henderson S, 2010, ACCIDENT ANAL PREV, V42, P1189, DOI 10.1016/j.aap.2010.01.009; Hoffman L, 2005, PSYCHOL AGING, V20, P610, DOI 10.1037/0882-7974.20.4.610; Hoffman L, 2010, PSYCHOL AGING, V25, P741, DOI 10.1037/a0019198; Hood DC, 2012, DOC OPHTHALMOL, V124, P1, DOI 10.1007/s10633-011-9296-8; Huurneman B, 2012, STRABISMUS, V20, P55, DOI 10.3109/09273972.2012.680230; Kleiner M, 2007, PERCEPTION, V36, P14; Lunsman M, 2008, PSYCHOL AGING, V23, P917, DOI 10.1037/a0013466; Matas NA, 2014, ACCIDENT ANAL PREV, V70, P74, DOI 10.1016/j.aap.2014.03.011; Mathias JL, 2009, INT PSYCHOGERIATR, V21, P637, DOI 10.1017/S1041610209009119; Negishi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147516; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Oshika T, 2006, OPHTHALMOLOGY, V113, P1807, DOI 10.1016/j.ophtha.2006.03.061; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Owsley C, 2016, ANNU REV VIS SCI, V2, P255, DOI 10.1146/annurev-vision-111815-114550; Owsley C, 2013, J GERONTOL A-BIOL, V68, P567, DOI 10.1093/gerona/gls185; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Scialfa CT, 2013, J GERONTOL B-PSYCHOL, V68, P522, DOI 10.1093/geronb/gbs086; Sekuler AB, 2000, EXP AGING RES, V26, P103, DOI 10.1080/036107300243588; Snellen H, 1873, PROBEBUCHSTABEN BEST; Snellen H., 1868, TEST TYPES DETERMINA; Told R, 2013, OPHTHALMOLOGE, V110, P960, DOI 10.1007/s00347-013-2813-2; Trick LM, 2010, ACCIDENT ANAL PREV, V42, P1661, DOI 10.1016/j.aap.2010.04.005; Vance DE, 2006, ACCIDENT ANAL PREV, V38, P823, DOI 10.1016/j.aap.2006.02.008; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Visual Awareness Research Group Inc, 2009, UFOV US GUID 6 1 4; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Weaver B, 2009, ACCIDENT ANAL PREV, V41, P76, DOI 10.1016/j.aap.2008.09.006; Woutersen K., 2017, J VIS, V17, P1, DOI [DOI 10.1167/17.14.1, 10.1167/17.14.1]; Yehezkel O, 2015, J VISION, V15, DOI 10.1167/15.6.12	56	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196534	10.1371/journal.pone.0196534	http://dx.doi.org/10.1371/journal.pone.0196534			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5RZ	29715316	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281100031
J	Lee, KM; Woo, SJ; Hwang, JM				Lee, Kyoung Min; Woo, Se Joon; Hwang, Jeong-Min			Factors associated with visual field defects of optic disc drusen	PLOS ONE			English	Article							NERVE HEAD DRUSEN; COHERENCE-TOMOGRAPHY; FIBER LAYER; AUTOMATED PERIMETRY; LOCATION; CHILDREN; EYES	Purpose To investigate the prevalence and risk factors for visual field defect in patients with optic disc drusen (ODD). Methods We assessed the visual field status of patients with ODD whose diagnosis were confirmed by spectral-domain optical coherence tomography (SD-OCT). Visual field defects were classified as normal, enlarged blind spot, or other defects. ODD were classified into either type 1 (without hyperreflective border and heterogenic internal reflectance) or type 2 (with hyperreflective border and lower internal reflectance). The prevalence and risk factors for each visual field defect was analyzed using logistic regression analysis and classification and regression tree (CART) modeling. Results Of the 40 eyes with ODD, 33 (83%) eyes were categorized as type 1 and 7 (17%) eyes were categorized as type 2 ODD. Regarding the visual field defects, 19 (48%) eyes showed normal visual field, 11 (28%) eyes showed enlarged blind spot, and 9 (24%) eyes showed other defects. The latter was more frequent in type 2 ODD (P = 0.001). Logistic regression analysis revealed that the factor associated with other defects was the thinning of the average retinal nerve fiber layer (RNFL) (per 10 mu m decrease, OR = 3.436, P = 0.004), and the factor associated with enlarged blind spot was the height of ODD (per 100 mu m increase, OR = 3.956, P = 0.023). CART modeling revealed that the average RNFL thickness lesser than 85.5 mu m, and then the ODD height larger than 348 mu m were the best split-up factors for predicting the type of visual field defects. Conclusions In this study, one-quarter of ODD patients showed abnormal visual field defect other than enlarged blind spot. These other visual field defects appeared to be associated with the axonal loss in the eyes with type 2 ODD.	[Lee, Kyoung Min] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Ophthalmol, Seoul, South Korea; [Woo, Se Joon; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Seongnam, Gyeonggi, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Seongnam, Gyeonggi, South Korea.	hjm@snu.ac.kr			Korea Health 21 R&D Project, Ministry of health, welfare and family affairs, Republic of Korea [A080299]	Korea Health 21 R&D Project, Ministry of health, welfare and family affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of health, welfare and family affairs, Republic of Korea (A080299). The funding organization had no role in the design or conduct of this research.	Auw-Haedrich C, 2002, SURV OPHTHALMOL, V47, P515, DOI 10.1016/S0039-6257(02)00357-0; BECK RW, 1985, ARCH OPHTHALMOL-CHIC, V103, P1155; Casado A, 2014, GRAEF ARCH CLIN EXP, V252, P1653, DOI 10.1007/s00417-014-2773-5; Chang MY, 2016, SURV OPHTHALMOL, V61, P745, DOI 10.1016/j.survophthal.2016.03.007; Ferreras A, 2008, INVEST OPHTH VIS SCI, V49, P3018, DOI 10.1167/iovs.08-1775; Fledelius HC, 2017, EUR J OPHTHALMOL, V27, P372, DOI 10.5301/ejo.5000864; Gili P, 2013, GRAEF ARCH CLIN EXP, V251, P2421, DOI 10.1007/s00417-013-2438-9; Hoover D L, 1988, J Pediatr Ophthalmol Strabismus, V25, P191; Katz BJ, 2006, AM J OPHTHALMOL, V141, P248, DOI 10.1016/j.ajo.2005.09.029; Lee AG, 2005, AM J OPHTHALMOL, V139, P1062, DOI 10.1016/j.ajo.2005.01.020; Lee KM, 2018, J NEUROOPHT IN PRESS; Lee KM, 2017, ACTA OPHTHALMOL, V95, pE329, DOI 10.1111/aos.13338; Lee KM, 2017, CAN J OPHTHALMOL, V52, pE52, DOI 10.1016/j.jcjo.2016.09.004; Lee KM, 2015, OPTOMETRY VISION SCI, V92, pS67, DOI 10.1097/OPX.0000000000000525; Lee KM, 2014, RETINA-J RET VIT DIS, V34, P1142, DOI 10.1097/IAE.0000000000000040; Lee KM, 2013, AM J OPHTHALMOL, V155, P1139, DOI 10.1016/j.ajo.2013.01.024; Lee KM, 2011, OPHTHALMOLOGY, V118, P971, DOI 10.1016/j.ophtha.2010.09.006; Loh W.Y., 2008, ENCY STAT QUALITY RE; Lorentzen SE, 1966, ACTA OPHTHALMOL, P1; Malmqvist L, 2017, J NEURO-OPHTHALMOL, DOI [10.1097/wno, DOI 10.1097/WNO]; Malmqvist L, 2017, INVEST OPHTH VIS SCI, V58, P3491, DOI 10.1167/iovs.17-21608; Malmqvist L, 2016, J NEURO-OPHTHALMOL, V36, P41, DOI 10.1097/WNO.0000000000000325; Merchant KY, 2013, OPHTHALMOLOGY, V120, P1409, DOI 10.1016/j.ophtha.2012.12.035; MUSTONEN E, 1983, ACTA OPHTHALMOL, V61, P1057; Noval S, 2013, GRAEF ARCH CLIN EXP, V251, P2445, DOI 10.1007/s00417-013-2384-6; Nowomiejska K, 2009, ACTA OPHTHALMOL, V87, P801, DOI 10.1111/j.1755-3768.2008.01364.x; Pinto LA, 2014, ACTA OPHTHALMOL, V92, pe286, DOI 10.1111/aos.12314; Sato T, 2013, AM J OPHTHALMOL, V156, P275, DOI 10.1016/j.ajo.2013.03.039; SCHOLL GB, 1992, ARCH OPHTHALMOL-CHIC, V110, P75, DOI 10.1001/archopht.1992.01080130077029; SPENCER WH, 1978, OPHTHALMOLOGY, V85, P21; STEVENS RA, 1981, AM J OPHTHALMOL, V92, P857, DOI 10.1016/S0002-9394(14)75644-2; Traber GL, 2017, OPHTHALMOLOGY, V124, P66, DOI 10.1016/j.ophtha.2016.09.022; TSO MOM, 1981, OPHTHALMOLOGY, V88, P1066; Wang DD, 2018, EYE, V32, P1145, DOI 10.1038/s41433-017-0009-8; Wilkins JM, 2004, J NEURO-OPHTHALMOL, V24, P125, DOI 10.1097/00041327-200406000-00006; Yi K, 2009, J GLAUCOMA, V18, P373, DOI 10.1097/IJG.0b013e31818624a4	36	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196001	10.1371/journal.pone.0196001	http://dx.doi.org/10.1371/journal.pone.0196001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708976	Green Published, gold, Green Submitted			2022-12-26	WOS:000431130100012
J	Okubo, H; Ando, H; Sorin, Y; Nakadera, E; Fukada, H; Morishige, J; Miyazaki, A; Ikejima, K				Okubo, Hironao; Ando, Hitoshi; Sorin, Yushi; Nakadera, Eisuke; Fukada, Hiroo; Morishige, Junichi; Miyazaki, Akihisa; Ikejima, Kenichi			Gadoxetic acid-enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C	PLOS ONE			English	Article							ORGANIC ANION TRANSPORTERS; RANDOMIZED PHASE-3 TRIAL; JAPANESE PATIENTS; HEPATOCELLULAR-CARCINOMA; VIRUS TREATMENT; POLYPEPTIDE; OMBITASVIR; DASABUVIR; CIRRHOSIS; FIBROSIS	Background Paritaprevir inhibits organic anion-transporting polypeptide (OATP)1B1 and OATP1B3, which transport bilirubin. Hyperbilirubinemia is an adverse event reported during hepatitis C treatment. Gadoxetic acid is also transported by OATP1B1/1B3. We evaluated whether the enhancement effect in gadoxetic acid-enhanced magnetic resonance (MR) imaging could predict the plasma concentration of paritaprevir and might anticipate the development of hyperbilirubinemia. Methods This prospective study evaluated 27 patients with hepatitis C who underwent gadoxetic acid-enhanced MR imaging prior to treatment with ombitasvir, paritaprevir, and ritonavir. The contrast enhancement index (CEI), a measure of liver enhancement during the hepatobiliary phase, was assessed. Plasma trough concentrations, and concentrations at 2, 4, and 6 h after dosing were determined 7 d after the start of treatment. Results Seven patients (26%) developed hyperbilirubinemia (>= 1.6 mg/dl). Paritaprevir trough concentration (C-trough) was significantly higher in patients with hyperbilirubinemia than in those without (p = 0.022). We found an inverse relationship between CEI and C-trough (r = 0.612, p = 0.001), while there was not a significantly weak inverse relationship between AUC(0-6 h) and CEI (r = -0.338, p = 0.085). The partial correlation coefficient between CEI and C-trough was -0.425 (p = 0.034), while excluding the effects of albumin and the FIB-4 index. Receiver operating characteristic (ROC) curve analysis showed that the CEI was relatively accurate in predicting hyperbilirubinemia, with area under the ROC of 0.882. Multivariate analysis showed that the CEI < 1.61 was the only independent predictor related to the development of hyperbilirubinemia, with an odds ratio of 9.08 (95% confidence interval 1.05-78.86, p = 0.046). Conclusions Hepatic enhancement with gadoxetic acid was independently related to paritaprevir concentration and was an independent pretreatment factor in predicting hyperbilirubinemia. Gadoxetic acid-enhanced MR imaging can therefore be useful in determining the risk of paritaprevir-induced hyperbilirubinemia.	[Okubo, Hironao; Sorin, Yushi; Nakadera, Eisuke; Fukada, Hiroo; Miyazaki, Akihisa] Juntendo Univ, Nerima Hosp, Dept Gastroenterol, Tokyo, Japan; [Ando, Hitoshi; Morishige, Junichi] Kanazawa Univ, Grad Sch Med Sci, Dept Cellular & Mol Funct Anal, Kanazawa, Ishikawa, Japan; [Ikejima, Kenichi] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo, Japan	Juntendo University; Kanazawa University; Juntendo University	Okubo, H (corresponding author), Juntendo Univ, Nerima Hosp, Dept Gastroenterol, Tokyo, Japan.	drokubo@juntendo-nerima.jp	ANDO, Hitoshi/O-8199-2016	ANDO, Hitoshi/0000-0001-6179-9993; Ikejima, Kenichi/0000-0002-2657-0840				Akai H, 2012, EUR J RADIOL, V81, P2973, DOI 10.1016/j.ejrad.2012.01.007; Bae KE, 2012, DIGEST DIS, V30, P617, DOI 10.1159/000343092; Chung H, 2010, INTERVIROLOGY, V53, P39, DOI 10.1159/000252782; Cieszanowski A, 2013, EUR J RADIOL, V82, P2176, DOI 10.1016/j.ejrad.2013.08.021; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Cui Y, 2001, J BIOL CHEM, V276, P9626, DOI 10.1074/jbc.M004968200; Furihata T, 2015, INT J ANTIMICROB AG, V46, P381, DOI 10.1016/j.ijantimicag.2015.05.013; Geddawy A, 2017, J TRANSL INTERN MED, V5, P8, DOI 10.1515/jtim-2017-0007; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gopalakrishnan SM, 2017, CLIN PHARMACOKINET, V56, P1, DOI 10.1007/s40262-016-0423-2; Goshima S, 2012, J MAGN RESON IMAGING, V36, P1148, DOI 10.1002/jmri.23758; Hagenbuch B, 2013, MOL ASPECTS MED, V34, P396, DOI 10.1016/j.mam.2012.10.009; Kumada H, 2015, HEPATOLOGY, V62, P1037, DOI 10.1002/hep.27972; Kumazawa K, 2012, HEPATOL RES, V42, P1081, DOI 10.1111/j.1872-034X.2012.01027.x; Leonhardt M, 2010, DRUG METAB DISPOS, V38, P1024, DOI 10.1124/dmd.110.032862; Liu CH, 2018, J GASTROEN HEPATOL, V33, P710, DOI 10.1111/jgh.13912; Matsuzaka Y, 2015, MOL PHARMACOL, V88, P1085, DOI 10.1124/mol.115.100578; Menon RM, 2016, BRIT J CLIN PHARMACO, V81, P929, DOI 10.1111/bcp.12873; Menon RM, 2015, J HEPATOL, V63, P20, DOI 10.1016/j.jhep.2015.01.026; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Nakai K, 2008, DRUG METAB DISPOS, V36, P1786, DOI 10.1124/dmd.107.020073; Nassif A, 2012, RADIOLOGY, V264, P741, DOI 10.1148/radiol.12112061; Nozawa T, 2005, DRUG METAB DISPOS, V33, P434, DOI 10.1124/dmd.104.001909; Okubo H, 2017, J CLIN PHARMACOL, V57, P369, DOI 10.1002/jcph.811; Okubo H, 2013, HEPATO-GASTROENTEROL, V60, P1547, DOI 10.5754/hge.13291; Okubo H, 2013, PHARMACOGENOMICS, V14, P1573, DOI 10.2217/pgs.13.132; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Sane RS, 2014, J PHARMACOL EXP THER, V351, P403, DOI 10.1124/jpet.114.218081; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Sato K, 2017, ADV THER, V34, P1449, DOI 10.1007/s12325-017-0506-y; Shebley M, 2017, DRUG METAB DISPOS, V45, P755, DOI 10.1124/dmd.116.074518; Smith NF, 2005, CANCER BIOL THER, V4, P815, DOI 10.4161/cbt.4.8.1867; Teschke R, 2017, EXPERT OPIN DRUG MET, V13, P425, DOI 10.1080/17425255.2017.1252749; Tomita Y, 2013, CLIN PHARMACOL THER, V94, P37, DOI 10.1038/clpt.2012.221; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Vanwelkenhuysen I, 2014, J CHROMATOGR B, V958, P43, DOI 10.1016/j.jchromb.2014.02.028; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; Yamaguchi H, 2008, CANCER LETT, V260, P163, DOI 10.1016/j.canlet.2007.10.040; Yamaguchi H, 2006, J LIPID RES, V47, P1196, DOI 10.1194/jlr.M500532-JLR200	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196747	10.1371/journal.pone.0196747	http://dx.doi.org/10.1371/journal.pone.0196747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709031	gold, Green Published, Green Submitted			2022-12-26	WOS:000431130100057
J	Franco-Munoz, C; Manjarres-Estremor, M; Ovalle-Bracho, C				Franco-Munoz, Carlos; Manjarres-Estremor, Merab; Ovalle-Bracho, Clemencia			Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia	PLOS ONE			English	Article							VITRO DRUG SUSCEPTIBILITY; VISCERAL LEISHMANIASIS; RESISTANCE; DONOVANI; SENSITIVITY; INFANTUM; GENE; IDENTIFICATION; AMPLIFICATION; AMASTIGOTES	Amphotericin B (AmB) is a recommended medication for the treatment of cutaneous and mucosal leishmaniasis in cases of therapeutic failure with first-line medications; however, little is known about the in vitro susceptibility to AmB of clinical isolates of the subgenus Viannia, which is most prevalent in South America. This work aimed to determine the in vitro susceptibility profiles to AmB of clinical isolates of the species L. (V.) panamensis, L. (V.) guyanensis and L. (V.) braziliensis. In vitro susceptibility to AmB was evaluated for 65 isolates. Macrophages derived from the U937 cell line were infected with promastigotes and exposed to different AmB concentrations. After 96 hours, the number of intracellular amastigotes was quantified by qPCR, and median effective concentration (EC50) was determined using the PROBIT model. The controls included sensitive strains and experimentally derived less sensitive strains generated in vitro, which presented EC50 values up to 7.57-fold higher than the values of the sensitive strains. The isolates were classified into groups according to their in vitro susceptibility profiles using Ward's hierarchical method. The susceptibility to AmB differed in an intraspecies-specific manner as follows: 28.21% (11/39) of L. (V.) panamensis strains, 50% (3/6) of L. (V.) guyanensis strains and 34.61% (9/26) of L. (V.) braziliensis strains were classified as less sensitive. The latter subset featured three susceptibility groups. We identified Colombian isolates with different AmB susceptibility profiles. In addition, the capacity of species of subgenus Viannia to develop lower susceptibility to AmB was demonstrated in vitro. These new findings should be considered in the pharmacovigilance of AmB in Colombia and South America.	[Franco-Munoz, Carlos; Manjarres-Estremor, Merab; Ovalle-Bracho, Clemencia] Hosp Univ Ctr Dermatol Federico Lleras Acosta ESE, Bogota, Colombia		Ovalle-Bracho, C (corresponding author), Hosp Univ Ctr Dermatol Federico Lleras Acosta ESE, Bogota, Colombia.	clemovalle@gmail.com	Ovalle-bracho, Clemencia/O-4004-2018		Centro Dermatologico Federico Lleras Acosta Project [4000.16.1U]	Centro Dermatologico Federico Lleras Acosta Project	This work was funded by Centro Dermatologico Federico Lleras Acosta Project ID: 4000.16.1U to CO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mohammed HI, 2005, ANTIMICROB AGENTS CH, V49, P3274, DOI 10.1128/AAC.49.8.3274-3280.2005; [Anonymous], 2010, GUIA AT CLIN INT PAC; Bekersky I, 2002, ANTIMICROB AGENTS CH, V46, P834, DOI 10.1128/AAC.46.3.834-840.2002; Berman JD, 1998, B WORLD HEALTH ORGAN, V76, P25; CORREDOR A, 1990, AM J TROP MED HYG, V42, P206; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Crump JA, 2008, ANTIMICROB AGENTS CH, V52, P1278, DOI 10.1128/AAC.01509-07; Cruz-Barrera ML, 2015, J CLIN MICROBIOL, V53, P1339, DOI 10.1128/JCM.02955-14; de Morais-Teixeira E, 2014, J ANTIMICROB CHEMOTH, V69, P150, DOI 10.1093/jac/dkt318; Di Giorgio C, 1999, J ANTIMICROB CHEMOTH, V44, P71, DOI 10.1093/jac/44.1.71; Durand R, 1998, ANTIMICROB AGENTS CH, V42, P2141, DOI 10.1128/AAC.42.8.2141; Equbal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097600; Escobar P, 2002, ACTA TROP, V81, P151, DOI 10.1016/S0001-706X(01)00197-8; Espuelas S, 2000, ANTIMICROB AGENTS CH, V44, P2190, DOI 10.1128/AAC.44.8.2190-2192.2000; Fernandez O, 2012, J CLIN MICROBIOL, V50, P2207, DOI 10.1128/JCM.00216-12; Ginouves M, 2017, AM J TROP MED HYG, V96, P1143, DOI 10.4269/ajtmh.16-0373; Gonzalez G, 2009, EXP PARASITOL, V122, P353, DOI 10.1016/j.exppara.2009.05.005; Gonzalez U, 2009, COCHRANE DB SYST REV, V15, DOI DOI 10.1002/14651858.CD004834; HANDMAN E, 1983, MOL BIOCHEM PARASIT, V7, P111, DOI 10.1016/0166-6851(83)90039-7; HASSAN MQ, 1992, J BIOSCIENCES, V17, P55, DOI 10.1007/BF02716774; Kumar A, 2014, ANTIMICROB AGENTS CH, V58, P6172, DOI 10.1128/AAC.02834-14; Fernandez OL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002871; Maia C, 2013, EXP PARASITOL, V135, P36, DOI 10.1016/j.exppara.2013.05.015; Marfurt J, 2003, J CLIN MICROBIOL, V41, P3147, DOI 10.1128/JCM.41.7.3147-3153.2003; Mbongo N, 1998, ANTIMICROB AGENTS CH, V42, P352; MILLER SI, 1986, NUCLEIC ACIDS RES, V14, P7341, DOI 10.1093/nar/14.18.7341; MOREIRA ESA, 1995, PARASITOL RES, V81, P291, DOI 10.1007/BF00931532; Morizot G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004304; MUHICH ML, 1987, NUCLEIC ACIDS RES, V15, P3141, DOI 10.1093/nar/15.7.3141; Mwenechanya R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005649; Natera S, 2007, INT J ANTIMICROB AG, V29, P637, DOI 10.1016/j.ijantimicag.2007.01.004; Nonata R, 1997, Trans R Soc Trop Med Hyg, V91, P77; OMS. Organizacao Mundial da Safide, 2010, CONTR LEISHM; Organizacion Panamericana de la Salud (OPS), 2013, LEISHM AM REC TRAT; Ovalle-Bracho C, 2016, INT J DERMATOL, V55, P531, DOI 10.1111/ijd.12910; Pardo CE, 2007, REV COLOMB ESTAD, P30; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Ravinetto R, 2016, TROP MED INT HEALTH, V21, P1490, DOI 10.1111/tmi.12784; Reveiz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061843; Rocio C, 2014, T ROY SOC TROP MED H, V108, P176, DOI 10.1093/trstmh/tru011; Rodriguez MC, 2017, J AM ACAD DERMATOL, V76, pAB111; SALAMANCA CAPUSIRI EFRAIN¹, 2015, Rev.Cs.Farm. y Bioq, V3, P29; Sampaio R N, 1997, Rev Soc Bras Med Trop, V30, P125, DOI 10.1590/S0037-86821997000200007; SAMPAIO S A P, 1971, International Journal of Dermatology, V10, P179, DOI 10.1111/j.1365-4362.1971.tb01694.x; Shaw JJ, 2002, WORLD CL PARASITES, V4, P11; Singh AK, 2001, EXP PARASITOL, V99, P141, DOI 10.1006/expr.2001.4663; Singh K, 2017, REDOX BIOL, V12, P350, DOI 10.1016/j.redox.2017.03.004; Srivastava P, 2011, J CLIN MICROBIOL, V49, P3088, DOI 10.1128/JCM.00173-11; Suman SS, 2016, BIOCHIMIE, V121, P312, DOI 10.1016/j.biochi.2015.12.017; Szekely GJ, 2005, J CLASSIF, V22, P151, DOI 10.1007/s00357-005-0012-9; Tiuman TS, 2011, INT J INFECT DIS, V15, pE525, DOI 10.1016/j.ijid.2011.03.021; Varela RE, 2009, EXP PARASITOL, V122, P134, DOI 10.1016/j.exppara.2009.02.012; Wortmann G, 2010, AM J TROP MED HYG, V83, P1028, DOI 10.4269/ajtmh.2010.10-0171; Yardley V, 2005, AM J TROP MED HYG, V73, P272, DOI 10.4269/ajtmh.2005.73.272; Zauli-Nascimento RC, 2010, TROP MED INT HEALTH, V15, P68, DOI 10.1111/j.1365-3156.2009.02414.x	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196247	10.1371/journal.pone.0196247	http://dx.doi.org/10.1371/journal.pone.0196247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698432	Green Submitted, gold, Green Published			2022-12-26	WOS:000431007600050
J	Hasan, SMT; Rahman, S; Locks, LM; Rahman, M; Hore, SK; Sacieeb, KN; Khan, MA; Ahmed, T				Hasan, S. M. Tafsir; Rahman, Sabuktagin; Locks, Lindsey Mina; Rahman, Mizanur; Hore, Samar Kumar; Sacieeb, Kazi Nazmus; Khan, Md. Alfazal; Ahmed, Tahmeed			Magnitude and determinants of inadequate third-trimester weight gain in rural Bangladesh	PLOS ONE			English	Article							ARSENIC EXPOSURE; BIRTH-WEIGHT; BODY-MASS; PREGNANCY; NUTRITION; OUTCOMES; PATTERN; WOMEN	Objectives The objective of this study was to estimate the magnitude and determinants of inadequate weight gain in the third-trimester among rural women in Matlab,Bangladesh. Methods The study analyzed data on weight gain in the third trimester in 1,883 pregnant women in Matlab, Bangladesh. All these women were admitted to Matlab hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) for childbirth during 2012-2014, and they had singleton live births at term. Data were retrieved from the electronic databases of Matlab Health and Demographic Surveillance System and Matlab hospital. A multivariable logistic regression for inadequate weight gain in the third trimester (<= 4 kg) was built with sociodemographic, environmental and maternal factors as predictors. Results One thousand and twenty-six (54%) pregnant women had inadequate weight gain in the third trimester. In the multivariable model, short stature turned out to be the most robust risk factor for inadequate weight gain in the third trimester (OR = 2.5; 95% CI 1.8, 3.5 for short compared to tall women). Pre-third-trimester BMI was inversely associated with insufficient weight gain (OR = 0.96; 95% CI 0.93, 0.99 for 1 unit increase in BMI). Other risk factors for inadequate weight gain in the third trimester were advanced age (OR = 1.9; 95% CI 1.2, 3.1 for >= 35 years compared to <= 19 years), parity (OR = 1.5; 95% CI 1.2, 1.9 for multipara compared to nulliparous women), low socioeconomic status (OR = 1.7; 95% CI 1.2, 2.3 for women in the lowest compared to women in the highest wealth quintile), low level of education (OR = 1.6; 95% CI 1.2, 2.1 for <= 5 years compared to >= 10 years of education), belonging to the Hindu religious community (OR = 1.8; 95% CI 1.3, 2.5), consuming arsenic-contaminated water (OR = 1.4; 95% CI 1.1, 1.9), and conceiving during monsoon or dry season compared to summer (OR = 1.4; 95% CI 1.1, 1.8). Conclusions Among rural Bangladeshi women in Matlab, third-trimester weight gain was in general poor. Maternal characteristics such as short stature, low BMI, advanced age, parity, low level of education and socioeconomic status, being Hindu, intake of arsenic contaminated water, and conceiving during monsoon or dry season were the risk factors for inadequate weight gain in the third trimester. Special attention should be given during prenatal care to women with the risk factors identified in this study.	[Hasan, S. M. Tafsir; Rahman, Sabuktagin; Sacieeb, Kazi Nazmus; Khan, Md. Alfazal; Ahmed, Tahmeed] Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Locks, Lindsey Mina] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Rahman, Mizanur] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Hore, Samar Kumar] Icddr B, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Rahman, Sabuktagin] Griffith Univ, Sch Med, Publ Hlth, Gold Coast, Qld, Australia	International Centre for Diarrhoeal Disease Research (ICDDR); Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; International Centre for Diarrhoeal Disease Research (ICDDR); Griffith University	Ahmed, T (corresponding author), Icddr B, Nutr & Clin Serv Div, Dhaka, Bangladesh.	tahmeed@icddrb.org	Hasan, S. M. Tafsir/AAK-6954-2020; Locks, Lindsey M/H-9225-2019	Hasan, S. M. Tafsir/0000-0002-6062-4072; Locks, Lindsey M/0000-0002-0019-9545; Khan, Md Alfazal/0000-0002-7916-482X	Swedish International Development Cooperation Agency (Sida); Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	Swedish International Development Cooperation Agency (Sida); Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This research study was funded by Swedish International Development Cooperation Agency (Sida). icddr.b acknowledges with gratitude the commitment of Sida to its research efforts. icddr.b is also grateful to the Governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysena C, 2011, J OBSTET GYNAECOL RE, V37, P734, DOI 10.1111/j.1447-0756.2010.01421.x; Abou-Zahr CL, 2003, ANTENATAL CARE DEV C, P1990; ABRAMS B, 1995, OBSTET GYNECOL, V86, P170, DOI 10.1016/0029-7844(95)00119-C; Ahmed T, 2005, NATL NUTR PROGRAMME; Alam DS, 2003, EUR J CLIN NUTR, V57, P151, DOI 10.1038/sj.ejcn.1601514; Aliyu AA, 2017, PAN AFRICAN MED J, V26; [Anonymous], 2014, SEAS; Asefa F, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0225-x; Bisai S., 2010, ETHIOPIAN J HLTH SCI, V20, P153; Coffey D, 2015, P NATL ACAD SCI USA, V112, P3302, DOI 10.1073/pnas.1416964112; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Drehmer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054704; Durie DE, 2011, OBSTET GYNECOL, V118, P569, DOI 10.1097/AOG.0b013e3182289f42; Farhangi MA, 2016, ECOL FOOD NUTR, V55, P258, DOI 10.1080/03670244.2016.1147437; FORD K, 1989, DEMOGRAPHY, V26, P425, DOI 10.2307/2061602; Fraser A, 2011, AM J CLIN NUTR, V93, P1285, DOI 10.3945/ajcn.110.008326; GOODBURN EA, 1995, STUD FAMILY PLANN, V26, P22, DOI 10.2307/2138048; HEDIGER ML, 1989, OBSTET GYNECOL, V74, P6; Hill B, 2016, WOMEN HEALTH ISS, V26, P123, DOI 10.1016/j.whi.2015.09.012; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Icddr b, 2016, HLTH DEM SURV SYST M, V48; icddrb, 2016, HLTH DEMOGRAPHIC SUR; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Ismail LC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i555; Jahan K, 2014, FOOD NUTR BULL, V35, P414, DOI 10.1177/156482651403500403; KATONA-APTE J, 1977, Journal of Tropical Pediatrics and Environmental Child Health, V23, P83; Kile ML, 2016, EPIDEMIOLOGY, V27, P173, DOI 10.1097/EDE.0000000000000416; King JC, 1987, ENERGY NUTR WOMEN, V52, P71; Kisuule I, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-121; LAWTON FG, 1988, BRIT J OBSTET GYNAEC, V95, P884, DOI 10.1111/j.1471-0528.1988.tb06574.x; MedCalc, LOGISTIC REGRESSION; Mola GDL, 2011, PAPUA NEW GUINEA MED, V54, P164; National Institute for Health and Care Excellence [NICE], 2010, DEL PREV DIAGN MAN N, P1; National Institutes of Health. Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2013, PREGN COND INF; Nyaruhucha C N M, 2006, Tanzan Health Res Bull, V8, P41; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Picciano MF, 2003, J NUTR, V133, p1997S, DOI 10.1093/jn/133.6.1997S; PITKIN RM, 1977, MED CLIN N AM, V61, P3, DOI 10.1016/S0025-7125(16)31346-3; Rahman A, 2007, AM J EPIDEMIOL, V165, P1389, DOI 10.1093/aje/kwm025; Raje L, 2012, J DEV ORIG HLTH DIS, V3, P387, DOI 10.1017/S2040174412000335; SIEGARIZ AM, 1994, OBSTET GYNECOL, V84, P565; U. S. National Library of Medicine. PubMed Health, PREGN TRIM; WHO/UNICEF/UNU, 2001, IRON DEFICIENCY ANAE; Zerfu TA, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0059-8	45	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196190	10.1371/journal.pone.0196190	http://dx.doi.org/10.1371/journal.pone.0196190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1WN	29698483	Green Published, gold			2022-12-26	WOS:000431007600044
J	Ma, YL; Gu, LT; Yang, LB; Sun, CH; Xie, SS; Fang, CC; Gong, YZ; Li, SJ				Ma, Yunlong; Gu, Lantao; Yang, Liubin; Sun, Chenghao; Xie, Shengsong; Fang, Chengchi; Gong, Yangzhang; Li, Shijun			Identifying artificial selection signals in the chicken genome	PLOS ONE			English	Article							MOLECULAR POPULATION-GENETICS; SOFT SWEEPS; POSITIVE SELECTION; ADAPTATION; EXPRESSION; GROWTH; ASSOCIATION; STATISTICS; SIGNATURES; MUTATION	Identifying the signals of artificial selection can contribute to further shaping economically important traits. Here, a chicken 600k SNP-array was employed to detect the signals of artificial selection using 331 individuals from 9 breeds, including Jingfen (JF), Jinghong (JH), Araucanas (AR), White Leghorn (WL), Pekin-Bantam (PB), Shamo (SH), Gallus-Gallus-Spadiceus (GA), Rheinlander (RH) and Vorwerkhuhn (VO). Per the population genetic structure, 9 breeds were combined into 5 breed-pools, and a 'two-step' strategy was used to reveal the signals of artificial selection. GA, which has little artificial selection, was defined as the reference population, and a total of 204, 155, 305 and 323 potential artificial selection signals were identified in AR_VO, PB, RH_WL and JH_JF, respectively. We also found signals derived from standing and de-novo genetic variations have contributed to adaptive evolution during artificial selection. Further enrichment analysis suggests that the genomic regions of artificial selection signals harbour genes, including THSR, PTHLH and PMCH, responsible for economic traits, such as fertility, growth and immunization. Overall, this study found a series of genes that contribute to the improvement of chicken breeds and revealed the genetic mechanisms of adaptive evolution, which can be used as fundamental information in future chicken functional genomics study.	[Ma, Yunlong; Gu, Lantao; Yang, Liubin; Xie, Shengsong; Fang, Chengchi; Gong, Yangzhang; Li, Shijun] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Hubei, Peoples R China; [Ma, Yunlong; Gu, Lantao; Yang, Liubin; Xie, Shengsong; Fang, Chengchi; Gong, Yangzhang; Li, Shijun] Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Wuhan, Hubei, Peoples R China; [Sun, Chenghao] Huadu Yukou Poultry Ind Co Ltd, Beijing, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Li, SJ (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Hubei, Peoples R China.; Li, SJ (corresponding author), Huazhong Agr Univ, Key Lab Swine Genet & Breeding, Minist Agr, Wuhan, Hubei, Peoples R China.	lishijun@mail.hzau.edu.cn		Ma, Yunlong/0000-0002-9892-3887	National Natural Science Foundation of China [31772585, 31601916]; Fundamental Research Funds for the Central Universities [0900202930, 2662015QD018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was financially supported by the National Natural Science Foundation of China (31772585, 31601916) and the Fundamental Research Funds for the Central Universities (0900202930, 2662015QD018). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Ai HS, 2015, NAT GENET, V47, P217, DOI 10.1038/ng.3199; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berti F, 2015, J ANAT, V227, P361, DOI 10.1111/joa.12353; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Connell S, 2013, G3-GENES GENOM GENET, V3, P881, DOI 10.1534/g3.113.006031; Dale MD, 2015, INT J MOL SCI, V16, P2663, DOI 10.3390/ijms16022663; Dunn IC, 2009, GEN COMP ENDOCR, V163, P225, DOI 10.1016/j.ygcen.2009.03.006; Eriksson J, 2012, ACTA U UPSALIENSIS; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Fan Y-F, 2013, BMC GENET, V14, P1; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Lee J, 2015, MOL GENET GENOMICS, V290, P1673, DOI 10.1007/s00438-015-1025-7; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Li S., 2011, J METALL, V2011, P1, DOI DOI 10.1109/ICBBE.2011.5781379; Lindholm-Perry AK, 2016, ANIM GENET, V47, P408, DOI 10.1111/age.12440; Ma Y, 2015, HEREDITY, V115, P426, DOI 10.1038/hdy.2015.42; Marie P, 2015, DATA BRIEF, V4, P430, DOI 10.1016/j.dib.2015.06.019; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Okamoto R, 2015, DEV GROWTH DIFFER, V57, P24, DOI 10.1111/dgd.12185; Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186; Pennings PS, 2006, MOL BIOL EVOL, V23, P1076, DOI 10.1093/molbev/msj117; Perrins C, 2003, FIREFLY ENCY BIRDS; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Psifidi A, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0252-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2015, GENOME BIOL EVOL, V7, P3299, DOI 10.1093/gbe/evv222; Qanbari S, 2014, LIVEST SCI, V166, P133, DOI 10.1016/j.livsci.2014.05.003; Qanbari S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004148; Reemers SS, 2009, J GEN VIROL, V90, P2134, DOI 10.1099/vir.0.012401-0; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Savarese MC, 2003, ITAL J ANIM SCI, V2, P64, DOI 10.4081/ijas.2003.s1.64; Schubert M, 2000, DEV DYNAM, V217, P205, DOI 10.1002/(SICI)1097-0177(200002)217:2<205::AID-DVDY7>3.0.CO;2-F; Sheng Z, 2015, GENOME BIOL, V16, P1; Suzuki Y, 2010, GENES GENET SYST, V85, P359, DOI 10.1266/ggs.85.359; Tang SQ, 2010, ANIM BIOTECHNOL, V21, P104, DOI 10.1080/10495390903328090; van Kaam JBCHM, 1998, LIVEST PROD SCI, V54, P133, DOI 10.1016/S0301-6226(97)00171-1; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vatsiou AI, 2016, MOL ECOL, V25, P89, DOI 10.1111/mec.13360; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yuan JW, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0161-1; Zhang H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-704; Zhang Y, 2010, CELL BIOL INT, V34, P1119, DOI 10.1042/CBI20090351	48	6	7	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196215	10.1371/journal.pone.0196215	http://dx.doi.org/10.1371/journal.pone.0196215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698423	Green Submitted, Green Published, gold			2022-12-26	WOS:000431007600045
J	Ohadi, S; Littlejohn, M; Mesgaran, M; Rooney, W; Bagavathiannan, M				Ohadi, Sara; Littlejohn, Matthew; Mesgaran, Mohsen; Rooney, William; Bagavathiannan, Muthukumar			Surveying the spatial distribution of feral sorghum (Sorghum bicolor L.) and its sympatry with johnsongrass (S. halepense) in South Texas	PLOS ONE			English	Article							OILSEED RAPE; PLANT INTRODUCTIONS; CULTIVATED SORGHUM; POPULATIONS; PERSISTENCE; IMPROVEMENT; FEEDSTOCK; DISPERSAL; MODEL; RISK	Sorghum (Sorghum bicolor) is an important grain and forage crop grown across the US. In some areas, sorghum can become feral along roadsides and other ruderal areas, as a result of seed spill during harvest or transport. In some of these situations, feral sorghum grows in or near established johnsongrass (S. halepense) populations. Johnsongrass, a wild relative of sorghum and an incredibly noxious weed, is capable of hybridizing with cultivated sorghum. Because commercial hybrid sorghum cultivars are produced with cytoplasmic male sterility, progeny of the hybrid crop which compose the founder feral populations also segregate for male sterility. Consequently, male sterility in feral sorghum may increase the risk of outcrossing with johnsongrass. Using field surveys and spatial modelling, the present study aimed at documenting the occurrence of feral sorghum and understanding the anthropogenic and environmental factors that influence its distribution. Further, this research documented the sympatry of feral sorghum and johnsongrass in the roadside habitat. A total of 2077 sites were visited during a systematic field survey conducted in fall 2014 in South Texas. Feral sorghum and johnsongrass were found in 360 and 939 sites, while the species co-existed at 48 sites (2.3% of all surveyed sites). The binary logistic analysis showed a significant association between the presence of feral sorghum and road type, road body-type, micro-topography of the sampling site, nearby land use, and the presence of johnsongrass, but no association with the distance to the nearest grain sorting facility. The probability of finding feral sorghum away from johnsongrass patches was generally higher than finding them co-occur in the same location. A probability map for spatial distribution of feral sorghum was developed using the nearby land use type and the regional habitat suitability for johnsongrass as two key predictors. Overall, results show that feral sorghum and johnsongrass co-occur at low frequencies in the roadside habitats of South Texas, but these low levels still present a significant opportunity for hybridization between the two species outside of cultivated fields.	[Ohadi, Sara; Littlejohn, Matthew; Mesgaran, Mohsen; Rooney, William; Bagavathiannan, Muthukumar] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Mesgaran, Mohsen] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Davis	Bagavathiannan, M (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	muthu@tamu.edu	mesgaran, mohsen danesh/Z-3700-2019	mesgaran, mohsen danesh/0000-0002-2738-5284; Bagavathiannan, Muthukumar/0000-0002-1107-7148				Adugna A, 2013, PLANT GENET RESOUR-C, V11, P196, DOI 10.1017/S1479262113000129; Ansong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080275; Arriola PE, 1996, AM J BOT, V83, P1153, DOI 10.2307/2446198; Bagavathiannan MV, 2008, AGR ECOSYST ENVIRON, V127, P1, DOI 10.1016/j.agee.2008.03.009; Bagavathiannan MV, 2010, EUPHYTICA, V173, P419, DOI 10.1007/s10681-010-0156-5; Bagavathiannan MV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148748; Benvenuti S, 2007, WEED BIOL MANAG, V7, P141, DOI 10.1111/j.1445-6664.2007.00249.x; DUARA BN, 1952, GENETICS, V37, P369; Duncan RP, 2014, METHODS ECOL EVOL, V5, P1255, DOI 10.1111/2041-210X.12288; Dweikat I, 2005, MOL BREEDING, V16, P93, DOI 10.1007/s11032-005-5021-1; Ejeta G, 2005, Crop Ferality and Volunteerism, P123; ENDRIZZI JOHN E., 1957, BOT GAZ, V119, P1, DOI 10.1086/335954; Garnier A, 2008, BASIC APPL ECOL, V9, P533, DOI 10.1016/j.baae.2007.08.014; GRESSEL J, 2005, CROP FERALITY VOLUNT; Han WG, 2012, COMPUT ELECTRON AGR, V84, P111, DOI 10.1016/j.compag.2012.03.005; Hoffman ML, 2002, WEED SCI, V50, P466, DOI 10.1614/0043-1745(2002)050[0466:USAAFM]2.0.CO;2; Hooftman DA, 2014, ANN BOT, V115, P147, DOI [10.1093/aob/mcu213PMID:25452253, DOI 10.1093/A0B/MCU213]; Korres NE, 2015, WEED TECHNOL, V29, P596, DOI 10.1614/WT-D-14-00152.1; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; LORENZ KJ, 1991, HDB CEREAL SCI TECHN; McWHORTER C. G., 1961, WEEDS, V9, P558, DOI 10.2307/4040804; Meffin R, 2015, AGR ECOSYST ENVIRON, V203, P119, DOI 10.1016/j.agee.2015.01.024; Morrell PL, 2005, MOL ECOL, V14, P2143, DOI 10.1111/j.1365-294X.2005.02579.x; Munier DJ, 2012, ENVIRON SCI POLLUT R, V19, P2281, DOI 10.1007/s11356-011-0733-8; Murray SC, 2008, CROP SCI, V48, P2180, DOI 10.2135/cropsci2008.01.0068; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pessel FD, 2001, THEOR APPL GENET, V102, P841, DOI 10.1007/s001220100583; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Pivard S, 2008, ECOL MODEL, V212, P147, DOI 10.1016/j.ecolmodel.2007.10.012; Pollnac F, 2012, BIOL INVASIONS, V14, P1753, DOI 10.1007/s10530-012-0188-y; Ratnavathi CV, 2011, SUGAR TECH, V13, P399, DOI 10.1007/s12355-011-0112-2; READER RJ, 1993, J ECOL, V81, P169, DOI 10.2307/2261232; Reichard SH, 2001, BIOSCIENCE, V51, P103, DOI 10.1641/0006-3568(2001)051[0103:HAAPOI]2.0.CO;2; Rooney WL, 2004, ADV AGRON, V83, P37, DOI 10.1016/S0065-2113(04)83002-5	34	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195511	10.1371/journal.pone.0195511	http://dx.doi.org/10.1371/journal.pone.0195511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698426	gold, Green Published			2022-12-26	WOS:000431007600010
J	Vazquez-Salazar, A; Becerra, A; Lazcano, A				Vazquez-Salazar, Alberto; Becerra, Arturo; Lazcano, Antonio			Evolutionary convergence in the biosyntheses of the imidazole moieties of histidine and purines	PLOS ONE			English	Article							PREBIOTIC SYNTHESIS; THERMUS-THERMOPHILUS; ORGANIC-COMPOUNDS; GENE DUPLICATION; AMINO-ACIDS; METAL-IONS; RNA; ADENINE; CATALYSIS; ORIGIN	Background The imidazole group is an ubiquitous chemical motif present in several key types of biomolecules. It is a structural moiety of purines, and plays a central role in biological catalysis as part of the side-chain of histidine, the amino acid most frequently found in the catalytic site of enzymes. Histidine biosynthesis starts with both ATP and the pentose phosphoribosyl pyrophosphate (PRPP), which is also the precursor for the de novo synthesis of purines. These two anabolic pathways are also connected by the imidazole intermediate 5-aminoimidazole-4-carboxamide ribotide (AICAR), which is synthesized in both routes but used only in purine biosynthesis. Rather surprisingly, the imidazole moieties of histidine and purines are synthesized by different, non-homologous enzymes. As discussed here, this phenomenon can be understood as a case of functional molecular convergence. Results In this work, we analyze these polyphyletic processes and argue that the independent origin of the corresponding enzymes is best explained by the differences in the function of each of the molecules to which the imidazole moiety is attached. Since the imidazole present in histidine is a catalytic moiety, its chemical arrangement allows it to act as an acid or a base. On the contrary, the de novo biosynthesis of purines starts with an activated ribose and all the successive intermediates are ribotides, with the key beta-glycosidic bondage joining the ribose and the imidazole moiety. This prevents purine ribonucleotides to exhibit any imidazole-dependent catalytic activity, and may have been the critical trait for the evolution of two separate imidazole-synthesizing-enzymes. We also suggest that, in evolutionary terms, the biosynthesis of purines predated that of histidine. Conclusions As reviewed here, other biosynthetic routes for imidazole molecules are also found in extant metabolism, including the autocatalytic cyclization that occurs during the formation of creatinine from creatine phosphate, as well as the internal cyclization of the Ala-Ser-Gly motif of some members of the ammonia-lyase and aminomutase families, that lead to the MIO cofactor. The diversity of imidazole-synthesizing pathways highlights the biological significance of this key chemical group, whose biosyntheses evolved independently several times.	[Vazquez-Salazar, Alberto; Becerra, Arturo; Lazcano, Antonio] Univ Nacl Autonoma Mexico, Fac Ciencias, Cd Univ, Cd De Mexico, Mexico; [Lazcano, Antonio] Colegio Nacl, Cd De Mexico, Mexico	Universidad Nacional Autonoma de Mexico	Lazcano, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Cd Univ, Cd De Mexico, Mexico.; Lazcano, A (corresponding author), Colegio Nacl, Cd De Mexico, Mexico.	alar@ciencias.unam.mx	Becerra, Arturo/U-2875-2019; Becerra, Arturo/J-8364-2015	Becerra, Arturo/0000-0002-7076-0342; Vazquez-Salazar, Alberto/0000-0002-5346-1834	CONACYT [404507]; PAPIIT-UNAM [IN223916]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	Alberto Vazquez-Salazar is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowship 404507 from CONACYT. Financial support to Arturo Becerra from PAPIIT-UNAM (IN223916) is gratefully acknowledged.; Alberto Vazquez-Salazar is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowship 404507 from CONACYT. Financial support from PAPIIT-UNAM (IN223916) is gratefully acknowledged. We are grateful to Ada Yonath, Marie-Christine Maurel, and Renato Fani for many conversations over the years on the origin of histidine biosynthesis, and thank Ricardo Hernandez-Morales for help with the manuscript.	Adamala K, 2014, COMPUT STRUCT BIOTEC, V9, DOI 10.5936/csbj.201402004; Akouche M, 2017, ANGEW CHEM INT EDIT, V56, P7920, DOI 10.1002/anie.201702633; Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Allen S, 2002, J BACTERIOL, V184, P6130, DOI 10.1128/JB.184.22.6130-6137.2002; Alvarez-Carreno C, 2013, ORIGINS LIFE EVOL B, V43, P363, DOI 10.1007/s11084-013-9344-3; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Bada JL, 2016, PHYS CHEM CHEM PHYS, V18, P20085, DOI 10.1039/c6cp03290g; Barona-Gomez F, 2003, EMBO REP, V4, P296, DOI 10.1038/sj.embor.embor771; Bazurto JV, 2014, J BACTERIOL, V196, P772, DOI 10.1128/JB.01087-13; Becerra A, 1998, ORIGINS LIFE EVOL B, V28, P539, DOI 10.1023/A:1006500327962; Beismann-Driemeyer S, 2001, J BIOL CHEM, V276, P20387, DOI 10.1074/jbc.M102012200; BOCHNER BR, 1982, CELL, V29, P929, DOI 10.1016/0092-8674(82)90455-X; BORK P, 1993, PROTEIN SCI, V2, P31; Borquez E, 2005, ORIGINS LIFE EVOL B, V35, P79, DOI 10.1007/s11084-005-5945-9; BORSOOK H, 1947, J BIOL CHEM, V168, P493; BRESLOW R, 1994, J MOL CATAL, V91, P161, DOI 10.1016/0304-5102(94)00046-8; Burton AS, 2012, CHEM SOC REV, V41, P5459, DOI 10.1039/c2cs35109a; Chaudhuri BN, 2003, BIOCHEMISTRY-US, V42, P7003, DOI 10.1021/bi034320h; Chaudhuri BN, 2001, STRUCTURE, V9, P987, DOI 10.1016/S0969-2126(01)00661-X; Cleaves HJ, 2008, ORIGINS LIFE EVOL B, V38, P105, DOI 10.1007/s11084-007-9120-3; Cooke HA, 2009, CURR OPIN CHEM BIOL, V13, P460, DOI 10.1016/j.cbpa.2009.06.013; Daignan-Fornier B, 2012, METABOLITES, V2, DOI 10.3390/metabo2020292; DECKER P, 1982, J CHROMATOGR, V244, P281, DOI 10.1016/S0021-9673(00)85692-7; DECOUT JL, 1993, ORIGINS LIFE EVOL B, V23, P299, DOI 10.1007/BF01582080; Delaye L, 2005, ORIGINS LIFE EVOL B, V35, P537, DOI 10.1007/s11084-005-5760-3; Due AV, 2011, P NATL ACAD SCI USA, V108, P3554, DOI 10.1073/pnas.1015996108; Edgcomb SP, 2002, PROTEINS, V49, P1, DOI 10.1002/prot.10177; FANI R, 1994, J MOL EVOL, V38, P489, DOI 10.1007/BF00178849; Frey P. A., 2007, ENZYMATIC REACTION M; Friedmann N, 1971, CHEM EVOLUTION ORIGI, P123; Gorlero M, 2009, FEBS LETT, V583, P153, DOI 10.1016/j.febslet.2008.11.052; Grimsley GR, 2009, PROTEIN SCI, V18, P247, DOI 10.1002/pro.19; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Henn-Sax M, 2002, BIOCHEMISTRY-US, V41, P12032, DOI 10.1021/bi026092h; Henn-Sax M, 2001, BIOL CHEM, V382, P1315, DOI 10.1515/BC.2001.163; Holliday GL, 2011, FEBS J, V278, P3835, DOI 10.1111/j.1742-4658.2011.08190.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang RQ, 2016, P NATL ACAD SCI USA, V113, P10613, DOI 10.1073/pnas.1602575113; Jacome R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139001; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jones CP, 2015, NAT STRUCT MOL BIOL, V22, P679, DOI 10.1038/nsmb.3073; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; Jukes Thomas H., 1966, MOL EVOLUTION; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Kovacs NA, 2017, MOL BIOL EVOL, V34, P1252, DOI 10.1093/molbev/msx086; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Lazcano A, 1999, J MOL EVOL, V49, P424, DOI 10.1007/PL00006565; Li CL, 1999, STRUCTURE, V7, P1155, DOI 10.1016/S0969-2126(99)80182-8; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; LOWE CU, 1963, NATURE, V199, P219, DOI 10.1038/199219a0; MALEY LE, 1950, NATURE, V165, P453, DOI 10.1038/165453a0; MAUREL MC, 1987, BIOCHIMIE, V69, P551, DOI 10.1016/0300-9084(87)90094-0; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; ORO J, 1963, NATURE, V197, P862, DOI 10.1038/197862a0; ORO J, 1984, ORIGINS LIFE EVOL B, V14, P237, DOI 10.1007/BF00933663; ORO J, 1960, BIOCHEM BIOPH RES CO, V2, P407, DOI 10.1016/0006-291X(60)90138-8; ORO J, 1961, ARCH BIOCHEM BIOPHYS, V94, P217, DOI 10.1016/0003-9861(61)90033-9; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Petrov AS, 2015, P NATL ACAD SCI USA, V112, P15396, DOI 10.1073/pnas.1509761112; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Raggi L, 2016, PHYS CHEM CHEM PHYS, V18, P20028, DOI 10.1039/c6cp00793g; REARDON D, 1995, FASEB J, V9, P497, DOI 10.1096/fasebj.9.7.7737457; Retey J, 2003, BBA-PROTEINS PROTEOM, V1647, P179, DOI 10.1016/S1570-9639(03)00091-8; RIEDER G, 1994, J BIOL CHEM, V269, P14386; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; SCHWARTZ AW, 1989, SCIENCE, V245, P1102, DOI 10.1126/science.11538344; SHEN C, 1990, J MOL EVOL, V31, P167, DOI 10.1007/BF02109492; SHEN C, 1990, J MOL EVOL, V31, P445, DOI 10.1007/BF02102070; SHEN C, 1987, ORIGINS LIFE EVOL B, V17, P295, DOI 10.1007/BF02386469; SMITH DWE, 1964, J BIOL CHEM, V239, P1848; SUBBIAH S, 1993, CURR BIOL, V3, P141, DOI 10.1016/0960-9822(93)90255-M; Suhadolnik R J, 1979, Prog Nucleic Acid Res Mol Biol, V22, P193, DOI 10.1016/S0079-6603(08)60801-6; SUNDBERG RJ, 1974, CHEM REV, V74, P471, DOI 10.1021/cr60290a003; Suzuki S, 2012, ACTA CRYSTALLOGR F, V68, P14, DOI 10.1107/S1744309111048184; Todd AE, 1999, CURR OPIN CHEM BIOL, V3, P548, DOI 10.1016/S1367-5931(99)00007-1; Vazquez-Salazar A, 2017, ORIGINS LIFE EVOL B, V47, P345, DOI 10.1007/s11084-016-9525-y; Velasco AM, 2002, J MOL EVOL, V55, P445, DOI 10.1007/s00239-002-2340-2; Verma S, 2010, ACCOUNTS CHEM RES, V43, P79, DOI 10.1021/ar9001334; Walton T, 2016, J AM CHEM SOC, V138, P11996, DOI 10.1021/jacs.6b07977; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468; White III H. B., 1982, PYRIDINE NUCLEOTIDE, P1; Wieczorek R, 2017, LIFE-BASEL, V7, DOI 10.3390/life7020019; Wieczorek R, 2013, CHEMBIOCHEM, V14, P217, DOI 10.1002/cbic.201200643; Yonath A, 2005, MOL CELLS, V20, P1; Yoshida A, 2016, J BIOL CHEM, V291, P21630, DOI 10.1074/jbc.M116.743021; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8	90	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196349	10.1371/journal.pone.0196349	http://dx.doi.org/10.1371/journal.pone.0196349			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698445	Green Submitted, gold, Green Published			2022-12-26	WOS:000431007600066
J	Klistorner, A; Wang, CY; Yiannikas, C; Parratt, J; Barton, J; You, YY; Graham, SL; Barnett, MH				Klistorner, Alexander; Wang, Chenyu; Yiannikas, Con; Parratt, John; Barton, Joshua; You, Yuyi; Graham, Stuart L.; Barnett, Michael H.			Diffusivity in the core of chronic multiple sclerosis lesions	PLOS ONE			English	Article							WHITE-MATTER; TENSOR ANISOTROPY; QUANTITATIVE MRI; WATER DIFFUSION; AXON DIAMETER; PARAMETERS; DENSITY; INJURY	Background Diffusion tensor imaging (DTI) has been suggested as a potential biomarker of disease progression, neurodegeneration and de/remyelination in MS. However, the pathological substrates that underpin alterations in brain diffusivity are not yet fully delineated. We propose that in highly cohesive fiber tracts: 1) a relative increase in parallel (axial) diffusivity (AD) may serve as a measure of increased extra-cellular space (ESC) within the core of chronic MS lesions and, as a result, may provide an estimate of the degree of tissue destruction, and 2) the contribution of the increased extra-cellular water to perpendicular (radial) diffusivity (RD) can be eliminated to provide a more accurate assessment of membranal (myelin) loss. Objective The purpose of this study was to isolate the contribution of extra-cellular water and demyelination to observed DTI indices in the core of chronic MS lesions, using the OR as an anatomically cohesive tract. Method Pre- and post-gadolinium (Gd) enhanced T1, T2 and DTI images were acquired from 75 consecutive RRMS patients. In addition, 25 age and gender matched normal controls were imaged using an identical MRI protocol (excluding Gd). The optic radiation (OR) was identified in individual patients using probabilistic tractography. The T2 lesions were segmented and intersected with the OR. Average eigenvalues were calculated within the core of OR lesions mask. The proportion of extra-cellular space (ECS) within the lesional core was calculated based on relative increase of AD, which was then used to normalise the perpendicular eigenvalues to eliminate the effect of the expanded ECS. In addition, modelling was implemented to simulate potential effect of various factors on lesional anisotropy. Results Of 75 patients, 41 (55%) demonstrated sizable T2 lesion volume within the ORs. All lesional eigenvalues were significantly higher compared to NAWM and controls. There was a strong correlation between AD and RD within the core of OR lesions, which was, however, not seen in OR NAWM of MS patients or normal controls. In addition, lesional anisotropy (FA) was predominantly driven by the perpendicular diffusivity, while in NAWM and in OR of normal controls all eigenvectors contributed to variation in FA. Estimated volume of ECS component constituted significant proportion of OR lesional volume and correlated significantly with lesional T1 hypointensity. While perpendicular diffusivity dropped significantly following normalisation, it still remained higher compared with diffusivity in OR NAWM. The "residual" perpendicular diffusivity also showed a substantial reduction of inter-subject variability. Both observed and modelled diffusion data suggested anisotropic nature of water diffusion in ESC. In addition, the simulation procedure offered a possible explanation for the discrepancy in relationship between eigenvalues and anisotropy in lesional tissue and NAWM. Conclusion This paper presents a potential technique for more reliably quantifying the effects of neuro-degeneration (tissue loss) versus demyelination in OR MS lesions. This may provide a simple and effective way for applying single tract diffusion analysis in MS clinical trials, with particular relevance to pro-remyelinating and neuroprotective therapeutics.	[Klistorner, Alexander; You, Yuyi] Univ Sydney, Save Sight Inst, Sydney Med Sch, Sydney, NSW, Australia; [Klistorner, Alexander; Graham, Stuart L.] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Klistorner, Alexander; Wang, Chenyu; Barton, Joshua; Barnett, Michael H.] Sydney Neuroimaging Anal Ctr, Sydney, NSW, Australia; [Wang, Chenyu; Barnett, Michael H.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Yiannikas, Con; Parratt, John] Royal North Shore Hosp, Sydney, NSW, Australia	University of Sydney; Macquarie University; University of Sydney; Royal North Shore Hospital	Klistorner, A (corresponding author), Univ Sydney, Save Sight Inst, Sydney Med Sch, Sydney, NSW, Australia.; Klistorner, A (corresponding author), Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia.; Klistorner, A (corresponding author), Sydney Neuroimaging Anal Ctr, Sydney, NSW, Australia.	sasha.klistorner@sydney.edu.au		Klistorner, Alexander/0000-0003-0361-6399; Graham, Stuart/0000-0001-7519-969X; , Yuyi/0000-0002-0175-3018	National Multiple Sclerosis Society (NMSS); Novartis Save Neuron Grant; Sydney Eye Hospital foundation grant; Sydney Medical School Foundation; National Health and Medical Research Council (NHMRC)	National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Novartis Save Neuron Grant; Sydney Eye Hospital foundation grant; Sydney Medical School Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Multiple Sclerosis Society (NMSS), Novartis Save Neuron Grant, Sydney Eye Hospital foundation grant, Sydney Medical School Foundation and National Health and Medical Research Council (NHMRC). The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; BARNES D, 1991, BRAIN, V114, P1271, DOI 10.1093/brain/114.3.1271; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BITNER C, 1987, DEV BRAIN RES, V37, P167, DOI 10.1016/0165-3806(87)90238-0; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chiang CW, 2014, NEUROIMAGE, V101, P310, DOI 10.1016/j.neuroimage.2014.06.064; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Descoteaux M., 2015, WILEY ENCY ELECT ELE, P1, DOI [10.1002/047134608X.W8258, DOI 10.1002/047134608X.W8258]; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Klistorner A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122114; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Miller DH, 2008, MULT SCLER, P69; Naismith RT, 2010, NEUROLOGY, V74, P1694, DOI 10.1212/WNL.0b013e3181e042c4; Oh J, 2013, NEUROLOGY, V80, P540, DOI 10.1212/WNL.0b013e31828154c5; ORMEROD IEC, 1987, BRAIN, V110, P1579, DOI 10.1093/brain/110.6.1579; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Pierpaoli C, 2004, P 12 ANN M ISMRM KYO, V21, P1215; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sbardella E, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/671730; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; SHERBONDY AJ, 2008, J VISION, V8; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Walhovd KB, 2014, NEUROSCIENCE, V276, P2, DOI 10.1016/j.neuroscience.2014.06.058; Wang Y, 2015, BRAIN, V138, P1223, DOI 10.1093/brain/awv046; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0194142	10.1371/journal.pone.0194142	http://dx.doi.org/10.1371/journal.pone.0194142			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694345	Green Published, Green Submitted, gold			2022-12-26	WOS:000430802400008
J	Yanai, R; Chen, S; Uchi, SH; Nanri, T; Connor, KM; Kimura, K				Yanai, Ryoji; Chen, Shang; Uchi, Sho-Hei; Nanri, Tomoaki; Connor, Kip M.; Kimura, Kazuhiro			Attenuation of choroidal neovascularization by dietary intake of omega-3 long-chain polyunsaturated fatty acids and lutein in mice	PLOS ONE			English	Article							MACULAR DEGENERATION; OXIDATIVE STRESS; CLINICAL-TRIAL; VITAMIN-E; N-3 PUFA; OMEGA-3-FATTY-ACIDS; BIOAVAILABILITY; ZEAXANTHIN; CELLS; CAROTENOIDS	Dietary omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) and lutein each protect against age-related macular degeneration (AMD). We here examined the effects of omega-3 LCPUFAs and lutein supplementation in a mouse model of AMD. Mice were assigned to four groups: (1) a control group fed an omega-3 LCPUFA +/- free diet, (2) a lutein group fed an omega-3 LCPUFA +/- free diet with oral administration of lutein, (3) an omega-3 group fed an omega-3 LCPUFA +/- supplemented diet, and (4) an omega-3 + lutein group fed an omega-3 LCPUFA +/- supplemented diet with oral administration of lutein. Mice were fed the defined diets beginning 2 weeks before, and received lutein with an oral gavage needle beginning 1 week before, induction of choroidal neovascularization (CNV) by laser photocoagulation. The area of CNV measured in choroidal flat-mount preparations was significantly reduced in mice fed omega-3 LCPUFAs or lutein compared with those in the control group, and it was reduced in an additive manner in those receiving both omega-3 LCPUFAs and lutein. The concentrations of various inflammatory mediators in the retina or choroid were reduced in mice fed omega-3 LCPUFAs or lutein, but no additive effect was apparent. The generation of reactive oxygen species (ROS) in chorioretinal lesions revealed by dihydroethidium staining as well as the expression of NADPH oxidase 4 (Nox4) in the retina revealed by immunohistofluorescence and immunoblot analyses were attenuated by omega-3 LCPUFAs and lutein in a synergistic manner. Our results thus show that dietary intake of omega-3 LCPUFAs and lutein attenuated CNV in an additive manner and in association with suppression of inflammatory mediator production, ROS generation, and Nox4 expression. Dietary supplementation with both omega-3 LCPUFAs and lutein warrants further study as a means to protect against AMD.	[Yanai, Ryoji; Chen, Shang; Uchi, Sho-Hei; Kimura, Kazuhiro] Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Ube, Yamaguchi, Japan; [Nanri, Tomoaki] Santen Pharmaceut Co Ltd, Osaka, Japan; [Connor, Kip M.] Harvard Med Sch, Dept Ophthalmol, Angiogenesis Lab, Massachusetts Eye & Ear Infirm, Cambridge, MA USA	Yamaguchi University; Santen Pharmaceutical Co Ltd; Harvard University; Massachusetts Eye & Ear Infirmary	Yanai, R (corresponding author), Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Ube, Yamaguchi, Japan.	yanai@yamaguchi-u.ac.jp		Connor, Kip/0000-0002-2048-9080; Yanai, Ryoji/0000-0002-0265-9760	Santen Pharmaceutical Co., Ltd., Osaka, Japan; Japan Society for the Promotion of Science [15K10869]	Santen Pharmaceutical Co., Ltd., Osaka, Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This was an investigator-industry collaborative study, funded by Santen Pharmaceutical Co., Ltd., Osaka, Japan. Tomoaki Nanri is an employee of Santen Pharmaceutical Co. Ltd. The funding organization provided support in the form of salary for author TN. Japan Society for the Promotion of Science (15K10869) supported Dr. Ryoji Yanai. The funding organization participated in the design of the study, interpretation of the data, review and approval of the manuscript, and had no role in the conduct of the study, data collection, or analysis of data derived from this study.	Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Bernstein PS, 2016, PROG RETIN EYE RES, V50, P34, DOI 10.1016/j.preteyeres.2015.10.003; Bowen PE, 2002, J NUTR, V132, P3668, DOI 10.1093/jn/132.12.3668; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Eisenhauer B, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020120; Haddad WM, 2017, RETINA-J RET VIT DIS, V37, P951, DOI 10.1097/IAE.0000000000001282; Han YM, 2016, ONCOTARGET, V7, P66606, DOI 10.18632/oncotarget.11261; Huang Y, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/297686; Jho D, 2003, AM SURGEON, V69, P32; Jia YP, 2017, MOLECULES, V22, DOI 10.3390/molecules22040610; Jing KP, 2013, ANTI-CANCER AGENT ME, V13, P1162, DOI 10.2174/18715206113139990319; Johansson I, 2015, AUTOPHAGY, V11, P1636, DOI 10.1080/15548627.2015.1061170; Kamoshita M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30226; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; Lee JH, 2009, NAT REV CARDIOL, V6, P753, DOI 10.1038/nrcardio.2009.188; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Meyers KJ, 2015, OPHTHALMOLOGY, V122, P2286, DOI 10.1016/j.ophtha.2015.07.029; Millen AE, 2015, JAMA OPHTHALMOL, V133, P1171, DOI 10.1001/jamaophthalmol.2015.2715; Miller JW, 2016, INVEST OPHTH VIS SCI, V57, P6911, DOI 10.1167/iovs.16-21201; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Monaghan-Benson E, 2010, AM J PATHOL, V177, P2091, DOI 10.2353/ajpath.2010.090878; Moraes ML, 2016, POULTRY SCI, V95, P237, DOI 10.3382/ps/pev325; Notarnicola M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030485; Nwachukwu ID, 2016, TRENDS FOOD SCI TECH, V49, P74, DOI 10.1016/j.tifs.2015.12.005; Ozawa Y, 2012, CURR PHARM DESIGN, V18, P51, DOI 10.2174/138161212798919101; Parada B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/368178; Pettersen K, 2016, FREE RADICAL BIO MED, V90, P158, DOI 10.1016/j.freeradbiomed.2015.11.018; Saini RK, 2015, FOOD RES INT, V76, P735, DOI 10.1016/j.foodres.2015.07.047; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Schick T, 2016, RETINA-J RET VIT DIS, V36, P787, DOI 10.1097/IAE.0000000000000756; Selvaraj RK, 2010, COMP BIOCHEM PHYS A, V157, P198, DOI 10.1016/j.cbpa.2010.06.172; Shaw PX, 2016, AIMS MOL SCI, V3, P196, DOI 10.3934/molsci.2016.2.196; Shin S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/568671; Shoda H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138241; Sikorav A, 2017, BRIT J OPHTHALMOL, V101, P438, DOI 10.1136/bjophthalmol-2015-308065; Surai PF, 2001, BRIT POULTRY SCI, V42, P252, DOI 10.1080/00071660120048519; Vannice G, 2014, J ACAD NUTR DIET, V114, P136, DOI 10.1016/j.jand.2013.11.001; Weylandt KH, 2011, CARCINOGENESIS, V32, P897, DOI 10.1093/carcin/bgr049; Widomska Justyna, 2014, J Clin Exp Ophthalmol, V5, P326; Williams CM, 2006, P NUTR SOC, V65, P42, DOI 10.1079/PNS2005473; Yanai R, 2014, P NATL ACAD SCI USA, V111, P9603, DOI 10.1073/pnas.1401191111	43	19	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196037	10.1371/journal.pone.0196037	http://dx.doi.org/10.1371/journal.pone.0196037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694386	gold, Green Published, Green Submitted			2022-12-26	WOS:000430802400057
J	Ysseldyk, R; McQuaid, RJ; Mclnnis, OA; Anisman, H; Matheson, K				Ysseldyk, Renate; McQuaid, Robyn J.; Mclnnis, Opal A.; Anisman, Hymie; Matheson, Kimberly			The ties that bind: Ingroup ties are linked with diminished inflammatory immune responses and fewer mental health symptoms through less rumination	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GROUP IDENTIFICATION; SOCIAL IDENTITY; DEPRESSIVE SYMPTOMS; RELIGIOUS IDENTITY; SELF-ESTEEM; SUPPORT; WELL; COMMUNITY; ADULTS	The present research explored whether components of social identity, namely ingroup ties, affect, and centrality, were differentially linked to mental health and inflammatory immune responses, and whether rumination mediated those relations. Study 1 (N = 138) indicated that stronger ingroup ties were associated with fewer mental health (depressive and posttraumatic stress) symptoms; those relations were mediated by the tendency for individuals with strong ties to rely less on ruminative coping to deal with a stressful life event. Study 2 (N = 54) demonstrated that ingroup ties were negatively associated with depressive symptoms, dispositional rumination, as well as stress-linked inflammatory elements at the physiological level. Consistent associations for centrality and ingroup affect were absent, suggesting that ingroup ties may have unique health benefits.	[Ysseldyk, Renate] Carleton Univ, Dept Hlth Sci, Ottawa, ON, Canada; [McQuaid, Robyn J.; Mclnnis, Opal A.; Anisman, Hymie; Matheson, Kimberly] Carleton Univ, Dept Neurosci, Ottawa, ON, Canada; [McQuaid, Robyn J.; Anisman, Hymie; Matheson, Kimberly] Univ Ottawa, Royals Inst Mental Hlth Res, Ottawa, ON, Canada	Carleton University; Carleton University; University of Ottawa	Ysseldyk, R (corresponding author), Carleton Univ, Dept Hlth Sci, Ottawa, ON, Canada.	renate.ysseldyk@carleton.ca	McQuaid, Robyn/ABB-4143-2021	Ysseldyk, Renate/0000-0002-1411-2017	Canadian Institutes of Health Research [86477]; Natural Sciences and Engineering Council of Canada [10891]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant #86477 awarded to K.M. and Natural Sciences and Engineering Council of Canada (www.nserc-crsng.gc.ca/index_eng.asp) grant #10891 awarded to H.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian M, 2014, J ADOLESCENCE, V37, P983, DOI 10.1016/j.adolescence.2014.07.010; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Audet MC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00416; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Birrer E, 2011, BEHAV COGN PSYCHOTH, V39, P381, DOI 10.1017/S1352465811000087; Bombay A, 2010, CULT DIVERS ETHN MIN, V16, P507, DOI 10.1037/a0021373; Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037/0022-3514.77.1.135; Bryant-Davis T, 2013, AM PSYCHOL, V68, P675, DOI 10.1037/a0034380; Cameron JE, 2004, SELF IDENTITY, V3, P239, DOI 10.1080/13576500444000047; Capuron L, 2001, PSYCHONEUROENDOCRINO, V26, P797, DOI 10.1016/S0306-4530(01)00030-0; Cho HJ, 2015, BRAIN BEHAV IMMUN, V46, P319, DOI 10.1016/j.bbi.2015.02.023; Cohen RA, 2011, J NEUROIMMUNOL, V233, P204, DOI 10.1016/j.jneuroim.2010.11.006; CONTRADA RJ, 1999, SELF SOCIAL IDENTITY; Cruwys T, 2015, SOC PSYCHOL PERS SCI, V6, P65, DOI 10.1177/1948550614543309; Cruwys T, 2014, PERS SOC PSYCHOL REV, V18, P215, DOI 10.1177/1088868314523839; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Earnshaw VA, 2015, AIDS BEHAV, V19, P41, DOI 10.1007/s10461-014-0758-3; Eisenberger NI, 2017, NEUROPSYCHOPHARMACOL, V42, P242, DOI 10.1038/npp.2016.141; Eisenberger NI, 2013, CURR OPIN NEUROBIOL, V23, P407, DOI 10.1016/j.conb.2013.01.006; Eisenberger NI, 2012, NAT NEUROSCI, V15, P669, DOI 10.1038/nn.3086; Eisenberger NI, 2010, BRAIN BEHAV IMMUN, V24, P558, DOI 10.1016/j.bbi.2009.12.009; Fischer P, 2010, REV GEN PSYCHOL, V14, P365, DOI 10.1037/a0021624; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Ford S, 2015, HEALTH PSYCHOL, V34, P775, DOI 10.1037/hea0000171; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Grant F, 2015, J APPL SOC PSYCHOL, V45, P383, DOI 10.1111/jasp.12305; Greenaway KH, 2015, J PERS SOC PSYCHOL, V109, P53, DOI 10.1037/pspi0000019; Harwood J, 2003, HEALTH COMMUN, V15, P145, DOI 10.1207/S15327027HC1502_3; Haslam S.A., 2012, SOCIAL CURE IDENTITY, P157, DOI [10.4324/9780203813195, DOI 10.4324/9780203813195]; Haslam SA, 2006, J APPL PSYCHOL, V91, P1037, DOI 10.1037/0021-9010.91.5.1037; Haslam SA, 2009, APPL PSYCHOL-INT REV, V58, P1, DOI 10.1111/j.1464-0597.2008.00379.x; Haslam SA, 2005, BRIT J SOC PSYCHOL, V44, P355, DOI 10.1348/014466605X37468; Hayes A., 2017, INTRO MEDIATION MODE; Hayes A. F., 2012, PROCESS VERSATILE CO; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Heffner KL, 2011, SOC SCI MED, V72, P1482, DOI 10.1016/j.socscimed.2011.03.016; Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001; Jackson JW, 2002, SELF IDENTITY, V1, P11, DOI 10.1080/152988602317232777; Jaremka LM, 2013, PSYCHOL SCI, V24, P1089, DOI 10.1177/0956797612464059; Jetten J., 2012, SOCIAL CURE IDENTITY; Jetten J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124609; Jones JM, 2012, BRIT J HEALTH PSYCH, V17, P798, DOI 10.1111/j.2044-8287.2012.02074.x; Jones JM, 2011, SOC PSYCHOL PERSONAL; Kachanoff FJ, 2016, EUR J SOC PSYCHOL, V46, P563, DOI 10.1002/ejsp.2199; Kelly O, 2007, DEPRESS ANXIETY, V24, P233, DOI 10.1002/da.20236; Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003; Kinnvall C, 2004, POLIT PSYCHOL, V25, P741, DOI 10.1111/j.1467-9221.2004.00396.x; Kroenke CH, 2013, BREAST CANCER RES TR, V137, P261, DOI 10.1007/s10549-012-2253-8; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Latrofa M, 2009, APPL PSYCHOL-INT REV, V58, P84, DOI 10.1111/j.1464-0597.2008.00383.x; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; Luchetti S, 2014, J NEUROPATH EXP NEUR, V73, P123, DOI 10.1097/NEN.0000000000000037; LUHTANEN R, 1992, PERS SOC PSYCHOL B, V18, P302, DOI 10.1177/0146167292183006; Ma K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050733; Matheson K, 2003, STRESS, V6, P223, DOI 10.1080/10253890310001594487; Matheson K., 2012, SOCIAL CURE IDENTITY, P133; McLaughlin KA, 2015, BIOL PSYCHIAT, V77, P375, DOI 10.1016/j.biopsych.2014.03.028; Merino SM, 2014, J SCI STUD RELIG, V53, P595, DOI 10.1111/jssr.12134; Mezuk B, 2010, BRAIN BEHAV IMMUN, V24, P1294, DOI 10.1016/j.bbi.2010.06.006; Miller K, 2015, PSYCHIAT RES, V228, P340, DOI 10.1016/j.psychres.2015.05.088; Muldoon OT, 2007, POLIT PSYCHOL, V28, P89, DOI 10.1111/j.1467-9221.2007.00553.x; Muldoon OT, 2012, POLIT PSYCHOL, V33, P259, DOI 10.1111/j.1467-9221.2012.00874.x; NolenHoeksema S, 1997, J PERS SOC PSYCHOL, V72, P855, DOI 10.1037/0022-3514.72.4.855; NOLENHOEKSEMA S, 1994, J PERS SOC PSYCHOL, V67, P92, DOI 10.1037/0022-3514.67.1.92; Obst PL, 2005, J COMMUNITY APPL SOC, V15, P127, DOI 10.1002/casp.813; Outten HR, 2009, APPL PSYCHOL-INT REV, V58, P146, DOI 10.1111/j.1464-0597.2008.00386.x; Polanco-Roman L, 2016, COGNITIVE THER RES, V40, P606, DOI 10.1007/s10608-016-9782-0; Putnam R., 2010, AM GRACE RELIG DIVID; Reinert Katia G, 2016, J Child Adolesc Trauma, V9, P231; Roley ME, 2015, J AFFECT DISORDERS, V180, P116, DOI 10.1016/j.jad.2015.04.006; Sani F, 2012, BRIT J SOC PSYCHOL, V51, P781, DOI 10.1111/j.2044-8309.2012.02101.x; Segerstrom SC, 2000, COGNITIVE THER RES, V24, P671, DOI 10.1023/A:1005587311498; Sharma S., 2010, PSYCHOL STUD, V55, P118, DOI DOI 10.1007/S12646-010-0011-8; Simons RL, 2017, SOC SCI MED, V185, P158, DOI 10.1016/j.socscimed.2017.03.005; Spinhoven P, 2015, BEHAV RES THER, V71, P101, DOI 10.1016/j.brat.2015.06.004; Szymanski DM, 2015, J BLACK PSYCHOL, V41, P170, DOI 10.1177/0095798414520707; Tajfel H., 1978, DIFFERENTIATION SOCI; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tiessen M., 2009, Pimatisiwin - A Journal of Aboriginal and Indigenous Community Health, V7, P241; Tomfohr LM, 2015, PSYCHOPHYSIOLOGY, V52, P1689, DOI 10.1111/psyp.12549; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Turner J.C., 1987, REDISCOVERING SOCIAL; Turner L, 2011, WOMEN HEALTH, V51, P151, DOI 10.1080/03630242.2011.558004; Verkuyten M, 2007, PERS SOC PSYCHOL B, V33, P1448, DOI 10.1177/0146167207304276; Waltz M, 1998, ARTHRIT CARE RES, V11, P356, DOI 10.1002/art.1790110507; Weiss DSMC, 1997, ASSESSING PSYCHOL TR; Yang YC, 2014, BIODEMOGR SOC BIOL, V60, P21, DOI 10.1080/19485565.2014.899452; Yang YC, 2013, J HEALTH SOC BEHAV, V54, P182, DOI 10.1177/0022146513485244; Ysseldyk R., 2014, J SOCIAL POLITICAL P, V2, P347, DOI [10.5964/jspp.v2i1.232, DOI 10.5964/JSPP.V2I1.232]; Ysseldyk R, 2007, PERS INDIV DIFFER, V42, P1573, DOI 10.1016/j.paid.2006.10.032; Ysseldyk R, 2016, J ENVIRON PSYCHOL, V47, P14, DOI 10.1016/j.jenvp.2016.04.016; Ysseldyk R, 2013, AGING MENT HEALTH, V17, P869, DOI 10.1080/13607863.2013.799120; Ysseldyk R, 2010, PERS SOC PSYCHOL REV, V14, P60, DOI 10.1177/1088868309349693	93	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195237	10.1371/journal.pone.0195237	http://dx.doi.org/10.1371/journal.pone.0195237			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7AK	29684053	gold, Green Published			2022-12-26	WOS:000430660600012
J	Cui, H; Hu, Y; Guo, DD; Zhang, AF; Gu, YJ; Zhang, SD; Zhao, CC; Gong, PH; Shen, XH; Li, YP; Wu, HZ; Wang, L; Zhao, ZJ; Fan, H				Cui, He; Hu, Ying; Guo, Didi; Zhang, Aifeng; Gu, Yuejun; Zhang, Shaodan; Zhao, Chengcheng; Gong, Pihai; Shen, Xiaohui; Li, Yiping; Wu, Huazhang; Wang, Ling; Zhao, Zhujiang; Fan, Hong			DNA methyltransferase 3A isoform b contributes to repressing Ecadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CLINICAL-SIGNIFICANCE; EXPRESSION; DNMT3A; CELLS; STEM; PROTEINS; SNAIL; GENE	DNA methyltransferase 3A (DNMT3A) has been recognised as a key element of epigenetic regulation in normal development, and the aberrant regulation of DNMT3A is implicated in multiple types of cancers, especially haematological malignancies. However, its clinical significance and detailed functional role in solid tumours remain unknown, although abnormal expression has gained widespread attention in these cancers. Here, we show that DNMT3A isoform b (DNMT3Ab), a member of the DNMT3A isoform family, is critical for directing epithelial-mesenchymal transition (EMT)-associated metastasis in gastric cancer (GC). DNMT3Ab is positively linked to tumour-node-metastasis (TNM) stage, lymph node metastasis and poor prognosis in GC patients. Overexpression of DNMT3Ab promotes GC cell migration and invasion as well as EMT through repression of E-cadherin. Meanwhile, DNMT3Ab promotes lung metastasis of GC in vivo. Mechanistic studies indicate that DNMT3Ab mediates the epigenetic inaction of the E-cadherin gene via DNA hypermethylation and histone modifications of H3K9me2 and H3K27me3. Depletion of DNMT3Ab effectively restores the expression of E-cadherin and reverses TGF-beta-induced EMT by reducing DNA methylation, H3K9me2 and H3K27me3 levels at the E-cadherin promoter. Importantly, DNMT3Ab cooperated with H3K9me2 and H3K27me3 contributes to the transcriptional regulation of E-cadherin in a Snail-dependent manner. Further, gene expression profiling analysis indicates that multiple metastasis-associated genes and oncogenic signalling pathways are regulated in response to DNMT3Ab overexpression. These results identify DNMT3Ab as a crucial regulator of metastasis-related genes in GC. Targeting the DNMT3Ab/Snail/E-cadherin axis may provide a promising therapeutic strategy in the treatment of metastatic GC with high DNMT3Ab expression.	[Cui, He; Hu, Ying; Guo, Didi; Gu, Yuejun; Zhang, Shaodan; Zhao, Chengcheng; Gong, Pihai; Shen, Xiaohui; Wu, Huazhang; Wang, Ling; Zhao, Zhujiang; Fan, Hong] Southeast Univ, Dept Med Genet & Dev Biol, Key Lab Dev Genes & Human Dis, Med Sch,Minist Educ, Nanjing 210009, Jiangsu, Peoples R China; [Cui, He] Jiangsu Prov Hosp, Nanjing 210029, Jiangsu, Peoples R China; [Cui, He] Nanjing Med Univ, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Aifeng; Li, Yiping] Southeast Univ, Sch Med, Dept Pathol, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China; Nanjing Medical University; Nanjing Medical University; Southeast University - China	Fan, H (corresponding author), Southeast Univ, Dept Med Genet & Dev Biol, Key Lab Dev Genes & Human Dis, Med Sch,Minist Educ, Nanjing 210009, Jiangsu, Peoples R China.	fanh@seu.edu.cn		Wu, Huazhang/0000-0002-5482-3761	National Natural Science Foundation of China [81672414, 81472548, 81171915, 81702789]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from National Natural Science Foundation of China (81672414, 81472548, 81171915 and 81702789). We thank Dr. Gang-Ning Liang at the Norris Cancer Center for generously providing the DNMT3Ab constructs. We also appreciate Dr. Jingfei Chen at Department of Oncology, Nanjing First Hospital, Nanjing Medical University, for providing tissue microarrays of GC patients. We also appreciate Dr. Kun Zhang at Department of Oncology, the Third Affiliated Hospital of Harbin Medical University, for providing the clinical samples of GC patients.	Calcagno DQ, 2013, WORLD J GASTROENTERO, V19, P1182, DOI 10.3748/wjg.v19.i8.1182; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cao XY, 2014, WORLD J GASTROENTERO, V20, P8201, DOI 10.3748/wjg.v20.i25.8201; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chaudry SF, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5473197; Chen BF, 2014, EPIGENETICS-US, V9, P669, DOI 10.4161/epi.28324; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Cui H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13781; Cui H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123926; DENG G, 1987, CANCER RES, V47, P3195; Deng T, 2009, BIOCHEM BIOPH RES CO, V387, P611, DOI 10.1016/j.bbrc.2009.07.093; Ding WJ, 2008, DIGEST DIS SCI, V53, P2083, DOI 10.1007/s10620-007-0145-2; Fan H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-12; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Foulks JM, 2012, J BIOMOL SCREEN, V17, P2, DOI 10.1177/1087057111421212; Gaidzik VI, 2018, LEUKEMIA, V32, P30, DOI 10.1038/leu.2017.200; Huang L, 2015, AM J TRANSL RES, V7, P2141; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung H, 2011, CANCER-AM CANCER SOC, V117, P2371, DOI 10.1002/cncr.25778; Kim BG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.73; Koike N, 1997, J CANCER RES CLIN, V123, P310, DOI 10.1007/s004320050063; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; Ma PP, 2015, CELL REP, V13, P1552, DOI 10.1016/j.celrep.2015.10.031; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Oliveira AMM, 2016, MOL PSYCHIATR, V21, P1130, DOI 10.1038/mp.2015.175; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng Z, 2014, WORLD J GASTROENTERO, V20, P5403, DOI 10.3748/wjg.v20.i18.5403; Pistore C, 2017, ONCOGENE, V36, P5551, DOI 10.1038/onc.2017.159; Prieto-Garcia E, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0980-8; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Suetake I, 2011, BIOCHEM J, V437, P141, DOI 10.1042/BJ20110241; Tan EJ, 2015, NUCLEIC ACIDS RES, V43, P162, DOI 10.1093/nar/gku1293; Thakur A, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0104-2; Thrumurthy SG, 2015, NAT REV CLIN ONCOL, V12, P676, DOI 10.1038/nrclinonc.2015.132; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Vogiatzi P, 2007, J CELL PHYSIOL, V211, P287, DOI 10.1002/jcp.20982; Wang Y, 2013, EXP CELL RES, V319, P160, DOI 10.1016/j.yexcr.2012.07.019; Weigt J, 2015, GASTROINTEST TUMORS, V2, P61, DOI 10.1159/000431304; Weis B, 2015, ONCOGENE, V34, P1822, DOI 10.1038/onc.2014.114; Wongtrakoongate P, 2015, WORLD J STEM CELLS, V7, P137, DOI 10.4252/wjsc.v7.i1.137; Yang J, 2011, MOL MED REP, V4, P1139, DOI 10.3892/mmr.2011.578; Yu QM, 2012, J SURG ONCOL, V106, P765, DOI 10.1002/jso.23116; Zhao Zhujiang, 2010, J Biomed Biotechnol, V2010, P737535, DOI 10.1155/2010/737535; Zu LD, 2016, CARCINOGENESIS, V37, P333, DOI 10.1093/carcin/bgw011	45	40	44	1	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 9	2018	37	32					4358	4371		10.1038/s41388-018-0285-1	http://dx.doi.org/10.1038/s41388-018-0285-1			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP8FA	29717263	hybrid, Green Published			2022-12-26	WOS:000441144300002
J	Panigrahi, P; Jere, A; Anamika, K				Panigrahi, Priyabrata; Jere, Abhay; Anamika, Krishanpal			FusionHub: A unified web platform for annotation and visualization of gene fusion events in human cancer	PLOS ONE			English	Article							EXPRESSION; DATABASE; DESIGN; IMPACT	Gene fusion is a chromosomal rearrangement event which plays a significant role in cancer due to the oncogenic potential of the chimeric protein generated through fusions. At present many databases are available in public domain which provides detailed information about known gene fusion events and their functional role. Existing gene fusion detection tools, based on analysis of transcriptomics data usually report a large number of fusion genes as potential candidates, which could be either known or novel or false positives. Manual annotation of these putative genes is indeed time-consuming. We have developed a web platform FusionHub, which acts as integrated search engine interfacing various fusion gene databases and simplifies large scale annotation of fusion genes in a seamless way. In addition, FusionHub provides three ways of visualizing fusion events: circular view, domain architecture view and network view. Design of potential siRNA molecules through ensemble method is another utility integrated in FusionHub that could aid in siRNA-based targeted therapy.	[Panigrahi, Priyabrata; Jere, Abhay; Anamika, Krishanpal] Persistent Syst, LABS, Pune, Maharashtra, India		Jere, A; Anamika, K (corresponding author), Persistent Syst, LABS, Pune, Maharashtra, India.	abhay_jere@persistent.com; anamika_krishanpal@persistent.com						Alaei-Mahabadi B, 2016, P NATL ACAD SCI USA, V113, P13768, DOI 10.1073/pnas.1606220113; Babiceanu M, 2016, NUCLEIC ACIDS RES, V44, P2859, DOI 10.1093/nar/gkw032; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bao ZS, 2014, GENOME RES, V24, P1765, DOI 10.1101/gr.165126.113; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Thang BN, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0495-2; Carrara M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/340620; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Elemento O., 2016, AGFUSION ANNOTATE VI, DOI [10.1101/080903, DOI 10.1101/080903]; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Frenkel-Morgenstern M, 2013, NUCLEIC ACIDS RES, V41, pD142, DOI 10.1093/nar/gks1041; Gavrilov K, 2015, P NATL ACAD SCI USA, V112, pE6597, DOI 10.1073/pnas.1517039112; Horn T, 2010, NUCLEIC ACIDS RES, V38, pW332, DOI 10.1093/nar/gkq317; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar-Sinha C, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0252-1; Latysheva NS, 2016, NUCLEIC ACIDS RES, V44, P4487, DOI 10.1093/nar/gkw282; Lee M, 2017, NUCLEIC ACIDS RES, V45, pD784, DOI 10.1093/nar/gkw1083; Liu S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1234; Liu YN, 2017, J GENET GENOMICS, V44, P119, DOI 10.1016/j.jgg.2016.12.004; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Mullenders J, 2009, CLIN CANCER RES, V15, P5811, DOI 10.1158/1078-0432.CCR-09-0261; Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392; Nicorici D, 2014, BIORXIV, P11650, DOI DOI 10.1101/011650; Novo FJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-33; Prakash T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013284; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Wang YJ, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0310-4; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Yu YP, 2014, AM J PATHOL, V184, P2840, DOI 10.1016/j.ajpath.2014.06.025	33	29	29	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196588	10.1371/journal.pone.0196588	http://dx.doi.org/10.1371/journal.pone.0196588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715310	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281100034
J	Renier, W; Bourdin, A; Rubbo, PA; Peries, M; Dedieu, L; Bendriss, S; Kremer, L; Canaan, S; Terru, D; Godreuil, S; Nagot, N; Van de Perre, P; Tuaillon, E				Renier, Wendy; Bourdin, Arnaud; Rubbo, Pierre-Alain; Peries, Marianne; Dedieu, Luc; Bendriss, Sophie; Kremer, Laurent; Canaan, Stephane; Terru, Dominique; Godreuil, Sylvain; Nagot, Nicolas; Van de Perre, Philippe; Tuaillon, Edouard			B cells response directed against Cut4 and CFP21 lipolytic enzymes in active and latent tuberculosis infections	PLOS ONE			English	Article							ANTIBODY-SECRETING CELLS; CUTINASE-LIKE PROTEINS; MYCOBACTERIUM-TUBERCULOSIS; HUMORAL IMMUNITY; FUNCTIONAL-ROLE; PLASMA-CELLS; GRANULOMAS; POPULATION; DIAGNOSIS; LIFETIME	Background Better understanding of the immune response directed against Mycobacterium tuberculosis (Mtb) is critical for development of vaccine strategies and diagnosis tests. Previous studies suggested that Mtb enzymes involved in lipid metabolism, are associated with persistence and/or reactivation of dormant bacilli. Methods Circulating antibodies secreting cells (ASCs), memory B cells, and antibodies directed against Cut4 (Rv3452) and CFP21 (Rv1984c) antigens were explored in subjects with either active- or latent-tuberculosis (LTB), and in Mtb-uninfected individuals. Results Circulating anti-Cut4 ASCs were detected in 11/14 (78.6%) subjects from the active TB group vs. 4/17 (23.5%) from the LTB group (p = 0.001). Anti-CFP21 ASCs were found in 11/- 14 (78.6%) active TB vs. in 5/17 (29.4%) LTB cases (p = 0.01). Circulating anti-Cut4 and anti-CFP21 ASCs were not detected in 38 Mtb uninfected controls. Memory B cells directed against either Cut4 or CFP21 were identified in 8/11 (72.7%) and in 9/11 (81.8%) subjects with LTB infection, respectively, and in 2/6 Mtb uninfected individuals (33.3%). High level of anti-Cut4 and anti-CFP21 IgG were observed in active TB cases. Conclusion Circulating IgG SCs directed against Cut4 or CFP21 were mostly detected in patients presenting an active form of the disease, suggesting that TB reactivation triggers an immune response against these two antigens.	[Renier, Wendy; Rubbo, Pierre-Alain; Peries, Marianne; Bendriss, Sophie; Terru, Dominique; Godreuil, Sylvain; Nagot, Nicolas; Van de Perre, Philippe; Tuaillon, Edouard] Univ Montpellier, Pathogenesis & Control Chron Infect, INSERM, EFS,CHU Montpellier, Montpellier, France; [Bourdin, Arnaud] Univ Montpellier, PhyMedExp, INSERM, EFS,CHU Montpellier, Montpellier, France; [Dedieu, Luc; Canaan, Stephane] Univ Aix Marseille, Lab Enzymol Interfaces & Physiol Lipolysis, CNRS, Marseille, France; [Kremer, Laurent] Univ Montpellier, Inst Res Infect Montpellier, INSERM, CNRS, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Tuaillon, E (corresponding author), Univ Montpellier, Pathogenesis & Control Chron Infect, INSERM, EFS,CHU Montpellier, Montpellier, France.	e-tuaillon@chu-montpellier.fr	Kremer, Laurent/M-4935-2017; Van de Perre, Philippe/B-9692-2008	Kremer, Laurent/0000-0002-6604-4458; Van de Perre, Philippe/0000-0002-3912-0427; godreuil, sylvain/0000-0003-3436-0082; Tuaillon, Edouard/0000-0001-5866-9530; Nagot, Nicolas/0000-0002-3493-2821	CHU de Montpellier [9179]	CHU de Montpellier	Funding was provided by CHU de Montpellier; ID Number 9179.	Abubakar I, 2013, THORAX, V68, P298, DOI 10.1136/thoraxjnl-2013-203247; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Brust B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025078; Caire-Brandli I, 2014, INFECT IMMUN, V82, P476, DOI 10.1128/IAI.01196-13; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; Dedieu L, 2013, BIOCHIMIE, V95, P66, DOI 10.1016/j.biochi.2012.07.008; Delorme V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046493; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Fournier AM, 2002, AIDS, V16, P1755, DOI 10.1097/00002030-200209060-00007; Fu RL, 2009, CLIN VACCINE IMMUNOL, V16, P686, DOI 10.1128/CVI.00486-08; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1722, DOI 10.1128/IAI.69.3.1722-1728.2001; Hinks TSC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-339; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Kahnert A, 2007, J INFECT DIS, V195, P46, DOI 10.1086/508894; Kapoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053657; Kozakiewicz L, 2013, ADV EXP MED BIOL, V783, P225, DOI 10.1007/978-1-4614-6111-1_12; Kremer S, 2016, PLOS ONE, V11, DOI [10.1371/JOURNAL.PONE.0162137, DOI 10.1371/JOURNAL.PONE.0162137]; Lee FEH, 2010, J INFECT DIS, V202, P1659, DOI 10.1086/657158; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Orduna P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-493; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Phuah JY, 2012, AM J PATHOL, V181, P508, DOI 10.1016/j.ajpath.2012.05.009; Raqib R, 2009, CLIN VACCINE IMMUNOL, V16, P521, DOI 10.1128/CVI.00391-08; Sable SB, 2005, INFECT IMMUN, V73, P3547, DOI 10.1128/IAI.73.6.3547-3558.2005; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Sebina I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106796; Sebina I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051381; Sousa AO, 2000, TUBERCLE LUNG DIS, V80, P27, DOI 10.1054/tuld.1999.0230; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Tuaillon E, 2009, J IMMUNOL, V182, P7155, DOI 10.4049/jimmunol.0803107; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Vendrell JP, 2004, PERIPHERAL BLOOD NAI, P277; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; Wang BL, 2005, INT J TUBERC LUNG D, V9, P1327; Wang C, 2011, MED MICROBIOL IMMUN, V200, P165, DOI 10.1007/s00430-011-0188-z; Weldingh K, 1999, FEMS IMMUNOL MED MIC, V23, P159, DOI 10.1111/j.1574-695X.1999.tb01235.x; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; WHO, 2017, GLOB TUB REP; Yang Y., 2014, BIOMED RES INT, V2014, P1, DOI DOI 10.1155/2014/823424; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330	52	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196470	10.1371/journal.pone.0196470	http://dx.doi.org/10.1371/journal.pone.0196470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709002	Green Submitted, Green Published, gold			2022-12-26	WOS:000431130100029
J	McGlashan, J; Nichols, M; Korn, A; Millar, L; Marks, J; Sanigorski, A; Pachucki, M; Swinburn, B; Allender, S; Economos, C				McGlashan, Jaimie; Nichols, Melanie; Korn, Ariella; Millar, Lynne; Marks, Jennifer; Sanigorski, Andrew; Pachucki, Mark; Swinburn, Boyd; Allender, Steven; Economos, Christina			Social network analysis of stakeholder networks from two community-based obesity prevention interventions	PLOS ONE			English	Article							PERSPECTIVE; SOMERVILLE; ADOPTION	Introduction Studies of community-based obesity prevention interventions have hypothesized that stake-holder networks are a critical element of effective implementation. This paper presents a quantitative analysis of the interpersonal network structures within a sub-sample of stake-holders from two past successful childhood obesity prevention interventions. Methods Participants were recruited from the stakeholder groups (steering committees) of two completed community-based intervention studies, Romp & Chomp (R&C), Australia (2004-2008) and Shape Up Somerville (SUS), USA (2003-2005). Both studies demonstrated significant reductions of overweight and obesity among children. Members of the steering committees were asked to complete a retrospective social network questionnaire using a roster of other committee members and free recall. Each participant was asked to recall the people with whom they discussed issues related to childhood obesity throughout the intervention period, along with providing the closeness and level of influence of each relationship. Results Networks were reported by 13 participants from the SUS steering committee and 8 participants from the R&C steering committee. On average, participants nominated 16 contacts with whom they discussed issues related to childhood obesity through the intervention, with approximately half of the relationships described as 'close' and 30% as 'influential'. The 'discussion' and 'close' networks had high clustering and reciprocity, with ties directed to other steering committee members, and to individuals external to the committee. In contrast, influential ties were more prominently directed internal to the steering committee, with higher network centralization, lower reciprocity and lower clustering. Discussion and conclusion Social network analysis provides a method to evaluate the ties within steering committees of community-based obesity prevention interventions. In this study, the network characteristics between a sub-set of stakeholders appeared to be supportive of diffused communication. Future work should prospectively examine stakeholder network structures in a heterogeneous sample of community-based interventions to identify elements most strongly associated with intervention effectiveness.	[McGlashan, Jaimie; Nichols, Melanie; Millar, Lynne; Marks, Jennifer; Sanigorski, Andrew; Swinburn, Boyd; Allender, Steven] Deakin Univ, Ctr Populat Hlth Res, Global Obes Ctr GLOBE, Geelong, Vic, Australia; [Korn, Ariella; Economos, Christina] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Pachucki, Mark] Univ Massachusetts, Dept Sociol, Computat Social Sci Inst, Amherst, MA 01003 USA; [Swinburn, Boyd] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand	Deakin University; Tufts University; University of Massachusetts System; University of Massachusetts Amherst; University of Auckland	McGlashan, J (corresponding author), Deakin Univ, Ctr Populat Hlth Res, Global Obes Ctr GLOBE, Geelong, Vic, Australia.	jaimie.mcglashan@deakin.edu.au	Allender, Steven/G-9881-2011; Millar, Lynne/AAS-4907-2020; Millar, Lynne/AAD-5983-2019	Allender, Steven/0000-0002-4842-3294; Nichols, Melanie/0000-0002-7834-5899; Pachucki, Mark/0000-0002-7855-2433	U.S. National Institutes of Health,'Systems Science to Guide Whole of Community Childhood Obesity Interventions' [1R01HL115485-01A1]; Australian National Health and Medical Research Council /Australian National Heart Foundation Career Development Fellowship [APP1045836]; Australian Government Research Training Program Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	U.S. National Institutes of Health,'Systems Science to Guide Whole of Community Childhood Obesity Interventions'; Australian National Health and Medical Research Council /Australian National Heart Foundation Career Development Fellowship; Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by a U.S. National Institutes of Health grant, 'Systems Science to Guide Whole of Community Childhood Obesity Interventions' (1R01HL115485-01A1). Allender is supported by funding from an Australian National Health and Medical Research Council /Australian National Heart Foundation Career Development Fellowship (APP1045836). McGlashan is supported by the Australian Government Research Training Program Scholarship.	Allender S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129683; Bastian M., 2009, GEPHI OPEN SOURCE SO; Borys JM, 2012, OBES REV, V13, P299, DOI 10.1111/j.1467-789X.2011.00950.x; Burgos A, 2017, COMMUNITY DEV, V48, P546, DOI 10.1080/15575330.2017.1344996; Chomitz V. R., 2013, SHAPE SOMERVILLE BUI; Christens BD, 2015, COMMUNITY DEV, V46, P420, DOI 10.1080/15575330.2015.1061680; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; de Groot FP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-522; de Silva-Sanigorski A, 2009, HLTH EATING ACTIVE P, V3; de Silva-Sanigorski AM, 2010, AM J CLIN NUTR, V91, P831, DOI 10.3945/ajcn.2009.28826; Economos CD, 2007, OBESITY, V15, P1325, DOI 10.1038/oby.2007.155; Economos CD, 2017, OBESITY, V25, P1155, DOI 10.1002/oby.21893; Economos CD, 2010, PREV MED, V50, pS97, DOI 10.1016/j.ypmed.2009.10.017; Fujimoto K, 2009, J COMMUNITY PSYCHOL, V37, P830, DOI 10.1002/jcop.20333; Gesell SB, 2012, J OBES, V2012, DOI 10.1155/2012/749832; Gesell SB, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-116; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Korn A, 2018, DEV TESTING IN PRESS; Lusher D, 2010, MEAS PHYS EDUC EXERC, V14, P211, DOI 10.1080/1091367X.2010.495559; Osypuk TL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124635; Pachucki MC, 2015, CURR OBES REP, V4, P217, DOI 10.1007/s13679-015-0145-z; Parra DC, 2011, SOC SCI MED, V73, P1365, DOI 10.1016/j.socscimed.2011.08.020; Pettman T, 2016, HEALTH PROMOT INT, V31, P582, DOI 10.1093/heapro/dav024; Scholz JT, 2008, J POLIT, V70, P393, DOI 10.1017/S0022381608080389; Uddin S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4337-1; Valente TW, 2007, AM J PUBLIC HEALTH, V97, P880, DOI 10.2105/AJPH.2005.063644; Wasserman S., 1994, INTRO SOCIAL NETWORK, P1, DOI [10.1017/CBO9780511815478, DOI 10.1017/CB09780511815478]; Wolfenden L, 2014, PREV MED, V62, P193, DOI 10.1016/j.ypmed.2014.01.031	28	21	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196211	10.1371/journal.pone.0196211	http://dx.doi.org/10.1371/journal.pone.0196211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1YS	29702660	Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300023
J	Lunev, S; Butzloff, S; Romero, AR; Linzke, M; Batista, FA; Meissner, KA; Muller, IB; Adawy, A; Wrenger, C; Groves, MR				Lunev, Sergey; Butzloff, Sabine; Romero, Atilio R.; Linzke, Marleen; Batista, Fernando A.; Meissner, Kamila A.; Mueller, Ingrid B.; Adawy, Alaa; Wrenger, Carsten; Groves, Matthew R.			Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERFACES; ASPARTATE-AMINOTRANSFERASE; QUATERNARY STRUCTURE; MALARIA; MECHANISMS; CRYSTALLIZATION; PURIFICATION; TRANSFECTION; METABOLISM; EXPRESSION	Malaria remains a major threat to human health, as strains resistant to current therapeutics are discovered. Efforts in finding new drug targets are hampered by the lack of sufficiently specific tools to provide target validation prior to initiating expensive drug discovery projects. Thus, new approaches that can rapidly enable drug target validation are of significant interest. In this manuscript we present the crystal structure of malate dehydrogenase from Plasmodium falciparum (PfMDH) at 2.4 angstrom resolution and structure-based mutagenic experiments interfering with the inter-oligomeric interactions of the enzyme. We report decreased thermal stability, significantly decreased specific activity and kinetic parameters of PfMDH mutants upon mutagenic disruption of either oligomeric interface. In contrast, stabilization of one of the interfaces resulted in increased thermal stability, increased substrate/ cofactor affinity and hyperactivity of the enzyme towards malate production at sub-millimolar substrate concentrations. Furthermore, the presented data show that our designed PfMDH mutant could be used as specific inhibitor of the wild type PfMDH activity, as mutated PfMDH copies were shown to be able to self-incorporate into the native assembly upon introduction in vitro, yielding deactivated mutant: wild-type species. These data provide an insight into the role of oligomeric assembly in regulation of PfMDH activity and reveal that recombinant mutants could be used as probe tool for specific modification of the wild type PfMDH activity, thus offering the potential to validate its druggability in vivo without recourse to complex genetics or initial tool compounds. Such tool compounds often lack specificity between host or pathogen proteins (or are toxic in in vivo trials) and result in difficulties in assessing cause and effect D particularly in cases when the enzymes of interest possess close homologs within the human host. Furthermore, our oligomeric interference approach could be used in the future in order to assess druggability of other challenging human pathogen drug targets.	[Lunev, Sergey; Romero, Atilio R.; Batista, Fernando A.; Adawy, Alaa; Groves, Matthew R.] Univ Groningen, Dept Pharm, Drug Design XB20, Struct Biol Unit, Groningen, Netherlands; [Butzloff, Sabine; Mueller, Ingrid B.] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Linzke, Marleen; Meissner, Kamila A.; Wrenger, Carsten] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Unit Drug Discovery, Sao Paulo, Brazil	University of Groningen; Bernhard Nocht Institut fur Tropenmedizin; Universidade de Sao Paulo	Groves, MR (corresponding author), Univ Groningen, Dept Pharm, Drug Design XB20, Struct Biol Unit, Groningen, Netherlands.; Wrenger, C (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Unit Drug Discovery, Sao Paulo, Brazil.	cwrenger@icb.usp.br; m.r.groves@rug.nl	Batista, Fernando/M-7586-2018; Batista, Fernando/AAD-5975-2021; Adawy, Alaa/K-6440-2015; Wrenger, Carsten/E-4110-2013	Batista, Fernando/0000-0001-5479-5329; Adawy, Alaa/0000-0001-5517-6693; Wrenger, Carsten/0000-0001-5987-1749; Lunev, Sergey/0000-0001-9867-6866; Groves, Matthew/0000-0001-9859-5177	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/12807-3, 2016/24790-9, 2014/23330-9, 2013/10288-1, 2015/26722-8]; Science without Borders Fellowship; Ubbo Emmius student fellowships; CAPES/Nuffic MALAR-ASP network [053/14]; European Union's Framework Programme for Research and Innovation Horizon under the Marie Sklodowska-Curie [675555]; Accelerated Early staGe drug discovery (AEGIS); Ubbo Emmius student	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Science without Borders Fellowship; Ubbo Emmius student fellowships; CAPES/Nuffic MALAR-ASP network; European Union's Framework Programme for Research and Innovation Horizon under the Marie Sklodowska-Curie; Accelerated Early staGe drug discovery (AEGIS); Ubbo Emmius student	The authors would like to acknowledge the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grants 2012/12807-3 and 2016/24790-9 to KAM, 2014/23330-9 to ML, 2013/10288-1 and 2015/26722-8 to CW). FB gratefully acknowledges funding through a Science without Borders Fellowship. Further the authors would like to acknowledge the Ubbo Emmius student fellowships of ML and the CAPES/Nuffic MALAR-ASP (053/14) network. This project has received funding from the European Unions Framework Programme for Research and Innovation Horizon 2020 (2014-2020) under the Marie Sklodowska-Curie Grant Agreement No. 675555, Accelerated Early staGe drug discovery (AEGIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biter AB, 2016, SCI REP-UK, V6, DOI 10.1038/srep18906; Bjork A, 2003, FEBS LETT, V553, P423, DOI 10.1016/S0014-5793(03)01076-7; Boucher JI, 2014, ELIFE, V3, DOI 10.7554/eLife.02304; BREITER DR, 1994, PROTEIN SCI, V3, P2023, DOI 10.1002/pro.5560031115; Butzloff S, 2013, ANAL DOWNSTREAM EFFE; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Crabb BS, 2007, TRENDS MICROBIOL, V15, P3, DOI 10.1016/j.tim.2006.11.006; Crabb BS, 2004, METH MOL B, V270, P263; Crabb BS, 1997, MOL BIOCHEM PARASIT, V90, P131, DOI 10.1016/S0166-6851(97)00143-6; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Hashimoto K, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035007; Hashimoto K, 2010, P NATL ACAD SCI USA, V107, P20352, DOI 10.1073/pnas.1012999107; Jain R, 2010, ACTA CRYSTALLOGR F, V66, P409, DOI 10.1107/S1744309110003933; Kirk K, 2007, CURR DRUG TARGETS, V8, P75, DOI 10.2174/138945007779315560; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel Evgeny, 2012, J Mol Biochem, V1, P76; LANGUNNASCH N, 1992, MOL BIOCHEM PARASIT, V50, P17, DOI 10.1016/0166-6851(92)90240-K; Lindner Jasmin, 2013, Int J Cell Biol, V2013, P435981, DOI 10.1155/2013/435981; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lunev S, CURRENT TOPICS MALAR; Meissner KA, 2017, CURR DRUG TARGETS, V18, P1069, DOI 10.2174/1389450117666160201115003; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Nishi H, 2013, PROG MOL BIOL TRANSL, V117, P3, DOI 10.1016/B978-0-12-386931-9.00001-5; Olszewski KL, 2011, MOL BIOCHEM PARASIT, V175, P95, DOI 10.1016/j.molbiopara.2010.09.001; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Painter HJ, 2010, ANTIMICROB AGENTS CH, V54, P5281, DOI 10.1128/AAC.00937-10; Pradhan A, 2009, BIOCHIMIE, V91, P1509, DOI 10.1016/j.biochi.2009.09.005; Pradhan A, 2009, MOL CELL BIOCHEM, V325, P141, DOI 10.1007/s11010-009-0028-2; Schomburg I, 2017, J BIOTECHNOL, V261, P194, DOI 10.1016/j.jbiotec.2017.04.020; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Tripathi AK, 2004, EUR J BIOCHEM, V271, P3488, DOI 10.1111/j.1432-1033.2004.04281.x; Valdar WSJ, 2001, PROTEINS, V42, P108; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Wang YZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09687-z; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wrenger C, 2012, ACTA CRYSTALLOGR F, V68, P659, DOI 10.1107/S1744309112014571; Wrenger C, 2012, CURR DRUG METAB, V13, P332, DOI 10.2174/138920012799320400; Wrenger C, 2011, J MOL BIOL, V405, P956, DOI 10.1016/j.jmb.2010.11.018	49	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195011	10.1371/journal.pone.0195011	http://dx.doi.org/10.1371/journal.pone.0195011			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694407	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400020
J	Millet, B; Pinazo, C; Banaru, D; Pages, R; Guiart, P; Pairaud, I				Millet, Bertrand; Pinazo, Christel; Banaru, Daniela; Pages, Remi; Guiart, Pierre; Pairaud, Ivane			Unexpected spatial impact of treatment plant discharges induced by episodic hydrodynamic events: Modelling Lagrangian transport of fine particles by Northern Current intrusions in the bays of Marseille (France)	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; NW MEDITERRANEAN SEA; IN-SITU; SEASONAL-VARIATION; COASTAL WATERS; RIVER INPUTS; TRACE-METALS; GULF; CIRCULATION; LIONS	Our study highlights the Lagrangian transport of solid particles discharged at the Marseille Wastewater Treatment Plant (WWTP), located at Cortiou on the southern coastline. We focused on episodic situations characterized by a coastal circulation pattern induced by intrusion events of the Northern Current (NC) on the continental shelf, associated with SE wind regimes. We computed, using MARS3D-RHOMA and ICHTHYOP models, the particle trajectories from a patch of 5.10(4) passive and conservative fine particles released at the WWTP outlet, during 2 chosen representative periods of intrusion of the NC in June 2008 and in October 2011, associated with S-SE and E-SE winds, respectively. Unexpected results highlighted that the amount of particles reaching the vulnerable shorelines of both northern and southern bays accounted for 21.2% and 46.3% of the WWTP initial patch, in June 2008 and October 2011, respectively. Finally, a conceptual diagram is proposed to highlight the mechanisms of dispersion within the bays of Marseille of the fine particles released at the WWTP outlet that have long been underestimated.	[Millet, Bertrand; Pinazo, Christel; Banaru, Daniela; Pages, Remi; Guiart, Pierre] Aix Marseille Univ, CNRS, Mediterranean Inst Oceanog UM 110, IRD, Campus Luminy, Marseille, France; [Millet, Bertrand; Pinazo, Christel; Banaru, Daniela; Pages, Remi; Guiart, Pierre] Univ Toulon & Var, CNRS, Mediterranean Inst Oceanog UM 110, IRD, La Garde, France; [Pairaud, Ivane] Ifremer, Lab Environm Ressources Prov Azur Corse, F-83507 La Seyne Sur Mer, France; [Pairaud, Ivane] Inst Francais Rech Exploitat Mer, Lab DYNECO DHYSED, Plouzane, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulon; Ifremer; Ifremer	Millet, B (corresponding author), Aix Marseille Univ, CNRS, Mediterranean Inst Oceanog UM 110, IRD, Campus Luminy, Marseille, France.; Millet, B (corresponding author), Univ Toulon & Var, CNRS, Mediterranean Inst Oceanog UM 110, IRD, La Garde, France.	bertrand.millet@univ-amu.fr	BANARU, Daniela/ABC-8603-2021; PINAZO, Christel/ABF-8800-2020; Pinazo, Christel/G-2746-2010; PINAZO, Christel/AID-3407-2022	BANARU, Daniela/0000-0002-8126-4328; PINAZO, Christel/0000-0002-1707-2858; Pages, Remi/0000-0002-3896-5372	Aix-Marseille Universite-OSU Institut Pytheas: cluster access and computational facilities; Bertrand Millet	Aix-Marseille Universite-OSU Institut Pytheas: cluster access and computational facilities; Bertrand Millet	Funded by Aix-Marseille Universite-OSU Institut Pytheas: cluster access and computational facilities; Bertrand Millet. Aix-Marseille Universite-Mediterranean Institute of Oceanography: Field Observations Database; Daniela Banaru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaru D, 2007, MAR POLLUT BULL, V54, P1385, DOI 10.1016/j.marpolbul.2007.05.022; Banaru D, 2014, J PLANKTON RES, V36, P145, DOI 10.1093/plankt/fbt083; Barrier N, 2016, OCEAN DYNAM, V66, P313, DOI 10.1007/s10236-016-0921-7; Cresson P, 2014, MAR ECOL PROG SER, V509, P15, DOI 10.3354/meps10866; Echevin V, 2003, J PHYS OCEANOGR, V33, P188, DOI 10.1175/1520-0485(2003)033<0188:IOACCW>2.0.CO;2; Fraysse M, 2014, J GEOPHYS RES-OCEANS, V119, P6535, DOI 10.1002/2014JC010022; Fraysse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080012; Gatti J., 2008, THESIS; Harmelin-Vivien M, 2010, BIOGEOCHEMISTRY, V100, P139, DOI 10.1007/s10533-010-9411-z; Harmelin-Vivien M, 2008, CONT SHELF RES, V28, P1911, DOI 10.1016/j.csr.2008.03.002; Jany C, 2012, RSTODELERPAC1202, P140; Lazure P, 2008, ADV WATER RESOUR, V31, P233, DOI 10.1016/j.advwatres.2007.06.010; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Nicolau R, 2012, WATER RES, V46, P6625, DOI 10.1016/j.watres.2012.01.031; Oursel B, 2014, ESTUAR COAST SHELF S, V138, P14, DOI 10.1016/j.ecss.2013.12.002; Oursel B, 2013, MAR POLLUT BULL, V69, P137, DOI 10.1016/j.marpolbul.2013.01.023; Pairaud IL, 2011, J MARINE SYST, V88, P20, DOI 10.1016/j.jmarsys.2011.02.010; Petrenko A, 2005, CONT SHELF RES, V25, P7, DOI 10.1016/j.csr.2004.09.004; Petrenko A, JULIO STATION DATA B; Petrenko AA, 2003, OCEANOL ACTA, V26, P323, DOI 10.1016/S0399-1784(03)00038-0; Pinazo C, MODELISATION BAIE MA, DOI [doi.org/10.1016/j.crvi.2006.04.002, DOI 10.1016/J.CRVI.2006.04.002]; Pradal MA, 2013, SPATIAL HETEROGENEIT, DOI 10.5402/2013/568487; Pradal MA, 2006, CR BIOL, V329, P541, DOI 10.1016/j.crvi.2006.04.002; Ross O, 2016, COASTAL SHELF SCI, V170, P1, DOI [10.1016/j.ecss.2015.12.022, DOI 10.1016/J.ECSS.2015.12.022]; Solemio, SOM STAT DAT BAS; Thibaut T, 2016, CRYPTOGAMIE ALGOL, V37, P233, DOI 10.7872/crya/v37.iss4.2016.233; Topcu NE, 2010, J EXP MAR BIOL ECOL, V389, P61, DOI 10.1016/j.jembe.2010.03.017	27	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195257	10.1371/journal.pone.0195257	http://dx.doi.org/10.1371/journal.pone.0195257			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694362	Green Published, gold			2022-12-26	WOS:000430802400025
J	Lopez-Ruz, MA; Lopez-Zuniga, MA; Gonzalvo, MC; Sampedro, A; Pasquau, J; Hidalgo, C; Rosario, J; Castilla, JA				Lopez-Ruz, Miguel A.; Lopez-Zuniga, Miguel A.; Carmen Gonzalvo, Maria; Sampedro, Antonio; Pasquau, Juan; Hidalgo, Carmen; Rosario, Javier; Antonio Castilla, Jose			Effect of monotherapy with darunavir/cobicistat on viral load and semen quality of HIV-1 patients	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DARUNAVIR/RITONAVIR MONOTHERAPY; ATAZANAVIR-RITONAVIR; REFERENCE VALUES; RNA; LOPINAVIR/RITONAVIR; EFFICACY; MASS	Many patients previously using darunavir/ritonavir (DRV/r) (800/100mg) have switched to darunavir/cobicistat (DRV/C) (800/150 mg) either as part of triple therapy (ART) or as monotherapy with DRV (mDRV). The latter approach continues to be used in some countries for patients receiving long-term treatment. However, to date, the behaviour of DRV/C in the seminal compartment has not been analysed. This study explores how the combination behaves in monotherapy, with respect to the control of viral load and seminal quality. To this end, we studied 20 patients who were treated with mDRV/C after previous treatment with mDRV/r for at least 24 weeks. A viral load control in seminal plasma similar to that published in the literature was observed after 24 weeks of treatment with mDRV/C (viral load positivity in 20% of patients). Similarly, semen quality was confirmed (70% normozoospermic) in patients treated with this formulation, as has previously been reported for ART and mDRV/r. The DRV levels measured in seminal plasma were above EC50, regardless of whether the seminal viral load was positive or negative. We conclude that this mDRV/C co-formulation behaves like mDRV/r in seminal plasma in terms of viral load control and semen quality.	[Lopez-Ruz, Miguel A.; Pasquau, Juan; Hidalgo, Carmen; Rosario, Javier] Hosp Univ Virgen Nieves, Unidad Enfermedades Infecciosas, Granada, Spain; [Lopez-Ruz, Miguel A.; Carmen Gonzalvo, Maria; Sampedro, Antonio; Pasquau, Juan; Hidalgo, Carmen; Rosario, Javier; Antonio Castilla, Jose] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain; [Lopez-Zuniga, Miguel A.] Complejo Hosp Jaen, UGC Med Interna, Jaen, Spain; [Carmen Gonzalvo, Maria; Antonio Castilla, Jose] Hosp Univ Virgen Nieves, UGC Lab Clin & UGC Obstetr & Ginecol, Unidad Reprod, Granada, Spain; [Sampedro, Antonio] Hosp Univ Virgen Nieves, UGC Microbiol, Granada, Spain; [Antonio Castilla, Jose] Univ Granada, Fac Med, Dept Anat & Embriol Humana, Granada, Spain	Hospital Universitario Virgen de las Nieves; Instituto de Investigacion Biosanitaria IBS Granada; Complejo Hospitalario de Jaen; Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; University of Granada	Lopez-Ruz, MA (corresponding author), Hosp Univ Virgen Nieves, Unidad Enfermedades Infecciosas, Granada, Spain.; Lopez-Ruz, MA (corresponding author), Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain.	malruz@ugr.es	Castilla, jose antonio/ABF-8754-2021; Sampedro, Antonio/AAV-6389-2021	Castilla, jose antonio/0000-0003-2185-565X; GONZALVO LOPEZ, MARIA DEL CARMEN/0000-0001-8208-9851; Pasquau, Juan/0000-0001-9409-9205; Lopez Zuniga, Miguel Angel/0000-0002-2583-316X				AIDS Study Group (GESIDA) of Spanish Society of Infectious Diseases Clinical Microbiology The National Plan, 2017, ENFERM INFECC MICROB; [Anonymous], 2008, PREZ DAR FULL PRESCR; [Anonymous], 2016, JAMA-J AM MED ASSOC, V316, P191, DOI DOI 10.1001/JAMA.2016.8900; Antinori A, 2015, AIDS, V29, P1811, DOI 10.1097/QAD.0000000000000778; Aouri M, 2013, J MASS SPECTROM, V48, P616, DOI 10.1002/jms.3200; Arribas JR, 2016, HIV MED, V17, P358, DOI 10.1111/hiv.12348; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Barreiro P, 2006, JAIDS-J ACQ IMM DEF, V43, P324, DOI 10.1097/01.qai.0000243091.40490.fd; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Bujan L, 2007, J ANDROL, V28, P444, DOI 10.2164/jandrol.106.001529; Cahn P, 2011, AIDS, V25, P929, DOI 10.1097/QAD.0b013e328345ee95; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Ghosn J, 2008, J ANTIMICROB CHEMOTH, V61, P1344, DOI 10.1093/jac/dkn098; Gianotti N, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0171611, 10]; Girard PM, 2017, HIV MED, V18, P5, DOI 10.1111/hiv.12386; Guaraldi G, 2014, INT J STD AIDS, V25, P207, DOI 10.1177/0956462413497701; Gunthard HF, 2001, J INFECT DIS, V183, P1318, DOI 10.1086/319864; Gutierrez-Valencia A, 2017, CLIN INFECT DIS, V65, P551, DOI 10.1093/cid/cix358; Katlama C, 2010, AIDS, V24, P2365, DOI 10.1097/QAD.0b013e32833dec20; Lambert-Niclot S, 2011, J MED VIROL, V83, P1391, DOI 10.1002/jmv.22119; Lambert-Niclot S, 2010, ANTIMICROB AGENTS CH, V54, P4910, DOI 10.1128/AAC.00725-10; Lopez Ruz MA, 2016, PLOS ONE, V11, P1; Lopez-Cortes LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148924; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; Moyle G, 2005, ANTIVIR THER, V10, pM47; Orkin C, 2013, HIV MED, V14, P49, DOI 10.1111/j.1468-1293.2012.01060.x; Pasquau J, 2014, J INT AIDS SOC, V17, P196, DOI 10.7448/IAS.17.4.19813; Pilatz A, 2014, AIDS, V28, P875, DOI 10.1097/QAD.0000000000000161; Sanchez-Pozo MC, 2013, HUM REPROD, V28, P10, DOI 10.1093/humrep/des355; Santos JR, 2016, AIDS RES HUM RETROV, V32, P452, DOI [10.1089/aid.2015.0248, 10.1089/AID.2015.0248]; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Swindells S, 2006, JAMA-J AM MED ASSOC, V296, P806, DOI 10.1001/jama.296.7.806; Tasmina K, 2014, AIDS RES THER, V11, P39, DOI [10.1186/1742-6405-11-39, DOI 10.1186/1742-6405-11-39]; Taylor S, 2001, SEX TRANSM INFECT, V77, P4, DOI 10.1136/sti.77.1.4; Taylor S, 2010, AIDS, V24, P2574, DOI 10.1097/QAD.0b013e32833ead18; Torres Cornejo A, 2016, CLIN MICROBIOL INFEC, V22; US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza P, 2007, AIDS, V21, P1309, DOI 10.1097/QAD.0b013e32814e6b1c; Yunquero L, 2015, REV ESP QUIM, V6, P308	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196257	10.1371/journal.pone.0196257	http://dx.doi.org/10.1371/journal.pone.0196257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689065	Green Submitted, Green Published, gold			2022-12-26	WOS:000430678800035
J	Olive, LS; Abhayaratna, WP; Byrne, D; Richardson, A; Telford, RD				Olive, Lisa S.; Abhayaratna, Walter P.; Byrne, Don; Richardson, Alice; Telford, Richard D.			Do self-reported stress and depressive symptoms effect endothelial function in healthy youth? The LOOK longitudinal study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; MENTAL STRESS; YOUNG-ADULTS; LIFE-STYLE; PART I; CHILDREN; ADOLESCENTS	Background and aims Endothelial dysfunction is thought to be an early indicator of risk for cardiovascular disease and has been associated with both stress and depression in adults and adolescents. Less is known of these relationships in younger populations, where the origins of CVD is thought to manifest. This study examined the effects of questionnaire derived psychosocial stress and depressive symptoms on endothelial function among children, following them through to adolescence. Method Participants were 203 grade 2 children (111 girls; M age = 7.6 +/- 0.3 years) from the LOOK longitudinal study, who were followed through to adolescence (16 years). Self-reported psychosocial stress and depression were assessed using the validated Children's Stress Questionnaire and a modified and validated version of the Children's Depression Inventory respectively; endothelial function was assessed using EndoPAT 2000 system at follow-up only; and adjustments were made for fitness, pubertal development and socioeconomic status. Results Although all relationships occurred in the hypothesised direction, no cross-sectional or prospective evidence of early symptoms of psychological stress or depression being associated with endothelial dysfunction was found among our asymptomatic cohort of adolescents (all p > .05). Conclusions In contrast to previous findings in adolescents, our data provided little evidence of any relationship between current or previous psychosocial stress or depression and endothelial function in 16-year-old boys and girls. However, our data need to be interpreted alongside the potential limitations in the sensitivity associated with self-report methods for detecting psychological distress of children.	[Olive, Lisa S.] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia; [Olive, Lisa S.; Abhayaratna, Walter P.; Byrne, Don] Australian Natl Univ, ANU Med Sch, Canberra, ACT, Australia; [Richardson, Alice] Australian Natl Univ, ANU Coll Hlth & Med, Canberra, ACT, Australia; [Telford, Richard D.] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia	Deakin University; Australian National University; Australian National University; University of Canberra	Olive, LS (corresponding author), Deakin Univ, Sch Psychol, Melbourne, Vic, Australia.; Olive, LS (corresponding author), Australian Natl Univ, ANU Med Sch, Canberra, ACT, Australia.	lisa.olive@deakin.edu.au		Abhayaratna, Walter/0000-0002-4908-0641; Telford, Richard/0000-0003-4485-9362	National Heart Foundation of Australia/National Health and Medical Research Council [GNT1056551]; Australian Research Council; Commonwealth Education Trust (New Zealand House, London, UK); Canberra Hospital Salaried Staff Specialists Fund	National Heart Foundation of Australia/National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of AustraliaNational Heart Foundation of Australia); Australian Research Council(Australian Research Council); Commonwealth Education Trust (New Zealand House, London, UK); Canberra Hospital Salaried Staff Specialists Fund	Support for this research was provided via a co-funded National Heart Foundation of Australia (https://www.heartfoundation.org.au)/National Health and Medical Research Council (https://www.nhmrc.gov.au) Postgraduate Scholarship [GNT1056551] awarded to LO; an Australian Research Council Linkage Grant to DB; and from The Commonwealth Education Trust (New Zealand House, London, UK); (http://www.commonwealth.org.uk/) awarded to DT. Adolescent work was funded by the Canberra Hospital Salaried Staff Specialists Fund awarded to WA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2009, INF PAP INTR SOC IND; Berenson GS, 2005, NEUROBIOL AGING, V26, P303, DOI 10.1016/j.neurobiolaging.2004.05.009; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Bruyndonckx L, 2013, INT J CARDIOL, V168, P3183, DOI 10.1016/j.ijcard.2013.07.236; Byrne DG, 2007, J ADOLESCENCE, V30, P393, DOI 10.1016/j.adolescence.2006.04.004; Byrne DG, 2011, INT J STRESS MANAGE, V18, P88, DOI 10.1037/a0021577; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Chen Y, 2017, ATHEROSCLEROSIS, V261, P131, DOI 10.1016/j.atherosclerosis.2017.03.012; [陈昀 Chen Yun], 2011, [预测, Forecasting], V30, P10; Cooper DC, 2011, PSYCHOSOM MED, V73, P360, DOI 10.1097/PSY.0b013e31821db79a; Costello EJ, 2006, J CHILD PSYCHOL PSYC, V47, P1263, DOI 10.1111/j.1469-7610.2006.01682.x; Deanfield J, 2005, J HYPERTENS, V23, P7, DOI 10.1097/00004872-200501000-00004; Demirtas T, 2014, INFLAMMATION, V37, P1432, DOI 10.1007/s10753-014-9867-4; DUKE PM, 1980, PEDIATRICS, V66, P918; Fathi R, 2001, AM HEART J, V141, P694, DOI 10.1067/mhj.2001.114972; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Glozier N, 2013, MED J AUSTRALIA, V199, P179, DOI 10.5694/mja13.10440; Grippo AJ, 2002, NEUROSCI BIOBEHAV R, V26, P941, DOI 10.1016/S0149-7634(03)00003-4; Grippo AJ, 2009, STRESS, V12, P1, DOI 10.1080/10253890802046281; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Kassel JD, 2003, PSYCHOL BULL, V129, P270, DOI 10.1037/0033-2909.129.2.270; Kiecolt-Glaser JK, 2015, BIOL PSYCHIAT, V77, P653, DOI 10.1016/j.biopsych.2014.05.018; Kovacs M., 1992, CHILDRENS DEPRESSION; Kovacs M., 1982, CHILDRENS DEPRESSION; Kraag G, 2006, J SCHOOL PSYCHOL, V44, P449, DOI 10.1016/j.jsp.2006.07.001; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lavoie KL, 2010, PSYCHOSOM MED, V72, P20, DOI 10.1097/PSY.0b013e3181c2d6b8; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; Merikangas KR, 2010, PEDIATRICS, V125, P75, DOI 10.1542/peds.2008-2598; Muller U, 2013, METABOLISM, V62, P634, DOI 10.1016/j.metabol.2012.11.003; Myers K, 2002, J AM ACAD CHILD PSY, V41, P634, DOI 10.1097/00004583-200206000-00004; Olive LS, 2017, HEALTH PSYCHOL, V36, P749, DOI 10.1037/hea0000496; Olive LS, 2012, MENTAL HLTH PHYS ACT, V5, P116, DOI DOI 10.1016/J.MHPA.2012.08.004; Olive LS, 2016, J BEHAV MED; Osika W, 2011, ARCH DIS CHILD, V96, P38, DOI 10.1136/adc.2008.152777; Pereira VH, 2013, INT J CARDIOL, V166, P30, DOI 10.1016/j.ijcard.2012.03.165; Poitras VJ, 2013, INT J PSYCHOPHYSIOL, V88, P124, DOI 10.1016/j.ijpsycho.2013.03.019; R Core Team, 2012, R LANG ENV STAT COMP; Sabiston CM, 2013, PREV MED, V56, P95, DOI 10.1016/j.ypmed.2012.11.013; Sakuragi S, 2009, HYPERTENSION, V53, P611, DOI 10.1161/HYPERTENSIONAHA.108.123364; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Telford RD, 2015, MED SCI SPORT EXER, V47, P974, DOI 10.1249/MSS.0000000000000493; Telford RD, 2009, J SCI MED SPORT, V12, P156, DOI 10.1016/j.jsams.2007.03.009; Tierney ESS, 2009, J PEDIATR-US, V154, P901, DOI 10.1016/j.jpeds.2008.12.028; Tomfohr LM, 2008, J BEHAV MED, V31, P137, DOI 10.1007/s10865-007-9141-4; Tomfohr LM, 2011, PSYCHOSOM MED, V73, P456, DOI 10.1097/PSY.0b013e3182228644; Tomkinson GR, 2003, SPORTS MED, V33, P285, DOI 10.2165/00007256-200333040-00003; Tuzcu EM, 2001, CIRCULATION, V103, P2705; van Sloten TT, 2014, PSYCHOL MED, V44, P1403, DOI 10.1017/S0033291713002043; Waloszek JM, 2015, J AFFECT DISORDERS, V175, P403, DOI 10.1016/j.jad.2015.01.008	51	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196137	10.1371/journal.pone.0196137	http://dx.doi.org/10.1371/journal.pone.0196137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7AK	29684063	Green Published, Green Submitted, gold			2022-12-26	WOS:000430660600039
J	Razzoli, M; Emmett, MJ; Lazar, MA; Bartolomucci, A				Razzoli, Maria; Emmett, Matthew J.; Lazar, Mitchell A.; Bartolomucci, Alessandro			-Adrenergic receptors control brown adipose UCP-1 tone and cold response without affecting its circadian rhythmicity	FASEB JOURNAL			English	Article						thermogenesis; locomotor activity; molecular clock; brown adipocytes; Rev-erb	REV-ERB-ALPHA; CLOCK; THERMOGENESIS; DISRUPTION; DISEASE; MOUSE; TEMPERATURE; ADIPOCYTES; ADAPTATION; EXPRESSION	Brown adipose tissue (BAT) thermogenic functions are primarily mediated by uncoupling protein (UCP)-1. Ucp1 gene expression is highly induced by cold temperature, via sympathetic nervous system and -adrenergic receptors (ARs). Ucp1 is also repressed by the clock gene Rev-erb, contributing to its circadian rhythmicity. In this study, we investigated mice lacking ARs (-less mice) to test the relationship between AR signaling and the BAT molecular clock. We found that in addition to controlling the induction of Ucp1 and other key BAT genes at near freezing temperatures, ARs are essential for the basal expression of BAT Ucp1 at room temperature. Remarkably, although basal Ucp1 expression is low throughout day and night in -less mice, the circadian rhythmicity of Ucp1 and clock genes in BAT is maintained. Thus, the requirement of AR signaling for BAT activity is independent of the circadian rhythmicity of Ucp1 expression and circadian oscillation of the molecular clock genes. On the other hand, we found that ARs are essential for the normal circadian rhythms of locomotor activity. Our results demonstrate that in addition to controlling the BAT response to extreme cold, AR signaling is necessary to maintain basal Ucp1 tone and to couple BAT circadian rhythmicity to the central clock.Razzoli, M., Emmett, M. J., Lazar, M. A., Bartolomucci, A. -Adrenergic receptors control brown adipose UCP-1 tone and cold response without affecting its circadian rhythmicity.	[Razzoli, Maria; Bartolomucci, Alessandro] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Emmett, Matthew J.; Lazar, Mitchell A.] Univ Penn, Div Endocrinol Diabet & Metab, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Pennsylvania Medicine	Bartolomucci, A (corresponding author), Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA.	abartolo@umn.edu	Lazar, Mitchell A/AAF-3738-2019	Lazar, Mitchell/0000-0001-8653-1280	U.S. National Institutes of Health, National Institute of Digestive Diabetes and Kidney Diseases [DK102496, DK45586, F30 DK104513]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045586, F30DK104513, R01DK102496] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Digestive Diabetes and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank B. B. Lowell (Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA) for providing the beta-less mice. This work was supported by U.S. National Institutes of Health, National Institute of Digestive Diabetes and Kidney Diseases Grants DK102496 (to A. B.), DK45586 (to M.A.L.), and F30 DK104513 (to M.J.E). The authors declare no conflicts of interest.	Arble DM, 2010, BEST PRACT RES CL EN, V24, P785, DOI 10.1016/j.beem.2010.08.003; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Aujard F, 2007, EXP GERONTOL, V42, P1079, DOI 10.1016/j.exger.2007.08.007; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cailotto C, 2005, EUR J NEUROSCI, V22, P2531, DOI 10.1111/j.1460-9568.2005.04439.x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chappuis S, 2013, MOL METAB, V2, P184, DOI 10.1016/j.molmet.2013.05.002; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kanzleiter T, 2005, PHYSIOL GENOMICS, V24, P37, DOI 10.1152/physiolgenomics.00204.2005; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lee J, 2013, MOL CELL BIOL, V33, P2327, DOI 10.1128/MCB.01421-12; Li SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070109; O'Keeffe SM, 2012, NEUROSCIENCE, V201, P219, DOI 10.1016/j.neuroscience.2011.11.002; Peirce V, 2013, LANCET DIABETES ENDO, V1, P353, DOI 10.1016/S2213-8587(13)70055-X; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Razzoli M, 2016, MOL METAB, V5, P19, DOI 10.1016/j.molmet.2015.10.005; REHNMARK S, 1990, J BIOL CHEM, V265, P16464; Reilly DF, 2008, ARTERIOSCL THROM VAS, V28, P121, DOI 10.1161/ATVBAHA.107.152538; Rosenwasser AM, 1996, PHYSIOL BEHAV, V60, P373, DOI 10.1016/0031-9384(96)00059-5; ROSENWASSER AM, 1989, PHARMACOL BIOCHEM BE, V33, P291, DOI 10.1016/0091-3057(89)90502-9; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Smolensky MH, 2016, CHRONOBIOL INT, V33, P1101, DOI 10.1080/07420528.2016.1184678; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; WELSH DK, 1986, J GERONTOL, V41, P579, DOI 10.1093/geronj/41.5.579; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zhu BK, 2017, CELL METAB, V25, P1305, DOI 10.1016/j.cmet.2017.05.004; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	34	18	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5640	5646		10.1096/fj.201800452R	http://dx.doi.org/10.1096/fj.201800452R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29715048	Green Published			2022-12-26	WOS:000447972500036
J	Yang, JH; Yan, W; Yu, YM; Wang, YX; Yang, T; Xue, LL; Yuan, X; Long, CF; Liu, ZW; Chen, XX; Hu, MS; Zheng, L; Qiu, Q; Pei, HY; Li, D; Wang, F; Bai, P; Wen, JL; Ye, HY; Chen, LJ				Yang, Jianhong; Yan, Wei; Yu, Yamei; Wang, Yuxi; Yang, Tao; Xue, Linlin; Yuan, Xue; Long, Caofeng; Liu, Zuowei; Chen, Xiaoxin; Hu, Mengshi; Zheng, Li; Qiu, Qiang; Pei, Heying; Li, Dan; Wang, Fang; Bai, Peng; Wen, Jiaolin; Ye, Haoyu; Chen, Lijuan			The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in beta-tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microtubule; cancer prevention; cancer; natural product; tubulin; X-ray crystallography; drug resistance; Chalcone; Colchicine; Millepachine; s-trans conformation; Tubulin	IN-VIVO; BIOLOGICAL EVALUATION; ANTICANCER AGENTS; CANCER-CELLS; RESISTANCE; MICROTUBULES; MECHANISMS; APOPTOSIS; INTERACT; POTENT	Inhibitors that bind to the paclitaxel- or vinblastine-binding sites of tubulin have been part of the pharmacopoeia of anticancer therapy for decades. However, tubulin inhibitors that bind to the colchicine-binding site are not used in clinical cancer therapy, because of their low therapeutic index. To address multidrug resistance to many conventional tubulin-binding agents, numerous efforts have attempted to clinically develop inhibitors that bind the colchicine-binding site. Previously, we have found that millepachine (MIL), a natural chalcone-type small molecule extracted from the plant Millettia pachycarpa, and its two derivatives (MDs) SKLB028 and SKLB050 have potential antitumor activities both in vitro and in vivo. However, their cellular targets and mechanisms are unclear. Here, biochemical and cellular experiments revealed that the MDs directly and irreversibly bind -tubulin. X-ray crystallography of the tubulin-MD structures disclosed that the MDs bind at the tubulin intradimer interface and to the same site as colchicine and that their binding mode is similar to that of colchicine. Of note, MDs inhibited tubulin polymerization and caused G(2)/M cell-cycle arrest. Comprehensive analysis further revealed that free MIL exhibits an s-cis conformation, whereas MIL in the colchicine-binding site in tubulin adopts an s-trans conformation. Moreover, introducing an -methyl to MDs to increase the proportion of s-trans conformations augmented MDs' tubulin inhibition activity. Our study uncovers a new class of chalcone-type tubulin inhibitors that bind the colchicine-binding site in -tubulin and suggests that the s-trans conformation of these compounds may make them more active anticancer agents.	[Yang, Jianhong; Yan, Wei; Yu, Yamei; Wang, Yuxi; Yang, Tao; Xue, Linlin; Yuan, Xue; Hu, Mengshi; Zheng, Li; Qiu, Qiang; Pei, Heying; Li, Dan; Wang, Fang; Bai, Peng; Wen, Jiaolin; Ye, Haoyu; Chen, Lijuan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Peoples R China; [Yang, Jianhong; Yan, Wei; Yu, Yamei; Wang, Yuxi; Yang, Tao; Xue, Linlin; Yuan, Xue; Hu, Mengshi; Zheng, Li; Qiu, Qiang; Pei, Heying; Li, Dan; Wang, Fang; Bai, Peng; Wen, Jiaolin; Ye, Haoyu; Chen, Lijuan] Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China; [Long, Caofeng; Liu, Zuowei; Chen, Xiaoxin] Guangdong Zhongsheng Pharmaceut Co Ltd, Dongguan 523325, Guangdong, Peoples R China	Sichuan University	Chen, LJ (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Peoples R China.; Chen, LJ (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu 610041, Peoples R China.	chenlijuan125@163.com	Wen, Jiaolin/GZL-0162-2022	Yang, Tao/0000-0003-0186-9907	National Natural Science Foundation of China [U1402222]; Guangdong Innovative Research Team Program [2011Y073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program	This work was supported by National Natural Science Foundation of China Grant U1402222 and Guangdong Innovative Research Team Program Grant 2011Y073. The authors declare that they have no conflicts of interest with the contents of this article.	AKTULGA E, 1980, HAEMATOLOGICA, V65, P399; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Buey RM, 2007, NAT CHEM BIOL, V3, P117, DOI 10.1038/nchembio853; Cao D, 2016, J MED CHEM, V59, P5721, DOI 10.1021/acs.jmedchem.6b00158; Cao D, 2013, EUR J MED CHEM, V62, P579, DOI 10.1016/j.ejmech.2013.01.007; Chinen T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9722; Clegg A, 2002, THORAX, V57, P20, DOI 10.1136/thorax.57.1.20; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Doodhi H, 2016, CURR BIOL, V26, P1713, DOI 10.1016/j.cub.2016.04.053; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; Field JJ, 2012, CHEM BIOL, V19, P686, DOI 10.1016/j.chembiol.2012.05.008; Fojo AT, 2005, SEMIN ONCOL, V32, pS3, DOI 10.1053/j.seminoncol.2005.09.010; Imazio M, 2015, TRENDS CARDIOVAS MED, V25, P129, DOI 10.1016/j.tcm.2014.09.011; Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kim JS, 2007, CLIN CANCER RES, V13, P6509, DOI 10.1158/1078-0432.CCR-07-1428; LOCKWOOD AH, 1979, P NATL ACAD SCI USA, V76, P1184, DOI 10.1073/pnas.76.3.1184; Lu Y, 2012, PHARM RES-DORDR, V29, P2943, DOI 10.1007/s11095-012-0828-z; Michaud LB, 2009, ANN PHARMACOTHER, V43, P1294, DOI 10.1345/aph.1M005; MORELAND LW, 1991, ARTHRITIS RHEUM-US, V34, P782, DOI 10.1002/art.1780340622; Nakagawa-Goto K, 2015, J MED CHEM, V58, P2378, DOI 10.1021/jm501859j; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Prota AE, 2014, ANGEW CHEM INT EDIT, V53, P1621, DOI 10.1002/anie.201307749; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; SACKS S, 1981, REV MED CHILE, V109, P239; Shan B, 1999, P NATL ACAD SCI USA, V96, P5686, DOI 10.1073/pnas.96.10.5686; Swain Sandra M, 2008, Clin Adv Hematol Oncol, V6, P455; Thomas NE, 2014, MOL CANCER THER, V13, P179, DOI 10.1158/1535-7163.MCT-13-0479; Towle MJ, 2011, CANCER RES, V71, P496, DOI 10.1158/0008-5472.CAN-10-1874; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wieczorek M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1093; Wu WS, 2013, CARCINOGENESIS, V34, P1636, DOI 10.1093/carcin/bgt087; Yang JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12103; Yang Z, 2014, J MED CHEM, V57, P7977, DOI 10.1021/jm500849z; Ye HY, 2012, FITOTERAPIA, V83, P1402, DOI 10.1016/j.fitote.2012.08.001	36	29	29	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9461	9472		10.1074/jbc.RA117.001658	http://dx.doi.org/10.1074/jbc.RA117.001658			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29691282	Green Published, hybrid			2022-12-26	WOS:000435441400029
J	Bogachev, MI; Volkov, VY; Markelov, OA; Trizna, EY; Baydamshina, DR; Melnikov, V; Murtazina, RR; Zelenikhin, PV; Sharafutdinov, IS; Kayumov, AR				Bogachev, Mikhail I.; Volkov, Vladimir Yu; Markelov, Oleg A.; Trizna, Elena Yu; Baydamshina, Diana R.; Melnikov, Vladislav; Murtazina, Regina R.; Zelenikhin, Pavel V.; Sharafutdinov, Irshad S.; Kayumov, Airat R.			Fast and simple tool for the quantification of biofilm-embedded cells sub-populations from fluorescent microscopic images	PLOS ONE			English	Article							2(5H)-FURANONE; DERIVATIVES; INHIBITORS	Fluorescent staining is a common tool for both quantitative and qualitative assessment of pro- and eukaryotic cells sub-population fractions by using microscopy and flow cytometry. However, direct cell counting by flow cytometry is often limited, for example when working with cells rigidly adhered either to each other or to external surfaces like bacterial biofilms or adherent cell lines and tissue samples. An alternative approach is provided by using fluorescent microscopy and confocal laser scanning microscopy (CLSM), which enables the evaluation of fractions of cells subpopulations in a given sample. For the quantitative assessment of cell fractions in microphotographs, we suggest a simple two-step algorithm that combines single cells selection and the statistical analysis. To facilitate the first step, we suggest a simple procedure that supports finding the balance between the detection threshold and the typical size of single cells based on objective cell size distribution analysis. Based on a series of experimental measurements performed on bacterial and eukaryotic cells under various conditions, we show explicitly that the suggested approach effectively accounts for the fractions of different cell sub-populations (like the live/dead staining in our samples) in all studied cases that are in good agreement with manual cell counting on microphotographs and flow cytometry data. This algorithm is implemented as a simple software tool that includes an intuitive and user-friendly graphical interface for the initial adjustment of algorithm parameters to the microphotographs analysis as well as for the sequential analysis of homogeneous series of similar microscopic images without further user intervention.	[Bogachev, Mikhail I.; Volkov, Vladimir Yu; Markelov, Oleg A.; Melnikov, Vladislav] St Petersburg Electrotech Univ, Radio Syst Dept, St Petersburg, Russia; [Bogachev, Mikhail I.; Volkov, Vladimir Yu; Markelov, Oleg A.; Melnikov, Vladislav] St Petersburg Electrotech Univ, Biomed Engn Res Ctr, St Petersburg, Russia; [Bogachev, Mikhail I.; Trizna, Elena Yu; Baydamshina, Diana R.; Murtazina, Regina R.; Zelenikhin, Pavel V.; Sharafutdinov, Irshad S.; Kayumov, Airat R.] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Volkov, Vladimir Yu] Bonch Bruevich State Telecommun Univ, Dept Radio Syst & Signal Proc, St Petersburg, Russia; [Volkov, Vladimir Yu] State Univ Aerosp Instrumentat, Dept Radio Engn Syst, St Petersburg, Russia	Saint Petersburg State Electrotechnical University; Saint Petersburg State Electrotechnical University; Kazan Federal University; Bonch-Bruevich St. Petersburg State University of Telecommunications; Saint Petersburg State University of Aerospace Instrumentation	Kayumov, AR (corresponding author), Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia.	kairatr@yandex.ru	Zelenikhin, Pavel V/E-7042-2014; Baydamshina, Diana/O-2907-2016; Kayumov, Airat/M-6725-2013; Volkov, Vladimir/B-4121-2017; Sharafutdinov, Irshad/AAV-5042-2021; Trizna, Elena/M-1607-2016; Markelov, Oleg/L-5904-2016; Sharafutdinov, Irshad/N-1685-2016; Volkov, Vladimir/AAH-4426-2019; Bogachev, Mikhail/C-1229-2011	Kayumov, Airat/0000-0001-7195-1557; Volkov, Vladimir/0000-0001-8552-4775; Sharafutdinov, Irshad/0000-0002-9873-9676; Markelov, Oleg/0000-0002-6099-8867; Sharafutdinov, Irshad/0000-0002-9873-9676; Bogachev, Mikhail/0000-0002-0356-5651; Zelenikhin, Pavel/0000-0003-1971-1745	Ministry of Education and Science of the Russian Federation [2.5475.2017/6.7]; Ministry of Education and Science of the Russian Federation; DAAD (Mikhail Lomonosov Russian-German bilateral travel grant); Russian Science Foundation [15-14-00046]; Program of competitive development of Kazan Federal University	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); DAAD (Mikhail Lomonosov Russian-German bilateral travel grant); Russian Science Foundation(Russian Science Foundation (RSF)); Program of competitive development of Kazan Federal University	The financial support of this work was provided by the Ministry of Education and Science of the Russian Federation (assignment 2.5475.2017/6.7 to MIB), by the Ministry of Education and Science of the Russian Federation and DAAD (Mikhail Lomonosov Russian-German bilateral travel grant to ISS), by the Russian Science Foundation (project No. 15-14-00046 to ARK) and by the Program of competitive development of Kazan Federal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M., 2004, IMAGE PROCESSING IMA, V11; ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Adan A, 2017, CRIT REV BIOTECHNOL, V37, P163, DOI 10.3109/07388551.2015.1128876; Atale N, 2014, J MICROSC-OXFORD, V255, P7, DOI 10.1111/jmi.12133; Baidamshina DR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46068; Beyenal H, 2004, J MICROBIOL METH, V59, P395, DOI 10.1016/j.mimet.2004.08.003; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Gerstner AOH, 2006, J IMMUNOL METHODS, V311, P130, DOI 10.1016/j.jim.2006.01.012; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; JI L, 1989, PATTERN RECOGN LETT, V9, P201, DOI 10.1016/0167-8655(89)90055-X; Kayumov AR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/890968; Klinger-Strobel M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154937; Lempitsky V, 2010, IEEE T PATTERN ANAL, V32, P1392, DOI 10.1109/TPAMI.2009.143; McMullan BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117186; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Mital J, 2006, CYTOM PART A, V69A, P13, DOI 10.1002/cyto.a.20202; Nattkemper TW, 2003, COMPUT BIOL MED, V33, P31, DOI 10.1016/S0010-4825(02)00060-4; Netuschil L, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-2; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Sharafutdinov IS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02246; Tawakoli PN, 2013, CLIN ORAL INVEST, V17, P841, DOI 10.1007/s00784-012-0792-3; Tchoukalova YD, 2003, J LIPID RES, V44, P1795, DOI 10.1194/jlr.D300001-JLR200; Trizna EY, 2015, ACTA NATURAE, V7, P102, DOI 10.32607/20758251-2015-7-2-102-107; Trizna E, 2016, BIONANOSCIENCE, V6, P423, DOI 10.1007/s12668-016-0258-1; van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x	25	45	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0193267	10.1371/journal.pone.0193267	http://dx.doi.org/10.1371/journal.pone.0193267			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715298	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281100002
J	Guerrero, E; Gili, JM; Grinyo, J; Raya, V; Sabates, A				Guerrero, Elena; Gili, Josep-Maria; Grinyo, Jordi; Raya, Vanesa; Sabates, Ana			Long-term changes in the planktonic cnidarian community in a mesoscale area of the NW Mediterranean	PLOS ONE			English	Article							EUROPEAN ATHECATE HYDROIDS; CLIMATE-CHANGE; JELLYFISH POPULATIONS; SARDINELLA-AURITA; MEDUSAE HYDROZOA; TIME-SERIES; ZOOPLANKTON; FISH; VARIABILITY; ATLANTIC	In the present work, possible long-term changes in the planktonic cnidarian community were investigated by analyzing (1) species and community spatial distribution patterns, (2) variations in abundance and (3) changes in species richness during three mesoscale surveys representative of the climatic and anthropogenic changes that have occurred during the last three decades (years: 1983, 2004 and 2011) in the NW Mediterranean. These surveys were conducted during the summer (June) along the Catalan coast. All surveys covered the same area, used the same sampling methodology, and taxonomic identification was conducted by the same team of experts. An increase in the abundance of total cnidaria was found from 1983 to 2011. The siphonophore Muggiaea atlantica and the hydromedusa Aglaura hemistoma were the most abundant species, while Muggiaea kochii presented the largest abundance increment over time. Temperature was the main environmental parameter driving significant differences in the cnidarian community composition, abundance and spatial distribution patterns among the surveys. Our results suggest that in the current climate change scenario, warm-water species abundances will be positively favored, and the community will suffer changes in their latitudinal distribution patterns. We consider it extremely important to study and monitor gelatinous zooplankton in mesoscale spatial areas to understand not only long-term changes in abundances but also changes in their spatial distributions since spatial changes are sensitive indicators of climate change.	[Guerrero, Elena; Gili, Josep-Maria; Grinyo, Jordi; Raya, Vanesa; Sabates, Ana] CSIC, Inst Ciencies Mar, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Guerrero, E (corresponding author), CSIC, Inst Ciencies Mar, Barcelona, Spain.	eguerrero@icm.csic.es	Grinyó, Jordi/Q-8098-2018; Sabates, Ana/AAA-1359-2019; Maynou, Francesc/A-6433-2011	Grinyó, Jordi/0000-0001-8425-1349; Maynou, Francesc/0000-0001-7200-6485; Guerrero, Elena/0000-0003-1657-6648	EU Project VECTORS [FP7 OCEAN-2010-266445, 266445]; Spanish projects - Spanish Ministry of Economy and Competitiveness [CTM2010-18874/MAR, CTM2015-68543-R]	EU Project VECTORS; Spanish projects - Spanish Ministry of Economy and Competitiveness	This study was partially supported by the EU Project VECTORS, FP7 OCEAN-2010-266445 (http://www.marine-vectors.eu, Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors, grant no. 266445) and the Spanish projects CTM2010-18874/MAR and CTM2015-68543-R, funded by the Spanish Ministry of Economy and Competitiveness.	Alvarino A., 1971, Bull Scripps Inst Oceanogr Berkeley Tech Ser, V16, P1; ARAI MN, 1988, CAN J ZOOL, V66, P1913, DOI 10.1139/z88-280; Bakun A, 2006, FISH FISH, V7, P316, DOI 10.1111/j.1467-2979.2006.00229.x; Berline L, 2012, PROG OCEANOGR, V97, P76, DOI 10.1016/j.pocean.2011.11.011; Blackett M, 2014, PROG OCEANOGR, V128, P1, DOI 10.1016/j.pocean.2014.07.004; BOERO F, 1993, BIOL J LINN SOC, V48, P239, DOI 10.1111/j.1095-8312.1993.tb00890.x; Boero F., 2016, EXPLAINING OCEAN WAR, P213, DOI DOI 10.2305/IUCN.CH.2016.08.EN; Bouillon J, 2004, SCI MAR, V68, P5, DOI 10.3989/scimar.2004.68s25; Brodeur RD, 2008, MAR BIOL, V154, P649, DOI 10.1007/s00227-008-0958-3; Brotz L, 2012, ACTA ADRIAT, V53, P213; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Calvo E, 2011, CLIM RES, V50, P1, DOI 10.3354/cr01040; Cardona L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031329; Carrasson M, 2002, MAR ECOL PROG SER, V241, P41, DOI 10.3354/meps241041; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Conversi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010633; D'Alcala MR, 2004, SCI MAR, V68, P65; D'Ambrosio M, 2016, MAR ENVIRON RES, V120, P103, DOI 10.1016/j.marenvres.2016.07.012; Garcia-Comas C, 2011, J MARINE SYST, V87, P216, DOI 10.1016/j.jmarsys.2011.04.003; Gili J.-M., 1987, P157; GILI JM, 1988, J PLANKTON RES, V10, P385, DOI 10.1093/plankt/10.3.385; Goy J., 1974, RAPPORTS PROCES VERB, V22, P125; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Guerrero E, 2018, J PLANKTON RES, V40, P178, DOI 10.1093/plankt/fby001; Guerrero E, 2016, SCI MAR, V80, P487, DOI 10.3989/scimar.04452.03A; Guerrero E, 2013, MAR ECOL-EVOL PERSP, V34, P71, DOI 10.1111/maec.12027; Haddock SHD, 2004, HYDROBIOLOGIA, V530, P549, DOI 10.1007/s10750-004-2653-9; Haury L.R., 1978, NATO Conference Series IV Marine Sciences, V3, P277; Hays GC, 2005, TRENDS ECOL EVOL, V20, P337, DOI 10.1016/j.tree.2005.03.004; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Licandro P, 2012, PROG OCEANOGR, V97, P152, DOI 10.1016/j.pocean.2011.11.004; de Puelles MLF, 2008, ICES J MAR SCI, V65, P311, DOI 10.1093/icesjms/fsn017; Lynam CP, 2011, GLOBAL CHANGE BIOL, V17, P767, DOI 10.1111/j.1365-2486.2010.02352.x; MACKIE GO, 1987, ADV MAR BIOL, V24, P97; Martin P, 2012, CLIMATIC CHANGE, V110, P925, DOI 10.1007/s10584-011-0091-z; Maso M, 1991, J MARINE SYST, V1, P441, DOI 10.1016/0924-7963(91)90008-I; Mayer AG, 1910, MEDUSAE WORLD, VII; Molinero JC, 2005, LIMNOL OCEANOGR, V50, P1213, DOI 10.4319/lo.2005.50.4.1213; Molinero JC, 2008, LIMNOL OCEANOGR, V53, P1456, DOI 10.4319/lo.2008.53.4.1456; Pages F, 2001, MAR ECOL PROG SER, V210, P13, DOI 10.3354/meps210013; PAGES F, 1991, MAR ECOL PROG SER, V75, P205, DOI 10.3354/meps075205; Pages Francesc, 1992, Scientia Marina, V56, P109; Penston MJ, 2008, J FISH DIS, V31, P361, DOI 10.1111/j.1365-2761.2008.00915.x; Postel L., 2000, P83, DOI 10.1016/B978-012327645-2/50005-0; PUGH PR, 1984, PROG OCEANOGR, V13, P461, DOI 10.1016/0079-6611(84)90016-8; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; RIERA T, 1986, Miscellania Zoologica (Barcelona), V10, P23; Rixen M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022702; Russell F. S., 1934, Journal of the Marine Biological Association Plymouth NS, V19, P555; Sabates A, 2013, J MARINE SYST, V111, P108, DOI 10.1016/j.jmarsys.2012.10.002; Sabates A, 2012, ICES J MAR SCI, V69, P1000, DOI 10.1093/icesjms/fss053; Sabates A, 2009, MAR ECOL PROG SER, V385, P227, DOI 10.3354/meps08058; Saiz E, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P183, DOI 10.1007/978-94-007-6704-1_11; Schuchert P, 2008, REV SUISSE ZOOL, V115, P221, DOI 10.5962/bhl.part.80426; Schuchert P, 2007, REV SUISSE ZOOL, V114, P195, DOI 10.5962/bhl.part.80395; Suikkanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066475; Tilves U, 2016, J PLANKTON RES, V38, P1243, DOI 10.1093/plankt/fbw059; Van Beveren E, 2016, ICES J MAR SCI, V73, P1474, DOI 10.1093/icesjms/fsw023; Vargas-Yanez M, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002799; Venables WN, 2002, TECHNOMETRICS; Zuur Alain F., 2009, P1; [No title captured]	67	9	9	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196431	10.1371/journal.pone.0196431	http://dx.doi.org/10.1371/journal.pone.0196431			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715282	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100022
J	Liu, LL; Han, RC; Yu, NJ; Zhang, W; Xing, LH; Xie, DM; Peng, DY				Liu, Lulu; Han, Rongchun; Yu, Nianjun; Zhang, Wei; Xing, Lihua; Xie, Dongmei; Peng, Daiyin			A method for extracting high-quality total RNA from plant rich in polysaccharides and polyphenols using Dendrobium huoshanense	PLOS ONE			English	Article							BIOACTIVITY	Acquiring high quality RNA is the basis of plant molecular biology research, plant genetics and other physiological investigations. At present, a large number of nucleotide isolation methods have been exploited or modified, such as commercial kits, CTAB, SDS methods and so on. Due to the nature of different plants, extraction methods vary. Moreover, efficiency of certain approach cannot be guaranteed due to composition of different plants and extracting high quality RNA from plants rich in polysaccharides and polyphenols are often difficult. The physical and chemical properties of polysaccharides which are similar to nucleic acids and other secondary metabolites will be coprecipitated with RNA irreversibly. Therefore, how to remove polysaccharides and other secondary metabolites during RNA extraction is the primary challenge. Dendrobium huoshanense is an Orchidaceae perennial herb that is rich in polysaccharides and other secondary metabolites. By using D. huoshanense as the subject, we improved the method originated from CHAN and made it suitable for plants containing high amount of polysaccharides and polyphenols. The extracted total RNA was clear and non-dispersive, with good integrity and no obvious contamination with DNA and other impurities. And it was also evaluated by gel electrophoresis, nucleic acid quantitative detector and PCR assessment. Thus, as a simple approach, it is suitable and efficient in RNA isolation for plants rich in polysaccharides and polyphenols.	[Liu, Lulu; Han, Rongchun; Yu, Nianjun; Zhang, Wei; Xing, Lihua; Xie, Dongmei; Peng, Daiyin] Anhui Univ Chinese Med, Sch Pharm, Hefei, Anhui, Peoples R China; [Han, Rongchun] Anhui Innovat Team Coll Sci Res Platform, Hefei, Anhui, Peoples R China	Anhui University of Chinese Medicine	Peng, DY (corresponding author), Anhui Univ Chinese Med, Sch Pharm, Hefei, Anhui, Peoples R China.	26490360@qq.com		Han, Rongchun/0000-0001-7520-9413	Education Department of Anhui Province [gxyq2017016]; Scientific Research Innovation Platform for Universities in Anhui Province [2015-49]; Quality Improvement Project for Anhui Authentic Chinese Herbal Medicine [2013-02]; Anhui University of Chinese Medicine [2017zrzd011]	Education Department of Anhui Province; Scientific Research Innovation Platform for Universities in Anhui Province; Quality Improvement Project for Anhui Authentic Chinese Herbal Medicine; Anhui University of Chinese Medicine	This study was supported, in part, by Education Department of Anhui Province (Grant No. gxyq2017016), Scientific Research Innovation Platform for Universities in Anhui Province (Grant No. 2015-49), Quality Improvement Project for Anhui Authentic Chinese Herbal Medicine (Grant No. 2013-02) and Anhui University of Chinese Medicine (Grant No. 2017zrzd011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported, in part, by Education Department of Anhui Province (Grant No. gxyq2017016), Scientific Research Innovation Platform for Universities in Anhui Province (Grant No. 2015-49), Quality Improvement Project for Anhui Authentic Chinese Herbal Medicine (Grant No. 2013-02) and Anhui University of Chinese Medicine (Grant No. 2017zrzd011).	Ahmad J, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-1003-3; Asif M, 2006, J AGR FOOD CHEM, V54, P5227, DOI 10.1021/jf053137n; Bao XS., 2001, MED PLANTS DENDROBIU; Betts NS, 2017, PLANT J, V91, P754, DOI 10.1111/tpj.13600; Birtic S, 2006, PHYTOCHEM ANALYSIS, V17, P144, DOI 10.1002/pca.903; Chan KL, 2007, NAT PROTOC, P184; Chang CC, 2010, J NAT PROD, V73, P229, DOI 10.1021/np900252f; Chen Nai-dong, 2014, Zhong Yao Cai, V37, P953; Dash PK, 2013, 3 BIOTECH, V3, P109, DOI 10.1007/s13205-012-0075-3; Deng Hui, 2017, Zhongguo Zhong Yao Za Zhi, V42, P130, DOI 10.19540/j.cnki.cjcmm.20161222.007; Deng Y, 2016, J PHARMACEUT BIOMED, V129, P163, DOI 10.1016/j.jpba.2016.06.051; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; Hsieh YSY, 2008, BIOORGAN MED CHEM, V16, P6054, DOI 10.1016/j.bmc.2008.04.042; HUANG Sen, 2007, EXTRACTION SEPARATIO; Huoshan County Annals (Guangxu), 2010, HUOSHAN COUNTY ANN G; Jiang Shao-Tong, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P613, DOI 10.1016/S1872-2075(06)60048-4; Jin Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146607; Lewis EL, 2017, JOVE-J VIS EXP, DOI 10.3791/56228; Li F, 2015, INT J BIOL MACROMOL, V72, P664, DOI 10.1016/j.ijbiomac.2014.08.026; Ma ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130234; Pan LH, 2014, INT J BIOL MACROMOL, V64, P420, DOI 10.1016/j.ijbiomac.2013.12.024; Qin Ziqing, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P803; Rashid A, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6010001; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Shu CW, 2014, ELECTRON J BIOTECHN, V17, DOI 10.1016/j.ejbt.2013.12.009; Wang Kai, 2017, Zhongguo Zhong Yao Za Zhi, V42, P1945, DOI 10.19540/j.cnki.cjcmm.2017.0082; Wei Ming, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P371; YANG Q, 1989, Zhongguo Zhongyao Zazhi, V14, P19; Yao L, 2016, J ANHUI U CHINESE ME, V35, P83; Zha XQ, 2017, CARBOHYD POLYM, V155, P252, DOI 10.1016/j.carbpol.2016.08.087; Zha XQ, 2014, INT J BIOL MACROMOL, V64, P377, DOI 10.1016/j.ijbiomac.2013.12.032; Zhao YJ, 2017, MICROSC RES TECHNIQ, V80, P712, DOI 10.1002/jemt.22856	32	33	37	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196592	10.1371/journal.pone.0196592	http://dx.doi.org/10.1371/journal.pone.0196592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715304	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281100035
J	Aamir, M; Singh, VK; Dubey, MK; Kashyap, SP; Zehra, A; Upadhyay, RS; Singh, S				Aamir, Mohd; Singh, Vinay Kumar; Dubey, Manish Kumar; Kashyap, Sarvesh Pratap; Zehra, Andleeb; Upadhyay, Ram Sanmukh; Singh, Surendra			Structural and functional dissection of differentially expressed tomato WRKY transcripts in host defense response against the vascular wilt pathogen (Fusarium oxysporum f. sp lycopersici)	PLOS ONE			English	Article							F-SP LYCOPERSICI; ARABIDOPSIS WRKY33; DNA-BINDING; SIGNALING PATHWAY; PLANT-RESISTANCE; GENE-EXPRESSION; SALICYLIC-ACID; PROTEIN MODELS; RT-PCR; STRESS	The WRKY transcription factors have indispensable role in plant growth, development and defense responses. The differential expression of WRKY genes following the stress conditions has been well demonstrated. We investigated the temporal and tissue-specific (root and leaf tissues) differential expression of plant defense-related WRKY genes, following the infection of Fusarium oxysporum f. sp. lycopersici (Fol) in tomato. The genome-wide computational analysis revealed that during the Fol infection in tomato, 16 different members of WRKY gene superfamily were found to be involved, of which only three WRKYs (SolyWRKY4, SolyWRKY33, and SolyWRKY37) were shown to have clear-cut differential gene expression. The quantitative real time PCR (qRT-PCR) studies revealed different gene expression profile changes in tomato root and leaf tissues. In root tissues, infected with Fol, an increased expression for SolyWRKY33 (2.76 fold) followed by SolyWRKY37 (1.93 fold) gene was found at 24 hrs which further increased at 48 hrs (5.0 fold). In contrast, the leaf tissues, the expression was more pronounced at an earlier stage of infection (24 hrs). However, in both cases, we found repression of SolyWRKY4 gene, which further decreased at an increased time interval. The biochemical defense programming against Fol pathogenesis was characterized by the highest accumulation of H(2)0(2) (at 48 hrs) and enhanced lignification. The functional diversity across the characterized WRKYs was explored through motif scanning using MEME suite, and the WRKYs specific gene regulation was assessed through the DNA protein docking studies The functional WRKY domain modeled had beta sheets like topology with coil and turns. The DNA-protein interaction results revealed the importance of core residues (Tyr, Arg, and Lys) in a feasible WRKY-W-box DNA interaction. The protein interaction network analysis revealed that the SolyWRKY33 could interact with other proteins, such as mitogen-activated protein kinase 5 (MAPK), sigma factor binding protein1 (SIB1) and with other WRKY members including WRKY70, WRKY1, and WRKY40, to respond various biotic and abiotic stresses. The STRING results were further validated through Predicted Tomato Interactome Resource (PTIR) database. The CELLO2GO web server revealed the functional gene ontology annotation and protein subcellular localization, which predicted that SolyWRKY33 is involved in amelioration of biological stress (39.3%) and other metabolic processes (39.3%). The protein (SolyWRKY33) most probably located inside the nucleus (91.3%) with having transcription factor binding activity. We conclude that the defense response following the Fol challenge was accompanied by differential expression of the SolyWRKY4(down arrow), SolyWRKY33(up arrow) and SolyWRKY37(up arrow) transcripts. The biochemical changes are occupied by elicitation of H2O2 generation and accumulation and enhanced lignified tissues.	[Aamir, Mohd; Dubey, Manish Kumar; Zehra, Andleeb; Upadhyay, Ram Sanmukh; Singh, Surendra] Banaras Hindu Univ, Lab Mycopathol & Microbial Technol, Ctr Adv Study Bot, Inst Sci, Varanasi, Uttar Pradesh, India; [Singh, Vinay Kumar] Banaras Hindu Univ, Inst Sci, Sch Biotechnol, Ctr Bioinformat, Varanasi, Uttar Pradesh, India; [Kashyap, Sarvesh Pratap] Indian Council Agr Res, Indian Inst Vegetable Res, Div Crop Improvement & Biotechnol, Varanasi, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Vegetable Research	Singh, S (corresponding author), Banaras Hindu Univ, Lab Mycopathol & Microbial Technol, Ctr Adv Study Bot, Inst Sci, Varanasi, Uttar Pradesh, India.	surendrasingh.bhu@gmail.com	Dubey, Manish Kumar/V-4836-2019	Dubey, Manish Kumar/0000-0003-0778-8606; AAMIR, MOHD/0000-0001-5935-9550				Aamir M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00819; AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Agarwal P, 2011, MOL BIOL REP, V38, P3883, DOI 10.1007/s11033-010-0504-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andolfo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094963; Asha B. B., 2011, International Journal of Microbiology Research, V3, P79; BAAYEN RP, 1988, CAN J BOT, V66, P784, DOI 10.1139/b88-115; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Baker CM, 2007, BIOPOLYMERS, V85, P456, DOI 10.1002/bip.20682; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27700; Banerjee Aditya, 2015, ScientificWorldJournal, V2015, P807560, DOI 10.1155/2015/807560; Baranwal VK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30794; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bellincampi D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00228; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bergougnoux V, 2014, BIOTECHNOL ADV, V32, P170, DOI 10.1016/j.biotechadv.2013.11.003; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birkenbihl RP, 2012, PLANT PHYSIOL, V159, P266, DOI 10.1104/pp.111.192641; Brand LH, 2013, NUCLEIC ACIDS RES, V41, P9764, DOI 10.1093/nar/gkt732; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Caarls L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00170; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Cheng Y, 2016, Genet Mol Res, V15, DOI 10.4238/gmr.15038675; CHOPADA GB, 2014, BIOSCAN S, V9, P351; Chuang GY, 2008, BIOPHYS J, V95, P4217, DOI 10.1529/biophysj.108.135814; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Corona RI, 2016, PROTEINS, V84, P1147, DOI 10.1002/prot.25061; Dang FF, 2013, PLANT CELL ENVIRON, V36, P757, DOI 10.1111/pce.12011; Das S, 2016, BIOINFORMATICS, V32, P2889, DOI 10.1093/bioinformatics/btw473; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Melo IS, 1999, REV MICROBIOL, V30, P104, DOI 10.1590/S0001-37141999000200003; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dror I, 2015, GENOME RES, V25, P1268, DOI 10.1101/gr.184671.114; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Gharbi Y, 2017, PHYSIOL MOL PLANT P, V97, P30, DOI 10.1016/j.pmpp.2016.12.001; Gimenez-Ibanez S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00072; Goncalves Joana P, 2009, BMC Res Notes, V2, P124, DOI 10.1186/1756-0500-2-124; Gujjar R, 2014, CURR SCI, V107, P1299; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Gupta S, 2014, J PLANT PHYSIOL, V171, P349, DOI 10.1016/j.jplph.2013.09.003; Gurjar G. S., 2012, American Journal of Plant Sciences, V3, P190, DOI 10.4236/ajps.2012.32023; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang SX, 2012, MOL GENET GENOMICS, V287, P495, DOI 10.1007/s00438-012-0696-6; Huang Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3123-2; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kirankumar R., 2008, Karnataka Journal of Agricultural Sciences, V21, P309; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai ZB, 2011, PLANT J, V66, P953, DOI 10.1111/j.1365-313X.2011.04553.x; Lai ZB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-68; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Li J., 2014, ROLE WRKY TFS ARABID; Li MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23101; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Lippok B, 2007, MOL PLANT MICROBE IN, V20, P420, DOI 10.1094/MPMI-20-4-0420; Lopez-Diaz C, 2018, MOL PLANT PATHOL, V19, P440, DOI 10.1111/mpp.12536; Lopez-Kleine L, 2013, GENOMICS, V101, P249, DOI 10.1016/j.ygeno.2013.02.001; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lyons R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121902; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Maeo K, 2001, BIOSCI BIOTECH BIOCH, V65, P2428, DOI 10.1271/bbb.65.2428; Malinovsky FG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00178; Mandal S, 2009, PLANT PHYSIOL BIOCH, V47, P642, DOI 10.1016/j.plaphy.2009.03.001; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Meena M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01408; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mickelbart MV, 2015, NAT REV GENET, V16, P237, DOI 10.1038/nrg3901; Miedes E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00358; Mohanta TK, 2016, SCI REP-UK, V6, DOI 10.1038/srep37309; Molan Y. Y., 2010, International Journal of Plant Breeding and Genetics, V4, P1, DOI 10.3923/ijpbg.2010.1.12; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nirmaladevi D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21367; Nishiuchi T, 2004, J BIOL CHEM, V279, P55355, DOI 10.1074/jbc.M409674200; Pandey K. K., 2014, Indian Phytopathology, V67, P383; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Panthee DR, 2010, CURR GENOMICS, V11, P30, DOI 10.2174/138920210790217927; Passardi F, 2005, PLANT CELL REP, V24, P255, DOI 10.1007/s00299-005-0972-6; Patel JS, 2016, FRONT PLANT SCI, V6, DOI [10.3389/fpla.2015.01206, 10.3389/fpls.2015.01206]; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pokala N, 2004, PROTEIN SCI, V13, P925, DOI 10.1110/ps.03486104; Pusztahelyi T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00573; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rongai D, 2017, EUR J PLANT PATHOL, V147, P229, DOI 10.1007/s10658-016-0994-7; Rossberg M, 2001, PLANT CELL, V13, P979, DOI 10.1105/tpc.13.4.979; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shahi SK, 2013, J MOL MODEL, V19, P973, DOI 10.1007/s00894-012-1635-5; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Singh VK, 2017, PLANT PHYSIOL BIOCH, V118, P320, DOI 10.1016/j.plaphy.2017.06.028; Sun MGF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-235; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Swarupa V, 2014, PLANTA, V239, P735, DOI 10.1007/s00425-013-2024-8; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor A, 2013, PLANT PATHOL, V62, P103, DOI 10.1111/j.1365-3059.2012.02624.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tominaga-Wada R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054019; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Upadhyay P, 2015, GENOM DATA, V6, P170, DOI 10.1016/j.gdata.2015.09.006; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; van Verk MC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-89; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Vlahovicek K, 2000, BIOINFORMATICS, V16, P1044, DOI 10.1093/bioinformatics/16.11.1044; Wada T, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2014.1000131; Wada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109093; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wurmbach E, 2003, METHODS, V31, P306, DOI 10.1016/S1046-2023(03)00161-0; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523; Yamasaki K, 2012, J BIOL CHEM, V287, P7683, DOI 10.1074/jbc.M111.279844; Yang JH, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00297; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshimoto K, 2010, FEBS LETT, V584, P1350, DOI 10.1016/j.febslet.2010.01.007; Yousfi FE, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02034; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527; Yue JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25047; Zehra A, 2017, BOT STUD, V58, DOI 10.1186/s40529-017-0198-2; Zhang Y, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-27; Zhang ZS, 2015, BIOCHEM SYST ECOL, V61, P218, DOI 10.1016/j.bse.2015.06.025; Zhang ZL, 2004, PLANT PHYSIOL, V134, P1500, DOI 10.1104/pp.103.034967; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhou J, 2015, J EXP BOT, V66, P4567, DOI 10.1093/jxb/erv221; Zhou J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00174; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003196	143	14	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0193922	10.1371/journal.pone.0193922	http://dx.doi.org/10.1371/journal.pone.0193922			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709017	Green Submitted, Green Published, gold			2022-12-26	WOS:000431130100004
J	Aithal, A; Junker, WM; Kshirsagar, P; Das, S; Kaur, S; Orzechowski, C; Gautam, SK; Jahan, R; Sheinin, YM; Lakshmanan, I; Ponnusamy, MP; Batra, SK; Jain, M				Aithal, Abhijit; Junker, Wade M.; Kshirsagar, Prakash; Das, Srustidhar; Kaur, Sukhwinder; Orzechowski, Catherine; Gautam, Shailendra Kumar; Jahan, Rahat; Sheinin, Yuri M.; Lakshmanan, Imayavaramban; Ponnusamy, Moorthy P.; Batra, Surinder K.; Jain, Maneesh			Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer	PLOS ONE			English	Article							CYTOPLASMIC TAIL; CELL-ADHESION; ANTIGEN CA125; SEA MODULE; MUCIN; CA125/MUC16; PROTEINS; DOMAIN; TUMORIGENESIS; METASTASIS	MUC16 is overexpressed in ovarian cancer and plays important roles in invasion and metastasis. Previously described monoclonal antibodies against cell surface expressed MUC16 recognize the N-terminal tandemly repeated epitopes present in cancer antigen 125 (CA125). MUC16 is cleaved at a specific location, thus, releasing CA125 into the extracellular space. Recent reports have indicated that the retained carboxy-terminal (CT) fragment of MUC16 might play an important role in tumorigenicity in diverse types of cancers. However, limited data is available on the fate and existence of CT fragment on the surface of the cancer cell. Herein, we characterize two monoclonal antibodies (mAbs) showing specificity to the retained juxtamembrane region of MUC16. For the first time, we demonstrate that MUC16 is cleaved in ovarian cancer cells (NIH:OVCAR-3 [OVCAR-3]) and that the cleaved MUC16 subunits remain associated with each other. Immunohistochemical analyses on different grades of ovarian tumor tissues indicated differential reactivity of CA125 and MUC16 CT mAbs. The CA125 (M11) mAb detected 32/40 (80%), while the CT mAb (5E6) detected 33/40 (82.5%) of total ovarian cancer cases. For serous and serous papillary cases, the CA125 (M11) mAb stained 27/31 cases (87%), while CT mAb (5E6) stained 29/31 cases (93.5%). The CT mAb(s) accurately predict expression of MUC16 since their epitopes are not tandemly repeated and their reactivity may not be dependent on O-linked glycosylation. These antibodies can serve as valuable reagents for understanding MUC16 cleavage and may also serve as potential therapeutic agents for treatment of ovarian cancer.	[Aithal, Abhijit; Kshirsagar, Prakash; Das, Srustidhar; Kaur, Sukhwinder; Orzechowski, Catherine; Gautam, Shailendra Kumar; Jahan, Rahat; Lakshmanan, Imayavaramban; Ponnusamy, Moorthy P.; Batra, Surinder K.; Jain, Maneesh] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Junker, Wade M.] Sanguine Diagnost & Therapeut Inc, Omaha, NE USA; [Sheinin, Yuri M.; Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Batra, Surinder K.; Jain, Maneesh] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Batra, SK; Jain, M (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Batra, SK (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.; Batra, SK; Jain, M (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	sbatra@unmc.edu; mjain@unmc.edu	Aithal, Abhijit/AAR-9856-2021; Gautam, Shailendra/GLQ-9528-2022; Gautam, Shailendra/ABD-2991-2021; Kshirsagar, Prakash/X-8420-2019; Das, Srustidhar/GVU-1044-2022	Gautam, Shailendra/0000-0002-8959-1331; Kshirsagar, Prakash/0000-0002-0110-0797; lakshmanan, Imayavaramban/0000-0003-1733-2223; Aithal, Abhijit/0000-0001-9035-7529; Junker, Wade/0000-0002-2649-3996	National Institutes of Health [R41 CA177288, U01 CA200466, R01 CA195586, R01 CA210637, R01 CA183459, U01 CA213862]; State of Nebraska Research and Development Technical and Financial Assistance program [15-01-0173]; NIH; NATIONAL CANCER INSTITUTE [R41CA177288, R01CA210637, U01CA213862, R01CA195586, R01CA183459, U01CA200466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Nebraska Research and Development Technical and Financial Assistance program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This authors in this study were supported by the grants from the National Institutes of Health (R41 CA177288, U01 CA200466, R01 CA195586, R01 CA210637, R01 CA183459, and U01 CA213862) and funding from the State of Nebraska Research and Development Technical and Financial Assistance program (15-01-0173). We are grateful to Dr. Carlstedt at Lund University (Lund, Sweden) for providing the LUM16-4 antiserum. We thank the UNMC Flow Cytometry Core Facility for their technical assistance. We thank Janice A. Taylor and James R. Talaska of the Advanced Microscopy Core Facility at the University of Nebraska Medical Center for providing assistance with confocal microscopy.; The authors in this study were supported by the grants from the National Institutes of Health (R41 CA177288, U01 CA200466, R01 CA195586, R01 CA210637, R01 CA183459, and U01 CA213862) and funding from the State of Nebraska Research and Development Technical and Financial Assistance program (15-01-0173). Dr. Wade Junker is a paid employee of Sanguine Diagnostics and Therapeutics Inc. and supported by the indicated NIH grants awarded to the company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita K, 2013, EUR J CELL BIOL, V92, P257, DOI 10.1016/j.ejcb.2013.10.005; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Boivin M, 2009, GYNECOL ONCOL, V115, P407, DOI 10.1016/j.ygyno.2009.08.007; Chen YJ, 2007, CANCER RES, V67, P4924, DOI 10.1158/0008-5472.CAN-06-4512; Comamala M, 2011, BRIT J CANCER, V104, P989, DOI 10.1038/bjc.2011.34; Croce MV, 2006, HISTOL HISTOPATHOL, V21, P849, DOI 10.14670/HH-21.849; Das S, 2015, CANCER RES, V75, P4669, DOI 10.1158/0008-5472.CAN-15-1050; Das S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09759; Das S, 2015, ONCOTARGET, V6, P5772, DOI 10.18632/oncotarget.3308; Davies JR, 2007, INT J BIOCHEM CELL B, V39, P1943, DOI 10.1016/j.biocel.2007.05.013; De la Cuesta R, 1999, INT J BIOL MARKER, V14, P106, DOI 10.1177/172460089901400208; Duska LR, 1999, J NATL CANCER I, V91, P1557, DOI 10.1093/jnci/91.18.1557; Felder M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-129; Giannakouros P, 2015, INT J ONCOL, V46, P91, DOI 10.3892/ijo.2014.2707; Gubbels JAA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-11; Haridas D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026839; Hogdall EVS, 2007, GYNECOL ONCOL, V104, P508, DOI 10.1016/j.ygyno.2006.09.028; Jain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023344; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakshmanan I, 2012, ONCOGENE, V31, P805, DOI 10.1038/onc.2011.297; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Liu Q, 2016, ONCOTARGET, V7, P36800, DOI 10.18632/oncotarget.9191; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Patankar MS, 2005, GYNECOL ONCOL, V99, P704, DOI 10.1016/j.ygyno.2005.07.030; Rao TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126633; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; Theriault C, 2011, GYNECOL ONCOL, V121, P434, DOI 10.1016/j.ygyno.2011.02.020; Wreschner DH, 2002, PROTEIN SCI, V11, P698, DOI 10.1110/ps.16502; Yin BWT, 2002, INT J CANCER, V98, P737, DOI 10.1002/ijc.10250; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0193907	10.1371/journal.pone.0193907	http://dx.doi.org/10.1371/journal.pone.0193907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708979	Green Published, gold, Green Submitted			2022-12-26	WOS:000431130100003
J	Dutta, S; Chakraborty, AK; Dey, P; Kar, P; Guha, P; Sen, S; Kumar, A; Sen, A; Chaudhuri, TK				Dutta, Somit; Chakraborty, Arnab Kumar; Dey, Priyankar; Kar, Pallab; Guha, Pokhraj; Sen, Subhajit; Kumar, Anoop; Sen, Arnab; Chaudhuri, Tapas Kumar			Amelioration of CCl4 induced liver injury in swiss albino mice by antioxidant rich leaf extract of Croton bonplandianus Baill	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARBON-TETRACHLORIDE; OXIDATIVE STRESS; NITRIC-OXIDE; GLUTATHIONE DEPLETION; SIGNAL-TRANSDUCTION; INDUCED APOPTOSIS; HEPATOTOXICITY; HEPATOCYTES; SENSITIZATION	The progress in industrialization has blessed mankind with a technologically superior lifestyle but poor management of industrial waste has in turn poisoned nature. One such chemical is carbon tetra chloride (CCl4), which is a potent environmental toxin emitted from chemical industries and its presence in the atmosphere is increasing at an alarming rate. Presence of CCl4 in human body is reported to cause liver damage through free radical mediated inflammatory processes. Kupffer cells present in the liver are potentially more sensitive to oxidative stress than hepatocytes. Kuffer cells produced tumor necrosis factor-alpha (TNF-alpha) in response to reactive oxygen species (ROS), that might further cause inflammation or apoptosis. In this study hepatoprotective capacity of antioxidant rich extract of Croton bonplandianus Baill. (CBL) was evaluated on CCl4 induced acute hepatotoxicity in murine model. Hydro-methanolic extract of C. bonplandianus leaf was used for evaluation of free radical scavenging activity. Liver cells of experimental mice were damaged using CCl4 and subsequently hepatoprotective potential of the plant extract was evaluated using series of in-vivo and in-vitro studies. In the hepatoprotective study, silymarin was used as a positive control. Antioxidant enzymes, pro-inflammatory markers, liver enzymatic and biochemical parameters were studied to evaluate hepatoprotective activity of Croton bonplandianus leaf extract. Free radical scavenging activity of CBL extract was also observed in WRL-68 cell line. The phytochemicals identified by GCMS analysis were scrutinized using in-silico molecular docking procedure. The results showed that CBL extract have potent free radical scavenging capacity. The biochemical parameters were over expressed due to CCl4 administration, which were significantly normalized by CBL extract treatment. This finding was also supported by histopathological evidences showing less hepatocellularnecrosis, inflammation and fibrosis in CBL and silymarin treated group, compared to CCl4 group. ROS generated due to H2O2 in WRL-68 cell line were normalize in the highest group (200 mu g/ml) when compared with control and negative control (CCl4) group. After molecular docking analysis, it was observed that the compound alpha-amyrin present in the leaf extract of C. bonplandianus has better potentiality to protect hepatocellular damages than the standard drug Silymarin. The present study provided supportive evidence that CBL extract possesses potent hepatoprotective capacity by ameliorating haloalkane induced liver injury in the murine model. The antioxidant and anti-inflammatory activities also affirm the same. The synergistic effects of the phytochemicals present in CBL are to be credited for all the hepatoprotective activity claimed above.	[Dutta, Somit; Dey, Priyankar; Guha, Pokhraj; Chaudhuri, Tapas Kumar] Univ North Bengal, Dept Zool, Cellular Immunol Lab, Siliguri, W Bengal, India; [Chakraborty, Arnab Kumar; Kar, Pallab; Sen, Arnab] Univ North Bengal, Dept Bot, Mol Genet Lab, Siliguri, W Bengal, India; [Sen, Subhajit] Univ N Bengal, Dept Biotechnol, OMICS Lab, Siliguri, W Bengal, India; [Kumar, Anoop] Univ North Bengal, Dept Biotechnol, ANMOL Lab, Siliguri, W Bengal, India; [Chaudhuri, Tapas Kumar] Bodoland Univ, Dept Zool, Kokrajhar, Assam, India	University of North Bengal; University of North Bengal; University of North Bengal; University of North Bengal	Chaudhuri, TK (corresponding author), Univ North Bengal, Dept Zool, Cellular Immunol Lab, Siliguri, W Bengal, India.; Chaudhuri, TK (corresponding author), Bodoland Univ, Dept Zool, Kokrajhar, Assam, India.	dr_tkc_nbu@rediffmail.com	KAR, PALLAB/AAZ-4222-2021; Dey, Priyankar/AFE-4921-2022; Dey, Priyankar/AAG-5125-2022; Kumar, Anoop/ABB-7336-2020	Dey, Priyankar/0000-0002-9513-425X; Dey, Priyankar/0000-0002-9513-425X; Guha, Dr. Pokhraj/0000-0003-0952-8111				Al-Shabanah OA, 1999, LIFE SCI, V66, P265; Amacher DE, 2002, HUM EXP TOXICOL, V21, P253, DOI 10.1191/0960327102ht247oa; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Aruoma O. I., 2003, MUTAT RES, V532, P9; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; Bhakat R. K., 2008, TRIBES TRIBALS, V2, P55; Branda M, 2006, HEPATOLOGY, V43, P891, DOI 10.1002/hep.21196; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Chaudhuri A.B., 2007, ENDANGERED MED PLANT, P226; Chia R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010627; Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082; De Iuliis GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006446; DEGROOT H, 1988, ARCH BIOCHEM BIOPHYS, V264, P591, DOI 10.1016/0003-9861(88)90325-6; Dey P, 2013, J PHARM SCI INNOV, V2, P1; Dey P, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1260-4; Dey P, 2015, CHEM-BIOL INTERACT, V235, P37, DOI 10.1016/j.cbi.2015.03.025; Di Meo S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1245049; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Feng YB, 2011, J ETHNOPHARMACOL, V138, P683, DOI 10.1016/j.jep.2011.09.032; Flora SJS, 2008, INDIAN J MED RES, V128, P501; Freshney R.I., 2005, CULTURE ANIMAL CELLS, DOI [10.1002/0471747599.CAC022, DOI 10.1002/0471747599.CAC022]; Gabele E, 2009, BIOCHEM BIOPH RES CO, V378, P348, DOI 10.1016/j.bbrc.2008.10.155; Hazra B, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-20; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Hoffman A, 2008, FREE RADICAL BIO MED, V45, P265, DOI 10.1016/j.freeradbiomed.2008.03.025; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Islam M. S., 2010, International Journal of Agricultural Technology, V6, P79; KIECZKA H, 1980, TOXICOL LETT, V5, P191, DOI 10.1016/0378-4274(80)90058-2; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Luck H., 1971, CATALASE METHODS ENZ; Mahakunakorn P, 2004, BIOL PHARM BULL, V27, P38, DOI 10.1248/bpb.27.38; Marvibaigi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158942; MASUDA Y, 1990, BIOCHEM PHARMACOL, V40, P1865; Matsumaru K, 2003, HEPATOLOGY, V37, P1425, DOI 10.1053/jhep.2003.50230; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Mishra S, 2011, INDIAN J NAT PROD RE, V2, P515; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Morio LA, 2001, TOXICOL APPL PHARM, V172, P44, DOI 10.1006/taap.2000.9133; Nagai H, 2002, HEPATOLOGY, V36, P55, DOI 10.1053/jhep.2002.33995; Nishanta R, 2012, PHARM BIOL, V40, P235; OHNO Y, 1985, J BIOL CHEM, V260, P8438; RUPRAH M, 1985, LANCET, V1, P1027, DOI 10.1016/S0140-6736(85)91624-1; RUWART MJ, 1989, HEPATOLOGY, V10, P801, DOI 10.1002/hep.1840100509; Sadasivam S., 2008, BIOCH METHODS, V3rd; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Torres MCM, 2008, CHEM BIODIVERS, V5, P2724, DOI 10.1002/cbdv.200890227; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsai CF, 2009, FOOD CHEM TOXICOL, V47, P2031, DOI 10.1016/j.fct.2009.05.021; U.S. Environmental Protection Agency, 2010, TOX REV CARB TETR; Vadlapudi V, 2010, PHARMACOPHORE, V1, P214; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046574; Zimmerman H J, 2000, Clin Liver Dis, V4, P73, DOI 10.1016/S1089-3261(05)70097-0; Zimmerman HJ., 1998, TOXICOLOGY LIVER, P3	56	58	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196411	10.1371/journal.pone.0196411	http://dx.doi.org/10.1371/journal.pone.0196411			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709010	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100025
J	Huits, R; De Kort, J; Van den Berg, R; Chong, L; Tsoumanis, A; Eggermont, K; Bartholomeeusen, K; Arien, KK; Jacobs, J; Van Esbroeck, M; Bottieau, E; Cnops, L				Huits, Ralph; De Kort, Jaclyn; Van den Berg, Riemsdijk; Chong, Luis; Tsoumanis, Achilleas; Eggermont, Kaat; Bartholomeeusen, Koen; Arien, Kevin K.; Jacobs, Jan; Van Esbroeck, Marjan; Bottieau, Emmanuel; Cnops, Lieselotte			Chikungunya virus infection in Aruba: Diagnosis, clinical features and predictors of post-chikungunya chronic polyarthralgia	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; REUNION ISLAND; PERSISTENT ARTHRALGIA; MUSCULOSKELETAL PAIN; LABORATORY FEATURES; ADULT PATIENTS; RISK-FACTORS; SOUTH-INDIA; OUTBREAK; FEVER	Background Chikungunya virus (CHIKV) emerged in Aruba for the first time in 2014. We studied the clinical presentation of acute CHIKV infection and the contribution of serologic and molecular assays to its diagnosis. In a cohort of confirmed CHIKV cases, we analysed the frequency, duration and predictors of post-chikungunya chronic polyarthralgia (pCHIK-CPA), defined as joint pains lasting longer than 6 weeks or longer than 1 year. Methodology Patient sera obtained within 10 days of symptom onset were tested for CHIKV, using an indirect immunofluorescence test for the detection of CHIKV-specific Immunoglobulin M (IgM) and post-hoc, by reverse-transcription polymerase chain reaction (RT-PCR). CHIKV was isolated from selected samples and genotyped. For confirmed CHIKV cases, clinical data from chart review were complemented by a Telephone survey, conducted 18-24 months after diagnosis. When joint pain was reported, the duration, presence of inflammatory signs, type and number of joints affected, were recorded. Joint involvement was scored according to the 2010 'American College of Rheumatology/ European League Against Rheumatism' criteria for seronegative rheumatoid arthritis (ACR-score). Risk factors for pCHIK-CPA were identified by logistic regression. Principal findings Acute CHIKV infection was diagnosed in 269 of 498 sera, by detection of IgM (n = 105), by RT-PCR (n = 59), or by both methods (n = 105). Asian genotype was confirmed in 7 samples. Clinical data were complete for 171 of 248 (69.0%) patients, aged 15 years or older (median 49.4 [35.0-59.6]). The female-to-male ratio was 2.2. The main acute symptoms were arthralgia (94%), fever (85%), myalgia (85%), headache (73%) and rash (63%). In patients with arthralgia (n = 160), pCHIK-CPA longer than 6 weeks was reported by 44% and longer than 1 year by 26% of cases. Inflammatory signs, stiffness, edema and redness were frequent (71 %, 39% and 21%, respectively). Joints involved were knees (66%), ankles (50%), fingers (52%), feet (46%), shoulders (36%), elbows (34%), wrists (35%), hips (31%), toes (28.1%) and spine (28.1%). Independent predictors of pCHIK-CPA longer than 1 year were female gender (OR 5.9, 95%-CI [2.1-19.6]); high ACR-score (7.4, [2.7-23.3]), and detection of CHIKV-RNA in serum beyond 7 days of symptom onset (6.4, [1.4-34.1]. Conclusions We identified 269 CHIKV patients after the first outbreak of Asian genotype CHIKV in Aruba in 2014-2015. RT-PCR yielded 59 (28%) additional CHIKV diagnoses compared to IgM antibody detection alone. Arthralgia, fever and skin rash were the dominant acute phase symptoms. pCHIK-CPA longer than 1 year affected 26% of cases and was predicted by female gender, high ACR-score and CHIKV-RNA detection beyond 7 days of symptom onset.	[Huits, Ralph; Tsoumanis, Achilleas; Eggermont, Kaat; Jacobs, Jan; Van Esbroeck, Marjan; Bottieau, Emmanuel; Cnops, Lieselotte] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [De Kort, Jaclyn] Horacio Oduber Hosp, Dept Internal Med, Oranjestad, Aruba; [Van den Berg, Riemsdijk; Chong, Luis] Landslab Aruba, Oranjestad, Aruba; [Bartholomeeusen, Koen; Arien, Kevin K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Arien, Kevin K.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Van den Berg, Riemsdijk; Chong, Luis] Dept Publ Hlth, Oranjestad, Aruba	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of Antwerp; KU Leuven	Huits, R (corresponding author), Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.	rhuits@itg.be	Jacobs, Jan/GRX-7316-2022; Huits, Ralph/I-8361-2019	Huits, Ralph/0000-0001-8803-9468; Van Esbroeck, Marjan/0000-0002-7294-6319; Cnops, Lieselotte/0000-0003-0658-1291	Belgian Ministry of Social Affairs through a fund within the Health Insurance System; Flanders Innovation & Entrepreneurship [140779]	Belgian Ministry of Social Affairs through a fund within the Health Insurance System; Flanders Innovation & Entrepreneurship	The authors received no external funding for this work. The National Reference Center of arboviruses (ITM) is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. LC holds an innovation mandate (140779) from the Flanders Innovation & Entrepreneurship.	Abdelnabi R, 2017, CURR OPIN VIROL, V24, P25, DOI 10.1016/j.coviro.2017.03.016; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; de Brito CAA, 2017, REV SOC BRAS MED TRO, V50, P585, DOI 10.1590/0037-8682-0479-2016; Blettery M, 2016, ARTHRITIS RHEUMATOL, V68, P2817, DOI 10.1002/art.39775; Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Bouquillard E, 2009, JOINT BONE SPINE, V76, P654, DOI 10.1016/j.jbspin.2009.08.005; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Central Bureau of Statistics, 2014, POP PROJ AR 2010 203; Charrel RN, 2014, CLIN MICROBIOL INFEC, V20, P662, DOI 10.1111/1469-0691.12694; Chopra A, 2012, EPIDEMIOL INFECT, V140, P842, DOI 10.1017/S0950268811001300; CHRONIC INFLAMMATORY RHEUMATISM, 2016, F1000RES, V5, P360, DOI DOI 10.12688/F1000RESEARCH.8235.2; Chursi S, 2014, AM J TROP MED HYG, V90, P410, DOI 10.4269/ajtmh.12-0681; Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381; Couturier E, 2012, RHEUMATOLOGY, V51, P1315, DOI 10.1093/rheumatology/kes015; da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044; de Andrade DC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-31; Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446; Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167; Essackjee K, 2013, POSTGRAD MED J, V89, P440, DOI 10.1136/postgradmedj-2012-131477; Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500; FOURIE ED, 1979, S AFR MED J, V56, P130; Franca LTC, 2002, Q REV BIOPHYS, V35, P169, DOI 10.1017/S0033583502003797; Gay N, 2016, AM J TROP MED HYG, V94, P393, DOI 10.4269/ajtmh.15-0308; Gerardin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4137; Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Huits R, 2018, CLIN MICROBIOL INFEC, V24, P78, DOI 10.1016/j.cmi.2017.06.004; Jain J, 2017, CLIN INFECT DIS, V65, P133, DOI 10.1093/cid/cix283; Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; Kularatne SAM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/639178; Lakshmi V, 2008, CLIN INFECT DIS, V46, P1436, DOI 10.1086/529444; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Langsjoen RM, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd, DOI 10.1371/journal.pntd.0005189]; Larrieu S, 2010, J CLIN VIROL, V47, P85, DOI 10.1016/j.jcv.2009.11.014; Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390; Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Macpherson C, 2016, AM J TROP MED HYG, V95, P890, DOI 10.4269/ajtmh.16-0122; Magurano F, 2015, VECTOR-BORNE ZOONOT, V15, P258, DOI 10.1089/vbz.2014.1724; Marti-Carvajal A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179028; Mathew AJ, 2011, INT J CLIN PRACT, V65, P1306, DOI 10.1111/j.1742-1241.2011.02792.x; Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670; Miner JJ, 2015, ARTHRITIS RHEUMATOL, V67, P1214, DOI 10.1002/art.39027; Moro ML, 2012, J INFECTION, V65, P165, DOI 10.1016/j.jinf.2012.04.005; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Nakaya HI, 2012, ARTHRITIS RHEUM-US, V64, P3553, DOI 10.1002/art.34631; Okabayashi T, 2015, J CLIN MICROBIOL, V53, P382, DOI 10.1128/JCM.02033-14; Padmakumar B, 2010, SE ASIAN J TROP MED, V41, P85; PAHO, 2016, NUMB REP CAS CHIK FE; Pan American Health Organization (PAHO), 2015, NUMB REP CAS CHIK FE; Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906; Prince HE, 2015, CLIN VACCINE IMMUNOL, V22, P291, DOI 10.1128/CVI.00720-14; Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3; Ray P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030025; Renault P, 2008, EMERG INFECT DIS, V14, P1327, DOI 10.3201/eid1408.080201; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Rodriguez-Morales AJ, 2016, ARTHRIT CARE RES, V68, P1849, DOI 10.1002/acr.22900; Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001; ROSS R. W., 1956, JOUR HYG, V54, P177; Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, P1, DOI [10.1371/joureatpred.0004199, DOI 10.1371/JOUREATPRED.0004199]; Sankari T, 2008, LANCET INFECT DIS, V8, P3, DOI 10.1016/S1473-3099(07)70295-5; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Sharp TM, 2014, MMWR-MORBID MORTAL W, V63, P1121; Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389; Soumahoro MK, 2009, PLOS ONE, V4, pA221, DOI 10.1371/journal.pone.0007800; Staikowsky F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007603; Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701; Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15; Thiberville SD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002004; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; van Aalst M, 2017, TRAVEL MED INFECT DI, V15, P8, DOI 10.1016/j.tmaid.2017.01.004; Van Den Bossche D, 2015, EPIDEMIOL INFECT, V143, P2227, DOI 10.1017/S0950268814000685; van Genderen FT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004625; Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004; Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753; Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764; Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391	85	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196630	10.1371/journal.pone.0196630	http://dx.doi.org/10.1371/journal.pone.0196630			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709007	gold, Green Submitted, Green Published			2022-12-26	WOS:000431130100046
J	Achilleos, C; Michael, S; Strati, K				Achilleos, Charis; Michael, Stella; Strati, Katerina			Terc is dispensable for most of the short-term HPV16 oncogene-mediated phenotypes in mice	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CARCINOMA CELLS; LABEL-RETAINING CELLS; E6 ONCOPROTEIN; MOUSE MODELS; TELOMERASE ACTIVITY; HTERT PROMOTER; GENE-PRODUCT; E7 ONCOGENE; IN-VIVO	High-risk human papillomaviruses (HPVs) have been shown in vitro to impinge on telomere homeostasis in a number of ways. However, the in vivo interaction of viruses with the telomere homeostasis apparatus has not been previously explored. Since E6 and E7 are the main viral oncogenes and key for viral replication, we have explored here the short-term phenotypes of the genes in the context of defective telomere homeostasis. We examined the short-term phenotypes of E6 and E7 in a context where the Terc component of the telomerase holoenzyme was knocked out. We determined that Terc was dispensable for most oncogene-mediated phenotypes. Surprisingly, E7-mediated reduction of label retaining cells was found to be in part dependent on the presence of Terc. Under the conditions examined here, there appears to be no compelling evidence Terc is required for most short-term viral oncogene mediated phenotypes. Further studies will elucidate its role in longer-term phenotypes.	[Achilleos, Charis; Michael, Stella; Strati, Katerina] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus	University of Cyprus	Strati, K (corresponding author), Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus.	strati.katerina@ucy.ac.cy	Strati, Katerina/GSN-2131-2022	Strati, Katerina/0000-0002-2332-787X; Michael, Stella/0000-0001-9664-2814	A.G. Leventis Foundation; University of Cyprus	A.G. Leventis Foundation; University of Cyprus	This study was funded by the A.G. Leventis Foundation and the University of Cyprus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akincilar SC, 2016, CELL MOL LIFE SCI, V73, P1659, DOI 10.1007/s00018-016-2146-9; Alcaraz-Perez F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4228; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; BICKENBACH JR, 1986, CELL TISSUE KINET, V19, P325, DOI 10.1111/j.1365-2184.1986.tb00684.x; Blackburn EH, 2005, MOL CANCER RES, V3, P477, DOI 10.1158/1541-7786.MCR-05-0147; Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Boyer SN, 1996, CANCER RES, V56, P4620; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; da Silva-Diz V, 2013, ONCOGENE, V32, P3732, DOI 10.1038/onc.2012.375; De Lange T, 2005, COLD SH Q B, V70, P197, DOI 10.1101/sqb.2005.70.032; Dilley RL, 2015, TRENDS CANCER, V1, P145, DOI 10.1016/j.trecan.2015.07.007; Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291; Gewin L, 2004, GENE DEV, V18, P2269, DOI 10.1101/gad.1214704; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Goytisolo FA, 2002, ONCOGENE, V21, P584, DOI 10.1038/sj.onc.1205085; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Jabbar SF, 2009, CANCER RES, V69, P4407, DOI 10.1158/0008-5472.CAN-09-0023; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Lambert PF, 2016, ANNU REV VIROL, V3, P473, DOI 10.1146/annurev-virology-100114-054908; Liu XF, 2005, J BIOL CHEM, V280, P10807, DOI 10.1074/jbc.M410343200; Liu XF, 2008, VIROLOGY, V375, P611, DOI 10.1016/j.virol.2008.02.025; Liu XF, 2009, P NATL ACAD SCI USA, V106, P18780, DOI 10.1073/pnas.0906357106; Michael S, 2013, VIROLOGY, V443, P218, DOI 10.1016/j.virol.2013.04.008; Miller J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003284; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; MUNGER K, 1989, J VIROL, V63, P4417; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Seo EJ, 2004, GYNECOL ONCOL, V94, P40, DOI 10.1016/j.ygno.2004.03.041; Shai A, 2007, CANCER RES, V67, P1626, DOI 10.1158/0008-5472.CAN-06-3344; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Song SY, 1999, J VIROL, V73, P5887, DOI 10.1128/JVI.73.7.5887-5893.1999; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Veldman T, 2003, P NATL ACAD SCI USA, V100, P8211, DOI 10.1073/pnas.1435900100; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001	40	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196604	10.1371/journal.pone.0196604	http://dx.doi.org/10.1371/journal.pone.0196604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698462	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600107
J	Brankston, G; Boughen, C; Ng, V; Fisman, DN; Sergeant, JM; Greer, AL				Brankston, Gabrielle; Boughen, Cyndi; Ng, Victoria; Fisman, David N.; Sergeant, Jan M.; Greer, Amy L.			Assessing the impact of environmental exposures and Cryptosporidium infection in cattle on human incidence of cryptosporidiosis in Southwestern Ontario, Canada	PLOS ONE			English	Article							PARVUM INFECTION; DAIRY-CATTLE; ZOONOTIC TRANSMISSION; GIARDIA; SEASONALITY; WATERSHEDS; OUTBREAKS; SELECTION; RAINFALL; OOCYSTS	Cryptosporidium is a waterborne parasite that causes diarrheal disease in humans and in cattle. Risk factors for human illness include contact with surface water such as lakes and rivers, exposure to contaminated municipal drinking water, as well as zoonotic transmission from livestock and agriculture. The objectives of this study are twofold: 1) to describe the temporal distribution of cryptosporidiosis in Southwestern Ontario; and 2) to determine the distribution of human cryptosporidiosis, in relation to exposures such as cryptosporidium positive cattle farms, weather events, and hydrological factors. Seasonal trends in 214 bovine and 87 human cases were assessed using regression models that predicted monthly case counts in relation to observed monthly case counts. A case-crossover approach was used to evaluate acute associations between daily environmental exposures, such as weather, hydrology, the presence of Cryptosporidium positive cattle farms within the region, and the risk of human Cryptosporidium infection. Annual seasonality was found for both human cases and bovine cases with human cases peaking in mid-summer and bovine cases peaking in late winter to early spring. Bovine cases that occurred 21 days prior to human cases were associated with a three-fold increase in the odds of human case occurrence. At both 9 and 14 days prior to human case onset, the odds of a human case increased twofold per 10-degree Celsius increase in air temperature. These results provide a preliminary hypothesis for the zoonotic transmission of cryptosporidiosis from cattle to humans via the environment and suggest that the timing of environmental conditions in relation to case occurrence is biologically plausible.	[Brankston, Gabrielle; Sergeant, Jan M.; Greer, Amy L.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Boughen, Cyndi] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada; [Ng, Victoria] Publ Hlth Agcy Canada, Natl Microbiol Lab, Guelph, ON, Canada; [Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Guelph; University of Guelph; Public Health Agency of Canada; University of Toronto	Greer, AL (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada.	agreer@uoguelph.ca		Ng, Victoria/0000-0002-7619-541X	Canadian Institutes for Health Research (CIHR); Canada Research Chairs Program	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	Funding for this work was provide by the Canadian Institutes for Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html) and the Canada Research Chairs Program (http://www.chairs-chaires.gc ca/home-accueileng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, WAT OFF; Betancourt WQ, 2004, VET PARASITOL, V126, P219, DOI 10.1016/j.vetpar.2004.09.002; Budu-Amoako E, 2012, ZOONOSES PUBLIC HLTH, V59, P424, DOI 10.1111/j.1863-2378.2012.01474.x; Collick AS, 2006, J ENVIRON QUAL, V35, P680, DOI 10.2134/jeq2005.0273; Diggle P, 1990, TIME SERIES BIOSTATI; Dixon B, 2011, VET PARASITOL, V175, P20, DOI 10.1016/j.vetpar.2010.09.032; Dorner SM, 2004, ENVIRON SCI TECHNOL, V38, P3370, DOI 10.1021/es035208+; Environment Canada, 2016, CAN NAT WEATH ARCH; Fayer R, 1998, INT J PARASITOL, V28, P49, DOI 10.1016/S0020-7519(97)00170-7; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Grand River Conservation Authority, 2014, BACKGR BRIEF RES OP; Hu WN, 2007, ANN EPIDEMIOL, V17, P679, DOI 10.1016/j.annepidem.2007.03.020; Hu WB, 2010, INT J BIOMETEOROL, V54, P433, DOI 10.1007/s00484-009-0294-4; Jagai JS, 2009, ENVIRON RES, V109, P465, DOI 10.1016/j.envres.2009.02.008; JOKIPII L, 1986, NEW ENGL J MED, V315, P1643, DOI 10.1056/NEJM198612253152604; King BJ, 2008, J APPL MICROBIOL, V104, P1311, DOI 10.1111/j.1365-2672.2007.03658.x; Lal A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083484; Lal A, 2013, TRENDS PARASITOL, V29, P83, DOI 10.1016/j.pt.2012.10.005; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Majowicz SE, 2001, CAN J PUBLIC HEALTH, V92, P62, DOI 10.1007/BF03404847; Majowicz SE, 2005, CAN J PUBLIC HEALTH, V96, P178, DOI 10.1007/BF03403685; Mohammed HO, 1999, VET PARASITOL, V83, P1, DOI 10.1016/S0304-4017(99)00032-1; Mosier DA, 2000, ANN NY ACAD SCI, V916, P102, DOI 10.1111/j.1749-6632.2000.tb05279.x; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Naumova Elena N., 2005, Journal of Water and Health, V3, P185; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; O'Handley RM, 2007, TRENDS PARASITOL, V23, P477, DOI 10.1016/j.pt.2007.08.005; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2015, REP DIS TRENDS ONT 2; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2014, REP DIS TRENDS ONT 2; Ontario Ministry of Agriculture, 2011, FOOD RUR AFF STAT; Portnov BA, 2007, J EXPO SCI ENV EPID, V17, P106, DOI 10.1038/sj.jes.7500533; Rabozzi G, 2012, SAF HEALTH WORK, V3, P77, DOI 10.5491/SHAW.2012.3.1.77; Robertson LJ, 2004, MICROBIAL ECOL, V47, P359, DOI 10.1007/s00248-003-0003-5; Stryhn H., 2012, METHODS EPIDEMIOLOGI; Swaffer BA, 2014, WATER RES, V67, P310, DOI 10.1016/j.watres.2014.08.055; Szonyi B, 2010, PARASITOL RES, V107, P317, DOI 10.1007/s00436-010-1864-4; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Vrbova L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-970; Wilkes G, 2011, WATER RES, V45, P5807, DOI 10.1016/j.watres.2011.06.021	41	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196573	10.1371/journal.pone.0196573	http://dx.doi.org/10.1371/journal.pone.0196573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698463	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600101
J	Casullo, J; Zeng, H; Belley, G; Artho, G				Casullo, Joseph; Zeng, Han; Belley, Genevieve; Artho, Giovanni			CT of the paraumbilical and ensiform veins in patients with superior vena cava or left brachiocephalic vein obstruction	PLOS ONE			English	Article							FALCIFORM LIGAMENT	The purpose of this study was to elaborate on the anastomoses between the paraumbilical and systemic veins, particularly the ensiform veins. The connections with the ensiform veins have received little attention in the anatomical and radiological literature, and remain incompletely described. Too small to be reliably traced in normal CT scans, the paraumbilical veins can dilate in response to increased blood flow from systemic veins in superior vena cava obstruction (SVCO), allowing a study of their arrangement and connections. Collateral paraumbilical veins were therefore analyzed retrospectively in 28 patients with SVCO using CT. We observed inferior and superior groups of collateral vessels in 23/28 (82%) and 17/28 (61%) patients, respectively. Inferior veins ascended towards the liver and drained into portal veins (19/28, 68%) or the umbilical vein (8/28, 29%); superior veins descended and drained into portal veins. The inferior veins (N = 27) could be traced to ensiform veins in almost all of the cases (26/27, 96%), and a little over half (14/27, 52%) were also traceable to subcutaneous and deep epigastric veins. They were opacified by ensiform (25/27, 93%), deep epigastric (4/27, 15%) and subcutaneous (4/27, 15%) veins. The superior veins (N = 17) were supplied by diaphragmatic (13/17, 76%) and ensiform veins (4/17, 24%); the diaphragmatic veins were branches of collateral internal thoracic, left pericardiacophrenic and anterior mediastinal veins. Collateral ensiform veins were observed in 22 patients and anastomosed with internal thoracic (19/22, 86%), superior epigastric (9/22, 41%), diaphragmatic (4/22, 18%), subcutaneous (3/22, 14%) and anterior mediastinal veins (1/22, 5%). These observations show that the paraumbilical veins communicate with ensiform, deep epigastric, subcutaneous and diaphragmatic veins, joining the liver to the properitoneal fat pad, anterior trunk, diaphragm and mediastinum. In SVCO, the most common sources of collateral flow to the paraumbilical veins are the ensiform and diaphragmatic branches of the internal thoracic veins.	[Casullo, Joseph; Zeng, Han; Belley, Genevieve; Artho, Giovanni] McGill Univ, Montreal Gen Hosp, Hlth Ctr, Dept Diagnost Radiol, Montreal, PQ, Canada	McGill University	Casullo, J (corresponding author), McGill Univ, Montreal Gen Hosp, Hlth Ctr, Dept Diagnost Radiol, Montreal, PQ, Canada.	joseph.casullo@muhc.mcgill.ca						Baumgarten P, 1891, ARB PATH ANAT TUBING, V1, P1; Braune W., 1884, VENENSYSTEM MENSCHLI, P62; Burow KA, 1838, ARCH ANATOMIE PHYSL, P44; BUTLER H, 1952, THORAX, V7, P159, DOI 10.1136/thx.7.2.159; Casullo J, 2014, AM J ROENTGENOL, V203, P594, DOI 10.2214/AJR.13.11689; Cho YJ, 2014, KOREAN J RADIOL, V15, P630, DOI 10.3348/kjr.2014.15.5.630; Couinaud C, 1957, FOIE ETUDES ANATOMIQ; Daga D, 2015, CLIN EXP HEPATOL, V1, P133, DOI 10.5114/ceh.2015.58042; Dahan H, 1998, AM J ROENTGENOL, V171, P1405, DOI 10.2214/ajr.171.5.9798887; Fasel JHD, 2008, ANAT REC, V291, P636, DOI 10.1002/ar.20658; FELDBERG MAM, 1990, SURG RADIOL ANAT, V12, P193, DOI 10.1007/BF01624523; Ibukuro K, 2000, AM J ROENTGENOL, V175, P153, DOI 10.2214/ajr.175.1.1750153; Ibukuro K, 2008, SURG RADIOL ANAT, V30, P311, DOI 10.1007/s00276-008-0325-6; Kaur R, 2008, Biomed Imaging Interv J, V4, pe37, DOI 10.2349/biij.4.4.e37; Kim SC, 2011, CARDIOVASC INTER RAD, V34, pS214, DOI 10.1007/s00270-010-0018-5; LAM KC, 1981, DIGEST DIS SCI, V26, P346, DOI 10.1007/BF01308377; LIN G, 1984, ACTA RADIOL DIAGN, V25, P1; MARTIN BF, 1980, J ANAT, V130, P305; MERKLIN RJ, 1971, AM J ANAT, V132, P33, DOI 10.1002/aja.1001320105; MORIN C, 1992, RADIOLOGY, V185, P253, DOI 10.1148/radiology.185.1.1523319; NORDENSON N. G., 1930, ZEITSCHR GES ANAT ABT 1 ZEITSCHR ANAT U ENTWCKLUNGSGESCH, V93, P223, DOI 10.1007/BF02117851; OBEL W, 1976, Folia Morphologica (Wroclaw), V35, P173; OHASHI I, 1995, RADIOLOGY, V196, P245, DOI 10.1148/radiology.196.1.7784576; Sappey C, 1859, COMPUT RENDUS SEANCE, V11, P3; Sappey MC, 1883, J ANAT PHYSL, V19, P517; Shi YX, 2014, HEMODIAL INT, V18, P793, DOI 10.1111/hdi.12131; Terada T, 2013, INT J CLIN EXP PATHO, V6, P816; TETALMAN MR, 1978, AM J ROENTGENOL, V130, P291, DOI 10.2214/ajr.130.2.291; Thomas, 1895, BIL MED INN MED AB D, V2, P1; von Haller A, 1756, ICONUM ANATOMICARUM; Warren LR, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-278; WEXLER L, 1968, CIRC RES, V23, P349, DOI 10.1161/01.RES.23.3.349	32	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196093	10.1371/journal.pone.0196093	http://dx.doi.org/10.1371/journal.pone.0196093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698414	Green Submitted, Green Published, gold			2022-12-26	WOS:000431007600036
J	Dobrzanski, T; Gravina, F; Steckling, B; Olchanheski, LR; Sprenger, RF; Santo, BCE; Galvao, CW; Reche, PM; Prestes, RA; Pileggi, SAV; Campos, FR; Azevedo, RA; Sadowsky, MJ; Beltrame, FL; Pileggi, M				Dobrzanski, Tatiane; Gravina, Fernanda; Steckling, Bruna; Olchanheski, Luiz R.; Sprenger, Ricardo F.; Espirito Santo, Bruno C.; Galvao, Carolina W.; Reche, Pericles M.; Prestes, Rosilene A.; Pileggi, Sonia A. V.; Campos, Francinete R.; Azevedo, Ricardo A.; Sadowsky, Michael J.; Beltrame, Flavio L.; Pileggi, Marcos			Bacillus megaterium strains derived from water and soil exhibit differential responses to the herbicide mesotrione	PLOS ONE			English	Article							OXIDATIVE STRESS; ESCHERICHIA-COLI; ANTIOXIDANT RESPONSES; TOXICITY ASSESSMENT; DEGRADING BACTERIA; HYDROGEN-PEROXIDE; DEGRADATION; MEMBRANE; ENZYMES; COMMUNITIES	The intense use of herbicides for weed control in agriculture causes selection pressure on soil microbiota and water ecosystems, possibly resulting in changes to microbial processes, such as biogeochemical cycles. These xenobiotics may increase the production of reactive oxygen species and consequently affect the survival of microorganisms, which need to develop strategies to adapt to these conditions and maintain their ecological functionality. This study analyzed the adaptive responses of bacterial isolates belonging to the same species, originating from two different environments (water and soil), and subjected to selection pressure by herbicides. The effects of herbicide Callisto and its active ingredient, mesotrione, induced different adaptation strategies on the cellular, enzymatic, and structural systems of two Bacillus megaterium isolates obtained from these environments. The lipid saturation patterns observed may have affected membrane permeability in response to this herbicide. Moreover, this may have led to different levels of responses involving superoxide dismutase and catalase activities, and enzyme polymorphisms. Due to these response systems, the strain isolated from water exhibited higher growth rates than did the soil strain, in evaluations made in oligotrophic culture media, which would be more like that found in semi-pristine aquatic environments. The influence of the intracellular oxidizing environments, which changed the mode of degradation of mesotrione in our experimental model and produced different metabolites, can also be observed in soil and water at sites related to agriculture. Since the different metabolites may present different levels of toxicity, we suggest that this fact should be considered in studies on the fate of agrochemicals in different environments.	[Dobrzanski, Tatiane; Gravina, Fernanda; Steckling, Bruna; Pileggi, Sonia A. V.; Pileggi, Marcos] Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Setor Ciencias Biol & Saude, Lab Microbiol Ambiental, Ponta Grossa, Parana, Brazil; [Olchanheski, Luiz R.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Lab Biol Mol & Ecol Microbiana, Sao Paulo, SP, Brazil; [Sprenger, Ricardo F.] Univ Fed Sao Carlos, Dept Quim, Separare Nucleo Cromatog, Sao Carlos, SP, Brazil; [Espirito Santo, Bruno C.] Univ Estadual Maringe, Dept Biotecnol Genet & Biol Celular, Lab Biotecnol Microbiana, Maringa, Parana, Brazil; [Galvao, Carolina W.] Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Setor Ciencias Biol & Saude, Lab Biol Mol Microbiana, Ponta Grossa, Parana, Brazil; [Reche, Pericles M.] Univ Estadual Ponta Grossa, Dept Enfermagem & Saude Publ, Setor Ciencias Biol & Saude, Lab Pesquisa Recursos Hidricos, Ponta Grossa, Parana, Brazil; [Prestes, Rosilene A.] Univ Tecnol Fed Parana, UTFPR, Dept Acad, Campus Ponta Grossa, Ponta Grossa, Parana, Brazil; [Campos, Francinete R.] Univ Fed Parana, Dept Farm, Lab Biociencias & Espectrometria Massas, Curitiba, Parana, Brazil; [Azevedo, Ricardo A.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Genet, Piracicaba, SP, Brazil; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Sadowsky, Michael J.] Univ Minnesota, Biotechnol Inst, St Paul, MN 55108 USA; [Beltrame, Flavio L.] Univ Estadual Ponta Grossa, Dept Ciencias Farmaceut, Setor Ciencias Biol & Saude, Lab Fitoterapia Tecnol & Quin Prod Nat, Ponta Grossa, Parana, Brazil	Universidade Estadual de Ponta Grossa; Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade Estadual de Ponta Grossa; Universidade Estadual de Ponta Grossa; Pontificia Universidade Catolica do Parana; Universidade Tecnologica Federal do Parana; Universidade Federal do Parana; Universidade de Sao Paulo; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Universidade Estadual de Ponta Grossa	Pileggi, M (corresponding author), Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Setor Ciencias Biol & Saude, Lab Microbiol Ambiental, Ponta Grossa, Parana, Brazil.	pileggimarcos@gmail.com	Campos, Francinete/AAU-1346-2020; Beltrame, Flavio Luis/H-8505-2015; Prestes, Rosilene/AAI-9089-2020; Pileggi, Marcos/B-8651-2012; Prestes, Rosilene Aparecida/AAS-7790-2020; Dobrzanski, Tatiane/ABE-2814-2020; Azevedo, Ricardo Antunes/F-8863-2011; Galvão, Carolina Weigert/V-5076-2019; Sadowsky, Michael/J-2507-2016	Beltrame, Flavio Luis/0000-0001-7067-5802; Pileggi, Marcos/0000-0003-1633-8295; Azevedo, Ricardo Antunes/0000-0001-7316-125X; Galvão, Carolina Weigert/0000-0002-8435-8944; Gravina, Fernanda/0000-0003-4942-3381; Sadowsky, Michael/0000-0001-8779-2781; Dobrzanski, Tatiane/0000-0002-0149-1329	Coordination for the Improvement of Higher Level Personnel (CAPES); National Council of Technological and Scientific Development (CNPq) [445083/2014-0, 401354/2014-8]; Foundation for Research Support of the State of Sao Paulo (FAPESP); Foundation for Research Support of the State of Parana (Fundacao Araucaria)	Coordination for the Improvement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Foundation for Research Support of the State of Parana (Fundacao Araucaria)	This study was funded by Coordination for the Improvement of Higher Level Personnel (CAPES) (http://www.capes.gov.br/); National Council of Technological and Scientific Development (CNPq) (http://www.cnpq.br/), Universal (Grant number: 445083/2014-0) and Science without Borders (Grant number: 401354/2014-8); Foundation for Research Support of the State of Sao Paulo (FAPESP) (http://www.fapesp.br/); and Foundation for Research Support of the State of Parana (Fundacao Araucaria) (http://www.fapprpr.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FUNCT PLANT BIOL; [Anonymous], PROCESS BIOCH; [Anonymous], TITLE ERROR; Azevedo RA, 1998, PHYSIOL PLANTARUM, V104, P280, DOI 10.1034/j.1399-3054.1998.1040217.x; Balague C, 2001, ENVIRON TOXICOL, V16, P43, DOI 10.1002/1522-7278(2001)16:1<43::AID-TOX50>3.0.CO;2-R; Bartosz G, 2009, BIOCHEM PHARMACOL, V77, P1303, DOI 10.1016/j.bcp.2008.11.009; Batisson I, 2009, ENVIRON POLLUT, V157, P1195, DOI 10.1016/j.envpol.2008.12.009; Bonnet JL, 2008, ARCH ENVIRON CON TOX, V55, P576, DOI 10.1007/s00244-008-9145-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckova M, 2010, CURR MICROBIOL, V61, P241, DOI 10.1007/s00284-010-9601-x; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cai ZQ, 2013, ENVIRON SCI POLLUT R, V20, P8831, DOI 10.1007/s11356-013-1852-1; CHEN Q, 1995, J BACTERIOL, V177, P6894, DOI 10.1128/jb.177.23.6894-6901.1995; Cia MC, 2012, ANN APPL BIOL, V161, P313, DOI 10.1111/j.1744-7348.2012.00575.x; Crouzet O, 2010, SOIL BIOL BIOCHEM, V42, P193, DOI 10.1016/j.soilbio.2009.10.016; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; DOMBEK KM, 1984, J BACTERIOL, V157, P233, DOI 10.1128/JB.157.1.233-239.1984; Dourado MN, 2015, ENVIRON SCI POLLUT R, V22, P19922, DOI 10.1007/s11356-015-5204-1; Durand S, 2006, LETT APPL MICROBIOL, V43, P222, DOI 10.1111/j.1472-765X.2006.01923.x; Gomes-Junior RA, 2007, FUNCT PLANT BIOL, V34, P449, DOI 10.1071/FP07010; Gort AS, 1998, J BACTERIOL, V180, P1402, DOI 10.1128/JB.180.6.1402-1410.1998; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Gratao PL, 2015, BIOMETALS, V28, P803, DOI 10.1007/s10534-015-9867-3; Gravina F, 2017, ECOTOX ENVIRON SAFE, V139, P89, DOI 10.1016/j.ecoenv.2017.01.027; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hlouchova K, 2012, BIOCHEMISTRY-US, V51, P3848, DOI 10.1021/bi300261p; Hult K, 2007, TRENDS BIOTECHNOL, V25, P231, DOI 10.1016/j.tibtech.2007.03.002; ICH, INT COUNC HARM TECHN; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Isik K, 2007, PROCESS BIOCHEM, V42, P235, DOI 10.1016/j.procbio.2006.08.013; Joly P, 2013, CHEMOSPHERE, V93, P2444, DOI 10.1016/j.chemosphere.2013.08.074; Karunathilaka SR, 2017, J AGR FOOD CHEM, V65, P224, DOI 10.1021/acs.jafc.6b04463; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Li XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134595; Li ZM, 2009, SOIL BIOL BIOCHEM, V41, P984, DOI 10.1016/j.soilbio.2008.10.026; Lin XY, 2009, ECOTOX ENVIRON SAFE, V72, P1899, DOI 10.1016/j.ecoenv.2009.04.016; Liu Z, 2011, MINER ENG, V24, P839, DOI 10.1016/j.mineng.2011.03.005; Ma R, 2013, PLANT PHYSIOL, V163, P363, DOI 10.1104/pp.113.223156; Margino S, 2011, INDONES J BIOTECHNOL, V12, P973; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; Martins PF, 2011, PROCESS BIOCHEM, V46, P1186, DOI 10.1016/j.procbio.2011.02.014; Meazza G, 2002, PHYTOCHEMISTRY, V60, P281, DOI 10.1016/S0031-9422(02)00121-8; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Mitchell G, 2001, PEST MANAG SCI, V57, P120, DOI 10.1002/1526-4998(200102)57:2<120::AID-PS254>3.0.CO;2-E; Olchanheski LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099960; Ortiz-Hernandez M.L., 2013, BIODEGRADATION LIFE, V10, P5772, DOI [10.5772/56098, DOI 10.5772/56098]; Parsons HT, 2011, BIOCHEM J, V440, P375, DOI 10.1042/BJ20110939; Peters LP, 2017, PLANTA, V245, P749, DOI 10.1007/s00425-016-2642-z; Peters LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112271; Pileggi M, 2012, CHEMOSPHERE, V86, P1127, DOI 10.1016/j.chemosphere.2011.12.041; Pompeu GB, 2017, PROTOPLASMA, V254, P771, DOI 10.1007/s00709-016-0989-4; Prione LP, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0240-x; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Saha SK, 2013, BIORESOURCE TECHNOL, V147, P23, DOI 10.1016/j.biortech.2013.08.022; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Seth V, 2001, PESTIC BIOCHEM PHYS, V71, P133, DOI 10.1006/pest.2001.2571; Shah SP, 2014, CHEM PHYS LIPIDS, V180, P61, DOI 10.1016/j.chemphyslip.2014.02.005; Shimizu K, 2014, METABOLITES, V4, P1, DOI 10.3390/metabo4010001; Tironi SP, 2009, PLANTA DANINHA, V27, P995, DOI 10.1590/S0100-83582009000500013; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107270; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zhang H, 2014, J ENVIRON SCI HEAL B, V49, P79, DOI 10.1080/03601234.2014.844610; Zhang Y, 2012, J HAZARD MATER, V229, P434, DOI 10.1016/j.jhazmat.2012.05.054; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; ANN APPL BIOL; CURR MICROBIOL	68	12	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196166	10.1371/journal.pone.0196166	http://dx.doi.org/10.1371/journal.pone.0196166			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694403	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400069
J	Laubmeier, AN; Wootton, K; Banks, JE; Bommarco, R; Curtsdotter, A; Jonsson, T; Roslin, T; Banks, HT				Laubmeier, A. N.; Wootton, Kate; Banks, J. E.; Bommarco, Riccardo; Curtsdotter, Alva; Jonsson, Tomas; Roslin, Tomas; Banks, H. T.			From theory to experimental design-Quantifying a trait-based theory of predator-prey dynamics	PLOS ONE			English	Article							BODY-MASS CONSTRAINTS; COMPLEX FOOD WEBS; INTERACTION STRENGTHS; INTRAGUILD PREDATION; SIZE; POPULATION; DIVERSITY; SUPPRESSION; STABILITY; ECOLOGY	Successfully applying theoretical models to natural communities and predicting ecosystem behavior under changing conditions is the backbone of predictive ecology. However, the experiments required to test these models are dictated by practical constraints, and models are often opportunistically validated against data for which they were never intended. Alternatively, we can inform and improve experimental design by an in-depth pre-experimental analysis of the model, generating experiments better targeted at testing the validity of a theory. Here, we describe this process for a specific experiment. Starting from food web ecological theory, we formulate a model and design an experiment to optimally test the validity of the theory, supplementing traditional design considerations with model analysis. The experiment itself will be run and described in a separate paper. The theory we test is that trophic population dynamics are dictated by species traits, and we study this in a community of terrestrial arthropods. We depart from the Allometric Trophic Network (ATN) model and hypothesize that including habitat use, in addition to body mass, is necessary to better model trophic interactions. We therefore formulate new terms which account for micro-habitat use as well as intra-and interspecific interference in the ATN model. We design an experiment and an effective sampling regime to test this model and the underlying assumptions about the traits dominating trophic interactions. We arrive at a detailed sampling protocol to maximize information content in the empirical data obtained from the experiment and, relying on theoretical analysis of the proposed model, explore potential shortcomings of our design. Consequently, since this is a "pre-experimental" exercise aimed at improving the links between hypothesis formulation, model construction, experimental design and data collection, we hasten to publish our findings before analyzing data from the actual experiment, thus setting the stage for strong inference.	[Laubmeier, A. N.; Banks, H. T.] North Carolina State Univ, Ctr Res Sci Computat, Raleigh, NC 27695 USA; [Wootton, Kate; Bommarco, Riccardo; Curtsdotter, Alva; Jonsson, Tomas; Roslin, Tomas] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Banks, J. E.] Calif State Univ Monterey Bay, Undergrad Res Opportun Ctr, Seaside, CA USA	University of North Carolina; North Carolina State University; Swedish University of Agricultural Sciences; California State University System; California State University Monterey Bay	Laubmeier, AN (corresponding author), North Carolina State Univ, Ctr Res Sci Computat, Raleigh, NC 27695 USA.	anjlaubmeier@gmail.com	Jonsson, Tomas/G-1787-2013; Roslin, Tomas/E-8648-2016; Banks, John E./AAN-2300-2020	Jonsson, Tomas/0000-0002-5234-9576; Roslin, Tomas/0000-0002-2957-4791; Banks, John E./0000-0001-6793-7613; Laubmeier, Amanda N./0000-0003-1056-1058; Curtsdotter, Alva/0000-0001-6870-7924; Wootton, Katherine/0000-0002-9033-8210	National Science Foundation under Research Training Grant (RTG) [DMS-1246991]; CRSC/Lord Fellowship; Air Force Office of Scientific Research [AFOSR FA9550-15-1-0298]; August T. Larsson guest researchers programme at the Swedish University of Agricultural Sciences; Swedish Research Council (VR) [2016-04580]; Swedish Research Council FORMAS [2016-01168]	National Science Foundation under Research Training Grant (RTG); CRSC/Lord Fellowship; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); August T. Larsson guest researchers programme at the Swedish University of Agricultural Sciences; Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This research was supported in part by the National Science Foundation under Research Training Grant (RTG) DMS-1246991, by a CRSC/Lord Fellowship, by the Air Force Office of Scientific Research under grant number AFOSR FA9550-15-1-0298, by the August T. Larsson guest researchers programme at the Swedish University of Agricultural Sciences, and by the Swedish Research Council (VR) under grant number 2016-04580 and the Swedish Research Council FORMAS under grant number 2016-01168.	Allinson M, 2015, ROYAL SOC OPEN SCI L; Banks HT, 2009, TEXTB MATH, P1; Banks HT, 2016, J INVERSE ILL-POSE P, V24, P413, DOI 10.1515/jiip-2015-0090; Banks HT, 2014, MONOGR RES NOTES MAT, P1; Banks HT, 2017, INVERSE PROBL SCI EN; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Blanchet FG, 2016, OIKOS, V125, P975, DOI 10.1111/oik.02838; Boit A, 2012, ECOL LETT, V15, P594, DOI 10.1111/j.1461-0248.2012.01777.x; Bosco FA, 2016, PERS PSYCHOL, V69, P709, DOI 10.1111/peps.12111; Boukal DS, 2014, J LIMNOL, V73, P171, DOI 10.4081/jlimnol.2014.826; Box GE, 1979, SAMPLING BAYES INFER; Brose U, 2008, J ANIM ECOL, V77, P1072, DOI 10.1111/j.1365-2656.2008.01408.x; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2010, FUNCT ECOL, V24, P28, DOI 10.1111/j.1365-2435.2009.01618.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Caswell H., 1975, SYSTEMS ANAL SIMULAT, P601; Cohen JE, 2005, P NATL ACAD SCI USA, V102, P684, DOI 10.1073/pnas.0408780102; Deraison H, 2015, ECOL LETT, V18, P1346, DOI 10.1111/ele.12529; Durrett R., 2005, PROBABILITY THEORY A; Eklof A, 2013, ECOL LETT, V16, P577, DOI 10.1111/ele.12081; Eslami M, 1994, THEORY SENSITIVITY D; Frank PM, 1978, INTRO SYSTEM SENSITI; Gilljam D, 2011, ADV ECOL RES, V45, P67, DOI 10.1016/B978-0-12-386475-8.00003-4; Gonzales JE, PROMISE PREREGISTRAT; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Kaartinen R, INTRAGUILD INT UNPUB; Kalinoski RM, 2016, OECOLOGIA, V180, P543, DOI 10.1007/s00442-015-3487-z; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Klecka J, 2013, J ANIM ECOL, V82, P1031, DOI 10.1111/1365-2656.12078; Lakatos I, 1968, P ARISTOTELIAN SOC, V69, P149, DOI [DOI 10.1093/ARISTOTELIAN/69.1.149, 10.1093/aristotelian/69.1.149]; Ottaviani D, 2006, J ZOOL, V269, P317, DOI 10.1111/j.1469-7998.2006.00060.x; Pain E., 2015, REGISTER YOUR STUDY; Peckarsky BL, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00236.1; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Rall BC, 2010, GLOBAL CHANGE BIOL, V16, P2145, DOI 10.1111/j.1365-2486.2009.02124.x; Rall BC, 2011, OIKOS, V120, P483, DOI 10.1111/j.1600-0706.2010.18860.x; ROSENHEIM JA, 1993, OECOLOGIA, V96, P439, DOI 10.1007/BF00317517; Rusch A, 2015, BASIC APPL ECOL, V16, P250, DOI 10.1016/j.baae.2015.02.003; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Schneider FD, 2012, ECOL LETT, V15, P436, DOI 10.1111/j.1461-0248.2012.01750.x; Skalski GT, 2001, ECOLOGY, V82, P3083; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Woodward G, 2005, ADV ECOL RES, V36, P85, DOI 10.1016/S0065-2504(05)36002-8	47	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195919	10.1371/journal.pone.0195919	http://dx.doi.org/10.1371/journal.pone.0195919			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694425	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400052
J	Krogsrud, SK; Fjell, AM; Tamnes, CK; Grydeland, H; Due-Tonnessen, P; Bjornerud, A; Sampaio-Baptista, C; Andersson, J; Johansen-Berg, H; Walhovd, KB				Krogsrud, Stine K.; Fjell, Anders M.; Tamnes, Christian K.; Grydeland, Hakon; Due-Tonnessen, Pauline; Bjornerud, Atle; Sampaio-Baptista, Cassandra; Andersson, Jesper; Johansen-Berg, Heidi; Walhovd, Kristine B.			Development of white matter microstructure in relation to verbal and visuospatial working memory-A longitudinal study	PLOS ONE			English	Article							HUMAN BRAIN; PROCESSING SPEED; SHORT-TERM; DIFFUSION; CHILDHOOD; CHILDREN; MATURATION; AGE; ADOLESCENCE; ADULTHOOD	Working memory capacity is pivotal for a broad specter of cognitive tasks and develops throughout childhood. This must in part rely on development of neural connections and white matter microstructure maturation, but there is scarce knowledge of specific relations between this and different aspects of working memory. Diffusion tensor imaging (DTI) enables us to study development of brain white matter microstructure. In a longitudinal DTI study of 148 healthy children between 4 and 11 years scanned twice with an on average 1.6 years interval, we characterized change in fractional anisotropy (FA), mean (MD), radial (RD) and axial diffusivity (AD) in 10 major white matter tracts hypothesized to be of importance for working memory. The results showed relationships between change in several tracts and change in visuospatial working memory. Specifically, improvement in visuospatial working memory capacity was significantly associated with decreased MD, RD and AD in inferior longitudinal fasciculus (ILF), inferior fronto-occipital fasciculus (IFOF) and uncinate fasciculus (UF) in the right hemisphere, as well as forceps major (FMaj). No significant relationships were found between change in DTI metrics and change in verbal working memory capacity. These findings yield new knowledge about brain development and corresponding working memory improvements in childhood.	[Krogsrud, Stine K.; Fjell, Anders M.; Tamnes, Christian K.; Grydeland, Hakon; Due-Tonnessen, Pauline; Bjornerud, Atle; Walhovd, Kristine B.] Univ Oslo, Dept Psychol, Res Grp Lifespan Changes Brain & Cognit, Oslo, Norway; [Fjell, Anders M.; Walhovd, Kristine B.] Oslo Univ Hosp, Unit Neuropsychol, Dept Phys Med & Rehabil, Oslo, Norway; [Due-Tonnessen, Pauline] Oslo Univ Hosp, Rikshosp, Dept Radiol, Oslo, Norway; [Bjornerud, Atle] Oslo Univ Hosp, Rikshosp, Dept Diagnost Phys, Oslo, Norway; [Sampaio-Baptista, Cassandra; Andersson, Jesper; Johansen-Berg, Heidi] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford Ctr Funct MRI Brain FMRIB, Oxford, England	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oxford	Krogsrud, SK (corresponding author), Univ Oslo, Dept Psychol, Res Grp Lifespan Changes Brain & Cognit, Oslo, Norway.	s..k.krogsrud@psykologi.uio.no		Johansen-Berg, Heidi/0000-0002-4134-9730; Sampaio Baptista, Cassandra/0000-0002-7893-0289; Grydeland, Hakon/0000-0001-5061-464X; Due-Tonnessen, Paulina/0000-0002-3615-1914	Norwegian Research Council (NRC) [204935]; NRC; Department of Psychology, University of Oslo; European Research Council's Starting Grant scheme (ERC) [313440, 283634]; Wellcome Trust [WT090955AIA]	Norwegian Research Council (NRC)(Research Council of Norway); NRC(National Research Centre (NRC)); Department of Psychology, University of Oslo; European Research Council's Starting Grant scheme (ERC)(European Research Council (ERC)); Wellcome Trust(Wellcome TrustEuropean Commission)	The study was financed by the Norwegian Research Council (NRC), grant number 204935 to K.B.W., A.M.F. and C.K.T. K.B.W. have also received other funding from NRC and the Department of Psychology, University of Oslo. K.B. W. and A.M.F. are also supported by European Research Council's Starting Grant scheme (ERC grant agreement 313440 to K.B.W. and 283634 to A.M.F.). H.J-B. and C.S-B. are supported by the Wellcome Trust grant number WT090955AIA).	Adams JW, 1997, J EXP CHILD PSYCHOL, V67, P21, DOI 10.1006/jecp.1997.2397; Alloway TP, 2006, CHILD DEV, V77, P1698, DOI 10.1111/j.1467-8624.2006.00968.x; Andersson J, 2007, TR07JA2 FMRIB; Andersson J. L. R., 2014, INT SOC MAGN RES MED; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson JLR., 2012, P INT SOC MAGN RESON, P2426; Baddeley A, 1986, WORKING MEMORY, V11; Baddeley A. D., 1974, WORKING MEMORY; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENES FM, 1989, SCHIZOPHRENIA BULL, V15, P585, DOI 10.1093/schbul/15.4.585; Brouwer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032316; Champod AS, 2010, J NEUROSCI, V30, P3849, DOI 10.1523/JNEUROSCI.0097-10.2010; Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005; Concha L, 2010, J NEUROSCI, V30, P996, DOI 10.1523/JNEUROSCI.1619-09.2010; COWAN N, 1994, J MEM LANG, V33, P234, DOI 10.1006/jmla.1994.1012; Darki F, 2015, CEREB CORTEX, V25, P1587, DOI 10.1093/cercor/bht352; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Forkel SJ, 2014, CORTEX, V56, P73, DOI 10.1016/j.cortex.2012.09.005; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Geng XJ, 2012, NEUROIMAGE, V61, P542, DOI 10.1016/j.neuroimage.2012.03.057; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Henson R., 2001, NEURAL WORKING MEMOR, P151; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Jarvis H.L., 2003, ED CHILD PSYCHOL, V20, P123; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Klarborg B, 2013, HUM BRAIN MAPP, V34, P3216, DOI 10.1002/hbm.22139; Klingberg T, 2006, NEUROPSYCHOLOGIA, V44, P2171, DOI 10.1016/j.neuropsychologia.2005.11.019; Krogsrud SK, 2016, NEUROIMAGE, V124, P473, DOI 10.1016/j.neuroimage.2015.09.017; Krogsrud SK, 2014, HUM BRAIN MAPP, V35, P5646, DOI 10.1002/hbm.22576; Lamp G, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00087; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; McKenna BS, 2015, J INT NEUROPSYCH SOC, V21, P330, DOI 10.1017/S1355617715000314; Mori S., 2005, MRI ATLAS HUMAN WHIT; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nelson CA, 2000, DEV PSYCHOL, V36, P109, DOI 10.1037/0012-1649.36.1.109; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nomura K, 2013, BEHAV NEUROL, V27, P229, DOI [10.3233/BEN-110249, 10.1155/2013/267408]; Ostby Y, 2011, NEUROPSYCHOLOGIA, V49, P3854, DOI 10.1016/j.neuropsychologia.2011.10.001; Peters BD, 2014, BIOL PSYCHIAT, V75, P248, DOI 10.1016/j.biopsych.2013.05.020; Peters BD, 2012, SCHIZOPHRENIA BULL, V38, P1308, DOI 10.1093/schbul/sbs054; Pickering SJ, 1998, MEM COGNITION, V26, P1117, DOI 10.3758/BF03201189; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Short SJ, 2013, NEUROIMAGE, V64, P156, DOI 10.1016/j.neuroimage.2012.09.021; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Thomason ME, 2009, J COGNITIVE NEUROSCI, V21, P316, DOI 10.1162/jocn.2008.21028; Uda S, 2015, DEV NEUROSCI-BASEL, V37, P182, DOI 10.1159/000373885; van der Ham IJM, 2009, BRAIN RES, V1297, P70, DOI 10.1016/j.brainres.2009.07.088; Vergani F, 2014, CORTEX, V56, P145, DOI 10.1016/j.cortex.2014.03.002; Vestergaard M, 2011, J COGNITIVE NEUROSCI, V23, P2135, DOI 10.1162/jocn.2010.21592; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Walsh M, 2011, BRAIN CONNECT, V1, P317, DOI 10.1089/brain.2011.0037; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280	69	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0195540	10.1371/journal.pone.0195540	http://dx.doi.org/10.1371/journal.pone.0195540			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7GN	29689058	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000430678800009
J	Huang, YX; Song, H; Tao, Y; Shao, XB; Zeng, XS; Xu, XL; Qi, JL; Sun, JF				Huang, Ying-Xue; Song, Hao; Tao, Yue; Shao, Xue-Bao; Zeng, Xue-Si; Xu, Xiu-Lian; Qi, Jin-Liang; Sun, Jian-Fang			& IT;Ovostatin & IT; 2 knockdown significantly inhibits the growth, migration, and tumorigenicity of cutaneous malignant melanoma cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROTEIN GRP78; SURFACE GRP78; CANCER; PROGRESSION; EXPRESSION; ACTIVATION; SURVIVAL; PATHWAY; BINDING	Background & para;& para;We previously identified ovostatin 2 (OVOS2) as a new candidate gene for cutaneous malignant melanoma (CMM) in a Chinese population. In this study, we aimed to investigate the exact role of OVOS2 in cell proliferation, invasion, and tumorigenesis of melanoma A375 cells.& para;& para;Methods & para;& para;The downregulation of OVOS2 expression was performed using lentiviral vectors with specific shRNA. The effects of OVOS2 expression on cell proliferation, cell cycle, cell migration, cell invasion, and potential of tumorigenesis were further investigated.& para;& para;Results & para;& para;The downregulation of OVOS2 significantly suppressed the proliferation of A375 cells and led to a G2/M phase block. The transwell cell migration assay showed that the reduced expression of OVOS2 also significantly inhibited the transmigration of A375 cells. The western blot results showed downregulated expression of p-FAK, p-AKT, and p-ERK. This was accompanied by the upregulated epithelial phenotypes E-cadherin and beta-catenin, and downregulated expression of mesenchymal phenotype N-cadherin after OVOS2 knockdown. The transplantation tumor experiment in BALB/C nude mouse showed that after an observation period of 32 days, the growth speed and weight of the transplanted tumors were significantly suppressed in the BALB/c nude mice subcutaneously injected with OVOS2 knocked-down A375 cells.& para;& para;Conclusion & para;& para;The inhibition of OVOS2 had significant suppressive effects on the proliferation, motility, and migration capabilities of A375 cells, suggesting a crucial promotive role of OVOS2 in the pathogenesis and progression of CMM. The involved mechanisms are at least partly associated with the overactivation of FAK/MAPK/ERK and FAK/PI3K/AKT signals.	[Huang, Ying-Xue; Song, Hao; Shao, Xue-Bao; Zeng, Xue-Si; Xu, Xiu-Lian; Sun, Jian-Fang] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Huang, Ying-Xue] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Tao, Yue] Nanjing Univ, Drum Tower Hosp, Med Sch, Nanjing, Jiangsu, Peoples R China; [Qi, Jin-Liang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Central South University; Nanjing University; Nanjing University	Xu, XL; Sun, JF (corresponding author), Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China.; Qi, JL (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	xxqjl@sina.com; QiJL@nju.edu.cn; jfsunpumcderm@sina.com		Sun, Jianfang/0000-0001-9229-4904	National Natural Science Foundation of China [81772916, 30700727, 81502750]; Natural Science Foundation of the Jiangsu Bureau of Science and Technology [BK20171132, BK2012505, BK20150111, BK20131063]; research Fund for Doctoral Program of Higher Education of China [20070023113]; Youth Foundation of PUMC [13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Bureau of Science and Technology(Natural Science Foundation of Jiangsu Province); research Fund for Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Youth Foundation of PUMC	This work was supported by the National Natural Science Foundation of China (81772916, 30700727, 81502750), the Natural Science Foundation of the Jiangsu Bureau of Science and Technology (BK20171132, BK2012505, BK20150111, BK20131063), the research Fund for Doctoral Program of Higher Education of China (No. 20070023113; http://www.moe.edu.cn), and the Youth Foundation of PUMC for Dr. XX (No. 13, 2011; http://www.pumc.edu.cn).	Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Cavallaro U, 2002, CANCER LETT, V176, P123, DOI 10.1016/S0304-3835(01)00759-5; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Davies MA, 2012, CANCER J, V18, P142, DOI 10.1097/PPO.0b013e31824d448c; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Finn L, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-23; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Ginnebaugh KR, 2014, EXPERT OPIN THER TAR, V18, P731, DOI 10.1517/14728222.2014.909807; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huang YX, 2013, J DERMATOL, V40, P901, DOI 10.1111/1346-8138.12294; Jiao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041591; Justus CR, 2014, JOVE-J VIS EXP, DOI 10.3791/51046; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Li G, 2001, CANCER RES, V61, P3819; Li ZP, 2006, CELL CYCLE, V5, P2440, DOI 10.4161/cc.5.21.3428; Marzuka A, 2015, J CELL PHYSIOL, V230, P2626, DOI 10.1002/jcp.25019; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mikesh LM, 2010, MELANOMA RES, V20, P485, DOI 10.1097/CMR.0b013e32833fafb4; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051735; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2015, J BIOL CHEM, V290, P9571, DOI 10.1074/jbc.M114.617837; Misra UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088373; Misra UK, 2013, BIOCHEMISTRY-US, V52, P4014, DOI 10.1021/bi400376s; National Cancer Institute, 2017, CANC STAT FACTS MEL; Ostmeier H, 2001, BRIT J DERMATOL, V145, P203, DOI 10.1046/j.1365-2133.2001.04335.x; Pestell RG, 2013, AM J PATHOL, V183, P3, DOI 10.1016/j.ajpath.2013.03.001; Selim MA, 2011, MELANOMA RES, V21, P323, DOI 10.1097/CMR.0b013e3283471042; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vockley JG, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1832; Welinder C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176167; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhuang LQ, 2009, HISTOPATHOLOGY, V54, P462, DOI 10.1111/j.1365-2559.2009.03242.x	36	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195610	10.1371/journal.pone.0195610	http://dx.doi.org/10.1371/journal.pone.0195610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684087	Green Published, gold, Green Submitted			2022-12-26	WOS:000430660600019
J	Pi, M; Kapoor, K; Ye, RS; Hwang, DJ; Miller, DD; Smith, JC; Baudry, J; Quarles, LD				Pi, Min; Kapoor, Karan; Ye, Ruisong; Hwang, Dong-Jin; Miller, Duane D.; Smith, Jeremy C.; Baudry, Jerome; Quarles, L. Darryl			Computationally identified novel agonists for GPRC6A	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; TESTOSTERONE REPLACEMENT; PEPTIDE-1 SECRETION; INSULIN-RESISTANCE; METABOLIC SYNDROME; SOFTWARE NEWS; BONE PROTEIN; OSTEOCALCIN; DYNAMICS; ENERGY	New insights into G protein coupled receptor regulation of glucose metabolism by beta-cells, skeletal muscle and liver hepatocytes identify GPRC6A as a potential therapeutic target for treating type 2 diabetes mellitus (T2D). Activating GPRC6A with a small molecule drug represents a potential paradigm-shifting opportunity to make significant strides in regulating glucose homeostasis by simultaneously correcting multiple metabolic derangements that underlie T2D, including abnormalities in beta-cell proliferation and insulin secretion and peripheral insulin resistance. Using a computational, structure-based high-throughput screening approach, we identified novel tri-phenyl compounds predicted to bind to the venus fly trap (VFT) and 7-transmembrane (7-TM) domains of GPRC6A. Experimental testing found that these compounds dose-dependently stimulated GPRC6A signaling in a heterologous cell expression system. Additional chemical modifications and functional analysis identified one tri-phenyl lead compound, DJ-V-159 that demonstrated the greatest potency in stimulating insulin secretion in beta-cells and lowering serum glucose in wild-type mice. Collectively, these studies show that GPRC6A is a "druggable" target for developing chemical probes to treat T2DM.	[Pi, Min; Ye, Ruisong; Quarles, L. Darryl] Univ Tennessee, Hlth Sci Ctr, Dept Med, Knoxville, TN 37996 USA; [Kapoor, Karan; Smith, Jeremy C.; Baudry, Jerome] UT ORNL Ctr Mol Biophys, Oak Ridge, TN 37831 USA; [Hwang, Dong-Jin; Miller, Duane D.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Smith, Jeremy C.; Baudry, Jerome] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Baudry, Jerome] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; University of Alabama System; University of Alabama Huntsville	Pi, M; Quarles, LD (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Med, Knoxville, TN 37996 USA.; Baudry, J (corresponding author), UT ORNL Ctr Mol Biophys, Oak Ridge, TN 37831 USA.; Baudry, J (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.; Baudry, J (corresponding author), Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA.	mpi@uthsc.edu; jbaudry@utk.edu; dquarles@uthsc.edu	Hwang, Dong-Jin/ABC-5874-2021; Ye, Ruisong/ABH-3897-2020; Kapoor, Karan/F-2758-2019; Ye, Ruisong/AAL-8956-2020	Kapoor, Karan/0000-0002-7719-0274; Ye, Ruisong/0000-0002-7970-1015; Hwang, Dong-Jin/0000-0002-0055-1916; Pi, Min/0000-0002-0319-8003; Quarles, L. Darryl/0000-0002-5082-7896	National Institutes of Health [AR37308]; American Diabetes Association [1-13-BS-149-BR]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [grant number AR37308] and American Diabetes Association (grant #1-13-BS-149-BR) (to LDQ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dhindsa S, 2016, DIABETES CARE, V39, P82, DOI 10.2337/dc15-1518; Evangelista W, 2016, BIOORGAN MED CHEM, V24, P4928, DOI 10.1016/j.bmc.2016.07.064; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2012, BONE, V50, P568, DOI 10.1016/j.bone.2011.04.017; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Hackett G, 2016, INT J CLIN PRACT, V70, P244, DOI 10.1111/ijcp.12779; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Iki M, 2012, OSTEOPOROSIS INT, V23, P761, DOI 10.1007/s00198-011-1600-7; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kapoor K, 2016, J CHEM INF MODEL, V56, P535, DOI 10.1021/acs.jcim.5b00596; Karsenty G, 2016, CELL, V164, P1248, DOI 10.1016/j.cell.2016.02.043; Karsenty G, 2014, MOL CELL ENDOCRINOL, V382, P521, DOI 10.1016/j.mce.2013.10.008; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lindberg K, 2014, J AM SOC NEPHROL, V25, P2169, DOI 10.1681/ASN.2013111209; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meigs JB, 2002, AM J MANAG CARE, V8, pS283; Meigs JB., 2002, AM J MANAGE CARE S, V8, pS93; Mizokami A, 2014, BONE, V69, P68, DOI 10.1016/j.bone.2014.09.006; Mizokami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057375; NISHIMOTO SK, 1990, ANAL BIOCHEM, V186, P273, DOI 10.1016/0003-2697(90)90079-O; NISHIMOTO SK, 1985, J BIOL CHEM, V260, P2832; NISHIMOTO SK, 1979, J BIOL CHEM, V254, P437; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Oya M, 2013, J BIOL CHEM, V288, P4513, DOI 10.1074/jbc.M112.402677; Phillips CM, 2010, J NUTR, V140, P238, DOI 10.3945/jn.109.115329; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pi M, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700770; Pi M, 2017, MOL METAB, V6, DOI 10.1016/j.molmet.2016.12.006; Pi M, 2016, ENDOCRINOLOGY, V157, P1866, DOI 10.1210/en.2015-2010; Pi M, 2015, MOL ENDOCRINOL, V29, P1759, DOI 10.1210/me.2015-1161; Pi M, 2012, ENDOCRINOLOGY, V153, P4608, DOI 10.1210/en.2012-1301; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Pi M, 2010, J BIOL CHEM, V285, P39953, DOI 10.1074/jbc.M110.158063; Pi M, 2010, J BONE MINER RES, V25, P1092, DOI 10.1359/jbmr.091037; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; White JP, 2013, MOL CELL ENDOCRINOL, V365, P174, DOI 10.1016/j.mce.2012.10.019; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	48	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195980	10.1371/journal.pone.0195980	http://dx.doi.org/10.1371/journal.pone.0195980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684031	Green Published, Green Submitted, gold			2022-12-26	WOS:000430660600027
J	Armingol, E; Tobar, E; Cabrera, R				Armingol, Erick; Tobar, Eduardo; Cabrera, Ricardo			Understanding the impact of the cofactor swapping of isocitrate dehydrogenase over the growth phenotype of Escherichia coli on acetate by using constraint-based modeling	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; FLUX ANALYSIS; BRANCH POINT; METABOLIC PATHWAYS; GLYOXYLATE BYPASS; ENZYME; STATE; PHOSPHORYLATION; EVOLUTION; BACTERIA	It has been proposed that NADP(+)-specificity of isocitrate dehydrogenase (ICDH) evolved as an adaptation of microorganisms to grow on acetate as the sole source of carbon and energy. In Escherichia coli, changing the cofactor specificity of ICDH from NADP(+) to NAD(+) (cofactor swapping) decreases the growth rate on acetate. However, the metabolic basis of this phenotype has not been analyzed. In this work, we used constraint-based modeling to investigate the effect of the cofactor swapping of ICDH in terms of energy production, response of alternative sources of NADPH, and partitioning of fluxes between ICDH and isocitrate lyase (ICL) -a crucial bifurcation when the bacterium grows on acetate-. We generated E. coli strains expressing NAD(+)-specific ICDH instead of the native enzyme, and bearing the deletion of the NADPH-producing transhydrogenase PntAB. We measured their growth rate and acetate uptake rate, modeled the distribution of metabolic fluxes by Flux Balance Analysis (FBA), and quantified the specific activities of NADPH-producing dehydrogenases in central pathways. The cofactor swapping of ICDH led to one-third decrease in biomass yield, irrespective of the presence of PntAB. According to our simulations, the diminution in growth rate observed upon cofactor swapping could be explained by one-half decrease in the total production of NADPH and a lower availability of carbon for biosynthesis because of a change in the partition at the isocitrate bifurcation. Together with an increased total ATP production, this scenario resulted in a 10-fold increment in the flux of ATP not used for growing purposes. PntAB was identified as the primary NADPH balancing response, with the dehydrogenases of the oxidative branch of the Pentose Phosphate Pathway and the malic enzyme playing a role in its absence. We propose that in the context of E. coli growing on acetate, the NADP(+)-specificity of ICDH is a trait that impacts not only NADPH production, but also the efficient allocation of carbon and energy.	[Armingol, Erick; Tobar, Eduardo; Cabrera, Ricardo] Univ Chile, Fac Ciencias, Lab Bioquirn & Biol Mol, Santiago, Chile	Universidad de Chile	Cabrera, R (corresponding author), Univ Chile, Fac Ciencias, Lab Bioquirn & Biol Mol, Santiago, Chile.	ricabrer@uchile.cl	Armingol, Erick/AGI-8012-2022	Armingol, Erick/0000-0002-1546-9165; Tobar, Eduardo/0000-0002-4686-8468; Cabrera, Ricardo/0000-0002-8896-3172	CONICYT [FONDECYT 1121170]; Universidad de Chile [VID ENL012/16]; CINV Millennium Institute; PEEI of Biology Department (Universidad de Chile)	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad de Chile; CINV Millennium Institute; PEEI of Biology Department (Universidad de Chile)	This work was supported by funding from Project FONDECYT 1121170 (CONICYT), Project VID ENL012/16 (Universidad de Chile), CINV Millennium Institute, and PEEI of Biology Department (Universidad de Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWORTH JM, 1964, BIOCHIM BIOPHYS ACTA, V89, P383, DOI 10.1016/0926-6569(64)90237-8; Assaad HI, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-474; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; CHEN RD, 1995, P NATL ACAD SCI USA, V92, P11666, DOI 10.1073/pnas.92.25.11666; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; ELMANSI EMT, 1994, COMPUT APPL BIOSCI, V10, P295; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; FARMER IS, 1976, EUR J BIOCHEM, V67, P115, DOI 10.1111/j.1432-1033.1976.tb10639.x; Fell DA, 1998, BIOTECHNOL BIOENG, V58, P121, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<121::AID-BIT2>3.3.CO;2-F; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Gerosa L, 2015, CELL SYST, V1, P270, DOI 10.1016/j.cels.2015.09.008; Haverkorn van Rijsewijk BRB, 2012, TRANSCRIPTIONAL REGU; Hidalgo AA, 2004, GENETICS, V167, P1069, DOI 10.1534/genetics.104.026682; Holms H, 1996, FEMS MICROBIOL REV, V19, P85, DOI 10.1111/j.1574-6976.1996.tb00255.x; HOLMS WH, 1986, FEMS MICROBIOL LETT, V34, P123; King ZA, 2014, METAB ENG, V24, P117, DOI 10.1016/j.ymben.2014.05.009; KORNBERG HL, 1966, BIOCHEM J, V99, P1; KOSHLAND DE, 1985, CURR TOP CELL REGUL, V27, P13; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; Lee S, 2000, COMPUT CHEM ENG, V24, P711, DOI 10.1016/S0098-1354(00)00323-9; Lee WH, 2013, APPL MICROBIOL BIOT, V97, P2761, DOI 10.1007/s00253-013-4750-z; Martinez I, 2008, METAB ENG, V10, P352, DOI 10.1016/j.ymben.2008.09.001; Murima P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12527; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nielsen J, 2003, J BACTERIOL, V185, P7031, DOI 10.1128/JB.185.24.7031-7035.2003; Oh MK, 2002, J BIOL CHEM, V277, P13175, DOI 10.1074/jbc.M110809200; Olavarria K, 2014, MICROBIOL-SGM, V160, P2780, DOI 10.1099/mic.0.082180-0; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Park HJ, 2010, J MICROBIOL BIOTECHN, V20, P1300, DOI 10.4014/jmb.1003.03025; Pirt SJ., 1982, ARCH MICROBIOL, V302, P133, DOI DOI 10.1007/BF00521294; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; SAKAMOTO N, 1975, J BACTERIOL, V124, P775, DOI 10.1128/JB.124.2.775-783.1975; SATRUSTEGUI J, 1983, MOL CELL BIOCHEM, V51, P123; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Shinar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000297; Taymaz-Nikerel H, 2010, BIOTECHNOL BIOENG, V107, P369, DOI 10.1002/bit.22802; Toro CS, 1998, J BACTERIOL, V180, P4750, DOI 10.1128/JB.180.17.4750-4752.1998; van Rijsewijk BRBH, 2016, MICROBIOL-SGM, V162, P1672, DOI 10.1099/mic.0.000346; WALSH K, 1984, J BIOL CHEM, V259, P9646; WALSH K, 1985, J BIOL CHEM, V260, P8430; Wang BJ, 2011, J MICROBIOL, V49, P797, DOI 10.1007/s12275-011-0487-5; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	51	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0196182	10.1371/journal.pone.0196182	http://dx.doi.org/10.1371/journal.pone.0196182			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677222	Green Published, Green Submitted, gold			2022-12-26	WOS:000430638900027
J	Zhao, J; Du, PZ; Cui, P; Qin, YY; Hu, CE; Wu, J; Zhou, ZW; Zhang, WH; Qin, LX; Huang, GJ				Zhao, Jing; Du, Peizhun; Cui, Peng; Qin, Yunyun; Hu, Cheng'en; Wu, Jing; Zhou, Zhongwen; Zhang, Wenhong; Qin, Lunxiu; Huang, Guangjian			LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer	ONCOGENE			English	Article							NONCODING RNA PVT1; ENDOTHELIAL GROWTH-FACTOR; PHASE-III; TUMORIGENICITY; PROLIFERATION; BEVACIZUMAB; METASTASIS; EXPRESSION; CISPLATIN; CELLS	Angiogenesis can aggravate gastric cancer progression. LncRNAs exert important roles in regulating various cancer behaviors. However, the functions and mechanisms of lncRNAs in angiogenesis remain largely unknown. Here we demonstrated that lncRNA PVT1 was upregulated and significantly associated with high-microvessel density and poor prognosis in gastric cancer. Through gain-and loss-of PVT1 expression, we found PVT1 could obviously induce angiogenesis within tumors, in addition to promoting tumor growth in vitro and in vivo. Mechanistically, PVT1 directly interacted with the signal transducer activator phospho-STAT3 in the nucleus, and increased its protein stability by protecting it from poly-ubiquitination and proteasome-dependent degradation. The binding of PVT1 activated the STAT3 signalling pathway, and successively elevated VEGFA expression to stimulate angiogenesis. The positive correlation of PVT1 and VEGFA expression was also verified in gastric cancer specimens, and high levels of PVT1 and VEGFA in combination frequently predicted shorter survival time. Moreover, we revealed that PVT1 was a STAT3-responsive lncRNA, as STAT3 could occupy the PVT1 promoter to facilitate its transcription. The positive feed-back loop of PVT1 and STAT3 continuously enhanced the oncogenic effects. Collectively, our study first elucidates the mechanism of PVT1-mediated angiogenesis via evoking the STAT3/VEGFA signalling axis, which provides promising target for developing new therapeutic strategy in gastric cancer.	[Zhao, Jing; Du, Peizhun; Qin, Yunyun; Hu, Cheng'en; Qin, Lunxiu; Huang, Guangjian] Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200040, Peoples R China; [Zhao, Jing; Qin, Lunxiu] Fudan Univ, Canc Metastasis Inst, Shanghai 200040, Peoples R China; [Du, Peizhun; Wu, Jing; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China; [Zhou, Zhongwen] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai 200040, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Qin, LX; Huang, GJ (corresponding author), Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200040, Peoples R China.; Qin, LX (corresponding author), Fudan Univ, Canc Metastasis Inst, Shanghai 200040, Peoples R China.; Zhang, WH (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China.	zhangwenhong@fudan.edu.cn; qinlx@fudan.edu.cn; gjhuang@fudan.edu.cn	高, 雨莉/HGU-8187-2022; Wu, Jing/GQI-1843-2022	Wu, Jing/0000-0002-1224-0912	Natural Science Foundation of China [81672378, 81201521, 81071994, 81672820, 81400007]; Foundation from Science and Technology Commission of Shanghai [09XD1400800]; National Major Scientific Instruments and Equipment Development Project of China [2013YQ15082909, 2012ZX10002012]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation from Science and Technology Commission of Shanghai; National Major Scientific Instruments and Equipment Development Project of China	This study was supported by the Natural Science Foundation of China (81672378, 81201521, 81071994, 81672820, and 81400007), the Foundation from Science and Technology Commission of Shanghai (09XD1400800), and the National Major Scientific Instruments and Equipment Development Project of China (2013YQ15082909, 2012ZX10002012).	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chen ZZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12598; Colombo T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304208; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Ferrara N, 2016, NAT REV DRUG DISCOV, V15, P385, DOI 10.1038/nrd.2015.17; Ferro A, 2014, EUR J CANCER, V50, P1330, DOI 10.1016/j.ejca.2014.01.029; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Guo XB, 2016, ONCOTARGET, V7, P30276, DOI 10.18632/oncotarget.7217; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hegde PS, 2013, CLIN CANCER RES, V19, P929, DOI 10.1158/1078-0432.CCR-12-2535; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Jariwala N, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.27; Kong R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0355-8; Li Y, 2017, CANCER LETT, V395, P31, DOI 10.1016/j.canlet.2017.02.035; Liu YJ, 2015, PROCEEDINGS OF 2015 INTERNATIONAL CONFERENCE ON FLUID POWER AND MECHATRONICS - FPM 2015, P1, DOI 10.1109/FPM.2015.7337074; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Shah MA, 2006, J CLIN ONCOL, V24, P5201, DOI 10.1200/JCO.2006.08.0887; Shen L, 2015, GASTRIC CANCER, V18, P168, DOI 10.1007/s10120-014-0351-5; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Van Cutsem E, 2015, GASTRIC CANCER, V18, P476, DOI 10.1007/s10120-014-0402-y; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang X, 2016, J HEPATOL, V64, P1283, DOI 10.1016/j.jhep.2016.01.019; Xu MD, 2017, CLIN CANCER RES, V23, P2071, DOI 10.1158/1078-0432.CCR-16-0742; Xu Z, 2017, ONCOGENE, V36, P1965, DOI 10.1038/onc.2016.356; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yuan CL, 2016, NEOPLASMA, V63, P442, DOI 10.4149/314_150825N45; Zhang YY, 2016, NAT STRUCT MOL BIOL, V23, P522, DOI 10.1038/nsmb.3211; Zhao J, 2015, CELL CYCLE, V14, P3112, DOI 10.1080/15384101.2015.1078034; Zhu Y, 2016, ONCOTARGET, V7, P14429, DOI 10.18632/oncotarget.7418	34	224	234	5	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 26	2018	37	30					4094	4109		10.1038/s41388-018-0250-z	http://dx.doi.org/10.1038/s41388-018-0250-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GO2YI	29706652				2022-12-26	WOS:000439847000004
J	Crabtree, MD; Mendonca, CATF; Bubb, QR; Clarke, J				Crabtree, Michael D.; Mendonca, Carolina A. T. F.; Bubb, Quenton R.; Clarke, Jane			Folding and binding pathways of BH3-only proteins are encoded within their intrinsically disordered sequence, not templated by partner proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; B cell lymphoma 2 (Bcl-2) family; biophysics; kinetics; protein folding; protein-protein interaction; thermodynamics; coupled folding and binding; IDP; phi value	TRANSITION-STATE; PEPTIDES; DOMAINS; KIX; MECHANISMS; MCL-1; PUMA	Intrinsically disordered regions are present in one-third of eukaryotic proteins and are overrepresented in cellular processes such as signaling, suggesting that intrinsically disordered proteins (IDPs) may have a functional advantage over folded proteins. Upon interacting with a partner macromolecule, a subset of IDPs can fold and bind to form a well-defined three-dimensional conformation. For example, disordered BH3-only proteins bind promiscuously to a large number of homologous BCL-2 family proteins, where they fold to a helical structure in a groove on the BCL-2-like protein surface. As two protein chains are involved in the folding reaction, and the structure is only formed in the presence of the partner macromolecule, this raises the question of where the folding information is encoded. Here, we examine these coupled folding and binding reactions to determine which component determines the folding and binding pathway. Using phi value analysis to compare transition state interactions between the disordered BH3-only proteins PUMA and BID and the folded BCL-2-like proteins A1 and MCL-1, we found that, even though the BH3-only protein is disordered in isolation and requires a stabilizing partner to fold, its folding and binding pathway is encoded in the IDP itself; the reaction is not templated by the folded partner. We suggest that, by encoding both its transition state and level of residual structure, an IDP can evolve a specific kinetic profile, which could be a crucial functional advantage of disorder.	[Crabtree, Michael D.; Mendonca, Carolina A. T. F.; Bubb, Quenton R.; Clarke, Jane] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge	Clarke, J (corresponding author), Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.	jc162@cam.ac.uk		Crabtree, Michael/0000-0003-1466-4011; Bubb, Quenton/0000-0002-9518-0731; A T F de Mendonca, Carolina/0000-0002-7927-0120	Biotechnology and Biological Sciences Research Council studentship; Cambridge Trust; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Science Without Borders Cambridge scholarship; Marshall scholarship	Biotechnology and Biological Sciences Research Council studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Trust; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Science Without Borders Cambridge scholarship; Marshall scholarship	Supported by a Biotechnology and Biological Sciences Research Council studentship.; Supported by the Cambridge Trust and a Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Science Without Borders Cambridge scholarship.; Supported by a Marshall scholarship.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Bonetti D, 2017, BIOCHEMISTRY-US, V56, P3780, DOI 10.1021/acs.biochem.7b00350; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dahal L, 2017, BIOPHYS J, V113, P2713, DOI 10.1016/j.bpj.2017.10.016; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Haq SR, 2012, J AM CHEM SOC, V134, P599, DOI 10.1021/ja209341w; Harmon TS, 2016, PROTEIN ENG DES SEL, V29, P339, DOI 10.1093/protein/gzw034; Hill SA, 2014, J MOL BIOL, V426, P21, DOI 10.1016/j.jmb.2013.08.027; Kiefhaber T, 2012, CURR OPIN STRUC BIOL, V22, P21, DOI 10.1016/j.sbi.2011.09.010; Kvansakul M, 2015, APOPTOSIS, V20, P136, DOI 10.1007/s10495-014-1051-7; Kvansakul M, 2014, METHOD ENZYMOL, V544, P49, DOI 10.1016/B978-0-12-417158-9.00003-0; Lowe ED, 2002, BIOCHEMISTRY-US, V41, P15625, DOI 10.1021/bi0268910; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; Nickson AA, 2010, METHODS, V52, P38, DOI 10.1016/j.ymeth.2010.06.003; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; Rogers JM, 2014, J AM CHEM SOC, V136, P5197, DOI 10.1021/ja4125065; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Toto A, 2016, BIOCHEMISTRY-US, V55, P3957, DOI 10.1021/acs.biochem.6b00505; Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002	33	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9718	9723		10.1074/jbc.RA118.002791	http://dx.doi.org/10.1074/jbc.RA118.002791			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29716994	hybrid, Green Published			2022-12-26	WOS:000436102300016
J	He, HL; Wang, J; Yannie, PJ; Kakiyama, G; Korzun, WJ; Ghosh, S				He, Hongliang; Wang, Jing; Yannie, Paul J.; Kakiyama, Genta; Korzun, William J.; Ghosh, Shobha			Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol-binding protein; cholesterol metabolism; atherosclerosis; dyslipidemia; diet; anti-atherogenic effect; cardiovascular disease; hepatic VLDL secretion; intracellular cholesterol transport; sterol carrier protein	CHOLESTERYL ESTER HYDROLASE; LIPID TRANSFER PROTEINS; BILE-ACID METABOLISM; TRANSGENIC EXPRESSION; L-FABP; OVEREXPRESSION; GENE; LOCALIZATION; ACCUMULATION; HEPATOCYTES	Intracellular cholesterol transport proteins move cholesterol to different subcellular compartments and thereby regulate its final metabolic fate. In hepatocytes, for example, delivery of high-density lipoprotein (HDL)-associated cholesterol for bile acid synthesis or secretion into bile facilitates cholesterol elimination from the body (anti-atherogenic effect), whereas delivery for esterification and subsequent incorporation into apolipoprotein B-containing atherogenic lipoproteins (e.g. very-low-density lipoprotein (VLDL)) enhances cholesterol secretion into the systemic circulation (pro-atherogenic effect). Intracellular cholesterol transport proteins such as sterol carrier protein-2 (SCP2) should, therefore, play a role in regulating these pro- or anti-atherosclerotic processes. Here, we sought to evaluate the effects of SCP2 deficiency on the development of diet-induced atherosclerosis. We generated LDLR-/- mice deficient in SCP2/SCPx (LS) and examined the effects of this deficiency on Western diet-induced atherosclerosis. SCP2/SCPx deficiency attenuated atherosclerosis in LS mice by >80% and significantly reduced plasma cholesterol and triglyceride levels. Investigation of the likely underlying mechanisms revealed a significant reduction in intestinal cholesterol absorption (given as an oral gavage) in SCP2/SCPx-deficient mice. Consistently, siRNA-mediated knockdown of SCP2 in intestinal cells significantly reduced cholesterol uptake. Furthermore, hepatic triglyceride/VLDL secretion from the liver or hepatocytes isolated from SCP2/SCPx-deficient mice was significantly reduced. These results indicate an important regulatory role for SCP2 deficiency in attenuating diet-induced atherosclerosis by limiting intestinal cholesterol absorption and decreasing hepatic triglyceride/VLDL secretion. These findings suggest targeted inhibition of SCP2 as a potential therapeutic strategy to reduce Western diet-induced dyslipidemia and atherosclerosis.	[He, Hongliang; Wang, Jing; Ghosh, Shobha] Virginia Commonwealth Univ, Med Ctr, Dept Internal Med, Richmond, VA 23298 USA; [Korzun, William J.] Virginia Commonwealth Univ, Med Ctr, Dept Clin & Lab Sci, Richmond, VA 23298 USA; [Yannie, Paul J.; Kakiyama, Genta; Ghosh, Shobha] Hunter Homes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA	Virginia Commonwealth University; Virginia Commonwealth University	Ghosh, S (corresponding author), VCU, Med Ctr, Div Pulm & Crit Care, Dept Internal Med, MMRB 6050,1220 E Broad St, Richmond, VA 23298 USA.	shobha@vcu.edu	He, Hongliang/Y-9779-2019	He, Hongliang/0000-0002-6099-4356	National Institutes of Health [HL097346]; VCU School of Medicine bridge grant award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VCU School of Medicine bridge grant award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL097346 and a VCU School of Medicine bridge grant award (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atshaves BP, 2009, J LIPID RES, V50, P1429, DOI 10.1194/jlr.M900020-JLR200; Basso F, 2007, J LIPID RES, V48, P114, DOI 10.1194/jlr.M600353-JLR200; Bie JH, 2012, AM J PHYSIOL-ENDOC M, V302, pE1283, DOI 10.1152/ajpendo.00511.2011; Billheimer J T, 1990, Subcell Biochem, V16, P301; CHANDERBHAN RF, 1986, ENDOCR RES, V12, P351, DOI 10.3109/07435808609035445; Coenen KR, 2007, J NUTR BIOCHEM, V18, P727, DOI 10.1016/j.jnutbio.2006.12.010; Fuchs M, 2001, J BIOL CHEM, V276, P48058, DOI 10.1074/jbc.M106732200; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Gallegos AM, 2000, CHEM PHYS LIPIDS, V105, P9, DOI 10.1016/S0009-3084(99)00128-0; Ghosh S, 2003, J LIPID RES, V44, P1833, DOI 10.1194/jlr.M300162-JLR200; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; HYLEMON PB, 1985, J BIOL CHEM, V260, P1015; Kannenberg F, 1999, J BIOL CHEM, V274, P35455, DOI 10.1074/jbc.274.50.35455; KHARROUBI A, 1988, J LIPID RES, V29, P287; Kriska T, 2006, J BIOL CHEM, V281, P23643, DOI 10.1074/jbc.M600744200; Martin GG, 2015, ARCH BIOCHEM BIOPHYS, V588, P25, DOI 10.1016/j.abb.2015.10.018; Martin GG, 2014, AM J PHYSIOL-GASTR L, V307, pG1130, DOI 10.1152/ajpgi.00209.2014; OHBA T, 1994, GENOMICS, V24, P370, DOI 10.1006/geno.1994.1630; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; ROFF CF, 1992, J BIOL CHEM, V267, P15902; SCALLEN TJ, 1985, CHEM PHYS LIPIDS, V38, P239, DOI 10.1016/0009-3084(85)90019-2; Schroeder F, 1996, P SOC EXP BIOL MED, V213, P150, DOI 10.3181/00379727-213-44047; Schroeder F, 2007, BBA-MOL CELL BIOL L, V1771, P700, DOI 10.1016/j.bbalip.2007.04.005; Seedorf U, 2000, BBA-MOL CELL BIOL L, V1486, P45, DOI 10.1016/S1388-1981(00)00047-0; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Storey SM, 2012, AM J PHYSIOL-GASTR L, V302, pG824, DOI 10.1152/ajpgi.00195.2011; Wang J, 2016, J LIPID RES, V57, P1712, DOI 10.1194/jlr.M069682; WOUTERS FS, 1995, BBA-LIPID LIPID MET, V1259, P192, DOI 10.1016/0005-2760(95)00163-7; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485; Zhao B, 2007, AM J PHYSIOL-CELL PH, V292, pC405, DOI 10.1152/ajpcell.00306.2006; ZILVERSMIT DB, 1984, J LIPID RES, V25, P1563	31	6	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9223	9231		10.1074/jbc.RA118.002290	http://dx.doi.org/10.1074/jbc.RA118.002290			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29700117	hybrid, Green Published			2022-12-26	WOS:000435441400008
J	McAteer, SP; Sy, BM; Wong, JL; Tollervey, D; Gally, DL; Tree, JJ				McAteer, Sean P.; Sy, Brandon M.; Wong, Julia L.; Tollervey, David; Gally, David L.; Tree, Jai J.			Ribosome maturation by the endoribonuclease YbeY stabilizes a type 3 secretion system transcript required for virulence of enterohemorrhagic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHLY CONSERVED PROTEIN; HIGH-THROUGHPUT ANALYSIS; UV CROSS-LINKING; POSTTRANSCRIPTIONAL REGULATION; TRANSLATION INITIATION; PATHOGENICITY ISLAND; RNA REGULATION; BINDING SITES; EXPRESSION; IDENTIFICATION	Enterohemorrhagic Escherichia coli (EHEC) is a significant human pathogen that colonizes humans and its reservoir host, cattle. Colonization requires the expression of a type 3 secretion (T3S) system that injects a mixture of effector proteins into host cells to promote bacterial attachment and disease progression. The T3S system is tightly regulated by a complex network of transcriptional and post-transcriptional regulators. Using transposon mutagenesis, here we identified the ybeZYX-Int operon as being required for normal T3S levels. Deletion analyses localized the regulation to the endoribonuclease YbeY, previously linked to 16S rRNA maturation and small RNA (sRNA) function. Loss of ybeY in EHEC had pleiotropic effects on EHEC cells, including reduced motility and growth and cold sensitivity. Using UV cross-linking and RNA-Seq (CRAC) analysis, we identified YbeY-binding sites throughout the transcriptome and discovered specific binding of YbeY to the "neck" and "beak" regions of 16S rRNA but identified no significant association of YbeY with sRNA, suggesting that YbeY modulates T3S by depleting mature ribosomes. In E. coli, translation is strongly linked tomRNAstabilization, and subinhibitory concentrations of the translation-initiation inhibitor kasugamycin provoked rapid degradation of a polycistronic mRNA encoding needle filament and needle tip proteins of the T3S system. We conclude that T3S is particularly sensitive to depletion of initiating ribosomes, explaining the inhibition of T3S in the Delta ybeY strain. Accessory virulence transcripts may be preferentially degraded in cells with reduced translational capacity, potentially reflecting prioritization in protein production.	[McAteer, Sean P.; Gally, David L.] Univ Edinburgh, Roslin Inst, Div Infect & Immun, Edinburgh EH25 9RG, Midlothian, Scotland; [Sy, Brandon M.; Wong, Julia L.; Tree, Jai J.] Univ New South Wales Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2033, Australia; [Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of New South Wales Sydney; University of Edinburgh	Gally, DL (corresponding author), Univ Edinburgh, Roslin Inst, Div Infect & Immun, Edinburgh EH25 9RG, Midlothian, Scotland.; Tree, JJ (corresponding author), Univ New South Wales Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW 2033, Australia.	david.gally@roslin.ed.ac.uk; j.tree@unsw.edu.au	Tollervey, David/AAR-6662-2020	Tollervey, David/0000-0003-2894-2772; Tree, Jai/0000-0001-8233-0975; Gally, David/0000-0002-2566-0844	National Health and Medical Research Council [APP1067241, APP1139313]; Australian Government; Roslin Institute through Biotechnology and Biological Sciences Research Council [BB/J004227/1, BB/P013740/1]; Wellcome Trust [109916/Z/15/Z]; BBSRC [BBS/E/D/20231761, BBS/E/D/20002173] Funding Source: UKRI	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR); Roslin Institute through Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Health and Medical Research Council Project Grants APP1067241 and APP1139313 (to J.J.T. and J.L.W.), an Australian Government research training program scholarship (to B.M.S.), Roslin Institute strategic program research support through Biotechnology and Biological Sciences Research Council Grants BB/J004227/1 and BB/P013740/1 (to D.L.G. and S.P.M.), and Wellcome Trust Grant 109916/Z/15/Z (to D.T.). The authors declare that they have no conflicts of interest with the contents of this article.	Arnold TE, 1998, RNA, V4, P319; Bhatt S, 2009, INFECT IMMUN, V77, P3552, DOI 10.1128/IAI.00418-09; Bicknell AA, 2017, BIOCHEM SOC T, V45, P339, DOI 10.1042/BST20160243; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Davies BW, 2010, MOL MICROBIOL, V78, P506, DOI 10.1111/j.1365-2958.2010.07351.x; Davis TK, 2013, INFECT DIS CLIN N AM, V27, P577, DOI 10.1016/j.idc.2013.05.010; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Dreyfus M, 2009, PROG MOL BIOL TRANSL, V85, P423, DOI 10.1016/S0079-6603(08)00811-8; Fernandez-Brando RJ, 2016, ANTIMICROB AGENTS CH, V60, P459, DOI 10.1128/AAC.02085-15; Furniss RCD, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00336-17; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Gruber CC, 2015, INFECT IMMUN, V83, P1286, DOI 10.1128/IAI.02918-14; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; Jacob AI, 2013, MOL CELL, V49, P427, DOI 10.1016/j.molcel.2012.11.025; Joyce SA, 1998, J MOL BIOL, V282, P241, DOI 10.1006/jmbi.1998.2027; Kaberdin VR, 2006, FEMS MICROBIOL REV, V30, P967, DOI 10.1111/j.1574-6976.2006.00043.x; Katsowich N, 2017, SCIENCE, V355, P735, DOI 10.1126/science.aah4886; Kendall MM, 2011, J BACTERIOL, V193, P6843, DOI 10.1128/JB.06141-11; Lai YS, 2013, CELL MICROBIOL, V15, P1796, DOI 10.1111/cmi.12179; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Leskinen K, 2015, MICROBIOL-SGM, V161, P285, DOI 10.1099/mic.0.083097-0; Liu JW, 2015, PLANT PHYSIOL, V168, P205, DOI 10.1104/pp.114.255000; Merlin C, 2002, J BACTERIOL, V184, P4573, DOI 10.1128/JB.184.16.4573-4581.2002; Pandey SP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-121; Pandey SP, 2011, NUCLEIC ACIDS RES, V39, P4691, DOI 10.1093/nar/gkr060; Radhakrishnan A, 2016, J MOL BIOL, V428, P3558, DOI 10.1016/j.jmb.2016.05.025; Rahal EA, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00024; Rasouly A, 2010, J BACTERIOL, V192, P4592, DOI 10.1128/JB.00448-10; Rasouly A, 2009, J BACTERIOL, V191, P2649, DOI 10.1128/JB.01663-08; Rodgers W, 2013, ANTIMICROB AGENTS CH, V57, P1632, DOI 10.1128/AAC.02316-12; Roe AJ, 2004, MOL MICROBIOL, V54, P337, DOI 10.1111/j.1365-2958.2004.04277.x; Rutberg B., 2002, MICROBIOLOGY, V148, P1795; Santos AS, 2015, CELL MICROBIOL, V17, P318, DOI 10.1111/cmi.12412; Saramago M, 2017, NUCLEIC ACIDS RES, V45, P1371, DOI 10.1093/nar/gkw1234; Schluenzen F, 2006, NAT STRUCT MOL BIOL, V13, P871, DOI 10.1038/nsmb1145; Schuwirth BS, 2006, NAT STRUCT MOL BIOL, V13, P879, DOI 10.1038/nsmb1150; Shakhnovich EA, 2009, MOL MICROBIOL, V74, P347, DOI 10.1111/j.1365-2958.2009.06856.x; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Sharp JS, 2003, J BACTERIOL, V185, P5372, DOI 10.1128/JB.185.18.5372-5379.2003; Sulthana S, 2013, J BIOL CHEM, V288, P12574, DOI 10.1074/jbc.C113.459172; Sy B, 2018, METHODS MOL BIOL, V1737, P251, DOI 10.1007/978-1-4939-7634-8_15; TOLLERVEY D, 1987, EMBO J, V6, P469, DOI 10.1002/j.1460-2075.1987.tb04777.x; Tree JJ, 2014, MOL CELL, V55, P199, DOI 10.1016/j.molcel.2014.05.006; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; van Diemen PA, 2005, INFECT IMMUN, V73, P1735, DOI 10.1128/IAI.73.3.1735-1743.2005; Vercruysse M., 2016, ESCHERICHIA COLI MBI, V7; Vercruysse M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004175; WAGNER LA, 1994, J BACTERIOL, V176, P1683, DOI 10.1128/jb.176.6.1683-1688.1994; Waters SA, 2017, EMBO J, V36, P374, DOI 10.15252/embj.201694639; Webb S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r8; Xu X., 2012, ESCHERICHIA COLI PLO, V8; Zhan CY, 2005, ACTA CRYSTALLOGR F, V61, P959, DOI 10.1107/S1744309105031131	54	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9006	9016		10.1074/jbc.RA117.000300	http://dx.doi.org/10.1074/jbc.RA117.000300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29678883	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000434941900023
J	Klangnurak, W; Fukuyo, T; Rezanujjaman, MD; Seki, M; Sugano, S; Suzuki, Y; Tokumoto, T				Klangnurak, Wanlada; Fukuyo, Taketo; Rezanujjaman, M. D.; Seki, Masahide; Sugano, Sumio; Suzuki, Yutaka; Tokumoto, Toshinobu			Candidate gene identification of ovulation-inducing genes by RNA sequencing with an in vivo assay in zebrafish	PLOS ONE			English	Article							CATFISH HETEROPNEUSTES-FOSSILIS; PROSTAGLANDIN RECEPTOR EP4B; CATHEPSIN-B; OOCYTE MATURATION; ORYZIAS-LATIPES; EXPRESSION; MEDAKA; INVOLVEMENT; VASOTOCIN; STARMAKER	We previously reported the microarray-based selection of three ovulation-related genes in zebrafish. We used a different selection method in this study, RNA sequencing analysis. An additional eight up-regulated candidates were found as specifically up-regulated genes in ovulation-induced samples. Changes in gene expression were confirmed by qPCR analysis. Furthermore, up-regulation prior to ovulation during natural spawning was verified in samples from natural pairing. Gene knock-out zebrafish strains of one of the candidates, the starmaker gene (stm), were established by CRISPR genome editing techniques. Unexpectedly, homozygous mutants were fertile and could spawn eggs. However, a high percentage of unfertilized eggs and abnormal embryos were produced from these homozygous females. The results suggest that the stm gene is necessary for fertilization. In this study, we selected additional ovulation-inducing candidate genes, and a novel function of the stm gene was investigated.	[Klangnurak, Wanlada; Tokumoto, Toshinobu] Shizuoka Univ, Natl Univ Corp, Grad Sch Sci & Technol, Integrated Biosci Sect,Suruga Ku, Ohya 836, Shizuoka, Japan; [Fukuyo, Taketo; Tokumoto, Toshinobu] Shizuoka Univ, Natl Univ Corp, Dept Biol Sci, Fac Sci, Shizuoka, Japan; [Rezanujjaman, M. D.; Tokumoto, Toshinobu] Shizuoka Univ, Natl Univ Corp, Grad Sch Sci & Technol, Biol Sci Course,Suruga Ku, Oya 836, Shizuoka, Japan; [Seki, Masahide; Sugano, Sumio; Suzuki, Yutaka] Univ Tokyo, Dept Computat Biol & Med Sci, Grad Sch Frontier Sci, Chiba, Japan	Shizuoka University; Shizuoka University; Shizuoka University; University of Tokyo	Tokumoto, T (corresponding author), Shizuoka Univ, Natl Univ Corp, Grad Sch Sci & Technol, Integrated Biosci Sect,Suruga Ku, Ohya 836, Shizuoka, Japan.; Tokumoto, T (corresponding author), Shizuoka Univ, Natl Univ Corp, Dept Biol Sci, Fac Sci, Shizuoka, Japan.; Tokumoto, T (corresponding author), Shizuoka Univ, Natl Univ Corp, Grad Sch Sci & Technol, Biol Sci Course,Suruga Ku, Oya 836, Shizuoka, Japan.	tokumato.toshinobu@shizuoka.ac.jp	Tokumoto, Toshinobu/R-7653-2019	Tokumoto, Toshinobu/0000-0001-9086-3608	Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS KAKENHI [25440154, 16K07419]; MEXT KAKENHI [221S0002]; Grants-in-Aid for Scientific Research [16K07419] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan and JSPS KAKENHI Grant Number 25440154 and 16K07419 (to TT). This work was also supported by MEXT KAKENHI (No. 221S0002). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Bajoghli B, 2009, DEV DYNAM, V238, P2860, DOI 10.1002/dvdy.22093; Bian B, 2016, MOL CARCINOGEN, V55, P671, DOI 10.1002/mc.22312; Bobe J, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-39; Bobe J, 2009, COMP BIOCHEM PHYS A, V153, P63, DOI 10.1016/j.cbpa.2008.10.021; Brunet FG, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0281-9; Burgerhout E, 2016, GEN COMP ENDOCR, V225, P185, DOI 10.1016/j.ygcen.2015.08.006; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Crespo D, 2015, SCI REP-UK, V5, DOI 10.1038/srep14210; Crespo D, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-34; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Fu A, 2008, CELL CYCLE, V7, P3823, DOI 10.4161/cc.7.24.7241; Fujimori C, 2012, MOL CELL ENDOCRINOL, V362, P76, DOI 10.1016/j.mce.2012.05.013; Fujimori C, 2011, MOL CELL ENDOCRINOL, V332, P67, DOI 10.1016/j.mce.2010.09.015; Goetz FW, 1997, FISH PHYSIOL BIOCHEM, V17, P33, DOI 10.1023/A:1007765902327; Guan R, 2013, DEV DYNAM, V242, P1395, DOI 10.1002/dvdy.24039; Gunnarsson L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-149; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joy KP, 2015, GEN COMP ENDOCR, V221, P54, DOI 10.1016/j.ygcen.2015.02.013; Klangnurak W, 2017, ZOOL LETT, V3, DOI 10.1186/s40851-017-0065-8; Knight OM, 2015, GEN COMP ENDOCR, V213, P50, DOI 10.1016/j.ygcen.2014.12.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu DT, 2017, GEN COMP ENDOCR, V247, P74, DOI 10.1016/j.ygcen.2017.01.019; Martyniuk CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059093; Mirkovic B, 2015, ONCOTARGET, V6, P19027, DOI 10.18632/oncotarget.3699; Murdoch WJ, 2002, REPRODUCTION, V123, P743, DOI 10.1530/rep.0.1230743; Ogiwara K, 2005, P NATL ACAD SCI USA, V102, P8442, DOI 10.1073/pnas.0502423102; Prathibha Y, 2016, J ENDOCRINOL, V231, P181, DOI 10.1530/JOE-16-0103; Qu C, 2017, ONCOTARGET, V8, P3144, DOI 10.18632/oncotarget.13673; Rawat A, 2015, FISH PHYSIOL BIOCHEM, V41, P509, DOI 10.1007/s10695-015-0026-0; Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruan J, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0503-9; Singh V, 2011, GEN COMP ENDOCR, V174, P15, DOI 10.1016/j.ygcen.2011.07.009; Sollner C, 2004, DEV GENES EVOL, V214, P582, DOI 10.1007/s00427-004-0440-2; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Tang HP, 2016, SCI REP-UK, V6, DOI 10.1038/srep28545; Tokumoto T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025206; Wendl T, 2002, DEVELOPMENT, V129, P3751; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zhu Y, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00037	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196544	10.1371/journal.pone.0196544	http://dx.doi.org/10.1371/journal.pone.0196544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715317	Green Submitted, gold, Green Published			2022-12-26	WOS:000431281100032
J	Anandavadivelan, P; Wikman, A; Johar, A; Lagergren, P				Anandavadivelan, Poorna; Wikman, Anna; Johar, Asif; Lagergren, Pernilla			Profiles of patient and tumour characteristics in relation to health-related quality of life after oesophageal cancer surgery	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; EORTC QUESTIONNAIRE MODULE; LONG-TERM SURVIVORS; PROGNOSTIC VALUE; ADENOCARCINOMA; COMPLICATIONS; QLQ-C30; SCORES; RECURRENCE; ONCOLOGY	Strong deterioration in health-related quality of life (HRQOL) is a major concern in a sub-group of long-term oesophageal cancer survivors. This study aimed to identify potential clustering of patients and tumour variables that predicts such deterioration. Patient and tumour variables were collected in a prospective cohort of patients who underwent surgery for oesophageal cancer in Sweden 2001-2005. Latent cluster analysis identified statistically significant clustering of these variables. Multivariable logistic regression adjusted for age, BMI, tumour stage and marital status was used to determine odds ratios (ORs) with 95% confidence intervals (Cls) between patient profiles and HRQOL at 3 and 5 years from surgery. Among 155 included patients at 3 years, three patient profiles were identified: 1) 'reference profile' (males, younger age, employed, upper secondary education, co-habitating, urban dwellers, adenocarcinoma and advanced tumour stage) (n = 47;30%), 2) 'adenocarcinoma profile' (middle age, unemployed/retired, males, low education, co-habitating, adenocarcinoma, advanced tumour stage, tumour in lower oesophagus/cardia, and co-morbidities (n = 79;51%), and 3) 'squamous-cell carcinoma profile' (unemployed/retired, middle-age, males, low BMI, urban dwellers, squamous-cell carcinoma, tumour in upper/middle oesophagus (n = 29;19%). These profiles did not differ regarding most HRQOL measures. Exceptions were the squamous-cell carcinoma profile, reporting more constipation (OR = 5.69; 95%Cl: 1.34-24.28) and trouble swallowing saliva (OR = 4.87; 95%Cl: 1.04-22.78) and the adenocarcinoma profile reporting more dyspnoea (OR = 2.60; 95%Cl: 1.00-6.77) and constipation (OR = 3.31; 95%Cl: 1.00-10.97) compared to the reference profile. Three distinct patient profiles were identified but these could not explain the substantial deterioration in HRQOL observed in the sub-sample of survivors.	[Anandavadivelan, Poorna; Johar, Asif; Lagergren, Pernilla] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Surg Care Sci, Stockholm, Sweden; [Wikman, Anna] Uppsala Univ, Dept Womens & Childrens Hlth, Reprod Hlth, Uppsala, Sweden	Karolinska Institutet; Karolinska University Hospital; Uppsala University	Anandavadivelan, P (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Surg Care Sci, Stockholm, Sweden.	poorna.anandavadivelan@ki.se		Anandavadivelan, Poorna/0000-0002-3471-1578	Swedish Cancer Society [CAN 2015/678]; Cancer Research Foundations of Radiumhemmet [141223]; Swedish Society of Medicine [SLS-594471]	Swedish Cancer Society(Swedish Cancer Society); Cancer Research Foundations of Radiumhemmet; Swedish Society of Medicine	This work was supported by the Swedish Cancer Society CAN 2015/678; The Cancer Research Foundations of Radiumhemmet: 141223 and the Swedish Society of Medicine SLS-594471. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Abate E, 2010, J AM COLL SURGEONS, V210, P428, DOI 10.1016/j.jamcollsurg.2010.01.006; Allison PJ, 2000, QUAL LIFE RES, V9, P951, DOI 10.1023/A:1008931906253; Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Blazeby JM, 2003, EUR J CANCER, V39, P1384, DOI 10.1016/S0959-8049(03)00270-3; Blazeby JM, 1996, EUR J CANCER, V32A, P1912, DOI 10.1016/0959-8049(96)00199-2; Blazeby JM, 2001, GUT, V49, P227, DOI 10.1136/gut.49.2.227; Derogar M, 2012, J CLIN ONCOL, V30, P1615, DOI 10.1200/JCO.2011.40.3568; Derogar M, 2012, J CLIN ONCOL, V30, P413, DOI 10.1200/JCO.2011.38.9791; Djarv T, 2010, J CLIN ONCOL, V28, P1666, DOI 10.1200/JCO.2009.23.5143; Djarv T, 2009, J CLIN ONCOL, V27, P1963, DOI 10.1200/JCO.2008.20.5864; Djarv T, 2008, BRIT J SURG, V95, P1121, DOI 10.1002/bjs.6293; Djarv T, 2014, BRIT J SURG, V101, P495, DOI 10.1002/bjs.9417; Djarv T, 2012, EXPERT REV GASTROENT, V6, P115, DOI [10.1586/EGH.11.91, 10.1586/egh.11.91]; Djarv T, 2011, EUR J CANCER, V47, P530, DOI 10.1016/j.ejca.2010.10.014; Dresner SM, 2000, BRIT J SURG, V87, P1426, DOI 10.1046/j.1365-2168.2000.01541.x; Fayers PM, 2001, EUR J CANCER, V37, P1331, DOI 10.1016/S0959-8049(01)00127-7; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gockel I, 2010, J SURG ONCOL, V102, P516, DOI 10.1002/jso.21434; Hellstadius Y, 2015, PSYCHO-ONCOLOGY, V24, P47, DOI 10.1002/pon.3583; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Lagergren P, 2007, CANCER, V110, P686, DOI 10.1002/cncr.22833; Langenhoff BS, 2001, BRIT J SURG, V88, P643, DOI 10.1046/j.1365-2168.2001.01755.x; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Lanza ST, 2013, STRUCT EQU MODELING, V20, P361, DOI 10.1080/10705511.2013.797816; Martin L, 2007, BRIT J SURG, V94, P1496, DOI 10.1002/bjs.5881; Martin L, 2009, BRIT J SURG, V96, P1308, DOI 10.1002/bjs.6723; Martin L, 2015, ANN SURG ONCOL, V22, P610, DOI 10.1245/s10434-014-3973-2; McKernan M, 2008, BRIT J CANCER, V98, P888, DOI 10.1038/sj.bjc.6604248; Official Statistics of Sweden, 1975, CENS POP HOUS 197 13; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Rouvelas I, 2005, LANCET ONCOL, V6, P864, DOI 10.1016/S1470-2045(05)70347-8; Siewert JR, 1998, BRIT J SURG, V85, P1457; Sobin CWLH, 2002, TNM CLASSIFICATION M; Tomaszewski KA, 2013, WSPOLCZESNA ONKOL, V17, P311, DOI 10.5114/wo.2013.35280; Viklund P, 2006, ANN SURG, V243, P204, DOI 10.1097/01.sla.0000197698.17794.eb; Viklund P, 2006, EUR J CANCER, V42, P1407, DOI 10.1016/j.ejca.2006.02.005; Yang CC, 2006, COMPUT STAT DATA AN, V50, P1090, DOI 10.1016/j.csda.2004.11.004; Zhu ZJ, 2011, ANN THORAC SURG, V91, P1502, DOI 10.1016/j.athoracsur.2011.01.007	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196187	10.1371/journal.pone.0196187	http://dx.doi.org/10.1371/journal.pone.0196187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708994	Green Submitted, Green Published, gold			2022-12-26	WOS:000431130100019
J	Joos, B; Markham, MR; Lewis, JE; Morris, CE				Joos, Bela; Markham, Michael R.; Lewis, John E.; Morris, Catherine E.			A model for studying the energetics of sustained high frequency firing	PLOS ONE			English	Article							ELECTRIC ORGAN DISCHARGES; SKELETAL-MUSCLE FIBERS; ELECTROPHORUS-ELECTRICUS; POTASSIUM CHANNELS; JAMMING SIGNALS; SODIUM-CHANNELS; BOLD SIGNAL; ELECTROLOCATION; FISH; EIGENMANNIA	Regulating membrane potential and synaptic function contributes significantly to the energetic costs of brain signaling, but the relative costs of action potentials (APs) and synaptic transmission during high-frequency firing are unknown. The continuous high-frequency (200-600Hz) electric organ discharge (EOD) of Eigenmannia, a weakly electric fish, underlies its electrosensing and communication. EODs reflect APs fired by the muscle-derived electrocytes of the electric organ (EO). Cholinergic synapses at the excitable posterior membranes of the elongated electrocytes control AP frequency. Based on whole-fish O-2 consumption, ATP demand per EOD-linked AP increases exponentially with AP frequency. Continual EOD-AP generation implies first, that ion homeostatic processes reliably counteract any dissipation of posterior membrane E-Na and E-K and second that high frequency synaptic activation is reliably supported. Both of these processes require energy. To facilitate an exploration of the expected energy demands of each, we modify a previous excitability model and include synaptic currents able to drive APs at frequencies as high as 600 Hz. Synaptic stimuli are modeled as pulsatile cation conductance changes, with or without a small (sustained) background conductance. Over the full species range of EOD frequencies (200-600 Hz) we calculate frequency-dependent "Na+-entry budgets" for an electrocyte AP as a surrogate for required 3Na(+)/2K(+)-ATPase activity. We find that the cost per AP of maintaining constant-amplitude APs increases nonlinearly with frequency, whereas the cost per AP for synaptic input current is essentially constant. This predicts that Na+ channel density should correlate positively with EOD frequency, whereas AChR density should be the same across fish. Importantly, calculated costs (inferred from Na+-entry through Nav and ACh channels) for electrocyte APs as frequencies rise are much less than expected from published whole-fish EOD-linked O-2 consumption. For APs at increasingly high frequencies, we suggest that EOD-related costs external to electrocytes (including packaging of synaptic transmitter) substantially exceed the direct cost of electrocyte ion homeostasis.	[Joos, Bela] Univ Ottawa, Dept Phys, Ottawa, ON, Canada; [Joos, Bela; Lewis, John E.; Morris, Catherine E.] Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada; [Markham, Michael R.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Lewis, John E.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Morris, Catherine E.] Ottawa Hosp, Res Inst, Neurosci, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Oklahoma System; University of Oklahoma - Norman; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Joos, B (corresponding author), Univ Ottawa, Dept Phys, Ottawa, ON, Canada.; Joos, B (corresponding author), Univ Ottawa, Ctr Neural Dynam, Ottawa, ON, Canada.	bjoos@uottawa.ca		Markham, Michael/0000-0002-2900-0077; Joos, Bela/0000-0001-8576-5579; Morris, Catherine/0000-0002-7401-6545; Lewis, John/0000-0003-0830-7368	Natural Sciences and Engineering Research Council of Canada; National Science Foundation [IOS1257580, IOS1350753]; Ottawa Hospital Research Institute; Division Of Integrative Organismal Systems [1257580, 1350753] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation(National Science Foundation (NSF)); Ottawa Hospital Research Institute; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	BJ and JEL thank the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) for funding. MRM acknowledges support from the National Science Foundation (https://www.nsf.gov/) (grants IOS1257580 and IOS1350753). CEM acknowledges support from the Ottawa Hospital Research Institute (www.ohri.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Assad C, 1998, J COMP PHYSIOL A, V183, P419, DOI 10.1007/s003590050268; Assad C, 1999, J EXP BIOL, V202, P1185; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Ban Y, 2015, J NEUROPHYSIOL, V114, P520, DOI 10.1152/jn.00475.2014; BASTIAN J, 1987, J COMP PHYSIOL A, V161, P825, DOI 10.1007/BF00610224; BASTIAN J, 1987, J COMP PHYSIOL A, V161, P811, DOI 10.1007/BF00610223; BENNETT MV, 1961, ANN NY ACAD SCI, V94, P458, DOI 10.1111/j.1749-6632.1961.tb35555.x; Bennett MVL., 1971, FISH PHYSIOL, P347, DOI DOI 10.1016/S1546-5098(08)60051-5; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; CANNON SC, 1993, BIOPHYS J, V65, P270, DOI 10.1016/S0006-3495(93)81045-2; Catania K, 2014, SCIENCE, V346, P1231, DOI 10.1126/science.1260807; DiFranco M, 2015, J PHYSIOL-LONDON, V593, P1213, DOI 10.1113/jphysiol.2014.283648; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; FERRARI MB, 1993, J COMP PHYSIOL A, V173, P281, DOI 10.1007/BF00212692; FERRARI MB, 1995, J NEUROSCI, V15, P4023; Fonseca-Azevedo K, 2012, P NATL ACAD SCI USA, V109, P18571, DOI 10.1073/pnas.1206390109; Gallant JR, 2014, SCIENCE, V344, P1522, DOI 10.1126/science.1254432; GIROD R, 1993, J PHYSIOL-LONDON, V471, P129, DOI 10.1113/jphysiol.1993.sp019894; Gotter AL, 1998, COMP BIOCHEM PHYS A, V119, P225, DOI 10.1016/S1095-6433(97)00414-5; Graydon CW, 2014, J NEUROSCI, V34, P8358, DOI 10.1523/JNEUROSCI.4493-13.2014; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; HEILIGENBERG W, 1973, J COMP PHYSIOL, V87, P137, DOI 10.1007/BF01352158; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35; Izhikevich EM, 2007, DYNAMICAL SYSTEMS NE, Vxvi; Kirschbaum F, 2008, J PHYSIOLOGY-PARIS, V102, P347, DOI 10.1016/j.jphysparis.2008.10.008; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; LESTER HA, 1978, J GEN PHYSIOL, V72, P847, DOI 10.1085/jgp.72.6.847; Lewis JE, 2014, J NEUROSCI, V34, P197, DOI 10.1523/JNEUROSCI.3180-13.2014; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MacIver MA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000769; Markham MR, 2016, INTEGR COMP BIOL, V56, P889, DOI 10.1093/icb/icw104; Markham MR, 2013, J EXP BIOL, V216, P2451, DOI 10.1242/jeb.082628; Markham MR, 2013, J NEUROPHYSIOL, V109, P1713, DOI 10.1152/jn.00875.2012; McAnelly ML, 2000, J NEUROSCI, V20, P3408, DOI 10.1523/JNEUROSCI.20-09-03408.2000; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Murta T, 2015, HUM BRAIN MAPP, V36, P391, DOI 10.1002/hbm.22623; Niven JE, 2016, CURR OPIN NEUROBIOL, V41, P129, DOI 10.1016/j.conb.2016.09.004; Olfert IM, 2016, AM J PHYSIOL-HEART C, V310, pH326, DOI 10.1152/ajpheart.00635.2015; PAPPONE PA, 1980, J PHYSIOL-LONDON, V306, P377, DOI 10.1113/jphysiol.1980.sp013403; Reardon EE, 2011, J EXP BIOL, V214, P4141, DOI 10.1242/jeb.059444; Salazar VL, 2013, J EXP BIOL, V216, P2459, DOI 10.1242/jeb.082735; SCHEICH H, 1977, J COMP PHYSIOL, V113, P181, DOI 10.1007/BF00611988; SCHWARTZ IR, 1975, J NEUROCYTOL, V4, P87, DOI 10.1007/BF01099098; Schwassmann HO, 2014, BRAIN BEHAV EVOLUT, V84, P288, DOI 10.1159/000367884; SHENKEL S, 1991, J GEN PHYSIOL, V97, P1013, DOI 10.1085/jgp.97.5.1013; Shifman AR, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0633; Sterratt D., 2011, PRINCIPLES COMPUTATI, Vxi; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Zhang TY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141764	52	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196508	10.1371/journal.pone.0196508	http://dx.doi.org/10.1371/journal.pone.0196508			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708986	Green Published, gold, Green Submitted			2022-12-26	WOS:000431130100037
J	Okuda, K; Takao, K; Watanabe, A; Miyakawa, T; Mizuguchi, M; Tanaka, T				Okuda, Kosuke; Takao, Keizo; Watanabe, Aya; Miyakawa, Tsuyoshi; Mizuguchi, Masashi; Tanaka, Teruyuki			Comprehensive behavioral analysis of the Cdkl5 knockout mice revealed significant enhancement in anxiety- and fear-related behaviors and impairment in both acquisition and long-term retention of spatial reference memory	PLOS ONE			English	Article							MENTAL-RETARDATION; INFANTILE SPASMS; NMDA RECEPTORS; NEURODEVELOPMENTAL DISORDER; CONDITIONED FEAR; RETT-SYNDROME; MUTANT MICE; MOUSE MODEL; HIPPOCAMPAL; POTENTIATION	Mutations in the Cyclin-dependent kinase-like 5 (CDKL5) gene cause severe neurodevelopmental disorders. Recently we have generated Cdkl5 KO mice by targeting exon 2 on the C57BL/6N background, and demonstrated postsynaptic overaccumulation of GluN2B-containing N-methyl-D-aspartate (NMDA) receptors in the hippocampus. In the current study, we subjected the Cdkl5 KO mice to a battery of comprehensive behavioral tests, aiming to reveal the effects of loss of CDKL5 in a whole perspective of motor, emotional, social, and cognition/memory functions, and to identify its undetermined roles. The neurological screen, rotarod, hot plate, prepulse inhibition, light/dark transition, open field, elevated plus maze, Porsolt forced swim, tail suspension, one-chamber and three-chamber social interaction, 24-h home cage monitoring, contextual and cued fear conditioning, Barnes maze, and T maze tests were applied on adult Cdk15 -/Y and +/Y mice. Cdk15 -/Y mice showed a mild alteration in the gait. Analyses of emotional behaviors revealed significantly enhanced anxiety-like behaviors of Cdk15 -/Y mice. Depressive-like behaviors and social interaction of Cdk15 -/Y mice were uniquely altered. The contextual and cued fear conditioning of Cdk15 -/Y mice were comparable to control mice; however, Cdk15 -/Y mice showed a significantly increased freezing time and a significantly decreased distance traveled during the pretone period in the altered context. Both acquisition and long-term retention of spatial reference memory were significantly impaired. The morphometric analysis of hippocampal CA1 pyramidal neurons revealed impaired dendritic arborization and immature spine development in Cdk15 -/Y mice. These results indicate that CDKL5 plays significant roles in regulating emotional behaviors especially on anxiety- and fear-related responses, and in both acquisition and long-term retention of spatial reference memory, which suggests that focus and special attention should be paid to the specific mechanisms of these deficits in the CDKL5 deficiency disorder.	[Okuda, Kosuke; Watanabe, Aya; Mizuguchi, Masashi; Tanaka, Teruyuki] Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Bunkyo Ku, Tokyo, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Patterns, Okazaki, Aichi, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Syst Med Sci, Toyoake, Aichi, Japan; [Takao, Keizo] Toyama Univ, Div Anim Resources & Dev, Life Sci Res Ctr, Toyama, Toyama, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fujita Health University; University of Toyama	Tanaka, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Bunkyo Ku, Tokyo, Japan.	tetanaka@m.u-tokyo.ac.jp	Takao, Keizo/B-9527-2008	Takao, Keizo/0000-0002-4734-3583; Tanaka, Teruyuki/0000-0003-2000-5354	Japan Society for the Promotion of Science [12J04298]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Comprehensive Research on Disability Health and Welfare (Neurological and Muscle diseases) Grant of the Ministry of Health, Labor and Welfare of Japan [24-007]; Japan Epilepsy Research Foundation; Mother and Child Health Foundation; Japan Rett Syndrome Support Organization;  [21659252];  [23500381];  [15K09614]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Comprehensive Research on Disability Health and Welfare (Neurological and Muscle diseases) Grant of the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Epilepsy Research Foundation; Mother and Child Health Foundation(Mother and Child Health Foundation); Japan Rett Syndrome Support Organization; ; ; 	This work was supported by Grants-in-Aid for Scientific Research 21659252, 23500381, 15K09614 (TT, MM) and Research Fellowship for Young Scientists 12J04298 (KO) from Japan Society for the Promotion of Science (http//www.jsps.go.jp/english/), Grants-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) (TT, KO, KT, TM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http.//www.mext.go.jp/en/), Comprehensive Research on Disability Health and Welfare (Neurological and Muscle diseases) Grant 24-007 of the Ministry of Health, Labor and Welfare of Japan (http.//www.mhlw.go.jp/english/) (TT), research grants from The Japan Epilepsy Research Foundation (http//www.epi-fj.jp) (TT), The Mother and Child Health Foundation (http://www.glico.co.jp/boshi/) (TT), and Japan Rett Syndrome Support Organization (http//:www.npo-rett.jp) (TT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091613; Bahi-Buisson N, 2011, MOL SYNDROMOL, V2, P137, DOI 10.1159/000331333; Bailey KR, 2009, FRONT NEUROSCI, P77; Barbiero I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05875-z; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Blanchard DC, 2011, NEUROSCI BIOBEHAV R, V35, P991, DOI 10.1016/j.neubiorev.2010.10.016; Bobsin K, 2016, J NEUROCHEM, V136, P752, DOI 10.1111/jnc.13428; Bothe GWM, 2004, GENES BRAIN BEHAV, V3, P149, DOI 10.1111/j.1601-183x.2004.00064.x; Carouge D, 2010, NEUROBIOL DIS, V38, P414, DOI 10.1016/j.nbd.2010.02.014; Chadman KK, 2009, AM J MED GENET B, V150B, P1, DOI 10.1002/ajmg.b.30777; Chen QA, 2010, J NEUROSCI, V30, P12777, DOI 10.1523/JNEUROSCI.1102-10.2010; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Della Sala G, 2016, BIOL PSYCHIAT, V80, P302, DOI 10.1016/j.biopsych.2015.08.028; Dunsmoor JE, 2015, BIOL PSYCHIAT, V78, P336, DOI 10.1016/j.biopsych.2015.04.010; Dymond S, 2015, BEHAV THER, V46, P561, DOI 10.1016/j.beth.2014.10.001; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Fuchs C, 2015, NEUROBIOL DIS, V82, P298, DOI 10.1016/j.nbd.2015.06.018; Fuchs C, 2014, NEUROBIOL DIS, V70, P53, DOI 10.1016/j.nbd.2014.06.006; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Jhang CL, 2017, HUM MOL GENET, V26, P3922, DOI 10.1093/hmg/ddx279; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kameshita I, 2008, BIOCHEM BIOPH RES CO, V377, P1162, DOI 10.1016/j.bbrc.2008.10.113; Kilstrup-Nielsen C, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/728267; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Komada Munekazu, 2008, J Vis Exp, DOI 10.3791/1088; KRIECKHA.EE, 1965, J COMP PHYSIOL PSYCH, V60, P36, DOI 10.1037/h0022302; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00029; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Mongeau R, 2003, J NEUROSCI, V23, P3855; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nawaz MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148634; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Ogonuki N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004943; Okuda K, 2017, NEUROBIOL DIS, V106, P158, DOI 10.1016/j.nbd.2017.07.002; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4; Pizzo R, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00261; Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Sekiguchi M, 2013, ARCH BIOCHEM BIOPHYS, V535, P257, DOI 10.1016/j.abb.2013.04.012; Shoji H, 2012, JOVE-J VIS EXP, DOI 10.3791/3300; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Sivilia S, 2016, GENES BRAIN BEHAV, V15, P491, DOI 10.1111/gbb.12292; Stork O, 2003, GENES BRAIN BEHAV, V2, P65, DOI 10.1034/j.1601-183X.2003.00008.x; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; Takao K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009460; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Takao Keizo, 2006, J Vis Exp, P104, DOI 10.3791/104; Tanda K, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-19; Tang S, 2017, J NEUROSCI, V37, P7420, DOI 10.1523/JNEUROSCI.0539-17.2017; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Trazzi S, 2016, HUM MOL GENET, V25, P3887, DOI 10.1093/hmg/ddw231; Uys Joachim D K, 2003, Curr Psychiatry Rep, V5, P274; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; Wang ITJ, 2012, P NATL ACAD SCI USA, V109, P21516, DOI 10.1073/pnas.1216988110; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Weaving LS, 2004, AM J HUM GENET, V75, P1079, DOI 10.1086/426462; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yao I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017317; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Zhu YC, 2013, P NATL ACAD SCI USA, V110, P9118, DOI 10.1073/pnas.1300003110	74	36	38	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196587	10.1371/journal.pone.0196587	http://dx.doi.org/10.1371/journal.pone.0196587			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702698	Green Submitted, Green Published, gold			2022-12-26	WOS:000431013300041
J	Barry, RL; Byun, NE; Williams, JM; Siuta, MA; Tantawy, MN; Speed, NK; Saunders, C; Galli, A; Niswender, KD; Avison, MJ				Barry, Robert L.; Byun, Nellie E.; Williams, Jason M.; Siuta, Michael A.; Tantawy, Mohammed N.; Speed, Nicole K.; Saunders, Christine; Galli, Aurelio; Niswender, Kevin D.; Avison, Malcolm J.			Brief exposure to obesogenic diet disrupts brain dopamine networks	PLOS ONE			English	Article							D2 RECEPTOR; FUNCTIONAL CONNECTIVITY; DEPENDENT MECHANISM; RAT-BRAIN; TRANSPORTER FUNCTION; COCAINE ABUSERS; INDUCED OBESITY; LEPTIN; INSULIN; MICE	Objective We have previously demonstrated that insulin signaling, through the downstream signaling kinase Akt, is a potent modulator of dopamine transporter (DAT) activity, which fine-tunes dopamine (DA) signaling at the synapse. This suggests a mechanism by which impaired neuronal insulin receptor signaling, a hallmark of diet-induced obesity, may contribute to impaired DA transmission. We tested whether a short-term (two-week) obesogenic high-fat (HF) diet could reduce striatal Akt activity, a marker of central insulin, receptor signaling and blunt striatal and dopaminergic network responsiveness to amphetamine (AMPH). Methods We examined the effects of a two-week HF diet on striatal DAT activity in rats, using AMPH as a probe in a functional magnetic resonance imaging (fMRI) assay, and mapped the disruption in AMPH-evoked functional connectivity between key dopaminergic targets and their projection areas using correlation and permutation analyses. We used phosphorylation of the Akt substrate GSK3 alpha in striatal extracts as a measure of insulin receptor signaling. Finally, we confirmed the impact of HF diet on striatal DA D2 receptor (D2R) availability using [F-18] fallypride positron emission tomography (PET). Results We found that rats fed a HF diet for only two weeks have reductions in striatal Akt activity, a marker of decreased striatal insulin receptor signaling and blunted striatal responsiveness to AMPH. HF feeding also reduced interactions between elements of the mesolimbic (nucleus accumbens-anterior cingulate) and sensorimotor circuits (caudate/putamen-thalamus-sensorimotor cortex) implicated in hedonic feeding. D2R availability was reduced in HF-fed animals. Conclusion These studies support the hypothesis that central insulin signaling and dopaminergic neuro-transmission are already altered after short-term HF feeding. Because AMPH induces DA efflux and brain activation, in large part via DAT, these findings suggest that blunted central nervous system insulin receptor signaling through a HF diet can impair DA homeostasis, thereby disrupting cognitive and reward circuitry involved in the regulation of hedonic feeding.	[Barry, Robert L.; Byun, Nellie E.; Williams, Jason M.; Siuta, Michael A.; Tantawy, Mohammed N.; Avison, Malcolm J.] Vanderbilt Univ, Inst Imaging Sci, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Byun, Nellie E.; Williams, Jason M.; Tantawy, Mohammed N.; Avison, Malcolm J.] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Byun, Nellie E.; Saunders, Christine; Galli, Aurelio; Avison, Malcolm J.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37235 USA; [Siuta, Michael A.; Niswender, Kevin D.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Speed, Nicole K.; Galli, Aurelio; Niswender, Kevin D.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN USA; [Galli, Aurelio; Niswender, Kevin D.; Avison, Malcolm J.] Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Nashville, TN USA; [Galli, Aurelio] Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN USA; [Niswender, Kevin D.] Tennessee Valley Healthcare Syst, Nashville, TN USA; [Barry, Robert L.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Harvard University; Massachusetts General Hospital	Byun, NE (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.; Byun, NE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA.; Byun, NE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37235 USA.	nellie.e.byun@vanderbilt.edu			National Institutes of Health [DK085712, DK020593, DK092986, DA35263]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Institutes of Health grants DK085712 (to KDN and AG), DK020593 (to KDN), DK092986 (to the Vanderbilt Diabetes Research and Training Center) (www.niddk.nih.gov) and DA35263 (to AG) (www.drugabuse.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WK, 2015, EUR J NEUROSCI, V42, P3095, DOI 10.1111/ejn.13117; Bifone A, 2010, MAGN RESON IMAGING, V28, P1200, DOI 10.1016/j.mri.2010.07.001; Billesa SK, 2012, MOL METAB, V1, P86, DOI 10.1016/j.molmet.2012.07.003; Blum K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00919; Byun NE, 2014, NEUROPSYCHOPHARMACOL, V39, P1578, DOI 10.1038/npp.2014.2; Carvalheira JBC, 2005, OBES RES, V13, P48, DOI 10.1038/oby.2005.7; Chen YCI, 2005, PSYCHOPHARMACOLOGY, V180, P705, DOI 10.1007/s00213-004-2034-0; Chen YCI, 2001, J MAGN RESON IMAGING, V14, P517, DOI 10.1002/jmri.1215; Cone JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058251; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dang LC, 2012, J NEUROSCI, V32, P9582, DOI 10.1523/JNEUROSCI.0909-12.2012; Davis LM, 2009, NEUROENDOCRINOLOGY, V89, P152, DOI 10.1159/000170586; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Jones KT, 2017, J NEUROCHEM, V140, P728, DOI 10.1111/jnc.13930; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2; Mandeville JB, 2004, MAGNET RESON MED, V52, P1272, DOI 10.1002/mrm.20278; Narayanaswami V, 2013, INT J OBESITY, V37, P1095, DOI 10.1038/ijo.2012.178; Owens WA, 2012, J NEUROSCI, V32, P2637, DOI 10.1523/JNEUROSCI.3759-11.2012; Paxinos G., 2007, THE RAT BRAIN IN STE; Pecina S, 2003, J NEUROSCI, V23, P9395; Pfaffly J, 2010, SYNAPSE, V64, P503, DOI 10.1002/syn.20755; Robertson SD, 2010, J NEUROSCI, V30, P11305, DOI 10.1523/JNEUROSCI.0126-10.2010; Rubins DJ, 2003, NEUROIMAGE, V20, P2100, DOI 10.1016/j.neuroimage.2003.07.011; Schwarz AJ, 2007, NEUROIMAGE, V34, P1627, DOI 10.1016/j.neuroimage.2006.11.010; Schwarz AJ, 2007, MAGN RESON MED, V57, P704, DOI 10.1002/mrm.21179; Schwarz AJ, 2009, NEUROIMAGE, V47, P302, DOI 10.1016/j.neuroimage.2009.03.064; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Speed N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025169; Szanto I, 2000, P NATL ACAD SCI USA, V97, P2355, DOI 10.1073/pnas.050580497; Szczypka MS, 2000, NAT GENET, V25, P102, DOI 10.1038/75484; Tantawy MN, 2009, NUCL MED BIOL, V36, P931, DOI 10.1016/j.nucmedbio.2009.06.007; Thanos PK, 2008, SYNAPSE, V62, P50, DOI 10.1002/syn.20468; Tomasi D, 2015, HUM BRAIN MAPP, V36, P120, DOI 10.1002/hbm.22617; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Volkow ND, 2013, BIOL PSYCHIAT, V73, P811, DOI 10.1016/j.biopsych.2012.12.020; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wei Y, 2007, MOL PHARMACOL, V71, P835, DOI 10.1124/mol.106.026351; Williams J, 2007, PLOS BIOL, V5, P2369, DOI 10.1371/journal.pbio.0050274; Zhao FQ, 2007, MAGN RESON MED, V57, P520, DOI 10.1002/mrm.21159; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	44	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0191299	10.1371/journal.pone.0191299	http://dx.doi.org/10.1371/journal.pone.0191299			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698491	Green Submitted, Green Published, gold			2022-12-26	WOS:000431007600001
J	de Vos, AS; van der Schoot, ECE; Rizopoulos, D; Janssen, MP				de Vos, Anneke S.; van der Schoot, Ellen C. E.; Rizopoulos, Dimitris; Janssen, Mart P.			Predicting anti-RhD titers in donors: Boostering response and decline rates are personal	PLOS ONE			English	Article							AGE	Background Anti-RhD immunised donors provide anti-RhD immunoglobulins used for the prevention of rhesus disease. These donors are periodically hyper-immunised (boostered) to retain a high titer level of anti-RhD. Study design and methods We analysed anti-RhD donor records from 1998 to 2016, consisting of 30,116 anti-RhD titers from 755 donors, encompassing 3,372 booster events. Various models were fit to these data to allow describing the anti-RhD titers over time. Results A random effects model with a log-linear anti-RhD titer decline over time and a saturating titer response to boostering is shown to fit the data well. This model contains two general model parameters, relating timing and maximum of the booster effect, as well as two parameters characterizing the individual donor, namely how fast the booster effect saturates with current titer and the anti-RhD decline rate. The average individual log(2) decline is 0.55 per year, i.e. a 32% decline in absolute titer, with half of the donors declining between 13% and 41% per year. Their anti-RhD titer peaks around 26 days following a booster event. Boostering response reduces with higher titers at boostering; at median titer (log(2) 11) the mean increase per booster is log(2) 0.38, that is from an absolute titer of 2048 to 2665 (+30%), with half of all donors increasing between 16% and 65% in their titer. Conclusion The model describes anti-RhD titer change per individual with only four parameters, two of which are donor specific. This information can be used to enhance the blood bank's immunisation programme, by deriving individualized immunization policies in which boostering is adjusted to the anticipated anti-RhD decline, effectiveness of boostering and titer levels required.	[de Vos, Anneke S.; Janssen, Mart P.] Sanquin Res, Transfus Technol Assessment Dept, Amsterdam, Netherlands; [van der Schoot, Ellen C. E.] Sanquin Res, Dept Expt Immunohematol, Amsterdam, Netherlands; [Rizopoulos, Dimitris] Erasmus Univ, Med Ctr, Dept Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Janssen, MP (corresponding author), Sanquin Res, Transfus Technol Assessment Dept, Amsterdam, Netherlands.	m.janssen@sanquin.nl		de Vos, Anneke S./0000-0002-4754-0026	Sanquin Research, Sanquin Blood Supply Foundation [PPOC-14-33]	Sanquin Research, Sanquin Blood Supply Foundation	This work was performed as part of the internally supported research project "Optimizing boostering strategies: a mathematical modelling approach" (Sanquin Research, Sanquin Blood Supply Foundation PPOC-14-33). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, DAILY MAIL; Daxboeck F, 2002, SCAND J INFECT DIS, V34, P577, DOI 10.1080/00365540110089836; Fitzmaurice G., 2010, APPL LONGITUDINAL AN; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Hsu JP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-414; Kapur R, 2014, BRIT J HAEMATOL, V166, P936, DOI 10.1111/bjh.12965; Koelewijn JM, 2009, BJOG-INT J OBSTET GY, V116, P1307, DOI 10.1111/j.1471-0528.2009.02244.x; Kumpel BM, 2003, CLIN EXP IMMUNOL, V132, P81, DOI 10.1046/j.1365-2249.2003.02119.x; Nasserinejad K, 2016, STAT MED, V35, P581, DOI 10.1002/sim.6759; PUTTICK AH, 1988, ANN RHEUM DIS, V47, P898, DOI 10.1136/ard.47.11.898; R Core Team, 2013, R LANG ENV STAT COMP; Reali Giorgio, 2007, Blood Transfus, V5, P3, DOI 10.2450/2007.0b18-06; van Hoeven LR, 2016, VOX SANG, V111, P171, DOI 10.1111/vox.12400; Weisstein Eric W., BIVARIATE NORMAL DIS	14	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196382	10.1371/journal.pone.0196382	http://dx.doi.org/10.1371/journal.pone.0196382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698437	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600070
J	Garnier, AS; Duveau, A; Demiselle, J; Croue, A; Subra, JF; Sayegh, J; Augusto, JF				Garnier, Anne-Sophie; Duveau, Agnes; Demiselle, Julien; Croue, Anne; Subra, Jean-Francois; Sayegh, Johnny; Augusto, Jean-Francois			Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; RENAL-ALLOGRAFT; GRAFT-SURVIVAL; RECIPIENTS; GLOMERULONEPHRITIS	IgA nephropathy (IgAN), the most frequent primary glomerulonephritis, affects young patients and is associated with a high risk of progression to end-stage renal disease. Consequently, patients with IgAN constitute an important proportion of candidates for kidney transplantation. Several studies showed a significant risk of IgAN recurrence on kidney graft, but the risks factors for recurrence remain to be accurately evaluated. Indeed, early identification of at risk patients may allow the optimization of treatment and the reduction of recurrence rate on the graft. In the present work, we studied the relationship between posttransplant serum IgA (sIgA) levels and the risk of IgAN recurrence after kidney transplantation. Recipients with IgAN had higher levels of sIgA as compared to patients with other nephropathies (p< 0.05). The prevalence of IgAN recurrence was 20.8% during the period of analysis (mean follow-up of 6 +/- 3.2 years). Serum IgA levels at M6, M12 and M24 posttransplant were significantly higher in patients with IgAN recurrence as compared to those without (p = 0.009, p = 0.035 and p = 0.029, respectively). Using receiver operating curve (ROC), sIgA at M6 and M12 post-transplant were significantly associated with IgAN recurrence (AUC = 0.771, p = 0.004 and AUC = 0.767, p = 0.016, respectively), while serum creatinine and proteinuria were not. Serum IgA level at month 6 was significantly associated with the occurrence of post-transplant IgA recurrence, whether it was analyzed as a continuous or a categorical variable. After successive adjustment on age, gender and proteinuria, sIgA remained a significant risk factor of post-transplant IgAN recurrence. Finally, survival free of IgAN recurrence was significantly better in patients with sIgA<222 mg/dL at month 6 as compare to IgAN patients with sIgA >= 222 mg/dL (p = 0.03). Thus, the present work supports a link between post-transplant sIgA levels and IgAN recurrence and suggests that sIgA may be a valuable predictive biomarker of IgAN recurrence in kidney transplant recipients.	[Garnier, Anne-Sophie; Duveau, Agnes; Demiselle, Julien; Subra, Jean-Francois; Sayegh, Johnny; Augusto, Jean-Francois] LUNAM Univ, Angers, France; [Garnier, Anne-Sophie; Duveau, Agnes; Demiselle, Julien; Subra, Jean-Francois; Sayegh, Johnny; Augusto, Jean-Francois] CHU Angers, Serv Nephrol Dialyse Transplantat, Angers, France; [Croue, Anne] CHU Angers, Dept Pathol Cellulaire & Tissulaire, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Augusto, JF (corresponding author), LUNAM Univ, Angers, France.; Augusto, JF (corresponding author), CHU Angers, Serv Nephrol Dialyse Transplantat, Angers, France.	jfaugusto@chu-anger.fr	Garnier, Anne-Sophie/ABG-5292-2021; Jean-François, Augusto/L-2887-2015	Jean-François, Augusto/0000-0003-1498-2132; DEMISELLE, JULIEN/0000-0002-7255-1114				Andresdottir MB, 2005, TRANSPLANTATION, V80, P1012, DOI 10.1097/01.tp.0000179150.84803.56; Berthelot L, 2015, KIDNEY INT, V88, P815, DOI 10.1038/ki.2015.158; Berthoux F, 2008, TRANSPLANTATION, V85, P1505, DOI 10.1097/TP.0b013e3181705ad4; Berthoux F, 2017, J AM SOC NEPHROL, V28, P1943, DOI 10.1681/ASN.2016060670; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Boyd JK, 2012, KIDNEY INT, V81, P833, DOI 10.1038/ki.2011.501; Han SS, 2010, TRANSPL INT, V23, P169, DOI 10.1111/j.1432-2277.2009.00966.x; Kim YS, 2001, TRANSPLANTATION, V71, P233, DOI 10.1097/00007890-200101270-00011; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McDonald SP, 2006, TRANSPLANTATION, V82, P759, DOI 10.1097/01.tp.0000230131.66971.45; Moriyama T, 2005, CLIN TRANSPLANT, V19, P41, DOI 10.1111/j.1399-0012.2005.00403.x; Moroni G, 2013, NEPHROL DIAL TRANSPL, V28, P1305, DOI 10.1093/ndt/gfs472; Ponticelli C, 2001, KIDNEY INT, V60, P1948, DOI 10.1046/j.1523-1755.2001.00006.x; Ponticelli C, 2010, CLIN J AM SOC NEPHRO, V5, P2363, DOI 10.2215/CJN.06720810; Wang AYM, 2001, AM J KIDNEY DIS, V38, P588, DOI 10.1053/ajkd.2001.26885; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Wyld ML, 2016, TRANSPLANTATION, V100, P1827, DOI 10.1097/TP.0000000000001093; Zhang J, 2013, NEPHROLOGY, V18, P125, DOI 10.1111/nep.12010; Zhang JJ, 2008, NEPHROL DIAL TRANSPL, V23, P207, DOI 10.1093/ndt/gfm492	19	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196101	10.1371/journal.pone.0196101	http://dx.doi.org/10.1371/journal.pone.0196101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694420	Green Submitted, gold, Green Published			2022-12-26	WOS:000430802400063
J	Yang, YJ; Moser, MAJ; Zhang, E; Zhang, WJ; Zhang, B				Yang, Yongji; Moser, Michael A. J.; Zhang, Edwin; Zhang, Wenjun; Zhang, Bing			Development of a statistical model for cervical cancer cell death with irreversible electroporation in vitro	PLOS ONE			English	Article							HIGH ELECTRIC-FIELDS; THERMAL INACTIVATION; TISSUE ABLATION; DESCRIBE; MICROORGANISMS; CONDUCTIVITY; DESTRUCTION; SAFETY; PULSE	Purpose The aim of this study was to develop a statistical model for cell death by irreversible electroporation (IRE) and to show that the statistic model is more accurate than the electric field threshold model in the literature using cervical cancer cells in vitro. Methods HeLa cell line was cultured and treated with different IRE protocols in order to obtain data for modeling the statistical relationship between the cell death and pulse-setting parameters. In total, 340 in vitro experiments were performed with a commercial IRE pulse system, including a pulse generator and an electric cuvette. Trypan blue staining technique was used to evaluate cell death after 4 hours of incubation following IRE treatment. Peleg-Fermi model was used in the study to build the statistical relationship using the cell viability data obtained from the in vitro experiments. A finite element model of IRE for the electric field distribution was also built. Comparison of ablation zones between the statistical model and electric threshold model (drawn from the finite element model) was used to show the accuracy of the proposed statistical model in the description of the ablation zone and its applicability in different pulse-setting parameters. Results The statistical models describing the relationships between HeLa cell death and pulse length and the number of pulses, respectively, were built. The values of the curve fitting parameters were obtained using the Peleg-Fermi model for the treatment of cervical cancer with IRE. The difference in the ablation zone between the statistical model and the electric threshold model was also illustrated to show the accuracy of the proposed statistical model in the representation of ablation zone in IRE. Conclusions This study concluded that: (1) the proposed statistical model accurately described the ablation zone of IRE with cervical cancer cells, and was more accurate compared with the electric field model; (2) the proposed statistical model was able to estimate the value of electric field threshold for the computer simulation of IRE in the treatment of cervical cancer; and (3) the proposed statistical model was able to express the change in ablation zone with the change in pulse-setting parameters.	[Yang, Yongji; Zhang, Wenjun] East China Univ Sci & Technol, Complex & Intelligent Syst Res Ctr, Tumor Ablat Grp, Shanghai, Peoples R China; [Moser, Michael A. J.] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Zhang, Edwin] Univ Toronto, Dept Med Imaging, Div Vasc & Intervent Radiol, Toronto, ON, Canada; [Zhang, Bing] Shanghai Univ, Sch Mechatron Engn & Automat, Biomed Sci & Technol Res Ctr, Shanghai, Peoples R China	East China University of Science & Technology; University of Saskatchewan; University of Toronto; Shanghai University	Zhang, WJ (corresponding author), East China Univ Sci & Technol, Complex & Intelligent Syst Res Ctr, Tumor Ablat Grp, Shanghai, Peoples R China.; Zhang, B (corresponding author), Shanghai Univ, Sch Mechatron Engn & Automat, Biomed Sci & Technol Res Ctr, Shanghai, Peoples R China.	chris.zhang@usask.ca; bingzhang84@shu.edu.cn	Moser, Mike/AAG-9669-2021; Zhang (zhang bing), Bing/L-8698-2017	Moser, Mike/0000-0003-0735-199X; Zhang (zhang bing), Bing/0000-0001-5650-2518	National Natural Science Foundation of China [51375166]; Natural Science and Engineering Research Council of Canada; Natural Science Foundation of Shanghai [15ZR1409300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	WZ received National Natural Science Foundation of China (51375166) and Natural Science and Engineering Research Council of Canada. This work was also partially supported by Natural Science Foundation of Shanghai (15ZR1409300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena CB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-102; Balidemaj E, 2016, PHYS MED BIOL, V61, P1596, DOI 10.1088/0031-9155/61/4/1596; Bigelow WD, 1921, J INFECT DIS, V29, P528, DOI 10.1093/infdis/29.5.528; Canatella PJ, 2001, BIOPHYS J, V80, P755, DOI 10.1016/S0006-3495(01)76055-9; COLE MB, 1993, J IND MICROBIOL, V12, P232, DOI 10.1007/BF01584195; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Garcia PA, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-34; Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7; Golberg A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-13; HAMILTON WA, 1967, BIOCHIM BIOPHYS ACTA, V148, P789, DOI 10.1016/0304-4165(67)90053-0; Ivorra A, 2009, PHYS MED BIOL, V54, P5949, DOI 10.1088/0031-9155/54/19/019; Jiang CL, 2015, ANN BIOMED ENG, V43, P887, DOI 10.1007/s10439-014-1133-2; Li JW, 2009, INT J ADV MANUF TECH, V42, P168, DOI 10.1007/s00170-008-1570-x; Linton RH, 1994, USE GOMPERTZ EQUATIO; Miklavcic D, 2000, BBA-GEN SUBJECTS, V1523, P73, DOI 10.1016/S0304-4165(00)00101-X; Neal RE, 2012, IEEE T BIO-MED ENG, V59, P1076, DOI 10.1109/TBME.2012.2182994; Nickfarjam A, 2014, INT J HYPERTHER, V30, P335, DOI 10.3109/02656736.2014.937775; Niessen C, 2016, J VASC INTERV RADIOL, V27, P480, DOI 10.1016/j.jvir.2015.12.025; Paiella S, 2015, DIGEST SURG, V32, P90, DOI 10.1159/000375323; PELEG M, 1995, J SCI FOOD AGR, V67, P93, DOI 10.1002/jsfa.2740670115; Phillips M, 2016, ANN BIOMED ENG, V44, P3144, DOI 10.1007/s10439-016-1624-4; Rubinsky J, 2008, J UROLOGY, V180, P2668, DOI 10.1016/j.juro.2008.08.003; SALE AJH, 1968, BIOCHIM BIOPHYS ACTA, V163, P37, DOI 10.1016/0005-2736(68)90030-8; SALE AJH, 1967, BIOCHIM BIOPHYS ACTA, V148, P781, DOI 10.1016/0304-4165(67)90052-9; Shao Q, 2017, ANN BIOMED ENG, P1; van Boekel MAJS, 2002, INT J FOOD MICROBIOL, V74, P139, DOI 10.1016/S0168-1605(01)00742-5; Wimmer T, 2015, CARDIOVASC INTER RAD, V38, P182, DOI 10.1007/s00270-014-0905-2; Yang Y, 2018, J ENG SCI MED DIAGNO, V1; Yao CG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15494-3; Yao CG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173181; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622; Zhang B, 2018, J ENG SCI MED DIAGNO, V1	33	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195561	10.1371/journal.pone.0195561	http://dx.doi.org/10.1371/journal.pone.0195561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694357	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400034
J	Dittrich, N; Agostino, D; Philippe, RA; Guglielmo, LGA; Place, N				Dittrich, Naiandra; Agostino, Daniel; Philippe, Roberta Antonini; Guglielmo, Luiz Guilherme A.; Place, Nicolas			Effect of hypnotic suggestion on knee extensor neuromuscular properties in resting and fatigued states	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; INTERVAL INTRACORTICAL INHIBITION; CORTICOCORTICAL INHIBITION; HYPNOSIS; PERFORMANCE; EXCITABILITY; CONTRACTIONS; EXERCISE; MUSCLE; SUSCEPTIBILITY	Purpose The aim of this study was to investigate whether hypnotic suggestions can alter knee extensor neuromuscular function at rest and during exercise. Methods Thirteen healthy volunteers (8 men and 5 women, 27 +/- 3 years old) took part in this counterbalanced, crossover study including two experimental (hypnosis and control) sessions. Knee extensor neuromuscular function was tested before and after hypnosis suggestion by using a combination of voluntary contraction, transcutaneous femoral nerve electrical stimulation and transcranial magnetic stimulation (TMS). A fatiguing exercise (sustained submaximal contraction at 20% maximal voluntary contraction (MVC) force) was also performed to evaluate the potential influence of hypnosis on the extent and origin of neuromuscular adjustments. Results Hypnosis did not (p>0.05) alter MVC force or knee extensor neural properties. Corticospinal excitability, assessed with the amplitude of knee extensor motor evoked potentials, was also unchanged (p>0.05), as was the level of intracortical inhibition assessed with paired pulse TMS (short-interval intracortical inhibition, SICI). Time to task failure (similar to 300 s) was not different (p>0.05) between the two sessions; accordingly, hypnosis did not influence neuromuscular adjustments measured during exercise and at task failure (p>0.05). Conclusion Hypnotic suggestions did not alter neuromuscular properties of the knee extensor muscles under resting condition or during/after exercise, suggesting that hypnosis-induced improvement in exercise performance and enhanced corticospinal excitability might be limited to highly susceptible participants.	[Dittrich, Naiandra; Guglielmo, Luiz Guilherme A.] Univ Fed Santa Catarina, Sports Ctr, Phys Effort Lab, Florianopolis, SC, Brazil; [Dittrich, Naiandra; Agostino, Daniel; Place, Nicolas] Univ Lausanne, Fac Biol & Med, Inst Sport Sci, Lausanne, Switzerland; [Philippe, Roberta Antonini] Univ Lausanne, Fac Social & Polit Sci, Inst Sport Sci, Lausanne, Switzerland	Universidade Federal de Santa Catarina (UFSC); University of Lausanne; University of Lausanne	Place, N (corresponding author), Univ Lausanne, Fac Biol & Med, Inst Sport Sci, Lausanne, Switzerland.	nicolas.place@unil.ch	Guglielmo, Luiz Guilherme GA Antonacci/I-1160-2015; Place, Nicolas/B-3416-2018	Guglielmo, Luiz Guilherme GA Antonacci/0000-0001-6757-5050; Antonini Philippe, Roberta/0000-0001-9650-5174; Place, Nicolas/0000-0001-9044-0621	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil [99999.006368/2015-08]; PDSE (Programa de Doutorado Sanduiche) program	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PDSE (Programa de Doutorado Sanduiche) program	This study was supported by grants and fellowship from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; process N. 99999.006368/2015-08), Brazil. Part of this study was supported by the PDSE (Programa de Doutorado Sanduiche) program.	Bioy A, 2010, EUR J CLIN HYPN, V10, P2; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Chen R, 1998, J NEUROPHYSIOL, V80, P2870, DOI 10.1152/jn.1998.80.6.2870; Crawford HJ., 1991, 5 INT C PSYCH BUD; Facco E, 2013, ANAESTHESIA, V68, P961, DOI 10.1111/anae.12251; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Green JP, 2005, INT J CLIN EXP HYP, V53, P259, DOI 10.1080/00207140590961321; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; HILGARD ER, 1961, PSYCHOL MONOGR, V75, P1; Hoeft F, 2012, ARCH GEN PSYCHIAT, V69, P1064, DOI 10.1001/archgenpsychiatry.2011.2190; Hunter SK, 2016, EXP BRAIN RES, V234, P2541, DOI 10.1007/s00221-016-4658-9; Iglesias A, 2011, AM J CLIN HYPN, V53, P183, DOI 10.1080/00029157.2011.10401756; IKAI M, 1961, J APPL PHYSIOL, V16, P157, DOI 10.1152/jappl.1961.16.1.157; Kihlstrom JF, 2013, CORTEX, V49, P365, DOI 10.1016/j.cortex.2012.05.016; Kittelson AJ, 2014, EXP BRAIN RES, V232, P3991, DOI 10.1007/s00221-014-4079-6; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Liggett DR, 2000, AM J CLIN HYPN, V43, P149, DOI 10.1080/00029157.2000.10404267; McNeil CJ, 2011, J PHYSIOL-LONDON, V589, P3533, DOI 10.1113/jphysiol.2011.207191; Montgomery GH, 2000, INT J CLIN EXP HYP, V48, P138, DOI 10.1080/00207140008410045; Moran TE, 2002, AM J CLIN HYPN, V44, P221, DOI 10.1080/00029157.2002.10403482; Neyroud D, 2013, J APPL PHYSIOL, V114, P1426, DOI 10.1152/japplphysiol.01539.2012; Neyroud D, 2012, MED SCI SPORT EXER, V44, P1243, DOI 10.1249/MSS.0b013e318245cc4d; Nicholls AR., 2005, ATHL INSIGHT, V7, P43; O'Leary TJ, 2015, MUSCLE NERVE, V52, P605, DOI 10.1002/mus.24584; Oakley DA, 2007, INT J CLIN EXP HYP, V55, P32, DOI 10.1080/00207140600995844; Pates J, 2002, SPORT PSYCHOL, V16, P34, DOI 10.1123/tsp.16.1.34; Patterson DR, 2003, PSYCHOL BULL, V129, P495, DOI 10.1037/0033-2909.129.4.495; RIDDING MC, 1995, J PHYSIOL-LONDON, V487, P541, DOI 10.1113/jphysiol.1995.sp020898; Robazza C, 1995, PERCEPT MOTOR SKILL, V81, P1364, DOI 10.2466/pms.1995.81.3f.1364; Rochette L, 2003, J APPL PHYSIOL, V95, P1515, DOI 10.1152/japplphysiol.00334.2003; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; ROUSH ES, 1951, J APPL PHYSIOL, V3, P404, DOI 10.1152/jappl.1951.3.7.404; Sidhu SK, 2013, ACTA PHYSIOL, V207, P194, DOI 10.1111/apha.12004; Stevens-Lapsley JE, 2013, ARCH GERONTOL GERIAT, V56, P279, DOI 10.1016/j.archger.2012.06.017; Strojnik V, 1998, J APPL PHYSIOL, V84, P344, DOI 10.1152/jappl.1998.84.1.344; Takahashi K, 2011, BRAIN STIMUL, V4, P90, DOI 10.1016/j.brs.2010.07.001; Takarada Y, 2014, NEUROSCI RES, V85, P28, DOI 10.1016/j.neures.2014.05.009; Temesi J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-40; Thomson AL, 2017, J POSIT PSYCHOL, V12, P628, DOI 10.1080/17439760.2016.1269184; Vanhaudenhuyse A, 2008, Rev Med Liege, V63, P424; Williams PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093284; Williamson JW, 2001, J APPL PHYSIOL, V90, P1392, DOI 10.1152/jappl.2001.90.4.1392; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	43	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195437	10.1371/journal.pone.0195437	http://dx.doi.org/10.1371/journal.pone.0195437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7AK	29684047	Green Published, gold			2022-12-26	WOS:000430660600014
J	Pes, GM; Ganau, A; Tognotti, E; Errigo, A; Rocchi, C; Dore, MP				Pes, Giovanni Mario; Ganau, Antonello; Tognotti, Eugenia; Errigo, Alessandra; Rocchi, Chiara; Dore, Maria Pina			The association of adult height with the risk of cardiovascular disease and cancer in the population of Sardinia	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SHORT STATURE; FOLLOW-UP; MENDELIAN RANDOMIZATION; SOCIOECONOMIC POSITION; MORTALITY; MEN; HEALTH; WOMEN; STROKE	The relationship between body height and the risk of non-communicable diseases such as cardiovascular disease and cancer has been the subject of much debate in the epidemiological literature. Concerns have recently arisen over spurious associations due to confounding factors like birth cohort, especially in the context of epidemiological transition. The population of Sardinia represents an interesting case study, as the average physical stature of inhabitants was the lowest recorded in Europe until a few decades ago. In this population we tested whether height is an independent risk factor for cardiovascular disease and cancer. We analysed the stature of 10,427 patients undergoing endoscopy for any reason, for whom a detailed clinical history of cardiovascular disease and/or malignancies had been documented. Poisson regression modelling was used to test the association between stature and disease risk. When patients were subdivided according to sex and height tertiles, the risk of cardiovascular disease proved significantly greater for subjects in the lowest tertile irrespective of sex (men: 1.87; 95% CI 1.41-2.47; women: 1.23; 95% CI 0.92-1.66) and smaller for those in the highest tertile (men: 0.51; 95% CI 0.35-0.75; women: 0.41; 95% CI 0.27-0.61). However, after adjusting the risk for birth cohort and established risk factors, it mostly resulted in non-significant values, although the overall trend persisted. Similar results were obtained for all-cancer risk (relative risk for men and women in the lowest tertile: 1.44; 95% CI 1.09-1.90 and 1.17; 95% CI 0.93-1.48, in the highest tertile: 0.51; 95% CI 0.36-0.72 and 0.62; 95% CI 0.47-0.81, respectively) as well as for some of the most common types of cancer. We concluded that the risk of developing cardiovascular disease and malignancies does not vary significantly with stature in the Sardinian population, after adjusting for birth cohort and more obvious risk factors.	[Pes, Giovanni Mario; Ganau, Antonello; Errigo, Alessandra; Rocchi, Chiara; Dore, Maria Pina] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy; [Pes, Giovanni Mario] Sardinia Longev Blue Zone Observ, Ogliastra, Italy; [Tognotti, Eugenia] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Dore, Maria Pina] Baylor Coll Med, Houston, TX 77030 USA	University of Sassari; University of Sassari; Baylor College of Medicine	Pes, GM (corresponding author), Univ Sassari, Dept Clin & Expt Med, Sassari, Italy.; Pes, GM (corresponding author), Sardinia Longev Blue Zone Observ, Ogliastra, Italy.	gmpes@uniss.it	Pes, Giovanni Mario/AAH-3340-2019; Errigo, Alessandra/ABI-2812-2020; Dore, Maria P/K-8391-2012; Ganau, Antonello/D-6899-2012; DORE, Maria Pina/AAV-7918-2021; Tognotti, Eugenia/AAX-5224-2021	Pes, Giovanni Mario/0000-0003-3265-2823; Errigo, Alessandra/0000-0002-9911-7270; DORE, Maria Pina/0000-0001-7305-3531; 				ALBANES D, 1988, CANCER RES, V48, P1658; Batty GD, 2006, ANN ONCOL, V17, P157, DOI 10.1093/annonc/mdj018; Bonita R, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23742; Budroni M, 2013, TUMORI J, V99, P408, DOI 10.1700/1334.14806; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; Dore MP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005254; Dore MP, 2016, HELICOBACTER, V21, P575, DOI 10.1111/hel.12314; Dore MP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005299; Engeland A, 2003, EPIDEMIOLOGY, V14, P293, DOI 10.1097/00001648-200305000-00008; Green J, 2011, LANCET ONCOL, V12, P785, DOI 10.1016/S1470-2045(11)70154-1; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; HEBERT PR, 1993, CIRCULATION, V88, P1437, DOI 10.1161/01.CIR.88.4.1437; Jousilahti P, 2000, AM J EPIDEMIOL, V151, P1112, DOI 10.1093/oxfordjournals.aje.a010155; KANNAM JP, 1994, CIRCULATION, V90, P2241, DOI 10.1161/01.CIR.90.5.2241; Kihara S, 2015, CURR CARDIOVASC RISK, V9, DOI 10.1007/s12170-015-0439-4; Koch D, 2011, ECON HUM BIOL, V9, P106, DOI 10.1016/j.ehb.2010.04.001; Korhonen PE, 2017, J HYPERTENS, V35, P1170, DOI 10.1097/HJH.0000000000001300; Lanari Donatella, 2011, Genus, V67, P75; Langenberg C, 2005, AM J PUBLIC HEALTH, V95, P628, DOI 10.2105/2004.046219; Liao YL, 1996, J AM COLL CARDIOL, V27, P678, DOI 10.1016/0735-1097(95)00512-9; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Nelson CP, 2015, NEW ENGL J MED, V372, P1608, DOI 10.1056/NEJMoa1404881; Norton K, 1996, ANTHROPOMETRICA, V1, P25; Nuesch E, 2016, INT J EPIDEMIOL, V45, P1927, DOI 10.1093/ije/dyv074; Nwasokwa ON, 1997, AM HEART J, V133, P147, DOI 10.1016/S0002-8703(97)70202-3; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Park CS, 2018, INT J EPIDEMIOL, V47, P289, DOI 10.1093/ije/dyx175; Pes GM, 2017, AM J PHYS ANTHROPOL, V163, P3, DOI 10.1002/ajpa.23177; Rosero-Bixby Luis, 2013, Vienna Yearb Popul Res, V11, P109; Salaris L, 2012, BIODEMOGR SOC BIOL, V58, P1, DOI 10.1080/19485565.2012.666118; Samaras Thomas T., 2012, Nutrition and Health (Bicester), V21, P247, DOI 10.1177/0260106013510996; Samaras Thomas T, 2013, Indian Heart J, V65, P66, DOI 10.1016/j.ihj.2012.12.016; Samaras TT, 2004, MED SCI MONITOR, V10, pRA63; Sanna E, 1993, Anthropol Anz, V51, P225; Sanna E, 2000, AM J HUM BIOL, V12, P782, DOI 10.1002/1520-6300(200011/12)12:6<782::AID-AJHB6>3.0.CO;2-L; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P111, DOI 10.1007/s10654-013-9867-y; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Smith GD, 2010, PERSPECT PSYCHOL SCI, V5, P527, DOI 10.1177/1745691610383505; Stearns S.C., 1992, pi; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Thrift AP, 2015, INT J EPIDEMIOL, V44, P662, DOI 10.1093/ije/dyv082; Tognotti E, 2009, EMERG INFECT DIS, V15, P1460, DOI 10.3201/eid1509.081317; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P427, DOI 10.1097/EDE.0000000000000081; WALKER M, 1989, INT J EPIDEMIOL, V18, P602, DOI 10.1093/ije/18.3.602	45	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0190888	10.1371/journal.pone.0190888	http://dx.doi.org/10.1371/journal.pone.0190888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677219	Green Submitted, Green Published, gold			2022-12-26	WOS:000430638900002
J	Schroeter, CB; Koehler, S; Kann, M; Schermer, B; Benzing, T; Brinkkoetter, PT; Rinschen, MM				Schroeter, Christina B.; Koehler, Sybille; Kann, Martin; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.; Rinschen, Markus M.			Protein half-life determines expression of proteostatic networks in podocyte differentiation	FASEB JOURNAL			English	Article						protein turnover; actin cytoskeleton; autophagy; lysosome; mass spectrometry	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; KIDNEY FILTRATION BARRIER; COLLECTING DUCT CELLS; PHOSPHOPROTEOMIC ANALYSIS; NEPHROTIC SYNDROME; PROTEOMIC ANALYSIS; ANALYSIS REVEALS; CULTURED PODOCYTES; SIGNALING PATHWAYS; GLOMERULAR PROTEIN	Podocytes are highly specialized, epithelial, postmitotic cells, which maintain the renal filtration barrier. When adapting to considerable metabolic and mechanical stress, podocytes need to accurately maintain their proteome. Immortalized podocyte cell lines are a widely used model for studying podocyte biology in health and disease in vitro. In this study, we performed a comprehensive proteomic analysis of the cultured human podocyte proteome in both proliferative and differentiated conditions at a depth of >7000 proteins. Similar to mouse podocytes, human podocyte differentiation involved a shift in proteostasis: undifferentiated podocytes have high expression of proteasomal proteins, whereas differentiated podocytes have high expression of lysosomal proteins. Additional analyses with pulsed stable-isotope labeling by amino acids in cell culture and protein degradation assays determined protein dynamics and half-lives. These studies unraveled a globally increased stability of proteins in differentiated podocytes. Mitochondrial, cytoskeletal, and membrane proteins were stabilized, particularly in differentiated podocytes. Importantly, protein half-lives strongly contributed to protein abundance in each state. These data suggest that regulation of protein turnover of particular cellular functions determines podocyte differentiation, a paradigm involving mitophagy and, potentially, of importance in conditions of increased podocyte stress and damage.Schroeter, C. B., Koehler, S., Kann, M., Schermer, B., Benzing, T., Brinkkoetter, P. T., Rinschen, M. M. Protein half-life determines expression of proteostatic networks in podocyte differentiation.	[Schroeter, Christina B.; Koehler, Sybille; Kann, Martin; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.; Rinschen, Markus M.] Univ Hosp Cologne, Dept Internal Med 2, Cologne, Germany; [Schroeter, Christina B.; Koehler, Sybille; Kann, Martin; Schermer, Bernhard; Benzing, Thomas; Brinkkoetter, Paul T.; Rinschen, Markus M.] Univ Cologne, CMMC, Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas; Rinschen, Markus M.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Schermer, Bernhard; Benzing, Thomas; Rinschen, Markus M.] Syst Biol Ageing Cologne SybaCol, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Rinschen, MM (corresponding author), Univ Hosp Cologne, CECAD Res Ctr, Nephrolab Cologne, Nephrol Forschungslab, Joseph Stelzmann St 26, D-50931 Cologne, Germany.	markus.rinschen@uk-koeln.de	Schermer, Bernhard/E-9972-2014; Benzing, Thomas/X-5476-2019; Rinschen, Markus/N-7283-2019	Schermer, Bernhard/0000-0002-5194-9000; Rinschen, Markus/0000-0002-9252-1342	German Research Foundation (DFG) [KA3217/4-1, SCHE1562-2, SFB829, BR2955/4-1]; University of Cologne postdoctoral grant	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Cologne postdoctoral grant	The authors thank Moin Saleem (Bristol University, Bristol, United Kingdom) for providing cell lines. The authors thank Ruth Herzog and Angelika Koeser (University Hospital Cologne) for excellent technical support. The authors acknowledge the help of Christian Frese and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) Proteomics Core Facility. This work was supported by German Research Foundation (DFG) Grants KA3217/4-1 (to M.K.), SCHE1562-2 (to B.S.), SFB829 (to T.B.), and BR2955/4-1 (to P.T.B.); and a University of Cologne postdoctoral grant (to M.M.R.). The authors thank Peter Frommolt and Prerana Wagle (CECAD Bioinformatics Facility) for reprocessing of mRNA sequencing data. The authors declare no conflicts of interest.	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Nguyen A, 2014, J BIOL CHEM, V289, P1688, DOI 10.1074/jbc.M113.515320; Bartram MP, 2016, HUM MOL GENET, V25, P1152, DOI 10.1093/hmg/ddv638; Barua M, 2014, KIDNEY INT, V85, P124, DOI 10.1038/ki.2013.354; Beeken M, 2014, J AM SOC NEPHROL, V25, P2511, DOI 10.1681/ASN.2013050522; Bierzynska A, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2016.00226; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Chittiprol S, 2011, AM J PHYSIOL-RENAL, V301, pF660, DOI 10.1152/ajprenal.00234.2011; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; Dhondt I, 2017, MOL CELL PROTEOMICS, V16, P1621, DOI 10.1074/mcp.RA117.000049; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Economou CG, 2004, J CELL SCI, V117, P3281, DOI 10.1242/jcs.01163; Endlich K, 2017, PFLUG ARCH EUR J PHY, V469, P937, DOI 10.1007/s00424-017-2025-8; Fierro-Monti I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080423; Frost LS, 2017, METHOD ENZYMOL, V587, P43, DOI 10.1016/bs.mie.2016.09.052; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gbadegesin RA, 2014, J AM SOC NEPHROL, V25, P1991, DOI 10.1681/ASN.2013090976; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Gee HY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10822; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; Griffin SV, 2004, AM J PATHOL, V165, P1175, DOI 10.1016/S0002-9440(10)63378-0; Gupta IR, 2013, J MED GENET, V50, P330, DOI 10.1136/jmedgenet-2012-101442; Hamacher-Brady A, 2016, CELL MOL LIFE SCI, V73, P775, DOI 10.1007/s00018-015-2087-8; Hartleben B, 2014, SEMIN NEPHROL, V34, P42, DOI 10.1016/j.semnephrol.2013.11.007; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hirota Y, 2015, AUTOPHAGY, V11, P332, DOI 10.1080/15548627.2015.1023047; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Janech MG, 2007, AM J PHYSIOL-RENAL, V292, pF501, DOI 10.1152/ajprenal.00298.2006; Jeruschke S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137043; Jiang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35671; Kambham N, 2000, AM J KIDNEY DIS, V36, P190, DOI 10.1053/ajkd.2000.8293; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kohli P, 2014, AM J PHYSIOL-CELL PH, V306, pC805, DOI 10.1152/ajpcell.00339.2013; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kreutzer R, 2009, BBA-MOL BASIS DIS, V1792, P982, DOI 10.1016/j.bbadis.2009.07.004; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kruppa AJ, 2016, TRAFFIC, V17, P878, DOI 10.1111/tra.12410; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Larance M, 2013, MOL CELL PROTEOMICS, V12, P638, DOI 10.1074/mcp.M112.024547; Liebau MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063506; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Matejas V, 2010, HUM MUTAT, V31, P992, DOI 10.1002/humu.21304; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; NAGATA M, 1993, ANAT EMBRYOL, V187, P275; Najafian B, 2011, KIDNEY INT, V79, P663, DOI 10.1038/ki.2010.484; Ni L, 2012, NEPHROLOGY, V17, P525, DOI 10.1111/j.1440-1797.2012.01619.x; Pasquier B, 2016, CELL MOL LIFE SCI, V73, P985, DOI 10.1007/s00018-015-2104-y; Pereira EM, 2016, AM J PHYSIOL-RENAL, V311, pF1015, DOI 10.1152/ajprenal.00283.2016; Prabakaran T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025065; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rattan SIS, 2010, ADV EXP MED BIOL, V694, P1; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Regier D. S., 1993, GENEREVIEWS, P1993; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rinschen MM, 2017, J AM SOC NEPHROL, V28, P2867, DOI 10.1681/ASN.2016101119; Rinschen MM, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf8165; Rinschen MM, 2016, AM J PHYSIOL-CELL PH, V311, pC404, DOI 10.1152/ajpcell.00121.2016; Rinschen MM, 2016, HUM MOL GENET, V25, P1328, DOI 10.1093/hmg/ddw016; Rinschen MM, 2015, PROTEOM CLIN APPL, V9, P1053, DOI 10.1002/prca.201400201; Rinschen MM, 2015, PROTEOMICS, V15, P1326, DOI 10.1002/pmic.201400235; Rinschen MM, 2014, J AM SOC NEPHROL, V25, P1509, DOI 10.1681/ASN.2013070760; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sandoval PC, 2013, J AM SOC NEPHROL, V24, P1793, DOI 10.1681/ASN.2013030279; Saurus P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21664; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shimada M, 2012, NEPHROL DIAL TRANSPL, V27, P81, DOI 10.1093/ndt/gfr271; Swiatecka-Urban A, 2013, PEDIATR NEPHROL, V28, P1723, DOI 10.1007/s00467-012-2281-y; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Tang VW, 2013, J CELL BIOL, V203, P815, DOI 10.1083/jcb.201304143; Tra T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027485; Thong KM, 2013, NEPHRON CLIN PRACT, V124, P31, DOI 10.1159/000354716; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vilchez D, 2014, TRENDS CELL BIOL, V24, P161, DOI 10.1016/j.tcb.2013.09.002; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wagle P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1695-x; Wasik AA, 2012, MOL BIOL CELL, V23, P3370, DOI 10.1091/mbc.E11-12-1010; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Yamamoto T, 2010, ADV CHRONIC KIDNEY D, V17, P487, DOI 10.1053/j.ackd.2010.09.005; Yang SP, 2015, DYNAMICS OF VEHICLE-ROAD COUPLED SYSTEM, P1, DOI 10.1007/978-3-662-45957-7_1; Zhang Y, 2015, DATA BRIEF, V4, P180, DOI 10.1016/j.dib.2015.05.013	97	10	10	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4696	4713		10.1096/fj.201701307R	http://dx.doi.org/10.1096/fj.201701307R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29694247				2022-12-26	WOS:000443817700007
J	May-Zhang, LS; Yermalitsky, V; Huang, JS; Pleasent, T; Borja, MS; Oda, MN; Jerome, WG; Yancey, PG; Linton, MF; Davies, SS				May-Zhang, Linda S.; Yermalitsky, Valery; Huang, Jiansheng; Pleasent, Tiffany; Borja, Mark S.; Oda, Michael N.; Jerome, W. Gray; Yancey, Patricia G.; Linton, MacRae F.; Davies, Sean S.			Modification by isolevuglandins, highly reactive gamma-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid peroxidation; high-density lipoprotein (HDL); atherosclerosis; oxidative stress; inflammation; aldehydes; isolevuglandins; reactive lipid species	APOLIPOPROTEIN-A-I; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; PROTEIN ADDUCTS; CARDIOVASCULAR-DISEASE; LIPID-PEROXIDATION; MYELOPEROXIDASE; HDL; MACROPHAGES; EFFLUX; OXIDATION	Cardiovascular disease risk depends on high-density lipoprotein (HDL) function, not HDL-cholesterol. Isolevuglandins (IsoLGs) are lipid dicarbonyls that react with lysine residues of proteins and phosphatidylethanolamine. IsoLG adducts are elevated in atherosclerosis. The consequences of IsoLG modification of HDL have not been studied. We hypothesized that IsoLG modification of apoA-I deleteriously alters HDL function. We determined the effect of IsoLG on HDL structure-function and whether pentylpyridoxamine (PPM), a dicarbonyl scavenger, can preserve HDL function. IsoLG adducts in HDL derived from patients with familial hypercholesterolemia (n = 10, 233.4 +/- 158.3 ng/mg) were found to be significantly higher than in healthy controls (n = 7, 90.1 +/- 33.4 pg/mg protein). Further, HDL exposed to myeloperoxidase had elevated IsoLG-lysine adducts (5.7 ng/mg protein) compared with unexposed HDL (0.5 ng/mg protein). Preincubation with PPM reduced IsoLG-lysine adducts by 67%, whereas its inactive analogue pentylpyridoxine did not. The addition of IsoLG produced apoA-I and apoA-II cross-links beginning at 0.3 molar eq of IsoLG/mol of apoA-I (0.3 eq), whereas succinylaldehyde and 4-hydroxynonenal required 10 and 30 eq. IsoLG increased HDL size, generating a subpopulation of 16-23 nm. 1 eq of IsoLG decreased HDL-mediated [H-3]cholesterol efflux from macrophages via ABCA1, which corresponded to a decrease in HDL-apoA-I exchange from 47.4% to only 24.8%. This suggests that IsoLG inhibits apoA-I from disassociating from HDL to interact with ABCA1. The addition of 0.3 eq of IsoLG ablated HDL's ability to inhibit LPS-stimulated cytokine expression by macrophages and increased IL-1 expression by 3.5-fold. The structural-functional effects were partially rescued with PPM scavenging.	[May-Zhang, Linda S.; Yermalitsky, Valery; Linton, MacRae F.; Davies, Sean S.] Vanderbilt Univ, Dept Pharmacol, 556B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Huang, Jiansheng; Yancey, Patricia G.; Linton, MacRae F.] Vanderbilt Univ Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37232 USA; [Jerome, W. Gray] Vanderbilt Univ Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Pleasent, Tiffany] Meharry Med Coll, Nashville, TN 37208 USA; [Borja, Mark S.] Calif State Univ East Bay, Dept Chem & Biochem, Hayward, CA 94542 USA; [Oda, Michael N.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Meharry Medical College; California State University System; California State University East Bay; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Davies, SS (corresponding author), Vanderbilt Univ, Dept Pharmacol, 556B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	sean.davies@vanderbilt.edu	Yancey, Patricia/ABB-5856-2021	Davies, Sean/0000-0001-9879-8062; May-Zhang, Linda/0000-0001-9486-419X	National Institutes of Health [HL116263, HL138745]; American Heart Association [17POST33660332]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL116263, F32HL138745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants HL116263 (to M. F. L. and S. S. D.) and HL138745 (to L. S. M.) and by American Heart Association Grant 17POST33660332 (to L. S. M.). S. S. D. and M. F. L. are inventors on a patent application for the use of PPM and related dicarbonyl scavengers for the treatment of cardiovascular disease. M. N. O. is a founder of and owns a significant stake in Seer Biologics, Inc., which could stand to benefit from the research described here. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKANUMA Y, 1968, J LIPID RES, V9, P620; Akinkuolie AO, 2014, CIRC-CARDIOVASC QUAL, V7, P55, DOI 10.1161/CIRCOUTCOMES.113.000675; Amarnath V, 2005, SYNTHETIC COMMUN, V35, P397, DOI 10.1081/SCC-200048945; ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Borja MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182217; Borja MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071541; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; Brame CJ, 1999, J BIOL CHEM, V274, P13139, DOI 10.1074/jbc.274.19.13139; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; CAVAILLON JM, 1990, INFECT IMMUN, V58, P2375, DOI 10.1128/IAI.58.7.2375-2382.1990; Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434; Colvin PL, 1999, J LIPID RES, V40, P1782; Davies SS, 2007, NAT PROTOC, V2, P2079, DOI 10.1038/nprot.2007.298; Davies SS, 2006, BIOCHEMISTRY-US, V45, P15756, DOI 10.1021/bi061860g; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Dove DE, 2005, AM J PHYSIOL-CELL PH, V288, pC586, DOI 10.1152/ajpcell.00210.2004; Enkisch C., 2009, EUR J ORG CHEM, V2009, P15; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Favari E, 2004, ARTERIOSCL THROM VAS, V24, P2345, DOI 10.1161/01.ATV.0000148706.15947.8a; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; FRANCIS GA, 1993, P NATL ACAD SCI USA, V90, P6631, DOI 10.1073/pnas.90.14.6631; Gao X, 2012, BIOCHEMISTRY-US, V51, P4633, DOI 10.1021/bi300555d; GARDNER HW, 1992, LIPIDS, V27, P686, DOI 10.1007/BF02536025; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Gauthamadasa K, 2012, J BIOL CHEM, V287, P7615, DOI 10.1074/jbc.M111.291070; Gonzalez MC, 2008, ARCH BIOCHEM BIOPHYS, V473, P34, DOI 10.1016/j.abb.2008.02.021; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Guo LL, 2015, ANTIOXID REDOX SIGN, V22, P1633, DOI 10.1089/ars.2014.6078; Guo LL, 2012, FREE RADICAL BIO MED, V53, P1226, DOI 10.1016/j.freeradbiomed.2012.07.077; Guo LL, 2011, J BIOL CHEM, V286, P18170, DOI 10.1074/jbc.M110.213470; Heier M, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0570-2; Hoppe G, 1997, BBA-LIPID LIPID MET, V1344, P1, DOI 10.1016/S0005-2760(96)00160-9; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; Kelesidis T, 2017, JAIDS-J ACQ IMM DEF, V75, P354, DOI 10.1097/QAI.0000000000001383; Kirabo A, 2014, J CLIN INVEST, V124, P4642, DOI 10.1172/JCI74084; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Lin CY, 1999, J LIPID RES, V40, P1618; Low H, 2012, JOVE-J VIS EXP, DOI 10.3791/3810; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; MCCALL M, 1995, ARTERIOSCL THROM VAS, V15, P1599, DOI 10.1161/01.ATV.15.10.1599; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; NAGANO Y, 1991, P NATL ACAD SCI USA, V88, P6457, DOI 10.1073/pnas.88.15.6457; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Norata GD, 2006, NUTR METAB CARDIOVAS, V16, P371, DOI 10.1016/j.numecd.2006.01.012; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Proudfoot JM, 2009, J LIPID RES, V50, P716, DOI 10.1194/jlr.M800607-JLR200; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; SALMON S, 1992, BIOCHIM BIOPHYS ACTA, V1125, P230, DOI 10.1016/0005-2760(92)90050-6; Salomon RG, 2000, BBA-MOL CELL BIOL L, V1485, P225, DOI 10.1016/S1388-1981(00)00038-X; Salomon RG, 2000, TRENDS CARDIOVAS MED, V10, P53, DOI 10.1016/S1050-1738(00)00040-2; Shah AS, 2013, J LIPID RES, V54, P2575, DOI 10.1194/jlr.R035725; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Solakivi T, 2005, Lipids Health Dis, V4, P25, DOI 10.1186/1476-511X-4-25; Soupene E, 2016, EXP BIOL MED, V241, P1933, DOI 10.1177/1535370216657447; Suzuki M, 2010, CIRCULATION, V122, P1919, DOI 10.1161/CIRCULATIONAHA.110.961193; Tan K, 2016, J DIABETES INVEST, V7, P445, DOI 10.1111/jdi.12487; ULEVITCH RJ, 1981, J CLIN INVEST, V67, P827, DOI 10.1172/JCI110100; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang WQ, 1998, J BIOL CHEM, V273, P17391, DOI 10.1074/jbc.273.28.17391; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737; Yancey PG, 2007, ARTERIOSCL THROM VAS, V27, P1123, DOI 10.1161/ATVBAHA.107.139592; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yu BL, 2010, IMMUNOL CELL BIOL, V88, P285, DOI 10.1038/icb.2009.112; Zagol-Ikapitte I.A., 2010, PHARMACEUTICS, V2, P18, DOI DOI 10.3390/pharmaceutics2010018; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	79	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9176	9187		10.1074/jbc.RA117.001099	http://dx.doi.org/10.1074/jbc.RA117.001099			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29712723	hybrid, Green Published			2022-12-26	WOS:000435441400004
J	Hailu, GG; Hagos, DG; Hagos, AK; Wasihun, AG; Dejene, TA				Hailu, Genet Gebrehiwet; Hagos, Dawit Gebregziabher; Hagos, Amlsha Kahsay; Wasihun, Araya Gebreyesus; Dejene, Tsehaye Asmelash			Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; DRUG-RESISTANCE; FOLLOW-UP; CHILDREN; PREDICTORS; MORTALITY; TUBERCULOSIS; MORBIDITY; ADHERENCE	Background Human immunodeficiency virus/Acquired immunodeficiency syndrome associated morbidity and mortality has reduced significantly since the introduction of highly active antiretroviral therapy. As a result of increasing access to highly active antiretroviral therapy, the survival and quality of life of the patients has significantly improved globally. Despite this promising result, regular monitoring of people on antiretroviral therapy is recommended to ensure whether there is an effective treatment response or not. This study was designed to assess virological and immunological failure of highly active antiretroviral therapy users among adults and adolescents in the Tigray region of Northern Ethiopia, where scanty data are available. Methods A retrospective follow up study was conducted from September 1 to December 30, 2016 to assess the magnitude and factors associated with virological and immunological failure among 260 adults and adolescents highly active antiretroviral therapy users who started first line ART between January 1, 2008 to March 1, 2016. A standardized questionnaire was used to collect socio-demographic and clinical data. SPSS Version21 statistical software was used for analysis. Bivariate and multivariate logistic regression analyses were conducted to identify factors associated to virological and immunological failure. Statistical association was declared significant if p-value was <= 0.05. Result A total of 30 (11.5%) and 17 (6.5%) participants experienced virological and immunological failure respectively in a median time of 36 months of highly active antiretroviral therapy. Virological failure was associated with non-adherence to medications, aged < 40 years old, having CD4(+) T-cells count < 250 cells/mu L and male gender. Similarly, immunological failure was associated with non-adherence, tuberculosis co-infection and Human immunodeficiency virus RNA >= 1000 copies/mL. Conclusions The current result shows that immunological and virological failure is a problem in a setting where highly active antiretroviral therapy has been largely scale up. The problem is more in patients with poor adherence. This will in turn affect the global targets of 90% viral suppression by 2020. This may indicate the need for more investment and commitment to improving patient adherence in the study area.	[Hailu, Genet Gebrehiwet; Hagos, Dawit Gebregziabher; Hagos, Amlsha Kahsay; Wasihun, Araya Gebreyesus; Dejene, Tsehaye Asmelash] Mekelle Univ, Dept Med Microbiol & Immunol, Coll Hlth Sci, Mekelle, Tigray, Ethiopia; [Hailu, Genet Gebrehiwet] Mekelle Univ, Dept Lab, Coll Hlth Sci, Ayder Comprehens Specialized Hosp, Mekelle, Tigray, Ethiopia; [Dejene, Tsehaye Asmelash] Axum Univ, Dept Med Microbiol, Coll Hlth Sci, Tigray, Ethiopia	Mekelle University; Mekelle University	Wasihun, AG (corresponding author), Mekelle Univ, Dept Med Microbiol & Immunol, Coll Hlth Sci, Mekelle, Tigray, Ethiopia.	araya13e25@gmail.com			Mekelle University, College of Health Sciences and study participants	Mekelle University, College of Health Sciences and study participants	Our appreciation goes to Mekelle University, College of Health Sciences and study participants for financial support and voluntarily participation respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdissa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-181; Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Alave J, 2013, REV CHIL INFECTOL, V30, P42, DOI 10.4067/S0716-10182013000100006; Assefa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-468; Barennes H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105736; Barry O, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-476; Castilho JL, 2014, AIDS RES HUM RETROV, V30, P446, DOI [10.1089/aid.2013.0208, 10.1089/AID.2013.0208]; Chawana T D, 2014, Cent Afr J Med, V60, P29; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; D'Amato RM, 1998, ANTIVIR THER, V3, P147; Dalhatu I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165528; Dow DE, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0567-3; Ekstrand ML, 2011, INT HEALTH, V3, P27, DOI 10.1016/j.inhe.2010.11.003; Federal Democratic Republic of Ethiopia Ministry of health, 2015, HSDP 4 ANN PERF REP; Gare J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134918; Hare AQ, 2014, AIDS BEHAV, V18, P2219, DOI 10.1007/s10461-014-0849-1; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Heestermans T, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000125; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Huang P, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007508; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Khienprasit N, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-42; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; Loubet P, 2015, J ANTIMICROB CHEMOTH, V70, P1881, DOI 10.1093/jac/dkv030; Makadzange AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144057; De La Hoz JM, 2014, COLOMB MEDICA, V45, P162; Mgelea EM, 2014, SAMJ S AFR MED J, V104, P696, DOI [10.7196/samj.7807, 10.7196/SAMJ.7807]; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Mulu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141318; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Musa BM, 2015, ANN THORAC MED, V10, P185, DOI 10.4103/1817-1737.160838; Njom Nlend AE, 2016, OPEN J PEDIAT, V6, P69; Ojha CR, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6817325; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Patel A, 2012, J FAM COMMUNITY MED, V19, P178, DOI 10.4103/2230-8229.102318; Patterson K, 2007, HIV MED, V8, P406, DOI 10.1111/j.1468-1293.2007.00485.x; Penot P, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18646; Puthanakit T, 2009, PEDIATR INFECT DIS J, V28, P488, DOI 10.1097/INF.0b013e318194eea6; Raffi F, 2017, J ANTIMICROB CHEMOTH, V72, P240, DOI 10.1093/jac/dkw369; Raja K., 2014, WORLD J AIDS, V4, P413, DOI DOI 10.4236/WJA.2014.44049; Ramadhani HO, 2007, CLIN INFECT DIS, V45, P1492, DOI 10.1086/522991; Robbins GK, 2010, CLIN INFECT DIS, V50, P779, DOI 10.1086/650537; Salou M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20683; Sang RKA, 2016, IOSR J DENT MED SCI, V15, P108, DOI DOI 10.9790/0853-15076108121; Seyler C, 2007, AIDS, V21, P1157, DOI 10.1097/QAD.0b013e3281c615da; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Teshome W, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0120-1; The Government of Regional States of Tigray, 2014, REP HLTH STAT TIGR R; Tsegaye E, 2011, ETHIOP J HEALTH DEV, V25, P102; UNAIDS, 2017, GLOB HIV STAT FACT S; von Braun A, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-016-0128-5; Wakibi SN, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-43; Waruru A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158881; Wegbreit J, 2006, AIDS, V20, P1217, DOI 10.1097/01.aids.0000232229.96134.56; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2008, UN ACC SCAL PRIOR HI; Yimer YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126026; Yirdaw KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125826; Zeleke A., 2016, INT J MED MED SCI, V8, P125, DOI [10.5897/IJMMS2015.1164, DOI 10.5897/IJMMS2015.1164]; Zhang Qing, 2012, World J Exp Med, V2, P70, DOI 10.5493/wjem.v2.i4.70	62	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196259	10.1371/journal.pone.0196259	http://dx.doi.org/10.1371/journal.pone.0196259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715323	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281100015
J	Cabirol, A; Cope, AJ; Barron, AB; Devaud, JM				Cabirol, Amelie; Cope, Alex J.; Barron, Andrew B.; Devaud, Jean-Marc			Relationship between brain plasticity, learning and foraging performance in honey bees	PLOS ONE			English	Article							DIVISION-OF-LABOR; MUSHROOM BODY CALYX; APIS-MELLIFERA; INSECT BRAIN; STRUCTURAL PLASTICITY; INTRINSIC NEURONS; SOCIAL-ROLE; BODIES; MEMORY; EXPERIENCE	Brain structure and learning capacities both vary with experience, but the mechanistic link between them is unclear. Here, we investigated whether experience-dependent variability in learning performance can be explained by neuroplasticity in foraging honey bees. The mushroom bodies (MBs) are a brain center necessary for ambiguous olfactory learning tasks such as reversal learning. Using radio frequency identification technology, we assessed the effects of natural variation in foraging activity, and the age when first foraging, on both performance in reversal learning and on synaptic connectivity in the MBs. We found that reversal learning performance improved at foraging onset and could decline with greater foraging experience. If bees started foraging before the normal age, as a result of a stress applied to the colony, the decline in learning performance with foraging experience was more severe. Analyses of brain structure in the same bees showed that the total number of synaptic boutons at the MB input decreased when bees started foraging, and then increased with greater foraging intensity. At foraging onset MB structure is therefore optimized for bees to update learned information, but optimization of MB connectivity deteriorates with foraging effort. In a computational model of the MBs sparser coding of information at the MB input improved reversal learning performance. We propose, therefore, a plausible mechanistic relationship between experience, neuroplasticity, and cognitive performance in a natural and ecological context.	[Cabirol, Amelie; Barron, Andrew B.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Cabirol, Amelie; Devaud, Jean-Marc] Toulouse Univ, CNRS, Res Ctr Anim Cognit, Ctr Integrat Biol,UPS, Toulouse, France; [Cope, Alex J.] Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England	Macquarie University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); University of Sheffield	Cabirol, A; Barron, AB (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.; Cabirol, A (corresponding author), Toulouse Univ, CNRS, Res Ctr Anim Cognit, Ctr Integrat Biol,UPS, Toulouse, France.	amelia.cabirol@gmail.com; andrew.barron@mq.edu.au	Cabirol, Amelie/AAI-7685-2020	Cabirol, Amelie/0000-0001-9376-1826; Barron, Andrew/0000-0002-8135-6628	Cotutelle International Macquarie University Research Excellence Scholarship [2015211]; French Ministry of Higher Education and Research; Centre National de Recherche Scientifique; Universite Toulouse III - Paul Sabatier; Australian Research Council [FT 140100452, DP150101172]; Engineering and Physical Sciences Research Council [EP/P006094/1]; EPSRC [EP/P006094/1] Funding Source: UKRI	Cotutelle International Macquarie University Research Excellence Scholarship; French Ministry of Higher Education and Research; Centre National de Recherche Scientifique; Universite Toulouse III - Paul Sabatier; Australian Research Council(Australian Research Council); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	AC is supported by a Cotutelle International Macquarie University Research Excellence Scholarship No. 2015211 and a scholarship from the French Ministry of Higher Education and Research. AC and JMD thank the Centre National de Recherche Scientifique and the Universite Toulouse III - Paul Sabatier. ABB is funded by an Australian Research Council Future Fellowship Grant FT 140100452 and an Australian Research Council Discovery Project Grant DP150101172. AJC is supported by Engineering and Physical Sciences Research Council grant no. EP/P006094/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bains JS, 2015, NAT REV NEUROSCI, V16, P377, DOI 10.1038/nrn3881; Bazhenov M, 2013, J NEUROSCI, V33, P5686, DOI 10.1523/JNEUROSCI.4145-12.2013; Bednarek E, 2011, NEURON, V69, P1132, DOI 10.1016/j.neuron.2011.02.034; Behrends A, 2007, EXP GERONTOL, V42, P1146, DOI 10.1016/j.exger.2007.09.003; Boitard C, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00198; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Cayco-Gajic NA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01109-y; Chang LH, 2015, J EXP BIOL, V218, P1715, DOI 10.1242/jeb.119198; Chechik G, 1999, NEURAL COMPUT, V11, P2061, DOI 10.1162/089976699300016089; Chittka L, 1997, BEHAV ECOL, V8, P239, DOI 10.1093/beheco/8.3.239; Deneve S, 2017, NEURON, V94, P969, DOI 10.1016/j.neuron.2017.05.016; Devaud JM, 2007, EUR J NEUROSCI, V26, P3193, DOI 10.1111/j.1460-9568.2007.05904.x; Devaud JM, 2015, P NATL ACAD SCI USA, V112, pE5854, DOI 10.1073/pnas.1508422112; Dobrin SE, 2011, ARTHROPOD STRUCT DEV, V40, P409, DOI 10.1016/j.asd.2011.01.003; Doidge N., 2007, BRAIN CHANGES ITELF; Dyer AG, 2014, ECOL MODEL, V277, P119, DOI 10.1016/j.ecolmodel.2014.01.009; Falibene A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00084; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Froese A, 2014, J COMP PHYSIOL A, V200, P183, DOI 10.1007/s00359-013-0877-8; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Giurfa M, 2001, ADAPT LEARN INTERDIS, V5, P22, DOI [10.1016/S1364-6613(00)01601-6, DOI 10.1016/S1364-6613(00)01601-6]; Gonzalez-Gomez PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090165; Groh C, 2012, J COMP NEUROL, V520, P3509, DOI 10.1002/cne.23102; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; Holahan MR, 2006, HIPPOCAMPUS, V16, P560, DOI 10.1002/hipo.20185; Hourcade B, 2010, J NEUROSCI, V30, P6461, DOI 10.1523/JNEUROSCI.0841-10.2010; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Hurtubise JL, 2017, NEUROSCIENCE, V345, P176, DOI 10.1016/j.neuroscience.2016.04.007; Ismail N, 2006, P NATL ACAD SCI USA, V103, P207, DOI 10.1073/pnas.0508318102; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Klein S, 2017, TRENDS ECOL EVOL, V32, P268, DOI 10.1016/j.tree.2016.12.009; Li L, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1323; Lin AC, 2014, NAT NEUROSCI, V17, P559, DOI 10.1038/nn.3660; LUNNEY GH, 1970, J EDUC MEAS, V7, P263, DOI 10.1111/j.1745-3984.1970.tb00727.x; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Menzel R, 2014, J PHYSIOL-PARIS, V108, P84, DOI 10.1016/j.jphysparis.2014.07.004; Morellini F, 2010, CEREB CORTEX, V20, P2712, DOI 10.1093/cercor/bhq017; Munch D, 2013, J EXP BIOL, V216, P1638, DOI 10.1242/jeb.078915; Muenz TS, 2015, DEV NEUROBIOL, V75, P1368, DOI 10.1002/dneu.22290; Munch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013504; Palm G, 2013, NEURAL NETWORKS, V37, P163, DOI 10.1016/j.neunet.2012.08.013; Pan Y, 2013, NEUROSCIENCE, V255, P76, DOI 10.1016/j.neuroscience.2013.09.065; Peng F, 2017, CURR BIOL, V27, P224, DOI 10.1016/j.cub.2016.10.054; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Powell SB, 2015, DEV NEUROSCI-BASEL, V37, P253, DOI 10.1159/000430091; R Core Team, 2013, R LANG ENV STAT COMP; Ren QZ, 2012, J NEUROSCI, V32, P11524, DOI 10.1523/JNEUROSCI.0827-12.2012; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Scheiner R, 2009, J EXP BIOL, V212, P994, DOI 10.1242/jeb.021188; Scholl C, 2014, DEV NEUROBIOL, V74, P1141, DOI 10.1002/dneu.22195; Seeley TD, 1985, HONEYBEE ECOLOGY STU; Shapira M, 2001, J MOL NEUROSCI, V17, P1, DOI 10.1385/JMN:17:1:1; Sovik E, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0989; Stieb SM, 2010, DEV NEUROBIOL, V70, P408, DOI 10.1002/dneu.20785; Szyszka P, 2005, J NEUROPHYSIOL, V94, P3303, DOI 10.1152/jn.00397.2005; Tonegawa S, 2015, CURR OPIN NEUROBIOL, V35, P101, DOI 10.1016/j.conb.2015.07.009; TRUJILLOCENOZ O, 1962, J ULTRA MOL STRUCT R, V7, P389, DOI 10.1016/S0022-5320(62)90035-7; Ushitani T, 2016, J EXP BIOL, V219, P412, DOI 10.1242/jeb.126920; Van Nest BN, 2017, DEV NEUROBIOL, V77, P1057, DOI 10.1002/dneu.22492; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Wu YY, 2012, LEARN MEMORY, V19, P478, DOI 10.1101/lm.025726.112	66	21	22	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196749	10.1371/journal.pone.0196749	http://dx.doi.org/10.1371/journal.pone.0196749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709023	Green Published, gold, Green Accepted			2022-12-26	WOS:000431130100058
J	di Rienzo, V; Bubici, G; Montemurro, C; Cillo, F				di Rienzo, Valentina; Bubici, Giovanni; Montemurro, Cinzia; Cillo, Fabrizio			Rapid identification of tomato Sw-5 resistance-breaking isolates of Tomato spotted wilt virus using high resolution melting and TaqMan SNP Genotyping assays as allelic discrimination techniques	PLOS ONE			English	Article							TIME RT-PCR; THRIPS TRANSMISSION; TSWV; GENE; TOSPOVIRUS; QUANTIFICATION; DISEASES; STRAINS; PROTEIN; CROPS	In tomato, resistance to Tomato spotted wilt virus (TSWV) is conferred by the dominant gene, designated Sw-5. Virulent Sw-5 resistance breaking (SRB) mutants of TSWV have been reported on Sw-5 tomato cultivars. Two different PCR-based allelic discrimination techniques, namely Custom TaqMan (TM) SNP Genotyping and high-resolution melting (HRM) assays, were developed and compared for their ability to distinguish between avirulent (Sw-5 non-infecting, SNI) and SRB biotypes. TaqMan assays proved to be more sensitive (threshold of detection in a range of 50-70 TSWV RNA copies) and more reliable than HRM, assigning 25 TSWV isolates to their correct genotype with an accuracy of 100%. Moreover, the TaqMan SNP assays were further improved developing a rapid and simple protocol that included crude leaf extraction for RNA template preparations. On the other hand, HRM assays showed higher levels of sensitivity than TaqMan when used to co-detect both biotypes in different artificial mixtures. These diagnostic assays contributed to gain preliminary information on the epidemiology of TSWV isolates in open field conditions. In fact, the presented data suggest that SRB isolates are present as stable populations established year round, persisting on both winter (globe artichoke) and summer (tomato) crops, in the same cultivated areas of Southern Italy.	[di Rienzo, Valentina; Montemurro, Cinzia] Spin SINAGRI SrI, Bari, Italy; [Bubici, Giovanni; Cillo, Fabrizio] CNR, Ist Protez Sostenibile Piante, Bari, Italy; [Montemurro, Cinzia] Univ Bari Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); Universita degli Studi di Bari Aldo Moro	Cillo, F (corresponding author), CNR, Ist Protez Sostenibile Piante, Bari, Italy.	fabrizio.cillo@ipsp.cnr.it	Cillo, Fabrizio/G-1178-2010; Bubici, Giovanni/O-4793-2015	Cillo, Fabrizio/0000-0001-9898-7533; Bubici, Giovanni/0000-0001-9143-2711; Montemurro, Cinzia/0000-0002-3748-2539; di RIENZO, VALENTINA/0000-0002-4071-8899	Ministry of Economy and Finance [I. 191/2009, l. 191/2009, Cod. PONO2_00395_3082360]; Ministry of Education, University and Research [Cod. PON02_00395_3082360]; SINAGRI s.r.l.	Ministry of Economy and Finance; Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); SINAGRI s.r.l.	This work was supported with a grant from the Ministry of Economy and Finance to the CNR, "Integrate knowledge for Sustainability and Innovation of Made in Italy Agro-Food" (CISIA, I. 191/2009), and a grant from the Ministry of Education, University and Research to the Public Private Laboratory GenoPom "Integrating post-genomic platforms to enhance the tomato production chain" (GenoPOMpro, Cod. PON02_00395_3082360). The funding company SINAGRI s.r.l. did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries to VdR and research materials. The specific roles of these authors are articulated in the 'author contributions' section.; The authors thank Dr. Michelino Tridentino and ISI Sementi S.p.A. Fidenza (PR)-Italy, for their valuable technical support in the field. This work was supported with a grant from the Ministry of Economy and Finance to the CNR, "Integrate knowledge for Sustainability and Innovation of Made in Italy Agro-Food" (CISIA, l. 191/2009), and a grant to the Public-Private Laboratory GenoPom "Integrating post-genomic platforms to enhance the tomato production chain" (GenoPOMpro, Cod. PONO2_00395_3082360). We have the following interests: Authors Valentina di Rienzo and Cinzia Montemurro are affiliated to SINAGRI s.r.l. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Acosta-Leal R, 2007, PHYTOPATHOLOGY, V97, P325, DOI 10.1094/PHYTO-97-3-0325; ADKINS S, 1995, VIROLOGY, V207, P308, DOI 10.1006/viro.1995.1083; Adkins S, 2000, MOL PLANT PATHOL, V1, P151, DOI 10.1046/j.1364-3703.2000.00022.x; Aramburu J, 2003, PLANT PATHOL, V52, P407, DOI 10.1046/j.1365-3059.2003.00829.x; Batuman O, 2017, PLANT DIS, V101, P637, DOI 10.1094/PDIS-09-16-1371-PDN; Bester R, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-219; Boonham N, 2002, J VIROL METHODS, V101, P37, DOI 10.1016/S0166-0934(01)00418-9; Brittlebank C. C., 1919, J AGR, V17, P1348; Brommonschenkel SH, 2000, MOL PLANT MICROBE IN, V13, P1130, DOI 10.1094/MPMI.2000.13.10.1130; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Canady MA, 2001, EUPHYTICA, V117, P19, DOI 10.1023/A:1004089504051; Ciuffo M, 2005, PLANT PATHOL, V54, P564, DOI 10.1111/j.1365-3059.2005.01203.x; Croxford AE, 2008, NEW PHYTOL, V180, P594, DOI 10.1111/j.1469-8137.2008.02588.x; Debreczeni DE, 2011, J VIROL METHODS, V176, P32, DOI 10.1016/j.jviromet.2011.05.027; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; di Rienzo V, 2016, FOOD CONTROL, V60, P124, DOI 10.1016/j.foodcont.2015.07.015; GOLDBACH R, 1994, SEMIN VIROL, V5, P113, DOI 10.1006/smvy.1994.1012; Gordillo LF, 2008, PLANT DIS, V92, P694, DOI 10.1094/PDIS-92-5-0694; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; Jacquot E, 2005, J VIROL METHODS, V125, P83, DOI 10.1016/j.jviromet.2005.01.003; Komorowska B, 2014, MOL CELL PROBE, V28, P186, DOI 10.1016/j.mcp.2014.03.002; Latham LJ, 1998, ANN APPL BIOL, V133, P385, DOI 10.1111/j.1744-7348.1998.tb05838.x; Li W, 2009, VIROLOGY, V390, P110, DOI 10.1016/j.virol.2009.04.027; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Loconsole G, 2013, MOL CELL PROBE, V27, P221, DOI 10.1016/j.mcp.2013.07.003; Lopez C, 2011, J GEN VIROL, V92, P210, DOI 10.1099/vir.0.026708-0; MILNE RG, 1984, INTERVIROLOGY, V22, P72, DOI 10.1159/000149536; Naidu RA, 2008, PLANT PATHOL, V57, P190, DOI 10.1111/j.1365-3059.2007.01707.x; OEPP/EPPO, 2004, B OEPP EPPO, V34, P155; OEPP/EPPO, 2016, EPPO AL LIST; Palloix A, 2009, NEW PHYTOL, V183, P190, DOI 10.1111/j.1469-8137.2009.02827.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roberts CA, 2000, J VIROL METHODS, V88, P1, DOI 10.1016/S0166-0934(00)00156-7; Rotenberg D, 2015, CURR OPIN VIROL, V15, P80, DOI 10.1016/j.coviro.2015.08.003; Samuel G., 1930, INVESTIGATIONS SPOTT; Sanzani SM, 2013, INT J FOOD MICROBIOL, V165, P111, DOI 10.1016/j.ijfoodmicro.2013.04.024; Schleinitz D, 2011, TARGETED SNP GENOTYP, P77; Sialer MMF, 2002, J PLANT PATHOL, V84, P145; Simko I, 2016, TRENDS PLANT SCI, V21, P528, DOI 10.1016/j.tplants.2016.01.004; Sin SH, 2005, P NATL ACAD SCI USA, V102, P5168, DOI 10.1073/pnas.0407354102; STEVENS MR, 1991, EUPHYTICA, V59, P9; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Thompson GJ, 1995, ACTA HORTIC, P379; Tsompana M, 2005, MOL ECOL, V14, P53, DOI 10.1111/j.1365-294X.2004.02392.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Zaccardelli M, 2008, ACTA HORTIC, V789, P147, DOI 10.17660/ActaHortic.2008.789.20	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196738	10.1371/journal.pone.0196738	http://dx.doi.org/10.1371/journal.pone.0196738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709020	Green Submitted, gold, Green Published			2022-12-26	WOS:000431130100056
J	Deleye, L; Gansemans, Y; De Coninck, D; Van Nieuwerburgh, F; Deforce, D				Deleye, Lieselot; Gansemans, Yannick; De Coninck, Dieter; Van Nieuwerburgh, Filip; Deforce, Dieter			Massively parallel sequencing of micro-manipulated cells targeting a comprehensive panel of disease-causing genes: A comparative evaluation of upstream whole-genome amplification methods	PLOS ONE			English	Article							GENERATION; ABERRATIONS; ANEUPLOIDY; ALIGNMENT; EMBRYOS	Single Gene Disorders (SGD) are still routinely diagnosed using PCR-based assays that need to be developed and validated for each individual disease-specific gene fragment. The TruSight One sequencing panel currently covers 12 Mb of genomic content, including 4813 genes associated with a clinical phenotype. When only a limited number of cells are available, whole genome amplification (WGA) is required prior to DNA target capture techniques such as the TruSight One panel. In this study, we compared 4 different WGA methods in combination with the TruSight One sequencing panel to perform single nucleotide polymorphism (SNP) genotyping starting from 3 micro-manipulated cells. This setting simulates clinical settings such as day-5 blastocyst biopsy for Preimplantation Genetic Testing (PGT), liquid biopsy of circulating tumor cells (CTCs) and cancer-cell profiling. Bulk cell samples were processed alongside these WGA samples to serve as a performance reference. Target coverage, coverage uniformity and SNP calling accuracy obtained using any of the WGA, is inferior to the results obtained on bulk cell samples. However, results after REPLI-g come close. Compared to the other WGA methods, the method using REPLI-g WGA results in a better coverage of the targeted genomic regions with a more uniform read depth. Consequently, this method also results in a more accurate SNP calling and could be considered for clinical genotyping of a limited number of cells.	[Deleye, Lieselot; Gansemans, Yannick; De Coninck, Dieter; Van Nieuwerburgh, Filip; Deforce, Dieter] Univ Ghent, Lab Pharmaceut Biotechnol, Ghent, Belgium	Ghent University	Van Nieuwerburgh, F (corresponding author), Univ Ghent, Lab Pharmaceut Biotechnol, Ghent, Belgium.	Filip.VanNieuwerburgh@ugent.be	Van Nieuwerburgh, Filip/H-9697-2015; Deleye, Lieselot/AAB-5305-2022; Deforce, Dieter LD/J-4725-2013	Van Nieuwerburgh, Filip/0000-0001-8815-5485; Deforce, Dieter LD/0000-0002-0635-661X; Gansemans, Yannick/0000-0001-5018-044X	BOF (Bijzonder Onderzoeksfonds) University Ghent [BOF12/GOA/011]; Hercules stichting	BOF (Bijzonder Onderzoeksfonds) University Ghent; Hercules stichting	This study was supported by a concerted research actions funding from BOF (Bijzonder Onderzoeksfonds) University Ghent, grant number BOF12/GOA/011 and samples were sequenced on a NextSeq500 Illumina sequencer which was funded by 'Hercules stichting'. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babayan A, 2017, ONCOTARGET, V8, P56066, DOI 10.18632/oncotarget.10701; Borgstrom E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171566; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; De Luca F, 2016, ONCOTARGET, V7, P26107, DOI 10.18632/oncotarget.8431; Deleye L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03711-y; Deleye L, 2015, FERTIL STERIL, V104, P1276, DOI 10.1016/j.fertnstert.2015.07.1144; Deleye L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11711; Dreesen J, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.277; Fiorentino F, 2014, FERTIL STERIL, V101, P1375, DOI 10.1016/j.fertnstert.2014.01.051; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Koehler U, 2013, J REPRODUKTIONSMED E, V10, P38; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HE, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0034-3; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Mucciolo M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060952; Normand E, 2016, PRENATAL DIAG, V36, P823, DOI 10.1002/pd.4866; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Russo Claudio Dello, 2014, J Prenat Med, V8, P57; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Treff NR, 2013, FERTIL STERIL, V99, P1377, DOI 10.1016/j.fertnstert.2012.12.018; Wells D, 2014, J MED GENET, V51, P553, DOI 10.1136/jmedgenet-2014-102497; Zegers-Hochschild F, 2017, HUM REPROD, V32, P1786, DOI 10.1093/humrep/dex234	24	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196334	10.1371/journal.pone.0196334	http://dx.doi.org/10.1371/journal.pone.0196334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698522	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600064
J	Heath, TK; Lutz, MR; Reidl, CT; Guzman, ER; Herbert, CA; Nocek, BP; Holz, RC; Olsen, KW; Ballicora, MA; Becker, DP				Heath, Tahirah K.; Lutz, Marlon R., Jr.; Reidl, Cory T.; Guzman, Estefany R.; Herbert, Claire A.; Nocek, Boguslaw P.; Holz, Richard C.; Olsen, Kenneth W.; Ballicora, Miguel A.; Becker, Daniel P.			Practical spectrophotometric assay for the dapE-encoded N-succinyl-L, L-diaminopimelic acid desuccinylase, a potential antibiotic target	PLOS ONE			English	Article							HELICOBACTER-PYLORI DAPE; HAEMOPHILUS-INFLUENZAE; SUBSTRATE-SPECIFICITY; LYSINE BIOSYNTHESIS; ESCHERICHIA-COLI; INHIBITION; PEPTIDES; PROTEINS; BINDING	A new enzymatic assay for the bacterial enzyme succinyl-diaminopimelate desuccinylase (DapE, E.C. 3.5.1.18) is described. This assay employs N-6-methyl-N-2-succinyl-L, L-diamino-pimelic acid (N-6-methyl-L,L-SDAP) as the substrate with ninhydrin used to detect cleavage of the amide bond of the modified substrate, wherein N-6-methylation enables selective detection of the primary amine enzymatic product. Molecular modeling supported preparation of the mono-N-6-methylated-L,L-SDAPas an alternate substrate for the assay, given binding in the active site of DapE predicted to be comparable to the endogenous substrate. The alternate substrate for the assay, N-6-methyl-L, L-SDAP, was synthesized from the tertbutyl ester of Boc-L-glutamic acid employing a Horner-Wadsworth-Emmons olefination followed by an enantioselective reduction employing Rh(I)(COD)(S,S)-Et-DuPHOS as the chiral catalyst. Validation of the new ninhydrin assay was demonstrated with known inhibitors of DapE from Haemophilus influenza (HiDapE) including captopril (IC50 = 3.4 [+/- 0.2] mu M, 3-mercaptobenzoic acid (IC50 = 21.8 [+/- 2.2] mu M, phenylboronic acid (IC50 = 316 [+/- 23.6] mu M, and 2-thiopheneboronic acid (IC50 = 111 [+/- 16] mu M. Based on these data, this assay is simple and robust, and should be amenable to high-throughput screening, which is an important step forward as it opens the door to medicinal chemistry efforts toward the discovery of DapE inhibitors that can function as a new class of antibiotics.	[Heath, Tahirah K.; Lutz, Marlon R., Jr.; Reidl, Cory T.; Guzman, Estefany R.; Herbert, Claire A.; Olsen, Kenneth W.; Ballicora, Miguel A.; Becker, Daniel P.] Loyola Univ Chicago, Dept Chem & Biochem, Chicago, IL 60660 USA; [Lutz, Marlon R., Jr.] Regis Technol Inc, Morton Grove, IL USA; [Nocek, Boguslaw P.] Univ Chicago, Computat Inst, Ctr Struct Genom Infect Dis, Chicago, IL 60637 USA; [Holz, Richard C.] Marquette Univ, Dept Chem, Milwaukee, WI 53233 USA	Loyola University Chicago; University of Chicago; Marquette University	Becker, DP (corresponding author), Loyola Univ Chicago, Dept Chem & Biochem, Chicago, IL 60660 USA.	dbecke3@luc.edu		Becker, Daniel/0000-0001-9392-0460	National Science Foundation [CHE-1412443]; Regis Technologies	National Science Foundation(National Science Foundation (NSF)); Regis Technologies	We thank the National Science Foundation, https://www.nsf.gov/ for CHE-1412443 to RCH for partially funding this research in supporting the research efforts and salary of BN. Regis Technologies provided support in the form of a salary for one author [ML] who is a part-time graduate student at Loyola University Chicago but is also employed full-time at Regis Technologies. Regis Technologies did provide financial support for graduate school tuition and research materials but did not play any role in the study design, decision to publish, or preparation of the manuscript. Regis Technologies was involved in data collection and analysis of synthetic compounds mentioned within the manuscript but retains no rights to the findings or contents of this manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bienvenue DL, 2003, BIOCHEMISTRY-US, V42, P10756, DOI 10.1021/bi034845+; Blatt LM, 2007, PCT Int Appl., P315, Patent No. 200760915896; Blatt LM, 2008, P315, Patent No. [2008-US62552; 2007-60915896, 200862552]; Cosper NJ, 2003, J AM CHEM SOC, V125, P14654, DOI 10.1021/ja036650v; Fraser RDB, 1973, PHYS PRINCIPLES TECH; FRIEDMAN M, 1970, BIOCHIM BIOPHYS ACTA, V207, P361, DOI 10.1016/0005-2795(70)90028-0; Friedman M, 2004, J AGR FOOD CHEM, V52, P385, DOI 10.1021/jf030490p; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gillner D, 2009, BIOORG MED CHEM LETT, V19, P6350, DOI 10.1016/j.bmcl.2009.09.077; Gillner DM, 2013, J BIOL INORG CHEM, V18, P155, DOI 10.1007/s00775-012-0965-1; Glinka T, 2008, P198, Patent No. [2008-US62785; 2007-60917616, 62785]; Glinka T, 2008, P198, Patent No. [2008-US62785; 2007-60917616, 200760917616]; HORENSTEIN BA, 1989, J AM CHEM SOC, V111, P6242, DOI 10.1021/ja00198a040; Howe RA, 1998, LANCET, V351, P602, DOI 10.1016/S0140-6736(05)78597-4; Jorgensen KB, 1999, TETRAHEDRON, V55, P10527, DOI 10.1016/S0040-4020(99)00576-1; Karita M, 1997, INFECT IMMUN, V65, P4158, DOI 10.1128/IAI.65.10.4158-4164.1997; KINDLER SH, 1960, J BIOL CHEM, V235, P3532; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; LIN Y, 1988, J BIOL CHEM, V263, P1622; Mandal RS, 2015, J BIOMOL STRUCT DYN, V33, P1460, DOI 10.1080/07391102.2014.954272; McGregor WC, 2007, J BIOL INORG CHEM, V12, P603, DOI 10.1007/s00775-007-0211-4; Nocek B, 2018, BIOCHEMISTRY-US, V57, P574, DOI 10.1021/acs.biochem.7b01151; Nocek BP, 2010, J MOL BIOL, V397, P617, DOI 10.1016/j.jmb.2010.01.062; Okano K, 2006, J AM CHEM SOC, V128, P7136, DOI 10.1021/ja0619455; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Pratt SD, 1997, J BIOMOL SCREEN, V2, P241, DOI 10.1177/108705719700200409; RAOUDA N, 2014, METALLOMICS, V6, P88, DOI DOI 10.1039/C3MT00125C; Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Starus A, 2015, BIOCHEMISTRY-US, V54, P4834, DOI 10.1021/acs.biochem.5b00475; Uda NR, 2011, BIOINORG CHEM APPL, V2011, DOI 10.1155/2011/306465; Wang W, 2002, SYNTHESIS-STUTTGART, P94; World Health Organization, WHOEMPIAU201712; Yin BD, 2000, PROCESS BIOCHEM, V35, P915, DOI 10.1016/S0032-9592(99)00157-0; Ziegler AJ, 2009, J ENZYM INHIB MED CH, V24, P22, DOI [10.1080/14756360701841426, 10.1080/14756360701841426 ]	36	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196010	10.1371/journal.pone.0196010	http://dx.doi.org/10.1371/journal.pone.0196010			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698518	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600028
J	Moretti, ML; Busso-Lopes, AF; Tararam, CA; Moraes, R; Muraosa, Y; Mikami, Y; Gonoi, T; Taguchi, H; Lyra, L; Reichert-Lima, F; Trabasso, P; de Hoog, GS; Al-Hatmi, AMS; Schreiber, AZ; Kamei, K				Moretti, Maria Luiza; Busso-Lopes, Ariane Fidelis; Tararam, Cibele Aparecida; Moraes, Renato; Muraosa, Yasunori; Mikami, Yuzuru; Gonoi, Tohru; Taguchi, Hideaki; Lyra, Luzia; Reichert-Lima, Franqueline; Trabasso, Plinio; de Hoog, Gerrit Sybren; Al-Hatmi, Abdullah Mohammed Said; Schreiber, Angelica Zaninelli; Kamei, Katsuhiko			Airborne transmission of invasive fusariosis in patients with hematologic malignancies	PLOS ONE			English	Article							CELL TRANSPLANT RECIPIENTS; SOLANI SPECIES COMPLEX; MOLD INFECTIONS; EPIDEMIOLOGY; NAPIFORME; KERATITIS; DISEASES; SYSTEM; AGENTS; COMMON	From 2006 to 2013, an increasing incidence of fusariosis was observed in the hematologic patients of our University Hospital. We suspected of an environmental source, and the indoor hospital air was investigated as a potential source of the fungemia. Air samplings were performed in the hematology and bone marrow transplant (BMT) wards using an air sampler with pre-defined air volumes. To study the molecular relationship among environmental and clinical isolates, 18 Fusarium spp. recovered from blood cultures were included in the study. DNA sequencing of a partial portion of TEF1 alpha gene was performed for molecular identification. Molecular typing was carried out by multi-locus sequence typing (MLST) using a four-gene scheme: TEF1 alpha, rDNA, RPB1 and RPB2. One hundred four isolates were recovered from the air of the hematology (n = 76) and the BMT (n = 28) wards. Fusarium isolates from the air were from five species complexes: Fusarium fujikuroi (FFSC, n = 56), Fusarium incarnatum-equiseti (FIESC, n = 24), Fusarium solani (FSSC, n = 13), Fusarium chlamydosporum (FCSC, n = 10), and Fusarium oxysporum (FOSC, n = 1). Fifteen Fusarium isolates recovered from blood belonged to FSSC, and three to FFSC. MLST identified the same sequence type (ST) in clinical and environmental isolates. ST1 was found in 5 isolates from blood and in 7 from the air, both identified as FSSC (Fusarium petroliphilum). STn1 was found in one isolate from blood and in one from the air, both identified as FFSC (Fusarium napiforme). F. napiforme was isolated from the air of the hospital room of the patient with fungemia due to F. napiforme. These findings suggested a possible clonal origin of the Fusarium spp. recovered from air and bloodcultures. In conclusion, our study found a diversity of Fusarium species in the air of our hospital, and a possible role of the air as source of systemic fusariosis in our immunocompromised patients.	[Moretti, Maria Luiza; Tararam, Cibele Aparecida; Moraes, Renato; Trabasso, Plinio] Univ Estadual Campinas, Dept Internal Med, Fac Med Sci, Campinas, SP, Brazil; [Busso-Lopes, Ariane Fidelis] Brazilian Biosci Natl Lab, Campinas, SP, Brazil; [Muraosa, Yasunori; Mikami, Yuzuru; Gonoi, Tohru; Taguchi, Hideaki; Kamei, Katsuhiko] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Lyra, Luzia; Reichert-Lima, Franqueline; Schreiber, Angelica Zaninelli] Univ Estadual Campinas, Dept Clin Pathol, Fac Med Sci, Campinas, SP, Brazil; [de Hoog, Gerrit Sybren; Al-Hatmi, Abdullah Mohammed Said] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands; [de Hoog, Gerrit Sybren; Al-Hatmi, Abdullah Mohammed Said] Univ Amsterdam, Inst Biodivers, Amsterdam, Netherlands; [de Hoog, Gerrit Sybren; Al-Hatmi, Abdullah Mohammed Said] Univ Amsterdam, Inst Ecosyst Dynam, Amsterdam, Netherlands; [de Hoog, Gerrit Sybren] Univ Fed Parana, Basic Pathol Dept, Curitiba, Parana, Brazil; [de Hoog, Gerrit Sybren] King Abdulaziz Univ, Biol Dept, Fac Sci, Jeddah, Saudi Arabia; [Al-Hatmi, Abdullah Mohammed Said] Minist Hlth, Ibri Hosp, Directorate Gen Hlth Serv, Muscat, Oman	Universidade Estadual de Campinas; Chiba University; Universidade Estadual de Campinas; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Amsterdam; University of Amsterdam; Universidade Federal do Parana; King Abdulaziz University	Moretti, ML (corresponding author), Univ Estadual Campinas, Dept Internal Med, Fac Med Sci, Campinas, SP, Brazil.	moretti.luiza@gmail.com	gonoi, tohru/AAC-5181-2021; Trabasso, Plinio/ABA-1811-2021; Schreiber, Angelica Zaninelli/C-8759-2012; , gonoi/GRS-0648-2022; Busso-Lopes, Ariane Fidelis/K-1383-2015; Trabasso, Plinio/C-3968-2013; Schreiber, Angelica/ABB-8568-2021	gonoi, tohru/0000-0003-3655-7911; Trabasso, Plinio/0000-0002-0588-4859; Schreiber, Angelica Zaninelli/0000-0002-5095-5054; , gonoi/0000-0003-3655-7911; Busso-Lopes, Ariane Fidelis/0000-0003-2280-1848; Trabasso, Plinio/0000-0002-0588-4859; Schreiber, Angelica/0000-0002-5095-5054; moretti, maria luiza/0000-0002-2280-5649; Muraosa, Yasunori/0000-0002-6979-3921	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [2012/51158-0]; Science and Technology Research Partnership for Sustainable Development, Japan (SATREPS); University of Campinas, Brazil [02P-29548-09]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Science and Technology Research Partnership for Sustainable Development, Japan (SATREPS); University of Campinas, Brazil	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP No. 2012/51158-0, and by the Science and Technology Research Partnership for Sustainable Development, Japan (SATREPS) and University of Campinas, Brazil, No. 02P-29548-09.; This project was supported by grants from the collaborative research project: Science and Technology Research Partnership for Sustainable Development, Japan (SATREPS) and University of Campinas, Brazil, No. 02P-29548-09 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP No. 2012/51158-0. We would like to thank Dr. Haruhisa Suga (Life Science Research Center, Gifu University, Gifu, Japan) for kindly providing the sequences of HS392 and HS393 primers.	Chilaka CA, 2017, TOXINS, V9, DOI 10.3390/toxins9010019; Al-Hatmi AMS, 2015, J ANTIMICROB CHEMOTH, V70, P1068, DOI 10.1093/jac/dku505; Alastruey-Izquierdo A, 2008, J ANTIMICROB CHEMOTH, V61, P805, DOI 10.1093/jac/dkn022; Anaissie EJ, 2001, CLIN INFECT DIS, V33, P1871, DOI 10.1086/324501; [Anonymous], 1976, P AM PHYTOPATH SOC, V3, P221; [Anonymous], 1967, J TROP MED HYG, V70, P181; Arikan S, 1999, J CLIN MICROBIOL, V37, P3946, DOI 10.1128/JCM.37.12.3946-3951.1999; Carlesse F, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0247-3; Cuenca-Estrella M, 2006, ANTIMICROB AGENTS CH, V50, P917, DOI 10.1128/AAC.50.3.917-921.2006; de Souza M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-492; Doczi I, 2004, CLIN MICROBIOL INFEC, V10, P773, DOI 10.1111/j.1469-0691.2004.00909.x; Edel-Hermann V, 2016, APPL ENVIRON MICROB, V82, P6483, DOI 10.1128/AEM.01939-16; Guevara-Suarez M, 2016, MYCOPATHOLOGIA, V181, P165, DOI 10.1007/s11046-016-9983-9; Hahn T, 2002, INFECT CONT HOSP EP, V23, P525, DOI 10.1086/502101; Homa M, 2013, MYCOSES, V56, P501, DOI 10.1111/myc.12062; LACAZ C.S., 2002, Rev. Inst. Med. trop. S. Paulo, V44, P297; Lass-Florl C, 2017, J ANTIMICROB CHEMOTH, V72, pI5, DOI 10.1093/jac/dkx028; Lee SK, 2000, ALLERGY, V55, P1190, DOI 10.1034/j.1398-9995.2000.00650.x; Litvinov N, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.004; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; MELCHER GP, 1993, J CLIN MICROBIOL, V31, P1461, DOI 10.1128/JCM.31.6.1461-1467.1993; Mosquera Gordillo M A, 2018, Arch Soc Esp Oftalmol (Engl Ed), V93, P283, DOI 10.1016/j.oftal.2017.08.005; Moya-Elizondo EA, 2011, PLANT DIS, V95, P1099, DOI 10.1094/PDIS-11-10-0795; Muhammed M, 2013, MEDICINE, V92, P305, DOI 10.1097/MD.0000000000000008; Muraosa Y, 2014, INT J MED MICROBIOL, V304, P505, DOI 10.1016/j.ijmm.2014.03.001; Nucci M, 2004, CLIN INFECT DIS, V38, P1237, DOI 10.1086/383319; Nucci M, 2013, CLIN MICROBIOL INFEC, V19, P745, DOI 10.1111/1469-0691.12002; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Donnell K, 2010, J CLIN MICROBIOL, V48, P3708, DOI 10.1128/JCM.00989-10; O'Donnell K, 2009, J CLIN MICROBIOL, V47, P3851, DOI 10.1128/JCM.01616-09; Panagopoulou P, 2002, J HOSP INFECT, V52, P185, DOI 10.1053/jhin.2002.1298; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Raad I, 2002, INFECT CONT HOSP EP, V23, P532, DOI 10.1086/502102; Scheel CM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-49; Short DPG, 2011, J CLIN MICROBIOL, V49, P4264, DOI 10.1128/JCM.05468-11; Smiley RW, 2009, PLANT DIS, V93, P73, DOI 10.1094/PDIS-93-1-0073; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tilak R, 2010, J INFECT DEV COUNTR, V4, P171, DOI 10.3855/jidc.309; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Zhang N, 2006, J CLIN MICROBIOL, V44, P2186, DOI 10.1128/JCM.00120-06	41	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196426	10.1371/journal.pone.0196426	http://dx.doi.org/10.1371/journal.pone.0196426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698435	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600079
J	Wang, Y; Hou, W; Wang, FS				Wang, Yu; Hou, Wei; Wang, Fusheng			Mining co-occurrence and sequence patterns from cancer diagnoses in New York State	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; HURRICANE SANDY; VISITS; OUTCOMES; CITY	The goal of this study is to discover disease co-occurrence and sequence patterns from large scale cancer diagnosis histories in New York State. In particular, we want to identify disparities among different patient groups. Our study will provide essential knowledge for clinical researchers to further investigate comorbidities and disease progression for improving the management of multiple diseases. We used inpatient discharge and outpatient visit records from the New York State Statewide Planning and Research Cooperative System (SPARCS) from 2011-2015. We grouped each patient's visit history to generate diagnosis sequences for seven most popular cancer types. We performed frequent disease co-occurrence mining using the Apriori algorithm, and frequent disease sequence patterns discovery using the cSPADE algorithm. Different types of cancer demonstrated distinct patterns. Disparities of both disease co-occurrence and sequence patterns were observed from patients within different age groups. There were also considerable disparities in disease co-occurrence patterns with respect to different claim types (i.e., inpatient, outpatient, emergency department and ambulatory surgery). Disparities regarding genders were mostly found where the cancer types were gender specific. Supports of most patterns were usually higher for males than for females. Compared with secondary diagnosis codes, primary diagnosis codes can convey more stable results. Two disease sequences consisting of the same diagnoses but in different orders were usually with different supports. Our results suggest that the methods adopted can generate potentially interesting and clinically meaningful disease co-occurrence and sequence patterns, and identify disparities among various patient groups. These patterns could imply comorbidities and disease progressions.	[Wang, Yu; Wang, Fusheng] SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA; [Hou, Wei] SUNY Stony Brook, Dept Family Populat & Prevent Med, Stony Brook, NY 11794 USA; [Wang, Fusheng] SUNY Stony Brook, Dept Biomed Informat, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, FS (corresponding author), SUNY Stony Brook, Dept Comp Sci, Stony Brook, NY 11794 USA.; Wang, FS (corresponding author), SUNY Stony Brook, Dept Biomed Informat, Stony Brook, NY 11794 USA.	fusheng.wang@stonybrook.edu	hou, wei/GWM-4800-2022; Wang, Fusheng/ABB-6248-2022	Wang, Fusheng/0000-0002-9369-9361	National Science Foundation-Advanced Cyberinfrastructure (ACI) [1443054]; National Science Foundation-Information and Intelligent Systems (IIS) [1350885]; National Science Foundation-Industrial Innovation and Partnerships (IIP) [1069147]; Direct For Computer & Info Scie & Enginr [1541063] Funding Source: National Science Foundation	National Science Foundation-Advanced Cyberinfrastructure (ACI); National Science Foundation-Information and Intelligent Systems (IIS); National Science Foundation-Industrial Innovation and Partnerships (IIP); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Science Foundation-Advanced Cyberinfrastructure (ACI)-1443054 (https://www.nsf.gov/cise/oac/about.jsp, received by FW); National Science Foundation-Information and Intelligent Systems (IIS)-1350885 (https://www.nsf.gov/div/index.jsp?div=IIS, received by FW); National Science Foundation-Industrial Innovation and Partnerships (IIP)-1069147 (https://www.nsf.gov/div/index.jsp?div=IIP), received by FW).	Agrawal R., 1994, P 20 INT C VER LARG, P487; American Cancer Society, 2017, CANC FACTS FIG 2017; Arakaki L, 2016, EPIDEMIOL INFECT, V144, P2374, DOI 10.1017/S0950268816000406; Bekelis K, 2016, J NEUROINTERVENTIONA; Bekelis K, 2016, CHILD NERV SYST, V32, P2159, DOI 10.1007/s00381-016-3114-2; Buchta C, ARULESSEQUENCES MINI; Chen X, 2017, P 2017 AMIA JOINT SU; Chen Xin, 2016, AMIA Annu Symp Proc, V2016, P391; He FT, 2016, DISASTER MED PUBLIC, V10, P512, DOI 10.1017/dmp.2016.89; Jensen AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5022; Kim H, 2016, DISASTER MED PUBLIC, V10, P344, DOI 10.1017/dmp.2015.189; Klema J, 2008, IEEE T SYST MAN CY C, V38, P3, DOI 10.1109/TSMCC.2007.906055; Kost Rhonda, 2012, AMIA Annu Symp Proc, V2012, P1284; Lopez-Soto PJ, 2016, NURS RES, V65, P435, DOI 10.1097/NNR.0000000000000184; Missios S, 2016, J NEURO-ONCOL, V128, P365, DOI 10.1007/s11060-016-2122-0; Munson ME, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/214353; National Cancer Institute, 2015, AGE; New York State Department of Health, 2016, STAT PLANN RES COOP; Ram S, 2015, IEEE J BIOMED HEALTH, V19, P1216, DOI 10.1109/JBHI.2015.2404829; SIEGEL RL, 2017, CA-CANCER J CLIN, V67, P7, DOI [10.3322/caac.21387, DOI 10.3322/CAAC.21387]; Tsoi AC, 2005, IEEE T KNOWL DATA EN, V17, P1420, DOI 10.1109/TKDE.2005.168; US Department of Health & Human Services, SUMM HIPAA PRIV RUL; Wang F, 2013, IEEE T PATTERN ANAL, V35, P272, DOI 10.1109/TPAMI.2012.111; Wang Y, 2017, J CONTROL SCI ENG, V2017, DOI 10.1155/2017/2428982; Welch HG, 1999, J GEN INTERN MED, V14, P223, DOI 10.1046/j.1525-1497.1999.00321.x; Zaki M. J., 2000, Proceedings of the Ninth International Conference on Information and Knowledge Management. CIKM 2000, P422, DOI 10.1145/354756.354849; Zaki MJ, 2001, MACH LEARN, V42, P31, DOI 10.1023/A:1007652502315	27	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0194407	10.1371/journal.pone.0194407	http://dx.doi.org/10.1371/journal.pone.0194407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698405	Green Submitted, Green Published, gold			2022-12-26	WOS:000431007600005
J	Wen, YX; Trinh, HV; Linton, CE; Tani, C; Norais, N; Martinez-Guzman, D; Ramesh, P; Sun, YD; Situ, F; Karaca-Griffin, S; Hamlin, C; Onkar, S; Tian, S; Hilt, S; Malyala, P; Lodaya, R; Li, N; Otten, G; Palladino, G; Friedrich, K; Aggarwal, Y; LaBranche, C; Duffy, R; Shen, XY; Tomaras, GD; Montefiori, DC; Fulp, W; Gottardo, R; Burke, B; Ulmer, JB; Zolla-Pazner, S; Liao, HX; Haynes, BF; Michael, NL; Kim, JH; Rao, M; O'Connell, RJ; Carfi, A; Barnett, SW				Wen, Yingxia; Trinh, Hung V.; Linton, Christine E.; Tani, Chiara; Norais, Nathalie; Martinez-Guzman, DeeAnn; Ramesh, Priyanka; Sun, Yide; Situ, Frank; Karaca-Griffin, Selen; Hamlin, Christopher; Onkar, Sayali; Tian, Sai; Hilt, Susan; Malyala, Padma; Lodaya, Rushit; Li, Ning; Otten, Gillis; Palladino, Giuseppe; Friedrich, Kristian; Aggarwal, Yukti; LaBranche, Celia; Duffy, Ryan; Shen, Xiaoying; Tomaras, Georgia D.; Montefiori, David C.; Fulp, William; Gottardo, Raphael; Burke, Brian; Ulmer, Jeffrey B.; Zolla-Pazner, Susan; Liao, Hua-Xin; Haynes, Barton F.; Michael, Nelson L.; Kim, Jerome H.; Rao, Mangala; O'Connell, Robert J.; Carfi, Andrea; Barnett, Susan W.			Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BROADLY NEUTRALIZING ANTIBODIES; VACCINE EFFICACY TRIAL; MONOCLONAL-ANTIBODY; HIV-1-INFECTED INDIVIDUALS; ENVELOPE GLYCOPROTEIN; NONHUMAN-PRIMATES; CROSS-REACTIVITY; IMMUNE PRESSURE; CELL RESPONSES	The RV144 Phase III clinical trial with ALVAC-HIV prime and AIDSVAX B/E subtypes CRF01_AE (A244) and B (MN) gp120 boost vaccine regime in Thailand provided a foundation for the future development of improved vaccine strategies that may afford protection against the human immunodeficiency virus type 1 (HIV-1). Results from this trial showed that immune responses directed against specific regions V1V2 of the viral envelope (Env) glycoprotein gp120 of HIV-1, were inversely correlated to the risk of HIV-1 infection. Due to the low production of gp120 proteins in CHO cells (2 +/- 20 mg/L), cleavage sites in V1V2 loops (A244) and V3 loop (MN) causing heterogeneous antigen products, it was an urgent need to generate CHO cells harboring A244 gp120 with high production yields and an additional, homogenous and uncleaved subtype B gp120 protein to replace MN used in RV144 for the future clinical trials. Here we describe the generation of Chinese Hamster Ovary (CHO) cell lines stably expressing vaccine HIV-1 Env antigens for these purposes: one expressing an HIV-1 subtype CRF01_AE A244 Env gp120 protein (A244.AE) and one expressing an HIV-1 subtype B 6240 Env gp120 protein (6240.B) suitable for possible future manufacturing of Phase I clinical trial materials with cell culture expression levels of over 100 mg/L. The antigenic profiles of the molecules were elucidated by comprehensive approaches including analysis with a panel of well-characterized monoclonal antibodies recognizing critical epitopes using Biacore and ELISA, and glycosylation analysis by mass spectrometry, which confirmed previously identified glycosylation sites and revealed unknown sites of O-linked and N-linked glycosylations at non-consensus motifs. Overall, the vaccines given with MF59 adjuvant induced higher and more rapid antibody (Ab) responses as well as higher Ab avidity than groups given with aluminum hydroxide. Also, bivalent proteins (A244.AE and 6240.B) formulated with MF59 elicited distinct V2-specific Abs to the epitope previously shown to correlate with decreased risk of HIV-1 infection in the RV144 trial. All together, these results provide critical information allowing the consideration of these candidate gp120 proteins for future clinical evaluations in combination with a potent adjuvant.	[Wen, Yingxia; Martinez-Guzman, DeeAnn; Ramesh, Priyanka; Sun, Yide; Situ, Frank; Karaca-Griffin, Selen; Hilt, Susan; Malyala, Padma; Lodaya, Rushit; Otten, Gillis; Palladino, Giuseppe; Aggarwal, Yukti; Burke, Brian] Novartis Vaccines & Diagnost, Cambridge, MA USA; [Trinh, Hung V.; Hamlin, Christopher; Onkar, Sayali; Michael, Nelson L.; Kim, Jerome H.; Rao, Mangala; O'Connell, Robert J.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Trinh, Hung V.; Hamlin, Christopher; Onkar, Sayali] Henry Jackson Fdn Adv Mil Med, Silver Spring, MD USA; [Linton, Christine E.; Tian, Sai; Li, Ning; Friedrich, Kristian; Ulmer, Jeffrey B.; Carfi, Andrea; Barnett, Susan W.] GSK, Rockville, MD USA; [Tani, Chiara; Norais, Nathalie] GSK, Siena, Italy; [LaBranche, Celia; Tomaras, Georgia D.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Duffy, Ryan; Shen, Xiaoying; Tomaras, Georgia D.; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA; [Fulp, William; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Zolla-Pazner, Susan] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Liao, Hua-Xin] Jinan Univ, Biomed Inst, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [O'Connell, Robert J.] Armed Forces Res Inst Med Sci, Bangkok, Thailand; [Wen, Yingxia; Otten, Gillis; Palladino, Giuseppe] Seqirus, Cambridge, MA USA; [Ramesh, Priyanka] Seqirus, Holly Springs, NC USA; [Malyala, Padma] Novartis, Cambridge, MA USA; [Li, Ning] EMD Serono Inc, Rockland, MA USA; [Burke, Brian] Nektar Therapeut, San Francisco, CA USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea; [Carfi, Andrea] Valera, Cambridge, MA USA; [Barnett, Susan W.] Bill & Melinda Gates Fdn, Seattle, WA USA	Novartis; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); GlaxoSmithKline; GlaxoSmithKline; Duke University; Duke University; Fred Hutchinson Cancer Center; Icahn School of Medicine at Mount Sinai; Jinan University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); CSL; CSL; Novartis; Merck KGaA; EMD Serono Inc.; Nektar Therapeutics; International Vaccine Institute; Bill & Melinda Gates Foundation	Ulmer, JB; Carfi, A; Barnett, SW (corresponding author), GSK, Rockville, MD USA.; Carfi, A (corresponding author), Valera, Cambridge, MA USA.; Barnett, SW (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA USA.	jeffrey.b.ulmer@gsk.com; andrea.carfi@valeratx.com; susan.barnett@gatesfoundation.org	Trinh, Hung/AAD-5469-2019; Gottardo, Raphael/HCH-3169-2022; Fulp, William/AAD-2369-2022; Zolla-Pazner, Susan/S-1864-2019; Ramesh, Priyanka/HHZ-0349-2022	Trinh, Hung/0000-0001-8014-9291; Zolla-Pazner, Susan/0000-0002-0750-2666; Gottardo, Raphael/0000-0002-3867-0232; Carfi, Andrea/0000-0001-5508-3809; Lodaya, Rushit/0000-0003-4107-3671; Fulp, William/0000-0001-6888-0794	Bill & Melinda Gates Foundation (BMGF) [OPP1017604, OPP1032144, OPP1151646]; Swiss National Science Foundation [P3SMP3_148406/1]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-11-2-0174, W81XWH-07-2-0067]; U.S. Department of Defense [W81XWH-11-2-0174, W81XWH-07-2-0067]; GlaxoSmithKline Biologicals SA	Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense(United States Department of Defense); GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This work was supported by Global Health Grant OPP1017604 to GSK and SWB and the Collaboration for AIDS Vaccine Discovery grants OPP1032144 (to Duke University and DCM) and OPP1151646 (to Fred Hutchison Cancer Research Center and RG) from the Bill & Melinda Gates Foundation (BMGF). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section below. HVT was partially supported by a grant from the Swiss National Science Foundation (P3SMP3_148406/1). The work performed at MHRP was supported by a cooperative agreement (W81XWH-11-2-0174) and (W81XWH-07-2-0067 to NLM) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense. This work was sponsored by GlaxoSmithKline Biologicals SA, which was involved in all stages of the study conduct and analysis.	Ackerman ME, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005315; Alam SM, 2013, P NATL ACAD SCI USA, V110, P18214, DOI 10.1073/pnas.1317855110; Alam SM, 2013, J VIROL, V87, P1554, DOI 10.1128/JVI.00718-12; Alving CR, 2016, EXPERT OPIN DRUG DEL, V13, P807, DOI 10.1517/17425247.2016.1151871; Asperger A, 2015, J PROTEOME RES, V14, P2633, DOI 10.1021/acs.jproteome.5b00175; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Bennett JW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004423; Berman PW., 1998, AIDS RES HUM RETRO S, V14, pS277; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Burke B, 2007, CURR HIV RES, V5, P625, DOI 10.2174/157016207782418533; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Cabello M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33971; Cao LW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14954; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; Chung AW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007736; Crispin M, 2013, NAT STRUCT MOL BIOL, V20, P771, DOI 10.1038/nsmb.2627; Dendouga N, 2012, VACCINE, V30, P3126, DOI 10.1016/j.vaccine.2012.01.088; Didierlaurent AM, 2017, EXPERT REV VACCINES, V16, P55, DOI 10.1080/14760584.2016.1213632; Du SX, 2008, PROTEIN EXPRES PURIF, V59, P223, DOI 10.1016/j.pep.2008.02.002; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Go EP, 2013, J PROTEOME RES, V12, P1223, DOI 10.1021/pr300870t; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Gray GE, 2016, CURR OPIN VIROL, V17, P104, DOI 10.1016/j.coviro.2016.02.010; HART TK, 1991, P NATL ACAD SCI USA, V88, P2189, DOI 10.1073/pnas.88.6.2189; Harvey DJ, 2012, J AM SOC MASS SPECTR, V23, P1955, DOI 10.1007/s13361-012-0425-8; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Horiya S, 2014, NAT CHEM BIOL, V10, P990, DOI 10.1038/nchembio.1685; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; KAHN JO, 1994, J INFECT DIS, V170, P1288, DOI 10.1093/infdis/170.5.1288; Karasavvas N, 2015, AIDS RES HUM RETROV, V31, P1178, DOI [10.1089/AID.2015.0034, 10.1089/aid.2015.0034]; Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Liao HX, 2013, J VIROL, V87, P4185, DOI 10.1128/JVI.02297-12; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Liu QB, 2017, NAT STRUCT MOL BIOL, V24, P370, DOI 10.1038/nsmb.3382; Lofano G, 2015, J IMMUNOL, V195, P1617, DOI 10.4049/jimmunol.1402604; Mahan AE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005456; Mayr LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070859; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; O'Hagan DT, 2007, EXPERT REV VACCINES, V6, P699, DOI 10.1586/14760584.6.5.699; Pan RM, 2015, J VIROL, V89, P8003, DOI 10.1128/JVI.00754-15; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Podda Audino, 2003, Expert Rev Vaccines, V2, P197, DOI 10.1586/14760584.2.2.197; Pollara J, 2013, CURR HIV RES, V11, P378, DOI 10.2174/1570162X113116660059; PRATT JW, 1959, J AM STAT ASSOC, V54, P655, DOI 10.2307/2282543; Rao M, 2016, CURR OPIN HIV AIDS, V11, P585, DOI 10.1097/COH.0000000000000315; Rerks-Ngarm S, 2013, J INFECT DIS, V207, P1195, DOI 10.1093/infdis/jis478; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Saksena NK, 2005, CELL RES, V15, P953, DOI 10.1038/sj.cr.7290373; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Shen XY, 2015, J VIROL, V89, P8643, DOI 10.1128/JVI.03635-14; Spurrier B, 2014, J VIROL, V88, P4100, DOI 10.1128/JVI.03153-13; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Tay MZ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005817; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tomaras G, 2016, PL01 02 OVERVIEW HUM; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang ZH, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4020017; Wise MC, 2015, J VIROL, V89, P9154, DOI 10.1128/JVI.00652-15; Yang WM, 2014, ANAL CHEM, V86, P6959, DOI 10.1021/ac500876p; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903; Zambonelli C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157391; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2014, EBIOMEDICINE, V1, P37, DOI 10.1016/j.ebiom.2014.10.022; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629	87	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0194266	10.1371/journal.pone.0194266	http://dx.doi.org/10.1371/journal.pone.0194266			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698406	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600003
J	Jimenez, AG; Winward, J; Beattie, U; Cipolli, W				Jimenez, Ana Gabriela; Winward, Josh; Beattie, Ursula; Cipolli, William			Cellular metabolism and oxidative stress as a possible determinant for longevity in small breed and large breed dogs	PLOS ONE			English	Article							HISTORY TRADE-OFFS; LIFE-SPAN; TELOMERE LENGTHS; DNA; MECHANISMS; CAPACITY; DAMAGE; SIZE; 8-HYDROXY-2-DEOXYGUANOSINE; RESTRICTION	Among species, larger animals tend to live longer than smaller ones, however, the opposite seems to be true for dogs-smaller dogs tend to live significantly longer than larger dogs across all breeds. We were interested in the mechanism that may allow for small breeds to age more slowly compared with large breeds in the context of cellular metabolism and oxidative stress. Primary dermal fibroblasts from small and large breed dogs were grown in culture. We measured basal oxygen consumption (OCR), proton leak, and glycolysis using a Seahorse XF96 oxygen flux analyzer. Additionally, we measured rates of reactive species (RS) production, reduced glutathione (GSH) content, mitochondrial content, lipid peroxidation (LPO) damage and DNA (8-OHdg) damage. Our data suggests that as dogs of both size classes age, proton leak is significantly higher in older dogs, regardless of size class. We found that all aspects of glycolysis were significantly higher in larger breeds compared with smaller breeds. We found significant differences between age classes in GSH concentration, and a negative correlation between DNA damage in puppies and mean breed life-span. Interestingly, RS production showed no differences across size and age class. Thus, large breed dogs may have higher glycolytic rates, and DNA damage, suggesting a potential mechanism for their decreased lifespan compared with small breed dogs.	[Jimenez, Ana Gabriela; Winward, Josh; Beattie, Ursula] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Cipolli, William] Colgate Univ, Dept Math, Hamilton, NY 13346 USA	Colgate University; Colgate University	Jimenez, AG (corresponding author), Colgate Univ, Dept Biol, Hamilton, NY 13346 USA.	ajimenez@colgate.edu		Beattie, Ursula/0000-0002-7131-3712	Colgate University	Colgate University	Colgate University funded this project.	[Anonymous], 2021, LANG ENV STAT COMP; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Austad SN, 2005, MECH AGEING DEV, V126, P43, DOI 10.1016/j.mad.2004.09.022; Austad SN, 2010, INTEGR COMP BIOL, V50, P783, DOI 10.1093/icb/icq131; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004; Cohen AA., 2017, BIOCH BIOPHYSICA ACT; Cortopassi GA, 1996, MECH AGEING DEV, V91, P211, DOI 10.1016/S0047-6374(96)01788-5; Cottet-Rousselle C, 2011, CYTOM PART A, V79A, P405, DOI 10.1002/cyto.a.21061; Deeb BJ., 1994, VET MED S, V89, P702; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Fan R, 2016, AGING-US, V8, P3209, DOI 10.18632/aging.101081; Fick LJ, 2012, CELL REP, V2, P1530, DOI 10.1016/j.celrep.2012.11.021; Galis F, 2007, J EXP ZOOL PART B, V308B, P119, DOI 10.1002/jez.b.21116; Gebhard AW, 2013, MOL CANCER THER, V12, P2446, DOI 10.1158/1535-7163.MCT-13-0310; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Greer KA, 2011, AGE, V33, P475, DOI 10.1007/s11357-010-9182-4; Guo JR, 2005, BIOTECHNOL LETT, V27, P3, DOI 10.1007/s10529-004-6294-x; HART RW, 1979, MECH AGEING DEV, V9, P203, DOI 10.1016/0047-6374(79)90100-3; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Head E, 2002, J NEUROCHEM, V82, P375, DOI 10.1046/j.1471-4159.2002.00969.x; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Jimenez AG, 2016, J COMP PHYSIOL B, V186, P813, DOI 10.1007/s00360-016-1002-4; Jin K, 2016, PATHOBIOL AGING AGE, V6, DOI 10.3402/pba.v6.33276; Kaneko T, 1996, MUTAT RES-DNAGING G, V316, P277, DOI 10.1016/S0921-8734(96)90010-7; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kraus C, 2013, AM NAT, V181, P492, DOI 10.1086/669665; Leiros M, 2015, ACS CHEM NEUROSCI, V6, P331, DOI 10.1021/cn500258c; Li Y, 1996, J GERONTOL A-BIOL, V51, pB403, DOI 10.1093/gerona/51A.6.B403; LITTLE JB, 1976, GERONTOLOGY, V22, P28, DOI 10.1159/000212123; Ljubisavljevic S, 2016, NEUROTOX RES, V30, P530, DOI 10.1007/s12640-016-9639-z; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lowseth Lisa A., 1990, Vet Clin Pathol, V19, P13, DOI 10.1111/j.1939-165X.1990.tb00535.x; Mandavilli Bhaskar S, 2010, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0935s53; McKevitt TP, 2002, J NUTR, V132, p1604S, DOI 10.1093/jn/132.6.1604S; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Michell AR, 1999, VET REC, V145, P625, DOI 10.1136/vr.145.22.625; Miller RA, 2011, AGEING RES REV, V10, P181, DOI 10.1016/j.arr.2010.01.002; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; MORGAN JA, 1972, TECHNOMETRICS, V14, P317, DOI 10.2307/1267424; MOSIER JE, 1989, VET CLIN N AM-SMALL, V19, P1, DOI 10.1016/S0195-5616(89)50001-9; Nasir L, 2001, NEOPLASIA, V3, P351, DOI 10.1038/sj.neo.7900173; Nemec A, 2000, ACTA VET BRNO, V69, P297, DOI 10.2754/avb200069040297; Patronek GJ, 1997, J GERONTOL A-BIOL, V52, pB171, DOI 10.1093/gerona/52A.3.B171; Ricklefs RE, 2008, FUNCT ECOL, V22, P379, DOI 10.1111/j.1365-2435.2008.01420.x; Rollo CD, 2002, EVOL DEV, V4, P55, DOI 10.1046/j.1525-142x.2002.01053.x; Samaras TT, 2002, AGEING RES REV, V1, P673, DOI 10.1016/S1568-1637(02)00029-6; Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Selman C, 2013, CURR BIOL, V23, pR451, DOI 10.1016/j.cub.2013.04.005; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Shi Y, 2010, INTEGR COMP BIOL, V50, P869, DOI 10.1093/icb/icq079; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V; Speakman JR, 2015, ECOL EVOL, V5, pS745, DOI 10.1002/ece3.1790; Todorova I, 2005, COMP CLIN PATHOL, V13, P190, DOI DOI 10.1007/S00580-005-0547-5; Tomsic K, 2016, ACTA VET-BEOGRAD, V66, P534, DOI 10.1515/acve-2016-0046; Urfer S. R., 2010, AGE, V33, P451; Vajdovich P, 1997, VET RES COMMUN, V21, P463, DOI 10.1023/A:1005929801735; Wang YL, 2007, J PROTEOME RES, V6, P1846, DOI 10.1021/pr060685n; WARBURG O, 1956, SCIENCE, V124, P269; Waters DJ, 2009, AGING CELL, V8, P752, DOI 10.1111/j.1474-9726.2009.00513.x	70	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195832	10.1371/journal.pone.0195832	http://dx.doi.org/10.1371/journal.pone.0195832			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694441	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400045
J	Alencar, AK; Carvalho, FI; Silva, AM; Martinez, ST; Calasans-Maia, JA; Frage, CM; Barreiro, EJ; Zapata-Sudo, G; Sudo, RT				Alencar, Allan K.; Carvalho, Fabio I.; Silva, Ananssa M.; Martinez, Sabrina T.; Calasans-Maia, Jorge A.; Frage, Carlos M.; Barreiro, Eliezer J.; Zapata-Sudo, Gisele; Sudo, Roberto T.			Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A(2A) receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; COMBINATION THERAPY; BOSENTAN; ACTIVATION; MECHANISMS	Introduction Pulmonary hypertension (PH) is characterized by enhanced pulmonary vascular resistance, which causes right ventricle (RV) pressure overload and results in right sided heart failure and death. This work investigated the effectiveness of a combined therapy with PDE5 inhibitor (PDE5i) and a new adenosine A2A receptor (A2AR) agonist in mitigating monocrotaline (MCT) induced PH in rats. Methods An in vitro isobolographic analysis was performed to identify possible synergistic relaxation effect between sildenafil and LASSBio 1359 in rat pulmonary arteries (PAs). In the in vivo experiments, PH was induced in male Wistar rats by a single intraperitoneal injection of 60 mg/kg MCT. Rats were divided into the following groups: control (saline injection only), MCT + vehicle, MCT + sildenafil, MCT + LASSBio 1359 and MCT + combination of sildenafil and LASSBio 1359. Fourteen days after the MCT injection, rats were treated daily with oral administration of the regimen therapies or vehicle for 14 days. Cardiopulmonary system function and structure were evaluated by echocardiography. RV systolic pressure and PA endothelial function were measured. Results Isobolographic analysis showed a synergistic interaction between sildenafil and LASSBio 1359 in rat PAs. Combined therapy with sildenafil and LASSBio 1359 but not monotreatment with low dosages of either sildenafil or LASSBio 1359 ameliorated all of PH related abnormalities in cardiopulmonary function and structure in MCT challenged rats. Conclusions The combination of sildenafil and LASSBio 1359 has a synergistic interaction, suggesting that combined use of these pharmacological targets may be an alternative to improve quality of life and outcomes for PH patients.	[Alencar, Allan K.; Carvalho, Fabio I.; Silva, Ananssa M.; Frage, Carlos M.; Barreiro, Eliezer J.; Zapata-Sudo, Gisele; Sudo, Roberto T.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Pesquisa Desenvolvimento Farm, Rio De Janeiro, RJ, Brazil; [Martinez, Sabrina T.] Univ Fed Fluminense, Inst Quim, Rio De Janeiro, RJ, Brazil; [Calasans-Maia, Jorge A.] Univ Fed Rio de Janeiro, Hosp Univ, Serv Anestesiol, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro	Sudo, RT (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Pesquisa Desenvolvimento Farm, Rio De Janeiro, RJ, Brazil.	rtakashisudo@gmail.com	Zapata-Sudo, Gisele/AAG-8790-2020; de Alencar, Allan Kardec AA Nogueira/I-2763-2014; Barreiro, Eliezer J/B-1131-2011	de Alencar, Allan Kardec AA Nogueira/0000-0002-3072-6270; Barreiro, Eliezer J/0000-0003-1759-0038	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Programa de Apoio a Nucleos de Experiencia (PRONEX); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Institute Nacional de Ciencia e Tecnologia (INCT-INOFAR) [465249/2014-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa de Apoio a Nucleos de Experiencia (PRONEX); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Institute Nacional de Ciencia e Tecnologia (INCT-INOFAR)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to GZ-S and RTS, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to AMS, Programa de Apoio a Nucleos de Experiencia (PRONEX), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) to AKA, and the Institute Nacional de Ciencia e Tecnologia (INCT-INOFAR (Proc. 465249/2014-0) to RTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar AK, 2017, EUR J PHARM SCI, V97, P208, DOI 10.1016/j.ejps.2016.11.009; Alencar AKN, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00858; Alencar AKN, 2014, INT J CARDIOL, V173, P154, DOI 10.1016/j.ijcard.2014.02.022; Alencar AKN, 2013, BRIT J PHARMACOL, V169, P953, DOI 10.1111/bph.12193; Badiani B, 2016, HEART LUNG CIRC, V25, P46, DOI 10.1016/j.hlc.2015.05.020; Barnett CF, 2006, VASC HEALTH RISK MAN, V2, P411, DOI 10.2147/vhrm.2006.2.4.411; Barst RJ, 2011, J HEART LUNG TRANSPL, V30, P632, DOI 10.1016/j.healun.2010.11.009; Epperson SA, 2009, AM J PHYSIOL-CELL PH, V296, pC1171, DOI 10.1152/ajpcell.00290.2008; Galie N, 2015, NEW ENGL J MED, V373, P834, DOI 10.1056/NEJMoa1413687; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Ghofrani HA, 2004, J AM COLL CARDIOL, V44, P1488, DOI 10.1016/j.jacc.2004.06.060; Hoeper MM, 2004, EUR RESPIR J, V24, P1007, DOI 10.1183/09031936.04.00051104; Humbert M, 2004, EUR RESPIR J, V24, P353, DOI 10.1183/09031936.04.00028404; Humbert M, 2016, THORAX, V71, P73, DOI 10.1136/thoraxjnl-2015-207170; Jones JE, 2002, AM J PHYSIOL-HEART C, V283, pH364, DOI 10.1152/ajpheart.00979.2001; Lajoie AC, 2016, LANCET RESP MED, V4, P291, DOI 10.1016/S2213-2600(16)00027-8; LEVENS N, 1991, J PHARMACOL EXP THER, V257, P1005; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; McLaughlin VV, 2006, AM J RESP CRIT CARE, V174, P1257, DOI 10.1164/rccm.200603-358OC; McLaughlin VV, 2010, J AM COLL CARDIOL, V55, P1915, DOI 10.1016/j.jacc.2010.01.027; Melani A, 2014, BRAIN RES, V1551, P59, DOI 10.1016/j.brainres.2014.01.014; Montes GC, 2016, J PHARMACOL EXP THER, V358, P315, DOI 10.1124/jpet.115.231241; Moura VJG, 2015, UROLOGY, V85, DOI 10.1016/j.urology.2015.02.006; Nekooeian AA, 1998, BRIT J PHARMACOL, V123, P1666, DOI 10.1038/sj.bjp.0701764; Nishida M, 2009, EUR J PHARMACOL, V614, P70, DOI 10.1016/j.ejphar.2009.04.016; Pereira SL, 2013, EUR J PHARMACOL, V702, P316, DOI 10.1016/j.ejphar.2013.01.050; Pettersen VLA, 2009, ANESTH ANALG, V109, P1312, DOI 10.1213/ane.0b013e3181b16ff5; Prins KW, 2016, CARDIOL CLIN, V34, P363, DOI 10.1016/j.ccl.2016.04.001; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sitbon O, 2015, NEW ENGL J MED, V373, P2522, DOI 10.1056/NEJMoa1503184; Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Sudo RT, 2010, J PAIN, V11, P71, DOI 10.1016/j.jpain.2009.08.001; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; TALLARIDA RJ, 1992, PAIN, V49, P93, DOI 10.1016/0304-3959(92)90193-F; Tallarida RJ, 2007, PHARMACOL THERAPEUT, V113, P197, DOI 10.1016/j.pharmthera.2006.08.002; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; van Suylen RJ, 1998, AM J RESP CRIT CARE, V157, P1423, DOI 10.1164/ajrccm.157.5.9709050; Varani K, 2006, AM J RESP CRIT CARE, V173, P398, DOI 10.1164/rccm.200506-869OC; Ventetuolo CE, 2011, AM J RESP CRIT CARE, V183, P659, DOI 10.1164/rccm.201007-1027OC; Wharton J, 2005, AM J RESP CRIT CARE, V172, P105, DOI 10.1164/rccm.200411-1587OC; Xu MH, 2011, J VASC RES, V48, P171, DOI 10.1159/000316935; Zapata-Sudo G, 2012, EUR J PHARMACOL, V690, P176, DOI 10.1016/j.ejphar.2012.05.043; Zhang M, 2016, J NEUROIMMUNOL, V293, P129, DOI 10.1016/j.jneuroim.2016.03.002	48	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195047	10.1371/journal.pone.0195047	http://dx.doi.org/10.1371/journal.pone.0195047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677206	Green Submitted, Green Published, gold			2022-12-26	WOS:000430638900008
J	Hoving, AM; Kraeima, J; Schepers, RH; Dijkstra, H; Potze, JH; Dorgelo, B; Witjes, MJH				Hoving, Astrid M.; Kraeima, Joep; Schepers, Rutger H.; Dijkstra, Hildebrand; Potze, Jan Hendrik; Dorgelo, Bart; Witjes, Max J. H.			Optimisation of three-dimensional lower jaw resection margin planning using a novel Black Bone magnetic resonance imaging protocol	PLOS ONE			English	Article							CT-MRI; SEGMENTATION; ACCURACY; IMAGES; RECONSTRUCTION; HEAD	Background MRI is the optimal method for sensitive detection of tumour tissue and pre-operative staging in oral cancer. When jawbone resections are necessary, the current standard of care for oral tumour surgery in our hospital is 3D virtual planning from CT data. 3D printed jawbone cutting guides are designed from the CT data. The tumour margins are difficult to visualise on CT, whereas they are clearly visible on MRI scans. The aim of this study was to change the conventional CT-based workflow by developing a method for 3D MRI-based lower jaw models. The MRI-based visualisation of the tumour aids in planning bone resection margins. Materials and findings A workflow for MRI-based 3D surgical planning with bone cutting guides was developed using a four-step approach. Key MRI parameters were defined (phase 1), followed by an application of selected Black Bone MRI sequences on healthy volunteers (phase 2). Three Black Bone MRI sequences were chosen for phase 3: standard, fat saturated, and an out of phase sequence. These protocols were validated by applying them on patients (n = 10) and comparison to corresponding CT data. The mean deviation values between the MRI-and the CT-based models were 0.63, 0.59 and 0.80 mm for the three evaluated Black Bone MRI sequences. Phase 4 entailed examination of the clinical value during surgery, using excellently fitting printed bone cutting guides designed from MRI-based lower jaw models, in two patients with oral cancer. The mean deviation of the resection planes was 2.3 mm, 3.8 mm for the fibula segments, and the mean axis deviation was the fibula segments of 1.9 E. Conclusions This study offers a method for 3D virtual resection planning and surgery using cutting guides based solely on MRI imaging. Therefore, no additional CT data are required for 3D virtual planning in oral cancer surgery.	[Hoving, Astrid M.; Kraeima, Joep; Schepers, Rutger H.; Witjes, Max J. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands; [Dijkstra, Hildebrand; Potze, Jan Hendrik; Dorgelo, Bart] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Groningen	Kraeima, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands.	j.kraeima@umcg.nl		Hoving, Astrid/0000-0001-9624-9035; Witjes, Max/0000-0002-4135-3246				Ababneh SY, 2011, MED IMAGE ANAL, V15, P438, DOI 10.1016/j.media.2011.01.007; Arezoomand S, 2015, INT J COMPUT ASS RAD, V10, P55, DOI 10.1007/s11548-014-1125-6; Biedert R, 2011, KNEE, V18, P340, DOI 10.1016/j.knee.2010.07.006; BROWN JS, 1994, BRIT J ORAL MAX SURG, V32, P347, DOI 10.1016/0266-4356(94)90024-8; Dean CJ, 2012, BRIT J RADIOL, V85, P61, DOI 10.1259/bjr/11855927; Dodin P, 2011, MED BIOL ENG COMPUT, V49, P1413, DOI 10.1007/s11517-011-0838-8; Eley KA, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20130236; Eley KA, 2012, BRIT J RADIOL, V85, P1457, DOI 10.1259/bjr/16830245; Eley KA, 2012, BRIT J RADIOL, V85, P272, DOI 10.1259/bjr/95110289; Eley KA, 2014, EUR RADIOL, V24, P2417, DOI 10.1007/s00330-014-3286-7; Fripp J, 2007, ACAD RADIOL, V14, P1201, DOI 10.1016/j.acra.2007.06.021; Goto TK, 2007, ORAL SURG ORAL MED O, V103, P550, DOI 10.1016/j.tripleo.2006.03.011; Iacono V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112990; Ji DX, 2013, INT J COMPUT ASS RAD, V8, P723, DOI 10.1007/s11548-012-0806-2; Khoo VS, 1997, RADIOTHER ONCOL, V42, P1, DOI 10.1016/S0167-8140(96)01866-X; Kraeima J, 2015, J CRANIO MAXILL SURG, V43, P1374, DOI 10.1016/j.jcms.2015.07.015; Kraiger M, 2012, COMPUT MED IMAG GRAP, V36, P85, DOI 10.1016/j.compmedimag.2011.07.006; Krempien Robert C, 2003, Brachytherapy, V2, P164, DOI 10.1016/S1538-4721(03)00133-8; Mongioj V, 1999, INT J RADIAT ONCOL, V43, P227, DOI 10.1016/S0360-3016(98)00363-0; Mutic S, 2001, INT J RADIAT ONCOL, V51, P255, DOI 10.1016/S0360-3016(01)01659-5; Radetzki F, 2015, ARCH ORTHOP TRAUM SU, V135, P667, DOI 10.1007/s00402-015-2185-y; Rathnayaka K, 2012, MED ENG PHYS, V34, P357, DOI 10.1016/j.medengphy.2011.07.027; Robinson AJ, 2015, BRIT J RADIOL, V88, P1; Schepers RH, 2015, J CRANIO MAXILL SURG, V43, P649, DOI 10.1016/j.jcms.2015.03.015; Ulin K, 2010, INT J RADIAT ONCOL, V77, P1584, DOI 10.1016/j.ijrobp.2009.10.017; Van den Broeck J, 2014, MED ENG PHYS, V36, P949, DOI 10.1016/j.medengphy.2014.03.016; VANHERK M, 1994, MED PHYS, V21, P1163, DOI 10.1118/1.597344; Wang XS, 2009, J APPL CLIN MED PHYS, V10, P3, DOI 10.1120/jacmp.v10i2.2906; Wlodarczyk J, 2015, INT J COMPUT ASS RAD, V10, P419, DOI 10.1007/s11548-014-1105-x	29	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0196059	10.1371/journal.pone.0196059	http://dx.doi.org/10.1371/journal.pone.0196059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677217	Green Submitted, Green Published, gold			2022-12-26	WOS:000430638900023
J	Li, XL; Yu, T; Shan, HT; Jiang, H; Sun, J; Zhao, XG; Su, W; Yang, LD; Shan, HL; Liang, HH				Li, Xuelian; Yu, Tong; Shan, Huitong; Jiang, Hua; Sun, Jian; Zhao, Xiaoguang; Su, Wei; Yang, Lida; Shan, Hongli; Liang, Haihai			lncRNA PFAL promotes lung fibrosis through CTGF by competitively binding miR-18a	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; long noncoding RNA; ceRNA; fibroblast	IDIOPATHIC PULMONARY-FIBROSIS; LONG NONCODING RNAS; CARDIAC FIBROSIS; EXPRESSION; GENE; PIRFENIDONE; MECHANISMS; PROGNOSIS; CANCER; AXIS	Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic parenchymal lung disease of unknown etiology and lacks an effective intervention. Long noncoding RNAs (lncRNAs) participate in organ fibrosis and various pulmonary diseases, but the role of lncRNAs in lung fibrosis is not fully understood. In the present study, we identified that lncRNA NONMMUT021928, designated as pulmonary fibrosis-associated lncRNA (PFAL), was up-regulated in the lungs of mice with experimental lung fibrosis, and in TGF-1-induced fibrotic lung fibroblasts. Further study showed that overexpression of PFAL promoted cell proliferation, migration, and fibroblast-myofibroblast transition. Overexpression further resulted in extracellular matrix deposition and fibrogenesis in lung fibroblasts through regulation of microRNA-18a (miR-18a). Importantly, knockdown of PFAL alleviated lung fibrosis both in vitro and in vivo. Mechanistically, our study showed that PFAL promoted lung-fibroblast activation and fibrogenesis by acting as a competing endogenous RNA for miR-18a: forced expression of PFAL inhibited the expression and activity of miR-18a, whereas silencing of PFAL had the opposite effect. Furthermore, we found that miR-18a was decreased during lung fibrosis in vitro and in vivo, as well as in patients with IPF. Moreover, knockdown of miR-18a led to fibrogenesis in lung fibroblasts, whereas enhanced expression of miR-18a attenuated TGF-1-induced lung fibrosis by directly targeting the regulation of connecting tissue growth factor. Taken together, these results revealed the effect and mechanism of lncRNA PFAL in pulmonary fibrosis and suggested that PFAL depletion may provide a novel strategy for the treatment of lung fibrosis.Li, X., Yu, T., Shan, H., Jiang, H., Sun, J., Zhao, X., Su, W., Yang, L., Shan, H., Liang, H. lncRNA PFAL promotes lung fibrosis through CTGF by competitively binding miR-18a.	[Li, Xuelian; Yu, Tong; Shan, Huitong; Jiang, Hua; Sun, Jian; Zhao, Xiaoguang; Su, Wei; Yang, Lida; Shan, Hongli; Liang, Haihai] Harbin Med Univ, State Prov Key Labs Biomed Pharmaceut China, Key Lab Cardiovasc Res, Minist Educ,Dept Pharmacol,Coll Pharm, Harbin, Heilongjiang, Peoples R China; [Yu, Tong; Shan, Huitong; Jiang, Hua; Sun, Jian; Zhao, Xiaoguang; Su, Wei; Shan, Hongli; Liang, Haihai] Harbin Med Univ, Heilongjiang Acad Med Sci, Northern Translat Med Res & Cooperat Ctr, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Liang, HH (corresponding author), Harbin Med Univ, Baojian Rd 157, Harbin 150081, Heilongjiang, Peoples R China.	lianghaihai@ems.hrbmu.edu.cn		Liang, Haihai/0000-0003-4446-7035; Xuelian, Li/0000-0001-9043-8580	National Natural Science Foundation of China [31671187, 81770284]; Scientific Fund of Heilongjiang Province for Youth [QC 2015100]; University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province [UNPYSCT-2016197]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Fund of Heilongjiang Province for Youth; University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province	This study was supported by the National Natural Science Foundation of China (Grants 31671187 and 81770284), the Scientific Fund of Heilongjiang Province for Youth (Grant QC 2015100), and the University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (Grant UNPYSCT-2016197). The authors declare no conflicts of interest.	Chen DL, 2017, THERANOSTICS, V7, P4836, DOI 10.7150/thno.20942; Chen L, 2017, J CELL BIOCHEM, V118, P1965, DOI 10.1002/jcb.25873; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Creemers EE, 2016, CIRC RES, V118, P108, DOI 10.1161/CIRCRESAHA.115.305242; da Rocha ST, 2017, NAT STRUCT MOL BIOL, V24, P197, DOI 10.1038/nsmb.3370; Du M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02229-1; Engreitz JM, 2016, NAT REV MOL CELL BIO, V17, P756, DOI 10.1038/nrm.2016.126; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Feng M, 2018, MOL THER, V26, P148, DOI 10.1016/j.ymthe.2017.09.024; Flaherty K. R., 2017, BMJ OPEN RESP RES, V4, DOI DOI 10.1136/BMFRESP-2017; Fox JL, 2013, RNA, V19, P177, DOI 10.1261/rna.036467.112; Geng HZ, 2017, BIOCHEM BIOPH RES CO, V491, P329, DOI 10.1016/j.bbrc.2017.07.101; Guo YZ, 2016, GENE, V591, P129, DOI 10.1016/j.gene.2016.07.008; Jiang XY, 2017, EPIGENOMICS-UK, V9, P1233, DOI 10.2217/epi-2017-0020; Kurita Y, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0600-3; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Liang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.207; Liang HH, 2018, THERANOSTICS, V8, P1180, DOI 10.7150/thno.20846; Liang HH, 2016, J MOL MED, V94, P655, DOI 10.1007/s00109-016-1381-8; Liang HH, 2014, MOL THER, V22, P1122, DOI 10.1038/mt.2014.42; Liu HZ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.500; Liu Y, 2018, BBA-MOL BASIS DIS, V1864, P420, DOI 10.1016/j.bbadis.2017.11.003; Makiguchi T, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0427-3; Min HY, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0583-2; Ohgawara T, 2009, FEBS LETT, V583, P1006, DOI 10.1016/j.febslet.2009.02.025; Sun H, 2016, J CELL MOL MED, V20, P1234, DOI 10.1111/jcmm.12783; Vancheri C, 2018, AM J RESP CRIT CARE, V197, P356, DOI 10.1164/rccm.201706-1301OC; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xu XX, 2018, CANCER MED-US, V7, P21, DOI 10.1002/cam4.1238; Yan WW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11904-8; Yang GH, 2015, GENE, V562, P138, DOI 10.1016/j.gene.2015.02.065; Zhang K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00204-4; Zhang Q, 2017, MOL THER, V25, P728, DOI 10.1016/j.ymthe.2016.12.017; Zhang YD, 2018, DESALIN WATER TREAT, V115, P64, DOI 10.5004/dwt.2018.22210	34	37	42	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5285	5297		10.1096/fj.201800055R	http://dx.doi.org/10.1096/fj.201800055R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29683732	Bronze			2022-12-26	WOS:000447972500008
J	O'Bryant, D; Wang, ZX				O'Bryant, Deon; Wang, Zhengxin			The essential role of WD repeat domain 77 in prostate tumor initiation induced by Pten loss	ONCOGENE			English	Article							RECEPTOR COFACTOR P44; TGF-BETA; SUPPRESSOR GENE; CANCER; DELETION; PROLIFERATION; COMPLEX; GROWTH; MOUSE; CELLS	Prostate cancer is the most commonly diagnosed malignancy among men, but few genetic factors that drive prostate cancer initiation have been identified. The WD repeat domain 77 (Wdr77) protein is essential for cellular proliferation when localizes in the cytoplasm of epithelial cells at the early stage of prostate development. In the adult prostate, it is transported into the nucleus and functions as a co-regulator of the androgen receptor to promote cellular differentiation and prostate function. This developmental process is reversed during prostate tumorigenesis, i.e.,Wdr77 is translocated from the nucleus into the cytoplasm to drive proliferation of prostate cancer cells. In this study, we used in vivo genetic studies to further investigate the role of Wdr77 in prostate tumorigenesis. We found that prostate-specific deletion of Wdr77 abolished prostate tumor initiation induced by loss of the tumor suppressor Pten. Mechanistically, Wdr77 ablation inhibited E2F3 activation and enhanced TGF beta signaling, leading to attenuated cellular proliferation induced by loss of Pten. These findings establish a critical role of Wdr77 for prostate tumor initiation.	[O'Bryant, Deon; Wang, Zhengxin] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Dept Biol Sci, Atlanta, GA 30314 USA	Clark Atlanta University	Wang, ZX (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Dept Biol Sci, Atlanta, GA 30314 USA.	zwang@cau.edu			NIH NIGMS-RISE [R25GM06414]; NIMHD RCMI [5G12MD007590]; NIMHD [5P20MD002285];  [W81XWH-12-1-0453 PC111461]	NIH NIGMS-RISE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD RCMI; NIMHD; 	We thank Ms. Shen Gao for animal work and technique support. DOB is supported by NIH NIGMS-RISE R25GM06414 and ZW is supported by W81XWH-12-1-0453 PC111461, NIMHD RCMI 5G12MD007590, and NIMHD 5P20MD002285. The funding agencies had no role in study design, data collection or analysis, decision to publish or manuscript preparation.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Bilir B, 2016, CANCER RES, V76, P1112, DOI 10.1158/0008-5472.CAN-15-1868; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Gao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049173; Gao S, 2010, ENDOCRINOLOGY, V151, P3941, DOI 10.1210/en.2009-1080; Gu Z, 2013, ONCOGENE, V32, P1888, DOI 10.1038/onc.2012.207; Gu ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022395; HATZFELD J, 1991, J EXP MED, V174, P925, DOI 10.1084/jem.174.4.925; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Jin CL, 2003, PROSTATE, V57, P160, DOI 10.1002/pros.10283; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Lebrun Jean-Jacques, 2012, ISRN Mol Biol, V2012, P381428, DOI 10.5402/2012/381428; Lin HK, 2004, MOL ENDOCRINOL, V18, P2409, DOI 10.1210/me.2004-0117; Liu WN, 2016, ASIAN J ANDROL, V18, P533, DOI 10.4103/1008-682X.177120; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Milella M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00024; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Prost S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e80; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Sheng XM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2632-3; Shtivelman E, 2014, ONCOTARGET, V5, P7217, DOI 10.18632/oncotarget.2406; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sitnicka E, 1996, BLOOD, V88, P82; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Yi PF, 2014, BIOCHEM BIOPH RES CO, V450, P409, DOI 10.1016/j.bbrc.2014.05.125; Yokoyama NN, 2014, AM J CLIN EXP UROL, V2, P27; Zhou LR, 2006, J MOL ENDOCRINOL, V37, P283, DOI 10.1677/jme.1.02062	42	7	7	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 26	2018	37	30					4151	4163		10.1038/s41388-018-0254-8	http://dx.doi.org/10.1038/s41388-018-0254-8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GO2YI	29706654				2022-12-26	WOS:000439847000008
J	AlQarni, S; Al-Sheikh, Y; Campbell, D; Drotar, M; Hannigan, A; Boyle, S; Herzyk, P; Kossenkov, A; Armfield, K; Jamieson, L; Bailo, M; Lieberman, PM; Tsimbouri, P; Wilson, JB				AlQarni, Sana; Al-Sheikh, Yazeed; Campbell, Donald; Drotar, Mark; Hannigan, Adele; Boyle, Shelagh; Herzyk, Pawel; Kossenkov, Andrew; Armfield, Kate; Jamieson, Lauren; Bailo, Mariarca; Lieberman, Paul M.; Tsimbouri, Penelope; Wilson, Joanna B.			Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2	ONCOGENE			English	Article							BURKITTS-LYMPHOMA; TRANSGENIC MICE; IN-VITRO; P53; EXPRESSION; SURVIVAL; PROTEIN; IMMORTALIZATION; TUMORIGENESIS; TRANSCRIPTION	Epstein-Barr virus (EBV)-associated Burkitt's lymphoma is characterised by the deregulation of c-Myc expression and a restricted viral gene expression pattern in which the EBV nuclear antigen-1 (EBNA1) is the only viral protein to be consistently expressed. EBNA1 is required for viral genome propagation and segregation during latency. However, it has been much debated whether the protein plays a role in viral-associated tumourigenesis. We show that the lymphomas which arise in E mu EBNA1 transgenic mice are unequivocally linked to EBNA1 expression and that both C-Myc and Mdm2 deregulation are central to this process. Tumour cell survival is supported by IL-2 and there is a skew towards CD8-positive T cells in the tumour environment, while the immune check-point protein PD-L1 is upregulated in the tumours. Additionally, several isoforms of Mdm2 are upregulated in the E mu EBNA1 tumours, with increased phosphorylation at ser166, an expression pattern not seen in E mu c-Myc transgenic tumours. Concomitantly, E2F1, Xiap, Mta1, C-Fos and Stat1 are upregulated in the tumours. Using four independent inhibitors of Mdm2 we demonstrate that the E mu EBNA1 tumour cells are dependant upon Mdm2 for survival (as they are upon c-Myc) and that Mdm2 inhibition is not accompanied by upregulation of p53, instead cell death is linked to loss of E2F1 expression, providing new insight into the underlying tumourigenic mechanism. This opens a new path to combat EBV-associated disease.	[AlQarni, Sana; Al-Sheikh, Yazeed; Campbell, Donald; Drotar, Mark; Hannigan, Adele; Herzyk, Pawel; Armfield, Kate; Jamieson, Lauren; Bailo, Mariarca; Tsimbouri, Penelope; Wilson, Joanna B.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Al-Sheikh, Yazeed] King Saud Univ, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Hannigan, Adele] TCBiopharm, 2 Parklands Way Holtown, Motherwell ML1 4WR, Scotland; [Boyle, Shelagh] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Kossenkov, Andrew; Lieberman, Paul M.] Wistar Inst Anat & Biol, Ctr Chem Biol & Translat Med, 3601 Spruce St, Philadelphia, PA 19104 USA	University of Glasgow; King Saud University; University of Edinburgh; The Wistar Institute	Wilson, JB (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.	Joanna.wilson@glasgow.ac.uk			Bloodwise; Wellcome Trust; BBSRC; Saudi Arabian PhD scholarships; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA093606] Funding Source: NIH RePORTER	Bloodwise; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Saudi Arabian PhD scholarships; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding contribution to the work includes former LRF (now Bloodwise) grants. AH was supported by a Wellcome Trust PhD studentship while at GU, KA is supported by a PhD BBSRC studentship. SA is, and YA was, supported by Saudi Arabian PhD scholarships.	Achilli F, 2005, AMYOTROPH LATERAL SC, V6, P111, DOI 10.1080/14660820510035351; Bill KLJ, 2016, CLIN CANCER RES, V22, P1150, DOI 10.1158/1078-0432.CCR-15-1522; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Canaan A, 2009, P NATL ACAD SCI USA, V106, P22421, DOI 10.1073/pnas.0911676106; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Deschamps T, 2017, J GEN VIROL, V98, P251, DOI 10.1099/jgv.0.000681; Drotar ME, 2003, INT J CANCER, V106, P388, DOI 10.1002/ijc.11224; Gnanasundram SV, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02282-w; Goodman A, 2017, NAT REV CLIN ONCOL, V14, P203, DOI 10.1038/nrclinonc.2016.168; Gu LB, 2016, CANCER CELL, V30, P623, DOI 10.1016/j.ccell.2016.08.015; Hannigan A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-184; Kang MS, 2005, P NATL ACAD SCI USA, V102, P820, DOI 10.1073/pnas.0408774102; Kennedy G, 2003, P NATL ACAD SCI USA, V100, P14269, DOI 10.1073/pnas.2336099100; Kojima K, 2010, MOL CANCER THER, V9, P2545, DOI 10.1158/1535-7163.MCT-10-0337; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Malik-Soni N, 2012, J VIROL, V86, P6999, DOI 10.1128/JVI.00194-12; O'Neil JD, 2008, J GEN VIROL, V89, P2833, DOI 10.1099/vir.0.2008/003392-0; Okoro Danielle R, 2012, Genes Cancer, V3, P311, DOI 10.1177/1947601912455323; Owen TJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-241; Renouf B, 2009, LEUKEMIA, V23, P1557, DOI 10.1038/leu.2009.92; Rosso Melissa, 2014, Subcell Biochem, V85, P247, DOI 10.1007/978-94-017-9211-0_14; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Schuster K, 2007, MOL CANCER RES, V5, P403, DOI 10.1158/1541-7786.MCR-06-0146; Sivachandran N, 2011, J VIROL, V85, P10425, DOI 10.1128/JVI.05293-11; Tempera I, 2016, J VIROL, V90, P345, DOI 10.1128/JVI.02318-15; Tian X, 2011, CELL SIGNAL, V23, P193, DOI 10.1016/j.cellsig.2010.09.003; Tsimbouri P, 2002, ONCOGENE, V21, P5182, DOI 10.1038/sj.onc.1205490; Tsimbourri P, 2008, J GEN VIROL, V89, P2821, DOI 10.1099/vir.0.83296-0; Volk EL, 2009, MOL CANCER RES, V7, P863, DOI 10.1158/1541-7786.MCR-08-0418; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wilson J B, 1992, Curr Top Microbiol Immunol, V182, P375; Wilson J B, 2001, Methods Mol Biol, V174, P361; Wilson JB, 1996, EMBO J, V15, P3117, DOI 10.1002/j.1460-2075.1996.tb00674.x; Wood VHJ, 2007, ONCOGENE, V26, P4135, DOI 10.1038/sj.onc.1210496; Xie N, 2016, SCI REP-UK, V6, DOI 10.1038/srep36171; Zhang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100960; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814; Zheng TS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3996; Zimber-Strobl U, 1999, CURR TOP MICROBIOL, V246, P315	39	15	16	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 19	2018	37	29					3998	4012		10.1038/s41388-018-0147-x	http://dx.doi.org/10.1038/s41388-018-0147-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GN5LP	29691476	Green Accepted			2022-12-26	WOS:000439101300007
J	Sekamatte, M; Krishnasamy, V; Bulage, L; Kihembo, C; Nantima, N; Monje, F; Ndumu, D; Sentumbwe, J; Mbolanyi, B; Aruho, R; Kaboyo, W; Mutonga, D; Basler, C; Paige, S; Behravesh, CB				Sekamatte, Musa; Krishnasamy, Vikram; Bulage, Lilian; Kihembo, Christine; Nantima, Noelina; Monje, Fred; Ndumu, Deo; Sentumbwe, Juliet; Mbolanyi, Betty; Aruho, Robert; Kaboyo, Winyi; Mutonga, David; Basler, Colin; Paige, Sarah; Behravesh, Casey Barton			Multisectoral prioritization of zoonotic diseases in Uganda, 2017: A One Health perspective	PLOS ONE			English	Article								Background Zoonotic diseases continue to be a public health burden globally. Uganda is especially vulnerable due to its location, biodiversity, and population. Given these concerns, the Ugandan government in collaboration with the Global Health Security Agenda conducted a One Health Zoonotic Disease Prioritization Workshop to identify zoonotic diseases of greatest national concern to the Ugandan government. Materials and methods The One Health Zoonotic Disease Prioritization tool, a semi-quantitative tool developed by the U.S. Centers for Disease Control and Prevention, was used for the prioritization of zoonoses. Workshop participants included voting members and observers representing multiple government and non-governmental sectors. During the workshop, criteria for prioritization were selected, and questions and weights relevant to each criterion were determined. We used a decision tree to provide a ranked list of zoonoses. Participants then established next steps for multisectoral engagement for the prioritized zoonoses. A sensitivity analysis demonstrated how criteria weights impacted disease prioritization. Results Forty-eight zoonoses were considered during the workshop. Criteria selected to prioritize zoonotic diseases were (1) severity of disease in humans in Uganda, (2) availability of effective control strategies, (3) potential to cause an epidemic or pandemic in humans or animals, 4) social and economic impacts, and (5) bioterrorism potential. Seven zoonotic diseases were identified as priorities for Uganda: anthrax, zoonotic influenza viruses, viral hemorrhagic fevers, brucellosis, African trypanosomiasis, plague, and rabies. Sensitivity analysis did not indicate significant changes in zoonotic disease prioritization based on criteria weights. Discussion One Health approaches and multisectoral collaborations are crucial to the surveillance, prevention, and control strategies for zoonotic diseases. Uganda used such an approach to identify zoonoses of national concern. Identifying these priority diseases enables Uganda's National One Health Platform and Zoonotic Disease Coordination Office to address these zoonoses in the future with a targeted allocation of resources.	[Sekamatte, Musa; Bulage, Lilian; Kihembo, Christine] Minist Hlth, Kampala, Uganda; [Sekamatte, Musa; Nantima, Noelina; Monje, Fred; Ndumu, Deo; Mbolanyi, Betty; Aruho, Robert] Natl One Hlth Platform, Zoonot Dis Coordinat Off, Kampala, Uganda; [Krishnasamy, Vikram; Basler, Colin; Behravesh, Casey Barton] US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Nantima, Noelina; Monje, Fred; Ndumu, Deo; Sentumbwe, Juliet] Minist Agr Anim Ind & Fisheries, Entebbe, Uganda; [Mbolanyi, Betty] Minist Water & Environm, Kampala, Uganda; [Aruho, Robert] Uganda Wildlife Author, Kampala, Uganda; [Kaboyo, Winyi; Mutonga, David] US Agcy Int Dev, Preparedness & Response Project, Kampala, Uganda; [Paige, Sarah] US Agcy Int Dev, Global Hlth Fellows Program 2, Washington, DC 20523 USA	Centers for Disease Control & Prevention - USA; United States Agency for International Development (USAID); United States Agency for International Development (USAID)	Krishnasamy, V (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	kvl4@cdc.gov	BARTON BEHRAVESH, Casey/HDL-8040-2022; Kihembo, Christine/ABA-2095-2020	BARTON BEHRAVESH, Casey/0000-0003-2270-5573; 	Government of Uganda; United States Centers for Disease Control and Prevention; United States Agency for International Development (USAID); USAID Emerging Pandemic Threats Program 2 - Preparedness and Response Project, Global Health Security Agenda	Government of Uganda; United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID Emerging Pandemic Threats Program 2 - Preparedness and Response Project, Global Health Security Agenda	This workshop was supported by the Government of Uganda, the United States Centers for Disease Control and Prevention, the United States Agency for International Development (USAID), the USAID Emerging Pandemic Threats Program 2 - Preparedness and Response Project as part of the Global Health Security Agenda. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NAT POP HOUS CENS 20; [Anonymous], 2009, SUSTAINING GLOBAL SU; Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases, ON HLTH ZOON DIS PRI; de St Maurice A, 2016, MMWR-MORBID MORTAL W, V65, P1200, DOI 10.15585/mmwr.mm6543a5; Federal Select Agent Program, FEDERAL SELECT AGENT; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Mbonye A, 2012, AFR HEALTH SCI, V12, P579, DOI 10.4314/ahs.v12i4.31; Munyua P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161576; OIE World Animal Health Information System D, WEEKL DIS INF; Pieracci EG, 2016, ONE HEALTH, V2, P131, DOI 10.1016/j.onehlt.2016.09.001; Rist CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109986; Saaty TL., 2008, INT J SERV SCI, V1, P2008, DOI [DOI 10.1504/IJSSCI.2008.017590, 10.1504/IJSSCI.2008.017590]; Salyer SJ, 2017, EMERG INFECT DIS, V23, pS57, DOI 10.3201/eid2313.170418; Uganda Bureau of Statistics D Agriculture, AGRICULTURE; United States Agency for International Development, UG BIOD TROP FOR ASS; WANG L, 2014, REV SCI TECH INT EP, V835, P33, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.834-836.33; WHO, UG DIS OUTBR NEWS	17	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196799	10.1371/journal.pone.019679	http://dx.doi.org/10.1371/journal.pone.019679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715287				2022-12-26	WOS:000431281100053
J	Zhang, GL; Pian, C; Chen, Z; Zhang, J; Xu, MM; Zhang, LY; Chen, YY				Zhang, Guangle; Pian, Cong; Chen, Zhi; Zhang, Jin; Xu, Mingmin; Zhang, Liangyun; Chen, Yuanyuan			Identification of cancer-related miRNA-lncRNA biomarkers using a basic miRNA-lncRNA network	PLOS ONE			English	Article							LONG NONCODING RNAS; TUMOR-ASSOCIATED MACROPHAGES; BREAST-CANCER; MICRORNA EXPRESSION; DOWN-REGULATION; INVASION; PROLIFERATION; GENE; SIGNATURE; MIGRATION	LncRNAs are regulatory noncoding RNAs that play crucial roles in many biological processes. The dysregulation of lncRNA is thought to be involved in many complex diseases; lncRNAs are often the targets of miRNAs in the indirect regulation of gene expression. Numerous studies have indicated that miRNA-lncRNA interactions are closely related to the occurrence and development of cancers. Thus, it is important to develop an effective method for the identification of cancer-related miRNA-lncRNA interactions. In this study, we compiled 155653 experimentally validated and predicted miRNA-lncRNA associations, which we defined as basic interactions. We next constructed an individual-specific miRNA-lncRNA network (ISMLN) for each cancer sample and a basic miRNA-lncRNA network (BMLN) for each type of cancer by examining the expression profiles of miRNAs and lncRNAs in the TCGA (The Cancer Genome Atlas) database. We then selected potential miRNA-lncRNA biomarkers based on the BLMN. Using this method, we identified cancer-related miRNA-lncRNA biomarkers and modules specific to a certain cancer. This method of profiling will contribute to the diagnosis and treatment of cancers at the level of gene regulatory networks.	[Zhang, Guangle; Chen, Zhi; Zhang, Jin; Xu, Mingmin; Zhang, Liangyun; Chen, Yuanyuan] Nanjing Agr Univ, Coll Sci, Dept Math, Nanjing, Jiangsu, Peoples R China; [Pian, Cong] Zhejiang Univ, Inst Insect Sci, Minist Agr, Key Lab Mol Biol Crop Pathogens & Insects, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Zhejiang University	Zhang, LY; Chen, YY (corresponding author), Nanjing Agr Univ, Coll Sci, Dept Math, Nanjing, Jiangsu, Peoples R China.	zlyun@njau.edu.cn; chenyuanyuan@njau.edu.cn	Chen, Yuanyuan/GXG-2130-2022	Pian, Cong/0000-0001-7401-2926	National Natural Science Foundation of China [11571173, 11401131, 11601233]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (11571173 to LYZ, 11401131 to YYC; 11601233 to ZC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Attema JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075517; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Bhan A, 2014, CHEMMEDCHEM, V9, P1932, DOI 10.1002/cmdc.201300534; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chen B, 2015, CANCER LETT, V356, P410, DOI 10.1016/j.canlet.2014.09.028; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fan SL, 2017, BIOMED PHARMACOTHER, V95, P1636, DOI 10.1016/j.biopha.2017.09.076; Fan ZY, 2016, TUMOR BIOL, V37, P13265, DOI 10.1007/s13277-016-5185-9; Guo LY, 2017, ONCOTARGET, V8, P68483, DOI 10.18632/oncotarget.19590; Hao YJ, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw057; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hirota T, 2012, LUNG CANCER, V77, P16, DOI 10.1016/j.lungcan.2011.12.018; Hu Q, 2014, ASIAN PAC J CANCER P, V15, P5137, DOI 10.7314/APJCP.2014.15.13.5137; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Huang YS, 2016, ONCOTARGET, V7, P43256, DOI 10.18632/oncotarget.9673; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jahangiri B, 2015, C 2015 STEM CELLS RE; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Li H, 2017, LUNG CANC; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li QY, 2017, ONCOTARGET, V8, P46136, DOI 10.18632/oncotarget.17556; Li WJ, 2017, ONCOL LETT, V14, P2559, DOI 10.3892/ol.2017.6426; Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023; Lin XC, 2014, INT J ONCOL, V45, P619, DOI 10.3892/ijo.2014.2431; Liu F, 2016, ONCOTARGET, V7, P49130, DOI 10.18632/oncotarget.9734; Liu XP, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw772; Liu Y, 2016, CANC RES, V76; Lottin S, 2002, CARCINOGENESIS, V23, P1885, DOI 10.1093/carcin/23.11.1885; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Manavalan TT, 2011, CANCER LETT, V313, P26, DOI 10.1016/j.canlet.2011.08.018; McCormick RI, 2013, BRIT J CANCER, V108, P1133, DOI 10.1038/bjc.2013.56; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miller P, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-P4-07-01; Ouyang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0340-7; Pan YL, 2016, ONCOTARGETS THER, V9, P6247, DOI 10.2147/OTT.S103650; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Redova M, 2013, TUMOR BIOL, V34, P481, DOI 10.1007/s13277-012-0573-2; Scarpati GD, 2012, INT J RADIAT ONCOL, V83, P1113, DOI 10.1016/j.ijrobp.2011.09.030; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stroy OO, 2012, VALUE MIR 508 3P KID; Tao SF, 2014, BIOCHEM BIOPH RES CO, V451, P74, DOI 10.1016/j.bbrc.2014.07.073; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521; Ulitsky I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/nrg.2016.85; Vikram R, 2014, BREAST CANCER-TOKYO, V21, P515, DOI 10.1007/s12282-014-0554-y; Wang C, 2015, INT J CLIN EXP MED, V8, P15648; Wang P, 2015, NUCLEIC ACIDS RES, V43, P3478, DOI 10.1093/nar/gkv233; Wang R, 2014, FEBS LETT, V588, P4438, DOI 10.1016/j.febslet.2014.09.045; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xu X, 2016, ONCOTARGET, V7, P20381, DOI 10.18632/oncotarget.7953; Yang J, 2015, INT J CLIN EXP PATHO, V8, P6656; Yao KY, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317707882; Ye ZB, 2015, INT J ONCOL, V46, P531, DOI 10.3892/ijo.2014.2759; Yu L, 2015, ONCOL REP, V34, P1845, DOI 10.3892/or.2015.4173; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141042; Zhang K, 2016, ONCOL REP, V36, P2911, DOI 10.3892/or.2016.5070; Zhang X, 2017, BIOL RES, V50, DOI 10.1186/s40659-017-0133-8; Zhao XB, 2016, CANCER BIOMARK, P1; Zhao XX, 2017, ONCOTARGET, V8, P30576, DOI 10.18632/oncotarget.15736; Zhao XQ, 2016, CHINA J MODERN MED, V26, P22; Zhou M, 2016, ONCOTARGET, V7, P56383, DOI 10.18632/oncotarget.10891; Zhou M, 2016, ONCOTARGET, V7, P32433, DOI 10.18632/oncotarget.8653; Zhou YL, 2015, INT J CLIN EXP PATHO, V8, P6312; Zou QY, 2016, ARCH BIOCHEM BIOPHYS, V610, P25, DOI 10.1016/j.abb.2016.09.007	71	60	62	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196681	10.1371/journal.pone.0196681	http://dx.doi.org/10.1371/journal.pone.0196681			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715309	Green Submitted, gold, Green Published			2022-12-26	WOS:000431281100044
J	Manjunatha, C; Sharma, S; Kulshreshtha, D; Gupta, S; Singh, K; Bhardwaj, SC; Aggarwal, R				Manjunatha, C.; Sharma, Sapna; Kulshreshtha, Deepika; Gupta, Sangeeta; Singh, Kartar; Bhardwaj, Subhash C.; Aggarwal, Rashmi			Rapid detection of Puccinia triticina causing leaf rust of wheat by PCR and loop mediated isothermal amplification	PLOS ONE			English	Article							F-SP TRITICI; LAMP ASSAY; DIAGNOSIS; PATHOGEN; CHICKPEA; MARKER; VIRUS; CHINA; DNA	Leaf rust of wheat caused by Puccinia triticina has significant impact on wheat production worldwide. Effective and quick detection methodologies are required to mitigate yield loss and time constraints associated with monitoring and management of leaf rust of wheat. In the present study, detection of P. triticina has been simplified by developing a rapid, reliable, efficient and visual colorimetric method i.e., loop mediated isothermal amplification of DNA (LAMP). Based on in silico analysis of P. triticina genome, PTS68, a simple sequence repeat was found highly specific to leaf rust fungus. A marker (PtRA(68)) was developed and its specificity was validated through PCR technique which gave a unique and sharp band of 919 bp in P. triticina pathotypes only. A novel gene amplification method LAMP which enables visual detection of pathogen by naked eye was developed for leaf rust pathogen. A set of six primers was designed from specific region of P. triticina and conditions were optimised to complete the observation process in 60 minutes at 65 degrees C. The assay developed in the study could detect presence of P. triticina on wheat at 24 hpi (pre-symptomatic stage) which was much earlier than PCR without requiring thermal cycler. Sensitivity of LAMP assay developed in the study was 100 fg which was more sensitive than conventional PCR (50 pg) and equivalent to qPCR (100 fg). The protocol developed in the study was utilized for detection of leaf rust infected samples collected from different wheat fields. LAMP based colorimetric detection assay showed sky blue color in positive reaction and violet color in negative reaction after addition of 120 mu M hydroxyl napthol blue (HNB) solution to reaction mixture. Similarly, 0.6 mg Ethidium bromide/ml was added to LAMP products, placed on transilluminator to witness full brightness in positive reaction and no such brightness could be seen in negative reaction mixture. Further, LAMP products spread in a ladder like banding pattern in gel electrophoresis. Our assay is significantly faster than the conventional methods used in the identification of P. triticina. The assay developed in the study shall be very much useful in the development of diagnostic kit for monitoring disease, creation of prediction model and efficient management of disease.	[Manjunatha, C.; Sharma, Sapna; Kulshreshtha, Deepika; Gupta, Sangeeta; Aggarwal, Rashmi] ICAR Indian Agr Res Inst, Div Plant Pathol, Fungal Mol Biol Lab, New Delhi, India; [Singh, Kartar] ICAR Natl Bur Plant Genet Resources, New Delhi, India; [Bhardwaj, Subhash C.] ICAR Indian Inst Wheat & Barley Res, Flowerdale, Shimla, India; [Manjunatha, C.] ICAR Indian Agr Res Inst, The Nilgiris, Tamil Nadu, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Aggarwal, R (corresponding author), ICAR Indian Agr Res Inst, Div Plant Pathol, Fungal Mol Biol Lab, New Delhi, India.	rashmi.aggarwal2@gmail.com	Bhardwaj, Subhash Chander/U-2644-2017	Bhardwaj, Subhash Chander/0000-0002-4070-8412; Manjunatha, C/0000-0002-1711-152X	ICAR-Indian Agricultural Research Institute [PGS/3-11/2012/10169]	ICAR-Indian Agricultural Research Institute	This work was supported by ICAR-Indian Agricultural Research Institute, Grant No. PGS/3-11/2012/10169, http://iari.res.in, Grant recipient author: CM.	Aggarwal R, 2011, CAN J MICROBIOL, V57, P934, DOI [10.1139/w11-089, 10.1139/W11-089]; Aggarwal R, 2017, AUSTRALAS PLANT PATH, V46, P577, DOI 10.1007/s13313-017-0524-x; Aggarwal R, 2017, J GEN PLANT PATHOL, V83, P205, DOI 10.1007/s10327-017-0723-x; Bolton MD, 2008, MOL PLANT PATHOL, V9, P563, DOI [10.1111/j.1364-3703.2008.00487.x, 10.1111/J.1364-3703.2008.00487.X]; Buhlmann A, 2013, J MICROBIOL METH, V92, P332, DOI 10.1016/j.mimet.2012.12.017; Das A, 2012, J CLIN MICROBIOL, V50, P1613, DOI 10.1128/JCM.06796-11; Fukuta S, 2004, EUR FOOD RES TECHNOL, V218, P496, DOI 10.1007/s00217-003-0862-5; Gao Y, 2016, AUSTRALAS PLANT PATH, V45, P361, DOI 10.1007/s13313-016-0422-7; Ghosh R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42737; Ghosh Raju, 2015, BMC Res Notes, V8, P40, DOI 10.1186/s13104-015-0997-z; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Hamada MS, 2012, CEREAL RES COMMUN, V40, P85, DOI 10.1556/CRC.40.2012.1.10; Hara-Kudo Y, 2005, FEMS MICROBIOL LETT, V253, P155, DOI 10.1016/j.femsle.2005.09.032; Kong XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28935; Kuan CP, 2010, J VIROL METHODS, V169, P61, DOI 10.1016/j.jviromet.2010.06.017; Kubota R, 2008, PHYTOPATHOLOGY, V98, P1045, DOI 10.1094/PHYTO-98-9-1045; Lihua C, 2008, LETT APPL MICROBIOL, V46, P501, DOI 10.1111/j.1472-765X.2007.02313.x; Liu TG, 2014, J INTEGR AGR, V13, P2438, DOI 10.1016/S2095-3119(14)60895-9; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NAGARAJAN S, 1980, PHYTOPATHOL Z, V98, P84; Nie XZ, 2005, PLANT DIS, V89, P605, DOI 10.1094/PD-89-0605; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Obura E, 2011, J MICROBIOL METH, V84, P312, DOI 10.1016/j.mimet.2010.12.011; Parida M, 2008, REV MED VIROL, V18, P407, DOI 10.1002/rmv.593; Sanzani SM, 2014, J PHYTOPATHOL, V162, P1, DOI 10.1111/jph.12147; Savazzini F, 2008, J MICROBIOL METH, V73, P185, DOI 10.1016/j.mimet.2008.02.004; Szabo LJ, 2007, MOL ECOL NOTES, V7, P708, DOI 10.1111/j.1471-8286.2007.01686.x; Xie LJ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-76; Xu M, 2017, RAPID DIAGNOSIS WHEA	29	14	15	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196409	10.1371/journal.pone.0196409	http://dx.doi.org/10.1371/journal.pone.0196409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698484	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600076
J	Segovia, KM; Franca, MS; Leyson, CL; Kapczynski, DR; Chrzastek, K; Bahnson, CS; Stallknecht, DE				Segovia, Karen M.; Franca, Monique S.; Leyson, Christina L.; Kapczynski, Darrell R.; Chrzastek, Klaudia; Bahnson, Charlie S.; Stallknecht, David E.			Heterosubtypic immunity increases infectious dose required to infect Mallard ducks with Influenza A virus	PLOS ONE			English	Article							AVIAN INFLUENZA; RT-PCR; SUBTYPES; PARAMYXOVIRUSES; CIRCULATION; ANTIBODIES; WATERFOWL; PATTERNS; BIRDS; GULLS	Previous field and experimental studies have demonstrated that heterosubtypic immunity (HSI) is a potential driver of Influenza A virus (IAV) prevalence and subtype diversity in mallards. Prior infection with IAV can reduce viral shedding during subsequent reinfection with IAV that have genetically related hemagglutinins (HA). In this experiment, we evaluated the effect of HSI conferred by an H3N8 IAV infection against increasing challenge doses of closely (H4N6) and distantly (H6N2) related IAV subtypes in mallards. Two groups of thirty 1-monthold mallards each, were inoculated with 10(5.9) 50% embryo infectious doses (EID50) of an H3N8 virus or a mock-inoculum. One month later, groups of five birds each were challenged with increasing doses of H4N6 or H6N2 virus; age-matched, single infection control ducks were included for all challenges. Results demonstrate that naive birds were infected after inoculation with 10(3) and 10(4) EID50 doses of the H4N6 or H6N2 virus, but not with 10(2) EID50 doses of either IAV. In contrast, with birds previously infected with H3N8 IAV, only one duck challenged with 10(4) EID50 of H4N6 IAV was shedding viral RNA at 2 days post-inoculation, and with H6N2 IAV, only birds challenged with the 10(4) EID50 dose were positive to virus isolation. Viral shedding in ducks infected with H6N2 IAV was reduced on days 2 and 3 post-inoculation compared to control birds. To explain the differences in the dose necessary to produce infection among H3-primed ducks challenged with H4N6 or H6N2 IAV, we mapped the amino acid sequence changes between H3 and H4 or H6 HA on predicted three-dimensional structures. Most of the sequence differences occurred between H3 and H6 at antigenic sites A, B, and D of the HA1 region. These findings demonstrate that the infectious dose necessary to infect mallards with IAV can increase as a result of HSI and that this effect is most pronounced when the HA of the viruses are genetically related.	[Segovia, Karen M.; Franca, Monique S.; Leyson, Christina L.] Univ Georgia, Poultry Diagnost & Res Ctr, Athens, GA 30602 USA; [Segovia, Karen M.; Leyson, Christina L.; Kapczynski, Darrell R.; Chrzastek, Klaudia] ARS, Southeast Poultry Res Lab, USDA, Athens, GA USA; [Bahnson, Charlie S.; Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA	University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); University System of Georgia; University of Georgia	Stallknecht, DE (corresponding author), Univ Georgia, Coll Vet Med, Dept Populat Hlth, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA.	dstall@uga.edu	Franca, Monique/J-3927-2019	Chrzastek, Klaudia/0000-0003-1264-6987	National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH), Department of Health and Human Services [HHSN272201400006C]; USDA, ARS CRIS funds [6040-32000-062-00D]	National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH), Department of Health and Human Services; USDA, ARS CRIS funds	This project was funded by the National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH), Department of Health and Human Services, under contract No HHSN272201400006C, and by USDA, ARS CRIS funds 6040-32000-062-00D (D.R.K. and K.C.). The funding agencies were not involved in the design, implementation, or publishing of this study and the research presented herein represents the opinions of the authors, but not necessarily the opinions of the funding agencies.	Alam S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176407; Bailey E, 2016, AVIAN DIS, V60, P346, DOI 10.1637/11086-041015-RegR; Benton KA, 2001, J IMMUNOL, V166, P7437, DOI 10.4049/jimmunol.166.12.7437; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Costa TP, 2010, AVIAN DIS, V54, P1286, DOI 10.1637/9480-072210-Reg.1; Dadonaite B, 2016, J GEN VIROL, V97, P1755, DOI 10.1099/jgv.0.000535; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; De Marco MA, 2014, VET MICROBIOL, V170, P418, DOI 10.1016/j.vetmic.2014.03.001; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; HALVORSON D, 1983, AVIAN DIS, V27, P77, DOI 10.2307/1590374; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Koopman G, 2016, J VIROL, V90, P1023, DOI 10.1128/JVI.02757-15; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Latorre-Margalef N, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006419; Latorre-Margalef N, 2015, EMERG INFECT DIS, V21, P2257, DOI 10.3201/eid2112.150413; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Li JW, 2014, INT J INFECT DIS, V27, P37, DOI 10.1016/j.ijid.2014.05.016; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pepin KM, 2012, J GEN VIROL, V93, P2575, DOI 10.1099/vir.0.045427-0; Ramey AM, 2014, J WILDLIFE DIS, V50, P916, DOI 10.7589/2013-09-232; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; Segovia KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170335; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Swayne DE, 2008, AVIAN DIS, V52, P455, DOI 10.1637/8229-012508-Reg.1; Velarde R, 2010, AVIAN DIS, V54, P411, DOI 10.1637/8808-040109-Reg.1; Verhagen JH, 2014, EMERG INFECT DIS, V20, P138, DOI 10.3201/eid2001.130984; Wahlgren J, 2015, INFECT ECOLOGY EPIDE, V5, P1; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Webster R, 2002, WHO MANUAL ANIMAL IN; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Wong JK, 2016, AVIAN DIS, V60, P337, DOI 10.1637/11104-042115-RegR	43	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196394	10.1371/journal.pone.0196394	http://dx.doi.org/10.1371/journal.pone.0196394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698449	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600072
J	Wang, YN; Yang, WC; Li, PW; Wang, HB; Zhang, YY; Zan, LS				Wang, Ya-Ning; Yang, Wu-Cai; Li, Pei-Wei; Wang, Hong-Bao; Zhang, Ying-Ying; Zan, Lin-Sen			Myocyte enhancer factor 2A promotes proliferation and its inhibition attenuates myogenic differentiation via myozenin 2 in bovine skeletal muscle myoblast	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; CELL-CYCLE; TRANSCRIPTIONAL MECHANISMS; FIBER-TYPE; MEF2; GENE; BINDING; CALSARCIN-1; DEFICIENCY; MICRORNAS	Myocyte enhancer factor 2A (MEF2A) is widely distributed in various tissues or organs and plays crucial roles in multiple biological processes. To examine the potential effects of MEF2A on skeletal muscle myoblast, the functional role of MFE2A in myoblast proliferation and differentiation was investigated. In this study, we found that the mRNA expression level of Mef2a was dramatically increased during the myogenesis of bovine skeletal muscle primary myoblast. Overexpression of MEF2A significantly promoted myoblast proliferation, while knockdown of MEF2A inhibited the proliferation and differentiation of myoblast. RT-PCR and western blot analysis revealed that this positive effect of MEF2A on the proliferation of myoblast was carried out by triggering cell cycle progression by activating CDK2 protein expression. Besides, MEF2A was found to be an important transcription factor that bound to the myozenin 2 (MyoZ2) proximal promoter and performed upstream of MyoZ2 during myoblast differentiation. This study provides the first experimental evidence that MEF2A is a positive regulator in skeletal muscle myoblast proliferation and suggests that MEF2A regulates myoblast differentiation via regulating MyoZ2.	[Wang, Ya-Ning; Yang, Wu-Cai; Li, Pei-Wei; Wang, Hong-Bao; Zan, Lin-Sen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Wang, Ya-Ning; Yang, Wu-Cai; Li, Pei-Wei; Wang, Hong-Bao; Zan, Lin-Sen] Natl Beef Cattle Improvement Ctr China, Yangling, Shaanxi, Peoples R China; [Zhang, Ying-Ying] Shanghai Acad Agr Sci, Anim Husb & Vet Res Inst, Shanghai, Peoples R China; [Zan, Lin-Sen] Natl & Prov Joint Engn Res Ctr Modern Cattle Biot, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Shanghai Academy of Agricultural Sciences	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Zan, LS (corresponding author), Natl Beef Cattle Improvement Ctr China, Yangling, Shaanxi, Peoples R China.; Zan, LS (corresponding author), Natl & Prov Joint Engn Res Ctr Modern Cattle Biot, Yangling, Shaanxi, Peoples R China.	zanlinsen@163.com		Zan, Lin-sen/0000-0001-6644-0250	National Modern Agricultural Industry Special Program - Ministry of Agriculture of the Peoples Republic of China [CARS-38]; Ministry of Finance of the Peoples Republic of China; National 863 Program of China - Ministry of Science and Technology of the Peoples Republic of China [2013AA102505]; National Science and Technology Support Projects - Ministry of Science and Technology of the Peoples Republic of China [2015BAD03B04]; Shaanxi Technological Innovation Engineering Program - Department of Science and Technology of Shaanxi Province [2014KTZB02-02-01]; National Natural Science Foundation of China - National Natural Science Foundation of China [31501937]	National Modern Agricultural Industry Special Program - Ministry of Agriculture of the Peoples Republic of China; Ministry of Finance of the Peoples Republic of China; National 863 Program of China - Ministry of Science and Technology of the Peoples Republic of China; National Science and Technology Support Projects - Ministry of Science and Technology of the Peoples Republic of China; Shaanxi Technological Innovation Engineering Program - Department of Science and Technology of Shaanxi Province; National Natural Science Foundation of China - National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 1. National Modern Agricultural Industry Special Program (Grant No. CARS-38) is funded by Ministry of Agriculture of the Peoples Republic of China (URL: http://www.moa.gov.cn/) and Ministry of Finance of the Peoples Republic of China (URL: http://www.mof.gov.cn/index.htm), Lin-Sen Zan received the funding; 2. National 863 Program of China (Grant No. 2013AA102505) is funded by Ministry of Science and Technology of the Peoples Republic of China (URL: http://www.most.gov.cn/), Lin-Sen Zan received the funding; 3. National Science and Technology Support Projects (Grant No. 2015BAD03B04) is funded by Ministry of Science and Technology of the Peoples Republic of China (URL: http://www.most.gov.cn/), Lin-Sen Zan received the funding; 4. Shaanxi Technological Innovation Engineering Program (Grant No. 2014KTZB02-02-01) is funded by Department of Science and Technology of Shaanxi Province (URL: http://www.sninfo.gov.cn), Lin-Sen Zan received the funding; 5. the National Natural Science Foundation of China (Grant No. 31501937) is funded by National Natural Science Foundation of China (URL: http://www.nsfc.gov.cn/), Ying-Ying Zhang received the funding; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almada AE, 2016, NAT REV MOL CELL BIO, V17, P267, DOI 10.1038/nrm.2016.7; ANDRES V, 1995, J BIOL CHEM, V270, P23246, DOI 10.1074/jbc.270.40.23246; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Cai L, 2012, ANNU REV CELL DEV BI, V28, P59, DOI 10.1146/annurev-cellbio-092910-154010; Cante-Barrett K, 2014, ONCOGENE, V33, P403, DOI 10.1038/onc.2013.56; Chen XP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/241983; Clark AL, 2015, J BIOL CHEM, V290, P23162, DOI 10.1074/jbc.M115.672659; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Estrella NL, 2015, J BIOL CHEM, V290, P24367, DOI 10.1074/jbc.M115.666461; Estrella NL, 2015, J BIOL CHEM, V290, P1256, DOI 10.1074/jbc.M114.589838; Estrella N, 2014, CELL MOL LIFE SCI, V71, P1641, DOI 10.1007/s00018-013-1512-0; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Harashima H, 2013, TRENDS CELL BIOL, V23, P345, DOI 10.1016/j.tcb.2013.03.002; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Heissler SM, 2016, J MOL BIOL, V428, P1927, DOI 10.1016/j.jmb.2016.01.022; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; Konno T, 2010, P NATL ACAD SCI USA, V107, P18097, DOI 10.1073/pnas.1012826107; Lee FXZ, 2016, BBA-MOL CELL RES, V1863, P686, DOI 10.1016/j.bbamcr.2016.01.013; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Liu SY, 2016, FEBS LETT, V590, P1417, DOI 10.1002/1873-3468.12169; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Moncaut N, 2013, FEBS J, V280, P3980, DOI 10.1111/febs.12379; Osio A, 2007, CIRC RES, V100, P766, DOI 10.1161/01.RES.0000263008.66799.aa; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Paulsson AK, 2010, J MOL CELL CARDIOL, V48, P1206, DOI 10.1016/j.yjmcc.2010.02.009; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Pon JR, 2016, ONCOTARGET, V7, P2297, DOI 10.18632/oncotarget.6223; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rando T, 2001, GENE DELIVERY MUSCLE; Ruggiero A, 2013, CARDIOVASC RES, V97, P44, DOI 10.1093/cvr/cvs294; Schiaffino S, 2002, TRENDS PHARMACOL SCI, V23, P569, DOI 10.1016/S0165-6147(02)02111-9; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Takada F, 2001, P NATL ACAD SCI USA, V98, P1595, DOI 10.1073/pnas.041609698; Talbot J, 2016, WIRES DEV BIOL, V5, P518, DOI 10.1002/wdev.230; Tiwari MK, 2016, NUCLEIC ACIDS RES, V44, P7742, DOI 10.1093/nar/gkw515; Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813; Wang H, 2014, MOL BIOL REP, V41, P251, DOI 10.1007/s11033-013-2858-y; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Welten SMJ, 2017, MOL THER-NUCL ACIDS, V7, P61, DOI 10.1016/j.omtn.2017.03.003; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963	48	31	32	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196255	10.1371/journal.pone.0196255	http://dx.doi.org/10.1371/journal.pone.0196255			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698438	Green Submitted, gold, Green Published			2022-12-26	WOS:000431007600053
J	Hara-Kuge, S; Nishihara, T; Matsuda, T; Kitazono, T; Teramoto, T; Nagai, T; Ishihara, T				Hara-Kuge, Sayuri; Nishihara, Tomonobu; Matsuda, Tomoki; Kitazono, Tomohiro; Teramoto, Takayuki; Nagai, Takeharu; Ishihara, Takeshi			An improved inverse-type Ca2+ indicator can detect putative neuronal inhibition in Caenorhabditis elegans by increasing signal intensity upon Ca2+ decrease	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEINS; GCAMP CALCIUM INDICATOR; IMAGING NEURAL ACTIVITY; IN-VIVO; TRANSGENIC MICE; INTRACELLULAR CALCIUM; CHEMOSENSORY NEURONS; C. ELEGANS; DYNAMICS; MICROFLUIDICS	Sensory processing is regulated by the coordinated excitation and inhibition of neurons in neuronal circuits. The analysis of neuronal activities has greatly benefited from the recent development of genetically encoded Ca2+ indicators (GECIs). These molecules change their fluorescence intensities or colours in response to changing levels of Ca2+ and can, therefore, be used to sensitively monitor intracellular Ca2+ concentration, which enables the detection of neuronal excitation, including action potentials. These GECIs were developed to monitor increases in Ca2+ concentration; therefore, neuronal inhibition cannot be sensitively detected by these GECIs. To overcome this difficulty, we hypothesised that an inverse-type of GECI, whose fluorescence intensity increases as Ca2+ levels decrease, could sensitively monitor reducing intracellular Ca2+ concentrations. We, therefore, developed a Ca2+ indicator named inverse-pericam 2.0 (IP2.0) whose fluorescent intensity decreases 25-fold upon Ca2+ binding in vitro. Using IP2.0, we successfully detected putative neuronal inhibition by monitoring the decrease in intracellular Ca2+ concentration in AWC ON and ASEL neurons in Caenorhabditis elegans. Therefore, IP2.0 is a useful tool for studying neuronal inhibition and for the detailed analysis of neuronal activities in vivo.	[Hara-Kuge, Sayuri; Nishihara, Tomonobu; Teramoto, Takayuki; Ishihara, Takeshi] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan; [Hara-Kuge, Sayuri; Teramoto, Takayuki; Ishihara, Takeshi] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Matsuda, Tomoki; Nagai, Takeharu] Osaka Univ, Dept Biomol Sci & Engn, Inst Sci & Ind Res, Osaka, Japan; [Kitazono, Tomohiro; Ishihara, Takeshi] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka, Japan	Kyushu University; Japan Science & Technology Agency (JST); Osaka University; Kyushu University	Ishihara, T (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan.; Ishihara, T (corresponding author), Japan Sci & Technol Agcy, CREST, Saitama, Japan.; Ishihara, T (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka, Japan.	ishihara.takeshi.718@m.kyushu-u.ac.jp	Matsuda, Tomoki/AAE-9910-2019	Nagai, Takeharu/0000-0003-2650-9895; Teramoto, Takayuki/0000-0001-7060-7148	Japan Society for the Promotion of Science [25115009, 26560461, 2311500]; Core Research for Evolutional Science and Technology [JPMJCR12W1, JPMJCR15N3]; Cooperative Research Program [2011B01]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Cooperative Research Program	This work was supported by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/) 25115009 to T.I., 26560461 to S.H.-K., and 2311500 to T.Nagai, the Core Research for Evolutional Science and Technology JPMJCR12W1 to T.I and JPMJCR15N3 to T.Nagai, and the Cooperative Research Program 2011B01 to T.I. for all experiments. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Arpino JAJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047132; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Borghuis BG, 2011, J NEUROSCI, V31, P2855, DOI 10.1523/JNEUROSCI.6064-10.2011; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Branson K, 2015, CELL, V163, P541, DOI 10.1016/j.cell.2015.10.014; Broussard GJ, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00097; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Helassa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep38276; Helassa N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15978; Inoue M, 2015, NAT METHODS, V12, P64, DOI [10.1038/NMETH.3185, 10.1038/nmeth.3185]; Kato S, 2015, CELL, V163, P656, DOI 10.1016/j.cell.2015.09.034; Kato S, 2014, NEURON, V81, P616, DOI 10.1016/j.neuron.2013.11.020; Larsch J, 2013, P NATL ACAD SCI USA, V110, pE4266, DOI 10.1073/pnas.1318325110; Laviv T, 2016, NAT METHODS, V13, P989, DOI [10.1038/NMETH.4046, 10.1038/nmeth.4046]; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nagai T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00090; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nguyen JP, 2016, P NATL ACAD SCI USA, V113, pE1074, DOI 10.1073/pnas.1507110112; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Piet R, 2015, FRONT NEUROENDOCRIN, V36, P15, DOI 10.1016/j.yfrne.2014.05.006; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Rose T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00088; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Shimozono S, 2004, EMBO REP, V5, P521, DOI 10.1038/sj.embor.7400142; Shinkai Y, 2011, J NEUROSCI, V31, P3007, DOI 10.1523/JNEUROSCI.4691-10.2011; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Sun XNR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3170; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; van Giesen L, 2016, NAT PROTOC, V11, P2389, DOI 10.1038/nprot.2016.144; Whitaker M, 2010, METHOD CELL BIOL, V99, P153, DOI [10.1016/S0091-679X(10)99006-7, 10.1016/B978-0-12-374841-6.00006-2]; Yamada Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00041; Yoshida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1750; Zhao YX, 2014, INTEGR BIOL-UK, V6, P714, DOI 10.1039/c4ib00039k; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	53	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0194707	10.1371/journal.pone.0194707	http://dx.doi.org/10.1371/journal.pone.0194707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694380	gold, Green Published, Green Submitted			2022-12-26	WOS:000430802400015
J	Shinjo, T; Tanaka, T; Okuda, H; Kawaguchi, AT; Oh-Hashi, K; Terada, Y; Isonishi, A; Morita-Takemura, S; Tatsumi, K; Kawaguchi, M; Wanaka, A				Shinjo, Takeaki; Tanaka, Tatsuhide; Okuda, Hiroaki; Kawaguchi, Akira T.; Oh-hashi, Kentaro; Terada, Yuki; Isonishi, Ayami; Morita-Takemura, Shoko; Tatsumi, Kouko; Kawaguchi, Masahiko; Wanaka, Akio			Propofol induces nuclear localization of Nrf2 under conditions of oxidative stress in cardiac H9c2 cells	PLOS ONE			English	Article							UP-REGULATION; PATHWAY; PREVENTION; APOPTOSIS; INJURY; DAMAGE	Oxidative stress contributes to myocardial ischemia-reperfusion injury, which causes cardiomyocyte death and precipitate life-threatening heart failure. Propofol has been proposed to protect cells or tissues against oxidative stress. However, the mechanisms underlying its beneficial effects are not fully elucidated. In the present study, we employed an in vitro oxidative injury model, in which rat cardiac H9c2 cells were treated with H2O2, and investigated roles of propofol against oxidative stress. Propofol treatment reduced H2O2-induced apoptotic cell death. While H2O2 induced expression of the antioxidant enzyme HO-1, propofol further increased HO-1 mRNA and protein levels. Propofol also promoted nuclear localization of Nrf2 in the presence of H2O2. Knockdown of Nrf2 using siRNA suppressed propofol-inducible Nrf2 and expression of Nrf2-downstream antioxidant enzyme. Knockdown of Nrf2 suppressed the propofol-induced cytoprotection. In addition, Nrf2 overexpression induced nuclear localization of Nrf2 and HO-1 expression. These results suggest that propofol exerts antioxidative effects by inducing nuclear localization of Nrf2 and expression of its downstream enzyme in cardiac cells. Finally, we examined the effect of propofol on cardiomyocytes using myocardial ischemia-reperfusion injury models. The expression level of Nrf2 protein was increased at 15 min after reperfusion in the ischemia-reperfusion and propofol group compared with ischemia-reperfusion group in penumbra region. These results suggest that propofol protects cells or tissues from oxidative stress via Nrf2/HO-1 cascade.	[Shinjo, Takeaki; Terada, Yuki; Kawaguchi, Masahiko] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara, Japan; [Tanaka, Tatsuhide; Isonishi, Ayami; Morita-Takemura, Shoko; Tatsumi, Kouko; Wanaka, Akio] Nara Med Univ, Dept Anat & Neurosci, Kashihara, Nara, Japan; [Okuda, Hiroaki] Kanazawa Univ, Grad Sch Med Sci, Dept Funct Anat, Kanazawa, Ishikawa, Japan; [Kawaguchi, Akira T.] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa, Japan; [Oh-hashi, Kentaro] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu, Japan; [Oh-hashi, Kentaro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan	Nara Medical University; Nara Medical University; Kanazawa University; Tokai University; Gifu University; Gifu University	Tanaka, T (corresponding author), Nara Med Univ, Dept Anat & Neurosci, Kashihara, Nara, Japan.	ttanaka@naramed-u.ac.jp	Wanaka, Akio/AAC-9754-2019; Okuda, Hiroaki/S-4959-2019; Wanaka, Akio/GPW-8926-2022; Wanaka, Akio/ABE-4671-2020	Wanaka, Akio/0000-0001-9951-9862; Okuda, Hiroaki/0000-0002-6252-9634; Tanaka, Tatsuhide/0000-0002-3373-9093; Takemura, Shoko/0000-0003-1872-4050; Isonishi, Ayami/0000-0003-3750-0482	JSPS KAKENHI [JP15K20058, JP15H02569]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP15K20058 (to TS) and JP15H02569 (to ATK). https://www.jsps.go.jp/english/ndex.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Chen TM, 2013, INT J MOL SCI, V14, P2684, DOI 10.3390/ijms14022684; Fan W, 2015, EUR REV MED PHARMACO, V19, P1520; Ge MA, 2015, J SURG RES, V196, P373, DOI 10.1016/j.jss.2015.03.016; Hao EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069452; Hsing CH, 2012, ANESTHESIOLOGY, V116, P868, DOI 10.1097/ALN.0b013e31824af68a; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lee S, 2011, MOL MED REP, V4, P351, DOI 10.3892/mmr.2011.432; Liebert A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42386; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Picard P, 2000, ANESTH ANALG, V90, P963; Ryu MJ, 2014, INT J MOL MED, V33, P964, DOI 10.3892/ijmm.2014.1643; Song HK, 2004, ANESTH ANALG, V98, P1724, DOI 10.1213/01.ANE.0000112317.68730.B0; Tsuchiya M, 2002, ACTA ANAESTH SCAND, V46, P1068, DOI 10.1034/j.1399-6576.2002.460903.x; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Wang YP, 2016, COLD REG SCI TECHNOL, V126, P10, DOI 10.1016/j.coldregions.2016.02.013; Wu KC, 2013, ONCOL REP, V30, P2304, DOI 10.3892/or.2013.2722; Yao WF, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/258567; Zhang XW, 2013, INT J CARDIOL, V167, P3027, DOI 10.1016/j.ijcard.2012.11.105; Zhu AF, 2017, J CARDIOVASC PHARM, V69, P170, DOI 10.1097/FJC.0000000000000454	23	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196191	10.1371/journal.pone.0196191	http://dx.doi.org/10.1371/journal.pone.0196191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689082	Green Published, gold, Green Submitted			2022-12-26	WOS:000430678800028
J	Chou, CC; Hsu, MY; Lin, CH; Lin, CC; Wang, CY; Shen, YC; Wang, IJ				Chou, Chien-Chih; Hsu, Min-Yen; Lin, Ching-Heng; Lin, Che-Chen; Wang, Chun-Yuan; Shen, Ying-Cheng; Wang, I-Jong			Risk of developing open-angle glaucoma in patients with carotid artery stenosis: A nationwide cohort study	PLOS ONE			English	Article							OCULAR BLOOD-FLOW; OPTIC DISC MICROCIRCULATION; LASER SPECKLE FLOWGRAPHY; RETROBULBAR CIRCULATION; NERVE HEAD; TENSION; ENDARTERECTOMY; PROGRESSION; PERFUSION; PRESSURE	Whether carotid artery stenosis (CAS) is an independent risk factor for open-angle glaucoma remains unclear. In this study, we investigated the association between CAS and the development of open-angle glaucoma in the Taiwanese population-based cohort derived from a longitudinal database containing claims data from the Taiwan National Health Insurance (NHI) program; this study enrolled 2093 patients with CAS and 8372 patients without CAS matched by age and sex from 1999 to 2010. Diagnoses of open-angle glaucoma (OAG) were identified during a follow-up period lasting through December 31, 2013. A Cox proportional hazards model was applied to evaluate the hazard ratio (HR) for OAG in the CAS cohort compared with the matched cohort. We found that the HR for open-angle glaucoma in the CAS cohort compared with the matched cohort. The adjusted HR for OAG in the CAS cohort was 1.50 (95% confidence interval, 1.11-2.02, P= .008). The Kaplan-Meier analysis revealed that the CAS cohort had a higher cumulative incidence of OAG than did the matched cohort during the follow-up period (log-rank test, P < .001). We concluded that CAS is a significantly independent risk factor for the development of OAG. Our finding is clinically important for the aging population, which has an increasing prevalence of CAS.	[Chou, Chien-Chih; Wang, Chun-Yuan; Shen, Ying-Cheng] Taichung Vet Gen Hosp, Dept Ophthalmol, Taichung, Taiwan; [Chou, Chien-Chih] Natl Taiwan Univ, Coll Med, Inst Clin Med, Taipei, Taiwan; [Hsu, Min-Yen] Chung Shan Med Univ Hosp, Dept Ophthalmol, Taichung, Taiwan; [Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Che-Chen] Taichung Vet Gen Hosp, HSRC, Taichung, Taiwan; [Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan	Taichung Veterans General Hospital; National Taiwan University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	ijong@ms8.hinet.net	Hsu, MinYen/AAT-2200-2021	Chou, Chien Chih/0000-0003-3332-0900; Wang, I-Jong/0000-0002-3045-0614				Aizawa N, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-113; Aizawa N, 2014, CLIN EXP OPHTHALMOL, V42, P293, DOI 10.1111/ceo.12130; Anderson DR, 1999, SURV OPHTHALMOL, V43, pS5, DOI 10.1016/S0039-6257(99)00046-6; Arai Naoyuki, 2014, Brain Nerve, V66, P1503, DOI 10.11477/mf.1416200065; Bulboaca Adriana, 2003, Oftalmologia, V58, P52; Bunin A Ia, 1995, Vestn Oftalmol, V111, P28; CARTER CJ, 1990, OPHTHALMOLOGY, V97, P49; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Chiang SJ, 2015, HEART, V101, P609, DOI 10.1136/heartjnl-2014-306198; Choi J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141905; Costa VP, 1997, OPHTHALMOLOGY, V104, P1994, DOI 10.1016/S0161-6420(97)30066-9; Drance S, 2001, ACTA OPHTHALMOL SCAN, V79, P545, DOI 10.1034/j.1600-0420.2001.790601.x; Flammer J, 1994, Surv Ophthalmol, V38 Suppl, pS3, DOI 10.1016/0039-6257(94)90041-8; Flammer J, 1998, PROG RETIN EYE RES, V17, P267, DOI 10.1016/S1350-9462(97)00006-2; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Greenfield DS, 2004, OPHTHAL SURG LAS IM, V35, P406, DOI 10.3928/1542-8877-20040901-09; Halliday A, 2004, LANCET, V363, P1491; Harju M, 2001, GRAEF ARCH CLIN EXP, V239, P271, DOI 10.1007/s004170100269; HARRIS A, 1994, AM J OPHTHALMOL, V118, P642, DOI 10.1016/S0002-9394(14)76579-1; Harris A, 2008, CAN J OPHTHALMOL, V43, P328, DOI 10.3129/i08-051; Hayreh S S, 1962, Br J Ophthalmol, V46, P65, DOI 10.1136/bjo.46.2.65; Hayreh SS, 2017, OPHTHALMOL RETINA, V1, P12, DOI 10.1016/j.oret.2016.08.003; Huck A, 2014, ACTA OPHTHALMOL, V92, pE336, DOI 10.1111/aos.12354; Hulsman CAA, 2007, ARCH OPHTHALMOL-CHIC, V125, P805, DOI 10.1001/archopht.125.6.805; Hwang DK, 2014, JAMA OPHTHALMOL, V132, P1446, DOI 10.1001/jamaophthalmol.2014.3333; JAMPOL LM, 1978, BRIT J OPHTHALMOL, V62, P324, DOI 10.1136/bjo.62.5.324; Kaiser HJ, 1997, AM J OPHTHALMOL, V123, P320, DOI 10.1016/S0002-9394(14)70127-8; Kawaguchi S, 2006, CEREBROVASC DIS, V22, P402, DOI 10.1159/000094859; Kawaguchi S, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/350475; Kobayashi W, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/468908; Kozobolis VP, 2007, GRAEF ARCH CLIN EXP, V245, P1639, DOI 10.1007/s00417-007-0589-2; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Memarzadeh F, 2010, INVEST OPHTH VIS SCI, V51, P2872, DOI 10.1167/iovs.08-2956; Michelson G, 1998, GRAEF ARCH CLIN EXP, V236, P80, DOI 10.1007/s004170050046; Michelson G, 1995, Ger J Ophthalmol, V4, P21; Moskovchenko K P, 1966, Vestn Oftalmol, V79, P48; Mughal MM, 2011, EXPERT REV CARDIOVAS, V9, P1315, DOI [10.1586/erc.11.120, 10.1586/ERC.11.120]; Nakazawa T, 2016, ASIA-PAC J OPHTHALMO, V5, P38, DOI 10.1097/APO.0000000000000183; Nicolela MT, 1996, AM J OPHTHALMOL, V122, P775, DOI 10.1016/S0002-9394(14)70373-3; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Rankin SJA, 1999, SURV OPHTHALMOL, V43, pS176, DOI 10.1016/S0039-6257(99)00043-0; Shiga Y, 2013, INVEST OPHTH VIS SCI, V54, P7699, DOI 10.1167/iovs.13-12930; Spacek M, 2013, ARCH MED SCI, V9, P1028, DOI 10.5114/aoms.2013.39216; Stewart WC, 2000, AM J OPHTHALMOL, V130, P274, DOI 10.1016/S0002-9394(00)00487-6; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315; Yamazaki Y, 1997, AM J OPHTHALMOL, V124, P287, DOI 10.1016/S0002-9394(14)70820-7; Yin ZQ, 1997, J GLAUCOMA, V6, P23	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0194533	10.1371/journal.pone.0194533	http://dx.doi.org/10.1371/journal.pone.0194533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684030	Green Published, Green Submitted, gold			2022-12-26	WOS:000430660600005
J	Nakamura, T; Chihara, M; Ichii, O; Otsuka-Kanazawa, S; Nagasaki, K; Elewa, YHA; Tatsumi, O; Kon, Y				Nakamura, Teppei; Chihara, Masataka; Ichii, Osamu; Otsuka-Kanazawa, Saori; Nagasaki, Ken-ichi; Elewa, Yaser Hosny Ali; Tatsumi, Osamu; Kon, Yasuhiro			Ovarian mast cells migrate toward ovary- fimbria connection in neonatal MRL/MpJ mice	PLOS ONE			English	Article							METAPHASE-SPECIFIC APOPTOSIS; MOUSE OVARY; STEM-CELLS; EXPRESSION; MRL; SPERMATOGENESIS; MAINTAIN; CANCER; OOCYTE; TESTIS	MRL/MpJ mice have abundant ovarian mast cells (MCs) as compared with other strains at postnatal day 0 (P0); however, they sharply decrease after birth. These ovarian MCs, particularly beneath the ovarian surface epithelium (SE), which express mucosal MC (MMC) marker, might participate in early follicular development. This study investigated the changes in spatiotemporal distribution of MCs in the perinatal MRL/MpJ mouse ovaries. At P0 to P7, the MCs were densely localized to the ovary, especially their caudomedial region around the ovary-fimbria connection. The neonatal ovarian MCs showed intermediate characteristics of MMC and connective tissue MC (CTMC), and the latter phenotype became evident with aging. However, the expression ratio of the MMC to CTMC marker increased from P0 to P4 in the MRL/MpJ mouse ovary. Similarly, the ratio of MCs facing SE to total MC number increased with aging, although the number of ovarian MCs decreased, indicating the relative increase in MMC phenotypes in the early neonatal ovary. Neither proliferating nor apoptotic MCs were found in the MRL/MpJ mouse ovaries. The parenchymal cells surrounding MCs at ovary-fimbria connection showed similar molecular expression patterns (E-cadherin(+)/Foxl2(-)/Gata4(+)) as that of the ovarian surface epithelial cells. At P2, around the ovary-fimbria connection, c-kit - immature oocytes formed clusters called nests, and some MCs localized adjacent to c-kit oocytes within the nests. These results indicated that in postnatal MRL/MpJ mice, ovarian MCs changed their distribution by migrating toward the parenchymal cells composing ovary-fimbria connection, which possessed similar characteristics to the ovarian surface epithelium. Thus, we elucidated the spatiotemporal alterations of the ovarian MCs in MRL/MpJ mice, and suggested their importance during the early follicular development by migrating toward the ovary-fimbria connection. MRL/MpJ mice would be useful to elucidate the relationship between neonatal immunity and reproductive systems.	[Nakamura, Teppei; Chihara, Masataka; Ichii, Osamu; Otsuka-Kanazawa, Saori; Elewa, Yaser Hosny Ali; Kon, Yasuhiro] Hokkaido Univ, Fac Vet Med, Dept Basic Vet Sci, Div Vet Med,Lab Anat, Sapporo, Hokkaido, Japan; [Nakamura, Teppei; Tatsumi, Osamu] Japan Food Res Labs, Chitose Lab, Sect Biol Sci, Chitose, Hokkaido, Japan; [Nagasaki, Ken-ichi] Japan Food Res Labs, Tama Lab, Sect Biol Safety Res, Tama Ku, Tokyo, Japan; [Elewa, Yaser Hosny Ali] Zagazig Univ, Fac Vet Med, Dept Histol & Cytol, Zagazig, Egypt	Hokkaido University; Egyptian Knowledge Bank (EKB); Zagazig University	Kon, Y (corresponding author), Hokkaido Univ, Fac Vet Med, Dept Basic Vet Sci, Div Vet Med,Lab Anat, Sapporo, Hokkaido, Japan.	y-kon@vetmed.hokudai.ac.jp	Elewa, Yaser/ABD-8332-2020; Elewa, Yaser/T-7550-2019	Elewa, Yaser/0000-0002-7347-4587; NAKAMURA, Teppei/0000-0003-3204-0245	Hokkaido University tenure track program; Japan Food Research Laboratories	Hokkaido University tenure track program; Japan Food Research Laboratories	This work was supported by Hokkaido University tenure track program. Teppei Nakamura, Ken-ichi Nagasaki and Osamu Tatsumi are employed by Japan Food Research Laboratories. Japan Food Research Laboratories provided support in the form of salaries for authors TN, KN and OT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported in part by the Hokkaido University tenure track program.	Aydin Y, 1998, COMP BIOCHEM PHYS A, V120, P255, DOI 10.1016/S1095-6433(98)00027-0; Chihara M, 2015, ANDROLOGY-US, V3, P991, DOI 10.1111/andr.12082; Chihara M, 2014, AM J PATHOL, V184, P2480, DOI 10.1016/j.ajpath.2014.06.004; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Halova I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00119; Hosotani M, 2018, LUPUS, V27, P82, DOI 10.1177/0961203317711772; Jones RL, 2013, DEV BIOL, V382, P186, DOI 10.1016/j.ydbio.2013.06.030; Kalesnikoff J, 2011, METHODS MOL BIOL, V677, P207, DOI 10.1007/978-1-60761-869-0_15; Kang JS, 2003, J HISTOCHEM CYTOCHEM, V51, P1447, DOI 10.1177/002215540305101105; Kazusa K, 2004, COMPARATIVE MED, V54, P179; Kon Y, 1999, CELL TISSUE RES, V296, P359, DOI 10.1007/s004410051296; Kon Y, 2000, ANAT HISTOL EMBRYOL, V29, P313, DOI 10.1046/j.1439-0264.2000.00279.x; Kon Y, 2007, ANAT HISTOL EMBRYOL, V36, P172, DOI 10.1111/j.1439-0264.2006.00728.x; Kon Y, 2001, MOL REPROD DEV, V58, P216, DOI 10.1002/1098-2795(200102)58:2&lt;216::AID-MRD11&gt;3.0.CO;2-C; Lam PY, 2013, CURR OPIN CELL BIOL, V25, P650, DOI 10.1016/j.ceb.2013.05.007; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Machelon V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-97; Nakamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100617; Nakamura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077246; Namiki Y, 2003, MOL REPROD DEV, V64, P179, DOI 10.1002/mrd.10208; Ng A, 2015, NAT REV MOL CELL BIO, V16, P625, DOI 10.1038/nrm4056; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Oldford SA, 2015, MOL IMMUNOL, V63, P113, DOI 10.1016/j.molimm.2014.02.020; Otani Y, 2015, AUTOIMMUNITY, V48, P402, DOI 10.3109/08916934.2015.1031889; Otsuka S, 2008, JPN J VET RES, V56, P129; Otsuka S, 2008, BIOL REPROD, V79, P9, DOI 10.1095/biolreprod.107.064519; Parrott JA, 2000, BIOL REPROD, V62, P1600, DOI 10.1095/biolreprod62.6.1600; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Welle M, 1997, J LEUKOCYTE BIOL, V61, P233, DOI 10.1002/jlb.61.3.233; Woidacki K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00029; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Wulff BC, 2013, EXP DERMATOL, V22, P507, DOI 10.1111/exd.12169; Yamashita Y, 2015, JPN J VET RES, V63, P25; Zweifel M, 2005, IMMUNOL CELL BIOL, V83, P587, DOI 10.1111/j.1440-1711.2005.01368.x	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196364	10.1371/journal.pone.0196364	http://dx.doi.org/10.1371/journal.pone.0196364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684078	Green Submitted, Green Published, gold			2022-12-26	WOS:000430660600057
J	Yang, Y; Yanai, RD; Driscoll, CT; Montesdeoca, M; Smith, KT				Yang, Yang; Yanai, Ruth D.; Driscoll, Charles T.; Montesdeoca, Mario; Smith, Kevin T.			Concentrations and content of mercury in bark, wood, and leaves in hardwoods and conifers in four forested sites in the northeastern USA	PLOS ONE			English	Article							DECIDUOUS UPLAND FORESTS; HUBBARD BROOK ECOSYSTEM; PINUS-NIGRA BARKS; ATMOSPHERIC MERCURY; UNITED-STATES; NORTHERN HARDWOOD; TREE-RINGS; LITTERFALL MERCURY; SPATIAL-PATTERNS; DRY DEPOSITION	Mercury (Hg) is deposited from the atmosphere to remote areas such as forests, but the amount of Hg in trees is not well known. To determine the importance of Hg in trees, we analyzed foliage, bark and bole wood of eight tree species at four sites in the northeastern USA (Huntington Forest, NY; Sleepers River, VT; Hubbard Brook, NH; Bear Brook, ME). Foliar concentrations of Hg averaged 16.3 ng g(-1) among the hardwood species, which was significantly lower than values in conifers, which averaged 28.6 ng g(-1) (p < 0.001). Similarly, bark concentrations of Hg were lower (p < 0.001) in hardwoods (7.7 ng g(-1)) than conifers (22.5 ng g(-1)). For wood, concentrations of Hg were higher in yellow birch (2.1-2.8 ng g(-1)) and white pine (2.3 ng g(-1)) than in the other species, which averaged 1.4 ng g(-1) (p < 0.0001). Sites differed significantly in Hg concentrations of foliage and bark (p = 0.02), which are directly exposed to the atmosphere, but the concentration of Hg in wood depended more on species (p < 0.001) than site (p = 0.60). The Hg contents of tree tissues in hardwood stands, estimated from modeled biomass and measured concentrations at each site, were higher in bark (mean of 0.10 g ha(-1)) and wood (0.16 g ha(-1)) than in foliage (0.06 g ha(-1)). In conifer stands, because foliar concentrations were higher, the foliar pool tended to be more important. Quantifying Hg in tree tissues is essential to understanding the pools and fluxes of Hg in forest ecosystems.	[Yang, Yang; Yanai, Ruth D.] SUNY Syracuse, Coll Environm Sci & Forestry, Dept Forest & Nat Resources Management, Syracuse, NY 13210 USA; [Driscoll, Charles T.; Montesdeoca, Mario] Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA; [Smith, Kevin T.] USDA Forest Serv, Northern Res Stn, Durham, NH USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Syracuse University; United States Department of Agriculture (USDA); United States Forest Service	Yang, Y (corresponding author), SUNY Syracuse, Coll Environm Sci & Forestry, Dept Forest & Nat Resources Management, Syracuse, NY 13210 USA.	yyang100@sry.edu	Driscoll, Charles/F-9832-2014; Brook, Hubbard/AAD-1112-2022; Yang, Yang/J-7971-2019; Yanai, Ruth D./O-3250-2019	Driscoll, Charles/0000-0003-2692-2890; Yang, Yang/0000-0002-2760-0992; Yanai, Ruth D./0000-0001-6987-2489	USDA Forest Service Northeastern States Research Cooperative [NYZ1127226]; National Science Foundation	USDA Forest Service Northeastern States Research Cooperative; National Science Foundation(National Science Foundation (NSF))	This project was funded by grants from the USDA Forest Service Northeastern States Research Cooperative (https://nsrcforest.org/project/quantifying-mercury-forest-biomass) under: (project number NYZ1127226) in 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Field assistance was provided by Daphne Taylor and Bruce Breitmeyer at Huntington Forest; Jamie Shanley and Ann Chalmers at Sleepers River; Ian Halm, Adam Wild, Ehren Moler, and Panmei Jiang at Hubbard Brook; and Ivan Fernandez, Marie Cecile Gruselle, and Kaizad Patel at Bear Brook. Mario Montesdeoca, Mariah Taylor, and Giselle Schreiber were instrumental in the laboratory analyses. This manuscript is a contribution of the Hubbard Brook Ecosystem Study. Hubbard Brook is part of the Long-Term Ecological Research (LTER) Network, which is supported by the National Science Foundation. The Hubbard Brook Experimental Forest is operated and maintained by the USDA Forest Service, Newtown Square, PA.	Abreu SN, 2008, B ENVIRON CONTAM TOX, V80, P294, DOI 10.1007/s00128-008-9366-0; [Anonymous], [No title captured]; Battles J.J., 2013, ENVIRON SCI TECH LET, V1, P15, DOI DOI 10.1021/EZ400033D; Becnel J, 2004, MICROCHEM J, V78, P205, DOI 10.1016/j.microc.2004.06.002; Bishop KH, 1998, BIOGEOCHEMISTRY, V40, P101, DOI 10.1023/A:1005983932240; Blackwell BD, 2015, ENVIRON POLLUT, V202, P126, DOI 10.1016/j.envpol.2015.02.036; Blackwell BD, 2014, BIOGEOCHEMISTRY, V119, P215, DOI 10.1007/s10533-014-9961-6; Bushey JT, 2008, ATMOS ENVIRON, V42, P6905, DOI 10.1016/j.atmosenv.2008.05.043; Chiarantini L, 2017, ENVIRON POLLUT, V227, P83, DOI 10.1016/j.envpol.2017.04.038; Chiarantini L, 2016, SCI TOTAL ENVIRON, V569, P105, DOI 10.1016/j.scitotenv.2016.06.029; Choi HD, 2008, ENVIRON SCI TECHNOL, V42, P5644, DOI 10.1021/es7028137; Dittman JA, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008351; Driscoll CT, 2007, BIOSCIENCE, V57, P17, DOI 10.1641/B570106; Elvir JA, 2010, ENVIRON MONIT ASSESS, V171, P129, DOI 10.1007/s10661-010-1523-3; *EPA U, 1998, MERC SOL SOL THERM D; Ericksen JA, 2003, ATMOS ENVIRON, V37, P1613, DOI 10.1016/S1352-2310(03)00008-6; Fleck JA, 1999, WATER AIR SOIL POLL, V115, P513, DOI 10.1023/A:1005194608598; Friedli HR, 2009, ENVIRON SCI TECHNOL, V43, P3507, DOI 10.1021/es802703g; Gerson JR, 2016, ENVIRON SCI TECHNOL, V50, P10943, DOI 10.1021/acs.est.6b02127; Gnamus A, 2000, ENVIRON SCI TECHNOL, V34, P3337, DOI 10.1021/es991419w; Graydon JA, 2008, ENVIRON SCI TECHNOL, V42, P8345, DOI 10.1021/es801056j; Grigal DF, 2003, J ENVIRON QUAL, V32, P393, DOI 10.2134/jeq2003.0393; Gueguen F, 2012, CHEMOSPHERE, V86, P1013, DOI 10.1016/j.chemosphere.2011.11.040; HUNTINGTON TG, 1988, SOIL SCI SOC AM J, V52, P1162, DOI 10.2136/sssaj1988.03615995005200040049x; Hutnik RJ, 2014, NORTHEAST NAT, V21, P529, DOI 10.1656/045.021.0402; JOHNSON DW, 1995, WATER AIR SOIL POLL, V80, P1069, DOI 10.1007/BF01189767; Johnson DW, 1992, ATMOSPHERIC DEPOSITI, P571; Korner C., 1995, ECOPHYSIOLOGY PHOTOS, P463, DOI DOI 10.1007/978-3-642-79354-7_22; Larcher W, 2003, PHYSL PLANT ECOLOGY; Luo Y, 2016, J GEOPHYS RES-BIOGEO, V121, P2006, DOI 10.1002/2016JG003388; Nasr M., 2015, BIOMONITORING, V2, P47; NORTON SA, 1992, ENVIRON POLLUT, V77, P279, DOI 10.1016/0269-7491(92)90087-Q; Obrist D, 2011, ENVIRON SCI TECHNOL, V45, P3974, DOI 10.1021/es104384m; Obrist D, 2009, BIOGEOSCI DISC, V6, P1777, DOI DOI 10.5194/BGD-6-1777-2009; Obrist D, 2007, BIOGEOCHEMISTRY, V85, P119, DOI 10.1007/s10533-007-9108-0; Obrist D, 2012, J PLANT NUTR SOIL SC, V175, P68, DOI 10.1002/jpln.201000415; Park BB, 2008, ECOSYSTEMS, V11, P325, DOI 10.1007/s10021-008-9126-3; RASMUSSEN PE, 1991, WATER AIR SOIL POLL, V56, P379, DOI 10.1007/BF00342285; RASMUSSEN PE, 1995, WATER AIR SOIL POLL, V80, P1039, DOI 10.1007/BF01189762; Rea AW, 1996, ATMOS ENVIRON, V30, P3257, DOI 10.1016/1352-2310(96)00087-8; Rea AW, 2002, WATER AIR SOIL POLL, V133, P49, DOI 10.1023/A:1012919731598; Reimann C, 2007, APPL GEOCHEM, V22, P1549, DOI 10.1016/j.apgeochem.2007.03.048; Richardson JB, 2015, BIOGEOSCIENCES, V12, P6737, DOI 10.5194/bg-12-6737-2015; Rimmer CC, 2010, ECOTOXICOLOGY, V19, P697, DOI 10.1007/s10646-009-0443-x; Risch MR, 2012, ENVIRON POLLUT, V161, P284, DOI 10.1016/j.envpol.2011.06.005; Schmeltz D, 2011, ECOTOXICOLOGY, V20, P1713, DOI 10.1007/s10646-011-0756-4; Sheehan KD, 2006, WATER AIR SOIL POLL, V170, P249, DOI 10.1007/s11270-006-3034-y; Siwik E, 2007, THESIS; Siwik EIH, 2010, ENVIRON POLLUT, V158, P2067, DOI 10.1016/j.envpol.2010.03.002; Siwik EIH, 2009, SCI TOTAL ENVIRON, V407, P6275, DOI 10.1016/j.scitotenv.2009.08.044; Somers R. C. Jr, 1986, THESIS; Wang JJ, 2012, ENVIRON SCI TECHNOL, V46, P769, DOI 10.1021/es2018708; WHITTAKER RH, 1979, ECOLOGY, V60, P203, DOI 10.2307/1936481; WHITTAKER RH, 1974, ECOL MONOGR, V44, P233, DOI 10.2307/1942313; Wright G, 2014, BIOGEOCHEMISTRY, V120, P149, DOI 10.1007/s10533-014-9987-9; Yang Y, 2017, INT J ENVIRON AN CH, V97, P456, DOI 10.1080/03067319.2017.1324852; Yu X, 2014, ECOL APPL, V24, P812, DOI 10.1890/13-0212.1; ZHANG L, 1995, WATER AIR SOIL POLL, V81, P163, DOI 10.1007/BF00477263; Zhou H, 2017, ENVIRON SCI TECH LET, V4, P91, DOI 10.1021/acs.estlett.6b00452; Zhou J, 2017, J GEOPHYS RES-BIOGEO, V122, P1260, DOI 10.1002/2017JG003776	60	22	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196293	10.1371/journal.pone.0196293	http://dx.doi.org/10.1371/journal.pone.0196293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684081	Green Submitted, Green Published, gold			2022-12-26	WOS:000430660600050
J	Bellesis, AG; Jecrois, AM; Hayes, JA; Schiffer, CA; Royer, WE				Bellesis, Andrew G.; Jecrois, Anne M.; Hayes, Janelle A.; Schiffer, Celia A.; Royer, William E., Jr.			Assembly of human C-terminal binding protein (CtBP) into tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTIONAL COREPRESSOR CTBP; CELLULAR PHOSPHOPROTEIN; NEGATIVE MODULATION; ADENOVIRUS E1A; BREAST-CANCER; REPRESSION; DOMAIN; NADH; TRANSFORMATION	C-terminal binding protein 1 (CtBP1) and CtBP2 are transcriptional coregulators that repress numerous cellular processes, such as apoptosis, by binding transcription factors and recruiting chromatin-remodeling enzymes to gene promoters. The NAD(H)-linked oligomerization of human CtBP is coupled to its co-transcriptional activity, which is implicated in cancer progression. However, the biologically relevant level of CtBP assembly has not been firmly established; nor has the stereochemical arrangement of the subunits above that of a dimer. Here, multi-angle light scattering (MALS) data established the NAD(+)-and NADH-dependent assembly of CtBP1 and CtBP2 into tetramers. An examination of subunit interactions within CtBP1 and CtBP2 crystal lattices revealed that both share a very similar tetrameric arrangement resulting from assembly of two dimeric pairs, with specific interactions probably being sensitive to NAD(H) binding. Creating a series of mutants of both CtBP1 and CtBP2, we tested the hypothesis that the crystallographically observed interdimer pairing stabilizes the solution tetramer. MALS data confirmed that these mutants disrupt both CtBP1 and CtBP2 tetramers, with the dimer generally remaining intact, providing the first stereochemical models for tetrameric assemblies of CtBP1 and CtBP2. The crystal structure of a subtle destabilizing mutant suggested that small structural perturbations of the hinge region linking the substrate-and NAD-binding domains are sufficient to weaken the CtBP1 tetramer. These results strongly suggest that the tetramer is important in CtBP function, and the series of CtBP mutants reported here can be used to investigate the physiological role of the tetramer.	[Bellesis, Andrew G.; Jecrois, Anne M.; Hayes, Janelle A.; Schiffer, Celia A.; Royer, William E., Jr.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Bellesis, Andrew G.] Clark Univ, Carlson Sch Chem & Biochem, Worcester, MA 01610 USA; [Bellesis, Andrew G.] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Bellesis, Andrew G.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Massachusetts System; University of Massachusetts Worcester; Clark University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Royer, WE (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	William.Royer@umassmed.edu		Bellesis, Andrew/0000-0003-2853-0057	National Institutes of Health [R01 GM119014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119014] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012028] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 GM119014 (to W. E. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achouri Y, 2007, BIOCHEM BIOPH RES CO, V352, P903, DOI 10.1016/j.bbrc.2006.11.111; Balasubramanian P, 2003, FEBS LETT, V537, P157, DOI 10.1016/S0014-5793(03)00119-4; Barroilhet L, 2013, ONCOGENE, V32, P3896, DOI 10.1038/onc.2012.380; Bergman LM, 2006, APOPTOSIS, V11, P879, DOI 10.1007/s10495-006-6651-4; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; Bi CL, 2018, BIOCHEM BIOPH RES CO, V495, P1980, DOI 10.1016/j.bbrc.2017.12.018; Birts CN, 2011, BIOL CELL, V103, P1, DOI 10.1042/BC20100067; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Corda D, 2006, TRENDS CELL BIOL, V16, P167, DOI 10.1016/j.tcb.2006.01.007; Cubillos-Rojas M, 2017, ONCOTARGET, V8, P61824, DOI 10.18632/oncotarget.18699; Deng H, 2013, J INVEST DERMATOL, V133, P1294, DOI 10.1038/jid.2012.487; Deng Y, 2012, MOL CARCINOGEN, V51, P500, DOI 10.1002/mc.20813; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Guan CQ, 2013, J CELL BIOCHEM, V114, P1343, DOI 10.1002/jcb.24475; Hilbert BJ, 2015, ACS CHEM BIOL, V10, P1118, DOI 10.1021/cb500820b; Hilbert BJ, 2014, FEBS LETT, V588, P1743, DOI 10.1016/j.febslet.2014.03.026; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Jin W, 2007, BIOCHEM PHARMACOL, V74, P851, DOI 10.1016/j.bcp.2007.06.017; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Madison DL, 2013, J BIOL CHEM, V288, P27836, DOI 10.1074/jbc.M113.493569; Mani-Telang P, 2007, FEBS LETT, V581, P5241, DOI 10.1016/j.febslet.2007.10.011; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Nardini M, 2006, PROTEIN SCI, V15, P1042, DOI 10.1110/ps.062115406; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Nardini M, 2009, BIOCHEM BIOPH RES CO, V381, P70, DOI 10.1016/j.bbrc.2009.02.010; Paliwal Seema, 2012, Genes Cancer, V3, P481, DOI 10.1177/1947601912463695; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Payankaulam S, 2010, CURR BIOL, V20, pR764, DOI 10.1016/j.cub.2010.06.037; Ray SK, 2017, FEBS LETT, V591, P205, DOI 10.1002/1873-3468.12501; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Sumner ET, 2017, ONCOGENE, V36, P4810, DOI 10.1038/onc.2017.106; Sun LD, 2016, CELL MOL LIFE SCI, V73, P4493, DOI 10.1007/s00018-016-2303-1; Thio SSC, 2004, NUCLEIC ACIDS RES, V32, P1836, DOI 10.1093/nar/gkh344; Van Holds K. F., 1971, PHYS BIOCH, p[43, 191]; Wang R, 2012, NEOPLASIA, V14, P905, DOI 10.1593/neo.121192; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Zhang YW, 2011, MOL CELL BIOL, V31, P375, DOI 10.1128/MCB.00772-10; Zheng X, 2015, ONCOTARGET, V6, P3752, DOI 10.18632/oncotarget.2915	49	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9101	9112		10.1074/jbc.RA118.002514	http://dx.doi.org/10.1074/jbc.RA118.002514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29700119	Green Published, hybrid			2022-12-26	WOS:000434941900031
J	Petti, LM; Marlatt, SA; Luo, Y; Scheideman, EH; Shelar, A; DiMaio, D				Petti, Lisa M.; Marlatt, Sara A.; Luo, Yong; Scheideman, Elizabeth H.; Shelar, Ashish; DiMaio, Daniel			Regulation of C-C chemokine receptor 5 (CCR5) stability by Lys(197) and by transmembrane protein aptamers that target it for lysosomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C-C chemokine receptor type 5 (CCR5); G protein-coupled receptor (GPCR); lysosome; chemokine; human immunodeficiency virus (HIV); HIV co-receptor; CCR2b; E5 protein; proximity ligation assay; transmembrane protein; traptamer	IMMUNODEFICIENCY-VIRUS TYPE-1; AGONIST-INDUCED ENDOCYTOSIS; PHOSPHORYLATION SITES; MOLECULAR-CLONING; BETA; EXPRESSION; DOMAIN; CXCR4; INTERNALIZATION; CORECEPTOR	C-C motif chemokine receptor 5 (CCR5) is a cell surface-associated, immune-regulatory G protein-coupled receptor (GCPR) with seven transmembrane helices. We previously reported the isolation and initial characterization of short artificial transmembrane protein aptamers, named traptamers, that specifically down-regulate CCR5 expression and inhibit infection of human T cells by HIV strains that use CCR5 as a co-receptor. Here, we investigated the mechanism of traptamer-mediated CCR5 down-regulation and show that most of the traptamers (designated class 1 traptamers) form a stable complex with CCR5 and target it for lysosome-mediated degradation. The ability of these traptamers to down-regulate CCR5 depended on Lys(197) in the fifth transmembrane helix of CCR5. In the absence of traptamers, substitution of Lys(197) to an uncharged amino acid increased CCR5 stability, and introduction of a lysine at the homologous position in CCR2b, a related chemokine receptor, decreased CCR2b levels. The prototypic class 2 traptamer BY6M4 also formed a complex with CCR5, but CCR5 down-regulation caused by class 2 traptamers did not depend on the lysosome or on Lys(197). These results demonstrate that traptamers use diverse mechanisms to down-regulate CCR5 and identify a specific amino acid that plays a central role in controlling chemokine receptor stability. Further studies of these traptamers are likely to provide new insights into CCR5 metabolism and biology and may suggest new therapeutic approaches to modulate the levels of CCR5 and other GPCRs.	[Petti, Lisa M.; Marlatt, Sara A.; Luo, Yong; Scheideman, Elizabeth H.; Shelar, Ashish; DiMaio, Daniel] Yale Sch Med, Dept Genet, POB 208005, New Haven, CT 06520 USA; [DiMaio, Daniel] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA; [DiMaio, Daniel] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [DiMaio, Daniel] Yale Canc Ctr, New Haven, CT 06520 USA; [Marlatt, Sara A.] Azusa Pacific Univ, 901 E Alosta Ave, Azusa, CA 91702 USA	Yale University; Yale University; Yale University; Yale University	DiMaio, D (corresponding author), Yale Sch Med, Dept Genet, POB 208005, New Haven, CT 06520 USA.	daniel.dimaio@yale.edu	Shelar, Ashish/AAC-9295-2022		NCI, National Institutes of Health [CA037157]; NATIONAL CANCER INSTITUTE [R01CA037157, R37CA037157] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health, Grant CA037157 (to D.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arias JF, 2012, CURR HIV RES, V10, P283, DOI 10.2174/157016212800792423; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Borroni EM, 2010, PHARMACOL THERAPEUT, V127, P1, DOI 10.1016/j.pharmthera.2010.04.006; Cammett TJ, 2010, P NATL ACAD SCI USA, V107, P3447, DOI 10.1073/pnas.0915057107; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Dube M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-114; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Freeman-Cook LL, 2004, J MOL BIOL, V338, P907, DOI 10.1016/j.jmb.2004.03.044; Glosson NL, 2010, J BIOL CHEM, V285, P37016, DOI 10.1074/jbc.M110.125849; He L, 2017, ELIFE, V6, DOI 10.7554/eLife.27701; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Huttenrauch F, 2002, J BIOL CHEM, V277, P30769, DOI 10.1074/jbc.M204033200; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Lau G, 2015, J BIOL CHEM, V290, P11041, DOI 10.1074/jbc.M115.640169; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lipovsky Alex, 2015, Methods Mol Biol, V1270, P437, DOI 10.1007/978-1-4939-2309-0_30; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; Oppermann M, 1999, J BIOL CHEM, V274, P8875, DOI 10.1074/jbc.274.13.8875; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Popa A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004699; Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161; Richards R, 2011, J VIROL, V85, P8766, DOI 10.1128/JVI.05021-11; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Scheideman EH, 2012, J VIROL, V86, P10281, DOI 10.1128/JVI.00910-12; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Zheng Y, 2017, IMMUNITY, V46, P1005, DOI 10.1016/j.immuni.2017.05.002; Zheng Y, 2016, NATURE, V540, P458, DOI 10.1038/nature20605	41	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8787	8801		10.1074/jbc.RA117.001067	http://dx.doi.org/10.1074/jbc.RA117.001067			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29678881	Green Published, hybrid			2022-12-26	WOS:000434941900006
J	Shahriari, Z; Heidari, B; Dadkhodaie, A				Shahriari, Zolfaghar; Heidari, Bahram; Dadkhodaie, Ali			Dissection of genotype x environment interactions for mucilage and seed yield in Plantago species: Application of AMMI and GGE biplot analyses	PLOS ONE			English	Article							MEDICINAL-PLANTS; DROUGHT STRESS; SECONDARY METABOLITES; STATISTICAL-ANALYSIS; TRIAL DATA; CULTIVATION; OVATA; ADAPTATION; LANCEOLATA; STABILITY	Genotype x environment interaction (GEI) is an important aspect of both plant breeding and the successful introduction of new cultivars. In the present study, additive main effects and multiplicative interactions (AMMI) and genotype (G) main effects and genotype (G) x environment (E) interaction (GGE) biplot analyses were used to identify stable genotypes and to dissect GEI in Plantago. In total, 10 managed field trials were considered as environments to analyze GEI in thirty genotypes belonging to eight Plantago species. Genotypes were evaluated in a drought stress treatment and in normal irrigation conditions at two locations in Shiraz (Bajgah) for three years (2013-2014-2015) and Kooshkak (Marvdasht, Fars, Iran) for two years (2014-2015). Three traits, seed yield and mucilage yield and content, were measured at each experimental site and in natural Plantago habitats. AMMI2 biplot analyses identified genotypes from several species with higher stability for seed yield and other genotypes with stable mucilage content and yield. P. lanceolata (G26), P. officinalis (G10), P. ovata (G14), P. ampleexcaulis (G11) and P. major (G4) had higher stability for seed yield. For mucilage yield, G21, G18 and G20 (P. psyllium), G1, G2 and G4 (P. major), G9 and G10 (P. officinalis) and P. lanceolata were identified as stable. G13 (P. ovata), G5 and G6 (P. major) and G30 (P. lagopus) had higher stability for mucilage content. No one genotype was found to have high levels of stability for more than one trait but some species had more than one genotype exhibiting stable trait performance. Based on trait variation, GGE biplot analysis identified two representative environments, one for seed yield and one for mucilage yield and content, with good discriminating ability. The identification of stable genotypes and representative environments should assist the breeding of new Plantago cultivars.	[Shahriari, Zolfaghar; Heidari, Bahram; Dadkhodaie, Ali] Shiraz Univ, Sch Agr, Dept Crop Prod & Plant Breeding, Shiraz, Iran	Shiraz University	Heidari, B (corresponding author), Shiraz Univ, Sch Agr, Dept Crop Prod & Plant Breeding, Shiraz, Iran.	bheidari@shirazu.ac.ir	Dadkhodaie, ali/X-2040-2018; Heidari, Bahram/Z-1162-2019; shahriari, zolfaghar/AAB-8285-2021; Dadkhodaie, Ali/ABE-8136-2021	Dadkhodaie, ali/0000-0001-7824-9162; Heidari, Bahram/0000-0002-5856-4592; 				Abera B, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-40; Aghaei Keyvan, 2013, Front Plant Sci, V4, P8, DOI 10.3389/fpls.2013.00008; Ahvazi M, 2012, IRAN J PHARM RES, V11, P185; Akinwale RO, 2014, CEREAL RES COMMUN, V42, P534, DOI 10.1556/CRC.42.2014.3.16; Akter A., 2014, J RICE RES, V2, P1; Al Hassan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160236; Annicchiarico P, 1997, EUPHYTICA, V94, P53, DOI 10.1023/A:1002954824178; Bekele E., 2007, STUDY ACTUAL SITUATI, P54; Canter PH, 2005, TRENDS BIOTECHNOL, V23, P180, DOI 10.1016/j.tibtech.2005.02.002; Carrubba A, 2002, ACTA HORTIC, P207, DOI 10.17660/ActaHortic.2002.576.30; Cavaliere C., HERBALGRAM, V81, P44; Fougat RS, 2014, AGRICULTURE-BASEL, V4, P199, DOI 10.3390/agriculture4020199; FOX PN, 1982, EUPHYTICA, V31, P645, DOI 10.1007/BF00039203; Gauch H.G., 1992, STAT ANAL REGIONAL Y; Gauch H. G. Jr., 1996, P85; GAUCH HG, 1988, BIOMETRICS, V44, P705, DOI 10.2307/2531585; Gauch HG, 2008, CROP SCI, V48, P866, DOI 10.2135/cropsci2007.09.0513; GENSTAT, 2009, GENSTAT; Ghaed-Rahimi L, 2013, ARCH AGRON SOIL SCI, V61, P1531; Haddadian K, 2014, INDIAN J TRADIT KNOW, V13, P681; Hanley ME, 1990, THESIS DURHAM U; Hongyu K., 2014, BIOMETR LETT, V51, P89, DOI [10.2478/bile-2014-0007, DOI 10.2478/BILE-2014-0007]; da Silveira LCI, 2013, SCI AGR, V70, P27, DOI 10.1590/S0103-90162013000100005; Islam M.R., 2014, FRIENDLY AGRIL J, V7, P20; Jamshidmoghaddam M, 2013, EUPHYTICA, V190, P357, DOI 10.1007/s10681-012-0776-z; Kleinwachter M, 2015, AGRON SUSTAIN DEV, V35, P121, DOI 10.1007/s13593-014-0260-3; Koocheki A., 2007, Asian Journal of Plant Sciences, V6, P1229; Koocheki A, 2004, J IRANIAN FIELD CROP, V2, P67; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Latzel V, 2009, OIKOS, V118, P1669, DOI 10.1111/j.1600-0706.2009.17767.x; Lin C. C., 1994, Proceedings of the International Conference, Chemistry in Water Reactors: Operating Experience and New Developments, P271; LIN CS, 1988, CAN J PLANT SCI, V68, P193, DOI 10.4141/cjps88-018; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Mathur S, 2003, EUPHYTICA, V133, P255, DOI 10.1023/A:1025747630140; Miehe-Steier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136073; Miranda GV, 2009, PESQUI AGROPECU BRAS, V44, P45, DOI 10.1590/S0100-204X2009000100007; Mirmasumi M, 2001, J AGR SCI TECH, V3, P155; Moreno-Gonzalez J, 2004, EUPHYTICA, V137, P119, DOI 10.1023/B:EUPH.0000040509.61017.94; Niinemets U, 2016, TREE PHYSIOL, V36, P129, DOI 10.1093/treephys/tpv128; Niyaki SAN, 2011, J MED PLANTS RES, V5, P30; Oliveira EJ, 2009, SCI AGR, V71, P139; Pank F., 2006, MED PLANT BIOTECHNOL; Parsaei P, 2016, PHARM LETT, V8; Purchase J. L., 2000, South African Journal of Plant and Soil, V17, P101; Rahimi A, 2013, J SOIL SCI PLANT NUT, V13, P341, DOI 10.4067/S0718-95162013005000028; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; ROMAGOSA I, 1993, THEOR APPL GENET, V86, P822, DOI 10.1007/BF00212607; Roostaei M, 2014, CROP J, V2, P154, DOI 10.1016/j.cj.2014.02.002; Sayadi F, 2013, IRANIAN J MED AROM P, V29, P783; Selmar D, 2013, PLANT CELL PHYSIOL, V54, P817, DOI 10.1093/pcp/pct054; Selmar D, 2013, IND CROP PROD, V42, P558, DOI 10.1016/j.indcrop.2012.06.020; Shahriari Z., 2016, 2 INT 14 IR GEN C; Sharafzadeh S., 2012, Journal of Applied Pharmaceutical Science, V2, P134; SHARMA PK, 1986, J ETHNOPHARMACOL, V17, P289, DOI 10.1016/0378-8741(86)90118-2; SIMMONDS NW, 1991, THEOR APPL GENET, V82, P363, DOI 10.1007/BF02190624; Sneller CH, 1997, CROP SCI, V37, P383, DOI 10.2135/cropsci1997.0011183X003700020013x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Van De Velde H, 2015, PLANT ECOL, V216, P1047, DOI 10.1007/s11258-015-0488-2; Walter J, 2016, PLANT BIOLOGY, V18, P262, DOI 10.1111/plb.12379; WOLFF K, 1987, HEREDITY, V58, P183, DOI 10.1038/hdy.1987.32; Xu YB, 2016, THEOR APPL GENET, V129, P653, DOI 10.1007/s00122-016-2691-5; Yan W, 2006, CAN J PLANT SCI, V86, P623, DOI 10.4141/P05-169; Yan WK, 2010, EUPHYTICA, V171, P355, DOI 10.1007/s10681-009-0030-5; Yan WK, 2005, CROP SCI, V45, P1004, DOI 10.2135/cropsci2004.0076; Yan WK, 2002, AGRON J, V94, P990, DOI 10.2134/agronj2002.0990; ZOBEL RW, 1988, AGRON J, V80, P388, DOI 10.2134/agronj1988.00021962008000030002x; Zubair M., 2012, THESIS; Zubair M, 2012, SCI HORTIC-AMSTERDAM, V136, P9, DOI 10.1016/j.scienta.2012.01.002	68	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196095	10.1371/journal.pone.0196095	http://dx.doi.org/10.1371/journal.pone.0196095			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715274	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100010
J	Storm, FA; Nair, KPS; Clarke, AJ; Van der Meulen, JM; Mazza, C				Storm, Fabio A.; Nair, K. P. S.; Clarke, Alison J.; Van der Meulen, Jill M.; Mazza, Claudia			Free-living and laboratory gait characteristics in patients with multiple sclerosis	PLOS ONE			English	Article							PARKINSONS-DISEASE IMPACT; OLDER-ADULTS; SPATIOTEMPORAL PARAMETERS; ACTIVITY MONITOR; ACCELEROMETER; ACCURACY; WALKING; PEOPLE; MILD; LIFE	Background Wearable sensors offer the potential to bring new knowledge to inform interventions in patients affected by multiple sclerosis (MS) by thoroughly quantifying gait characteristics and gait deficits from prolonged daily living measurements. The aim of this study was to characterise gait in both laboratory and daily life conditions for a group of patients with moderate to severe ambulatory impairment due to MS. To this purpose, algorithms to detect and characterise gait from wearable inertial sensors data were also validated. Methods Fourteen patients with MS were divided into two groups according to their disability level (EDSS 6.5-6.0 and EDSS 5.5-5.0, respectively). They performed both intermittent and continuous walking bouts (WBs) in a gait laboratory wearing waist and shank mounted inertial sensors. An algorithm (W-CWT) to estimate gait events and temporal parameters (mean and variability values) using data recorded from the waist mounted sensor (Dynaport, Mc Roberts) was tested against a reference algorithm (S-REF) based on the shank-worn sensors (OPAL, APDM). Subsequently, the accuracy of another algorithm (W-PAM) to detect and classify WBs was also tested. The validated algorithms were then used to quantify gait characteristics during short (sWB, 5-50 steps), intermediate (iWB, 51-100 steps) and long (lWB, >100 steps) daily living WBs and laboratory walking. Group means were compared using a two-way ANOVA. Results W-CWT compared to S-REF showed good gait event accuracy (0.05-0.10 s absolute error) and was not influenced by disability level. It slightly overestimated stride time in intermittent walking (0.012 s) and overestimated highly variability of temporal parameters in both intermittent (17.5%-58.2%) and continuous walking (11.2%-76.7%). The accuracy of W-PAM was speed-dependent and decreased with increasing disability. The ANOVA analysis showed that patients walked at a slower pace in daily living than in the laboratory. In daily living gait, all mean temporal parameters decreased as the WB duration increased. In the sWB, the patients with a lower disability score showed, on average, lower values of the temporal parameters. Variability decreased as the WB duration increased. Conclusions This study validated a method to quantify walking in real life in people with MS and showed how gait characteristics estimated from short walking bouts during daily living may be the most informative to quantify level of disability and effects of interventions in patients moderately affected by MS. The study provides a robust approach for the quantification of recognised clinically relevant outcomes and an innovative perspective in the study of real life walking.	[Storm, Fabio A.; Mazza, Claudia] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Storm, Fabio A.; Nair, K. P. S.; Mazza, Claudia] Univ Sheffield, INSIGNEO Inst Sil Med, Sheffield, S Yorkshire, England; [Nair, K. P. S.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Neurol, Sheffield, S Yorkshire, England; [Clarke, Alison J.; Van der Meulen, Jill M.] Sheffield Teaching Hosp NHS Fdn Trust, Gait Lab, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Storm, FA (corresponding author), Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England.; Storm, FA (corresponding author), Univ Sheffield, INSIGNEO Inst Sil Med, Sheffield, S Yorkshire, England.	fabioalexander.storm@gmail.com	Nair, Krishnan/AAE-3474-2020; Storm, Fabio/AAE-2334-2019	Nair, Krishnan/0000-0002-4004-2315; Storm, Fabio/0000-0002-5977-8090; Mazza, Claudia/0000-0002-5215-1746	UK EPSRC [EP/K03877X/1]; National Institute for Health Research (NIHR) Sheffield Biomedical Research Centre (Translational Neuroscience); EPSRC [EP/K03877X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K03877X/1] Funding Source: researchfish	UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research (NIHR) Sheffield Biomedical Research Centre (Translational Neuroscience); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This is a summary of independent research partially funded by the UK EPSRC (Grant EP/K03877X/1) and carried out at the National Institute for Health Research (NIHR) Sheffield Biomedical Research Centre (Translational Neuroscience). The views expressed are those of the authors and not necessarily those of the EPSRC, NHS, the NIHR or the Department of Health.	Aminian K, 2002, J BIOMECH, V35, P689, DOI 10.1016/S0021-9290(02)00008-8; Beijer TR, 2013, J PARKINSON DIS, V3, P199, DOI 10.3233/JPD-130179; Brajdic A, 2013, SIGCHI C P; Brodie MAD, 2016, MED BIOL ENG COMPUT, V54, P663, DOI 10.1007/s11517-015-1357-9; Buckley C, 2017, GAIT POSTURE, V52, P265, DOI 10.1016/j.gaitpost.2016.11.047; Comber L, 2017, GAIT POSTURE, V51, P25, DOI 10.1016/j.gaitpost.2016.09.026; Coulter EH, 2017, MED ENG PHYS, V45, P78, DOI 10.1016/j.medengphy.2017.03.008; Dall PM, 2013, MED SCI SPORT EXER, V45, P1995, DOI 10.1249/MSS.0b013e3182955780; Del Din S, 2016, IEEE J BIOMED HEALTH, V20, P838, DOI 10.1109/JBHI.2015.2419317; Del Din S, 2016, MOVEMENT DISORD, V31, P1293, DOI 10.1002/mds.26718; Del Din S, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0154-5; Dijkstra B, 2008, AGE AGEING, V37, P436, DOI 10.1093/ageing/afn097; Dijkstra B, 2010, ARCH PHYS MED REHAB, V91, P1272, DOI 10.1016/j.apmr.2010.05.004; Galna B, 2015, MOVEMENT DISORD, V30, P359, DOI 10.1002/mds.26110; Granat M, 2015, GAIT POSTURE, V42, P85, DOI 10.1016/j.gaitpost.2015.04.012; Hemmett L, 2004, QJM-INT J MED, V97, P671, DOI 10.1093/qjmed/hch105; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Langer D, 2009, THORAX, V64, P2; Lee JK, 2011, MED BIOL ENG COMPUT, V49, P707, DOI 10.1007/s11517-011-0736-0; Maetzler W, 2015, MOVEMENT DISORD, V30, P1203, DOI 10.1002/mds.26317; McCamley J, 2012, GAIT POSTURE, V36, P316, DOI 10.1016/j.gaitpost.2012.02.019; Moon Y, 2015, MULT SCLER INT, V2015, DOI 10.1155/2015/964790; Moon Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171346; Motl RW, 2013, PHYS MED REH CLIN N, V24, P325, DOI 10.1016/j.pmr.2012.11.004; Motl RW, 2011, DISABIL HEALTH J, V4, P52, DOI 10.1016/j.dhjo.2010.02.003; Mulder T, 2002, GAIT POSTURE, V16, P198, DOI 10.1016/S0966-6362(01)00157-6; Najafi B, 2009, GAIT POSTURE, V29, P261, DOI 10.1016/j.gaitpost.2008.09.002; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Preiningerova JL, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0001-0; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; Robles-Garcia V, 2015, J APPL BIOMECH, V31, P189, DOI 10.1123/jab.2013-0319; Sandroff BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093511; Sandroff BM, 2014, J NEUROL SCI, V340, P50, DOI 10.1016/j.jns.2014.02.024; Schmidt AL, 2011, J GERIATR PHYS THER, V34, P41, DOI 10.1519/JPT.0b013e31820aa921; Shull PB, 2014, GAIT POSTURE, V40, P11, DOI 10.1016/j.gaitpost.2014.03.189; Socie MJ, 2013, GAIT POSTURE, V38, P51, DOI 10.1016/j.gaitpost.2012.10.012; Sosnoff JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028021; Stansfield B, 2015, MED ENG PHYS, V37, P42, DOI 10.1016/j.medengphy.2014.10.003; Storm FA, 2016, GAIT POSTURE, V50, P42, DOI 10.1016/j.gaitpost.2016.08.012; SWINGLER RJ, 1992, Q J MED, V83, P325; Tamburini P, 2018, GAIT POSTURE, V59, P248, DOI 10.1016/j.gaitpost.2017.10.024; Trojaniello D, 2013, 24 C INT SOC BIOM, P1; Trojaniello D, 2013, CONVERGING CLIN ENG, V120, P741, DOI [10.1007/978-3-642-34546-3_120, DOI 10.1007/978-3-642-34546-3_120]; Trojaniello D, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-152; Trojaniello D, 2014, GAIT POSTURE, V40, P487, DOI 10.1016/j.gaitpost.2014.07.007; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; Weiss A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096675; Weiss A, 2011, NEUROREHAB NEURAL RE, V25, P810, DOI 10.1177/1545968311424869; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Zwibel HL, 2009, ADV THER, V26, P1043, DOI 10.1007/s12325-009-0082-x	50	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196463	10.1371/journal.pone.0196463	http://dx.doi.org/10.1371/journal.pone.0196463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715279	Green Accepted, Green Published			2022-12-26	WOS:000431281100024
J	Traylor, M; Walker, JL; Corrigan, AA; Hernandez, MA; Newhouse, SJ; Folarin, AA; Patel, H; Ross, PJ; Sanderson, JD; Spicer, J; Prescott, NJ; Mathew, CG; Marinaki, AM; Lewis, CM				Traylor, Matthew; Walker, Jemma L.; Corrigan, Adele A.; Hernandez, Monica A.; Newhouse, Stephen J.; Folarin, Amos A.; Patel, Hamel; Ross, Paul J.; Sanderson, Jeremy D.; Spicer, James; Prescott, Natalie J.; Mathew, Christopher G.; Marinaki, Anthony M.; Lewis, Cathryn M.			Exome array analysis of adverse reactions to fluoropyrimidine-based therapy for gastrointestinal cancer	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HAND-FOOT SYNDROME; COLORECTAL-CANCER; COMMON DISEASES; TOXICITY; CAPECITABINE; VARIANTS; FLUOROURACIL; SEQUENCE; DPYD	Fluoropyrimidines, including 5-fluororacil (5FU) and its pro-drug Capecitabine, are the common treatment for colorectal, breast, neck and head cancers D either as monotherapy or in combination therapy. Adverse reactions (ADRs) to the treatment are common and often result in treatment discontinuation or dose reduction. Factors contributing to ADRs, including genetic variation, are poorly characterized. We performed exome array analysis to identify genetic variants that contribute to adverse reactions. Our final dataset consisted of 504 European ancestry individuals undergoing fluoropyrimidine-based therapy for gastrointestinal cancer. A subset of 254 of these were treated with Capecitabine. All individuals were genotyped on the Illumina HumanExome Array. Firstly, we performed SNP and gene-level analyses of protein-altering variants on the array to identify novel associations the following ADRs, which were grouped into four phenotypes based on symptoms of diarrhea, mucositis, and neutropenia and hand-and-foot syndrome. Secondly, we performed detailed analyses of the HLA region on the same phenotypes after imputing the HLA alleles and amino acids. No protein-altering variants, or sets of protein-altering variants collapsed into genes, were associated with the main outcomes after Bonferroni correction. We found evidence that the HLA region was enriched for associations with Hand-and-Foot syndrome (p = 0.023), but no specific SNPs or HLA alleles were significant after Bonferroni correction. Larger studies will be required to characterize the genetic contribution to ADRs to 5FU. Future studies that focus on the HLA region are likely to be fruitful.	[Traylor, Matthew; Walker, Jemma L.; Prescott, Natalie J.; Mathew, Christopher G.; Lewis, Cathryn M.] Kings Coll London, Dept Med & Mol Genet, London, England; [Walker, Jemma L.] London Sch Hyg & Trop Med, London, England; [Corrigan, Adele A.; Hernandez, Monica A.; Marinaki, Anthony M.] Guys & St Thomas Hosp NHS Fdn Trust, St Thomas Hosp, Purine Res Lab, GSTS Pathol, London, England; [Newhouse, Stephen J.; Folarin, Amos A.; Patel, Hamel] Kings Coll London, South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London, England; [Newhouse, Stephen J.; Folarin, Amos A.; Patel, Hamel] Kings Coll London, Inst Psychiat, London, England; [Ross, Paul J.; Sanderson, Jeremy D.] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England; [Ross, Paul J.; Sanderson, Jeremy D.] Kings Coll London, London, England; [Spicer, James] Kings Coll London, Guys Hosp, Div Canc Studies, London, England; [Mathew, Christopher G.] Univ Witwatersrand, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa; [Lewis, Cathryn M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat Ctr, London, England	University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust; South London & Maudsley NHS Trust; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Witwatersrand; University of London; King's College London	Traylor, M (corresponding author), Kings Coll London, Dept Med & Mol Genet, London, England.	mt628@medschl.cam.ac.uk	Prescott, Natalie/AHE-5121-2022; Folarin, Amos/AAD-5525-2020; Prescott, Natalie J/F-6490-2011; Lewis, Cathryn M/A-5225-2010; Lewis, Cathryn/M-8766-2019; Mathew, Christopher George/G-3434-2015	Prescott, Natalie/0000-0002-5901-7371; Folarin, Amos/0000-0002-0333-1927; Prescott, Natalie J/0000-0002-5901-7371; Lewis, Cathryn M/0000-0002-8249-8476; Lewis, Cathryn/0000-0002-8249-8476; Spicer, James/0000-0003-3732-8491; Mathew, Christopher George/0000-0003-4178-1838	National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust	National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust(National Institute for Health Research (NIHR)); King's College London; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust	This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London and by the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.; This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London and by the NIHR Biomedical Research Centre at Guys and St Thomas NHS Foundation Trust and Kings College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bajetta E, 2005, J CLIN ONCOL, V23, P2155, DOI 10.1200/JCO.2005.02.167; Caronia D, 2011, CLIN CANCER RES, V17, P2006, DOI 10.1158/1078-0432.CCR-10-1741; Fernandez-Rozadilla C, 2013, PHARMACOGENOMICS J, V13, P209, DOI 10.1038/tpj.2012.2; Ghaleb AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129314; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Lee AM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju298; Lee AM, 2014, J CLIN ONCOL, V32, P989, DOI 10.1200/JCO.2013.53.4479; Levy E, 1998, J CLIN ONCOL, V16, P3537, DOI 10.1200/JCO.1998.16.11.3537; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Loganayagam A, 2013, BRIT J CANCER, V108, P2505, DOI 10.1038/bjc.2013.262; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Meulendijks D, 2015, LANCET ONCOL, V16, P1639, DOI 10.1016/S1470-2045(15)00286-7; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosmarin D, 2015, GUT, V64, P111, DOI 10.1136/gutjnl-2013-306571; Rosmarin D, 2014, J CLIN ONCOL, V32, P1031, DOI 10.1200/JCO.2013.51.1857; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; Siontis KCM, 2010, EUR J HUM GENET, V18, P832, DOI 10.1038/ejhg.2010.26; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Vadasz Z, 2014, CLIN REV ALLERG IMMU, V47, P17, DOI 10.1007/s12016-013-8360-4; Wang GT, 2014, AM J HUM GENET, V94, P770, DOI 10.1016/j.ajhg.2014.04.004; Wheeler HE, 2014, PHARMACOGENET GENOM, V24, P231, DOI 10.1097/FPC.0000000000000037; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang RX, 2012, ANN ONCOL, V23, P1348, DOI 10.1093/annonc/mdr400	28	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0188911	10.1371/journal.pone.0188911	http://dx.doi.org/10.1371/journal.pone.0188911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715290	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000431281100001
J	Honjo, K; Shiraki, H; Ashina, S				Honjo, Keita; Shiraki, Hiroto; Ashina, Shuichi			Dynamic linear modeling of monthly electricity demand in Japan: Time variation of electricity conservation effect	PLOS ONE			English	Article							ENERGY DEMAND; THERMAL COMFORT; KALMAN FILTER; CO2 EMISSIONS; TRENDS; LOAD; SEASONALITY; INDUSTRIAL; BUILDINGS; EVOLUTION	After the severe nuclear disaster in Fukushima, which was triggered by the Great East Japan earthquake in March 2011, nuclear power plants in Japan were temporarily shut down for mandatory inspections. To prevent large-scale blackouts, the Japanese government requested companies and households to reduce electricity consumption in summer and winter. It is reported that the domestic electricity demand had a structural decrease because of the electricity conservation effect (ECE). However, quantitative analysis of the ECE is not sufficient, and especially time variation of the ECE remains unclear. Understanding the ECE is important because Japan's NDC (nationally determined contribution) assumes the reduction of CO2 emissions through aggressive energy conservation. In this study, we develop a time series model of monthly electricity demand in Japan and estimate time variation of the ECE. Moreover, we evaluate the impact of electricity conservation on CO2 emissions from power plants. The dynamic linear model is used to separate the ECE from the effects of other irrelevant factors (e.g. air temperature, economic production, and electricity price). Our result clearly shows that consumers' electricity conservation behavior after the earthquake was not temporary but became established as a habit. Between March 2011 and March 2016, the ECE on industrial electricity demand ranged from 3.9% to 5.4%, and the ECE on residential electricity demand ranged from 1.6% to 7.6%. The ECE on the total electricity demand was estimated at 3.2%-6.0%. We found a seasonal pattern that the residential ECE in summer is higher than that in winter. The emissions increase from the shutdown of nuclear power plants was mitigated by electricity conservation. The emissions reduction effect was estimated at 0.82 MtCO(2)-2.26 MtCO(2) (-4.5% on average compared to the zero-ECE case). The time-varying ECE is necessary for predicting Japan's electricity demand and CO2 emissions after the earthquake.	[Honjo, Keita] CESS, Global Environm & Nat Symbiosis Div, Kamitanadare 914, Kazo, Saitama 3470115, Japan; [Shiraki, Hiroto] Univ Shiga Prefecture, Sch Environm Sci, Hassaka 2500, Hikone, Shiga 5228533, Japan; [Ashina, Shuichi] NIES, Ctr Social & Environm Syst Res, Onogawa 16-2, Tsukuba, Ibaraki 3058506, Japan	University Shiga Prefecture; National Institute for Environmental Studies - Japan	Honjo, K (corresponding author), CESS, Global Environm & Nat Symbiosis Div, Kamitanadare 914, Kazo, Saitama 3470115, Japan.	honjo.keita@pref.saitama.lg.jp	Honjo, Keita/AAY-3032-2020; Shiraki, Hiroto/H-7479-2019	Honjo, Keita/0000-0002-0597-7051; Shiraki, Hiroto/0000-0001-7197-7933	Ministry of the Environment, Japan, Environmental Research and Technology Development Fund [2-1402]; Saitama Prefecture, Japan	Ministry of the Environment, Japan, Environmental Research and Technology Development Fund; Saitama Prefecture, Japan	This work was supported by Ministry of the Environment, Japan, Environmental Research and Technology Development Fund 2-1402 (SA) (http://www.env.go.jp/policy/kenkyu/suishin/english/index.html); and the Saitama Prefecture, Japan, budget allocation from the Saitama Prefecture to CESS (KH) (https://www.pref.saitama.lg.jp/a0103/29yosa.html [in Japanese]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi OI, 2014, ENERG ECON, V45, P435, DOI 10.1016/j.eneco.2014.07.012; Agency for Natural Resources and Energy, 2017, EN SURV STAT; Agency for Natural Resources and Energy, 2015, GEN EN STAT; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arisoy I, 2014, ENERGY, V66, P959, DOI 10.1016/j.energy.2014.01.016; Bank of Japan, 2017, CORP GOODS PRIC IND; Buyukalaca O, 2001, APPL ENERG, V69, P269, DOI 10.1016/S0306-2619(01)00017-4; Chang Y, 2014, ENERG ECON, V46, P334, DOI 10.1016/j.eneco.2014.10.003; Chen Y, 2010, IEEE T POWER SYST, V25, P322, DOI 10.1109/TPWRS.2009.2030426; Cho SH, 2016, ENERG ECON, V55, P223, DOI 10.1016/j.eneco.2016.01.014; Commandeur J. J. F., 2007, INTRO STATE SPACE TI; Damiati SA, 2016, BUILD ENVIRON, V109, P208, DOI 10.1016/j.buildenv.2016.09.024; Dilaver Z, 2011, ENERG ECON, V33, P426, DOI 10.1016/j.eneco.2010.10.001; Dordonnat V, 2008, INT J FORECASTING, V24, P566, DOI 10.1016/j.ijforecast.2008.08.010; Fujimi T, 2014, ENERG POLICY, V68, P447, DOI 10.1016/j.enpol.2013.12.019; Harvey A. C., 1991, FORECASTING STRUCTUR; HARVEY AC, 1986, J ROY STAT SOC A STA, V149, P187, DOI 10.2307/2981553; Hayashida M, 2013, CRIEPI SHORT RUN MAC; Honjo K, 2014, REG SCI POLICY PRACT, V6, P13, DOI 10.1111/rsp3.12013; Hoshino Y., 2012, J JAPAN SOC ENERGY R, V34, P15; Hunt LC, 2005, ENERG POLICY, V33, P1409, DOI 10.1016/j.enpol.2003.12.019; Hunt LC, 2003, ENERG ECON, V25, P93, DOI 10.1016/S0140-9883(02)00072-5; Indraganti M, 2013, BUILD ENVIRON, V61, P114, DOI 10.1016/j.buildenv.2012.12.008; Inglesi-Lotz R, 2011, ENERG POLICY, V39, P3690, DOI 10.1016/j.enpol.2011.03.078; Japan Nuclear Safety Institute, 2017, LIC STAT JAP NUCL FA; Jiang FQ, 2009, THEOR APPL CLIMATOL, V97, P349, DOI 10.1007/s00704-008-0078-5; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kabe S., 2016, DENRYOKU KEIZAI KENK, V63, P1; Kimura O, 2015, PERSISTENCY ELECT SA; Kimura O, 2016, ECON ENERGY ENV POL, V5, P51, DOI 10.5547/2160-5890.5.1.okim; KITAGAWA G, 1984, J AM STAT ASSOC, V79, P378, DOI 10.2307/2288279; Mase T, 2016, DENRYOKU KEIZAI KENK, V63, P12; Ministry of Economy, 2015, TRAD IND LONG TERM E; Ministry of Economy, 2017, TRAD IND MEAS EL SUP; Ministry of Economy Trade and Industry, 2017, IND ALL IND ACT; Ministry of Economy Trade and Industry, 2011, REG PUTT EFF RESTR E; Mizuho Information and Research Institute, 2016, FUT COMM GLOB WARM; Morita T, 2013, RIETI DISCUSSION PAP; Mourshed M, 2011, APPL ENERG, V88, P3737, DOI 10.1016/j.apenergy.2011.05.024; Nishio K., 2015, EX POST ANAL ELECTRI; Nuclear Regulation Authority, 2013, ENF NEW REG REQ COMM; OCCTO, 2018, OUTL EL SUPPL DEM CR; Ortiz J, 2014, ENERG BUILDINGS, V80, P23, DOI 10.1016/j.enbuild.2014.04.053; Paatero JV, 2006, INT J ENERG RES, V30, P273, DOI 10.1002/er.1136; Pedregal DJ, 2010, ENERG CONVERS MANAGE, V51, P105, DOI 10.1016/j.enconman.2009.08.028; Petris G., 2010, J STAT SOFTWARE, V36; Petris G, 2009, USE R, P1, DOI 10.1007/b135794_1; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Sampei Y, 2009, GLOBAL ENVIRON CHANG, V19, P203, DOI 10.1016/j.gloenvcha.2008.10.005; Shiraki H, 2016, ENERGY, V114, P478, DOI 10.1016/j.energy.2016.08.019; Statistics Bureau, 2017, POP EST; Statistics Bureau, 2017, CONS PRIC IND; Sun C, 2016, J POWER SOURCES, V325, P723, DOI 10.1016/j.jpowsour.2016.06.076; Takeda H, 2016, ENERGY, V104, P184, DOI 10.1016/j.energy.2016.03.070; Taniguchi A, 2016, ENERG BUILDINGS, V112, P80, DOI 10.1016/j.enbuild.2015.11.064; The Institute of Energy Economics Japan, 2017, EDMC DAT	57	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196331	10.1371/journal.pone.0196331	http://dx.doi.org/10.1371/journal.pone.0196331			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE3RI	29708988	Green Submitted, Green Published, gold			2022-12-26	WOS:000431130100024
J	Munoz, M; Ausin, B; Santos-Olmo, AB; Harter, M; Volkert, J; Schulz, H; Sehner, S; Dehoust, MC; Suling, A; Wegscheider, K; Canuto, A; Crawford, MJ; Grassi, L; Da Ronch, C; Hershkovitz, Y; Quirk, A; Rotenstein, O; Shalev, AY; Strehle, J; Weber, K; Wittchen, HU; Andreas, S				Munoz, Manuel; Ausin, Berta; Santos-Olmo, Ana B.; Haerter, Martin; Volkert, Jana; Schulz, Holger; Sehner, Susanne; Dehoust, Maria Christina; Suling, Anna; Wegscheider, Karl; Canuto, Alessandra; Crawford, Mike J.; Grassi, Luigi; Da Ronch, Chiara; Hershkovitz, Yael; Quirk, Alan; Rotenstein, Ora; Shalev, Arieh Y.; Strehle, Jens; Weber, Kerstin; Wittchen, Hans-Ulrich; Andreas, Sylke			Alcohol use, abuse and dependence in an older European population: Results from the MentDis_ICF65+study	PLOS ONE			English	Article							COMORBIDITY-SURVEY-REPLICATION; NATIONAL EPIDEMIOLOGIC SURVEY; MENTAL-HEALTH; USE DISORDERS; ANXIETY DISORDERS; UNITED-STATES; ADULTS; PREVALENCE; DRINKING; PEOPLE	Background Alcohol use disorders (AUD) in older people have been the subject of increasing interest in Europe and worldwide. However, thus far, no reliable data exist regarding the prevalence of AUD in people over the age of 65 years in Europe. Objective To assess the current (past month), 12-month and lifetime prevalence of alcohol use, abuse and dependence in people aged 65-84 years. Study design The MentDis_ICF65+ study was a representative stepwise cross-sectional survey that was conducted in six European and associated cities (Hamburg, Germany; Ferrara, Italy; London/Canterbury, England; Madrid, Spain; Geneva, Switzerland and Jerusalem, Israel). Method In total, 3,142 community-dwelling people aged between 65 and 84 years who lived in participating cities were assessed with an age-sensitive diagnostic interview (CIDI65+). Results The prevalence of lifetime alcohol use was 81% for the overall sample. The observed AUD (DSM-IV-TR) prevalence was as follows: current, 1.1%; 12-month, 5.3% and lifetime, 8.8%. Alcohol consumption and AUD were more prevalent in males, and a significant interaction between gender and city was observed; greater gender differences in the prevalence of these disorders were observed in Hamburg, London/Canterbury and Geneva in comparison to the other cities. The prevalence of lifetime alcohol consumption and 12-month AUD tended to be lower in older persons. Conclusion The results highlight the appropriateness of using age-adjusted diagnostic tools (CIDI65+) to identify alcohol use and AUD in older people. Different alcohol use patterns were observed in males and females. The results seem to indicate the presence of different alcohol use patterns between northern and southern European countries. Specialized services are proposed, including brief and/or more intensive interventions framed intensive and more simple interventions framed in stepped care strategies, to improve the social and health resources available for older people across Europe.	[Munoz, Manuel; Ausin, Berta; Santos-Olmo, Ana B.] Univ Complutense Madrid, Sch Psychol, Madrid, Spain; [Haerter, Martin; Volkert, Jana; Schulz, Holger; Dehoust, Maria Christina; Andreas, Sylke] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Volkert, Jana] Heidelberg Univ, Dept Psychosocial Prevent, Heidelberg, Germany; [Sehner, Susanne; Suling, Anna; Wegscheider, Karl] Univ Med Ctr Hamburg Eppendorf, Inst Med Biometry & Epidemiol, Hamburg, Germany; [Canuto, Alessandra] East Vaud Psychiat Inst, Nant Fdn, Geneva, Switzerland; [Crawford, Mike J.; Quirk, Alan] Royal Coll Psychiatrist, London, England; [Grassi, Luigi; Da Ronch, Chiara] Univ Ferrara, Inst Psychiat, Dept Biomed & Specialty Surg Sci, Ferrara, Italy; [Hershkovitz, Yael; Rotenstein, Ora] Hadassah Univ, Dept Psychiat, Med Ctr, Jerusalem, Israel; [Shalev, Arieh Y.] NY Langone Med Ctr, Dept Psychiat, New York, NY USA; [Strehle, Jens; Wittchen, Hans-Ulrich] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany; [Weber, Kerstin] Univ Hosp Geneva, Curabilis, Med Direct, Geneva, Switzerland; [Andreas, Sylke] Alpen Adria Univ Klagenfurt, Inst Psychol, Klagenfurt, Austria	Complutense University of Madrid; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Ferrara; Hebrew University of Jerusalem; Hadassah University Medical Center; Technische Universitat Dresden; University of Geneva; University of Klagenfurt	Ausin, B (corresponding author), Univ Complutense Madrid, Sch Psychol, Madrid, Spain.	bertaausin@psi.ucm.es	Ausín, Berta/I-7846-2016; Volkert, Jana/HHZ-8677-2022; Volkert, Jana/ABE-3460-2020; MUNOZ, MANUEL/F-7035-2016; Costanza, Alessandra/ABD-8226-2020; Santos-Olmo, Ana/ABC-6016-2021; Costanza, Alessandra/ABD-8231-2020; Wittchen, Hans-Ulrich/ABA-8901-2020	Ausín, Berta/0000-0001-9497-0275; Volkert, Jana/0000-0003-1555-2599; MUNOZ, MANUEL/0000-0003-2406-7800; Costanza, Alessandra/0000-0001-6387-6462; Santos-Olmo, Ana/0000-0002-6046-163X; Costanza, Alessandra/0000-0001-6387-6462; Wittchen, Hans-Ulrich/0000-0002-6311-7711; Crawford, Mike/0000-0003-3137-5772; Andreas, Sylke/0000-0002-1060-1411; Shalev, Arieh/0000-0001-9425-050X; Harter, Martin/0000-0001-7443-9890; GRASSI, Luigi/0000-0002-1050-4494	European Commission within the 7th Framework Research Program of the EU [223105]	European Commission within the 7th Framework Research Program of the EU	This work was supported by a grant from the European Commission (Grant No: 223105) within the 7th Framework Research Program of the EU. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P8; American Psychiatric Association APA, 2000, DIAGN STAT MAN DSM I; Andreas S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-62; Blanco C, 2008, AM J PSYCHIAT, V165, P905, DOI 10.1176/appi.ajp.2008.07101660; Blazer DG, 2009, AM J GERIAT PSYCHIAT, V17, P237, DOI 10.1097/JGP.0b013e318190b8ef; Boschloo L, 2012, BRIT J PSYCHIAT, V200, P476, DOI 10.1192/bjp.bp.111.097550; Bosmans JE, 2014, INT J GERIATR PSYCH, V29, P182, DOI 10.1002/gps.3987; Byers AL, 2010, ARCH GEN PSYCHIAT, V67, P489, DOI 10.1001/archgenpsychiatry.2010.35; Crome IB, 2018, AGE AGEING, V47, P164, DOI 10.1093/ageing/afx191; De Almeida MDV, 2005, AGEING INT, V30, P377; Di Bari M, 2002, J CLIN EPIDEMIOL, V55, P41, DOI 10.1016/S0895-4356(01)00408-5; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Garrido MM, 2011, J AM GERIATR SOC, V59, P50, DOI 10.1111/j.1532-5415.2010.03220.x; Goncalves DC, 2014, ARCH GERONTOL GERIAT, V59, P393, DOI 10.1016/j.archger.2014.04.013; Gowing LR, 2015, ADDICTION, V110, P904, DOI 10.1111/add.12899; Han B, 2011, PSYCHIAT SERV, V62, P291, DOI 10.1176/ps.62.3.pss6203_0291; HANSON BS, 1994, ADDICTION, V89, P725, DOI 10.1111/j.1360-0443.1994.tb00958.x; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Helmchen H, 1996, NERVENARZT, V67, P739, DOI 10.1007/s001150050048; Hu YY, 2015, AGE AGEING, V44, P84, DOI 10.1093/ageing/afu083; Institute of Alcohol Studies, 2005, ALC CONS HARM UK EU; Karel MJ, 2012, AM PSYCHOL, V67, P184, DOI 10.1037/a0025393; Kelfve S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2114-6; Kelly S, 2017, INTERVENTIONS PREVEN, V20, P1, DOI [10.1093/AGEING/AFX132, DOI 10.1093/AGEING/AFX132]; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KNAUPER B, 1994, J PSYCHIATR RES, V28, P147, DOI 10.1016/0022-3956(94)90026-4; Liang WB, 2011, BRIT J PSYCHIAT, V199, P219, DOI 10.1192/bjp.bp.110.086116; O'Connell H, 2003, BMJ-BRIT MED J, V327, P664, DOI 10.1136/bmj.327.7416.664; Pirkola SP, 2005, SOC PSYCH PSYCH EPID, V40, P1, DOI 10.1007/s00127-005-0848-7; Riedel-Heller SG, 2006, ACTA PSYCHIAT SCAND, V113, P388, DOI 10.1111/j.1600-0447.2005.00632.x; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; StataCorp, 2013, STATA STAT SOFTW REL; Tait RJ, 2006, BRIT J PSYCHIAT, V188, P554, DOI 10.1192/bjp.188.6.554; Volkert J, 2018, INT PSYCHOGERIATR, V30, P1027, DOI 10.1017/S1041610217002526; Volkert J, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1534-5; Volkert J, 2013, AGEING RES REV, V12, P339, DOI 10.1016/j.arr.2012.09.004; Waern M, 2014, AGE AGEING, V43, P228, DOI 10.1093/ageing/aft136; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wittchen HU, 2015, INT J METH PSYCH RES, V24, P116, DOI 10.1002/mpr.1455	39	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196574	10.1371/journal.pone.0196574	http://dx.doi.org/10.1371/journal.pone.0196574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE3RI	29708993	gold, Green Published, Green Submitted			2022-12-26	WOS:000431130100040
J	Li, S; Dou, XL; Gao, RQ; Ge, XZ; Qian, MP; Wan, L				Li, Shuo; Dou, Xialiang; Gao, Ruiqi; Ge, Xinzhou; Qian, Minping; Wan, Lin			A remark on copy number variation detection methods	PLOS ONE			English	Article							INTERNATIONAL HAPMAP PROJECT; AUTISM; MAP	Copy number variations (CNVs) are gain and loss of DNA sequence of a genome. High throughput platforms such as microarrays and next generation sequencing technologies (NGS) have been applied for genome wide copy number losses. Although progress has been made in both approaches, the accuracy and consistency of CNV calling from the two platforms remain in dispute. In this study, we perform a deep analysis on copy number losses on 254 human DNA samples, which have both SNP microarray data and NGS data publicly available from Hapmap Project and 1000 Genomes Project respectively. We show that the copy number losses reported from Hapmap Project and 1000 Genome Project only have < 30% overlap, while these reports are required to have cross-platform (e.g. PCR, microarray and high-throughput sequencing) experimental supporting by their corresponding projects, even though state-of-art calling methods were employed. On the other hand, copy number losses are found directly from HapMap microarray data by an accurate algorithm, i.e. CNVhac, almost all of which have lower read mapping depth in NGS data; furthermore, 88% of which can be supported by the sequences with breakpoint in NGS data. Our results suggest the ability of microarray calling CNVs and the possible introduction of false negatives from the unessential requirement of the additional cross-platform supporting. The inconsistency of CNV reports from Hapmap Project and 1000 Genomes Project might result from the inadequate information containing in microarray data, the inconsistent detection criteria, or the filtration effect of cross-platform supporting. The statistical test on CNVs called from CNVhac show that the microarray data can offer reliable CNV reports, and majority of CNV candidates can be confirmed by raw sequences. Therefore, the CNV candidates given by a good caller could be highly reliable without cross-platform supporting, so additional experimental information should be applied in need instead of necessarily.	[Li, Shuo; Dou, Xialiang; Gao, Ruiqi; Ge, Xinzhou; Qian, Minping] Peking Univ, Sch Math Sci, Beijing, Peoples R China; [Wan, Lin] Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Li, Shuo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Dou, Xialiang] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Gao, Ruiqi; Ge, Xinzhou] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA USA	Peking University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago; University of California System; University of California Los Angeles	Qian, MP (corresponding author), Peking Univ, Sch Math Sci, Beijing, Peoples R China.; Wan, L (corresponding author), Chinese Acad Sci, Acad Math & Syst Sci, Natl Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China.	qianmp@math.pku.edu.cn; lwan@amss.ac.cn	Wan, Lin/ABG-6345-2021	Wan, Lin/0000-0002-3511-0512	NSFC [11571349, 91630314]; Strategic Priority Research Program of the CAS [XDB13050000]; NCMIS of the CAS; LSC of the CAS; Youth Innovation Promotion Association of the CAS	NSFC(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the CAS; NCMIS of the CAS; LSC of the CAS; Youth Innovation Promotion Association of the CAS	This work is supported by the NSFC grants (Nos.11571349, 91630314), the Strategic Priority Research Program of the CAS (XDB13050000), the NCMIS of the CAS, the LSC of the CAS, the Youth Innovation Promotion Association of the CAS.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Gai X, 2012, MOL PSYCHIATR, V17, P402, DOI 10.1038/mp.2011.10; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Siva Nayanah, 2008, Nat Biotechnol, V26, P256, DOI 10.1038/nbt0308-256b; St Clair D, 2009, SCHIZOPHRENIA BULL, V35, P9, DOI 10.1093/schbul/sbn147; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wang Q, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-24	17	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196226	10.1371/journal.pone.0196226	http://dx.doi.org/10.1371/journal.pone.0196226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702671	Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300024
J	Mukai, H; Ming, P; Lindholm, B; Heimburger, O; Barany, P; Anderstam, B; Stenvinkel, P; Qureshi, AR				Mukai, Hideyuki; Ming, Pei; Lindholm, Bengt; Heimburger, Olof; Barany, Peter; Anderstam, Bjorn; Stenvinkel, Peter; Qureshi, Abdul Rashid			Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC-RENAL-FAILURE; GLOMERULAR-FILTRATION-RATE; LEAN BODY-MASS; SYSTEMIC INFLAMMATION; DIALYSIS PATIENTS; HEMODIALYSIS-PATIENTS; MORTALITY; MALNUTRITION; DYSFUNCTION	Background Cardiovascular disease (CVD), protein-energy wasting (PEW), and inflammation are common interrelated features of chronic kidney disease (CKD). Less is known about lung dysfunction in CKD and its possible role in this context. We evaluated lung function and its association with estimated glomerular filtration rate (GFR), CVD, PEW, and inflammation in individuals with normal to severely reduced GFR. Methods In 404 individuals with GFR category G1 (n = 31; GFR > 90mL/min/1.73 m(2)), G2 (n = 46), G3 (n = 33), G4 (n = 49) and G5 (n = 245; GFR<15mL/min/1.73 m(2)), pulmonary function was assessed by spirometry. Obstructive (OLD) and restrictive (RLD) lung dysfunction was defined based on forced vital capacity (FVC), forced expiratory volume in the first second (FEV1) and peak expiratory flow (PEF), expressed as percentages of predicted values (% FEV1, % FVC and % PEF, respectively). PEW was evaluated by subjective global assessment, handgrip strength (HGS) and lean body mass index (LBMI), and inflammation by interleukin-6 and high sensitivity C-reactive protein. Results RLD (defined as FEV1/FVC >= 0.70 and % FVC<80) associated with GFR and was present in 36% of G5 and 14% of G1-4 individuals. OLD (FEV1/FVC<0.70) was less common with similar prevalence among G1-4 (9%) and G5 (11%) individuals. Notably, 64% of those with concomitant presence of PEW, inflammation and clinical signs of CVD had RLD while 79% of those lacking these complications had normal lung function. In multivariate logistic regression analysis, RLD associated with CVD, PEW and inflammation, after adjusting for Framingham's CVD risk score, serum albumin, and GFR category. Conclusions RLD is a common complication in patients with advanced CKD, especially in those with concomitant presence of CVD, inflammation and PEW. RLD appears to be an integral albeit scarcely explored consequence of pulmonary-renal interactions in CKD patients.	[Mukai, Hideyuki; Ming, Pei; Lindholm, Bengt; Heimburger, Olof; Barany, Peter; Anderstam, Bjorn; Stenvinkel, Peter; Qureshi, Abdul Rashid] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden; [Mukai, Hideyuki; Ming, Pei; Lindholm, Bengt; Heimburger, Olof; Barany, Peter; Anderstam, Bjorn; Stenvinkel, Peter; Qureshi, Abdul Rashid] Karolinska Inst, Dept Clin Sci Intervent & Technol, Baxter Novum, Stockholm, Sweden; [Ming, Pei] Tianjin Univ Tradit Chinese Med, Affiliated Teaching Hosp 1, Renal Dept, Tianjin, Peoples R China	Karolinska Institutet; Karolinska Institutet; Tianjin University of Traditional Chinese Medicine	Qureshi, AR (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden.; Qureshi, AR (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Baxter Novum, Stockholm, Sweden.	tony.qureshi@ki.se	Qureshi, Abdul Rashid Tony/G-1358-2010	Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Barany, Peter/0000-0001-6501-8293; Stenvinkel, Peter/0000-0002-8785-4820; Heimburger, Olof/0000-0003-0901-4145	Baxter Healthcare Corporation; Amgen Inc; Swedish Research council; Martin Rind Foundation; Njurfonden; Westmans Foundation	Baxter Healthcare Corporation; Amgen Inc(Amgen); Swedish Research council(Swedish Research CouncilEuropean Commission); Martin Rind Foundation; Njurfonden; Westmans Foundation	This study was supported by grants from Baxter Healthcare Corporation and Amgen Inc to Karolinska Institutet. The grant from Baxter Healthcare Corporation was a general grant to Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, to support research activities at Karolinska Institutet to promote the understanding and treatment of renal disease which made it possible to carry out this and other studies. The grant from Amgen Inc was given to Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, to support two observational studies on inflammation in dialysis patients treated by hemodialysis and peritoneal dialysis respectively. The study also benefited from generous support from Swedish Research council (Peter Stenvinkel), Martin Rind Foundation (Peter Stenvinkel), Njurfonden (Peter Stenvinkel), and Westmans Foundation. Bengt Lindholm is employed by Baxter Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, KIDNEY INT SUPPL, V3, P19, DOI DOI 10.1038/KISUP.2012.64; BARK H, 1988, RESPIRATION, V54, P153, DOI 10.1159/000195516; Betjes MGH, 2013, BLOOD PURIFICAT, V36, P173, DOI 10.1159/000356084; Betjes MGH, 2013, NAT REV NEPHROL, V9, P255, DOI 10.1038/nrneph.2013.44; BISTRIAN BR, 1992, P SOC EXP BIOL MED, V200, P220; Bologa RM, 1998, AM J KIDNEY DIS, V32, P107, DOI 10.1053/ajkd.1998.v32.pm9669431; BUSH A, 1985, J ROY SOC MED, V78, P849, DOI 10.1177/014107688507801012; Carrero JJ, 2008, CLIN NUTR, V27, P557, DOI 10.1016/j.clnu.2008.04.007; Cerasola G, 2010, J HYPERTENS, V28, P2357, DOI 10.1097/HJH.0b013e32833ec377; Chang HR, 1998, JPEN-PARENTER ENTER, V22, P156, DOI 10.1177/0148607198022003156; Clapp BR, 2004, CARDIOVASC RES, V64, P172, DOI 10.1016/j.cardiores.2004.06.020; Covic A, 2018, AM J KIDNEY DIS, V71, P412, DOI 10.1053/j.ajkd.2017.10.009; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Desmeules S, 2004, NEPHROL DIAL TRANSPL, V19, P1182, DOI 10.1093/ndt/gfh016; Dong J, 2008, KIDNEY INT, V73, P334, DOI 10.1038/sj.ki.5002644; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Hancox RJ, 2016, RESP MED, V111, P54, DOI 10.1016/j.rmed.2015.12.007; Honda Y, 2017, INT J CARDIOL, V241, P395, DOI 10.1016/j.ijcard.2017.04.049; Hu JR, 2017, NEPHROL DIAL TRANSPL, V32, P113, DOI 10.1093/ndt/gfw416; Incalzi RA, 2010, CHEST, V137, P831, DOI 10.1378/chest.09-1710; Isoyama N, 2015, NEPHROL DIAL TRANSPL, V30, P84, DOI 10.1093/ndt/gfu259; Johnston AK, 2008, THORAX, V63, P599, DOI 10.1136/thx.2007.088112; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Machowska A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163826; MacNee W, 2011, AM J RESP CRIT CARE, V184, P1327, DOI 10.1164/rccm.201110-1764ED; Mallamaci F, 2010, JACC-CARDIOVASC IMAG, V3, P586, DOI 10.1016/j.jcmg.2010.02.005; Mallampalli Antara, 2004, Nutr Clin Pract, V19, P550, DOI 10.1177/0115426504019006550; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Nascimento MM, 2004, NEPHROL DIAL TRANSPL, V19, P1823, DOI 10.1093/ndt/gfh190; Navaneethan SD, 2016, AM J KIDNEY DIS, V68, P414, DOI 10.1053/j.ajkd.2016.03.415; Olafsdottir IS, 2013, RESP MED, V107, P91, DOI 10.1016/j.rmed.2012.09.020; Pecoits R, 2003, AM J KIDNEY DIS, V41, P1212, DOI 10.1016/S0272-6386(03)00353-6; Pomidori L, 2016, J NEPHROL, V29, P863, DOI 10.1007/s40620-016-0325-2; PREZANT DJ, 1990, LUNG, V168, P1, DOI 10.1007/BF02719668; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Siri W., 1961, TECHNIQUES MEASURING, P223; Stenvinkel P, 2000, NEPHROL DIAL TRANSPL, V15, P953, DOI 10.1093/ndt/15.7.953; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Sun J, 2016, CLIN J AM SOC NEPHRO, V11, P1163, DOI 10.2215/CJN.10441015; Tuder Rubin M, 2012, Proc Am Thorac Soc, V9, P62, DOI 10.1513/pats.201201-012MS; Turcios NL, 2012, PAEDIATR RESPIR REV, V13, P44, DOI 10.1016/j.prrv.2011.04.006; van Gestel YRBM, 2009, NEPHROL DIAL TRANSPL, V24, P2763, DOI 10.1093/ndt/gfp171; Yilmaz MI, 2011, NEPHROL DIAL TRANSPL, V26, P3537, DOI 10.1093/ndt/gfr081; Yilmaz S, 2016, MED SCI MONITOR, V22, P2779, DOI 10.12659/MSM.897480; Yoon JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094125; Yoon SH, 2009, NEPHRON CLIN PRACT, V111, pC1, DOI 10.1159/000175444; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016	55	16	17	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0195585	10.1371/journal.pone.0195585	http://dx.doi.org/10.1371/journal.pone.0195585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702682	Green Submitted, Green Published, gold			2022-12-26	WOS:000431013300005
J	Cherkas, V; Grebenyuk, S; Osypenko, D; Dovgan, AV; Grushevskyi, EO; Yedutenko, M; Sheremet, Y; Dromaretsky, A; Bozhenko, A; Agashkov, K; Kononenko, NI; Belan, P				Cherkas, Volodymyr; Grebenyuk, Sergei; Osypenko, Denys; Dovgan, Alexandr V.; Grushevskyi, Eugene O.; Yedutenko, Matthew; Sheremet, Yevhenii; Dromaretsky, Andrew; Bozhenko, Arseniy; Agashkov, Kirill; Kononenko, Nikolai I.; Belan, Pavel			Measurement of intracellular concentration of fluorescently-labeled targets in living cells	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; HIPPOCAMPAL-NEURONS; PROTEIN; HIPPOCALCIN; QUANTITATION; PROKARYOTES; ACTIVATION; EXPRESSION; RESOLUTION; GFP	Estimations of intracellular concentrations of fluorescently-labeled molecules within living cells are very important for guidance of biological experiments and interpretation of their results. Here we propose a simple and universal approach for such estimations. The approach is based upon common knowledge that the dye fluorescence is directly proportional to its quantum yield and the number of its molecules and that a coefficient of proportionality is determined by spectral properties of the dye and optical equipment used to record fluorescent signals. If two fluorescent dyes are present in the same volume, then a ratio of their concentrations is equal to a ratio of their fluorescence multiplied by some dye-and equipment-dependent coefficient. Thus, if the coefficient and concentration of one dye is known then the concentration of another dye can be determined. Here we have demonstrated how to calculate this coefficient (called a ratio factor) and how to use it for concentration measurements of fluorescently tagged molecules. As an example of how this approach can be used, we estimated a concentration of exogenously expressed neuronal Ca2+ sensor protein, hippocalcin, tagged by a fluorescent protein in a dendritic tree of rat hippocampal neurons loaded via a patch pipette with Alexa Fluor dye of known concentration. The new approach should allow performing a fast, inexpensive and reliable quantitative analysis of fluorescently-labeled targets in different parts of living cells.	[Cherkas, Volodymyr; Grebenyuk, Sergei; Osypenko, Denys; Dovgan, Alexandr V.; Grushevskyi, Eugene O.; Yedutenko, Matthew; Sheremet, Yevhenii; Dromaretsky, Andrew; Bozhenko, Arseniy; Kononenko, Nikolai I.; Belan, Pavel] Bogomoletz Inst Physiol, Dept Mol Biophys, Kiev, Ukraine; [Agashkov, Kirill] Bogomoletz Inst Physiol, Dept Sensory Signaling, Kiev, Ukraine; [Belan, Pavel] Kiev Acad Univ, Kiev, Ukraine	National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; National Academy of Sciences Ukraine; Kyiv Academic University	Belan, P (corresponding author), Bogomoletz Inst Physiol, Dept Mol Biophys, Kiev, Ukraine.; Belan, P (corresponding author), Kiev Acad Univ, Kiev, Ukraine.	pasha@biph.kiev.ua	Dovgan, Alexandr/I-7493-2018; Belan, Pavel/AAV-3522-2021	Belan, Pavel/0000-0001-5429-3716; Alexandr, Dovgan/0000-0002-0395-4147; Grushevskyi, Eugene/0000-0003-1779-8306; Sheremet, Yevhenii/0000-0001-9951-2943; Osypenko, Denys/0000-0001-7588-9201; Dromaretsky, Andrew/0000-0003-3455-5656; Agashkov, Kirill/0000-0002-3975-8789; Cherkas, Volodymyr/0000-0003-0877-5081	National Academy of Sciences of Ukraine (NASU) [parallel to-1-12]; NASU [67/15-]	National Academy of Sciences of Ukraine (NASU); NASU	This work was funded by the National Academy of Sciences of Ukraine (NASU); grant NASU (#parallel to-1-12), grant NASU (#67/15-); URL of funder's website: http://www.nas.gov.ua/EN/Pages/ default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, MOL PROBES HDB; Carrascosa JL, 2001, MICRON, V32, P43, DOI 10.1016/S0968-4328(00)00027-5; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiu CS, 2002, J NEUROSCI, V22, P10251; Chroma Technology, 2016, CHROM SPECTR VIEW; Dinant C, 2008, J MICROSC-OXFORD, V231, P97, DOI 10.1111/j.1365-2818.2008.02020.x; Dovgan AV, 2010, EUR J NEUROSCI, V32, P347, DOI 10.1111/j.1460-9568.2010.07303.x; Dundr M, 2002, J STRUCT BIOL, V140, P92, DOI 10.1016/S1047-8477(02)00521-X; Furtado A, 2002, ANAL BIOCHEM, V310, P84, DOI 10.1016/S0003-2697(02)00281-6; Furuta Y, 1999, NEUROCHEM RES, V24, P651, DOI 10.1023/A:1021000425070; Gell C., 2013, HDB SINGLE MOL FLUOR; Gething MJ, 1997, NATURE, V388, P329, DOI 10.1038/40979; Hack NJ, 2000, J NEUROSCI METH, V95, P177, DOI 10.1016/S0165-0270(99)00178-8; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hatahet F, 2014, BBA-PROTEINS PROTEOM, V1844, P1402, DOI 10.1016/j.bbapap.2014.02.014; Koushik SV, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940367; Lakowicz Joseph R., 2006, PRINCIPLES FLUORESCE, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4]; Leavesley SJ, 2013, CYTOM PART A, V83, P898, DOI 10.1002/cyto.a.22340; Markova O, 2008, NEUROSCI LETT, V442, P152, DOI 10.1016/j.neulet.2008.06.089; Molleman A., 2003, PATCH CLAMPING INTRO, DOI [10.1002/0470856521, DOI 10.1002/0470856521]; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nikon Instrumrnts, 2016, INTR FLUOR PROT; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Phair RD, 2001, NAT REV MOL CELL BIO, V2, P898, DOI 10.1038/35103000; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; ThermoFisher Scientific, 2016, FLUOR SPECTRAVIEWER; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0194031	10.1371/journal.pone.0194031	http://dx.doi.org/10.1371/journal.pone.0194031			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694385	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000430802400006
J	Kirschner, GK; Stahl, Y; Imani, J; von Korff, M; Simon, R				Kirschner, Gwendolyn K.; Stahl, Yvonne; Imani, Jafargholi; von Korff, Maria; Simon, Ruediger			Fluorescent reporter lines for auxin and cytokinin signalling in barley (Hordeum vulgare)	PLOS ONE			English	Article							ARABIDOPSIS ROOT; CELL-DIFFERENTIATION; EFFLUX CARRIER; PIN GENES; TRANSPORT; MERISTEM; EXPRESSION; GROWTH; PROTEINS; MAIZE	The phytohormones auxin and cytokinin control development and maintenance of plant meristems and stem cell systems. Fluorescent protein reporter lines that monitor phytohormone controlled gene expression programmes have been widely used to study development and differentiation in the model species Arabidopsis, but equivalent tools are still missing for the majority of crop species. Barley (Hordeum vulgare) is the fourth most abundant cereal crop plant, but knowledge on these important phytohormones in regard to the barley root and shoot stem cell niches is still negligible. We have now analysed the role of auxin and cytokinin in barley root meristem development, and present fluorescent protein reporter lines that allow to dissect auxin and cytokinin signalling outputs in vivo. We found that application of either auxin or cytokinin to barley seedlings negatively impacts root meristem growth. We further established a barley cytokinin reporter, TCSnew, which revealed significant cytokinin signalling in the stele cells proximal to the QC, and in the differentiated root cap cells. Application of exogenous cytokinin activated signalling in the root stem cell niche. Commonly employed auxin reporters DR5 or DR5v2 failed to respond to auxin in barley. However, analysis of putative auxin signalling targets barley PLETHORA1 (HvPLT1) is expressed in a similar pattern as its orthologue AtPLT1 from Arabidopsis, i.e. in the QC and the surrounding cells. Furthermore, the PINFORMED1 (HvPIN1) auxin efflux carrier was found to be expressed in root and shoot meristems, where it polarly localized to the plasma membrane. HvPIN1 expression is negatively regulated by cytokinin and its intracellular localisation is sensitive to brefeldinA (BFA). With this study, we provide the first fluorescent reporter lines as a tool to study auxin and cytokinin signalling and response pathways in barley.	[Kirschner, Gwendolyn K.; Stahl, Yvonne; Simon, Ruediger] Heinrich Heine Univ, Inst Dev Genet, Dusseldorf, Germany; [Kirschner, Gwendolyn K.; Stahl, Yvonne; Simon, Ruediger] Heinrich Heine Univ, Cluster Excellence Plant Sci, Dusseldorf, Germany; [Imani, Jafargholi] Justus Liebig Univ, Inst Phytopathol & Appl Zool, Res Ctr BioSyst Land Use & Nutr IFZ, Giessen, Germany; [von Korff, Maria] Heinrich Heine Univ Dusseldorf, Inst Plant Genet, Dusseldorf, Germany; [von Korff, Maria] Heinrich Heine Univ Dusseldorf, Cluster Excellence Plant Sci, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Justus Liebig University Giessen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Simon, R (corresponding author), Heinrich Heine Univ, Inst Dev Genet, Dusseldorf, Germany.; Simon, R (corresponding author), Heinrich Heine Univ, Cluster Excellence Plant Sci, Dusseldorf, Germany.	ruediger.simon@hhu.de	; Simon, Rudiger/T-6755-2018	Stahl, Yvonne/0000-0002-7543-5186; Simon, Rudiger/0000-0002-1317-7716	Deutsche Forschungsgemeinschaft through CEPLAS [EXC1028]	Deutsche Forschungsgemeinschaft through CEPLAS	Work in Rudiger Simon's lab has been supported by the Deutsche Forschungsgemeinschaft through CEPLAS (EXC1028) (www.ceplas.eu); We thank Carin Theres for technical assistance in the lab, Marc Somssich and Ikram Blilou for valuable discussions about the manuscript and Dolf Weijers for kindly providing the DR5v2 plasmid. We would furthermore like to acknowledge the Center of Advanced Imaging (CAi) at the Heinrich Heine University Dusseldorf for help with microscopy and MorphographX. Work in RS and MvKS labs was supported by the DFG through CEPLAS (EXC1028).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bishopp A, 2011, CURR OPIN PLANT BIOL, V14, P10, DOI 10.1016/j.pbi.2010.08.014; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brunoud G, 2012, NATURE, V482, P103, DOI 10.1038/nature10791; Carraro N, 2006, PLANT PHYSIOL, V142, P254, DOI 10.1104/pp.106.080119; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; de Reuille PB, 2015, ELIFE, V4, DOI 10.7554/eLife.05864; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Ding ZJ, 2010, P NATL ACAD SCI USA, V107, P12046, DOI 10.1073/pnas.1000672107; EVANS ML, 1994, PLANTA, V194, P215, DOI 10.1007/BF01101680; Forestan C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00016; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Gallavotti A, 2008, PLANT PHYSIOL, V147, P1913, DOI 10.1104/pp.108.121541; Galuszka P, 2007, J PLANT GROWTH REGUL, V26, P255, DOI 10.1007/s00344-007-9008-5; Ganguly A, 2010, PLANT PHYSIOL, V153, P1046, DOI 10.1104/pp.110.156505; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hejatko J, 2006, NAT PROTOC, V1, P1939, DOI 10.1038/nprot.2006.333; Imani J, 2011, PLANT J, V67, P726, DOI 10.1111/j.1365-313X.2011.04620.x; Kirschner GK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01240; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; Kleine-Vehn J, 2009, PLANT CELL, V21, P3839, DOI 10.1105/tpc.109.071639; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Krecek P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-249; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lampropoulos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083043; Li P, 2011, ACTA BIOCH BIOPH SIN, V43, P688, DOI 10.1093/abbs/gmr068; Liao CY, 2015, NAT METHODS, V12, P207, DOI [10.1038/NMETH.3279, 10.1038/nmeth.3279]; Mahonen AP, 2014, NATURE, V515, P125, DOI 10.1038/nature13663; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Martinez CC, 2016, DEV BIOL, V419, P85, DOI 10.1016/j.ydbio.2016.08.011; Martinez-de la Cruz E, 2015, J PLANT PHYSIOL, V176, P147, DOI 10.1016/j.jplph.2014.11.012; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Miyashita Y, 2010, PLANT SCI, V178, P424, DOI 10.1016/j.plantsci.2010.02.018; Moubayidin L, 2013, DEV CELL, V26, P405, DOI 10.1016/j.devcel.2013.06.025; Mrizova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079029; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Mussig C, 2003, PLANT PHYSIOL, V133, P1261, DOI 10.1104/pp.103.028662; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; O'Connor DL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003447; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Podlesakova K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039293; Pospisilova H, 2016, NEW BIOTECHNOL, V33, P692, DOI 10.1016/j.nbt.2015.12.005; R Core Development Team, 2014, R LANG ENV STAT COMP, P409; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Ruzicka K, 2009, P NATL ACAD SCI USA, V106, P4284, DOI 10.1073/pnas.0900060106; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Saini S, 2013, PLANT CELL REP, V32, P741, DOI 10.1007/s00299-013-1430-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stahl Y, 2005, INT J DEV BIOL, V49, P479, DOI 10.1387/ijdb.041929ys; Stahl Y, 2009, PLANT SIGNAL BEHAV, V4, P634, DOI 10.4161/psb.4.7.8970; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; TAGLIANI L, 1986, BIOCHEM GENET, V24, P839, DOI 10.1007/BF00554523; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; WADDINGTON SR, 1983, ANN BOT-LONDON, V51, P119, DOI 10.1093/oxfordjournals.aob.a086434; Wang JR, 2009, MOL PLANT, V2, P823, DOI 10.1093/mp/ssp023; Warner CA, 2014, PLANT PHYSIOL, V166, P1684, DOI 10.1104/pp.114.244673; Werner T, 2010, PLANT CELL, V22, P3905, DOI 10.1105/tpc.109.072694; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Yang J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00256; Zalewski W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115729; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052; Zhang WJ, 2013, CURR BIOL, V23, P1979, DOI 10.1016/j.cub.2013.08.008; Zhang YX, 2014, J EXP BOT, V65, P4919, DOI 10.1093/jxb/eru249; Zurcher E, 2013, PLANT PHYSIOL, V161, P1066, DOI 10.1104/pp.112.211763	74	12	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196086	10.1371/journal.pone.0196086	http://dx.doi.org/10.1371/journal.pone.0196086			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694399	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400060
J	Lee, BJ; Zhou, YY; Lee, JS; Shine, BK; Seo, JA; Lee, D; Kim, YS; Choi, HK				Lee, Byeong-Ju; Zhou, Yaoyao; Lee, Jae Soung; Shine, Byeung Kon; Seo, Jeong-Ah; Lee, Doyup; Kim, Young-Suk; Choi, Hyung-Kyoon			Discrimination and prediction of the origin of Chinese and Korean soybeans using Fourier transform infrared spectrometry (FT-IR) with multivariate statistical analysis	PLOS ONE			English	Article							GEOGRAPHICAL ORIGIN; QUALITY-CONTROL; SOY ISOFLAVONE; SPECTROSCOPY; METABOLOMICS; MIR	The ability to determine the origin of soybeans is an important issue following the inclusion of this information in the labeling of agricultural food products becoming mandatory in South Korea in 2017. This study was carried out to construct a prediction model for discriminating Chinese and Korean soybeans using Fourier-transform infrared (FT-IR) spectroscopy and multivariate statistical analysis. The optimal prediction models for discriminating soybean samples were obtained by selecting appropriate scaling methods, normalization methods, variable influence on projection (VIP) cutoff values, and wave-number regions. The factors for constructing the optimal partial-least-squares regression (PLSR) prediction model were using second derivatives, vector normalization, unit variance scaling, and the 4000 +/- 400 cm +/- 1 region (excluding water vapor and carbon dioxide). The PLSR model for discriminating Chinese and Korean soybean samples had the best predictability when a VIP cutoff value was not applied. When Chinese soybean samples were identified, a PLSR model that has the lowest root-mean-square error of the prediction value was obtained using a VIP cutoff value of 1.5. The optimal PLSR prediction model for discriminating Korean soybean samples was also obtained using a VIP cutoff value of 1.5. This is the first study that has combined FT-IR spectroscopy with normalization methods, VIP cutoff values, and selected wave-number regions for discriminating Chinese and Korean soybeans.	[Lee, Byeong-Ju; Zhou, Yaoyao; Lee, Jae Soung; Choi, Hyung-Kyoon] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Shine, Byeung Kon] Natl Agr Prod Qual Management Serv, Gimcheon, South Korea; [Seo, Jeong-Ah] Soongsil Univ, Sch Syst Biomed Sci, Seoul, South Korea; [Lee, Doyup] Kookmin Univ, Dept Bio & Fermentat Convergence Technol, Seoul, South Korea; [Kim, Young-Suk] Ewha Womans Univ, Dept Food Sci & Engn, Seoul, South Korea	Chung Ang University; Soongsil University; Kookmin University; Ewha Womans University	Choi, HK (corresponding author), Chung Ang Univ, Coll Pharm, Seoul, South Korea.	hykychoi@cau.ac.kr		Choi, Hyung-Kyoon/0000-0002-4523-0534	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(IPET) through Advanced Production Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [316081-04]; National Research Foundation of Korea [NRF-2015R1A5A1008958]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(IPET) through Advanced Production Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(IPET) through Advanced Production Technology Development Program funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (316081-04 awarded to HKC). This work was also funded by the National Research Foundation of Korea (NRF-2015R1A5A1008958 awarded to HKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albulescu M, 2007, REV ROUM CHIM, V52, P537; Anderson JW, 1999, AM J CLIN NUTR, V70, p464S, DOI 10.1093/ajcn/70.3.464s; Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43; Bondia-Pons I, 2014, FOOD RES INT, V63, P132, DOI 10.1016/j.foodres.2014.01.067; Bruun SW, 2006, APPL SPECTROSC, V60, P1029, DOI 10.1366/000370206778397371; Chawla S, 2013, PLANT DIS, V97, P568, DOI 10.1094/PDIS-05-12-0479-FE; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Eriksson L., 2013, MULTI MEGAVARIATE DA; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Filik J, 2012, ANALYST, V137, P853, DOI 10.1039/c2an15995c; Garip S, 2009, FOOD CHEM, V113, P1301, DOI 10.1016/j.foodchem.2008.08.063; Jin G, 2017, J OLEO SCI, V66, P337, DOI 10.5650/jos.ess16154; 안형균, 2012, [KOREAN JOURNAL OF CROP SCIENCE, 한국작물학회지], V57, P296, DOI 10.7740/kjcs.2012.57.3.296; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Lammers K, 2009, SOIL BIOL BIOCHEM, V41, P340, DOI 10.1016/j.soilbio.2008.11.005; Lee SW, 1988, J KOREAN SOC FOOD CU, V3, P331; Li RY, 2012, CRYST RES TECHNOL, V47, P377, DOI 10.1002/crat.201200016; Li SY, 2014, SCI JUSTICE, V54, P98, DOI 10.1016/j.scijus.2013.07.005; Liu JY, 2013, J CHEM TECHNOL BIOT, V88, P1807, DOI 10.1002/jctb.4027; Luo DS, 2017, INT J FOOD SCI TECH, V52, P714, DOI 10.1111/ijfs.13326; Mateos-Aparicio I, 2008, NUTR HOSP, V23, P305; Mori Mari, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS39, DOI 10.1111/j.1440-1681.2004.04117.x; Ordoudi SA, 2014, FOOD CHEM, V150, P414, DOI 10.1016/j.foodchem.2013.11.014; Owen A. J., 1995, USES DERIVATIVE SPEC; Ravindranath MH, 2004, ADV EXP MED BIOL, V546, P121; Rayaprolu SJ, 2017, J FOOD SCI TECH MYS, V54, P38, DOI 10.1007/s13197-016-2426-2; 김미현, 2009, [Korean Journal of Food Science and Technology, 한국식품과학회지], V41, P292; Sarkar FH, 2002, CANCER METAST REV, V21, P265, DOI 10.1023/A:1021210910821; Staniszewska-Slezak E, 2015, ANALYST, V140, P2273, DOI 10.1039/c4an01864h; Taku K, 2011, MATURITAS, V70, P333, DOI 10.1016/j.maturitas.2011.09.001; VANDEVOORT FR, 1992, FOOD RES INT, V25, P397, DOI 10.1016/0963-9969(92)90115-L; Zhao XY, 2015, J FOOD PROCESS PRES, V39, P2017, DOI 10.1111/jfpp.12442	32	28	28	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196315	10.1371/journal.pone.0196315	http://dx.doi.org/10.1371/journal.pone.0196315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689113	Green Published, gold, Green Submitted			2022-12-26	WOS:000430678800043
J	Prosser, CM; Hedgpeth, BM				Prosser, Christopher M.; Hedgpeth, Bryan M.			Effects of bioturbation on environmental DNA migration through soil media	PLOS ONE			English	Article							BIODIVERSITY; ADSORPTION; ABUNDANCE	Extracting and identifying genetic material from environmental media (i.e. water and soil) presents a unique opportunity for researchers to assess biotic diversity and ecosystem health with increased speed and decreased cost as compared to traditional methods (e.g. trapping). The heterogeneity of soil mineralogy, spatial and temporal variations however present unique challenges to sampling and interpreting results. Specifically, fate/transport of genetic material in the terrestrial environment represents a substantial data gap. Here we investigate to what degree, benthic fauna transport genetic material through soil. Using the red worm (Eisenia fetida), we investigate how natural movement through artificial soil affect the transport of genetic material. All experiments were run in Frabill (R) Habitat (R) II worm systems with approximately 5 cm depth of artificial soil. We selected an "exotic" source of DNA not expected to be present in soil, zebrafish (Danio rerio) tissue. Experiment groups contained homogenized zebrafish tissue placed in a defined location combined with a varying number of worms (10, 30 or 50 worms per experimental group). Experimental groups comprised two controls and three treatment groups (representing different worm biomass) in triplicate. A total of 210 soil samples were randomly collected over the course of 15 days to investigate the degree of genetic transfer, and the rate of detection. Positive detections were identified in 14% - 38% of samples across treatment groups, with an overall detection rate of 25%. These findings highlight two important issues when utilizing environmental DNA for biologic assessments. First, benthic fauna are capable of redistributing genetic material through a soil matrix. Second, despite a defined sample container and abundance of worm biomass, as many as 86% of the samples were negative. This has substantial implications for researchers and managers who wish to interpret environmental DNA results from terrestrial systems. Studies such as these will aid in future study protocol design and sample collection methodology.	[Prosser, Christopher M.; Hedgpeth, Bryan M.] ExxonMobil Biomed Sci Inc, Annandale, NJ 08801 USA	Exxon Mobil Corporation	Prosser, CM (corresponding author), ExxonMobil Biomed Sci Inc, Annandale, NJ 08801 USA.	Christopher.m.prosser@exxonmobil.com		Prosser, Christopher/0000-0002-5209-1878; Hedgpeth, Bryan/0000-0002-9503-4945	ExxonMobil Biomedical Sciences Incorporated	ExxonMobil Biomedical Sciences Incorporated(Exxon Mobil Corporation)	Funding was provided by ExxonMobil Biomedical Sciences Incorporated. The funder provided support in the form of salaries for authors [CMP; BMH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1934, ENV SCI TECHNOL; [Anonymous], 2006, NAT BIOTECHNOL; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Cai P, 2006, ENVIRON SCI TECHNOL, V40, P2971, DOI 10.1021/es0522985; Fahner NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157505; Garg V. K., 2008, Environmentalist, V28, P483, DOI 10.1007/s10669-008-9173-5; Gibson JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138432; Gugerli F, 2013, MOL ECOL, V22, P3433, DOI 10.1111/mec.12356; Hunter ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121655; Jerde CL, 2010, CONSERV LETT, P1; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Nielsen KM, 2004, NAT BIOTECHNOL, V22, P1110, DOI 10.1038/nbt1006; OGRAM AV, 1994, APPL ENVIRON MICROB, V60, P393, DOI 10.1128/AEM.60.2.393-396.1994; Pietramellara G, 2009, BIOL FERT SOILS, V45, P219, DOI 10.1007/s00374-008-0345-8; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Porter TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0142759; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Trevors JT, 1996, ANTON LEEUW INT J G, V70, P1, DOI 10.1007/BF00393564	18	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196430	10.1371/journal.pone.0196430	http://dx.doi.org/10.1371/journal.pone.0196430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689092	Green Published, Green Submitted, gold			2022-12-26	WOS:000430678800053
J	Kokate, SB; Dixit, P; Das, L; Rath, S; Roy, AD; Poirah, I; Chakraborty, D; Rout, N; Singh, SP; Bhattacharyya, A				Kokate, Shrikant Babanrao; Dixit, Pragyesh; Das, Lopamudra; Rath, Suvasmita; Roy, Arjama Dhar; Poirah, Indrajit; Chakraborty, Debashish; Rout, Niranjan; Singh, Shivaram Prasad; Bhattacharyya, Asima			Acetylation-mediated Siah2 stabilization enhances PHD3 degradation in Helicobacter pylori-infected gastric epithelial cancer cells	FASEB JOURNAL			English	Article						E3 ubiquitin ligase; hypoxia-inducible factor; cancer invasiveness; post-translational modification; proteasomal degradation	HYPOXIA-INDUCIBLE FACTOR; UBIQUITIN LIGASE SIAH2; PROLYL-HYDROXYLASES; TRANSCRIPTIONAL ACTIVITY; CARCINOMA CELLS; HIF-ALPHA; HIF-1-ALPHA; ACTIVATION; EXPRESSION; PROTEIN	Gastric epithelial cells infected with Helicobacter pylori acquire highly invasive and metastatic characteristics. The seven in absentia homolog (Siah)2, an E3 ubiquitin ligase, is one of the major proteins that induces invasiveness of infected gastric epithelial cells. We find that p300-driven acetylation of Siah2 at lysine 139 residue stabilizes the molecule in infected cells, thereby substantially increasing its efficiency to degrade prolyl hydroxylase (PHD)3 in the gastric epithelium. This enhances the accumulation of an oncogenic transcription factor hypoxia-inducible factor 1 (Hif1) in H. pylori-infected gastric cancer cells in normoxic condition and promotes invasiveness of infected cells. Increased acetylation of Siah2, Hif1 accumulation, and the absence of PHD3 in the infected human gastric metastatic cancer biopsy samples and in invasive murine gastric cancer tissues further confirm that the acetylated Siah2 (ac-Siah2)-Hif1 axis is crucial in promoting gastric cancer invasiveness. This study establishes the importance of a previously unrecognized function of ac-Siah2 in regulating invasiveness of H. pylori-infected gastric epithelial cells.Kokate, S. B., Dixit, P., Das, L., Rath, S., Roy, A. D., Poirah, I., Chakraborty, D., Rout, N., Singh, S. P., Bhattacharyya, A. Acetylation-mediated Siah2 stabilization enhances PHD3 degradation in Helicobacter pylori-infected gastric epithelial cancer cells.	[Kokate, Shrikant Babanrao; Dixit, Pragyesh; Das, Lopamudra; Rath, Suvasmita; Roy, Arjama Dhar; Poirah, Indrajit; Chakraborty, Debashish; Bhattacharyya, Asima] HBNI, Natl Inst Sci Educ & Res NISER Bhubaneswar, Sch Biol Sci, PO Bhimpur Padanpur,Via Jatni, Bhubaneswar 752050, Odisha, India; [Rout, Niranjan] Acharya Harihar Reg Canc Ctr, Dept Oncopathol, Cuttack, Odisha, India; [Singh, Shivaram Prasad] Srirama Chandra Bhanja SCB Med Coll, Dept Gastroenterol, Cuttack, Odisha, India	Homi Bhabha National Institute; National Institute of Science Education & Research (NISER); Srirama Chandra Bhanja Medical College & Hospital	Bhattacharyya, A (corresponding author), HBNI, Natl Inst Sci Educ & Res NISER Bhubaneswar, Sch Biol Sci, PO Bhimpur Padanpur,Via Jatni, Bhubaneswar 752050, Odisha, India.	asima@niser.ac.in	Singh, Shivaram Prasad/AAR-1521-2020; Rath, Suvasmita/N-7915-2017; Bhattacharyya, Asima/J-7423-2012	Singh, Shivaram Prasad/0000-0002-8197-2674; Rath, Suvasmita/0000-0001-8738-1560; Bhattacharyya, Asima/0000-0001-7292-6644; Rout, Niranjan/0000-0002-8501-5994; Dixit, Pragyesh/0000-0001-6907-3767; Kokate, Shrikant/0000-0002-6274-537X	Indian Department of Biotechnology [BT/PR15092/GBD/27/311/2011]; Indian Science and Engineering Research Board [SB/SO/BB-0015/2014]; Indian Department of Atomic Energy (DAE)	Indian Department of Biotechnology; Indian Science and Engineering Research Board; Indian Department of Atomic Energy (DAE)	This work was supported by the Indian Department of Biotechnology (BT/PR15092/GBD/27/311/2011), and by the Indian Science and Engineering Research Board (SB/SO/BB-0015/2014) (to A.B.). S.B.K., P.D., A.D.R., I.P., and D.C. are supported by fellowships from Indian Department of Atomic Energy (DAE). The authors declare no conflicts of interest.	Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Anavi S, 2014, FREE RADICAL BIO MED, V71, P61, DOI 10.1016/j.freeradbiomed.2014.03.007; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Baba K, 2013, J BIOL CHEM, V288, P18393, DOI 10.1074/jbc.M112.438762; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bhattacharyya A, 2010, AM J PHYSIOL-GASTR L, V299, pG1177, DOI 10.1152/ajpgi.00372.2010; Bhattacharyya A, 2009, GASTROENTEROLOGY, V136, P2258, DOI 10.1053/j.gastro.2009.02.014; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Chaugule VK, 2016, BIOCHEM SOC T, V44, P212, DOI 10.1042/BST20150209; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Das L, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.26; Das L, 2016, BIOCHEM J, V473, P1629, DOI 10.1042/BCJ20160187; Deng WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep39787; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Garcia-Limones C, 2016, ONCOGENE, V35, P4289, DOI 10.1038/onc.2015.495; Gobert AP, 2017, CURR TOP MICROBIOL, V400, P27, DOI 10.1007/978-3-319-50520-6_2; Griffiths EA, 2007, BRIT J CANCER, V96, P95, DOI 10.1038/sj.bjc.6603524; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Hatakeyama M, 2014, CELL HOST MICROBE, V15, P306, DOI 10.1016/j.chom.2014.02.008; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Jung JH, 2013, INT J MED SCI, V10, P1217, DOI 10.7150/ijms.6054; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Knauer SK, 2015, CYTOKINE GROWTH F R, V26, P405, DOI 10.1016/j.cytogfr.2015.04.002; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liang YJ, 2015, CANCER RES, V75, P3672, DOI 10.1158/0008-5472.CAN-15-0930; Liu SP, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.405; Matak P, 2015, J IMMUNOL, V194, P3259, DOI 10.4049/jimmunol.1401260; Mazzon M, 2013, P NATL ACAD SCI USA, V110, P12444, DOI 10.1073/pnas.1302140110; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Muller S, 2014, ONCOTARGET, V5, P3184; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2009, MOL CANCER RES, V7, P443, DOI 10.1158/1541-7786.MCR-08-0458; Niecknig H, 2012, FREE RADICAL RES, V46, P705, DOI 10.3109/10715762.2012.669041; Nihira NT, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8026; Nolan KA, 2015, EXP CELL RES, V330, P371, DOI 10.1016/j.yexcr.2014.07.034; Noto J. M., 2017, GUT, V18; Park JH, 2003, CLIN CANCER RES, V9, P433; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Qian JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077625; Rath S, 2017, INT J BIOCHEM CELL B, V82, P28, DOI 10.1016/j.biocel.2016.11.014; Rath S, 2015, FASEB J, V29, P796, DOI 10.1096/fj.14-257501; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rohwer N, 2009, BRIT J CANCER, V100, P772, DOI 10.1038/sj.bjc.6604919; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; Schaffer K, 2015, FEBS J, V282, P2260, DOI 10.1111/febs.13270; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thomas S, 2012, CANCER RES, V72, P5600, DOI 10.1158/0008-5472.CAN-11-3666; Tsugawa H, 2012, CELL HOST MICROBE, V12, P764, DOI 10.1016/j.chom.2012.10.014; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; Wong CSF, 2013, CANCER RES, V73, P2400, DOI 10.1158/0008-5472.CAN-12-4348; Zhao CH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-419; Zhao Q, 2016, ONCOL RES, V23, P129, DOI 10.3727/096504015X14500513118029; Zhao Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132746; Zhu CL, 2013, MOL BIOL REP, V40, P6055, DOI 10.1007/s11033-013-2715-z	67	7	7	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5378	5389		10.1096/fj.201701344RRR	http://dx.doi.org/10.1096/fj.201701344RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688807				2022-12-26	WOS:000447972500015
J	Pavan, S; Meyer-Schaller, N; Diepenbruck, M; Kalathur, RKR; Saxena, M; Christofori, G				Pavan, Simona; Meyer-Schaller, Nathalie; Diepenbruck, Maren; Kalathur, Ravi Kiran Reddy; Saxena, Meera; Christofori, Gerhard			A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; TUMOR PROGRESSION; MASTER REGULATOR; MIR-200 FAMILY; MEK KINASE; PROTEIN; ACTIVATION; ERK5; PATHWAY	An epithelial to mesenchymal transition (EMT) has been correlated to malignant tumor progression and metastasis by promoting cancer cell migration and invasion and chemoresistance. Hence, finding druggable EMT effectors is critical to efficiently interfere with metastasis formation and to overcome therapy resistance. We have employed a high-content microscopy screen in combination with a kinome and phosphatome-wide siRNA library to identify signaling pathways underlying an EMT of murine mammary epithelial cells and breast cancer cells. This screen identified the MEK5-ERK5 axis as a critical player in TGF beta-mediated EMT. Suppression of MEK5-ERK5 signaling completely prevented the morphological and molecular changes occurring during a TGF beta-induced EMT and, conversely, forced highly metastatic breast cancer cells into a differentiated epithelial state. Inhibition of MEK5-ERK5 signaling also repressed breast cancer cell migration and invasion and substantially reduced lung metastasis without affecting primary tumor growth. The results suggest that the MEK5-ERK5 signaling axis via activation of MEF2B and other transcription factors plays an important role in the induction and maintenance of breast cancer cell migration and invasion and thus represents an exploitable target for the pharmacological inhibition of cancer cell metastasis.	[Pavan, Simona; Meyer-Schaller, Nathalie; Diepenbruck, Maren; Kalathur, Ravi Kiran Reddy; Saxena, Meera; Christofori, Gerhard] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland	University of Basel	Pavan, S; Christofori, G (corresponding author), Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.	simona.pavan@unibas.ch; gerhard.christofori@unibas.ch		Saxena, Meera/0000-0002-4060-4218	SystemsX.ch MTD project MetastasiX; Swiss National Science Foundation; Swiss Cancer League; Krebsliga Beider Basel; Marie-Heim Vogtlin grant from the Swiss National Foundation	SystemsX.ch MTD project MetastasiX; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Krebsliga Beider Basel; Marie-Heim Vogtlin grant from the Swiss National Foundation	This work was supported by the SystemsX.ch MTD project MetastasiX, the Swiss National Science Foundation, the Swiss Cancer League, and Krebsliga Beider Basel. N.M.-S. was supported by a Marie-Heim Vogtlin grant from the Swiss National Foundation.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Badshah II, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00071; Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cavallaro U, 2002, CANCER LETT, V176, P123, DOI 10.1016/S0304-3835(01)00759-5; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Chao TH, 1999, J BIOL CHEM, V274, P36035, DOI 10.1074/jbc.274.51.36035; Chen RQ, 2012, CANCER RES, V72, P1579, DOI 10.1158/0008-5472.CAN-11-2055; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Diepenbruck M, 2016, CURR OPIN CELL BIOL, V43, P7, DOI 10.1016/j.ceb.2016.06.002; Diepenbruck M, 2014, J CELL SCI, V127, P1523, DOI 10.1242/jcs.139865; El-Deiry WS, 2016, CANCER RES, V76, P5189, DOI 10.1158/0008-5472.CAN-16-2055; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gui Ting, 2012, J Signal Transduct, V2012, P289243, DOI 10.1155/2012/289243; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Javaid S, 2015, MOL CANCER RES, V13, P934, DOI 10.1158/1541-7786.MCR-14-0604; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Klein AM, 2013, CURR OPIN CELL BIOL, V25, P272, DOI 10.1016/j.ceb.2013.01.002; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Laurent J, 2011, CANCER RES, V71, P3781, DOI 10.1158/0008-5472.CAN-10-3684; Lotz-Jenne C, 2016, ONCOTARGET, V7, P25983, DOI 10.18632/oncotarget.8418; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marchetti A, 2008, CELL SIGNAL, V20, P2113, DOI 10.1016/j.cellsig.2008.08.002; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mody N, 2003, BIOCHEM J, V372, P567, DOI 10.1042/BJ20030193; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Sun WY, 2000, J BIOL CHEM, V275, P24421, DOI 10.1074/jbc.M003148200; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; von Minckwitz G, 2007, EXPERT OPIN PHARMACO, V8, P485, DOI 10.1517/14656566.8.4.485; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang QK, 2010, CANCER CELL, V18, P258, DOI 10.1016/j.ccr.2010.08.008; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	66	32	35	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 2	2018	37	31					4197	4213		10.1038/s41388-018-0270-8	http://dx.doi.org/10.1038/s41388-018-0270-8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP1HN	29713055				2022-12-26	WOS:000440566100001
J	Sirtl, S; Knoll, G; Trinh, DT; Lang, I; Siegmund, D; Gross, S; Schuler-Thurner, B; Neubert, P; Jantsch, J; Wajant, H; Ehrenschwender, M				Sirtl, Simon; Knoll, Gertrud; Dieu Thuy Trinh; Lang, Isabell; Siegmund, Daniela; Gross, Stefanie; Schuler-Thurner, Beatrice; Neubert, Patrick; Jantsch, Jonathan; Wajant, Harald; Ehrenschwender, Martin			Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors	ONCOGENE			English	Article							APOPTOSIS-INDUCING LIGAND; CELL-SURFACE ANTIGEN; MITOCHONDRIAL-MEMBRANE; TUMORICIDAL ACTIVITY; ANTITUMOR-ACTIVITY; DENDRITIC CELLS; HIGH-SALT; CASPASE 8; TRAIL; BAX	Attempts to exploit the cytotoxic activity of death receptors (DR) for treating cancer have thus far been disappointing. DR activation in most malignant cells fails to trigger cell death and may even promote tumor growth by activating cell death-independent DR-associated signaling pathways. Overcoming apoptosis resistance is consequently a prerequisite for successful clinical exploitation of DR stimulation. Here we show that hyperosmotic stress in the tumor microenvironment unleashes the deadly potential of DRs by enforcing BCL-2 addiction of cancer cells. Hypertonicity robustly enhanced cytotoxicity of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and other DR ligands in various cancer entities. Initial events in TRAIL DR signaling remained unaffected, but hypertonic conditions unlocked activation of the mitochondrial death pathway and thus amplified the apoptotic signal. Mechanistically, we demonstrate that hyperosmotic stress imposed a BCL-2-addiction on cancer cells to safeguard the integrity of the outer mitochondrial membrane (OMM), essentially exhausting the protective capacity of BCL-2-like pro-survival proteins. Deprivation of these mitochondrial safeguards licensed DR-generated truncated BH3-interacting domain death agonist (tBID) to activate BCL-2-associated X protein (BAX) and initiated mitochondrial outer membrane permeabilization (MOMP). Our work highlights that hyperosmotic stress in the tumor environment primes mitochondria for death and lowers the threshold for DR-induced apoptosis. Beyond TRAIL-based therapies, our findings could help to strengthen the efficacy of other apoptosis-inducing cancer treatment regimens.	[Sirtl, Simon; Knoll, Gertrud; Dieu Thuy Trinh; Neubert, Patrick; Jantsch, Jonathan; Ehrenschwender, Martin] Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany; [Lang, Isabell; Siegmund, Daniela; Wajant, Harald] Univ Hosp Wurzburg, Div Mol Internal Med Med Clin & Polyclin 2, Rontgenring 11, D-97070 Wurzburg, Germany; [Gross, Stefanie; Schuler-Thurner, Beatrice] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Dermatol, Ulmenweg 18, D-91054 Erlangen, Germany	University of Regensburg; University of Wurzburg; University of Erlangen Nuremberg	Ehrenschwender, M (corresponding author), Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	martin.ehrenschwender@ukr.de		Ehrenschwender, Martin/0000-0003-4681-8628; Lang, Isabell/0000-0002-6369-4973; Gross, Stefanie/0000-0002-5406-1736	Deutsche Forschungsgemeinschaft (DFG) [EH 465/2-1, JA 1993/4-1, WA 1025/24-1]; Roggenbuck Stiftung; Universitatsstiftung Angela Schotz-Keilholz; Medical Faculty of the University of Regensburg (ReForM-B-program); Deutsche Krebshilfe [111703]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Roggenbuck Stiftung; Universitatsstiftung Angela Schotz-Keilholz; Medical Faculty of the University of Regensburg (ReForM-B-program); Deutsche Krebshilfe(Deutsche Krebshilfe)	ME is supported by grants from Deutsche Forschungsgemeinschaft (DFG Grant EH 465/2-1), the Roggenbuck Stiftung, the Universitatsstiftung Angela Schotz-Keilholz, and the Medical Faculty of the University of Regensburg (ReForM-B-program). JJ is supported by grants from Deutsche Forschungsgemeinschaft (DFG Grant JA 1993/4-1). HW is supported by grants from Deutsche Forschungsgemeinschaft (DFG Grant WA 1025/24-1) and Deutsche Krebshilfe (Grant 111703).	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bhola PD, 2016, MOL CELL, V61, P695, DOI 10.1016/j.molcel.2016.02.019; Bittner S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.355; Callus BA, 2008, J MOL BIOL, V384, P313, DOI 10.1016/j.jmb.2008.09.041; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Clem RJ, 2001, J BIOL CHEM, V276, P7602, DOI 10.1074/jbc.M010259200; de Miguel D, 2016, CELL DEATH DIFFER, V23, P733, DOI 10.1038/cdd.2015.174; Delbridge ARD, 2016, NAT REV CANCER, V16, P99, DOI 10.1038/nrc.2015.17; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Dewson Grant, 2015, Cold Spring Harb Protoc, V2015, P477, DOI 10.1101/pdb.prot086462; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Ehrenschwender M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.534; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; Fischereder M, 2017, AM J PHYSIOL-RENAL, V313, pF319, DOI 10.1152/ajprenal.00703.2016; Franco D, 2002, CELL DEATH DIFFER, V9, P1090, DOI 10.1038/sj.cdd.4401074; Galvez A, 2001, CELL TISSUE RES, V304, P279, DOI 10.1007/s004410100358; Ganesan V, 2012, BIOPHYS J, V103, P483, DOI 10.1016/j.bpj.2012.06.047; Gillissen B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.67; Graves JD, 2014, CANCER CELL, V26, P177, DOI 10.1016/j.ccr.2014.04.028; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Huang K, 2016, J BIOL CHEM, V291, P11843, DOI 10.1074/jbc.M115.711051; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Knoll G, 2016, ONCOTARGET, V7, P41488, DOI 10.18632/oncotarget.9206; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; Kums J, 2017, MABS-AUSTIN, V9, P506, DOI 10.1080/19420862.2016.1274844; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Mariani SM, 1998, EUR J IMMUNOL, V28, P1492, DOI 10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X; Michea L, 2000, AM J PHYSIOL-RENAL, V278, pF209, DOI 10.1152/ajprenal.2000.278.2.F209; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Nikpey E, 2017, HYPERTENSION, V69, P660, DOI 10.1161/HYPERTENSIONAHA.116.08539; O'Neill KL, 2016, GENE DEV, V30, P973, DOI 10.1101/gad.276725.115; OEHM A, 1992, J BIOL CHEM, V267, P10709; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pecot J, 2016, CELL REP, V17, P3347, DOI 10.1016/j.celrep.2016.11.064; Reis CR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.61; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schug ZT, 2011, CELL DEATH DIFFER, V18, P538, DOI 10.1038/cdd.2010.135; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Telford W, 2016, CURR PROTOC CYTOM, V77; Thomann S, 2015, IMMUNOLOGY, V146, P327, DOI 10.1111/imm.12509; Todt F, 2015, EMBO J, V34, P67, DOI 10.15252/embj.201488806; Trebing J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.555; Tuthill MH, 2015, ONCOGENE, V34, P2138, DOI 10.1038/onc.2014.156; von Karstedt S, 2017, NAT REV CANCER, V17, P352, DOI 10.1038/nrc.2017.28; Wajant H, 2015, CELL DEATH DIFFER, V22, P1727, DOI 10.1038/cdd.2015.109; Wajant H, 2001, ONCOGENE, V20, P4101, DOI 10.1038/sj.onc.1204558; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang C, 2012, ONCOGENE, V31, P3177, DOI 10.1038/onc.2011.497; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yaacoub K, 2016, CANCER LETT, V378, P150, DOI 10.1016/j.canlet.2016.05.012; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	60	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 26	2018	37	30					4122	4136		10.1038/s41388-018-0265-5	http://dx.doi.org/10.1038/s41388-018-0265-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GO2YI	29706657	hybrid, Green Published			2022-12-26	WOS:000439847000006
J	Blanchette-Farra, N; Kita, D; Konstorum, A; Tesfay, L; Lemler, D; Hegde, P; Claffey, KP; Torti, FM; Torti, SV				Blanchette-Farra, Nicole; Kita, Daniel; Konstorum, Anna; Tesfay, Lia; Lemler, David; Hegde, Poornima; Claffey, Kevin P.; Torti, Frank M.; Torti, Suzy V.			Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer	ONCOGENE			English	Article							GENE-EXPRESSION PATTERNS; TGF-BETA SUPERFAMILY; TRANSFERRIN RECEPTOR; EPITHELIAL-CELLS; IRON-METABOLISM; MOLECULAR PORTRAITS; ACTIVATION; PROTEIN; GROWTH; STAT3	Hepcidin is a peptide hormone that negatively regulates iron efflux and plays an important role in controlling the growth of breast tumors. In patients with breast cancer, the combined expression of hepcidin and its membrane target, ferroportin, predict disease outcome. However, mechanisms that control hepcidin expression in breast cancer cells remain largely unknown. Here, we use three-dimensional breast cancer spheroids derived from cell lines and breast cancer patients to probe mechanisms of hepcidin regulation in breast cancer. We observe that the extent of hepcidin induction and pathways of its regulation are markedly changed in breast cancer cells grown in three dimensions. In monolayer culture, BMPs, particularly BMP6, regulate hepcidin transcription. When breast cancer cells are grown as spheroids, there is a > 10-fold induction in hepcidin transcripts. Microarray analysis combined with knockdown experiments reveal that GDF-15 is the primary mediator of this change. The increase in hepcidin as breast cells develop a three-dimensional architecture increases intracellular iron, as indicated by an increase in the iron storage protein ferritin. Immunohistochemical staining of human breast tumors confirms that both GDF-15 and hepcidin are expressed in breast cancer specimens. Further, levels of GDF-15 are significantly correlated with levels of hepcidin at both the mRNA and protein level in patient samples, consistent with a role for GDF-15 in control of hepcidin in human breast tumors. Inclusion of tumor-associated fibroblasts in breast cancer spheroids further induces hepcidin. This induction is mediated by fibroblast-dependent secretion of IL-6. Breast cancer cells grown as spheroids are uniquely receptive to IL-6-dependent induction of hepcidin by tumor-associated fibroblasts, since IL6 does not induce hepcidin in cells grown as monolayers. Collectively, our results suggest a new paradigm for tumormediated control of iron through the control of hepcidin by tumor architecture and the breast tumor microenvironment.	[Blanchette-Farra, Nicole; Tesfay, Lia; Lemler, David; Torti, Suzy V.] Univ Connecticut, Hlth Ctr, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Kita, Daniel; Claffey, Kevin P.] Univ Connecticut, Hlth Ctr, Dept Cell Biol, Farmington, CT 06030 USA; [Konstorum, Anna] Univ Connecticut, Hlth Ctr, Ctr Quantitat Med, Farmington, CT 06030 USA; [Hegde, Poornima] Univ Connecticut, Hlth Ctr, Dept Pathol, Farmington, CT USA; [Torti, Frank M.] Univ Connecticut, Hlth Ctr, Dept Med, Farmington, CT USA; [Kita, Daniel] Alex Pharmaceut, New Haven, CT USA; [Lemler, David] North Carolina State Univ, Dept Mol Biomed Sci, Raleigh, NC USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of North Carolina; North Carolina State University	Torti, SV (corresponding author), Univ Connecticut, Hlth Ctr, Dept Mol Biol & Biophys, Farmington, CT 06030 USA.	storti@uchc.edu	Lemler, David/GZG-4253-2022		NCI [R01CA188025, R01CA171101, F32CA214030]; NATIONAL CANCER INSTITUTE [F32CA214030, R01CA188025, R01CA171101] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI R01CA188025 (SVT), NCI R01CA171101 (FMT), and NCI F32CA214030 (AK). We thank Li Chen and Drs. Nathaniel Dyment and David Rowe for assistance in image acquisition, Tara L Arvedson (Amgen, Thousand Oaks, CA) for a generous gift of anti-ferroportin antibody and Xiaohong Wang for her assistance in histological sectioning.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arman A, 2003, ADV EXP MED BIOL, V534, P297; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Bruzzese F, 2014, CANCER RES, V74, P3408, DOI 10.1158/0008-5472.CAN-13-2259; CALDENHOVEN E, 1995, J BIOL CHEM, V270, P25778, DOI 10.1074/jbc.270.43.25778; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; Cooke KS, 2013, BLOOD, V122, P3054, DOI 10.1182/blood-2013-06-505792; Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Francia G, 2004, MOL CELL BIOL, V24, P6837, DOI 10.1128/mcb.24.15.6837-6849.2004; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Howlader N, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju055; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Li C, 2016, ONCOTARGET, V7, P860, DOI 10.18632/oncotarget.6205; Li YL, 2017, ONCOTARGET, V8, P1508, DOI 10.18632/oncotarget.13649; Liu XF, 2017, NAT PROTOC, V12, P439, DOI 10.1038/nprot.2016.174; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Longati P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-95; Marques O, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2228-y; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nath S, 2016, PHARMACOL THERAPEUT, V163, P94, DOI 10.1016/j.pharmthera.2016.03.013; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nguyen DH, QUANTIFYING CHROMOGE, DOI [10.1038/protex.2013.097, DOI 10.1038/PROTEX.2013.097]; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Park YJ, 2010, BMB REP, V43, P91, DOI 10.5483/BMBRep.2010.43.2.091; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Pinnix ZK, 2010, SCI TRANSL MED, V2; Riedl A, 2017, J CELL SCI, V130, P203, DOI 10.1242/jcs.188102; Saias L, 2015, CANCER RES, V75, P2426, DOI 10.1158/0008-5472.CAN-14-3534; Sasahara A, 2017, ONCOTARGET, V8, P24869, DOI 10.18632/oncotarget.15276; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schober A, 2001, J COMP NEUROL, V439, P32, DOI 10.1002/cne.1333; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tesfay L, 2015, CANCER RES, V75, P2254, DOI 10.1158/0008-5472.CAN-14-2465; Theil EC, 2016, ACCOUNTS CHEM RES, V49, P784, DOI 10.1021/ar500469e; TONIK SE, 1986, BREAST CANCER RES TR, V7, P71, DOI 10.1007/BF01806791; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Wang W, 2014, CANCER RES, V74, P497, DOI 10.1158/0008-5472.CAN-13-1224; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wilkinson J, 2003, ADV ENZYME REGUL, V43, P135, DOI 10.1016/S0065-2571(02)00037-7; WINAND FJ, 2014, J MOL BIOMARK DIAGN, V5, P199; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; WRBA F, 1986, VIRCHOWS ARCH A, V410, P69, DOI 10.1007/BF00710908; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yalcin Mehmet Muhittin, 2016, J Diabetes Res, V2016, P1240843, DOI 10.1155/2016/1240843; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Yilmaz H, 2016, INDIAN J HEMATOL BLO, V32, P221, DOI 10.1007/s12288-015-0551-0; Yu M, 2012, MOL CELL BIOL, V32, P3913, DOI 10.1128/MCB.00068-12; Zhang SP, 2014, CELL SIGNAL, V26, P2539, DOI 10.1016/j.cellsig.2014.07.029	72	31	31	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 19	2018	37	29					4013	4032		10.1038/s41388-018-0243-y	http://dx.doi.org/10.1038/s41388-018-0243-y			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GN5LP	29695834	Green Accepted			2022-12-26	WOS:000439101300008
J	Gangangari, KK; Humm, JL; Larson, SM; Pillarsetty, NVK				Gangangari, Kishore K.; Humm, John L.; Larson, Steven M.; Pillarsetty, Naga Vara Kishore			TMSOTf assisted synthesis of 2 '-deoxy-2 '-[F-18]fluoro-beta-D-arabinofuranosylcytosine ([F-18]FAC)	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; GENE-EXPRESSION; NUCLEOSIDES; GEMCITABINE; ANALOG; STRATEGY	[(18)f]FAC (2'-deoxy-2'-[(18)f] fluoro-beta-D-arabinofuranosylcytosine, 1) is a versatile probe for imaging deoxycytidine kinase (dCK) expression levels in vivo. dCK is responsible for phosphorylation of deoxycytidine (dC, 2) and other nucleoside analogs, plays a key role in immune activation and has demonstrated to be one of the key enzymes in activating nucleoside based drugs including gemcitabine. Reported synthesis of [(18)f]FAC is high yielding but is quite challenging requiring bromination using HBr and careful drying of excess HBr which is critical for successful synthesis. Here in we report a simplified trimethylsilyl trifluoromethanesulfonate (TMSOTf) assisted synthesis of [(18)f]FAC eliminating the need of bromination and drying. [(18)f]FAC (ss-anomer) was synthesized with average isolated decay corrected yield of 10.59 +/- 4.2% (n = 6) with radiochemical purity of >98% and total synthesis time of 158 +/- 19 min.	[Gangangari, Kishore K.; Larson, Steven M.; Pillarsetty, Naga Vara Kishore] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Gangangari, Kishore K.] CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA; [Gangangari, Kishore K.] CUNY, Grad Ctr, PhD Program Chem, New York, NY USA; [Humm, John L.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Larson, Steven M.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Pillarsetty, Naga Vara Kishore] Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Pillarsetty, NVK (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA.; Pillarsetty, NVK (corresponding author), Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA.	pillarsn@mskcc.org		Pillarsetty, Naga Vara Kishore/0000-0002-1750-7436	IMRAS seed grant; NIH [1 R01 CA194321]; NIH Cancer Center [2 P30 CA008748-48]; National Science Foundation [IGERT 0965983]; NATIONAL CANCER INSTITUTE [R01CA172546, R01CA194321, P30CA008748] Funding Source: NIH RePORTER	IMRAS seed grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding from IMRAS seed grant (MSKCC) and NIH grant 1 R01 CA194321in supporting this work is gratefully acknowledged. Technical services provided by the MSKCC Small Animal Imaging Core Facility, supported in part by NIH Cancer Center Support Grant No 2 P30 CA008748-48, are gratefully acknowledged. The authors thank Integrative Graduate Education and Research Traineeship (IGERT 0965983 at Hunter College) by the National Science Foundation for their generous support.	Alauddin MM, 2007, EUR J NUCL MED MOL I, V34, P822, DOI 10.1007/s00259-006-0305-1; Anderson H, 2010, NUCL MED BIOL, V37, P439, DOI 10.1016/j.nucmedbio.2010.01.003; Burris H, 1997, J CLIN ONCOL, V15, P6; Cai HC, 2011, NUCL MED BIOL, V38, P659, DOI 10.1016/j.nucmedbio.2011.01.003; ERIKSSON S, 1994, ADV ENZYME REGUL, V34, P13, DOI 10.1016/0065-2571(94)90006-X; HOWELL HG, 1988, J ORG CHEM, V53, P85, DOI 10.1021/jo00236a017; Kroep JR, 2002, MOL CANCER THER, V1, P371; Laing RE, 2009, P NATL ACAD SCI USA, V106, P2847, DOI 10.1073/pnas.0812890106; Lazari M, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-52; Meyer JP, 2014, J LABELLED COMPD RAD, P57; Pillarsetty N, 2006, J MED CHEM, V49, P5377, DOI 10.1021/jm0512847; Radu CG, 2008, NAT MED, V14, P783, DOI 10.1038/nm1724; Russell J, 2017, MOL IMAGING BIOL, V19, P885, DOI 10.1007/s11307-017-1078-6; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; VISSER GWM, 1986, APPL RADIAT ISOTOPES, V37, P1074; VORBRUGGEN H, 1981, CHEM BER-RECL, V114, P1234, DOI 10.1002/cber.19811140404; WRIGHT JA, 1970, J MED CHEM, V13, P269, DOI 10.1021/jm00296a024; Wu CY, 2009, APPL RADIAT ISOTOPES, V67, P1362, DOI 10.1016/j.apradiso.2009.02.083; Zhang HW, 2012, NUCL MED BIOL, V39, P1182, DOI 10.1016/j.nucmedbio.2012.06.008	19	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196784	10.1371/journal.pone.019678	http://dx.doi.org/10.1371/journal.pone.019678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715301				2022-12-26	WOS:000431281100052
J	Miyaoku, K; Nakamoto, A; Nishida, H; Kumano, G				Miyaoku, Kaori; Nakamoto, Ayaki; Nishida, Hiroki; Kumano, Gaku			Control of Pem protein level by localized maternal factors for transcriptional regulation in the germline of the ascidian, Halocynthia roretzi	PLOS ONE			English	Article							ZYGOTIC GENE-EXPRESSION; CENTROSOME-ATTRACTING BODY; MESSENGER-RNA; CELL FATE; P-TEFB; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; UNEQUAL CLEAVAGES; EARLY EMBRYOS; REPRESSION	Localized maternal mRNAs play important roles in embryogenesis, e.g. the establishment of embryonic axes and the developmental cell fate specification, in various animal species. In ascidians, a group of maternal mRNAs, called postplasmic/PEM RNAs, is localized to a subcellular structure, called the Centrosome-Attracting Body (CAB), which contains the ascidian germ plasm, and is inherited by the germline cells during embryogenesis. Posterior end mark (Pem), a postplasmic/PEM RNAs member, represses somatic gene expression in the germline during cleavage stages by inhibition of RNA polymerase II activity. However, the functions of other postplasmic/PEM RNAs members in germline formation are largely unknown. In this study, we analyzed the functions of two postplasmic/PEM RNAs, Popk-1 and Zf-1, in transcriptional regulation in the germline cells. We show that Popk-1 contributes to transcriptional quiescence by controlling the size of the CAB and amount of Pem protein translated at the CAB. Our studies also indicated that zygotic expression of a germline gene starts around the onset of gastrulation and that the decrease of Pem protein is necessary and sufficient for the zygotic germline gene expression. Finally, further studies showed that the decrease of the Pem protein level is facilitated by Zf-1. Taken together, we propose that postplasmic/PEM RNAs such as Popk-1 and Zf-1 control the protein level of the transcriptional repressor Pem and regulate its transcriptional state in the ascidian germline.	[Miyaoku, Kaori; Nakamoto, Ayaki; Kumano, Gaku] Tohoku Univ, Grad Sch Life Sci, Asamushi Res Ctr Marine Biol, Asamushi, Aomori, Japan; [Miyaoku, Kaori; Nishida, Hiroki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Machikaneyama Cho, Toyonaka, Osaka, Japan	Tohoku University; Osaka University	Miyaoku, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Asamushi Res Ctr Marine Biol, Asamushi, Aomori, Japan.; Miyaoku, K (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Machikaneyama Cho, Toyonaka, Osaka, Japan.	k-mok@dc.tohoku.ac.jp	Nishida, Hiroki/B-1851-2008; Kumano, Gaku/AAE-1527-2019	Nishida, Hiroki/0000-0002-7249-1668; 	Japan Society for the promotion of Sciences [23570252, 15K07071, 22370078]; Ministry of Education, Culture, Sports, Science and Technology [16H01250]	Japan Society for the promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for Scientific Research (KAKENHI) 23570252 and 15K07071, Japan Society for the promotion of Sciences (https://www.jsps.go.jp/english/index.html) and by Grant-in-Aid for Scientific Research (KAKENHI) on Innovative Areas, 'Mechanisms regulating gamete formation in animals' (16H01250), the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/en/), to Gaku Kumano. Also, this study was supported by Grant-in-Aid for Scientific Research (KAKENHI) 22370078, Japan Society for the Promotion of Sciences (https//www.jsps.go.jp/english/index.html), to Hiroki Nishida. These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Asaoka M, 1998, MECH DEVELOP, V78, P153, DOI 10.1016/S0925-4773(98)00164-6; Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Bontems F, 2009, CURR BIOL, V19, P414, DOI 10.1016/j.cub.2009.01.038; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Deshpande G, 1999, CELL, V99, P271, DOI 10.1016/S0092-8674(00)81658-X; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ewen-Campen B, 2010, MOL REPROD DEV, V77, P3, DOI 10.1002/mrd.21091; Fujimura M, 2000, DEV GENES EVOL, V210, P64, DOI 10.1007/s004270050012; Guven-Ozkan T, 2008, CELL, V135, P149, DOI 10.1016/j.cell.2008.07.040; Hanazawa M, 2011, J CELL BIOL, V192, P929, DOI 10.1083/jcb.201010106; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; Hibino T, 1998, DEV GROWTH DIFFER, V40, P85; Iseto T, 1999, DEV GROWTH DIFFER, V41, P601; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kobayashi K, 2003, DEVELOPMENT, V130, P5179, DOI 10.1242/dev.00732; Kumano G., 2014, NEW PRINCIPLES DEV P, P3, DOI 10.1007/978-4-431-54634-4_1.; Kumano G, 2007, DEV DYNAM, V236, P1732, DOI 10.1002/dvdy.21108; Kumano G, 2006, DEV BIOL, V300, P770, DOI 10.1016/j.ydbio.2006.07.033; Kumano G, 2011, CURR BIOL, V21, P1308, DOI 10.1016/j.cub.2011.06.050; Lai F, 2010, DEVELOPMENT, V139, P1476; Leatherman JL, 2002, CURR BIOL, V12, P1681, DOI 10.1016/S0960-9822(02)01182-X; Lemaire P, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150053; Machado RJ, 2005, DEV BIOL, V287, P289, DOI 10.1016/j.ydbio.2005.08.044; Makabe KW, 2012, WIRES DEV BIOL, V1, P501, DOI 10.1002/wdev.54; Makabe KW, 2001, DEVELOPMENT, V128, P2555; Marlow Florence, 2015, F1000Res, V4, DOI 10.12688/f1000research.6995.1; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; MIYA T, 1994, DEV GROWTH DIFFER, V36, P39; Miya T, 1997, DEVELOPMENT, V124, P5149; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Nakamura A, 2010, CURR OPIN CELL BIOL, V22, P709, DOI 10.1016/j.ceb.2010.08.012; Nakamura Y, 2005, DEVELOPMENT, V132, P4731, DOI 10.1242/dev.02049; Nakamura Y, 2003, GENE EXPR PATTERNS, V5, P429; Negishi T, 2007, CURR BIOL, V17, P1014, DOI 10.1016/j.cub.2007.05.047; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; Nishida H, 2001, NATURE, V409, P724, DOI 10.1038/35055568; NISHIKATA T, 1987, DEVELOPMENT, V99, P163; NISHIKATA T, 1987, DEV BIOL, V121, P408, DOI 10.1016/0012-1606(87)90177-1; Paix A, 2011, DEV BIOL, V357, P211, DOI 10.1016/j.ydbio.2011.06.019; Prodon F, 2007, DEV DYNAM, V236, P1968; Robert VJ, 2015, CELL MOL LIFE SCI, V72, P3599, DOI 10.1007/s00018-015-1942-y; Rongo C, 1996, TRENDS GENET, V12, P102, DOI 10.1016/0168-9525(96)81421-1; Sardet C, 2005, BIOL CELL, V97, P35; Sasakura Y, 2000, DEV BIOL, V220, P365, DOI 10.1006/dbio.2000.9626; SATOH N, 1981, J EMBRYOL EXP MORPH, V64, P61; Satoh N., 1994, DEV BIOL ASCIDIANS; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Shirae-Kurabayashi M, 2006, DEVELOPMENT, V133, P2683, DOI 10.1242/dev.02446; Shirae-Kurabayashi M, 2011, DEVELOPMENT, V138, P2871, DOI 10.1242/dev.058131; SMITH KD, 1967, J EXP ZOOL, V164, P393, DOI 10.1002/jez.1401640309; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Strome S, 2015, NAT REV MOL CELL BIO, V16, P406, DOI 10.1038/nrm4009; Swartz SZ, 2014, DEVELOPMENT, V141, P3134, DOI 10.1242/dev.110395; Takamura K, 2002, DEV GENES EVOL, V212, P11, DOI 10.1007/s00427-001-0204-1; Timinszky G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002506; Tomioka M, 2002, ZOOL SCI, V19, P49, DOI 10.2108/zsj.19.49; Venkatarama T, 2010, DEVELOPMENT, V137, P651, DOI 10.1242/dev.038554; WADA S, 1995, MECH DEVELOP, V51, P115, DOI 10.1016/0925-4773(95)00359-9; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Yoshida S, 1996, DEVELOPMENT, V122, P2005; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203	63	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196500	10.1371/journal.pone.0196500	http://dx.doi.org/10.1371/journal.pone.0196500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709000	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100035
J	Naz, R; Nosheen, A; Yasmin, H; Bano, A; Keyani, R				Naz, Rabia; Nosheen, Asia; Yasmin, Humaira; Bano, Asghari; Keyani, Rumana			Botanical-chemical formulations enhanced yield and protection against Bipolaris sorokiniana in wheat by inducing the expression of pathogenesis-related proteins	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; ESSENTIAL OILS; LEAF EXTRACT; RICE; PEROXIDASE; INDUCTION; BLIGHT; PLANT	Two experiments (pot and field experiments) were conducted in two consecutive years to evaluate the protective effects of botanical-chemical formulations on physiological, biochemical performance and grain yield of wheat inoculated with Bipolaris sorokiniana. We compared different formulations comprising Calotropis procera, Jacaranda mimosifolia, Thevetia peruviana extracts, chemical fungicide (mefenoxam) and salicylic acid to modulate the defense system of wheat host plants. Among the selected plant species J. mimosifolia aqueous and methanolic leaf extracts (1.2% w/v) resulted in 96 to 97% inhibition against B. sorokiniana. Both in pot and field experiments, among all the formulations of selected plant extracts the combined formulation of JAF2 (J. mimosifolia 0.6%)+MFF2 (mefenoxam 0.1%) lowered the dose of chemical fungicide required to reduce the leaf spot blotch disease. The same formulation induced resistance in wheat apparently through the accumulation of peroxidase, polyphenol oxidase, protease, acid invertase, chitinase and phenylalanine ammonia lyase. This formulation also stimulated the defense-related gene expression of PR-proteins. The same treatment gave even more increase (48%, 12% and 22%) in no. of grains/spike, grains weight and grain yield, than the MFF1 (mefenoxam 0.2%). We conclude that foliar application of J. mimosifolia leaf extract with very low dose of chemical fungicide (J. mimosifolia 0.6%+mefenoxam 0.1%) is a promising approach for the management of leaf blight and spot blotch in wheat.	[Naz, Rabia; Nosheen, Asia; Yasmin, Humaira; Keyani, Rumana] COMSATS Inst Informat Technol CIIT, Dept Biosci, Islamabad, Pakistan; [Bano, Asghari] Univ Wah, Dept Biosci, Wah Gantt, Pakistan	COMSATS University Islamabad (CUI)	Naz, R (corresponding author), COMSATS Inst Informat Technol CIIT, Dept Biosci, Islamabad, Pakistan.	rabia.naz@comsats.edu.pk	Naz, Rabia/AAI-8801-2020; Keyani, Rumana/AAN-2321-2020; Yasmin, Humaira/ABB-1384-2021; Yasmin, Humaira/AAS-9944-2020; Yasmin, Humaira/AAO-6630-2020	Yasmin, Humaira/0000-0002-4220-4808; Yasmin, Humaira/0000-0002-8738-4216; Naz, Rabia/0000-0002-2716-2267	Higher Education Commission of Pakistan; HEC [074-0998-Av4-036]	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); HEC	The authors express their deep sense of gratitude to the Higher Education Commission of Pakistan for financial support for this research work. The personal identification number (PIN) for this financial support/scholarship from HEC is 074-0998-Av4-036. http://hec.gov.pk/english/pages/home.aspx.	AFTABUDDIN A, 1991, P 1 INT WORKSH COMM, P45; [Anonymous], 1996, STAND EV SYST RIC, V4th; Ashry N. A., 2011, World Journal of Agricultural Sciences, V7, P78; Barkai-Golan R., 2001, POSTHARVEST DIS FRUI, P108, DOI [10.1016/b978-044450584-2/50008-3, DOI 10.1016/B978-044450584-2/50008-3, 10.1016/B978-044450584-2/50007-1]; Bdliya BS, 2008, ARCH PHYTOPATHOLOGY, P1; Biswas SK., 2012, J PLANT PATHOL MICRO, V3, P1, DOI [10.4172/2157-7471.1000128, DOI 10.4172/2157-7471.1000128]; Catinot J, 2008, FEBS LETT, V582, P473, DOI 10.1016/j.febslet.2007.12.039; El-Mougy N. S., 2004, Egyptian Journal of Phytopathology, V32, P23; Gomez K.A., 1984, STAT PROCEDURE AGR R, V2nd; Gong YP, 2001, BOT BULL ACAD SINICA, V42, P259; Gozzo F, 2013, J AGR FOOD CHEM, V61, P12473, DOI 10.1021/jf404156x; Hadi M. R., 2010, American-Eurasian Journal of Agricultural and Environmental Science, V7, P492; Hossain M. M., 2016, Bulletin of the Institute of Tropical Agriculture Kyushu University, V39, P43; Hsu CL, 2003, FOOD CHEM, V83, P85, DOI 10.1016/S0308-8146(03)00053-0; HWANG BK, 1986, PHYTOPATHOLOGY, V76, P365, DOI 10.1094/Phyto-76-365; Iftikhar S, 2006, PAK J BOT, V38, P205; Iram S, 2004, PAKISTAN J BOT, V36, P439; Joseph B., 2008, GLOB J BIOTECH BIOCH, V3, P56; Joshi AK, 2007, FIELD CROP RES, V103, P53, DOI 10.1016/j.fcr.2007.04.010; Kagale S, 2004, PHYSIOL MOL PLANT P, V65, P91, DOI 10.1016/j.pmpp.2004.11.008; Kagale S, 2011, PLANT SIGNAL BEHAV, V6, P919, DOI 10.4161/psb.6.7.15304; Kamalakannan A., 2001, Indian Phytopathology, V54, P490; KAR M, 1976, PLANT PHYSIOL, V57, P315, DOI 10.1104/pp.57.2.315; Kishwar A, 1992, SARHAD J AGR, V8, P541; Koike ST, 2011, USITC PUBL, V7252; Kumar J, 2002, MOL PLANT PATHOL, V3, P185, DOI 10.1046/j.1364-3703.2002.00120.x; Lee SO, 2007, PLANT PATHOLOGY J, V23, P97, DOI 10.25231/pee.2017.23.4.97; Lopes MA, 2008, MYCOL RES, V112, P399, DOI 10.1016/j.mycres.2007.10.017; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martinez J.A., 2012, FUNGICIDES PLANT ANI, V13, P12; MCDONALD CE, 1965, ANAL BIOCHEM, V10, P175, DOI 10.1016/0003-2697(65)90255-1; Nashwa SMA, 2012, PLANT PROTECT SCI, V48, P74, DOI 10.17221/14/2011-PPS; Naz R, 2014, PHYTOPATHOLOGY, V104, P933, DOI 10.1094/PHYTO-11-13-0317-R; Nduagu C., 2008, Journal of Applied Biosciences, V6, P184; Nguefack J, 2004, INT J FOOD MICROBIOL, V94, P329, DOI 10.1016/j.ijfoodmicro.2004.02.017; Paul PK, 2002, PHYSIOL MOL PLANT P, V61, P3, DOI 10.1006/pmpp.2002.0412; Ramirez MG, 2004, J MICROBIOL METH, V56, P213, DOI 10.1016/j.mimet.2003.10.011; Rosyara UR, 2009, J PLANT PATHOL, V91, P113; Saravanakumar D, 2007, CROP PROT, V26, P556, DOI 10.1016/j.cropro.2006.05.007; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Soylu S., 2008, BIOCH RESPONSES PLAN, p33 ; Stangarlin Jose R., 2000, Summa Phytopathologica, V26, P34; Suzuki LS, 2003, PHYTON-ANN REI BOT A, V43, P179; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; VETTER JL, 1958, J AGR FOOD CHEM, V6, P39, DOI 10.1021/jf60083a006; Vimala R., 2009, Journal of Biopesticides, V2, P111; Washington JA, 1980, MANUAL CLIN MICROBIO, V56, P279; Xue L, 1998, PHYTOPATHOLOGY, V88, P359, DOI 10.1094/PHYTO.1998.88.4.359; Yang VW, 2007, INT BIODETER BIODEGR, V59, P302, DOI 10.1016/j.ibiod.2006.09.004	49	14	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196194	10.1371/journal.pone.0196194	http://dx.doi.org/10.1371/journal.pone.0196194			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708983	Green Published, gold, Green Submitted			2022-12-26	WOS:000431130100020
J	Farhangi, MA; Dehghan, P; Jahangiry, L				Farhangi, Mandieh Abbasalizad; Dehghan, Parvin; Jahangiry, Leila			Mental health problems in relation to eating behavior patterns, nutrient intakes and health related quality of life among Iranian female adolescents	PLOS ONE			English	Article							DIETARY PATTERNS; DIFFICULTIES QUESTIONNAIRE; SURVEY SF-36; BODY-IMAGE; HIGH-FAT; DISORDERS; ASSOCIATIONS; RELIABILITY; POPULATION; DEPRESSION	Aims To identify the association between mental health problems, eating behavior patterns, nutrient intakes and health related quality of life (HRQoL) among Iranian female adolescents. Materials and methods The current cross-sectional study conducted among three high-schools randomly selected from 10-day-public high schools in the selected sub-county from Tabriz city-Iran between December 2015 through March 2016. Participants were a sample of 107 adolescent girls aged 15-17 years old. Anthropometric parameters were measured and assessments of HRQoL, mental health problems and eating behavioral patterns were performed by Short Form 36 (SF-36), Strengths and Difficulties Questionnaires (SDQ) and Eating Behavioral Pattern Questionnaire (EBPQ) respectively. Dietary intake was assessed using a semiquantitative Food-Frequency Questionnaire (FFQ) adapted for the Iranian society. Quality of life was measured with HRQoL questionnaire. Quantitative analysis using independent sample t test was performed for comparison of continuous variables between two subgroups (unlikely, possible/ probable) of each category of mental health problem. Multiple logistic regression was used to measure the potential predictors (e. g. eating patterns and HRQoL) of mental health problems in two models of crude and adjusted for age and body mass index (BMI). P values less than 0.05 were considered as statistically significant. Results Indicators of conduct problems and hyperactivity disorders were the most prevalent mental health problems among female adolescents (25.2% and 18.6% respectively). The prevalence of hyperactivity disorders among female adolescents was 35.5%. Female adolescents in high scores of 'snacking and convenience', 'planning ahead' and 'meal skipping' eating patterns were more likely to have indicators of emotional disorders (P < 0.05). Also, being in the high tertile of 'low fat eating' pattern made adolescents less likely to have hyperactivity disorders (P < 0.05). Moreover, according to our finding, high scores of vitality and mental health components of HRQoL were associated with reduced likelihood of emotional disorders, conduct disorders and hyperactivity disorders. No significant difference in terms of BMI and nutrient intakes in different categories of mental health problems according to SDQ scoring was identified. Conclusions In the current study unhealthy eating patterns including 'snacking and convenience', 'planning ahead' and 'meal skipping' eating patterns were positive predictors of "emotional disorders" while "low fat" eating pattern was negative predictor of hyperactivity disorders.	[Farhangi, Mandieh Abbasalizad] Tabriz Univ Med Sci, Nutr Res Ctr, Tabriz, Iran; [Dehghan, Parvin] Tabriz Univ Med Sci, Dept Nutr & Biochem, Drug Appl Res Ctr, Tabriz, Iran; [Jahangiry, Leila] Tabriz Univ Med Sci, Hlth Educ & Hlth Promot Dept, Tabriz Hlth Serv Management Res Ctr, Tabriz, Iran	Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science	Jahangiry, L (corresponding author), Tabriz Univ Med Sci, Hlth Educ & Hlth Promot Dept, Tabriz Hlth Serv Management Res Ctr, Tabriz, Iran.	leilajahangiri1392@yahoo.com	Jahangiry, Leila/F-9880-2017; Farhangi, Mahdieh Abbasalizad/AAC-6758-2019	Jahangiry, Leila/0000-0002-0491-5764; 	Nutrition Research Center, Tabriz University of Medical Sciences	Nutrition Research Center, Tabriz University of Medical Sciences	This research has been supported by a grant from Nutrition Research Center, Tabriz University of Medical Sciences.	Ahmad Ghanizadeh M.D., 2007, IRAN J PSYCHIAT, V2, P65; Alipour B, 2015, EAT WEIGHT DISORD-ST, V20, P465, DOI 10.1007/s40519-015-0184-1; [Anonymous], HLTH PEOPLE 2020 HLT; Atilola O, 2013, J DEV BEHAV PEDIATR, V34, P129, DOI 10.1097/DBP.0b013e31828123a6; Azadbakht L, 2012, NUTRITION, V28, P242, DOI 10.1016/j.nut.2011.05.018; Chin Y. S., 2009, Pakistan Journal of Nutrition, V8, P425; Chisuwa-Hayami N, 2017, HEALTH PROMOT PERSPE, V7, P80, DOI 10.15171/hpp.2017.15; Cortese Samuele, 2012, Curr Top Behav Neurosci, V9, P199, DOI 10.1007/7854_2011_154; Dehghan P, 2015, HEALTH PROMOT PERSPE, V5, P128, DOI 10.15171/hpp.2015.015; Edwards MK, 2017, HEALTH PROMOT PERSPE, V7, P124, DOI 10.15171/hpp.2017.23; Eisenberg N, 2001, CHILD DEV, V72, P1112, DOI 10.1111/1467-8624.00337; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Essel G, THESIS; Farhangi MA, 2016, OBES RES CLIN PRACT, V10, pS64, DOI 10.1016/j.orcp.2015.05.011; Fonseca MJ, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-64; Ghanoonparvar MR, 2006, PERSIAN CUISINE TRAD; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greally P, 2010, ROYAL COLL SURG IREL, V3, P33; Hezomi H, 2018, HEALTH PROMOT PERSPE, V8, P79, DOI 10.15171/hpp.2018.10; Howard AL, 2011, J ATTEN DISORD, V15, P403, DOI 10.1177/1087054710365990; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Jacka FN, 2013, BRIT J NUTR, V109, P2059, DOI 10.1017/S0007114512004102; Jacka FN, 2012, J AFFECT DISORDERS, V141, P79, DOI 10.1016/j.jad.2012.02.018; Jacka FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024805; Jacka FN, 2010, AUST NZ J PSYCHIAT, V44, P435, DOI 10.3109/00048670903571598; Jacques PF, 2001, AM J CLIN NUTR, V73, P1, DOI 10.1093/ajcn/73.1.1; Kaczmarczyk MM, 2013, PSYCHONEUROENDOCRINO, V38, P1553, DOI 10.1016/j.psyneuen.2013.01.004; Kafatos A., 2011, J AM DIET ASSOC, V100, P1487; Kukreti VT, 2013, HEALTH PROMOT PERSPE, V3, P255, DOI 10.5681/hpp.2013.029; Leadbeater BJ, 1999, DEV PSYCHOL, V35, P1268, DOI 10.1037/0012-1649.35.5.1268; Lien L, 2007, PUBLIC HEALTH NUTR, V10, P422, DOI 10.1017/S1368980007258550; Lien L, 2006, AM J PUBLIC HEALTH, V96, P1815, DOI 10.2105/AJPH.2004.059477; Mamplekou E, 2010, J NUTR HEALTH AGING, V14, P449; Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698; Mokhtari M, 2013, J EPIDEMIOL GLOB HEA, V3, P83, DOI 10.1016/j.jegh.2013.02.005; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Montazeri A, 2005, QUAL LIFE RES, V14, P875, DOI 10.1007/s11136-004-1014-5; Noorbala AA, 2004, BRIT J PSYCHIAT, V184, P70, DOI 10.1192/bjp.184.1.70; Oellingrath IM, 2014, PUBLIC HEALTH NUTR, V17, P2554, DOI 10.1017/S1368980013002747; Overby N, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.17231; Phinney JS, 2003, J SOC PSYCHOL, V143, P707, DOI 10.1080/00224540309600426; Plaisted CS, 1999, J AM DIET ASSOC, V99, pS84, DOI 10.1016/S0002-8223(99)00421-6; Polivy J, 2005, CAN J PUBLIC HEALTH, V96, pS43, DOI 10.1007/BF03405201; Ptacek R, 2014, MED SCI MONITOR, V20, P608, DOI 10.12659/MSM.890495; Rabbani Ali, 2012, Acta Med Iran, V50, P169; Racine S, 2011, EATING DISORDERS CHI, P63; Roberts J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-6; Saarni SI, 2007, BRIT J PSYCHIAT, V190, P326, DOI 10.1192/bjp.bp.106.025106; Sarr P. T., 2010, Journal of the National Institute of Public Health, V59, P64; Sawyer MG, 2002, J AM ACAD CHILD PSY, V41, P530, DOI 10.1097/00004583-200205000-00010; Schlack R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-628; Schlundt DG, 2003, J AM DIET ASSOC, V103, P338, DOI 10.1053/jada.2003.50049; Sharifi N, 2013, HEALTH PROMOT PERSPE, V3, P11, DOI 10.5681/hpp.2013.002; Sherina M S, 2004, Med J Malaysia, V59, P207; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weng TT, 2012, PUBLIC HEALTH NUTR, V15, P673, DOI 10.1017/S1368980011003077; WHO, 2000, WOM MENT HLTH EV BAS; World Health Organization, 2017, MENT HLTH MENT DIS; Xiaoli Y, 2014, PLOS ONE, V14; Zervaki K, 2017, NUTR FOOD SCI, V47, P511, DOI [10.1108/NFS-12-2016-0189, 10.1108/nfs-12-2016-0189]	61	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0195669	10.1371/journal.pone.0195669	http://dx.doi.org/10.1371/journal.pone.0195669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1YS	29702683	gold, Green Published, Green Submitted			2022-12-26	WOS:000431013300006
J	Kojola, I; Hallikaine, V; Helle, T; Swenson, JE				Kojola, Ilpo; Hallikaine, Ville; Helle, Timo; Swenson, Jon E.			Can only poorer European countries afford large carnivores?	PLOS ONE			English	Article							ECONOMIC-GROWTH; BIODIVERSITY CONSERVATION; KUZNETS CURVE; POPULATION; RECOVERY; CONFLICT; WILDLIFE; DECLINES	Background One of the classic approaches in environmental economics is the environmental Kuznets curve, which predicts that when a national economy grows from low to medium levels, threats to biodiversity conservation increase, but they decrease when the economy moves from medium to high. We evaluated this approach by examining how population densities of the brown bear (Ursus arctos), gray wolf (Canis lupus), and Eurasian lynx (Lynx lynx) were related to the national economy in 24 European countries. Methodology/Principal findings We used forest proportions, the existence of a compensation system, and country group (former socialist countries, Nordic countries, other countries) as covariates in a linear model with the first-and the second-order polynomial terms of per capita gross domestic product (GDP). Country group was treated as a random factor, but remained insignificant and was ignored. All models concerning brown bear and wolf provided evidence that population densities decreased with increasing GDP, but densities of lynx were virtually independent of GDP. Models for the wolf explained >80% of the variation in densities, without a difference between the models with all independent variables and the model with only GDP. For the bear, the model with GDP alone accounted for 10%, and all three variables 33%, of the variation in densities. Conclusions Wolves exhibit a higher capacity for dispersal and reproduction than bear or lynx, but still exists at the lowest densities in wealthy European countries. We are aware that several other factors, not available for our models, influenced large carnivore densities. Based on the pronounced differences among large carnivore species in their countrywide relationships between densities and GDP, and a strikingly high relationship for the gray wolf, we suggest that our results reflected differences in political history and public acceptance of these species among countries. The compensation paid for the damages caused by the carnivores is not a key to higher carnivore densities, but might be necessity for the presence of large carnivores to be accepted in countries with high GDP.	[Kojola, Ilpo; Hallikaine, Ville] Nat Resources Inst Finland Luke, Rovaniemi, Finland; [Helle, Timo] Rovaniementie 1456, Aska, Finland; [Swenson, Jon E.] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resources Management, Trondheim, Norway; [Swenson, Jon E.] Norwegian Inst Nat Res, Trondheim, Norway	Natural Resources Institute Finland (Luke); Norwegian University of Life Sciences; Norwegian Institute Nature Research	Kojola, I (corresponding author), Nat Resources Inst Finland Luke, Rovaniemi, Finland.	ilpp.kojola@luke.fi	Hallikainen, Ville/E-8766-2013; Swenson, Jon/AAE-2890-2019	Hallikainen, Ville/0000-0001-5384-8265; 				Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Andersen Reidar, 2010, P14; Andersone-Tilley Z, 2010, EUROPEAN UNGULATES T; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boitani Luigi, 2003, P317; Bragina EV, 2015, CONSERV BIOL, V29, P844, DOI 10.1111/cobi.12450; Bragina EV, 2018, FRONTIERS ECOL ENV; Bulte EH, 2005, J WILDLIFE MANAGE, V69, P14, DOI 10.2193/0022-541X(2005)069&lt;0014:WCWDMB&gt;2.0.CO;2; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Christensen R. H. B, 2016, LMER TEST TESTS LINE; Czech B, 2008, CONSERV BIOL, V22, P1389, DOI 10.1111/j.1523-1739.2008.01089.x; Dickman J, 2011, PNAS, V108, P13937, DOI [10.1073/pnas.1012972108, DOI 10.1073/PNAS.1012972108]; Gangaas KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068849; Ginsberg JR, 2001, CONSERV BIOL SER, V5, P498; Kaczensky P, 2013, STATUS MANAGEMENT DI; Kojola I, 2014, WILDLIFE BIOL, V20, P279, DOI 10.2981/wlb.00042; Koop G, 1999, J DEV ECON, V58, P231, DOI 10.1016/S0304-3878(98)00110-2; Kowalczyk R, 2015, MAMMAL RES, V60, P3, DOI 10.1007/s13364-014-0203-z; Kuznets S, 1955, AM ECON REV, V45, P1; Liberg Olof, 2010, P37; Linnell John D.C., 2003, Acta Zoologica Lituanica, V13, P34, DOI 10.1080/13921657.2003.10512541; Loe J, 2004, AMBIO, V33, P283, DOI 10.1639/0044-7447(2004)033[0283:LCAHSA]2.0.CO;2; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Naughton-Treves L, 1999, LAND DEGRAD DEV, V10, P311, DOI 10.1002/(SICI)1099-145X(199907/08)10:4<311::AID-LDR362>3.0.CO;2-3; Nelson Fred, 2009, Human Dimensions of Wildlife, V14, P381, DOI 10.1080/10871200903045228; Nieminen M., 2013, Rangifer, V33, P79; Penteriani V, 2016, SCI REP-UK, V6, DOI 10.1038/srep20552; Persson J, 2015, CONSERV LETT, V8, P345, DOI 10.1111/conl.12171; Polaina E, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00505.1; Putman R., 2011, UNGULATE MANAGEMENT, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Ruusila Vesa, 2010, P86; SELDEN TM, 1994, J ENVIRON ECON MANAG, V27, P147, DOI 10.1006/jeem.1994.1031; SNOWDON P, 1991, CAN J FOREST RES, V21, P720, DOI 10.1139/x91-101; Stern DI, 2004, WORLD DEV, V32, P1419, DOI 10.1016/j.worlddev.2004.03.004; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 2014, SCIENCE, V344, P475, DOI 10.1126/science.1252690; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wawrzyniak Piotr, 2010, P223; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Wotschikowsky Ulrich, 2010, P201	44	10	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0194711	10.1371/journal.pone.0194711	http://dx.doi.org/10.1371/journal.pone.0194711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1YS	29702651	gold, Green Published			2022-12-26	WOS:000431013300002
J	Monesson-Olson, B; McClain, JJ; Case, AE; Dorman, HE; Turkewitz, DR; Steiner, AB; Downes, GB				Monesson-Olson, Bryan; McClain, Jon J.; Case, Abigail E.; Dorman, Hanna E.; Turkewitz, Daniel R.; Steiner, Aaron B.; Downes, Gerald B.			Expression of the eight GABAA receptor a subunits in the developing zebrafish central nervous system	PLOS ONE			English	Article							VERTEBRATE GENOME EVOLUTION; MESSENGER-RNAS; RAT-BRAIN; EPILEPTIC SEIZURES; LARVAL ZEBRAFISH; MUTANT ZEBRAFISH; OLFACTORY-BULB; SPINAL NEURONS; MAUTHNER CELLS; KNOCKOUT MICE	GABA is a robust regulator of both developing and mature neural networks. It exerts many of its effects through GABA(A) receptors, which are heteropentamers assembled from a large array of subunits encoded by distinct genes. In mammals, there are 19 different GABA(A) subunit types, which are divided into the alpha, beta, gamma, delta, epsilon, Pi, theta and rho subfamilies. The immense diversity of GABA(A) receptors is not fully understood. However, it is known that specific isoforms, with their distinct biophysical properties and expression profiles, tune responses to GABA. Although larval zebrafish are well-established as a model system for neural circuit analysis, little is known about GABA(A) receptors diversity and expression in this system. Here, using database analysis, we show that the zebrafish genome contains at least 23 subunits. All but the mammalian theta and epsilon subunits have at least one zebrafish ortholog, while five mammalian GABA(A) receptor subunits have two zebrafish orthologs. Zebrafish contain one subunit, 134, which does not have a clear mammalian ortholog. Similar to mammalian GABA(A) receptors, the zebrafish a subfamily is the largest and most diverse of the subfamilies. In zebrafish there are eight a subunits, and RNA in situ hybridization across early zebrafish development revealed that they demonstrate distinct patterns of expression in the brain, spinal cord, and retina. Some subunits were very broadly distributed, whereas others were restricted to small populations of cells. Subunit-specific expression patterns in zebrafish resembled were those found in frogs and rodents, which suggests that the roles of different GABA(A) receptor isoforms are largely conserved among vertebrates. This study provides a platform to examine isoform specific roles of GABA(A) receptors within zebrafish neural circuits and it highlights the potential of this system to better understand the remarkable heterogeneity of GABA(A) receptors.	[Monesson-Olson, Bryan; Downes, Gerald B.] Univ Massachusetts, Neurosci & Behav Grad Program, Amherst, MA 01003 USA; [Monesson-Olson, Bryan; McClain, Jon J.; Case, Abigail E.; Dorman, Hanna E.; Downes, Gerald B.] Univ Massachusetts, Biol Dept, Amherst, MA 01003 USA; [Turkewitz, Daniel R.; Steiner, Aaron B.] Pace Univ, Dept Biol & Hlth Sci, Pleasantville, NY USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Pace University	Downes, GB (corresponding author), Univ Massachusetts, Neurosci & Behav Grad Program, Amherst, MA 01003 USA.; Downes, GB (corresponding author), Univ Massachusetts, Biol Dept, Amherst, MA 01003 USA.	gbdownes@bio.umass.edu		Case, Abigail/0000-0001-7563-492X; Steiner, Aaron/0000-0002-6120-9671	University of Massachusetts Faculty Research/Healey Endowment Grant; National Science Foundation [1456866]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R15DC015352] Funding Source: NIH RePORTER	University of Massachusetts Faculty Research/Healey Endowment Grant; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a University of Massachusetts Faculty Research/Healey Endowment Grant and National Science Foundation Grant 1456866. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baxendale S, 2012, DIS MODEL MECH, V5, P773, DOI 10.1242/dmm.010090; BERNHARDT RR, 1992, J COMP NEUROL, V326, P263, DOI 10.1002/cne.903260208; BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; Bowery NG, 2006, BRIT J PHARMACOL, V147, pS109, DOI 10.1038/sj.bjp.0706443; Chua HC, 2017, ADV PHARMACOL, V79, P1, DOI 10.1016/bs.apha.2017.03.003; Cocco A, 2017, NEUROSCIENCE, V343, P300, DOI 10.1016/j.neuroscience.2016.07.018; Connaughton VP, 2008, VISUAL NEUROSCI, V25, P139, DOI 10.1017/S0952523808080322; Cunliffe VT, 2016, J NEUROSCI METH, V260, P91, DOI 10.1016/j.jneumeth.2015.07.015; Darlison MG, 2005, CELL MOL NEUROBIOL, V25, P607, DOI 10.1007/s10571-005-4004-4; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; Delgado-Lezama R, 2013, CURR PHARM DESIGN, V19, P4485, DOI 10.2174/1381612811319240013; Downes GB, 2002, GENESIS, V34, P196, DOI 10.1002/gene.10120; Egawa K, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00170; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fetcho JR, 2008, BRAIN RES REV, V57, P86, DOI 10.1016/j.brainresrev.2007.06.018; Folgueira M, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-32; Friedrich RW, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00071; Fritschy JM, 2014, EUR J NEUROSCI, V39, P1845, DOI 10.1111/ejn.12534; Gonzalez-Nunez V., 2015, BIOCH BIOPHYS REPORT, V3, P11; Griffin A, 2016, PROG BRAIN RES, V226, P195, DOI 10.1016/bs.pbr.2016.03.012; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hale ME, 2016, J NEUROGENET, V30, P89, DOI 10.1080/01677063.2016.1182526; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Hortopan GA, 2010, J NEUROSCI, V30, P13718, DOI 10.1523/JNEUROSCI.1887-10.2010; Hubbard JM, 2016, CURR BIOL, V26, P2841, DOI 10.1016/j.cub.2016.08.026; Kaeser GE, 2011, DEV DYNAM, V240, P862, DOI 10.1002/dvdy.22580; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Mack-Bucher JA, 2007, EUR J NEUROSCI, V25, P460, DOI 10.1111/j.1460-9568.2006.05290.x; Marquart GD, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00078; Martyniuk CJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000894; McLean DL, 2011, CURR OPIN NEUROBIOL, V21, P110, DOI 10.1016/j.conb.2010.09.011; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; Mueller T, ATLAS EARLY ZEBRAFIS, pxiii, DOI [10.1186/1749-8104-7-32, DOI 10.1186/1749-8104-7-32]; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Peng ZC, 2014, NEUROCHEM RES, V39, P1104, DOI 10.1007/s11064-013-1202-1; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Randlett O, 2015, NAT METHODS, V12, P1039, DOI 10.1038/NMETH.3581; Ronneberger O, 2012, NAT METHODS, V9, P735, DOI [10.1038/NMETH.2076, 10.1038/nmeth.2076]; Roy B, 2014, NEUROREPORT, V25, P1232, DOI 10.1097/WNR.0000000000000258; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Simon J, 2004, J BIOL CHEM, V279, P41422, DOI 10.1074/jbc.M401354200; Sinkkonen ST, 2000, J NEUROSCI, V20, P3588, DOI 10.1523/JNEUROSCI.20-10-03588.2000; Stehr CM, 2006, TOXICOL SCI, V92, P270, DOI 10.1093/toxsci/kfj185; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tretter V, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.007.2008; Triller A, 1997, NEUROSCIENCE, V80, P133, DOI 10.1016/S0306-4522(97)00092-4; Tsang SY, 2007, MOL BIOL EVOL, V24, P599, DOI 10.1093/molbev/msl188; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wolman M, 2012, DEV NEUROBIOL, V72, P366, DOI 10.1002/dneu.20872	60	26	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196083	10.1371/journal.pone.0196083	http://dx.doi.org/10.1371/journal.pone.0196083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702678	gold, Green Submitted, Green Published			2022-12-26	WOS:000431013300018
J	Pejakovic, S; Wiggers, L; Coupeau, D; Kirschvink, N; Mason, J; Muylkens, B				Pejakovic, Srdan; Wiggers, Laetitia; Coupeau, Damien; Kirschvink, Nathalie; Mason, James; Muylkens, Benoit			Test selection for antibody detection according to the seroprevalence level of Schmallenberg virus in sheep	PLOS ONE			English	Article							BELGIUM; DISEASE; CATTLE	Schmallenberg virus (SBV), initially identified in Germany in 2011, spread rapidly throughout Europe causing significant economic losses in ruminant livestock. The ability to correctly detect emerging and re-emerging diseases such as SBV with reliable tests is of high importance. Firstly, we tested diagnostic performance, specificity, and sensitivity of three different assays used in SBV antibody detection using control sheep samples of determined status. After obtaining the results from the control samples, we assessed the potential of the assays to detect previously infected animals in field situations. The samples were investigated using IDEXX Schmallenberg virus Antibody Test Kit, ID Screen Schmallenberg virus Competition Multi-species ELISA and Serum Neutralisation Test (SNT). Analysis of control samples revealed that SNT was the most suitable test, which was therefore used to calculate concordance and test performance for the two other ELISA tests. To evaluate whether different assay performances had an impact under field conditions, sheep samples from two different contexts were tested: the emergence of SBV in Ireland and the re-emergence of SBV in Belgium. Comparing the results obtained from different assays to the non-reference standard assay SNT, we showed considerable differences in estimates of their sensitivity to detect SBV antibodies and to measure seroprevalence of the sheep flocks. Finally, a calculation of the number of randomly selected animals that needs to be screened from a finite flock, showed that SNT and ID.Vet are the most suitable to detect an introduction of the disease in low seroprevalence situations. The IDEXX ELISA test was only able to detect SBV antibodies in a higher seroprevalence context, which is not optimal for monitoring freedom of disease and surveillance studies.	[Pejakovic, Srdan; Wiggers, Laetitia; Coupeau, Damien; Kirschvink, Nathalie; Muylkens, Benoit] Univ Namur, NAmur Res Inst Life Sci NARILIS, Namur, Belgium; [Pejakovic, Srdan; Wiggers, Laetitia; Coupeau, Damien; Kirschvink, Nathalie; Muylkens, Benoit] Univ Namur, Fac Sci, Dept Vet Med, Integrated Vet Res Unit, Namur, Belgium; [Mason, James] Univ Dublin, Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	University of Namur; University of Namur; Trinity College Dublin	Muylkens, B (corresponding author), Univ Namur, NAmur Res Inst Life Sci NARILIS, Namur, Belgium.; Muylkens, B (corresponding author), Univ Namur, Fac Sci, Dept Vet Med, Integrated Vet Res Unit, Namur, Belgium.	benoit.muylkens@unamur.be		Pejakovic, Srdan/0000-0003-1739-1610; Kirschvink, Nathalie/0000-0003-1788-4212				Barrett D, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0564-9; Breard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053446; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Claine F, 2013, EMERG INFECT DIS, V19, P1115, DOI 10.3201/eid1907.121768; Conlan AJK, 2012, VET REC, V171, P540, DOI [10.1136/vr.e7928, 10.1136/vr.e7878]; Coupeau D, 2016, ARCH VIROL, V161, P1353, DOI 10.1007/s00705-016-2787-x; De Regge N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087005; Delooz L, 2017, TRANSBOUND EMERG DIS, V64, P1641, DOI 10.1111/tbed.12552; Harris KA, 2014, VET REC, V175, P172, DOI 10.1136/vr.102295; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; IDEXX Laboratories Inc, IDEXX SCHMALL AB TES; Loeffen W, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-44; Mansfield KL, 2013, J VIROL METHODS, V188, P139, DOI 10.1016/j.jviromet.2012.11.031; Martinelle L, 2014, TRANSBOUND EMERG DIS, V61, P285, DOI 10.1111/tbed.12030; Meroc E, 2013, TRANSBOUND EMERG DIS, V60, P4, DOI 10.1111/tbed.12042; Poskin A, 2016, VET MICROBIOL, V183, P50, DOI 10.1016/j.vetmic.2015.11.036; Rasmussen LD, 2012, EMERG INFECT DIS, V18, P1204, DOI 10.3201/eid1807.120385; Saegerman C, 2014, TRANSBOUND EMERG DIS, V61, P469, DOI 10.1111/tbed.12047; van den Brom R, 2012, TIJDSCHR DIERGENEESK, V137, P106; van der Poel WHM, 2014, VET REC, V174, P380, DOI 10.1136/vr.102180; Weaver DM, 2000, J VET INTERN MED, V14, P569, DOI 10.1892/0891-6640(2000)014&lt;0569:PTOCII&gt;2.3.CO;2; Wernike K, 2017, TRANSBOUND EMERG DIS, V64, P1405, DOI 10.1111/tbed.12517; Wernike K, 2015, EMERG INFECT DIS, V21, P1202, DOI 10.3201/eid2107.150180	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196532	10.1371/journal.pone.0196532	http://dx.doi.org/10.1371/journal.pone.0196532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702694	Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300037
J	Fanfani, F; Monterossi, G; Ghizzoni, V; Rossi, ED; Dinoi, G; Inzani, F; Fagotti, A; Alletti, SG; Scarpellini, F; Nero, C; Santoro, A; Scambia, G; Zannoni, GF				Fanfani, Francesco; Monterossi, Giorgia; Ghizzoni, Viola; Rossi, Esther D.; Dinoi, Giorgia; Inzani, Frediano; Fagotti, Anna; Alletti, Salvatore Gueli; Scarpellini, Francesca; Nero, Camilla; Santoro, Angela; Scambia, Giovanni; Zannoni, Gian F.			One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer	PLOS ONE			English	Article							PROSPECTIVE MULTICENTER; MAPPING ALGORITHM; SENTI-ENDO; SURVIVAL; LYMPHADENECTOMY; INCLUSIONS; STRATEGIES; BIOPSY; TRIAL; ASSAY	Introduction The aim of the current study is to evaluate the detection rate of micro- and macro-metastases of the One-Step Nucleic Acid Amplification (OSNA) compared to frozen section examination and subsequent ultra-staging examination in early stage endometrial cancer (EC). Material and methods From March 2016 to June 2016, data of 40 consecutive FIGO stage I EC patients were prospectively collected in an electronic database. The sentinel lymph node mapping was performed in all patients. All mapped nodes were removed and processed. Sentinel lymph nodes were sectioned and alternate sections were respectively examined by OSNA and by frozen section analysis. After frozen section, the residual tissue from each block was processed with step-level sections (each step at 200 micron) including H&E and IHC slides. Results Sentinel lymph nodes mapping was successful in 29 patients (72.5%). In the remaining 11 patients (27.5%), a systematic pelvic lymphadenectomy was performed. OSNA assay sensitivity and specificity were 87.5% and 100% respectively. Positive and negative predictive values were 100% and 99% respectively, with a diagnostic accuracy of 99%. As far as frozen section examination and subsequent ultra-staging analysis was concerned, we reported sensitivity and specificity of 50% and 94.4% respectively; positive and negative predictive values were 14.3% and 99%, respectively, with an accuracy of 93.6%. In one patient, despite negative OSNA and frozen section analysis of the sentinel node, a macro-metastasis in 1 non-sentinel node was found. Conclusions The combination of OSNA procedure with the sentinel lymph node mapping could represent an efficient intra-operative tool for the selection of early-stage EC patients to be submitted to systematic lymphadenectomy.	[Fanfani, Francesco] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Monterossi, Giorgia; Ghizzoni, Viola; Dinoi, Giorgia; Fagotti, Anna; Alletti, Salvatore Gueli; Nero, Camilla; Scambia, Giovanni] Univ Cattolica Sacro Cuore, Dept Women & Child Hlth, Div Gynecol Oncol, Rome, Italy; [Rossi, Esther D.; Inzani, Frediano; Scarpellini, Francesca; Santoro, Angela; Zannoni, Gian F.] Univ Cattolica Sacro Cuore, Dept Women & Child Hlth, Gynecol Oncol Pathol Unit, Rome, Italy	G d'Annunzio University of Chieti-Pescara; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Fanfani, F (corresponding author), Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy.	francesco.fanfani@unich.it	fagotti, anna AF/K-5233-2018; Santoro, Angela/AAC-5833-2022; Rossi, esther/R-8601-2017; Nero, Camilla/AAB-3854-2019; santoro, angela/AAC-2025-2019; Zannoni, Gian Franco/AAC-4754-2020; Monterossi, Giorgia/AAB-7427-2019; Inzani, Frediano/K-2091-2018; Alletti, Salvatore Gueli/K-5682-2018; Fanfani, Francesco/Q-1154-2015	santoro, angela/0000-0002-6964-5152; Zannoni, Gian Franco/0000-0002-4473-7560; Alletti, Salvatore Gueli/0000-0003-3886-3007; Nero, Camilla/0000-0002-4442-4046; Rossi, Esther/0000-0003-3819-4229; Fanfani, Francesco/0000-0003-1991-7284				Abu-Rustum NR, 2013, ANN SURG ONCOL, V20, P353, DOI 10.1245/s10434-012-2685-8; Abu-Rustum NR, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.010; Altgassen C, 2009, GYNECOL ONCOL, V114, P284, DOI 10.1016/j.ygyno.2009.04.020; Ballester M, 2011, LANCET ONCOL, V12, P469, DOI 10.1016/S1470-2045(11)70070-5; Barlin JN, 2012, GYNECOL ONCOL, V125, P531, DOI 10.1016/j.ygyno.2012.02.021; Buda A, 2017, GYNECOL ONCOL, V147, P528, DOI 10.1016/j.ygyno.2017.09.033; Buda A, 2016, J MINIM INVAS GYN, V23, P265, DOI 10.1016/j.jmig.2015.09.022; Darin MC, 2016, J MINIM INVAS GYN, V23, P186, DOI 10.1016/j.jmig.2015.10.011; Chaudhry A, 2014, EJSO-EUR J SURG ONC, V40, P150, DOI 10.1016/j.ejso.2013.12.007; Darai E, 2015, GYNECOL ONCOL, V136, P54, DOI 10.1016/j.ygyno.2014.09.011; Delpech Y, 2008, SURG ONCOL, V17, P237, DOI 10.1016/j.suronc.2008.04.001; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Guller U, 2012, CANCER-AM CANCER SOC, V118, P6039, DOI 10.1002/cncr.27667; HORN LC, 1995, PATHOL RES PRACT, V191, P991, DOI 10.1016/S0344-0338(11)80597-2; Kim CH, 2013, INT J GYNECOL CANCER, V23, P964, DOI 10.1097/IGC.0b013e3182954da8; Kim HS, 2012, JPN J CLIN ONCOL, V42, P405, DOI 10.1093/jjco/hys019; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Koh WJ, 2015, J NATL COMPR CANC NE, V13, P1321, DOI 10.6004/jnccn.2015.0162; Kurman R.J., 2014, WHO CLASSIFICATION T, V4th; Lopez-Ruiz ME, 2016, GYNECOL ONCOL, V143, P54, DOI 10.1016/j.ygyno.2016.07.106; Nagai T, 2015, ANN SURG ONCOL, V22, P980, DOI 10.1245/s10434-014-4038-2; Nakagawa K, 2016, LUNG CANCER, V97, P1, DOI 10.1016/j.lungcan.2016.03.015; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Schiavone MB, 2016, ANN SURG ONCOL, V23, P196, DOI 10.1245/s10434-015-4612-2; Sinno AK, 2016, GYNECOL ONCOL, V143, P281, DOI 10.1016/j.ygyno.2016.08.323; Stewart CJR, 2011, INT J GYNECOL PATHOL, V30, P484, DOI 10.1097/PGP.0b013e3182158944; Szychta P, 2016, ARCH MED SCI, V12, P1239, DOI 10.5114/aoms.2016.62902; TAZELAAR HD, 1986, HUM PATHOL, V17, P100, DOI 10.1016/S0046-8177(86)80166-6; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Yaguchi Y, 2011, ANN SURG ONCOL, V18, P2289, DOI 10.1245/s10434-011-1591-9; Yamamoto H, 2016, ANN SURG ONCOL, V23, P391, DOI 10.1245/s10434-015-4880-x	32	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195877	10.1371/journal.pone.0195877	http://dx.doi.org/10.1371/journal.pone.0195877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698418	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600021
J	Gervasi, F; Ferrante, P; Dettori, MT; Scortichini, M; Verde, I				Gervasi, Fabio; Ferrante, Patrizia; Dettori, Maria Teresa; Scortichini, Marco; Verde, Ignazio			Transcriptome reprogramming of resistant and susceptible peach genotypes during Xanthomonas arboricola pv. pruni early leaf infection	PLOS ONE			English	Article							DIFFERENTIALLY-EXPRESSED GENES; HOST-PATHOGEN INTERACTIONS; RNA-SEQ; DEFENSE RESPONSES; ARABIDOPSIS-THALIANA; PLANT IMMUNITY; HYDROGEN-PEROXIDE; BACTERIAL-INFECTION; PROTEIN-KINASE; TOMATO DC3000	Bacterial spot caused by Xanthomonas arboricola pv. pruni (Xap) is a major threat to Prunus species worldwide. The molecular mechanisms of peach resistance to Xap during early leaf infection were investigated by RNA-Seq analysis of two Prunus persica cultivars, 'Redkist' (resistant), and 'JH Hale' (susceptible) at 30 minutes, 1 and 3 hours-post-infection (hpi). Both cultivars exhibited extensive modulation of gene expression at 30 mpi, which reduced significantly at 1 hpi, increasing again at 3 hpi. Overall, 714 differentially expressed genes (DEGs) were detected in 'Redkist' (12% at 30 mpi and 1 hpi and 88% at 3 hpi). In 'JH Hale', 821 DEGs were identified (47% at 30 mpi and 1 hpi and 53% at 3 hpi). Highly up-regulated genes (fold change > 100) at 3 hpi exhibited higher fold change values in 'Redkist' than in 'JH Hale'. RNA-Seq bioinformatics analyses were validated by RT-qPCR. In both cultivars, DEGs included genes with putative roles in perception, signal transduction, secondary metabolism, and transcription regulation, and there were defense responses in both cultivars, with enrichment for the gene ontology terms, 'immune system process', 'defense response', and 'cell death'. There were particular differences between the cultivars in the intensity and kinetics of modulation of expression of genes with putative roles in transcriptional activity, secondary metabolism, photosynthesis, and receptor and signaling processes. Analysis of differential exon usage (DEU) revealed that both cultivars initiated remodeling their transcriptomes at 30 mpi; however, 'Redkist' exhibited alternative exon usage for a greater number of genes at every time point compared with 'JH Hale'. Candidate resistance genes (WRKY-like, CRK-like, Copper amine oxidase-like, and TIR-NBS-LRR-like) are of interest for further functional characterization with the aim of elucidating their role in Prunus spp. resistance to Xap.	[Gervasi, Fabio; Ferrante, Patrizia; Dettori, Maria Teresa; Scortichini, Marco; Verde, Ignazio] Ctr Olivicoltura Frutticoltura & Agrumicoltura CR, Consiglio Ric Agr & Analisi Econ Agr CREA, Rome, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Verde, I (corresponding author), Ctr Olivicoltura Frutticoltura & Agrumicoltura CR, Consiglio Ric Agr & Analisi Econ Agr CREA, Rome, Italy.	ignazio.verde@crea.gov.it	Verde, Ignazio/K-6348-2019	FERRANTE, PATRIZIA/0000-0001-7577-9096; Verde, Ignazio/0000-0002-9139-955X	Ministero delle Politiche Agricole Alimentari e Forestali -Italy (MiPAAF) [DM14999/7303/08, DM 11960//7742/2010]	Ministero delle Politiche Agricole Alimentari e Forestali -Italy (MiPAAF)	This work was supported by the Ministero delle Politiche Agricole Alimentari e Forestali -Italy (MiPAAF, http://www.politcheagricole.it) through the projects "DRUPOMICS" (Grant # DM14999/7303/08) and RESPAT (Grant # DM 11960//7742/2010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034954; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Angelini R, 2010, PLANT PHYSIOL BIOCH, V48, P560, DOI 10.1016/j.plaphy.2010.02.001; [Anonymous], 2006, B OEPP, V36, P129, DOI DOI 10.1111/j.1365-2338.2006.00925.x; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Biondi E., 2009, IOBC/WPRS Bulletin, V43, P277; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bolwell GP, 1997, PHYSIOL MOL PLANT P, V51, P347, DOI 10.1006/pmpp.1997.0129; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Chen KG, 2003, PLANT MOL BIOL, V53, P61, DOI 10.1023/B:PLAN.0000009265.72567.58; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen M, 2016, MOL GENET GENOMICS, V291, P1319, DOI 10.1007/s00438-016-1171-6; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Czernic P, 1999, PLANT J, V18, P321, DOI 10.1046/j.1365-313X.1999.00447.x; Daurelio LD, 2011, J PLANT PHYSIOL, V168, P382, DOI 10.1016/j.jplph.2010.07.014; de Torres M, 2003, PLANT J, V33, P665, DOI 10.1046/j.1365-313X.2003.01653.x; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Encinas-Villarejo S, 2009, J EXP BOT, V60, P3043, DOI 10.1093/jxb/erp152; Frampton R. A., 2012, INT J MICROBIOL, V2012, DOI [10.1155/2012/326452, DOI 10.1155/2012/326452]; Fu XZ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-55; Gassmann W, 2008, CURR TOP MICROBIOL, V326, P219; Grewal RK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-49; Howard BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074183; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Jones JB, 2007, ANNU REV PHYTOPATHOL, V45, P245, DOI 10.1146/annurev.phyto.45.062806.094411; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Katagiri F, 2004, CURR OPIN PLANT BIOL, V7, P506, DOI 10.1016/j.pbi.2004.07.013; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Keil H. L., 1974, Fruit Varieties Journal, V28, P16; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kim DS, 2014, J EXP BOT, V65, P2295, DOI 10.1093/jxb/eru109; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Kunjeti SG, 2012, MOL PLANT PATHOL, V13, P454, DOI 10.1111/j.1364-3703.2011.00761.x; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Lewis LA, 2015, PLANT CELL, V27, P3038, DOI 10.1105/tpc.15.00471; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodha TD, 2012, MOL BIOTECHNOL, V50, P87, DOI 10.1007/s12033-011-9418-2; Marini F, 2001, NEW PHYTOL, V149, P301, DOI 10.1046/j.1469-8137.2001.00017.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Okie W. R., 2008, The peach: botany, production and uses, P139, DOI 10.1079/9781845933869.0139; Okie W. R., 1998, AGR HDB, V714; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Ramonell KM, 2002, MOL PLANT PATHOL, V3, P301, DOI 10.1046/j.1364-3703.2002.00123.x; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Rubio M, 2015, MOL PLANT PATHOL, V16, P164, DOI 10.1111/mpp.12169; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Scortichini M, 1996, J PHYTOPATHOL, V144, P69, DOI 10.1111/j.1439-0434.1996.tb01491.x; Scortichini M, 2010, J PLANT PATHOL, V92, pS73; Seyfferth C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00697; Sherif S, 2012, J PLANT PHYSIOL, V169, P731, DOI 10.1016/j.jplph.2012.02.003; Sherif S, 2012, PLANT CELL REP, V31, P697, DOI 10.1007/s00299-011-1188-6; Simeone A. M., 1985, ACTA HORTIC, V173, P541; Socquet-Juglard D, 2012, J PLANT PATHOL, V94, DOI 10.4454/jpp.v94i1sup.015; Socquet-Juglard D, 2013, TREE GENET GENOMES, V9, P409, DOI 10.1007/s11295-012-0562-z; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Staiger D, 2013, NEW PHYTOL, V197, P394, DOI 10.1111/nph.12022; Strauss T, 2012, P NATL ACAD SCI USA, V109, P19480, DOI 10.1073/pnas.1212415109; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; van Verk MC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-88; Verde I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3606-9; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; WERNER DJ, 1986, HORTSCIENCE, V21, P127; Wise RP, 2007, ANNU REV PHYTOPATHOL, V45, P329, DOI 10.1146/annurev.phyto.45.011107.143944; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yang NN, 2013, TREE GENET GENOMES, V9, P573, DOI 10.1007/s11295-012-0580-x; Yang SM, 2014, INT J MOL SCI, V15, P10424, DOI 10.3390/ijms150610424; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Yoda H, 2003, PLANT PHYSIOL, V132, P1973, DOI 10.1104/pp.103.024737; Yoda H, 2009, PLANT MOL BIOL, V70, P103, DOI 10.1007/s11103-009-9459-0; Yoshioka H, 2008, PLANT SIGNAL BEHAV, V3, P153, DOI 10.4161/psb.3.3.5537; Yu C, 2014, RICE, V7, DOI 10.1186/s12284-014-0020-7; Zhu Q, 1996, CURR OPIN GENET DEV, V6, P624, DOI 10.1016/S0959-437X(96)80093-1; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	83	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196590	10.1371/journal.pone.0196590	http://dx.doi.org/10.1371/journal.pone.0196590			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698473	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600104
J	Huang, HS; Deng, JZ; Lan, YB; Yang, AQ; Deng, XL; Zhang, L				Huang, Huasheng; Deng, Jizhong; Lan, Yubin; Yang, Aqing; Deng, Xiaoling; Zhang, Lei			A fully convolutional network for weed mapping of unmanned aerial vehicle (UAV) imagery	PLOS ONE			English	Article								Appropriate Site Specific Weed Management (SSWM) is crucial to ensure the crop yields. Within SSWM of large-scale area, remote sensing is a key technology to provide accurate weed distribution information. Compared with satellite and piloted aircraft remote sensing, unmanned aerial vehicle (UAV) is capable of capturing high spatial resolution imagery, which will provide more detailed information for weed mapping. The objective of this paper is to generate an accurate weed cover map based on UAV imagery. The UAV RGB imagery was collected in 2017 October over the rice field located in South China. The Fully Convolutional Network (FCN) method was proposed for weed mapping of the collected imagery. Transfer learning was used to improve generalization capability, and skip architecture was applied to increase the prediction accuracy. After that, the performance of FCN architecture was compared with Patch_based CNN algorithm and Pixel_based CNN method. Experimental results showed that our FCN method outperformed others, both in terms of accuracy and efficiency. The overall accuracy of the FCN approach was up to 0.935 and the accuracy for weed recognition was 0.883, which means that this algorithm is capable of generating accurate weed cover maps for the evaluated UAV imagery.	[Huang, Huasheng; Deng, Jizhong; Lan, Yubin] South China Agr Univ, Coll Engn, Guangzhou, Guangdong, Peoples R China; [Huang, Huasheng; Deng, Jizhong; Lan, Yubin; Deng, Xiaoling; Zhang, Lei] Natl Ctr Int Collaborat Res Precis Agr Aviat Pest, Guangzhou, Guangdong, Peoples R China; [Yang, Aqing; Deng, Xiaoling] South China Agr Univ, Coll Elect Engn, Guangzhou, Guangdong, Peoples R China; [Zhang, Lei] South China Agr Univ, Coll Agr, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University; South China Agricultural University	Lan, YB (corresponding author), South China Agr Univ, Coll Engn, Guangzhou, Guangdong, Peoples R China.; Lan, YB (corresponding author), Natl Ctr Int Collaborat Res Precis Agr Aviat Pest, Guangzhou, Guangdong, Peoples R China.	ylan@scau.edu.cn	Lan, Yubin/W-3695-2018		National Key Research and Development Plan: High Efficient Ground and Aerial Spraying Technology and Intelligent Equipment, China [2016YFD0200700]; Ministry of Agriculture of the People's Republic of China; Science and Technology Planning Project of Guangdong Province, China [2017A020208046]; Department of Science and Technology of Guangdong Province, China; National Natural Science Fund, China [61675003]; National Natural Science Foundation of China	National Key Research and Development Plan: High Efficient Ground and Aerial Spraying Technology and Intelligent Equipment, China; Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); Science and Technology Planning Project of Guangdong Province, China; Department of Science and Technology of Guangdong Province, China; National Natural Science Fund, China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: 1. the National Key Research and Development Plan: High Efficient Ground and Aerial Spraying Technology and Intelligent Equipment, China; grant number: 2016YFD0200700; http://service.most.gov.crit2015trtg_all/20160622/1108.html; funding institution: Ministry of Agriculture of the People's Republic of China; the author receiving the funding: Yubin Lan; role of funder in this study: study design, decision to publish. 2: Science and Technology Planning Project of Guangdong Province, China; grant number: 2017A020208046; http://www.gdstc.gov.cni; funding institution: Department of Science and Technology of Guangdong Province, China; the author receiving the funding: Jizhong Deng; role of funder in this study: study design, decision to publish. 3: The National Natural Science Fund, China; grant number: 61675003; http://www.nsfc.gov.cn/publish/portal0/; funding institution: National Natural Science Foundation of China; the author receiving the funding: Xiaoling Deng; role of funder in this study: study design, preparation of the manuscript.	Alexandridis T., 2017, SENSORS, V17, P2007; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bejiga MB, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9020100; Castaldi F, 2017, PRECIS AGRIC, V18, P76, DOI 10.1007/s11119-016-9468-3; Castro A.I., 2012, PRECIS AGRIC, V13, P302; Csurka G, 2013, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2013, DOI 10.5244/C.27.32; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Donahue J., 2013, ARXIV13101531, P647; Fu G, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9050498; Gao Z, 2017, IEEE J BIOMEDICAL HL, V91-9; Hu F, 2015, REMOTE SENS-BASEL, V7, P14680, DOI 10.3390/rs71114680; Koger CH, 2003, WEED TECHNOL, V17, P696, DOI 10.1614/WT02-122; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lan YB, 2010, COMPUT ELECTRON AGR, V74, P34, DOI 10.1016/j.compag.2010.07.001; Langkvist M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8040329; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Lopez-Granados F, 2016, PRECIS AGRIC, V17, P183, DOI 10.1007/s11119-015-9415-8; Maggiori E, 2016, ARXIV161101962, P11; Maggiori E, 2017, IEEE T GEOSCI REMOTE, V55, P645, DOI 10.1109/TGRS.2016.2612821; Pena JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077151; Mnih V., 2013, THESIS; Perez-Ortiz M, 2015, APPL SOFT COMPUT, V37, P533, DOI 10.1016/j.asoc.2015.08.027; Schwartz AM, 1998, J AM MOSQUITO CONTR, V14, P78; Sherrah J., 2016, ARXIV160602585, P9; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Tamouridou AA, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102307; Yu J, 2016, PESTIC BIOCH PHYS	30	70	73	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196302	10.1371/journal.pone.0196302	http://dx.doi.org/10.1371/journal.pone.0196302			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698500	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600059
J	Jeong, J; Kim, G; Moon, C; Kim, HJ; Kim, TH; Jang, J				Jeong, Jinsun; Kim, Guehye; Moon, Cheol; Kim, Hyun Jung; Kim, Tae Ho; Jang, Jichan			Pathogen Box screening for hit identification against Mycobacterium abscessus	PLOS ONE			English	Article							TUBERCULOSIS; RESISTANCE; INFECTION; GENE	Mycobacterium abscessus is a rapidly growing life-threatening mycobacterium with multiple drug-resistance mechanisms. However, there is no official regimen for M. abscessus therapy. In this study, we screened the Pathogen Box, which contains 400 drug-like molecules active against neglected diseases, to identify active molecules targeting Mycobacterium abscessus using resazurin live/dead assays. In this screening assay, the Z-factor was 0.7, as an indicator of the statistical confidence of the assay. A cut-off of 80% growth inhibition in the screening resulted in the identification of four different compounds at a single concentration (20 mu M). Dose-response curves identified three different hit candidates, i.e., MMV688508, MMV688844, and MMV688845, which generated good inhibitory curves. All hit candidates were expected to have different molecular targets. Among them, MMV688844 showed the best minimum inhibitory concentration value for not only wild-type M. abscessus but also for nine different R and S morphotype clinical isolates. Thus, we found that MMV688844, identified from the Pathogen Box screen, may be a promising candidate in the M. abscessus drug discovery pipeline.	[Jeong, Jinsun; Kim, Guehye; Jang, Jichan] Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21plus, Jinju, South Korea; [Moon, Cheol] Semyung Univ, Dept Clin Lab Sci, Jecheon, South Korea; [Kim, Hyun Jung; Kim, Tae Ho; Jang, Jichan] Gyeongsang Natl Univ, Res Inst Life Sci, Div Life Sci, Jinju, South Korea	Gyeongsang National University; Semyung University; Gyeongsang National University	Jang, J (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21plus, Jinju, South Korea.; Jang, J (corresponding author), Gyeongsang Natl Univ, Res Inst Life Sci, Div Life Sci, Jinju, South Korea.	jichanjang@gnu.ac.kr		Moon, Cheol/0000-0001-7849-650X	Gyeongsang National University; National Research Foundation of Korea [NRF-2011-0001759, 2014R1A1A1007464, 2016R1D1A1A02937214]; BK21plus	Gyeongsang National University; National Research Foundation of Korea(National Research Foundation of Korea); BK21plus	This research was supported by a grant from funds of the research promotion program, Gyeongsang National University, 2016 and by the National Research Foundation of Korea (grants NRF-2011-0001759, 2014R1A1A1007464, and 2016R1D1A1A02937214). Jinsun Jeong was supported by the BK21plus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Angelique Doy and Benoit Laleu, Medicines for Malaria Venture in the administrative and logistical aspects. This research was supported by a grant from funds of the research promotion program, Gyeongsang National University, 2016 and by the National Research Foundation of Korea (grants NRF-2011-0001759, 2014R1A1A1007464, and 2016R1D1A1A02937214). Jinsun Jeong was supported by the BK2lplus. English-language editing of the article was carried out by Editage, a division of Cactus Communications. We declare that we have no conflicts of interest.	Balasubramanian V, 2014, ANTIMICROB AGENTS CH, V58, P495, DOI 10.1128/AAC.01903-13; Ballell L, 2013, CHEMMEDCHEM, V8, P313, DOI 10.1002/cmdc.201200428; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Cai Y, 2012, J ANTIBIOT, V65, P175, DOI 10.1038/ja.2011.142; Caverly LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117657; Ferro BE, 2015, J ANTIMICROB CHEMOTH, V70, P811, DOI 10.1093/jac/dku431; Griffith DE, 2015, ANN AM THORAC SOC, V12, P436, DOI 10.1513/AnnalsATS.201501-015OI; Heo J, 2017, SLAS DISCOV, V22, P144, DOI 10.1177/1087057116675887; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Jang MA, 2013, J HUM GENET, V58, P298, DOI 10.1038/jhg.2013.19; Rebollo-Lopez MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142293; Kim TS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02752-16, 10.1128/aac.02752-16]; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; Lee Richard A., 2010, CHEST J M ABSTR, V138; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Nessar R, 2011, J ANTIMICROB CHEMOTH, V66, P1719, DOI 10.1093/jac/dkr209; Novosad SA, 2016, EMERG INFECT DIS, V22, P511, DOI 10.3201/eid2203.150828; Paknikar SS, 2012, N AM J MED SCI, V4, P537, DOI 10.4103/1947-2714.103312; Pang YK, 2013, RESPIROL CASE REP, V1, P31, DOI 10.1002/rcr2.17; Pooley HB, 2016, APPL ENVIRON MICROB, V82, P5553, DOI 10.1128/AEM.01668-16; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Roux AL, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160185; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Sorrentino F, 2016, ANTIMICROB AGENTS CH, V60, P640, DOI 10.1128/AAC.01920-15; Taneja NK, 2007, J ANTIMICROB CHEMOTH, V60, P288, DOI 10.1093/jac/dkm207; Tortoli E, 2016, INT J SYST EVOL MICR, V66, P4471, DOI 10.1099/ijsem.0.001376	27	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195595	10.1371/journal.pone.0195595	http://dx.doi.org/10.1371/journal.pone.0195595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698397	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600013
J	Nascimento, CS; Cecilio, AB; Mendoza-Cortez, JW; Nascimento, CS; Neto, FB; Grangeiro, LC				Nascimento, Camila Seno; Cecilio Filho, Arthur Bernardes; Mendoza-Cortez, Juan Waldir; Nascimento, Carolina Seno; Bezerra Neto, Francisco; Grangeiro, Leilson Costa			Effect of population density of lettuce intercropped with rocket on productivity and land-use efficiency	PLOS ONE			English	Article								The objective of this study was to evaluate the influence of the spacing of lettuce rows on the production of a lettuce-rocket intercropping system over two growing seasons (11 August to 25 September 2011 and 12 January to 24 February 2012) in Jaboticabal, Sao Paulo, Brazil. We evaluated 11 treatments in each season: lettuce-rocket intercrops with five row spacings for the lettuce (0.20, 0.25, 0.30, 0.35 and 0.40 m) and the rocket planted midway between the lettuce rows, sole crops of lettuce at the same five row spacings and a sole crop of rocket. Fresh and dry masses of the lettuce and rocket and number of lettuce leaves per plant were highest with a lettuce row spacing of 0.40 m, but the productivities of the lettuce and rocket were higher with a lettuce row spacing of 0.20 m. The productivities and fresh and dry weights of the lettuce and rocket and the number of lettuce leaves per plant were highest in the sole crops, but the fresh and dry weights of the rocket were higher with intercropping. The land equivalent ratios were > 1.0 in both seasons in all intercrops and were highest for the densest crop (1.41). Intercropping was therefore 41% more efficient than sole cropping for the production of lettuce and rocket.	[Nascimento, Camila Seno; Cecilio Filho, Arthur Bernardes; Nascimento, Carolina Seno] Univ Estadual Paulista UNESP, Dept Plant Prod, Campus Jaboticabal, Sao Paulo, Brazil; [Mendoza-Cortez, Juan Waldir] Univ Nacl Agr La Molina, Fac Agron, Dept Fitotecnia, Av La Molina S-N, Lima, Peru; [Bezerra Neto, Francisco; Grangeiro, Leilson Costa] Univ Fed Rural Semiarido UFERSA, Dept Plant Sci, Mossoro, RN, Brazil	Universidade Estadual Paulista; University Nacional Agraria La Molina; Universidade Federal Rural do Semi-Arido (UFERSA)	Cecilio, AB (corresponding author), Univ Estadual Paulista UNESP, Dept Plant Prod, Campus Jaboticabal, Sao Paulo, Brazil.	rutra@fcav.unesp.br	Cecílio Filho, Arthur/D-7237-2012; Cecilio Filho, Arthur Bernardes/AGR-7901-2022	Cecílio Filho, Arthur/0000-0002-6706-5496; Cecilio Filho, Arthur Bernardes/0000-0002-6706-5496	FAPESP-Fundacao de Apoio a Pesquisa do Estado de Sao Paulo [2011/10784-3]	FAPESP-Fundacao de Apoio a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was financially supporting by FAPESP-Fundacao de Apoio a Pesquisa do Estado de Sao Paulo, by granting scholarship to the first author, Camila Seno Nascimento (award number 2011/10784-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, SOIL TAX BAS SYST SO; Barbosa A. P., 2015, African Journal of Agricultural Research, V10, P1083; Barbosa J.C., 2015, AGROESTAT SYSTEM STA; Barros AP, 2011, HORTIC BRAS, V29, P398, DOI 10.1590/S0102-05362011000300024; Bezerra Neto Francisco, 2003, Hortic. Bras., V21, P635, DOI 10.1590/S0102-05362003000400012; Costa CC, 2007, HORTIC BRAS, V25, P34, DOI 10.1590/S0102-05362007000100008; de Oliveira EQ, 2010, HORTIC BRAS, V28, P36, DOI 10.1590/S0102-05362010000100007; Pelloso IAD, 2012, SEMIN-CIENC AGRAR, V33, P459, DOI 10.5433/1679-0359.2012v33n2p459; Gou F, 2017, FIELD CROP RES, V200, P122, DOI 10.1016/j.fcr.2016.09.015; Huang Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114910, 10.1371/journal.pone.0131053]; Ijoyah M. O., 2012, Scientific Journal of Crop Science, V1, P55; KEATING BA, 1993, FIELD CROP RES, V34, P273, DOI 10.1016/0378-4290(93)90118-7; Li CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008049; Mao LL, 2016, FIELD CROP RES, V187, P1, DOI 10.1016/j.fcr.2015.12.005; Monteith JL., 1977, ROYAL SOC LONDON P B; Najafi S., 2014, International Research Journal of Applied and Basic Sciences, V8, P549; Neto FB, 2012, ECOL INDIC, V14, P11, DOI 10.1016/j.ecolind.2011.07.006; Sinoquet H., 1995, ECOPHYSIOLOGY TROPIC; TRANI P. E., 1997, RECOMENDACAO ADUBACA, V100, P168; van Raij, 1997, RECOMENDACOES ADUBAC, P155; Wang MC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085626, 10.1371/journal.pone.0111040]; Wang ZG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113984; Willey R. W., 1979, Field Crop Abstracts, V32, P1; WILLEY RW, 1990, AGR WATER MANAGE, V17, P215, DOI 10.1016/0378-3774(90)90069-B; Zhang L, 2008, FIELD CROP RES, V107, P29, DOI 10.1016/j.fcr.2007.12.014; Zhu JQ, 2014, J EXP BOT, V65, P641, DOI 10.1093/jxb/ert408	26	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0194756	10.1371/journal.pone.0194756	http://dx.doi.org/10.1371/journal.pone.0194756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698401	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600007
J	Prentice, LM; Miller, RR; Knaggs, J; Mazloomian, A; Hernandez, RA; Franchini, P; Parsa, K; Tessier-Cloutier, B; Lapuk, A; Huntsman, D; Schaeffer, DF; Sheffield, BS				Prentice, Leah M.; Miller, Ruth R.; Knaggs, Jeff; Mazloomian, Alborz; Hernandez, Rosalie Aguirre; Franchini, Patrick; Parsa, Kourosh; Tessier-Cloutier, Basile; Lapuk, Anna; Huntsman, David; Schaeffer, David F.; Sheffield, Brandon S.			Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; AMERICAN SOCIETY; MOLECULAR PATHOLOGY; SEQUENCE ARTIFACTS; BREAST-CANCER; GUIDELINE; ONCOLOGY; KRAS; DNA; RECOMMENDATIONS	Genomic analysis of cancer tissues is an essential aspect of personalized oncology treatment. Though it has been suggested that formalin fixation of patient tissues may be suboptimal for molecular studies, this tissue processing approach remains the industry standard. Therefore clinical molecular laboratories must be able to work with formalin fixed, paraffin embedded (FFPE) material. This study examines the effects of pre-analytic variables introduced by routine pathology processing on specimens used for clinical reports produced by next-generation sequencing technology. Tissue resected from three colorectal cancer patients was subjected to 2, 15, 24, and 48 hour fixation times in neutral buffered formalin. DNA was extracted from all tissues twice, once with uracil-N-glycosylase (UNG) treatment to counter deamination effects, and once without. Of note, deamination events at methylated cytosine, as found at CpG sites, remains unaffected by UNG. After extraction a two-step PCR targeted sequencing method was performed using the Illumina MiSeq and the data was analyzed via a custom-built bioinformatics pipeline, including filtration of reads with mapping quality <30. A larger baseline group of samples (n = 20) was examined to establish if there was a sample performance difference between the two DNA extraction methods, with/without UNG treatment. There was no statistical difference between sequencing performance of the two extraction methods when comparing read counts (raw, mapped, and filtered) and read quality (% mapped,% filtered). Analyzing mutation type, there was no significant difference between mutation calls until the 48 hour fixation treatment. At 48 hours there is a significant increase in C/G -> T/A mutations that is not represented in DNA treated with UNG. This suggests these errors may be due to deamination events triggered by a longer fixation time. However the allelic frequency of these events remained below the limit of detection for reportable mutations in this assay (<2%). We do however recommend that suspected intratumoral heterogeneity events be verified by re-sequencing the same FFPE block.	[Prentice, Leah M.; Miller, Ruth R.; Knaggs, Jeff; Mazloomian, Alborz; Hernandez, Rosalie Aguirre; Franchini, Patrick; Parsa, Kourosh; Lapuk, Anna; Huntsman, David] Contextual Genom Inc, Vancouver, BC, Canada; [Tessier-Cloutier, Basile; Schaeffer, David F.; Sheffield, Brandon S.] Univ British Columbia, Dept Pathol & Lab Med, Anat Pathol, Vancouver, BC, Canada; [Sheffield, Brandon S.] William Osler Hlth Syst, Dept Lab Med, Brampton, ON, Canada	University of British Columbia	Prentice, LM (corresponding author), Contextual Genom Inc, Vancouver, BC, Canada.	Iprentice@contextualgenomics.com	Huntsman, David/ABE-6082-2020	Knaggs, Jeff/0000-0002-1206-0583	Contextual Genomics	Contextual Genomics	Contextual Genomics provided support in the form of salaries for the authors LMP, RRM, JK, AM, RAH, PF, KP, AL, and DH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Chen GL, 2014, MOL DIAGN THER, V18, P587, DOI 10.1007/s40291-014-0115-2; Ding JR, 2012, BIOINFORMATICS, V28, P167, DOI 10.1093/bioinformatics/btr629; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hsu HC, 2016, ONCOTARGET, V7, P22257, DOI 10.18632/oncotarget.8076; Lamy A, 2011, MODERN PATHOL, V24, P1090, DOI 10.1038/modpathol.2011.60; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Roth RM, 2015, AM J CLIN PATHOL, V143, P336, DOI 10.1309/AJCP4D7RXOBHLKGJ; Sepulveda AR, 2017, J ONCOL PRACT, V13, P333, DOI 10.1200/JOP.2017.022152; Serizawa M, 2015, CANCER GENET-NY, V208, P415, DOI 10.1016/j.cancergen.2015.05.001; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wong SQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-23	19	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196434	10.1371/journal.pone.0196434	http://dx.doi.org/10.1371/journal.pone.0196434			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698444	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600081
J	Seong, KM; Coates, BS; Kim, DH; Hansen, AK; Pittendrigh, BR				Seong, Keon Mook; Coates, Brad S.; Kim, Do-Hyup; Hansen, Allison K.; Pittendrigh, Barry R.			Differentially expressed microRNAs associated with changes of transcript levels in detoxification pathways and DDT-resistance in the Drosophila melanogaster strain 91-R	PLOS ONE			English	Article							REGULATES PYRETHROID RESISTANCE; INSECTICIDE RESISTANCE; CULEX-PIPIENS; CHLORANTRANILIPROLE RESISTANCE; MAMMALIAN MICRORNAS; SUSCEPTIBLE STRAINS; MIR-310 CLUSTER; WEB SERVER; SMALL RNAS; GENES	Dichloro-diphenyl-trichloroethane (DDT) resistance among arthropod species is a model for understanding the molecular adaptations in response to insecticide exposures. Previous studies reported that DDT resistance may involve one or multiple detoxification genes, such as cytochrome P450 monooxygenases (P450s), glutathione S-transferases (GSTs), esterases, and ATP binding cassette (ABC) transporters, or changes in the voltage-sensitive sodium channel. However, the possible involvement of microRNAs (miRNAs) in the post-transcriptional regulation of genes associated with DDT resistance in the Drosophila melanogaster strain 91-R remains poorly understood. In this study, the majority of the resulting miRNAs discovered in small RNA libraries from 91-R and the susceptible control strain, 91-C, ranged from 16-25 nt, and contained 163 precursors and 256 mature forms of previously-known miRNAs along with 17 putative novel miRNAs. Quantitative analyses predicted the differential expression of ten miRNAs between 91-R and 91-C, and, based on Gene Ontology and pathway analysis, these ten miRNAs putatively target transcripts encoding proteins involved in detoxification mechanisms. RT-qPCR validated an inverse correlation between levels of differentially-expressed miRNAs and their putatively targeted transcripts, which implies a role of these miRNAs in the differential regulation of detoxification pathways in 91-R compared to 91-C. This study provides evidence associating the differential expression of miRNAs in response to multigenerational DDT selection in Drosophila melanogaster and provides important clues for understanding the possible roles of miRNAs in mediating insecticide resistance traits.	[Seong, Keon Mook; Pittendrigh, Barry R.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Coates, Brad S.] Iowa State Univ, USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Kim, Do-Hyup; Hansen, Allison K.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Michigan State University; Iowa State University; United States Department of Agriculture (USDA); University of California System; University of California Riverside	Seong, KM (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	seongkeo@msu.edu	Kim, Dohyup/Y-5629-2019	Hansen, Allison/0000-0002-3066-5527; Coates, Brad/0000-0001-8908-1529				Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berge JB, 1998, PHILOS T R SOC B, V353, P1701, DOI 10.1098/rstb.1998.0321; Berger M, 2016, MOL ECOL, V25, P5692, DOI 10.1111/mec.13882; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Casida JE, 1998, ANNU REV ENTOMOL, V43, P1, DOI 10.1146/annurev.ento.43.1.1; Chahine S, 2011, J EXP BIOL, V214, P462, DOI 10.1242/jeb.048884; Chen WF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6549; Cicek IO, 2016, GENETICS, V202, P1167, DOI 10.1534/genetics.115.185371; Coronnello C, 2013, NUCLEIC ACIDS RES, V41, pW159, DOI 10.1093/nar/gkt379; Daborn P, 2001, MOL GENET GENOMICS, V266, P556, DOI 10.1007/s004380100531; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dhahbi JM, 2016, GENOM INSIGHTS, P29, DOI [10.4137/GEI.S38147, 10.4137/gei.s38147, 10.4137/GEIEI.S38147]; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; ffrench-Constant R, 2006, BIOESSAYS, V28, P6, DOI 10.1002/bies.20354; FORGASH AJ, 1984, PESTIC BIOCHEM PHYS, V22, P178, DOI 10.1016/0048-3575(84)90087-7; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gellatly KJ, 2015, PESTIC BIOCHEM PHYS, V121, P107, DOI 10.1016/j.pestbp.2015.01.001; Gendron CM, 2017, AGING CELL, V16, P1434, DOI 10.1111/acel.12673; Gramates LS, 2017, NUCLEIC ACIDS RES, V45, pD663, DOI 10.1093/nar/gkw1016; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo Q, 2017, INSECT BIOCHEM MOLEC, V84, P15, DOI 10.1016/j.ibmb.2017.03.006; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hong S, 2014, INSECT BIOCHEM MOLEC, V55, P39, DOI 10.1016/j.ibmb.2014.10.007; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Kapoor AJ, 2013, FASEB J, V27; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kuruganti S, 2007, GENE, V388, P43, DOI 10.1016/j.gene.2006.09.019; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Goff G, 2017, PEST MANAG SCI, V73, P493, DOI 10.1002/ps.4470; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lei ZT, 2015, PARASITOL RES, V114, P699, DOI 10.1007/s00436-014-4236-7; Li HM, 2008, INSECT MOL BIOL, V17, P325, DOI 10.1111/j.1365-2583.2008.00808.x; Li XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep14095; Li Y, 2017, DEV COMP IMMUNOL, V68, P34, DOI 10.1016/j.dci.2016.11.014; Liu BQ, 2016, J MED ENTOMOL, V53, P1205, DOI 10.1093/jme/tjw083; Liu Q, 2016, ONCOL REP, V36, P189, DOI 10.3892/or.2016.4788; Lomate Purushottam R., 2015, Open Access Insect Physiology, V5, P13; Lu J, 2008, MOL BIOL EVOL, V25, P929, DOI 10.1093/molbev/msn040; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8; Marco A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140024; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mateo L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004560; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; MERRELL DJ, 1956, J ECON ENTOMOL, V49, P300, DOI 10.1093/jee/49.3.300; Organization WH, 2006, WHOHTMMAL20061112; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Peng W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159591; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROUSH RT, 1987, ANNU REV ENTOMOL, V32, P361, DOI 10.1146/annurev.en.32.010187.002045; Sanchez-Diaz I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133956; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seong KM, 2017, GENOME BIOL EVOL, V9, P3356, DOI 10.1093/gbe/evx252; Seong KM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23355; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Steele LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123066; Steele LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098584; Strycharz JP, 2013, PESTIC BIOCHEM PHYS, V107, P207, DOI 10.1016/j.pestbp.2013.06.010; Szabo PM, 2010, CURR BIOINFORM, V5, P81, DOI 10.2174/157489310790596394; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Tian MM, 2016, PARASITOL RES, V115, P4511, DOI 10.1007/s00436-016-5238-4; Tsurudome K, 2010, NEURON, V68, P879, DOI 10.1016/j.neuron.2010.11.016; Van Peer G, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1260; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Wang XW, 2014, BIOINFORMATICS, V30, P1377, DOI 10.1093/bioinformatics/btu045; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Wostenberg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051829; Wu R., 2012, J BIOMET BIOSTAT, V3, pe109; Xiong XP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006034; Xu LN, 2015, SCI REP-UK, V5, DOI 10.1038/srep15461; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhang YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152924; Zhou YY, 2016, ENVIRON TOXICOL PHAR, V45, P98, DOI 10.1016/j.etap.2016.05.019; Zhu B, 2017, SCI REP-UK, V7, DOI 10.1038/srep40713; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	99	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196518	10.1371/journal.pone.0196518	http://dx.doi.org/10.1371/journal.pone.0196518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698530	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600092
J	Chen, NK; Chang, HC; Bilgin, A; Bernstein, A; Trouard, TP				Chen, Nan-kuei; Chang, Hing-Chiu; Bilgin, Ali; Bernstein, Adam; Trouard, Theodore P.			A diffusion-matched principal component analysis (DM-PCA) based two-channel denoising procedure for high-resolution diffusion-weighted MRI	PLOS ONE			English	Article							NONLINEAR PHASE CORRECTION; INHERENT CORRECTION; PARKINSONS-DISEASE; PROPELLER EPI; MULTISHOT; IMAGES; REDUCTION; ERRORS; RANK; RECONSTRUCTION	Over the past several years, significant efforts have been made to improve the spatial resolution of diffusion-weighted imaging (DWI), aiming at better detecting subtle lesions and more reliably resolving white-matter fiber tracts. A major concern with high-resolution DWI is the limited signal-to-noise ratio (SNR), which may significantly offset the advantages of high spatial resolution. Although the SNR of DWI data can be improved by denoising in post-processing, existing denoising procedures may potentially reduce the anatomic resolvability of high-resolution imaging data. Additionally, non-Gaussian noise induced signal bias in low-SNR DWI data may not always be corrected with existing denoising approaches. Here we report an improved denoising procedure, termed diffusion-matched principal component analysis (DM-PCA), which comprises 1) identifying a group of (not necessarily neighboring) voxels that demonstrate very similar magnitude signal variation patterns along the diffusion dimension, 2) correcting low-frequency phase variations in complex-valued DWI data, 3) performing PCA along the diffusion dimension for real-and imaginary-components (in two separate channels) of phase-corrected DWI voxels with matched diffusion properties, 4) suppressing the noisy PCA components in real-and imaginary-components, separately, of phase-corrected DWI data, and 5) combining real-and imaginary-components of denoised DWI data. Our data show that the new two-channel (i.e., for real-and imaginary-components) DM-PCA denoising procedure performs reliably without noticeably compromising anatomic resolvability. Non-Gaussian noise induced signal bias could also be reduced with the new denoising method. The DM-PCA based denoising procedure should prove highly valuable for high-resolution DWI studies in research and clinical uses.	[Chen, Nan-kuei; Bilgin, Ali; Bernstein, Adam; Trouard, Theodore P.] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA; [Chen, Nan-kuei; Bilgin, Ali; Trouard, Theodore P.] Univ Arizona, Dept Med Imaging, Tucson, AZ 85721 USA; [Chen, Nan-kuei] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27708 USA; [Chang, Hing-Chiu] Univ Hong Kong, Dept Diagnost Radiol, Hong Kong, Hong Kong, Peoples R China; [Bilgin, Ali] Univ Arizona, Dept Elect & Comp Engn, Tucson, AZ 85721 USA; [Bilgin, Ali; Trouard, Theodore P.] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Trouard, Theodore P.] Univ Arizona, Evelyn F McKnight Brain Inst, Tucson, AZ USA	University of Arizona; University of Arizona; Duke University; University of Hong Kong; University of Arizona; University of Arizona; University of Arizona	Chen, NK (corresponding author), Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.; Chen, NK (corresponding author), Univ Arizona, Dept Med Imaging, Tucson, AZ 85721 USA.; Chen, NK (corresponding author), Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27708 USA.	nkchen@email.arizona.edu	; Chen, Nan-kuei/E-7791-2016	Chang, Hing-Chiu/0000-0001-8634-328X; Chen, Nan-kuei/0000-0001-6564-4219	NIH [R01 NS 074045, R21 EB 018419]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB018419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074045] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research is supported by NIH Grants R01 NS 074045 and R21 EB 018419 (NC). The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2014, HUM BRAIN MAPP, V35, P1921, DOI 10.1002/hbm.22302; Atkinson D, 2006, MAGN RESON MED, V56, P1135, DOI 10.1002/mrm.21046; Bammer P, 1999, RADIOLOGY, V211, P799, DOI 10.1148/radiology.211.3.r99jn15799; Bao LJ, 2013, MED IMAGE ANAL, V17, P442, DOI 10.1016/j.media.2013.01.006; Becker SMA, 2014, NEUROIMAGE, V95, P90, DOI 10.1016/j.neuroimage.2014.03.053; Bruce IP, 2017, NEUROIMAGE, V159, P46, DOI 10.1016/j.neuroimage.2017.07.035; Butts K, 1996, MAGNET RESON MED, V35, P763, DOI 10.1002/mrm.1910350518; Chang HC, 2015, NEUROIMAGE, V118, P667, DOI 10.1016/j.neuroimage.2015.06.016; Chang HC, 2015, MAGN RESON MED, V73, P1872, DOI 10.1002/mrm.25318; Chen NK, 2013, NEUROIMAGE, V72, P41, DOI 10.1016/j.neuroimage.2013.01.038; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Deng J, 2008, MAGN RESON MED, V59, P947, DOI 10.1002/mrm.21525; Ding ZH, 2005, MAGN RESON MED, V53, P485, DOI 10.1002/mrm.20339; Dong ZJ, 2018, MAGN RESON MED, V79, P1525, DOI 10.1002/mrm.26768; Eichner C, 2015, NEUROIMAGE, V122, P373, DOI 10.1016/j.neuroimage.2015.07.074; Frank LR, 2010, NEUROIMAGE, V49, P1510, DOI 10.1016/j.neuroimage.2009.09.010; Galantucci S, 2017, RADIOLOGY, V283, P515, DOI 10.1148/radiol.2016160274; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Guhaniyogi S, 2016, MAGN RESON MED, V75, P639, DOI 10.1002/mrm.25624; Guo H, 2016, MAGN RESON MED, V75, P169, DOI 10.1002/mrm.25594; Herbst M, 2017, MAGN RESON MED, V78, P1476, DOI 10.1002/mrm.26545; Herbst M, 2015, MAGN RESON MED, V74, P1675, DOI 10.1002/mrm.25547; Hu ZX, 2017, MAGN RESON MED, V78, P172, DOI 10.1002/mrm.26361; Ibarretxe-Bilbao N, 2010, MOVEMENT DISORD, V25, P1888, DOI 10.1002/mds.23208; Jeong HK, 2013, MAGN RESON MED, V69, P793, DOI 10.1002/mrm.24320; Joshi N, 2017, J NEUROL, V264, P1497, DOI 10.1007/s00415-017-8555-3; Lam F, 2016, MAGN RESON MED, V75, P433, DOI 10.1002/mrm.25643; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Li ZQ, 2011, MAGN RESON MED, V66, P341, DOI 10.1002/mrm.23033; Liao CY, 2017, MAGN RESON MED, V77, P1359, DOI 10.1002/mrm.26199; Liu CL, 2004, MAGN RESON MED, V52, P1388, DOI 10.1002/mrm.20288; Liu WT, 2016, MAGN RESON MED, V75, P280, DOI 10.1002/mrm.25586; Ma XD, 2016, NEUROIMAGE, V138, P88, DOI 10.1016/j.neuroimage.2016.05.079; Mahmood MT, 2016, OPT REV, V23, P460, DOI 10.1007/s10043-016-0220-z; Mani M, 2017, MAGN RESON MED, V78, P494, DOI 10.1002/mrm.26382; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Manjon JV, 2012, MED IMAGE ANAL, V16, P18, DOI 10.1016/j.media.2011.04.003; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Meoded A, 2017, NEURORADIOLOGY, V59, P445, DOI 10.1007/s00234-017-1831-1; MILLER AJ, 1993, MAGN RESON IMAGING, V11, P1051, DOI 10.1016/0730-725X(93)90225-3; Miller KL, 2011, NEUROIMAGE, V57, P167, DOI 10.1016/j.neuroimage.2011.03.070; Miller KL, 2003, MAGN RESON MED, V50, P343, DOI 10.1002/mrm.10531; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Parker GJM, 2000, J MAGN RESON IMAGING, V11, P702, DOI 10.1002/1522-2586(200006)11:6<702::AID-JMRI18>3.0.CO;2-A; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pipe JG, 2002, MAGNET RESON MED, V47, P42, DOI 10.1002/mrm.10014; Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rolheiser TM, 2011, J NEUROL, V258, P1254, DOI 10.1007/s00415-011-5915-2; Samsonov AA, 2004, MAGN RESON MED, V52, P798, DOI 10.1002/mrm.20207; Shah A, 2017, BRAIN CONNECT, V7, P347, DOI 10.1089/brain.2017.0506; Skare S, 2006, MAGN RESON MED, V55, P1298, DOI 10.1002/mrm.20890; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Song AW, 2014, BRAIN CONNECT, V4, P636, DOI 10.1089/brain.2014.0270; Truong TK, 2014, MAGN RESON MED, V71, P790, DOI 10.1002/mrm.24709; Truong TK, 2012, MAGN RESON MED, V68, P1255, DOI 10.1002/mrm.24124; Van AT, 2009, IEEE T MED IMAGING, V28, P1770, DOI 10.1109/TMI.2009.2023212; Wang FN, 2005, MAGN RESON MED, V54, P1232, DOI 10.1002/mrm.20677; Wiest-Daessle N, 2007, LECT NOTES COMPUT SC, V4792, P344; Wirestam R, 2006, MAGN RESON MED, V56, P1114, DOI 10.1002/mrm.21036; Wu WC, 2017, J MAGN RESON IMAGING, V46, P646, DOI 10.1002/jmri.25664; Zhang XY, 2017, NEUROIMAGE, V156, P128, DOI 10.1016/j.neuroimage.2017.04.017; Zhang Z, 2015, NEUROIMAGE, V105, P552, DOI 10.1016/j.neuroimage.2014.10.022	64	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195952	10.1371/journal.pone.0195952	http://dx.doi.org/10.1371/journal.pone.0195952			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694400	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400053
J	Chiu, WY; Yang, WS; Chien, JY; Lee, JJ; Tsai, KS				Chiu, Wei-Yih; Yang, Wei-Shiung; Chien, Jung Yien; Lee, Jang-Jaer; Tsai, Keh-Sung			The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects	PLOS ONE			English	Article							ORAL BISPHOSPHONATE THERAPY; RISK-FACTORS; POSITION PAPER; BREAST-CANCER; COHORT; ASSOCIATION; TRIALS	Background Although bisphosphonate-related osteonecrosis of the jaw (ONJ) develops mainly after tooth extractions (TEs), the strength of the association between them and how the existence of the disease among bisphosphonate (BP)-treated osteoporotic patients exposed to TE remain uncertain. Methods A nationwide retrospective cohort study investigated the influence of alendronate and TE on the development of ONJ. Results Incidence of ONJ following long-term alendronate therapy was 262/100,000 person-years, while no event developed in the control group on raloxifene. Overall prevalence of ONJ in osteoporotic subjects receiving alendronate was estimated at 0.34% which rose to 2.16% after TE. Multiple logistic regression analysis, adjusted for the potential confounders, showed TE (adjusted odds ratio, 9.60 [4.33 +/- 21.29]), drug duration exceeding 3 years (3.00 [1.33 +/- 6.76]), and concomitant rheumatoid arthritis (4.94 [1.64 +/- 14.90]) were independent predictors of ONJ. Conclusions This article strengthens the relationship between ONJ and BPs. Among osteoporotic patients exposed to alendronate, TE confers a 9.6-fold increased risk for ONJ and it should be performed with caution irrespective of drug duration.	[Chiu, Wei-Yih; Yang, Wei-Shiung; Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Chiu, Wei-Yih; Yang, Wei-Shiung; Chien, Jung Yien; Tsai, Keh-Sung] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chiu, Wei-Yih; Yang, Wei-Shiung; Chien, Jung Yien; Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Chiu, Wei-Yih; Tsai, Keh-Sung] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Chiu, Wei-Yih; Yang, Wei-Shiung; Chien, Jung Yien] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lee, Jang-Jaer] Natl Taiwan Univ Hosp, Dept Dent, Div Oral & Maxillofacial Surg, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Tsai, KS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan.; Tsai, KS (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Tsai, KS (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Tsai, KS (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.; Lee, JJ (corresponding author), Natl Taiwan Univ Hosp, Dept Dent, Div Oral & Maxillofacial Surg, Taipei, Taiwan.	leejj@ntuh.gov.tw; kstsaimd@yahoo.com		CHIEN, JUNG-YIEN/0000-0002-7718-0594; TSAI, KEH-SUNG/0000-0001-8528-1566; CHIU, WEI-YIH/0000-0003-3124-7121	Osteoporosis and Metabolic Bone Diseases Research Fund; Department of Medical Research in the authors' hospital [105-N3322]	Osteoporosis and Metabolic Bone Diseases Research Fund; Department of Medical Research in the authors' hospital	This work was supported by the Osteoporosis and Metabolic Bone Diseases Research Fund and research grants from the Department of Medical Research in the authors' hospital (105-N3322) to WYC. This study is based in part on data from the NHIRD provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by National Health Research Institutes (Registered number: NHIRD-103-162). The interpretation and conclusions contained herein do not represent those of National Health Insurance Administration, Ministry of Health and Welfare or National Health Research Institutes.; This study is based in part on data from the NHIRD provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by National Health Research Institutes (Registered number: NHIRD-103-162). The interpretation and conclusions contained herein do not represent those of National Health Insurance Administration, Ministry of Health and Welfare or National Health Research Institutes.	Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Barasch A, 2011, J DENT RES, V90, P439, DOI 10.1177/0022034510397196; Ben-Aharon I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070044; Chiu WY, 2014, J CLIN ENDOCR METAB, V99, P2729, DOI 10.1210/jc.2013-4119; Coleman R, 2015, LANCET, V386, P1353, DOI 10.1016/S0140-6736(15)60908-4; Fehm T, 2009, GYNECOL ONCOL, V112, P605, DOI 10.1016/j.ygyno.2008.11.029; Hansen PJ, 2013, CLIN ORAL INVEST, V17, P1829, DOI 10.1007/s00784-012-0873-3; Hasegawa T, 2017, OSTEOPOROSIS INT, V28, P2465, DOI 10.1007/s00198-017-4063-7; Hasegawa T, 2013, J CRANIO MAXILL SURG, V41, P558, DOI 10.1016/j.jcms.2012.11.023; Hong JW, 2010, OSTEOPOROSIS INT, V21, P847, DOI 10.1007/s00198-009-1024-9; Howie RN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132520; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Kwok T, 2016, Hong Kong Med J, V22 Suppl 2, pS46; Lee JJ, 2013, HEAD NECK-J SCI SPEC, V35, P1787, DOI 10.1002/hed.23235; Lo JC, 2016, BONE, V85, P142, DOI 10.1016/j.bone.2016.01.002; Lo JC, 2011, J AM GERIATR SOC, V59, P916, DOI 10.1111/j.1532-5415.2011.03371.x; Lo JC, 2010, J ORAL MAXIL SURG, V68, P243, DOI 10.1016/j.joms.2009.03.050; Mhaskar R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003188.pub3; Palaska PK, 2009, ONCOLOGIST, V14, P1154, DOI 10.1634/theoncologist.2009-0115; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Saad F, 2012, ANN ONCOL, V23, P1341, DOI 10.1093/annonc/mdr435; Thumbigere-Math V, 2012, AM J CLIN ONCOL-CANC, V35, P386, DOI 10.1097/COC.0b013e3182155fcb; Vahtsevanos K, 2009, J CLIN ONCOL, V27, P5356, DOI 10.1200/JCO.2009.21.9584; Vestergaard P, 2012, J ORAL MAXIL SURG, V70, P821, DOI 10.1016/j.joms.2011.02.093; Yamazaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079376; Yamazaki T, 2012, BONE, V51, P882, DOI 10.1016/j.bone.2012.08.115; Yoneda T, 2017, J BONE MINER METAB, V35, P6, DOI 10.1007/s00774-016-0810-7; Yoneda T, 2010, J BONE MINER METAB, V28, P365, DOI 10.1007/s00774-010-0162-7	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196419	10.1371/journal.pone.0196419	http://dx.doi.org/10.1371/journal.pone.0196419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694412	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400089
J	Chrobok, NL; Bol, JGJM; Jongenelen, CA; Breve, JJP; El Alaoui, S; Wilhelmus, MMM; Drukarch, B; van Dam, AM				Chrobok, Navina L.; Bol, John G. J. M.; Jongenelen, Cornelis A.; Breve, John J. P.; El Alaoui, Said; Wilhelmus, Micha M. M.; Drukarch, Benjamin; van Dam, Anne-Marie			Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TISSUE TRANSGLUTAMINASE; INFLAMMATION; FIBRONECTIN; ACTIVATION; CHEMOKINES; MIGRATION; INTEGRIN; CELLS	The neurodegenerative disease multiple sclerosis (MS) is pathologically characterized by the massive influx of immune cells into the central nervous system. This contributes to demyelination and axonal damage which causes symptoms such as motor and cognitive dysfunctions. The migration of leukocytes from the blood vessel is orchestrated by a multitude of factors whose determination is essential in reducing cellular influx in MS patients and the experimental autoimmune encephalomyelitis (EAE) animal model. The here studied enzyme tissue Transglutaminase (TG2) is present intracellularly, on the cell surface and extracellularly. There it contributes to cellular adhesion and migration via its transamidation activity and possibly by facilitating cellular interaction with the extracellular matrix. Previous data from our group showed reduced motor symptoms and cellular infiltration after using a pharmacological TG2 transamidation activity inhibitor in a rat EAE model. However, it remained elusive if the cross-linking activity of the enzyme resulted in the observed effects. To follow-up, we now characterized two new small molecule TG2 activity inhibitors, BJJF078 and ERW1041E. Both compounds are potent inhibitor of recombinant human and mouse Transglutaminase enzyme activity, mainly TG2 and the close related enzyme TG1. In addition they did not affect the binding of TG2 to the extracellular matrix substrate fibronectin, a process via which TG2 promotes cellular adhesion and migration. We found, that ERW1041E but not BJJF078 resulted in reduced EAE disease motor-symptoms while neither caused apparent changes in pathology (cellular influx), Transglutaminase activity or expression of inflammation related markers in the spinal cord, compared to vehicle treated controls. Although we cannot exclude issues on bioavailability and in vivo efficacy of the used compounds, we hypothesize that extracellular TG1/TG2 activity is of greater importance than (intra-)cellular activity in mouse EAE pathology.	[Chrobok, Navina L.; Bol, John G. J. M.; Jongenelen, Cornelis A.; Breve, John J. P.; Wilhelmus, Micha M. M.; Drukarch, Benjamin; van Dam, Anne-Marie] Vrije Univ Amsterdam Med Ctr, Amsterdam Neurosci, Dept Anat & Neurosci, Amsterdam, Netherlands; [El Alaoui, Said] Covalab, Villeurbanne, France	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Dam, AM (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Neurosci, Dept Anat & Neurosci, Amsterdam, Netherlands.	amw.vandam@vumc.nl		Wilhelmus, Micha/0000-0001-5546-6551; Drukarch, Benjamin/0000-0002-2417-8888	European Union [289964]	European Union(European Commission)	This work was supported by a European Union Framework Program 7 Marie Curie TRANSPATH ITN 289964 grant received by AMW van Dam (https://ec.europa.eu/research/fp7/index_en.cfm). The funder provided support in the form of salaries for authors [NLC AMWVD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Bobholz JA, 2003, CURR OPIN NEUROL, V16, P283, DOI 10.1097/00019052-200306000-00006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chrobok NL, 2016, AMINO ACIDS; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cristofanilli M, 2017, MULT SCLER J, V23, P1707, DOI 10.1177/1352458516684022; Dafik L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030642; Dafik L, 2011, CHEM BIOL, V18, P58, DOI 10.1016/j.chembiol.2010.11.004; de Jager M, 2013, NEUROBIOL AGING, V34, P1159, DOI 10.1016/j.neurobiolaging.2012.10.005; DiRaimondo TR, 2014, ACS CHEM BIOL, V9, P266, DOI 10.1021/cb4006408; Ferrara G, 2016, ACTA NEUROPATHOL, V132, P23, DOI 10.1007/s00401-016-1563-z; Goverse G, 2016, J IMMUNOL, V196, P5148, DOI 10.4049/jimmunol.1501106; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Junqueira S.C., 2016, MOL NEUROBIOL; Kipp M., 2016, BRAIN PATHOL; Korneck B, 2003, BRAIN RES BULL, V61, P321, DOI 10.1016/S0361-9230(03)00095-9; Lassmann H, 2016, ACTA NEUROPATHOL; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Miller S. D., 2007, CURRENT PROTOCOLS IM; Oertel K, 2007, ANAL BIOCHEM, V367, P152, DOI 10.1016/j.ab.2007.05.011; Oh K, 2012, CLIN IMMUNOL, V145, P122, DOI 10.1016/j.clim.2012.08.009; Pinzon NE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40995; Pucci E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007621.pub2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sheremata WA, 2005, CNS DRUGS, V19, P909, DOI 10.2165/00023210-200519110-00002; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; STEFFEN BJ, 1994, AM J PATHOL, V145, P189; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; van der Wildt B, 2016, NUCL MED BIOL, V43, P232, DOI 10.1016/j.nucmedbio.2016.01.003; van Horssen J, 2006, NEUROBIOL DIS, V24, P484, DOI 10.1016/j.nbd.2006.08.005; van Strien ME, 2015, BRAIN BEHAV IMMUN, V50, P141, DOI 10.1016/j.bbi.2015.06.023; Verhaar R, 2011, NEUROCHEM INT, V58, P785, DOI 10.1016/j.neuint.2011.03.004; Watts RE, 2006, J MED CHEM, V49, P7493, DOI 10.1021/jm060839a; Yakubov B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089285; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048	39	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196433	10.1371/journal.pone.0196433	http://dx.doi.org/10.1371/journal.pone.0196433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689097	Green Published, Green Submitted, gold			2022-12-26	WOS:000430678800054
J	Ponnusamy, A; Sinha, S; Hyde, GD; Borland, SJ; Taylor, RF; Pond, E; Eyre, HJ; Inkson, CA; Gilmore, A; Ashton, N; Kalra, PA; Canfield, AE				Ponnusamy, Arvind; Sinha, Smeeta; Hyde, Gareth D.; Borland, Samantha J.; Taylor, Rebecca F.; Pond, Emma; Eyre, Heather J.; Inkson, Colette A.; Gilmore, Andrew; Ashton, Nick; Kalra, Philip A.; Canfield, Ann E.			FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis	PLOS ONE			English	Article							FARNESYL TRANSFERASE INHIBITOR; VASCULAR CALCIFICATION; FARNESYLTRANSFERASE INHIBITOR; ARTERIAL CALCIFICATION; IN-VITRO; LONAFARNIB; MECHANISMS; SENESCENCE; DISEASE; GROWTH	Background Vascular calcification is associated with increased cardiovascular morbidity and mortality in patients with atherosclerosis, diabetes and chronic kidney disease. However, no viable treatments for this condition have been identified. This study aimed to determine whether farnesyl transferase inhibitors (FTIs) can reduce vascular calcification and the mechanism by which this reduction occurs. Results We demonstrate that FTI-277 significantly inhibits phosphate-induced mineral deposition by vascular smooth muscle cells (VSMC) in vitro, prevents VSMC osteogenic differentiation, and increases mRNA expression of matrix Gla protein (MGP), an inhibitor of mineralization. FTI-277 increases Akt signaling in VSMC in short-term serum-stimulation assays and in long-term mineralization assays. In contrast, manumycin A has no effect on Akt signaling or mineralization. Co-incubation of VSMC with FTI-277 and SH6 (an Akt inhibitor) significantly reduces the inhibitory effect of FTI-277 on mineralization, demonstrating that FTI-277 inhibits calcification by activating Akt signaling. Over-expression of the constitutively active p110 sub-unit of PI3K in VSMC using adenovirus activates Akt, inhibits mineralization, suppresses VSMC differentiation and significantly enhances MGP mRNA expression. FTI277 also inhibits phosphate-induced activation of caspase 3 and apoptosis of VSMC, and these effects are negated by co-incubation with SH6. Finally, using an ex vivo model of vascular calcification, we demonstrate that FTI-277 inhibits high phosphate-induced mineralization in aortic rings derived from rats with end-stage renal failure. Conclusions Together, these results demonstrate that FTI-277 inhibits VSMC mineral deposition by upregulating PI3K/Akt signaling and preventing apoptosis, suggesting that targeting farnesylation, or Akt specifically, may have therapeutic potential for the prevention of vascular calcification.	[Ponnusamy, Arvind; Sinha, Smeeta; Kalra, Philip A.] Salford Royal NHS Fdn Trust, Vasc Res Grp, Salford, Lancs, England; [Ponnusamy, Arvind; Sinha, Smeeta; Hyde, Gareth D.; Borland, Samantha J.; Taylor, Rebecca F.; Pond, Emma; Eyre, Heather J.; Inkson, Colette A.; Ashton, Nick; Kalra, Philip A.; Canfield, Ann E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Cardiovasc Sci,Sch Med Sci, Manchester, Lancs, England; [Gilmore, Andrew] Univ Manchester, Div Canc Studies, Manchester, Lancs, England; [Gilmore, Andrew] Univ Manchester, Manchester Acad Hlth Sci Ctr, Wellcome Trust Ctr Cell Matrix Res, Sch Med Sci,Fac Biol Med & Hlth, Manchester, Lancs, England; [Ponnusamy, Arvind] Royal Preston Hosp, Renal Dept, Preston, Lancs, England; [Hyde, Gareth D.] Imperial Coll, Natl Heart & Lung Inst, London, England; [Pond, Emma] Univ Birmingham, Inst Canc & Genom Sci, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England; [Eyre, Heather J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Pharm & Optometry,Sch Hlth Sci, Manchester, Lancs, England; [Inkson, Colette A.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Manchester Fungal Infect Grp,Sch Biol Sci, Manchester, Lancs, England	Salford Royal NHS Foundation Trust; University of Manchester; University of Manchester; University of Manchester; Royal Preston Hospital; Imperial College London; Cancer Research UK; University of Birmingham; University of Manchester; University of Manchester	Canfield, AE (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Cardiovasc Sci,Sch Med Sci, Manchester, Lancs, England.	ann.canfield@manchester.ac.uk		Eyre, Heather/0000-0001-9932-3595; Taylor, Rebecca/0000-0003-4033-3793; Ashton, Nick/0000-0003-3366-1617; Borland, Samantha/0000-0001-7358-5829	Renal Research Fund; Salford Royal NHS Foundation Trust; NIHR-Manchester Biomedical Research Centre [2008-12]; British Heart Foundation [PG/08/075/25545, PG/16/23/32088, FS/10/52/28678]; Industrial CASE award from the BBSRC [BB/1532245/1]; Wellcome Trust [203128/Z/16/Z]; BBSRC; Wellcome Trust; University of Manchester Strategic Fund	Renal Research Fund; Salford Royal NHS Foundation Trust; NIHR-Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Industrial CASE award from the BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester Strategic Fund	This work was funded by the Renal Research Fund, Salford Royal NHS Foundation Trust, NIHR-Manchester Biomedical Research Centre (2008-12), British Heart Foundation (PG/08/075/25545, PG/16/23/32088 and FS/10/52/28678) and an Industrial CASE award from the BBSRC (BB/1532245/1). The Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, is supported by core funding from the Wellcome Trust (203128/Z/16/Z). The Bioimaging Facility microscopes used in this study were purchased with grants from BBSRC, Wellcome Trust and the University of Manchester Strategic Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2009, CARDIOVASC RES, V81, P260, DOI 10.1093/cvr/cvn279; Alsina M, 2004, BLOOD, V103, P3271, DOI 10.1182/blood-2003-08-2764; Borland SJ, 2017, CARDIOVASC RES, V113, P1639, DOI 10.1093/cvr/cvx178; Bostrom KI, 2016, VASC PHARMACOL, V84, P8, DOI 10.1016/j.vph.2016.05.014; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; Caraglia M, 2007, J CELL PHYSIOL, V211, P533, DOI 10.1002/jcp.20960; Chun KH, 2003, CANCER RES, V63, P4796; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Collett GDM, 2007, CIRC RES, V100, P502, DOI 10.1161/01.RES.0000258854.03388.02; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; David E, 2005, BLOOD, V106, P4322, DOI 10.1182/blood-2005-06-2584; Demer LL, 2014, ARTERIOSCL THROM VAS, V34, P715, DOI 10.1161/ATVBAHA.113.302070; Deng L, 2015, ARTERIOSCL THROM VAS, V35, P175, DOI 10.1161/ATVBAHA.114.304786; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Duque G, 2011, BRIT J PHARMACOL, V162, P1109, DOI 10.1111/j.1476-5381.2010.01111.x; Gordon LB, 2014, CIRCULATION, V130, P27, DOI 10.1161/CIRCULATIONAHA.113.008285; Gordon LB, 2012, P NATL ACAD SCI USA, V109, P16666, DOI 10.1073/pnas.1202529109; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Ho CY, 2016, ARTERIOSCL THROM VAS, V36, P1475, DOI 10.1161/ATVBAHA.116.306717; Hyde GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102096; Jono S, 1997, ARTERIOSCL THROM VAS, V17, P1135, DOI 10.1161/01.ATV.17.6.1135; Kim H, 2012, J CELL MOL MED, V16, P273, DOI 10.1111/j.1582-4934.2011.01294.x; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Kyathanahalli CN, 2011, BIOCHEM PHARMACOL, V81, P1237, DOI 10.1016/j.bcp.2011.03.002; Leopold JA, 2015, TRENDS CARDIOVAS MED, V25, P267, DOI 10.1016/j.tcm.2014.10.021; Liu YW, 2013, CIRC RES, V112, pE99, DOI 10.1161/CIRCRESAHA.111.300543; Liu YW, 2011, FRONT BIOSCI-LANDMRK, V16, P1302, DOI 10.2741/3790; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Morris TG, 2018, J LIPID RES, V59, P69, DOI 10.1194/jlr.M079731; Nakano-Kurimoto R, 2009, AM J PHYSIOL-HEART C, V297, pH1673, DOI 10.1152/ajpheart.00455.2009; Niessner H, 2011, J INVEST DERMATOL, V131, P468, DOI 10.1038/jid.2010.297; Nikolov IG, 2013, ATHEROSCLEROSIS, V229, P42, DOI 10.1016/j.atherosclerosis.2013.02.041; Oh SH, 2008, CLIN CANCER RES, V14, P1581, DOI 10.1158/1078-0432.CCR-07-0952; Paloian NJ, 2014, AM J PHYSIOL-RENAL, V307, pF891, DOI 10.1152/ajprenal.00163.2014; Price PA, 2000, ARTERIOSCL THROM VAS, V20, P317, DOI 10.1161/01.ATV.20.2.317; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Qiu CT, 2017, MOL CELL BIOCHEM, V433, P149, DOI 10.1007/s11010-017-3023-z; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Rodriguez-Pena AB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/124902; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Shanahan CM, 2013, NAT REV NEPHROL, V9, P661, DOI 10.1038/nrneph.2013.176; Son BK, 2007, EUR J PHARMACOL, V556, P1, DOI 10.1016/j.ejphar.2006.09.070; Stieglitz E, 2015, PEDIATR BLOOD CANCER, V62, P629, DOI 10.1002/pbc.25342; Sugita M, 2007, ARTERIOSCL THROM VAS, V27, P1390, DOI 10.1161/ATVBAHA.107.140673; Sun SY, 2004, CANCER BIOL THER, V3, P1092, DOI 10.4161/cbt.3.11.1176; Sun SY, 2004, CANCER BIOL THER, V3, p9 ; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Zhan JK, 2015, INT J CARDIOL, V189, P188, DOI 10.1016/j.ijcard.2015.04.086; Zhu DX, 2014, J MOL ENDOCRINOL, V52, P77, DOI 10.1530/JME-13-0136	51	26	30	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196232	10.1371/journal.pone.0196232	http://dx.doi.org/10.1371/journal.pone.0196232			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689070	Green Submitted, Green Published, gold			2022-12-26	WOS:000430678800033
J	Gonzalez-Ballester, D; Sanz-Luque, E; Galvan, A; Fernandez, E; de Montaigu, A				Gonzalez-Ballester, David; Sanz-Luque, Emanuel; Galvan, Aurora; Fernandez, Emilio; de Montaigu, Amaury			Arginine is a component of the ammonium-CYG56 signalling cascade that represses genes of the nitrogen assimilation pathway in & IT;Chlamydomonas reinhardtii & IT;	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NITRATE REDUCTASE; TRANSCRIPTIONAL REGULATION; NO PRODUCTION; CHLAMYDOMONAS; EXPRESSION; STARVATION; BIOSYNTHESIS; ACCUMULATION; PROTEINS	Nitrogen assimilation and metabolism are essential processes for all living organisms, yet there is still much to be learnt on how they are regulated. The use of Chlamydomonas reinhardtiias a model system has been instrumental not only in identifying conserved regulation mechanisms that control the nitrogen assimilation pathway, but also in understanding how the intracellular nitrogen status regulates metabolic processes of industrial interest such as the synthesis of biolipids. While the genetic regulators that control the nitrogen pathway are successfully being unravelled, other layers of regulation have received less attention. Amino acids, for example, regulate nitrogen assimilation in certain organisms, but their role in Chlamydomonas has not thoroughly been explored. Previous results had suggested that arginine might repress key genes of the nitrogen assimilation pathway by acting within the ammonium negative signalling cascade, upstream of the nitric oxide (NO) inducible guanylate cyclase CYG56. We tested this hypothesis with a combination of genetic and chemical approaches. Antagonising the effects of arginine with an arginine biosynthesis mutant or with two chemical analogues released gene expression from ammonium mediated repression. The cyg56 and related non1 mutants, which are partially insensitive to ammonium repression, were also partially insensitive to repression by arginine. Finally, we show that the addition of arginine to the medium leads to an increase in intracellular NO. Our data reveal that arginine acts as a negative signal for the assimilation of nitrogen within the ammonium-CYG56 negative signalling cascade, and provide a connection between amino acid metabolism and nitrogen assimilation in microalgae.	[Gonzalez-Ballester, David; Sanz-Luque, Emanuel; Galvan, Aurora; Fernandez, Emilio; de Montaigu, Amaury] Univ Cordoba, Dept Bioquim & Biol Mol, Campus Rabanales, Cordoba, Spain; [Sanz-Luque, Emanuel] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [de Montaigu, Amaury] Heinrich Heine Univ, Inst Quantitat Genet & Genom Plants, Dusseldorf, Germany	Universidad de Cordoba; Carnegie Institution for Science; Heinrich Heine University Dusseldorf	Fernandez, E; de Montaigu, A (corresponding author), Univ Cordoba, Dept Bioquim & Biol Mol, Campus Rabanales, Cordoba, Spain.; de Montaigu, A (corresponding author), Heinrich Heine Univ, Inst Quantitat Genet & Genom Plants, Dusseldorf, Germany.	bb1feree@uco.es; montaigu@mpipz.mpg.de	Gonzalez-Ballester, David/AFT-1441-2022; Sanz-Luque, Emanuel/Z-2166-2019; Fernandez, Emilio/H-2892-2015; Gonzalez-Ballester, David/M-5551-2013; de Montaigu, Amaury/A-4121-2018; Galvan Cejudo, Aurora/A-9483-2010	Gonzalez-Ballester, David/0000-0003-0024-1886; Sanz-Luque, Emanuel/0000-0002-7300-9730; Gonzalez-Ballester, David/0000-0003-0024-1886; de Montaigu, Amaury/0000-0003-1366-2989; Fernandez Reyes, Emilio/0000-0001-5957-5392; Galvan Cejudo, Aurora/0000-0002-7564-2281	Ministerio de Economia y Competitividad [BFU2015-70649-P]; Junta de Andalucia [B10-502]	Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work was supported by Ministerio de Economia y Competitividad, Grant BFU2015-70649-P to EF and by Junta de Andalucia, Grant: B10-502 to EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Calatrava V, 2017, J EXP BOT, V68, P2593, DOI 10.1093/jxb/erw507; Camargo A, 2007, PLANT CELL, V19, P3491, DOI 10.1105/tpc.106.045922; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Chamizo-Ampudia A, 2016, PLANT CELL ENVIRON, V39, P2097, DOI 10.1111/pce.12739; Chellamuthu VR, 2014, CELL, V159, P1188, DOI 10.1016/j.cell.2014.10.015; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; de Lomana ALG, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0391-z; de Montaigu A, 2011, J EXP BOT, V62, P1425, DOI 10.1093/jxb/erq384; de Montaigu A, 2010, PLANT CELL, V22, P1532, DOI 10.1105/tpc.108.062380; Eppink MHM, 2017, CURRENT ALGAE PRODUC, P1, DOI [10.1007/10_2016_64, DOI 10.1007/10_2016_64]; Fernandez E, 2007, J EXP BOT, V58, P2279, DOI 10.1093/jxb/erm106; GALVAN A, 1991, BIOCHIM BIOPHYS ACTA, V1074, P6, DOI 10.1016/0304-4165(91)90030-K; Glass ADM, 2003, CRIT REV PLANT SCI, V22, P453, DOI [10.1080/713989757, 10.1080/07352680390243512]; Gonzalez-Ballester D, 2004, PLANT MOL BIOL, V56, P863, DOI 10.1007/s11103-004-5292-7; Gonzalez-Ballester D, 2005, PLANT PHYSIOL, V137, P522, DOI 10.1104/pp.104.050914; Gonzalez-Ballester D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-24; Jeandroz S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4403; KIRK DL, 1978, PLANT PHYSIOL, V61, P556, DOI 10.1104/pp.61.4.556; Konishi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2621; Liaudet L, 1998, J INFECT DIS, V177, P127, DOI 10.1086/513813; Llacer JL, 2008, CURR OPIN STRUC BIOL, V18, P673, DOI 10.1016/j.sbi.2008.11.002; LOPPES R, 1972, GENETICA, V43, P422, DOI 10.1007/BF00156137; Loppes R, 1999, PLANT MOL BIOL, V41, P701, DOI 10.1023/A:1006381527119; Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plouviez M, 2017, PLANT J, V91, P45, DOI 10.1111/tpj.13544; RADOMSKI MW, 1990, BRIT J PHARMACOL, V101, P325, DOI 10.1111/j.1476-5381.1990.tb12709.x; Rockel P, 2002, J EXP BOT, V53, P103, DOI 10.1093/jexbot/53.366.103; ROSENTHAL GA, 1977, Q REV BIOL, V52, P155, DOI 10.1086/409853; Santolini J, 2017, NITRIC OXIDE-BIOL CH, V63, P30, DOI 10.1016/j.niox.2016.09.005; Sanz-Luque E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155128; Sanz-Luque E, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00899; SCHLOSS JA, 1984, MOL CELL BIOL, V4, P424, DOI 10.1128/MCB.4.3.424; Slocum RD, 2005, PLANT PHYSIOL BIOCH, V43, P729, DOI 10.1016/j.plaphy.2005.06.007; Wei LL, 2014, PLANT CELL, V26, P353, DOI 10.1105/tpc.113.120121; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Wyant GA, 2017, CELL, V171, P642, DOI 10.1016/j.cell.2017.09.046; Zalutskaya Z, 2015, PLANT SCI, V240, P1, DOI 10.1016/j.plantsci.2015.08.019; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017	40	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196167	10.1371/journal.pone.0196167	http://dx.doi.org/10.1371/journal.pone.0196167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684072	Green Published, gold			2022-12-26	WOS:000430660600041
J	Guo, XF; Qiu, W; Liu, QL; Qian, MY; Wang, SB; Zhang, ZP; Gao, X; Chen, ZH; Xue, H; Li, G				Guo, Xiaofan; Qiu, Wei; Liu, Qinglin; Qian, Mingyu; Wang, Shaobo; Zhang, Zongpu; Gao, Xiao; Chen, Zihang; Xue, Hao; Li, Gang			Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways	ONCOGENE			English	Article							NF-KAPPA-B; BLOOD-BRAIN-BARRIER; TUMOR MICROENVIRONMENT; LINKING INFLAMMATION; ROR-ALPHA; GLIOBLASTOMA; ACTIVATION; CANCER; MIGRATION; DIFFERENTIATION	While immunosuppressive environments mediated by myeloid-derived suppressor cells (MDSCs) have been well documented in glioma patients, the mechanisms of MDSC development and activation have not been clearly defined. Here, we elucidated a role for glioma-derived exosomes (GDEs) in potentiating an MDSC pathway. We isolated normoxiastimulated and hypoxia-stimulated GDEs and studied their MDSC induction abilities in vivo and in vitro. Analyses of spleen and bone marrow MDSC proportions (flow cytometry) and reactive oxygen species (ROS), arginase activity, nitric oxide (NO), T-cell proliferation and immunosuppressive cytokine (IL-10 and TGF-beta, ELISA) levels were used to assess MDSC expansion and functional capacity. We also performed microRNA (miRNA) sequencing analysis of two types of GDEs to find miRNAs that potentially mediate the development and activation of MDSCs. GDE miRNA intracellular signaling in MDSCs was also studied. Hypoxia promoted the secretion of GDEs, and mouse MDSCs could uptake GDEs. Hypoxia-stimulated GDEs had a stronger ability to induce MDSCs than N-GDEs. The hypoxia-inducible expression of miR-10a and miR-21 in GDEs mediated GDE-induced MDSC expansion and activation by targeting RAR-related orphan receptor alpha (RORA) and phosphatase and tensin homolog (PTEN). Mice inoculated with miR-10a or miR-21 knockout glioma cells generated fewer MDSCs than those inoculated with normal glioma cells. These data elucidated a mechanism by which glioma cells influence the differentiation and activation of MDSCs via exosomes and demonstrated how local glioma hypoxia affects the entirety of tumor immune environments.	[Guo, Xiaofan; Qiu, Wei; Qian, Mingyu; Wang, Shaobo; Zhang, Zongpu; Gao, Xiao; Chen, Zihang; Xue, Hao; Li, Gang] Shandong Univ, Brain Sci Res Inst, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Liu, Qinglin; Xue, Hao; Li, Gang] Shandong Univ, Qilu Hosp, Dept Neurosurg, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University	Xue, H; Li, G (corresponding author), Shandong Univ, Brain Sci Res Inst, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Xue, H; Li, G (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurosurg, 107 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	undeadadams@163.com; ligangqiluhospital@163.com	Xue, Hao/GXV-4717-2022; Liu, Qing/GWC-9222-2022; liu, qingqing/HHD-0360-2022; Wang, Shaobo/AAI-4190-2020	Wang, Shaobo/0000-0001-7759-1687; Li, Gang/0000-0003-3184-1032	National Natural Science Foundation of China [81101594, 81372719, 81172403, 81300510, 81402077, 81571284, 91542115, 81702468]; National Natural Science Foundation of Shandong Province of China [2017CXGC1203]; Taishan Scholars of Shandong Province of China [ts201511093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shandong Province of China; Taishan Scholars of Shandong Province of China	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81101594; 81372719; 81172403; 81300510; 81402077; 81571284; 91542115; 81702468), National Natural Science Foundation of Shandong Province of China (No. 2017CXGC1203) and Taishan Scholars of Shandong Province of China (No. ts201511093).	Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Bott A, 2017, ONCOTARGET, V8, P43897, DOI 10.18632/oncotarget.14915; Chen CC, 2016, CELL MOL BIOENG, V9, P509, DOI 10.1007/s12195-016-0458-3; Condamine T, 2015, ANNU REV MED, V66, P97, DOI 10.1146/annurev-med-051013-052304; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Dubois LG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00418; Dunn-Pirio AM, 2017, CANCER-AM CANCER SOC, V123, P734, DOI 10.1002/cncr.30371; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garcia JA, 2015, FASEB J, V29, P3863, DOI 10.1096/fj.15-273656; Gieryng A, 2016, WSPOLCZESNA ONKOL, V20, P345, DOI 10.5114/wo.2016.64592; Guo XF, 2016, ONCOTARGET, V7, P80521, DOI 10.18632/oncotarget.11825; Guo X, 2015, ONCOTARGET, V6, P41620, DOI 10.18632/oncotarget.5871; Hannafon BN, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0753-x; Hellwinkel JE, 2016, NEURO-ONCOLOGY, V18, P497, DOI 10.1093/neuonc/nov170; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jeker LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036684; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Li LM, 2014, J IMMUNOL, V192, P1034, DOI 10.4049/jimmunol.1301309; Li L, 2016, CANCER RES, V76, P1770, DOI 10.1158/0008-5472.CAN-15-1625; Liu CR, 2007, BLOOD, V109, P4336, DOI 10.1182/blood-2006-09-046201; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; Nduom EK, 2015, NEURO-ONCOLOGY, V17, P9, DOI 10.1093/neuonc/nov151; Noman MZ, 2015, CANCER RES, V75, P3771, DOI 10.1158/0008-5472.CAN-15-0405; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Otvos B, 2016, STEM CELLS, V34, P2026, DOI 10.1002/stem.2393; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tadokoro H, 2013, J BIOL CHEM, V288, P34343, DOI 10.1074/jbc.M113.480822; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Vos KE, 2016, NEURO-ONCOLOGY, V18, P58, DOI 10.1093/neuonc/nov244; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Wu W, 2015, GUT, V64, P1755, DOI 10.1136/gutjnl-2014-307980; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Xue H, 2016, AUTOPHAGY, V12, P1129, DOI 10.1080/15548627.2016.1178446; Xue H, 2016, ONCOTARGET, V7, P4785, DOI 10.18632/oncotarget.6735; Yang TZ, 2015, PHARM RES-DORDR, V32, P2003, DOI 10.1007/s11095-014-1593-y; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zaidi AH, 2016, BIOCHEM J, V473, P859, DOI 10.1042/BJ20150624; Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489	49	136	143	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 2	2018	37	31					4239	4259		10.1038/s41388-018-0261-9	http://dx.doi.org/10.1038/s41388-018-0261-9			21	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP1HN	29713056				2022-12-26	WOS:000440566100004
J	Wang, SX; Jia, MM; He, ZK; Liu, XS				Wang, Shixiang; Jia, Mingming; He, Zaoke; Liu, Xue-Song			APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer	ONCOGENE			English	Article							MULTIPLE HUMAN CANCERS; PD-1 BLOCKADE; BREAST-CANCER; EXPRESSION PROFILES; ADVANCED MELANOMA; ADENOCARCINOMA; MUTAGENESIS; TUMORS; HYPERMUTATION; INFILTRATION	Non-small cell lung cancer (NSCLC) is known to carry heavy mutation load. Besides smoking, cytidine deaminase APOBEC3B plays a key role in the mutation process of NSCLC. APOBEC3B is also reported to be upregulated and predicts bad prognosis in NSCLC. However, targeting APOBEC3B high NSCLC is still a big challenge. Here we show that APOBEC3B upregulation is significantly associated with immune gene expression, and APOBEC3B expression positively correlates with known immunotherapy response biomarkers, including: PD-L1 expression and T-cell infiltration in NSCLC. Importantly, APOBEC mutational signature is specifically enriched in NSCLC patients with durable clinical benefit after immunotherapy and APOBEC mutation count can be better than total mutation in predicting immunotherapy response. In together, this work provides evidence that APOBEC3B upregulation and APOBEC mutation count can be used as novel predictive markers in guiding NSCLC checkpoint blockade immunotherapy.	[Wang, Shixiang; Jia, Mingming; He, Zaoke; Liu, Xue-Song] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201203, Peoples R China; [Wang, Shixiang; Jia, Mingming; He, Zaoke] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Wang, Shixiang; Jia, Mingming; He, Zaoke] Univ Chinese Acad Sci, Beijing, Peoples R China	ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, XS (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201203, Peoples R China.	liuxs@shanghaitech.edu.cn	Liu, Xue-Song/ADF-2183-2022; Wang, Shixiang/ABF-1926-2021	Liu, Xue-Song/0000-0002-7736-0077; Wang, Shixiang/0000-0001-9855-7357; Jia, Mingming/0000-0002-8757-5856; He, Zaoke/0000-0002-5756-3862	Shanghai Pujiang Program [16PJ1407400]; National Natural Science Foundation of China [31771373]; ShanghaiTech University.	Shanghai Pujiang Program(Shanghai Pujiang Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ShanghaiTech University.	We are grateful to the TCGA research network (http://cancergenome.nih.gov/), and the Broad-Novartis Cancer Cell Line Encyclopedia (http://www.broadinstitute.org/ccle/home) for providing the data analyzed in this manuscript. We thank Raymond Shuter for editing the text. We also thank Pengfei Lv of ShanghaiTech for the critical discussions. This work was supported in part by the Shanghai Pujiang Program (16PJ1407400), the National Natural Science Foundation of China (31771373) and startup funding from ShanghaiTech University.	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Boichard A, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1284719; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cescon DW, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1069-y; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Danaher P, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0215-8; Dong ZY, 2017, CLIN CANCER RES, V23, P3012, DOI 10.1158/1078-0432.CCR-16-2554; Dong ZY, 2016, TUMOR BIOL, V37, P4251, DOI 10.1007/s13277-016-4812-9; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Leonard B, 2015, CANCER RES, V75, P4538, DOI 10.1158/0008-5472.CAN-15-2171-T; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Maruyama W, 2016, BIOCHEM BIOPH RES CO, V478, P1466, DOI 10.1016/j.bbrc.2016.08.148; Middlebrooks CD, 2016, NAT GENET, V48, P1330, DOI 10.1038/ng.3670; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Periyasamy M, 2017, NUCLEIC ACIDS RES, V45, P11056, DOI 10.1093/nar/gkx721; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Saini N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006385; Sasaki H, 2014, BIOMED REP, V2, P392, DOI 10.3892/br.2014.256; Schabath MB, 2016, ONCOGENE, V35, P3209, DOI 10.1038/onc.2015.375; Shi JX, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002162; Shukuya T, 2016, J THORAC ONCOL, V11, P976, DOI 10.1016/j.jtho.2016.02.015; Smid M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12910; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Starrett GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12918; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Tang HD, 2016, CANCER CELL, V29, P285, DOI 10.1016/j.ccell.2016.02.004; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Ulloa-Montoya F, 2013, J CLIN ONCOL, V31, P2388, DOI 10.1200/JCO.2012.44.3762; Wang E, 2013, J CLIN ONCOL, V31, P2369, DOI 10.1200/JCO.2013.49.2157; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yan SM, 2016, J CANCER, V7, P618, DOI 10.7150/jca.14030	51	110	111	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 19	2018	37	29					3924	3936		10.1038/s41388-018-0245-9	http://dx.doi.org/10.1038/s41388-018-0245-9			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GN5LP	29695832	Green Published, hybrid			2022-12-26	WOS:000439101300002
J	Lei, SF; Clydesdale, L; Dai, AT; Cai, XQ; Feng, Y; Yang, DH; Liang, YL; Koole, C; Zhao, PS; Coudrat, T; Christopoulos, A; Wang, MW; Wootten, D; Sexton, PM				Lei, Saifei; Clydesdale, Lachlan; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Yang, Dehua; Liang, Yi-Lynn; Koole, Cassandra; Zhao, Peishen; Coudrat, Thomas; Christopoulos, Arthur; Wang, Ming-Wei; Wootten, Denise; Sexton, Patrick M.			Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); glucagon; receptor structure-function; cell signaling; site-directed mutagenesis; biased agonism; GLP-1 receptor; glucagon-like peptide-1; class B peptide hormone; ERK kinase; arrestin; transmembrane domain	CRYO-EM STRUCTURE; GLP-1 RECEPTOR; TRANSMEMBRANE DOMAIN; LIGAND-BINDING; N-TERMINUS; ACTIVATION; COMPLEX; MECHANISM; RESIDUES; CORE	G protein-coupled receptors (GPCRs) can be differentially activated by ligands to generate multiple and distinct downstream signaling profiles, a phenomenon termed biased agonism. The glucagon-like peptide-1 receptor (GLP-1R) is a class B GPCR and a key drug target for managing metabolic disorders; however, its peptide agonists display biased signaling that affects their relative efficacies. In this study, we combined mutagenesis experiments and mapping of surface mutations onto recently described GLP-1R structures, which revealed two major domains in the GLP-1/GLP-1R/G(s) protein active structure that are differentially important for both receptor quiescence and ligand-specific initiation and propagation of biased agonism. Changes to the conformation of transmembrane helix (TM) 5 and TM 6 and reordering of extracellular loop 2 were essential for the propagation of signaling linked to cAMP formation and intracellular calcium mobilization, whereas ordering and packing of residues in TMs 1 and 7 were critical for extracellular signal-regulated kinase 1/2 (pERK) activity. On the basis of these findings, we propose a model of distinct peptide-receptor interactions that selectively control how these different signaling pathways are engaged. This work provides important structural insight into class B GPCR activation and biased agonism.	[Lei, Saifei; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Yang, Dehua; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Lei, Saifei; Dai, Antao; Cai, Xiaoqing; Feng, Yang; Yang, Dehua; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Clydesdale, Lachlan; Liang, Yi-Lynn; Koole, Cassandra; Zhao, Peishen; Coudrat, Thomas; Christopoulos, Arthur; Wootten, Denise; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Lei, Saifei; Wang, Ming-Wei] Univ Chinese Acad Sci, Sch Pharm, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Wang, Ming-Wei; Wootten, Denise; Sexton, Patrick M.] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Monash University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University	Wang, MW (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China.; Wang, MW (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China.; Wootten, D; Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia.; Wang, MW (corresponding author), Univ Chinese Acad Sci, Sch Pharm, 19A Yuquan Rd, Beijing 100049, Peoples R China.; Wang, MW; Wootten, D; Sexton, PM (corresponding author), Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China.	mwwang@simm.ac.cn; denise.wootten@monash.edu; patrick.sexton@monash.edu	Wootten, Denise/ABD-5703-2021; Yang, Dehua/M-5789-2019; Sexton, Patrick M/B-1319-2008; Zhao, Peishen/AFQ-6840-2022; Christopoulos, Arthur/B-6207-2013	Wootten, Denise/0000-0003-4563-1642; Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Coudrat, Thomas/0000-0001-9197-1889	National Health and Medical Research Council of Australia [1061044, 1065410, 1126857]; National Health and Medical Research Council [1055134]; Shanghai Science and Technology Development Fund [15DZ2291600]; National Natural Science Foundation of China [81573479]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12020347, XDA12040308]; Chinese Academy of Sciences	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Shanghai Science and Technology Development Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by National Health and Medical Research Council of Australia Project Grants 1061044, 1065410, and 1126857; National Health and Medical Research Council Program Grant 1055134; Shanghai Science and Technology Development Fund Grant 15DZ2291600; National Natural Science Foundation of China Grant 81573479; and Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDA12020347 and XDA12040308. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of the Postgraduate Overseas Study Fellowship from the Chinese Academy of Sciences.	Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Costa-Neto CM, 2016, MOL PHARMACOL, V90, P587, DOI 10.1124/mol.116.105940; Dal Maso E, 2018, BIOCHEM PHARMACOL, V150, P212, DOI 10.1016/j.bcp.2018.02.005; de Graaf C, 2016, PHARMACOL REV, V68, P954, DOI 10.1124/pr.115.011395; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Dods RL, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150253; Hager MV, 2017, BIOCHEM PHARMACOL, V136, P99, DOI 10.1016/j.bcp.2017.03.018; Hager MV, 2016, J AM CHEM SOC, V138, P14970, DOI 10.1021/jacs.6b08323; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Jazayeri A, 2017, NATURE, V546, P254, DOI 10.1038/nature22800; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Koole C, 2015, J PHARMACOL EXP THER, V353, P52, DOI 10.1124/jpet.114.220913; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koole C, 2011, MOL PHARMACOL, V80, P486, DOI 10.1124/mol.111.072884; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Mukund S, 2013, J BIOL CHEM, V288, P36168, DOI 10.1074/jbc.M113.496984; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Song GJ, 2017, NATURE, V546, P312, DOI 10.1038/nature22378; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Weston C, 2014, BRIT J PHARMACOL, V171, P3651, DOI 10.1111/bph.12716; Wootten D, 2017, CHEM REV, V117, P111, DOI 10.1021/acs.chemrev.6b00049; Wootten D, 2016, BIOCHEM PHARMACOL, V118, P68, DOI 10.1016/j.bcp.2016.08.015; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Yin YT, 2017, J BIOL CHEM, V292, P9865, DOI 10.1074/jbc.M117.782987; Yin YT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.42; Zhang HN, 2018, NATURE, V553, P106, DOI 10.1038/nature25153; Zhang HK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9918; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zhao LH, 2016, J BIOL CHEM, V291, P15119, DOI 10.1074/jbc.M116.726620	40	31	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9370	9387		10.1074/jbc.RA118.003278	http://dx.doi.org/10.1074/jbc.RA118.003278			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29717000	Green Published, hybrid			2022-12-26	WOS:000435441400022
J	Abdulrahman, BA; Abdelaziz, DH; Schatzl, HM				Abdulrahman, Basant A.; Abdelaziz, Dalia H.; Schatzl, Hermann M.			Autophagy regulates exosomal release of prions in neuronal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGGREGATE-PRONE PROTEINS; CELLULAR PRION; NEURODEGENERATIVE DISEASES; EXTRACELLULAR VESICLES; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; INFECTED CELLS; UNCONVENTIONAL SECRETION; MULTIVESICULAR BODIES; SELF-DIGESTION	Prions are protein-based infectious agents that autocatalytically convert the cellular prion protein PrP C to its pathological isoform PrPSc. Subsequent aggregation and accumulation of PrPSc in nervous tissues causes several invariably fatal neurodegenerative diseases in humans and animals. Prions can infect recipient cells when packaged into endosome-derived nanoparticles called exosomes, which are present in biological fluids such as blood, urine, and saliva. Autophagy is a basic cellular degradation and recycling machinery that also affects exosomal processing, but whether autophagy controls release of prions in exosomes is unclear. Our work investigated the effect of autophagy modulation on exosomal release of prions and how this interplay affects cellular prion infection. Exosomes isolated from cultured murine central neuronal cells (CAD5) and peripheral neuronal cells (N2a) contained prions as shown by immunoblotting for PrPSc, prion-conversion activity, and cell culture infection. We observed that autophagy stimulation with the mTOR inhibitor rapamycin strongly inhibited exosomal prion release. In contrast, inhibition of autophagy by wortmannin or CRISPR/ Cas9-mediated knockout of the autophagy protein Atg5 (autophagy-related 5) greatly increased the release of exosomes and exosome-associated prions. We also show that a difference in exosomal prion release between CAD5 and N2a cells is related to differences at the level of basal autophagy. Taken together, our results indicate that autophagy modulation can control lateral transfer of prions by interfering with their exosomal release. We describe a novel role of autophagy in the prion life cycle, an understanding that may provide useful targets for containing prion diseases.	[Abdulrahman, Basant A.; Abdelaziz, Dalia H.; Schatzl, Hermann M.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4Z6, Canada; [Abdulrahman, Basant A.; Abdelaziz, Dalia H.; Schatzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB T2N 4Z6, Canada; [Abdulrahman, Basant A.; Abdelaziz, Dalia H.] Helwan Univ, Dept Biochem & Mol Biol, Fac Pharm, Cairo 11795, Egypt; [Schatzl, Hermann M.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Schatzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Calgary; University of Calgary; Egyptian Knowledge Bank (EKB); Helwan University; University of Wyoming; University of Wyoming	Schatzl, HM (corresponding author), Univ Calgary, Fac Vet Med, TRW 2D10,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	hschaetz@ucalgary.ca		Schatzl, Hermann/0000-0003-4972-8740; Abdulrahman, Basant/0000-0002-4970-6835	NINDS, National Institutes of Health [R01 NS076853-01A1]; Alberta Innovates-Health Solutions [201200002, 201300020, 201600010]; Canadian Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-05130]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates-Health Solutions; Canadian Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant R01 NS076853-01A1, Alberta Innovates-Health Solutions Grant 201200002, 201300020, and 201600010, and Canadian Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2015-05130. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Baixauli F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00403; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; Cortes CJ, 2014, DRUG DISCOV TODAY, V19, P963, DOI 10.1016/j.drudis.2014.02.014; Cortes CJ, 2012, J NEUROSCI, V32, P12396, DOI 10.1523/JNEUROSCI.6189-11.2012; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Dias MVS, 2016, AUTOPHAGY, V12, P2113, DOI 10.1080/15548627.2016.1226735; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gilch S, 2001, EMBO J, V20, P3957, DOI 10.1093/emboj/20.15.3957; Gilch S, 2011, TOP CURR CHEM, V305, P51, DOI 10.1007/128_2011_159; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Guo BB, 2016, J BIOL CHEM, V291, P5128, DOI 10.1074/jbc.M115.684258; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Ishibashi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137958; Janas AM, 2016, BBA-BIOMEMBRANES, V1858, P1139, DOI 10.1016/j.bbamem.2016.02.011; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liberski PP, 2004, INT J BIOCHEM CELL B, V36, P2473, DOI 10.1016/j.biocel.2004.04.016; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nakagaki T, 2013, AUTOPHAGY, V9, P1386, DOI 10.4161/auto.25381; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Porto-Carreiro I, 2005, BLOOD CELL MOL DIS, V35, P143, DOI 10.1016/j.bcmd.2005.06.013; Properzi F, 2013, BIOMARK MED, V7, P769, DOI 10.2217/bmm.13.63; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qi YP, 1997, J NEUROSCI, V17, P1217; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Quek C, 2017, BIOCHEM BIOPH RES CO, V483, P1178, DOI 10.1016/j.bbrc.2016.09.090; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rester R, 2010, P NATL ACAD SCI USA, V107, P13147; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schatzl HM, 1997, J VIROL, V71, P8821; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shrivastava S, 2016, J VIROL, V90, P1387, DOI 10.1128/JVI.02383-15; Sikorska B, 2004, INT J BIOCHEM CELL B, V36, P2563, DOI 10.1016/j.biocel.2004.04.014; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Tang Z, 2015, BBA-MOL CELL RES, V1853, P1646, DOI 10.1016/j.bbamcr.2015.03.003; Telling GC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003090; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Yun SW, 2007, J NEUROVIROL, V13, P328, DOI 10.1080/13550280701361516; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zanusso G, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2016.92; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	82	71	72	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8956	8968		10.1074/jbc.RA117.000713	http://dx.doi.org/10.1074/jbc.RA117.000713			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29700113	hybrid, Green Published			2022-12-26	WOS:000434941900019
J	Luo, ZZ; Li, W; Wu, QH; Zhang, L; Tian, LS; Liu, LL; Ding, Y; Yuan, J; Chen, ZW; Lan, LN; Wu, XB; Cai, YM; Hong, FC; Feng, TJ; Zhang, M; Chen, XS				Luo, Zhen-Zhou; Li, Wu; Wu, Qiu-Hong; Zhang, Li; Tian, Li-Shan; Liu, Lan-Lan; Ding, Yi; Yuan, Jun; Chen, Zhong-Wei; Lan, Li-Na; Wu, Xiao-Bing; Cai, Yu-Mao; Hong, Fu-Chang; Feng, Tie-Jian; Zhang, Min; Chen, Xiang-Sheng			Population-based study of chlamydial and gonococcal infections among women in Shenzhen, China: Implications for programme planning	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; FEMALE SEX WORKERS; ECTOPIC PREGNANCY; YOUNG-ADULTS; RISK-FACTORS; CONDOM USE; TRACHOMATIS; PREVALENCE	This study was aimed to estimate the prevalences of chlamydia (CT) and gonococcal (NG) infections and explore risk factors associated with the CT infection among women in Shenzhen, China. We collected socio-demographic and clinical data from women (aged 20-60) and determined positivity of CT or NG by nucleic acid amplification test (NAAT) with self-collected urine specimens. We estimated prevalence of CT and NG and determined risk factors associated with CT infection. Among 9,207 participants, 4.12% (95% confidence interval [CI], 3.71%-4.53%) tested positive for CT and 0.17% (95% CIs, 0.09%-0.25%) for NG. Factors significantly associated with CT infection included being an ethnic minority (ethnicity other than Han China) (Adjusted odds ratio [AOR], 1.9; 95% CI, 1.2-3.0), using methods other than condom for contraception (AOR, 1.5; 95% CI, 1.2-1.8), having a history of adverse pregnancy outcomes (AOR, 1.4; 95% CI, 1.1-1.8), and experiencing reproductive tract symptoms in the past three months (AOR, 1.3; 95% CI, 1.0-1.7). we found that CT infection is prevalent among women in Shenzhen, China and associated with both demographic and behavioral factors. A comprehensive CT screening, surveillance and treatment programme targeting this population is warranted.	[Luo, Zhen-Zhou; Li, Wu; Wu, Qiu-Hong; Zhang, Li; Tian, Li-Shan; Liu, Lan-Lan; Ding, Yi; Yuan, Jun; Chen, Zhong-Wei] Shenzhen Nanshan Ctr Chron Dis Control, Shenzhen, Peoples R China; [Lan, Li-Na; Wu, Xiao-Bing; Cai, Yu-Mao; Hong, Fu-Chang; Feng, Tie-Jian; Zhang, Min] Shenzhen Ctr Chron Dis Control, Shenzhen, Peoples R China; [Chen, Xiang-Sheng] Chinese Acad Med Sci, Nanjing, Jiangsu, Peoples R China; [Chen, Xiang-Sheng] Peking Union Med Coll, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Chen, Xiang-Sheng] Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College	Zhang, M (corresponding author), Shenzhen Ctr Chron Dis Control, Shenzhen, Peoples R China.; Chen, XS (corresponding author), Chinese Acad Med Sci, Nanjing, Jiangsu, Peoples R China.; Chen, XS (corresponding author), Peking Union Med Coll, Inst Dermatol, Nanjing, Jiangsu, Peoples R China.; Chen, XS (corresponding author), Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China.	szdaisymin@126.com; chenxs@ncstdlc.org		Li, Wu/0000-0003-3517-4425	Sanming Project in Medicine in Shenzhen [SZSM201611077]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2016-I2M-3-021]; Nanshan Bureau of Health and Family Planning of Shenzhen	Sanming Project in Medicine in Shenzhen; Chinese Academy of Medical Sciences Initiative for Innovative Medicine; Nanshan Bureau of Health and Family Planning of Shenzhen	Sanming Project in Medicine in Shenzhen (SZSM201611077) and Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2016-I2M-3-021) supported the study. This study was a part of the comprehensive programme for control of chlamydial infections sponsored by the Nanshan Bureau of Health and Family Planning of Shenzhen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was a part of the comprehensive programme for control of chlamydial infections sponsored by the Nanshan Bureau of Health and Family Planning of Shenzhen. We thank staff at the Nanshan Hospital of Maternal and Child Care for their wonderful assistance to implementation of this study in sites. We are also very grateful to all participants of this study for their cooperation. We also appreciate Dr. Kate Muessig for providing English editorial assistance.	Afrasiabi S, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.8(4)2015.15576; Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; [阿米娜·胡马尔 Amina · Humaer], 2017, [中华生殖与避孕杂志, Chinese Journal of Reproduction and Contraception], V37, P227; Bozicevic I, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-230; BRUNHAM RC, 1992, J INFECT DIS, V165, P1076, DOI 10.1093/infdis/165.6.1076; Carcamo CP, 2012, LANCET INFECT DIS, V12, P765, DOI 10.1016/S1473-3099(12)70144-5; Centers for Disease Control and Prevention, 2016, SEX TRANSM DIS SURV; Chandra NL, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.5.30453; Chen XS, 2005, AIDS PATIENT CARE ST, V19, P853, DOI 10.1089/apc.2005.19.853; Cheng JQ, 2007, SEX TRANSM INFECT, V83, P347, DOI 10.1136/sti.2006.023655; CHOW JM, 1990, JAMA-J AM MED ASSOC, V263, P3164, DOI 10.1001/jama.263.23.3164; Davey DLJ, 2016, SEX TRANSM DIS, V43, P450, DOI 10.1097/OLQ.0000000000000460; Gong XiangDong, 2014, Chinese Journal of Dermatology, V47, P310; Goulet V, 2010, SEX TRANSM INFECT, V86, P263, DOI 10.1136/sti.2009.038752; Hafner LM, 2014, VACCINE, V32, P1563, DOI 10.1016/j.vaccine.2013.08.020; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Harder E, 2016, SEX TRANSM DIS, V43, P113, DOI 10.1097/OLQ.0000000000000394; Honey E, 2002, SEX TRANSM INFECT, V78, P406, DOI 10.1136/sti.78.6.406; Huang YY, 2014, AIDS BEHAV, V18, pS118, DOI 10.1007/s10461-013-0645-3; Klovstad H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-150; Lanjouw E, 2016, INT J STD AIDS, V27, P333, DOI 10.1177/0956462415618837; Li ZJ, 2017, EARLY WARNING FOR INFECTIOUS DISEASE OUTBREAK: THEORY AND PRACTICE, P203, DOI 10.1016/B978-0-12-812343-0.00010-2; Liu ZY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-74; Low N, 2012, EUR J PUBLIC HEALTH, V22, P556, DOI 10.1093/eurpub/ckr046; Masese LN, 2017, SEXUALLY TRANSMIT S2, V91, P1; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Paz-Bailey G, 2005, ARCH PEDIAT ADOL MED, V159, P536, DOI 10.1001/archpedi.159.6.536; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Rantsi T, 2016, SEX TRANSM DIS, V43, P382, DOI 10.1097/OLQ.0000000000000432; Redmond SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115753; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Torrone E, 2014, MMWR-MORBID MORTAL W, V63, P834; van den Broek IVF, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4316; Velicko I, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011312; Wang HX, 2017, NEW MICROBIOL, V40, P113; Wong WCW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172561; Workowski KA, 2015, CLIN INFECT DIS, V61, pS759, DOI 10.1093/cid/civ771; Yue XiaoLi, 2016, Chinese Journal of Dermatology, V49, P308; Zhu LP, 2010, INT J INFECT DIS, V14, pE45, DOI 10.1016/j.ijid.2009.09.009; Zou X, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-490	42	17	21	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e196516	10.1371/journal.pone.0196516	http://dx.doi.org/10.1371/journal.pone.0196516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715319	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100029
J	Park, HE; Park, HT; Jung, YH; Yoo, HS				Park, Hyun-Eui; Park, Hong-Tae; Jung, Young Hoon; Yoo, Han Sang			Gene expression profiles of immune-regulatory genes in whole blood of cattle with a subclinical infection of Mycobacterium avium subsp paratuberculosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; T-CELL; GRANULOMA-FORMATION; JOHNES-DISEASE; PROLIFERATION; TUBERCULOSIS; MACROPHAGES; INHIBITION; RESPONSES; SURVIVAL	Johne's disease is a chronic wasting disease of ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP), resulting in inflammation of intestines and persistent diarrhea. The initial host response against MAP infections is mainly regulated by the Th1 response, which is characterized by the production of IFN-gamma. With the progression of disease, MAP can survive in the host through the evasion of the host's immune response by manipulating the host immune response. However, the host response during subclinical phases has not been fully understood. Immune regulatory genes, including Th17-derived cytokines, interferon regulatory factors, and calcium signaling-associated genes, are hypothesized to play an important role during subclinical phases of Johne's disease. Therefore, the present study was conducted to analyze the expression profiles of immune regulatory genes during MAP infection in whole blood. Different expression patterns of genes were identified depending on the infection stages. Downregulation of IL-17A, IL-17F, IL-22, IL-26, HMGB1, and IRF4 and upregulation of PIP5K1C indicate suppression of the Th1 response due to MAP infection and loss of granuloma integrity. In addition, increased expression of IRF5 and IRF7 suggest activation of IFN-alpha/beta signaling during subclinical stages, which induced indoleamine 2,3-dioxygenase mediated depletion of tryptophan metabolism. Increased expression of CORO1A indicate modulation of calcium signaling, which enhanced the survival of MAP. Taken together, distinct host gene expression induced by MAP infection indicates enhanced survival of MAP during subclinical stages.	[Park, Hyun-Eui; Park, Hong-Tae; Yoo, Han Sang] Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea; [Jung, Young Hoon] Natl Inst Anim Sci, Rural Dev Adm, Wonju, South Korea; [Yoo, Han Sang] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea	Seoul National University (SNU); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU)	Yoo, HS (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea.; Yoo, HS (corresponding author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea.	yoohs@snu.ac.kr		YOO, HAN SANG/0000-0003-0548-0835	Cooperative Research Program for Agriculture Science & Technology Development [PJ00897001]; Rural Development Administration; BK21 PLUS; Research Institute for Veterinary Sciences, Seoul National University, Republic of Korea	Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); BK21 PLUS; Research Institute for Veterinary Sciences, Seoul National University, Republic of Korea	This work was supported by the Cooperative Research Program for Agriculture Science & Technology Development (project no. PJ00897001), Rural Development Administration, BK21 PLUS and the Research Institute for Veterinary Sciences, Seoul National University, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendano N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104238; Andres-Benito P, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00546; Arsenault RJ, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-54; Awuh JA, 2015, P NATL ACAD SCI USA, V112, pE4272, DOI 10.1073/pnas.1423449112; Bernut A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005986; Bo M, 2018, CLIN EXP RHEUMATOL; BUERGELT CD, 1978, VET PATHOL, V15, P196, DOI 10.1177/030098587801500206; BUKHOLM G, 1984, INFECT IMMUN, V45, P62, DOI 10.1128/IAI.45.1.62-66.1984; Casey ME, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00023; Cossu D, 2015, MULT SCLER J, V21, P984, DOI 10.1177/1352458514557304; Coulter F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01252; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; Cronan MR, 2016, IMMUNITY, V45, P861, DOI 10.1016/j.immuni.2016.09.014; David J, 2014, VET RES, V45, DOI 10.1186/s13567-014-0096-5; David J, 2014, VET IMMUNOL IMMUNOP, V160, P107, DOI 10.1016/j.vetimm.2014.04.006; Dhiman R, 2014, J INFECT DIS, V209, P578, DOI 10.1093/infdis/jit495; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Fallarino F, 2003, ADV EXP MED BIOL, V527, P183; Fecteau ME, 2013, CAN VET J, V54, P1083; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Ganusov VV, 2015, VET RES, V46, DOI 10.1186/s13567-015-0204-1; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hostetter J, 2003, COMP IMMUNOL MICROB, V26, P269, DOI 10.1016/S0147-9571(02)00070-X; Ishihara T, 2005, BIOMED RES-TOKYO, V26, P179, DOI 10.2220/biomedres.26.179; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jayachandran R, 2015, INT IMMUNOPHARMACOL, V28, P825, DOI 10.1016/j.intimp.2015.03.045; Khare S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161946; Koets AP, 2015, VET RES, V46, DOI 10.1186/s13567-015-0185-0; Li H, 2017, J NANOTECHNOL, V2017, P1, DOI DOI 10.1016/J.BI0PHA.2017.01.037; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Magombedze G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146844; Mahnke J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35521; Mameli G, 2016, SCI REP-UK, V6, DOI 10.1038/srep22401; Marino R, 2017, MOL IMMUNOL, V91, P259, DOI 10.1016/j.molimm.2017.08.017; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Miot C, 2015, GUT, V64, P1466, DOI 10.1136/gutjnl-2013-306604; Munster P, 2013, J ZOO WILDLIFE MED, V44, P176, DOI 10.1638/1042-7260-44.1.176; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Nam S, 2016, ARCH PHARM RES, V39, P1548, DOI 10.1007/s12272-016-0854-1; Park HongTae, 2014, Korean Journal of Veterinary Research, V54, P55, DOI 10.14405/kjvr.2014.54.1.55; Park HE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178336; Park HE, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw022; Park KT, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00064; Plain KM, 2011, INFECT IMMUN, V79, P3821, DOI 10.1128/IAI.05204-11; Queval CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02284; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Rathnaiah G, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00187; Rendon-Mitchell B, 2003, J IMMUNOL, V170, P3890, DOI 10.4049/jimmunol.170.7.3890; Robinson MW, 2011, INFECT IMMUN, V79, P2089, DOI 10.1128/IAI.00779-10; Rumsey J, 2006, MED SCI MONITOR; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schiavoni G, 2004, J IMMUNOL, V173, P1266, DOI 10.4049/jimmunol.173.2.1266; Schill NJ, 2014, J CELL SCI, V127, P2189, DOI 10.1242/jcs.132423; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Sevilla IA, 2014, APPL ENVIRON MICROB, V80, P3757, DOI 10.1128/AEM.01026-14; Shin MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138770; Shin MK, 2015, J MICROBIOL BIOTECHN, V25, P255, DOI 10.4014/jmb.1408.08059; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Smith SG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00644; Stabel J. R., 2006, Animal Health Research Reviews, V7, P61, DOI 10.1017/S1466252307001168; Stephen-Victor E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005624; Tengvall S, 2016, J INNATE IMMUN, V8, P15, DOI 10.1159/000434646; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Tiwari A, 2006, CAN VET J, V47, P874; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Uribe-Querol E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01368; Verschoor CP, 2010, VET IMMUNOL IMMUNOP, V137, P1, DOI 10.1016/j.vetimm.2010.03.026; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Zhang MZ, 2011, J VET DIAGN INVEST, V23, P41, DOI 10.1177/104063871102300106; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030	77	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196502	10.1371/journal.pone.0196502	http://dx.doi.org/10.1371/journal.pone.0196502			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698503	gold, Green Submitted, Green Published			2022-12-26	WOS:000431007600088
J	Frezza, E; Martin, J; Lavery, R				Frezza, Elisa; Martin, Juliette; Lavery, Richard			A molecular dynamics study of adenylyl cyclase: The impact of ATP and G-protein binding	PLOS ONE			English	Article							PARTICLE MESH EWALD; CRYSTAL-STRUCTURE; FORCE-FIELD; RESP MODEL; CAMP; MECHANISM; SIMULATION; FORSKOLIN; DOMAINS; GROMACS	Adenylyl cyclases (ACs) catalyze the biosynthesis of cyclic adenosine monophosphate (cAMP) from adenosine triphosphate (ATP) and play an important role in many signal transduction pathways. The enzymatic activity of ACs is carefully controlled by a variety of molecules, including G-protein subunits that can both stimulate and inhibit cAMP production. Using homology models developed from existing structural data, we have carried out all-atom, microsecond-scale molecular dynamics simulations on the AC5 isoform of adenylyl cyclase and on its complexes with ATP and with the stimulatory G-protein subunit Gs alpha. The results show that both ATP and Gs alpha binding have significant effects on the structure and flexibility of adenylyl cyclase. New data on ATP bound to AC5 in the absence of Gs alpha notably help to explain how Gs alpha binding enhances enzyme activity and could aid product release. Simulations also suggest a possible coupling between ATP binding and interactions with the inhibitory G-protein subunit G alpha i.	[Frezza, Elisa; Martin, Juliette; Lavery, Richard] Univ Lyon 1, Inst Biol & Chim Proteines, MMSB, CNRS,UMR 5086, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Lavery, R (corresponding author), Univ Lyon 1, Inst Biol & Chim Proteines, MMSB, CNRS,UMR 5086, Lyon, France.	richard.lavery@ibcp.fr	Martin, Juliette/T-9457-2019; Martin, Juliette/N-5545-2016; Frezza, Elisa/AAK-3536-2020; Lavery, Richard/G-1422-2011	Martin, Juliette/0000-0002-4787-0885; Martin, Juliette/0000-0002-4787-0885; Frezza, Elisa/0000-0003-0122-7859; Lavery, Richard/0000-0001-9901-6640	European Union Seventh Framework Programme [720270]; CINES super-computer OCCIGEN [2016 D -201607758, 2017- A0020707585]	European Union Seventh Framework Programme(European Commission); CINES super-computer OCCIGEN	We thank the European Union Seventh Framework Programme (no. FP7/20072013), under grant agreement no. 720270 (SGA1) - The Human Brain Project for funding, http://www.humanbrainproject.eu/en/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; We thank the European Union Seventh Framework Programme (No. FP7/2007-2013), under Grant Agreement No. 720270 (SGA1) - The Human Brain Project for funding. EF and RL wish to acknowledge GENCI for a generous allocation of computer time on the CINES super-computer OCCIGEN (Grant 2016 D -201607758 and Grant 2017- A0020707585). We thank Paolo Carloni and Siri Camee van Keulen (Institut des Sciences et Inge A nierie Chimiques, EPFL, Switzerland) for helpful discussions. We thank Pietro Vidossich (Computational Biomedicine, Forschungszentrum Julich, Germany) for providing the RESP charges for FOK and for helpful discussions.	Alasbahi RH, 2012, PHARMAZIE, V67, P5, DOI 10.1691/ph.2012.1642; Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Berendsen H.J.C., 1984, PROC NATO ADV STUDY, V1984, P475; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; DANG LX, 1995, J AM CHEM SOC, V117, P6954, DOI 10.1021/ja00131a018; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Finkelstein A. V., 2002, PROTEIN PHYS COURSE; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; GILMAN AG, 1995, BIOSCIENCE REP, V15, P65, DOI 10.1007/BF01200143; Hahn DK, 2015, BIOCHEMISTRY-US, V54, P6252, DOI 10.1021/acs.biochem.5b00655; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Harvey SC, 1998, J COMPUT CHEM, V19, P726, DOI 10.1002/(SICI)1096-987X(199805)19:7<726::AID-JCC4>3.0.CO;2-S; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Ho D, 2010, HEART FAIL REV, V15, P495, DOI 10.1007/s10741-010-9183-5; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; JACOBOWITZ O, 1993, J BIOL CHEM, V268, P3829; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laskowski RA, 1995, J MOL GRAPHICS, V13, P328; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Masada N, 2012, BIOCHEMISTRY-US, V51, P7917, DOI 10.1021/bi300646y; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Moreira IS, 2014, BBA-GEN SUBJECTS, V1840, P16, DOI 10.1016/j.bbagen.2013.08.027; Neves-Zaph SR, 2015, METHODS MOL BIOL, V1294, P203, DOI 10.1007/978-1-4939-2537-7_16; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patel TB, 2001, GENE, V269, P13, DOI 10.1016/S0378-1119(01)00448-6; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; RALL TW, 1958, J BIOL CHEM, V232, P1065; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Steegborn C, 2014, BBA-MOL BASIS DIS, V1842, P2535, DOI 10.1016/j.bbadis.2014.08.012; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Keulen SC, 2017, BIOCHEMISTRY-US, V56, P271, DOI 10.1021/acs.biochem.6b00388; van Keulen SC, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005673; Vatner SF, 2013, AM J PHYSIOL-HEART C, V305, pH1, DOI 10.1152/ajpheart.00080.2013; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang SC, 2009, NEUROSIGNALS, V17, P169, DOI 10.1159/000200076; Whisnant RE, 1996, P NATL ACAD SCI USA, V93, P6621, DOI 10.1073/pnas.93.13.6621; Yan SZ, 1996, J BIOL CHEM, V271, P10941, DOI 10.1074/jbc.271.18.10941; Yan SZ, 1997, J BIOL CHEM, V272, P12342, DOI 10.1074/jbc.272.19.12342; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	72	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196207	10.1371/journal.pone.0196207	http://dx.doi.org/10.1371/journal.pone.0196207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694437	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400074
J	Savoldelli, C; Chamorey, E; Bettega, G				Savoldelli, Charles; Chamorey, Emmanuel; Bettega, Georges			Computer-assisted teaching of bilateral sagittal split osteotomy: Learning curve for condylar positioning	PLOS ONE			English	Article							ORTHOGNATHIC SURGERY; RAMUS OSTEOTOMY; MANDIBULAR SETBACK; DYSFUNCTION; RESORPTION; NAVIGATION; ACCURACY	Bilateral sagittal split osteotomy (BSSO) is a widely-performed procedure in orthognathic surgery for the correction of dentofacial deformity. Condylar positioning is a critical step during BSSO to maximize functional and morphological results. The unsuitable positioning of condyles represents one of the causative mechanisms that may induce temporomandibular joint noxious effects after BSSO. Repositioning devices can assist surgeons in maintaining the preoperative condylar position; however, empirical repositioning methods based on experience gained are still commonly used. Trainee learning curves are difficult to assess. The aim of this study was to evaluate the relevance of computer-assisted surgery in the acquisition of condylar positioning skills. Forty-eight patients underwent BSSO performed by six maxillofacial trainees (four junior residents and two senior experienced residents). A condyle positioning system (CPS) was used by a senior surgeon to record a condylar position score during the procedure. Firstly, scores were recorded when the trainee manually positioned the condyle without access to the CPS score (phase 1) and then when the trainee positioned the condyle and performed osteosynthesis with visual access to the CPS score (phase 2). Six parameters describing condylar three-dimensional motions were assessed: translational motion from top to bottom (TB), back to front (BF), and left to right (LR), axial rotation (AR), sagittal rotation (SR), frontal rotation (FR), and a total score (TS). There were no significant differences between junior and senior residents in condyle positioning without access to the CPS. Condyles were significantly better positioned during phase 2 with access to the CPS (p< 0.001). Over time, use of the CPS (phase 2) produced significantly quicker improvements in scores (p = 0.042). For those teaching surgeries to trainees, computerassisted devices can potentially result in more rapid learning curves than traditional obser-vations- imitation" models. Use of a CPS by trainees facilitated condylar repositioning that resulted in an accurate occlusal result and avoidance of adverse effects on the temporomandibular joint.	[Savoldelli, Charles] Univ Hosp Nice, Head & Neck Inst, Dept Oral & Maxillofacial Surg, Nice, France; [Chamorey, Emmanuel] Ctr Antoine Lacassagne, Biostat Dept, Nice, France; [Bettega, Georges] Ctr Hosp Annecy Genevois, Dept Oral & Maxillofacial Surg, Metz Tessy, France; [Bettega, Georges] Grenoble Univ Hosp, Plast & Maxillofacial Surg Dept, Grenoble, France	CHU Nice; UNICANCER; Centre Antoine Lacassagne; Centre Hospitalier Annecy Genevois; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Savoldelli, C (corresponding author), Univ Hosp Nice, Head & Neck Inst, Dept Oral & Maxillofacial Surg, Nice, France.	savoldelli.c@chu-nice.fr	Chamorey, Emmanuel/AGO-9982-2022	bettega, georges/0000-0001-5401-0747				Abdel-Galil K, 2009, BRIT J ORAL MAX SURG, V47, P140, DOI 10.1016/j.bjoms.2008.07.189; Andersen SA, 2015, JAMA OTOLARYNGOL, V141, P913, DOI 10.1001/jamaoto.2015.1563; [Anonymous], 1948, JAMA-J AM MED ASSOC, V138, P929, DOI [10.1001/jama.1948.02900120071035, DOI 10.1001/JAMA.1948.02900120071035]; Azarmehr I, 2017, J ORAL MAXIL SURG, V75, P1987, DOI 10.1016/j.joms.2017.01.004; Bays Robert A, 2003, Oral Maxillofac Surg Clin North Am, V15, P229; Benateau H, 2014, REV STOMATOL CHIR, P245, DOI [10.1016/j.revsto.2014.06.003, DOI 10.1016/J.REVSTO.2014.06.003]; Berlin NL, 2016, PLAST RECONSTR SURG, V138, p273E, DOI 10.1097/PRS.0000000000002384; Bettega G, 2013, REV STOMATOL CHIR, V114, P205, DOI 10.1016/j.revsto.2013.06.001; Bettega G, 2002, J ORAL MAXIL SURG, V60, P27, DOI 10.1053/joms.2002.29069; Biau DJ, 2008, BRIT J SURG, V95, P925, DOI 10.1002/bjs.6056; Brunner WC, 2004, J SURG RES, V122, P150, DOI 10.1016/j.jss.2004.08.006; Chen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139743; Chen XJ, 2016, EXPERT REV MED DEVIC, V13, P1043, DOI 10.1080/17434440.2016.1243054; Collyer J, 2010, BRIT J ORAL MAX SURG, V48, P79, DOI 10.1016/j.bjoms.2009.04.037; Costa F, 2008, ORAL SURG ORAL MED O, V106, P179, DOI 10.1016/j.tripleo.2007.11.027; DAL PONT G, 1959, Minerva Chir, V14, P1138; DAWSON PE, 1973, J PROSTHET DENT, V29, P100, DOI 10.1016/0022-3913(73)90148-0; Dicker GJ, 2015, INT J ORAL MAX SURG, V44, P627, DOI 10.1016/j.ijom.2015.01.001; Dicker GJ, 2012, INT J ORAL MAX SURG, V41, P1131, DOI 10.1016/j.ijom.2012.03.013; Elfring R, 2010, COMPUT AIDED SURG, V15, P1, DOI 10.3109/10929081003647239; ELLIS E, 1994, J ORAL MAXIL SURG, V52, P536, DOI 10.1016/0278-2391(94)90085-X; Ellis E, 1996, J ORAL MAXIL SURG, V54, P176, DOI 10.1016/S0278-2391(96)90443-7; Ha MH, 2013, KOREAN J ORTHOD, V43, P263, DOI 10.4041/kjod.2013.43.6.263; Han JJ, 2015, J CRANIO MAXILL SURG, V43, P1918, DOI 10.1016/j.jcms.2015.08.004; Harris MD, 1999, J ORAL MAXIL SURG, V57, P650, DOI 10.1016/S0278-2391(99)90422-6; Hwang SJ, 2000, J CRANIO MAXILL SURG, V28, P85, DOI 10.1054/jcms.2000.0129; Hwang SJ, 2004, J CRANIO MAXILL SURG, V32, P103, DOI 10.1016/j.jcms.2003.09.007; Kienle M, 2012, J ORAL MAXILLOFAC SU, V70, pe59; Kim YI, 2010, J ORAL REHABIL, V37, P262, DOI 10.1111/j.1365-2842.2009.02056.x; Kobayashi T, 2012, BRIT J ORAL MAX SURG, V50, P176, DOI 10.1016/j.bjoms.2011.02.006; Lee CY, 2013, J ORAL MAXIL SURG, V71, pe65, DOI [10.1016/j.joms.2013.06.119, DOI 10.1016/J.JOMS.2013.06.119]; Lund B, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-82; Mezger U, 2013, LANGENBECK ARCH SURG, V398, P501, DOI 10.1007/s00423-013-1059-4; Moulton CAE, 2006, ANN SURG, V244, P400, DOI 10.1097/01.sla.0000234808.85789.6a; Mousoulea S, 2017, EUR J ORTHODONT, V39, P294, DOI 10.1093/ejo/cjw045; Nestel D, 2017, ADV HEALTH SCI EDUC, V22, P639, DOI 10.1007/s10459-016-9697-2; Oh SM, 2013, J CRANIOFAC SURG, V24, P1535, DOI 10.1097/SCS.0b013e31829028be; Qi XD, 2012, J CRANIO MAXILL SURG, V40, pE159, DOI 10.1016/j.jcms.2011.07.024; Roh YC, 2014, J CRANIO MAXILL SURG, V42, P1958, DOI 10.1016/j.jcms.2014.08.008; Shea CH, 2000, HUM MOVEMENT SCI, V19, P737, DOI 10.1016/S0167-9457(00)00021-X; Stokbro K, 2014, INT J ORAL MAX SURG, V43, P957, DOI 10.1016/j.ijom.2014.03.011; Suojanen J, 2017, J CRANIO MAXILL SURG, V45, P990, DOI 10.1016/j.jcms.2017.02.021; Ueki K, 2012, OR SURG OR MED OR PA, V114, P567, DOI 10.1016/j.oooo.2011.12.026; Weber RA, 2016, PLAST RECONSTR SURG, V137, P1057, DOI 10.1097/01.prs.0000475825.09531.68; Wolford LM, 2015, J ORAL MAXIL SURG, V73, P1994, DOI 10.1016/j.joms.2015.03.023; Wolford LM, 2003, J ORAL MAXIL SURG, V61, P655, DOI 10.1053/joms.2003.50131; Yu HB, 2011, J CRANIOFAC SURG, V22, P648, DOI 10.1097/SCS.0b013e318207f2e8; Zhang N, 2016, OR SURG OR MED OR PA, V122, P143, DOI 10.1016/j.oooo.2016.03.004	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196136	10.1371/journal.pone.0196136	http://dx.doi.org/10.1371/journal.pone.0196136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694423	gold, Green Submitted, Green Published			2022-12-26	WOS:000430802400068
J	Abdollahpour, I; Nedjat, S; Mansournia, MA; Schuster, T				Abdollahpour, Ibrahim; Nedjat, Saharnaz; Mansournia, Mohammad Ali; Schuster, Tibor			Estimation of the marginal effect of regular drug use on multiple sclerosis in the Iranian population	PLOS ONE			English	Article							PROPENSITY SCORES; RISK; EPIDEMIOLOGY; SELECTION	There are only few reports regarding the role of lifetime drug or substance use in multiple sclerosis (MS) etiology. In this study, we investigated the potential effect of drug or substance exposure on the onset of MS diagnosis. We conducted a population-based incident case control study in Tehran. Cases (n = 547) were 15-50 years old persons with MS identified from the Iranian Multiple Sclerosis Society (IMSS) register during August 7, 2013, and November 17, 2015. Population-based controls (n = 1057) were 15-50 years old and were recruited by random digit telephone dialing. Inverse-probability-of-treatment weighing (IPTW) using two sets of propensity scores (PSs) was used to estimate marginal incidence odds ratios (ORs) for MS contrasting pre-specified substance use. The estimated marginal OR was 6.03 (95% confidence interval: 3.54; 10.3, using trimmed weights at the 95th percentile of the stabilized weight distribution) in both IPTW analyses comparing lifetime substance use (opioids, cannabis, inhalants, hallucinogens and stimulants) for at least one time monthly during a six-months or longer period vs. no such history of drug use. Subject to limitation of causal claims based on case-control studies, this study suggests that monthly drug or substance use for a period of at least six consecutive months, may increase the risk of MS by factor 3.5 or higher.	[Abdollahpour, Ibrahim] Arak Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Arak, Iran; [Nedjat, Saharnaz] Univ Tehran Med Sci, Knowledge Utilizat Res Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Schuster, Tibor] McGill Univ, Dept Family Med, Montreal, PQ, Canada	Tehran University of Medical Sciences; Tehran University of Medical Sciences; McGill University	Mansournia, MA (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran.	mansournia_ma@yahoo.com	Abdollapour, Ibrahim/M-9329-2017	Abdollapour, Ibrahim/0000-0002-8607-4507	Tehran University of Medical Sciences [93-04-10-240/691]; Multiple Sclerosis Research Center (MSRC)	Tehran University of Medical Sciences(Tehran University of Medical Sciences); Multiple Sclerosis Research Center (MSRC)	The study was funded by Tehran University of Medical Sciences (93-04-10-240/691) and Multiple Sclerosis Research Center (MSRC).	Abdollahpour I, MULTIPLE SCLEROSIS J; Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Allen AS, 2011, AM J EPIDEMIOL, V173, P752, DOI 10.1093/aje/kwq406; Amin-Esmaeili M, 2016, ADDICTION, V111, P1836, DOI 10.1111/add.13453; [Anonymous], 1992, NUTR REL 2 4; Binson D., 2000, J OFF STAT, V16, P53; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; BROSSEAU L, 1993, NEUROEPIDEMIOLOGY, V12, P6, DOI 10.1159/000110294; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Clagett B, 2013, AM J EPIDEMIOL, V178, P1638, DOI 10.1093/aje/kwt164; Elhami SR, 2011, NEUROEPIDEMIOLOGY, V36, P141, DOI 10.1159/000324708; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Gundersen D. A., 2013, AM J EPIDEMIOL; HARTGE P, 1984, AM J EPIDEMIOL, V120, P825, DOI 10.1093/oxfordjournals.aje.a113955; Hawkes CH, 2014, MULT SCLER RELAT DIS, V3, P40, DOI 10.1016/j.msard.2013.05.002; Hedstrom AK, 2011, MULT SCLER J, V17, P788, DOI 10.1177/1352458511399610; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Heydarpour P, 2014, MULT SCLER J, V20, P512, DOI 10.1177/1352458513494496; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Mansson R, 2007, AM J EPIDEMIOL, V166, P332, DOI 10.1093/aje/kwm069; Massey JT, 1997, RESPONSE RATES RANDO, P707; Nelson LM, 2000, AM J EPIDEMIOL, V151, P156, DOI 10.1093/oxfordjournals.aje.a010183; Newman Stephen C, 2006, Epidemiol Perspect Innov, V3, P2, DOI 10.1186/1742-5573-3-2; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ponsonby AL, 2013, MULT SCLER J, V19, P1717, DOI 10.1177/1352458513483887; Rose S, 2014, AM J EPIDEMIOL; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397	31	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196244	10.1371/journal.pone.0196244	http://dx.doi.org/10.1371/journal.pone.0196244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689063	Green Published, Green Submitted, gold			2022-12-26	WOS:000430678800034
J	Liang, XF; Wang, B; Dong, QY; Li, LN; Rollins, JA; Zhang, R; Sun, GY				Liang, Xiaofei; Wang, Bo; Dong, Qiuyue; Li, Lingnan; Rollins, Jeffrey A.; Zhang, Rong; Sun, Guangyu			Pathogenic adaptations of Colletotrichum fungi revealed by genome wide gene family evolutionary analyses	PLOS ONE			English	Article							HIDDEN MARKOV MODEL; APPRESSORIUM FORMATION; GLOEOSPORIOIDES; PROTEIN; IDENTIFICATION; CHROMOSOME; INFECTION; GLOMERELLA; PREDICTION; VIRULENCE	The fungal genus Colletotrichum contains hemibiotrophic phytopathogens being highly variable in host and tissue specificities. We sequenced a C. fructicola genome (1104-7) derived from an isolate of apple in China and compared it with the reference genome (Nara_ gc5) derived from an isolate of strawberry in Japan. Mauve alignment and BlastN search identified 0.62 Mb lineage-specific (LS) genomic regions in 1104-7 with a length criterion of 10 kb. Genes located within LS regions evolved more dynamically, and a strongly elevated proportion of genes were closely related to non-Colletotrichum sequences. Two LS regions, containing nine genes in total, showed features of fungus-to-fungus horizontal transfer supported by both gene order collinearity and gene phylogeny patterns. We further compared the gene content variations among 13 Colletotrichum and 11 non-Colletotrichum genomes by gene function annotation, OrthoMCL grouping and CAFE analysis. The results provided a global evolutionary picture of Colletotrichum gene families, and identified a number of strong duplication/loss events at key phylogenetic nodes, such as the contraction of the detoxification-related RTA1 family in the monocot-specializing graminicola complex and the expansions of several ammonia production-related families in the fruit-infecting gloeosporioides complex. We have also identified the acquirement of a RbsD/FucU fucose transporter from bacterium by the Colletotrichum ancestor. In sum, this study summarized the pathogenic evolutionary features of Colletotrichum fungi at multiple taxonomic levels and highlights the concept that the pathogenic successes of Colletotrichum fungi require shared as well as lineage-specific virulence factors.	[Liang, Xiaofei; Wang, Bo; Dong, Qiuyue; Li, Lingnan; Zhang, Rong; Sun, Guangyu] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Liang, Xiaofei; Wang, Bo; Dong, Qiuyue; Li, Lingnan; Zhang, Rong; Sun, Guangyu] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Rollins, Jeffrey A.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA	Northwest A&F University - China; Northwest A&F University - China; State University System of Florida; University of Florida	Zhang, R; Sun, GY (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Zhang, R; Sun, GY (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	rongzh@nwsuaf.edu.cn; sgy@nwsuaf.edu.cn			Chinese Universities Scientific Fund [Z109021712, Z109021610]; National Science Foundation of China [31601595]; General Financial Grant from the China Postdoctoral Science Foundation [2016M592844]; China Agriculture Research System [CARS-28]; USDA National Institute of Food and Agriculture, Hatch project [1005726]	Chinese Universities Scientific Fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Financial Grant from the China Postdoctoral Science Foundation; China Agriculture Research System; USDA National Institute of Food and Agriculture, Hatch project	This work was supported by Chinese Universities Scientific Fund (Z109021712, Z109021610), the National Science Foundation of China (31601595), the General Financial Grant from the China Postdoctoral Science Foundation (2016M592844), the China Agriculture Research System (CARS-28) and the USDA National Institute of Food and Agriculture, Hatch project 1005726. The funders had no role in the design of the study or the collection, analysis or interpretation of the data or the writing of the manuscript.	Alkan N, 2013, MOL PLANT MICROBE IN, V26, P1345, DOI 10.1094/MPMI-03-13-0080-R; Baccile JA, 2016, NAT CHEM BIOL, V12, P419, DOI [10.1038/NCHEMBIO.2061, 10.1038/nchembio.2061]; Barcelos QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090910; Baroncelli R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2917-6; Baroncelli R, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00540-14; Beimforde C, 2014, MOL PHYLOGENET EVOL, V78, P386, DOI 10.1016/j.ympev.2014.04.024; Brown CK, 2005, P NATL ACAD SCI USA, V102, P18391, DOI 10.1073/pnas.0504954102; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen WP, 2014, GENOME BIOL EVOL, V6, P1620, DOI 10.1093/gbe/evu132; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Crouch J., 2014, GENOMICS PLANT ASS F, P69, DOI DOI 10.1007/978-3-662-44053-7_3; Daniel B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156892; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Dilokpimol A, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0651-6; Dong SM, 2015, CURR OPIN GENET DEV, V35, P57, DOI 10.1016/j.gde.2015.09.001; Edgerton CW, 1914, AM J BOT, V1, P244, DOI 10.2307/2435256; Faino L, 2016, GENOME RES, V26, P1091, DOI 10.1101/gr.204974.116; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Gan P, 2016, GENOME BIOL EVOL, V8, P1467, DOI 10.1093/gbe/evw089; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; GUNN FJ, 1994, MOL MICROBIOL, V12, P799, DOI 10.1111/j.1365-2958.1994.tb01066.x; Hacquard S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11362; He CZ, 1998, GENETICS, V150, P1459; HE CZ, 1995, MYCOL RES, V99, P1325, DOI 10.1016/S0953-7562(09)81216-1; Hirooka Y, 2014, MYCOL PROG, V13, P13, DOI 10.1007/s11557-012-0887-x; Hiruma K, 2016, CELL, V165, P464, DOI 10.1016/j.cell.2016.02.028; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HWANG CS, 1995, MOL GEN GENET, V247, P282, DOI 10.1007/BF00293196; Hyde KD, 2009, FUNGAL DIVERS, V39, P1; Kleemann J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002643; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Lauge R, 1997, MOL PLANT MICROBE IN, V10, P725, DOI 10.1094/MPMI.1997.10.6.725; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu F, 2014, PERSOONIA, V33, P83, DOI 10.3767/003158514X684447; Manire CA, 2002, J CLIN MICROBIOL, V40, P4273, DOI 10.1128/JCM.40.11.4273-4280.2002; Masel AM, 1996, MOL PLANT MICROBE IN, V9, P339, DOI 10.1094/MPMI-9-0339; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Miyara I, 2010, MOL PLANT MICROBE IN, V23, P304, DOI 10.1094/MPMI-23-3-0304; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000056; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plissonneau C, 2016, MBIO, V7, DOI [10.1128/mBio.01231-16, 10.1128/mbio.01231-16]; Prusky D, 2001, MOL PLANT MICROBE IN, V14, P1105, DOI 10.1094/MPMI.2001.14.9.1105; Prusky D, 2007, FEMS MICROBIOL LETT, V268, P1, DOI 10.1111/j.1574-6968.2006.00603.x; Prusky D, 2013, ANNU REV PHYTOPATHOL, V51, P155, DOI 10.1146/annurev-phyto-082712-102349; Redinbo MR, 2005, DRUG DISCOV TODAY, V10, P313, DOI 10.1016/S1359-6446(05)03383-0; Rockenbach MF, 2016, PHYTOPATHOLOGY, V106, P774, DOI 10.1094/PHYTO-09-15-0222-R; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Schafhauser T, 2016, ENVIRON MICROBIOL, V18, P3728, DOI 10.1111/1462-2920.13294; SCHILLING B, 1995, MOL GEN GENET, V247, P430, DOI 10.1007/BF00293144; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Soustre I, 1996, CURR GENET, V30, P121, DOI 10.1007/s002940050110; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Tai T., 1990, PLANT MOL BIOL REP, V8, P297, DOI [10.1007/BF02668766, DOI 10.1007/BF02668766]; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Todd RB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-214; Vesper SJ, 2004, ADV APPL MICROBIOL, V55, P191, DOI 10.1016/S0065-2164(04)55007-4; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; Winter RL, 2010, J FELINE MED SURG, V12, P828, DOI 10.1016/j.jfms.2010.07.005; Xu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22926; Xue CY, 2002, PLANT CELL, V14, P2107, DOI 10.1105/tpc.003426; Ye Y, 2016, ANGEW CHEM INT EDIT, V55, P8072, DOI 10.1002/anie.201602611; Zampounis A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00821-16	76	28	30	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196303	10.1371/journal.pone.0196303	http://dx.doi.org/10.1371/journal.pone.0196303			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689067	Green Published, Green Submitted, gold			2022-12-26	WOS:000430678800042
J	Lee-Sayer, SSM; Dougan, MN; Cooper, J; Sanderson, L; Dosanjh, M; Maxwell, CA; Johnson, P				Lee-Sayer, Sally S. M.; Dougan, Meghan N.; Cooper, Jesse; Sanderson, Leslie; Dosanjh, Manisha; Maxwell, Christopher A.; Johnson, Pauline			CD44-mediated hyaluronan binding marks proliferating hematopoietic progenitor cells and promotes bone marrow engraftment	PLOS ONE			English	Article							PERIPHERAL-BLOOD MONOCYTES; REGULATORY T-CELLS; STEM-CELLS; CHONDROITIN SULFATE; CD44 EXPRESSION; RECEPTOR CD44; IFN-GAMMA; IN-VITRO; ACID; MACROPHAGES	CD44 is a widely expressed cell adhesion molecule that binds to the extracellular matrix component, hyaluronan. However, this interaction is not constitutive in most immune cells at steady state, as the ability of CD44 to engage hyaluronan is highly regulated. While activated T cells and macrophages gain the ability to bind hyaluronan by CD44, the status in other immune cells is less studied. Here we found a percentage of murine eosinophils, natural killer and natural killer T cells were capable of interacting with hyaluronan at steady state. To further investigate the consequences of hyaluronan binding by CD44 in the hematopoietic system, point mutations of CD44 that either cannot bind hyaluronan (LOF-CD44) or have an increased affinity for hyaluronan (GOF-CD44) were expressed in CD44-deficient bone marrow. Competitive bone marrow reconstitution of irradiated mice revealed an early preference for GOF-CD44 over WT-CD44 expressing cells, and for WT-CD44 over LOF-CD44 expressing cells, in the hematopoietic progenitor cell compartment. The advantage of the hyaluronan-binding cells was observed in the hematopoietic stem and progenitor populations, and was maintained throughout the immune system. Hematopoietic stem cells bound minimal hyaluronan at steady state, and this was increased when the cells were induced to proliferate whereas multipotent progenitors had an increased ability to bind hyaluronan at steady state. In vitro, the addition of hyaluronan promoted their proliferation. Thus, proliferating hematopoietic progenitors bind hyaluronan, and hyaluronan binding cells have a striking competitive advantage in bone marrow engraftment.	[Lee-Sayer, Sally S. M.; Dougan, Meghan N.; Cooper, Jesse; Sanderson, Leslie; Dosanjh, Manisha; Johnson, Pauline] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Dougan, Meghan N.; Maxwell, Christopher A.] Univ British Columbia, British Columbia Childrens Hosp Res Inst, Dept Pediat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Johnson, P (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada.	pauline@mail.ubc.ca	Sanderson, Leslie/GZG-9357-2022; Maxwell, Christopher A/B-3044-2011; Johnson, Pauline/G-9659-2019	Sanderson, Leslie/0000-0002-8026-406X; Maxwell, Christopher A/0000-0002-0713-7136; Johnson, Pauline/0000-0001-7367-4653; Maxwell, Christopher/0000-0002-0860-4031	Canadian Institute of Health Research [MOP 119503]; Natural Sciences and Engineering Research Council of Canada (NSERC); Galloway Leukemia Research Seed Funding; NSERC	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Galloway Leukemia Research Seed Funding; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institute of Health Research (MOP 119503) to P.J., the Natural Sciences and Engineering Research Council of Canada (NSERC) to P.J., and the Galloway Leukemia Research Seed Funding to C.A.M. S.S.M.L. was supported by scholarships from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alenzi FQB, 2004, BRIT J BIOMED SCI, V61, P99, DOI 10.1080/09674845.2004.11732652; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Boulais PE, 2015, BLOOD, V125, P2621, DOI 10.1182/blood-2014-09-570192; Brown KL, 2001, J IMMUNOL, V167, P5367, DOI 10.4049/jimmunol.167.9.5367; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Cao HM, 2016, HAEMATOLOGICA, V101, P26, DOI 10.3324/haematol.2015.135921; Chen JY, 2016, NATURE, V530, P223, DOI 10.1038/nature16943; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; CULTY M, 1994, J LEUKOCYTE BIOL, V56, P605, DOI 10.1002/jlb.56.5.605; DEBELDER AN, 1975, CARBOHYD RES, V44, P251, DOI 10.1016/S0008-6215(00)84168-3; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Dong Y, 2018, MUCOSAL IMMUNOL, V11, P601, DOI 10.1038/mi.2017.83; Firan M, 2006, BLOOD, V107, P619, DOI 10.1182/blood-2005-06-2277; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Goncharova V, 2012, J BIOL CHEM, V287, P25419, DOI 10.1074/jbc.M112.376699; Graham VA, 2007, EUR J IMMUNOL, V37, P925, DOI 10.1002/eji.200635882; HATHCOCK KS, 1993, J IMMUNOL, V151, P6712; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lee-Sayer SSM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00150; LESLEY J, 1994, J EXP MED, V180, P383, DOI 10.1084/jem.180.1.383; Levesque MC, 1996, J IMMUNOL, V156, P1557; MacNamara KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028669; Maeshima N, 2011, EUR J IMMUNOL, V41, P1108, DOI 10.1002/eji.201040870; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; Matrosova VY, 2004, STEM CELLS, V22, P544, DOI 10.1634/stemcells.22-4-544; MURAKAMI S, 1990, J IMMUNOL, V145, P3618; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2003, BLOOD, V101, P856, DOI 10.1182/blood-2002-05-1344; Olaku V, 2011, MOL BIOL CELL, V22, P2777, DOI 10.1091/mbc.E11-02-0134; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Poon GFT, 2015, J IMMUNOL, V195, P632, DOI 10.4049/jimmunol.1402506; Ruffell B, 2005, BIOCHEM BIOPH RES CO, V334, P306, DOI 10.1016/j.bbrc.2005.06.108; Ruffell B, 2008, J IMMUNOL, V181, P7044, DOI 10.4049/jimmunol.181.10.7044; Ruffell B, 2011, J BIOL CHEM, V286, P19179, DOI 10.1074/jbc.M110.200790; Sackstein R, 2011, CURR OPIN HEMATOL, V18, P239, DOI 10.1097/MOH.0b013e3283476140; Sague SL, 2004, J INTERF CYTOK RES, V24, P301, DOI 10.1089/107999004323065093; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Takeda M, 2003, J BIOL CHEM, V278, P43550, DOI 10.1074/jbc.M308199200; Termeer C, 2001, J LEUKOCYTE BIOL, V70, P715; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032	56	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196011	10.1371/journal.pone.0196011	http://dx.doi.org/10.1371/journal.pone.0196011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684048	Green Submitted, Green Published, gold			2022-12-26	WOS:000430660600031
J	Uusi-Makela, MIE; Barker, HR; Bauerlein, CA; Hakkinen, T; Nykter, M; Ramet, M				Uusi-Makela, Meri I. E.; Barker, Harlan R.; Bauerlein, Carina A.; Hakkinen, Tomi; Nykter, Matti; Ramet, Mika			Chromatin accessibility is associated with CRISPR-Cas9 efficiency in the zebrafish (Danio rerio)	PLOS ONE			English	Article							ZYGOTIC GENOME ACTIVATION; GUIDE RNA DESIGN; NUCLEOSOMES INHIBIT; DNA METHYLATION; TRANSITION; ENDONUCLEASE; CAS9; INTERROGATION; EMBRYOGENESIS; TRANSCRIPTION	CRISPR-Cas9 technology is routinely applied for targeted mutagenesis in model organisms and cell lines. Recent studies indicate that the prokaryotic CRISPR-Cas9 system is affected by eukaryotic chromatin structures. Here, we show that the likelihood of successful mutagenesis correlates with transcript levels during early development in zebrafish (Danio rerio) embryos. In an experimental setting, we found that guide RNAs differ in their onset of mutagenesis activity in vivo. Furthermore, some guide RNAs with high in vitro activity possessed poor mutagenesis activity in vivo, suggesting the presence of factors that limit the mutagenesis in vivo. Using open access datasets generated from early developmental stages of the zebrafish, and guide RNAs selected from the CRISPRz database, we provide further evidence for an association between gene expression during early development and the success of CRISPR-Cas9 mutagenesis in zebrafish embryos. In order to further inspect the effect of chromatin on CRISPR-Cas9 mutagenesis, we analysed the relationship of selected chromatin features on CRISPR-Cas9 mutagenesis efficiency using publicly available data from zebrafish embryos. We found a correlation between chromatin openness and the efficiency of CRISPR-Cas9 mutagenesis. These results indicate that CRISPR-Cas9 mutagenesis is influenced by chromatin accessibility in zebrafish embryos.	[Uusi-Makela, Meri I. E.; Bauerlein, Carina A.; Ramet, Mika] Univ Tampere, BioMediTech Inst, Lab Expt Immunol, Tampere, Finland; [Uusi-Makela, Meri I. E.; Bauerlein, Carina A.; Hakkinen, Tomi; Nykter, Matti; Ramet, Mika] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Barker, Harlan R.] Univ Tampere, Fac Med & Life Sci, Lab Anat, Tampere, Finland; [Hakkinen, Tomi; Nykter, Matti] Univ Tampere, BioMediTech Inst, Lab Computat Biol, Tampere, Finland; [Ramet, Mika] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Unit, Oulu, Finland; [Ramet, Mika] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University; University of Oulu; University of Oulu; Tampere University; Tampere University Hospital	Uusi-Makela, MIE; Ramet, M (corresponding author), Univ Tampere, BioMediTech Inst, Lab Expt Immunol, Tampere, Finland.; Uusi-Makela, MIE; Ramet, M (corresponding author), Univ Tampere, Fac Med & Life Sci, Tampere, Finland.; Ramet, M (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Unit, Oulu, Finland.; Ramet, M (corresponding author), Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland.; Ramet, M (corresponding author), Tampere Univ Hosp, Dept Pediat, Tampere, Finland.	meri.uusi-makela@staff.uta.fi; mika.ramet@uta.fi		Barker, Harlan/0000-0003-4125-2522; Nykter, Matti/0000-0001-6956-2843	Tampere Tuberculosis Foundation; Finnish Concordia Fund; Sigrid Juselius Foundation; University of Tampere Doctoral School; Finnish Cultural Foundation - Maili Autio Fund	Tampere Tuberculosis Foundation; Finnish Concordia Fund; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Tampere Doctoral School; Finnish Cultural Foundation - Maili Autio Fund	This study was supported with the following grants: Tampere Tuberculosis Foundation (http://www.tuberkuloosisaatio.fi/) (MU;MR); Finnish Concordia Fund (http://www.konkordia-liitto.com/) (MU); Sigrid Juselius Foundation (http://sigridjuselius.fi/apurahat/) (MR); University of Tampere Doctoral School (http://www.uta.fi/english/doctoralschool/index.html) (MU); Finnish Cultural Foundation - Maili Autio Fund (https://skr.fi/) (HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen IS, 2012, BIOCHEM BIOPH RES CO, V417, P1139, DOI 10.1016/j.bbrc.2011.12.077; [Anonymous], 2014, SCIPY OPEN SOURCE SC; Aspatwar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134263; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Chen XY, 2016, NUCLEIC ACIDS RES, V44, P6482, DOI 10.1093/nar/gkw524; Chen YC, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005840; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Domcke S, 2015, NATURE, V528, P575, DOI 10.1038/nature16462; Farboud B, 2015, GENETICS, V199, P959, DOI 10.1534/genetics.115.175166; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaaij LJT, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1013-1; KANE DA, 1993, DEVELOPMENT, V119, P447; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CM, 2017, EXP PHYSL; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McGaughey DM, 2014, G3-GENES GENOM GENET, V4, P861, DOI 10.1534/g3.113.009514; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Palfy M, 2017, CURR OPIN GENET DEV, V43, P53, DOI 10.1016/j.gde.2016.12.001; Rahman MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181943; Singh R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv575; Smith JD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0900-9; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tsompana M, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-33; Varshney GK, 2016, NUCLEIC ACIDS RES, V44, pD822, DOI 10.1093/nar/gkv998; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424	51	52	52	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196238	10.1371/journal.pone.0196238	http://dx.doi.org/10.1371/journal.pone.0196238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684067	Green Published, gold			2022-12-26	WOS:000430660600045
J	Yoshida, S; Nishimura, N; Yurino, H; Kobayashi, M; Horiguchi, K; Yano, K; Hashimoto, S; Kato, T; Kato, Y				Yoshida, Saishu; Nishimura, Naoto; Yurino, Hideaki; Kobayashi, Masaaki; Horiguchi, Kotaro; Yano, Kentaro; Hashimoto, Shin-ichi; Kato, Takako; Kato, Yukio			Differentiation capacities of PS-clusters, adult pituitary stem/progenitor cell clusters located in the parenchymal-niche, of the rat anterior lobe	PLOS ONE			English	Article							FOLLICULO-STELLATE CELLS; STEM-CELLS; BRAIN ASTROCYTES; GROWTH-FACTOR; GLAND; CULTURE; SYSTEM; LAYER	Pituitary endocrine cells are supplied by Sox2-expressing stem/progenitor cells in the anterior lobe of the adult pituitary. In relation to their microenvironment ("niche"), SOX2-positive cells exist in two types of niches; the marginal cell layer-niche and the parenchymal-niche. Recently, we isolated dense stem/progenitor cell clusters from the parenchymal-niche as parenchymal stem/progenitor cell (PS)-clusters. We classified these PS-clusters into three subtypes based on differences in S100 beta-expression (S100 beta-positive, -negative, and -mixed type), and reported that S100 beta-positive PS-clusters exhibited the capacity for differentiation into endocrine cells under 3-dimensional cultivation system. In the present study, we further characterized S100 beta-positive PS-clusters using an in vitro 2-dimensional cultivation system. The results demonstrated that S100 beta-positive PS-clusters in the 2-dimensional cultivation system proliferated more actively than S100 beta-negative clusters. Moreover, in 2-dimensional cultivation conditions, S100 beta-positive PS-clusters showed differentiation capacity into non-endocrine cells (Myogenin-, alpha SMA-, NG2-, or SOX17-positive cells) but not into endocrine cells, whereas S100 beta-negative PS-clusters did not. Collectively, PS-clusters were heterogeneous, exhibiting different proliferation and differentiation properties based on the difference in S100 beta-expression. Specifically, a part of SOX2-positive cells in the parenchymal-niche had capacities for differentiation into non-endocrine cells, and S100 beta-positive PS-clusters may be in more progressive stages toward differentiation than S100 beta-negative clusters.	[Yoshida, Saishu; Nishimura, Naoto; Kato, Yukio] Meiji Univ, Grad Sch Agr, Div Life Sci, Kanagawa, Japan; [Yoshida, Saishu; Kato, Takako] Meiji Univ, Org Strateg Coordinat Res & Intellectual Property, Kanagawa, Japan; [Yoshida, Saishu; Kato, Takako; Kato, Yukio] Meiji Univ, Inst Reprod & Endocrinol, Kanagawa, Japan; [Yurino, Hideaki; Hashimoto, Shin-ichi] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Kobayashi, Masaaki; Yano, Kentaro; Kato, Yukio] Meiji Univ, Sch Agr, Dept Life Sci, Kanagawa, Japan; [Horiguchi, Kotaro] Kyorin Univ, Dept Hlth Sci, Lab Anat & Cell Biol, Tokyo, Japan	Meiji University; Meiji University; Meiji University; Kanazawa University; Meiji University; Kyorin University	Kato, Y (corresponding author), Meiji Univ, Grad Sch Agr, Div Life Sci, Kanagawa, Japan.; Kato, Y (corresponding author), Meiji Univ, Inst Reprod & Endocrinol, Kanagawa, Japan.; Kato, Y (corresponding author), Meiji Univ, Sch Agr, Dept Life Sci, Kanagawa, Japan.	yukato@meiji.ac.jp		Kobayashi, Masaaki/0000-0003-4580-2819	Japan Society for the Promotion of Science (JSPS) KAKENHI [16K18818, 15J11564, 24580435, 26292166]; MEXT; Institute of Science and Technology, Meiji University; Meiji University International Institute for BioResource Research (MUIIR)	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute of Science and Technology, Meiji University; Meiji University International Institute for BioResource Research (MUIIR)	This work was partially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 16K18818 and 15J11564 to S.Y., 24580435 to T.K., and 26292166 to Y.K.); the MEXT-Supported Program for the Strategic Research Foundation at Private Universities; a research grant (A) to Y.K. from the Institute of Science and Technology, Meiji University; and Meiji University International Institute for BioResource Research (MUIIR). And, there are no conflicts of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoniadou CL, 2013, CELL STEM CELL, V13, P433, DOI 10.1016/j.stem.2013.07.004; Chen M, 2013, CELL TISSUE RES, V354, P823, DOI 10.1007/s00441-013-1713-8; Devnath S, 2008, J NEUROENDOCRINOL, V20, P687, DOI 10.1111/j.1365-2826.2008.01716.x; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; FERRARA N, 1987, P NATL ACAD SCI USA, V84, P5773, DOI 10.1073/pnas.84.16.5773; GOSPODAROWICZ D, 1989, BIOCHEM BIOPH RES CO, V165, P292, DOI 10.1016/0006-291X(89)91068-1; Gremeaux L, 2012, STEM CELLS DEV, V21, P801, DOI 10.1089/scd.2011.0496; HASEGAWA Y, 1994, HORM RES, V41, P55, DOI 10.1159/000183944; Higuchi M, 2014, CELL TISSUE RES, V357, P323, DOI 10.1007/s00441-014-1861-5; Horiguchi K, 2016, CELL TISSUE RES, V363, P513, DOI 10.1007/s00441-015-2256-y; Itakura E, 2007, ENDOCRINOLOGY, V148, P1518, DOI 10.1210/en.2006-1390; Ogawa S, 1997, BIOCHEM BIOPH RES CO, V234, P712, DOI 10.1006/bbrc.1997.6704; Osuna M, 2012, J ENDOCRINOL, V213, P231, DOI 10.1530/JOE-12-0043; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pineda ET, 2013, CELLS TISSUES ORGANS, V197, P399, DOI 10.1159/000346166; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rizzoti K, 2013, CELL STEM CELL, V13, P419, DOI 10.1016/j.stem.2013.07.006; Soji T, 1997, MICROSC RES TECHNIQ, V39, P138, DOI 10.1002/(SICI)1097-0029(19971015)39:2<138::AID-JEMT5>3.0.CO;2-H; SOJI T, 1989, TISSUE CELL, V21, P849, DOI 10.1016/0040-8166(89)90036-0; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; VANKELECOM H, 1989, NEUROENDOCRINOLOGY, V49, P102, DOI 10.1159/000125097; Vankelecom H, 2014, MOL CELL ENDOCRINOL, V385, P2, DOI 10.1016/j.mce.2013.08.018; Yoshida S, 2011, J NEUROENDOCRINOL, V23, P933, DOI 10.1111/j.1365-2826.2011.02198.x; Yoshida S, 2016, STEM CELL RES, V17, P318, DOI 10.1016/j.scr.2016.08.016; Yoshida S, 2009, BIOCHEM BIOPH RES CO, V385, P11, DOI 10.1016/j.bbrc.2009.05.027; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196029	10.1371/journal.pone.0196029	http://dx.doi.org/10.1371/journal.pone.0196029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684040	Green Submitted, gold, Green Published			2022-12-26	WOS:000430660600034
J	Ono, E; Murota, H; Mori, Y; Yoshioka, Y; Nomura, Y; Munetsugu, T; Yokozeki, H; Katayama, I				Ono, Emi; Murota, Hiroyuki; Mori, Yuki; Yoshioka, Yoshichika; Nomura, Yuko; Munetsugu, Takichi; Yokozeki, Hiroo; Katayama, Ichiro			Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment	PLOS ONE			English	Article							ECCRINE SWEAT; SKIN SURFACE; INNATE DEFENSE; IN-VIVO; BARRIER; DERMCIDIN; GLAND; KALLIKREIN; POTASSIUM; INHIBITOR	Sweat includes active components and metabolites, which are needed to maintain skin homeostasis. Component changes in sweat derived from atopic dermatitis (AD) have been reported. To investigate the influence of sweat components on the pathogenesis of AD, we performed a multifaceted assessment, including nuclear magnetic resonance spectroscopy-based metabolomic analysis, and linked these features to clinical features of AD. Distinctive properties of AD sweat are the quite-variation in protein, anti-microbial peptides and glucose concentrations. pH, sodium, and other salt levels in sweat of AD were comparable to that of healthy subjects. Sweat from AD patients with acute inflammation had a more prominent increase in glucose concentration than sweat from healthy individuals or those with AD with chronic inflammation. Topical glucose application delayed recovery of transepidermal water loss in barrier-disrupted mice. Furthermore, the glucose transporter GLUT2 was highly expressed in the lumen of sweat glands from AD patients. AD patients with chronic inflammation had significantly increased GLUT2 mRNA expression and near normal sweat glucose levels. Despite the small sample size in our study, we speculate that the increased glucose levels might be affected by AD severity and phenotype. We hope that this report will bring novel insight into the impact of sweat components on the clinical manifestation of AD.	[Ono, Emi; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Course Integrated Med, Suita, Osaka, Japan; [Mori, Yuki; Yoshioka, Yoshichika] Osaka Univ, Immunol Frontier Res Ctr, Biofunct Imaging Lab, Suita, Osaka, Japan; [Nomura, Yuko] Nomura Dermatol Clin, Yokohama, Kanagawa, Japan; [Munetsugu, Takichi; Yokozeki, Hiroo] Tokyo Med & Dent Univ, Dept Dermatol, Bunkyo Ku, Tokyo, Japan	Osaka University; Osaka University; Tokyo Medical & Dental University (TMDU)	Murota, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Dermatol, Course Integrated Med, Suita, Osaka, Japan.	h-murota@derma.med.osaka-u.ac.jp	Mori, Yuki/AAH-9283-2020	Mori, Yuki/0000-0003-4208-0005; Ono, Emi/0000-0002-7646-8764; yi lang, pian shan/0000-0002-3270-1085	Japan Society for Promotion of Science [17K07591]; Maruho Takagi Dermatology Foundation	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Maruho Takagi Dermatology Foundation	This study was supported by research grant from the Japan Society for Promotion of Science (ID: 17K07591), and from the Maruho Takagi Dermatology Foundation to Hiroyuki Murota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYSEN TC, 1984, J APPL PHYSIOL, V56, P1302, DOI 10.1152/jappl.1984.56.5.1302; Denda M, 2011, EXP DERMATOL, V20, P943, DOI 10.1111/j.1600-0625.2011.01329.x; Deng D, 2016, PROTEIN SCI, V25, P546, DOI 10.1002/pro.2858; Fluhr JW, 2006, EXP DERMATOL, V15, P483, DOI 10.1111/j.1600-0625.2006.00437.x; HIBINO T, 1994, J INVEST DERMATOL, V102, P214, DOI 10.1111/1523-1747.ep12371765; IMAYAMA S, 1994, J ALLERGY CLIN IMMUN, V94, P195, DOI 10.1016/0091-6749(94)90040-X; Kato T, 2005, J ALLERGY CLIN IMMUN, V116, P169, DOI 10.1016/j.jaci.2005.03.044; Kimata H, 2007, J PSYCHOSOM RES, V62, P57, DOI 10.1016/j.jpsychores.2006.05.006; Kutyshenko VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028824; Luo ZF, 2009, ENDOCRINE, V36, P60, DOI 10.1007/s12020-009-9198-7; Mark H, 2013, INT J COSMETIC SCI, V35, P163, DOI 10.1111/ics.12019; Mena-Bravo A, 2014, J PHARMACEUT BIOMED, V90, P139, DOI 10.1016/j.jpba.2013.10.048; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; Murakami M, 2002, J INVEST DERMATOL, V119, P1090, DOI 10.1046/j.1523-1747.2002.19507.x; Murota H, 2015, J DERMATOL SCI, V77, P3, DOI 10.1016/j.jdermsci.2014.08.011; Parente P, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-34; Rieg S, 2005, J IMMUNOL, V174, P8003, DOI 10.4049/jimmunol.174.12.8003; SATO K, 1973, J CLIN INVEST, V52, P2166, DOI 10.1172/JCI107401; SATO K, 1989, J AM ACAD DERMATOL, V20, P537, DOI 10.1016/S0190-9622(89)70063-3; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schmid-Wendtner MH, 2006, SKIN PHARMACOL PHYS, V19, P296, DOI 10.1159/000094670; SHELMIRE JB, 1959, J INVEST DERMATOL, V32, P471, DOI 10.1038/jid.1959.77; Sugawara T, 2012, J DERMATOL SCI, V66, P154, DOI 10.1016/j.jdermsci.2012.02.011; SULZBERGER MB, 1947, J INVEST DERMATOL, V9, P221, DOI 10.1038/jid.1947.92; Watabe A, 2013, J DERMATOL SCI, V72, P177, DOI 10.1016/j.jdermsci.2013.06.005; WEVERS RA, 1994, CLIN CHEM, V40, P1245; Williams JR, 2004, BRIT J DERMATOL, V150, P1154, DOI 10.1111/j.1365-2133.2004.05869.x; YOKOZEKI H, 1991, AM J PHYSIOL, V260, pR314, DOI 10.1152/ajpregu.1991.260.2.R314	28	21	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195960	10.1371/journal.pone.0195960	http://dx.doi.org/10.1371/journal.pone.0195960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677207	Green Submitted, Green Published, gold			2022-12-26	WOS:000430638900018
J	Stykel, MG; Humphries, K; Kirby, MP; Czaniecki, C; Wang, TY; Ryan, T; Bamm, V; Ryan, SD				Stykel, Morgan G.; Humphries, Kayla; Kirby, Mathew P.; Czaniecki, Chris; Wang, Tinya; Ryan, Tammy; Bamm, Vladimir; Ryan, Scott D.			Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease	FASEB JOURNAL			English	Article						neurodegeneration; isogenic hiPSCs; anterograde transport; reactive nitrogen species; tubulin nitration	PROTEIN-TYROSINE NITRATION; DOPAMINERGIC NEURON LOSS; NITRIC-OXIDE SYNTHASE; ALPHA-SYNUCLEIN GENE; NERVE GROWTH-FACTOR; COMPLEX-I; TRANSGENIC MICE; PC12 CELLS; EXPOSURE; PARAQUAT	Neuronal loss in Parkinson's disease (PD) is associated with aberrant mitochondrial function in dopaminergic (DA) neurons of the substantia nigra pars compacta. An association has been reported between PD onset and exposure to mitochondrial toxins, including the agrochemicals paraquat (PQ), maneb (MB), and rotenone (Rot). Here, with the use of a patient-derived stem cell model of PD, allowing comparison of DA neurons harboring a mutation in the -synuclein (-syn) gene (SNCA-A53T) against isogenic, mutation-corrected controls, we describe a novel mechanism whereby NO, generated from SNCA-A53T mutant neurons exposed to Rot or PQ/MB, inhibits anterograde mitochondrial transport through nitration of -tubulin (-Tub). Nitration of -Tub inhibited the association of both -syn and the mitochondrial motor protein kinesin 5B with the microtubules, arresting anterograde transport. This was, in part, a result of nitration of -Tub in the C-terminal domain. These effects were rescued by inhibiting NO synthesis with the NOS inhibitor N-nitro-L-arginine methyl ester. Collectively, our results are the first to demonstrate a gene by environment interaction in PD, whereby agrochemical exposure selectively triggers a deficit in mitochondrial transport by nitrating the microtubules in neurons harboring the SNCA-A53T mutation.Stykel, M. G., Humphries, K., Kirby, M. P., Czaniecki, C., Wang, T., Ryan, T., Bamm, V., Ryan, S. D. Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease.	[Stykel, Morgan G.; Humphries, Kayla; Kirby, Mathew P.; Czaniecki, Chris; Wang, Tinya; Ryan, Tammy; Bamm, Vladimir; Ryan, Scott D.] Univ Guelph, Dept Mol & Cellular Biol, Sci Complex,Room 3456,50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Ryan, Scott D.] Scintillon Inst, Neurodegenerat Dis Ctr, San Diego, CA USA	University of Guelph	Ryan, SD (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex,Room 3456,50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	sryan03@uoguelph.ca		Ryan, Tammy/0000-0002-0428-8932; Bamm, Vladimir/0000-0002-3686-1991; Ryan, Scott/0000-0001-9829-4649; Stykel, Morgan/0000-0002-4799-4220	Parkinson Society of Canada [2014-685]; Natural Sciences and Engineering Research Council of Canada [RG060805, CRDPJ490841-15]; Ontario Graduate Scholarship	Parkinson Society of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	The authors acknowledge Carla Coakley (University of Guelph) for technical assistance in the preparation of this manuscript, Michaela Struder-Kypke (Advanced Analysis Center, University of Guelph) for assistance with live-cell image acquisition, and Agata Zienowicz (University of Guelph) for tubulin purification. This work was supported, in part, by the Parkinson Society of Canada (2014-685 to S.D.R.), the Natural Sciences and Engineering Research Council of Canada (RG060805 and CRDPJ490841-15 to S.D.R.; Undergraduate Student Research Awards to M.P.K.), and an Ontario Graduate Scholarship to M.G.S. The authors declare no conflicts of interest.	Bamm VV, 2011, BIOPHYS J, V101, P1248, DOI 10.1016/j.bpj.2011.07.035; Barthwal MK, 2001, REDOX REP, V6, P297, DOI 10.1179/135100001101536436; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Brooks AI, 1999, BRAIN RES, V823, P1, DOI 10.1016/S0006-8993(98)01192-5; Cappelletti G, 2003, EXP CELL RES, V288, P9, DOI 10.1016/S0014-4827(03)00209-X; Cappelletti G, 2006, NEUROSCI LETT, V401, P159, DOI 10.1016/j.neulet.2006.03.009; Cartelli D, 2016, SCI REP-UK, V6, DOI 10.1038/srep33289; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chavarria C, 2013, ARCH BIOCHEM BIOPHYS, V533, P25, DOI 10.1016/j.abb.2013.02.009; Chinta SJ, 2011, FREE RADICAL RES, V45, P53, DOI 10.3109/10715762.2010.509398; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Connor BP, 1996, NEUROPHARMACOLOGY, V35, P459, DOI 10.1016/0028-3908(95)00194-8; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Dardiotis E, 2013, TOXICOLOGY, V307, P17, DOI 10.1016/j.tox.2012.12.016; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Dixit A, 2013, BBA-MOL BASIS DIS, V1832, P1227, DOI 10.1016/j.bbadis.2013.03.019; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Gatto NM, 2010, NEUROEPIDEMIOLOGY, V35, P191, DOI 10.1159/000315157; Gautier CA, 2016, HUM MOL GENET, V25, P2972, DOI 10.1093/hmg/ddw148; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Greenamyre JT, 2010, TRENDS PHARMACOL SCI, V31, P141, DOI 10.1016/j.tips.2009.12.006; Guillette EA, 1998, ENVIRON HEALTH PERSP, V106, P347, DOI 10.2307/3434041; Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lefevre J, 2011, J BIOL CHEM, V286, P3065, DOI 10.1074/jbc.M110.144089; Li H, 2008, P NATL ACAD SCI USA, V105, P2169, DOI 10.1073/pnas.0711647105; LI W, 1987, TOXICOL APPL PHARM, V91, P96, DOI 10.1016/0041-008X(87)90197-9; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Livernois AM, 2009, ANAL BIOCHEM, V392, P70, DOI 10.1016/j.ab.2009.05.023; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Markopoulou K, 2008, ACTA NEUROPATHOL, V116, P25, DOI 10.1007/s00401-008-0372-4; Martin LJ, 2007, REV NEUROSCIENCE, V18, P115; Muller CM, 2005, J NEUROPATH EXP NEUR, V64, P623; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Paul KC, 2016, ENVIRON HEALTH PERSP, V124, P570, DOI 10.1289/ehp.1408976; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Devoto VMP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05334-9; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Ryan T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03241-9; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Schwarz TL, 2013, COLD SPRING HARB PER, V5; Sheldon KL, 2015, J BIOL CHEM, V290, P26784, DOI 10.1074/jbc.M115.678854; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Shlevkov E, 2016, P NATL ACAD SCI USA, V113, pE6097, DOI 10.1073/pnas.1612283113; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; Srivastava P, 2007, FEBS J, V274, P4788, DOI 10.1111/j.1742-4658.2007.06004.x; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tapias V, 2017, CELL MOL LIFE SCI, V74, P2851, DOI 10.1007/s00018-017-2541-x; Tedeschi G, 2005, PROTEOMICS, V5, P2422, DOI 10.1002/pmic.200401208; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Wecht JM, 2011, ARCH PHYS MED REHAB, V92, P1789, DOI 10.1016/j.apmr.2011.03.022; Xiong ZK, 2015, EXP THER MED, V9, P553, DOI 10.3892/etm.2014.2099; Yamaguchi K, 2005, ACTA NEUROPATHOL, V110, P298, DOI 10.1007/s00401-005-1042-4; Zhang J, 2003, J NEUROCHEM, V84, P336, DOI 10.1046/j.1471-4159.2003.01525.x; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	80	22	22	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5350	5364		10.1096/fj.201700759RR	http://dx.doi.org/10.1096/fj.201700759RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688812				2022-12-26	WOS:000447972500013
J	Wang, SJ; Li, JJ; Xie, J; Liu, F; Duan, YC; Wu, Y; Huang, SL; He, XH; Wang, ZL; Wu, XH				Wang, Shaojia; Li, Jiajia; Xie, Jie; Liu, Fei; Duan, Yachen; Wu, Yong; Huang, Shenglin; He, Xianghuo; Wang, Ziliang; Wu, Xiaohua			Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin beta 4/SNAI1/SIRT3 signaling pathway	ONCOGENE			English	Article							PD-L1 EXPRESSION; OVARIAN-CANCER; CELL; CARCINOMA; SIRT3; MICROENVIRONMENT; PROLIFERATION; TOLERANCE; PROGNOSIS; BREAST	Although PD-L1 has been shown to play a well-characterized role in inhibiting antitumor immunity via engagement of its receptor PD-1 in T lymphocytes, little is known about the tumor cell-intrinsic function of PD-L1 and its association with prognosis. Here, we investigate this issue and dissect the molecular mechanisms underlying the role of PD-L1 in glucose metabolism, proliferation, migration, and invasion in human cervical cancer cells. As a result, we found that PD-L1 overexpression in cervical cancer cells increases glucose metabolism and metastasis-related behaviors. Mechanistically, PDL1 bound directly to integrin beta 4 (ITGB4), activating the AKT/GSK3 beta signaling pathway and consequently inducing the expression of the transcriptional repressor SNAI1. SNAIL in turn influenced the expression of genes involved in the epithelial-to-mesenchymal transition and regulated glucose metabolism by inhibiting SIRT3 promoter activity. High expression of PD-L1 and ITGB4 in human cervical carcinomas was significantly associated with lymph node metastasis and poor prognosis. Finally, F-18-fluorodeoxyglucose microPET/CT and bioluminescence imaging analyses of cervical xenograft tumors in mice revealed that PD-L1 overexpression markedly increases tumor glucose uptake and promotes lymph node metastasis. Together, these results demonstrate that PD-L1 can promote the growth and metastasis of cervical cancer by activating the ITGB4/SNAI1/SIRT3 signaling pathway, and also suggest the possibility of targeting PD-L1 and its downstream effectors as a potential approach for interfering with cervical cancer growth and metastasis.	[Wang, Shaojia; Li, Jiajia; Liu, Fei; Duan, Yachen; Wu, Yong; Huang, Shenglin; He, Xianghuo; Wang, Ziliang; Wu, Xiaohua] Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai 200032, Peoples R China; [Wang, Shaojia; Li, Jiajia; Liu, Fei; Duan, Yachen; Wu, Yong; Huang, Shenglin; He, Xianghuo; Wang, Ziliang; Wu, Xiaohua] Fudan Univ, Shanghai Canc Ctr, Canc Inst, Shanghai 200032, Peoples R China; [Wang, Shaojia; Li, Jiajia; Xie, Jie; Liu, Fei; Duan, Yachen; Wu, Yong; Wang, Ziliang; Wu, Xiaohua] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Xie, Jie] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Wang, ZL; Wu, XH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Gynecol Oncol, Shanghai 200032, Peoples R China.; Wang, ZL; Wu, XH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Canc Inst, Shanghai 200032, Peoples R China.; Wang, ZL; Wu, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China.	huf_zlwang@126.com; wu.xh@fudan.edu.cn	Huang, Shenglin/N-9472-2018; He, Xianghuo/I-1497-2014; Wang, Zhiquan/HHS-6768-2022	Huang, Shenglin/0000-0003-1279-0794; He, Xianghuo/0000-0001-8872-668X; 	National Nature Science Foundation of China [81672569]; National Nature Science Young Foundation of China [81502235]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Young Foundation of China	We thank RuiBi for the samples for the TMA study, Guangqi Qin for manufacturing the TMAs, and Jun Chen and Jianping Zhang for help with animal imaging. This work was supported in part by grants from the National Nature Science Foundation of China (81672569 to X.W.) and the National Nature Science Young Foundation of China (81502235 to Z.W.).	Ata R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010189; Atahan IL, 2007, INT J GYNECOL CANCER, V17, P833, DOI 10.1111/j.1525-1438.2007.00895.x; Bertsias GK, 2009, ARTHRITIS RHEUM-US, V60, P207, DOI 10.1002/art.24227; Bouvier C, 2016, ONCOTARGET, V7, P64702, DOI 10.18632/oncotarget.11876; Cai GF, 2004, CELL IMMUNOL, V230, P89, DOI 10.1016/j.cellimm.2004.09.004; Cao YJ, 2011, CANCER RES, V71, P1235, DOI 10.1158/0008-5472.CAN-10-2217; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chen MF, 2016, ONCOTARGET, V7, P7913, DOI 10.18632/oncotarget.6861; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chowdhury S, 2016, ONCOTARGET, V7, P32318, DOI 10.18632/oncotarget.8698; Clark CA, 2016, CANCER RES, V76, P6964, DOI 10.1158/0008-5472.CAN-16-0258; Dai SY, 2014, CELL IMMUNOL, V290, P72, DOI 10.1016/j.cellimm.2014.05.006; Dong HD, 1999, NAT MED, V5, P1365; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Heeren AM, 2015, ONCOTARGET, V6, P32484, DOI 10.18632/oncotarget.5398; Heeren AM, 2015, CANCER IMMUNOL RES, V3, P48, DOI 10.1158/2326-6066.CIR-14-0149; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Howitt BE, 2016, JAMA ONCOL, V2, P518, DOI 10.1001/jamaoncol.2015.6326; Ji SR, 2016, CLIN CANCER RES, V22, P3950, DOI 10.1158/1078-0432.CCR-15-2380; Kang T, 2017, ACS NANO, V11, P1397, DOI 10.1021/acsnano.6b06477; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Leong SPL, 2014, CA-CANCER J CLIN, V64, P196, DOI 10.3322/caac.21217; Liu EY, 2017, ONCOTARGET, V8, P19467, DOI 10.18632/oncotarget.14444; Liu F, 2016, ONCOTARGET, V7, P8896, DOI 10.18632/oncotarget.6840; Nathanson SD, 2015, SEMIN CELL DEV BIOL, V38, P106, DOI 10.1016/j.semcdb.2014.10.002; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Paul NR, 2015, J CELL BIOL, V210, P1013, DOI 10.1083/jcb.201502040; Qin T, 2015, ONCOTARGET, V6, P33972, DOI 10.18632/oncotarget.5583; Qorraj M, 2017, LEUKEMIA, V31, P470, DOI 10.1038/leu.2016.214; Schreiner B, 2008, EUR J IMMUNOL, V38, P2706, DOI 10.1002/eji.200838137; Schumacker PT, 2011, CANCER CELL, V19, P299, DOI 10.1016/j.ccr.2011.03.001; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Sun ZJ, 2015, CANCER RES, V75, P1635, DOI 10.1158/0008-5472.CAN-14-3016; Udager AM, 2016, ANN ONCOL, V27, P1706, DOI 10.1093/annonc/mdw216; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Wang SJ, 2016, AM J CANCER RES, V6, P1108; Wang ZL, 2015, ONCOTARGET, V6, P6670, DOI 10.18632/oncotarget.3118; Wu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131403; Wu SF, 2017, ONCOTARGET, V8, P16421, DOI 10.18632/oncotarget.14851; Zhang YH, 2015, AM J REPROD IMMUNOL, V74, P201, DOI 10.1111/aji.12365; ZHOU XL, 2015, MED ONCOL, V32, DOI DOI 10.1007/S12032-015-0655-2; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	46	55	57	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 26	2018	37	30					4164	4180		10.1038/s41388-018-0252-x	http://dx.doi.org/10.1038/s41388-018-0252-x			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GO2YI	29706653				2022-12-26	WOS:000439847000009
J	Wang, ZQ; Huang, JL; Zhou, SR; Luo, FT; Tan, QY; Sun, XD; Ni, ZH; Chen, HG; Du, XL; Xie, YL; Chen, L				Wang, Zuqiang; Huang, Junlan; Zhou, Siru; Luo, Fengtao; Tan, Qiaoyan; Sun, Xianding; Ni, Zhenhong; Chen, Hangang; Du, Xiaolan; Xie, Yangli; Chen, Lin			Loss of Fgfr1 in chondrocytes inhibits osteoarthritis by promoting autophagic activity in temporomandibular joint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondrocyte; autophagy; fibroblast growth factor receptor (FGFR); osteoarthritis; cartilage; FGFR1; mandibular cartilage	ARTICULAR-CARTILAGE; SUBCHONDRAL BONE; STEM-CELLS; RECEPTOR 1; GROWTH; MOUSE; DELETION; EXPRESSION; PATHOGENESIS; ACTIVATION	Temporomandibular joint osteoarthritis (TMJ OA) is a common degenerative disease with few effective disease-modifying treatments in the clinic. Fibroblast growth factor (FGF) signaling is implicated in articular cartilage homeostasis, but the functional roles of FGFR1 in TMJ OA remain largely unknown. In this study, we report that deletion of Fgfr1 in TMJ chondrocytes delayed TMJ OA progression in the age-associated spontaneous OA model and the abnormal dental occlusion OA model. Immunohistochemical staining revealed that Fgfr1 deficiency decreased the expressions of MMP13 (matrix metalloproteinase-13), ADAMTS5 (a disintegrin and metalloproteinase with thrombospondin motifs 5), and COL10A1 but increased aggrecan expression level in two TMJ OA models. Furthermore, our data show that inactivation of FGFR1 signaling may promote autophagic activity in TMJ. FGFR1 inhibitor decreased the expressions of Mmp13, Adamts5, and Runx2 in IL-1-stimulated condylar chondrocytes, whereas autophagy inhibitors abrogated the protective effects of the FGFR1 inhibitor. Thus, our study indicates inactivated FGFR1 signaling ameliorates TMJ OA progression partially by promoting autophagic activity. Manipulation of this signaling may be a potential therapeutic approach to modify TMJ OA.	[Wang, Zuqiang; Huang, Junlan; Zhou, Siru; Luo, Fengtao; Tan, Qiaoyan; Sun, Xianding; Ni, Zhenhong; Chen, Hangang; Du, Xiaolan; Xie, Yangli; Chen, Lin] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Ctr Bone Metab & Repair,Trauma Ctr, Dept Rehabil Med,Res Inst Surg,Daping Hosp, Yangzi River Rd 10, Chongqing 400042, Peoples R China	Army Medical University	Du, XL; Xie, YL; Chen, L (corresponding author), Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Ctr Bone Metab & Repair,Trauma Ctr, Dept Rehabil Med,Res Inst Surg,Daping Hosp, Yangzi River Rd 10, Chongqing 400042, Peoples R China.	dxl_xiaolan@163.com; xieyangli841015@163.com; linchen70@163.com	Sun, Xianding/AAB-1267-2020; Luo, Fengtao/E-1236-2017	, tan/0000-0002-8534-4763; Chen, Lin/0000-0001-7764-9412; zhenhong, ni/0000-0002-7464-4074	Special Funds for Major State Basic Research Program of China (973 Program) [2014CB942904]; National Natural Science Foundation of China [81530071, 81772359]; TMMU Doctorate in Military Topics Grant [JSKT201608]; Chongqing Foundation & Advanced Research Project [cstc2017jcyjAX0148]	Special Funds for Major State Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); TMMU Doctorate in Military Topics Grant; Chongqing Foundation & Advanced Research Project	This work was supported by Special Funds for Major State Basic Research Program of China (973 Program) Grant 2014CB942904, National Natural Science Foundation of China Grants 81530071 and 81772359, TMMU Doctorate in Military Topics Grant JSKT201608, and Chongqing Foundation & Advanced Research Project Grant cstc2017jcyjAX0148. The authors declare that they have no conflicts of interest with the contents of this article.	Boileau C, 2005, ANN RHEUM DIS, V64, P891, DOI 10.1136/ard.2004.026906; Bouderlique T, 2016, ANN RHEUM DIS, V75, P627, DOI 10.1136/annrheumdis-2015-207742; Carames B, 2015, ARTHRITIS RHEUMATOL, V67, P1568, DOI 10.1002/art.39073; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; Chen J, 2009, OSTEOARTHR CARTILAGE, V17, P354, DOI 10.1016/j.joca.2008.05.021; Cheng L, 2016, SCI REP-UK, V6, P1, DOI 10.1038/srep34820; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Cinque L, 2015, NATURE, V528, P272, DOI 10.1038/nature16063; DEBONT LGM, 1993, INT J ORAL MAX SURG, V22, P200, DOI 10.1016/S0901-5027(05)80636-8; Ellman MB, 2008, GENE, V420, P82, DOI 10.1016/j.gene.2008.04.019; HORIO T, 1989, J ORAL REHABIL, V16, P177, DOI 10.1111/j.1365-2842.1989.tb01331.x; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Li X, 2012, J CELL BIOCHEM, V113, P2532, DOI 10.1002/jcb.24129; Liu YD, 2014, OSTEOARTHR CARTILAGE, V22, P302, DOI 10.1016/j.joca.2013.11.014; Lotz MK, 2011, NAT REV RHEUMATOL, V7, P579, DOI 10.1038/nrrheum.2011.109; Lu L, 2014, J ORAL FACIAL PAIN H, V28, P68, DOI 10.11607/jop.1082; LUDER HU, 1988, AM J ANAT, V182, P197, DOI 10.1002/aja.1001820302; Martin G, 2003, INFLAMMATION, V27, P233, DOI 10.1023/A:1025040631514; Milam Stephen B, 2005, Odontology, V93, P7, DOI 10.1007/s10266-005-0056-7; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Sasaki H, 2012, ARTHRITIS RHEUM-US, V64, P1920, DOI 10.1002/art.34323; Schminke B, 2014, CELL MOL LIFE SCI, V71, P1081, DOI 10.1007/s00018-013-1436-8; Settembre C, 2008, GENE DEV, V22, P2645, DOI 10.1101/gad.1711308; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Sugita S, 2015, P NATL ACAD SCI USA, V112, P3080, DOI 10.1073/pnas.1419699112; Tanaka E, 2008, J DENT RES, V87, P296, DOI 10.1177/154405910808700406; Tang JZ, 2016, ARTHRITIS RHEUMATOL, V68, P2432, DOI 10.1002/art.39739; Wang XD, 2015, J DENT RES, V94, P666, DOI 10.1177/0022034515574770; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Wang XF, 2015, AUTOPHAGY, V11, P1998, DOI 10.1080/15548627.2015.1091551; Weng TJ, 2012, ARTHRITIS RHEUM-US, V64, P3982, DOI 10.1002/art.34645; Yan DY, 2012, J CELL BIOCHEM, V113, P2856, DOI 10.1002/jcb.24160; Yan D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3441; Yang T, 2015, J DENT RES, V94, P803, DOI 10.1177/0022034515576051; Zarb GA, 1999, J OROFAC PAIN, V13, P295; Zhang J, 2012, CIRC RES, V110, pE29, DOI 10.1161/CIRCRESAHA.111.255950; Zhang MA, 2013, APOPTOSIS, V18, P423, DOI 10.1007/s10495-013-0811-0; Zhang Y, 2015, ANN RHEUM DIS, V74, P1432, DOI 10.1136/annrheumdis-2013-204599; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zhou SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24039; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	44	19	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8761	8774		10.1074/jbc.RA118.002293	http://dx.doi.org/10.1074/jbc.RA118.002293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29691281	Green Published, hybrid			2022-12-26	WOS:000434941900004
J	Airagnes, G; Lemogne, C; Goldberg, M; Hoertel, N; Roquelaure, Y; Limosin, F; Zins, M				Airagnes, Guillaume; Lemogne, Cedric; Goldberg, Marcel; Hoertel, Nicolas; Roquelaure, Yves; Limosin, Frederic; Zins, Marie			Job exposure to the public in relation with alcohol, tobacco and cannabis use: Findings from the CONSTANCES cohort study	PLOS ONE			English	Article							PSYCHOSOCIAL WORK-ENVIRONMENT; SOCIAL ANXIETY DISORDER; STRESS; DRINKING; RISK; GENDER; WOMEN; CONSUMPTION; DEPRESSION; SMOKING	Objectives To examine the associations between job exposure to the public (e.g., customers, guests, users of a public service, patients) and alcohol, tobacco and cannabis use. Methods From the French population-based CONSTANCES cohort, 16,566 men and 17,426 women currently working were included between 2012 and 2016. They reported their exposure to the public (daily versus no daily), and among the daily exposed participants (10,323 men and 13,318 women), the frequency of stressful exposure (often versus rarely). Dependent variables were: chronic alcohol consumption (<1(1), 1-27(1-13), 28-42(14-28), > 42(28) drinks per week in men(women)), heavy episodic drinking (never, at most once a month, more than once a month), alcohol use risk with Alcohol Use Disorders Identification Test (mild, dangerous, problematic or dependence), tobacco use (non-smoker, former smoker, 1-9, 10-19, > 19 cigarettes per day) and cannabis use (never, not in past year, less than once a month, once a month or more). Logistic regressions provided odds ratios of substance use, stratifying for gender and adjusting for sociodemographic confounders, depression, effort-reward imbalance and perceived health status. Results Exposed men had higher risks of alcohol (chronic alcohol consumption, heavy episodic drinking and alcohol use risk), tobacco and cannabis use. Exposed women had higher risks of tobacco and cannabis use. In men, stressful exposure was associated with increased risks of heavy episodic drinking, tobacco and cannabis use. In women, stressful exposure was associated with increased risks of chronic alcohol consumption, alcohol use risk, tobacco and cannabis use. All these findings remained significant in multivariable analyses, taking into account sociodemographic variables, depressive symptoms, perceived health status and effort-reward imbalance. Conclusions Interventions to reduce emotional job demand should systematically integrate assessment and prevention measures of addictive behaviors. Vulnerable workers may be offered more specific interventions to reduce the impact of exposure to the public on their substance use.	[Airagnes, Guillaume; Lemogne, Cedric; Hoertel, Nicolas; Limosin, Frederic] Hop Univ Paris Ouest, AP HP, Dept Psychiat & Addictol, Paris, France; [Airagnes, Guillaume; Lemogne, Cedric; Goldberg, Marcel; Hoertel, Nicolas; Limosin, Frederic; Zins, Marie] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Airagnes, Guillaume; Goldberg, Marcel; Zins, Marie] INSERM, Populat Based Epidemiol Cohorts, UMS 011, Villejuif, France; [Airagnes, Guillaume; Zins, Marie] INSERM, VIMA, UMR 1168, Villejuif, France; [Lemogne, Cedric] INSERM, Ctr Psychiat & Neurosci, U894, Paris, France; [Roquelaure, Yves] Univ Angers, UMR 1085, Ester, Irest Inserm, Angers, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers	Airagnes, G (corresponding author), Hop Univ Paris Ouest, AP HP, Dept Psychiat & Addictol, Paris, France.; Airagnes, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France.; Airagnes, G (corresponding author), INSERM, Populat Based Epidemiol Cohorts, UMS 011, Villejuif, France.; Airagnes, G (corresponding author), INSERM, VIMA, UMR 1168, Villejuif, France.	guillaume.airagnes@aphp.fr	, Hoertel/H-9457-2015; Lemogne, Cédric/Q-6091-2019; Zins, Marie/AAX-6551-2021; Goldberg, Marcel/I-7834-2012; Airagnes, Guillaume/M-8309-2017; ROQUELAURE, Yves/J-8208-2015	, Hoertel/0000-0002-7890-1349; Goldberg, Marcel/0000-0002-6161-5880; Airagnes, Guillaume/0000-0002-3494-5083; ROQUELAURE, Yves/0000-0001-6918-0909	Caisse Nationale d'Assurance Maladie des travailleurs salaries-CNAMTS; Agence nationale de la recherche [ANR-11-INBS-0002]; MSD; AstraZeneca; Lundbeck; Interministerial Mission for Combating Drugs and Addictive Behaviors ("Mission Interministerielle de Lutte contre les Drogues et les Conduites Addictives", MILDECA)	Caisse Nationale d'Assurance Maladie des travailleurs salaries-CNAMTS; Agence nationale de la recherche(French National Research Agency (ANR)); MSD; AstraZeneca(AstraZeneca); Lundbeck(Lundbeck Corporation); Interministerial Mission for Combating Drugs and Addictive Behaviors ("Mission Interministerielle de Lutte contre les Drogues et les Conduites Addictives", MILDECA)	The CONSTANCES cohort is supported by the Caisse Nationale d'Assurance Maladie des travailleurs salaries-CNAMTS. CONSTANCES is accredited as a "National Infrastructure for Biology and health" by the governmental Investissements d'avenir program and was funded by the Agence nationale de la recherche (ANR-11-INBS-0002 Grant). CONSTANCES also receives funding from MSD, AstraZeneca and Lundbeck managed by INSERM-Transfert. This study has received a funding from the Interministerial Mission for Combating Drugs and Addictive Behaviors ("Mission Interministerielle de Lutte contre les Drogues et les Conduites Addictives", MILDECA). None of the authors are salaried by the funders of the CONSTANCES cohort. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the National Health Insurance Fund ("Caisse nationale d'assurance maladie des travailleurs salaries", CNAMTS) and its Health Screening Centres ("Centres d'examens de sante"), responsible for collecting a large part of the data. The CONSTANCES cohort is supported by the Caisse Nationale d'Assurance Maladie des travailleurs salaries-CNAMTS. CONSTANCES is accredited as a "National Infrastructure for Biology and health" by the governmental Investissements d'avenir program.	Ait-Daoud N, 2017, PSYCHIAT CLIN N AM, V40, P285, DOI 10.1016/j.psc.2017.01.005; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Babor T.F., 2001, ALCOHOL USE DISORDER; Billings DW, 2008, J OCCUP ENVIRON MED, V50, P960, DOI 10.1097/JOM.0b013e31816c435b; Blanco C, 2016, JAMA PSYCHIAT, V73, P388, DOI 10.1001/jamapsychiatry.2015.3229; Buckner JD, 2008, J PSYCHIATR RES, V42, P230, DOI 10.1016/j.jpsychires.2007.01.002; Buckner JD, 2006, BEHAV THER, V37, P381, DOI 10.1016/j.beth.2006.02.007; Buckner JD, 2013, ADDICT BEHAV, V38, P2388, DOI 10.1016/j.addbeh.2013.03.007; Carton M S G, 2007, CONTRIBUTION VARIABL, P64; Chen VCH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130044; Colell E, 2014, AM J IND MED, V57, P837, DOI 10.1002/ajim.22333; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Escriba-Aguir V, 2006, INT ARCH OCC ENV HEA, V80, P127, DOI 10.1007/s00420-006-0110-y; Frone MR, 1999, ALCOHOL RES HEALTH, V23, P284; FUHRER R, 1989, Psychiatrie and Psychobiologie, V4, P163; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; Goldberg M, 2017, OCCUP ENVIRON MED, V74, P66, DOI 10.1136/oemed-2016-103678; Goldin PR, 2010, EMOTION, V10, P83, DOI 10.1037/a0018441; Grandey A A, 2000, J Occup Health Psychol, V5, P95, DOI 10.1037/1076-8998.5.1.95; Hakanen JJ, 2006, J SCHOOL PSYCHOL, V43, P495, DOI 10.1016/j.jsp.2005.11.001; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Haukoos JS, 2007, ACAD EMERG MED, V14, P662, DOI 10.1197/j.aem.2006.11.037; Head J, 2004, OCCUP ENVIRON MED, V61, P219, DOI 10.1136/oem.2002.005256; Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313; Hooftman WE, 2005, J OCCUP ENVIRON MED, V47, P244, DOI 10.1097/01.jom.0000150387.14885.6b; Kidorf M, 1999, PSYCHOL ADDICT BEHAV, V13, P134, DOI 10.1037/0893-164X.13.2.134; Kornreich C, 2002, ALCOHOL ALCOHOLISM, V37, P394, DOI 10.1093/alcalc/37.4.394; Labrie JW, 2007, J STUD ALCOHOL DRUGS, V68, P393, DOI 10.15288/jsad.2007.68.393; Lima CT, 2013, J STUD ALCOHOL DRUGS, V74, P212, DOI 10.15288/jsad.2013.74.212; Lohse T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148563; McCreary DR, 1999, J COUNS PSYCHOL, V46, P109, DOI 10.1037/0022-0167.46.1.109; Melchior M, 2007, PSYCHOL MED, V37, P1119, DOI 10.1017/S0033291707000414; Moore TM, 2005, AGGRESS VIOLENT BEH, V10, P171, DOI 10.1016/j.avb.2003.10.002; Morois S, 2017, EUR J PUBLIC HEALTH, V27, P482, DOI 10.1093/eurpub/ckx012; Mykletun A, 2008, EUR PSYCHIAT, V23, P77, DOI 10.1016/j.eurpsy.2007.10.005; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; Redonnet B, 2012, DRUG ALCOHOL DEPEN, V121, P231, DOI 10.1016/j.drugalcdep.2011.09.002; Reed PL, 2006, AM J EPIDEMIOL, V163, P404, DOI 10.1093/aje/kwj064; Rivera-Torres P, 2013, INT J ENV RES PUB HE, V10, P375, DOI 10.3390/ijerph10010375; Sabbath EL, 2012, J OCCUP ENVIRON MED, V54, P598, DOI 10.1097/JOM.0b013e31824af5a8; Schneider SL, 2013, COMP SOC RES, V30, P365, DOI 10.1108/S0195-6310(2013)0000030017; Schulte MT, 2009, CLIN PSYCHOL REV, V29, P535, DOI 10.1016/j.cpr.2009.06.003; Shield KD, 2015, IMPACT ADDICTIVE SUB, P181, DOI DOI 10.1093/ACPROF:OSO/9780198714002.003.0009; Siegrist J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040432; Sinha Rajita, 2007, Curr Psychiatry Rep, V9, P388, DOI 10.1007/s11920-007-0050-6; Stewart SH, 2007, J HOSP MED, V2, P372, DOI 10.1002/jhm.211; Stier H, 2014, WORK EMPLOY SOC, V28, P225, DOI 10.1177/0950017013510758; Sullivan LE, 2005, AM J MED, V118, P330, DOI 10.1016/j.amjmed.2005.01.007; Temple EC, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00040; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; Wang JL, 2008, J EPIDEMIOL COMMUN H, V62, P42, DOI 10.1136/jech.2006.050591; Weissenborn R, 2003, PSYCHOPHARMACOLOGY, V165, P306, DOI 10.1007/s00213-002-1281-1; Weng SF, 2013, ADDICTION, V108, P307, DOI 10.1111/add.12015; WHO, 2004, GLOB STAT REP ALC 20; Wiesbeck GA, 2008, NEUROPSYCHOBIOLOGY, V57, P26, DOI 10.1159/000123119; WINSHIP C, 1984, AM SOCIOL REV, V49, P512, DOI 10.2307/2095465	56	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196330	10.1371/journal.pone.0196330	http://dx.doi.org/10.1371/journal.pone.0196330			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5RZ	29715268	gold, Green Submitted, Green Published			2022-12-26	WOS:000431281100018
J	Ziemba, BP; Falke, JJ				Ziemba, Brian P.; Falke, Joseph J.			A PKC-MARCKS-PI3K regulatory module links Ca2+ and PIP3 signals at the leading edge of polarized macrophages	PLOS ONE			English	Article							PROTEIN-KINASE-C; PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR; MARCKS-RELATED PROTEIN; SUBSTRATE MARCKS; SINGLE-MOLECULE; PKC-ALPHA; PHOSPHOINOSITIDE 3-KINASE; EUKARYOTIC CHEMOTAXIS; NEUTROPHIL CHEMOTAXIS; CALMODULIN-BINDING	The leukocyte chemosensory pathway detects attractant gradients and directs cell migration to sites of inflammation, infection, tissue damage, and carcinogenesis. Previous studies have revealed that local Ca2+ and PIP3 signals at the leading edge of polarized leukocytes play central roles in positive feedback loop essential to cell polarization and chemotaxis. These prior studies showed that stimulation of the leading edge Ca2+ signal can strongly activate PI3K, thereby triggering a larger PIP3 signal, but did not elucidate the mechanistic link between Ca2+ and PIP3 signaling. A hypothesis explaining this link emerged, postulating that Ca2+-activated PKC displaces the MARCKS protein from plasma membrane PIP2, thereby releasing sequestered PIP2 to serve as the target and substrate lipid of PI3K in PIP3 production. In vitro single molecule studies of the reconstituted pathway on lipid bilayers demonstrated the feasibility of this PKC-MARCKS-PI3K regulatory module linking Ca2+ and PIP3 signals in the reconstituted system. The present study tests the model predictions in live macrophages by quantifying the effects of: (a) two pathway activators-PDGF and ATP that stimulate chemoreceptors and Ca2+ influx, respectively; and (b) three pathway inhibitors-wortmannin, EGTA, and Go6976 that inhibit PI3K, Ca2+ influx, and PKC, respectively; on (c) four leading edge activity sensors-AKT-PH-mRFP, CKAR, MARCKSp-mRFP, and leading edge area that report on PIP3 density, PKC activity, MARCKS membrane binding, and leading edge expansion/contraction, respectively. The results provide additional evidence that PKC and PI3K are both essential elements of the leading edge positive feedback loop, and strongly support the existence of a PKC-MARCKS-PI3K regulatory module linking the leading edge Ca2+ and PIP3 signals. As predicted, activators stimulate leading edge PKC activity, displacement of MARCKS from the leading edge membrane and increased leading edge PIP3 levels, while inhibitors trigger the opposite effects. Comparison of the findings for the ameboid chemotaxis of leukocytes with recently published findings for the mesenchymal chemotaxis of fibroblasts suggests that some features of the emerging leukocyte leading edge core pathway (PLC-DAG-Ca2+-PKC-MARCKS-PIP2-PI3K-PIP3) may well be shared by all chemotaxing eukaryotic cells, while other elements of the leukocyte pathway may be specialized features of these highly optimized, professional gradient-seeking cells. More broadly, the findings suggest a molecular mechanism for the strong links between phospho-MARCKS and many human cancers.	[Falke, Joseph J.] Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA; Univ Colorado, Mol Biophys Program, Boulder, CO USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Falke, JJ (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	falke@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019	ZIEMBA, BRIAN/0000-0002-0508-6830; FALKE, JOSEPH/0000-0002-3704-4694	National Institutes of Health [R01 GM063235]; NIH [R01 GM063235]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, Grant R01 GM063235.	Andrews Simon, 2007, Sci STKE, V2007, pcm3, DOI 10.1126/stke.4072007cm3; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Artemenko Y, 2014, CELL MOL LIFE SCI, V71, P3711, DOI 10.1007/s00018-014-1638-8; Asokan SB, 2014, DEV CELL, V31, P747, DOI 10.1016/j.devcel.2014.10.024; Bear JE, 2014, CURR OPIN CELL BIOL, V30, P74, DOI 10.1016/j.ceb.2014.06.005; Beerman RW, 2015, CELL REP, V13, P2107, DOI 10.1016/j.celrep.2015.11.010; Buckles TC, 2017, BIOPHYS J, V113, P2396, DOI 10.1016/j.bpj.2017.09.018; Cai HQ, 2011, SEMIN CELL DEV BIOL, V22, P834, DOI 10.1016/j.semcdb.2011.07.020; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Capsoni F, 2012, INT J IMMUNOPATH PH, V25, P617, DOI 10.1177/039463201202500308; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Choudhury GG, 1997, AM J PHYSIOL-RENAL, V273, pF931, DOI 10.1152/ajprenal.1997.273.6.F931; Coffer PJ, 1998, BIOCHEM J, V329, P121; Corbalan-Garcia S, 2007, BIOCHEM SOC T, V35, P1046, DOI 10.1042/BST0351046; Desai BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00580; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Eckert RE, 2010, AM J RESP CELL MOL, V42, P586, DOI 10.1165/rcmb.2008-0394OC; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Falke JJ, 2014, CHEM PHYS LIPIDS, V182, P73, DOI 10.1016/j.chemphyslip.2014.01.002; Faria RX, 2010, N-S ARCH PHARMACOL, V382, P73, DOI 10.1007/s00210-010-0523-8; Fong LWR, 2017, CANCER METAST REV, V36, P737, DOI 10.1007/s10555-017-9709-6; Gadi D, 2011, MOL BIOL CELL, V22, P4908, DOI 10.1091/mbc.E11-07-0614; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gambardella L, 2013, J LEUKOCYTE BIOL, V94, P603, DOI 10.1189/jlb.1112564; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Grandage VL, 2006, BRIT J HAEMATOL, V135, P303, DOI 10.1111/j.1365-2141.2006.06291.x; Graziano BR, 2017, J CELL BIOL, V216, P2515, DOI 10.1083/jcb.201604113; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; HEEMSKERK FMJ, 1993, BIOCHEM BIOPH RES CO, V190, P236, DOI 10.1006/bbrc.1993.1036; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; INABA T, 1993, J BIOL CHEM, V268, P24353; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Johnson HE, 2016, BIOPHYS J, V111, P1827, DOI 10.1016/j.bpj.2016.09.022; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Katz S, 2011, ARCH BIOCHEM BIOPHYS, V513, P144, DOI 10.1016/j.abb.2011.06.013; Kawamura H, 2012, IMMUNOLOGY, V136, P448, DOI 10.1111/j.1365-2567.2012.03601.x; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lai CL, 2010, J MOL BIOL, V402, P301, DOI 10.1016/j.jmb.2010.07.037; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; Lien EC, 2017, CURR OPIN CELL BIOL, V45, P62, DOI 10.1016/j.ceb.2017.02.007; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Maree AFM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002402; Martin KJS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116250; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McLaughlin S, 2005, BIOCHEM SOC SYMP, V72, P189, DOI 10.1042/bss0720189; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mohan K, 2017, BIOPHYS J, V113, P185, DOI 10.1016/j.bpj.2017.05.035; Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4; Nagano K, 2012, MOL CELL PROTEOMICS, V11, P1690, DOI 10.1074/mcp.M112.019778; NAIRN AC, 1992, CIBA F SYMP, V164, P145; Nairn AC, 1992, CIBA F SYMP, V164, P54; Niggli V, 1997, EUR J PHARMACOL, V335, P43, DOI 10.1016/S0014-2999(97)01169-2; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; Palmer RH, 1996, FEBS LETT, V378, P281, DOI 10.1016/0014-5793(95)01454-3; Perez-Lara A, 2012, BBA-MOL CELL BIOL L, V1821, P1434, DOI 10.1016/j.bbalip.2012.06.012; Porumb T, 1997, EUR BIOPHYS J BIOPHY, V25, P239, DOI 10.1007/s002490050036; POWIS G, 1994, CANCER RES, V54, P2419; ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sanchez-Bautista S, 2006, J MOL BIOL, V362, P901, DOI 10.1016/j.jmb.2006.07.093; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; STACEY KJ, 1993, IMMUNOL CELL BIOL, V71, P75, DOI 10.1038/icb.1993.8; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tranquillo R T, 1991, ASGSB Bull, V4, P75; Van de Parre TJL, 2005, BIOCHEM BIOPH RES CO, V327, P356, DOI 10.1016/j.bbrc.2004.12.027; VERGHESE GM, 1994, J BIOL CHEM, V269, P9361; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Wang MJ, 2014, CELL REP, V9, P1110, DOI 10.1016/j.celrep.2014.09.047; Weiger Michael C, 2012, Subcell Biochem, V59, P217, DOI 10.1007/978-94-007-3015-1_7; WILKINSON PC, 1975, EXP CELL RES, V93, P420, DOI 10.1016/0014-4827(75)90468-1; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yang HW, 2016, NAT CELL BIOL, V18, P191, DOI 10.1038/ncb3292; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Ziemba BP, 2016, BIOCHEMISTRY-US, V55, P6395, DOI 10.1021/acs.biochem.6b00908; Ziemba BP, 2016, BIOPHYS J, V110, P1811, DOI 10.1016/j.bpj.2016.03.001; Ziemba BP, 2014, BIOCHEMISTRY-US, V53, P1697, DOI 10.1021/bi4016082	87	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196678	10.1371/journal.pone.0196678	http://dx.doi.org/10.1371/journal.pone.0196678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715315	Green Submitted, gold, Green Published			2022-12-26	WOS:000431281100043
J	Liang, LH; Yuan, J; Zhang, ST; Zhao, P				Liang, Lihua; Yuan, Jia; Zhang, Songtao; Zhao, Peng			Design a software real-time operation platform for wave piercing catamarans motion control using linear quadratic regulator based genetic algorithm	PLOS ONE			English	Article							ROLL STABILIZATION	This work presents optimal linear quadratic regulator (LQR) based on genetic algorithm (GA) to solve the two degrees of freedom (2 DoF) motion control problem in head seas for wave piercing catamarans (WPC). The proposed LQR based GA control strategy is to select optimal weighting matrices (Q and R). The seakeeping performance of WPC based on proposed algorithm is challenged because of multi-input multi-output (MIMO) system of uncertain coefficient problems. Besides the kinematical constraint problems of WPC, the external conditions must be considered, like the sea disturbance and the actuators (a T-foil and two flaps) control. Moreover, this paper describes the MATLAB and LabVIEW software plats to simulate the reduction effects of WPC. Finally, the real-time (RT) Nl CompactRIO embedded controller is selected to test the effectiveness of the actuators based on proposed techniques. In conclusion, simulation and experimental results prove the correctness of the proposed algorithm. The percentage of heave and pitch reductions are more than 18% in different high speeds and bad sea conditions. And the results also verify the feasibility of Nl CompactRIO embedded controller.	[Liang, Lihua; Yuan, Jia; Zhang, Songtao; Zhao, Peng] Harbin Engn Univ, Coll Automat, Nangang Dist 145, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University	Yuan, J (corresponding author), Harbin Engn Univ, Coll Automat, Nangang Dist 145, Harbin, Heilongjiang, Peoples R China.	cherry@hrbeu.edu.cn						Ang KK, 2002, SMART MATER STRUCT, V11, P98, DOI 10.1088/0964-1726/11/1/311; Bittencourt AA, 2009, INT C INT SYST APPL; Davis MR, 2003, INT J MARIT ENG, DOI [10.3940/rina.ijme.2003.a2.17031, DOI 10.3940/RINA.IJME.2003.A2.17031]; de Canete F, 2012, APPL SOFT COMPUT, V12, P2728, DOI 10.1016/j.asoc.2012.03.062; De la Cruz JM, 2004, IEEE CONTR SYST MAG, V24, P47, DOI 10.1109/MCS.2004.1275431; Faltinsen O, PHYS ENG SCI; Fluent Inc, 2003, GAMBIT MOD GUID; Foghahaayee HN, 2014, APPL SOFT COMPUT, V18, P82, DOI 10.1016/j.asoc.2014.01.019; Fossen T., 2002, MARINE CONTROL SYSTE; Fossen T. I., 1994, GUIDANCE CONTROL OCE; Gupta S, 2014, ARCH ELECTR ENG, V63, P469, DOI 10.2478/aee-2014-0034; Hassani K, 2016, APPL SOFT COMPUT, V41, P66, DOI 10.1016/j.asoc.2015.12.024; HAYWOOD AJ, 1995, CONTROL ENG PRACT, V3, P695, DOI 10.1016/0967-0661(95)00046-W; Ikeda Y, SEAKEEPING PERFORMAN; Kim MH, UNDERWATER AUTONOMOU; Kumar EV, 2013, PROCEDIA ENGINEER, V64, P169, DOI 10.1016/j.proeng.2013.09.088; Lavroff J, 2013, MAR STRUCT, V33, P120, DOI 10.1016/j.marstruc.2013.05.001; Lewis E.V., 1989, PRINCIPLES NAVAL ARC, VIII; Lewis F. L., 1986, OPTIMAL CONTROL; Lghani M, 2014, CONTROL ENG PRACT, V24, P1, DOI [10.1016/j.conengprac.2013.11.007, DOI 10.1016/J.CONENGPRAC.2013.11.007]; Li J.D., 2007, SHIP SEAKEEPING; Liang H. B., 2011, THESIS; Liang L., 2015, J COMPUTATIONAL INFO, V11, P3217; Liang LH, 2013, 2013 IEEE INT C MECH; Liang LH, 2016, P 35 CHIN CONTR C; Liang LH, 2016, 2016 IEEE INT C MECH; Liang LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168972; Liu ZQ, 2013, OCEAN ENG, V72, P25, DOI 10.1016/j.oceaneng.2013.06.009; Lloyd A., 1989, SEAKEEPING SHIP BEHA; Machado JAT, 2010, COMMUN NONLINEAR SCI, V15, P482, DOI 10.1016/j.cnsns.2009.04.030; Maldonado Y, 2013, APPL SOFT COMPUT, V13, P496, DOI 10.1016/j.asoc.2012.08.032; Marco P, 2014, ISA T, V53, P402, DOI [10.1016/j.isatra.2013.09.003, DOI 10.1016/J.ISATRA.2013.09.003]; Oura T, MANEUVERABILITY WAVE; Perez T, EE02037; Tarapada R, 2009, J REINF PLAST COMP, V28, P1383, DOI [10.1177/0731684408089506, DOI 10.1177/0731684408089506]; VANAMERONGEN J, 1990, AUTOMATICA, V26, P679, DOI 10.1016/0005-1098(90)90045-J; Vishal Jyoti O, 2015, IND INT C POW EL IIC; Wang F., 2004, COMPUTATIONAL FLUID; Wang XL, 2008, OPTIMIZATION METHODS; Wongsathan C, 2009, 2008 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-4, P951, DOI 10.1109/ROBIO.2009.4913127; Wu LK, 2000, SHIP BOAT, V3, P15; Zhang FM, GTS ROV ALPHA GEORGI; Zhang ST, 2014, 2014 IEEE INT C MECH; Zhang Wan-feng, 2010, Technical Acoustics, V29, P344, DOI 10.3969/j.issn1000-3630.2010.03.023	44	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196107	10.1371/journal.pone.0196107	http://dx.doi.org/10.1371/journal.pone.0196107			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709008	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100015
J	Saha, S; Gupta, V; Dawood, FS; Broor, S; Lafond, KE; Chadha, MS; Rai, SK; Krishnan, A				Saha, Siddhartha; Gupta, Vivek; Dawood, Fatimah S.; Broor, Shobha; Lafond, Kathryn E.; Chadha, Mandeep S.; Rai, Sanjay K.; Krishnan, Anand			Estimation of community-level influenza-associated illness in a low resource rural setting in India	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; NORTHERN INDIA; CHILDREN; SURVEILLANCE; BANGLADESH; MULTISITE; COST	Objective To estimate rates of community-level influenza-like-illness (ILI) and influenza-associated ILI in rural north India. Methods During 2011, we conducted household-based healthcare utilization surveys (HUS) for any acute medical illness (AMI) in preceding 14days among residents of 28villages of Ballabgarh, in north India. Concurrently, we conducted clinic-based surveillance (CBS) in the area for AMI episodes with illness onset <= 3days and collected nasal and throat swabs for influenza virus testing using real-time polymerase chain reaction. Retrospectively, we applied ILI case definition (measured/reported fever and cough) to HUS and CBS data. We attributed 14days of risk-time per person surveyed in HUS and estimated community ILI rate by dividing the number of ILI cases in HUS by total risk-time. We used CBS data on influenza positivity and applied it to HUS-based community ILI rates by age, month, and clinic type, to estimate the community influenza-associated ILI rates. Findings The HUS of 69,369 residents during the year generated risk-time of 3945 person-years (p-y) and identified 150 (5%, 95% CI: 4-6) ILI episodes (38 ILI episodes/1,000 p-y; 95% CI 32-44). Among 1,372 ILI cases enrolled from clinics, 126 (9%; 95% CI 8-11) had laboratoryconfirmed influenza (A (H3N2) = 72; B = 54). After adjusting for age, month, and clinic type, overall influenza-associated ILI rate was 4.8/1,000 p-y; rates were highest among children <5 years (13; 95% CI: 4-29) and persons >= 60 years (11; 95% CI: 2-30). Conclusion We present a novel way to use HUS and CBS data to generate estimates of community burden of influenza. Although the confidence intervals overlapped considerably, higher point estimates for burden among young children and older adults shows the utility for exploring the value of influenza vaccination among target groups.	[Saha, Siddhartha] India Off, US Ctr Dis Control & Prevent, Influenza Program, New Delhi, India; [Gupta, Vivek; Rai, Sanjay K.; Krishnan, Anand] All India Inst Med Sci, Ctr Community Med, New Delhi, India; [Dawood, Fatimah S.; Lafond, Kathryn E.] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Broor, Shobha] All India Inst Med Sci, Dept Microbiol, New Delhi, India; [Chadha, Mandeep S.] Natl Inst Virol, Pune, Maharashtra, India; [Broor, Shobha] SGT Med Coll, Hosp & Res Inst, Gurgaon, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Centers for Disease Control & Prevention - USA; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Saha, S (corresponding author), India Off, US Ctr Dis Control & Prevent, Influenza Program, New Delhi, India.	ssaha1@cdc.gov	Broor, Shobha/AAX-4163-2021; Krishnan, Anand/D-8537-2012	Broor, Shobha/0000-0001-9679-4180; Krishnan, Anand/0000-0002-9173-7811; Gupta, Vivek/0000-0002-6157-3705; Saha, Siddhartha/0000-0002-7494-267X	National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, (CDC) Atlanta, US [U01 IP000206]	National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, (CDC) Atlanta, US	This study was supported by cooperative agreements U01 IP000206 from the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, (CDC) Atlanta, US. The scientists from CDC participated in study design, data analysis, decision to publish, and preparation of the manuscript. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.	Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Centers for Disease Control & Prevention, 2012, CDC PROT REALT RTPCR; Chadha MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124122; Directorate General of Health Servcies, 2016, SEAS INFL GUID VACC; European Centre for Disease Prevention and Control, 2012, INFL EUR SEAS 2011 2; Fowlkes A, 2013, INFLUENZA OTHER RESP, V7, P694, DOI 10.1111/irv.12014; Ganatra Rahul, 2012, Morbidity and Mortality Weekly Report, V61, P414; Hirve S, 2015, J INFECTION, V70, P160, DOI 10.1016/j.jinf.2014.08.015; Kant S, 2013, INT J EPIDEMIOL, V42, P758, DOI 10.1093/ije/dyt055; Lindblade KA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-885; Ministry of Health Family Welfare GoI, 2017, NAT HLTH POL 2017; MONTO AS, 1995, AM J EPIDEMIOL, V141, P502, DOI 10.1093/oxfordjournals.aje.a117464; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Najnin N, 2011, J HEALTH POPUL NUTR, V29, P523, DOI 10.3329/jhpn.v29i5.8907; Oliveira CR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1456-8; Peasah SK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1685-6; Simmerman JM, 2006, VACCINE, V24, P4417, DOI 10.1016/j.vaccine.2005.12.060; World Health Organization, 2015, MAN EST DIS BURD ASS; Zhang T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1614-z	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196495	10.1371/journal.pone.0196495	http://dx.doi.org/10.1371/journal.pone.0196495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698505	Green Submitted, gold, Green Published			2022-12-26	WOS:000431007600087
J	Khaing, NEE; Shyong, TE; Lee, J; Soekojo, CY; Ng, A; Van Dam, RM				Khaing, Nang Ei Ei; Shyong, Tai E.; Lee, Jeannette; Soekojo, Cinnie Yentia; Ng, Alvin; Van Dam, Rob M.			Epicardial and visceral adipose tissue in relation to subclinical atherosclerosis in a Chinese population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ABDOMINAL FAT DISTRIBUTION; RISK-FACTORS; CARDIOVASCULAR-DISEASE; PERICARDIAL FAT; HEART-DISEASE; ASSOCIATION; CALCIUM; CALCIFICATION; PROGRESSION	Background Body fatness is associated with risk of coronary heart disease and it has been postulated that epicardial adipose tissue (EAT) may have a particularly detrimental effect because of its localized toxic effects. We therefore aimed to examine the association between EAT and coronary artery calcification and compared this with associations for visceral adipose tissue (VAT) and other regional fat depots. Methods We conducted a cross-sectional study of 487 Chinese participants aged 50 years old and above, living in Singapore. Participants, free from known diabetes mellitus and coronary heart diseases, completed interviews, a health screening to evaluate obesity and cardiovascular disease risk factors, and computed tomography scans of the abdomen and coronary arteries. Associations between regional fat depots and subclinical atherosclerosis defined as CAC> = 100 were determined by multiple logistic regression analysis. Results Epicardial adipose tissue (EAT) was highly correlated with visceral adipose tissue (VAT) (Pearson r = 0.72) and trunk fat mass (r = 0.66). The age and sex-adjusted odd ratio (OR) (in 1-SD increase) of subclinical atherosclerosis was 1.28 (1.01 +/- 1.61) for EAT and 1.40 (1.04 +/- 1.88) for VAT. These associations were weaker and non-significant after adjusting for markers of dyslipidemia and hyperglycemia. Total body fat, subcutaneous abdominal fat, and leg, arm and trunk fat mass were not significantly associated with atherosclerosis. Conclusion VAT and EAT showed similar associations with coronary artery calcification and the associations could be mediated by traditional risk factors in this ethnic Chinese population.	[Khaing, Nang Ei Ei; Shyong, Tai E.; Lee, Jeannette; Van Dam, Rob M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Shyong, Tai E.; Soekojo, Cinnie Yentia; Van Dam, Rob M.] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore; [Ng, Alvin] Mt Elizabeth Med Ctr, Singapore, Singapore; [Ng, Alvin] Singapore Gen Hosp, Dept Endocrinol, Singapore, Singapore; [Van Dam, Rob M.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA	National University of Singapore; National University of Singapore; Mount Elizabeth Medical Centre; Singapore General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Khaing, NEE (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.	ephnang@nus.edu.sg	van Dam, Rob M/F-9674-2010; Khaing, Nang Ei Ei/C-2219-2011	van Dam, Rob M/0000-0002-7354-8734; Tai, E Shyong/0000-0003-2929-8966; Khaing, Nang Ei Ei/0000-0002-5361-0481; Soekojo, Cinnie/0000-0001-8376-8872	National Medical Research Council [NMRC/1094/2006]; Endocrine and Metabolic Society of Singapore [EMSS 2007/05]; Singapore Consortium of Cohort Studies - A*STAR Biomedical Research Council [05/1/21/19/425]; Ministry of Health, Singapore	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Endocrine and Metabolic Society of Singapore; Singapore Consortium of Cohort Studies - A*STAR Biomedical Research Council; Ministry of Health, Singapore	This study was supported by National Medical Research Council (http://www.nmrc.gov.sg/content/nmrc_internet/home.html) (grant NMRC/1094/2006), Endocrine and Metabolic Society of Singapore (http://emss.org.sg/) (grant EMSS 2007/05) (recipient:AN), the Singapore Consortium of Cohort Studies which was funded by A*STAR Biomedical Research Council (https://www.a-star.edu.sg/About-A-STAR/Biomedical-Research-Council/BMRC-Board.aspx) (grant 05/1/ 21/19/425) and Ministry of Health, Singapore (https://www.moh.gov.sg/content/moh_web/home.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allen NB, 2014, JAMA-J AM MED ASSOC, V311, P490, DOI 10.1001/jama.2013.285122; Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264; DiTomasso D, 2010, ATHEROSCLEROSIS, V208, P531, DOI 10.1016/j.atherosclerosis.2009.08.015; Divers J, 2010, J CLIN ENDOCR METAB, V95, P5382, DOI 10.1210/jc.2010-0793; Fujimoto WY, 1999, DIABETES CARE, V22, P1808, DOI 10.2337/diacare.22.11.1808; Gorter PM, 2008, AM J CARDIOL, V102, P380, DOI 10.1016/j.amjcard.2008.04.002; Lear SA, 2007, STROKE, V38, P2422, DOI 10.1161/STROKEAHA.107.484113; Lovejoy JC, 1996, METABOLISM, V45, P1119, DOI 10.1016/S0026-0495(96)90011-6; Mahabadi AA, 2014, JACC-CARDIOVASC IMAG, V7, P909, DOI 10.1016/j.jcmg.2014.07.002; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Nakazato R, 2012, ATHEROSCLEROSIS, V221, P422, DOI 10.1016/j.atherosclerosis.2011.12.018; Nang EEK, 2009, AM J EPIDEMIOL, V169, P1454, DOI 10.1093/aje/kwp076; Ng AC, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.12; Oikawa M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/483982; Oike M, 2014, OBES RES CLIN PRACT, V8, pE448, DOI 10.1016/j.orcp.2013.09.002; Park JS, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-29; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Tran T, 2014, EUR HEART J-CARD IMG, V15, P423, DOI 10.1093/ehjci/jet175; Yerramasu A, 2012, ATHEROSCLEROSIS, V220, P223, DOI 10.1016/j.atherosclerosis.2011.09.041; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196328	10.1371/journal.pone.0196328	http://dx.doi.org/10.1371/journal.pone.0196328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694442	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400082
J	Lopez-Ortega, M; Williams, T				Lopez-Ortega, Maurilio; Williams, Trevor			Natural enemy defense, provisioning and oviposition site selection as maternal strategies to enhance offspring survival in a sub-social bug	PLOS ONE			English	Article							TROPHIC-EGG-PRODUCTION; SUBSOCIAL BURROWER BUG; FREE SPACE; ADOMERUS-TRIGUTTULUS; FOOD QUALITY; SHIELD BUG; TRADE-OFF; HOST USE; HETEROPTERA; PLANT	The influence of maternal defense against natural enemies, maternal provisioning and oviposition site selection on offspring survival before and after hatching were examined in a semelparous pentatomid bug, Ramosiana insignis. Oviposition occurs on leaves of Schoepfia schreberi, or surrounding vegetation from which nymphs migrate to feed exclusively on S. schreberi flower buds. Oviposition is asynchronous; the mother lays additional eggs immediately prior to hatching of the core brood that rapidly consume the additional eggs. In the absence of maternal defense egg masses were more heavily parasitized, suffered ant predation and an increased prevalence of sibling cannibalism. Maternal provisioning in the form of addition eggs significantly reduced the prevalence of sibling cannibalism of core brood eggs. Migration of the core brood away from the oviposition site was also significantly higher in the absence of maternal provisioning. If not consumed, additional eggs were capable of producing viable progeny of both sexes, indicating that they were in fact marginal progeny. The average clutch size on non-host vegetation was numerically greater than clutches laid on host trees (borderline significant P = 0.058). A greater number of additional eggs were deposited with clutches laid on non-host vegetation compared to those on the host plant. Egg masses on non-host vegetation were less likely to be discovered by parasitoids, compared to those on the host tree. Overall, clutches on non-host vegetation produced one third more offspring than clutches on the host tree. We conclude that R. insignis females present a remarkable combination of maternal defense, provisioning of additional eggs and oviposition site selection as strategies to enhance offspring survival in both the egg and nymph stages.	[Lopez-Ortega, Maurilio] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa, Veracruz, Mexico; [Williams, Trevor] Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico	Universidad Veracruzana; Instituto de Ecologia - Mexico	Williams, T (corresponding author), Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico.	trevor.inecol@gmail.com	Williams, Trevor/F-1447-2011; Williams, Trevor/ABG-3961-2020; Lopez, Maurilio/AAM-9557-2021	Williams, Trevor/0000-0003-3414-3440; Lopez, Maurilio/0000-0001-6484-1798				Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Cocroft RB, 2002, BEHAV ECOL, V13, P125, DOI 10.1093/beheco/13.1.125; Conti Eric, 2000, Journal of Hymenoptera Research, V9, P385; Crawley M.J., 1993, GLIM ECOLOGISTS; Crespi BJ., CANNIBALISM ECOLOGY; Deas JB, 2012, P ROY SOC B-BIOL SCI, V279, P847, DOI 10.1098/rspb.2011.1585; Eitam A, 2004, PHYSIOL ENTOMOL, V29, P188, DOI 10.1111/j.0307-6962.2004.0372.x; Filippi L, 2002, ECOL ENTOMOL, V27, P152, DOI 10.1046/j.1365-2311.2002.00392.x; Filippi L, 2009, NATURWISSENSCHAFTEN, V96, P201, DOI 10.1007/s00114-008-0463-z; FOX LR, 1992, OECOLOGIA, V89, P574, DOI 10.1007/BF00317166; Frechette B, 2000, EUR J ENTOMOL, V97, P507, DOI 10.14411/eje.2000.078; Godfray H.C.J., 1987, Oxford Surveys in Evolutionary Biology, V4, P117; Gols R, 2005, J ANIM ECOL, V74, P1059, DOI 10.1111/j.1365-2656.2005.01003.x; Gratton C, 1999, ECOLOGY, V80, P773, DOI 10.1890/0012-9658(1999)080[0773:DEFSEE]2.0.CO;2; Heard SB, 2006, OECOLOGIA, V150, P421, DOI 10.1007/s00442-006-0529-6; Hironaka M, 2005, ETHOLOGY, V111, P1089, DOI 10.1111/j.1439-0310.2005.01112.x; Kessler A, 2002, ECOLOGY, V83, P2346, DOI 10.1890/0012-9658(2002)083[2346:MQSOOI]2.0.CO;2; KORMILEV NICOLAS A., 1951, REV SOC ENT ARGENTINA, V15, P83; Kudo S, 2005, OIKOS, V111, P459, DOI 10.1111/j.1600-0706.2005.14173.x; Kudo S, 2004, OIKOS, V107, P28, DOI 10.1111/j.0030-1299.2004.13169.x; Kudo S, 2001, OIKOS, V92, P208, DOI 10.1034/j.1600-0706.2001.920202.x; Kudo S, 2006, CAN J ZOOL, V84, P723, DOI 10.1139/Z06-050; Lamey TC, 1996, OIKOS, V77, P285, DOI 10.2307/3546067; Lopez M, 2010, P ENTOMOL SOC WASH, V112, P81, DOI 10.4289/0013-8797-112.1.81; Lopez-Ortega M, 2013, ENVIRON ENTOMOL, V42, P231, DOI 10.1603/EN12284; Mappes J, 1997, EVOL ECOL, V11, P237, DOI 10.1023/A:1018408201713; Meiners T, 2006, EUR J ENTOMOL, V103, P765, DOI 10.14411/eje.2006.103; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Moon DC, 2006, ECOL ENTOMOL, V31, P236, DOI 10.1111/j.1365-2311.2006.00785.x; Mukai H, 2018, ECOL EVOL, V8, P3376, DOI 10.1002/ece3.3894; Murphy SM, 2004, P NATL ACAD SCI USA, V101, P18048, DOI 10.1073/pnas.0406490102; NAKAHIRA T, 1994, NATURWISSENSCHAFTEN, V81, P413, DOI 10.1007/s001140050097; Nakahira T, 2008, J INSECT BEHAV, V21, P306, DOI 10.1007/s10905-008-9129-0; Numerical Algorithms Group, 1993, GEN LIN INT MOD GLIM; Obermaier E, 2006, B ENTOMOL RES, V96, P337, DOI 10.1079/BER2006431; OHSAKI N, 1994, ECOLOGY, V75, P59, DOI 10.2307/1939382; Perfecto I, 2003, ENVIRON ENTOMOL, V32, P163, DOI 10.1603/0046-225X-32.1.163; Perry JC, 2006, OIKOS, V112, P706; Perry JC, 2005, BEHAV ECOL SOCIOBIOL, V58, P578, DOI 10.1007/s00265-005-0947-1; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Randlkofer B, 2007, CHEMOECOLOGY, V17, P177, DOI 10.1007/s00049-007-0377-9; Schausberger P, 2008, J ANIM ECOL, V77, P1109, DOI 10.1111/j.1365-2656.2008.01440.x; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; Singer MC., 1986, PLANT INSECT INTERAC, P65; Singer MS, 2004, ECOLOGY, V85, P2747, DOI 10.1890/03-0827; Tallamy DW, 1999, ANIM BEHAV, V57, P727, DOI 10.1006/anbe.1998.1008; Udayagiri S, 2000, BIOL CONTROL, V17, P234, DOI 10.1006/bcon.1999.0802; Wiklund C, 2008, OECOLOGIA, V157, P287, DOI 10.1007/s00442-008-1077-z; Williams L, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.29	50	4	4	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195665	10.1371/journal.pone.0195665	http://dx.doi.org/10.1371/journal.pone.0195665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694361	gold, Green Published			2022-12-26	WOS:000430802400039
J	Nibouche, S; Costet, L; Holt, JR; Jacobson, A; Pekarcik, A; Sadeyen, J; Armstrong, JS; Peterson, GC; McLaren, N; Medina, RF				Nibouche, Samuel; Costet, Laurent; Holt, Jocelyn R.; Jacobson, Alana; Pekarcik, Adrian; Sadeyen, Joelle; Armstrong, J. Scott; Peterson, Gary C.; McLaren, Neal; Medina, Raul F.			Invasion of sorghum in the Americas by a new sugarcane aphid (Melanaphis sacchari) superclone	PLOS ONE			English	Article							HEMIPTERA APHIDIDAE; HOMOPTERA-APHIDIDAE; MYZUS-PERSICAE; HOST-RANGE; DIVERGENCE; MANAGEMENT; HAPLOTYPE; COMPLEX; FLORIDA; CLONES	In the United States (US), the sugarcane aphid (SCA) Melanaphis sacchari (Zehnter) (Hemiptera: Aphididae) was introduced in the 1970s, however at that time it was only considered a pest of sugarcane. In 2013, a massive outbreak of M. sacchari occured on sorghum, resulting in significant economic damage to sorghum grown in North America including the US, Mexico, and Puerto Rico. The aim of the present study was to determine if the SCA pest emergence in American sorghum resulted from the introduction of new genotypes. To this end we used microsatellite markers and COI sequencing to compare the genetic diversity of SCA populations collected in the Americas after the 2013 SCA outbreak on sorghum (during 2013 +/- 2017) to older samples collected before the pest outbreak (during 2007 +/- 2009). Our results show that the SCA outbreak in the Americas and the Caribbean observed since 2013 belong to populations exhibiting low genetic diversity and consisting of a dominant clonal lineage, MLL-F, which colonizes Sorghum spp. and sugarcane. The comparison of MLL-F specimens collected post-2013 with specimens collected in Louisiana in 2007 revealed that both populations are genetically distinct, according to COI sequencing and microsatellite data analyses. Our result suggest that MLL-F is a new invasive genotype introduced into the Americas that has spread rapidly across sorghum growing regions in the US, Mexico, Honduras and the Caribbean. The origin of this introduction is either Africa or Asia, with Asia being the most probable source.	[Nibouche, Samuel; Costet, Laurent; Sadeyen, Joelle] CIRAD, UMR PVBMT, La Reunion, France; [Holt, Jocelyn R.; Medina, Raul F.] Texas A&M Univ, Dept Entomol, TAMU MS, College Stn, TX 77843 USA; [Jacobson, Alana; Pekarcik, Adrian] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Armstrong, J. Scott] USDA ARS, Wheat Peanut & Other Field Crops Res, Stillwater, OK USA; [Peterson, Gary C.] Texas A&M AgriLife Res & Extens Ctr, Lubbock, TX USA; [McLaren, Neal] Univ Free State, Nat & Agr Sci, Bloemfontein, South Africa	CIRAD; Texas A&M University System; Texas A&M University College Station; Auburn University System; Auburn University; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University of the Free State	Nibouche, S (corresponding author), CIRAD, UMR PVBMT, La Reunion, France.	samuel.nibouche@cirad.fr	Medina, Raul F/S-8294-2016; Nibouche, Samuel/C-1964-2008; Costet, Laurent/AAQ-1579-2020; Costet, Laurent/C-2281-2011; McLaren, Neal Wynne/AAK-2821-2020	Medina, Raul F/0000-0002-8697-8901; Nibouche, Samuel/0000-0003-2675-1382; Costet, Laurent/0000-0003-3199-2885; McLaren, Neal Wynne/0000-0002-8122-5783	European Union: Agricultural Fund for Rural Development; Conseil Departemental de La Reunion; Conseil Regional de La Reunion; Centre de Cooperation internationale en Recherche agronomique pour le Developpement; Southern Region IPM Center in the US award from the USDA National Institute of Food and Agriculture [2012-51120-20088]; United Sorghum Checkoff Program; Groupe d'Interet Scientifique "Infrastructures en Biologie Sante et Agronomie"	European Union: Agricultural Fund for Rural Development; Conseil Departemental de La Reunion; Conseil Regional de La Reunion; Centre de Cooperation internationale en Recherche agronomique pour le Developpement; Southern Region IPM Center in the US award from the USDA National Institute of Food and Agriculture; United Sorghum Checkoff Program; Groupe d'Interet Scientifique "Infrastructures en Biologie Sante et Agronomie"	This work was co-funded by the European Union: Agricultural Fund for Rural Development (https://ec.europa.eu/agriculture/cap-funding_en), by the Conseil Departemental de La Reunion (http://www.cg974.fr), by the Conseil Regional de La Reunion (https://www.regionreunion.com) and by the Centre de Cooperation internationale en Recherche agronomique pour le Developpement (www.cirad.fr), as well as by the Southern Region IPM Center in the US award number 2012-51120-20088 from the USDA National Institute of Food and Agriculture (https://nifa.usda.gov/grants), the United Sorghum Checkoff Program (https://www.ams.usda.gov/rules-regulations/research-promotion/sorghum), and was carried out in part on the Plant Protection Platform which is co-financed by the Groupe d'Interet Scientifique "Infrastructures en Biologie Sante et Agronomie" (www.ibisa.net). The use of trade, firm, or corporation names in this publication is for the information and convenience of the reader. Such use does not constitute an official endorsement or approval by the United States Department of Agriculture or the Agricultural Research Service of any product or service to the exclusion of others that may be suitable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andris M, 2010, MOL ECOL RESOUR, V10, P1106, DOI 10.1111/j.1755-0998.2010.02916.x; Anstead JA, 2002, B ENTOMOL RES, V92, P17, DOI 10.1079/BER2001141; Armstrong JS, 2015, J ECON ENTOMOL, V108, P576, DOI 10.1093/jee/tou065; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Bailleul D, 2016, METHODS ECOL EVOL, V7, P966, DOI 10.1111/2041-210X.12550; Belkhir K., 1996, 5171 CNRS UMR; Berlanga-Padilla Angélica M., 2016, Rev. Mex. Mic, V44, P51; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Blackman RL, 2017, APHIDS WORLDS PLANTS; Blackman RL, 1990, WORLD PERSPECTIVES B, P197; Bowling RD, 2016, J INTEGR PEST MANAG, V7, DOI 10.1093/jipm/pmw011; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guo CS, 2011, J INTEGR PLANT BIOL, V53, P178, DOI 10.1111/j.1744-7909.2010.01019.x; Halbert SE, 2000, FLA ENTOMOL, V83, P79, DOI 10.2307/3496232; Halbert Susan E., 2000, Revue Francaise d'Entomologie (Nouvelle Serie), V22, P109; HALL DG, 1988, FLA ENTOMOL, V71, P138, DOI 10.2307/3495361; Harris-Shultz K, 2017, CROP SCI, V57, P2064, DOI 10.2135/cropsci2016.12.1010; Harrison JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017524; Hernandez-Castellano C, 2014, REDIA, V97, P137; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Li RongGai, 2014, Research on Crops, V15, P84; Ligges U., 2003, J STAT SOFTW, V8, P1, DOI [DOI 10.18637/JSS.V008.I11, 10.18637/jss.v008.i11]; Margaritopoulos JT, 2003, B ENTOMOL RES, V93, P131, DOI 10.1079/BER2002222; Mead F. W., 1978, COOP PLANT PEST REP, V3, P475; Medina RF, 2017, ENTOMOL EXP APPL, V162, P358, DOI 10.1111/eea.12547; Mondor EB, 2007, BIOL INVASIONS, V9, P87, DOI 10.1007/s10530-006-9010-z; Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582; Nibouche S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143704; Nibouche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106067; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Pena-Martinez R, 2016, SOUTHWEST ENTOMOL, V41, P127, DOI 10.3958/059.041.0114; Piffaretti J, 2013, MOL ECOL, V22, P3916, DOI 10.1111/mec.12371; Schenck S, 2000, PLANT DIS, V84, P1085, DOI 10.1094/PDIS.2000.84.10.1085; Singh BU, 2004, CROP PROT, V23, P739, DOI 10.1016/j.cropro.2004.01.004; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Teacher AGF, 2011, MOL ECOL RESOUR, V11, P151, DOI 10.1111/j.1755-0998.2010.02890.x; Vorburger C, 2003, MOL ECOL, V12, P3493, DOI 10.1046/j.1365-294X.2003.01998.x; Way M, 2015, INT SUGAR J, V117, P654; Zimmerman EC, 1948, INSECTS OF HAWAII, V5	41	53	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196124	10.1371/journal.pone.0196124	http://dx.doi.org/10.1371/journal.pone.0196124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694435	Green Published, Green Submitted, gold			2022-12-26	WOS:000430802400065
J	Chen, SS; Wohlers, E; Ruud, E; Moon, J; Ni, B; Celi, FS				Chen, Shanshan; Wohlers, Erica; Ruud, Eric; Moon, Jon; Ni, Bin; Celi, Francesco S.			Improving temporal accuracy of human metabolic chambers for dynamic metabolic studies	PLOS ONE			English	Article							BODY INDIRECT CALORIMETER; TRANSIENT-RESPONSE; ALGORITHM	Metabolic chambers are powerful tools for assessing human energy expenditure, providing flexibility and comfort for the subjects in a near free-living environment. However, the flexibility offered by the large living room size creates challenges in the assessment of dynamic human metabolic signals-such as those generated during high-intensity interval training and short-term involuntary physical activities-with sufficient temporal accuracy. Therefore, this paper presents methods to improve the temporal accuracy of metabolic chambers. The proposed methods include 1) adopting a shortest possible step size, here one minute, to compute the finite derivative terms for the metabolic rate calculation, and 2) applying a robust noise reduction method-total variation denoising-to minimize the large noise generated by the short derivative term whilst preserving the transient edges of the dynamic metabolic signals. Validated against 24-hour gas infusion tests, the proposed method reconstructs dynamic metabolic signals with the best temporal accuracy among state-of-the-art approaches, achieving a root mean square error of 0.27 kcal/min (18.8 J/s), while maintaining a low cumulative error in 24-hour total energy expenditure of less than 45 kcal/day (188280 J/day). When applied to a human exercise session, the proposed methods also show the best performance in terms of recovering the dynamics of exercise energy expenditure. Overall, the proposed methods improve the temporal resolution of the chamber system, enabling metabolic studies involving dynamic signals such as short interval exercises to carry out the metabolic chambers.	[Chen, Shanshan] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23284 USA; [Chen, Shanshan; Ni, Bin; Celi, Francesco S.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA; [Wohlers, Erica; Ruud, Eric; Moon, Jon] MEI Res Ltd, Edina, MN USA	Virginia Commonwealth University; Virginia Commonwealth University	Chen, SS (corresponding author), Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23284 USA.; Chen, SS (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA.	shanshan.chen@vcuhealth.org	Chen, Shanshan/AAO-2763-2020; Chen, Shanshan/C-6240-2015	Chen, Shanshan/0000-0003-3165-0674	MEI	MEI	MEI provided salaries for EW, ER, and JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SC, BN and FSC did not receive any specific funding for this study. The specific role of these authors are articulated in the 'author contributions' section.	Aster RC, 2005, PARAMETER ESTIMATION; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; BROWN D, 1984, MED BIOL ENG COMPUT, V22, P333, DOI 10.1007/BF02442102; Brychta RJ, 2009, IEEE ENG MED BIO, P6864, DOI 10.1109/IEMBS.2009.5333121; Chen KY, 2013, J CLIN ENDOCR METAB, V98, pE1218, DOI 10.1210/jc.2012-4213; Condat L, 2013, IEEE SIGNAL PROC LET, V20, P1054, DOI 10.1109/LSP.2013.2278339; Figueiredo MAT, 2006, IEEE IMAGE PROC, P2633; Granato L, 2004, J APPL PHYSIOL, V96, P1045, DOI 10.1152/japplphysiol.00788.2003; Henning B, 1996, MED BIOL ENG COMPUT, V34, P207, DOI 10.1007/BF02520075; Lenzen F, 2004, P EC, V2004; Lighton JRB, 2011, COMP BIOCHEM PHYS A, V158, P265, DOI 10.1016/j.cbpa.2010.11.026; Lighton JRB, 2008, MEASURING METABOLIC; MOON JK, 1995, J NUTR, V125, P220; Nguyen T, 2003, MED BIOL ENG COMPUT, V41, P572, DOI 10.1007/BF02345320; Oppenheim AV, 1983, SIGNALS SYSTEMS, V2; Pendar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139508; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; Selesnick I., 2012, NYU POLYTECHNIC SCH; Tarantola A, 2005, INVERSE PROBLEM THEO; Tokuyama K, 2007, JPN J PHYS FIT SPORT, V56, P315, DOI 10.7600/jspfsm.56.315; Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008; Wang L, 2005, P ANN INT IEEE EMBS, P6695, DOI 10.1109/IEMBS.2005.1616039; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Westerterp Klaas R, 2004, Nutr Metab (Lond), V1, P5	24	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0193467	10.1371/journal.pone.0193467	http://dx.doi.org/10.1371/journal.pone.0193467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689096	Green Published, gold, Green Submitted			2022-12-26	WOS:000430678800005
J	Reyes-Uribe, P; Adrianzen-Ruesta, MP; Deng, Z; Echevarria-Vargas, I; Mender, I; Saheb, S; Liu, Q; Altieri, DC; Murphy, ME; Shay, JW; Lieberman, PM; Villanueva, J				Reyes-Uribe, Patricia; Adrianzen-Ruesta, Maria Paz; Deng, Zhong; Echevarria-Vargas, Ileabett; Mender, Ilgen; Saheb, Steven; Liu, Qin; Altieri, Dario C.; Murphy, Maureen E.; Shay, Jerry W.; Lieberman, Paul M.; Villanueva, Jessie			Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma	ONCOGENE			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; INHIBITOR IMETELSTAT; DNA-DAMAGE; PROMOTER MUTATIONS; RESISTANCE; CANCER; CELLS; INDUCTION; ACTIVATION; PATHWAYS	Targeting RAS is one of the greatest challenges in cancer therapy. Oncogenic mutations in NRAS are present in over 25% of melanomas and patients whose tumors harbor NRAS mutations have limited therapeutic options and poor prognosis. Thus far, there are no clinical agents available to effectively target NRAS or any other RAS oncogene. An alternative approach is to identify and target critical tumor vulnerabilities or non-oncogene addictions that are essential for tumor survival. We investigated the consequences of NRAS blockade in NRAS-mutant melanoma and show that decreased expression of the telomerase catalytic subunit, TERT, is a major consequence. TERT silencing or treatment of NRAS-mutant melanoma with the telomerase-dependent telomere uncapping agent, 6-thio-2'-deoxyguanosine (6-thio-dG), led to rapid cell death, along with evidence of both telomeric and non-telomeric DNA damage, increased ROS levels, and upregulation of a mitochondrial antioxidant adaptive response. Combining 6-thio-dG with the mitochondrial inhibitor Gamitrinib attenuated this adaptive response and more effectively suppressed NRAS-mutant melanoma. Our study uncovers a robust dependency of NRAS-mutant melanoma on TERT, and provides proof-of-principle for a new combination strategy to combat this class of tumors, which could be expanded to other tumor types.	[Reyes-Uribe, Patricia; Adrianzen-Ruesta, Maria Paz; Echevarria-Vargas, Ileabett; Saheb, Steven; Liu, Qin; Murphy, Maureen E.; Villanueva, Jessie] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Deng, Zhong; Lieberman, Paul M.] Wistar Inst Anat & Biol, Gene Express & Regulat Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Mender, Ilgen; Shay, Jerry W.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Altieri, Dario C.] Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Villanueva, Jessie] Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA	The Wistar Institute; The Wistar Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; The Wistar Institute; The Wistar Institute	Villanueva, J (corresponding author), Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.; Villanueva, J (corresponding author), Wistar Inst Anat & Biol, Melanoma Res Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.	jvillanueva@wistar.org		MENDER, ILGEN/0000-0002-7552-2618; Liu, Qin/0000-0001-9964-580X	NIH [R01CA215733, K01CA175269, P01CA114046, P50CA174523]; American Cancer Society; V Foundation for Cancer Research; Melanoma Research Alliance; Melanoma Research Foundation; Martha Rogers Trust; NCI NRSA Cancer Biology Training Grant [T32 CA009171]; Worldwide Cancer Research [15-0338]; Pennsylvania Department of Health; Cancer Center Support Grant (CCSG) [P30CA010815]; NATIONAL CANCER INSTITUTE [R01CA139319, R35CA220446, T32CA009171, P01CA025874, P30CA010815, K01CA175269, R01CA140652, P50CA174523, P01CA140043, P01CA114046, R01CA215733] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); V Foundation for Cancer Research; Melanoma Research Alliance; Melanoma Research Foundation; Martha Rogers Trust; NCI NRSA Cancer Biology Training Grant; Worldwide Cancer Research; Pennsylvania Department of Health; Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work in our laboratory is supported by NIH grants R01CA215733, K01CA175269, P01CA114046, P50CA174523, the American Cancer Society, the V Foundation for Cancer Research, the Melanoma Research Alliance, the Melanoma Research Foundation, and the Martha Rogers Trust. IEV was supported by NCI NRSA T32 CA009171 Cancer Biology Training Grant to the Wistar Institute, and Z.D. is supported by Worldwide Cancer Research (15-0338). This project was funded, in part, under a grant with the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. Support for shared resources utilized in this study was provided by Cancer Center Support Grant (CCSG) P30CA010815 to the Wistar Institute.	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Baerlocher GM, 2015, NEW ENGL J MED, V373, P920, DOI 10.1056/NEJMoa1503479; Bagheri S, 2006, P NATL ACAD SCI USA, V103, P11306, DOI 10.1073/pnas.0510085103; Bryan C, 2015, STRUCTURE, V23, P1934, DOI 10.1016/j.str.2015.08.006; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chae YC, 2012, CANCER CELL, V22, P331, DOI 10.1016/j.ccr.2012.07.015; Chiba K, 2017, SCIENCE, V357, P1416, DOI 10.1126/science.aao0535; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; Easty DJ, 2011, PIGM CELL MELANOMA R, V24, P446, DOI 10.1111/j.1755-148X.2011.00836.x; Fleisig HB, 2016, ONCOGENE, V35, P218, DOI 10.1038/onc.2015.75; Garcia-Beccaria M, 2015, EMBO MOL MED, V7, P930, DOI 10.15252/emmm.201404497; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; Griewank KG, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju246; Gupta R, 2014, P NATL ACAD SCI USA, V111, pE3062, DOI 10.1073/pnas.1411370111; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hrdlickova R, 2012, MOL CELL BIOL, V32, P4283, DOI 10.1128/MCB.00550-12; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Jafri MA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0324-x; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Johnson DB, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0330-z; Johnson DB, 2014, CLIN CANCER RES, V20, P4186, DOI 10.1158/1078-0432.CCR-13-3270; Joseph I, 2010, CANCER RES, V70, P9494, DOI 10.1158/0008-5472.CAN-10-0233; Kang BH, 2010, CLIN CANCER RES, V16, P4779, DOI 10.1158/1078-0432.CCR-10-1818; Koh CM, 2015, J CLIN INVEST, V125, P2109, DOI 10.1172/JCI79134; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kovalenko OA, 2010, AGING CELL, V9, P203, DOI 10.1111/j.1474-9726.2010.00551.x; Li YH, 2016, P NATL ACAD SCI USA, V113, P14402, DOI 10.1073/pnas.1611106113; Li YH, 2014, CANCER RES, V74, P1639, DOI 10.1158/0008-5472.CAN-13-3568; Listerman I, 2013, CANCER RES, V73, P2817, DOI 10.1158/0008-5472.CAN-12-3082; Maertens O, 2013, CANCER DISCOV, V3, P338, DOI 10.1158/2159-8290.CD-12-0313; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Mender I, 2015, BIO PROTOC, V5; Mender I, 2015, CANCER DISCOV, V5, P82, DOI 10.1158/2159-8290.CD-14-0609; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nissan MH, 2014, CANCER RES, V74, P2340, DOI 10.1158/0008-5472.CAN-13-2625; Nosrati M, 2004, CLIN CANCER RES, V10, P4983, DOI 10.1158/1078-0432.CCR-04-0134; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Postow MA, 2017, LANCET ONCOL, V18, P414, DOI 10.1016/S1470-2045(17)30172-9; Puri N, 2004, FASEB J, V18, P1373, DOI 10.1096/fj.04-1774com; Queisser A, 2013, CANCER GENET-NY, V206, P374, DOI 10.1016/j.cancergen.2013.10.001; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Sharma NK, 2012, NUCLEIC ACIDS RES, V40, P712, DOI 10.1093/nar/gkr758; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; Shin KH, 2004, CLIN CANCER RES, V10, P2551, DOI 10.1158/1078-0432.CCR-0669-3; Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Tefferi A, 2015, NEW ENGL J MED, V373, P908, DOI 10.1056/NEJMoa1310523; Vallarelli AF, 2016, ONCOTARGET, V7, P53127, DOI 10.18632/oncotarget.10634; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Viceconte N, 2017, CELL REP, V19, P2529, DOI 10.1016/j.celrep.2017.05.046; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wong DJL, 2016, CANCER TREAT RES, V167, P251, DOI 10.1007/978-3-319-22539-5_10; Zhang G, 2016, J CLIN INVEST, V126, P1834, DOI 10.1172/JCI82661	62	31	32	3	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 26	2018	37	30					4058	4072		10.1038/s41388-018-0247-7	http://dx.doi.org/10.1038/s41388-018-0247-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GO2YI	29695835	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000439847000002
J	Peng, L; Zhang, FJ; Shang, RF; Wang, XY; Chen, JY; Chou, JJ; Ma, JB; Wu, LG; Huang, Y				Peng, Ling; Zhang, Fengjuan; Shang, Renfu; Wang, Xueyan; Chen, Jiayi; Chou, James J.; Ma, Jinbiao; Wu, Ligang; Huang, Ying			Identification of substrates of the small RNA methyltransferase Hen1 in mouse spermatogonial stem cells and analysis of its methyl-transfer domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; RNA methyltransferase; spermatogenesis; RNA; RNA modification; 3'-end methylation; Hen1; methyltransferase domain; piRNA; spermatogonial stem cell	PIWI-INTERACTING RNAS; GENOME BROWSER; BIOGENESIS; SIRNAS; MIRNAS; MECHANISMS; MICRORNAS; STABILITY; INSIGHTS; DATABASE	Small noncoding RNAs (sncRNAs) regulate many genes in eukaryotic cells. Hua enhancer 1 (Hen1) is a 2-O-methyltransferase that adds a methyl group to the 2-OH of the 3-terminal nucleotide of sncRNAs. The types and properties of sncRNAs may vary among different species, and the domain composition, structure, and function of Hen1 proteins differ accordingly. In mammals, Hen1 specifically methylates sncRNAs called P-element-induced wimpy testis-interacting RNAs (piRNAs). However, other types of sncRNAs that are methylated by Hen1 have not yet been reported, and the structures and the substrates of mammalian Hen1 remain unknown. Here, we report that mouse Hen1 (mHen1) performs 3-end methylation of classical piRNAs, as well as those of most noncanonical piRNAs derived from rRNAs, small nuclear RNAs and tRNAs in murine spermatogonial stem cells. Moreover, we found that a distinct class of tRNA-derived sncRNAs are mHen1 substrates. We further determined the crystal structure of the putative methyltransferase domain of human Hen1 (HsHen1) in complex with its cofactor AdoMet at 2.0 resolution. We observed that HsHen1 has an active site similar to that of plant Hen1. We further found that the putative catalytic domain of HsHen1 alone exhibits no activity. However, an FXPP motif at its N terminus conferred full activity to this domain, and additional binding assays suggested that the FXPP motif is important for substrate binding. Our findings shed light on its methylation substrates in mouse spermatogonial stem cells and the substrate-recognition mechanism of mammalian Hen1.	[Peng, Ling; Zhang, Fengjuan; Shang, Renfu; Wang, Xueyan; Chou, James J.; Wu, Ligang; Huang, Ying] Univ Chinese Acad Sci, Chinese Acad Sci,CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Shanghai Key Lab Mol Andro, Natl Ctr Prot Sci Shanghai,Shanghai Sci Res Ctr,S, Beijing, Peoples R China; [Wang, Xueyan; Chou, James J.] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Chen, Jiayi; Ma, Jinbiao] Fudan Univ, State Key Lab Genet Engn, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci,Inst Plant Biol,Dept Biochem, Shanghai 200438, Peoples R China; [Chou, James J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Fudan University; Harvard University; Harvard Medical School	Wu, LG; Huang, Y (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci,CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Shanghai Key Lab Mol Andro, Natl Ctr Prot Sci Shanghai,Shanghai Sci Res Ctr,S, Beijing, Peoples R China.	lgwu@sibcb.ac.cn; huangy@sibcb.ac.cn	Chou, James J/N-9840-2013; Chen, Jiayi/GZM-5106-2022; Huang, Ying/AFM-0838-2022	Chou, James J/0000-0002-4442-0344; Huang, Ying/0000-0002-2806-2874	Chinese Academy of Sciences [XDB08010202, XDB19040102]; Ministry of Science and Technology of China [2014CB943100]; National Natural Science Foundation of China [91640102, 91440107, 31470781, 31230041]; Shanghai Municipal Commission for Science and Technology [12JC1409400]; Chinese Academy of Sciences; State Key Laboratory of Molecular Biology	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Molecular Biology	This work was supported by Strategic Priority Research Program Grants of the Chinese Academy of Sciences XDB08010202 (to Y. H.) and XDB19040102 (to L. W.), Ministry of Science and Technology of China Grant 2014CB943100 (to L. W.), National Natural Science Foundation of China Grants 91640102 (to Y. H.), 91440107 and 31470781 (to L. W.), and Grant 31230041 (to J. M.), Shanghai Municipal Commission for Science and Technology Grant 12JC1409400 (to L. W.), the Open Research Project on Major Infrastructure of Science and Technology of the Chinese Academy of Sciences, and the State Key Laboratory of Molecular Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Billi AC, 2012, PLOS GENET, V8, P84, DOI 10.1371/journal.pgen.1002617; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan CM, 2009, P NATL ACAD SCI USA, V106, P17699, DOI 10.1073/pnas.0907540106; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chen XM, 2002, DEVELOPMENT, V129, P1085; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Ding DQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00854-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falciatori I, 2003, FASEB J, V17, P376, DOI 10.1096/fj.03-0744fje; Hayashi R, 2016, NATURE, V539, P588, DOI 10.1038/nature20162; Hirano T, 2014, RNA, V20, P1223, DOI 10.1261/rna.045310.114; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Huang Y, 2009, NATURE, V461, P823, DOI 10.1038/nature08433; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Izumi N, 2016, CELL, V164, P962, DOI 10.1016/j.cell.2016.01.008; Jain R, 2011, RNA, V17, P429, DOI 10.1261/rna.2500711; Jain R, 2010, RNA, V16, P316, DOI 10.1261/rna.1926510; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jung I, 2014, COMPUT BIOL CHEM, V50, P60, DOI 10.1016/j.compbiolchem.2014.01.008; Kamminga LM, 2010, EMBO J, V29, P3688, DOI 10.1038/emboj.2010.233; Keam SP, 2014, NUCLEIC ACIDS RES, V42, P8984, DOI 10.1093/nar/gku620; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirino Y, 2007, RNA, V13, P1397, DOI 10.1261/rna.659307; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Lim RSM, 2015, SEMIN CELL DEV BIOL, V47-48, P17, DOI 10.1016/j.semcdb.2015.10.025; Lim SL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005620; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Montgomery TA, 2012, PLOS GENET, V8, P72, DOI 10.1371/journal.pgen.1002616; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Sun YH, 2017, ELIFE, V6, DOI [10.7554/eLife.24695, 10.7554/elife.24695]; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7876; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu B, 2010, NUCLEIC ACIDS RES, V38, P5844, DOI 10.1093/nar/gkq348; Zhai J., 2013, COLD SPRING HARB SYM, V77, P213, DOI DOI 10.1101/sqb.2013.77.014779; Zhai JX, 2013, PLANT CELL, V25, P2417, DOI 10.1105/tpc.113.114603; Zhang Y, 2017, CELL RES, V27, P1392, DOI 10.1038/cr.2017.125	53	6	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9981	9994		10.1074/jbc.RA117.000837	http://dx.doi.org/10.1074/jbc.RA117.000837			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29703750	hybrid, Green Published			2022-12-26	WOS:000437096700005
J	Cabre, EJ; Martinez-Calle, M; Prieto, M; Fedorov, A; Olmeda, B; Loura, LMS; Perez-Gil, J				Cabre, Elisa J.; Martinez-Calle, Marta; Prieto, Manuel; Fedorov, Alexander; Olmeda, Barbara; Loura, Luis M. S.; Perez-Gil, Jesus			Homo- and hetero-oligomerization of hydrophobic pulmonary surfactant proteins SP-B and SP-C in surfactant phospholipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pulmonary surfactant; protein-protein interaction; protein complex; lung; membrane structure; fluorescence resonance energy transfer (FRET); fluorescence anisotropy	RESONANCE ENERGY-TRANSFER; AIR-WATER-INTERFACE; LUNG SURFACTANT; II PNEUMOCYTES; LIPID-BILAYER; 2 DIMENSIONS; MODEL; FLUORESCENCE; FILMS; MONOLAYERS	Pulmonary surfactant is a lipid/protein mixture that reduces surface tension at the respiratory air-water interface in lungs. Among its nonlipidic components are pulmonary surfactant-associated proteins B and C (SP-B and SP-C, respectively). These highly hydrophobic proteins are required for normal pulmonary surfactant function, and whereas past literature works have suggested possible SP-B/SP-C interactions and a reciprocal modulation effect, no direct evidence has been yet identified. In this work, we report an extensive fluorescence spectroscopy study of both intramolecular and intermolecular SP-B and SP-C interactions, using a combination of quenching and FRET steady-state and time-resolved methodologies. These proteins are compartmentalized in full surfactant membranes but not in pure 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) vesicles, in accordance with their previously described preference for liquid disordered phases. From the observed static self-quenching and homo-FRET of BODIPY-FL labeled SP-B, we conclude that this protein forms homoaggregates at low concentration (lipid:protein ratio, 1:1000). Increases in polarization of BODIPY-FL SP-B and steady-state intensity of WT SP-B were observed upon incorporation of under-stoichiometric amounts of WT SP-C. Conversely, Marina Blue-labeled SP-C is quenched by over-stoichiometric amounts of WT SP-B, whereas under-stoichiometric concentrations of the latter actually increase SP-C emission. Time-resolved hetero-FRET from Marina Blue SP-C to BODIPY-FL SP-B confirm distinct protein aggregation behaviors with varying SP-B concentration. Based on these multiple observations, we propose a model for SP-B/SP-C interactions, where SP-C might induce conformational changes on SP-B complexes, affecting its aggregation state. The conclusions inferred from the present work shed light on the synergic functionality of both proteins in the pulmonary surfactant system.	[Cabre, Elisa J.; Martinez-Calle, Marta; Olmeda, Barbara; Perez-Gil, Jesus] Univ Complutense Madrid, Dept Biochem, Fac Biol, Madrid 28040, Spain; [Martinez-Calle, Marta; Olmeda, Barbara; Perez-Gil, Jesus] Hosp 12 Octubre, Res Inst, E-28041 Madrid, Spain; [Prieto, Manuel; Fedorov, Alexander] Univ Lisbon, Inst Super Tecn, CQFM IN, P-1049001 Lisbon, Portugal; [Prieto, Manuel; Fedorov, Alexander] Univ Lisbon, Inst Super Tecn, IBB, P-1049001 Lisbon, Portugal; [Loura, Luis M. S.] Univ Coimbra, Fac Pharm, P-3000548 Coimbra, Portugal; [Loura, Luis M. S.] Univ Coimbra, Ctr Quim Coimbra, P-3004535 Coimbra, Portugal	Complutense University of Madrid; Hospital Universitario 12 de Octubre; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Coimbra; Universidade de Coimbra	Loura, LMS (corresponding author), Univ Coimbra, Fac Farm, Polo Ciencias Saude, P-3000548 Coimbra, Portugal.; Perez-Gil, J (corresponding author), Univ Complutense, Dept Bioquim, Fac Biol, Jose Antonio Novais 12, E-28040 Madrid, Spain.	lloura@ff.uc.pt; jperezgil@bio.ucm.es	Perez-Gil, Jesus/H-3102-2019; Olmeda, Bárbara/H-1440-2015; Calle, Marta Martínez/H-1451-2015; Prieto, Manuel/N-4448-2013	Perez-Gil, Jesus/0000-0003-3587-7147; Olmeda, Bárbara/0000-0001-6004-1603; Calle, Marta Martínez/0000-0003-1198-2532; fedorov, alexander/0000-0003-2454-6908; Prieto, Manuel/0000-0003-3012-6598; Jimenez-Cabre, Elisa/0000-0002-0493-6477	Spanish Ministry of Economy [BIO2015-67930-R]; Regional Government of Madrid [S2013/MIT-2807]; Fundacao para a Ciencia e a tecnologia (Portugal) [FAPESP/20107/2014, SAICTPAC/0019/2015, SFRH/BPD/111301/2015]; Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) [007630 UID/QUI/00313/2013]; COMPETE2020-UE; Portugal 2020/FEDER;  [PTDC/DTP-FTO/2784/2014]	Spanish Ministry of Economy(Spanish Government); Regional Government of Madrid; Fundacao para a Ciencia e a tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Portuguese Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); COMPETE2020-UE; Portugal 2020/FEDER; 	This work was supported in part by Spanish Ministry of Economy Grant BIO2015-67930-R and Regional Government of Madrid Grant S2013/MIT-2807 (to J. P. G.). This work was also supported by Projects FAPESP/20107/2014 and SAICTPAC/0019/2015 from Fundacao para a Ciencia e a tecnologia (Portugal) (to M. P.); Grant SFRH/BPD/111301/2015 from Fundacao para a Ciencia e a Tecnologia (Portugal) (to A. F.); and Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) Projects 007630 UID/QUI/00313/2013, co-funded by COMPETE2020-UE, and PTDC/DTP-FTO/2784/2014, co-funded by Portugal 2020/FEDER (to L. M. S. L). The authors declare that they have no conflicts of interest with the contents of this article.	Almlen A, 2008, J APPL PHYSIOL, V104, P1101, DOI 10.1152/japplphysiol.00865.2007; BAATZ JE, 1990, BIOCHEMISTRY-US, V29, P6714, DOI 10.1021/bi00480a022; BAATZ JE, 1991, CHEM PHYS LIPIDS, V60, P163, DOI 10.1016/0009-3084(91)90039-E; de la Serna JB, 2013, FARADAY DISCUSS, V161, P535, DOI 10.1039/c2fd20096a; Brasch F, 2003, J BIOL CHEM, V278, P49006, DOI 10.1074/jbc.M306844200; Brasch F, 2002, AM J RESP CELL MOL, V26, P659, DOI 10.1165/ajrcmb.26.6.4744; Cabre EJ, 2012, BBA-BIOMEMBRANES, V1818, P1717, DOI 10.1016/j.bbamem.2012.03.008; Cabre EJ, 2009, BIOPHYS J, V97, P768, DOI 10.1016/j.bpj.2009.04.057; Castanho MARB, 1997, EUR BIOPHYS J BIOPHY, V26, P253, DOI 10.1007/s002490050078; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; CREUWELS LAJM, 1995, J BIOL CHEM, V270, P16225, DOI 10.1074/jbc.270.27.16225; Cruz A, 2004, BIOPHYS J, V86, P308, DOI 10.1016/S0006-3495(04)74106-5; Cruz A, 2000, EUR BIOPHYS J BIOPHY, V29, P204, DOI 10.1007/PL00006647; CURSTEDT T, 1987, EUR J BIOCHEM, V168, P255, DOI 10.1111/j.1432-1033.1987.tb13414.x; DAVENPORT L, 1985, BIOCHEMISTRY-US, V24, P4097, DOI 10.1021/bi00336a044; de Almeida RFM, 2009, CHEM PHYS LIPIDS, V157, P61, DOI 10.1016/j.chemphyslip.2008.07.011; de la Serna JB, 2004, J BIOL CHEM, V279, P40715, DOI 10.1074/jbc.M404648200; Filipe HAL, 2015, PHYS CHEM CHEM PHYS, V17, P20066, DOI 10.1039/c5cp01596k; Gerson KD, 2008, J BIOL CHEM, V283, P10330, DOI 10.1074/jbc.M707516200; Guttentag S, 2003, AM J RESP CELL MOL, V28, P69, DOI 10.1165/rcmb.2002-0111OC; Haugland R.P., 2002, HDB FLUORESCENT PROB; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; JOHNSON ID, 1991, ANAL BIOCHEM, V198, P228, DOI 10.1016/0003-2697(91)90418-S; Klenz U, 2008, BIOPHYS J, V95, P699, DOI 10.1529/biophysj.108.131102; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; Loura LMS, 2000, J PHYS CHEM B, V104, P6920, DOI 10.1021/jp000246q; Loura LMS, 1996, BIOPHYS J, V71, P1823, DOI 10.1016/S0006-3495(96)79383-9; Loura LMS, 2001, BIOPHYS J, V80, P776, DOI 10.1016/S0006-3495(01)76057-2; Loura LMS, 2000, BBA-BIOMEMBRANES, V1467, P101, DOI 10.1016/S0005-2736(00)00211-X; Loura LMS, 2012, INT J MOL SCI, V13, P15252, DOI 10.3390/ijms131115252; Loura LMS, 2010, EUR BIOPHYS J BIOPHY, V39, P589, DOI 10.1007/s00249-009-0547-5; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MORROW MR, 1993, BIOCHEMISTRY-US, V32, P4397, DOI 10.1021/bi00067a032; Nag K, 1998, BIOPHYS J, V74, P2983, DOI 10.1016/S0006-3495(98)78005-1; Olmeda B, 2017, ANN ANAT, V209, P78, DOI 10.1016/j.aanat.2016.09.008; Olmeda B, 2015, FASEB J, V29, P4236, DOI 10.1096/fj.15-273458; Olmeda B, 2013, EUR BIOPHYS J BIOPHY, V42, P209, DOI 10.1007/s00249-012-0858-9; Parra E, 2015, CHEM PHYS LIPIDS, V185, P153, DOI 10.1016/j.chemphyslip.2014.09.002; Parra E, 2011, BIOCHEM J, V438, P555, DOI 10.1042/BJ20110681; PEREZGIL J, 1993, BIOCHIM BIOPHYS ACTA, V1168, P261, DOI 10.1016/0005-2760(93)90181-8; PEREZGIL J, 1995, BIOCHEMISTRY-US, V34, P3964, DOI 10.1021/bi00012a014; Plasencia I, 2004, BIOCHEM J, V377, P183, DOI 10.1042/BJ20030815; Plasencia I, 2001, BIOCHEM J, V359, P651, DOI 10.1042/0264-6021:3590651; Plasencia I, 2001, ANAL BIOCHEM, V296, P49, DOI 10.1006/abio.2001.5222; Roldan N, 2016, BIOPHYS J, V111, P1703, DOI 10.1016/j.bpj.2016.09.016; Ross M, 2002, EUR BIOPHYS J BIOPHY, V31, P52, DOI 10.1007/s002490100181; Ryan MA, 2005, BIOCHEMISTRY-US, V44, P861, DOI 10.1021/bi0485575; Schurch D, 2010, BIOPHYS J, V99, P3290, DOI 10.1016/j.bpj.2010.09.039; SNYDER B, 1982, BIOPHYS J, V40, P137, DOI 10.1016/S0006-3495(82)84468-8; Stahlman MT, 2000, LAB INVEST, V80, P395, DOI 10.1038/labinvest.3780044; Sun WC, 1998, BIOORG MED CHEM LETT, V8, P3107, DOI 10.1016/S0960-894X(98)00578-2; SUZUKI Y, 1989, AM REV RESPIR DIS, V140, P75, DOI 10.1164/ajrccm/140.1.75; TANEVA S, 1994, BIOPHYS J, V66, P1158, DOI 10.1016/S0006-3495(94)80897-5; Taneva SG, 2000, BIOPHYS J, V79, P2010, DOI 10.1016/S0006-3495(00)76449-6; UMBERGER JQ, 1945, J AM CHEM SOC, V67, P1099, DOI 10.1021/ja01223a023; VANDENBUSSCHE G, 1992, EUR J BIOCHEM, V203, P201, DOI 10.1111/j.1432-1033.1992.tb19848.x; vanderMeer B.W., 2013, FRET FORSTER RESONAN, DOI [10.1002/9783527656028.ch04, DOI 10.1002/9783527656028.CH04]; Wang GR, 2007, BBA-BIOMEMBRANES, V1768, P2060, DOI 10.1016/j.bbamem.2007.06.025; WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1; Wustneck N, 2003, BIOPHYS J, V84, P1940, DOI 10.1016/S0006-3495(03)75002-4; Wustneck R, 2005, ADV COLLOID INTERFAC, V117, P33, DOI 10.1016/j.cis.2005.05.001	62	21	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9399	9411		10.1074/jbc.RA117.000222	http://dx.doi.org/10.1074/jbc.RA117.000222			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29700110	hybrid, Green Published			2022-12-26	WOS:000435441400024
J	Islam, Z; Gurevic, I; Strutzenberg, TS; Ghosh, AK; Iqbal, T; Kohen, A				Islam, Zahidul; Gurevic, Ilya; Strutzenberg, Timothy S.; Ghosh, Ananda K.; Iqbal, Tasnia; Kohen, Amnon			Bacterial versus human thymidylate synthase: Kinetics and functionality	PLOS ONE			English	Article							HYDROGEN-TRANSFER REACTIONS; ESCHERICHIA-COLI; DIHYDROFOLATE-REDUCTASE; HYDRIDE TRANSFER; MESSENGER-RNA; CATALYTIC MECHANISM; ENZYME CATALYSIS; DNTP POOLS; TRANSFERS; INHIBITION	Thymidylate Synthase (TSase) is a highly conserved enzyme that catalyzes the production of the DNA building block thymidylate. Structurally, functionally and mechanistically, bacterial and mammalian TSases share remarkable similarities. Because of this closeness, bacterial enzymes have long been used as model systems for human TSase. Furthermore, while TSase inhibitors have long served as chemotherapeutic drugs, no TSase inhibitor serves as an antibiotic. Despite their high resemblance, the mammalian TSases are distinct in a few known aspects, such as having a N-terminal tail and two insertions in the primary sequence and active/inactive conformations. Here, we aim to comprehensively characterize human (hs) TSase and delineate its contrasts and the similarities to the well-studied Escherichia coli (ec) TSase. We found that, in contrast to ecTSase, Mg2+ does not enhance reaction rates for hsTSase. The temperature dependence of intrinsic kinetic isotope effects (KIEs), on the other hand, suggests that Mg2+ has little or no impact on the transition state of hydride transfer in either enzyme, and that the transition state for the hydride transfer in hsTSase is looser than in ecTSase. Additionally, the substrates' binding order is strictly ordered for ecTSase but slightly less ordered for hsTSase. The observed kinetic and functional differences between bacterial and human enzymes may aid in the development of antibiotic drugs with reduced toxicity.	[Islam, Zahidul; Gurevic, Ilya; Strutzenberg, Timothy S.; Ghosh, Ananda K.; Iqbal, Tasnia; Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Islam, Zahidul] Univ Calif Berkeley, Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Strutzenberg, Timothy S.] Scripps Res Inst, Dept Mol Med, Jupiter, FL USA	University of Iowa; University of California System; University of California Berkeley; Scripps Research Institute	Islam, Z; Kohen, A (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.; Islam, Z (corresponding author), Univ Calif Berkeley, Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA.	zahid@berkeley.edu; amnon-kohen@uiowa.edu	Ghosh, Ananda/E-6640-2019; Islam, Zahidul/AAV-6188-2021	Ghosh, Ananda/0000-0002-5485-4760; Islam, Zahidul/0000-0001-9177-7998; Strutzenberg, Tim/0000-0003-0598-534X	NIH [R01GM065368]; University of Iowa Center for Biocatalysis and Bioprocessing; Predoctoral Training Program in Biotechnology, NIH grant [T32GM008365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065368] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa Center for Biocatalysis and Bioprocessing; Predoctoral Training Program in Biotechnology, NIH grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant R01GM065368 to AK. ZI acknowledges the support of a training fellowship from the University of Iowa Center for Biocatalysis and Bioprocessing and the Predoctoral Training Program in Biotechnology, NIH grant T32GM008365. IG acknowledges the support of a training fellowship from the Predoctoral Training Program in Biotechnology, NIH grant T32GM008365.	Agrawal N, 2004, ANAL BIOCHEM, V328, P44, DOI 10.1016/j.ab.2004.01.029; Agrawal N, 2004, BIOCHEMISTRY-US, V43, P1998, DOI 10.1021/bi036124g; ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Antoniou D, 2006, CHEM REV, V106, P3170, DOI 10.1021/cr0503052; Birdsall DL, 1996, J MOL BIOL, V255, P522, DOI 10.1006/jmbi.1996.0043; BLAKLEY RL, 1962, J BIOL CHEM, V237, P812; Brunn ND, 2012, CHEMBIOCHEM, V13, P2738, DOI 10.1002/cbic.201200603; Carosati E, 2012, J MED CHEM, V55, P10272, DOI 10.1021/jm300850v; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; Cook P. F., 2007, ENZYME KINETICS MECH; Cook P. F., 2007, ENZYME KINETICS MECH, P253; Cook PF, 1991, ENZYME MECH ISOTOPE; Costi MP, 2002, BBA-MOL BASIS DIS, V1587, P206, DOI 10.1016/S0925-4439(02)00083-2; DAVISSON VJ, 1989, J BIOL CHEM, V264, P9145; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Finer-Moore JS, 2003, BIOCHEMISTRY-US, V42, P248, DOI 10.1021/bi020599a; Fraczyk T, 2015, BBA-PROTEINS PROTEOM, V1854, P1922, DOI 10.1016/j.bbapap.2015.08.007; Francis K, 2016, BIOCHEMISTRY-US, V55, P1100, DOI 10.1021/acs.biochem.5b00945; Garg D, 2013, NUCLEIC ACIDS RES, V41, P4159, DOI 10.1093/nar/gkt098; Ghosh AK, 2015, PHYS CHEM CHEM PHYS, V17, P30867, DOI 10.1039/c5cp01246e; Hanoian P, 2015, ACCOUNTS CHEM RES, V48, P482, DOI 10.1021/ar500390e; Hardy LW, 1995, ACTA BIOCHIM POL, V42, P367; Hay S, 2012, NAT CHEM, V4, P161, DOI [10.1038/NCHEM.1223, 10.1038/nchem.1223]; Hong BY, 2007, BIOCHEMISTRY-US, V46, P14188, DOI 10.1021/bi701363s; Islam Z, 2015, ACS CATAL, V5, P6061, DOI 10.1021/acscatal.5b01332; Islam Z, 2014, J AM CHEM SOC, V136, P9850, DOI 10.1021/ja504341g; Jarmula A, 2010, BIOORGAN MED CHEM, V18, P3361, DOI 10.1016/j.bmc.2010.04.019; Klinman JP, 2013, ANNU REV BIOCHEM, V82, P471, DOI 10.1146/annurev-biochem-051710-133623; Kohen A, 2015, ACCOUNTS CHEM RES, V48, P466, DOI 10.1021/ar500322s; KUHN A, 1985, J BACTERIOL, V163, P906, DOI 10.1128/JB.163.3.906-912.1985; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Layfield JP, 2014, CHEM REV, V114, P3466, DOI 10.1021/cr400400p; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Liu J, 2002, BBA-MOL BASIS DIS, V1587, P174, DOI 10.1016/S0925-4439(02)00080-7; Ludwiczak J, 2016, MOL BIOSYST, V12, P1333, DOI 10.1039/c6mb00026f; Maglia G, 2003, J AM CHEM SOC, V125, P13372, DOI 10.1021/ja035692g; Marcus RA, 2007, J PHYS CHEM B, V111, P6643, DOI 10.1021/jp071589s; Nagel ZD, 2010, CHEM REV, V110, pPR41, DOI 10.1021/cr1001035; Northrop D. B, 1991, ENZYME MECH ISOTOPE, P181; Oliver FJ, 1996, EXPERIENTIA, V52, P995, DOI 10.1007/BF01920108; Parkin D., 1991, METHODS DETERMINATIO, P269; PedersenLane J, 1997, PROTEIN EXPRES PURIF, V10, P256, DOI 10.1006/prep.1997.0750; Phan J, 2001, BIOCHEMISTRY-US, V40, P1897, DOI 10.1021/bi002413i; Pudney CR, 2009, J AM CHEM SOC, V131, P17072, DOI 10.1021/ja908469m; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; Rose Michal G, 2002, Clin Colorectal Cancer, V1, P220, DOI 10.3816/CCC.2002.n.003; Roston D, 2014, ARCH BIOCHEM BIOPHYS, V544, P96, DOI 10.1016/j.abb.2013.10.010; Roston D, 2013, MOLECULES, V18, P5543, DOI 10.3390/molecules18055543; Singh P, 2016, METHOD ENZYMOL, V577, P287, DOI 10.1016/bs.mie.2016.05.017; Spencer HT, 1997, BIOCHEMISTRY-US, V36, P4212, DOI 10.1021/bi961794q; Stroud RM, 2003, BIOCHEMISTRY-US, V42, P239, DOI 10.1021/bi020598i; Taddia L, 2015, DRUG RESIST UPDATE, V23, P20, DOI 10.1016/j.drup.2015.10.003; Wang L, 2006, P NATL ACAD SCI USA, V103, P15753, DOI 10.1073/pnas.0606976103; Wang Z, 2013, J AM CHEM SOC, V135, P7583, DOI 10.1021/ja400761x; Wang Z, 2012, J AM CHEM SOC, V134, P17722, DOI 10.1021/ja307859m; Wang Z, 2012, ADV PROTEIN CHEM STR, V87, P155, DOI 10.1016/B978-0-12-398312-1.00006-8; Wang Z, 2010, J AM CHEM SOC, V132, P9820, DOI 10.1021/ja103010b; WATAYA Y, 1972, J AM CHEM SOC, V94, P8927, DOI 10.1021/ja00780a059	59	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196506	10.1371/journal.pone.0196506	http://dx.doi.org/10.1371/journal.pone.0196506			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715278	gold, Green Published, Green Submitted			2022-12-26	WOS:000431281100028
J	Tovar, C; Patchett, AL; Kim, V; Wilson, R; Darby, J; Lyons, AB; Woods, GM				Tovar, Cesar; Patchett, Amanda L.; Kim, Vitna; Wilson, Richard; Darby, Jocelyn; Lyons, A. Bruce; Woods, Gregory M.			Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease	PLOS ONE			English	Article							PHASE-II TRIAL; LUNG-CANCER; IMMUNE-RESPONSE; HEAT-SHOCK-PROTEIN-70 HSP70; CHAPEROKINE ACTIVITY; STRESS-PROTEINS; MESSENGER-RNAS; IN-VITRO; CELLS; IMMUNOTHERAPY	The Tasmanian devil (Sarcophilus harrisii), the largest extant carnivorous marsupial and endemic to Tasmania, is at the verge of extinction due to the emergence of a transmissible cancer known as devil facial tumour disease (DFTD). DFTD has spread over the distribution range of the species and has been responsible for a severe decline in the global devil population. To protect the Tasmanian devil from extinction in the wild, our group has focused on the development of a prophylactic vaccine. Although this work has shown that vaccine preparations using whole DFTD tumour cells supplemented with adjuvants can induce antiDFTD immune responses, alternative strategies that induce stronger and more specific immune responses are required. In humans, heat shock proteins (HSPs) derived from tumour cells have been used instead of whole-tumour cell preparations as a source of antigens for cancer immunotherapy. As HSPs have not been studied in the Tasmanian devil, this study presents the first characterisation of HSPs in this marsupial and evaluates the suitability of these proteins as antigenic components for the enhancement of a DFTD vaccine. We show that tissues and cancer cells from the Tasmanian devil express constitutive and inducible HSP. Additionally, this study suggests that HSP derived from DFTD cancer cells are immunogenic supporting the future development of a HSP-based vaccine against DFTD.	[Tovar, Cesar; Patchett, Amanda L.; Kim, Vitna; Darby, Jocelyn; Woods, Gregory M.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Wilson, Richard] Univ Tasmania, Cent Sci Lab, Hobart, Tas, Australia; [Lyons, A. Bruce; Woods, Gregory M.] Univ Tasmania, Sch Med, Hobart, Tas, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania; University of Tasmania	Tovar, C (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	Cesar.Tovar@utas.edu.au	Patchett, Amanda L/A-7468-2015; Wilson, Richard/H-8429-2012	Patchett, Amanda L/0000-0002-8424-4680; Lyons, Alan/0000-0002-8508-5853; Wilson, Richard/0000-0003-0152-4394	Australian Research Council [LP130100218]; Save The Tasmanian Devil Program Appeal	Australian Research Council(Australian Research Council); Save The Tasmanian Devil Program Appeal	GW is supported by funding from the Australian Research Council (LP130100218), URL: http://www.arc.gov.au/. VK is supported by a scholarship from the Save The Tasmanian Devil Program Appeal, URL: http://www.tassiedevil.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Naseri A, 2013, J PROTEOME RES, V12, P5313, DOI 10.1021/pr400661g; Asea A, 2005, EXERC IMMUNOL REV, V11, P34; Asea Alexzander, 2006, Current Immunology Reviews, V2, P209, DOI 10.2174/157339506778018514; Baena-Lopez LA, 2008, J PROTEOME RES, V7, P2780, DOI 10.1021/pr800006x; Binder RJ, 2014, J IMMUNOL, V193, P5765, DOI 10.4049/jimmunol.1401417; Bloch O, 2014, NEURO-ONCOLOGY, V16, P274, DOI 10.1093/neuonc/not203; Boudesco C, 2018, METHODS MOL BIOL, V1709, P371, DOI 10.1007/978-1-4939-7477-1_27; Calini V, 2003, TOXICOL IN VITRO, V17, P561, DOI 10.1016/S0887-2333(03)00116-4; Ciocca DR, 2012, CURR MOL MED, V12, P1183, DOI 10.2174/156652412803306684; Crane CA, 2013, CLIN CANCER RES, V19, P205, DOI 10.1158/1078-0432.CCR-11-3358; Desmetz C, 2008, J PROTEOME RES, V7, P3830, DOI 10.1021/pr800130d; Flies AS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00581; Folgueira C, 2005, J BIOL CHEM, V280, P35172, DOI 10.1074/jbc.M505559200; Fucikova J, 2016, BLOOD, V128, P3113, DOI [10.1182/blood-2016-08731737, 10.1182/blood-2016-08-731737]; Garbuz DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027205; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Giaginis C, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-14; Graner M, 2000, CANCER IMMUNOL IMMUN, V49, P476, DOI 10.1007/s002620000138; Graner MW, 2013, INT J HYPERTHER, V29, P380, DOI 10.3109/02656736.2013.793406; Hamelin C, 2011, FEBS J, V278, P4845, DOI 10.1111/j.1742-4658.2011.08385.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hess K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23508-x; Hjerpe E, 2013, INT J GYNECOL CANCER, V23, P448, DOI 10.1097/IGC.0b013e318284308b; Hwang YJ, 2009, YONSEI MED J, V50, P399, DOI 10.3349/ymj.2009.50.3.399; JOSHIBARVE S, 1992, J BIOL CHEM, V267, P21038; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Krause SW, 2004, CLIN CANCER RES, V10, P3699, DOI 10.1158/1078-0432.CCR-03-0683; Kreiss A, 2015, VACCINE, V33, P3016, DOI 10.1016/j.vaccine.2015.01.039; Kreiss A., 2009, THESIS; Lee SJ, 2001, CELL STRESS CHAPERON, V6, P273, DOI 10.1379/1466-1268(2001)006<0273:ROIHSP>2.0.CO;2; Li XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107507; Li ZH, 2005, CLIN CANCER RES, V11, P4460, DOI 10.1158/1078-0432.CCR-05-0250; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marnbula SS, 2007, METHODS, V43, P168, DOI 10.1016/j.ymeth.2007.06.009; Mazzaferro V, 2003, CLIN CANCER RES, V9, P3235; McCarthy MM, 2008, ANN ONCOL, V19, P590, DOI 10.1093/annonc/mdm545; Milani V, 2005, INT IMMUNOL, V17, P257, DOI 10.1093/intimm/dxh203; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Multhoff G, 2015, CANCER LETT, V368, P179, DOI 10.1016/j.canlet.2015.02.013; Obeid M, 2007, IMMUNOL REV, V220, P22, DOI 10.1111/j.1600-065X.2007.00567.x; Patchett Amanda L, 2018, Oncotarget, V9, P15895, DOI 10.18632/oncotarget.24634; Patchett AL, 2015, DEV COMP IMMUNOL, V53, P123, DOI 10.1016/j.dci.2015.07.003; Patel K, 2014, CANCER CHEMOTH PHARM, V74, P1015, DOI 10.1007/s00280-014-2584-8; Pearse AM, 2012, CANCER GENET-NY, V205, P101, DOI 10.1016/j.cancergen.2011.12.001; Pilla L, 2006, CANCER IMMUNOL IMMUN, V55, P958, DOI 10.1007/s00262-005-0084-8; Randazzo M, 2012, INT J CANCER, V130, P2219, DOI 10.1002/ijc.27332; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Salimu J, 2015, CANCER IMMUNOL RES, V3, P678, DOI 10.1158/2326-6066.CIR-14-0079; Schmid TE, 2012, CURR MED CHEM, V19, P1765; Shevtsov M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00171; Shevtsov MA, 2014, ONCOTARGETS THER, V7, P1071, DOI 10.2147/OTT.S62764; Shi YK, 2014, CLIN CANCER RES, V20, P6016, DOI 10.1158/1078-0432.CCR-14-0174; Shinagawa N, 2008, CANCER IMMUNOL IMMUN, V57, P165, DOI 10.1007/s00262-007-0359-3; Siddle HV, 2007, IMMUNOGENETICS, V59, P753, DOI 10.1007/s00251-007-0238-2; Siddle HV, 2013, P NATL ACAD SCI USA, V110, P5103, DOI 10.1073/pnas.1219920110; Specht HM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00162; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Testori A, 2008, J CLIN ONCOL, V26, P955, DOI 10.1200/JCO.2007.11.9941; Tovar C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43827; WELCH WJ, 1993, PHILOS T ROY SOC B, V339, P327, DOI 10.1098/rstb.1993.0031; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu JM, 2017, TRENDS PHARMACOL SCI, V38, P226, DOI 10.1016/j.tips.2016.11.009; Zhang KC, 2017, J CANCER, V8, P1826, DOI 10.7150/jca.18946; Zhang YF, 2013, ONCOL LETT, V6, P1543, DOI 10.3892/ol.2013.1616	67	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196469	10.1371/journal.pone.0196469	http://dx.doi.org/10.1371/journal.pone.0196469			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702669	Green Published, gold, Green Accepted			2022-12-26	WOS:000431013300034
J	Dewald, JH; Cavdarli, S; Steenackers, A; Delannoy, CP; Mortuaire, M; Spriet, C; Noel, M; Groux-Degroote, S; Delannoy, P				Dewald, Justine H.; Cavdarli, Sumeyye; Steenackers, Agata; Delannoy, Clement P.; Mortuaire, Marlene; Spriet, Corentin; Noel, Maxence; Groux-Degroote, Sophie; Delannoy, Philippe			TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GD3 SYNTHASE GENE; G(D3) SYNTHASE; STEM-CELLS; ENHANCES PROLIFERATION; C-MET; ALPHA; GLYCOSPHINGOLIPIDS; ACTIVATION; METABOLISM	Gangliosides are glycosphingolipids concentrated in glycolipid-enriched membrane microdomains. Mainly restricted to the nervous system in healthy adult, complex gangliosides such as G(D3) and G(D2) have been shown to be involved in aggressiveness and metastasis of neuro-ectoderm derived tumors such as melanoma and neuroblastoma. GD3 synthase (GD3S), the key enzyme that controls the biosynthesis of complex gangliosides, was shown to be over-expressed in Estrogen Receptor (ER)-negative breast cancer tumors, and associated with a decreased overall survival of patients. We previously demonstrated that GD3S expression in ER-negative breast cancer cells induced a proliferative phenotype and an increased tumor growth. In addition, our results clearly indicate that Tumor Necrosis Factor (TNF) induced GD3S over-expression in breast cancer cells via NF kappa B pathway. In this study, we analyzed the effect of TNF on ganglioside biosynthesis and expression in breast cancer cells from different molecular subtypes. We showed that TNF up-regulated the expression of GD3S in MCF-7 and Hs578T cells, whereas no change was observed for MDA-MB-231. We also showed that TNF induced an increased expression of complex gangliosides at the cell surface of a small proportion of MCF-7 cells. These results demonstrate that TNF differentially regulates gangliosides expression in breast cancer cell lines and establish a possible link between inflammation at the tumor site environment, expression of complex gangliosides and tumor development.	[Dewald, Justine H.; Cavdarli, Sumeyye; Steenackers, Agata; Delannoy, Clement P.; Mortuaire, Marlene; Noel, Maxence; Groux-Degroote, Sophie; Delannoy, Philippe] Univ Lille, UMR CNRS 8576, Struct & Funct Glycobiol Unit, Lille, France; [Spriet, Corentin] Univ Lille, Bio Imaging Ctr Lille, Lille, France; [Steenackers, Agata] NIDDK, Lab Cell & Mol Biol, NIH, Bethesda, MD USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Delannoy, P (corresponding author), Univ Lille, UMR CNRS 8576, Struct & Funct Glycobiol Unit, Lille, France.	philippe.delannoy@univ-lille.fr	Spriet, Corentin/ABE-4215-2021	Spriet, Corentin/0000-0002-5805-3426; Groux-Degroote, Sophie/0000-0002-9964-6519; Delannoy, Clement/0000-0002-2070-4000; Delannoy, Philippe/0000-0001-6467-7553; Cavdarli, Sumeyye/0000-0003-4520-3402	University of Lille; La Ligue Regionale contre le Cancer grant	University of Lille; La Ligue Regionale contre le Cancer grant	This work was supported by the University of Lille and La Ligue Regionale contre le Cancer grant.; This work was supported by the University of Lille and La Ligue Regionale contre le Cancer. We are indebted to the Research Federation FRABio (Univ. Lille, CNRS, FR 3688, FRABio, Biochimie Structurale et Fonctionnelle des Assemblages Biomoleculaires) for providing the scientific and technical environment conducive to achieving this work.	Ariga T, 2008, J LIPID RES, V49, P1157, DOI 10.1194/jlr.R800007-JLR200; Asiedu MK, 2011, CANCER RES, V71, P4707, DOI 10.1158/0008-5472.CAN-10-4554; Battula VL, 2012, J CLIN INVEST, V122, P2066, DOI 10.1172/JCI59735; Birkle S, 2003, BIOCHIMIE, V85, P455, DOI 10.1016/S0300-9084(03)00006-3; Bobowski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062559; Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049; Cazet A, 2010, MOL CANCER RES, V8, P1526, DOI 10.1158/1541-7786.MCR-10-0302; Cazet A, 2009, BIOL CHEM, V390, P601, DOI 10.1515/BC.2009.054; CIUCANU I, 1984, J CHROMATOGR, V284, P179, DOI 10.1016/S0021-9673(01)87813-4; Colomb F, 2017, BIOCHEM J, V474, P65, DOI 10.1042/BCJ20160602; Dewald JH, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5040043; Dyari HRE, 2017, FASEB J, V31, P5246, DOI 10.1096/fj.201700033R; Furukawa K, 2006, ANN NY ACAD SCI, V1086, P185, DOI 10.1196/annals.1377.017; Furukawa K, 2012, J BIOCHEM, V151, P573, DOI 10.1093/jb/mvs043; Groux-Degroote S, 2017, CHEMBIOCHEM, V18, P1146, DOI 10.1002/cbic.201600705; Guerardel Y., 2015, CARBOHYDRATE CHEM ST, P35; HACKETT AJ, 1977, J NATL CANCER I, V58, P1795, DOI 10.1093/jnci/58.6.1795; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Julien Sylvain, 2013, Cells, V2, P751, DOI 10.3390/cells2040751; Kang NY, 2007, BBA-GENE STRUCT EXPR, V1769, P622, DOI 10.1016/j.bbaexp.2007.08.001; Katanov C, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0080-7; Krengel U, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00325; Liang YJ, 2013, P NATL ACAD SCI USA, V110, P4968, DOI 10.1073/pnas.1302825110; Marquina G, 1996, CANCER RES, V56, P5165; Miyata M, 2014, BIOCHEM BIOPH RES CO, V445, P504, DOI 10.1016/j.bbrc.2014.02.038; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PROKAZOVA NV, 1994, LIPIDS, V29, P1, DOI 10.1007/BF02537083; Rabu C, 2012, FUTURE ONCOL, V8, P943, DOI [10.2217/FON.12.88, 10.2217/fon.12.88]; Raval G, 2007, J IMMUNOL, V178, P6642, DOI 10.4049/jimmunol.178.10.6642; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Ruckhaberle E, 2009, J CANCER RES CLIN, V135, P1005, DOI 10.1007/s00432-008-0536-6; Sarkar TR, 2015, ONCOGENE, V34, P2958, DOI 10.1038/onc.2014.245; SCHNAAR RL, 1994, METHOD ENZYMOL, V230, P348; Steenackers A, 2012, CR CHIM, V15, P3, DOI 10.1016/j.crci.2011.05.004; Svennerholm L, 1980, Adv Exp Med Biol, V125, P11; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196369	10.1371/journal.pone.0196369	http://dx.doi.org/10.1371/journal.pone.0196369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698439	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600069
J	Iseki, Y; Shibutani, M; Maeda, K; Nagahara, H; Fukuoka, T; Matsutani, S; Kashiwagi, S; Tanaka, H; Hirakawa, K; Ohira, M				Iseki, Yasuhito; Shibutani, Masatsune; Maeda, Kiyoshi; Nagahara, Hisashi; Fukuoka, Tatsunari; Matsutani, Shinji; Kashiwagi, Shinichiro; Tanaka, Hiroaki; Hirakawa, Kosei; Ohira, Masaichi			A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections	PLOS ONE			English	Article							CD8(+) T-CELL; PROGNOSTIC-SIGNIFICANCE; SURVIVAL	Purpose Numerous reports indicate that tumor-infiltrating lymphocytes (TILs) are a prognostic factor in various cancers and that they must be good biomarkers. However, the methods of evaluating TILs differ in each study; thus, there is not yet a standardized methodology for evaluating TILs. The purpose of this study is to evaluate the prognostic significance of tumorinfiltrating lymphocytes (TILs) in patients with colorectal cancer (CRC) using the new method proposed by the International TILs Working Group in breast cancer and to standardize the method of evaluating TILs in CRC. Methods We retrospectively reviewed a database of 160 patients with Stage II or III CRC. The density of TILs was assessed by measuring the area occupied by mononuclear cells over the stromal area on hematoxylin and eosin (H-E)-stained sections. We set 42% as the cut-off percentage of the area occupied by TILs according to the receiver operating characteristic curve, and we classified patients into the high-TILs and the low-TILs groups. Results The rates of relapse-free survival (RFS) and overall survival (OS) in the high-TILs group were significantly higher than those in the low-TILs group. A multivariate analysis showed that the density of TILs was independently associated with RFS and OS. Moreover, the density of TILs assessed by an observer was significantly associated with the density of TILs assessed by the automated imaging software program. Conclusions The new method for evaluating TILs, which was recommended by the International TILs Working Group in breast cancer, might be a useful predictive factor in colorectal cancer patients.	[Iseki, Yasuhito; Shibutani, Masatsune; Maeda, Kiyoshi; Nagahara, Hisashi; Fukuoka, Tatsunari; Matsutani, Shinji; Kashiwagi, Shinichiro; Tanaka, Hiroaki; Hirakawa, Kosei; Ohira, Masaichi] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka, Japan	Osaka Metropolitan University	Shibutani, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka, Japan.	fbxbj429@ybb.ne.jp	Kashiwagi, Shinichiro/AAC-7070-2019; Kashiwagi, Shinichiro/AAE-5243-2020; Tanaka, Hiroaki/V-8501-2019	Kashiwagi, Shinichiro/0000-0002-0460-9599; Kashiwagi, Shinichiro/0000-0002-0460-9599; 				Canna K, 2005, BRIT J CANCER, V92, P651, DOI 10.1038/sj.bjc.6602419; Chew A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022047; Chiba T, 2004, BRIT J CANCER, V91, P1711, DOI 10.1038/sj.bjc.6602201; Correale P, 2010, J IMMUNOTHER, V33, P435, DOI 10.1097/CJI.0b013e3181d32f01; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Funada Y, 2003, ONCOL REP, V10, P309; Huh JW, 2012, ARCH SURG-CHICAGO, V147, P366, DOI 10.1001/archsurg.2012.35; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122183; Klintrup K, 2005, EUR J CANCER, V41, P2645, DOI 10.1016/j.ejca.2005.07.017; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; McArdle CS, 2002, BRIT J CANCER, V86, P331, DOI 10.1038/sj.bjc.6600120; Mei Z, 2014, BRIT J CANCER, V110, P1595, DOI 10.1038/bjc.2014.46; Menon AG, 2004, LAB INVEST, V84, P493, DOI 10.1038/labinvest.3700055; Ngan CY, 2007, J SURG ONCOL, V95, P652, DOI 10.1002/jso.20638; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Sobin LH, 2009, TNM CLASSIFICATION M, P73; Swisher SK, 2016, ANN SURG ONCOL, V23, P2242, DOI 10.1245/s10434-016-5173-8; Teng FF, 2015, AM J CANCER RES, V5, P2064; Vayrynen JP, 2013, BRIT J CANCER, V109, P1839, DOI 10.1038/bjc.2013.508	21	29	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0192744	10.1371/journal.pone.0192744	http://dx.doi.org/10.1371/journal.pone.0192744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698402	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600002
J	Pena-Diaz, P; Mach, J; Kriegova, E; Poliak, P; Tachezy, J; Lukes, J				Pena-Diaz, Priscila; Mach, Jan; Kriegova, Eva; Poliak, Pavel; Tachezy, Jan; Lukes, Julius			Trypanosomal mitochondrial intermediate peptidase does not behave as a classical mitochondrial processing peptidase	PLOS ONE			English	Article							PROTEIN IMPORT; ARABIDOPSIS-THALIANA; SACCHAROMYCES-CEREVISIAE; PRECURSOR PROTEINS; BRUCEI; CLEAVAGE; IDENTIFICATION; LOCALIZATION; EUKARYOTES; EVOLUTION	Upon their translocation into the mitochondrial matrix, the N-terminal pre-sequence of nuclear-encoded proteins undergoes cleavage by mitochondrial processing peptidases. Some proteins require more than a single processing step, which involves several peptidases. Down-regulation of the putative Trypanosoma brucei mitochondrial intermediate peptidase (MIP) homolog by RNAi renders the cells unable to grow after 48 hours of induction. Ablation of MIP results in the accumulation of the precursor of the trypanosomatid-specific trCOIV protein, the largest nuclear-encoded subunit of the cytochrome c oxidase complex in this flagellate. However, the trCOIV precursor of the same size accumulates also in trypanosomes in which either alpha or beta subunits of the mitochondrial processing peptidase (MPP) have been depleted. Using a chimeric protein that consists of the N-terminal sequence of a putative subunit of respiratory complex I fused to a yellow fluorescent protein, we assessed the accumulation of the precursor protein in trypanosomes, in which RNAi was induced against the alpha or beta subunits of MPP or MIP. The observed accumulation of precursors indicates MIP depletion affects the activity of the cannonical MPP, or at least one of its subunits.	[Pena-Diaz, Priscila; Kriegova, Eva; Lukes, Julius] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Budweis, Czech Republic; [Mach, Jan; Tachezy, Jan] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Poliak, Pavel; Lukes, Julius] Univ South Bohemia, Fac Sci, Ceske Budejovice, Budweis, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Charles University Prague; University of South Bohemia Ceske Budejovice	Pena-Diaz, P; Lukes, J (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Budweis, Czech Republic.; Lukes, J (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Budweis, Czech Republic.	p.pena.diaz@gmail.com; jula@paru.cas.cz	Peña-Diaz, Priscila/AAI-1209-2020; Mach, Jan/C-3641-2017; Pena-Diaz, Priscila/G-9503-2014; Lukes, Julius/H-6760-2012	Peña-Diaz, Priscila/0000-0002-9428-6737; Lukes, Julius/0000-0002-0578-6618; Mach, Jan/0000-0002-4777-9280	Czech Grant Agency [16-18699S, 15-21974S]; ERC CZ [LL1601]; NPU II by MEYS [LQ1604]; ERD Funds [OPVVV 16_019/0000759]; Biotechnology and Biomedicine Center of the Czech Academy of Sciences and Charles University (BIOCEV) [CZ.1.05/1.1.00/02.0109]; NPU II [LQ1604]; BIOCEV [CZ.1.05/1.1.00/02.0109]	Czech Grant Agency(Grant Agency of the Czech Republic); ERC CZ; NPU II by MEYS; ERD Funds; Biotechnology and Biomedicine Center of the Czech Academy of Sciences and Charles University (BIOCEV); NPU II; BIOCEV	Support from the Czech Grant Agency (16-18699S to JL and 15-21974S to JL), the ERC CZ (LL1601 to JL), the NPU II provided by MEYS (LQ1604 to JT), ERD Funds (OPVVV 16_019/0000759 to JL and JT) and the Biotechnology and Biomedicine Center of the Czech Academy of Sciences and Charles University (BIOCEV) CZ.1.05/1.1.00/02.0109 (to JT) is kindly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Andre Schneider (Universitat Bern) for the kind gift of the alphaMPP, beta-MPP, and MIP RNAi cell lines, as well as helpful discussions, and Eva Stribrna for technical help. Support from the Czech Grant Agency (16-18699S to JL), the ERC CZ (LL1601 to JL), the NPU II (LQ1604), BIOCEV CZ.1.05/1.1.00/02.0109 and the ERD Funds, project OPVVV 16_019/0000759 (to JL and JT) are kindly acknowledged.	Adamec J, 1999, ARCH BIOCHEM BIOPHYS, V370, P77, DOI 10.1006/abbi.1999.1397; Adamec J., 2002, ENZYMES, V22, P77; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Branda SS, 1999, HUM MOL GENET, V8, P1099, DOI 10.1093/hmg/8.6.1099; BRANDA SS, 1995, J BIOL CHEM, V270, P27366, DOI 10.1074/jbc.270.45.27366; Carrie C, 2015, J EXP BOT, V66, P2691, DOI 10.1093/jxb/erv064; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Desy S, 2012, MOL BIOCHEM PARASIT, V185, P161, DOI 10.1016/j.molbiopara.2012.07.005; Eckers E, 2012, BIOL CHEM, V393, P513, DOI 10.1515/hsz-2011-0255; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hannaert V, 2003, EUR J BIOCHEM, V270, P3205, DOI 10.1046/j.1432-1033.2003.03692.x; HAWLITSCHEK G, 1988, CELL, V53, P795, DOI 10.1016/0092-8674(88)90096-7; Hildenbeutel M, 2008, INT REV CEL MOL BIO, V268, P147, DOI 10.1016/S1937-6448(08)00805-8; HORWICH AL, 1985, EMBO J, V4, P1129, DOI 10.1002/j.1460-2075.1985.tb03750.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HURT EC, 1984, EMBO J, V3, P3149, DOI 10.1002/j.1460-2075.1984.tb02272.x; ISAYA G, 1991, J CELL BIOL, V113, P65, DOI 10.1083/jcb.113.1.65; ISAYA G, 1994, MOL CELL BIOL, V14, P5603, DOI 10.1128/MCB.14.8.5603; ISAYA G, 1995, GENOMICS, V28, P450, DOI 10.1006/geno.1995.1174; ISAYA G, 1992, J BIOL CHEM, V267, P7904; KALOUSEK F, 1988, P NATL ACAD SCI USA, V85, P7536, DOI 10.1073/pnas.85.20.7536; KALOUSEK F, 1992, EMBO J, V11, P2803, DOI 10.1002/j.1460-2075.1992.tb05347.x; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kovarova J, 2014, EUKARYOT CELL, V13, P353, DOI 10.1128/EC.00235-13; Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199; Long S, 2008, P NATL ACAD SCI USA, V105, P13468, DOI 10.1073/pnas.0806762105; Mach J, 2013, GENOME BIOL EVOL, V5, P860, DOI 10.1093/gbe/evt056; Maguire F, 2014, CURR BIOL, V24, pR518, DOI 10.1016/j.cub.2014.03.075; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; Maslov DA, 2002, MOL BIOCHEM PARASIT, V125, P113, DOI 10.1016/S0166-6851(02)00235-9; MIURA S, 1986, BIOCHEM BIOPH RES CO, V134, P1151, DOI 10.1016/0006-291X(86)90371-2; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; OU WJ, 1989, EMBO J, V8, P2605, DOI 10.1002/j.1460-2075.1989.tb08400.x; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Rawlings ND, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P325, DOI 10.1016/B978-0-12-382219-2.00077-6; SCHMIDT B, 1984, EUR J BIOCHEM, V144, P581, DOI 10.1111/j.1432-1033.1984.tb08505.x; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Smid O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000243; Straub SP, 2016, BIOL CHEM, V397, P1097, DOI 10.1515/hsz-2016-0145; Teixeira PF, 2013, BBA-MOL CELL RES, V1833, P360, DOI 10.1016/j.bbamcr.2012.03.012; Verner Z, 2015, INT REV CEL MOL BIO, V315, P73, DOI 10.1016/bs.ircmb.2014.11.001; Vogtle FN, 2011, MOL BIOL CELL, V22, P2135, DOI 10.1091/mbc.E11-02-0169; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; YANG M, 1988, EMBO J, V7, P3857, DOI 10.1002/j.1460-2075.1988.tb03271.x	61	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196474	10.1371/journal.pone.0196474	http://dx.doi.org/10.1371/journal.pone.0196474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698456	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600085
J	Takahashi, I; Matsuzaki, T; Kuroki, H; Hoso, M				Takahashi, Ikufumi; Matsuzaki, Taro; Kuroki, Hiroshi; Hoso, Masahiro			Induction of osteoarthritis by injecting monosodium iodoacetate into the patellofemoral joint of an experimental rat model	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; FOOT ORTHOSES; ANIMAL-MODELS; KNEE; HISTOPATHOLOGY; PAIN; PREVALENCE; RECOMMENDATIONS; CHONDROCYTES; PATHOGENESIS	This study aimed to investigate the histopathological changes in the patellofemoral joint using a rat model of osteoarthritis that was induced using monosodium iodoacetate, and to establish a novel model of patellofemoral osteoarthritis in a rat model using histopathological analysis. Sixty male rats were used. Osteoarthritis was induced through a single intra-articular injection of monosodium iodoacetate in both knee joints. Animals were equally divided into two experimental groups based on the monosodium iodoacetate dose: 0.2 mg and 1.0 mg. Histopathological changes in the articular cartilage of the patellofemoral joint and the infrapatellar fat pad were examined at 3 days, 1 week, 2 weeks, 4 weeks, 8 weeks, and 12 weeks after the monosodium iodoacetate injection. In the 1.0-mg group, the representative histopathological findings of osteoarthritis were observed in the articular cartilage of the patellofemoral joint over time. Additionally, the Osteoarthritis Research Society International scores of the patellofemoral joint increased over time. The synovitis scores of the infrapatellar fat pad in both groups were highest at 3 days, and then the values decreased over time. The fibrosis score of the infrapatellar fat pad in the 1.0-mg group increased with time, whereas the fibrosis score in the 0.2-mg group remained low. Representative histopathological findings of osteoarthritis were observed in the articular cartilage of the patellofemoral joint in a rat model of osteoarthritis induced using monosodium iodoacetate. With appropriate selection, this model may be regarded as an ideal patellofemoral osteoarthritis model.	[Takahashi, Ikufumi] Kanazawa Univ Hosp, Sect Rehabil, Kanazawa, Ishikawa, Japan; [Takahashi, Ikufumi; Kuroki, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Motor Funct Anal, Human Hlth Sci, Kyoto, Japan; [Matsuzaki, Taro; Hoso, Masahiro] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kyoto University; Kanazawa University	Hoso, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa, Japan.	hoso@mhs.mp.kanazawa-u.ac.jp			Japan Society for the Promotion of Science, KAKENHI [17K13051]	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Japan Society for the Promotion of Science, KAKENHI grant-in-aid for Young Scientists B (number 17K13051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2010, OSTEOARTHR CARTILAGE, V18, pS2, DOI 10.1016/j.joca.2010.07.013; Arendt EA, 2016, KNEE SURG SPORT TR A, V24, P1836, DOI 10.1007/s00167-016-4103-4; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Chang NJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040829; Chia WT, 2010, J BONE JOINT SURG BR, V92B, P1710, DOI 10.1302/0301-620X.92B12.23366; Cifuentes DJ, 2010, OSTEOARTHR CARTILAGE, V18, P1088, DOI 10.1016/j.joca.2010.04.004; Clark AL, 2005, OSTEOARTHR CARTILAGE, V13, P1100, DOI 10.1016/j.joca.2005.07.010; Clark AL, 2008, EXERC SPORT SCI REV, V36, P30, DOI 10.1097/jes.0b013e31815e4217; Collins NJ, 2017, KNEE, V24, P76, DOI 10.1016/j.knee.2016.09.016; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Drew BT, 2016, OSTEOARTHR CARTILAGE, V24, P224, DOI 10.1016/j.joca.2015.09.004; Duncan RC, 2006, RHEUMATOLOGY, V45, P757, DOI 10.1093/rheumatology/kei270; DUNHAM J, 1992, INT J EXP PATHOL, V73, P455; Egloff C, 2014, OSTEOARTHR CARTILAGE, V22, P1886, DOI 10.1016/j.joca.2014.07.026; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Guingamp C, 1997, ARTHRITIS RHEUM, V40, P1670, DOI 10.1002/art.1780400917; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839; Janusz MJ, 2001, OSTEOARTHR CARTILAGE, V9, P751, DOI 10.1053/joca.2001.0472; Jiang LP, 2013, J ORTHOP RES, V31, P364, DOI 10.1002/jor.22250; Kanazawa H, 2017, J ORTHOP TRAUMATOL, V18, P23, DOI 10.1007/s10195-016-0428-5; Kelly S, 2012, OSTEOARTHR CARTILAGE, V20, P305, DOI 10.1016/j.joca.2012.01.002; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kobayashi S, 2016, OSTEOARTHR CARTILAGE, V24, P1697, DOI 10.1016/j.joca.2016.05.011; Kuyinu EL, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0346-5; Lampropoulou-Adamidou Kalliopi, 2014, Eur J Orthop Surg Traumatol, V24, P263, DOI 10.1007/s00590-013-1205-2; Lankhorst NE, 2017, OSTEOARTHR CARTILAGE, V25, P647, DOI 10.1016/j.joca.2016.12.006; Lee YH, 2017, MAGN RESON IMAGING, V35, P61, DOI 10.1016/j.mri.2016.08.014; MEACHIM G, 1974, ANN RHEUM DIS, V33, P39, DOI 10.1136/ard.33.1.39; Mills K, 2014, BEST PRACT RES CL RH, V28, P73, DOI 10.1016/j.berh.2014.01.006; Moon SJ, 2012, OSTEOARTHR CARTILAGE, V20, P1426, DOI 10.1016/j.joca.2012.08.002; MORI Y, 1991, Arthroscopy, V7, P182; Nomura M, 2017, OSTEOARTHR CARTILAGE, V25, P727, DOI 10.1016/j.joca.2016.11.013; Poole R, 2010, OSTEOARTHR CARTILAGE, V18, pS10, DOI 10.1016/j.joca.2010.05.027; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Saito R, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1393-8; Scanzello CR, 2012, BONE, V51, P249, DOI 10.1016/j.bone.2012.02.012; Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026; Takahashi Ikufumi, 2017, J Phys Ther Sci, V29, P590, DOI 10.1589/jpts.29.590; Teeple E, 2013, AAPS J, V15, P438, DOI 10.1208/s12248-013-9454-x; Tsai PH, 2016, OSTEOARTHR CARTILAGE, V24, P129, DOI 10.1016/j.joca.2015.07.015; Udo M, 2016, OSTEOARTHR CARTILAGE, V24, P1284, DOI 10.1016/j.joca.2016.02.005; van der List JP, 2017, KNEE, V24, P2, DOI 10.1016/j.knee.2015.11.002; Wyndow N, 2017, J FOOT ANKLE RES, V10, DOI 10.1186/s13047-017-0200-y; Zhang X, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1524-2	45	38	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196625	10.1371/journal.pone.0196625	http://dx.doi.org/10.1371/journal.pone.0196625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698461	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600110
J	Hidalgo-de-la-Tobal, JA; Morales-Bojorquez, E; Gonzalez-Pelaez, SS; Bautista-Romero, JJ; Lluch-Cota, DB				Angel Hidalgo-de-la-Tobal, Jose; Morales-Bojorquez, Enrique; Scarry Gonzalez-Pelaez, Sergio; Jesus Bautista-Romero, J.; Bernardo Lluch-Cota, Daniel			Modeling the temporal periodicity of growth increments based on harmonic functions	PLOS ONE			English	Article							PANOPEA-GENEROSA; MULTIMODEL INFERENCE; AGE-DETERMINATION; BAJA-CALIFORNIA; PACIFIC GEODUCK; VALIDATION; MORTALITY; SELECTION; BIVALVIA; GLOBOSA	Age estimation methods based on hard structures require a process of validation to confirm the periodical pattern of growth marks. Among such processes, one of the most used is the marginal increment ratio (MIR), which was stated to follow a sinusoidal cycle in a population. Despite its utility, in most cases, its implementation has lacked robust statistical analysis. Accordingly, we propose a modeling approach for the temporal periodicity of growth increments based on single and second order harmonic functions. For illustrative purposes, the MIR periodicities for two geoduck species (Panopea generosa and Panopea globosa) were modeled to identify the periodical pattern of growth increments in the shell. This model identified an annual periodicity for both species but described different temporal patterns. The proposed procedure can be broadly used to objectively define the timing of the peak, the degree of symmetry, and therefore, the synchrony of band deposition of different species on the basis of MIR data.	[Angel Hidalgo-de-la-Tobal, Jose; Morales-Bojorquez, Enrique; Scarry Gonzalez-Pelaez, Sergio; Jesus Bautista-Romero, J.; Bernardo Lluch-Cota, Daniel] Ctr Invest Biol Noroeste CIBNOR, La Paz, Bcs, Mexico; [Jesus Bautista-Romero, J.] Univ Autonoma Baja California Sur, Dept Ciencias Marinas & Costeras, Posgrad Ciencias Marinas & Costeras, La Paz, Bcs, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Universidad Autonoma de Baja California	Morales-Bojorquez, E (corresponding author), Ctr Invest Biol Noroeste CIBNOR, La Paz, Bcs, Mexico.	emorales@cibnor.mx	Bautista-Romero, J. Jesús/G-1995-2019; Bojórquez, Enrique Morales/I-2863-2015; Lluch-Cota, Daniel B./AEU-0658-2022	Bautista-Romero, J. Jesús/0000-0002-2736-7625; Bojórquez, Enrique Morales/0000-0001-6705-1636; Hidalgo-de-la-Toba, Jose Angel/0000-0002-3523-4558	Consejo Nacional de Ciencia y Teconologia Mexico [241603, 279953]	Consejo Nacional de Ciencia y Teconologia Mexico	This work was supported by Consejo Nacional de Ciencia y Teconologia Mexico (http://conacyt.gob.mx/) grant No. 241603, and grant No. 279953 (JAHT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose WG, 2012, POLAR BIOL, V35, P345, DOI 10.1007/s00300-011-1080-4; Hidalgo-De-La-Toba JA, 2015, J SHELLFISH RES, V34, P91, DOI 10.2983/035.034.0112; Ashworth EC, 2017, CAN J FISH AQUAT SCI, V74, P680, DOI 10.1139/cjfas-2015-0471; Beamish CA, 2005, AFR ZOOL, V40, P63; Black BA, 2008, CAN J FISH AQUAT SCI, V65, P2572, DOI 10.1139/F08-158; Bliss CI, 1958, CONN AGR EXP STATION, V615, P3, DOI [DOI 10.2307/2333558, 10.2307/2333558]; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; De Guevara GCL, 2011, MAR BIOL RES, V7, P488, DOI 10.1080/17451000.2010.528201; Cerrato RM, 2000, FISH RES, V46, P39, DOI 10.1016/S0165-7836(00)00131-4; Chen Y, 1999, CAN J FISH AQUAT SCI, V56, P1525, DOI 10.1139/cjfas-56-9-1525; Chen Y, 2003, FISH FISH, V4, P105, DOI 10.1046/j.1467-2979.2003.00111.x; CisnerosMata MA, 1996, CIENC MAR, V22, P427, DOI 10.7773/cm.v22i4.876; CLOERN JE, 1978, J FISH RES BOARD CAN, V35, P1479, DOI 10.1139/f78-231; Cortez-Lucero G, 2011, REV BIOL MAR OCEANOG, V46, P453, DOI 10.4067/S0718-19572011000300014; Freitas TMD, 2011, NEOTROP ICHTHYOL, V9, P839; DeAngelis DL, 2005, CAN J FISH AQUAT SCI, V62, P781, DOI 10.1139/F05-050; Calderon-Aguilera LE, 2010, J SHELLFISH RES, V29, P319, DOI 10.2983/035.029.0206; Eide A., 2003, Marine Resource Economics, V18, P81; Fontoura NF, 1996, J FISH BIOL, V48, P569, DOI 10.1006/jfbi.1996.0058; Gonzalez-Pelaez SS, 2013, MALACOLOGIA, V56, P85, DOI 10.4002/040.056.0206; Goodwin C.L., 1976, P NATL SHELLFISH ASS, V65, P49; Gribben PE, 2005, B MAR SCI, V77, P119; Haas DL, 2016, ENV BIOL FISHES; Haddon M., 2011, MODELLING QUANTITATI; Hallmann N, 2008, PALAEOGEOGR PALAEOCL, V269, P115, DOI 10.1016/j.palaeo.2008.08.010; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Hu GY, 2016, FISHERIES SCI, V82, P597, DOI 10.1007/s12562-016-0991-y; Bautista-Romero JJ, 2015, J SHELLFISH RES, V34, P21, DOI 10.2983/035.034.0105; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Juneja VK, 2009, INT J FOOD MICROBIOL, V131, P106, DOI 10.1016/j.ijfoodmicro.2009.01.034; Kastelle CR, 2011, PALAEOGEOGR PALAEOCL, V311, P126, DOI 10.1016/j.palaeo.2011.08.015; Kilada R, 2017, FISH B-NOAA, V115, P42, DOI 10.7755/FB.115.1.4; Kilada RW, 2007, J SHELLFISH RES, V26, P443, DOI 10.2983/0730-8000(2007)26[443:ADVGAM]2.0.CO;2; Lessa R, 2016, J FISH BIOL, V89, P977, DOI 10.1111/jfb.13002; Lewis DE, 1997, MAR ECOL PROG SER, V158, P177, DOI 10.3354/meps158177; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Matta ME, 2016, POLAR BIOL, V39, P2427, DOI 10.1007/s00300-016-1917-y; Mercier L, 2011, ESTUAR COAST SHELF S, V92, P534, DOI 10.1016/j.ecss.2011.02.001; Morita K, 2001, CAN J FISH AQUAT SCI, V58, P1805, DOI 10.1139/cjfas-58-9-1805; Morsan E, 2004, FISH RES, V69, P343, DOI 10.1016/j.fishres.2004.06.012; Neter J., 1996, APPL LINEAR STAT MOD; Okamura H, 2013, J FISH BIOL, V82, P1239, DOI 10.1111/jfb.12062; Okamura H, 2009, CAN J FISH AQUAT SCI, V66, P771, DOI 10.1139/F09-039; Pawitan Y., 2001, ALL LIKELIHOOD STAT, DOI [10.2307/3621915, DOI 10.2307/3621915]; Piercy AN, 2007, MAR FRESHWATER RES, V58, P34, DOI 10.1071/MF05195; PITCHER TJ, 1973, J APPL ECOL, V10, P599, DOI 10.2307/2402304; Prince E.D., 1988, COL VOL SCI PAP ICCA, V27, P194; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; RESTREPO VR, 1991, CAN J FISH AQUAT SCI, V48, P1431, DOI 10.1139/f91-170; Gonzalez-Pelaez SS, 2015, J SHELLFISH RES, V34, P101, DOI 10.2983/035.034.0113; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P130, DOI 10.1016/j.palaeo.2005.03.049; SHAUL W, 1982, CAN J FISH AQUAT SCI, V39, P632, DOI 10.1139/f82-089; Thorarinsdotti Gudrun G., 1999, Phuket Marine Biological Center Special Publication, V19, P41; Thorn GJ, 2016, MATH BIOSCI, V271, P62, DOI 10.1016/j.mbs.2015.10.016; Vadopalas B, 2011, J SHELLFISH RES, V30, P303, DOI 10.2983/035.030.0216; Wakefield CB, 2017, ICES J MAR SCI, V74, P180, DOI 10.1093/icesjms/fsw137; Wang YJ, 2006, FISH RES, V77, P220, DOI 10.1016/j.fishres.2005.08.011; Zhu GP, 2010, ENVIRON BIOL FISH, V88, P253, DOI 10.1007/s10641-010-9636-7	60	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196189	10.1371/journal.pone.0196189	http://dx.doi.org/10.1371/journal.pone.0196189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694381	Green Published, Green Submitted, gold			2022-12-26	WOS:000430802400072
J	Lu, Y; Yu, T; Liu, JY; Gu, LN				Lu, Ying; Yu, Ting; Liu, Jingyao; Gu, Lina			Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; OXIDATIVE STRESS; HEME OXYGENASE-1; NLRP3 INFLAMMASOME; ACTIVATION; APOPTOSIS; INHIBITION; RETICULUM; DELETION; RELEASE	Background A major feature of acute lung injury (ALI) is excessive inflammation in the lung. Vitexin is an active component from medicinal plants which has antioxidant and anti-inflammatory activities. Oxidative stress and inflammation play important roles in the pathophysiological processes in ALI. In the current study, we investigate the effect and potential mechanisms of Vitexin on lipopolysaccharide (LPS)-induced ALI. Methods ALI was induced by LPS intratracheal instillation in C57BL/6 wild-type mice and Nrf2 gene knocked down (Nrf2-/-) mice. One hour before LPS challenge, Vitexin or vehicle intraperitoneal injection was performed. Bronchoalveolar lavage fluid and lung tissues were examined for lung inflammation and injury at 24 h after LPS challenge. Results Our animal study's results showed that LPS-induced recruitment of neutrophils and elevation of proinflammatory cytokine levels were attenuated by Vitexin treatment. Vitexin decreased lung edema and alveolar protein content. Moreover, Vitexin activated nuclear factor erythroid-2-related factor 2 (Nrf2), and increased the activity of its target gene heme oxygenase (HO)-1. The LPS-induced reactive oxygen species were inhibited by Vitexin. In addition, the activation of the nucleotide-binding domain and leucine-rich repeat PYD-containing protein 3 (NLRP3) inflammasome was suppressed by Vitexin. However, these effects of Vitexin were abolished in the Nrf2-/-mice. Our cell studies showed that Vitexin enhanced the expression of Nrf2 and HO-1 activity. Moreover, reactive oxygen species (ROS) and IL-1 beta productions were reduced in Vitexin-treated cells. However, knockdown of Nrf2 by siRNA in RAW cells reversed the benefit of Vitexin. Conclusions Vitexin suppresses LPS-induced ALI by controlling Nrf2 pathway.	[Lu, Ying; Gu, Lina] Jilin Univ, Hosp 1, Intens Care Unit, Changchun, Jilin, Peoples R China; [Yu, Ting] Jilin Univ, Hosp 2, Dept Nutr, Changchun, Jilin, Peoples R China; [Liu, Jingyao] Jilin Univ, Hosp 1, Dept Neurol, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Gu, LN (corresponding author), Jilin Univ, Hosp 1, Intens Care Unit, Changchun, Jilin, Peoples R China.	LinaGu20006@163.com						Abderrazak A, 2015, REDOX BIOL, V4, P296, DOI 10.1016/j.redox.2015.01.008; Che X, 2016, AM J TRANSL RES, V8, P3319; Clark JE, 2000, BIOCHEM J, V348, P615, DOI 10.1042/0264-6021:3480615; COCHRANE CG, 1983, J CLIN INVEST, V71, P754, DOI 10.1172/JCI110823; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Galam L, 2016, AM J PHYSIOL-LUNG C, V310, pL572, DOI 10.1152/ajplung.00417.2015; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Han SC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/720457; HESS ML, 1981, J MOL CELL CARDIOL, V13, P767, DOI 10.1016/0022-2828(81)90258-3; Hybertson BM, 2000, INFLAMMATION, V24, P289, DOI 10.1023/A:1007092529261; Jones HD, 2014, AM J RESP CELL MOL, V50, P270, DOI 10.1165/rcmb.2013-0087OC; Kim JH, 2005, ARCH PHARM RES, V28, P195, DOI 10.1007/BF02977715; Kurutas EB, 2005, MEDIAT INFLAMM, P390, DOI 10.1155/MI.2005.390; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Leaver SK, 2007, BMJ-BRIT MED J, V335, P389, DOI 10.1136/bmj.39293.624699.AD; Lin WC, 2011, J PHARMACOL EXP THER, V339, P45, DOI 10.1124/jpet.111.181560; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mac Sweeney R, 2016, LANCET, V388, P2416, DOI 10.1016/S0140-6736(16)00578-X; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Min JW, 2015, NEUROPHARMACOLOGY, V99, P38, DOI 10.1016/j.neuropharm.2015.07.007; Murakami K, 2002, SHOCK, V18, P236, DOI 10.1097/00024382-200209000-00006; Nikam A, 2016, J MED CHEM, V59, P756, DOI 10.1021/acs.jmedchem.5b01509; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; PRABHAKAR MC, 1981, PLANTA MED, V43, P396, DOI 10.1055/s-2007-971532; Sawle P, 2008, CHEM RES TOXICOL, V21, P1484, DOI 10.1021/tx800115g; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tao W, 2018, SHOCK, V50, P589, DOI 10.1097/SHK.0000000000001067; Tao W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160359; Tao W, 2012, INFLAMMATION, V35, P150, DOI 10.1007/s10753-011-9300-1; Venturini CL, 2018, BIOMED PHARMACOTHER, V97, P143, DOI 10.1016/j.biopha.2017.10.073; Wang FF, 2017, MOL MED REP, V15, P1079, DOI 10.3892/mmr.2017.6114; Wu JQ, 2014, MOLECULES, V19, P1685, DOI 10.3390/molecules19021685; Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093; Yu GG, 2015, CELL PHYSIOL BIOCHEM, V36, P474, DOI 10.1159/000430113; Zhai ZL, 2012, FREE RADICAL BIO MED, V53, P172, DOI 10.1016/j.freeradbiomed.2012.04.023; Zhang SL, 2017, MOL IMMUNOL, V85, P214, DOI 10.1016/j.molimm.2017.02.020; Zhang Y, 2016, J PINEAL RES, V60, P405, DOI 10.1111/jpi.12322; Zhao HL, 2017, AM J PHYSIOL-LUNG C, V312, pL155, DOI 10.1152/ajplung.00449.2016	38	28	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196405	10.1371/journal.pone.0196405	http://dx.doi.org/10.1371/journal.pone.0196405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694408	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400087
J	Bisagni, A; Pagano, M; Maramotti, S; Zanelli, F; Bonacini, M; Tagliavini, E; Braglia, L; Paci, M; Mozzarelli, A; Croci, S				Bisagni, Alessandra; Pagano, Maria; Maramotti, Sally; Zanelli, Francesca; Bonacini, Martina; Tagliavini, Elena; Braglia, Luca; Paci, Massimiliano; Mozzarelli, Andrea; Croci, Stefania			Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients	PLOS ONE			English	Article							SURVIVAL	Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (gefitinib, erlotinib and afatinib) are indicated as first-line therapy in patients with non-small cell lung cancer (NSCLC) whose tumors harbor activating mutations in the EGFR gene. Erlotinib is also used in second and third-line therapy for patients whose tumors have wild type EGFR but to date there are no validated biomarkers useful to identify which patients may benefit from this treatment. The expression level of four miRNAs: miR-133b, -146a, -7 and -21 which target EGFR was investigated by real-time PCR in tumor specimens from NSCLC patients treated with erlotinib administered as the second or third line. We found that miR-133b expression level better discriminated responder from non-responder patients to erlotinib. Higher levels of miR-133b in NSCLCs were associated with longer progression-free survival time of patients. Functional analyses on miR-133b through transfection of a miR-133b mimic in A549 and H1299 NSCLC cell lines indicated that increasing miR-133b expression level led to a decreased cell growth and altered morphology but did not affect sensitivity to erlotinib. The detection of miR-133b expression levels in tumors help in the identification of NSCLC patients with a better prognosis and who are likely to benefit from second and third-line therapy with erlotinib.	[Bisagni, Alessandra; Tagliavini, Elena] IRCCS Reggio Emilia, Azienda Unita Sanitaria Locale, Pathol Unit, Reggio Emilia, Italy; [Pagano, Maria; Zanelli, Francesca] IRCCS Reggio Emilia, Azienda Unita Sanitaria Locale, Oncol Unit, Reggio Emilia, Italy; [Maramotti, Sally; Bonacini, Martina; Croci, Stefania] IRCCS Reggio Emilia, Azienda Unita Sanitaria Locale, Clin Immunol Allergy & Adv Biotechnol Unit, Reggio Emilia, Italy; [Braglia, Luca] IRCCS Reggio Emilia, Azienda Unita Sanitaria Locale, Sci Directorate, Reggio Emilia, Italy; [Paci, Massimiliano] IRCCS Reggio Emilia, Azienda Unita Sanitaria Locale, Thorac Surg Unit, Reggio Emilia, Italy; [Mozzarelli, Andrea] Univ Parma, Dept Food & Drug, Parma, Italy	University of Parma	Bisagni, A (corresponding author), IRCCS Reggio Emilia, Azienda Unita Sanitaria Locale, Pathol Unit, Reggio Emilia, Italy.	alessandra.bisagni@ausl.re.it	Pagano, Maria/K-2469-2018; Bonacini, Martina/J-4705-2018; Paci, Massimiliano/AAC-2127-2020; ZANELLI, FRANCESCA/AAL-5507-2020; Tagliavini, Elena/AAB-1915-2021; Braglia, Luca/AAL-7565-2021; Bisagni, Alessandra/AAL-7079-2021; Croci, Stefania/K-2899-2016	Bonacini, Martina/0000-0002-6830-6781; Paci, Massimiliano/0000-0001-7400-1792; ZANELLI, FRANCESCA/0000-0003-3348-3435; Tagliavini, Elena/0000-0003-4138-4357; Braglia, Luca/0000-0001-8225-2938; Bisagni, Alessandra/0000-0001-8484-7871; Croci, Stefania/0000-0002-8622-0439	ONLUS "Associazione Vittorio Lodini per la ricerca in chirurgia toracica"; Azienda Unita Sanitaria Locale -IRCCS of Reggio Emilia, Italy	ONLUS "Associazione Vittorio Lodini per la ricerca in chirurgia toracica"; Azienda Unita Sanitaria Locale -IRCCS of Reggio Emilia, Italy	This work was supported by ONLUS "Associazione Vittorio Lodini per la ricerca in chirurgia toracica" and Azienda Unita Sanitaria Locale -IRCCS of Reggio Emilia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFATINIB HV, 1962, FUTURE ONCOL; [Anonymous], 2001, J THORAC ONCOL; Bronte Giuseppe, 2011, Front Biosci (Elite Ed), V3, P879; BRYANT JL, 2011, BRIT J CANCER, V465, P5191; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chen SW, 2015, INT J CLIN EXP PATHO, V8, P14983; CIULEANU T, 1985, LANCET ONCOL; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; CROCI S, 2015, ANN RHEUM DIS, P2092; DOWELL J, 2012, NAT REV DRUG DISCOV; DZIADZIUSZKO R, 2007, ANN ONCOL; DZIADZIUSZKO R, 1987, CCR; Edge S. B., 2010, AJCC CANC STAGING MA, P7; FUKUOKA MWUY, 2010, JCO, V33, P4235; GARASSINO MC, 2003, LANCET ONCOL; HAN JY, 2011, JCO, V36, P8456; Korpanty GJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00204; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; LI J, 2002, ONCOTARGET; LI T, 1923, CCR; Liu LX, 2012, FEBS J, V279, P3800, DOI 10.1111/j.1742-4658.2012.08741.x; MAEMONDO M, 1930, N ENGL J MED; MARKER FOR, 2009, CLIN LUNG CANCER, V6, P9371; MITSUDOMI T, 1964, LANCET ONCOL; MOK T, 1999, N ENGL J MED; Muhsin M, 2003, NAT REV DRUG DISCOV, V2, P515, DOI 10.1038/nrd1136; RAPONI M, 1987, CANCER RES; ROSELL R, 2010, LANCET ONCOL, V1016, P1470; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; SHARMA SV, 1988, NAT REV CANCER; TAKAMIZAWA J, 2008, CANCER RES, V1158, P4; TRAVIS WD, 1960, J THORAC ONCOL, V10, P1097; TRAVIS WD, 1990, J THORAC ONCOL; TRAVIS WD, 2006, J THORAC ONCOL; TRAVIS WD, 1984, J THORAC ONCOL; TRAVIS WD, 1936, J THORAC ONCOL; TRAVIS WD, 2016, J THORAC ONCOL, V6, P1; TRAVIS WD, 2009, J THORAC ONCOL, V7, P143; TRAVIS WD, 2012, J THORAC ONCOL, V8741, P3469; Travis WD, 2006, J THORAC ONCOL, V1, pS13, DOI 10.1097/01243894-200611001-00004; Wang YJ, 2016, ANAL BIOCHEM, V508, P46, DOI 10.1016/j.ab.2016.05.027; Wang YY, 2012, J NEURO-ONCOL, V106, P217, DOI 10.1007/s11060-011-0679-1; WEISS GJ, 2006, ANN ONCOL; WU YL, 2004, ONCOL; YAN G, 2005, MED ONCOL; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang XC, 2016, ONCOL LETT, V12, P3619, DOI 10.3892/ol.2016.5044; ZHANG YQ, 1923, J CANCER; ZHEN Y, 2000, ONCOL RES; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; J THORAC ONCOL, P1243	52	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196350	10.1371/journal.pone.0196350	http://dx.doi.org/10.1371/journal.pone.0196350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689091	Green Submitted, Green Published, gold			2022-12-26	WOS:000430678800047
J	Rosenblum, S				Rosenblum, Sara			Inter-relationships between objective handwriting features and executive control among children with developmental dysgraphia	PLOS ONE			English	Article							WORKING-MEMORY; PERFORMANCE; SCHOOL; TRANSCRIPTION; PROFICIENT; VALIDITY; DEFICITS; ABILITY	Objective To describe handwriting and executive control features and their inter-relationships among children with developmental dysgraphia, in comparison to controls. Method Participants included 64 children, aged 10-12 years, 32 with dysgraphia based on the Handwriting Proficiency Screening Questionnaire (HPSQ) and 32 matched controls. Children copied a paragraph onto paper affixed to a digitizer that supplied handwriting process objective measures (Computerized Penmanship Evaluation Tool (ComPET). Their written product was evaluated by the Hebrew Handwriting Evaluation (HHE). Parents completed the Behavior Rating Inventory of Executive Function (BRIEF) questionnaire about their child's executive control abilities. Results Significant group differences were found for handwriting performance measures (HHE and ComPET) and executive control domains (BRIEF). Based on one discriminate function, including handwriting performance and executive control measures, 98.4% of the participants were correctly classified into groups. Significant correlations were found in each group between working memory and legibility as well as for other executive domains and handwriting measures. Furthermore, twenty percent of the variability of the mean pressure applied towards the writing surface among children with was explained by their 'emotional control' (BRIEF). Conclusion The results strongly suggest consideration of executive control domains to obtain better insight into handwriting impairment characteristics among children with dysgraphia to improve their identification, evaluation and the intervention process.	[Rosenblum, Sara] Univ Haifa, Lab Complex Human Act & Participat CHAP, Dept Occupat Therapy, Fac Welf & Hlth Sci, Har Hakarmel, Israel	University of Haifa	Rosenblum, S (corresponding author), Univ Haifa, Lab Complex Human Act & Participat CHAP, Dept Occupat Therapy, Fac Welf & Hlth Sci, Har Hakarmel, Israel.	rosens@univ.haifa.ac.il						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Berninger V.W., 2012, WRITING MOSAIC NEW P, P65, DOI DOI 10.4324/9780203808481; Berninger VW, 2011, READ WRIT, V24, P151, DOI 10.1007/s11145-010-9262-y; Berninger VW, 2010, LANG SPEECH HEAR SER, V41, P179, DOI 10.1044/0161-1461(2009/08-0002); BERNINGER VW, 1991, J SCHOOL PSYCHOL, V29, P57, DOI 10.1016/0022-4405(91)90016-K; Berninger VW, 2004, SCI PRACT NEUROPSYCH, P328; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Chevignard MP, 2010, BRAIN IMPAIR, V11, P125, DOI 10.1375/brim.11.2.125; Connelly V., 2005, EDUC PSYCHOL-UK, V25, P99, DOI [10.1080/0144341042000294912, DOI 10.1080/0144341042000294912]; Dawson P., 2010, EXECUTIVE SKILLS CHI; DENCKLA MB, 1992, HDB DEV NEUROPSYCHOL, V6, P455; Ellis A.W., 1982, NORMALITY PATHOLOGY; Engel-Yeger B, 2009, AM J OCCUP THER, V63, P182, DOI 10.5014/ajot.63.2.182; Erez N., 1999, HEBREW HANDWRITING E; Erez N, 2013, OTJR-OCCUP PART HEAL, V33, P218, DOI 10.3928/15394492-20130912-04; Feder KP, 2007, DEV MED CHILD NEUROL, V49, P312, DOI 10.1111/j.1469-8749.2007.00312.x; Gioia GA, 2000, BRIEF BEHAV RATING I; Graham S, 2006, DEV NEUROPSYCHOL, V29, P43, DOI 10.1207/s15326942dn2901_4; Graham S, 2000, EDUC PSYCHOL, V35, P3, DOI 10.1207/S15326985EP3501_2; Graham S, 2007, EXECUTIVE FUNCTION E, P216; HAMSTRABLETZ L, 1993, J LEARN DISABIL, V26, P689, DOI 10.1177/002221949302601007; Hayes J. R., 1980, COGNITIVE PROCESS, P3; Hughes DM, 2009, INT J LANG COMM DIS, V44, P901, DOI [10.3109/13682820802425693, 10.1080/13682820802425693]; Isquith PK, 2005, MENT RETARD DEV D R, V11, P209, DOI 10.1002/mrdd.20075; Jones D, 1999, J EDUC PSYCHOL, V91, P44, DOI 10.1037/0022-0663.91.1.44; Josman  N., 2011, COGNITION OCCUPATION, P223; Jovanovski D, 2007, PSYCHIAT RES, V151, P47, DOI 10.1016/j.psychres.2006.09.012; Karlsdottir R, 2002, PERCEPT MOTOR SKILL, V94, P623, DOI 10.2466/PMS.94.2.623-662; Kellogg RT, 2007, ACTA PSYCHOL, V124, P382, DOI 10.1016/j.actpsy.2006.02.005; Kushki A, 2011, RES DEV DISABIL, V32, P1058, DOI 10.1016/j.ridd.2011.01.026; Lachter L., 2006, THESIS; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Marr D, 2001, ISRAELI J OCCUPATION, V10, P109; McCandless Stephen, 2007, J Atten Disord, V10, P381, DOI 10.1177/1087054706292115; McCloskey G, 2009, SCHBASE PRACT ACT, P1; MCHALE K, 1992, AM J OCCUP THER, V46, P898, DOI 10.5014/ajot.46.10.898; Medwell J, 2008, LANG EDUC-UK, V22, P34, DOI 10.2167/le722.0; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Rosenblum S, 2006, AM J OCCUP THER, V60, P28, DOI 10.5014/ajot.60.1.28; Rosenblum S, 2003, AM J OCCUP THER, V57, P129, DOI 10.5014/ajot.57.2.129; Rosenblum  S., 2014, RECENT ADV NEURAL NE, V26, P269, DOI DOI 10.1007/978-3-319-04129-2_27; Rosenblum S, 2008, AM J OCCUP THER, V62, P298, DOI 10.5014/ajot.62.3.298; Rosenblum S, 2006, HUM MOVEMENT SCI, V25, P608, DOI 10.1016/j.humov.2006.07.005; Rosenblum S, 2015, HUM MOVEMENT SCI, V43, P201, DOI 10.1016/j.humov.2015.03.014; Rosenblum S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00357; Rosenblum S, 2010, RES DEV DISABIL, V31, P502, DOI 10.1016/j.ridd.2009.10.016; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Smits-Engelsman B.C.M., 1994, ADV HANDWRITING DRAW, P187; SmitsEngelsman BCM, 1997, J EXP CHILD PSYCHOL, V67, P164, DOI 10.1006/jecp.1997.2400; St Clair-Thompson HL, 2006, Q J EXP PSYCHOL, V59, P745, DOI 10.1080/17470210500162854; Thomassen A. J, 1985, TIME MIND BEHAV, P253; Toglia J, 2013, AM J OCCUP THER, V67, P515, DOI 10.5014/ajot.2013.008482; VANGALEN GP, 1991, HUM MOVEMENT SCI, V10, P165, DOI 10.1016/0167-9457(91)90003-G; Volman MJM, 2006, AM J OCCUP THER, V60, P451, DOI 10.5014/ajot.60.4.451; Wray D., 2007, LITERACY, V41, P10, DOI DOI 10.1111/J.1467-9345.2007.00453.X; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891	57	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196098	10.1371/journal.pone.0196098	http://dx.doi.org/10.1371/journal.pone.0196098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7GN	29689111	Green Published, gold, Green Submitted			2022-12-26	WOS:000430678800026
J	Abu-Shaheen, A; Yousef, S; Riaz, M; Nofal, A; AlFayyad, I; Khan, S; Heena, H				Abu-Shaheen, Amani; Yousef, Shehu; Riaz, Muhammad; Nofal, Abdullah; AlFayyad, Isamme; Khan, Sarfaraz; Heena, Humariya			Testing the validity and reliability of the Arabic version of the pain DETECT questionnaire in the assessment of neuropathic pain	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; LOW-BACK-PAIN; PAINDETECT QUESTIONNAIRE; SCREENING QUESTIONNAIRE; LEEDS ASSESSMENT; GRADING SYSTEM; PREVALENCE; GUIDELINES; MECHANISMS; SYMPTOMS	Introduction Neuropathic pain (NP) can cause substantial suffering and, therefore, it must be diagnosed and treated promptly. Diagnosis of NP can be difficult and if made by an expert pain physician is considered the gold standard, however where expert help may not be easily available, screening tools for NP can be used. The painDETECT questionnaire (PD-Q) is a simple screening tool and has been widely used in several languages. We developed an Arabic version of PD-Q and tested its validity and reliability. Methods The original PD-Q was translated into the Arabic language by a team of experts. The translated version of the PD-Q was administered to the study population, which included patients having moderate to severe pain for at least three months. Reliability of the Arabic version was evaluated by an intra-class-correlation coefficient (ICC) between pre- and post-measures and Cronbach's alpha values. Validity was measured by receiver operating characteristic (ROC) curve. Expert pain physician diagnosis was considered as the gold standard for comparing the diagnostic accuracy. Results A total of 375 patients were included in the study, of which 153 (40.8%) patients were diagnosed with NP and 222 [59.2%] patients had nociceptive pain. The ICC between pre- and post-PD-Q scale total scores for the overall sample, NP group, and NocP group was 0.970 (95% CI, 0.964-0.976), 0.963 (95% CI, 0.949-0.973), and 0.962 (95% CI, 0.951-0.971), respectively. The Cronbach's a values for the post-assessment measures in the overall sample, NP group, and nociceptive pain group, were 0.764, 0.684, and 0.746, respectively. The area under the ROC curve was 0.775 (95% CI, 0.725-0.825) for the PD-Q total score. Conclusion The Arabic version of the PD-Q showed good reliability and validity in the detection of NP component in patients with chronic pain.	[Abu-Shaheen, Amani; AlFayyad, Isamme; Heena, Humariya] King Fahad Med City, Res Ctr, Riyadh, Saudi Arabia; [Yousef, Shehu; Khan, Sarfaraz] King Fahad Med City, Anesthesia Dept, Riyadh, Saudi Arabia; [Riaz, Muhammad] Univ Leicester, Ctr Med, Epidemiol Dept Hlth Sci, Leicester, Leics, England; [Nofal, Abdullah] King Saud Univ Med City, Riyadh, Saudi Arabia	King Fahad Medical City; King Fahad Medical City; University of Leicester; King Saud University	Abu-Shaheen, A (corresponding author), King Fahad Med City, Res Ctr, Riyadh, Saudi Arabia.	aabushaheen@kfmc.med.sa	/AAD-1563-2020; Riaz, Muhammad/AAA-5500-2021	Riaz, Muhammad/0000-0002-5512-1745; Alfayyad, Isamme/0000-0003-3326-5147	Intramural Research Fund at King Fahad Medical City (KFMC), Riyadh	Intramural Research Fund at King Fahad Medical City (KFMC), Riyadh	The work was supported by Intramural Research Fund at King Fahad Medical City (KFMC), Riyadh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shaheen A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192307; Alkan H, 2013, PAIN MED, V14, P1933, DOI 10.1111/pme.12222; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Baron R, 2010, LANCET NEUROL, V9, P807, DOI 10.1016/S1474-4422(10)70143-5; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Bennett MI, 2007, PAIN, V127, P199, DOI 10.1016/j.pain.2006.10.034; Cruccu G, 2010, EUR J NEUROL, V17, P1010, DOI 10.1111/j.1468-1331.2010.02969.x; De Andres J, 2012, CLIN J PAIN, V28, P243, DOI 10.1097/AJP.0b013e31822bb35b; DEBARROS GAM, 2016, REV DOR SAO PAULO S1, V17, pS15; El Sissi W, 2010, J INT MED RES, V38, P2135, DOI 10.1177/147323001003800629; Finnerup Nanna B, 2015, Lancet Neurol, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Finnerup NB, 2016, PAIN, V157, P1599, DOI 10.1097/j.pain.0000000000000492; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Freynhagen R, 2016, CURR MED RES OPIN, V32, P1033, DOI 10.1185/03007995.2016.1157460; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hallstrom H, 2011, PAIN, V152, P772, DOI 10.1016/j.pain.2010.11.019; Hassan AE, 2004, SAUDI MED J, V25, P1986; International Association for the Study of Pain (IASP), 2017, IASP TAX; Jahan Saulat, 2017, Int J Health Sci (Qassim), V11, P9; Jensen TS, 2011, PAIN, V152, P2204, DOI 10.1016/j.pain.2011.06.017; Jespersen A, 2010, CURR MED RES OPIN, V26, P2041, DOI 10.1185/03007995.2010.502748; Krause SJ, 2003, CLIN J PAIN, V19, P306, DOI 10.1097/00002508-200309000-00004; Matsubayashi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068013; McCarberg B, 2006, AM J MANAG CARE, V12, pS263; McDermott AM, 2006, EUR J PAIN, V10, P127, DOI 10.1016/j.ejpain.2005.01.014; Portenoy R, 2006, CURR MED RES OPIN, V22, P1555, DOI 10.1185/030079906X115702; Sung JK, 2017, PAIN PRACT, V17, P494, DOI 10.1111/papr.12472; Timmerman H, 2013, PAIN PRACT, V13, P206, DOI 10.1111/j.1533-2500.2012.00577.x; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0194358	10.1371/journal.pone.0194358	http://dx.doi.org/10.1371/journal.pone.0194358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684014	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000430660600004
J	Longobardo, LMP; Oliva-Moreno, J				Pena Longobardo, Luz Maria; Oliva-Moreno, Juan			Differences in labour participation between people living with HIV and the general population: Results from Spain along the business cycle	PLOS ONE			English	Article							PROPENSITY SCORE; HEALTH-STATUS; LONG-TERM; EMPLOYMENT; HIV/AIDS; MARKET; PREDICTORS; FRANCE; WORK	Background HIV/AIDS (Human immunodeficiency virus/Acquired immune deficiency syndrome) not only has a strong impact on the health of the worldwide population but also affects the labour status of HIV-positive people. The primary aim of this paper is to compare the labour participation of people living with HIV (PlwHIV) with the labour participation of the general population along the last business cycle in Spain. Method The data used are from the Hospital Survey on HIV-AIDS, with a total sample size of 4,651 PlwHIV and the Labour Force Survey from 2001 to 2010, with a total sample size of 660,674 individuals as general population. Propensity Score Matching method was used to analyse the differences between the labour participation of PlwHIV and the general population. Additionally, several specific models categorised into different subgroups (gender, education, source of infection and level of defences) were also performed. Results We identified a convergence in labour participation across the period in the two populations considered: PlwHIV was 23% less likely to have a job than the general population during 2001-2002 and 14% less likely during 2009-2010. This convergence is mainly explained by two facts: first, the positive evolution of people infected by sex; second, the change in the PlwHIV population composition with a decreasing weight of people infected by drug use throughout the decade. Thereby, at the end of period, there was no statistical difference in the employment rate between PlwHIV infected through sex and the general population but there was strongly difference in PlwHIV infected through drugs. Conclusion Inmunological status, source of infection and level of education play a relevant role among the PlwHIV population when comparing their labour participation with the general population. In spite of this positive result, the likelihood of being employed in HIV-positive people continues to be different from that of non-carriers. Our study shows that institutional features of labour markets are relevant and should be considered in comparison between countries.	[Pena Longobardo, Luz Maria; Oliva-Moreno, Juan] Univ Castilla La Mancha, Fac Law & Social Sci, Dept Econ Anal & Finance, Toledo, Spain	Universidad de Castilla-La Mancha	Longobardo, LMP (corresponding author), Univ Castilla La Mancha, Fac Law & Social Sci, Dept Econ Anal & Finance, Toledo, Spain.	luzmaria.pena@uclm.es	Oliva, Juan/A-1299-2011; Pena Longobardo, Luz Maria/K-6413-2017	Oliva, Juan/0000-0002-8997-0307; Pena Longobardo, Luz Maria/0000-0001-7224-2189	Spanish Ministry of Economy and Competitiveness [ECON2013-48217-C2-2-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was funded by the Spanish Ministry of Economy and Competitiveness under the "Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad, Plan Estatal de Investigacion Cientifica Tecnica y de Innovacion 2013-2016" programme. Research project reference: ECON2013-48217-C2-2-R (http://invesfeps.ulpgc.es/en ). The funder had no influence over the conducting of this study or the drafting of this manuscript.; This work was funded by the Spanish Ministry of Economy and Competitiveness under the "Programa Estatal de Investigacion, Desarrollo e Innovacion Orientada a los Retos de la Sociedad, Plan Estatal de Investigacion Cientifica Tecnica y de Innovacion 2013-2016" programme. Research project reference: ECON2013-48217-C2-2-R (http://invesfeps.ulpgces/en). The funder had no influence over the conducting of this study or the drafting of this manuscript. We also thank "Plan Nacional sobre el sida" and General Directorate of Public Health, Quality and Innovation-Ministry of Health, Social Services and Equality for facilitating the microdata of Hospital Survey on HIV/AIDS patients.	Annequin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165634; Annequin M, 2015, AIDS, V29, P1537, DOI 10.1097/QAD.0000000000000722; Auld MC, 2002, HEALTH ECON, V11, P471, DOI 10.1002/hec.753; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Ball L., 2004, 20185 NBER; Barlow P, 2015, J PUBLIC HEALTH POL, V36, P452, DOI 10.1057/jphp.2015.25; Bentolila S, 2017, SERIES-J SPAN ECON, V8, P1, DOI 10.1007/s13209-017-0155-z; BLANCHARD O, 1995, AM ECON REV, V85, P212; Cochran W, 1973, SANKHYA INDIAN J STA, V35, P416; Dehejia RH, 1999, J AM STAT ASSOC, V94, P1053, DOI 10.2307/2669919; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Dray-Spira R, 2003, AIDS CARE, V15, P739, DOI 10.1080/09540120310001618595; Dray-Spira R, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000255082.31728.52; Dray-Spira R, 2012, AIDS, V26, P207, DOI 10.1097/QAD.0b013e32834dcf61; Elzi L, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw022; Evans-Lacko S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069792; Fiori F, 2016, SOC SCI MED, V153, P90, DOI 10.1016/j.socscimed.2016.02.010; Fogarty AS, 2007, AIDS, V21, pS37, DOI 10.1097/01.aids.0000255083.69846.59; Galarraga O, 2010, HEALTH ECON, V19, P173, DOI 10.1002/hec.1458; Garcia-Gomez P, 2012, EMPLOYMENT WAGES PEO; Garcia-Gomez P, 2013, J HUM RESOUR, V48, P873; Goldman DP, 2004, HEALTH SERV RES, V39, P1691, DOI 10.1111/j.1475-6773.2004.00313.x; Gross M, 2016, INT J PUBLIC HEALTH, V61, P593, DOI 10.1007/s00038-015-0750-3; Heckman JJ, 1998, REV ECON STUD, V65, P261, DOI 10.1111/1467-937X.00044; Hornstein A., 2016, EC Q, V101, P125, DOI [10.21144/eq1010203, DOI 10.21144/EQ1010203]; International Labour Organization, 2005, ILO PROGR HIV AIDS W; Laaksonen E, 2009, J EPIDEMIOL COMMUNIT; LAURSEN E, 1995, SCAND J SOC MED, V23, P189, DOI 10.1177/140349489502300309; LEIGH JP, 1995, J ACQ IMMUN DEF SYND, V8, P392; MASSAGLI MP, 1994, AM J PUBLIC HEALTH, V84, P1976, DOI 10.2105/AJPH.84.12.1976; Oliva J, 2010, HEALTH ECON, V19, P491, DOI 10.1002/hec.1487; Rabkin JG, 2004, PSYCHOSOM MED, V66, P72, DOI 10.1097/01.PSY.0000108083.43147.6D; Rodger AJ, 2010, OCCUP MED-OXFORD, V60, P423, DOI 10.1093/occmed/kqq077; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; RUBIN DB, 1973, BIOMETRICS, V29, P185, DOI 10.2307/2529685; Rueda S, 2011, AIDS CARE, V23, P435, DOI 10.1080/09540121.2010.507952; Sanz-Rebollo Y, 9135 IZA; Sarti S, 2016, SOC SCI RES, V57, P116, DOI 10.1016/j.ssresearch.2015.12.010; Sendi P, 2007, SOC SCI MED, V64, P2355, DOI 10.1016/j.socscimed.2007.02.032; Spanish Ministry of Health and Social Services, 2013, GEN SECR AIDS PLAN H; Urbanos-Garrido RM, 2015, EUR J HEALTH ECON, V16, P175, DOI 10.1007/s10198-014-0563-y; Van Gorp WG, 2007, J INT NEUROPSYCH SOC, V13, P80, DOI 10.1017/S1355617707070117; Wagener MN, 2017, J OCCUP REHABIL; Worthington C, 2012, AIDS BEHAV, V16, P231, DOI 10.1007/s10461-011-9986-y; YELIN EH, 1991, AM J PUBLIC HEALTH, V81, P79, DOI 10.2105/AJPH.81.1.79	46	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195735	10.1371/journal.pone.0195735	http://dx.doi.org/10.1371/journal.pone.0195735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD7AK	29684076	gold, Green Published, Green Submitted			2022-12-26	WOS:000430660600022
J	You, C; Lin, DKJ; Young, SS				You, Cheng; Lin, Dennis K. J.; Young, S. Stanley			Time series smoother for effect detection	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; AIR-POLLUTION; REGRESSION; MORTALITY; SPLINES; HEALTH	In environmental epidemiology, it is often encountered that multiple time series data with a long-term trend, including seasonality, cannot be fully adjusted by the observed covariates. The long-term trend is difficult to separate from abnormal short-term signals of interest. This paper addresses how to estimate the long-term trend in order to recover short-term signals. Our case study demonstrates that the current spline smoothing methods can result in significant positive and negative cross-correlations from the same dataset, depending on how the smoothing parameters are chosen. To circumvent this dilemma, three classes of time series smoothers are proposed to detrend time series data. These smoothers do not require fine tuning of parameters and can be applied to recover short-term signals. The properties of these smoothers are shown with both a case study using a factorial design and a simulation study using datasets generated from the original dataset. General guidelines are provided on how to discover short-term signals from time series with a long-term trend. The benefit of this research is that a problem is identified and characteristics of possible solutions are determined.	[You, Cheng; Lin, Dennis K. J.] Penn State Univ, Dept Stat, State Coll, PA 16801 USA; [Young, S. Stanley] CGStat LLC, Raleigh, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	You, C (corresponding author), Penn State Univ, Dept Stat, State Coll, PA 16801 USA.	czy112@psu.edu			American Petroleum Institute	American Petroleum Institute	S. Stanley Young is the owner of CGStat, a one-person limited liability company, and is partially funded by the American Petroleum Institute. There are no patents, products in development, or marketed products to declare. Cheng You and Dennis K.J. Lin are unfunded for this research. The authors are responsible for all aspects of this study: study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Carracedo-Martinez E, 2010, ENVIRON HEALTH PERSP, V118, P1173, DOI 10.1289/ehp.0901485; Cleveland R.B., 1990, J OFF STAT, V6, P3; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; Douglas S, 1999, CHRONOBIOL INT, V16, P199, DOI 10.3109/07420529909019086; Duarte BPM, 2003, IND ENG CHEM RES, V42, P99, DOI 10.1021/ie0107744; Fang X, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011487; Hastie T.J., 1990, MONOGRAPHS STAT APPL, V43; Lopiano KK, 2015, ARXIV150203062; Marra G, 2010, STAT METHODS MED RES, V19, P107, DOI 10.1177/0962280208096688; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Ramsay TO, 2003, EPIDEMIOLOGY, V14, P18, DOI 10.1097/00001648-200301000-00009; SCHWARTZ J, 1994, CAN J STAT, V22, P471, DOI 10.2307/3315405; Schwartz J, 1999, EPIDEMIOLOGY, V10, P17, DOI 10.1097/00001648-199901000-00005; Schwartz J., 2003, MORBIDITY MORTALITY, V20, P25; Terzi Y, 2009, SCI RES ESSAYS, V4, P867; Touloumi G, 2004, ENVIRONMETRICS, V15, P101, DOI 10.1002/env.623; von Klot S, 2005, CIRCULATION, V112, P3073, DOI 10.1161/CIRCULATIONAHA.105.548743; Wood SN, 2015, J R STAT SOC C-APPL, V64, P139, DOI 10.1111/rssc.12068	20	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195360	10.1371/journal.pone.0195360	http://dx.doi.org/10.1371/journal.pone.0195360			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684033	gold, Green Submitted, Green Published			2022-12-26	WOS:000430660600013
J	Asen, AK; Goebel, L; Rey-Rico, A; Sohier, J; Zurakowski, D; Cucchiarini, M; Madry, H				Asen, Ann-Kathrin; Goebel, Lars; Rey-Rico, Ana; Sohier, Jerome; Zurakowski, David; Cucchiarini, Magali; Madry, Henning			Sustained spatiotemporal release of TGF-1 confers enhanced very early chondrogenic differentiation during osteochondral repair in specific topographic patterns	FASEB JOURNAL			English	Article						cartilage defect; large animal model; cartilage repair; scaffold	ARTICULAR-CARTILAGE REPAIR; TRANSFORMING GROWTH FACTOR-BETA(1); MESENCHYMAL STEM-CELLS; FULL-THICKNESS DEFECTS; IN-VIVO; SUBCHONDRAL BONE; ENCAPSULATED CHONDROCYTES; PROGENITOR CELLS; MODEL; TISSUE	The continuous presence of TGF- is critically important to induce effective chondrogenesis. To investigate chondrogenesis in a cartilage defect, we tested the hypothesis that the implantation of TGF-1-releasing scaffolds improves very early cartilage repair in vivo. Spatiotemporal controlled release of TGF-1 was achieved from multiblock scaffolds that were implanted in osteochondral defects in the medial femoral condyles of adult minipigs. We observed a sustained presence of TGF-1 at 4 wk in vivo, which significantly promoted structural aspects of early overall cartilage repair, especially cellularity, cellular morphology, and safranin O staining intensity. Furthermore, early aggrecan and type II collagen production were both increased in specific topographic patterns in cartilaginous repair tissue. Sustained release of TGF-1 also increased cell numbers and proliferation, staining intensities for the stem cell surface marker, CD105, and number of stromal cell-derived factor-1 (SDF-1) -positive cells within cartilaginous repair tissue. These data identify a mechanism by which TGF-1 modulates early chondrogenesis by primarily increasing the number of progenitor cells arising from the subchondral bone marrow compartment via the SDF-1/chemokine (CXC motif) receptor 4 pathway, their proliferation, differentiation, and extracellular matrix deposition in specific topographic patterns, highlighting the pivotal role played by TGF-1 during this crucial phase.Asen, A.-K., Goebel, L., Rey-Rico, A., Sohier, J., Zurakowski, D., Cucchiarini, M., Madry, H. Sustained spatiotemporal release of TGF-1 confers enhanced very early chondrogenic differentiation during osteochondral repair in specific topographic patterns.	[Asen, Ann-Kathrin; Goebel, Lars; Rey-Rico, Ana; Cucchiarini, Magali; Madry, Henning] Saarland Univ, Med Ctr, Ctr Expt Orthopaed, Homburg, Germany; [Goebel, Lars; Madry, Henning] Saarland Univ, Med Ctr, Dept Orthopaed Surg, Homburg, Germany; [Sohier, Jerome] CNRS, Inst Biol & Chem Prot, Lyon, France; [Zurakowski, David] Harvard Med Sch, Childrens Hosp Boston, Dept Anesthesia, Boston, MA USA; [Zurakowski, David] Harvard Med Sch, Childrens Hosp Boston, Dept Surg, Boston, MA USA	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Centre National de la Recherche Scientifique (CNRS); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Madry, H (corresponding author), Univ Saarland, Gebaude 37,Kirrberger Str 1,Bldg 37-38, D-66421 Homburg, Germany.	henning.madry@uks.eu	Goebel, Lars/AAF-3497-2020; Rico, Ana Rey/K-5951-2014; sohier, jerome/O-1923-2017; Rey-Rico, Ana/AAK-9298-2021; Madry, Henning/AAP-7115-2020	Goebel, Lars/0000-0002-9907-264X; Rico, Ana Rey/0000-0003-1682-498X; sohier, jerome/0000-0002-2696-5754; Rey-Rico, Ana/0000-0003-1682-498X; 	Center of Experimental Orthopaedics, Saarland University Medical Center	Center of Experimental Orthopaedics, Saarland University Medical Center	The authors thank Dr. Lorenzo Moroni (Maastricht University, Maastricht, The Netherlands) for helpful discussions. This research was funded by the Center of Experimental Orthopaedics, Saarland University Medical Center. The study sponsor was not involved in the study design, data collection, or analysis or in the writing of the manuscript. Furthermore, receiving funding did not affect the decision to submit the manuscript for publication. The data sets generated and/or analyzed during the current study are available from the corresponding researcher on reasonable request. The authors declare no conflicts of interest.	Alegre-Aguaron E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088053; Alliston T, 2014, CURR OSTEOPOROS REP, V12, P366, DOI 10.1007/s11914-014-0213-4; Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805; Barron V, 2015, ANN BIOMED ENG, V43, P2069, DOI 10.1007/s10439-015-1246-2; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bartha Lajos, 2013, Eur J Orthop Surg Traumatol, V23, P81, DOI 10.1007/s00590-011-0907-6; Bian LM, 2011, BIOMATERIALS, V32, P6425, DOI 10.1016/j.biomaterials.2011.05.033; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Chen MJ, 2018, J THEOR BIOL, V439, P1, DOI 10.1016/j.jtbi.2017.11.024; Chen PF, 2015, BIOMATERIALS, V39, P114, DOI 10.1016/j.biomaterials.2014.10.049; CRITCHLOW MA, 1995, BONE, V16, P521, DOI 10.1016/8756-3282(95)00085-R; Cucchiarini M, 2014, GENE THER, V21, P811, DOI 10.1038/gt.2014.58; Fan HB, 2010, J BIOMED MATER RES A, V95A, P982, DOI 10.1002/jbm.a.32899; Ferguson CM, 2004, J ORTHOP RES, V22, P687, DOI 10.1016/j.orthres.2003.10.023; Fisher MB, 2016, CARTILAGE, V7, P174, DOI 10.1177/1947603515623030; Gao L, 2019, AM J SPORT MED, V47, P222, DOI 10.1177/0363546517740575; Gao L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45189; Goebel L, 2012, OSTEOARTHR CARTILAGE, V20, P1046, DOI 10.1016/j.joca.2012.05.010; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Guermazi A, 2017, ARTHRITIS RHEUMATOL, V69, P560, DOI 10.1002/art.39970; HAYAMIZU TF, 1991, DEV BIOL, V145, P164, DOI 10.1016/0012-1606(91)90222-O; Hunziker EB, 1996, J BONE JOINT SURG AM, V78A, P721, DOI 10.2106/00004623-199605000-00012; Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS171; Kaul G, 2006, J GENE MED, V8, P100, DOI 10.1002/jgm.819; Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8; Lee CH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009696; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Madry H, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/1609685; Madry H, 2014, TISSUE ENG PART B-RE, V20, P106, DOI [10.1089/ten.teb.2013.0271, 10.1089/ten.TEB.2013.0271]; Madry H, 2012, KNEE SURG SPORT TR A, V20, P407, DOI 10.1007/s00167-011-1705-8; Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z; Mao JJ, 2005, BIOL CELL, V97, P289, DOI 10.1042/BC20040100; Maruki H, 2017, J BIOMED MATER RES B, V105, P2592, DOI 10.1002/jbm.b.33792; MEACHIM G, 1971, J ANAT, V109, P317; Mello MA, 2006, J ORTHOP RES, V24, P2095, DOI 10.1002/jor.20233; Mendelson A, 2011, FASEB J, V25, P3496, DOI 10.1096/fj.10-176305; Nakamura N, 2009, ARTHROSCOPY, V25, P531, DOI 10.1016/j.arthro.2009.02.007; Orth P, 2013, OSTEOARTHR CARTILAGE, V21, P614, DOI 10.1016/j.joca.2013.01.008; Orth P, 2015, PROG HISTOCHEM CYTO, V50, P19, DOI 10.1016/j.proghi.2015.10.001; Orth P, 2013, TISSUE ENG PART C-ME, V19, P885, DOI [10.1089/ten.tec.2012.0699, 10.1089/ten.TEC.2012.0699]; Orth P, 2012, AM J SPORT MED, V40, P828, DOI 10.1177/0363546511430376; Rey-Rico A, 2015, J BIOMED MATER RES A, V103, P371, DOI 10.1002/jbm.a.35181; Ripamonti U, 1996, J BONE MINER RES, V11, P938; Schmitz N, 2010, OSTEOARTHR CARTILAGE, V18, pS113, DOI 10.1016/j.joca.2010.05.026; Sellers RS, 1997, J BONE JOINT SURG AM, V79A, P1452, DOI 10.2106/00004623-199710000-00002; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009; Sohier J, 2007, INT J PHARMACEUT, V332, P80, DOI 10.1016/j.ijpharm.2006.09.037; Sohier J, 2003, EUR J PHARM BIOPHARM, V55, P221, DOI 10.1016/S0939-6411(02)00161-3; Sridhar BV, 2014, J BIOMED MATER RES A, V102, P4464, DOI 10.1002/jbm.a.35115; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tuan RS, 2013, J AM ACAD ORTHOP SUR, V21, P303, DOI 10.5435/JAAOS-21-05-303; Ulrich-Vinther M, 2005, Eur Cell Mater, V10, P40; Vagima Y, 2011, METHODS MOL BIOL, V750, P277, DOI 10.1007/978-1-61779-145-1_19; Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018; Wang WG, 2014, BIRTH DEFECTS RES C, V102, P37, DOI 10.1002/bdrc.21058; Ying BB, 2013, BRIT J ORAL MAX SURG, V51, P241, DOI 10.1016/j.bjoms.2012.05.014; Yu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1274, DOI 10.1002/art.39049; Zhou TF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11322-w; Zhu YH, 2015, MOL MED REP, V12, P5573, DOI 10.3892/mmr.2015.4068	61	15	17	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5298	5311		10.1096/fj.201800105R	http://dx.doi.org/10.1096/fj.201800105R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688810	Bronze			2022-12-26	WOS:000447972500009
J	Puentes-Cala, E; Liebeke, M; Markert, S; Harder, J				Puentes-Cala, Edinson; Liebeke, Manuel; Markert, Stephanie; Harder, Jens			Limonene dehydrogenase hydroxylates the allylic methyl group of cyclic monoterpenes in the anaerobic terpene degradation by Castellaniella defragrans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin; dehydrogenase; enzyme; terpenoid; nicotinamide adenine dinucleotide (NAD); anaerobic; biodegradation; ferredoxin; limonene; monoterpene	DENITRIFYING ALCALIGENES-DEFRAGRANS; SACCHAROMYCES-CEREVISIAE; PHYTOENE DESATURASE; BIOSYNTHESIS; PROTEIN; FAD; METABOLISM; ABSORPTION; ACTIVATION; EXPRESSION	The enzymatic functionalization of hydrocarbons is a central step in the global carbon cycle initiating the mineralization of methane, isoprenes, and monoterpenes, the most abundant biologically produced hydrocarbons. Also, terpene-modifying enzymes have found many applications in the energy-economic biotechnological production of fine chemicals. Here, we describe a limonene dehydrogenase that was purified from the facultatively anaerobic betaproteobacterium Castellaniella defragrans 65Phen grown on monoterpenes under denitrifying conditions in the absence of molecular oxygen. The purified limonene:ferrocenium oxidoreductase activity hydroxylated the methyl group of limonene (1-methyl-4-(1-methylethenyl)-cyclohex-1-ene) yielding perillyl alcohol ([4-(prop-1-en-2-yl)cyclohex-1-en-1-yl]methanol). The enzyme had a DTT:perillyl alcohol oxidoreductase activity yielding limonene. Mass spectrometry and molecular size determinations revealed a heterodimeric enzyme comprising CtmA and CtmB. Recently, the two proteins had been identified by transposon mutagenesis and proteomics as part of the cyclic terpene metabolism (ctm) in C. defragrans and are annotated as FAD-dependent oxidoreductases of the protein domain family phytoene dehydrogenases and related proteins (COG1233). CtmAB is the first heterodimeric enzyme in this protein superfamily. Flavins in the purified CtmAB are oxidized by ferrocenium and are reduced by limonene. Heterologous expression of CtmA, CtmB, and CtmAB in Escherichia coli demonstrated that limonene dehydrogenase activity required both subunits, each carrying a flavin cofactor. Native CtmAB oxidized a wide range of monocyclic monoterpenes containing the allylic methyl group motif (1-methyl-cyclohex-1-ene). In conclusion, we have identified CtmAB as a hydroxylating limonene dehydrogenase and the first heteromer in a family of FAD-dependent dehydrogenases acting on allylic methylene or methyl CH-bonds. We suggest placing in Enzyme Nomenclature as new entry EC 1.17.99.8.	[Puentes-Cala, Edinson; Harder, Jens] Max Planck Inst Marine Microbiol, Dept Microbiol, Celsiusstr 1, D-28359 Bremen, Germany; [Liebeke, Manuel] Max Planck Inst Marine Microbiol, Dept Symbiosis, Celsiusstr 1, D-28359 Bremen, Germany; [Markert, Stephanie] Ernst Moritz Arndt Univ Greifswald, Pharmaceut Biotechnol, Felix Hausdorff Str, D-17489 Greifswald, Germany	Max Planck Society; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald	Harder, J (corresponding author), Max Planck Inst Marine Microbiol, Dept Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	jharder@mpi-bremen.de	Markert, Stephanie/AAL-5591-2021; Liebeke, Manuel/F-3559-2012	Markert, Stephanie/0000-0003-0923-3305; Puentes Cala, Edinson Andres/0000-0003-0587-2177; Liebeke, Manuel/0000-0002-2339-1409	Max Planck Society; DAAD in Germany; Corporacion para la Investigacion de la Corrosion in Colombia; COLCIENCIAS in Colombia	Max Planck Society(Max Planck SocietyFoundation CELLEX); DAAD in Germany(Deutscher Akademischer Austausch Dienst (DAAD)); Corporacion para la Investigacion de la Corrosion in Colombia; COLCIENCIAS in Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported in part by the Max Planck Society. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a grant from the DAAD in Germany and from the Corporacion para la Investigacion de la Corrosion and COLCIENCIAS in Colombia.	Ahn JW, 2015, ENZYME MICROB TECH, V77, P29, DOI 10.1016/j.enzmictec.2015.05.005; AlBabili S, 1996, PLANT J, V9, P601, DOI 10.1046/j.1365-313X.1996.9050601.x; Aliverti A, 1999, METH MOL B, V131, P9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boll M., 2010, HDB HYDROCARBON LIPI, P1011, DOI DOI 10.1007/978-3-540-77587-4_71; Boronat A, 2015, ADV BIOCHEM ENG BIOT, V148, P3, DOI 10.1007/10_2014_285; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitenbach J, 2013, ARCH BIOCHEM BIOPHYS, V529, P86, DOI 10.1016/j.abb.2012.11.003; Brennan TCR, 2013, APPL ENVIRON MICROB, V79, P3590, DOI 10.1128/AEM.00463-13; Cheong TK, 2000, APPL BIOCHEM BIOTECH, V84-6, P903, DOI 10.1385/ABAB:84-86:1-9:903; Chiang YR, 2007, J BIOL CHEM, V282, P13240, DOI 10.1074/jbc.M610963200; Cornelissen S, 2013, BIOTECHNOL BIOENG, V110, P1282, DOI 10.1002/bit.24801; Costas AMG, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00440-17; Cunane LM, 2005, BIOCHEMISTRY-US, V44, P2963, DOI 10.1021/bi048020r; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Demmer JK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01746-3; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Erman W.F, 1985, CHEM MONOTERPENES EN; Gemmecker S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131717; Heider J, 2016, J MOL MICROB BIOTECH, V26, P45, DOI 10.1159/000441357; Heyen U, 2000, APPL ENVIRON MICROB, V66, P3004, DOI 10.1128/AEM.66.7.3004-3009.2000; Heyen U, 1998, FEMS MICROBIOL LETT, V169, P67, DOI 10.1111/j.1574-6968.1998.tb13300.x; Holstein SA, 2004, LIPIDS, V39, P293, DOI 10.1007/s11745-004-1233-3; Jevsevar S, 2005, BIOTECHNOL PROGR, V21, P632, DOI 10.1021/bp0497839; Jongedijk E, 2015, YEAST, V32, P159, DOI 10.1002/yea.3038; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Koziol J., 1971, FLUOROMETRIC ANAL RI, P253; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHMAN TC, 1990, BIOCHEMISTRY-US, V29, P10594, DOI 10.1021/bi00499a004; Marostica MR, 2007, QUIM NOVA, V30, P382, DOI 10.1590/S0100-40422007000200027; MULLER F, 1972, EUR J BIOCHEM, V25, P573, DOI 10.1111/j.1432-1033.1972.tb01730.x; Petasch J, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-164; Sakai M, 1996, J MOL STRUCT, V379, P9, DOI 10.1016/0022-2860(95)09176-9; Sandmann G, 2009, ARCH BIOCHEM BIOPHYS, V483, P169, DOI 10.1016/j.abb.2008.10.004; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Schmidt-Dannert C, 2015, ADV BIOCHEM ENG BIOT, V148, P19, DOI 10.1007/10_2014_283; Schwab W, 2013, EUR J LIPID SCI TECH, V115, P3, DOI 10.1002/ejlt.201200157; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh A, 2014, ANALYST, V139, P5747, DOI 10.1039/c4an01325e; Steiger S, 2015, MICROBIOL-SGM, V161, P194, DOI 10.1099/mic.0.083519-0; Strijkstra A, 2014, APPL ENVIRON MICROB, V80, P7592, DOI 10.1128/AEM.02385-14; Tao L, 2005, APPL ENVIRON MICROB, V71, P3294, DOI 10.1128/AEM.71.6.3294-3301.2005; Tholl D, 2015, ADV BIOCHEM ENG BIOT, V148, P63, DOI 10.1007/10_2014_295; van Beilen JB, 2005, APPL ENVIRON MICROB, V71, P1737, DOI 10.1128/AEM.71.4.1737-1744.2005; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093; Zhang ZJ, 2014, FOOD CHEM, V150, P307, DOI 10.1016/j.foodchem.2013.10.160	49	9	9	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9520	9529		10.1074/jbc.RA117.001557	http://dx.doi.org/10.1074/jbc.RA117.001557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29716998	Green Published, hybrid			2022-12-26	WOS:000435441400034
J	Dalal, S; Connelly, B; Singh, M; Singh, K				Dalal, Suman; Connelly, Barbara; Singh, Mahipal; Singh, Krishna			NF2 signaling pathway plays a pro-apoptotic role in beta-adrenergic receptor stimulated cardiac myocyte apoptosis	PLOS ONE			English	Article							RAT VENTRICULAR MYOCYTES; HIPPO PATHWAY; HEART-FAILURE; CELL; PHOSPHORYLATION; MITOCHONDRIA; KINASE; MERLIN; ACTIVATION; INSIGHTS	beta-adrenergic receptor (beta-AR) stimulation induces cardiac myocyte apoptosis in vitro and in vivo. Neurofibromin 2 (NF2) is a member of the ezrin/radixin/moesin (ERM) family of proteins. Post-translational modifications such as phosphorylation and sumoylation affect NF2 activity, subcellular localization and function. Here, we tested the hypothesis that beta-AR stimulation induces post-translational modifications of NF2, and NF2 plays a pro-apoptotic role in beta-AR-stimulated myocyte apoptosis. Methods and results Treatment of adult rat ventricular myocytes (ARVMs) with beta-AR agonist (isoproterenol) for 15 min increased phosphorylation (serine-518) and sumoylation of NF2. Co-immunoprecipitation assay confirmed beta-AR-stimulated sumoylation of NF2. beta-AR stimulation enhanced nuclear translocation of phosphorylated and sumoylated NF2. Specific inhibition of beta(1)-AR and protein kinase A (PKA) decreased beta-AR-stimulated increase in NF2 post-translational modifications, while inhibition of beta(2)-AR had no effect. Activation of adenylyl cyclase using forskolin (FSK) mimicked the effects of beta-AR stimulation. beta-AR stimulation and expression of wild-type (WT)-NF2 using adenoviruses increased phosphorylation of mammalian sterile like kinase-1/2 (MST1/2) and yes activated protein (YAP), downstream targets of NF2. Knockdown of NF2 using siRNA in H9C2 cardiomyocytes decreased beta-AR-stimulated increase in NF2 and YAP phosphorylation. siRNA-mediated knockdown of NF2 decreased beta-AR-stimulated increase in apoptosis, while expression of WT-NF2 induced apoptosis in ARVMs. Expression of WT-NF2 stimulated the mitochondrial death pathway as evidenced by activation of c-Jun N-terminal Kinases (JNKs), and increase in cytosolic cytochrome c levels and Bax expression. Conclusion beta-AR stimulation affects post-translational modifications of NF2 via the involvement beta(1)-AR/PKA/cAMP pathway, and NF2 plays a pro-apoptotic role in beta-AR-stimulated myocyte apoptosis via the phosphorylation (inactivation) of YAP and involvement of mitochondrial death pathway.	[Dalal, Suman; Connelly, Barbara; Singh, Mahipal; Singh, Krishna] East Tennessee State Univ, James H Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Singh, Krishna] East Tennessee State Univ, Ctr Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA; [Singh, Krishna] James H Quillen Vet Affairs Med Ctr, Mountain Home, TN 37604 USA	East Tennessee State University; East Tennessee State University	Singh, K (corresponding author), East Tennessee State Univ, James H Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.; Singh, K (corresponding author), East Tennessee State Univ, Ctr Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA.; Singh, K (corresponding author), James H Quillen Vet Affairs Med Ctr, Mountain Home, TN 37604 USA.	singhk@etsu.edu		Connelly, Barbara/0000-0002-1635-9478; Singh, Krishna/0000-0003-0399-2191	Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development [BX002332, BX000640]; National Institutes of Health [R15HL129140]; Institutional Research and Improvement account;  [C06RR0306551]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL129140] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002332, I01BX000640] Funding Source: NIH RePORTER	Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Research and Improvement account; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Merit Review awards (BX002332 and BX000640) from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development, National Institutes of Health (R15HL129140), and funds from Institutional Research and Improvement account (to KS) and C06RR0306551.	Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Chen L, 2010, MINERVA CARDIOANGIOL, V58, P213; CLAYCOMB WC, 1980, DEV BIOL, V80, P466, DOI 10.1016/0012-1606(80)90419-4; Colucci WS, 2000, J CARD FAIL, V6, P1; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Cooper J, 2014, FEBS LETT, V588, P2743, DOI 10.1016/j.febslet.2014.04.001; Dalal S, 2014, AM J PHYSIOL-HEART C, V306, pH1182, DOI 10.1152/ajpheart.00954.2013; Dalal S, 2012, MOL CELL BIOCHEM, V364, P59, DOI 10.1007/s11010-011-1205-7; Felley-Bosco E, 2014, TRANSL LUNG CANCER R, V3, P75, DOI 10.3978/j.issn.2218-6751.2014.02.03; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Guo L, 2012, J NEUROSCI, V32, P17251, DOI 10.1523/JNEUROSCI.2461-12.2012; Gutmann DH, 2002, NEOPLASIA, V4, P279, DOI 10.1038/sj.neo.7900249; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; He MJ, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0013-6; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Hilton BA, 2015, MOL CELL, V60, P35, DOI 10.1016/j.molcel.2015.08.008; Iwai-Kanai E, 1999, CIRCULATION, V100, P305, DOI 10.1161/01.CIR.100.3.305; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Ji Xinyan, 2017, Yichuan, V39, P546, DOI 10.16288/j.yczz.17-094; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; Krishnamurthy P, 2007, HYPERTENSION, V49, P865, DOI 10.1161/01.HYP.0000258703.36986.13; Laulajainen M, 2008, ONCOGENE, V27, P3233, DOI 10.1038/sj.onc.1210988; Li W, 2014, CANCER CELL, V26, P48, DOI 10.1016/j.ccr.2014.05.001; Lu JR, 2008, LARYNGOSCOPE, V118, P169, DOI 10.1097/MLG.0b013e3181566594; Matsuda T, 2016, CIRC RES, V119, P596, DOI 10.1161/CIRCRESAHA.116.308586; Menon B, 2006, AM J PHYSIOL-CELL PH, V290, pC254, DOI 10.1152/ajpcell.00235.2005; Menon B, 2007, J MOL CELL CARDIOL, V42, P653, DOI 10.1016/j.yjmcc.2006.12.011; Mia MM, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.85; Moon S, 2017, EMBO REP, V18, P61, DOI 10.15252/embr.201642683; Nadal-Ginard B, 2003, J CLIN INVEST, V111, P1457, DOI 10.1172/JCI200318611; Qi Q, 2014, ONCOGENE, V33, P4893, DOI 10.1038/onc.2013.438; Remondino A, 2003, CIRC RES, V92, P136, DOI 10.1161/01.RES.0000054624.03539.B4; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; Rosca MG, 2013, J MOL CELL CARDIOL, V55, P31, DOI 10.1016/j.yjmcc.2012.09.002; Schulman Howard, 2010, Drug Discov Today Dis Mech, V7, pe117, DOI 10.1016/j.ddmec.2010.07.005; Shizukuda Y, 1998, AM J PHYSIOL-HEART C, V275, pH961, DOI 10.1152/ajpheart.1998.275.3.H961; Shizukuda Y, 2002, J MOL CELL CARDIOL, V34, P823, DOI 10.1006/jmcc.2002.2020; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; Singh M, 2010, CARDIOVASC RES, V86, P20, DOI 10.1093/cvr/cvp402; SPERELAKIS N, 1994, MOL CELL BIOCHEM, V140, P103, DOI 10.1007/BF00926749; Sucharov CC, 2011, J CARD FAIL, V17, P592, DOI 10.1016/j.cardfail.2011.03.006; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Zaugg M, 2000, CIRCULATION, V102, P344; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	48	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196626	10.1371/journal.pone.0196626	http://dx.doi.org/10.1371/journal.pone.0196626			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709009	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100044
J	Gholampour, S				Gholampour, Seifollah			FSI simulation of CSF hydrodynamic changes in a large population of non-communicating hydrocephalus patients during treatment process with regard to their clinical symptoms	PLOS ONE			English	Article							ENDOSCOPIC 3RD VENTRICULOSTOMY; CEREBROSPINAL-FLUID FLOW; INTRACRANIAL-PRESSURE; MECHANICAL-BEHAVIOR; DYNAMICS; SHUNTS; VOLUME	3D fluid-structure interaction modelling was utilized for simulation of 13 normal subjects, 11 non-communicating hydrocephalus (NCH) patients at pre-treatment phase, and 3 patients at five post-treatment phases. Evaluation of ventricles volume and maximum CSF pressure (before shunting) following results validation indicated that these parameters were the most proper hydrodynamic indices and the NCH type doesn't have any significant effect on changes in two indices. The results confirmed an appropriate correlation between these indices although the correlation decreased slightly after the occurrence of disease. NCH raises the intensity of vortex and pulsatility (2.4 times) of CSF flow while the flow remains laminar. On day 18 after shunting, the CSF pressure decreased 81.0% and all clinical symptoms of patients vanished except for headache. Continuing this investigation during the treatment process showed that maximum CSF pressure is the most sensitive parameter to patients' clinical symptoms. Maximum CSF pressure has decreased proportional to the level of decrease in clinical symptoms and has returned close to the pressure range in normal subjects faster than other parameters and simultaneous with disappearance of patients' clinical symptoms (from day 81 after shunting). However, phase lag between flow rate and pressure gradient functions and the degree of CSF pulsatility haven't returned to normal subjects' conditions even 981 days after shunting and NCH has also caused a permanent volume change (of 20.1%) in ventricles. Therefore, patients have experienced a new healthy state in new hydrodynamic conditions after shunting and healing. Increase in patients' intracranial compliance was predicted with a more accurate non-invasive method than previous experimental methods up to more than 981 days after shunting. The changes in hydrodynamic parameters along with clinical reports of patients can help to gain more insight into the pathophysiology of NCH patients.	[Gholampour, Seifollah] Islamic Azad Univ, Dept Biomed Engn, Tehran North Branch, Tehran, Iran	Islamic Azad University	Gholampour, S (corresponding author), Islamic Azad Univ, Dept Biomed Engn, Tehran North Branch, Tehran, Iran.	s.gholampour@iau-tnb.ac.r		Gholampour, Seifollah/0000-0002-4924-4239				Baledent O, 2001, INVEST RADIOL, V36, P368, DOI 10.1097/00004424-200107000-00003; Battal B, 2011, BRIT J RADIOL, V84, P758, DOI 10.1259/bjr/66206791; Cheng S, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001025; Chiastra C, 2014, J MECH BEHAV BIOMED, V34, P217, DOI 10.1016/j.jmbbm.2014.02.009; Cinalli G, 2012, PEDIAT HYDROCEPHALUS; Dewan MC, 2017, J NEUROSURG-PEDIATR, V19, P578, DOI 10.3171/2017.1.PEDS16536; Dutta-Roy T, 2008, J BIOMECH, V41, P2263, DOI 10.1016/j.jbiomech.2008.04.014; Edsbagge M, 2004, AM J PHYSIOL-REG I, V287, pR1450, DOI 10.1152/ajpregu.00215.2004; Eide PK, 2010, ACTA NEUROL SCAND, V122, P262, DOI 10.1111/j.1600-0404.2009.01304.x; Eide PK, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-5; Eide PK, 2016, J NEUROSURG, V125, P1493, DOI 10.3171/2015.11.JNS151529; Eide PK, 2016, CLIN NEUROL NEUROSUR, V149, P33, DOI 10.1016/j.clineuro.2016.07.024; Farahmand D, 2015, J NEUROL NEUROSUR PS, V86, P222, DOI 10.1136/jnnp-2014-307873; Fin Loic, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P163, DOI 10.1080/1025584031000097933; Gholampour S., 2014, INT CLIN NEUROSCI J, V1, P1, DOI [10.22037/icnj.v1i1.6536, DOI 10.22037/ICNJ.V1I1.6536]; Gholampour S, 2017, J CLIN NEUROSCI, V35, P50, DOI 10.1016/j.jocn.2016.09.012; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kurtcuoglu V, 2005, J BIOMECH ENG-T ASME, V127, P264, DOI 10.1115/1.1865191; Kurtcuoglu V, 2007, J BIOMECH, V40, P1235, DOI 10.1016/j.jbiomech.2006.05.031; Lawley JS, 2016, J APPL PHYSIOL, V120, P251, DOI 10.1152/japplphysiol.00370.2015; Linninger A, 2013, ENG SCI FUNDAMENTALS, V1, P130; Linninger AA, 2007, IEEE T BIO-MED ENG, V54, P291, DOI 10.1109/TBME.2006.886853; Linninger AA, 2009, ANN BIOMED ENG, V37, P1434, DOI 10.1007/s10439-009-9691-4; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; MALM J, 1995, J NEUROL NEUROSUR PS, V58, P715, DOI 10.1136/jnnp.58.6.715; Mathias T, 2016, OCHSNER J, V16, P136; Oreskovic D, 2016, PHYSIOL REV, V96, P1661, DOI 10.1152/physrev.00021.2016; Peladeau-Pigeon M, 2013, PHYS MED BIOL, V58, P6111, DOI 10.1088/0031-9155/58/17/6111; Pople IK, 2002, J NEUROL NEUROSUR PS, V73, pI17; Rasul FT, 2013, ACTA NEUROCHIR, V155, P883, DOI 10.1007/s00701-013-1657-5; Saehle T, 2015, J NEUROL SCI, V350, P33, DOI 10.1016/j.jns.2015.02.003; Stephensen H, 2005, J NEUROL NEUROSUR PS, V76, P965, DOI 10.1136/jnnp.2004.039834; Stone SSD, 2014, J NEUROSURG-PEDIATR, V14, P439, DOI 10.3171/2014.7.PEDS14152; Sweetman B, 2011, COMPUT BIOL MED, V41, P67, DOI 10.1016/j.compbiomed.2010.12.001; Tangen K, 2017, J CEREBR BLOOD F MET, V37, P128; Tangen KM, 2017, ANESTH ANALG, V124, P1686, DOI 10.1213/ANE.0000000000002011; Tangen KM, 2015, J BIOMECH, V48, P2144, DOI 10.1016/j.jbiomech.2015.02.018; Tavner ACR, 2016, J MECH BEHAV BIOMED, V61, P511, DOI 10.1016/j.jmbbm.2016.04.010; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Vardakis JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084577; WOMERSLEY JR, 1957, PHYS MED BIOL, V2, P178, DOI 10.1088/0031-9155/2/2/305; YASHON D, 1966, NATURE, V212, P709, DOI 10.1038/212709a0; Zhang H, 2003, COMPUT STRUCT, V81, P1071, DOI 10.1016/S0045-7949(03)00009-9; Zhu DC, 2006, J MAGN RESON IMAGING, V24, P756, DOI 10.1002/jmri.20679	47	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196216	10.1371/journal.pone.0196216	http://dx.doi.org/10.1371/journal.pone.0196216			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708982	Green Published, gold, Green Submitted			2022-12-26	WOS:000431130100022
J	Kong, LL; Qiu, LL; Guo, QX; Chen, Y; Zhang, X; Chen, BW; Zhang, Y; Chang, GB				Kong, Linglin; Qiu, Lingling; Guo, Qixin; Chen, Ying; Zhang, Xin; Chen, Bowen; Zhang, Yang; Chang, Guobin			Long-term in vitro culture and preliminary establishment of chicken primordial germ cell lines	PLOS ONE			English	Article							GENETIC-MODIFICATION; EXPRESSION; PLURIPOTENCY; TRANSMISSION; CLEAVAGE; PIGGYBAC; SYSTEM; NANOG	Primordial germ cells (PGCs) are precursors of functional gametes and can be used as efficient transgenic tools and carriers in bioreactors. Few methods for long-term culture of PGCs are available. In this study, we tested various culture conditions for PGCs, and used the optimum culture system to culture chicken gonad PGCs for about three hundred days. Long-term-cultured PGCs were detected and characterized by karyotype analysis, immunocytochemical staining of SSEA-1, c-kit, Sox2, cDAZL, and quantitative RT-PCR for specific genes like Tert, DAZL, POUV, and NANOG. Cultured PGCs labeled with PKH26 were reinjected into Stage X recipient embryos and into the dorsal aorta of Stage 14-17 embryos to assay their ability of migration into the germinal crescent and gonads, respectively. In conclusion, the most suitable culture system for PGCs is as follows: feeder layer cells treated with 20 mu g/mL mitomycin C for 2 hours, and with 50% conditioned medium added to the factor culture medium. PGCs cultured in this system retain their pluripotency and the unique ability of migration without transformation, indicating the successful preliminary establishment of chicken primordial germ cell lines and these PGCs can be considered for use as carriers in transgenic bioreactors.	[Kong, Linglin; Qiu, Lingling; Guo, Qixin; Chen, Ying; Zhang, Xin; Chen, Bowen; Zhang, Yang; Chang, Guobin] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Chang, GB (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	gbchang@yzu.edu.cn			National Natural Science Foundation of China [31372297]; National Science & Technology Pillar Program of China [2015BAD03B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program of China	This research was supported by the National Natural Science Foundation of China (31372297 to Guobin Chang), and National Science & Technology Pillar Program of China (2015BAD03B03 to Guobin Chang).	Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Canon S, 2006, DEV DYNAM, V235, P2889, DOI 10.1002/dvdy.20927; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; DUBOIS R, 1969, CR ACAD SCI D NAT, V269, P205; ENGLAND MA, 1993, J ANAT, V183, P67; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Han JY, 2009, COMP IMMUNOL MICROB, V32, P61, DOI 10.1016/j.cimid.2007.11.010; Kapoor A, 2013, ACS CHEM NEUROSCI, V4, P1093, DOI 10.1021/cn400039s; Kim JN, 2010, BIOL REPROD, V82, P257, DOI 10.1095/biolreprod.109.079723; Kito G, 2010, J REPROD DEVELOP, V56, P341, DOI 10.1262/jrd.09-218A; KUWANA T, 1987, ANAT RECORD, V219, P164, DOI 10.1002/ar.1092190209; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Lee HJ, 2016, FASEB J, V30, P555, DOI 10.1096/fj.15-274712; Leighton PA, 2008, MOL REPROD DEV, V75, P1163, DOI 10.1002/mrd.20859; Liu CH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094409; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; Naeemipour M, 2013, MOL REPROD DEV, V80, P849, DOI 10.1002/mrd.22216; Naito M, 2015, ANIM REPROD SCI, V153, P50, DOI 10.1016/j.anireprosci.2014.12.003; Nakamura Y, 2010, REPROD FERT DEVELOP, V22, P1237, DOI 10.1071/RD10056; Nieuwkoop PD, 1980, PRIMORDIAL GERM CELL; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Park TS, 2000, MOL REPROD DEV, V56, P475, DOI 10.1002/1098-2795(200008)56:4&lt;475::AID-MRD5&gt;3.0.CO;2-M; Shiue YL, 2009, REPROD DOMEST ANIM, V44, P55, DOI 10.1111/j.1439-0531.2007.00990.x; Song YH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113381; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Xu L, 2016, TUMOR BIOL, V2016, P1, DOI DOI 10.1152/AJPCELL.00309.2015	28	4	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196459	10.1371/journal.pone.0196459	http://dx.doi.org/10.1371/journal.pone.0196459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709001	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100028
J	Arambourou, H; Fuertes, I; Vulliet, E; Daniele, G; Noury, P; Delorme, N; Abbaci, K; Barata, C				Arambourou, Helene; Fuertes, Inmaculada; Vulliet, Emmanuelle; Daniele, Gaelle; Noury, Patrice; Delorme, Nicolas; Abbaci, Khedidja; Barata, Carlos			Fenoxycarb exposure disrupted the reproductive success of the amphipod Gammarus fossarum with limited effects on the lipid profile	PLOS ONE			English	Article							JUVENILE-HORMONE ANALOG; DAPHNIA-MAGNA; FRESH-WATER; LARVAL EXPOSURE; CRUSTACEAN; TOXICITY; BEHAVIOR; CHLORPYRIFOS; INSECTICIDE; PESTICIDE	Insect growth regulator insecticides mimic the action of hormones on the growth and development of insect pests. However, they can affect the development of non-target arthropods. In the present study, we tested the effects of the growth regulator insecticide fenoxycarb on several endpoints in the freshwater crustacean Gammarus fossarum (Amphipoda). Females carrying embryos in their open brood pouch were exposed to 50 mu g L-1 fenoxycarb throughout the entire oogenesis (i.e. 21 days). After exposure, newborn individuals from exposed embryos were removed from the maternal open brood pouch for lipidomic analysis, while males were added to assess the reproductive success. After fertilization, the lipid profile, energy reserve content (lipids, proteins and glycogen), and activity of phenoloxidase - an enzyme involved in the immune response -were measured in females. No significant effect of fenoxycarb exposure was observed on the lipid profile of both newborn individuals and females, while reproductive success was severely impaired in exposed females. Particularly, precopulatory behavior was significantly reduced and fertilized eggs were unviable. This study highlighted the deleterious effects of the insect growth regulator fenoxycarb on gammarid reproduction, which could have severe repercussions on population dynamics.	[Arambourou, Helene; Noury, Patrice; Delorme, Nicolas; Abbaci, Khedidja] Irstea Lyon, Riverly Res Unit, Villeurbanne, France; [Fuertes, Inmaculada; Barata, Carlos] CSIC, Spanish Res Council, Inst Environm Assessment & Water Res IDAEA, Dept Environm Chem, Barcelona, Spain; [Vulliet, Emmanuelle; Daniele, Gaelle] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, ENS Lyon,Inst Sci Analyt,UMR 5280, Villeurbanne, France	INRAE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Arambourou, H (corresponding author), Irstea Lyon, Riverly Res Unit, Villeurbanne, France.	helene.arambourou@irstea.fr	Fuertes, Inmaculada/AAV-4231-2021	Fuertes, Inmaculada/0000-0001-8415-7993; VULLIET, Emmanuelle/0000-0002-6325-1531	French EC2C0 program (INSU-CNRS); French Institute of Science and Technology for the Environment and Agriculture (Irstea); Spanish grant [CTM2014-51985-R]	French EC2C0 program (INSU-CNRS); French Institute of Science and Technology for the Environment and Agriculture (Irstea); Spanish grant(Spanish Government)	This study was funded by the French EC2C0 program (INSU-CNRS) to Helene Arambourou and the French Institute of Science and Technology for the Environment and Agriculture (Irstea). Lipidomic analyses were supported by the Spanish grant CTM2014-51985-R to Carlos Barata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arambourou H, 2017, ECOTOX ENVIRON SAFE, V144, P193, DOI 10.1016/j.ecoenv.2017.06.017; Arambourou H, 2015, CHEMOSPHERE, V128, P148, DOI 10.1016/j.chemosphere.2015.01.044; Beugnet F, 2012, TRENDS PARASITOL, V28, P267, DOI 10.1016/j.pt.2012.04.004; Biondi A, 2015, CHEMOSPHERE, V128, P142, DOI 10.1016/j.chemosphere.2015.01.034; Bitondi MMG, 1998, J INSECT PHYSIOL, V44, P499, DOI 10.1016/S0022-1910(97)00113-3; Blockwell SJ, 1998, ARCH ENVIRON CON TOX, V35, P432, DOI 10.1007/s002449900399; BODAR CWM, 1989, ECOTOX ENVIRON SAFE, V17, P333, DOI 10.1016/0147-6513(89)90054-7; BOROWSKY B, 1987, J EXP MAR BIOL ECOL, V107, P131, DOI 10.1016/0022-0981(87)90191-2; Carlson GR, 2001, PEST MANAG SCI, V57, P115, DOI 10.1002/1526-4998(200102)57:2<115::AID-PS245>3.0.CO;2-A; CLARKE A, 1985, MAR BIOL, V88, P247, DOI 10.1007/BF00392587; Cornet S, 2012, J ZOOL, V286, P312, DOI 10.1111/j.1469-7998.2011.00882.x; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; European Food Safety Authority, 2010, EFSA J, V8, P1779, DOI [10.2903/j.efsa.2010.1779, DOI 10.2903/J.EFSA.2010.1779]; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geffard O, 2010, ENVIRON TOXICOL CHEM, V29, P2249, DOI 10.1002/etc.268; Gerhardt Almut, 2011, INT J ZOOL, V2011; Ginjupalli GK, 2013, CHEMOSPHERE, V92, P1260, DOI 10.1016/j.chemosphere.2013.04.061; GomezLechon MJ, 1996, ANAL BIOCHEM, V236, P296, DOI 10.1006/abio.1996.0170; GREEN DWJ, 1986, ARCH ENVIRON CON TOX, V15, P465, DOI 10.1007/BF01056557; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; HARTNOLL RG, 1980, CRUSTACEANA, V38, P253, DOI 10.1163/156854080X00166; Heckmann LH, 2005, PEST MANAG SCI, V61, P627, DOI 10.1002/ps.1048; Jordao R, 2016, ENVIRON SCI TECHNOL, V50, P13565, DOI 10.1021/acs.est.6b04768; Jordao R, 2016, SCI TOTAL ENVIRON, V545, P127, DOI 10.1016/j.scitotenv.2015.12.097; Jordao R, 2015, ENVIRON HEALTH PERSP, V123, P813, DOI 10.1289/ehp.1409163; Jubeaux G, 2012, AQUAT TOXICOL, V112, P72, DOI 10.1016/j.aquatox.2012.01.011; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; LYES MC, 1979, MAR BEHAV PHYSIOL, V6, P47, DOI 10.1080/10236247909378552; Miyakawa H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2868; Nakamura A, 2007, ACTA TROP, V103, P222, DOI 10.1016/j.actatropica.2007.06.009; Nates SF, 2000, COMP BIOCHEM PHYS C, V127, P317, DOI 10.1016/S0742-8413(00)00157-2; Nauen R., 2002, Pesticide Outlook, V13, P241, DOI 10.1039/b211171n; Navis S, 2015, AQUAT TOXICOL, V159, P176, DOI 10.1016/j.aquatox.2014.12.016; R Development Core Team, 2017, R LANG ENV STAT COMP; Rehm EJ, 2009, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5127, DOI 10.1101/PDB.PR0T5127]; Tokishita S, 2006, BIOCHEM BIOPH RES CO, V345, P362, DOI 10.1016/j.bbrc.2006.04.102; Toyota K, 2017, J APPL TOXICOL, V37, P374, DOI 10.1002/jat.3368; Varo I, 2006, SCI TOTAL ENVIRON, V366, P148, DOI 10.1016/j.scitotenv.2005.10.006; Wayama M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053618; Whitley E, 2002, CRIT CARE, V6, P509, DOI 10.1186/cc1820; Xuereb B, 2009, AQUAT TOXICOL, V94, P114, DOI 10.1016/j.aquatox.2009.06.010	42	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196461	10.1371/journal.pone.0196461	http://dx.doi.org/10.1371/journal.pone.0196461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702662	Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300033
J	Hossain, M; Mekhilef, S; Afifi, F; Halabi, LM; Olatomiwa, L; Seyedmahmoudian, M; Horan, B; Stojcevski, A				Hossain, Monowar; Mekhilef, Saad; Afifi, Firdaus; Halabi, Laith M.; Olatomiwa, Lanre; Seyedmahmoudian, Mehdi; Horan, Ben; Stojcevski, Alex			Application of the hybrid ANFIS models for long term wind power density prediction with extrapolation capability	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; RENEWABLE ENERGY; SPEED PREDICTION; NEURAL-NETWORKS; SYSTEM; OPTIMIZATION; FEASIBILITY; IRAN	In this paper, the suitability and performance of ANFIS (adaptive neuro-fuzzy inference system), ANFIS-PSO (particle swarm optimization), ANFIS-GA (genetic algorithm) and ANFISDE (differential evolution) has been investigated for the prediction of monthly and weekly wind power density (WPD) of four different locations named Mersing, Kuala Terengganu, Pulau Langkawi and Bayan Lepas all in Malaysia. For this aim, standalone ANFIS, ANFISPSO, ANFIS-GA and ANFIS-DE prediction algorithm are developed in MATLAB platform. The performance of the proposed hybrid ANFIS models is determined by computing different statistical parameters such as mean absolute bias error (MABE), mean absolute percentage error (MAPE), root mean square error (RMSE) and coefficient of determination (R-2). The results obtained from ANFIS-PSO and ANFIS-GA enjoy higher performance and accuracy than other models, and they can be suggested for practical application to predict monthly and weekly mean wind power density. Besides, the capability of the proposed hybrid ANFIS models is examined to predict the wind data for the locations where measured wind data are not available, and the results are compared with the measured wind data from nearby stations.	[Hossain, Monowar; Mekhilef, Saad; Halabi, Laith M.] Univ Malaya, Dept Elect Engn, Power Elect & Renewable Energy Res Lab PEARL, Kuala Lumpur, Malaysia; [Afifi, Firdaus] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Comp Syst & Technol, Kuala Lumpur, Malaysia; [Olatomiwa, Lanre] Fed Univ Technol, Dept Elect & Elect Engn, PMB 65, Minna, Nigeria; [Seyedmahmoudian, Mehdi; Stojcevski, Alex] Swinburne Univ Technol, Sch Software & Elect Engn, Melbourne, Vic, Australia; [Horan, Ben] Deakin Univ, Sch Engn, Clayton, Vic, Australia	Universiti Malaya; Universiti Malaya; Swinburne University of Technology; Deakin University	Hossain, M; Mekhilef, S (corresponding author), Univ Malaya, Dept Elect Engn, Power Elect & Renewable Energy Res Lab PEARL, Kuala Lumpur, Malaysia.	apumonowar@gmail.com; saad@um.edu.my	Saad, Mekhilef/B-9652-2010; Seyedmahmoudian, Mohammadmehdi/ABE-9588-2020; Halabi, Laith M./HGU-8089-2022; Hossain, Monowar/AAD-5204-2021; Afifi, Firdaus/P-1969-2019; Afifi, Firdaus/GWD-0977-2022; Olatomiwa, Lanre/J-3227-2016	Saad, Mekhilef/0000-0001-8544-8995; Seyedmahmoudian, Mohammadmehdi/0000-0002-2538-4077; Halabi, Laith M./0000-0003-2571-1960; Afifi, Firdaus/0000-0002-5906-8195; Olatomiwa, Lanre/0000-0002-2044-4974; Hossain, Monowar/0000-0002-1911-7861; Horan, Ben/0000-0002-6723-259X; Stojcevski, Alex/0000-0002-3584-6597	University of Malaya, Malaysia [FG007-17AFR, RP043B-17AET]	University of Malaya, Malaysia(Universiti Malaya)	The authors would like to acknowledge the financial support received from the University of Malaya, Malaysia, through Frontier Research Grant No. FG007-17AFR and Innovative Technology Grant No. RP043B-17AET.; The authors would like to acknowledge the financial support received from the University of Malaya, Malaysia, through Frontier Research Grant No. FG007-17AFR and Innovative Technology Grant No. RP043B-17AET.	Aagreh Y, 2013, APPL ENERG, V103, P25, DOI 10.1016/j.apenergy.2012.10.008; Afifi F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162627; Akdag SA, 2009, ENERG CONVERS MANAGE, V50, P1761, DOI 10.1016/j.enconman.2009.03.020; Azad HB, 2014, IEEE T SUSTAIN ENERG, V5, P546, DOI 10.1109/TSTE.2014.2300150; Bashir ZA, 2009, IEEE T POWER SYST, V24, P20, DOI 10.1109/TPWRS.2008.2008606; Bekele G, 2012, APPL ENERG, V97, P5, DOI 10.1016/j.apenergy.2011.11.059; Bozkurt OO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175915; Cao JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157551; Eberhart R., 1995, MHS'95. Proceedings of the Sixth International Symposium on Micro Machine and Human Science (Cat. No.95TH8079), P39, DOI 10.1109/MHS.1995.494215; FIRDAUS AFIFI I., 2017, THESIS; Haque AU, 2014, IEEE ELECTR POW ENER, P184, DOI 10.1109/EPEC.2014.7; Hegerty B., 2009, MEX INT C ART INT; Hossain M, 2017, J CLEAN PROD, V167, P395, DOI 10.1016/j.jclepro.2017.08.081; Hossain M, 2017, SUSTAIN CITIES SOC, V28, P358, DOI 10.1016/j.scs.2016.10.008; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; Huffaker R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115123; Islam MR, 2011, ENERGY, V36, P985, DOI 10.1016/j.energy.2010.12.011; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Jowder FAL, 2009, APPL ENERG, V86, P538, DOI 10.1016/j.apenergy.2008.08.006; Juang C, 2010, COMBINATION PARTICLE; Jung J, 2014, RENEW SUST ENERG REV, V31, P762, DOI 10.1016/j.rser.2013.12.054; Justus C. G., 1978, WINDS WIND SYSTEM PE, V1; Kahraman HT, 2016, 2016 15TH IEEE INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2016), P447, DOI [10.1109/ICMLA.2016.184, 10.1109/ICMLA.2016.0079]; Lei LL, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/8594049; Mitchell Melanie, 1998, INTRO GENETIC ALGORI; Mohammadi K, 2016, ENERG CONVERS MANAGE, V108, P322, DOI 10.1016/j.enconman.2015.11.015; Mohammadi K, 2015, ENERGY, V86, P232, DOI 10.1016/j.energy.2015.03.111; Mohammadi K, 2013, ENERG CONVERS MANAGE, V65, P463, DOI 10.1016/j.enconman.2012.09.004; Ohunakin OS, 2011, APPL ENERG, V88, P3197, DOI 10.1016/j.apenergy.2011.03.022; Okumus I, 2016, ENERG CONVERS MANAGE, V123, P362, DOI 10.1016/j.enconman.2016.06.053; Olatomiwa L, 2016, SUSTAIN ENERGY TECHN, V13, P1, DOI 10.1016/j.seta.2015.11.001; Peng HW, 2013, RENEW ENERG, V50, P590, DOI 10.1016/j.renene.2012.07.022; Pousinho HMI, 2011, ENERG CONVERS MANAGE, V52, P397, DOI 10.1016/j.enconman.2010.07.015; Ramadan HS, 2017, J CLEAN PROD, V161, P1283, DOI 10.1016/j.jclepro.2017.01.120; Ramasamy P, 2015, RENEW ENERG, V80, P338, DOI 10.1016/j.renene.2015.02.034; Rodriguez O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124830; Shamshirband S, 2016, RENEW SUST ENERG REV, V59, P429, DOI 10.1016/j.rser.2015.12.269; Shamshirband S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103414; Sheela KG, 2013, NEUROCOMPUTING, V122, P425, DOI 10.1016/j.neucom.2013.06.008; Shoorehdeli MA, 2009, APPL SOFT COMPUT, V9, P833, DOI 10.1016/j.asoc.2008.11.001; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Sun C, 2015, IEEE T CONTR SYST T, V23, P1197, DOI 10.1109/TCST.2014.2359176; Thakagi H., 1983, P IFAC S FUZZ INF KN, P55; Ul Haque A, 2014, IEEE T POWER SYST, V29, P1663, DOI 10.1109/TPWRS.2014.2299801; Wang ZP, 2017, IEEE ACCESS, V5, P21286, DOI 10.1109/ACCESS.2017.2759094; Zhang L., 2015, OXID MED CELL LONGEV, V2015, P1, DOI [10.1155/2015/714756, DOI 10.1016/J.ATM0SENV.2015.01.001]; Zhang L, 2018, RENEW SUST ENERG REV, V81, P1868, DOI 10.1016/j.rser.2017.05.283	47	23	23	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0193772	10.1371/journal.pone.0193772	http://dx.doi.org/10.1371/journal.pone.0193772			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702645	Green Submitted, gold, Green Published			2022-12-26	WOS:000431013300001
J	Pilgrim, N; Jani, N; Mathur, S; Kahabuka, C; Seria, V; Makyao, N; Apicella, L; Pulerwitz, J				Pilgrim, Nanlesta; Jani, Nrupa; Mathur, Sanyukta; Kahabuka, Catherine; Seria, Vaibhav; Makyao, Neema; Apicella, Lou; Pulerwitz, Julie			Provider perspectives on PrEP for adolescent girls and young women in Tanzania: The role of provider biases and quality of care	PLOS ONE			English	Article							ORAL PREEXPOSURE PROPHYLAXIS; AFRICAN WOMEN; HIV PREVENTION; HEALTH SYSTEM; UNITED-STATES; ATTITUDES; SERVICES; PERCEPTIONS; INFECTION; KNOWLEDGE	Background Oral pre-exposure prophylaxis (PrEP) has the potential to reduce HIV acquisition among adolescent girls and young women (AGYW) in sub-Saharan Africa. However, health care providers' (HCPs) perspectives and interactions with potential clients can substantially influence effective provision of quality health services. We examine if HCPs' knowledge, attitude, and skills, as well as their perceptions of facility readiness to provide PrEP are associated with their willingness to provide PrEP to AGYW at high risk of HIV in Tanzania. Methods A self-administered questionnaire was given to 316 HCPs from 74 clinics in two districts and 24 HCPs participated in follow-up in-depth interviews (IDIs). We conducted bivariate and multivariable Poisson regression to assess factors associated with willingness to provide PrEP to AGYW. Thematic content analysis was used to analyze the IDIs, which expanded upon the quantitative results. Results Few HCPs (3.5%) had prior PrEP knowledge, but once informed, 61.1% were willing to prescribe PrEP to AGYW. Higher negative attitudes toward adolescent sexuality and greater concerns about behavioral disinhibition due to PrEP use were associated with lower willingness to prescribe PrEP. Qualitatively, HCPs acknowledged that biases, rooted in cultural norms, often result in stigmatizing and discriminatory care toward AGYW, a potential barrier for PrEP provision. However, better training to provide HIV services was associated with greater willingness to prescribe PrEP. Conversely, HCPs feared the potential negative impact of PrEP on the provision of existing HIV services (e.g., overburdened staff), and suggested the integration of PrEP into non-HIV services and the use of paramedical professionals to facilitate PrEP provision. Conclusions Preparing for PrEP introduction requires more than solely training HCPs on the clinical aspects of providing PrEP. It requires a two-pronged strategy: addressing HCPs' biases regarding sexual health services to AGYW; and preparing the health system infrastructure for the introduction of PrEP.	[Pilgrim, Nanlesta; Jani, Nrupa; Mathur, Sanyukta; Seria, Vaibhav; Apicella, Lou; Pulerwitz, Julie] Populat Council, Washington, DC 20008 USA; [Kahabuka, Catherine] CSK Res Solut, Dar Es Salaam, Tanzania; [Makyao, Neema] Natl AIDS Control Programme, Dar Es Salaam, Tanzania	Population Council	Pilgrim, N (corresponding author), Populat Council, Washington, DC 20008 USA.	npilgrim@popcouncil.org	Saria, Vaibhav/AAZ-6138-2021	Saria, Vaibhav/0000-0001-9121-5370; Jani, Nrupa/0000-0001-6768-9963; Mathur, Sanyukta/0000-0003-1645-6734	Bill & Melinda Gates Foundation [0PP1150068, 0PP1136778]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funded by Bill & Melinda Gates Foundation-0PP1150068- https //www.gatesfoundation.org/ Bill & Melinda Gates Foundation -0PP1136778- https//www.gatesfoundation.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CSK Research Solutions (CSK) is a private firm that supports design and implementation of research studies and program monitoring and evaluation activities in Tanzania. CSK did not fund the study but served as the Tanzanian research partner in the study. CSK received a sub-contract from the Population Council to collect data, participate in data analysis and participate in the preparation of the manuscript.	Ahanonu Ezihe Loretta, 2014, J Family Reprod Health, V8, P33; Ayres L, 2003, QUAL HEALTH RES, V13, P871, DOI 10.1177/1049732303013006008; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Becker D, 2007, PERSPECT SEX REPRO H, V39, P206, DOI 10.1363/3920607; Bekker LG, 2018, LANCET HIV, V5, pE68, DOI 10.1016/S2352-3018(17)30156-X; Blumenthal Jill, 2014, Virtual Mentor, V16, P909, DOI 10.1001/virtualmentor.2014.16.11.stas1-1411; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; Caceres CF, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21108; Castel AD, 2015, JAIDS-J ACQ IMM DEF, V70, P520, DOI 10.1097/QAI.0000000000000780; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Corneli AL, 2014, JAIDS-J ACQ IMM DEF, V66, P324, DOI 10.1097/QAI.0000000000000158; Creswell J.W., 2011, DESIGNING CONDUCTION, V2nd, P457; Donaldson E., 2016, KNOWLEDGE ATTITUDES; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Friese S, 2014, QUALITATIVE DATA ANA; Geibel S, 2017, J ADOLESCENT HEALTH, V60, pS35, DOI 10.1016/j.jadohealth.2016.09.026; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kruk ME, 2008, HEALTH POLICY, V85, P263, DOI 10.1016/j.healthpol.2007.09.003; Mack N, 2015, AFR J REPROD HEALTH, V19, P54; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mathur S, 2016, LANCET HIV, V3, pE406, DOI 10.1016/S2352-3018(16)30115-1; Mimiaga MJ, 2014, AIDS CARE, V26, P684, DOI 10.1080/09540121.2013.845289; Mullins TLK, 2016, AIDS PATIENT CARE ST, V30, P339, DOI 10.1089/apc.2016.0048; Nair M, 2015, J ADOLESCENT HEALTH, V57, P288, DOI 10.1016/j.jadohealth.2015.05.011; Pilgrim NA, 2014, HEALTH COMMUN, V29, P505, DOI 10.1080/10410236.2013.777328; Pulerwitz J, 2016, BUILDING EVIDENCE GU, DOI DOI 10.31899/HIV7.1008; Ross I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173057; Sam-Agudu NA, 2016, PEDIATR RES, V79, P838, DOI 10.1038/pr.2016.28; Seidman D, 2016, CONTRACEPTION, V93, P463, DOI 10.1016/j.contraception.2015.12.018; Shaeer KM, 2014, J AM PHARM ASSOC, V54, P610, DOI 10.1331/JAPhA.2014.14014; Sofaer S, 2005, ANNU REV PUBL HEALTH, V26, P513, DOI 10.1146/annurev.publhealth.25.050503.153958; Sowicz TJ, 2014, J ASSOC NURSE AIDS C, V25, P496, DOI 10.1016/j.jana.2014.07.005; Statacorp, 2013, STAT 13 BAS REF MAN; Tang EC, 2014, AIDS RES HUM RETROV, V30, P416, DOI [10.1089/aid.2013.0212, 10.1089/AID.2013.0212]; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS), 2013, ICF INT TANZ HIV AID; UNAIDS, 2016, PREV GAP REP; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Warenius LU, 2006, REPROD HEALTH MATTER, V14, P119, DOI 10.1016/S0968-8080(06)27242-2; Wheelock A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001234; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2015, GLOB STAND QUAL HLTH; Yun K, 2018, SEX TRANSM INFECT, V94, P163, DOI 10.1136/sextrans-2017-053217	44	33	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196280	10.1371/journal.pone.0196280	http://dx.doi.org/10.1371/journal.pone.0196280			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1YS	29702659	gold, Green Published, Green Submitted			2022-12-26	WOS:000431013300025
J	Sarkar, A; Gogia, N; Farley, K; Payton, L; Singh, A				Sarkar, Ankita; Gogia, Neha; Farley, Kevin; Payton, Lydia; Singh, Amit			Characterization of a morphogenetic furrow specific Gal4 driver in the developing Drosophila eye	PLOS ONE			English	Article							POLARITY GENE HEDGEHOG; TGF-BETA FAMILY; RETINAL DIFFERENTIATION; IMAGINAL DISK; ORGAN SIZE; DORSAL-EYE; WINGLESS; MELANOGASTER; PROGRESSION; PATHWAY	The ability to express a gene of interest in a spatio-temporal manner using Gal4-UAS system has allowed the use of Drosophila model to study various biological phenomenon. During Drosophila eye development, a synchronous wave of differentiation called Morphogenetic furrow (MF) initiates at the posterior margin resulting in differentiation of retinal neurons. This synchronous differentiation is also observed in the differentiating retina of vertebrates. Since MF is highly dynamic, it can serve as an excellent model to study patterning and differentiation. However, there are not any Gal4 drivers available to observe the gain- of-function or loss-of-function of a gene specifically along the dynamic MF. The decapentaplegic (dpp) gene encodes a secreted protein of the transforming growth factor-beta (TGF-beta) superfamily that expresses at the posterior margin and then moves with the MF. However, unlike the MF associated pattern of dpp gene expression, the targeted dpp-Gal4 driver expression is restricted to the posterior margin of the developing eye disc. We screened GMR lines harboring regulatory regions of dpp fused with Gal4 coding region to identify MF specific enhancer of dpp using a GFP reporter gene. We employed immuno-histochemical approaches to detect gene expression. The rationale was that GFP reporter expression will correspond to the dpp expression domain in the developing eye. We identified two new dpp-Gal4 lines, viz., GMR17E04-Gal4 and GMR18D08-Gal4 that carry sequences from first intron region of dpp gene. GMR17E04-Gal4 drives expression along the MF during development and later in the entire pupal retina whereas GMR18D08-Gal4 drives expression of GFP transgene in the entire developing eye disc, which later drives expression only in the ventral half of the pupal retina. Thus, GMR18D08-Gal4 will serve as a new reagent for targeting gene expression in the ventral half of the pupal retina. We compared misexpression phenotypes of Wg, a negative regulator of eye development, using GMR17E04-Gal4, GMR18D08-Gal4 with existing dpp-Gal4 driver. The eye phenotypes generated by using our newly identified MF specific driver are not similar to the ones generated by existing dpp-Gal4 driver. It suggests that misexpression studies along MF needs revisiting using the new Gal4 drivers generated in our studies.	[Sarkar, Ankita; Gogia, Neha; Farley, Kevin; Payton, Lydia; Singh, Amit] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Singh, Amit] Univ Dayton, Premed Program, Dayton, OH 45469 USA; [Singh, Amit] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA; [Singh, Amit] Univ Dayton, Integrat Sci & Engn Ctr, Dayton, OH 45469 USA; [Singh, Amit] Indiana State Univ, Ctr Genome Advocacy, Terre Haute, IN 47809 USA	University of Dayton; University of Dayton; University of Dayton; University of Dayton; Indiana State University	Singh, A (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.; Singh, A (corresponding author), Univ Dayton, Premed Program, Dayton, OH 45469 USA.; Singh, A (corresponding author), Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA.; Singh, A (corresponding author), Univ Dayton, Integrat Sci & Engn Ctr, Dayton, OH 45469 USA.; Singh, A (corresponding author), Indiana State Univ, Ctr Genome Advocacy, Terre Haute, IN 47809 USA.	asingh1@udayton.edu	Gogia, Neha/S-4777-2019; Sarkar, Ankita/AAC-8549-2020; Singh, Amit/T-5619-2019	Gogia, Neha/0000-0002-0544-1265; Singh, Amit/0000-0002-2962-2255; Farley, Kevin Xavier/0000-0002-1588-6874	National Institute of General Medical Sciences (NIGMS) [1R15 GM124654-01]; University of Dayton; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM124654] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Dayton; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institute of General Medical Sciences (NIGMS) -1R15 GM124654-01, STEM Catalyst Grant from University of Dayton to Amit Singh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azpiazu N, 1998, GENE DEV, V12, P261, DOI 10.1101/gad.12.2.261; Barolo S, 2012, BIOESSAYS, V34, P135, DOI 10.1002/bies.201100121; Bergmann A, 2003, CURR OPIN CELL BIOL, V15, P717, DOI 10.1016/j.ceb.2003.10.002; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Blair SS, 2003, DEVELOPMENT, V130, P5065, DOI 10.1242/dev.00774; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; Burke R, 1996, DEV BIOL, V179, P360, DOI 10.1006/dbio.1996.0267; Casares F, 2000, DEVELOPMENT, V127, P1499; Chanut F, 1997, DEVELOPMENT, V124, P559; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Cohen S. M., 1993, DEV DROSOPHILA MELAN, P747; Curtiss J, 2000, DEVELOPMENT, V127, P1325; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gogia N, 2018, REPOSITORY DPP ENHAN, DOI [10.26890/ddlla2d621bht, DOI 10.26890/DDLLA2D621BHT]; Greenwood S, 1999, DEVELOPMENT, V126, P5795; Hartenstein V, 2002, RES PRO CEL, V37, P219; HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Held L. I. J., 2002, IMAGINAL DISC, P197; Ito K, 1997, DEVELOPMENT, V124, P761; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jory A, 2012, CELL REP, V2, P1014, DOI 10.1016/j.celrep.2012.09.010; Kango-Singh M, 2003, DEV BIOL, V256, P48, DOI 10.1016/S0012-1606(02)00123-9; Kango-Singh M, 2009, DEV DYNAM, V238, P1627, DOI 10.1002/dvdy.21996; Kumar JP, 2013, MOL GENETICS AXIAL P, P75; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MA CY, 1995, DEVELOPMENT, V121, P2279; Morrison CM, 2010, GENESIS, V48, P3, DOI 10.1002/dvg.20571; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Nordstrom W, 1996, DEV BIOL, V180, P213, DOI 10.1006/dbio.1996.0296; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oros SM, 2010, DEV BIOL, V346, P258, DOI 10.1016/j.ydbio.2010.07.030; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pignoni F, 1997, DEVELOPMENT, V124, P271; Poulson D. F., 1950, BIOL DROSOPHILA, P168; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Royet J, 1997, DEVELOPMENT, V124, P4793; Sepp KJ, 1999, GENETICS, V151, P1093; Seto ES, 2004, TRENDS CELL BIOL, V14, P45, DOI 10.1016/j.tcb.2003.11.004; SINGH A, 1995, CURR SCI INDIA, V68, P517; Singh A, 2005, GENETICS, V171, P169, DOI 10.1534/genetics.105.044180; Singh A, 1998, CURR SCI INDIA, V74, P841; Singh A, 2002, DEVELOPMENT, V129, P4271; Singh Ajai, 2004, Mens Sana Monogr, V2, P5; Singh A, 2005, AD DEV BIOL, V14, P59, DOI 10.1016/S1574-3349(04)14004-0; Singh A, 2006, DEVELOPMENT, V133, P4771, DOI 10.1242/dev.02686; Singh A, 2012, DEV DYNAM, V241, P1, DOI 10.1002/dvdy.23712; Singh A, 2012, DEV DYNAM, V241, P69, DOI 10.1002/dvdy.22764; Singh A, 2011, DEV BIOL, V359, P199, DOI 10.1016/j.ydbio.2011.08.017; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Steffensmeier AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078717; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Tare M., 2013, **DROPPED REF**, P37; Tare M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.338; Tare M, 2013, GENESIS, V51, P68, DOI 10.1002/dvg.22355; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Verghese S, 2012, CELL DEATH DIFFER, V19, P1664, DOI 10.1038/cdd.2012.48; Verghese S, 2013, MOL GENETICS AXIAL P, P229; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wittkorn E, 2015, DEVELOPMENT, V142, P2002, DOI 10.1242/dev.117358; Wolff Tanya, 1993, P1277; Won JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128169; Won JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121999	72	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196365	10.1371/journal.pone.0196365	http://dx.doi.org/10.1371/journal.pone.0196365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702674	Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300029
J	Silva, AC; Souza, AF				Silva, Augusto C.; Souza, Alexandre F.			Aridity drives plant biogeographical sub regions in the Caatinga, the largest tropical dry forest and woodland block in South America	PLOS ONE			English	Article							NORTHEASTERN BRAZIL; ATLANTIC FOREST; NEOTROPICAL BIODIVERSITY; PATTERNS; VEGETATION; DIVERSITY; FRAMEWORK; HISTORY; REGIONALIZATION; PLEISTOCENE	Our aims were to quantify and map the plant sub regions of the the Caatinga, that covers 844,453 km(2) and is the largest block of seasonally dry forest in South America. We performed spatial analyses of the largest dataset of woody plant distributions in this region assembled to date (of 2,666 shrub and tree species; 260 localities), compared these distributions with the current phytogeographic regionalizations, and investigated the potential environmental drivers of the floristic patterns in these sub regions. Phytogeographical regions were identified using quantitative analyses of species turnover calculated as Simpson dissimilarity index. We applied an interpolation method to map NMDS axes of compositional variation over the entire extent of the Caatinga, and then classified the compositional dissimilarity according to the number of biogeographical sub regions identified a priori using k-means analysis. We used multinomial logistic regression models to investigate the influence of contemporary climatic productivity, topographic complexity, soil characteristics, climate stability since the last glacial maximum, and the human footprint in explaining the identified sub regions. We identified nine spatially cohesive biogeographical sub regions. Current productivity, as indicated by an aridity index, was the only explanatory variable retained in the best model, explaining nearly half of the floristic variability between sub regions. The highest rates of endemism within the Caatinga were in the Core and Periphery Chapada Diamantina sub regions. Our findings suggest that the topographic complexity, soil variation, and human footprint in the Caatinga act on woody plant distributions at local scales and not as determinants of broad floristic patterns. The lack of effect of climatic stability since the last glacial maximum probably results from the fact that a single measure of climatic stability does not adequately capture the highly dynamic climatic shifts the region suffered during the Pleistocene. There was limited overlap between our results and previous Caatinga classifications.	[Silva, Augusto C.] Univ Fed Rio Grande do Norte, CB, Programa Posgrad Ecol, Campus Univ, Natal, RN, Brazil; [Souza, Alexandre F.] Univ Fed Rio Grande do Norte, CB, Dept Ecol, Campus Univ, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Silva, AC (corresponding author), Univ Fed Rio Grande do Norte, CB, Programa Posgrad Ecol, Campus Univ, Natal, RN, Brazil.	agst.25@gmail.com	Souza, Alexandre F./G-3016-2011	Souza, Alexandre F./0000-0001-7468-3631	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial support was provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through a scholarship to Augusto Cesar da Silva. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was provided by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) through a scholarship to ACS. The assistance of Greyce Kelly F. Silva, Lara M. Alves, Luiza S. Cantidio, and Thalita W. P. Nunes who also worked on data entry is gratefully acknowledged. Guilherme G. Mazzochini kindly helped with soil and current climate data. Comments by Carlos Roberto S. D. Fonseca, Guilherme G. Mazzochini, Marcelo F. Moro, and one anonymous referee greatly helped to improve an earlier version of this manuscript.	Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Antonelli A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00130; Auler AS, 2004, J QUATERNARY SCI, V19, P693, DOI 10.1002/jqs.876; Banda-R K, 2016, SCIENCE, V353, P1383, DOI 10.1126/science.aaf5080; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Becerra JX, 2005, P NATL ACAD SCI USA, V102, P10919, DOI 10.1073/pnas.0409127102; Beck J, 2012, ECOGRAPHY, V35, P673, DOI 10.1111/j.1600-0587.2012.07364.x; Beuchle R, 2015, APPL GEOGR, V58, P116, DOI 10.1016/j.apgeog.2015.01.017; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caetano S, 2008, MOL ECOL, V17, P3147, DOI 10.1111/j.1365-294X.2008.03817.x; Collevatti R. G., 2013, American Journal of Plant Sciences, V4, P792, DOI 10.4236/ajps.2013.44098; Collevatti RG, 2012, MOL ECOL, V21, P5845, DOI 10.1111/mec.12071; Costa GC, 2018, GLOBAL ECOL BIOGEOGR, V27, P285, DOI 10.1111/geb.12694; CRIA, 2016, RED SPECIESLINK; da Silva J.M.C., 2017, CAATINGA LARGEST TRO, P359; Dapporto L, 2014, J BIOGEOGR, V41, P1639, DOI 10.1111/jbi.12315; Dapporto L, 2013, ECOGRAPHY, V36, P1070, DOI 10.1111/j.1600-0587.2013.00444.x; De Oliveira PE, 1999, PALAEOGEOGR PALAEOCL, V152, P319, DOI 10.1016/S0031-0182(99)00061-9; Dick CW, 2005, P NATL ACAD SCI USA, V102, P10757, DOI 10.1073/pnas.0505013102; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Ebach MC, 2015, J BIOGEOGR, V42, P1801, DOI 10.1111/jbi.12558; Eisenlohr PV, 2014, ACTA BOT BRAS, V28, P227, DOI 10.1590/S0102-33062014000200009; Fernandes A, 2007, FITOGEOGRAFIA BRASIL; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Fine PVA, 2015, ANNU REV ECOL EVOL S, V46, P369, DOI 10.1146/annurev-ecolsys-112414-054102; Frenette-Dussault C, 2012, J VEG SCI, V23, P208, DOI 10.1111/j.1654-1103.2011.01350.x; Garreaud RD, 2009, PALAEOGEOGR PALAEOCL, V281, P180, DOI 10.1016/j.palaeo.2007.10.032; Gonzalez-Orozco CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092558; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; Heikinheimo H, 2007, J BIOGEOGR, V34, P1053, DOI 10.1111/j.1365-2699.2006.01664.x; Heikinheimo H, 2012, J BIOGEOGR, V39, P1633, DOI 10.1111/j.1365-2699.2012.02723.x; Hengl T., 2016, PLOS ONE; Hijmans R.J., 2016, RASTER GEOGRAPHIC DA; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Lambers H., 2006, PLANT PHYSL ECOLOGY; Leal I.R., 2005, MEGADIVERSIDADE, V1, P139; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; López Ramiro P., 2006, Darwiniana, nueva serie, V44, P18; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; Manhaes AP, 2016, DIVERS DISTRIB, V22, P932, DOI 10.1111/ddi.12459; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; Melo R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151850; Menezes MOT, 2016, J ARID ENVIRON, V135, P22, DOI 10.1016/j.jaridenv.2016.08.006; Metzger MJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P549, DOI 10.1111/j.1466-822x.2005.00190.x; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Moro MF, 2016, BOT REV, V82, P91, DOI 10.1007/s12229-016-9164-z; Moro Marcelo Freire, 2015, Rodriguésia, V66, P717, DOI 10.1590/2175-7860201566305; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Moura MR, 2017, J BIOGEOGR, V44, P640, DOI 10.1111/jbi.12900; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Neves DM, 2015, J BIOGEOGR, V42, P1566, DOI 10.1111/jbi.12529; Nimer E., 1972, REV BRAS GEOGR, V34, P3; Oliveira-Filho Ary T., 2009, Rodriguésia, V60, P237, DOI 10.1590/2175-7860200960201; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; P Grime J., 2012, EVOLUTIONARY STRATEG, DOI [DOI 10.1002/9781118223246, 10.1002/9781118223246]; Pennington RT, 2006, NEW PHYTOL, V172, P605, DOI 10.1111/j.1469-8137.2006.01902.x; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Quan C, 2013, PALAEOGEOGR PALAEOCL, V386, P86, DOI 10.1016/j.palaeo.2013.05.008; Queiroz P, 2017, CAATINGA LARGEST TRO, P23; Rezende VL, 2017, J BIOGEOGR, V44, P2365, DOI 10.1111/jbi.13013; Ribeiro EMS, 2016, ECOLOGY, V97, P1583, DOI 10.1890/15-1122.1; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricklefs RE, 2016, P NATL ACAD SCI USA, V113, P674, DOI 10.1073/pnas.1523683113; Rito KF, 2017, PLANT ECOL, V218, P749, DOI 10.1007/s11258-017-0726-x; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Rodal MJN, 2008, BRAZ J BIOL, V68, P467, DOI 10.1590/S1519-69842008000300003; Rueda M, 2010, J BIOGEOGR, V37, P2067, DOI 10.1111/j.1365-2699.2010.02388.x; Pessenda LCR, 2010, PALAEOGEOGR PALAEOCL, V297, P597, DOI 10.1016/j.palaeo.2010.09.008; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Salvador S, 2004, PROC INT C TOOLS ART, P576; Santiago L.S., 2016, TREE PHYSIOL, V6, DOI [10.1007/978-3-319-27422-5_11, DOI 10.1007/978-3-319-27422-5_11]; Santos JC, 2011, TROP CONSERV SCI, V4, P276, DOI 10.1177/194008291100400306; Silva AC, 2016, BRAZ J BOT, V39, P605, DOI 10.1007/s40415-016-0273-z; Silva JLA, 2018, ECOL EVOL, V8, P4, DOI 10.1002/ece3.3547; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; Thessler S, 2005, GLOBAL ECOL BIOGEOGR, V14, P315, DOI 10.1111/j.1466-822x.2005.00158.x; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Velloso A. L., 2002, ECORREGIOES PROPOSTA; Veloso HP, 1991, CLASSIFICACAO VEGETA; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Vieira FD, 2015, BOT J LINN SOC, V177, P189, DOI 10.1111/boj.12241; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Zappi Daniela C., 2003, Boletim de Botanica da Universidade de Sao Paulo, V21, P345; Zappi Daniela C., 2015, Rodriguésia, V66, P1085, DOI 10.1590/2175-7860201566411; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	98	47	47	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196130	10.1371/journal.pone.0196130	http://dx.doi.org/10.1371/journal.pone.0196130			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702668	Green Published, gold, Green Submitted			2022-12-26	WOS:000431013300020
J	Hrafnkelsdottir, SM; Brychta, RJ; Rognvaldsdottir, V; Gestsdottir, S; Chen, KY; Johannsson, E; Guomundsdottir, SL; Arngrimsson, SA				Hrafnkelsdottir, Soffia M.; Brychta, Robert J.; Rognvaldsdottir, Vaka; Gestsdottir, Sunna; Chen, Kong Y.; Johannsson, Erlingur; Guomundsdottir, Sigridur L.; Arngrimsson, Sigurbjorn A.			Less screen time and more frequent vigorous physical activity is associated with lower risk of reporting negative mental health symptoms among Icelandic adolescents	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; SEDENTARY BEHAVIOR; LIFE SATISFACTION; GENDER-DIFFERENCES; SELF-ESTEEM; DEPRESSION; ANXIETY; EXERCISE; INDICATORS; YOUTH	Objective Few studies have explored the potential interrelated associations of screen time and physical activity with mental health in youth, particularly using objective methods. We examined cross-sectional associations of these variables among Icelandic adolescents, using objective and subjective measurements of physical activity. Methods Data were collected in the spring of 2015 from 315 tenth grade students (mean age 15.8 years) in six elementary schools in metropolitan Reykjavik, Iceland. Participants reported, via questionnaire, on demographics, weekly frequency of vigorous physical activity, daily hours of screen time and mental health status (symptoms of depression, anxiety and somatic complaints, self-esteem and life satisfaction). Total physical activity was measured over one week with wrist-worn accelerometers. Body composition was determined by DXA-scanning. Poisson regression analysis was used to explore independent and interactive associations of screen time and physical activity with mental health variables, adjusting for gender, body fat percentage and maternal education. Results Less screen time (below the group median of 5.3 h/day) and more frequent vigorous physical activity (>= 4x/week) were each associated with reporting fewer symptoms of depression, anxiety, low self-esteem, and life dissatisfaction. No significant associations were observed between objectively measured physical activity and mental health outcomes. Interactive regression analysis showed that the group reporting both less screen time and more frequent vigorous physical activity had the lowest risk of reporting symptoms of depression, anxiety, low self-esteem, and life dissatisfaction. Conclusions Reports of less screen time and more frequent vigorous physical activity were associated with lower risk of reporting mental health problems among Icelandic adolescents. Those who reported a combination of engaging in less screen time and more frequent vigorous physical activity had the lowest risk, suggesting a synergistic relationship between the two behaviors on mental health outcomes. Our results support guiding youth towards more active and less sedentary/screen-based lifestyle.	[Hrafnkelsdottir, Soffia M.; Rognvaldsdottir, Vaka; Gestsdottir, Sunna; Johannsson, Erlingur; Guomundsdottir, Sigridur L.; Arngrimsson, Sigurbjorn A.] Univ Iceland, Ctr Sport & Hlth Sci, Reykjavik, Iceland; [Brychta, Robert J.; Chen, Kong Y.] NIDDK, Diabet Endocrinol & Obes Branch, Bethesda, MD 20892 USA; [Johannsson, Erlingur] Bergen Univ Coll, Dept Sport & Phys Act, Bergen, Norway	University of Iceland; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Western Norway University of Applied Sciences	Hrafnkelsdottir, SM (corresponding author), Univ Iceland, Ctr Sport & Hlth Sci, Reykjavik, Iceland.	smh10@hi.is	Rögnvaldsdóttir, Vaka/AAR-2000-2020; Chen, Kong/P-1685-2019	Rögnvaldsdóttir, Vaka/0000-0003-4244-3152; Chen, Kong/0000-0002-0306-1904; Gudmundsdottir, Sigridur Lara/0000-0002-6189-5894; Gestsdottir, G. Sunna/0000-0002-3590-6262	University of Iceland Research Fund [HI16120043]; Icelandic Centre for research (RANNIS) [152509-051]; Icelandic Centre for Research (RANNIS); University of Iceland Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK071014, ZICDK071013] Funding Source: NIH RePORTER	University of Iceland Research Fund; Icelandic Centre for research (RANNIS); Icelandic Centre for Research (RANNIS); University of Iceland Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by The University of Iceland Research Fund (grant number HI16120043, https://sjodir.hi.is/node/16129; authors receiving grant: smh, saa) and the Icelandic Centre for research (RANNIS) (grant number 152509-051, https://en.rannis.is/funding/research/icelandic-research-fund/, all authors).; The authors would like to thank the participants of the study, the staff at participating schools and the MS students involved in the data collection (Runa S. Stefansdottir, Bjarki Gislason, Steinar L. Runarsson and Vala M. Johannsdottir). They also thank The Icelandic Centre for Research (RANNIS) and the University of Iceland Research Fund for financial support.	Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Boden JM, 2008, DEV PSYCHOPATHOL, V20, P319, DOI 10.1017/S0954579408000151; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Collings PJ, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0222-4; De Moor MHM, 2008, ARCH GEN PSYCHIAT, V65, P897, DOI 10.1001/archpsyc.65.8.897; DEROGATIS LR, 1971, ARCH GEN PSYCHIAT, V24, P454; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dollman J, 2005, BRIT J SPORT MED, V39, P892, DOI 10.1136/bjsm.2004.016675; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Feng Q, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100914, 10.1371/journal.pone.0104348]; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Gestsdottir S, 2015, SCAND J PUBLIC HEALT, V43, P269, DOI 10.1177/1403494815569864; Hale L, 2015, SLEEP MED REV, V21, P50, DOI 10.1016/j.smrv.2014.07.007; Hamer M, 2009, PEDIATRICS, V123, P1263, DOI 10.1542/peds.2008-1523; Heijnen S, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01890; Hoare E, 2014, OBES REV, V15, P40, DOI 10.1111/obr.12069; Hoare E, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0432-4; Iannotti RJ, 2009, INT J PUBLIC HEALTH, V54, P191, DOI 10.1007/s00038-009-5410-z; Iceland Statistics, 2015, STAT YB IC, P34; Jayakody K, 2014, BRIT J SPORT MED, V48, P187, DOI 10.1136/bjsports-2012-091287; Kahn JA, 2008, J ADOLESCENT HEALTH, V42, P369, DOI 10.1016/j.jadohealth.2007.11.143; Kling KC, 1999, PSYCHOL BULL, V125, P470, DOI 10.1037/0033-2909.125.4.470; Kremer P, 2014, J SCI MED SPORT, V17, P183, DOI 10.1016/j.jsams.2013.03.012; Lacruz ME, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-579; Larun L, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004691.pub2; Maras D, 2015, PREV MED, V73, P133, DOI 10.1016/j.ypmed.2015.01.029; Matin N, 2017, INT HEALTH, V9, P58, DOI 10.1093/inthealth/ihw044; McLaughlin KA, 2011, SOC SCI MED, V73, P1088, DOI 10.1016/j.socscimed.2011.06.011; Mekary RA, 2013, AM J EPIDEMIOL, V178, P474, DOI 10.1093/aje/kws590; Miguel-Berges ML, 2018, CLIN J SPORT MED, V28, P64, DOI 10.1097/JSM.0000000000000419; Morrison KM, 2015, J AFFECT DISORDERS, V172, P18, DOI 10.1016/j.jad.2014.09.014; MUTZ DC, 1993, COMMUN RES, V20, P51, DOI 10.1177/009365093020001003; Overby NC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-80; Park AL, 2013, SOC PSYCH PSYCH EPID, V48, P1829, DOI 10.1007/s00127-013-0697-8; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Patel V, 2013, J ADOLESCENT HEALTH, V52, P511, DOI 10.1016/j.jadohealth.2013.03.003; Patel V, 2013, J ADOLESCENT HEALTH, V52, pS36, DOI 10.1016/j.jadohealth.2012.04.016; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Perraton LG, 2010, J EVAL CLIN PRACT, V16, P597, DOI 10.1111/j.1365-2753.2009.01188.x; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Reddon H, 2017, MED SCI SPORT EXER, V49, P1606, DOI 10.1249/MSS.0000000000001275; Reiss F, 2013, SOC SCI MED, V90, P24, DOI 10.1016/j.socscimed.2013.04.026; Rideout V.J., 2010, HENRY J KAIS FAM FOU; Roman-Vinas B, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0449-8; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Rothon C, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-32; Sigfusdottir ID, 2008, SCAND J PUBLIC HEALT, V36, P361, DOI 10.1177/1403494807088457; Stein Cynthia, 2007, J Adolesc Health, V40, DOI 10.1016/j.jadohealth.2006.11.147; Suchert V, 2016, J ADOLESCENCE, V48, P11, DOI 10.1016/j.adolescence.2016.01.005; Suchert V, 2015, PREV MED, V76, P48, DOI 10.1016/j.ypmed.2015.03.026; Suchert V, 2015, J ADOLESCENCE, V42, P50, DOI 10.1016/j.adolescence.2015.03.014; Suldo SM, 2006, SOC INDIC RES, V78, P179, DOI 10.1007/s11205-005-8208-2; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Trinh L, 2015, J CAN ACAD CHILD ADO, V24, P17; Urrila AS, 2015, ACTA PHYSIOL, V213, P758, DOI 10.1111/apha.12449; Valois RF, 2001, AM J HEALTH BEHAV, V25, P353, DOI 10.5993/AJHB.25.4.1; Vila M, 2009, J PEDIATR PSYCHOL, V34, P989, DOI 10.1093/jpepsy/jsp005; von Soest T, 2014, J ABNORM CHILD PSYCH, V42, P403, DOI 10.1007/s10802-013-9785-1; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2013, MENT HLTH ACT PLAN 2; Wu XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119607	61	43	44	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196286	10.1371/journal.pone.0196286	http://dx.doi.org/10.1371/journal.pone.0196286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1WN	29698499	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600058
J	Mcllhone, AE; Beausoleil, NJ; Kells, NJ; Mellor, DJ; Johnson, CB				Mcllhone, Amanda E.; Beausoleil, Ngaio J.; Kells, Nikki J.; Mellor, David J.; Johnson, Craig B.			Effects of noxious stimuli on the electroencephalogram of anaesthetised chickens (Gallus gallus domesticus)	PLOS ONE			English	Article							PIGS SUS-SCROFA; BROILER-CHICKENS; NOCICEPTIVE STIMULATION; BEHAVIORAL-RESPONSES; PAIN PERCEPTION; TAIL DOCKING; CAUTERY IRON; HALOTHANE; BRAIN; BIRDS	The reliable assessment and management of avian pain is important in the context of animal welfare. Overtly expressed signs of pain vary substantially between and within species, strains and individuals, limiting the use of behaviour in pain studies. Similarly, physiological indices of pain can also vary and may be confounded by influence from non-painful stimuli. In mammals, changes in the frequency spectrum of the electroencephalogram (EEG) recorded under light anaesthesia (the minimal anaesthesia model; MAM) have been shown to reliably indicate cerebral responses to noxious stimuli in a range of species. The aim of the current study was to determine whether the MAM can be applied to the study of nociception in birds. Ten chickens were lightly anaesthetised with halothane and their EEG recorded using surface electrodes during the application of supramaximal mechanical, thermal and electrical noxious stimuli. Spectral analysis revealed no EEG responses to any of these stimuli. Given that birds possess the neural apparatus to detect and process pain, and that the applied noxious stimuli elicit behavioural signs of pain in conscious chickens, this lack of response probably relates to methodological limitations. Anatomical differences between the avian and mammalian brains, along with a paucity of knowledge regarding specific sites of pain processing in the avian brain, could mean that EEG recorded from the head surface is insensitive to changes in neural activity in the pain processing regions of the avian brain. Future investigations should examine alternative electrode placement sites, based on avian homologues of the mammalian brain regions involved in pain processing.	[Mcllhone, Amanda E.; Beausoleil, Ngaio J.; Kells, Nikki J.; Mellor, David J.; Johnson, Craig B.] Massey Univ, Sch Vet Sci, Anim Welf Sci & Bioeth Ctr, Palmerston North, New Zealand	Massey University	Beausoleil, NJ (corresponding author), Massey Univ, Sch Vet Sci, Anim Welf Sci & Bioeth Ctr, Palmerston North, New Zealand.	N.J.Beausoleil@massey.ac.nz	Kells, Nikki/S-9943-2019	Kells, Nikki/0000-0003-1884-6533	Massey University IVABS Post Graduate Research Fund	Massey University IVABS Post Graduate Research Fund	This research was supported by the Massey University IVABS Post Graduate Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Beckers GJL, 2015, NEUROSCI BIOBEHAV R, V50, P120, DOI 10.1016/j.neubiorev.2014.07.019; Benson ER, 2012, AVIAN DIS, V56, P884, DOI 10.1637/10163-040912-Reg.1; BROMM B, 1984, PAIN MEASUREMENT MAN; Butler AB, 2005, BIOESSAYS, V27, P923, DOI 10.1002/bies.20280; Butler AB, 2006, BIOL BULL-US, V211, P106, DOI 10.2307/4134586; Caplen G, 2013, VET J, V198, P616, DOI 10.1016/j.tvjl.2013.09.013; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Gentle MJ, 1992, ANIM WELFARE, V1, P235; Gentle MJ, 2011, APPL ANIM BEHAV SCI, V135, P252, DOI 10.1016/j.applanim.2011.10.023; GENTLE MJ, 1991, RES VET SCI, V50, P95, DOI 10.1016/0034-5288(91)90060-2; GENTLE MJ, 1987, PHYSIOL BEHAV, V40, P781, DOI 10.1016/0031-9384(87)90283-6; Gibson TJ, 2007, NZ VET J, V55, P152, DOI [10.1080/00480169.2007.36760, DOI 10.1080/00480169.2007.36760]; GOELZ MF, 1990, AM J VET RES, V51, P458; Gunturkun O, 2005, CURR OPIN NEUROBIOL, V15, P686, DOI 10.1016/j.conb.2005.10.003; Haga HA, 2005, VET ANAESTH ANALG, V32, P1, DOI 10.1111/j.1467-2995.2004.00225.x; Hawkins MG, 2006, J EXOT PET MED, V15, P177, DOI 10.1053/j.jepm.2006.06.004; HENDRICKSON CM, 1980, NEUROPHARMACOLOGY, V19, P731, DOI 10.1016/0028-3908(80)90064-7; Hoppes S, 2003, J AVIAN MED SURG, V17, P124, DOI 10.1647/2002-008; Hothersall B, 2016, ANIM WELFARE, V25, P55, DOI 10.7120/09627286.25.1.055; Hothersall B, 2011, J NEUROSCI METH, V201, P220, DOI 10.1016/j.jneumeth.2011.07.028; Jaensch SM, 1999, J AVIAN MED SURG, V13, P15; Johnson CB, 2005, VET ANAESTH ANALG, V32, P61, DOI 10.1111/j.1467-2995.2005.00228.x; Johnson C, 2016, ANIMALS-BASEL, V6, DOI 10.3390/ani6110071; Johnson CB, 2009, VET ANAESTH ANALG, V36, P273, DOI 10.1111/j.1467-2995.2009.00448.x; Kaka U, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/305367; Karten HJ, 2013, CURR BIOL, V23, pR12, DOI 10.1016/j.cub.2012.11.013; Kells NJ, 2017, VET ANAESTH ANALG, V44, P1166, DOI 10.1016/j.vaa.2017.02.004; Kells NJ, 2017, VET ANAESTH ANALG, V44, P1156, DOI 10.1016/j.vaa.2017.02.003; Kongara K, 2014, GSTF J VET SCI, V1, P38, DOI [10.5176/2345-7880_1.1.5, DOI 10.5176/2345-7880_1.1.5]; Kongara K, 2010, RES VET SCI, V88, P127, DOI 10.1016/j.rvsc.2009.05.012; Kuenzel W.J., 1988, STEREOTAXIC ATLAS BR; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Lesku JA, 2014, CURR BIOL, V24, pR12, DOI 10.1016/j.cub.2013.10.005; Livingston A, 1994, J VET ANAESTH, V21, P73, DOI DOI 10.1111/J.1467-2995.1994.TB00490.X; Low PS, 2008, P NATL ACAD SCI USA, V105, P9081, DOI 10.1073/pnas.0703452105; LUDDERS JW, 1995, J AM ANIM HOSP ASSOC, V31, P38, DOI 10.5326/15473317-31-1-38; Machin KL, 2005, SEMIN AVIAN EXOT PET, V14, P236, DOI 10.1053/j.saep.2005.09.004; Machin KL, 2002, AM J VET RES, V63, P821, DOI 10.2460/ajvr.2002.63.821; Martin JE, 2016, PHYSIOL BEHAV, V163, P25, DOI 10.1016/j.physbeh.2016.04.038; MAYHEW IG, 1990, BRIT VET J, V146, P509, DOI 10.1016/0007-1935(90)90054-7; McIlhone AE, 2017, VET MED SCI UNPUB; McIlhone AE, 2014, VET ANAESTH ANALG, V41, P613, DOI 10.1111/vaa.12154; Mellor DJ, 2000, BIOLOGY OF ANIMAL STRESS, P171, DOI 10.1079/9780851993591.0171; Murrell JC, 2007, BRIT J ANAESTH, V98, P366, DOI 10.1093/bja/ael377; Murrell JC, 2006, J VET PHARMACOL THER, V29, P325, DOI 10.1111/j.1365-2885.2006.00758.x; Murrell JC, 2005, VET ANAESTH ANALG, V32, P212, DOI 10.1111/j.1467-2995.2005.00201.x; Murrell JC, 2003, VET ANAESTH ANALG, V30, P138, DOI 10.1046/j.1467-2995.2003.00138.x; Paul-Murphy JR, 1999, AM J VET RES, V60, P1213; RAJ ABM, 1990, RES VET SCI, V49, P355, DOI 10.1016/0034-5288(90)90073-D; Reiner A, 2005, ANAT REC PART A, V287A, P1080, DOI 10.1002/ar.a.20253; REINER A, 1984, J COMP NEUROL, V228, P245, DOI 10.1002/cne.902280210; Sandercock DA, 2004, BRAIN RES REV, V46, P155, DOI 10.1016/j.brainresrev.2004.07.020; Sandercock DA, 2014, PHYSIOL BEHAV, V133, P252, DOI 10.1016/j.physbeh.2014.05.030; Schnitzler A, 2000, J CLIN NEUROPHYSIOL, V17, P592, DOI 10.1097/00004691-200011000-00005; Singh PM, 2017, VET ANAESTH ANALG, V44, P538, DOI 10.1016/j.vaa.2016.05.006; Tisdale RK, 2017, BRAIN BEHAV EVOLUT, V89, P249, DOI 10.1159/000475590; Wang YA, 2010, P NATL ACAD SCI USA, V107, P12676, DOI 10.1073/pnas.1006645107; WOOLLEY SC, 1987, COMP BIOCHEM PHYS A, V88, P27, DOI 10.1016/0300-9629(87)90093-4	59	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196454	10.1371/journal.pone.0196454	http://dx.doi.org/10.1371/journal.pone.0196454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698446	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600083
J	Pande, M; Joon, A; Brewster, AM; Chen, WV; Hoppers, JL; Eng, C; Shete, S; Casey, G; Schumacher, F; Lin, Y; Harrison, TA; White, E; Ahsan, H; Andrulis, IL; Whittemore, AS; John, EM; Win, AK; Makalic, E; Schmidt, DF; Kapuscinski, MK; Ochs-Balcom, HM; Gallinger, S; Jenkins, MA; Newcomb, PA; Lindor, NM; Peters, U; Amos, CI; Lynch, PM				Pande, Mala; Joon, Aron; Brewster, Abenaa M.; Chen, Wei V.; Hoppers, John L.; Eng, Cathy; Shete, Sanjay; Casey, Graham; Schumacher, Fredrick; Lin, Yi; Harrison, Tabitha A.; White, Emily; Ahsan, Habibul; Andrulis, Irene L.; Whittemore, Alice S.; John, Esther M.; Win, Aung Ko; Makalic, Enes; Schmidt, Daniel F.; Kapuscinski, Miroslaw K.; Ochs-Balcom, Heather M.; Gallinger, Steven; Jenkins, Mark A.; Newcomb, Polly A.; Lindor, Noralane M.; Peters, Ulrike; Amos, Christopher I.; Lynch, Patrick M.			Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies	PLOS ONE			English	Article							FAMILY REGISTRY; RISK; ROBO1; COLON; CHEK2; EPIDEMIOLOGY; EXPRESSION; RESOURCE; SPECTRUM; CARRIERS	Background Clustering of breast and colorectal cancer has been observed within some families and cannot be explained by chance or known high-risk mutations in major susceptibility genes. Potential shared genetic susceptibility between breast and colorectal cancer, not explained by high-penetrance genes, has been postulated. We hypothesized that yet undiscovered genetic variants predispose to a breast-colorectal cancer phenotype. Methods To identify variants associated with a breast-colorectal cancer phenotype, we analyzed genome-wide association study (GWAS) data from cases and controls that met the following criteria: cases (n = 985) were women with breast cancer who had one or more first-or second-degree relatives with colorectal cancer, men/women with colorectal cancer who had one or more first-or second-degree relatives with breast cancer, and women diagnosed with both breast and colorectal cancer. Controls (n = 1769), were unrelated, breast and colorectal cancer-free, and age-and sex-frequency-matched to cases. After imputation, 6,220,060 variants were analyzed using the discovery set and variants associated with the breast-colorectal cancer phenotype at P<5.0E-04 (n = 549, at 60 loci) were analyzed for replication (n = 293 cases and 2,103 controls). Results Multiple correlated SNPs in intron 1 of the ROBO1 gene were suggestively associated with the breast-colorectal cancer phenotype in the discovery and replication data (most significant; rs7430339, P-discovery = 1.2E-04; rs7429100, P-replication = 2.8E-03). In meta-analysis of the discovery and replication data, the most significant association remained at rs7429100 (P = 1.84E-06). Conclusion The results of this exploratory analysis did not find clear evidence for a susceptibility locus with a pleiotropic effect on hereditary breast and colorectal cancer risk, although the suggestive association of genetic variation in the region of ROBO1, a potential tumor suppressor gene, merits further investigation.	[Pande, Mala; Lynch, Patrick M.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Joon, Aron; Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Brewster, Abenaa M.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Chen, Wei V.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Hoppers, John L.; Win, Aung Ko; Makalic, Enes; Schmidt, Daniel F.; Kapuscinski, Miroslaw K.; Jenkins, Mark A.] Univ Melbourne, Sch Populat & Global Hlth, Epidemiol & Inst Hlth & Environm, Parkville, Vic, Australia; [Eng, Cathy] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA; [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Casey, Graham] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Schumacher, Fredrick] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Lin, Yi; Harrison, Tabitha A.; White, Emily; Newcomb, Polly A.; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Ahsan, Habibul] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA; [Andrulis, Irene L.; Gallinger, Steven] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Mt Sinai Hlth Syst, Dept Mol Genet, Toronto, ON, Canada; [Whittemore, Alice S.; John, Esther M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA USA; [John, Esther M.] Canc Prevent Inst Calif, Dept Epidemiol, Fremont, CA USA; [Ochs-Balcom, Heather M.] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Dept Epidemiol & Environm Hlth, Buffalo, NY USA; [Lindor, Noralane M.] Mayo Clin, Dept Hlth Sci Res, Scottsdale, AZ USA; [Amos, Christopher I.] Dartmouth Coll, Dept Community & Family Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Melbourne; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Virginia; Case Western Reserve University; Fred Hutchinson Cancer Center; University of Chicago; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Stanford University; Cancer Prevention Institute of California; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Mayo Clinic; Mayo Clinic Phoenix; Dartmouth College	Pande, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.	mpande@mdanderson.org	Schumacher, Fredrick/R-6043-2019; Ochs-Balcom, Heather M/F-3500-2012; Win, Aung K./J-6204-2015; Jenkins, Mark/P-7803-2015	Schumacher, Fredrick/0000-0002-3073-7463; Win, Aung K./0000-0002-2794-5261; Joon, Aron/0000-0003-2615-2179; Pande, Mala/0000-0002-2504-4742; Jenkins, Mark/0000-0002-8964-6160; Makalic, Enes/0000-0003-3017-0871; Hopper, John/0000-0002-8567-173X; Eng, Cathy/0000-0003-2335-0612	National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services [BCFR: UM1 CA164920, CCFR: UM1 CA167551, U01/U24 CA074783, U01/U24 CA074799, U01 CA074778, U01/U24 CA097735, U01/U24 CA074794, U01/U24 CA074800, U01/U24 CA074806, U01 CA137088, K05 CA154337, U01 CA188392, K07 CA160753]; NCI/NIH [U01 CA122839, R01 CA143237]; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NATIONAL CANCER INSTITUTE [U01CA097735, R01CA143237, K07CA160753, U01CA074806, U24CA074794, K05CA154337, UM1CA167551, U01CA122839, U24CA074800, U01CA074783, U01CA137088, U01CA074799, U24CA074783, U01CA188392, U24CA074806, P30CA023108, UM1CA164920, U01CA074794, U24CA074799, U24CA097735] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grants from the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services-BCFR: UM1 CA164920 (EMJ); CCFR: UM1 CA167551 and through cooperative agreements with U01/U24 CA074783 (Ontario CCFR to SG), U01/U24 CA074799 (USC CCFR to RWH), U01 CA074778 and U01/U24 CA097735 (Australasian CCFR, to JLH and MAJ), U01/U24 CA074794 (Seattle CCFR to PAN), U01/U24 CA074800 (Mayo Clinic CCFR to NML), U01/U24 CA074806 (Hawaii CCFR to LL); U01 CA137088 (GECCO to UP), K05 CA154337 (VITAL to EW); U01 CA188392 (to FS), K07 CA160753 (to MP). The Colon CFR Illumina GWAS was supported by NCI/NIH grant U01 CA122839 and R01 CA143237 (to GC). The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahsan H, 2014, CANCER EPIDEM BIOMAR, V23, P658, DOI 10.1158/1055-9965.EPI-13-0340; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bhattacharya R, 2016, J GENET, V95, P551, DOI 10.1007/s12041-016-0678-2; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Cheng THT, 2015, SCI REP-UK, V5, DOI 10.1038/srep17369; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Daley D, 2008, AM J HUM GENET, V82, P723, DOI 10.1016/j.ajhg.2008.01.007; Dallol A, 2002, ONCOGENE, V21, P3020, DOI 10.1038/sj.onc.1205421; Dong CH, 2001, INT J CANCER, V92, P883, DOI 10.1002/ijc.1261; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fehringer G, 2016, CANCER RES, V76, P5103, DOI 10.1158/0008-5472.CAN-15-2980; Figueiredo JC, 2011, CANCER EPIDEM BIOMAR, V20, P758, DOI 10.1158/1055-9965.EPI-10-0675; Friedenson Bernard, 2005, MedGenMed, V7, P60; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Grone J, 2006, ONCOL REP, V15, P1437; Hung RJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv246; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; Kadouri L, 2007, J MED GENET, V44, P467, DOI 10.1136/jmg.2006.048173; Lindstrom S, 2017, CANCER EPIDEM BIOMAR, V26, P1427, DOI 10.1158/1055-9965.EPI-17-0211; Lipton L, 2001, Fam Cancer, V1, P189, DOI 10.1023/A:1021101014264; LYNCH HT, 1972, J AMER MED ASSOC, V222, P1631, DOI 10.1001/jama.222.13.1631; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Naseem H, 2006, CLIN GENET, V70, P388, DOI 10.1111/j.1399-0004.2006.00698.x; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Peng B, 2010, HUM GENET, V127, P699, DOI 10.1007/s00439-010-0824-5; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pezzolesi MG, 2006, AM J HUM GENET, V79, P923, DOI 10.1086/508943; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin FX, 2015, SCI REP-UK, V5, DOI 10.1038/srep14430; Scott Rodney J, 2004, Hered Cancer Clin Pract, V2, P25, DOI 10.1186/1897-4287-2-1-25; Stolfi C, 2013, INT J MOL SCI, V14, P23774, DOI 10.3390/ijms141223774; Vasen HFA, 2001, AM J HUM GENET, V68, P1533, DOI 10.1086/320610; Villacis RAR, 2016, TUMOR BIOL, V37, P3145, DOI 10.1007/s13277-015-4145-0; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yu HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05732-z	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196245	10.1371/journal.pone.0196245	http://dx.doi.org/10.1371/journal.pone.0196245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698419	Green Published, gold			2022-12-26	WOS:000431007600049
J	Silva, NCBS; Gill, DP; Owen, AM; Liu-Ambrose, T; Hachinski, V; Shigematsu, R; Petrella, RJ				Silva, Narlon Cassio Boa Sorte; Gill, Dawn P.; Owen, Adrian M.; Liu-Ambrose, Teresa; Hachinski, Vladimir; Shigematsu, Ryosuke; Petrella, Robert J.			Cognitive changes following multiple-modality exercise and mind-motor training in older adults with subjective cognitive complaints: The M4 study	PLOS ONE			English	Article							SQUARE-STEPPING EXERCISE; MEMORY COMPLAINTS; ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; AEROBIC EXERCISE; RISK-FACTORS; IMPAIRMENT; DECLINE; COMMUNITY; ASSOCIATION	Background We investigated the effects of multiple-modality exercise with additional mind-motor training on cognition in community-dwelling older adults with subjective cognitive complaints. Methods Participants (n = 127, mean age 67.5 [7.3] years, 71% women) were randomized to receive 45 minutes of multiple-modality exercise with additional 15 minutes of either mind-motor training (M4, n = 63) or control (balance, range of motion and breathing exercises [M2, n = 64]). In total, both groups exercised 60 minutes/day, 3 days/week, for 24 weeks. Standardized global cognitive functioning (GCF), concentration, reasoning, planning, and memory were assessed at 24 weeks and after a 28-week no-contact follow-up. Results There were no significant differences in the study primary outcomes. The M4 group, however, showed trends for greater improvements in GCF and memory (both, P = .07) compared to the M2 group at 24 weeks. Significant differences between group in GCF (P = .03) and memory (P = .02) were observed after the 28-week no-contact follow-up favouring the M4 group. Discussion Additional mind-motor training did not impart immediate greater benefits to cognition among the study participants.	[Silva, Narlon Cassio Boa Sorte; Petrella, Robert J.] Western Univ, Sch Kinesiol, Fac Hlth Sci, London, ON, Canada; [Silva, Narlon Cassio Boa Sorte; Gill, Dawn P.; Petrella, Robert J.] Lawson Hlth Res Inst, London, ON, Canada; [Gill, Dawn P.; Petrella, Robert J.] Western Univ, Grad Program Hlth & Rehabil Sci, Fac Hlth Sci, London, ON, Canada; [Gill, Dawn P.; Petrella, Robert J.] Western Univ, Sch Hlth Studies, Fac Hlth Sci, London, ON, Canada; [Gill, Dawn P.; Petrella, Robert J.] Western Univ, Dept Family Med, Ctr Studies Family Med, London, ON, Canada; [Gill, Dawn P.; Petrella, Robert J.] Western Univ, Canadian Ctr Act & Aging, London, ON, Canada; [Owen, Adrian M.] Western Univ, Brain & Mind Inst, Dept Psychol, London, ON, Canada; [Liu-Ambrose, Teresa] Univ British Columbia, Dept Phys Therapy, Fac Med, Vancouver, BC, Canada; [Liu-Ambrose, Teresa] Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Hachinski, Vladimir] Western Univ, London Hlth Sci Ctr, Dept Clin Neurol Sci, London, ON, Canada; [Shigematsu, Ryosuke] Mie Univ, Fac Educ, Tsu, Mie, Japan	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of British Columbia; London Health Sciences Centre; Western University (University of Western Ontario); Mie University	Petrella, RJ (corresponding author), Western Univ, Sch Kinesiol, Fac Hlth Sci, London, ON, Canada.; Petrella, RJ (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.; Petrella, RJ (corresponding author), Western Univ, Grad Program Hlth & Rehabil Sci, Fac Hlth Sci, London, ON, Canada.; Petrella, RJ (corresponding author), Western Univ, Sch Hlth Studies, Fac Hlth Sci, London, ON, Canada.; Petrella, RJ (corresponding author), Western Univ, Dept Family Med, Ctr Studies Family Med, London, ON, Canada.; Petrella, RJ (corresponding author), Western Univ, Canadian Ctr Act & Aging, London, ON, Canada.	robert.petrella@schulich.uwo.ca	Boa Sorte Silva, Nárlon/ABH-1468-2021; Liu-Ambrose, Teresa/W-2332-2019; Shigematsu, Ryosuke/AAW-7348-2021	Boa Sorte Silva, Nárlon/0000-0002-4847-3742; Liu-Ambrose, Teresa/0000-0002-8297-5308; Shigematsu, Ryosuke/0000-0002-4852-1265	Canadian Institutes of Health Research [MOP 130474]; St. Joseph's Health Care Foundation [048-1415]; Mitacs Globalink Graduate Fellowship (NCBSS); Fellowship in the Care of the Elderly Research, a training award through the Aging, Rehabilitation, and Geriatric Care Research Centre of the Lawson Health Research Institute; St. Joseph's Health Care Foundation (MAG)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); St. Joseph's Health Care Foundation; Mitacs Globalink Graduate Fellowship (NCBSS); Fellowship in the Care of the Elderly Research, a training award through the Aging, Rehabilitation, and Geriatric Care Research Centre of the Lawson Health Research Institute; St. Joseph's Health Care Foundation (MAG)	This work was supported by the Canadian Institutes of Health Research (RJP; grant number: MOP 130474), St. Joseph's Health Care Foundation (RJP; grant number: 048-1415) (http://www.cihr-irsc.gc.ca/e/193.html). The other funding sources listed were studentships and fellowships awards to students: Mitacs Globalink Graduate Fellowship (NCBSS) http://www.mitacs.ca/en/programs/globalink/globalink-graduate-fellowship <http://www.mitacs.ca/en/programs/globalink/globalink-graduate-fellowship>, and Fellowship in the Care of the Elderly Research, a training award through the Aging, Rehabilitation, and Geriatric Care Research Centre of the Lawson Health Research Institute in partnership with the St. Joseph's Health Care Foundation (MAG) https://www.sjhcfoundation.org/ <https://www.spcfoundatiortorg/>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; Amariglio RE, 2011, J AM GERIATR SOC, V59, P1612, DOI 10.1111/j.1532-5415.2011.03543.x; Barnes DE, 2013, JAMA INTERN MED, V173, P797, DOI 10.1001/jamainternmed.2013.189; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Buckley RF, 2015, NEUROPSYCHOLOGY, V29, P571, DOI 10.1037/neu0000156; Cespon J, 2018, AGEING RES REV, V43, P81, DOI 10.1016/j.arr.2018.03.001; Chao LL, 2010, NEUROBIOL AGING, V31, P368, DOI 10.1016/j.neurobiolaging.2008.05.004; Chen ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098630; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fitzmaurice G, 2011, APPL LONGITUDINAL AN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gates N, 2013, AM J GERIAT PSYCHIAT, V21, P1086, DOI 10.1016/j.jagp.2013.02.018; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Gregory MA, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0190-9; Gregory MA, 2013, CURR SPORT MED REP, V12, P256, DOI 10.1249/JSR.0b013e31829a74fd; Hampshire A, 2012, NEURON, V76, P1225, DOI 10.1016/j.neuron.2012.06.022; Heyward V., 2014, ADV FITNESS ASSESSME, V7th; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jonasson LS, 2017, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00336; Kaup AR, 2015, NEUROLOGY, V85, P1852, DOI 10.1212/WNL.0000000000002153; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Teixeira CVL, 2013, PSYCHOGERIATRICS, V13, P148, DOI 10.1111/psyg.12017; Liu C, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/730652; Liu-Ambrose T, 2016, NEUROLOGY, V87, P2082, DOI 10.1212/WNL.0000000000003332; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Monsell SE, 2012, INT PSYCHOGERIATR, V24, P1553, DOI 10.1017/S1041610212000452; Mortimer JA, 2012, J ALZHEIMERS DIS, V30, P757, DOI 10.3233/JAD-2012-120079; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nishiguchi S, 2015, J AM GERIATR SOC, V63, P1355, DOI 10.1111/jgs.13481; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Perrotin A, 2017, ALZHEIMERS DEMENT, V13, P550, DOI 10.1016/j.jalz.2016.08.011; Saykin AJ, 2012, OLDER ADULTS COGNITI, V67, P834; Shigematsu R, 2014, J GERONTOL GERIAT RE, V3, P2, DOI DOI 10.4172/2167-7182.1000147; Shigematsu R, 2008, J GERONTOL A-BIOL, V63, P76, DOI 10.1093/gerona/63.1.76; Shigematsu R, 2008, AGING CLIN EXP RES, V20, P19; Silva NCBS, 2018, EXP GERONTOL, V103, P17, DOI 10.1016/j.exger.2017.12.011; Silva NCBS, 2017, ARCH GERONTOL GERIAT, V68, P149, DOI 10.1016/j.archger.2016.10.009; Sink KM, 2015, JAMA-J AM MED ASSOC, V314, P781, DOI 10.1001/jama.2015.9617; Smith JC, 2013, J ALZHEIMERS DIS, V37, P197, DOI 10.3233/JAD-130467; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stuckey M, 2012, CRIT REV PHYS REHAB, V24, P109, DOI DOI 10.1615/CRITREVPHYSREHABILMED.2013006823; ten Brinke LF, 2015, BRIT J SPORT MED, V49, P248, DOI 10.1136/bjsports-2013-093184; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Waldofff FB, 2009, INT J GERIATR PSYCH, V24, P602, DOI 10.1002/gps.2163; Young J, 2015, AEROBIC EXERCISE IMP, V4, DOI [10.1002/14651858.CD005381.pub4, DOI 10.1002/14651858.CD005381.PUB4]	53	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196356	10.1371/journal.pone.0196356	http://dx.doi.org/10.1371/journal.pone.0196356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1WN	29698440	Green Submitted, Green Published, gold			2022-12-26	WOS:000431007600067
J	Berihuete-Azorin, M; Girbal, J; Pique, R; Palomo, A; Terradas, X				Berihuete-Azorin, Marian; Girbal, Josep; Pique, Raquel; Palomo, Antoni; Terradas, Xavier			Punk's not dead. Fungi for tinder at the Neolithic site of La Draga (NE Iberia)	PLOS ONE			English	Article							BANYOLES; SPAIN	This paper presents the study of the fungi remains preserved in the waterlogged deposits of the Neolithic site of La Draga. These resources had the potential of being used as food and medicine, but also as tinder. Fire was without a doubt one of the most important resources for past people. It was used for lighting, heating, processing food and other materials, cooking and protection, and also possessed social and ritual significance. Hearths are one of the most common features at archaeological sites, but very often little attention is paid to the question of how these fires were lit, and they are seldom reflected in the archaeological record. In order to produce fire by percussion, an intermediate material is required between the sparks and the fuel. Fruiting bodies of fungi are a potential form of tinder, but are less inclined to be well-preserved than other materials. This paper presents the fungal fruiting bodies found at the Neolithic site of La Draga and discusses the meaning of their presence within the archaeological context of the site and European Prehistory.	[Berihuete-Azorin, Marian] Hohenheim Univ, Inst Bot, Stuttgart, Germany; [Girbal, Josep] Univ Autonoma Barcelona, Dept Anim Biol Plant Biol & Ecol, Barcelona, Spain; [Pique, Raquel] Univ Autonoma Barcelona, Dept Prehist, Barcelona, Spain; [Palomo, Antoni] Archaeol Museum Catalonia, Barcelona, Spain; [Terradas, Xavier] CSIC, IMF, Archeol Social Dynam, Barcelona, Spain	University Hohenheim; Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF)	Berihuete-Azorin, M (corresponding author), Hohenheim Univ, Inst Bot, Stuttgart, Germany.	mberihueteazorin@gmail.com	Berihuete Azorín, Marian/H-9833-2015; Terradas, Xavier/H-7968-2015	Berihuete Azorín, Marian/0000-0002-6248-1562; Terradas, Xavier/0000-0002-8000-5607; Pique Huerta, Raquel/0000-0002-8253-6874	 [2015ACUP0191];  [2014/100822];  [HAR2016-76534-C2-1-R];  [HAR2016-76534-C2-2-R];  [437 K117]	; ; ; ; 	RP, XT, MB, JG, AP: - 2015ACUP0191 and 2014/100822. The Digital Reconstruction of the Prehistoric Past:Virtual Reality and Artificial Intelligence for understanding social life in the Neolithic. Associacio Catalana d'Universitats Publiques (ACUP) and Obra Social "La Caixa). https://obrasociallacaixa.org/ca/investigacion-y-salud/investigacion-ciencias-sociales-humanidades/convocatorias. - HAR2016-76534-C2-1-R and. Simulacion computacional de fenomenos historicos de cambio social y tecnologico durante el neolitico. and HAR2016-76534-C2-2-R Producciones, variabilidad tecnica e innovacion tecnologica en el Neolitico. Ministerio de Economia y Competitividad (MINECO). http://www.idi.mineco.gob.es. - 437 K117. La Draga en el proces de neolititzacio del nord-est peninsular.. Departament de Cultura de la Generalitat de Catalunya. http://cultura.gencat.cat/ca/departament/.. The funders provide the economic means for the excavations at La Draga site, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RP: ICREA Academia. Institucio Catalana de Recerca i Estudis Avancats (ICREA). littps.//www.icrea.cat/en.	Anderson MK, 2013, J ETHNOBIOL, V33, P33, DOI 10.2993/0278-0771-33.1.33; Antolin F., 2011, POBLAT LACUSTRE NEOL, P147; Bernicchia A, 2006, MYCOL RES, V110, P14, DOI 10.1016/j.mycres.2005.09.012; Boa E, 2004, NONWOOD FOREST PRODU; Bogdanovic I., 2015, 5 C NEOL PEN ACT LIS, P228; Bosch A., 2006, ELS OBJECTES FUSTA P; Bosch A, 2011, EXCAVACIONS 2000 200; Bosch A, 2011, POBLAT LACUSTRE NEOL, P19; Bosch A., 2000, POBLAT LACUSTRE NEOL, V2; Breitenbach J., 1986, CHAMPIGNONS SANS LAM; Ferme LC, 2014, HOLOCENE, V24, P266, DOI 10.1177/0959683613517400; Collina-Girard J., 2011, PRODUCTION FEU RENCO, P25; Corner E., 1950, SEAMER P PREHISTORY, V9, P123; Dugan F. M., 2008, FUNGI ANCIENT WORLD; Ellis M.B., 1987, MICROFUNGI LAND PLAN; Fakoya S, 2012, TAF PREV MED B, P11; Gebhardt P, 2007, BIOORG MED CHEM LETT, V17, P2558, DOI 10.1016/j.bmcl.2007.02.008; Girbal J., 2000, POBLAT LACUSTRE NEOL; Girbal J., 2011, POBLAT LACUSTRE NEOL; JULICH W., 1989, GUIDA DETERMINAZIONE, V2; Keller J, 1991, B SOC FRIBOURGOISE S, V80, P105, DOI [10.5169/seals-308707, DOI 10.5169/SEALS-308707]; Kreisel Hanns, 2009, Zeitschrift fuer Mykologie, V75, P33; O'Regan HJ, 2016, J ARCHAEOL SCI, V75, P139, DOI 10.1016/j.jas.2016.09.009; Palomo, 2013, REGARDS CROISES OUTI, P383; Palomo A., 2014, SPAIN J WETL ARHCAEO, V14, P58, DOI [10.1179/1473297114Z.00000000010, DOI 10.1179/1473297114Z.00000000010]; Palomo A, 2011, ANTIQUITY, V85, P759, DOI 10.1017/S0003598X00068290; Papp N, 2017, GENET RESOUR CROP EV, V64, P101, DOI 10.1007/s10722-015-0335-2; Peintner U, 2000, MAN IN ICE, V4, P143; Pique R., 2016, QUAT INT; Pique R., 2000, POBLAT LACUSTRE NEOL, P141; Pique R, 2015, J ARCHAEOL SCI, V55, P166, DOI 10.1016/j.jas.2015.01.005; Power RC, 2015, J ARCHAEOL SCI, V60, P39, DOI 10.1016/j.jas.2015.04.003; Revelles J, 2015, PALAEOGEOGR PALAEOCL, V435, P70, DOI 10.1016/j.palaeo.2015.06.002; Revelles J, 2014, ENVIRON ARCHAEOL, V19, P298, DOI 10.1179/1749631414Y.0000000033; Roussel B, 2002, CRYPTOGAMIE MYCOL, V23, P349; Roussel B, 2005, PRODUCTION FEU PERCU; Sa?a M., 2011, POBLAT LACUSTRE NEOL, P177; Tarrus i Galter J, 2009, CATALAN HIST REV, P17; TERBERGER T, 1996, ARCHAOL KORRESPONDEN, V26, P13; Terradas X., 2017, FUNDAM ISSUES ARCHAE, P199, DOI 10.1007/978-3-319-52939-4_8; Tolar T, 2011, VEG HIST ARCHAEOBOT, V20, P207, DOI 10.1007/s00334-010-0280-0; Uzunov Blagoy Angelov, 2015, J MYCOL, V2015, DOI [10.1155/2015/361053/, DOI 10.1155/2015/361053, 10.1155/2015/361053]; Wachtel-Galor S., 2011, GANODERMA LUCIDUM; Webster J., 1983, PILZE, DOI [10.1007/978-3-642-68825-6, DOI 10.1007/978-3-642-68825-6]; Webster J., 2007, INTRO FUNGI, V3rd	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195846	10.1371/journal.pone.0195846	http://dx.doi.org/10.1371/journal.pone.0195846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	29694409	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400047
J	Cappelletti, P; Tallarita, E; Rabattoni, V; Campomenosi, P; Sacchi, S; Pollegioni, L				Cappelletti, Pamela; Tallarita, Elena; Rabattoni, Valentina; Campomenosi, Paola; Sacchi, Silvia; Pollegioni, Loredano			Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line	PLOS ONE			English	Article							AMINO-ACID OXIDASE; GLIOMA-CELLS; D-SERINE; SCHIZOPHRENIA; METABOLISM; TRANSPORTERS; PRODH; RAT; EXPRESSION; RELEASE	L-Proline is a multifunctional amino acid that plays an essential role in primary metabolism and physiological functions. Proline is oxidized to glutamate in the mitochondria and the FAD-containing enzyme proline oxidase (PO) catalyzes the first step in L-proline degradation pathway. Alterations in proline metabolism have been described in various human diseases, such as hyperprolinemia type I, velo-cardio-facial syndrome/Di George syndrome, schizophrenia and cancer. In particular, the mutation giving rise to the substitution Leu441-Pro was identified in patients suffering of schizophrenia and hyperprolinemia type I. Here, we report on the expression of wild-type and L441P variants of human PO in a U87 glioblastoma human cell line in an attempt to assess their effect on glutamate metabolism. The subcellular localization of the flavoenzyme is not altered in the L441P variant, for which specific activity is halved compared to the wild-type PO. While this decrease in activity is significantly less than that previously proposed, an effect of the substitution on the enzyme stability is also apparent in our studies. At 24 hours of growth from transient transfection, the intracellular level of proline, glutamate, and glutamine is decreased in cells expressing the PO variants as compared to control U87 cells, reaching a similar figure at 72 h. On the other hand, the extracellular levels of the three selected amino acids show a similar time course for all clones. Furthermore, PO overexpression does not modify to a significant extent the expression of GLAST and GLT-1 glutamate transporters. Altogether, these results demonstrate that the proline pathway links cellular proline levels with those of glutamate and glutamine. On this side, PO might play a regulatory role in glutamatergic neurotransmission by affecting the cellular concentration of glutamate.	[Cappelletti, Pamela; Tallarita, Elena; Rabattoni, Valentina; Campomenosi, Paola; Sacchi, Silvia; Pollegioni, Loredano] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Cappelletti, Pamela; Campomenosi, Paola; Sacchi, Silvia; Pollegioni, Loredano] Politecn Milan, Prot Factory Res Ctr, Milan, Italy; [Cappelletti, Pamela; Campomenosi, Paola; Sacchi, Silvia; Pollegioni, Loredano] Univ Insubria, Milan, Italy	University of Insubria; Polytechnic University of Milan; University of Insubria	Cappelletti, P (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy.; Cappelletti, P (corresponding author), Politecn Milan, Prot Factory Res Ctr, Milan, Italy.; Cappelletti, P (corresponding author), Univ Insubria, Milan, Italy.	pamela.cappelletti.pc@gmail.com	Campomenosi, Paola/C-9729-2011	Campomenosi, Paola/0000-0002-8853-1134; POLLEGIONI, LOREDANO/0000-0003-1733-7243; Cappelletti, Pamela/0000-0002-2062-4852	Fondi di Ateneo per la Ricerca	Fondi di Ateneo per la Ricerca	Loredano Pollegioni and Silvia Sacchi received funding for this work from Fondi di Ateneo per la Ricerca.	Bauer D, 2010, SCHIZOPHR RES, V117, P92, DOI 10.1016/j.schres.2009.07.025; Behrens PF, 2000, J NEURO-ONCOL, V47, P11, DOI 10.1023/A:1006426917654; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Bianchi L, 2004, NEUROCHEM RES, V29, P325, DOI 10.1023/B:NERE.0000010462.72557.6d; Clelland CL, 2011, SCHIZOPHR RES, V131, P139, DOI 10.1016/j.schres.2011.05.006; Cohen SM, 1997, BRAIN RES, V769, P333, DOI 10.1016/S0006-8993(97)00721-X; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Lee A, 2012, J CHEM NEUROANAT, V43, P52, DOI 10.1016/j.jchemneu.2011.10.005; Pereira MSL, 2017, ONCOTARGET, V8, P22279, DOI 10.18632/oncotarget.15299; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Lopez-Bayghen E, 2011, IUBMB LIFE, V63, P816, DOI 10.1002/iub.536; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Maxwell SA, 2003, J BIOL CHEM, V278, P9784, DOI 10.1074/jbc.M210012200; Maynard TM, 2008, MOL CELL NEUROSCI, V39, P439, DOI 10.1016/j.mcn.2008.07.027; Mitsubuchi H, 2008, J NUTR, V138, p2016S, DOI 10.1093/jn/138.10.2016S; Olivares O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16031; Olney JW, 2003, CURR OPIN PHARMACOL, V3, P101, DOI 10.1016/S1471-4892(02)00002-4; Oresic M, 2011, GENOME MED, V3, DOI 10.1186/gm233; Pandhare J, 2009, J CELL BIOCHEM, V107, P759, DOI 10.1002/jcb.22174; Panosyan EH, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3148-1; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Phang JM, 2012, FRONT BIOSCI-LANDMRK, V17, P1835, DOI 10.2741/4022; Phang JM, 2001, DISORDERS PROLINE HY, P1821; Renick SE, 1999, J NEUROSCI, V19, P21, DOI 10.1523/JNEUROSCI.19-01-00021.1999; Sacchi S, 2008, J BIOL CHEM, V283, P22244, DOI 10.1074/jbc.M709153200; Sacchi S, 2011, MOL CELL NEUROSCI, V48, P20, DOI 10.1016/j.mcn.2011.06.001; Servet C, 2012, FRONT BIOSCI-LANDMRK, V17, P607, DOI 10.2741/3947; Shao W, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-197; Shoji K, 2006, NEUROSCI LETT, V392, P75, DOI 10.1016/j.neulet.2005.08.063; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tallarita E, 2012, PROTEIN EXPRES PURIF, V82, P345, DOI 10.1016/j.pep.2012.01.021; Tanner JJ, 2008, AMINO ACIDS, V35, P719, DOI 10.1007/s00726-008-0062-5; Williams HJ, 2003, AM J MED GENET B, V120B, P42, DOI 10.1002/ajmg.b.20049; Willis A, 2008, AMINO ACIDS, V35, P673, DOI 10.1007/s00726-008-0111-0; Wyse ATS, 2011, METAB BRAIN DIS, V26, P159, DOI 10.1007/s11011-011-9246-x; Ye ZC, 1999, CANCER RES, V59, P4383; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; Yu XC, 2009, NEUROSCI LETT, V451, P212, DOI 10.1016/j.neulet.2009.01.018; Zhang J, 2017, EMBO J, V36, P1302, DOI 10.15252/embj.201696151	43	20	20	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196283	10.1371/journal.pone.0196283	http://dx.doi.org/10.1371/journal.pone.0196283			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694413	Green Published, Green Submitted, gold			2022-12-26	WOS:000430802400078
J	de la Fuente, MO; Febrero-Bande, M; Munoz, MP; Dominguez, A				Oviedo de la Fuente, Manuel; Febrero-Bande, Manuel; Pilar Munoz, Maria; Dominguez, Angela			Predicting seasonal influenza transmission using functional regression models with temporal dependence	PLOS ONE			English	Article							SURVEILLANCE; MORTALITY	This paper proposes a novel approach that uses meteorological information to predict the incidence of influenza in Galicia (Spain). It extends the Generalized Least Squares (GLS) methods in the multivariate framework to functional regression models with dependent errors. These kinds of models are useful when the recent history of the incidence of influenza are readily unavailable (for instance, by delays on the communication with health informants) and the prediction must be constructed by correcting the temporal dependence of the residuals and using more accessible variables. A simulation study shows that the GLS estimators render better estimations of the parameters associated with the regression model than they do with the classical models. They obtain extremely good results from the predictive point of view and are competitive with the classical time series approach for the incidence of influenza. An iterative version of the GLS estimator (called iGLS) was also proposed that can help to model complicated dependence structures. For constructing the model, the distance correlation measure R was employed to select relevant information to predict influenza rate mixing multivariate and functional variables. These kinds of models are extremely useful to health managers in allocating resources in advance to manage influenza epidemics.	[Oviedo de la Fuente, Manuel; Febrero-Bande, Manuel] Technol Inst Ind Math ITMATI, Campus Vida, Santiago De Compostela, Spain; [Oviedo de la Fuente, Manuel; Febrero-Bande, Manuel] Univ Santiago de Compostela, Dept Stat Math Anal & Optimizat, MODESTYA Grp, Campus Vida, Santiago De Compostela, Spain; [Pilar Munoz, Maria] Univ Politecn Cataluna, Dept Stat & Operat Res, Barcelona, Spain; [Pilar Munoz, Maria; Dominguez, Angela] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Dominguez, Angela] Univ Barcelona, Dept Med, Barcelona, Spain; [Oviedo de la Fuente, Manuel] Edif Inst Invest Tecnol,Planta 1, Santiago De Compostela 15782, Spain	Universidade de Santiago de Compostela; Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona	de la Fuente, MO (corresponding author), Technol Inst Ind Math ITMATI, Campus Vida, Santiago De Compostela, Spain.; de la Fuente, MO (corresponding author), Univ Santiago de Compostela, Dept Stat Math Anal & Optimizat, MODESTYA Grp, Campus Vida, Santiago De Compostela, Spain.; de la Fuente, MO (corresponding author), Edif Inst Invest Tecnol,Planta 1, Santiago De Compostela 15782, Spain.	manuel.oviedo@usc.es	Bande, Manuel Febrero/C-8078-2012; de la Fuente, Manuel Oviedo/AAB-8040-2019	Bande, Manuel Febrero/0000-0002-9536-2973; de la Fuente, Manuel Oviedo/0000-0001-7360-3249	Catalan Agency for the Management of Grants for University Research (AGAUR) [2014/SGR 1403]; Spanish Ministry of Economy and Competitiveness [MTM2013-41383-P, MTM2016-76969-P]; European Regional Development Fund (ERDF)	Catalan Agency for the Management of Grants for University Research (AGAUR); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund (ERDF)(European Commission)	This study was funded by the Catalan Agency for the Management of Grants for University Research (AGAUR Grant number 2014/SGR 1403) and cofunded by the Spanish Ministry of Economy and Competitiveness (Grant numbers MTM2013-41383-P and MTM2016-76969-P) and European Regional Development Fund (ERDF).	Aneiros-Perez G, 2008, J MULTIVARIATE ANAL, V99, P834, DOI 10.1016/j.jmva.2007.04.010; Aneiros-Perez G, 2006, STAT PROBABIL LETT, V76, P1102, DOI 10.1016/j.spl.2005.12.007; Antoniadis A, 2003, J MULTIVARIATE ANAL, V87, P133, DOI 10.1016/S0047-259X(03)00028-9; Battey H, 2013, J MULTIVARIATE ANAL, V120, P1, DOI 10.1016/j.jmva.2013.04.009; Besse PC, 2000, SCAND J STAT, V27, P673, DOI 10.1111/1467-9469.00215; Cardot H, 2003, STAT SINICA, V13, P571; Cardot H, 2007, PROBAB THEORY REL, V138, P325, DOI 10.1007/s00440-006-0025-2; Carmack PS, 2012, J NONPARAMETR STAT, V24, P269, DOI 10.1080/10485252.2012.655733; Chen D, 2011, ANN STAT, V39, P1720, DOI 10.1214/11-AOS882; Chiou JM, 2003, J R STAT SOC B, V65, P405, DOI 10.1111/1467-9868.00393; CHOI K, 1981, AM J EPIDEMIOL, V113, P215, DOI 10.1093/oxfordjournals.aje.a113090; Conesa D, 2015, STAT METHODS MED RES, V24, P206, DOI 10.1177/0962280211414853; Cuevas A, 2004, COMPUT STAT DATA AN, V47, P111, DOI 10.1016/j.csda.2003.10.021; Damon J., 2005, STAT INFERENCE STOCH, V8, P185, DOI DOI 10.1007/S11203-004-1031-6; Delicado P, 2010, ENVIRONMETRICS, V21, P224, DOI 10.1002/env.1003; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Febrero- Bande M, 2014, CONTRIBUTIONS INFINI, P107; Febrero-Bande M, 2013, TEST-SPAIN, V22, P278, DOI 10.1007/s11749-012-0308-0; Febrero-Bande M, 2012, J STAT SOFTW, V51, P1; Ferraty F, 2013, TEST-SPAIN, V22, P293, DOI 10.1007/s11749-012-0306-2; Ferraty F., 2006, SPR S STAT; Ferraty F, 2009, COMPUT STAT DATA AN, V53, P1400, DOI 10.1016/j.csda.2008.11.023; Giraldo R, 2011, ENVIRON ECOL STAT, V18, P411, DOI 10.1007/s10651-010-0143-y; Goia A, 2012, STAT PROBABIL LETT, V82, P1005, DOI 10.1016/j.spl.2012.02.009; GOLDSTEIN H, 1986, BIOMETRIKA, V73, P43; Hohle M, 2008, COMPUT STAT DATA AN, V52, P4357, DOI 10.1016/j.csda.2008.02.015; Hormann S, 2010, ANN STAT, V38, P1845, DOI 10.1214/09-AOS768; Horvath L., 2012, INFERENCE FUNCTIONAL, V200; Kariya T, 2004, GEN LEAST SQUARES; Menafoglio A, 2013, ELECTRON J STAT, V7, P2209, DOI 10.1214/13-EJS843; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Muller HG, 2008, J AM STAT ASSOC, V103, P1534, DOI 10.1198/016214508000000751; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; Paul M, 2011, STAT MED, V30, P1118, DOI 10.1002/sim.4177; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Preda C, 2005, COMPUT STAT DATA AN, V48, P149, DOI 10.1016/j.csda.2003.10.003; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Sorensen H, 2013, STAT MED, V32, P5222, DOI 10.1002/sim.5989; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Ugarte MD, 2010, ENVIRONMETRICS, V21, P270, DOI 10.1002/env.1011; Van- Tam J, 2012, EPIDEMIOLOGY CLIN FE, P1; Watson JM, 2012, INFLUENZA SURVEILLAN, p9 , DOI [10.1079/9781845938567.0009, DOI 10.1079/9781845938567.0009]	44	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0194250	10.1371/journal.pone.0194250	http://dx.doi.org/10.1371/journal.pone.0194250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694350	Green Submitted, Green Published, gold			2022-12-26	WOS:000430802400009
J	Valdemarsen, T; Quintana, CO; Thorsen, SW; Kristensen, E				Valdemarsen, Thomas; Quintana, Cintia O.; Thorsen, Sandra W.; Kristensen, Erik			Benthic macrofauna bioturbation and early colonization in newly flooded coastal habitats	PLOS ONE			English	Article							MARENZELLERIA-VIRIDIS POLYCHAETA; SCOLOPLOS-ARMIGER POLYCHAETA; MANAGED REALIGNMENT; ARENICOLA-MARINA; NEREIS-DIVERSICOLOR; INTERTIDAL MUDFLATS; ORGANIC-MATTER; REACTION-RATES; SEDIMENT; IMPACT	How will coastal soils in areas newly flooded with seawater function as habitat for benthic marine organisms? This research question is highly relevant as global sea level rise and coastal realignment will cause flooding of soils and form new marine habitats. In this study, we tested experimentally the capacity of common marine polychaetes, Marenzelleria viridis, Nereis (Hediste) diversicolor and Scoloplos armiger to colonize and modify the biogeochemistry of the newly established Gyldensteen Coastal Lagoon, Denmark. All tested polychaetes survived relatively well (28 +/- 89%) and stimulated carbon dioxide release (TCO2) by 97 +/- 105% when transferred to newly flooded soils, suggesting that soil characteristics are modified rapidly by colonizing fauna. A field survey showed that the pioneering benthic community inside the lagoon was structurally different from the marine area outside the lagoon, and M. viridis and S. armiger were not among the early colonizers. These were instead N. diversicolor and Polydora cornuta with an abundance of 1603 and 540 ind m(-2), respectively. Considering the species-specific effects of N. diversicolor on TCO2 release and its average abundance in the lagoon, we estimate that organic carbon degradation was increased by 219% in the first year of flooding. We therefore conclude that early colonizing polychaetes modify the soils and may play an important role in the ecological and successional developments, e. g. C cycling and biodiversity, in newly flooded coastal ecosystems. Newly flooded soils have thus a strong potential to develop into well-functioning marine ecosystems.	[Valdemarsen, Thomas; Quintana, Cintia O.; Thorsen, Sandra W.; Kristensen, Erik] Univ Southern Denmark, Dept Biol, Odense M, Denmark	University of Southern Denmark	Valdemarsen, T (corresponding author), Univ Southern Denmark, Dept Biol, Odense M, Denmark.	valdemarsen@gmail.com	; Quintana, Cintia Organo/B-7797-2012; Valdemarsen, Thomas/B-8032-2012	Kristensen, Erik/0000-0001-7259-0132; Quintana, Cintia Organo/0000-0002-3022-6145; Valdemarsen, Thomas/0000-0002-5561-2413	Aage V. Jensen Nature Foundation; Danish Council for Independent Research [12-127012]; Danish Council for Strategic Research [12-132701]	Aage V. Jensen Nature Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The work was funded by the Aage V. Jensen Nature Foundation and the Danish Council for Independent Research (contract # 12-127012) to EK and from the Danish Council for Strategic Research (contract # 12-132701) to EK. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller RC, 1998, J MAR RES, V56, P905, DOI 10.1357/002224098321667413; ALLER RC, 1994, CHEM GEOL, V114, P331, DOI 10.1016/0009-2541(94)90062-0; Banta GT, 1999, AQUAT MICROB ECOL, V19, P189, DOI 10.3354/ame019189; BOCHERT R, 1995, MAR BIOL, V123, P763, DOI 10.1007/BF00349119; Bolam SG, 2004, J EXP MAR BIOL ECOL, V306, P157, DOI 10.1016/j.jembe.2004.01.007; Craft C, 2003, MAR ECOL PROG SER, V257, P45, DOI 10.3354/meps257045; DALES RP, 1950, J MAR BIOL ASSOC UK, V29, P321, DOI 10.1017/S0025315400055405; Delefosse M, 2012, MAR ECOL PROG SER, V461, P83, DOI 10.3354/meps09821; Essink Karel, 1993, Netherlands Journal of Aquatic Ecology, V27, P237, DOI 10.1007/BF02334787; Evans PR, 1998, MAR POLLUT BULL, V37, P535; French PW, 2006, ESTUAR COAST SHELF S, V67, P409, DOI 10.1016/j.ecss.2005.11.035; Garbutt RA, 2006, MAR POLLUT BULL, V53, P155, DOI 10.1016/j.marpolbul.2005.09.015; GIBBS PE, 1968, J MAR BIOL ASSOC UK, V48, P225, DOI 10.1017/S0025315400032550; Gilbert F, 2003, J MAR RES, V61, P101, DOI 10.1357/002224003321586426; GUNTHER CP, 1992, J EXP MAR BIOL ECOL, V159, P203, DOI 10.1016/0022-0981(92)90037-B; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; Hansen K, 1998, J EXP MAR BIOL ECOL, V231, P201, DOI 10.1016/S0022-0981(98)00070-7; Kauppi L, 2015, BIOL INVASIONS, V17, P2055, DOI 10.1007/s10530-015-0860-0; Kristensen E, 2003, MAR ECOL PROG SER, V265, P141, DOI 10.3354/meps265141; Kristensen E, 2001, Geochem Trans, V2, P92, DOI 10.1186/1467-4866-2-92; KRISTENSEN E, 1984, HOLARCTIC ECOL, V7, P249; KRISTENSEN E, 1995, J MAR RES, V53, P675, DOI 10.1357/0022240953213115; KRISTENSEN E, 1988, OPHELIA, V29, P127, DOI 10.1080/00785326.1988.10430824; Kristensen E, 2001, GEOCHIM COSMOCHIM AC, V65, P419, DOI 10.1016/S0016-7037(00)00532-9; Kristensen E, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00041; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Kristensen E, 2011, MAR ECOL PROG SER, V425, P125, DOI 10.3354/meps09007; Kruse I, 2004, J SEA RES, V51, P53, DOI 10.1016/j.seares.2003.05.004; Kruse I, 2003, MAR BIOL, V143, P511, DOI 10.1007/s00227-003-1112-x; Levin LA, 2002, ECOL APPL, V12, P1785, DOI 10.1890/1051-0761(2002)012[1785:NAMSOH]2.0.CO;2; Levin LA, 1996, MAR ECOL PROG SER, V141, P67, DOI 10.3354/meps141067; Malham SK, 2012, J MAR BIOL ASSOC UK, V92, P1563, DOI 10.1017/S0025315412000355; MARTIN WR, 1992, J MAR RES, V50, P125, DOI 10.1357/002224092784797737; Mazik K, 2007, MAR POLLUT BULL, V55, P564, DOI 10.1016/j.marpolbul.2007.09.017; Michaud E, 2006, J EXP MAR BIOL ECOL, V337, P178, DOI 10.1016/j.jembe.2006.06.025; Montserrat F, 2008, MAR ECOL PROG SER, V372, P43, DOI 10.3354/meps07769; Moseman SM, 2004, ESTUAR COAST SHELF S, V60, P755, DOI 10.1016/j.ecss.2004.03.013; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Nielsen OI, 2003, AQUAT MICROB ECOL, V33, P95, DOI 10.3354/ame033095; Nilsson HC, 1997, J MARINE SYST, V11, P249, DOI 10.1016/S0924-7963(96)00111-X; Nordstrom MC, 2014, MAR ECOL PROG SER, V500, P43, DOI 10.3354/meps10686; Norkko A, 2006, J EXP MAR BIOL ECOL, V330, P195, DOI 10.1016/j.jembe.2005.12.027; Norkko J, 2015, ECOSYSTEMS, V18, P1424, DOI 10.1007/s10021-015-9909-2; Nunn AD, 2016, ECOL ENG, V87, P71, DOI 10.1016/j.ecoleng.2015.11.009; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Quintana CO, 2018, ESTUAR COAST, V41, P1766, DOI 10.1007/s12237-018-0376-9; Quintana CO, 2015, SCI REP-UK, V5, DOI 10.1038/srep16122; Quintana CO, 2013, BIOGEOCHEMISTRY, V115, P95, DOI 10.1007/s10533-012-9820-2; Quintana CO, 2007, J EXP MAR BIOL ECOL, V352, P392, DOI 10.1016/j.jembe.2007.08.015; Quintana CO, 2011, J EXP MAR BIOL ECOL, V397, P179, DOI 10.1016/j.jembe.2010.12.006; Ray GL, 2000, MAR POLLUT BULL, V40, P1186, DOI 10.1016/S0025-326X(00)00083-7; Renz JR, 2014, MAR ECOL PROG SER, V505, P145, DOI 10.3354/meps10756; RICE DL, 1986, MAR ECOL PROG SER, V30, P9, DOI 10.3354/meps030009; Rosenberg R, 2001, SCI MAR, V65, P107, DOI 10.3989/scimar.2001.65s2107; Sanz-Lazaro C, 2015, BIOGEOSCIENCES, V12, P4565, DOI 10.5194/bg-12-4565-2015; Sanz-Lazaro C, 2011, ECOL APPL, V21, P2664, DOI 10.1890/10-2219.1; Shull DH, 1997, J MAR RES, V55, P153, DOI 10.1357/0022240973224454; Sjogaard KS, 2017, BIOGEOSCIENCES, V14, P4375, DOI 10.5194/bg-14-4375-2017; Snelgrove PVR, 2014, TRENDS ECOL EVOL, V29, P398, DOI 10.1016/j.tree.2014.05.002; Stenak M., 2005, INDDAEMMEDE LANDSKAB; SUNDBY B, 1992, LIMNOL OCEANOGR, V37, P1129, DOI 10.4319/lo.1992.37.6.1129; Thorsen SW, 2016, AKUEL NATURVINDENSKA, V1, P20; Valdemarsen T, 2015, BIOGEOSCIENCES, V12, P1765, DOI 10.5194/bg-12-1765-2015; Valdemarsen T, 2010, MAR ECOL PROG SER, V400, P37, DOI 10.3354/meps08400; Valdemarsen T, 2014, MAR ECOL PROG SER, V503, P41, DOI 10.3354/meps10747; Valdemarsen T, 2011, J EXP MAR BIOL ECOL, V410, P45, DOI 10.1016/j.jembe.2011.10.006; Valdemarsen T, 2010, GEOCHIM COSMOCHIM AC, V74, P1593, DOI 10.1016/j.gca.2009.12.009; Volkenborn N, 2006, J EXP MAR BIOL ECOL, V330, P169, DOI 10.1016/j.jembe.2005.12.025; Wendelboe K, 2013, J SEA RES, V76, P31, DOI 10.1016/j.seares.2012.10.013; Weston NB, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000071; Weston NB, 2011, BIOGEOCHEMISTRY, V102, P135, DOI 10.1007/s10533-010-9427-4; WINTHER U, 1985, SARSIA, V70, P1	72	13	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196097	10.1371/journal.pone.0196097	http://dx.doi.org/10.1371/journal.pone.0196097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694390	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400061
J	Botzman, M; Gat-Viks, I				Botzman, Maya; Gat-Viks, Irit			Significant common environmental effects on leukocyte subpopulations	PLOS ONE			English	Article							HUMAN IMMUNE-SYSTEM; INFLAMMATORY-BOWEL-DISEASE; MEMBRANE NANOTUBES; ALLERGIC DISEASES; GENE-EXPRESSION; FLOW-CYTOMETRY; CELLS; THROMBOMODULIN; LYMPHOCYTES; MECHANISMS	Major efforts are invested in the analysis of phenotypic variation in a population of individuals. While many of these studies focus on the genetic basis of phenotypic variation via measurements of DNA polymorphic sites, the environmental effects are still elusive. Here we propose a methodology, called CCCE ('Cell Composition Common Environment'), to identify environmental effects on the composition of immune cell functionalities. Specifically, CCCE is focused on the common experiences that are shared between siblings (the 'common environment'), designed to correct for cell subpopulation heterogeneity, and is based on a multicolor flow cytometry analysis across a large cohort of human monozygotic and dizygotic twins. We demonstrate that the CCCE methodology can provide insights on the relations between common environmental effects and the heterogenic functions of several immune cell types, such as NK cells effector functions and coagulation-related capabilities of monocytes. The software described in this article is available at http://csgi.tau.ac.il/CCCE.	[Botzman, Maya; Gat-Viks, Irit] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Tel Aviv, Israel	Tel Aviv University	Gat-Viks, I (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Tel Aviv, Israel.	iritgv@post.tau.ac.il			ISF fund [1643/13, 288/16]; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease [41/11]; European Research Council [637885]	ISF fund; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease; European Research Council(European Research Council (ERC)European Commission)	This research was supported by an ISF fund no. 1643/13 and 288/16, by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University, and by the Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease, Center No 41/11 (MB). IGV is a Faculty Fellow of the Edmond J. Safra Center for Bioinformatics at Tel Aviv University and an Alon Fellow. Research in the IGV lab was supported by the European Research Council (637885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkim C, 2007, TURK J GASTROENTEROL, V18, P82; [Anonymous], 2011, NATURE, DOI DOI 10.1038/NATURE10423.PMID:21937992; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Brodin P, 2017, NAT REV IMMUNOL, V17, P21, DOI 10.1038/nri.2016.125; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Chauveau A, 2010, P NATL ACAD SCI USA, V107, P5545, DOI 10.1073/pnas.0910074107; Comerci CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047664; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Dai L, 2004, J THROMB HAEMOST, V2, P2200, DOI 10.1111/j.1538-7836.2004.01034.x; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Davis DM, 2009, NAT REV IMMUNOL, V9, P543, DOI 10.1038/nri2602; De Leval L, 2015, GENE EXPRESSION PROF, V109, P4952, DOI [10.1182/blood-2006-10-055145, DOI 10.1182/BLOOD-2006-10-055145]; De Rosa SC, 2003, NAT MED, V9, P112, DOI 10.1038/nm0103-112; Dwyer KM, 2007, PURINERG SIGNAL, V3, P171, DOI 10.1007/s11302-006-9050-y; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Gjevestad GO, 2015, CURR CARDIOVASC RISK, V9, DOI 10.1007/s12170-015-0463-4; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; Huang SK, 2015, J THORAC DIS, V7, P23, DOI 10.3978/j.issn.2072-1439.2014.12.13; Julia V, 2015, NAT REV IMMUNOL, V15, P308, DOI 10.1038/nri3830; Kunz G, 2002, BLOOD, V99, P3646, DOI 10.1182/blood.V99.10.3646; Li YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-34; Liston A, 2016, TRENDS IMMUNOL, V37, P637, DOI 10.1016/j.it.2016.08.002; Lu Y, 2016, IMMUNITY, V45, P1162, DOI 10.1016/j.immuni.2016.10.025; Mangino M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13850; McNerney ME, 2006, CURR TOP MICROBIOL, V298, P91; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Oestreicher J. L., 2001, Pharmacogenomics Journal, V1, P272; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Rabausch K, 2005, CIRC RES, V96, pE1, DOI 10.1161/01.RES.0000153150.27690.f2; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Salvetti M, 2000, IMMUNOL TODAY, V21, P342, DOI 10.1016/S0167-5699(00)01658-3; Santin AD, 2005, BRIT J CANCER, V92, P1561, DOI 10.1038/sj.bjc.6602480; Satta N, 1997, BRIT J HAEMATOL, V96, P534, DOI 10.1046/j.1365-2141.1997.d01-2059.x; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; Shantsila E, 2009, THROMB HAEMOSTASIS, V102, P916, DOI 10.1160/TH09-01-0023; SMERDON RA, 1993, DIABETES, V42, P127, DOI 10.2337/diabetes.42.1.127; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Twine NC, 2003, CANCER RES, V63, P6069; Vrijheid M, 2014, ENVIRON HEALTH PERSP, V122, P535, DOI 10.1289/ehp.1307204; Wedel I, 1962, INTRO QUANTITATIVE G, P140, DOI [10.1002/bimj.19620040211, DOI 10.1002/BIMJ.19620040211]; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	44	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196193	10.1371/journal.pone.0196193	http://dx.doi.org/10.1371/journal.pone.0196193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689083	gold, Green Published, Green Submitted			2022-12-26	WOS:000430678800029
J	Lemes, RB; Nunes, K; Carnavalli, JEP; Kimura, L; Mingroni-Netto, RC; Meyer, D; Otto, PA				Lemes, Renan B.; Nunes, Kelly; Carnavalli, Juliana E. P.; Kimura, Lilian; Mingroni-Netto, Regina C.; Meyer, Diogo; Otto, Paulo A.			Inbreeding estimates in human populations: Applying new approaches to an admixed Brazilian isolate	PLOS ONE			English	Article							HOMOZYGOSITY; RUNS	The analysis of genomic data (similar to 400,000 autosomal SNPs) enabled the reliable estimation of inbreeding levels in a sample of 541 individuals sampled from a highly admixed Brazilian population isolate (an African-derived quilombo in the State of Sao Paulo). To achieve this, different methods were applied to the joint information of two sets of markers (one complete and another excluding loci in patent linkage disequilibrium). This strategy allowed the detection and exclusion of markers that biased the estimation of the average population inbreeding coefficient (Wright's fixation index FIS), which value was eventually estimated as around 1% using any of the methods we applied. Quilombo demographic inferences were made by analyzing the structure of runs of homozygosity (ROH), which were adapted to cope with a highly admixed population with a complex foundation history. Our results suggest that the amount of ROH <2Mb of admixed populations should be somehow proportional to the genetic contribution from each parental population.	[Lemes, Renan B.; Nunes, Kelly; Carnavalli, Juliana E. P.; Kimura, Lilian; Mingroni-Netto, Regina C.; Meyer, Diogo; Otto, Paulo A.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Evolutionary Biol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Otto, PA (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Evolutionary Biol, Sao Paulo, SP, Brazil.	otto@usp.br	Lemes, Renan B/P-9507-2017; Kimura, Lilian/AAS-6855-2020; Mingroni-Netto, Regina C/C-9927-2012; Otto, Paulo/L-5464-2014; Nunes, Kelly/AAU-6879-2021; Otto, Paulo A./AAA-8258-2022	Lemes, Renan B/0000-0002-5177-3105; Mingroni-Netto, Regina C/0000-0001-9233-5227; Otto, Paulo/0000-0001-8810-6608; Nunes, Kelly/0000-0003-0864-2414; Otto, Paulo A./0000-0001-8810-6608	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [905629, 1645581]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [870214/1997-7, 305888/2015 3]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo from Brazil [2011/50595-5, 12/09950-9, 12/18010-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID Human Genome Center Project) from Brazil [2013/08028]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo from Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID Human Genome Center Project) from Brazil	This paper was funded by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (905629 to RBL, 1645581 to KN), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (870214/1997-7 to JEPC, 305888/2015 3 to DM); and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/50595-5 to LK, 12/09950-9 to KN, 12/18010-0 to DM, and CEPID Human Genome Center Project 2013/08028), all from Brazil.	Abdellaoul A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118935; Alvarez G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005174; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Auricchio MTBDM, 2007, HUM BIOL, V79, P667; Ben Halim N, 2015, ANN HUM GENET, V79, P402, DOI 10.1111/ahg.12131; Carothers AD, 2006, ANN HUM GENET, V70, P666, DOI 10.1111/j.1469-1809.2006.00263.x; Ceballos FC, 2013, HEREDITY, V111, P114, DOI 10.1038/hdy.2013.25; Ceballos FC, 2018, NAT REV GENET, V19, P220, DOI 10.1038/nrg.2017.109; Ceballos FC, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4489-0; CURIECOHEN M, 1982, GENETICS, V100, P339; FYFE JL, 1951, J AGR SCI, V41, P371, DOI 10.1017/S0021859600049558; Gogarten SM, 2012, BIOINFORMATICS, V28, P3329, DOI 10.1093/bioinformatics/bts610; Jalkh N, 2015, EUR J HUM GENET, V23, P1364, DOI 10.1038/ejhg.2014.246; Joshi PK, 2015, NATURE, V523, P459, DOI 10.1038/nature14618; Karafet TM, 2015, EUR J HUM GENET, V23, P1405, DOI 10.1038/ejhg.2014.299; Kimura L, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22930; Kimura L, 2013, AM J HUM BIOL, V25, P35, DOI 10.1002/ajhb.22335; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Lemes RB, 2014, HUM BIOL, V86, P276, DOI 10.13110/humanbiology.86.4.0276; Leutenegger AL, 2011, EUR J HUM GENET, V19, P583, DOI 10.1038/ejhg.2010.205; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Nunes K, 2016, HUM IMMUNOL, V77, P307, DOI 10.1016/j.humimm.2015.11.004; Otto PA, 2015, J GENET, V94, P759, DOI 10.1007/s12041-015-0573-2; Pemberton TJ, 2014, HUM HERED, V77, P37, DOI 10.1159/000362878; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Pippucci T, 2014, HUM HERED, V77, P63, DOI 10.1159/000362412; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2013, GENET MED, V15, P753, DOI 10.1038/gim.2013.108; Souza I. R., 1992, BRAZ J GENET, V15, P439; Teo SM, 2011, J HUM GENET, V56, P524, DOI 10.1038/jhg.2011.52; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	31	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196360	10.1371/journal.pone.0196360	http://dx.doi.org/10.1371/journal.pone.0196360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689090	Green Published, Green Submitted, gold			2022-12-26	WOS:000430678800048
J	Packialakshmi, B; Zhou, XM				Packialakshmi, Balamurugan; Zhou, Xiaoming			Experimental autoimmune encephalomyelitis (EAE) up-regulates the mitochondrial activity and manganese superoxide dismutase (MnSOD) in the mouse renal cortex	PLOS ONE			English	Article							SODIUM; STIMULATION; PROGRESSION; NA,K-ATPASE; EXPRESSION; INDUCTION; CELLS; ASSAY; GAMMA	Increases of the activity of mitochondrial electron transport chain generally lead to increases of production of ATP and reactive oxygen species (ROS) as by-products. MnSOD is the first line of defense against the stress induced by mitochondrial ROS. Our previous studies demonstrated that EAE progression increased Na, K-ATPase activity in the mouse kidney cortex. Since mitochondria are the major source of ATP, our present studies were sought to determine whether EAE progression increased mitochondrial activity. We found that severe EAE increased mitochondrial complex II and IV activities without significantly affecting complex I activity with corresponding increases of ROS in the isolated mitochondria and native kidney cortex. Severe EAE augmented both cytosolic and mitochondrial MnSOD protein levels and activities and decreased the specific activity of mitochondrial MnSOD when the total mitochondrial MnSOD activity was normalized to the protein level. Using HEK293 cells as a model free of interference from immune reactions, we found that activation of Na, K-ATPase by monensin for 24 hours increased complex II activity, mitochondrial ROS and MnSOD protein abundance, and decreased the specific activity of the mitochondrial MnSOD. Inhibition of Na, K-ATPase by ouabain or catalase attenuated the effects of monensin on the mitochondrial complex II activity, ROS, MnSOD protein level and specific activity. Kockdown of MnSOD by RNAi reduced the mitochondrial ability to generate ATP. In conclusion, EAE increases mitochondrial activity possibly to meet the energy demand from increased Na, KATPase activity. EAE increases mitochondrial MnSOD protein abundance to compensate for the loss of the specific activity of the enzyme, thus minimizing the harmful effects of ROS.	[Packialakshmi, Balamurugan; Zhou, Xiaoming] Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Zhou, XM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA.	xiaoming.zhou@usuhs.edu	Packialakshmi, Balamurugan/AFS-2372-2022		National Heart Lung and Blood Institute [MED-83-3923]; Henry Jackson Foundation for the Advancement of Military Medicine [MED-83-3923]; National MS Society Grant [PP3448]	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Henry Jackson Foundation for the Advancement of Military Medicine; National MS Society Grant	This work was funded in part by the grant (MED-83-3923) from the collaborative health initiative research program between the National Heart Lung and Blood Institute and the Henry Jackson Foundation for the Advancement of Military Medicine and the National MS Society Grant PP3448 to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar U, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00281; Aziz D M, 2005, Homeopathy, V94, P229, DOI 10.1016/j.homp.2005.07.001; Calabresi PA, 2002, NEUROLOGY, V59, P1799, DOI 10.1212/01.WNL.0000036618.68674.7A; Campbell GR, 2014, MULT SCLER J, V20, P1806, DOI 10.1177/1352458514544537; Cherry AD, 2015, ANTIOXID REDOX SIGN, V22, P965, DOI 10.1089/ars.2014.6200; Clausen MV, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00371; ERECINSKA M, 1991, J NEUROSCI, V11, P2410; Fajardo NMP, 2016, BIOCHEM PHARMACOL, V118, P1, DOI 10.1016/j.bcp.2016.04.008; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Flores-Mendoza G, 2018, TRENDS MOL MED, V24, P364, DOI 10.1016/j.molmed.2018.02.003; Gao JY, 2002, J GEN PHYSIOL, V119, P297, DOI 10.1085/jgp.20028501; GUFFANTI AA, 1981, P NATL ACAD SCI-BIOL, V78, P1481, DOI 10.1073/pnas.78.3.1481; GUPTA RS, 1986, J CELL PHYSIOL, V127, P197, DOI 10.1002/jcp.1041270202; Hall DJ, 2012, J CEREBR BLOOD F MET, V32, P23, DOI 10.1038/jcbfm.2011.119; Hamana A, 2017, MOL PHARMACEUT, V14, P1212, DOI 10.1021/acs.molpharmaceut.6b01093; Harris DCH, 1997, CLIN EXP PHARMACOL P, V24, P916, DOI 10.1111/j.1440-1681.1997.tb02719.x; Hernandez AL, 2015, J CLIN INVEST, V125, P4212, DOI 10.1172/JCI81151; Holthouser KA, 2010, AM J PHYSIOL-RENAL, V299, pF77, DOI 10.1152/ajprenal.00581.2009; Indo HP, 2015, J CLIN BIOCHEM NUTR, V56, P1, DOI 10.3164/jcbn.14-42; Ip WKE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7931; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jose PA, 2016, EXP PHYSIOL, V101, P465, DOI 10.1113/EP085286; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Li X, 2013, IMMUNOLOGY, V138, P208, DOI 10.1111/imm.12029; Li Y, 2010, MOL CARCINOGEN, V49, P44, DOI 10.1002/mc.20575; Luk E, 2005, J BIOL CHEM, V280, P22715, DOI 10.1074/jbc.M504257200; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; Maiti AK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15434; MANDEL LJ, 1986, KIDNEY INT, V29, P3, DOI 10.1038/ki.1986.2; Marsh-Wakefield F, 2015, CURR TOP BEHAV NEURO, V26, P117, DOI 10.1007/7854_2014_359; Mehrabian Z, 2005, J NEUROCHEM, V93, P850, DOI 10.1111/j.1471-4159.2005.03066.x; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Miro O, 1998, J NEUROSCI METH, V80, P107, DOI 10.1016/S0165-0270(97)00204-5; Mirza A, 2017, CLIN IMMUNOL, V183, P213, DOI 10.1016/j.clim.2017.03.001; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Munusamy S, 2009, FREE RADICAL BIO MED, V46, P1149, DOI 10.1016/j.freeradbiomed.2009.01.022; Peterson LK, 2008, AUTOIMMUNITY, V41, P526, DOI 10.1080/08916930802128680; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; Raineri I, 1996, J INTERF CYTOK RES, V16, P61, DOI 10.1089/jir.1996.16.61; RECTOR FC, 1983, AM J PHYSIOL, V244, pF461, DOI 10.1152/ajprenal.1983.244.5.F461; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Sun F, 2013, CURR OPIN STRUC BIOL, V23, P526, DOI 10.1016/j.sbi.2013.06.013; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yi BQ, 2015, TRANSL RES, V166, P103, DOI 10.1016/j.trsl.2014.11.007; Zhang CL, 2010, J NEUROSCI, V30, P3555, DOI 10.1523/JNEUROSCI.4551-09.2010; Zhou XM, 2017, CELL IMMUNOL, V317, P18, DOI 10.1016/j.cellimm.2017.04.006; Zhou XM, 2012, AM J PHYSIOL-RENAL, V303, pF674, DOI 10.1152/ajprenal.00076.2012; Zhou XM, 2010, P NATL ACAD SCI USA, V107, P7072, DOI 10.1073/pnas.1002795107; Zhou XM, 2003, AM J PHYSIOL-CELL PH, V285, pC319, DOI 10.1152/ajpcell.00536.2002; Zhuo JL, 2013, COMPR PHYSIOL, V3, P1079, DOI 10.1002/cphy.c110061; Zou XH, 2017, J BIOENERG BIOMEMBR, V49, P325, DOI 10.1007/s10863-017-9718-8	52	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196277	10.1371/journal.pone.0196277	http://dx.doi.org/10.1371/journal.pone.0196277			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689072	gold, Green Published, Green Submitted			2022-12-26	WOS:000430678800036
J	Chen, PYT; Funk, MA; Brignole, EJ; Drennan, CL				Chen, Percival Yang-Ting; Funk, Michael A.; Brignole, Edward J.; Drennan, Catherine L.			Disruption of an oligomeric interface prevents allosteric inhibition of Escherichia coli class Ia ribonucleotide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; nucleoside; nucleotide biosynthesis; mutagenesis mechanism; ribonucleotide reductase; protein-protein interaction; 44 ring; allosteric inhibition; radical-based chemistry; tyrosyl radical cofactor	RADICAL PROPAGATION PATHWAY; DIPHOSPHATE REDUCTASE; DIFFERENTIAL EXPRESSION; MAMMALIAN-CELLS; DNA-REPLICATION; LARGE SUBUNIT; PROTEIN R1; ATP-CONE; IN-VIVO; MUTAGENESIS	Ribonucleotide reductases (RNRs) convert ribonucleotides to deoxynucleotides, a process essential for DNA biosynthesis and repair. Class Ia RNRs require two dimeric subunits for activity: an (2) subunit that houses the active site and allosteric regulatory sites and a (2) subunit that houses the diferric tyrosyl radical cofactor. Ribonucleotide reduction requires that both subunits form a compact (22) state allowing for radical transfer from (2) to (2). RNR activity is regulated allosterically by dATP, which inhibits RNR, and by ATP, which restores activity. For the well-studied Escherichia coli class Ia RNR, dATP binding to an allosteric site on promotes formation of an (44) ring-like state. Here, we investigate whether the (44) formation causes or results from RNR inhibition. We demonstrate that substitutions at the - interface (S37D/S39A-(2), S39R-(2), S39F-(2), E42K-(2), or L43Q-(2)) that disrupt the (44) oligomer abrogate dATP-mediated inhibition, consistent with the idea that (44) formation is required for dATP's allosteric inhibition of RNR. Our results further reveal that the - interface in the inhibited state is highly sensitive to manipulation, with a single substitution interfering with complex formation. We also discover that residues at the - interface whose substitution has previously been shown to cause a mutator phenotype in Escherichia coli (i.e. S39F-(2) or E42K-(2)) are impaired only in their activity regulation, thus linking this phenotype with the inability to allosterically down-regulate RNR. Whereas the cytotoxicity of RNR inhibition is well-established, these data emphasize the importance of down-regulation of RNR activity.	[Chen, Percival Yang-Ting; Funk, Michael A.; Brignole, Edward J.; Drennan, Catherine L.] MIT, Dept Chem, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA; [Brignole, Edward J.; Drennan, Catherine L.] MIT, Dept Biol, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA; [Brignole, Edward J.; Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Funk, Michael A.] Amer Assoc Advancement Sci, 1200 New York Ave NW, Washington, DC 20005 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), MIT, Dept Chem, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Dept Biol, 31 Ames St,Bldg 68-680, Cambridge, MA 02139 USA.	cdrennan@mit.edu			National Science Foundation [NSF-0070319]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Deborah Pheasant for assistance in collecting analytical ultracentrifugation data and Samuel Thompson for assistance with the site-directed mutagenesis. Dr. Nozomi Ando and Dr. Christina M. Zimanyi provided valuable discussions. Analytical ultracentrifugation data were collected at the MIT Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems, supported by National Science Foundation Grant NSF-0070319. EM images were collected at the W. M. Keck Microscopy Facility (Whitehead Institute).	Abid MR, 1999, J BIOL CHEM, V274, P35991, DOI 10.1074/jbc.274.50.35991; Ahluwalia D, 2012, DNA REPAIR, V11, P480, DOI 10.1016/j.dnarep.2012.02.001; Ando N, 2016, BIOCHEMISTRY-US, V55, P373, DOI 10.1021/acs.biochem.5b01207; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Aravind L, 2000, J MOL MICROB BIOTECH, V2, P191; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Aye Y, 2012, CHEM BIOL, V19, P799, DOI 10.1016/j.chembiol.2012.05.015; Aye Y, 2011, P NATL ACAD SCI USA, V108, P9815, DOI 10.1073/pnas.1013274108; Birgander PL, 2004, J BIOL CHEM, V279, P14496, DOI 10.1074/jbc.M310142200; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; BOLLINGER JM, 1991, SCIENCE, V253, P292, DOI 10.1126/science.1650033; Brignole EJ, 2018, ELIFE, V7, DOI [10.7554/eLife.3150, 10.7554/eLife.31502]; Brignole EJ, 2012, BIOCHEM SOC T, V40, P523, DOI 10.1042/BST20120081; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; CARAS IW, 1988, MOL CELL BIOL, V8, P2698, DOI 10.1128/MCB.8.7.2698; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; CLIMENT I, 1992, BIOCHEMISTRY-US, V31, P4801, DOI 10.1021/bi00135a009; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; DOBELN UV, 1976, J BIOL CHEM, V251, P3616; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; ERIKSSON S, 1977, J BIOL CHEM, V252, P6132; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Gon S, 2011, P NATL ACAD SCI USA, V108, P19311, DOI 10.1073/pnas.1113664108; HERTEL LW, 1990, CANCER RES, V50, P4417; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Johansson R, 2016, STRUCTURE, V24, P906, DOI 10.1016/j.str.2016.03.025; Jonna VR, 2015, J BIOL CHEM, V290, P17339, DOI 10.1074/jbc.M115.649624; KARLSSON M, 1992, J BIOL CHEM, V267, P12622; Kasrayan A, 2004, J BIOL CHEM, V279, P31050, DOI 10.1074/jbc.M400693200; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; LARSSON A, 1966, J BIOL CHEM, V241, P2533; LASSMANN G, 1992, BIOCHEM BIOPH RES CO, V188, P879, DOI 10.1016/0006-291X(92)91138-G; Licht S., 1999, COMPREHENSIVE NATURA, P163; LORI F, 1994, SCIENCE, V266, P801, DOI 10.1126/science.7973634; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Minnihan EC, 2013, P NATL ACAD SCI USA, V110, P3835, DOI 10.1073/pnas.1220691110; Minnihan EC, 2011, J AM CHEM SOC, V133, P9430, DOI 10.1021/ja201640n; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; RUSSEL M, 1985, J BACTERIOL, V163, P238, DOI 10.1128/JB.163.1.238-242.1985; Rutschmann OT, 1998, AIDS, V12, pF71, DOI 10.1097/00002030-199808000-00003; SALOWE SP, 1986, J BACTERIOL, V165, P363, DOI 10.1128/jb.165.2.363-366.1986; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15748, DOI 10.1021/ja076459b; SJOBERG BM, 1978, J BIOL CHEM, V253, P6863; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; THELANDER L, 1974, J BIOL CHEM, V249, P4858; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Torrents E, 2006, J BIOL CHEM, V281, P25287, DOI 10.1074/jbc.M601794200; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; van der Donk WA, 1998, BIOCHEMISTRY-US, V37, P6419, DOI 10.1021/bi9729357; Wang J, 2007, P NATL ACAD SCI USA, V104, P14324, DOI 10.1073/pnas.0706803104; Wheeler LJ, 2005, DNA REPAIR, V4, P1450, DOI 10.1016/j.dnarep.2005.09.003; Wisitpitthaya S, 2016, ACS CHEM BIOL, V11, P2021, DOI 10.1021/acschembio.6b00303; Yokoyama K, 2011, J AM CHEM SOC, V133, P18420, DOI 10.1021/ja207455k; Zimanyi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.07141; Zimanyi CM, 2012, STRUCTURE, V20, P1374, DOI 10.1016/j.str.2012.05.009	68	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10404	10412		10.1074/jbc.RA118.002569	http://dx.doi.org/10.1074/jbc.RA118.002569			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29700111	Green Published, hybrid			2022-12-26	WOS:000437096700037
J	Bottino-Rojas, V; Talyuli, OAC; Carrara, L; Martins, AJ; James, AA; Oliveira, PL; Paiva-Silva, GO				Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Carrara, Luana; Martins, Ademir J.; James, Anthony A.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.			The redox-sensing gene Nrf2 affects intestinal homeostasis, insecticide resistance, and Zika virus susceptibility in the mosquito Aedes aegypti	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENGUE VIRUS; TRANSCRIPTION FACTORS; PYRETHROID RESISTANCE; TISSUE HOMEOSTASIS; OXIDATIVE STRESS; DUAL OXIDASE; VECTOR; ACTIVATION; MECHANISMS; EXPRESSION	Production and degradation of reactive oxygen species (ROS) are extensively regulated to ensure proper cellular responses to various environmental stimuli and stresses. Moreover, physiologically generated ROS function as secondary messengers that can influence tissue homeostasis. The cap'n'collar transcription factor known as nuclear factor erythroid-derived factor 2 (Nrf2) coordinates an evolutionarily conserved transcriptional activation pathway that mediates antioxidant and detoxification responses in many animal species, including insects and mammals. Here, we show that Nrf2-mediated signaling affects embryo survival, midgut homeostasis, and redox biology in Aedes aegypti, a mosquito species vector of dengue, Zika, and other disease-causing viruses. We observed that AeNrf2 silencing increases ROS levels and stimulates intestinal stem cell proliferation. Because ROS production is a major aspect of innate immunity in mosquito gut, we found that a decrease in Nrf2 signaling results in reduced microbiota growth and Zika virus infection. Moreover, we provide evidence that AeNrf2 signaling also controls transcriptional adaptation of A. aegypti to insecticide challenge. Therefore, we conclude that Nrf2-mediated response regulates assorted gene clusters in A. aegypti that determine cellular and midgut redox balance, affecting overall xenobiotic resistance and vectorial adaptation of the mosquito.	[Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil; [Carrara, Luana; Martins, Ademir J.] Fundacao Oswaldo Cruz, Laficave, Inst Oswaldo Cruz, BR-21040360 Rio De Janeiro, RJ, Brazil; [Martins, Ademir J.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; University of California System; University of California Irvine; University of California System; University of California Irvine	Paiva-Silva, GO (corresponding author), Univ Fed Rio de Janeiro, Predio CCS Rm DSS05,Cid Univ Ilha Fundao, BR-21902 Rio De Janeiro, RJ, Brazil.	gosilva@bioqmed.ufrj.br	Martins, Ademir/W-3251-2019; Martins, Ademir J./B-4117-2009; Bottino-Rojas, Vanessa/AAX-2172-2020; L. Oliveira, Pedro/A-9438-2010	Martins, Ademir/0000-0001-5739-1215; Bottino-Rojas, Vanessa/0000-0001-8019-9942; Talyuli Cunha, Octavio Augusto/0000-0002-7026-463X; James, Anthony/0000-0001-5577-3308; L. Oliveira, Pedro/0000-0003-0307-354X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoarnento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; National Institute of Health [AI115595, AI29746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029746, R37AI029746, U01AI115595] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoarnento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoarnento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; and National Institute of Health Grants AI115595 (to A. J. M.) and AI29746 (to A. A. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985; Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878; Carter JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139899; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cheng YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32000; Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388; Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189; David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174; Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Gentile C, 2005, Mem. Inst. Oswaldo Cruz, V100, P545, DOI 10.1590/S0074-02762005000600008; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Heiss EH, 2013, REDOX BIOL, V1, P359, DOI 10.1016/j.redox.2013.06.001; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Huang HX, 2017, VIROLOGY, V503, P1, DOI 10.1016/j.virol.2016.12.019; Ingham VA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4086-7; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jin YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005634; Jones RM, 2015, CELL REP, V12, P1217, DOI 10.1016/j.celrep.2015.07.042; Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224; Kalsi M, 2017, INSECT BIOCHEM MOLEC, V83, P1, DOI 10.1016/j.ibmb.2017.02.002; Kalsi M, 2015, INSECT BIOCHEM MOLEC, V65, P47, DOI 10.1016/j.ibmb.2015.08.002; Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009; Kramer LD, 2016, CURR OPIN VIROL, V21, P81, DOI 10.1016/j.coviro.2016.08.008; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Lacher SE, 2015, FREE RADICAL BIO MED, V88, P452, DOI 10.1016/j.freeradbiomed.2015.06.044; Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018; Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005; Magalhaes T, 2008, ARCH INSECT BIOCHEM, V68, P134, DOI 10.1002/arch.20238; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Misra JR, 2013, INSECT BIOCHEM MOLEC, V43, P1116, DOI 10.1016/j.ibmb.2013.09.005; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Peng T, 2016, INSECT MOL BIOL, V25, P450, DOI 10.1111/imb.12230; Pitoniak A, 2015, FREE RADICAL BIO MED, V88, P302, DOI 10.1016/j.freeradbiomed.2015.06.020; Poupardin R, 2010, INSECT MOL BIOL, V19, P185, DOI 10.1111/j.1365-2583.2009.00967.x; Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001; Rahman MM, 2013, AGING CELL, V12, P554, DOI 10.1111/acel.12078; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Riaz MA, 2013, AQUAT TOXICOL, V126, P326, DOI 10.1016/j.aquatox.2012.09.010; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Sterkel M, 2017, TRENDS PARASITOL, V33, P633, DOI 10.1016/j.pt.2017.04.008; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tromp N, 2016, LANCET, V387, P1053, DOI 10.1016/S0140-6736(16)00659-0; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Wan H, 2014, PEST MANAG SCI, V70, P1048, DOI 10.1002/ps.3645; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	88	24	25	3	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9053	9063		10.1074/jbc.RA117.001589	http://dx.doi.org/10.1074/jbc.RA117.001589			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29685890	Green Published, hybrid			2022-12-26	WOS:000434941900027
J	Petit, AP; Garcia-Petit, C; Bueren-Calabuig, JA; Vuillard, LM; Ferry, G; Boutin, JA				Petit, Alain-Pierre; Garcia-Petit, Christel; Bueren-Calabuig, Juan A.; Vuillard, Laurent M.; Ferry, Gilles; Boutin, Jean A.			A structural study of the complex between neuroepithelial cell transforming gene 1 (Net1) and RhoA reveals a potential anticancer drug hot spot	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; PROTEIN; GTPASES; ACTIVATION; CHALLENGES; INHIBITOR; PDZRHOGEF; PHENIX	The GTPase RhoA is a major player in many different regulatory pathways. RhoA catalyzes GTP hydrolysis, and its catalysis is accelerated when RhoA forms heterodimers with proteins of the guanine nucleotide exchange factor (GEF) family. Neuroepithelial cell transforming gene 1 (Net1) is a RhoA-interacting GEF implicated in cancer, but the structural features supporting the RhoA/Net1 interaction are unknown. Taking advantage of a simple production and purification process, here we solved the structure of a RhoA/Net1 heterodimer with X-ray crystallography at 2-A resolution. Using a panel of several techniques, including molecular dynamics simulations, we characterized the RhoA/Net1 interface. Moreover, deploying an extremely simple peptide-based scanning approach, we found that short peptides (penta-to nonapeptides) derived from the protein/ protein interaction region of RhoA could disrupt the RhoA/ Net1 interaction and thereby diminish the rate of nucleotide exchange. The most inhibitory peptide, EVKHF, spanning residues 102-106 in the RhoA sequence, displayed an IC50 of similar to 100 mu M without further modifications. The peptides identified here could be useful in further investigations of the RhoA/Net1 interaction region. We propose that our structural and functional insights might inform chemical approaches for transforming the pentapeptide into an optimized pseudopeptide that antagonizes Net1-mediated RhoA activation with therapeutic anticancer potential.	[Petit, Alain-Pierre; Bueren-Calabuig, Juan A.] Univ Dundee, Drug Discovery Unit, Div Biol Chem & Drug Discovery, Sch Life Sci, Dundee DD1 5EH, Scotland; [Garcia-Petit, Christel] Univ Dundee, MRC, Sch Life Sci, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Vuillard, Laurent M.; Ferry, Gilles; Boutin, Jean A.] Inst Rech SERVIER, Chim, Biol, Pole Expertise Biotechnol, F-78290 Croissy Sur Seine, France	University of Dundee; University of Dundee; Servier; Institut de Recherches Internationales Servier	Boutin, JA (corresponding author), Inst Rech SERVIER, Chim, Biol, Pole Expertise Biotechnol, F-78290 Croissy Sur Seine, France.	jean.boutin@servier.com	Boutin, Jean Albert/W-9103-2019	Boutin, Jean Albert/0000-0003-0068-7204	Tenovus Scotland; MRC [MC_PC_15036, MC_PC_17158] Funding Source: UKRI	Tenovus Scotland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported in part by Tenovus Scotland.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Azeez KRA, 2014, BIOCHEM J, V464, P231, DOI 10.1042/BJ20140606; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Biro M, 2014, BRIT J PHARMACOL, V171, P5491, DOI 10.1111/bph.12658; Blundell TL, 2006, PHILOS T R SOC B, V361, P413, DOI 10.1098/rstb.2005.1800; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Case D.A, 2014, AMBER TOOLS15; Cierpicki T, 2009, PROTEIN SCI, V18, P2067, DOI 10.1002/pro.219; Cramer LP, 1999, BIOCHEM SOC SYMP, V65, P173; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Derewenda U, 2004, STRUCTURE, V12, P1955, DOI 10.1016/j.str.2004.09.003; Diviani D, 2016, CELL CHEM BIOL, V23, P1135, DOI 10.1016/j.chembiol.2016.07.015; Dougherty PG, 2017, BIOCHEM J, V474, P1109, DOI 10.1042/BCJ20160619; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang L, 2015, MOL MED REP, V12, P7439, DOI 10.3892/mmr.2015.4385; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koth AP, 2014, J PHYSIOL-PARIS, V108, P270, DOI 10.1016/j.jphysparis.2014.08.007; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lenoir M, 2014, J BIOL CHEM, V289, P23992, DOI 10.1074/jbc.M114.561787; Leyden J, 2006, BRIT J CANCER, V94, P1204, DOI 10.1038/sj.bjc.6603054; Loge C, 2002, J ENZYM INHIB MED CH, V17, P381, DOI 10.1080/1475636021000005659; Loirand G, 2008, CURR OPIN PHARMACOL, V8, P174, DOI 10.1016/j.coph.2007.12.006; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Ma BY, 2014, CURR PHARM DESIGN, V20, P1293, DOI 10.2174/13816128113199990073; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Murray D, 2008, BRIT J CANCER, V99, P1322, DOI 10.1038/sj.bjc.6604688; Page R, 2005, P NATL ACAD SCI USA, V102, P1901, DOI 10.1073/pnas.0408490102; Peng FF, 2008, DIABETES, V57, P1683, DOI 10.2337/db07-1149; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Renaud JP, 2016, NAT REV DRUG DISCOV, V15, P679, DOI 10.1038/nrd.2016.123; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Schaefer Antje, 2014, Small GTPases, V5, P6, DOI 10.4161/21541248.2014.968004; Smithers CC, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020026; Srougi MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017108; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tao WW, 2015, J BIOL CHEM, V290, P20086, DOI 10.1074/jbc.M115.657742; Vega Francisco M, 2018, Small GTPases, V9, P384, DOI 10.1080/21541248.2016.1253528; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ye K, 2014, TUMOR BIOL, V35, P11219, DOI 10.1007/s13277-014-2454-3; Zandvakili I, 2017, ONCOGENE, V36, P3213, DOI 10.1038/onc.2016.473; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	54	6	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9064	9077		10.1074/jbc.RA117.001123	http://dx.doi.org/10.1074/jbc.RA117.001123			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29695506	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000434941900028
J	Chikandiwa, A; Kelly, H; Sawadogo, B; Ngou, J; Pisa, PT; Gibson, L; Didelot, MN; Meda, N; Weiss, HA; Segondy, M; Mayaud, P; Delany-Moretlwe, S				Chikandiwa, Admire; Kelly, Helen; Sawadogo, Bernard; Ngou, Jean; Pisa, Pedro T.; Gibson, Lorna; Didelot, Marie-Noelle; Meda, Nicolas; Weiss, Helen A.; Segondy, Michel; Mayaud, Philippe; Delany-Moretlwe, Sinead		HARP Study Grp	Prevalence, incidence and correlates of low risk HPV infection and anogenital warts in a cohort of women living with HIV in Burkina Faso and South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; OF-THE-LITERATURE; HUMAN-PAPILLOMAVIRUS; GENITAL WARTS; ANTIRETROVIRAL THERAPY; IMPACT; EPIDEMIOLOGY; VACCINATION; NEOPLASIA; BURDEN	Objective To report the prevalence and incidence of low-risk human papillomavirus infection (LR-HPV) and anogenital warts (AGW) among women living with HIV (WLHIV) in Burkina Faso (BF) and South Africa (SA), and to explore HIV-related factors associated with these outcomes. Methods We enrolled 1238 WLHIV (BF = 615; SA = 623) aged 25 +/- 50 years and followed them at three time points (6, 12 and 16 months) after enrolment. Presence of AGW was assessed during gynaecological examination. Cervico-vaginal swabs for enrolment and month 16 follow-up visits were tested for HPV infection by Inno-LiPA (R) genotyping. Logistic regression was used to assess risk factors for prevalent infection or AGW. Cox regression was used to assess risk factors for incident AGW. Results Women in SA were more likely than those in BF to have prevalent LR-HPV infection (BF: 27.1% vs. SA: 40.9%; p<0.001) and incident LR-HPV infection (BF: 25.8% vs. SA: 31.6%, p = 0.05). Prevalence of persistent LR-HPV was similar in the two countries (BF: 33.3% vs. SA: 30.4%; p = 0.54), as were prevalence and incidence of AGW (Prevalence: BF: 7.5% vs. SA: 5.7%; p = 0.21; Incidence: BF: 2.47 vs. SA: 2.33 per 100 person-years; p = 0.41). HPV6 was associated with incident AGW (BF: adjusted Hazard Ratio (aHR) = 4.88; 95% CI: 1.36-17.45; SA: aHR = 5.02; 95% CI: 1.40-17.99). Prevalent LR-HPV (BF: adjusted Odds Ratio [aOR = 1.86]; 95% CI: 1.01-3.41; SA: aOR = 1.75; 95% CI: 0.88-3.48); persistent LR-HPV (BF: aOR = 1.92; 95% CI: 0.44-8.44; SA: aOR = 2.81; 95% CI: 1.07-7.41) and prevalent AGW (BF: aOR = 1.53; 95% CI: 0.61-3.87; SA: aOR = 4.11; 95% CI: 1.20-14.10) were each associated with low CD4+ counts (i.e. <200 vs. >500 cells/mu L). Duration of ART and HIV plasma viral load were not associated with any LR-HPV infection or AGW outcomes. Conclusion LR-HPV infection and AGW are common in WLHIV in sub-Saharan Africa. Type-specific HPV vaccines and effective ART with immunological reconstitution could reduce the burden of AGW in this population.	[Chikandiwa, Admire; Pisa, Pedro T.; Mayaud, Philippe; Delany-Moretlwe, Sinead] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa; [Kelly, Helen; Gibson, Lorna; Weiss, Helen A.; Mayaud, Philippe] London Sch Hyg & Trop Med, Clin Res Dept, London, England; [Sawadogo, Bernard; Meda, Nicolas] Univ Ouagadougou, Ctr Rech Int Sante, Ouagadougou, Burkina Faso; [Ngou, Jean; Didelot, Marie-Noelle; Segondy, Michel] Univ Montpellier, INSERM, EFS, Montpellier, France	University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Chikandiwa, A (corresponding author), Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa.	achikandiwa@wrhi.ac.za	weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; DJIGMA, Florencia Wendkuuni/0000-0002-6895-6725; MAYAUD, Philippe/0000-0001-5730-947X	European Commission (EC) 7th Framework Programme [HEALTH-2010-F2-265396]; UK Medical Research Council (MRC) PHINDS scheme [PH01/14-39]; Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; DELTAS Africa Initiative [107768/Z/15/Z]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK) [107768/Z/15/Z]; UK government; National Research Foundation (NRF) of South Africa [110807]; MRC [MR/M01231X/1] Funding Source: UKRI; Medical Research Council [MR/K012126/1, MR/M01231X/1] Funding Source: researchfish	European Commission (EC) 7th Framework Programme; UK Medical Research Council (MRC) PHINDS scheme; Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government; National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors of this publication received funding from the European Commission (EC) 7th Framework Programme under grant agreement No. HEALTH-2010-F2-265396 and from the UK Medical Research Council (MRC) PHINDS scheme (PH01/14-39). The first author of is a fellow of the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No:54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK government. The statements made and views expressed are solely the responsibility of the fellow. The first author was supported in part by the National Research Foundation (NRF) of South Africa (Grant Number: 110807), however findings and conclusions expressed in this publication are that of the author and the NRF accepts no liability whatsoever in this regard.	Banura C, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-27; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; Department of Health RoSA, NAT CONS GUID PREV M; Djigma FW, 2011, ACTA TROP, V117, P202, DOI 10.1016/j.actatropica.2010.12.007; Dolev JC, 2008, AIDS, V22, P1213, DOI 10.1097/QAD.0b013e3283021aa3; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Garland SM, 2016, CLIN INFECT DIS, V63, P519, DOI 10.1093/cid/ciw354; Ghanem KG, 2011, SEX TRANSM INFECT, V87, P385, DOI 10.1136/sextrans-2011-050005; Insinga RP, 2005, PHARMACOECONOMICS, V23, P1107, DOI 10.2165/00019053-200523110-00004; Jeynes C, 2009, INT J STD AIDS, V20, P557, DOI 10.1258/ijsa.2008.008412; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Kavanaugh BE, 2012, SEX TRANSM DIS, V39, P902, DOI 10.1097/OLQ.0b013e318275ec7f; Kelly HA, 2017, AIDS, V31, P273, DOI 10.1097/QAD.0000000000001301; LaMontagne DS, 2017, INT J GYNECOL OBSTET, V138, P7, DOI 10.1002/ijgo.12186; Low AJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-20; Massad LS, 2004, AM J OBSTET GYNECOL, V190, P1241, DOI 10.1016/j.ajog.2003.12.037; Mazarico E, 2015, EUR J GYNAECOL ONCOL, V36, P677; Mbulawa ZZA, 2010, J GEN VIROL, V91, P3023, DOI 10.1099/vir.0.020669-0; QCMD, 2016, QUAL CONTR MOL DIAGN; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P930; Silverberg MJ, 2002, SEX TRANSM DIS, V29, P427, DOI 10.1097/00007435-200208000-00001; UK-NEQAS, 2016, IMM MON PROGR ACCR; VIH/SIDA Mdlscmdlcl, NORM PROT PRIS CHARG; Wiley DJ, 2002, CLIN INFECT DIS, V35, pS210, DOI 10.1086/342109; World Health Organization, 2017, SUMM WHO POS PAP VAC; Xue XN, 2010, CANCER EPIDEM BIOMAR, V19, P159, DOI 10.1158/1055-9965.EPI-09-0546	29	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196018	10.1371/journal.pone.0196018	http://dx.doi.org/10.1371/journal.pone.0196018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715305	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000431281100008
J	Leon, CG; Moraga, R; Valenzuela, C; Gugliandolo, C; Lo Giudice, A; Papale, M; Vilo, C; Dong, QF; Smith, CT; Rossello-Mora, R; Yanez, J; Campos, VL				Leon, Carla G.; Moraga, Ruben; Valenzuela, Cristian; Gugliandolo, Concetta; Lo Giudice, Angelina; Papale, Maria; Vilo, Claudia; Dong, Qunfeng; Smith, Carlos T.; Rossello-Mora, Ramon; Yanez, Jorge; Campos, Victor L.			Effect of the natural arsenic gradient on the diversity and arsenic resistance of bacterial communities of the sediments of Camarones River (Atacama Desert, Chile)	PLOS ONE			English	Article							OXIDIZING BACTERIA; VOLCANIC-ROCKS; OXIDATION; GENES; OXIDASE; MOBILIZATION; SPECIATION; REDUCTION; WATERS; IDENTIFICATION	Arsenic (As), a highly toxic metalloid, naturally present in Camarones River (Atacama Desert, Chile) is a great health concern for the local population and authorities. In this study, the taxonomic and functional characterization of bacterial communities associated to metal-rich sediments from three sites of the river (sites M1, M2 and M3), showing different arsenic concentrations, were evaluated using a combination of approaches. Diversity of bacterial communities was evaluated by Illumina sequencing. Strains resistant to arsenic concentrations varying from 0.5 to 100 mM arsenite or arsenate were isolated and the presence of genes coding for enzymes involved in arsenic oxidation (aio) or reduction (arsC) investigated. Bacterial communities showed a moderate diversity which increased as arsenic concentrations decreased along the river. Sequences of the dominant taxonomic groups (abundances >= 1%) present in all three sites were affiliated to Proteobacteria (range 40.3-47.2%), Firmicutes (8.4-24.8%), Acidobacteria (10.4-17.1%), Actinobacteria (5.4-8.1%), Chloroflexi (3.9-7.5%), Planctomycetes (1.2-5.3%), Gemmatimonadetes (1.2-1.5%), and Nitrospirae (1.1-1.2%). Bacterial communities from sites M2 and M3 showed no significant differences in diversity between each other (p = 0.9753) but they were significantly more diverse than M1 (p<0.001 and p<0.001, respectively). Sequences affiliated with Proteobacteria, Firmicutes, Acidobacteria, Chloroflexi and Actinobacteria at M1 accounted for more than 89% of the total classified bacterial sequences present but these phyla were present in lesser proportions in M2 and M3 sites. Strains isolated from the sediment of sample M1, having the greatest arsenic concentration (498 mg kg(-1)), showed the largest percentages of arsenic oxidation and reduction. Genes aio were more frequently detected in isolates from M1	[Leon, Carla G.; Valenzuela, Cristian; Vilo, Claudia; Smith, Carlos T.; Campos, Victor L.] Univ Concepcion, Fac Biol Sci, Dept Microbiol, Environm Microbiol Lab, Concepcion, Chile; [Moraga, Ruben] Arturo Prat Univ, Fac Renewable Nat Resources, Microbiol Lab, Iquique, Chile; [Gugliandolo, Concetta; Lo Giudice, Angelina; Papale, Maria] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy; [Lo Giudice, Angelina] Natl Res Council IAMC CNR, Inst Coastal Marine Environm, Messina, Italy; [Dong, Qunfeng] Loyola Univ Chicago, Dept Publ Hlth Sci, Ctr Biomed Informat, Maywood, IL USA; [Rossello-Mora, Ramon] Inst Mediterrani Estudis Avancats CSIC UIB, Marine Microbiol Grp, Esporles, Spain; [Yanez, Jorge] Univ Concepcion, Fac Chem Sci, Dept Analyt & Inorgan Chem, Concepcion, Chile	Universidad de Concepcion; Universidad Arturo Prat; University of Messina; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Loyola University Chicago; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universidad de Concepcion	Campos, VL (corresponding author), Univ Concepcion, Fac Biol Sci, Dept Microbiol, Environm Microbiol Lab, Concepcion, Chile.	vcampos@udec.cl	Rossello-Mora, Ramon/L-4650-2014; Gonzalez, Carlos/V-7628-2019; Papale, Maria/AAC-6049-2020; Gugliandolo, Concetta/L-6855-2015	Rossello-Mora, Ramon/0000-0001-8253-3107; Gugliandolo, Concetta/0000-0002-9125-3999; Papale, Maria/0000-0002-6013-4436	FONDECYT, Chile [11130383 CONICYT]; Grant VRID-UdeC [213.036.040.1.0]; CONICYT-PCHA/ Doctorado Nacional [2013-21130371]	FONDECYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Grant VRID-UdeC; CONICYT-PCHA/ Doctorado Nacional	This work was supported by Grant FONDECYT No 11130383 CONICYT, Chile; Grant VRID-UdeC (213.036.040.1.0) and CONICYT-PCHA/ Doctorado Nacional/ 2013-21130371.; This research was supported by Grant FONDECYT No 11130383 CONICYT, Chile; Grant VRID-UdeC (213.036.040.1.0) and CONICYT-PCHA/ Doctorado Nacional/ 2013-21130371	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Al-Abed SR, 2007, CHEMOSPHERE, V66, P775, DOI 10.1016/j.chemosphere.2006.07.045; ANDERSON GL, 1992, J BIOL CHEM, V267, P23674; Andreoni V, 2012, CURR MICROBIOL, V65, P212, DOI 10.1007/s00284-012-0149-9; Arriaza B, 2010, J ARCHAEOL SCI, V37, P1274, DOI 10.1016/j.jas.2009.12.030; Azarbad H, 2015, BIOL FERT SOILS, V51, P879, DOI 10.1007/s00374-015-1033-0; Bahar MM, 2012, BIODEGRADATION, V23, P803, DOI 10.1007/s10532-012-9567-4; Battaglia-Brunet F, 2002, J APPL MICROBIOL, V93, P656, DOI 10.1046/j.1365-2672.2002.01726.x; Borch T, 2010, ENVIRON SCI TECHNOL, V44, P15, DOI 10.1021/es9026248; Brito-Echeverria J, 2009, EXTREMOPHILES, V13, P557, DOI 10.1007/s00792-009-0238-2; BYERS SC, 1978, HYDROBIOLOGIA, V58, P43, DOI 10.1007/BF00018894; Cai L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-4; Campos VL, 2011, ARCH ENVIRON CON TOX, V61, P185, DOI 10.1007/s00244-010-9601-7; Campos VL, 2009, J BASIC MICROB, V49, pS93, DOI 10.1002/jobm.200900028; Costa PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119465; Costa PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095655; DOMINGO JL, 1995, REPROD TOXICOL, V9, P105, DOI 10.1016/0890-6238(94)00060-3; Dong D, 2014, BIOSCI BIOTECH BIOCH, V78, P1963, DOI 10.1080/09168451.2014.940276; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Escalante G, 2009, B ENVIRON CONTAM TOX, V83, P657, DOI 10.1007/s00128-009-9868-4; Gihring TM, 2001, ENVIRON SCI TECHNOL, V35, P3857, DOI 10.1021/es010816f; Gillan DC, 2015, ENVIRON MICROBIOL, V17, P1991, DOI 10.1111/1462-2920.12627; Gu YF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176696; Guzman-Fierro VG, 2015, INT J ENVIRON SCI TE, V12, P1353, DOI 10.1007/s13762-014-0512-4; Inskeep WP, 2007, ENVIRON MICROBIOL, V9, P934, DOI 10.1111/j.1462-2920.2006.01215.x; Inskeep WP, 2002, BOOK SOIL P, P183; Jiang DW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00360; Jones CA, 2000, SOIL SCI SOC AM J, V64, P600, DOI 10.2136/sssaj2000.642600x; Kashyap DR, 2006, J BACTERIOL, V188, P1081, DOI 10.1128/JB.188.3.1081-1088.2006; Krumova K, 2008, BIOTECHNOL BIOTEC EQ, V22, P721, DOI 10.1080/13102818.2008.10817541; Kumaresan M, 2001, CURR SCI INDIA, V80, P837; Leist M, 2000, J HAZARD MATER, V76, P125, DOI 10.1016/S0304-3894(00)00188-6; Leon C, 2012, WORLD J MICROB BIOT, V28, P1511, DOI 10.1007/s11274-011-0953-6; Lett MC, 2012, J BACTERIOL, V194, P207, DOI 10.1128/JB.06391-11; Li P, 2014, GEOMICROBIOL J, V31, P802, DOI 10.1080/01490451.2014.893181; Li XY, 2012, J BACTERIOL, V194, P4473, DOI 10.1128/JB.00907-12; Lievremont D, 2009, BIOCHIMIE, V91, P1229, DOI 10.1016/j.biochi.2009.06.016; Luo JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108185; Macur RE, 2004, ENVIRON SCI TECHNOL, V38, P104, DOI 10.1021/es034455a; Macur RE, 2001, ENVIRON SCI TECHNOL, V35, P3676, DOI 10.1021/es0105461; McLaughlin MJ, 2001, ENVIRON TOXICOL CHEM, V20, P2639, DOI [10.1897/1551-5028(2001)020&lt;2639:BZCISA&gt;2.0.CO;2, 10.1002/etc.5620201132]; Muller D, 2003, J BACTERIOL, V185, P135, DOI 10.1128/JB.185.1.135-141.2003; Muller D, 2006, INT J SYST EVOL MICR, V56, P1765, DOI 10.1099/ijs.0.64308-0; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Paez-Espino D, 2009, BIOMETALS, V22, P117, DOI 10.1007/s10534-008-9195-y; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quemeneur M, 2008, APPL ENVIRON MICROB, V74, P4567, DOI 10.1128/AEM.02851-07; Quemeneur M, 2010, APPL ENVIRON MICROB, V76, P4566, DOI 10.1128/AEM.03104-09; Rehman A, 2010, AFR J BIOTECHNOL, V9, P1493; ROSEN BP, 1991, ARCH BIOCHEM BIOPHYS, V284, P381, DOI 10.1016/0003-9861(91)90312-7; Saltikov CW, 2002, APPL ENVIRON MICROB, V68, P280, DOI 10.1128/AEM.68.1.280-288.2002; Shafiquzzaman M, 2011, DESALINATION, V265, P60, DOI 10.1016/j.desal.2010.07.031; Sheik CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040059; Silva-Pinto V, 2010, REV MED CHILE, V138, P461, DOI /S0034-98872010000400010; Steely S, 2007, MICROCHEM J, V86, P235, DOI 10.1016/j.microc.2007.03.009; Stolz JF, 1999, FEMS MICROBIOL REV, V23, P615, DOI 10.1016/S0168-6445(99)00024-8; Stolz JE, 2006, ANNU REV MICROBIOL, V60, P107, DOI 10.1146/annurev.micro.60.080805.142053; Valenzuela C, 2009, B ENVIRON CONTAM TOX, V82, P593, DOI 10.1007/s00128-009-9659-y; vanden Hoven RN, 2004, BBA-BIOENERGETICS, V1656, P148, DOI 10.1016/j.bbabio.2004.03.001; Walton HF, 1970, REVERTE MEXICANA, P225; Wang SL, 2006, J HAZARD MATER, V138, P459, DOI 10.1016/j.jhazmat.2006.09.048; Wang YP, 2016, COLD REG SCI TECHNOL, V126, P10, DOI 10.1016/j.coldregions.2016.02.013; Warelow TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072535; Yamamura S, 2014, J BIOSCI BIOENG, V118, P1, DOI 10.1016/j.jbiosc.2013.12.011; Yamamura S, 2009, CHEMOSPHERE, V77, P169, DOI 10.1016/j.chemosphere.2009.07.071; Yanez J, 2005, J ENVIRON MONITOR, V7, P1335, DOI 10.1039/b506313b; Yanez J, 2015, J ENVIRON SCI HEAL A, V50, P1, DOI 10.1080/10934529.2015.964594; Ye HP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42037; Zargar K, 2010, J BACTERIOL, V192, P3755, DOI 10.1128/JB.00244-10	69	10	10	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0195080	10.1371/journal.pone.0195080	http://dx.doi.org/10.1371/journal.pone.0195080			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715297	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281100005
J	Penttinen, L; Rutanen, C; Saloheimo, M; Kruus, K; Rouvinen, J; Hakulinen, N				Penttinen, Leena; Rutanen, Chiara; Saloheimo, Markku; Kruus, Kristiina; Rouvinen, Juha; Hakulinen, Nina			A new crystal form of Aspergillus oryzae catechol oxidase and evaluation of copper site structures in coupled binuclear copper enzymes	PLOS ONE			English	Article							ACTIVE-SITE; TYROSINASE; MECHANISM; PURIFICATION; REFINEMENT; HEMOCYANIN; RADIATION; INSIGHTS; CLONING; TYPE-3	Coupled binuclear copper (CBC) enzymes have a conserved type 3 copper site that binds molecular oxygen to oxidize various mono- and diphenolic compounds. In this study, we found a new crystal form of catechol oxidase from Aspergillus oryzae (AoCO(4)) and solved two new structures from two different crystals at 1.8-angstrom and at 2.5-angstrom resolutions. These structures showed different copper site forms (met/deoxy and deoxy) and also differed from the copper site observed in the previously solved structure of AoCO(4). We also analysed the electron density maps of all of the 56 CBC enzyme structures available in the protein data bank (PDB) and found that many of the published structures have vague copper sites. Some of the copper sites were then re-refined to find a better fit to the observed electron density. General problems in the refinement of metalloproteins and metal centres are discussed.	[Penttinen, Leena; Rutanen, Chiara; Rouvinen, Juha; Hakulinen, Nina] Univ Eastern Finland, Dept Chem, Joensuu Campus, Joensuu, Finland; [Saloheimo, Markku; Kruus, Kristiina] VTT Tech Res Ctr Finland Ltd, Espoo, Finland	University of Eastern Finland; VTT Technical Research Center Finland	Hakulinen, N (corresponding author), Univ Eastern Finland, Dept Chem, Joensuu Campus, Joensuu, Finland.	nina.hakulinen@uef.fi	Rutanen, Chiara/AAI-4003-2020	Rutanen, Chiara/0000-0001-9962-8364; Penttinen, Leena/0000-0002-7847-1676; Rouvinen, Juha/0000-0003-1843-5718; Hakulinen, Nina/0000-0003-4471-7188	Academy of Finland: Biotieteiden ja Ympariston Tutkimuksen Toimikunta [256937, 292705]; Academy of Finland: Luonnontieteiden ja Tekniikan Tutkimuksen toimikunta [297314]; VTT Technical Research Center of Finland Ltd.	Academy of Finland: Biotieteiden ja Ympariston Tutkimuksen Toimikunta; Academy of Finland: Luonnontieteiden ja Tekniikan Tutkimuksen toimikunta; VTT Technical Research Center of Finland Ltd.	This study was funded by the Academy of Finland: Biotieteiden ja Ympariston Tutkimuksen Toimikunta (Award numbers 256937 and 292705 to Nina Hakulinen) and Academy of Finland: Luonnontieteiden ja Tekniikan Tutkimuksen toimikunta (297314 to Chiara Rutanen). Markku Saloheimo and Kristiina Kruus are employed by VTT Technical Research Center of Finland Ltd. VTT Technical Research Center of Finland Ltd. provided support in the form of salaries for authors M.S. and K.K., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bowman SEJ, 2016, ACCOUNTS CHEM RES, V49, P695, DOI 10.1021/acs.accounts.5b00538; Carugo O, 2005, TRENDS BIOCHEM SCI, V30, P213, DOI 10.1016/j.tibs.2005.02.009; Eicken C, 1998, FEBS LETT, V436, P293, DOI 10.1016/S0014-5793(98)01113-2; Eickman NC, 1980, J AM CHEM SOC, V102, P7339; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garman EF, 2007, J SYNCHROTRON RADIAT, V14, P1, DOI 10.1107/S0909049506053015; Gasparetti C, 2010, APPL MICROBIOL BIOT, V86, P213, DOI 10.1007/s00253-009-2258-3; Ginsbach JW, 2012, P NATL ACAD SCI USA, V109, P10793, DOI 10.1073/pnas.1208718109; Groothaert MH, 2003, J AM CHEM SOC, V125, P7629, DOI 10.1021/ja029684w; Hakulinen N, 2006, BIOCHEM BIOPH RES CO, V350, P929, DOI 10.1016/j.bbrc.2006.09.144; Hakulinen N, 2013, J BIOL INORG CHEM, V18, P917, DOI 10.1007/s00775-013-1038-9; Halfen JA, 1996, SCIENCE, V271, P1397, DOI 10.1126/science.271.5254.1397; HAZES B, 1993, PROTEIN SCI, V2, P597; HIMMELWRIGHT RS, 1980, J AM CHEM SOC, V102, P7339, DOI 10.1021/ja00544a031; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; JOLLEY RL, 1974, J BIOL CHEM, V249, P335; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanteev M, 2013, J BIOL INORG CHEM, V18, P895, DOI 10.1007/s00775-013-1034-0; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Komori H, 2014, ACTA CRYSTALLOGR D, V70, P772, DOI 10.1107/S1399004713033051; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar KSD, 2015, J APPL CRYSTALLOGR, V48, P939, DOI 10.1107/S1600576715006287; Le Roes-Hill M, 2009, TRENDS BIOTECHNOL, V27, P248, DOI 10.1016/j.tibtech.2009.01.001; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Lind T, 1999, J PHYS CHEM B, V103, P1193, DOI 10.1021/jp982321r; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molitor C, 2016, P NATL ACAD SCI USA, V113, pE1806, DOI 10.1073/pnas.1523575113; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murthy NN, 2001, INORG CHEM, V40, P628, DOI 10.1021/ic000792y; Rompel A, 1999, J BIOL INORG CHEM, V4, P56, DOI 10.1007/s007750050289; Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t; Solomon EI, 2011, FARADAY DISCUSS, V148, P11, DOI 10.1039/c005500j; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Suzuki H, 2006, J BIOL CHEM, V281, P30251, DOI 10.1074/jbc.M605726200; Teramae S, 2004, J INORG BIOCHEM, V98, P746, DOI 10.1016/j.jinorgbio.2003.11.009; Virador VM, 2010, J AGR FOOD CHEM, V58, P1189, DOI 10.1021/jf902939q; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOOLERY GL, 1984, J AM CHEM SOC, V106, P86, DOI 10.1021/ja00313a019	42	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196691	10.1371/journal.pone.0196691	http://dx.doi.org/10.1371/journal.pone.0196691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715329	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100047
J	Gomez-Rodriguez, EY; Uresti-Rivera, EE; Patron-Soberano, OA; Islas-Osuna, MA; Flores-Martinez, A; Riego-Ruiz, L; Rosales-Saavedra, MT; Casas-Flores, S				Yazmin Gomez-Rodriguez, Elida; Elena Uresti-Rivera, Edith; Araceli Patron-Soberano, Olga; Auxiliadora Islas-Osuna, Maria; Flores-Martinez, Alberto; Riego-Ruiz, Lina; Teresa Rosales-Saavedra, Maria; Casas-Flores, Sergio			Histone acetyltransferase TGF-1 regulates Trichoderma atroviride secondary metabolism and mycoparasitism	PLOS ONE			English	Article							HARZIANUM ENDOCHITINASE GENE; PROTEINASE-ENCODING GENE; BIOCONTROL ACTIVITY; CHROMATIN-STRUCTURE; GLIOCLADIUM-VIRENS; BIOLOGICAL-CONTROL; TRICHOSTATIN-A; BLUE-LIGHT; ACETYLATION; MECHANISMS	Some filamentous fungi of the Trichoderma genus are used as biocontrol agents against airborne and soilborne phytopathogens. The proposed mechanism by which Trichoderma spp. antagonizes phytopathogens is through the release of lytic enzymes, antimicrobial compounds, mycoparasitism, and the induction of systemic disease-resistance in plants. Here we analyzed the role of TGF-1 (Trichoderma Gen Five-1), a histone acetyltransferase of Trichoderma atroviride, in mycoparasitism and antibiosis against the phytopathogen Rhizoctonia solani. Trichostatin A (TSA), a histone deacetylase inhibitor that promotes histone acetylation, slightly affected T. atroviride and R. solani growth, but not the growth of the mycoparasite over R. solani. Application of TSA to the liquid medium induced synthesis of antimicrobial compounds. Expression analysis of the mycoparasitism-related genes ech-42 and prb-1, which encode an endochitinase and a proteinase, as well as the secondary metabolism-related genes pbs-1 and tps-1, which encode a peptaibol synthetase and a terpene synthase, respectively, showed that they were regulated by TSA. A T. atroviride strain harboring a deletion of tgf-1 gene showed slow growth, thinner and less branched hyphae than the wild-type strain, whereas its ability to coil around the R. solani hyphae was not affected. Delta tgf-1 presented a diminished capacity to grow over R. solani, but the ability of its mycelium -free culture filtrates (MFCF) to inhibit the phytopathogen growth was enhanced. Intriguingly, addition of TSA to the culture medium reverted the enhanced inhibition growth of Delta tgf-1 MFCF on R. solani at levels compared to the wild-type MFCF grown in medium amended with TSA. The presence of R. solani mycelium in the culture medium induced similar proteinase activity in a Delta tgf-1 compared to the wild-type, whereas the chitinolytic activity was higher in a Delta tgf-1 mutant in the absence of R. solani, compared to the parental strain. Expression of mycoparasitism- and secondary metabolism-related genes in Delta tgf-1 was differentially regulated in the presence or absence of R. solani. These results indicate that histone acetylation may play important roles in the biocontrol mechanisms of T. atroviride.	[Yazmin Gomez-Rodriguez, Elida; Elena Uresti-Rivera, Edith; Araceli Patron-Soberano, Olga; Riego-Ruiz, Lina; Teresa Rosales-Saavedra, Maria; Casas-Flores, Sergio] IPICYT, Div Mol Biol, San Luis Potosi, San Luis Potosi, Mexico; [Auxiliadora Islas-Osuna, Maria] Ctr Invest Alimentac & Desarrollo, Lab Genet & Biol Mol Plantas, Hermosillo, Sonora, Mexico; [Flores-Martinez, Alberto] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato, Mexico	Instituto Potosino Investigacion Cientifica y Tecnologica; CIAD - Centro de Investigacion en Alimentacion y Desarrollo; Universidad de Guanajuato	Casas-Flores, S (corresponding author), IPICYT, Div Mol Biol, San Luis Potosi, San Luis Potosi, Mexico.	scasas@ipicyt.edu.mx	Casas-Flores, Sergio/S-6985-2019; Islas-Osuna, María A./AAI-3764-2020	Casas-Flores, Sergio/0000-0002-9612-9268; Islas-Osuna, María A./0000-0002-7170-3366; Riego-Ruiz, Lina/0000-0002-2883-8871; Uresti Rivera, Edith Elena/0000-0003-4760-8841	CONACYT [193931, 206894]; Consejo Nacional de Ciencia y Tecnologia (Mexico) [CB 2013-01-220791];  [CB-2013-01-220791]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	This work was supported by grant CB-2013-01-220791 to SC-F. Elida Yazmin Gomez-Rodriguez and Edith Elena Uresti-Rivera are indebted to CONACYT for doctoral fellowships number 193931 and 206894 respectively. The authors wish to thank Isabel Isordia Jasso and Nicolas Gomez-Hernandez for their technical support. We also thank Laboratory for Nanoscience and Nanotechnology Research (LINAN) for providing access to LINAN's electron microscopy facilities.; This work was supported by grant CB 2013-01-220791 to SC-F by the Consejo Nacional de Ciencia y Tecnologia (Mexico). Elida Yazmin Gomez-Rodriguez and Edith Elena Uresti-Rivera are indebted to CONACYT for doctoral fellowships number 193931 and 206894 respectively.	Ali IKM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-7; Salas-Marina MA, 2011, EUR J PLANT PATHOL, V131, P15, DOI 10.1007/s10658-011-9782-6; Baek JM, 1998, FUNGAL GENET BIOL, V23, P34, DOI 10.1006/fgbi.1997.1025; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Brenna A, 2012, MOL BIOL CELL, V23, P3863, DOI 10.1091/mbc.E12-02-0142; Canovas D, 2014, GENETICS, V197, P1175, DOI 10.1534/genetics.114.165688; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; CARSOLIO C, 1994, P NATL ACAD SCI USA, V91, P10903, DOI 10.1073/pnas.91.23.10903; Carsolio C, 1999, APPL ENVIRON MICROB, V65, P929; Choy JS, 2002, MOL CELL BIOL, V22, P8215, DOI 10.1128/MCB.22.23.8215-8225.2002; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; DELPINO MMS, 1994, BIOCHEM J, V303, P723, DOI 10.1042/bj3030723; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Flores A, 1997, CURR GENET, V31, P30, DOI 10.1007/s002940050173; GEREMIA RA, 1993, MOL MICROBIOL, V8, P603, DOI 10.1111/j.1365-2958.1993.tb01604.x; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grimaldi B, 2006, MOL BIOL CELL, V17, P4576, DOI 10.1091/mbc.E06-03-0232; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; He Hongpeng, 2003, Briefings in Functional Genomics & Proteomics, V2, P234, DOI 10.1093/bfgp/2.3.234; Herrera-Estrella A, 1999, EXS, V87, P171; Howell CR, 2003, PLANT DIS, V87, P4, DOI 10.1094/PDIS.2003.87.1.4; HOWELL CR, 1983, CAN J MICROBIOL, V29, P321, DOI 10.1139/m83-053; HOWELL CR, 1995, PHYTOPATHOLOGY, V85, P469, DOI 10.1094/Phyto-85-469; Inbar J, 1996, ADV EXP MED BIOL, V408, P229; Isakov E, 2008, MOL BIOCHEM PARASIT, V158, P82, DOI 10.1016/j.molbiopara.2007.11.014; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Klar AJS, 2001, GENETICS, V158, P919; Komon-Zelazowska M, 2007, EUKARYOT CELL, V6, P2332, DOI 10.1128/EC.00143-07; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Lee I, 2009, FUNGAL GENET BIOL, V46, P782, DOI 10.1016/j.fgb.2009.06.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorito M, 1996, J BACTERIOL, V178, P6382, DOI 10.1128/jb.178.21.6382-6385.1996; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Gonzalez-Prieto JM, 2014, FUNGAL GENET BIOL, V71, P86, DOI 10.1016/j.fgb.2014.09.002; Martinez-Soto D, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov055; Masuda H., 1975, COASTAL FISHES SO JA; Mathivanan N., 2008, V14, P129; Mendoza-Mendoza A, 2003, P NATL ACAD SCI USA, V100, P15965, DOI 10.1073/pnas.2136716100; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mukherjee M, 2006, CURR GENET, V50, P193, DOI 10.1007/s00294-006-0075-0; Mukherjee PK, 2011, J BIOL CHEM, V286, P4544, DOI 10.1074/jbc.M110.159723; Monfil VO, 2014, BIOTECHNOLOGY AND BIOLOGY OF TRICHODERMA, P429, DOI 10.1016/B978-0-444-59576-8.00032-1; Osorio-Concepcion M, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02922-16, 10.1128/aem.02922-16]; Reaves Jimmy L., 1994, PNWRP474 USDA FOR SE; Reyes-Dominguez Y, 2008, EUKARYOT CELL, V7, P656, DOI 10.1128/EC.00184-07; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; Ricci AR, 2002, MOL CELL BIOL, V22, P4033, DOI 10.1128/MCB.22.12.4033-4042.2002; Sanz L, 2004, CURR GENET, V46, P277, DOI 10.1007/s00294-004-0532-6; Schmoll M, 2016, MICROBIOL MOL BIOL R, V80, P205, DOI 10.1128/MMBR.00040-15; Seidl-Seiboth V, 2013, FEBS J, V280, P1226, DOI 10.1111/febs.12113; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shoresh M, 2010, ANNU REV PHYTOPATHOL, V48, P21, DOI 10.1146/annurev-phyto-073009-114450; Shwab EK, 2007, EUKARYOT CELL, V6, P1656, DOI 10.1128/EC.00186-07; Simonetti G, 2007, FEMS YEAST RES, V7, P1371, DOI 10.1111/j.1567-1364.2007.00276.x; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; SUMMERBELL RC, 1987, NEW PHYTOL, V105, P437, DOI 10.1111/j.1469-8137.1987.tb00881.x; Szekeres A, 2004, FEMS MICROBIOL LETT, V233, P215, DOI [10.1111/j.1574-6968.2004.tb09485.x, 10.1016/j.femsle.2004.02.012]; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; TSUJI N, 1976, J ANTIBIOT, V29, P1, DOI 10.7164/antibiotics.29.1; Vargas WA, 2014, MICROBIOL-SGM, V160, P2319, DOI 10.1099/mic.0.079210-0; Velazquez-Robledo R, 2011, MOL PLANT MICROBE IN, V24, P1459, DOI 10.1094/MPMI-02-11-0045; Vogel HJ, 1956, MICROB GENET B, V13, P42; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Wei XY, 2005, CAN J MICROBIOL, V51, P423, DOI 10.1139/W05-006; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xin Q, 2013, CURR MICROBIOL, V67, P580, DOI 10.1007/s00284-013-0396-4; Xue-Franzen Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-200; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Zutz C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/540292	74	13	14	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0193872	10.1371/journal.pone.0193872	http://dx.doi.org/10.1371/journal.pone.0193872			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708970	Green Submitted, Green Published, gold			2022-12-26	WOS:000431130100002
J	Lieffere, JRL; Ekwaru, JP; Ohinmaa, A; Veugelers, PJ				Lieffere, Jessica R. L.; Ekwaru, John Paul; Ohinmaa, Arto; Veugelers, Paul J.			The economic burden of not meeting food recommendations in Canada: The cost of doing nothing	PLOS ONE			English	Article							HEALTH-CARE SAVINGS; PHYSICAL INACTIVITY; TOBACCO SMOKING; EXCESS WEIGHT; CARDIOVASCULAR-DISEASE; OBESITY; ALCOHOL; CANCERS	Few studies have estimated the economic burden of chronic diseases (e.g., type 2 diabetes, cardiovascular diseases, cancers) attributable to unhealthy eating. In this study, we estimated the economic burden of chronic disease attributable to not meeting Canadian food recommendations. We first obtained chronic disease risk estimates for intakes of both protective (1. vegetables; 2. fruit; 3. whole grains; 4. milk; 5. nuts and seeds) and harmful (6. processed meat; 7. red meat; 8. sugar-sweetened beverages) foods from the Global Burden of Disease Study, and food intakes from the 2004 Canadian Community Health Survey 24-hour dietary recalls (n = 33,932 respondents). We then calculated population attributable fractions (PAFs) for all relevant food-chronic disease combinations by age and sex groups. These PAFs were then mathematically combined for each disease for each age and sex group. We then estimated attributable costs by multiplying these combined PAFs with estimated 2014 annual direct health care (hospital, drug, physician) and indirect (human capital approach) costs for each disease. We found that not meeting recommendations for the eight foods was responsible for CAD$13.8 billion/year (direct health care: CAD$5.1 billion, indirect: CAD$8.7 billion). Nuts and seeds and whole grains were the top cost contributors rather than vegetables and fruit. Our findings suggest that unhealthy eating constitutes a tremendous economic burden to Canada that is similar in magnitude to the burden of smoking and larger than that of physical inactivity which were estimated using similar approaches. A status quo in promotion of healthy eating will allow this burden to continue. Interventions to reduce the health and economic burden of unhealthy eating in Canada may be more effective if they are broad in focus and include promotion of nuts and seeds and whole grains along with vegetables and fruit rather than have a narrow focus such as primarily on vegetables and fruit.	[Lieffere, Jessica R. L.; Ekwaru, John Paul; Ohinmaa, Arto; Veugelers, Paul J.] Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada; [Lieffere, Jessica R. L.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada	University of Alberta; University of Saskatchewan	Veugelers, PJ (corresponding author), Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada.	paul.veugelers@ualberta.ca			Collaborative Research and Innovation Opportunities (CRIO) Team program from Alberta Innovates (Al) [201300671]; Canada Research Chair in Population Health; Alberta Research Chair in Nutrition and Disease Prevention; Alberta Innovates Health Scholarship; Social Science and Humanities Research Council (SSHRC); Canadian Institute for Health Research (CIHR); Canadian Foundation for Innovation (CFI); Statistics Canada	Collaborative Research and Innovation Opportunities (CRIO) Team program from Alberta Innovates (Al); Canada Research Chair in Population Health; Alberta Research Chair in Nutrition and Disease Prevention; Alberta Innovates Health Scholarship; Social Science and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Statistics Canada	This research was funded through the Collaborative Research and Innovation Opportunities (CRIO) Team program from Alberta Innovates (Al) (grant number 201300671 to PJV). PJV holds a Canada Research Chair in Population Health, an Alberta Research Chair in Nutrition and Disease Prevention, and an Alberta Innovates Health Scholarship. All interpretations and opinions in the present study are those of the authors. This research was also supported by funds to the Canadian Research Data Centre Network (CRDCN) from the Social Science and Humanities Research Council (SSHRC), the Canadian Institute for Health Research (CIHR), the Canadian Foundation for Innovation (CFI) and Statistics Canada. Although the research and analysis are based on data from Statistics Canada, the opinions expressed do not represent the views of Statistics Canada or the Canadian Research Data Centre Network (CRDCN).	Abdullah MMH, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00167; Anderson TJ, 2016, CAN J CARDIOL, V32, P1263, DOI 10.1016/j.cjca.2016.07.510; Anis AH, 2010, OBES REV, V11, P31, DOI 10.1111/j.1467-789X.2009.00579.x; Azevedo ESG, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0148761; BARNARD ND, 1995, PREV MED, V24, P646, DOI 10.1006/pmed.1995.1100; Birmingham CL, 1999, CAN MED ASSOC J, V160, P483; Blouin C, 2016, CAN J PUBLIC HEALTH, V107, pE507, DOI [10.17269/CJPH.107.5585, 10.17269/cjph.107.5585]; Cadilhac DA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-483; Canadian Cancer Society, RED PROC MEAT; Canadian Institute for Health Information, 2015, NAT HLTH EXP TRENDS; Cancer Care Ontario Public Health Ontario, 2012, TAK ACT PREV CHRON D; Choi BCK, 1996, J EPIDEMIOL COMMUN H, V50, P81, DOI 10.1136/jech.50.1.81; Doidge JC, 2012, J NUTR, V142, P1772, DOI 10.3945/jn.111.154161; Ekwaru JP, 2017, PUBLIC HEALTH NUTR, V20, P515, DOI 10.1017/S1368980016002846; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Frazao E, 1999, AGR INFORMATION B, P5; Garriguet Didier, 2007, Health Rep, V18, P17; Health Canada, 2003, CUST TAB; Health Canada, 2006, CANADIAN COMMUNITY H; Health Canada, 2002, EC BURD ILLN CAN 199; Health Canada, 2007, EATING WELL CANADAS; Health Canada H., 2014, DEV US SURV TOOL CLA; Healthy Aging and Wellness Working Group, 2006, HLTH AG CAN NEW VIS; International Agency for Research on Cancer, IARC MONOGRAPHS EVAL; Janssen I, 2012, APPL PHYSIOL NUTR ME, V37, P803, DOI [10.1139/h2012-061, 10.1139/H2012-061]; Johnson JA, 2006, DIABETES CARE, V29, P2403, DOI 10.2337/dc06-0735; Jones AC., 2017, HLTH EC IMPACT TAX S; Kaiserman M J, 1997, Chronic Dis Can, V18, P13; Katzmarzyk PT, 2000, CAN MED ASSOC J, V163, P1435; Katzmarzyk PT, 2004, CAN J APPL PHYSIOL, V29, P90, DOI 10.1139/h04-008; Kirkpatrick SI, 2015, J NUTR, V145, P1596, DOI 10.3945/jn.114.208579; Kirkpatrick SI, 2012, J ACAD NUTR DIET, V112, P624, DOI 10.1016/j.jand.2011.11.012; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Krueger H, 2016, CURR ONCOL, V23, P241, DOI 10.3747/co.23.2952; Krueger H, 2016, HEALTH PROMOT CHRON, V36, P76, DOI 10.24095/hpcdp.36.4.02; Krueger H, 2013, CHRON DIS INJ CAN, V33, P236; Krueger H, 2017, CAN J PUBLIC HEALTH, V108, pE152, DOI [10.17269/CJPH.108.5721, 10.17269/cjph.108.5721]; Krueger H, 2015, CAN J PUBLIC HEALTH, V106, pE171, DOI 10.17269/cjph.106.4994; Krueger H, 2014, CAN J PUBLIC HEALTH, V105, pE69, DOI 10.17269/cjph.105.4084; Manuel DG, 2016, 4 9 BILLION DECREASE; McCarron DA, 2004, AM J HYPERTENS, V17, P88, DOI 10.1016/j.amjhyper.2003.08.008; Meier T, 2017, J DENT RES, V96, P845, DOI 10.1177/0022034517708315; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; Moffatt E, 2011, CAN J PUBLIC HEALTH, V102, P144, DOI 10.1007/BF03404164; Munene LAE, 2015, HEALTH REP, V26, P12; Public Health Agency of Canada, 2014, EC BURD ILLN CAN 200; Rehm J, 2007, J STUD ALCOHOL DRUGS, V68, P886, DOI 10.15288/jsad.2007.68.886; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Soller L, 2015, J ALLER CL IMM-PRACT, V3, P291, DOI 10.1016/j.jaip.2014.11.006; Statistcis Canada, LEAD CAUS DEATH SEX; Taylor G, 2016, CHIEF PUBLIC HLTH OF; Tooze JA, 2006, J AM DIET ASSOC, V106, P1575, DOI 10.1016/j.jada.2006.07.003; Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063; Tran Bach Xuan, 2013, Cost Eff Resour Alloc, V11, P3, DOI 10.1186/1478-7547-11-3; United States Department of Agriculture (USDA), AMPM USDA AUT MULT P; Whiteman DC, 2015, AUST NZ J PUBL HEAL, V39, P403, DOI 10.1111/1753-6405.12468; WHO, 2008 2013 ACT PLAN G; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Xie XD, 1999, PHARMACOL RES, V39, P185, DOI 10.1006/phrs.1998.0423	60	28	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196333	10.1371/journal.pone.0196333	http://dx.doi.org/10.1371/journal.pone.0196333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1YS	29702680	Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300028
J	Vandenwijngaert, S; Ledsky, CD; Agha, O; Wu, C; Hu, DJ; Bagchi, A; Domian, IJ; Buys, ES; Newton-Cheh, C; Bloch, DB				Vandenwijngaert, Sara; Ledsky, Clara D.; Agha, Obiajulu; Wu, Connie; Hu, Dongjian; Bagchi, Aranya; Domian, Ibrahim J.; Buys, Emmanuel S.; Newton-Cheh, Christopher; Bloch, Donald B.			MicroRNA-425 and microRNA-155 cooperatively regulate atrial natriuretic peptide expression and cGMP production	PLOS ONE			English	Article							CELL-DERIVED CARDIOMYOCYTE; BLOOD-PRESSURE; MIR-155; HYPERTENSION; RECEPTOR; TARGET; ANGIOGENESIS; NEPRILYSIN; INHIBITOR; VARIANTS	Aims Atrial natriuretic peptide (ANP), secreted primarily by atrial cardiomyocytes, decreases blood pressure by raising cyclic 3',5'-guanosine monophosphate (cGMP) levels and inducing vasorelaxation, natriuresis, and diuresis. Raising the level of ANP has been shown to be an effective treatment for hypertension. To advance the future development of an anti-microRNA (miR) approach to increasing expression of ANP, we investigated the regulation of NPPA expression by two miRs: miR-425 and miR-155. We examined whether miR-425 and miR-155 have an additive effect on the expression and function of ANP. Methods and results Human embryonic stem cell-derived cardiomyocytes (hESC-CMs) were transfected with miR-425, miR-155, or a combination of the two miRs. Two days later, NPPA expression was measured using real time qPCR. Each of the miRs decreased NPPA expression over a wide range of concentrations, with a significant reduction at concentrations as low as 1 nM. The combination of miR-425 and miR-155 reduced NPPA expression to a greater extent than either miR-425 or miR-155 alone. An in vitro assay was developed to study the potential biological significance of the miR-induced decrease in NPPA expression. The cooperative effect of miR-425 and miR-155 on NPPA expression was associated with a significant decrease in cGMP levels. Conclusions These data demonstrate that miR-425 and miR-155 regulate NPPA expression in a cooperative manner. Targeting both miRNAs with anti-miRs (possibly at submaximal concentrations) might prove to be a more effective strategy to modulate ANP levels, and thus blood pressure, than targeting either miRNA alone.	[Vandenwijngaert, Sara; Ledsky, Clara D.; Agha, Obiajulu; Wu, Connie; Bagchi, Aranya; Buys, Emmanuel S.; Bloch, Donald B.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Vandenwijngaert, Sara; Ledsky, Clara D.; Agha, Obiajulu; Wu, Connie; Hu, Dongjian; Bagchi, Aranya; Domian, Ibrahim J.; Buys, Emmanuel S.; Newton-Cheh, Christopher; Bloch, Donald B.] Harvard Med Sch, Boston, MA 02115 USA; [Hu, Dongjian; Domian, Ibrahim J.; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Dept Med, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Domian, Ibrahim J.] Harvard Stem Cell Inst, Cambridge, MA USA; [Newton-Cheh, Christopher] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Bloch, Donald B.] Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Bloch, DB (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.; Bloch, DB (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Bloch, DB (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.	bloch@helix.mgh.harvard.edu	Hu, Dongjian/S-7010-2019	Bloch, Donald/0000-0002-6828-4754; Agha, Obiajulu/0000-0003-2439-2638; Bagchi, Aranya/0000-0002-5531-0538	National Institutes of Health [R01HL113933, R01HL124262]; National Institutes of Diabetes and Digestive and Kidney Diseases [DK082971]; Leducq Fondation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Leducq Fondation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [R01HL113933 and R01HL124262 to C.N-C, R01HL113933 to S.V., https://www.nih.gov]; the National Institutes of Diabetes and Digestive and Kidney Diseases [DK082971 to D.B.B., https://www.niddk.nih.gov]; and the Leducq Fondation [D.B.B., https://www. fondationleducq.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora P, 2013, J CLIN INVEST, V123, P3378, DOI 10.1172/JCI67383; Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Dick E, 2010, BIOCHEM SOC T, V38, P1037, DOI 10.1042/BST0381037; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gomez IG, 2015, J CLIN INVEST, V125, P141, DOI 10.1172/JCI75852; Harding SE, 2007, PHARMACOL THERAPEUT, V113, P341, DOI 10.1016/j.pharmthera.2006.08.008; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; Kario K, 2014, HYPERTENSION, V63, P698, DOI 10.1161/HYPERTENSIONAHA.113.02002; Lai X, 2012, NUCLEIC ACIDS RES, V40, P8818, DOI 10.1093/nar/gks657; Lee SH, 2015, ONCOTARGET, V6, P33269, DOI 10.18632/oncotarget.5037; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani I, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150136; Mani I, 2016, AM J PHYSIOL-RENAL, V310, pF68, DOI 10.1152/ajprenal.00205.2015; MIALL W E, 1963, Br Med J, V1, P75; Ruilope LM, 2010, LANCET, V375, P1255, DOI 10.1016/S0140-6736(09)61966-8; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Qi CL, 2014, ONCOTARGET, V5, P9966, DOI 10.18632/oncotarget.2483; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Synnergren J, 2011, PHYSIOL GENOMICS, V43, P581, DOI 10.1152/physiolgenomics.00074.2010; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Williams B, 2017, HYPERTENSION, V69, P411, DOI 10.1161/HYPERTENSIONAHA.116.08556; Wu C, 2016, MOL CELL BIOL, V36, P1977, DOI 10.1128/MCB.01114-15	30	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196697	10.1371/journal.pone.0196697	http://dx.doi.org/10.1371/journal.pone.0196697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698509	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600120
J	Amiryousefi, A; Hyvonen, J; Poczai, P				Amiryousefi, Ali; Hyvonen, Jaakko; Poczai, Peter			The chloroplast genome sequence of bittersweet (Solanum dulcamara): Plastid genome structure evolution in Solanaceae	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; RNA; DNA; GENES; ORGANIZATION; ANNOTATION; REPEATS; L.; TRANSCRIPTOME; PSEUDOGENES	Bittersweet (Solanum dulcamara) is a native Old World member of the nightshade family. This European diploid species can be found from marshlands to high mountainous regions and it is a common weed that serves as an alternative host and source of resistance genes against plant pathogens such as late blight (Phytophthora infestans). We sequenced the complete chloroplast genome of bittersweet, which is 155,580 bp in length and it is characterized by a typical quadripartite structure composed of a large (85,901 bp) and small (18,449 bp) single-copy region interspersed by two identical inverted repeats (25,615 bp). It consists of 112 unique genes from which 81 are protein-coding, 27 tRNA and four rRNA genes. All bittersweet plastid genes including non-functional ones and even intergenic spacer regions are transcribed in primary plastid transcripts covering 95.22% of the genome. These are later substantially edited in a post-transcriptional phase to activate gene functions. By comparing the bittersweet plastid genome with all available Solanaceae sequences we found that gene content and synteny are highly conserved across the family. During genome comparison we have identified several annotation errors, which we have corrected in a manual curation process then we have identified the major plastid genome structural changes in Solanaceae. Interpreted in a phylogenetic context they seem to provide additional support for larger clades. The plastid genome sequence of bittersweet could help to benchmark Solanaceae plastid genome annotations and could be used as a reference for further studies. Such reliable annotations are important for gene diversity calculations, synteny map constructions and assigning partitions for phylogenetic analysis with de novo sequenced plastomes of Solanaceae.	[Amiryousefi, Ali; Hyvonen, Jaakko] Univ Helsinki, Fac Biol & Environm Sci, Organismal Evolutionary Biol Res Program, Viikki Plant Sci Ctr, Helsinki, Finland; [Hyvonen, Jaakko; Poczai, Peter] Univ Helsinki, Finnish Museum Nat Hist Bot, Helsinki, Finland	University of Helsinki; University of Helsinki	Poczai, P (corresponding author), Univ Helsinki, Finnish Museum Nat Hist Bot, Helsinki, Finland.	peter.poczai@gmail.com	Hyvonen, Jaakko T/H-5120-2012					Amiryousefi A, 2018, BIOINFORMATICS, V34, P3030, DOI 10.1093/bioinformatics/bty220; [Anonymous], 2018, RAXML NEXT GENERATIO, DOI [10.5281/zenodo.593079, DOI 10.5281/ZENODO.593079]; Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; Bohs L., 2005, SYST BOT, V104, P27, DOI DOI 10.1111/J.1365-2699.2007.01870.X; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bombarely A, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.74, 10.1038/NPLANTS.2016.74]; Child A, 2001, SOLANACEAE, VV, P39; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; DARCY WG, 1972, ANN MO BOT GARD, V59, P262, DOI 10.2307/2394758; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Germain A, 2013, WIRES RNA, V4, P295, DOI 10.1002/wrna.1161; Golas TM, 2010, PLANT SYST EVOL, V285, P103, DOI 10.1007/s00606-009-0260-y; Golas TM, 2010, POTATO RES, V53, P69, DOI 10.1007/s11540-010-9151-4; Goloboff P, 2008, CLADISTICS, V24, P91; Hajianfar R, 2016, PHYSIOL MOL PLANT P, V93, P22, DOI 10.1016/j.pmpp.2015.12.001; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HOCH B, 1991, NATURE, V353, P178, DOI 10.1038/353178a0; Hotto AM, 2012, TRENDS PLANT SCI, V17, P737, DOI 10.1016/j.tplants.2012.08.002; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jo YD, 2011, PLANT CELL REP, V30, P217, DOI 10.1007/s00299-010-0929-2; Kahlau S, 2006, J MOL EVOL, V63, P194, DOI 10.1007/s00239-005-0254-5; Karol KG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-321; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Knapp S, 2013, PHYTOKEYS, V22, P1, DOI [10.3897/phytokeys.@.4041, 10.3897/phytokeys.22.4041]; Kumar P, 2009, NAT PROD RES, V23, P719, DOI 10.1080/14786410802267692; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092501; Lester RN., 1991, SOLANACEAE, P283; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mathe I, 1979, BIOL TAXONOMY SOLANA, P211; McKain MR, 2017, BIOINFORMATICS, V33, P130, DOI 10.1093/bioinformatics/btw583; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Mower JP, 2009, NUCLEIC ACIDS RES, V37, pW253, DOI 10.1093/nar/gkp337; Nagy E, 2017, DATA BRIEF, V15, P606, DOI 10.1016/j.dib.2017.10.009; Nee M., 1999, SOLANACEAE, VIV, P285; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Oldenburg DJ, 2016, CURR GENET, V62, P431, DOI 10.1007/s00294-015-0548-0; Oldenburg DJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00883; Oldenkott B, 2014, RNA, V20, P1499, DOI 10.1261/rna.045575.114; OLMSTEAD RG, 1992, ANN MO BOT GARD, V79, P346, DOI 10.2307/2399773; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Perry KL, 2011, PLANT DIS, V95, P619, DOI 10.1094/PDIS-10-10-0768; Poczai P, 2011, ANN APPL BIOL, V159, P141, DOI 10.1111/j.1744-7348.2011.00482.x; Poczai P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187199; Poczai P, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-459; Poczai P, 2013, GENE, V530, P143, DOI 10.1016/j.gene.2013.08.013; Poczai P, 2011, BIOTECHNOL LETT, V33, P2317, DOI 10.1007/s10529-011-0701-x; Sarkinen T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-214; Samson N, 2007, PLANT BIOTECHNOL J, V5, P339, DOI 10.1111/j.1467-7652.2007.00245.x; Sarkinen T, 2015, TAXON, V64, P945, DOI 10.12705/645.5; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmitz-Linneweber C, 2002, MOL BIOL EVOL, V19, P1602, DOI 10.1093/oxfordjournals.molbev.a004222; Shi C, 2016, SCI REP-UK, V6, DOI 10.1038/srep30135; Shi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059620; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Smith SD, 2006, AM J BOT, V93, P1140, DOI 10.3732/ajb.93.8.1140; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Sugita M, 1997, MOL GEN GENET, V257, P23, DOI 10.1007/s004380050619; Takacs A. P., 2001, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V66, P183; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tillich M, 2006, MOL BIOL EVOL, V23, P1912, DOI 10.1093/molbev/msl054; Tillich M, 2017, NUCLEIC ACIDS RES, V45, pW6, DOI 10.1093/nar/gkx391; Tsudzuki T, 2001, J MOL EVOL, V53, P327, DOI 10.1007/s002390010222; Vallejo-Marin M, 2007, NEW PHYTOL, V173, P415, DOI 10.1111/j.1469-8137.2006.01924.x; VERA A, 1994, EMBO J, V13, P2211, DOI 10.1002/j.1460-2075.1994.tb06498.x; Sanchez-Puerta MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098353; Wang WQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140285; Weese TL, 2007, SYST BOT, V32, P445, DOI 10.1600/036364407781179671; Weng ML, 2014, MOL BIOL EVOL, V31, P645, DOI 10.1093/molbev/mst257; WOODBURY NW, 1988, CURR GENET, V14, P75, DOI 10.1007/BF00405857; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110656; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhelyazkova P, 2012, PLANT CELL, V24, P123, DOI 10.1105/tpc.111.089441	87	58	59	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196069	10.1371/journal.pone.0196069	http://dx.doi.org/10.1371/journal.pone.0196069			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694416	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400059
J	Hart, JP; Tache, K; Lovis, WA				Hart, John P.; Tache, Karine; Lovis, William A.			Freshwater reservoir offsets and food crusts: Isotope, AMS, and lipid analyses of experimental cooking residues	PLOS ONE			English	Article							PREHISTORIC CENTRAL PLAINS; ARCHAEOLOGICAL POTTERY; BULK DELTA-C-13; C-14 ANALYSIS; DATES; CARBON; MAIZE; VARIABILITY; RELIABILITY; CONTINUITY	Freshwater reservoir offsets (FROs) occur when AMS dates on charred, encrusted food residues on pottery predate a pot's chronological context because of the presence of ancient carbon from aquatic resources such as fish. Research over the past two decades has demonstrated that FROs vary widely within and between water bodies and between fish in those water bodies. Lipid analyses have identified aquatic biomarkers that can be extracted from cooking residues as potential evidence for FROs. However, lacking has been efforts to determine empirically how much fish with FROs needs to be cooked in a pot with other resources to result in significant FRO on encrusted cooking residue and what percentage of fish C in a residue is needed to result in the recovery of aquatic biomarkers. Here we provide preliminary assessments of both issues. Our results indicate that in historically-contingent, high alkalinity environments <20% C from fish may result in a statistically significant FRO, but that biomarkers for aquatic resources may be present in the absence of a significant FRO.	[Hart, John P.] New York State Museum & Sci Serv, Res & Collect Div, 3140 Cultural Educ Ctr, Albany, NY 12230 USA; [Tache, Karine] CUNY Queens Coll, Dept Anthropol, Queens, NY USA; [Lovis, William A.] Michigan State Univ, Dept Anthropol, E Lansing, MI 48824 USA; [Lovis, William A.] Michigan State Univ, MSU Museum, E Lansing, MI 48824 USA	City University of New York (CUNY) System; Michigan State University; Michigan State University	Hart, JP (corresponding author), New York State Museum & Sci Serv, Res & Collect Div, 3140 Cultural Educ Ctr, Albany, NY 12230 USA.	john.hart@nysed.gov	Hart, John/H-7419-2014	Hart, John/0000-0003-2009-0624; Tache, Karine/0000-0003-0460-498X	New York State Museum	New York State Museum	We thank Rick Morse, Bryan Weatherwax, and Jeremy Wright (New York State Museum) for capturing the fish used in this study; Brian Bird (New York State Museum) for obtaining the maize; Robert Feranec (New York State Museum) for providing help in the lab with sample preparation; Alexandre Lucquin (University of York) for assisting with the lipid analysis; Susan Winchell-Sweeney (New York State Museum) for Fig 1, and Feranec and Gerald Urquhart (Michigan State University) for commenting on an earlier draft of the paper. Four peer reviewers provided important comments and suggestions. Radiocarbon and isotope assays were funded by the New York State Museum.	Berstan R, 2008, ANTIQUITY, V82, P702, DOI 10.1017/S0003598X00097325; Boudin M, 2009, P INT M BRUSS MAY 30, P727; Butman DE, 2015, NAT GEOSCI, V8, P112, DOI [10.1038/ngeo2322, 10.1038/NGEO2322]; Cerling TE, 2016, P NATL ACAD SCI USA, V113, P13330, DOI 10.1073/pnas.1614938113; Community Science Institute, 2017, STREAMS LAKES DATA S; Correa-Ascencio M, 2014, ANAL METHODS-UK, V6, P1330, DOI 10.1039/c3ay41678j; Craig OE, 2013, NATURE, V496, P351, DOI 10.1038/nature12109; Craig OE, 2011, P NATL ACAD SCI USA, V108, P17910, DOI 10.1073/pnas.1107202108; Evershed RP, 2008, ARCHAEOMETRY, V50, P101, DOI 10.1111/j.1475-4754.2007.00368.x; Fernandes R, 2014, J ARCHAEOL SCI, V50, P153, DOI 10.1016/j.jas.2014.07.006; Fischer A, 2003, RADIOCARBON, V45, P449, DOI 10.1017/S003382220003280X; Fraser RA, 2013, J ARCHAEOL SCI, V40, P4754, DOI 10.1016/j.jas.2013.01.032; Hansel FA, 2004, TETRAHEDRON LETT, V45, P2999, DOI 10.1016/j.tetlet.2004.01.111; Hart JP, 2007, RADIOCARBON, V49, P1403, DOI 10.1017/S0033822200043228; Hart JP, 2007, J ARCHAEOL SCI, V34, P804, DOI 10.1016/j.jas.2006.08.006; Hart JP, 2014, RADIOCARBON, V56, P341, DOI 10.2458/56.16898; Hart JP, 2013, AM ANTIQUITY, V78, P536, DOI 10.7183/0002-7316.78.3.536; Hart JP, 2012, J ARCHAEOL SCI, V39, P3470, DOI 10.1016/j.jas.2012.06.006; Hart JP, 2012, AM ANTIQUITY, V77, P315, DOI 10.7183/0002-7316.77.2.315; Hart JP, 2009, J ARCHAEOL SCI, V36, P2206, DOI 10.1016/j.jas.2009.06.005; Hart John P., 2014, MIDWEST ARCHAEOLOGIC, V1, P161; HASTORF CA, 1985, NATURE, V315, P489, DOI 10.1038/315489a0; Heron C, 2015, RADIOCARBON, V57, P707, DOI 10.2458/azu_rc.57.18454; Heron C, 2015, J ARCHAEOL SCI, V63, P33, DOI 10.1016/j.jas.2015.08.002; Keaveney EM, 2012, J ARCHAEOL SCI, V39, P1306, DOI 10.1016/j.jas.2011.12.025; LOVIS WA, 1990, AM ANTIQUITY, V55, P382, DOI 10.2307/281656; Lovis WA, 2015, RADIOCARBON, V57, P557, DOI 10.2458/azu_rc.57.18352; Lovis WA, 2011, J ARCHAEOL SCI, V38, P2726, DOI 10.1016/j.jas.2011.06.010; Lucquin A, 2016, P NATL ACAD SCI USA, V113, P3991, DOI 10.1073/pnas.1522908113; Morton JD, 2004, J ARCHAEOL SCI, V31, P503, DOI 10.1016/j.jas.2003.10.001; Mullins HT, 2011, J PALEOLIMNOL, V45, P243, DOI 10.1007/s10933-011-9495-z; Nomokonova T, QUATERNARY INT J SC, V290-291, P110; Oras E, 2017, J ARCHAEOL SCI, V78, P112, DOI 10.1016/j.jas.2016.11.010; Parker AC, 1910, NEW YORK STATE MUSEU, V44; Philippsen B, 2013, HERIT SCI, V1, DOI 10.1186/2050-7445-1-24; Philippsen B, 2013, RADIOCARBON, V55, P1085, DOI 10.1017/S0033822200048001; Roper DC, 2013, RADIOCARBON, V55, P151; St-Pierre CG, 2015, AM ANTIQUITY, V80, P408, DOI 10.7183/0002-7316.80.2.408; Stott AW, 2003, ANAL CHEM, V75, P5037, DOI 10.1021/ac020743y; Stott AW, 2001, RADIOCARBON, V43, P191; Svyatko SV, 2017, RADIOCARBON, V59, P1597, DOI 10.1017/RDC.2017.11; Tache K, 2015, ANTIQUITY, V89, P177, DOI 10.15184/aqy.2014.36; Walter SRS, 2015, RADIOCARBON, V57, P109, DOI 10.2458/azu_rc.57.18118; WARD GK, 1978, ARCHAEOMETRY, V20, P19, DOI 10.1111/j.1475-4754.1978.tb00208.x; Waugh FW, 1916, ANTHR SERIES PENNSYL, V12; Waugh FW, 1916, MEMOIR, V86	46	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196407	10.1371/journal.pone.0196407	http://dx.doi.org/10.1371/journal.pone.0196407			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	29694436	Green Published, gold			2022-12-26	WOS:000430802400088
J	Liu, SY; Triantis, KP; Zhao, L; Wang, YF				Liu, Shiyong; Triantis, Konstantinos P.; Zhao, Li; Wang, Youfa			Capturing multi-stage fuzzy uncertainties in hybrid system dynamics and agent-based models for enhancing policy implementation in health systems research	PLOS ONE			English	Article							BIG DATA; PERCEPTION; SIMULATION; LOGIC; RISK; TAX	Background In practical research, it was found that most people made health-related decisions not based on numerical data but on perceptions. Examples include the perceptions and their corresponding linguistic values of health risks such as, smoking, syringe sharing, eating energy-dense food, drinking sugar-sweetened beverages etc. For the sake of understanding the mechanisms that affect the implementations of health-related interventions, we employ fuzzy variables to quantify linguistic variable in healthcare modeling where we employ an integrated system dynamics and agent-based model. Methodology In a nonlinear causal-driven simulation environment driven by feedback loops, we mathematically demonstrate how interventions at an aggregate level affect the dynamics of linguistic variables that are captured by fuzzy agents and how interactions among fuzzy agents, at the same time, affect the formation of different clusters(groups) that are targeted by specific interventions. Results In this paper, we provide an innovative framework to capture multi-stage fuzzy uncertainties manifested among interacting heterogeneous agents (individuals) and intervention decisions that affect homogeneous agents (groups of individuals) in a hybrid model that combines an agent-based simulation model (ABM) and a system dynamics models (SDM). Having built the platform to incorporate high-dimension data in a hybrid ABM/SDM model, this paper demonstrates how one can obtain the state variable behaviors in the SDM and the corresponding values of linguistic variables in the ABM. Conclusions This research provides a way to incorporate high-dimension data in a hybrid ABM/SDM model. This research not only enriches the application of fuzzy set theory by capturing the dynamics of variables associated with interacting fuzzy agents that lead to aggregate behaviors but also informs implementation research by enabling the incorporation of linguistic variables at both individual and institutional levels, which makes unstructured linguistic data meaningful and quantifiable in a simulation environment. This research can help practitioners and decision makers to gain better understanding on the dynamics and complexities of precision intervention in healthcare. It can aid the improvement of the optimal allocation of resources for targeted group (s) and the achievement of maximum utility. As this technology becomes more mature, one can design policy flight simulators by which policy/intervention designers can test a variety of assumptions when they evaluate different alternatives interventions.	[Liu, Shiyong] Southwestern Univ Finance & Econ, Res Inst Econ & Management, Chengdu, Sichuan, Peoples R China; [Triantis, Konstantinos P.] Virginia Polytech Inst & State Univ, Grado Dept Ind & Syst Engn, Falls Church, VA USA; [Zhao, Li] Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Policy & Hlth Management, Chengdu, Sichuan, Peoples R China; [Wang, Youfa] Ball State Univ, Fisher Inst Hlth & Well Being, Muncie, IN 47306 USA	Southwestern University of Finance & Economics - China; Virginia Polytechnic Institute & State University; Sichuan University; Ball State University	Liu, SY (corresponding author), Southwestern Univ Finance & Econ, Res Inst Econ & Management, Chengdu, Sichuan, Peoples R China.; Wang, YF (corresponding author), Ball State Univ, Fisher Inst Hlth & Well Being, Muncie, IN 47306 USA.	shiyongliu2006@gmail.com; ywang26@bsu.edu	Liu, Shiyong/ABG-8226-2020	Liu, Shiyong/0000-0003-4463-9431	Chinese National Social Science Foundation [12CGL103]; Fundamental Research Funds for the Central Universities; Southwestern University of Finance and Economics; US National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [NICHD] [1R01HD064685-01A1, U54HD070725]; NICHD; NIH Office of Behavioral and Social Sciences Research (OBSSR)	Chinese National Social Science Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Southwestern University of Finance and Economics; US National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [NICHD]; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH Office of Behavioral and Social Sciences Research (OBSSR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by research grants from the Chinese National Social Science Foundation (12CGL103) and the Fundamental Research Funds for the Central Universities to SL, and the Southwestern University of Finance and Economics, the US National Institutes of Health (NIH) (research grants 1R01HD064685-01A1 and U54HD070725 to YW from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [NICHD]). The U54 project is co-funded by the NICHD and the NIH Office of Behavioral and Social Sciences Research (OBSSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acton QA, 2013, ISSUES ARTIFICIAL IN; Azmak O, 2015, BIG DATA, V3, P173, DOI 10.1089/big.2015.0012; Baki S, INT ENV MOD SOFTW SO; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Chawla NV, 2013, J GEN INTERN MED, V28, pS660, DOI 10.1007/s11606-013-2455-8; Chen CLP, 2015, IEEE T FUZZY SYST, V23, P2163, DOI 10.1109/TFUZZ.2015.2406889; Chen DY, 2010, ACTA MATH SIN, V26, P1383, DOI 10.1007/s10114-010-7191-y; Chiang TC, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0287-2; Collins B, 2016, PHARMACOECONOMICS, V34, P101, DOI 10.1007/s40273-015-0306-7; Cordon O, 2000, IEEE T FUZZY SYST, V8, P335, DOI 10.1109/91.855921; Djanatliev A., 2012, P 2012 WINT SIM C WS, P1, DOI [10.1109/WSC.2012.6465024, DOI 10.1109/WSC.2012.6465024]; Dubois D., 1988, POSSIBILITY THEORY A; Ferrada F, 2017, IFIP ADV INFORM COMM, V499; Figueredo GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118359; Gachter S, 2013, J EUR ECON ASSOC, V11, P548, DOI 10.1111/jeea.12015; Gao A, 2014, P 2014 WINT SIM C DE; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Hartley RVL, 1928, BELL SYST TECH J, V7, P535, DOI 10.1002/j.1538-7305.1928.tb01236.x; Hassan Samer, 2010, International Journal of Reasoning-based Intelligent Systems, V2, P118, DOI 10.1504/IJRIS.2010.034907; Izquierdo LR, 2015, JASSS-J ARTIF SOC S, V18; Klir G.J., 1995, FUZZY SETS FUZZY LOG, DOI 10.1109/9780470544341.ch11; Kunsch P, 2008, EUR J OPER RES, V185, P1285, DOI 10.1016/j.ejor.2006.05.048; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Liu SY, 2016, J OPER RES SOC, V67, P708, DOI 10.1057/jors.2015.99; Liu SY, 2011, SYST RES BEHAV SCI, V28, P245, DOI 10.1002/sres.1064; Liu SY, 2010, TRANSPORT RES A-POL, V44, P596, DOI 10.1016/j.tra.2010.04.001; Macal CM, 2010, WINT SIMUL C PROC, P371, DOI 10.1109/WSC.2010.5679148; MAMDANI EH, 1977, IEEE T COMPUT, V26, P1182, DOI 10.1109/TC.1977.1674779; Marin M, 2006, PROCEEDINGS OF THE 2006 WINTER SIMULATION CONFERENCE, VOLS 1-5, P667, DOI 10.1109/WSC.2006.323144; Massad E, 2009, FUZZY LOGIC ACTION A; Mei S, 2014, IEEE T FUZZY SYST, V22, P264, DOI 10.1109/TFUZZ.2013.2251638; Moore SE, 2010, J NATL MED ASSOC, V102, P119, DOI 10.1016/S0027-9684(15)30499-5; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Oncken C, 2005, PREV MED, V40, P779, DOI 10.1016/j.ypmed.2004.09.024; Pankaj S., 1994, EUR J OPER RES, V78, P380; Rodriguez RM, 2012, IEEE T FUZZY SYST, V20, P109, DOI 10.1109/TFUZZ.2011.2170076; Scholl H.J., 2001, P HAW INT C SYST SCI, P62, DOI [10.1109/HICSS.2001.926296, DOI 10.1109/HICSS.2001.926296]; Schryver J, 2015, OPEN J MODELLING SIM, V3, P196, DOI [10.4236/ojmsi.2015.34019, DOI 10.4236/OJMSI.2015.34019]; Shafer G.A., 1976, MATH THEORY EVIDENCE; Shafiei E, 2013, TRANSPORT REV, V33, P44, DOI 10.1080/01441647.2012.745632; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Smyth BP, 2007, ADDICT BEHAV, V32, P1943, DOI 10.1016/j.addbeh.2006.12.021; Stemate Luminita, 2007, 2007 Winter Simulation Conference, DOI 10.1109/WSC.2007.4419891; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Tansella M, 2009, BRIT J PSYCHIAT, V195, P283, DOI 10.1192/bjp.bp.109.065565; Teodorovic D, 1999, TRANSPORT RES A-POL, V33, P337, DOI 10.1016/S0965-8564(98)00024-X; Teose M., 2011, P INT JOINT C ARTIFI, V22, P2531, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-421; Walker AE, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-22; Wallentin G, 2017, ECOL MODEL, V345, P165, DOI 10.1016/j.ecolmodel.2016.11.007; Winter J, 2014, HEALTH ECON, V23, P564, DOI 10.1002/hec.2933; Yager RR, 2002, IEEE T FUZZY SYST, V7, P462; ZADEH LA, 1975, INFORM SCIENCES, V9, P43, DOI 10.1016/0020-0255(75)90017-1; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI 10.1016/0020-0255(75)90046-8; Zadeh LA, 1973, 411 ERLM; Zimmerman HJ., 1980, FUZZY SETS DECISION; Zimmermann HJ, 2000, EUR J OPER RES, V122, P190, DOI 10.1016/S0377-2217(99)00228-3	57	5	5	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0194687	10.1371/journal.pone.0194687	http://dx.doi.org/10.1371/journal.pone.0194687			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	29694364	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400014
J	Prang, KH; Newnam, S; Berecki-Gisolf, J				Prang, Khic-Houy; Newnam, Sharon; Berecki-Gisolf, Janneke			"That's what you do for people you love": A qualitative study of social support and recovery from a musculoskeletal injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; FAMILY-MEMBERS; SELF-MANAGEMENT; OUTCOMES; HEALTH; EXPERIENCES; DISABILITY; DISORDERS; COMMUNITY	Background Social support has been identified as a significant factor in facilitating better health outcomes following injury. However, research has primarily focused on the role of social support from the perspective of the person experiencing an injury. Limited research has examined the experiences of the family members and friends of a person with injury. This study aims to explore the perceptions and experiences of social support and recovery following a transport-related musculoskeletal injury (MSI) in a population of injured persons and their family members and friends. Methods This study was conducted using a phenomenological qualitative research design. In-depth semi-structured interviews were conducted with ten persons with MSI, recruited via the Transport Accident Commission (TAC) in Victoria, Australia. Seven family members and friends were also interviewed. The data was analysed using constant comparative method and thematic analysis. Results Several themes were identified including: (1) key sources and types of support received, (2) relationship development and (3) challenges of providing and receiving support. Participants with MSI reported stories about how the social network provided emotional and tangible support. Family members and friends confirmed the supportive acts provided to the participants with MSI. Positive iterative changes in relationships were reported by the participants with MSI. Participants with MSI, their family members and friends described several difficulties including loss of independence, feeling like a burden, and the impact of caring on health and well-being. Conclusions The role of social support is complex given the multitude of people involved in the recovery process. The findings of this study suggest that persons with MSI may benefit from support groups and maintenance of existing support networks. Furthermore, family members and friends engaged in the recovery process may benefit from support in this role.	[Prang, Khic-Houy; Newnam, Sharon; Berecki-Gisolf, Janneke] Monash Univ, Accid Res Ctr, Melbourne, Vic, Australia; [Prang, Khic-Houy] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia	Monash University; University of Melbourne	Prang, KH (corresponding author), Monash Univ, Accid Res Ctr, Melbourne, Vic, Australia.; Prang, KH (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia.	khic-houy.prang@unimelb.edu.au		Prang, Khic-Houy/0000-0001-9194-6472	Transport Accident Commission (TAC); Worksafe Victoria (WSV) via the Institute for Safety, Compensation and Recovery Research (ISCRR)	Transport Accident Commission (TAC); Worksafe Victoria (WSV) via the Institute for Safety, Compensation and Recovery Research (ISCRR)	This research was supported by a scholarship from the Transport Accident Commission (TAC) and Worksafe Victoria (WSV) via the Institute for Safety, Compensation and Recovery Research (ISCRR). Views expressed are those of the authors and not the funding agencies.	Asfaw A, 2015, AM J IND MED, V58, P1205, DOI 10.1002/ajim.22500; Baltov P, 2008, DISABIL REHABIL, V30, P1947, DOI 10.1080/09638280701791245; Barak A, 2008, COMPUT HUM BEHAV, V24, P1867, DOI 10.1016/j.chb.2008.02.004; Berecki-Gisolf J, 2013, ACCIDENT ANAL PREV, V51, P129, DOI 10.1016/j.aap.2012.11.010; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buitenhuis J, 2003, SPINE, V28, P896, DOI 10.1097/00007632-200305010-00011; Cacioppo JT, 2003, PERSPECT BIOL MED, V46, pS39, DOI 10.1353/pbm.2003.0049; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; Coronas Ramon, 2008, Depress Anxiety, V25, pE16, DOI 10.1002/da.20324; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Crotty MM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0897-x; Dembe AE, 2001, AM J IND MED, V40, P403, DOI 10.1002/ajim.1113; Dickson A, 2010, PSYCHOL HEALTH, V25, P1101, DOI 10.1080/08870440903038949; Gagnon A, 2016, DISABIL REHABIL, V38, P433, DOI 10.3109/09638288.2015.1044035; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Heaney C. A., 2008, HLTH BEHAV HLTH ED T; Hogan BE, 2002, CLIN PSYCHOL REV, V22, P381, DOI 10.1016/S0272-7358(01)00102-7; Holeva V, 2001, BEHAV THER, V32, P65, DOI 10.1016/S0005-7894(01)80044-7; Hours M, 2010, ACCIDENT ANAL PREV, V42, P412, DOI 10.1016/j.aap.2009.09.002; Isaksson G, 2008, SCAND J OCCUP THER, V15, P236, DOI 10.1080/11038120802194265; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kreuter M, 2000, SPINAL CORD, V38, P2, DOI 10.1038/sj.sc.3100933; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Muller R, 2013, INT J REHABIL RES, V36, P236, DOI 10.1097/MRR.0b013e32835dd5ff; Murgatroyd D, 2015, BMC PUBLIC HEALTH, V15, P1; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; Newnam S, 2014, PUBLIC HEALTH, V128, P587, DOI 10.1016/j.puhe.2014.04.004; Nijs J, 2011, CLIN RHEUMATOL, V30, P927, DOI 10.1007/s10067-011-1712-7; Ogilvie R, 2015, INJURY, V46, P1834, DOI 10.1016/j.injury.2015.03.030; Ogilvie R, 2015, INJURY, V46, P1841, DOI 10.1016/j.injury.2015.05.036; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Prang K-H, 2015, HEALTH QUAL LIFE OUT, V13, P1; Rosenbloom BN, 2013, J PAIN RES, V6, P39, DOI 10.2147/JPR.S38878; Sleney J, 2014, INJURY, V45, P312, DOI 10.1016/j.injury.2012.12.025; Spiegel DA, 2008, J BONE JOINT SURG AM, V90A, P915, DOI 10.2106/JBJS.G.00637; Urquhart DM, 2006, ANZ J SURG, V76, P600, DOI 10.1111/j.1445-2197.2006.03785.x; World Health Organization, 2013, GLOB STAT REP ROAD S	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196337	10.1371/journal.pone.0196337	http://dx.doi.org/10.1371/journal.pone.0196337			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	29694438	Green Published, gold			2022-12-26	WOS:000430802400084
J	Yokoyama, H; Sato, K; Ogawa, T; Yamamoto, SI; Nakazawa, K; Kawashima, N				Yokoyama, Hikaru; Sato, Koji; Ogawa, Tetsuya; Yamamoto, Shin-Ichiro; Nakazawa, Kimitaka; Kawashima, Noritaka			Characteristics of the gait adaptation process due to split-belt treadmill walking under a wide range of right-left speed ratios in humans	PLOS ONE			English	Article							LOCOMOTOR ADAPTATION; MOTOR ADAPTATION; INTERLIMB COORDINATION; CATS; LEG; ORGANIZATION; GENERATION; NETWORKS; DURATION; FEEDBACK	The adaptability of human bipedal locomotion has been studied using split-belt treadmill walking. Most of previous studies utilized experimental protocol under remarkably different split ratios (e.g. 1: 2, 1: 3, or 1: 4). While, there is limited research with regard to adaptive process under the small speed ratios. It is important to know the nature of adaptive process under ratio smaller than 1: 2, because systematic evaluation of the gait adaptation under small to moderate split ratios would enable us to examine relative contribution of two forms of adaptation (reactive feedback and predictive feedforward control) on gait adaptation. We therefore examined a gait behavior due to on split-belt treadmill adaptation under five belt speed difference conditions (from 1: 1.2 to 1: 2). Gait parameters related to reactive control (stance time) showed quick adjustments immediately after imposing the split-belt walking in all five speed ratios. Meanwhile, parameters related to predictive control (step length and anterior force) showed a clear pattern of adaptation and subsequent aftereffects except for the 1: 1.2 adaptation. Additionally, the 1: 1.2 ratio was distinguished from other ratios by cluster analysis based on the relationship between the size of adaptation and the aftereffect. Our findings indicate that the reactive feedback control was involved in all the speed ratios tested and that the extent of reaction was proportionally dependent on the speed ratio of the split-belt. On the contrary, predictive feedforward control was necessary when the ratio of the split-belt was greater. These results enable us to consider how a given split-belt training condition would affect the relative contribution of the two strategies on gait adaptation, which must be considered when developing rehabilitation interventions for stroke patients.	[Yokoyama, Hikaru; Ogawa, Tetsuya; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Yokoyama, Hikaru; Sato, Koji; Kawashima, Noritaka] Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan; [Yokoyama, Hikaru] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Sato, Koji; Yamamoto, Shin-Ichiro] Shibaura Inst Technol, Dept Biosci & Engn, Grad Sch Engn & Sci, Saitama, Japan	University of Tokyo; Japan Society for the Promotion of Science; Shibaura Institute of Technology	Kawashima, N (corresponding author), Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Res Inst, Tokorozawa, Saitama, Japan.	nori@rehab.go.jp	Yokoyama, Hikaru/GLT-6054-2022		Japan Society for the Promotion of Science (JSPS) [15K12617, 15J09583]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Challenging Exploratory Research (15K12617) to N.K. and a Grant-in-Aid for Doctoral Fellowship (15J09583) to H.Y. from the Japan Society for the Promotion of Science (JSPS).	ALLEN GI, 1974, PHYSIOL REV, V54, P957, DOI 10.1152/physrev.1974.54.4.957; Bastian AJ, 2011, CURR OPIN NEUROBIOL, V21, P596, DOI 10.1016/j.conb.2011.06.007; Bhanpuri NH, 2013, J NEUROSCI, V33, P14301, DOI 10.1523/JNEUROSCI.0784-13.2013; Boisgontier MP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00212; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; Choi JT, 2009, BRAIN, V132, P722, DOI 10.1093/brain/awn333; DUYSENS J, 1980, BRAIN RES, V187, P321, DOI 10.1016/0006-8993(80)90206-1; Finley JM, 2013, J PHYSIOL-LONDON, V591, P1081, DOI 10.1113/jphysiol.2012.245506; FORSSBERG H, 1980, ACTA PHYSIOL SCAND, V108, P283, DOI 10.1111/j.1748-1716.1980.tb06534.x; Frigon A, 2013, J NEUROSCI, V33, P8559, DOI 10.1523/JNEUROSCI.3931-12.2013; Fujiki S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0542; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Hoogkamer W, 2015, J NEUROPHYSIOL, V114, P1693, DOI 10.1152/jn.00936.2014; Hoogkamer W, 2015, J NEUROPHYSIOL, V114, P1705, DOI 10.1152/jn.00937.2014; Jayaram G, 2012, J NEUROPHYSIOL, V107, P2950, DOI 10.1152/jn.00645.2011; Jayaram G, 2011, CEREB CORTEX, V21, P1901, DOI 10.1093/cercor/bhq263; Kiehn O, 2016, NAT REV NEUROSCI, V17, P224, DOI 10.1038/nrn.2016.9; Lacquaniti F, 2012, J PHYSIOL-LONDON, V590, P2189, DOI 10.1113/jphysiol.2011.215137; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Mawase F, 2013, J NEUROPHYSIOL, V109, P2216, DOI 10.1152/jn.00938.2012; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Musselman KE, 2007, J NEUROPHYSIOL, V97, P1247, DOI 10.1152/jn.00891.2006; Musselman KE, 2011, J NEUROPHYSIOL, V105, P2195, DOI 10.1152/jn.01002.2010; O'Connor SM, 2012, GAIT POSTURE, V36, P102, DOI 10.1016/j.gaitpost.2012.01.014; Ogawa T, 2015, J EXP BIOL, V218, P3192, DOI 10.1242/jeb.120865; Ogawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121951; Ogawa T, 2014, J NEUROPHYSIOL, V111, P722, DOI 10.1152/jn.00497.2012; Ogawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046349; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Reisman DS, 2010, PHYS THER, V90, P187, DOI 10.2522/ptj.20090073; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Shimansky Y, 2004, EXP BRAIN RES, V155, P156, DOI 10.1007/s00221-003-1713-0; Torres-Oviedo G, 2010, J NEUROSCI, V30, P17015, DOI 10.1523/JNEUROSCI.4205-10.2010; Vasudevan EVL, 2011, J NEUROSCI, V31, P3055, DOI 10.1523/JNEUROSCI.5781-10.2011; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Vazquez A, 2015, J NEUROPHYSIOL, V114, P3255, DOI 10.1152/jn.00302.2015; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Winter DA., 1987, BIOMECHANICS MOTOR C; Yakovenko S, 2005, J NEUROPHYSIOL, V94, P1057, DOI 10.1152/jn.00991.2004; Yanagihara D, 1996, P NATL ACAD SCI USA, V93, P13292, DOI 10.1073/pnas.93.23.13292; Yang JF, 2005, J NEUROSCI, V25, P6869, DOI 10.1523/JNEUROSCI.1765-05.2005; Yang JF, 2004, CAN J PHYSIOL PHARM, V82, P662, DOI 10.1139/Y04-070	45	25	25	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0194875	10.1371/journal.pone.0194875	http://dx.doi.org/10.1371/journal.pone.0194875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694404	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400018
J	Frolinger, T; Smith, C; Cobo, CF; Sims, S; Brathwaite, J; de Boer, S; Huang, J; Pasinetti, GM				Frolinger, Tal; Smith, Chad; Cobo, Carmen Freire; Sims, Steven; Brathwaite, Justin; de Boer, Sterre; Huang, Jing; Pasinetti, Giulio M.			Dietary polyphenols promote resilience against sleep deprivation-induced cognitive impairment by activating protein translation	FASEB JOURNAL			English	Article						memory consolidation; mTORC1; BDPP	CAP-DEPENDENT TRANSLATION; LONG-TERM POTENTIATION; OBJECT RECOGNITION; MEMORY CONSOLIDATION; GENE-EXPRESSION; SYNAPTIC PLASTICITY; MAMMALIAN TARGET; MESSENGER-RNA; MOUSE MODEL; MOLECULAR-MECHANISMS	Previous evidence has suggested that dietary supplementation with a bioactive dietary polyphenol preparation (BDPP) rescues impairment of hippocampus-dependent memory in a mouse model of sleep deprivation (SD). In the current study, we extend our previous evidence and demonstrate that a mechanism by which dietary BDPP protects against SD-mediated cognitive impairment is via mechanisms that involve phosphorylation of the mammalian target of rapamycin complex 1 and its direct downstream targets, including the eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) and the ribosomal protein S6 kinase -1 (p70S6K). In additional mechanistic studies in vitro, we identified the brain bioavailable phenolic metabolites derived from the metabolism of dietary BDPP that are responsible for the attenuation of SD-mediated memory impairments. On the basis of high-throughput bioavailability studies of brain bioavailable metabolites after dietary BDPP treatment, we found that select polyphenol metabolites [e.g., cyanidin-3-O-glucoside and 3-(3-hydroxyphenyl) propionic acid] were able to rescue mTOR and p70S6K phosphorylation in primary cortico-hippocampal neuronal cultures, as well as rescue 4E-BP1 phosphorylation in response to treatment with 4EGI-1, a specific inhibitor of eIF4E-eIF4G interaction. Our findings reveal a previously unknown role for dietary polyphenols in the rescue of SD-mediated memory impairments via mechanisms involving the promotion of protein translation.Frolinger, T., Smith, C., Cobo, C. F., Sims, S., Brathwaite, J., de Boer, S., Huang, J., Pasinetti, G. M. Dietary polyphenols promote resilience against sleep deprivation-induced cognitive impairment by activating protein translation.	[Frolinger, Tal; Smith, Chad; Cobo, Carmen Freire; Sims, Steven; Brathwaite, Justin; de Boer, Sterre; Huang, Jing; Pasinetti, Giulio M.] Icahn Sch Med Mt Sinai, Dept Neurol, 1 Gustave L Levy Pl,Box 1137, New York, NY 10029 USA; [de Boer, Sterre] Vrije Univ Amsterdam, VUMC Sch Med Sci, Amsterdam, Netherlands; [Huang, Jing] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Pasinetti, Giulio M.] James J Peters Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; Vrije Universiteit Amsterdam; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Pasinetti, GM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, 1 Gustave L Levy Pl,Box 1137, New York, NY 10029 USA.	giulio.pasinetti@mssm.edu		Pasinetti, Giulio/0000-0002-1524-5196	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH) [P50-AT008661-01]; Office of Dietary Supplements (ODS); National Center for Complementary & Integrative Health [P50AT008661] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Grant P50-AT008661-01 from the U.S. National Institutes of Health (NIH) National Center for Complementary and Integrative Health (NCCIH), and the Office of Dietary Supplements (ODS). G.M.P. holds a Senior Veterans Affairs Career Scientist Award. The contents of this study do not represent the views of the NCCIH, the ODS, the NIH, the U.S. Department of Veterans Affairs, or the U.S. Government. The authors declare no conflicts of interest.	Abbott SM, 2016, NAT SCI SLEEP, V8, P55, DOI 10.2147/NSS.S78947; Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798; Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Anderson KN, 2013, NAT SCI SLEEP, V5, P61, DOI 10.2147/NSS.S34842; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Banko JL, 2008, PROG BRAIN RES, V169, P59, DOI 10.1016/S0079-6123(07)00004-0; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bermudez-Rattoni F, 2005, LEARN MEMORY, V12, P447, DOI 10.1101/lm.97605; Biever A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00075; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blount JW, 2012, BIOCHEM BIOPH RES CO, V417, P457, DOI 10.1016/j.bbrc.2011.11.139; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cirelli C, 2000, J NEUROSCI, V20, P9187; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Cirelli C, 2000, SLEEP, V23, P453; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Costa-Mattioli M, 2008, PROG BRAIN RES, V169, P81, DOI 10.1016/S0079-6123(07)00005-2; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Dias GP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/541971; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flowers A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0395-4; Foukas LC, 2004, BIOCHEM BIOPH RES CO, V319, P541, DOI 10.1016/j.bbrc.2004.04.191; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Gal-Ben-Ari S, 2012, LEARN MEMORY, V19, P410, DOI 10.1101/lm.026849.112; Gold PE, 2008, NEUROBIOL LEARN MEM, V89, P201, DOI 10.1016/j.nlm.2007.10.006; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Gronli J, 2014, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00224; Groppo R, 2009, CURR OPIN CELL BIOL, V21, P444, DOI 10.1016/j.ceb.2009.01.011; Guan ZW, 2004, BRAIN RES, V1018, P38, DOI 10.1016/j.brainres.2004.05.032; Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Havekes R, 2016, ELIFE, V5, DOI 10.7554/eLife.13424; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hernandez PJ, 2008, NEUROBIOL LEARN MEM, V89, P293, DOI 10.1016/j.nlm.2007.09.010; Hines DJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.136; Ho L, 2013, FASEB J, V27, P769, DOI 10.1096/fj.12-212118; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hsieh T. C., 2012, ISRN UROL, V2012, DOI DOI 10.5402/2012/272697.; Hublin C, 2001, SLEEP, V24, P392, DOI 10.1093/sleep/24.4.392; Igaz LM, 2002, J NEUROSCI, V22, P6781; Igaz LM, 2004, NEUROTOX RES, V6, P189, DOI 10.1007/BF03033221; Ishikawa A, 2006, EUR J NEUROSCI, V24, P243, DOI 10.1111/j.1460-9568.2006.04874.x; Janus A, 2005, CELL MOL BIOL LETT, V10, P479; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Krikorian R, 2010, BRIT J NUTR, V103, P730, DOI 10.1017/S0007114509992364; Kumar T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047042; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Le Tourneau C, 2008, BRIT J CANCER, V99, P1197, DOI 10.1038/sj.bjc.6604636; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maas S, 2010, DISCOV MED, V10, P379; McManus CJ, 2011, CURR OPIN GENET DEV, V21, P373, DOI 10.1016/j.gde.2011.04.001; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Palchykova S, 2006, NEUROBIOL LEARN MEM, V85, P263, DOI 10.1016/j.nlm.2005.11.005; Pasinetti Giulio Maria, 2012, Planta Med, V78, pE24, DOI 10.1055/s-0035-1545846; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Seibt Julie, 2012, Commun Integr Biol, V5, P491, DOI 10.4161/cib.21010; Seibt J, 2012, CURR BIOL, V22, P676, DOI 10.1016/j.cub.2012.02.016; Somarajan BI, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00025; Souza AD, 2015, CURR TOP BEHAV NEURO, V25, P65, DOI 10.1007/7854_2014_360; Sweatt JD, 1999, LEARN MEMORY, V6, P399, DOI 10.1101/lm.6.5.399; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Tudor JC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4949; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Vecsey CG, 2012, PHYSIOL GENOMICS, V44, P981, DOI 10.1152/physiolgenomics.00084.2012; Vecsey CG, 2009, NATURE, V461, P1122, DOI 10.1038/nature08488; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vogel-Ciernia Annie, 2014, Curr Protoc Neurosci, V69, DOI 10.1002/0471142301.ns0831s69; Wang DJ, 2015, MOL NUTR FOOD RES, V59, P1025, DOI 10.1002/mnfr.201400544; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Wang J, 2012, J NEUROSCI, V32, P5144, DOI 10.1523/JNEUROSCI.6437-11.2012; Wang J, 2010, J ALZHEIMERS DIS, V22, P653, DOI 10.3233/JAD-2010-101074; Wang JJ, 2014, CHIN HERB MED, V6, P42, DOI 10.1016/S1674-6384(14)60005-8; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Wisor JP, 2013, PHYSIOL GENOMICS, V45, P26, DOI 10.1152/physiolgenomics.00156.2012; Yaghouby F, 2014, IEEE ENG MED BIO, P3771, DOI 10.1109/EMBC.2014.6944444; Zagaar MA, 2016, MOL NEUROBIOL, V53, P2900, DOI 10.1007/s12035-015-9176-4; Zhao W, 2015, NEUROCHEM INT, V89, P191, DOI 10.1016/j.neuint.2015.07.023; Zhong LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032195	96	15	15	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5390	5404		10.1096/fj.201800030R	http://dx.doi.org/10.1096/fj.201800030R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29702026	Bronze, Green Published			2022-12-26	WOS:000447972500016
J	Sinha, D; Kalimutho, M; Bowles, J; Chan, AL; Merriner, DJ; Bain, AL; Simmons, JL; Freire, R; Lopez, JA; Hobbs, RM; O'Bryan, MK; Khanna, KK				Sinha, Debottam; Kalimutho, Murugan; Bowles, Josephine; Chan, Ai-Leen; Merriner, D. Jo; Bain, Amanda L.; Simmons, Jacinta L.; Freire, Raimundo; Lopez, J. Alejandro; Hobbs, Robin M.; O'Bryan, Moira K.; Khanna, Kum Kum			Cep55 overexpression causes male-specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling	FASEB JOURNAL			English	Article						spermatogenesis; mouse model; azoospermia; male infertility	SPERMATOGONIAL STEM-CELLS; MALE GERM-CELLS; INTERCELLULAR BRIDGES; SELF-RENEWAL; MALE-INFERTILITY; UNDIFFERENTIATED SPERMATOGONIA; ESCRT MACHINERY; MOUSE TESTES; CYTOKINESIS; SPERMATOGENESIS	Spermatogenesis is a dynamic process involving self-renewal and differentiation of spermatogonial stem cells, meiosis, and ultimately, the differentiation of haploid spermatids into sperm. Centrosomal protein 55 kDa (CEP55) is necessary for somatic cell abscission during cytokinesis. It facilitates equal segregation of cytoplasmic contents between daughter cells by recruiting endosomal sorting complex required for transport machinery (ESCRT) at the midbody. In germ cells, CEP55, in partnership with testes expressed-14 (TEX14) protein, has also been shown to be an integral component of intercellular bridge before meiosis. Various in vitro studies have demonstrated a role for CEP55 in multiple cancers and other diseases. However, its oncogenic potential in vivo remains elusive. To investigate, we generated ubiquitously overexpressing Cep55 transgenic (Cep55(Tg/Tg)) mice aiming to characterize its oncogenic role in cancer. Unexpectedly, we found that Cep55(Tg/Tg) male mice were sterile and had severe and progressive defects in spermatogenesis related to spermatogenic arrest and lack of spermatids in the testes. In this study, we characterized this male-specific phenotype and showed that excessively high levels of Cep55 results in hyperactivation of PI3K/protein kinase B (Akt) signaling in testis. In line with this finding, we observed increased phosphorylation of forkhead box protein O1 (FoxO1), and suppression of its nuclear retention, along with the relative enrichment of promyelocytic leukemia zinc finger (PLZF) -positive cells. Independently, we observed that Cep55 amplification favored upregulation of ret (Ret) proto-oncogene and glial-derived neurotrophic factor family receptor -1 (Gfra1). Consistent with these data, we observed selective down-regulation of genes associated with germ cell differentiation in Cep55-overexpressing testes at postnatal day 10, including early growth response-4 (Egr4) and spermatogenesis and oogenesis specific basic helix-loop-helix-1 (Sohlh1). Thus, Cep55 amplification leads to a shift toward the initial maintenance of undifferentiated spermatogonia and ultimately results in progressive germ cell loss. Collectively, our findings demonstrate that Cep55 overexpression causes change in germ cell proportions and manifests as a Sertoli cell only tubule phenotype, similar to that seen in many azoospermic men.Sinha, D., Kalimutho, M., Bowles, J., Chan, A.-L., Merriner, D. J., Bain, A. L., Simmons, J. L., Freire, R., Lopez, J. A., Hobbs, R. M., O'Bryan, M. K., Khanna, K. K. Cep55 overexpression causes male-specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling.	[Sinha, Debottam; Kalimutho, Murugan; Bain, Amanda L.; Simmons, Jacinta L.; Lopez, J. Alejandro; Khanna, Kum Kum] Queensland Inst Med Res QIMR Berghofer Med Res In, Herston, Qld, Australia; [Sinha, Debottam; Kalimutho, Murugan; Lopez, J. Alejandro] Griffith Univ, Sch Nat Sci, Nathan, Qld, Australia; [Bowles, Josephine] Univ Queensland, Sch Biomed Sci, Inst Mol Biosci, St Lucia, Qld, Australia; [Chan, Ai-Leen; Hobbs, Robin M.] Monash Univ, Germline Stem Cell Lab, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Chan, Ai-Leen; Hobbs, Robin M.] Monash Univ, Dept Anat & Dev Biol, Monash Biomed Discovery Inst, Clayton, Vic, Australia; [Merriner, D. Jo; O'Bryan, Moira K.] Monash Univ, Sch Biol Sci, Male Infertil & Germ Cell Biol Lab, 25 Rainforest Walk, Clayton, Vic 3800, Australia; [Freire, Raimundo] Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, Tenerife, Spain	Griffith University; University of Queensland; Australian Regenerative Medicine Institute; Monash University; Monash University; Monash University; Universidad de la Laguna	O'Bryan, MK (corresponding author), Monash Univ, Sch Biol Sci, Male Infertil & Germ Cell Biol Lab, 25 Rainforest Walk, Clayton, Vic 3800, Australia.; Khanna, KK (corresponding author), QIMR Berghofer Med Res Inst, 300 Herston Rd, Brisbane, Qld 4006, Australia.	moira.obryan@monash.edu; kumkum.khanna@qimrberghofer.edu.au	Simmons, Jacinta/GLT-7261-2022; Lopez, J. Alejandro/B-9290-2008; Bowles, Josephine/AAG-4903-2020; O'Bryan, Moira K/F-8256-2012; Simmons, Jacinta L/S-2373-2018; Lopez, J. Alejandro/P-4129-2019; Freire, Raimundo/Q-7660-2019; Kalimutho, Murugan/AAD-1441-2019; Sinha, Debottam/J-5521-2019; Hobbs, Robin/I-2577-2014	Simmons, Jacinta/0000-0002-9311-1046; Lopez, J. Alejandro/0000-0001-9370-1516; Bowles, Josephine/0000-0003-2867-7438; O'Bryan, Moira K/0000-0001-7298-4940; Simmons, Jacinta L/0000-0002-9311-1046; Lopez, J. Alejandro/0000-0001-9370-1516; Freire, Raimundo/0000-0003-4473-8894; Sinha, Debottam/0000-0001-7153-856X; Chan, Ai-Leen/0000-0003-3553-7249; Kalimutho, Murugan/0000-0002-0772-8673; Khanna, Kum Kum/0000-0001-8650-5381; Hobbs, Robin/0000-0002-3853-2614	Griffith University International Postgraduate Research Scholarship (GUIPRS); Griffith University Postgraduate Research Scholarship (GUPRS); Cancer Council Queensland (CCQ) [1087363]; Spanish Ministry of Economy (MINECO) [SAF2016-80626-R]; National Health and Medical Research Council (NHMRC) [APP1058356]; Australian Research Council (ARC) Future Fellowship [FT140101029]; NH&MRC Program Grant [1017028]	Griffith University International Postgraduate Research Scholarship (GUIPRS); Griffith University Postgraduate Research Scholarship (GUPRS); Cancer Council Queensland (CCQ)(Cancer Council Queensland); Spanish Ministry of Economy (MINECO)(Spanish Government); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Future Fellowship(Australian Research Council); NH&MRC Program Grant(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank the members of the K.K.K. laboratory for helpful discussions and technical assistance and the QIMR Berghofer Animal facility staff and Nigel Waterhouse and Tam Hong Nguyen for microscopy assistance. D.S. is supported by a Griffith University International Postgraduate Research Scholarship (GUIPRS) and Griffith University Postgraduate Research Scholarship (GUPRS). M.K. is supported by Cancer Council Queensland (CCQ) Project Grant 1087363. R.F. is supported by Spanish Ministry of Economy (MINECO) Grant SAF2016-80626-R. M.K.O. is supported by a fellowship from the National Health and Medical Research Council (NH & MRC; APP1058356). R.M.H. is supported by an Australian Research Council (ARC) Future Fellowship FT140101029. The K.K.K. laboratory is supported by NH&MRC Program Grant 1017028. The authors declare no conflicts of interest.	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Aponte PM, 2005, APMIS, V113, P727, DOI 10.1111/j.1600-0463.2005.apm_302.x; Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Bhasin S, 1997, ANN MED, V29, P261, DOI 10.3109/07853899708999344; Bondeson ML, 2017, CLIN GENET, V92, P510, DOI 10.1111/cge.13012; Boucher D, 2015, FASEB J, V29, P3326, DOI 10.1096/fj.14-269944; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chang YC, 2010, J CELL BIOCHEM, V109, P1274, DOI 10.1002/jcb.22517; Chen CH, 2007, ONCOGENE, V26, P4272, DOI 10.1038/sj.onc.1210207; Chen CH, 2009, ONCOGENE, V28, P2723, DOI 10.1038/onc.2009.128; Chen CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005052; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; De Rooij DG, 1998, INT J EXP PATHOL, V79, P67, DOI 10.1046/j.1365-2613.1998.00057.x; De Rooij DG, 2000, J ANDROL, V21, P776; Ding XB, 2016, SCI REP-UK, V6, DOI 10.1038/srep28218; Durcova-Hills G, 2008, CURR TOP DEV BIOL, V83, P185, DOI [10.1016/S0070-2153(08)00406-7, 10.1016/S0070-2153(09)00406-7]; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; FAWCETT DW, 1959, J BIOPHYS BIOCHEM CY, V5, P453, DOI 10.1083/jcb.5.3.453; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Flannigan R, 2017, BEST PRACT RES CL OB, V44, P26, DOI 10.1016/j.bpobgyn.2017.05.002; Frosk P, 2017, J MED GENET, V54, P490, DOI 10.1136/jmedgenet-2016-104296; Geister KA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005569; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Gonzalez-Merino E, 2007, FERTIL STERIL, V88, P600, DOI 10.1016/j.fertnstert.2006.12.020; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Guo GQ, 2004, J THEOR BIOL, V229, P139, DOI 10.1016/j.jtbi.2004.03.010; Haglund Kaisa, 2011, Communicative & Integrative Biology, V4, P1, DOI 10.4161/cib.4.1.13550; Handel MA, 1999, J EXP ZOOL, V285, P243, DOI 10.1002/(SICI)1097-010X(19991015)285:3&lt;243::AID-JEZ7&gt;3.0.CO;2-#; Hara K, 2014, CELL STEM CELL, V14, P658, DOI 10.1016/j.stem.2014.01.019; Hart RJ, 2015, HUM REPROD, V30, P2713, DOI 10.1093/humrep/dev244; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; He ZP, 2009, MICROSC RES TECHNIQ, V72, P586, DOI 10.1002/jemt.20698; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; HUCKINS C, 1978, ANAT REC, V192, P529, DOI 10.1002/ar.1091920407; Inoda S, 2009, J IMMUNOTHER, V32, P474, DOI 10.1097/CJI.0b013e3181a1d109; Iwamori T, 2010, MOL CELL BIOL, V30, P2280, DOI 10.1128/MCB.01392-09; Jain S, 2004, DEVELOPMENT, V131, P5503, DOI 10.1242/dev.01421; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Jeffery J, 2016, ONCOGENE, V35, P683, DOI 10.1038/onc.2015.128; Jeffery J, 2015, FASEB J, V29, P1999, DOI 10.1096/fj.14-265090; Jijiwa M, 2008, GENES CELLS, V13, P365, DOI 10.1111/j.1365-2443.2008.01171.x; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Hamra FK, 2007, J BIOL CHEM, V282, P721, DOI 10.1074/jbc.M608398200; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim HJ, 2015, P NATL ACAD SCI USA, V112, P12372, DOI 10.1073/pnas.1418606112; KLUIN PM, 1981, INT J ANDROL, V4, P475, DOI 10.1111/j.1365-2605.1981.tb00732.x; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Maatouk DM, 2008, CURR TOP DEV BIOL, V83, P151, DOI 10.1016/S0070-2153(08)00405-5; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mierzwa B, 2014, DEV CELL, V31, P525, DOI 10.1016/j.devcel.2014.11.006; Mittal D, 2016, CANCER RES, V76, P4372, DOI 10.1158/0008-5472.CAN-16-0544; Moreno SG, 2010, DEV BIOL, V342, P74, DOI 10.1016/j.ydbio.2010.03.007; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nagano R, 2000, ANAT REC, V258, P210; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley MJ, 2011, BIOL REPROD, V85, P347, DOI 10.1095/biolreprod.111.091330; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Saitou M, 2009, FRONT BIOSCI-LANDMRK, V14, P1068, DOI 10.2741/3294; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Seshagiri PB, 2001, J BIOSCIENCES, V26, P429, DOI 10.1007/BF02704745; SILBER SJ, 1995, HUM REPROD, V10, P1031, DOI 10.1093/oxfordjournals.humrep.a136085; Tanaka SS, 2010, DEV DYNAM, V239, P2851, DOI 10.1002/dvdy.22417; Tao JQ, 2014, TUMOR BIOL, V35, P4389, DOI 10.1007/s13277-013-1578-1; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; WEBER JE, 1987, AM J ANAT, V180, P1, DOI 10.1002/aja.1001800102; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	84	29	32	3	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4984	4999		10.1096/fj.201701096RR	http://dx.doi.org/10.1096/fj.201701096RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29683733	Bronze			2022-12-26	WOS:000443817700030
J	Wu, J; Wang, PC; Li, L; You, CJ; Wang, YS				Wu, Jun; Wang, Pengcheng; Li, Lin; You, Changjun; Wang, Yinsheng			Cytotoxic and mutagenic properties of minor-groove O-2-alkylthymidine lesions in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; DNA damage; DNA polymerase; mutagenesis; mutagenesis mechanism; alkylating agent; DNA alkylation; O2-alkylthymidine; translesion synthesis; translesion synthesis polymerase; DNA adduct; polymerase	PYRIDYLOXOBUTYL DNA-ADDUCTS; TRANSLESION SYNTHESIS; IN-VITRO; REPLICATIVE BYPASS; MASS-SPECTROMETRY; REPAIR PATHWAYS; TRANSCRIPTION; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; ALKYLTRANSFERASE; O2-ETHYLTHYMINE	Endogenous metabolism, environmental exposure, and cancer chemotherapy can lead to alkylation of DNA. It has been well documented that, among the different DNA alkylation products, minor-groove O-2-alkylthymidine (O-2-alkyldT) lesions are inefficiently repaired. In the present study, we examined how seven O-2-alkyldT lesions, with the alkyl group being a Me, Et, nPr, iPr, nBu, iBu, or sBu, are recognized by the DNA replication machinery in human cells. We found that the replication bypass efficiencies of these lesions decrease with increasing length of the alkyl chain, and that these lesions induce substantial frequencies of TA and TG mutations. Replication experiments using isogenic cells deficient in specific translesion synthesis (TLS) DNA polymerases revealed that the absence of polymerase or polymerase , but not polymerase or polymerase , significantly decreased both the bypass efficiencies and the mutation frequencies for those O-2-alkyldT lesions carrying a straight-chain alkyl group. Moreover, the mutagenic properties of the O-2-alkyldT lesions were influenced by the length and topology of the alkyl chain and by TLS polymerases. Together, our results provide important new knowledge about the cytotoxic and mutagenic properties of O-2-alkyldT lesions, and illustrate the roles of TLS polymerases in replicative bypass of these lesions in human cells.	[Wu, Jun; Li, Lin; You, Changjun; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Wang, Pengcheng; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.; Wang, YS (corresponding author), Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022	You, Changjun/0000-0003-4301-2098; Wang, Pengcheng/0000-0003-4581-983X	National Institutes of Health [R01 ES025121]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health Grant R01 ES025121 (to Y. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BRENT TP, 1988, P NATL ACAD SCI USA, V85, P1759, DOI 10.1073/pnas.85.6.1759; BRONSTEIN SM, 1992, CANCER RES, V52, P2008; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Chen HJC, 2012, ANAL CHEM, V84, P2521, DOI 10.1021/ac203405y; Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; DENENGELSE L, 1987, CARCINOGENESIS, V8, P751; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Lao YB, 2007, CHEM RES TOXICOL, V20, P246, DOI 10.1021/tx060208j; Lao YB, 2007, CHEM RES TOXICOL, V20, P235, DOI 10.1021/tx060207r; Li L, 2009, CHEM RES TOXICOL, V22, P1464, DOI 10.1021/tx9001572; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu S, 2015, CHEM SOC REV, V44, P7829, DOI 10.1039/c5cs00316d; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; SANCHEZ JA, 1992, J CELL SCI, V103, P907; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Singer B., 1983, MOL BIOL MUTAGENS CA; Taylor ER, 2003, VIROLOGY, V315, P103, DOI 10.1016/S0042-6822(03)00588-9; Upadhyaya P, 2003, CHEM RES TOXICOL, V16, P180, DOI 10.1021/tx0256376; Upadhyaya P, 2008, CHEM RES TOXICOL, V21, P1468, DOI 10.1021/tx8001109; Wang LJ, 1997, CHEM RES TOXICOL, V10, P562, DOI 10.1021/tx9602067; Wang MY, 2003, CHEM RES TOXICOL, V16, P616, DOI 10.1021/tx034003b; Weerasooriya S, 2015, DNA REPAIR, V35, P63, DOI 10.1016/j.dnarep.2015.09.023; Williams NL, 2016, CHEM RES TOXICOL, V29, P1755, DOI 10.1021/acs.chemrestox.6b00252; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; You CJ, 2012, J BIOL CHEM, V287, P40915, DOI 10.1074/jbc.M112.418681; You CJ, 2012, NAT CHEM BIOL, V8, P817, DOI 10.1038/NCHEMBIO.1046; Zhai QQ, 2014, NUCLEIC ACIDS RES, V42, P10529, DOI 10.1093/nar/gku748; Zhai QQ, 2014, CARCINOGENESIS, V35, P2002, DOI 10.1093/carcin/bgu085; Ziegler K, 2004, J VIROL METHODS, V122, P123, DOI 10.1016/j.jviromet.2004.08.012	34	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8638	8644		10.1074/jbc.RA118.003133	http://dx.doi.org/10.1074/jbc.RA118.003133			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29685891	Green Published, hybrid			2022-12-26	WOS:000434205700026
J	Lin, Y; Liu, L; Sheng, YJ; Shen, CB; Zheng, XD; Zhou, FS; Yang, S; Yin, XY; Zhang, XJ				Lin, Yan; Liu, Lu; Sheng, Yujun; Shen, Changbing; Zheng, Xiaodong; Zhou, Fusheng; Yang, Sen; Yin, Xianyong; Zhang, Xuejun			A catalog of potential putative functional variants in psoriasis genome-wide association regions	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; SUSCEPTIBILITY LOCI; IKAROS; RUNX3; IDENTIFICATION; REVEALS; STAT4	Psoriasis is a common inflammatory skin disease, with considerable genetic contribution. Genome-wide association studies have successfully identified a number of genomic regions for the risk of psoriasis. However, it is challenging to pinpoint the functional causal variants and then further decipher the genetic mechanisms underlying each region. In order to prioritize potential functional causal variants within psoriasis susceptibility regions, we integrated the genetic association findings and functional genomic data publicly available, i.e. histone modifications in relevant immune cells. We characterized a pervasive enrichment pattern of psoriasis variants in five core histone marks across immune cells/tissues. We discovered that genetic alleles within psoriasis association regions might influence gene expression levels through significantly affecting the binding affinities of 17 transcription factors. We established a catalog of 654 potential functional causal variants for psoriasis and suggested that they significantly overlapped with causal variants for autoimmune diseases. We identified potential causal variant rs79824801 overlay with the peaks of five histone marks in primary CD4+ T cells. Its alternative allele affected the binding affinity of transcription factor IKZF1. This study highlights the complex genetic architecture and complicated mechanisms for psoriasis. The findings will inform the functional experiment design for psoriasis.	[Lin, Yan; Liu, Lu; Sheng, Yujun; Zheng, Xiaodong; Zhou, Fusheng; Yang, Sen; Yin, Xianyong; Zhang, Xuejun] Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Inst Dermatol, Hefei, Anhui, Peoples R China; [Lin, Yan] Anhui Med Univ, Affiliated Hosp 4, Dept Dermatol, Hefei, Anhui, Peoples R China; [Lin, Yan; Liu, Lu; Sheng, Yujun; Zheng, Xiaodong; Zhou, Fusheng; Yang, Sen; Yin, Xianyong; Zhang, Xuejun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Lin, Yan; Liu, Lu; Sheng, Yujun; Zheng, Xiaodong; Zhou, Fusheng; Yang, Sen; Yin, Xianyong; Zhang, Xuejun] State Key lab Dermatol Incubat, Hefei, Anhui, Peoples R China; [Shen, Changbing] China Japan Friendship Hosp, Dept Dermatol, Beijing, Peoples R China; [Yin, Xianyong] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI USA	Anhui Medical University; Anhui Medical University; Anhui Medical University; China-Japan Friendship Hospital; University of Michigan System; University of Michigan	Yin, XY; Zhang, XJ (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Inst Dermatol, Hefei, Anhui, Peoples R China.; Yin, XY; Zhang, XJ (corresponding author), Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China.; Yin, XY; Zhang, XJ (corresponding author), State Key lab Dermatol Incubat, Hefei, Anhui, Peoples R China.; Yin, XY (corresponding author), Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI USA.	xianyongyin@gmail.com; ayzxj@vip.sina.com	SHENG, Yu/GXZ-8269-2022					Adamson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059367; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed M, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0129-5; Allman D, 2006, BLOOD, V108, P4025, DOI 10.1182/blood-2006-03-007757; Benham H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4317; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Coetzee SG, 2015, BIOINFORMATICS, V31, P3847, DOI 10.1093/bioinformatics/btv470; Coetzee SG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks542; Das A, 2017, HUM IMMUNOL, V78, P724, DOI 10.1016/j.humimm.2017.08.006; Das S, 2015, EUR J HUM GENET, V23, P844, DOI 10.1038/ejhg.2014.172; de Masson A, 2016, M S-MED SCI, V32, P253, DOI 10.1051/medsci/20163203009; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dyke SOM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0723-0; Ecker JR, 2012, NATURE, V489, P52, DOI 10.1038/489052a; Elder JT, 2009, GENES IMMUN, V10, P201, DOI 10.1038/gene.2009.11; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Eriksen KW, 2005, J INVEST DERMATOL, V125, P936, DOI 10.1111/j.0022-202X.2005.23864.x; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Farnham PJ, 2012, J BIOL CHEM, V287, P30885, DOI 10.1074/jbc.R112.365940; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Fu DD, 2016, MOL MED REP, V13, P4606, DOI 10.3892/mmr.2016.5108; Fu DD, 2015, IMMUNOL LETT, V166, P55, DOI 10.1016/j.imlet.2015.05.014; Hardison RC, 2012, J BIOL CHEM, V287, P30932, DOI 10.1074/jbc.R112.352427; Hiz MM, 2015, CENT EUR J IMMUNOL, V40, P437, DOI 10.5114/ceji.2015.57146; Hu SJ, 2013, MOD RHEUMATOL, V23, P205, DOI 10.1007/s10165-012-0706-x; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Li Y, 2013, J MED GENET, V50, P812, DOI 10.1136/jmedgenet-2013-101787; Lower KM, 2013, HUM MUTAT, V34, P1140, DOI 10.1002/humu.22343; Martin G, 2012, LAB INVEST, V92, P1058, DOI 10.1038/labinvest.2012.69; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Movassagh M, 2004, INT IMMUNOL, V16, P867, DOI 10.1093/intimm/dxh090; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Popa OM, 2016, ARCH IMMUNOL THER EX, V64, pS123, DOI 10.1007/s00005-016-0444-4; Rhie SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063925; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Sheng Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5331; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stuart PE, 2010, NAT GENET, V42, P1000, DOI 10.1038/ng.693; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Tang HY, 2014, NAT GENET, V46, P45, DOI 10.1038/ng.2827; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Yao LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6114; Yap WH, 2005, FEBS LETT, V579, P4470, DOI 10.1016/j.febslet.2005.07.018; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zolotarenko A, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.97	55	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196635	10.1371/journal.pone.0196635	http://dx.doi.org/10.1371/journal.pone.0196635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715312	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100038
J	Al Rowaihi, IS; Paillier, A; Rasul, S; Karen, R; Grotzinger, SW; Takanabe, K; Eppinger, J				Al Rowaihi, Israa Salem; Paillier, Alexis; Rasul, Shahid; Karen, Ram; Groetzinger, Stefan Wolfgang; Takanabe, Kazuhiro; Eppinger, Jorg			Poly(3-hydroxybutyrate) production in an integrated electromicrobial setup: Investigation under stress-inducing conditions	PLOS ONE			English	Article							RALSTONIA-EUTROPHA; CELLS; GENE; 3-HYDROXYBUTYRATE; ENHANCEMENT; EXPRESSION; TOLERANCE; CULTURES; FORMATE; PROTEIN	Poly (3-hydroxybutyrate) (PHB), a biodegradable polymer, can be produced by different microorganisms. The PHB belongs to the family of polyhydroxyalkanoate (PHA) that mostly accumulates as a granule in the cytoplasm of microorganisms to store carbon and energy. In this study, we established an integrated one-pot electromicrobial setup in which carbon dioxide is reduced to formate electrochemically, followed by sequential microbial conversion into PHB, using the two model strains, Methylobacterium extorquens AM1 and Cupriavidus necator H16. This setup allows to investigate the influence of different stress conditions, such as coexisting electrolysis, relatively high salinity, nutrient limitation, and starvation, on the production of PHB. The overall PHB production efficiency was analyzed in reasonably short reaction cycles typically as short as 8 h. As a result, the PHB formation was detected with C. necator H16 as a biocatalyst only when the electrolysis was operated in the same solution. The specificity of the source of PHB production is discussed, such as salinity, electricity, concurrent hydrogen production, and the possible involvement of reactive oxygen species (ROS).	[Al Rowaihi, Israa Salem; Paillier, Alexis; Rasul, Shahid; Karen, Ram; Takanabe, Kazuhiro; Eppinger, Jorg] King Abdullah Univ Sci & Technol, KAUST Catalysis Ctr, Phys Sci & Engn Div, Thuwal, Saudi Arabia; [Groetzinger, Stefan Wolfgang] Tech Univ Munich, Dept Mech Engn, Inst Biochem Engn, Garching, Germany; [Groetzinger, Stefan Wolfgang] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; Technical University of Munich; King Abdullah University of Science & Technology	Takanabe, K (corresponding author), King Abdullah Univ Sci & Technol, KAUST Catalysis Ctr, Phys Sci & Engn Div, Thuwal, Saudi Arabia.	kazuhiro.takanabe@kaust.edu.sa	Rasul, Shahid/AAT-2734-2020; rasul, shahid/N-9384-2013; Eppinger, Jörg/AAJ-6924-2020; Takanabe, Kazuhiro/D-6119-2011	Rasul, Shahid/0000-0002-2543-0205; rasul, shahid/0000-0002-2543-0205; Eppinger, Jörg/0000-0001-7886-7059; Takanabe, Kazuhiro/0000-0001-5374-9451; Al Rowaihi, Israa/0000-0002-6953-8787	King Abdullah University of Science and Technology (KAUST)	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	The research reported in this publication was supported by King Abdullah University of Science and Technology (KAUST).	Al Rowaihi I.S., 2018, BIORESOURCE TECHNOL, V1, P61, DOI 10.1016/j.biteb.2018.02.007; de las Heras AM, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0598-0; FRIEDEBOLD J, 1993, J BACTERIOL, V175, P4719, DOI 10.1128/JB.175.15.4719-4728.1993; Goh LK, 2014, APPL BIOCHEM BIOTECH, V172, P1585, DOI 10.1007/s12010-013-0634-z; Grunwald S, 2015, MICROB BIOTECHNOL, V8, P155, DOI 10.1111/1751-7915.12149; Jeon B. Y., 2013, MICROBIOL, V3, P42, DOI DOI 10.4236/AIM.2013.31006; Kadouri D, 2005, CRIT REV MICROBIOL, V31, P55, DOI 10.1080/10408410590899228; Kessler B, 1998, BIOCH PRINCIPLES MEC, P48; Koller M, 2017, NEW BIOTECHNOL, V37, P24, DOI 10.1016/j.nbt.2016.05.001; Kourmentza Constantina, 2017, Bioengineering-Basel, V4, P55, DOI 10.3390/bioengineering4020055; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Lichtenthaler FW, 1997, PURE APPL CHEM, V69, P1853, DOI 10.1351/pac199769091853; Liu C, 2016, SCIENCE, V352, P1210, DOI 10.1126/science.aaf5039; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Mravec F, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw094; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nguyen SD, 2003, FREE RADICAL RES, V37, P1319, DOI 10.1080/1071-5760310001621351; Obruca S, 2016, APPL MICROBIOL BIOT, V100, P1365, DOI 10.1007/s00253-015-7162-4; Oehmen A, 2005, J CHROMATOGR A, V1070, P131, DOI 10.1016/j.chroma.2005.02.020; Pham TH, 2004, MICROBIOL-SGM, V150, P3405, DOI 10.1099/mic.0.27357-0; Iustman LJR, 2015, EXTREMOPHILES, V19, P207, DOI 10.1007/s00792-014-0700-7; Ruiz JA, 2004, CURR MICROBIOL, V48, P396, DOI 10.1007/s00284-003-4183-5; Salin K, 2015, P ROY SOC B-BIOL SCI, V282, P14, DOI 10.1098/rspb.2015.1028; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Smejkalova H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013001; Srinivasan S, 2002, APPL ENVIRON MICROB, V68, P5925, DOI 10.1128/AEM.68.12.5925-5932.2002; Torella JP, 2015, P NATL ACAD SCI USA, V112, pE1507, DOI 10.1073/pnas.1503606112; Vandamme P, 2004, INT J SYST EVOL MICR, V54, P2285, DOI 10.1099/ijs.0.63247-0; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang Q, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-47; Yellore VS, 1999, LETT APPL MICROBIOL, V29, P171, DOI 10.1046/j.1365-2672.1999.00608.x; Zhao YH, 2007, FEMS MICROBIOL LETT, V276, P34, DOI 10.1111/j.1574-6968.2007.00904.x	32	20	21	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196079	10.1371/journal.pone.0196079	http://dx.doi.org/10.1371/journal.pone.0196079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698424	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000431007600035
J	Hleap, JS; Blouin, C				Hleap, Jose Sergio; Blouin, Christian			The response to selection in Glycoside Hydrolase Family 13 structures: A comparative quantitative genetics approach	PLOS ONE			English	Article							ALPHA-AMYLASE FAMILY; COVARIANCE MATRICES; COMPARATIVE BIOLOGY; RATIONAL DESIGN; GEOMETRIC SHAPE; EVOLUTION; SEQUENCE; DOMAIN; THERMOSTABILITY; STABILITY	The Glycoside Hydrolase Family 13 (GH13) is both evolutionarily diverse and relevant to many industrial applications. Its members hydrolyze starch into smaller carbohydrates and members of the family have been bioengineered to improve catalytic function under industrial environments. We introduce a framework to analyze the response to selection of GH13 protein structures given some phylogenetic and simulated dynamic information. We find that the TIM-barrel (a conserved protein fold consisting of eight a-helices and eight parallel beta-strands that alternate along the peptide backbone, common to all amylases) is not selectable since it is under purifying selection. We also show a method to rank important residues with higher inferred response to selection. These residues can be altered to effect change in properties. In this work, we define fitness as inferred thermodynamic stability. We show that under the developed framework, residues 112Y, 122K, 124D, 125W, and 126P are good candidates to increase the stability of the truncated a-amylase protein from Geobacillus thermoleovorans (PDB code: 4E2O; alpha-1,4-glucan-4-glucanohydrolase; EC 3.2.1.1). Overall, this paper demonstrates the feasibility of a framework for the analysis of protein structures for any other fitness landscape.	[Hleap, Jose Sergio] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Hleap, Jose Sergio] SQUALUS Fdn, Cali, Colombia; [Blouin, Christian] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada; [Hleap, Jose Sergio] Off 7209,740 Dr Penfield Ave, Montreal, PQ H3A 0G1, Canada	McGill University; Dalhousie University	Hleap, JS (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Hleap, JS (corresponding author), SQUALUS Fdn, Cali, Colombia.; Hleap, JS (corresponding author), Off 7209,740 Dr Penfield Ave, Montreal, PQ H3A 0G1, Canada.	jshleap@squalus.org		Hleap, Jose Sergio/0000-0003-2602-5276; Blouin, Christian/0000-0002-4434-4142	NSERC [120504858]; Departamento Administrativo de Ciencia y Tecnologia - Colciencias (Colombia) through the CALDAS scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Departamento Administrativo de Ciencia y Tecnologia - Colciencias (Colombia) through the CALDAS scholarship	NSERC partially financed the project of this article under the grant No. 120504858. This work was also partially supported by the Departamento Administrativo de Ciencia y Tecnologia - Colciencias (Colombia) through the CALDAS scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D. C., 2003, Mathematical Methods for Protein Structure Analysis and Design. C.I.M.E. Summer School. Advanced Lectures (Lecture Notes in Bioinformatics Vol.2666), P109; Alfaro JA, 2014, CAPTURING DYNAMICS P; Andre I, 2014, CURR OPIN CHEM BIOL, V19, P17, DOI 10.1016/j.cbpa.2013.11.014; ARNOLD SJ, 1992, AM NAT, V140, pS85, DOI 10.1086/285398; Ben Ali M, 2006, BIOCHEM J, V394, P51, DOI 10.1042/BJ20050726; Blasco A, 2001, J ANIM SCI, V79, P2023; Bloom JD, 2004, BIOPHYS J, V86, P2758, DOI 10.1016/S0006-3495(04)74329-5; Blows M, 2009, ADAPTATION AND FITNESS IN ANIMAL POPULATIONS, P83, DOI 10.1007/978-1-4020-9005-9_6; Bothast RJ, 2005, APPL MICROBIOL BIOT, V67, P19, DOI 10.1007/s00253-004-1819-8; Bozic N, 2017, AMYLASE, V1, P12, DOI DOI 10.1515/AMYLASE-2017-0002; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen A, 2015, ENZYME MICROB TECH, V78, P74, DOI 10.1016/j.enzmictec.2015.06.013; Cheverud JM, 2007, GENET MOL BIOL, V30, P461, DOI 10.1590/S1415-47572007000300027; CHEVERUD JM, 1985, EVOLUTION, V39, P1335, DOI 10.1111/j.1558-5646.1985.tb05699.x; Cheverud JM, 1996, J EVOLUTION BIOL, V9, P5, DOI 10.1046/j.1420-9101.1996.9010005.x; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dey TB, 2016, PROCESS BIOCHEM, V51, P1380, DOI 10.1016/j.procbio.2016.06.021; Dryden I. L, 2011, SHAPES PACKAGE, P549; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Fort J, 2007, J BIOL CHEM, V282, P31444, DOI 10.1074/jbc.M704524200; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Ghollasi M, 2013, ENZYME MICROB TECH, V53, P406, DOI 10.1016/j.enzmictec.2013.09.001; Gupta R, 2003, PROCESS BIOCHEM, V38, P1599, DOI 10.1016/S0032-9592(03)00053-0; Haber A, 2015, EVOL BIOL, V42, P99, DOI 10.1007/s11692-014-9302-7; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hansen TF, 2008, J EVOLUTION BIOL, V21, P1201, DOI 10.1111/j.1420-9101.2008.01573.x; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Housworth EA, 2004, AM NAT, V163, P84, DOI 10.1086/380570; Janecek S, 2002, BIOLOGIA, V57, P29; JANECEK S, 1994, EUR J BIOCHEM, V224, P519, DOI 10.1111/j.1432-1033.1994.00519.x; JANECEK S, 1992, BIOCHEM J, V288, P1069, DOI 10.1042/bj2881069; Janecek S, 1997, J MOL EVOL, V45, P322, DOI 10.1007/PL00006236; Janecek S, 2016, CELL MOL LIFE SCI, V73, P2707, DOI 10.1007/s00018-016-2246-6; Janecek S, 2014, CELL MOL LIFE SCI, V71, P1149, DOI 10.1007/s00018-013-1388-z; JESPERSEN HM, 1993, J PROTEIN CHEM, V12, P791, DOI 10.1007/BF01024938; Klingenberg CP, 2003, EVOLUTION, V57, P191; Klingenberg CP, 2001, EVOLUTION, V55, P2342; Lambert PC, 2005, STAT MED, V24, P2401, DOI 10.1002/sim.2112; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Li CF, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-18; Liu L, 2014, APPL ENVIRON MICROB, V80, P798, DOI 10.1128/AEM.03045-13; Lu ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22465; LYNCH M, 1991, EVOLUTION, V45, P1065, DOI [10.2307/2409716, 10.1111/j.1558-5646.1991.tb04375.x]; MacGregor EA, 2005, BIOLOGIA, V60, P5; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Machovic M, 2003, BIOLOGIA, V58, P1127; Marroig G, 2001, EVOLUTION, V55, P2576; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; Mok SC, 2013, ENZYME MICROB TECH, V53, P46, DOI 10.1016/j.enzmictec.2013.03.009; NAKAJIMA R, 1986, APPL MICROBIOL BIOT, V23, P355; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Proa M, 2013, EVOLUTION, V67, P185, DOI 10.1111/j.1558-5646.2012.01746.x; Ranjani V, 2014, SCI REP-UK, V4, DOI 10.1038/srep05850; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.1111/j.1558-5646.1992.tb02070.x; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Revell LJ, 2007, EVOL ECOL RES, V9, P261; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sorensen DA., 2002, STAT BIOL HEALTH; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; Svensson B, 2014, GLYCOSIDE HYDROLASE, V13; TAKATA H, 1992, J BIOL CHEM, V267, P18447; Tang SY, 2006, FEBS J, V273, P3335, DOI 10.1111/j.1742-4658.2006.05337.x; TERRAPON N, 2017, PRACTICAL GUIDE USIN, P117, DOI DOI 10.1007/978-4-431-56454-6_6; Thompson R, 2008, P R SOC B, V275, P679, DOI 10.1098/rspb.2007.1417; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Walsh B, 2009, ANNU REV ECOL EVOL S, V40, P41, DOI 10.1146/annurev.ecolsys.110308.120232; Zhang QG, 2017, PROCESS BIOCHEM, V53, P88, DOI 10.1016/j.procbio.2016.11.012	70	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196135	10.1371/journal.pone.0196135	http://dx.doi.org/10.1371/journal.pone.0196135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698417	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600039
J	Lunar, MM; Lepej, SZ; Tomazic, J; Vovko, TD; Pecavar, B; Turel, G; Maver, M; Poljak, M				Lunar, Maja M.; Lepej, Snjezana Zidovec; Tomazic, Janez; Vovko, Tomaz D.; Pecavar, Blaz; Turel, Gabriele; Maver, Manja; Poljak, Mario			HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update	PLOS ONE			English	Article							NON-B SUBTYPES; NAIVE PATIENTS; PREVALENCE; EUROPE; EPIDEMIOLOGY; TRANSMISSION; PERFORMANCE; POPULATION; SEQUENCES; GREECE	HIV-positive individuals that have a detected transmitted drug resistance (TDR) at baseline have a higher risk of virological failure with antiretroviral therapy (ART). This study offers an update on the prevalence of TDR in Slovenia, looks for onward transmission of TDR, and reassesses the need for baseline drug resistance testing. Blinded questionnaires and partial pol sequences were obtained from 54.5% (168/308) of all of the patients diagnosed with HIV-1 from 2011 to 2016. Subtype B was detected in 82.7% (139/168) of patients, followed by subtype A (8.3%), subtype C (2.4%), and CRF01_AE (1.8%). Surveillance drug resistance mutations (SDRMs) were found in four individuals (2.4%), all of them men who have sex with men (MSM) and infected with subtype B. K103N was detected in two patients and T68D and T215D in one person each, corresponding to a prevalence of 0%, 1.2%, and 1.2% of TDR to protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs), and non-NRTIs (NNRTIs), respectively. The impact of mutations on drug susceptibility was found to be most pronounced for NNRTIs. No forward spread of TDR within the country was observed; however, phylogenetic analysis revealed several new introductions of HIV into Slovenia in recent years, possibly due to increased risky behavior by MSM. This was indirectly confirmed by a substantial increase in syphilis cases and HIV-1 non-B sub-types during the study period. A drug-resistant HIV variant with good transmission fitness is thus more likely to be imported into Slovenia in the near future, and so TDR should be closely monitored.	[Lunar, Maja M.; Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Lepej, Snjezana Zidovec] Dr Fran Mihaljevic Univ Hosp Infect Dis, Zagreb, Croatia; [Tomazic, Janez; Vovko, Tomaz D.; Pecavar, Blaz; Turel, Gabriele; Maver, Manja] Univ Ljubljana, Med Ctr, Dept Infect Dis, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Poljak, M (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	maria.poljak@mf.uni-lj.si		Lunar, Maja/0000-0003-1262-338X				Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Alexiev I, 2015, J ANTIMICROB CHEMOTH, V70, P1874, DOI 10.1093/jac/dkv011; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreis S, 2017, J GLOB ANTIMICROB RE, V10, P106, DOI 10.1016/j.jgar.2017.05.011; Babic DZ, 2006, VIRUS RES, V118, P156, DOI 10.1016/j.virusres.2005.12.006; Beloukas A, 2016, INFECT GENET EVOL, V46, P180, DOI 10.1016/j.meegid.2016.06.033; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brand D, 2014, J CLIN MICROBIOL, V52, P4010, DOI 10.1128/JCM.01141-14; Dauwe K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1217-0; Dean AG, 2013, OPENEPI OPEN SOURCE; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Garcia-Lerma JG, 2001, P NATL ACAD SCI USA, V98, P13907, DOI 10.1073/pnas.241300698; Grgic I, 2013, AIDS RES HUM RETROV, V29, P329, DOI [10.1089/aid.2012.0191, 10.1089/AID.2012.0191]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lunar MM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0802-6; Lunar MM, 2013, AIDS RES HUM RETROV, V29, P343, DOI [10.1089/AID.2012.0152, 10.1089/aid.2012.0152]; Mezei M, 2011, AIDS RES HUM RETROV, V27, P1243, DOI [10.1089/aid.2011.0077, 10.1089/AID.2011.0077]; Paraskevis D, 2017, INFECT GENET EVOL, V54, P183, DOI [10., 10.1016/j.meegid.2017.07.003]; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Pecavar B, 2016, INFEKCIJSKE BOLEZNI, P53; Pham QD, 2014, AIDS, V28, P2751, DOI 10.1097/QAD.0000000000000494; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Ragonnet-Cronin M, 2016, J INFECT DIS, V213, P1410, DOI 10.1093/infdis/jiv758; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Simonetti FR, 2014, INFECT GENET EVOL, V23, P176, DOI 10.1016/j.meegid.2014.02.007; Stanojevic M, 2014, AIDS RES HUM RETROV, V30, P634, DOI [10.1089/aid.2013.0270, 10.1089/AID.2013.0270]; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Wertheim JO, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex008; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; World Health Organisation (WHO), 2017, HIV DRUG RES REP 201	33	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196670	10.1371/journal.pone.0196670	http://dx.doi.org/10.1371/journal.pone.0196670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698470	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600116
J	Nakajima, N; Hayashida, M; Jansson, J; Maruyama, O; Akutsu, T				Nakajima, Natsu; Hayashida, Morihiro; Jansson, Jesper; Maruyama, Osamu; Akutsu, Tatsuya			Determining the minimum number of protein-protein interactions required to support known protein complexes	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; INTERACTION NETWORKS; SACCHAROMYCES-CEREVISIAE; CLUSTERING-TREE; YEAST; PREDICTION; DATASETS; INTACT; CANCER	The prediction of protein complexes from protein-protein interactions (PPIs) is a well-studied problem in bioinformatics. However, the currently available PPI data is not enough to describe all known protein complexes. In this paper, we express the problem of determining the minimum number of (additional) required protein-protein interactions as a graph theoretic problem under the constraint that each complex constitutes a connected component in a PPI network. For this problem, we develop two computational methods: one is based on integer linear programming (ILPMinPPI) and the other one is based on an existing greedytype approximation algorithm (GreedyMinPPI) originally developed in the context of communication and social networks. Since the former method is only applicable to datasets of small size, we apply the latter method to a combination of the CYC2008 protein complex dataset and each of eight PPI datasets (STRING, MINT, BioGRID, IntAct, DIP, BIND, WI-PHI, iRefIndex). The results show that the minimum number of additional required PPIs ranges from 51 (STRING) to 964 (BIND), and that even the four best PPI databases, STRING (51), BioGRID (67), WI-PHI (93) and iRefIndex (85), do not include enough PPIs to form all CYC2008 protein complexes. We also demonstrate that the proposed problem framework and our solutions can enhance the prediction accuracy of existing PPI prediction methods. ILPMinPPI can be freely downloaded from http://sunflower.kuicr.kyoto-u.ac.jp/similar to nakajima/.	[Nakajima, Natsu] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan; [Hayashida, Morihiro] Matsue Coll, Natl Inst Technol, Dept Elect Engn & Comp Sci, 14-4 Nishiikumacho, Matsue, Shimane 6908518, Japan; [Jansson, Jesper] Hong Kong Polytech Univ, Dept Comp, Kowloon, Hong Kong, Peoples R China; [Maruyama, Osamu] Kyushu Univ, Inst Math Ind, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan; [Akutsu, Tatsuya] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto 6110011, Japan	University of Tokyo; Hong Kong Polytechnic University; Kyushu University; Kyoto University	Nakajima, N (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.; Akutsu, T (corresponding author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto 6110011, Japan.	nakajima@kuicr.kyoto-u.ac.jp; takutsu@kuicr.kyoto-u.ac.jp		Jansson, Jesper/0000-0001-6859-8932; Akutsu, Tatsuya/0000-0001-9763-797X	JSPS, Japan [26240034, 16K00392]; Hakubi Project at Kyoto University, Japan; JSPS KAKENHI [26330330]	JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hakubi Project at Kyoto University, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	T. Akutsu was partially supported by JSPS, Japan, (Grants-in-Aid 26240034). M. Hayashida was partially supported by JSPS, Japan (Grants-in-Aid 16K00392). J. Jansson was partially supported by the Hakubi Project at Kyoto University, Japan. O. Maruyama was partially supported by JSPS KAKENHI Grant Number 26330330.; T. Akutsu was partially supported by JSPS, Japan, (Grants-in-Aid 26240034). M. Hayashida was partially supported by JSPS, Japan, (Grants-in-Aid 16K00392). J. Jansson was partially supported by the Hakubi Project at Kyoto University, Japan. O. Maruyama was supported by JSPS KAKENHI Grant Number 26330330.	Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Angluin D, 2015, J COMB OPTIM, V29, P418, DOI 10.1007/s10878-013-9603-2; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen XW, 2011, NUCLEIC ACIDS RES, V39, pD750, DOI 10.1093/nar/gkq943; Chockler G, 2007, PODC'07: PROCEEDINGS OF THE 26TH ANNUAL ACM SYMPOSIUM ON PRINCIPLES OF DISTRIBUTED COMPUTING, P109; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hosur R, 2011, J MOL BIOL, V405, P1295, DOI 10.1016/j.jmb.2010.11.025; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jin QX, 2015, TUMOR BIOL, V36, P1895, DOI 10.1007/s13277-014-2791-2; Kiemer L, 2007, PROTEOMICS, V7, P932, DOI 10.1002/pmic.200600448; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Korach E, 2003, MATH PROGRAM, V98, P385, DOI 10.1007/s10107-003-0410-x; Korach E, 2008, DISCRETE APPL MATH, V156, P444, DOI 10.1016/j.dam.2006.12.004; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030938; Macropol K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-283; Maruyama O, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S14; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Michaut M, 2008, BIOINFORMATICS, V24, P1625, DOI 10.1093/bioinformatics/btn249; Murakami Y, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-213; Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Padhorny D, 2016, P NATL ACAD SCI USA, V113, pE4286, DOI 10.1073/pnas.1603929113; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodgers-Melnick E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-608; Ruan PY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S2-S6; Sambourg L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-605; Schmitt T, 2014, NUCLEIC ACIDS RES, V42, pD380, DOI 10.1093/nar/gkt984; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Singh R, 2010, NUCLEIC ACIDS RES, V38, pW508, DOI 10.1093/nar/gkq481; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195545	10.1371/journal.pone.0195545	http://dx.doi.org/10.1371/journal.pone.0195545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698482	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600012
J	Sondergaard, MJ; Friis, MB; Hansen, DS; Jorgensen, IM				Sondergaard, Mia Johanna; Friis, Martin Barfred; Hansen, Dennis Schroder; Jorgensen, Inger Merete			Clinical manifestations in infants and children with Mycoplasma pneumoniae infection	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; POPULATION; DISEASE; AGE	Background Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in older children. Pulmonary and extra-pulmonary symptoms associated with M. pneumoniae infection are reported. M. pneumoniae is mainly epidemic in Denmark with the recurrence every 4-7th year. Aims Retrospectively, to describe the epidemiology and clinical features, in infants and children, during the M. pneumoniae epidemic in 2010 and 2011. Methods All children under the age of 16 that were tested for M. pneumoniae during the period 01.02.2010 +/- 31.01.2012 were included. Medical charts, as well as radiological findings, were reviewed for all children with M. pneumoniae. A post-hoc analysis of viral co-infections was done on part of the cohort. Results 134 of 746 children were tested positive for M. pneumoniae by PCR or serology. Positive tests were found in 65% of children seven years and older, in 30% of 2-6-year-olds and 4% of infants (less than two years of age). Viral co-infection was found in 27% of the tested samples. The clinical presentation was a cough, asthma-like symptoms and low-grade fever. Extra-pulmonary symptoms were common and presented as nausea/vomiting by 33% of the children and skin manifestations by 25%. 84% of the children had a chest x-ray taken, and there were positive radiological findings in 94% of these. Conclusion M. pneumoniae also affected infants and young children and symptoms were similar to infections with respiratory viruses, but severe LRTI were also seen. During an up-coming epidemic, assessment of extra-pulmonary manifestations can be helpful when diagnosing M. pneumoniae infections.	[Sondergaard, Mia Johanna; Jorgensen, Inger Merete] Nordsjaellands Hosp, Dept Paediat, Hillerod, Denmark; [Friis, Martin Barfred; Hansen, Dennis Schroder] Herlev Hosp, Dept Clin Microbiol, Herlev, Denmark	University of Copenhagen; Herlev & Gentofte Hospital	Sondergaard, MJ (corresponding author), Nordsjaellands Hosp, Dept Paediat, Hillerod, Denmark.	sondergaard.mia@gmail.com		Jorgensen, Inger Merete/0000-0001-5229-2381	Department of Paediatrics, Nordsjaellands Hospital, Hillerod, Denmark; Department of Clinical Microbiology, Herlev Hospital, Herlev, Denmark	Department of Paediatrics, Nordsjaellands Hospital, Hillerod, Denmark; Department of Clinical Microbiology, Herlev Hospital, Herlev, Denmark	The involved departments (Department of Paediatrics, Nordsjaellands Hospital, Hillerod, Denmark and Department of Clinical Microbiology, Herlev Hospital, Herlev, Denmark) sponsored this study by financing the microbiological analyses that was done supplementary to the clinical workups and by salaries to MJS, MBF, DSH, and IMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasri M, 2011, HIPPOKRATIA, V15, P147; Berg AS, 2016, PEDIATR INFECT DIS J, V35, pE69, DOI 10.1097/INF.0000000000001009; Bjorn Anne-Mette Bay, 2002, Ugeskr Laeger, V164, P1805; Defilippi A, 2008, RESP MED, V102, P1762, DOI 10.1016/j.rmed.2008.06.022; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Gadsby NJ, 2012, EURO SURVEILL B EUR, V17; Gardiner SJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004875.pub5; GLEZEN WP, 1971, J PEDIATR-US, V78, P397, DOI 10.1016/S0022-3476(71)80218-4; Harris M, 2011, THORAX, V66, pII1, DOI 10.1136/thoraxjnl-2011-200598; Hornsleth A, 1967, Ugeskr Laeger, V129, P1259; Hornsleth A, 1967, Ugeskr Laeger, V129, P1253; Inchley CS, 2017, PEDIATR INFECT DIS J, V36, P930, DOI 10.1097/INF.0000000000001628; Korppi M, 2004, RESPIROLOGY, V9, P109, DOI 10.1111/j.1440-1843.2003.00522.x; Mulholland S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004875.pub4; Olson D, 2015, PEDIATRICS, V136, pE386, DOI 10.1542/peds.2015-0278; Othman N, 2005, J PAEDIATR CHILD H, V41, P671, DOI 10.1111/j.1440-1754.2005.00757.x; Sorensen CM, 2013, DAN MED J, V60; Spuesens EBM, 2014, J INFECTION, V69, pS42, DOI 10.1016/j.jinf.2014.07.017; Spuesens EBM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001444; Statens Serum Institut, 2015, MYC PNEUM INF; Stocki T, 2012, EURO SURVEILL B EUR, V17; Stokholm J, 2016, LANCET RESP MED, V4, P19, DOI [10.1016/S2213-2600(15)00500-7, 10.1016/S2213-2600(16)00050-3]; Tsai V, 2011, J EMERG MED, V40, P324, DOI 10.1016/j.jemermed.2008.02.027; Uldum SA, 2012, EURO SURVEILL B EUR, V17; Uldum Soren Anker, 2012, Ugeskr Laeger, V174, P730; Waites KB, 2003, PEDIATR PULM, V36, P267, DOI 10.1002/ppul.10346; Zalenzink D, 2009, MYCOPLASMA PNEUMONIA	27	46	54	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195288	10.1371/journal.pone.0195288	http://dx.doi.org/10.1371/journal.pone.0195288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698412	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600008
J	Eckert, NR; Poston, B; Riley, ZA				Eckert, Nathaniel R.; Poston, Brach; Riley, Zachary A.			Differential processing of nociceptive input within upper limb muscles	PLOS ONE			English	Article							CUTANEOUS SILENT PERIOD; STATIC SHOULDER POSITIONS; CORTICOMOTOR EXCITABILITY; FINGERTIP STIMULATION; REFLEX RESPONSES; PRECISION GRIP; MOTOR CORTEX; HUMANS; HAND; INHIBITION	The cutaneous silent period is an inhibitory evoked response that demonstrates a wide variety of responses in muscles of the human upper limb. Classically, the cutaneous silent period results in a characteristic muscle pattern of extensor inhibition and flexor facilitation within the upper limb, in the presence of nociceptive input. The aims of the current study were: 1) to primarily investigate the presence and characteristics of the cutaneous silent period response across multiple extensor and flexor muscles of the upper limb, and 2) to secondarily investigate the influence of stimulation site on this nociceptive reflex response. It was hypothesized that the cutaneous silent period would be present in all muscles, regardless of role (flexion/extension) or the stimulation site. Twenty-two healthy, university-age adults (14 males; 8 females; 23 +/- 5 yrs) participated in the study. Testing consisted of three different stimulation sites (Digit II, V, and II+III nociceptive stimulation) during a low intensity, sustained muscle contraction, in which, 7 upper limb muscles were monitored via surface EMG recording electrodes. Distal muscles of the upper limb presented with the earliest reflex onset times, longest reflex duration, and lowest level of EMG suppression when compared to the more proximal muscles, regardless of extensor/flexor role. Additionally, the greatest overall inhibitory influence was expressed within the distal muscles. In conclusion, the present study provides a new level of refinement within the current understanding of the spinal organization associated with nociceptive input processing and the associated motor control of the upper limb. Subsequently, these results have further implications on the impact of nociception on supraspinal processing.	[Eckert, Nathaniel R.] Univ Indianapolis, Dept Kinesiol, Indianapolis, IN 46227 USA; [Poston, Brach] Univ Nevada Las Vegas, Dept Kinesiol & Nutr Sci, Las Vegas, NV USA; [Riley, Zachary A.] Indiana Univ Purdue Univ, Dept Kinesiol, Indianapolis, IN 46202 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Indiana University System; Indiana University-Purdue University Indianapolis	Eckert, NR (corresponding author), Univ Indianapolis, Dept Kinesiol, Indianapolis, IN 46227 USA.	eckertnr@uindy.edu	Eckert, Nathanial/AGI-4504-2022	Eckert, Nathanial/0000-0002-0236-1809				CACCIA G, 1974, MINERVA MED, V64, P4884; CACCIA MR, 1973, J NEUROL NEUROSUR PS, V36, P960, DOI 10.1136/jnnp.36.6.960; Criswell E., 2010, CRAMS INTRO SURFACE; Devanne H, 2002, J NEUROPHYSIOL, V87, P3006, DOI 10.1152/jn.2002.87.6.3006; Don R, 2008, EUR J NEUROSCI, V28, P559, DOI 10.1111/j.1460-9568.2008.06330.x; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; Floeter MK, 1998, MUSCLE NERVE, V21, P591, DOI 10.1002/(SICI)1097-4598(199805)21:5<591::AID-MUS5>3.0.CO;2-3; Floeter MK, 2003, MUSCLE NERVE, V28, P391, DOI 10.1002/mus.10447; GARNETT R, 1980, J PHYSIOL-LONDON, V303, P351, DOI 10.1113/jphysiol.1980.sp013290; Ginanneschi F, 2006, BRAIN RES, V1073, P332, DOI 10.1016/j.brainres.2005.12.021; Ginanneschi F, 2005, EXP BRAIN RES, V161, P374, DOI 10.1007/s00221-004-2084-x; ILES JF, 1992, J PHYSIOL-LONDON, V455, P425, DOI 10.1113/jphysiol.1992.sp019309; Inghilleri M, 1997, ELECTROMYOGR MOTOR C, V105, P109, DOI 10.1016/S0924-980X(97)96579-6; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Kofler M, 2004, NEUROSCI LETT, V360, P69, DOI 10.1016/j.neulet.2004.02.035; Kofler M, 2003, CLIN NEUROPHYSIOL, V114, P973, DOI 10.1016/S1388-2457(03)00060-9; Kumru H, 2009, J PHYSIOL-LONDON, V587, P587, DOI 10.1113/jphysiol.2008.164186; Leis AA, 2000, NEUROLOGY, V55, P1305, DOI 10.1212/WNL.55.9.1305; Leis AA, 1998, MUSCLE NERVE, V21, P1243, DOI 10.1002/(SICI)1097-4598(199810)21:10<1243::AID-MUS1>3.0.CO;2-B; LEMON RN, 1981, J PHYSIOL-LONDON, V311, P497, DOI 10.1113/jphysiol.1981.sp013601; PICARD N, 1992, J NEUROPHYSIOL, V68, P1867, DOI 10.1152/jn.1992.68.5.1867; Rose PK, 2003, NAT NEUROSCI, V6, P1243, DOI 10.1038/nn1203-1243; ROTHWELL JC, 1991, EXP PHYSIOL, V76, P159, DOI 10.1113/expphysiol.1991.sp003485; Serrao M, 2006, J NEUROSCI, V26, P3505, DOI 10.1523/JNEUROSCI.5160-05.2006; Serrao M, 2001, CLIN NEUROPHYSIOL, V112, P2007, DOI 10.1016/S1388-2457(01)00675-7; Shahani B, 1973, STUDIES NORMAL HUMAN; SHEFNER JM, 1993, MUSCLE NERVE, V16, P278, DOI 10.1002/mus.880160306; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; UNCINI A, 1991, ELECTROEN CLIN NEURO, V81, P344, DOI 10.1016/0168-5597(91)90023-Q	31	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196129	10.1371/journal.pone.0196129	http://dx.doi.org/10.1371/journal.pone.0196129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694394	gold, Green Published			2022-12-26	WOS:000430802400067
J	Ojanen, SP; Finnila, MAJ; Reunamo, AE; Ronkainen, AP; Mikkonen, S; Herzog, W; Saarakkala, S; Korhonen, RK				Ojanen, Simo P.; Finnila, Mikko A. J.; Reunamo, Aino E.; Ronkainen, Ari P.; Mikkonen, Santtu; Herzog, Walter; Saarakkala, Simo; Korhonen, Rami K.			Site-specific glycosaminoglycan content is better maintained in the pericellular matrix than the extracellular matrix in early post-traumatic osteoarthritis	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; RABBIT ARTICULAR-CARTILAGE; DEFORMATION-BEHAVIOR; SAFRANIN-O; TRANSECTION; KNEE; CHONDROCYTES; QUANTITATION; COMPRESSION; COLLAGEN	Introduction One of the characteristics of early osteoarthritis (OA) is the loss of fixed charged density (FCD) of glycosaminoglycans in the superficial zone of articular cartilage. However, possible local changes in the FCD content of the pericellular matrix (PCM) are not fully understood. Hence, our aim was to investigate the effect of unilateral anterior cruciate ligament transection (ACLT) in rabbit knees on estimated FCD in the PCM compared to that in the ECM, and relate these results with cell morphology. Methods Articular cartilage samples were collected from ACLT, contralateral and intact control knee joints from lateral and medial femoral condyles and tibial plateaus, and from the femoral groove and patella. Histological samples were prepared and stained with Safranin-O to estimate the FCD content around the chondrocytes in the PCM and the ECM with digital densitometry. Results As a result of ACLT, the greatest decreases in the FCD content of the PCM were observed in the superficial zone of the lateral femoral condyle (p = 0.02), medial tibial plateau (p = 0.002) and patellar (p < 0.001) cartilage. The normalized FCD content of the PCM compared to the surrounding ECM was increased most in the femoral condyles (p < 0.01) and medial tibial plateau (p = 0.02) cartilage. The high normalized FCD content of the PCM in the superficial zone of lateral femoral condyle cartilage was consistent with the round cell morphology in that location. Conclusions In conclusion, we suggest that certain sites in the knee joint, particularly the lateral femoral condyle cartilage, experience less FCD loss in the PCM than in the ECM in early post-traumatic OA, which could lead to altered cell shape.	[Ojanen, Simo P.; Finnila, Mikko A. J.; Reunamo, Aino E.; Ronkainen, Ari P.; Mikkonen, Santtu; Korhonen, Rami K.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Ojanen, Simo P.; Finnila, Mikko A. J.; Saarakkala, Simo] Univ Oulu, Fac Med, Res Unit Med Imaging Phys & Technol, Oulu, Finland; [Herzog, Walter] Univ Calgary, Schulich Sch Engn, Mech & Mfg Engn, Calgary, AB, Canada; [Herzog, Walter] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada; [Saarakkala, Simo] Oulu Univ Hosp, Dept Diagnost Radiol, Oulu, Finland	University of Eastern Finland; University of Oulu; University of Calgary; University of Calgary; University of Oulu	Ojanen, SP (corresponding author), Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.; Ojanen, SP (corresponding author), Univ Oulu, Fac Med, Res Unit Med Imaging Phys & Technol, Oulu, Finland.	simo.ojanen@uef.fi	Herzog, Walter/AAG-7188-2020; Finnila, Mikko/X-6492-2019; Saarakkala, Simo/F-5839-2013; Mikkonen, Santtu/E-8568-2011; Ronkainen, Ari Petteri/J-8249-2016	Herzog, Walter/0000-0002-5341-0033; Saarakkala, Simo/0000-0003-2850-5484; Mikkonen, Santtu/0000-0003-0595-0657; Reunamo, Aino/0000-0002-0772-3223; Finnila, Mikko/0000-0002-3348-5759; Ojanen, Simo/0000-0003-4386-0716; Ronkainen, Ari Petteri/0000-0003-2766-5267; Korhonen, Rami/0000-0002-3486-7855	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC [336267, 281180]; Academy of Finland [268378, 303786, 286526, 307331]; University of Eastern Finland	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC(European Research Council (ERC)); Academy of Finland(Academy of Finland); University of Eastern Finland	This work was supported by the following: European Research Council under the European Unions Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement no. 336267, PhD Simo Saarakkala; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Academy of Finland, grant nos. 268378 and 303786, PhD Simo Saarakkala; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sigrid Juselius Foundation, PhD Simo Saarakkala; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Strategic funding from the University of Oulu, PhD Simo Saarakkala; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. European Research Council under the European Unions Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement no. 281180, PhD Rami Korhonen; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Academy of Finland, grant no. 286526, PhD Rami Korhonen; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sigrid Juselius Foundation, PhD Rami Korhonen; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Paivikki and Sakari Sohlberg Foundation, Mr. Simo Ojanen; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pohjois-Savon Rahasto; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Canadian Institutes of Health Research (CIHR), PhD Walter Herzog; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Killam Foundation, PhD Walter Herzog; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Canada Research Chair Program, PhD Walter Herzog; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Majja Tor Nesslingin Saatio (FI), PhD Santtu Mikkonen; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Academy of Finland, grant no. 307331, PhD Santtu Mikkonen; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Strategic funding from the University of Eastern Finland, PhD Mikko Finnila; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	BRAY RC, 1992, J ORTHOP RES, V10, P157, DOI 10.1002/jor.1100100202; Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021; CARNEY S L, 1984, Journal of Orthopaedic Research, V2, P201, DOI 10.1002/jor.1100020301; CARNEY SL, 1985, J ORTHOPAED RES, V3, P140, DOI 10.1002/jor.1100030203; Chang DG, 1997, OSTEOARTHR CARTILAGE, V5, P357, DOI 10.1016/S1063-4584(97)80039-8; Clark AL, 2003, J BIOMECH, V36, P553, DOI 10.1016/S0021-9290(02)00424-4; EYRE DR, 1980, BIOCHEM J, V188, P823, DOI 10.1042/bj1880823; Florea C, 2015, OSTEOARTHR CARTILAGE, V23, P414, DOI 10.1016/j.joca.2014.11.023; Galois L, 2003, RHEUMATOLOGY, V42, P692, DOI 10.1093/rheumatology/keg094; Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162; Gushue DL, 2005, J ORTHOP RES, V23, P735, DOI 10.1016/j.orthres.2005.01.005; Han SK, 2010, J R SOC INTERFACE, V7, P895, DOI 10.1098/rsif.2009.0458; Han SK, 2009, MED ENG PHYS, V31, P1038, DOI 10.1016/j.medengphy.2009.05.013; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Huttu MRJ, 2014, CONNECT TISSUE RES, V55, P282, DOI 10.3109/03008207.2014.912645; Intema F, 2010, OSTEOARTHR CARTILAGE, V18, P691, DOI 10.1016/j.joca.2010.01.004; KEMPSON GE, 1970, BIOCHIM BIOPHYS ACTA, V215, P70, DOI 10.1016/0304-4165(70)90388-0; Kiraly K, 1996, HISTOCHEM J, V28, P99, DOI 10.1007/BF02331414; KIVIRANTA I, 1985, HISTOCHEMISTRY, V82, P249, DOI 10.1007/BF00501401; Korhonen RK, 2011, CELL MOL BIOENG, V4, P484, DOI 10.1007/s12195-011-0178-7; Korhonen RK, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2898725; Makela JTA, 2014, OSTEOARTHR CARTILAGE, V22, P869, DOI 10.1016/j.joca.2014.04.010; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; MAROUDAS A, 1969, BIOCHIM BIOPHYS ACTA, V177, P492, DOI 10.1016/0304-4165(69)90311-0; Miyata S, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001369; Mow V., 1991, STRUCTURE FUNCTION A, P143; Mow VC., 2004, BASIC ORTHOPAEDIC BI; POOLE CA, 1992, J CELL SCI, V103, P1101; Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x; Rieppo J, 2003, CELLS TISSUES ORGANS, V175, P121, DOI 10.1159/000074628; Saarakkala S, 2010, OSTEOARTHR CARTILAGE, V18, P73, DOI 10.1016/j.joca.2009.08.003; Sah RL, 1997, J ORTHOP RES, V15, P197, DOI 10.1002/jor.1100150207; SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502; SANDY JD, 1984, ARTHRITIS RHEUM, V27, P388, DOI 10.1002/art.1780270405; Stockwell R A, 1978, J Clin Pathol Suppl (R Coll Pathol), V12, P7; STOCKWELL RA, 1983, J ANAT, V136, P425; Tanska P, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/164146; Turunen SM, 2013, OSTEOARTHR CARTILAGE, V21, P505, DOI 10.1016/j.joca.2012.12.001; VonTress M, 2003, TECHNOMETRICS, V4, P99, DOI [10.1198/tech.2003.s13, DOI 10.1198/TECH.2003.S13]; Wilusz RE, 2012, MATRIX BIOL, V31, P320, DOI 10.1016/j.matbio.2012.05.002; Yoshioka M, 1996, OSTEOARTHR CARTILAGE, V4, P87, DOI 10.1016/S1063-4584(05)80318-8	41	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196203	10.1371/journal.pone.0196203	http://dx.doi.org/10.1371/journal.pone.0196203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694389	gold, Green Published			2022-12-26	WOS:000430802400073
J	Ulyanova, AV; Shirokov, RE				Ulyanova, Alexandra V.; Shirokov, Roman E.			Voltage-dependent inward currents in smooth muscle cells of skeletal muscle arterioles	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; CALCIUM-CHANNELS; NA+ CHANNELS; MESENTERIC-ARTERY; PROTEIN-KINASE; ELECTRICAL-ACTIVITY; SINGLE MYOCYTES; IONIC CURRENTS; MICE DEFICIENT; MYOGENIC TONE	Voltage-dependent inward currents responsible for the depolarizing phase of action potentials were characterized in smooth muscle cells of 4(th) order arterioles in mouse skeletal muscle. Currents through L-type Ca2+ channels were expected to be dominant; however, action potentials were not eliminated in nominally Ca2+-free bathing solution or by addition of Ltype Ca2+ channel blocker nifedipine (10 mu M). Instead, Na+ channel blocker tetrodotoxin (TTX, 1 mu M) reduced the maximal velocity of the upstroke at low, but not at normal (2 mM), Ca2+ in the bath. The magnitude of TTX-sensitive currents recorded with 140 mM Na + was about 20 pA/pF. TTX-sensitive currents decreased five-fold when Ca2+ increased from 2 to 10 mM. The currents reduced three-fold in the presence of 10 mM caffeine, but remained unaltered by 1 mM of isobutylmethylxanthine (IBMX). In addition to L-type Ca2+ currents (15 pA/pF in 20 mM Ca2+), we also found Ca2+ currents that are resistant to 10 mu M nifedipine (5 pA/pF in 20 mM Ca2+). Based on their biophysical properties, these Ca2+ currents are likely to be through voltage-gated T-type Ca2+ channels. Our results suggest that Na+ and at least two types (T-and L-) of Ca2+ voltage-gated channels contribute to depolarization of smooth muscle cells in skeletal muscle arterioles. Voltage-gated Na + channels appear to be under a tight control by Ca2+ signaling.	[Ulyanova, Alexandra V.; Shirokov, Roman E.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA; [Ulyanova, Alexandra V.] Univ Penn, Dept Neurosurg, Penn Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine	Ulyanova, AV (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA.; Ulyanova, AV (corresponding author), Univ Penn, Dept Neurosurg, Penn Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA.	ulyanova@pennmedicin.upenn.edu		Ulyanova, Alexandra/0000-0002-1319-5279	NIMH NIH HHS [R01 MH079406] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AARONSON PI, 1988, J PHYSIOL-LONDON, V405, P57, DOI 10.1113/jphysiol.1988.sp017321; Abd El-Rahman RR, 2013, AM J PHYSIOL-HEART C, V304, pH58, DOI 10.1152/ajpheart.00476.2012; Amberg GC, 2007, J PHYSIOL-LONDON, V579, P187, DOI 10.1113/jphysiol.2006.124420; Bartlett IS, 2000, J VASC RES, V37, P568, DOI 10.1159/000054090; BEAN BP, 1986, CIRC RES, V59, P229, DOI 10.1161/01.RES.59.2.229; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Berra-Romani R, 2005, AM J PHYSIOL-HEART C, V289, pH137, DOI 10.1152/ajpheart.01156.2004; Biswas S, 2008, J GEN PHYSIOL, V131, P197, DOI 10.1085/jgp.200709863; Bjorling K, 2013, ACTA PHYSIOL, V207, P709, DOI 10.1111/apha.12066; Burns WR, 2004, MICROCIRCULATION, V11, P279, DOI 10.1080/10739680490425985; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Cohen KD, 2003, MICROCIRCULATION, V10, P133, DOI 10.1038/sj/mn.7800178; Cox RH, 1998, J VASC RES, V35, P310, DOI 10.1159/000025600; Crunelli V, 2005, J PHYSIOL-LONDON, V562, P121, DOI 10.1113/jphysiol.2004.076273; DAVIS JPL, 1992, EXP PHYSIOL, V77, P857, DOI 10.1113/expphysiol.1992.sp003652; deRoos ADG, 1996, PFLUG ARCH EUR J PHY, V431, P556, DOI 10.1007/s004240050035; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Dora KA, 2017, ACTA PHYSIOL, V219, P202, DOI 10.1111/apha.12656; Dora KA, 2016, MICROCIRCULATION, V23, P626, DOI 10.1111/micc.12322; Feng MG, 2004, AM J PHYSIOL-RENAL, V286, pF331, DOI 10.1152/ajprenal.00251.2003; FLEISCHMANN BK, 1994, P NATL ACAD SCI USA, V91, P11914, DOI 10.1073/pnas.91.25.11914; Fort A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007360; GANITKEVICH VY, 1990, J PHYSIOL-LONDON, V426, P19, DOI 10.1113/jphysiol.1990.sp018125; GARAVITO RM, 1984, J BIOL CHEM, V259, P4254; Garland CJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3806; GORDIENKO DV, 1994, AM J PHYSIOL, V266, pF325, DOI 10.1152/ajprenal.1994.266.2.F325; GRAHAM JM, 1975, J PHYSIOL-LONDON, V247, P473, DOI 10.1113/jphysiol.1975.sp010942; Harraz OF, 2015, J GEN PHYSIOL, V145, P405, DOI 10.1085/jgp.201511361; Hashad AM, 2017, J PHYSIOL-LONDON, V595, P1111, DOI 10.1113/JP273329; Hatakeyama T, 2006, J PHYSIOL-LONDON, V574, P275, DOI 10.1113/jphysiol.2006.108175; Herzog RI, 2003, J NEUROSCI, V23, P8261; Hill MA, 2006, CLIN HEMORHEOL MICRO, V34, P67; Hill MA, 2010, FEBS LETT, V584, P2033, DOI 10.1016/j.febslet.2010.02.045; HIRST GDS, 1982, J PHYSIOL-LONDON, V333, P53, DOI 10.1113/jphysiol.1982.sp014438; HIRST GDS, 1986, J PHYSIOL-LONDON, V371, P289, DOI 10.1113/jphysiol.1986.sp015975; Ho WSV, 2013, AM J PHYSIOL-CELL PH, V304, pC739, DOI 10.1152/ajpcell.00164.2012; Jo T, 2004, FEBS LETT, V567, P339, DOI 10.1016/j.febslet.2004.04.092; KEATINGE WR, 1968, J PHYSIOL-LONDON, V194, P169, DOI 10.1113/jphysiol.1968.sp008400; KEATINGE WR, 1968, J PHYSIOL-LONDON, V194, P183, DOI 10.1113/jphysiol.1968.sp008401; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P211, DOI 10.1111/j.1469-7793.1998.211br.x; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; Kotecha N, 2005, AM J PHYSIOL-HEART C, V289, pH1326, DOI 10.1152/ajpheart.00323.2005; Kuo IYT, 2014, PFLUG ARCH EUR J PHY, V466, P767, DOI 10.1007/s00424-013-1430-x; KURIYAMA H, 1981, J PHYSIOL-LONDON, V317, P383, DOI 10.1113/jphysiol.1981.sp013831; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lee-Kwon W, 2007, AM J PHYSIOL-RENAL, V292, pF404, DOI 10.1152/ajprenal.00070.2006; LEIJTEN PAA, 1984, J PHYSIOL-LONDON, V357, P327, DOI 10.1113/jphysiol.1984.sp015502; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Matchkov VV, 2006, AM J PHYSIOL-HEART C, V291, pH357, DOI 10.1152/ajpheart.00681.2005; Meguro K, 2009, AM J PHYSIOL-HEART C, V296, pH211, DOI 10.1152/ajpheart.00960.2008; Mikkelsen MF, 2016, J PHYSIOL-LONDON, V594, P5881, DOI 10.1113/JP271470; Morita H, 1999, CIRC RES, V85, P596, DOI 10.1161/01.RES.85.7.596; Murphy BA, 2009, AM J PHYSIOL-CELL PH, V297, pC750, DOI 10.1152/ajpcell.00127.2009; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; NUMANN R, 1994, J NEUROSCI, V14, P4226; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; OKABE K, 1988, PFLUG ARCH EUR J PHY, V411, P423, DOI 10.1007/BF00587722; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 2004, MOL INTERV, V4, P16, DOI 10.1124/mi.4.1.16; Pitt GS, 2016, PROTEIN SCI, V25, P1573, DOI 10.1002/pro.2960; Saleh S, 2005, J PHYSIOL-LONDON, V568, P155, DOI 10.1113/jphysiol.2005.090951; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; SMIRNOV SV, 1992, J PHYSIOL-LONDON, V457, P455, DOI 10.1113/jphysiol.1992.sp019387; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Taylor MS, 1999, AM J PHYSIOL-GASTR L, V276, pG909, DOI 10.1152/ajpgi.1999.276.4.G909; TAYLOR RE, 1976, BIOPHYS J, V16, pA27; Teramoto N, 2012, PFLUG ARCH EUR J PHY, V464, P493, DOI 10.1007/s00424-012-1153-4; Thuesen AD, 2017, ACTA PHYSIOL, V219, P640, DOI 10.1111/apha.12732; Tykocki NR, 2011, SMOOTH MUSCLE ION CH; VanBavel E, 2002, AM J PHYSIOL-HEART C, V283, pH2239, DOI 10.1152/ajpheart.00531.2002; WATANABE C, 1992, J PHYSIOL-LONDON, V456, P193, DOI 10.1113/jphysiol.1992.sp019333; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YAMAMOTO D, 1984, BIOPHYS J, V45, P337, DOI 10.1016/S0006-3495(84)84159-4; Yamamoto Y, 2001, J PHYSIOL-LONDON, V535, P181, DOI 10.1111/j.1469-7793.2001.00181.x; Young KA, 2005, J PHYSIOL-LONDON, V565, P349, DOI 10.1113/jphysiol.2004.081422; ZELCER E, 1982, BLOOD VESSELS, V19, P301; Zhu HL, 2008, BIOPHYS J, V94, P3340, DOI 10.1529/biophysj.107.117192; Zhu HL, 2010, J CELL PHYSIOL, V223, P234, DOI 10.1002/jcp.22032	80	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0194980	10.1371/journal.pone.0194980	http://dx.doi.org/10.1371/journal.pone.0194980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694371	gold, Green Submitted, Green Published			2022-12-26	WOS:000430802400019
J	Brillatz, T; Lauritano, C; Jacminmi, M; Khamma, S; Marcourt, L; Righi, D; Romano, G; Esposito, F; Ianora, A; Queiroz, EF; Wolfender, JL; Crawford, AD				Brillatz, Theo; Lauritano, Chiara; Jacminmi, Maxime; Khamma, Supitcha; Marcourt, Laurence; Righi, Davide; Romano, Giovanna; Esposito, Francesco; Ianora, Adrianna; Queiroz, Emerson F.; Wolfender, Jean-Luc; Crawford, Alexander D.			Zebrafish-based identification of the antiseizure nucleoside inosine from the marine diatom Skeletonema marinoi	PLOS ONE			English	Article							MOUSE SEIZURE MODELS; BIOASSAY-GUIDED MICROFRACTIONATION; CYANOBACTERIUM LYNGBYA-MAJUSCULA; ANTICONVULSANT ACTIVITY; NATURAL-PRODUCT; TREATING EPILEPSY; CELL-DEATH; PENTYLENETETRAZOLE; BEHAVIOR; ALGA	With the goal of identifying neuroactive secondary metabolites from microalgae, a micro-scale in vivo zebrafish bioassay for antiseizure activity was used to evaluate bioactivities of the diatom Skeletonema marinoi, which was recently revealed as being a promising source of drug-like small molecules. A freeze-dried culture of S. marinoi was extracted by solvents with increasing polarities (hexane, dichloromethane, methanol and water) and these extracts were screened for anticonvulsant activity using a larval zebrafish epilepsy model with seizures induced by the GABA(A) antagonist pentylenetetrazole. The methanolic extract of S. marinoi exhibited significant anticonvulsant activity and was chosen for bioassay-guided fractionation, which associated the bioactivity with minor constituents. The key anticonvulsant constituent was identified as the nucleoside inosine, a well-known adenosine receptor agonist with previously reported antiseizure activities in mice and rat epilepsy models, but not reported to date as a bioactive constituent of microalgae. In addition, a UHPLC-HRMS metabolite profiling was used for dereplication of the other constituents of S. marinoi. Structures of the isolated compounds were elucidated by nuclear magnetic resonance and high-resolution spectrometry. These results highlight the potential of zebrafish-based screening and bioassay-guided fractionation to identify neuroactive marine natural products.	[Brillatz, Theo; Khamma, Supitcha; Marcourt, Laurence; Righi, Davide; Queiroz, Emerson F.; Wolfender, Jean-Luc] Univ Lausanne, Univ Geneva, EPGL, Sch Pharmaceut Sci, Geneva, Switzerland; [Lauritano, Chiara; Romano, Giovanna; Esposito, Francesco; Ianora, Adrianna] Stn Zool Anton Dohrn, Integrat Marine Ecol Dept, Naples, Italy; [Jacminmi, Maxime; Crawford, Alexander D.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Belvaux, Luxembourg; [Jacminmi, Maxime; Crawford, Alexander D.] Theracule Sarl, Belval, Luxembourg; [Crawford, Alexander D.] Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway	University of Geneva; University of Lausanne; Stazione Zoologica Anton Dohrn di Napoli; University of Luxembourg; Norwegian University of Life Sciences	Wolfender, JL (corresponding author), Univ Lausanne, Univ Geneva, EPGL, Sch Pharmaceut Sci, Geneva, Switzerland.; Lauritano, C; Ianora, A (corresponding author), Stn Zool Anton Dohrn, Integrat Marine Ecol Dept, Naples, Italy.	chiara.lauritano@szn.it; adrianna.ianora@szn.it; jean-luc.wolfender@unige.ch	Jean-Luc, Wolfender JLW/O-2163-2018; Jean-Luc, Wolfender JLW/EWV-1043-2022; Ianora, Adrianna/O-3408-2019; Romano, Giovanna/F-4561-2015; Queiroz, Emerson Ferreira/AAU-6235-2020; Lauritano, Chiara/Q-4166-2018	Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Romano, Giovanna/0000-0002-4898-7153; Lauritano, Chiara/0000-0003-4580-9594	European Union 7th Framework Program [312184]; Swiss National Science Foundation (SNF R'Equip grant) [316030_164095]	European Union 7th Framework Program(European Commission); Swiss National Science Foundation (SNF R'Equip grant)(Swiss National Science Foundation (SNSF))	The research leading to these results was part of the PHARMASEA project (312184) which received funding from the European Union 7th Framework Program. The School of Pharmaceutical Sciences of the University of Geneva (Prof. J-L. Wolfender) is thankful to the Swiss National Science Foundation for the support in the acquisition of the NMR 600 MHz (SNF R'Equip grant 316030_164095). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054166; Ahmed SA, 2008, J NAT PROD, V71, P513, DOI 10.1021/np0703287; Akiyama T, 2009, J NAT PROD, V72, P1552, DOI 10.1021/np900355m; An SM, 2017, MITOCHONDRIAL DNA A, V28, P19, DOI 10.3109/19401736.2015.1106523; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Bozarth A, 2009, APPL MICROBIOL BIOT, V82, P195, DOI 10.1007/s00253-008-1804-8; Buenafe OE, 2013, ACS CHEM NEUROSCI, V4, P1479, DOI 10.1021/cn400140e; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Carotenuto Y, 2014, HARMFUL ALGAE, V31, P153, DOI 10.1016/j.hal.2013.11.002; Challal S, 2015, PLANTA MED, V81, P1636, DOI 10.1055/s-0035-1545912; Challal S, 2014, ACS CHEM NEUROSCI, V5, P993, DOI 10.1021/cn5001342; Challal S, 2012, CHIMIA, V66, P229, DOI 10.2533/chimia.2012.229; CHIKASHITA H, 1993, CHEM LETT, P477, DOI 10.1246/cl.1993.477; Crawford AD, 2008, PLANTA MED, V74, P624, DOI 10.1055/s-2008-1034374; della Greca M., 1989, Biochimica et Biophysica Acta, V1004, P271, DOI 10.1016/0005-2760(89)90277-4; Dellai A, 2012, CANC CELL INT, V12; Desbois AP, 2008, APPL MICROBIOL BIOT, V81, P755, DOI 10.1007/s00253-008-1714-9; Dorandeu F, 2002, BIOCHEM PHARMACOL, V63, P755, DOI 10.1016/S0006-2952(01)00896-6; ENDO H, 1982, AGR BIOL CHEM TOKYO, V46, P2183, DOI 10.1080/00021369.1982.10865422; FALKOWSKI PG, 1994, PHOTOSYNTH RES, V39, P235, DOI 10.1007/BF00014586; Fontana A, 2007, PURE APPL CHEM, V79, P481, DOI 10.1351/pac200779040481; Ganzella M, 2011, PHARMACOL BIOCHEM BE, V100, P271, DOI 10.1016/j.pbb.2011.09.001; Gutierrez M, 2009, J ORG CHEM, V74, P5267, DOI 10.1021/jo900578j; HODGES R, 1964, TETRAHEDRON, V20, P1463, DOI 10.1016/S0040-4020(01)99140-9; Holzgrabe U, 2010, PROG NUCL MAG RES SP, V57, P229, DOI 10.1016/j.pnmrs.2010.05.001; Ingebrigtsen RA, 2016, J APPL PHYCOL, V28, P939, DOI 10.1007/s10811-015-0631-4; Jaspars M, 2016, J MAR BIOL ASSOC UK, V96, P151, DOI 10.1017/S0025315415002106; Jimenez EC, 2002, EPILEPSY RES, V51, P73, DOI 10.1016/S0920-1211(02)00101-8; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kovacs Z, 2015, NEUROSCIENCE, V300, P593, DOI 10.1016/j.neuroscience.2015.05.054; Kovacs Z, 2014, MINI-REV MED CHEM, V14, P1033, DOI 10.2174/1389557514666141107120226; Lauritano C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20611-x; Lauritano C, 2016, MAR DRUGS, V14, DOI 10.3390/md14120220; Lauritano C, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00068; Lauritano C, 2015, MAR GENOM, V24, P89, DOI 10.1016/j.margen.2015.01.007; Lauritano C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1574-5; LEWIN E, 1985, EPILEPSIA, V26, P258, DOI 10.1111/j.1528-1157.1985.tb05415.x; Lifshits M, 2012, J NAT PROD, V75, P209, DOI 10.1021/np200909x; Long SM, 2014, MAR DRUGS, V12, P3307, DOI 10.3390/md12063307; Maes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043850; Megiddo I, 2016, EPILEPSIA, V57, P464, DOI 10.1111/epi.13294; Orellana-Paucar AM, 2012, EPILEPSY BEHAV, V24, P14, DOI 10.1016/j.yebeh.2012.02.020; NAGLE DG, 1994, J ORG CHEM, V59, P7227, DOI 10.1021/jo00103a012; Naviner M, 1999, AQUACULTURE, V174, P15, DOI 10.1016/S0044-8486(98)00513-4; Orefice I, 2015, MAR GENOM, V24, P81, DOI 10.1016/j.margen.2015.06.008; Paganoni S, 2017, AMYOTROPH LAT SCL FR, V18, P309, DOI 10.1080/21678421.2016.1223270; Pandey A., 2014, J PHARMACOGNOSY PHYT, V2, P115; PASCHKE RF, 1954, J AM OIL CHEM SOC, V31, P5, DOI 10.1007/BF02544760; Pauli GF, 2014, J MED CHEM, V57, P9220, DOI 10.1021/jm500734a; Prestegard SK, 2009, MAR DRUGS, V7, P605, DOI 10.3390/md7040605; Rho MC, 1996, PLANTA MED, V62, P473, DOI 10.1055/s-2006-957944; Robert Guillard, 1975, CULTURE MARINE INVER, P29; Romano G., 2016, MAR ENV RES; Santulli L, 2016, PHARMACOL RES, V107, P211, DOI 10.1016/j.phrs.2016.03.016; Schachter SC, 2009, NEUROTHERAPEUTICS, V6, P415, DOI 10.1016/j.nurt.2008.12.004; Schwarzschild MA, 2014, JAMA NEUROL, V71, P141, DOI 10.1001/jamaneurol.2013.5528; Sefbom J, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0184; Singh IP, 1999, J NAT PROD, V62, P1333, DOI 10.1021/np990162c; SKOLNICK P, 1979, P NATL ACAD SCI USA, V76, P1515, DOI 10.1073/pnas.76.3.1515; SPENCE I, 1979, EXPERIENTIA, V35, P238, DOI 10.1007/BF01920638; Stivala CE, 2015, NAT PROD REP, V32, P411, DOI 10.1039/c4np00089g; Su JY, 1997, CHEM J CHINESE U, V18, P1333; Sushanth VR, 2015, INDIAN J GEO-MAR SCI, V44, P69; Vermoesen K, 2011, EPILEPSY BEHAV, V22, P450, DOI 10.1016/j.yebeh.2011.08.016; Wahab A, 2010, PHARMACEUTICALS, V3, P2090, DOI 10.3390/ph3072090; West KHJ, 2016, PLANTA MED, V82, P754, DOI 10.1055/s-0042-106391; Westerfield, 2000, ZEBRAFISH BOOK GUIDE; Yuan JP, 2011, MOL NUTR FOOD RES, V55, P150, DOI 10.1002/mnfr.201000414	68	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196195	10.1371/journal.pone.0196195	http://dx.doi.org/10.1371/journal.pone.0196195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689077	Green Published, Green Submitted, gold			2022-12-26	WOS:000430678800030
J	Gomes, RS; Moreira, FTC; Fernandes, R; Sales, MGF				Gomes, Rui S.; Moreira, Felismina T. C.; Fernandes, Ruben; Sales, M. Goreti F.			Sensing CA 15-3 in point-of-care by electropolymerizing O-phenylenediamine (oPDA) on Au-screen printed electrodes	PLOS ONE			English	Article							TUMOR-MARKER CA15-3; BREAST-CANCER; SENSITIVE DETECTION; ENZYME-IMMUNOASSAY; RAMAN-SPECTROSCOPY; BIOSENSORS; SURFACE; AMINOPHENOL; POLYANILINE; ANTIBODIES	This work presents an alternative device for cancer screening in liquid biopsies. It combines a biomimetic film (i) with electrochemical detection (ii). The biomimetic film (i) was obtained by electro-polymerizing amine-substituted benzene rings around a CA 15-3 target. This protein target was previously adsorbed on a gold (Au) support and incubated in charged monomers (4-Styrenesulfonate sodium and 3-Hydroxytyraminium chloride). The protein was further eliminated by enzymatic activity, leaving behind vacant sites for subsequent rebinding. Electrochemical detection (ii) was achieved on an Au working electrode, designed on commercial screen-printed electrodes. Raman spectroscopy, atomic force microscopy and ellipsometric readings were used to follow the chemical modification of the Au surface. The ability of the material to rebind CA15-3 was monitored by electrochemical techniques. The device displayed linear responses to CA15-3 ranging from 0.25 to 10.00 U/mL, with detection limits of 0.05 U/mL. Accurate results were obtained by applying the sensor to the analysis of CA15-3 in PBS buffer and in serum samples. This biosensing device displayed successful features for the detection of CA 15-3 and constitutes a promising tool for breast cancer screening procedures in point-of-care applications. Moreover, its scale-up seems feasible as it contains a plastic antibody assembled in situ, in less than 1 minute, and the analysis of serum takes less than 30 minutes.	[Gomes, Rui S.; Moreira, Felismina T. C.; Sales, M. Goreti F.] Polytech Inst Porto, Sch Engn, BioMark ISEP, Porto, Portugal; [Gomes, Rui S.; Moreira, Felismina T. C.; Sales, M. Goreti F.] Minho Univ, Ctr Biol Engn, CEB, Braga, Portugal; [Gomes, Rui S.; Fernandes, Ruben] Univ Porto, Fac Engn, Porto, Portugal; [Gomes, Rui S.; Fernandes, Ruben] Univ Porto, Med Fac, Pharmacol Ctr & Biopathol Chem, Porto, Portugal; [Fernandes, Ruben] Polytech Inst Porto, Super Hlth Sch, Porto, Portugal	Polytechnic Institute of Porto; Universidade do Minho; Universidade do Porto; Universidade do Porto; Polytechnic Institute of Porto	Sales, MGF (corresponding author), Polytech Inst Porto, Sch Engn, BioMark ISEP, Porto, Portugal.; Sales, MGF (corresponding author), Minho Univ, Ctr Biol Engn, CEB, Braga, Portugal.	goreti.sales@gmail.com	SALES, Maria Goreti FERREIRA/K-9199-2013; Sales, Maria Goreti Ferreira/V-4408-2019; Fernandes, Ruben/L-5753-2013	SALES, Maria Goreti FERREIRA/0000-0001-9936-7336; Sales, Maria Goreti Ferreira/0000-0001-9936-7336; Fernandes, Ruben/0000-0001-8933-3984; Moreira, Felismina/0000-0003-4237-8952	European Research Council [ERC-StG-3P's/2012, GA 311086]	European Research Council(European Research Council (ERC)European Commission)	The authors acknowledge the financial support of European Research Council though the Starting Grant, ERC-StG-3P's/2012, GA 311086 (to MGF Sales).	Abe Y, 1988, Gan No Rinsho, V34, P1672; Apodaca DC, 2011, ACS APPL MATER INTER, V3, P191, DOI 10.1021/am100805y; Boyer MI, 2000, J PHYS CHEM B, V104, P8952, DOI 10.1021/jp000946v; Cabral-Miranda G, 2014, J MATER CHEM B, V2, P3087, DOI 10.1039/c3tb21740j; Chen LX, 2011, CHEM SOC REV, V40, P2922, DOI 10.1039/c0cs00084a; Choong CL, 2009, BIOSENS BIOELECTRON, V25, P652, DOI 10.1016/j.bios.2008.11.025; Ciri-Marjanovic G, 2008, J RAMAN SPECTROSC, V39, P1375, DOI 10.1002/jrs.2007; COLOMER R, 1989, BRIT J CANCER, V59, P283, DOI 10.1038/bjc.1989.58; Daniels JS, 2007, ELECTROANAL, V19, P1239, DOI 10.1002/elan.200603855; do Nascimento GM, 2008, J RAMAN SPECTROSC, V39, P772, DOI 10.1002/jrs.1841; Duffy MJ, 2010, CLIN CHIM ACTA, V411, P1869, DOI 10.1016/j.cca.2010.08.039; Frasco MF, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030523; Grzywa R, 2014, ALTEX-ALTERN ANIM EX, V31, P43, DOI 10.14573/altex.1309181; He ZH, 2002, CHINESE CHEM LETT, V13, P1090; Henry OYF, 2008, BIOSENS BIOELECTRON, V23, P1769, DOI 10.1016/j.bios.2008.02.010; Katz A, 2000, NATURE, V403, P286, DOI 10.1038/35002032; Levin O, 2005, ELECTROCHIM ACTA, V50, P1573, DOI 10.1016/j.electacta.2004.10.028; Li JP, 2009, SENSOR ACTUAT B-CHEM, V140, P663, DOI 10.1016/j.snb.2009.04.067; Lin JH, 2005, BIOSENS BIOELECTRON, V20, P1461, DOI 10.1016/j.bios.2004.05.008; Liu YM, 2008, J SEP SCI, V31, P1151, DOI 10.1002/jssc.200700590; Malitesta C, 1999, ANAL CHEM, V71, P1366, DOI 10.1021/ac980674g; Mohammadnejad J, 2006, J IMMUNOASS IMMUNOCH, V27, P139, DOI 10.1080/15321810600573077; Moreira FTC, 2013, SENSOR ACTUAT B-CHEM, V182, P733, DOI 10.1016/j.snb.2013.03.099; Moreira FTC, 2011, BIOSENS BIOELECTRON, V28, P243, DOI 10.1016/j.bios.2011.07.026; Moreira FTC, 2011, BIOSENS BIOELECTRON, V26, P4760, DOI 10.1016/j.bios.2011.05.045; Piletsky SA, 2000, ANAL CHEM, V72, P4381, DOI 10.1021/ac0002184; Rasooly A, 2006, BIOSENS BIOELECTRON, V21, P1851, DOI 10.1016/j.bios.2006.01.003; Reddy SM, 2011, ELECTROCHIM ACTA, V56, P9203, DOI 10.1016/j.electacta.2011.07.132; Rimmer S, 1998, CHROMATOGRAPHIA, V47, P470, DOI 10.1007/BF02466483; Sayyah SM, 2006, J APPL POLYM SCI, V99, P3093, DOI 10.1002/app.22915; Sharma PS, 2012, ANAL BIOANAL CHEM, V402, P3177, DOI 10.1007/s00216-011-5696-6; Shi M, 2011, J CHROMATOGR B, V879, P2840, DOI 10.1016/j.jchromb.2011.08.013; Soletormos G, 2004, EUR J CANCER, V40, P481, DOI 10.1016/j.ejca.2003.10.015; Stejskal J, 2015, PROG POLYM SCI, V41, P1, DOI 10.1016/j.progpolymsci.2014.10.007; Suni II, 2008, TRAC-TREND ANAL CHEM, V27, P604, DOI 10.1016/j.trac.2008.03.012; Titirici MM, 2006, CHEM MATER, V18, P1773, DOI 10.1021/cm052153x; Tothill IE, 2009, SEMIN CELL DEV BIOL, V20, P55, DOI 10.1016/j.semcdb.2009.01.015; Trchova M, 2014, ELECTROCHIM ACTA, V122, P28, DOI 10.1016/j.electacta.2013.10.133; Tucerri R., 2010, OPEN PHYS CHEM J, V4, P62; Turner NW, 2006, BIOTECHNOL PROGR, V22, P1474, DOI 10.1021/bp060122g; Wang GJ, 2013, MICROCHIM ACTA, V180, P651, DOI 10.1007/s00604-013-0973-z; Wang J, 2006, BIOSENS BIOELECTRON, V21, P1887, DOI 10.1016/j.bios.2005.10.027; Wu J, 2007, BIOSENS BIOELECTRON, V23, P114, DOI 10.1016/j.bios.2007.03.023; Wu J, 2007, TRAC-TREND ANAL CHEM, V26, P679, DOI 10.1016/j.trac.2007.05.007; Wu SG, 2010, ANALYST, V135, P2523, DOI 10.1039/c0an00191k; Yuan XZ, 2010, ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY IN PEM FUEL CELLS: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1007/978-1-84882-846-9; Zayats M, 2011, MACROMOLECULES, V44, P3966, DOI 10.1021/ma200355j; Zdyrko B, 2009, BIOINTERPHASES, V4, pFA17, DOI 10.1116/1.3101907; Zhang XL, 2006, ANAL CHIM ACTA, V558, P110, DOI 10.1016/j.aca.2005.11.032	49	26	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196656	10.1371/journal.pone.0196656	http://dx.doi.org/10.1371/journal.pone.0196656			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715330	Green Published, gold, Green Submitted			2022-12-26	WOS:000431281100041
J	Chow, HW; Ho, CH				Chow, Hsueh-wen; Ho, Chia-Hua			Does the use of outdoor fitness equipment by older adults qualify as moderate to vigorous physical activity?	PLOS ONE			English	Article							BUILT ENVIRONMENT; CANCER PREVENTION; HEALTH-BENEFITS; PUBLIC-HEALTH; IMPACT; GYM; ASSOCIATION; DESIGN; PEOPLE; STATE	Despite the rapid worldwide expansion of parks with outdoor fitness equipment (OFE), no objective data regarding the intensity of activity associated with using OFE are available. Hence, this study quantified the energy expenditure and intensity of physical activity by examining four outdoor fitness devices widely used by older adults and provides objective evidence-based intensity references for the Compendium of Physical Activities. Sixteen older adults (mean age: 70.7 +/- 5.6 yr) equipped with a portable metabolic system for measuring energy expenditure and activity intensity completed tasks while walking or using four types of OFE. Descriptive statistics and repeated-measures ANOVA with the Bonferroni post hoc test were employed. The energy expenditure and activity intensity for using an air walker at tempos of 80, 100, and 120 bpm were 50.78 +/- 14.76 (2.81 +/- 0.85), 59.62 +/- 14.23 (3.26 +/- 0.82), and 65.62 +/- 18.27 (3.55 +/- 1.02) cal/kg/min (METs), respectively. The induced energy and intensity output values for a ski machine were 54.00 +/- 14.31 (3.02 +/- 0.87), 68.87 +/- 22.74 (3.82 +/- 1.35), and 74.55 +/- 23.39 (4.05 +/- 1.35) cal/kg/min (METs), at 80, 100, and 120 bpm, respectively. The energy output for a waist twister at 60 bpm was 38.43 +/- 20.16 cal/kg/min (2.05 +/- 1.15 METs), and that for a double arm stretch at 80 bpm was 31.05 +/- 12.58 cal/kg/min (1.63 +/- 0.70 METs). These findings indicate that activity on the ski machine and air walker could be considered to have moderate intensity, whereas the intensity of activity on the waist twister and double arm stretch was significantly lower than that for walking at either 3.2 km/h or 4 km/h and could be considered only light intensity. The MET values for the OFE were lower than those for similar indoor fitness equipment. The results of this study provide crucial implications for public health practices concerning the development of active living environments.	[Chow, Hsueh-wen; Ho, Chia-Hua] Natl Cheng Kung Univ, Grad Inst Phys Educ Hlth & Leisure Studies, Tainan, Taiwan	National Cheng Kung University	Chow, HW (corresponding author), Natl Cheng Kung Univ, Grad Inst Phys Educ Hlth & Leisure Studies, Tainan, Taiwan.	hwchow@mail.ncku.edu.tw	Chow, Hsueh-wen/ABI-6926-2020	Chow, Hsueh-wen/0000-0003-2620-6878	Ministry of Science and Technology, Taiwan [MOST 104-2410-H-006-074]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology, Taiwan, under grant number MOST 104-2410-H-006-074 to HWC.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Atkinson JL, 2005, AM J HEALTH PROMOT, V19, P304, DOI 10.4278/0890-1171-19.4.304; Berke EM, 2007, AM J PUBLIC HEALTH, V97, P486, DOI 10.2105/AJPH.2006.085837; Bettencourt L, 2012, J AGING PHYS ACTIV, V20, pS276; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Brug J, 2017, INT J BEHAV NUTR PHY, V14, DOI [10.1186/s12966-017-0609-5, 10.1186/s12966-017-0609-5c]; Carlin A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182083; Chao A, 2004, CANCER EPIDEM BIOMAR, V13, P2187; Chow H-w, 2014, NEED ASSESSMENT HLTH; Chow HW, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040448; Cohen A, 2010, PLAYGROUNDS SENIORS; Cohen DA, 2012, HEALTH PLACE, V18, P39, DOI 10.1016/j.healthplace.2011.09.008; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Condello G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3800-8; Copeland J.L., 2016, OUTDOOR FITNESS EQUI; Copeland JL, 2017, J PHYS ACT HEALTH, V14, P344, DOI 10.1123/jpah.2016-0277; Cranney L, 2016, HEALTH PLACE, V37, P26, DOI 10.1016/j.healthplace.2015.11.002; Cunningham GO, 2004, AM J HEALTH PROMOT, V18, P435, DOI 10.4278/0890-1171-18.6.435; Department of Health and Human Services, 2008, PHYS ACT GUID AM 200; Field A., 2013, DISCOVERING STAT IBM; Furber S, 2014, HEALTH PROMOT J AUST, V25, P211, DOI 10.1071/HE14038; Greyling G.A., 2016, USAGE OUTDOOR GYMS S; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Aparicio EH, 2010, RETOS, P99; Howe CCF, 2014, J SPORT SCI, V32, P157, DOI 10.1080/02640414.2013.812231; Howell D, 2002, STAT METHODS PSYCHOL; Kern DS, 2001, J APPL PHYSIOL, V91, P2224, DOI 10.1152/jappl.2001.91.5.2224; Kershaw C., 2017, 3 INT C CHANGING CIT; Lee IM, 2003, MED SCI SPORT EXER, V35, P1823, DOI 10.1249/01.MSS.0000093620.27893.23; Levine JA, 2005, PUBLIC HEALTH NUTR, V8, P1123, DOI 10.1079/PHN2005800; Li FZ, 2008, AM J PREV MED, V35, P38, DOI 10.1016/j.amepre.2008.03.021; Marcus BH, 1999, AM J HEALTH PROMOT, V14, P118, DOI 10.4278/0890-1171-14.2.118; McClave SA, 2003, JPEN-PARENTER ENTER, V27, P16, DOI 10.1177/014860710302700116; Volp ACP, 2011, NUTR HOSP, V26, P430, DOI [10.3305/nh.2011.26.3.5181, 10.1590/S0212-16112011000300002]; Powell KE, 2005, AM J PREV MED, V28, P216, DOI 10.1016/j.amepre.2004.10.031; Ramirez P.C., 2017, EUR J PHYSIOTHER, V19, P54, DOI [10.1080/21679169.2017.1381322, DOI 10.1080/21679169.2017.1381322]; Reis RS, 2016, LANCET, V388, P1337, DOI 10.1016/S0140-6736(16)30728-0; Sallis JF, 2009, AM J PREV MED, V36, pS86, DOI 10.1016/j.amepre.2009.01.002; Schrack JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009292; Scott A, 2014, HEALTH PROMOT J AUST, V25, P212, DOI 10.1071/HE14037; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; St-Onge MP, 2010, NUTRITION, V26, P152, DOI 10.1016/j.nut.2009.07.004; Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047; Tai Tzu-Yao, 2014, 19 ANN C EUR COLL SP; Taylor AH, 2004, J SPORT SCI, V22, P703, DOI 10.1080/02640410410001712421; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; The Trust for Public Land, 2015, FITN ZON PROGR MIAM; Thune I, 2001, MED SCI SPORT EXER, V33, pS530, DOI 10.1097/00005768-200106001-00025; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WHO, 2007, GLOB AG FRIENDL CIT; Wu D-R, 2017, 22 EUR COLL SPORT SC	53	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196507	10.1371/journal.pone.0196507	http://dx.doi.org/10.1371/journal.pone.0196507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709035	Green Published, gold, Green Submitted			2022-12-26	WOS:000431130100036
J	Wakida, NM; Cruz, GMS; Ro, CC; Moncada, EG; Khatibzadeh, N; Flanagan, LA; Berns, MW				Wakida, Nicole M.; Cruz, Gladys Mae S.; Ro, Clarissa C.; Moncada, Emmanuel G.; Khatibzadeh, Nima; Flanagan, Lisa A.; Berns, Michael W.			Phagocytic response of astrocytes to damaged neighboring cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DISEASE	This study aims to understand the phagocytic response of astrocytes to the injury of neurons or other astrocytes at the single cell level. Laser nanosurgery was used to damage individual cells in both primary mouse cortical astrocytes and an established astrocyte cell line. In both cases, the release of material/substances from laser-irradiated astrocytes or neurons induced a phagocytic response in near-by astrocytes. Propidium iodide stained DNA originating from irradiated cells was visible in vesicles of neighboring cells, confirming phagocytosis of material from damaged cortical cells. In the presence of an intracellular pH indicator dye, newly formed vesicles correspond to acidic pH fluorescence, thus suggesting lysosome bound degradation of cellular debris. Cells with shared membrane connections prior to laser damage had a significantly higher frequency of induced phagocytosis compared to isolated cells with no shared membrane. The increase in phagocytic response of cells with a shared membrane occurred regardless of the extent of shared membrane (a thin filopodial connection vs. a cell cluster with significant shared membrane). In addition to the presence (or lack) of a membrane connection, variation in phagocytic ability was also observed with differences in injury location within the cell and distance separating isolated astrocytes. These results demonstrate the ability of an astrocyte to respond to the damage of a single cell, be it another astrocyte, or a neuron. This single-cell level of analysis results in a better understanding of the role of astrocytes to maintain homeostasis in the CNS, particularly in the sensing and removal of debris in damaged or pathologic nervous tissue.	[Wakida, Nicole M.; Cruz, Gladys Mae S.; Moncada, Emmanuel G.; Khatibzadeh, Nima; Berns, Michael W.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92717 USA; [Wakida, Nicole M.; Cruz, Gladys Mae S.; Moncada, Emmanuel G.; Khatibzadeh, Nima; Berns, Michael W.] Univ Calif Irvine, Med Clin, Irvine, CA 92717 USA; [Ro, Clarissa C.; Flanagan, Lisa A.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Ro, Clarissa C.; Flanagan, Lisa A.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA; [Flanagan, Lisa A.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Flanagan, Lisa A.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Berns, Michael W.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wakida, NM (corresponding author), Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92717 USA.; Wakida, NM (corresponding author), Univ Calif Irvine, Med Clin, Irvine, CA 92717 USA.	nwakida@uci.edu		Berns, Michael/0000-0002-9640-2885	Air Force Office of Scientific Research [FA9550-17-1-0193]; National Science Foundation CAREER Award [IOS-1254060]; NIH-MARC U-STAR [GM069337]; David and Lucile Packard Foundation in Los Altos, CA; Hoag Foundation in Huntington Pk, CA	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation CAREER Award(National Science Foundation (NSF)); NIH-MARC U-STAR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation in Los Altos, CA; Hoag Foundation in Huntington Pk, CA	This work was supported by the Air Force Office of Scientific Research award number FA9550-17-1-0193, National Science Foundation CAREER Award (IOS-1254060, LAF), NIH-MARC U-STAR (training grant number GM069337), David and Lucile Packard Foundation in Los Altos, CA, and Hoag Foundation in Huntington Pk, CA.	Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Flanagan LA, 2008, STEM CELLS, V26, P656, DOI 10.1634/stemcells.2007-0810; Gomez-Godinez V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq836; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Vernon PJ, 2013, ANTIOXID REDOX SIGN, V18, P677, DOI 10.1089/ars.2012.4810; Wakida NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015462	13	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196153	10.1371/journal.pone.0196153	http://dx.doi.org/10.1371/journal.pone.0196153			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708987	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100018
J	Bartels, M; Govers, A; Polak, R; Vervoort, S; van Boxtel, R; Pals, C; Bierings, M; van Solinge, W; Egberts, T; Nieuwenhuis, E; Mokry, M; Coffer, PJ				Bartels, Marije; Govers, Anita; Polak, Roel; Vervoort, Stephin; van Boxtel, Ruben; Pals, Cornelieke; Bierings, Marc; van Solinge, Wouter; Egberts, Toine; Nieuwenhuis, Edward; Mokry, Michel; Coffer, Paul James			Megakaryocyte lineage development is controlled by modulation of protein acetylation	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; INHIBITOR VALPROIC ACID; TRANS-RETINOIC ACID; HISTONE DEACETYLASE INHIBITORS; ACUTE MYELOGENOUS LEUKEMIA; HEMATOPOIETIC STEM-CELLS; C-MYB; MYELODYSPLASTIC SYNDROME; TRANSCRIPTION FACTORS; INDUCED THROMBOCYTOPENIA	Treatment with lysine deacetylase inhibitors (KDACi) for haematological malignancies, is accompanied by haematological side effects including thrombocytopenia, suggesting that modulation of protein acetylation affects normal myeloid development, and specifically megakaryocyte development. In the current study, utilising ex-vivo differentiation of human CD34+ haematopoietic progenitor cells, we investigated the effects of two functionally distinct KDACi, valproic acid (VPA), and nicotinamide (NAM), on megakaryocyte differentiation, and lineage choice decisions. Treatment with VPA increased the number of megakaryocyte/erythroid progenitors (MEP), accompanied by inhibition of megakaryocyte differentiation, whereas treatment with NAM accelerated megakaryocyte development, and stimulated polyploidisation. Treatment with both KDACi resulted in no significant effects on erythrocyte differentiation, suggesting that the effects of KDACi primarily affect megakaryocyte lineage development. H3K27Ac ChIP-sequencing analysis revealed that genes involved in myeloid development, as well as megakaryocyte/erythroid (ME)-lineage differentiation are uniquely modulated by specific KDACi treatment. Taken together, our data reveal distinct effects of specific KDACi on megakaryocyte development, and ME-lineage decisions, which can be partially explained by direct effects on promoter acetylation of genes involved in myeloid differentiation.	[Bartels, Marije; Govers, Anita; Vervoort, Stephin; Pals, Cornelieke; Coffer, Paul James] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Bartels, Marije; Govers, Anita; Vervoort, Stephin; Pals, Cornelieke; Coffer, Paul James] Univ Med Ctr Utrecht, Regenerat Med Ctr, Utrecht, Netherlands; [Bartels, Marije; Govers, Anita; Bierings, Marc; Nieuwenhuis, Edward; Mokry, Michel; Coffer, Paul James] Univ Med Ctr Utrecht, Div Pediat, Utrecht, Netherlands; [Polak, Roel] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [van Boxtel, Ruben] Hubrecht Inst, Dept Dev Biol & Stem Cell Res, Utrecht, Netherlands; [van Solinge, Wouter; Egberts, Toine] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Egberts, Toine] Univ Med Ctr Utrecht, Dept Clin Pharm, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Coffer, PJ (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands.; Coffer, PJ (corresponding author), Univ Med Ctr Utrecht, Regenerat Med Ctr, Utrecht, Netherlands.; Coffer, PJ (corresponding author), Univ Med Ctr Utrecht, Div Pediat, Utrecht, Netherlands.	p.j.coffer@umcutrecht.nl	Egberts, Toine/A-6625-2012; Mokry, Michal/AAN-3809-2021; Egberts, Toine/K-4579-2019; Coffer, Paul/AAF-7970-2020; Vervoort, Stephin/AAP-7854-2020	Egberts, Toine/0000-0003-1758-7779; Mokry, Michal/0000-0002-5298-4852; Egberts, Toine/0000-0003-1758-7779; Van Solinge, Wouter/0000-0003-2867-2581; van Boxtel, Ruben/0000-0003-1285-2836; Vervoort, Stephin/0000-0001-7459-126X	KWF kankerbestrijding (beurs voor arts-assistenten) grant [4855]	KWF kankerbestrijding (beurs voor arts-assistenten) grant	This work was supported by KWF kankerbestrijding (beurs voor arts-assistenten) grant 4855 (kwf.nl) to AG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2000, J PEDIAT HEMATOL ONC, V22, P62, DOI 10.1097/00043426-200001000-00012; Ali A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.260; Bartels M, 2012, J CLIN PSYCHOPHARM, V32, P832, DOI 10.1097/JCP.0b013e318270e5e2; Bartels M, 2010, HAEMATOL-HEMATOL J, V95, P1052, DOI 10.3324/haematol.2009.008870; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Bishton MJ, 2011, BLOOD, V117, P3658, DOI 10.1182/blood-2010-11-318055; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bug G, 2005, CANCER, V104, P2717, DOI 10.1002/cncr.21589; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Candelaria M, 2017, ANN HEMATOL, V96, P1825, DOI 10.1007/s00277-017-3103-x; Chambers AE, 2003, EUR J CANCER, V39, P1165, DOI 10.1016/S0959-8049(03)00072-8; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V81, P498, DOI 10.1016/j.bcp.2010.11.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Eliades A, 2010, J BIOL CHEM, V285, P18909, DOI 10.1074/jbc.M110.102145; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fraczek J, 2013, EXPERT OPIN DRUG MET, V9, P441, DOI 10.1517/17425255.2013.754011; Fraga MF, 2005, CELL CYCLE, V4, P1377, DOI 10.4161/cc.4.10.2113; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Garcia P, 2011, J THROMB HAEMOST, V9, P1572, DOI 10.1111/j.1538-7836.2011.04396.x; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Garcia-Manero G, 2012, J CLIN ONCOL, V30, P2204, DOI 10.1200/JCO.2011.38.3265; Giammona LM, 2006, BRIT J HAEMATOL, V135, P554, DOI 10.1111/j.1365-2141.2006.06341.x; Giammona LM, 2009, EXP HEMATOL, V37, P1340, DOI 10.1016/j.exphem.2009.08.004; Goldfarb AN, 2007, ONCOGENE, V26, P6795, DOI 10.1038/sj.onc.1210762; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hu YL, 2009, MOL CELL BIOL, V29, P5181, DOI 10.1128/MCB.00545-09; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Jain N, 2010, EXPERT OPIN PHARMACO, V11, P3073, DOI 10.1517/14656566.2010.534779; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jiang XJ, 2012, CANCER LETT, V326, P135, DOI 10.1016/j.canlet.2012.07.030; Khot A, 2013, EXPERT OPIN INV DRUG, V22, P1211, DOI 10.1517/13543784.2013.815165; Komor M, 2005, STEM CELLS, V23, P1154, DOI 10.1634/stemcells.2004-0171; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Kuendgen A, 2006, CANCER-AM CANCER SOC, V106, P112, DOI 10.1002/cncr.21552; Kuendgen A, 2005, ANN HEMATOL, V84, P61, DOI 10.1007/s00277-005-0026-8; Kuendgen A, 2011, CLIN EPIGENETICS, V2, P389, DOI 10.1007/s13148-011-0031-9; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Levin J, 1999, BLOOD, V94, P3037, DOI 10.1182/blood.V94.9.3037.421k42_3037_3047; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu B, 2010, EXP HEMATOL, V38, P685, DOI 10.1016/j.exphem.2010.03.019; Lordier L, 2008, BLOOD, V112, P3164, DOI 10.1182/blood-2008-03-144956; Lordier L, 2010, BLOOD, V116, P2345, DOI 10.1182/blood-2010-01-265785; Mahmud M, 2010, LEUKEMIA RES, V34, P139, DOI 10.1016/j.leukres.2009.07.019; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; MAY RB, 1993, EPILEPSIA, V34, P1098, DOI 10.1111/j.1528-1157.1993.tb02139.x; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Muralidhar SA, 2011, J BIOL CHEM, V286, P2343, DOI 10.1074/jbc.M110.115725; Muto T, 2013, J EXP MED, V210, P2627, DOI 10.1084/jem.20131144; Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148; Nasreddine W, 2008, EPILEPSIA, V49, P438, DOI 10.1111/j.1528-1167.2007.01429.x; Novotny-Diermayr V, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.14; Oguro H, 2012, J EXP MED, V209, P445, DOI 10.1084/jem.20111709; Pang LY, 2005, J CLIN INVEST, V115, P3332, DOI 10.1172/JCI26720; Petrella A, 2011, MINI-REV MED CHEM, V11, P519, DOI 10.2174/138955711795843347; Raslova H, 2007, BLOOD, V109, P3225, DOI 10.1182/blood-2006-07-037838; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Romanski A, 2012, CELL CYCLE, V11, P3219, DOI 10.4161/cc.21565; Roy A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.119; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Shivdasani RA, 2001, STEM CELLS, V19, P397, DOI 10.1634/stemcells.19-5-397; Skov V, 2012, LEUKEMIA LYMPHOMA, V53, P123, DOI 10.3109/10428194.2011.597905; ten Berg MJ, 2011, BIOMARKERS, V16, P51, DOI 10.3109/1354750X.2010.526243; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; van Boxtel R, 2013, CELL DEATH DIFFER, V20, P1219, DOI 10.1038/cdd.2013.81; Vasudev K, 2010, J CLIN PSYCHOPHARM, V30, P282, DOI 10.1097/JCP.0b013e3181db2684; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Vulcano F, 2006, EXP CELL RES, V312, P1590, DOI 10.1016/j.yexcr.2006.01.017; Wada T, 2009, J BIOL CHEM, V284, P30673, DOI 10.1074/jbc.M109.042242; Walasek MA, 2012, BLOOD, V119, P3050, DOI 10.1182/blood-2011-08-375386; Wen Q, 2009, BLOOD, V114, P153, DOI 10.1182/blood-2008-11-190801; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Xie CZ, 2012, PEDIATR BLOOD CANCER, V59, P1245, DOI 10.1002/pbc.24152; Xie H, 2013, CELL STEM CELL; Young CS, 2017, ONCOTARGET, V8, P51429, DOI 10.18632/oncotarget.18009; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	82	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196400	10.1371/journal.pone.0196400	http://dx.doi.org/10.1371/journal.pone.0196400			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698469	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600074
J	Dhumale, P; Menon, S; Chiang, J; Puschel, AW				Dhumale, Pratibha; Menon, Sindhu; Chiang, Joanna; Pueschel, Andreas W.			The loss of the kinases SadA and SadB results in early neuronal apoptosis and a reduced number of progenitors	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; POSTMITOTIC NEURONS; INTERMEDIATE PROGENITORS; NEURAL PROGENITORS; ALZHEIMERS-DISEASE; CORTICAL-NEURONS; CEREBRAL-CORTEX; RADIAL GLIA; CELL-DEATH; POLARIZATION	The neurons that form the mammalian neocortex originate from progenitor cells in the ventricular (VZ) and subventricular zone (SVZ). Newborn neurons are multipolar but become bipolar during their migration from the germinal layers to the cortical plate (CP) by forming a leading process and an axon that extends in the intermediate zone (IZ). Once they settle in the CP, neurons assume a highly polarized morphology with a single axon and multiple dendrites. The AMPK-related kinases SadA and SadB are intrinsic factors that are essential for axon formation during neuronal development downstream of Lkb1. The knockout of both genes encoding Sad kinases (Sada and Sadb) results not only in a loss of axons but also a decrease in the size of the cortical plate. The defect in axon formation has been linked to a function of Sad kinases in the regulation of microtubule binding proteins. However, the causes for the reduced size of the cortical plate in the Sada(-/-); Sadb(-/-) knockout remain to be analyzed in detail. Here we show that neuronal cell death is increased and the number of neural progenitors is decreased in the Sada(-/-); Sadb(-/-) CP. The reduced number of progenitors is a non-cell autonomous defect since they do not express Sad kinases. These defects are restricted to the neocortex while the hippocampus remains unaffected.	[Dhumale, Pratibha; Menon, Sindhu; Chiang, Joanna; Pueschel, Andreas W.] Westialische Wilhelms Univ, Inst Mol Zellbiol, Munster, Germany; [Dhumale, Pratibha; Chiang, Joanna; Pueschel, Andreas W.] Univ Munster, Cells In Mot Cluster Excellence, Munster, Germany; [Dhumale, Pratibha] Univ Southern Denmark, Dept Cardiovasc & Renal Res, Odense, Denmark; [Menon, Sindhu] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada	University of Munster; University of Southern Denmark; University of Toronto	Puschel, AW (corresponding author), Westialische Wilhelms Univ, Inst Mol Zellbiol, Munster, Germany.; Puschel, AW (corresponding author), Univ Munster, Cells In Mot Cluster Excellence, Munster, Germany.	apuschel@uni-muenster.de		Menon, Sindhu/0000-0001-6066-5520	Deutsche Forschungsgemeinschaft [PU-102-12, EXC 1003 - CiM]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de) PU-102-12 (A.W.P.) and EXC 1003 - CiM (A.W.P.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrusiak MG, 2012, J NEUROSCI, V32, P14809, DOI 10.1523/JNEUROSCI.1912-12.2012; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Arendt T, 2002, J NEURAL TRANSM-SUPP, P77; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Chen YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033105; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571; Folch J, 2012, NEUROTOX RES, V22, P195, DOI 10.1007/s12640-011-9277-4; Funahashi Y, 2014, CURR OPIN NEUROBIOL, V27, P215, DOI 10.1016/j.conb.2014.04.009; Gil-Sanz C, 2014, J NEUROSCI, V34, P10475, DOI 10.1523/JNEUROSCI.1793-14.2014; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Kim JSM, 2010, DEVELOPMENT, V137, P93, DOI 10.1242/dev.041459; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lilley BN, 2014, P NATL ACAD SCI USA, V111, P1138, DOI 10.1073/pnas.1321990111; Lilley BN, 2013, NEURON, V79, P39, DOI 10.1016/j.neuron.2013.05.017; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Muller M, 2010, J CELL SCI, V123, P286, DOI 10.1242/jcs.058230; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Namba T, 2015, PHYSIOL REV, V95, P995, DOI 10.1152/physrev.00025.2014; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Parthasarathy S, 2014, DEVELOPMENT, V141, P3324, DOI 10.1242/dev.114173; Pilaz LJ, 2016, NEURON, V89, P83, DOI 10.1016/j.neuron.2015.12.007; Sakakibara A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00116; Schelski M., 2017, MOL CELL NEUROSCI; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P92, DOI 10.1111/j.1601-183X.2007.00377.x; Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409; Shah B, 2017, CEREB CORTEX, V27, P1253, DOI 10.1093/cercor/bhv341; Shelly M, 2011, DEV NEUROBIOL, V71, P508, DOI 10.1002/dneu.20884; Veleva-Rotse BO, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-5; Wang W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10936; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Yang R, 2014, J CELL SCI, V127, P3463, DOI 10.1242/jcs.146696; Yang Y, 2003, J NEUROSCI, V23, P2557; Yogev S, 2017, NEURON, V96, P638, DOI 10.1016/j.neuron.2017.10.021; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196698	10.1371/journal.pone.0196698	http://dx.doi.org/10.1371/journal.pone.0196698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698519	gold, Green Submitted, Green Published			2022-12-26	WOS:000431007600121
J	Berber-Villamar, NK; Netzahuatl-Munoz, AR; Morales-Barrera, L; Chavez-Camarillo, GM; Flores-Ortiz, CM; Cristiani-Urbina, E				Karina Berber-Villamar, Nayda; Rosa Netzahuatl-Munoz, Alma; Morales-Barrera, Liliana; Ma Chavez-Camarillo, Griselda; Mateo Flores-Ortiz, Cesar; Cristiani-Urbina, Eliseo			Corncob as an effective, eco-friendly, and economic biosorbent for removing the azo dye Direct Yellow 27 from aqueous solutions	PLOS ONE			English	Article							AGRICULTURAL WASTE; ACTIVATED CARBON; LOW-COST; NICKEL(II) IONS; METHYLENE-BLUE; TEXTILE DYES; REACTIVE DYE; CONGO RED; FOOD DYES; ADSORPTION	The corncob is an agricultural waste generated in huge quantities during corn processing. In this paper, we tested the capacity of corncob particles for water purification by removing the azo dye Direct Yellow 27 (DY27) via biosorption. The biosorption process was investigated in terms of the kinetics, equilibria, and thermodynamics. Batch biosorption studies showed that the biosorption performance has strong inverse correlations to the solution pH and the corncob particle size, and it increases quickly with increasing contact time and initial dye concentration. The pseudo-second-order kinetic model provides the best fit to the experimental data, whereas the Redlich-Peterson isotherm model is most suitable for describing the observed equilibrium biosorption. The biosorption process is exothermic, spontaneous, and physisorption in character. Fourier transform infrared (FTIR) spectroscopy and confocal scanning laser microscopy (CSLM) studies suggest that lignocellulose and proteins play key roles in the biosorption of DY27 from aqueous solutions by corncob. Furthermore, after biosorption onto the corncob, the dye can be effectively desorbed using 0.1 M NaOH solution. Therefore, the corncob can be used as a promising biosorbent to remediate DY27-contaminated water and wastewater.	[Karina Berber-Villamar, Nayda; Morales-Barrera, Liliana; Ma Chavez-Camarillo, Griselda; Cristiani-Urbina, Eliseo] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Ingn Bioquim, Unidad Profes Adolfo Lopez Mateos, Ciudad De Mexico, Mexico; [Rosa Netzahuatl-Munoz, Alma] Univ Politecn Tlaxcala, Tepeyanco, Tlaxcala, Mexico; [Mateo Flores-Ortiz, Cesar] Univ Nacl Autonoma Mexico, Fac Estudios Superior Iztacala, Unidad Biotecnol & Prototipos, Tlalnepantla, Estado De Mexic, Mexico; [Mateo Flores-Ortiz, Cesar] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Lab Nacl Salud, Tlalnepantla, Estado De Mexic, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Cristiani-Urbina, E (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Ingn Bioquim, Unidad Profes Adolfo Lopez Mateos, Ciudad De Mexico, Mexico.	ecristianiu@yahoo.com.mx	MORALES-BARRERA, LILIANA/GSD-2320-2022; Flores Ortiz, Cesar Mateo/GLT-3391-2022; Muñoz, Alma Rosa Netzahuatl/ABC-9252-2020; Morales-Barrera, Liliana/GSD-2373-2022	Flores Ortiz, Cesar Mateo/0000-0002-5837-799X; Muñoz, Alma Rosa Netzahuatl/0000-0003-1963-8357; Flores-Ortiz, Cesar Mateo/0000-0002-1841-1065; Cristiani-Urbina, Eliseo/0000-0002-8470-0711				Adeel S, 2015, CELLULOSE, V22, P2095, DOI 10.1007/s10570-015-0596-0; Ahmad T, 2012, ENVIRON SCI POLLUT R, V19, P1464, DOI 10.1007/s11356-011-0709-8; Ahmed F, 2016, BULG CHEM COMMUN, V48, P71; Aksu Z, 2006, J HAZARD MATER, V137, P418, DOI 10.1016/j.jhazmat.2006.02.019; Aljeboree AM, 2017, ARAB J CHEM, V10, pS3381, DOI 10.1016/j.arabjc.2014.01.020; Apostol LC, 2012, BIODEGRADATION, V23, P725, DOI 10.1007/s10532-012-9548-7; Aranda-Garcia E, 2019, ENVIRON SCI POLLUT R, V26, P3157, DOI 10.1007/s11356-017-0248-z; Barka N, 2013, J TAIWAN INST CHEM E, V44, P52, DOI 10.1016/j.jtice.2012.09.007; Becker V, 2008, GASTROINTEST ENDOSC, V68, P319, DOI 10.1016/j.gie.2008.01.033; Belhachemi M, 2011, APPL WATER SCI, V1, P111, DOI 10.1007/s13201-011-0014-1; Bharathi KS, 2013, APPL WATER SCI, V3, P773, DOI 10.1007/s13201-013-0117-y; Bharathi KS, 2013, APPL WATER SCI, V3, P673, DOI 10.1007/s13201-013-0103-4; Byberg R, 2013, ENVIRON SCI POLLUT R, V20, P3570, DOI 10.1007/s11356-013-1551-y; Calero M, 2013, ECOL ENG, V58, P344, DOI 10.1016/j.ecoleng.2013.07.012; Cao Q, 2006, BIORESOURCE TECHNOL, V97, P110, DOI 10.1016/j.biortech.2005.02.026; Cengiz S, 2012, CHEM ENG J, V189, P32, DOI 10.1016/j.cej.2012.02.015; Chan SL, 2016, J TAIWAN INST CHEM E, V61, P306, DOI 10.1016/j.jtice.2016.01.010; Cheriti A., 2011, J EXPANDING ISSUES D, V1, P319; Choi YS, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-013-1801-0; Coates J., 2000, ENCY ANAL CHEM, DOI DOI 10.1002/9780470027318.A5606; Cordoba J, 2013, REV LATINOAM QUIM, P171, DOI [10.1016/j.biortech.2019.122244, DOI 10.1016/J.BIORTECH.2019.122244]; De Micco V, 2007, BIOTECH HISTOCHEM, V82, P209, DOI 10.1080/10520290701713981; Devi P, 2017, MAR DRUGS, V15, DOI 10.3390/md15020030; Diaz-Munoz LL, 2016, J MOL LIQ, V215, P555, DOI 10.1016/j.molliq.2016.01.022; Dotto GL, 2013, CHEM ENG J, V214, P8, DOI 10.1016/j.cej.2012.10.027; Dotto GL, 2012, BIORESOURCE TECHNOL, V103, P123, DOI 10.1016/j.biortech.2011.10.038; Dotto GL, 2015, GREEN CHEMISTRY FOR DYES REMOVAL FROM WASTEWATER: RESEARCH TRENDS AND APPLICATIONS, P295; Dotto GL, 2011, QUIM NOVA, V34, P1193, DOI 10.1590/S0100-40422011000700017; Du YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108647; El Haddad M, 2014, J TAIWAN INST CHEM E, V45, P533, DOI 10.1016/j.jtice.2013.05.002; Vazquez-Palma DE, 2017, FRESEN ENVIRON BULL, V26, P3501; Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042; Fiol N, 2009, ENVIRON CHEM LETT, V7, P79, DOI 10.1007/s10311-008-0139-0; Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013; Garg UK, 2007, J HAZARD MATER, V140, P60, DOI 10.1016/j.jhazmat.2006.06.056; GIP L, 1987, MYCOSES, V30, P21; Guerrero-Coronilla I, 2015, J ENVIRON MANAGE, V152, P99, DOI 10.1016/j.jenvman.2015.01.026; Guerrero-Coronilla I, 2014, ENVIRON ENG MANAG J, V13, P1917; Hasan M, 2008, CHEM ENG J, V136, P164, DOI 10.1016/j.cej.2007.03.038; Heidkamp GF, 2017, LAB J D BUSINESS WEB; Hernandez-Zamora M, 2015, ENVIRON SCI POLLUT R, V22, P10811, DOI 10.1007/s11356-015-4277-1; Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043; Puentes-Cardenas IJ, 2016, J NANOMATER, V2016, DOI 10.1155/2016/3542359; Khataee AR, 2013, INT BIODETER BIODEGR, V83, P33, DOI 10.1016/j.ibiod.2013.04.004; Kubo S, 2005, BIOMACROMOLECULES, V6, P2815, DOI 10.1021/bm050288q; Kuo CY, 2008, J COLLOID INTERF SCI, V327, P308, DOI 10.1016/j.jcis.2008.08.038; Lee M, 2011, CHEMSUSCHEM, V4, P581, DOI 10.1002/cssc.201100074; Leyva-Ramos R, 2005, SEP PURIF TECHNOL, V45, P41, DOI 10.1016/j.seppur.2005.02.005; Lim LBL, 2015, ENVIRON EARTH SCI, V73, P3239, DOI 10.1007/s12665-014-3616-8; Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010; Liu RG, 2005, CELLULOSE, V12, P25, DOI 10.1023/B:CELL.0000049346.28276.95; Mahmud K, 2012, DESALIN WATER TREAT, V41, P170, DOI 10.1080/19443994.2012.664699; Mertens D., 2005, OFFICIAL METHODS ANA, V18th ed., P1; Moran JI, 2008, CELLULOSE, V15, P149, DOI 10.1007/s10570-007-9145-9; Moyo M, 2017, PROCESS SAF ENVIRON, V111, P40, DOI 10.1016/j.psep.2017.06.007; Pedrazzi R, 2003, IND DYES CHEM PROPER, P459; Piccin JS, 2009, J FOOD ENG, V95, P16, DOI 10.1016/j.jfoodeng.2009.03.017; Plazinski W, 2009, ADV COLLOID INTERFAC, V152, P2, DOI 10.1016/j.cis.2009.07.009; Ramos L., 2006, Rev. argent. microbiol., V38, P4; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; Netzahuatl-Munoz AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137086; Rosas-Hernandez Y, 2016, THESIS; Safa Y, 2011, DESALINATION, V272, P313, DOI 10.1016/j.desal.2011.01.040; Saha P, 2010, WATER AIR SOIL POLL, V213, P287, DOI 10.1007/s11270-010-0384-2; Salleh MAM, 2011, DESALINATION, V280, P1, DOI 10.1016/j.desal.2011.07.019; Salvi NA, 2017, APPL WATER SCI, V7, P3041, DOI 10.1007/s13201-016-0417-0; Schiewer S, 2008, BIORESOURCE TECHNOL, V99, P1896, DOI 10.1016/j.biortech.2007.03.060; Sigma-Aldrich, CALC WHIT STAIN; Sigma-Aldrich, FLUOR; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Tang SX, 2016, WATER SCI TECHNOL, V73, P2654, DOI 10.2166/wst.2016.120; Tasar S, 2014, J ENVIRON CHEM ENG, V2, P1018, DOI 10.1016/j.jece.2014.03.015; Tondi G, 2015, IND CROP PROD, V65, P422, DOI 10.1016/j.indcrop.2014.11.005; Tunc O, 2009, J HAZARD MATER, V163, P187, DOI 10.1016/j.jhazmat.2008.06.078; Vafakhah S, 2014, J ENVIRON CHEM ENG, V2, P356, DOI 10.1016/j.jece.2014.01.005; van de Velde F, 2003, COLLOID SURFACE B, V31, P159, DOI 10.1016/S0927-7765(03)00135-8; Verma AK, 2012, J ENVIRON MANAGE, V93, P154, DOI 10.1016/j.jenvman.2011.09.012; Vijayaraghavan K, 2008, DYES PIGMENTS, V76, P726, DOI 10.1016/j.dyepig.2007.01.013; Vijayaraghavan K, 2006, J HAZARD MATER, V133, P304, DOI 10.1016/j.jhazmat.2005.10.016; Wang SL, 2011, CHEM ENG J, V174, P289, DOI 10.1016/j.cej.2011.09.031; Yagub MT, 2014, ADV COLLOID INTERFAC, V209, P172, DOI 10.1016/j.cis.2014.04.002; Zaman A., 2016, TOXICITY WASTE MANAG, P51, DOI [10.4018/978-1-4666-9734-8.ch003, DOI 10.4018/978-1-4666-9734-8.CH003]	82	35	36	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196428	10.1371/journal.pone.0196428	http://dx.doi.org/10.1371/journal.pone.0196428			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698442	gold, Green Submitted, Green Published			2022-12-26	WOS:000431007600080
J	Yang, Y; Yan, YN; Wang, YX; Xu, J; Ren, J; Xu, L; Jonas, JB; Wei, WB				Yang, Yan; Yan, Yan Ni; Wang, Ya Xing; Xu, Jie; Ren, Jie; Xu, Liang; Jonas, Jost B.; Wei, Wen Bin			Ten-year cumulative incidence of epiretinal membranes assessed on fundus photographs. The Beijing Eye Study 2001/2011	PLOS ONE			English	Article							BLUE MOUNTAINS EYE; MINI-MENTAL-STATE; RISK-FACTORS; VISUAL IMPAIRMENT; PREVALENCE; ASSOCIATIONS; POPULATION; PROGRESSION; THICKNESS; CHINESE	Purpose To assess the 10-year incidence and progression of epiretinal membranes (ERMs). Methods The population-based longitudinal Beijing Eye Study, which included 4439 subjects (age: 40 +years) in 2001, was repeated in 2011 with 2695 subjects participating (66.4% of the survivors). The study participants underwent a detailed ophthalmic examination, including retinal photography. Assessing fundus photograohs, ERMs were classified as cellophane macular reflex (CMR) without retinal folds, or as preretinal macular fibrosis (PMF) without or with retinal folds. Results Fundus photographs were available for 2476 subjects with a mean age of 69.0 +/- 7.8 years (range: 51-93 years) and mean axial length of 23.3 +/- 0.9 mm (range: 19.92-26.33mm). The 10-year incidence of ERMs was 8.4% (208/2476 participants; 95% confidence interval (CI): 7.4,9.5). ERMs developed bilaterally in 50 (24%) individuals and unilaterally in 158 (76%) persons. The incidence of PMFs with 2.5% (95% CI: 1.9, 3.1) was lower than the incidence of CMRs with 5.9% (95% CI: 5.0, 6.9). Higher 10-year incidence of ERMs was associated with older age (P<0.001; odds ratio (OR): 1.06; 95% CI: 1.04,1.09), previous cataract surgery (P = 0.003; OR: 3.32; 95% CI: 1.51,7.29) and presence of a complete posterior vitreous detachment (P = 0.02; OR: 1.84; 95% CI: 1.12,3.02). In the age groups of <60 years, 60-69 years, 70-79 years and 80+ years, incidence of ERMs was 3.1%, 10.0%, 14.4% and 10.9%, respectively, with no significant gender difference. Conclusions In Chinese aged 40+ years, the 10-year incidence of ERMs (8.4%) increased with older age, previous cataract surgery and complete posterior vitreous detachment. The ten-year incidence was lower for PMFs (2.5%) than for CMRs (5.9%).	[Yang, Yan; Yan, Yan Ni; Wei, Wen Bin] Capital Med Univ, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China; [Yang, Yan; Ren, Jie] Beijing Aier Intech Eye Hosp, Beijing, Peoples R China; [Wang, Ya Xing; Xu, Jie; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Mannheim, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Wei, WB (corresponding author), Capital Med Univ, Beijing Key Lab Intraocular Tumor Diag & Treatmen, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr,Beijing Tongren Hosp, Beijing, Peoples R China.	tr_weiwenbin@163.com	Xu, Jie/AIE-0524-2022; wei, wei/HHR-8613-2022; xu, jie/GQR-1913-2022; wang, YA XING/K-9671-2016	xu, jie/0000-0002-2039-7055; wang, YA XING/0000-0003-2749-7793; Jonas, Jost/0000-0003-2972-5227	State Natural Sciences Fund [81041018]; Natural Sciences Fund of Beijing government [7092021, 7112031]	State Natural Sciences Fund(National Natural Science Foundation of China (NSFC)); Natural Sciences Fund of Beijing government	Supported by State Natural Sciences Fund (81041018) and the Natural Sciences Fund of Beijing government (7092021; 7112031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung KZ, 2013, RETINA-J RET VIT DIS, V33, P1026, DOI 10.1097/IAE.0b013e3182733f25; Cheung N, 2016, BR J OPHTHALMOL, V101, P1; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Duan XR, 2009, INVEST OPHTH VIS SCI, V50, P2018, DOI 10.1167/iovs.08-2624; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fong CSU, 2013, AM J OPHTHALMOL, V156, P312, DOI 10.1016/j.ajo.2013.03.022; Fraser-Bell S, 2004, INVEST OPHTH VIS SCI, V45, P1732, DOI 10.1167/iovs.03-1295; Fraser-Bell S, 2003, OPHTHALMOLOGY, V110, P34, DOI 10.1016/S0161-6420(02)01443-4; Isaico R, 2013, ACTA OPHTHALMOL, V91, pE581, DOI 10.1111/aos.12177; Joe SG, 2013, ACTA OPHTHALMOL, V91, pE242, DOI 10.1111/aos.12017; Johnson MW, 2010, AM J OPHTHALMOL, V149, P371, DOI 10.1016/j.ajo.2009.11.022; Jonas JB, 2009, ACTA OPHTHALMOL, V87, P247, DOI 10.1111/j.1755-3768.2008.01385.x; Kawasaki R, 2008, BRIT J OPHTHALMOL, V92, P1320, DOI 10.1136/bjo.2008.144626; Kawasaki R, 2009, EYE, V23, P1045, DOI 10.1038/eye.2008.238; Klein R, 1994, Trans Am Ophthalmol Soc, V92, P403; Koh V, 2012, INVEST OPHTH VIS SCI, V53, P1018, DOI 10.1167/iovs.11-8557; McCarty DJ, 2005, AM J OPHTHALMOL, V140, P288, DOI 10.1016/j.ajo.2005.03.032; Mitchell P, 1997, OPHTHALMOLOGY, V104, P1033, DOI 10.1016/S0161-6420(97)30190-0; Ng CH, 2011, OPHTHALMOLOGY, V118, P694, DOI 10.1016/j.ophtha.2010.08.009; Nishi Y, 2013, ACTA OPHTHALMOL, V91, pE353, DOI 10.1111/aos.12060; Okamoto F, 2010, INVEST OPHTH VIS SCI, V51, P744, DOI 10.1167/iovs.09-3992; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111320; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009; You Q, 2008, EYE, V22, P874, DOI 10.1038/sj.eye.6702786; Zhu XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051445	25	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195768	10.1371/journal.pone.0195768	http://dx.doi.org/10.1371/journal.pone.0195768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698410	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600018
J	Yoon, HJ; Kim, BS; Moon, CM; Yoo, J; Lee, KE; Kim, Y				Yoon, Hai-Jeon; Kim, Bom Sahn; Moon, Chang Mo; Yoo, Jang; Lee, Ko Eun; Kim, Yemi			Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer	PLOS ONE			English	Article							INFLAMMATION; TOMOGRAPHY	Background This study investigated the prognostic value of diffuse splenic uptake on F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) in gastric cancer (GC) patients. Methods A total of 134 pathology confirmed GC patients who underwent PET/CT for staging work-ups were enrolled. The maximal standardized uptake value (SUVmax) of primary tumor (T-max), spleen (S-max), and spleen to liver uptake ratio (SLR) were measured. The prognostic value of PET-measured parameters in GC patients for predicting recurrence-free survival (RFS) and overall survival (OS) were assessed. And the relationships of the parameters with hematological and inflammatory parameters were also investigated. Results During follow-up period, 19 patients (14.1%) had disease recurrence and 12 (8.9%) died from GC. In univariate analysis, hematocrit (p<0.001 and p = 0.002), neutrophil to lymphocyte ratio (NLR; p = 0.021 and p = 0.040), AJCC staging (p< 0.001 and p< 0.001), adjuvant chemotherapy (p< 0.001 and p< 0.001), Tmax (p = 0.004 and p = 0.005), and SLR (p = 0.005 and p = 0.016) were significant prognostic factors for RFS and OS, whereas platelet to lymphocyte ratio (PLR; p = 0.034) was a significant prognostic factor for RFS. In multivariate analysis, only SLR was an independent prognostic factor for RFS (p = 0.018, adjusted HR = 3.011, 95% CI = 1.207 +/- 7.511). SLR were significantly associated with serum hematocrit level (r = -0.256, p = 0.002), PLR (r = 0.362, p = 0.001), and Tmax (r = 0.280, p = 0.001). Conclusion Diffuse splenic uptake on FDG PET/CT was correlated with the level of hematological and inflammatory parameters and was an independent predictor for RFS in GC.	[Yoon, Hai-Jeon; Kim, Bom Sahn; Yoo, Jang] Ewha Womans Univ, Dept Nucl Med, Coll Med, Seoul, South Korea; [Moon, Chang Mo; Lee, Ko Eun] Ewha Womans Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Moon, Chang Mo] Ewha Womans Univ, Tissue Injury Def Res Ctr, Seoul, South Korea; [Kim, Yemi] Ewha Womans Univ, Coll Med, Clin Res Inst, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University	Kim, BS (corresponding author), Ewha Womans Univ, Dept Nucl Med, Coll Med, Seoul, South Korea.; Moon, CM (corresponding author), Ewha Womans Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Moon, CM (corresponding author), Ewha Womans Univ, Tissue Injury Def Res Ctr, Seoul, South Korea.	kbomsahn@ewha.ac.kr; mooncm27@ewha.ac.kr		Kim, Bom Sahn/0000-0003-2520-7182	National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1C1A2A01054113, NRF-2017R1D1A1B03035311]; NRF - Ministry of Science and ICT [NRF-2015R1C1A1A02037051, 2010-0027945]	National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); NRF - Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number, NRF-2015R1C1A2A01054113: Hai-Jeon Yoon & grant number, NRF-2017R1D1A1B03035311: Chang Mo Moon) and by the NRF grant funded by the Ministry of Science and ICT (grant number, NRF-2015R1C1A1A02037051: Bom Sahn Kim & grant number, 2010-0027945: Chang Mo Moon).	Alexandrakis MG, 2003, AM J CLIN ONCOL-CANC, V26, P135, DOI 10.1097/00000421-200304000-00007; Berlth F, 2014, WORLD J GASTROENTERO, V20, P5679, DOI 10.3748/wjg.v20.i19.5679; Chen B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165133; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Choi AR, 2013, WORLD J GASTROENTERO, V19, P5302, DOI 10.3748/wjg.v19.i32.5302; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Graziosi L, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-103; Gunaldi M, 2015, INT J CLIN EXP MED, V8, P5937; Hu ZD, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.26; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim CH, 2010, J BLOOD MED, V1, P13, DOI 10.2147/JBM.S7224; Kotzerke J, 1999, EUR J NUCL MED, V26, P31, DOI 10.1007/s002590050356; Lee JW, 2017, CLIN LUNG CANCER, V18, P198, DOI 10.1016/j.cllc.2016.07.001; Lee S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-350; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meier JM, 2007, SEMIN NUCL MED, V37, P154, DOI 10.1053/j.semnuclmed.2007.02.001; Oguma K, 2010, FUTURE ONCOL, V6, P515, DOI [10.2217/fon.10.13, 10.2217/FON.10.13]; Park SH, 2006, CANCER CHEMOTH PHARM, V57, P91, DOI 10.1007/s00280-005-0027-2; Shiraishi N, 2007, J SURG ONCOL, V96, P14, DOI 10.1002/jso.20631; Vaidyanathan S, 2015, CLIN RADIOL, V70, P787, DOI 10.1016/j.crad.2015.03.010; Xu ZS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163719; Yu Q, 2013, ASIAN PAC J CANCER P, V14, P5735, DOI 10.7314/APJCP.2013.14.10.5735	23	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196110	10.1371/journal.pone.0196110	http://dx.doi.org/10.1371/journal.pone.0196110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698422	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600037
J	Bernhem, K; Blom, H; Brismar, H				Bernhem, Kristoffer; Blom, Hans; Brismar, Hjalmar			Quantification of endogenous and exogenous protein expressions of Na,K-ATPase with super-resolution PALM/STORM imaging	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; MOLECULE LOCALIZATION MICROSCOPY; PAIR CORRELATION-ANALYSIS; FLUORESCENT-PROBES; ALPHA-SUBUNITS; AMPA RECEPTORS; TRANSPORT; CELLS	Transient transfection of fluorescent fusion proteins is a key enabling technology in fluorescent microscopy to spatio-temporally map cellular protein distributions. Transient transfection of proteins may however bypass normal regulation of expression, leading to overexpression artefacts like misallocations and excess amounts. In this study we investigate the use of STORM and PALM microscopy to quantitatively monitor endogenous and exogenous protein expression. Through incorporation of an N-terminal hemagglutinin epitope to a mMaple3 fused Na, K-ATPase (alpha(1) isoform), we analyze the spatial and quantitative changes of plasma membrane Na, K-ATPase localization during competitive transient expression. Quantification of plasma membrane protein density revealed a time dependent increase of Na, K-ATPase, but no increase in size of protein clusters. Results show that after 41h transfection, the total plasma membrane density of Na, K-ATPase increased by 63% while the endogenous contribution was reduced by 16%.	[Bernhem, Kristoffer; Blom, Hans; Brismar, Hjalmar] Royal Inst Technol, Dept Appl Phys, Sci Life Lab, Stockholm, Sweden; [Brismar, Hjalmar] Karolinska Inst, Dept Womens & Childrens Hlth, Sci Life Lab, Stockholm, Sweden	Royal Institute of Technology; Karolinska Institutet	Brismar, H (corresponding author), Royal Inst Technol, Dept Appl Phys, Sci Life Lab, Stockholm, Sweden.; Brismar, H (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Sci Life Lab, Stockholm, Sweden.	brismar@kth.se	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003	Swedish Research Council [2013-6041, 2015-4198, 2016-00968]; Swedish foundation for strategic research [RIF14-0091]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish foundation for strategic research(Swedish Foundation for Strategic Research)	This work was supported by Swedish Research Council www.vr.se 2013-6041 to H.B., Swedish Research Council www.vr.se 2015-4198 to HJ.B., Swedish Research Council www.vr.se 2016-00968 to HJ.B., Swedish foundation for strategic research www.stratresearcg.se RIF14-0091 to H.B Marta och Gunnar V. Philipsons foundation. to HJ.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; Arystarkhova E, 1996, J BIOL CHEM, V271, P23407, DOI 10.1074/jbc.271.38.23407; Baddeley D, 2011, NANO RES, V4, P589, DOI 10.1007/s12274-011-0115-z; Bernhem K, 2018, BIOINFORMATICS, V34, P137, DOI 10.1093/bioinformatics/btx553; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Ceroni F, 2015, NAT METHODS, V12, P415, DOI [10.1038/NMETH.3339, 10.1038/nmeth.3339]; Coltharp C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051725; Durisic N, 2014, CURR OPIN CHEM BIOL, V20, P22, DOI 10.1016/j.cbpa.2014.04.005; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; Ehmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5650; Fricke F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14072; Gibson TJ, 2013, NAT METHODS, V10, P715, DOI 10.1038/nmeth.2534; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Liebmann T, 2012, J NEUROSCI, V32, P17998, DOI 10.1523/JNEUROSCI.1804-12.2012; MacGillavry HD, 2013, NEURON, V78, P615, DOI 10.1016/j.neuron.2013.03.009; Nair D, 2013, J NEUROSCI, V33, P13204, DOI 10.1523/JNEUROSCI.2381-12.2013; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Nicovich PR, 2017, NAT PROTOC, V12, P453, DOI 10.1038/nprot.2016.166; Opazo F, 2012, NAT METHODS, V9, P938, DOI 10.1038/nmeth.2179; Puchner EM, 2013, P NATL ACAD SCI USA, V110, P16015, DOI 10.1073/pnas.1309676110; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sengupta P, 2013, NAT PROTOC, V8, P345, DOI 10.1038/nprot.2013.005; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Shivanandan A, 2014, FEBS LETT, V588, P3595, DOI 10.1016/j.febslet.2014.06.014; TAMKUN MM, 1986, J BIOL CHEM, V261, P1009; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Violin JD, 2006, J BIOL CHEM, V281, P36411, DOI 10.1074/jbc.M607956200; Wang SY, 2014, P NATL ACAD SCI USA, V111, P8452, DOI 10.1073/pnas.1406593111	37	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195825	10.1371/journal.pone.0195825	http://dx.doi.org/10.1371/journal.pone.0195825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694368	Green Submitted, gold, Green Published			2022-12-26	WOS:000430802400044
J	Paoli, A; Weladji, RB; Holand, O; Kumpula, J				Paoli, Amelie; Weladji, Robert B.; Holand, Oystein; Kumpula, Jouko			Winter and spring climatic conditions influence timing and synchrony of calving in reindeer	PLOS ONE			English	Article							RANGIFER-TARANDUS; RED DEER; POPULATION-DYNAMICS; GESTATION LENGTH; PLANT PHENOLOGY; INTERANNUAL VARIATION; REPRODUCTIVE SUCCESS; COHORT VARIATION; BIRTH SYNCHRONY; WILD REINDEER	In a context of climate change, a mismatch has been shown to occur between some species' reproductive phenology and their environment. So far, few studies have either documented temporal trends in calving phenology or assessed which climatic variables influence the calving phenology in ungulate species, yet the phenology of ungulates' births affects offspring survival and population's recruitment rate. Using a long-term dataset (45 years) of birth dates of a semi-domesticated reindeer population in Kaamanen, North Finland, we show that calving season has advanced by similar to 7 days between 1970 and 2016. Advanced birth dates were associated with lower precipitation and a reduced snow cover in April and warmer temperatures in April-May. Improved females' physical condition in late gestation due to warmer temperatures in April-May and reduced snow conditions in April probably accounted for such advance in calving date. On the other hand, a lengthening of the calving season was reported following a warmer temperature in January, a higher number of days when mean temperature exceeds 0 degrees C in October-November and a decreasing snow cover from October to November. By affecting the inter-individual heterogeneity in the plastic response of females' calving date to better climatic conditions in fall and winter, climatic variability contributed to weaken the calving synchrony in this herd. Whether variability in climatic conditions form environmental cues for the adaptation of calving phenology by females to climate change is however uncertain, but it is likely. As such this study enhances our understanding on how reproductive phenology of ungulate species would be affected by climate change.	[Paoli, Amelie; Weladji, Robert B.] Concordia Univ, Dept Biol, Montreal, PQ, Canada; [Holand, Oystein] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Kumpula, Jouko] Nat Resources Inst Finland, Reindeer Res Stn, Kaamanen, Finland	Concordia University - Canada; Norwegian University of Life Sciences; Natural Resources Institute Finland (Luke)	Weladji, RB (corresponding author), Concordia Univ, Dept Biol, Montreal, PQ, Canada.	robert.weladji@concordia.ca			Natural Sciences and Engineering Research Council of Canada [303807]; NORFORSK; NSERC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NORFORSK; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funded by Natural Sciences and Engineering Research Council of Canada, (grant number 303807) to RBW. OH was supported by NORFORSK. NSERC funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 1998, J MAMMAL, V79, P287, DOI 10.2307/1382865; Amoroso EC, 1960, MARSHALLS PHYSL REPR, P707; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Baskin LM., 1970, REINDEER ECOLOGY BEH; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERGER J, 1992, ECOLOGY, V73, P323, DOI 10.2307/1938743; BERGERUD AT, 1975, CAN J ZOOL, V53, P1213, DOI 10.1139/z75-145; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bowyer RT, 1998, J MAMMAL, V79, P1332, DOI 10.2307/1383025; BUNNELL FL, 1982, CAN J ZOOL, V60, P1, DOI 10.1139/z82-001; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CAMERON RD, 1993, CAN J ZOOL, V71, P480, DOI 10.1139/z93-069; Caro SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001517; Clements MN, 2011, FUNCT ECOL, V25, P691, DOI 10.1111/j.1365-2435.2010.01812.x; Cook JG, 2004, WILDLIFE MONOGR, P1; DAUPHINE TC, 1974, J WILDLIFE MANAGE, V38, P54, DOI 10.2307/3800200; Eloranta E., 1986, RANGIFER, V6, P115, DOI 10.7557/2.6.2.635; Epstein HE, 2000, ECOL APPL, V10, P824, DOI 10.1890/1051-0761(2000)010[0824:ATNBMO]2.0.CO;2; ESTES R D, 1976, East African Wildlife Journal, V14, P135; ESTES RD, 1979, Z TIERPSYCHOL, V50, P45; Fauchald P, 2004, OIKOS, V107, P583, DOI 10.1111/j.0030-1299.2004.12945.x; Feder C, 2008, OECOLOGIA, V156, P773, DOI 10.1007/s00442-008-1035-9; FESTABIANCHET M, 1988, J ZOOL, V214, P653, DOI 10.1111/j.1469-7998.1988.tb03764.x; FestaBianchet M, 1997, CAN J ZOOL, V75, P1372, DOI 10.1139/z97-763; Findlay C, 1982, EVOLUTION N Y, P786; Flydal K, 2002, WILDLIFE BIOL, V8, P145, DOI 10.2981/wlb.2002.019; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Gaillard JM, 1997, OECOLOGIA, V112, P502, DOI 10.1007/s004420050338; GAILLARD JM, 1993, J MAMMAL, V74, P738, DOI 10.2307/1382296; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gochfeld M., 1980, P207; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; GUINNESS FE, 1978, J ZOOL, V185, P105; Holand O, 2003, J WILDLIFE MANAGE, V67, P25, DOI 10.2307/3803058; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; Kumpula J, 2003, POLAR RES, V22, P225, DOI 10.1111/j.1751-8369.2003.tb00109.x; KUMPULA J, 1992, Rangifer, V12, P93; L'Italien L, 2012, ETHOLOGY, V118, P783, DOI 10.1111/j.1439-0310.2012.02073.x; Lane JE, 2012, NATURE, V489, P554, DOI 10.1038/nature11335; Langvatn R, 2004, AM NAT, V163, P763, DOI 10.1086/383594; Lent P. C., 1966, Zeitschrift fuer Tierpsychologie, V23, P701; Linnell JDC, 1998, J ZOOL, V244, P497, DOI 10.1017/S0952836998004038; Loe LE, 2005, J ANIM ECOL, V74, P579, DOI 10.1111/j.1365-2656.2005.00987.x; Marshall FHA, 1937, PROC R SOC SER B-BIO, V122, P413, DOI 10.1098/rspb.1937.0034; Mazerolle MJ, 2017, R PACKAGE AICCMODAVG; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Moyes K, 2011, GLOBAL CHANGE BIOL, V17, P2455, DOI 10.1111/j.1365-2486.2010.02382.x; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; Mysterud A, 2009, J ANIM ECOL, V78, P1002, DOI 10.1111/j.1365-2656.2009.01553.x; Nieminen M., 2013, Rangifer, V33, P79; Nussey DH, 2005, J ANIM ECOL, V74, P387, DOI 10.1111/j.1365-2656.2005.00941.x; Parker K.L., 1985, P161; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; PARKER KL, 1990, CAN J ZOOL, V68, P106, DOI 10.1139/z90-015; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parry Canziani O, 2007, CHANGE CLIMATE 2007; Pettorelli N, 2005, BIOL LETT-UK, V1, P24, DOI 10.1098/rsbl.2004.0262; Plard F, 2014, ECOGRAPHY, V37, P241, DOI 10.1111/j.1600-0587.2013.00414.x; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 2003, CAN J ZOOL, V81, P1709, DOI 10.1139/Z03-172; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Putman RJ, 1996, MAMMAL REV, V26, P81, DOI 10.1111/j.1365-2907.1996.tb00148.x; R Core Team, 2021, R LANGUAGE ENV STAT; RACHLOW JL, 1991, J MAMMAL, V72, P487, DOI 10.2307/1382131; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; REIMERS E, 1983, CAN J ZOOL, V61, P211, DOI 10.1139/z83-026; REIMERS E, 1983, ARCTIC ALPINE RES, V15, P107, DOI 10.2307/1550986; Reimers Eigil, 2002, Rangifer, V22, P61; Reimers Eigil, 1997, Rangifer, V17, P105; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ropstad E, 2000, ANIM REPROD SCI, V60, P561, DOI 10.1016/S0378-4320(00)00100-7; Rowell JE, 2009, THERIOGENOLOGY, V72, P190, DOI 10.1016/j.theriogenology.2009.01.022; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; RUTBERG AT, 1984, J MAMMAL, V65, P418, DOI 10.2307/1381088; Sadleir R.M.F.S., 1969, ECOLOGY REPROD WILD; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Scott IC, 2008, ANIM REPROD SCI, V109, P206, DOI 10.1016/j.anireprosci.2007.11.025; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Sinclair ARE, 2000, ECOLOGY, V81, P2100, DOI 10.1890/0012-9658(2000)081[2100:WDPASO]2.0.CO;2; SKOGLAND T, 1984, Rangifer, V4, P39; SKOGLAND T, 1983, OECOLOGIA, V60, P156, DOI 10.1007/BF00379517; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; THOMPSON RW, 1982, CAN J ZOOL, V60, P1781, DOI 10.1139/z82-231; Tveraa T, 2003, OECOLOGIA, V137, P370, DOI 10.1007/s00442-003-1373-6; Tveraa T, 2007, OIKOS, V116, P706, DOI [10.1111/j.2006.0030-1299.15257.x, 10.1111/j.0030-1299.2007.15257.x]; Tyler NJC, 2010, ECOL MONOGR, V80, P197, DOI 10.1890/09-1070.1; Veiberg V, 2017, OIKOS, V126, P980, DOI 10.1111/oik.03815; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Weladji RB, 2006, CLIM RES, V32, P119, DOI 10.3354/cr032119; Weladji RB, 2003, OECOLOGIA, V136, P317, DOI 10.1007/s00442-003-1257-9; Weladji RB, 2003, BEHAV ECOL SOCIOBIOL, V53, P308, DOI 10.1007/s00265-002-0572-1; Weladji Robert B., 2002, Rangifer, V22, P33; Weladji RB, 2006, P ROY SOC B-BIOL SCI, V273, P1239, DOI 10.1098/rspb.2005.3393; Wilson AJ, 2005, EVOLUTION, V59, P451	105	22	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195603	10.1371/journal.pone.0195603	http://dx.doi.org/10.1371/journal.pone.0195603			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694410	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000430802400036
J	Ai, FX; Eisenhauer, N; Xie, YW; Zhu, JG; Jousset, A; Du, WC; Yin, Y; Zhang, XW; Ji, R; Guo, HY				Ai, Fuxun; Eisenhauer, Nico; Xie, Yuwei; Zhu, Jianguo; Jousset, Alexandre; Du, Wenchao; Yin, Ying; Zhang, Xiaowei; Ji, Rong; Guo, Hongyan			Elevated CO2 accelerates polycyclic aromatic hydrocarbon accumulation in a paddy soil grown with rice	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; PAHS; DEGRADATION; NITROGEN; PLANT	The concentration of atmospheric carbon dioxide (CO2) and polycyclic aromatic hydrocarbons (PAHs) contents in the environment have been rising due to human activities. Elevated CO2 (eCO(2)) levels have been shown to affect plant physiology and soil microbes, which may alter the degradation of organic pollutants. Here, we study the effect of eCO(2) on PAH accumulation in a paddy soil grown with rice. We collected soil and plant samples after rice harvest from a free-air CO2 enrichment (FACE) system, which had already run for more than 15 years. Our results show that eCO(2) increased PAH concentrations in the soil, and we link this effect to a shift in soil microbial community structure and function. Elevated CO2 changed the composition of soil microbial communities, especially by reducing the abundance of some microbial groups driving PAH degradation. Our study indicates that elevated CO2 levels may weaken the self-cleaning ability of soils related to organic pollutants. Such changes in the function of soil microbial communities may threaten the quality of crops, with unknown implications for food safety and human health in future climate scenarios.	[Ai, Fuxun; Xie, Yuwei; Du, Wenchao; Yin, Ying; Zhang, Xiaowei; Ji, Rong; Guo, Hongyan] Nanjing Univ, Sch Environm, Stake Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China; [Eisenhauer, Nico] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Eisenhauer, Nico] Univ Leipzig, Inst Biol, Leipzig, Germany; [Zhu, Jianguo] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Jousset, Alexandre] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands	Nanjing University; Leipzig University; Chinese Academy of Sciences; Institute of Soil Science, CAS; Utrecht University	Guo, HY (corresponding author), Nanjing Univ, Sch Environm, Stake Key Lab Pollut Control & Resource Reuse, Nanjing, Jiangsu, Peoples R China.	hyguo@nju.edu.cn	Jousset, Alexandre/C-7607-2011; Eisenhauer, Nico/I-3191-2019; Ji, Rong/E-5473-2011; Eisenhauer, Nico/I-5932-2012; Xie, Yuwei/CAI-7227-2022; Zhang, Xiaowei/I-2259-2012	Eisenhauer, Nico/0000-0002-0371-6720; Ji, Rong/0000-0002-1724-5253; Eisenhauer, Nico/0000-0002-0371-6720; Xie, Yuwei/0000-0001-5652-6413; Ai, Fuxun/0000-0002-4794-9315; Zhang, Xiaowei/0000-0001-8974-9963	National Natural Science Foundation of China [21177058]; Program of New Century Excellent Talents in University [NCET-12-0266]; Ministry of Education of the People's Republic of China; International SAMP;T Cooperation Program of China [31261140364]; Minstry of Science and Technology of the People's Republic of China; Knowledge Innovation Program of Chinese Academy of Sciences [KZCX-SW-440]; Chinese Academy of Sciences; German Research Foundation [FZT 118]; German Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ministry of Education of the People's Republic of China(Ministry of Education, China); International SAMP;T Cooperation Program of China; Minstry of Science and Technology of the People's Republic of China; Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); German Research Foundation(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG))	This work was supported by the National Natural Science Foundation of China (grant no. 21177058), HG got funding from National Natural Science Foundation of China, (http://www.nsfc.gov.cn/english/site_1/index.html) and supporting study design, data collection and analysis, decision to publish, and preparation of the manuscript. This work was also supported by Program of New Century Excellent Talents in University (NCET-12-0266), HG got funding from Ministry of Education of the People's Republic of China, (http://en.moe.gov.cn/) and supporting study design, data collection and analysis; International S&T Cooperation Program of China (grant no. 31261140364), JZ got funding from Minstry of Science and Technology of the People's Republic of China, (http://www.most.gov.cn/eng/) and supporting study design, data collection and analysis; Knowledge Innovation Program of Chinese Academy of Sciences (grant no. KZCX-SW-440), JZ got funding from Chinese Academy of Sciences, (http://english.cas.cn/) and supporting study design, data collection and analysis; and the German Research Foundation (FZT 118), NE got funding from German Research Foundation, (http://www.dfg.de/en/) and supporting preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Baumard P, 1998, ESTUAR COAST SHELF S, V47, P77, DOI 10.1006/ecss.1998.0337; Chen YP, 2014, SCI REP-UK, V4, DOI 10.1038/srep04287; Chung HG, 2007, GLOBAL CHANGE BIOL, V13, P980, DOI 10.1111/j.1365-2486.2007.01313.x; Curlevski NJA, 2014, SOIL BIOL BIOCHEM, V70, P263, DOI 10.1016/j.soilbio.2013.12.010; de Menezes A, 2012, ENVIRON MICROBIOL, V14, P2577, DOI 10.1111/j.1462-2920.2012.02781.x; Du WC, 2017, SCI TOTAL ENVIRON, V578, P408, DOI 10.1016/j.scitotenv.2016.10.197; Duran J, 2018, ECOLOGY, V99, P1184, DOI 10.1002/ecy.2199; Eisenhauer N, 2012, GLOBAL CHANGE BIOL, V18, P435, DOI 10.1111/j.1365-2486.2011.02555.x; El-Saeid MH, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-7063-1; Formanek P, 2014, SCI WORLD J, DOI 10.1155/2014/730149; Gruter D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-68; Guo HY, 2011, ENVIRON SCI TECHNOL, V45, P6997, DOI 10.1021/es2001584; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Johnsen AR, 2005, MICROB ECOL, V50, P488, DOI 10.1007/s00248-005-0022-5; Kipopoulou AM, 1999, ENVIRON POLLUT, V106, P369, DOI 10.1016/S0269-7491(99)00107-4; Lange M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7707; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Manninen S, 2010, SOIL BIOL BIOCHEM, V42, P1967, DOI 10.1016/j.soilbio.2010.07.017; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Wilcke W, 2007, GEODERMA, V141, P157, DOI 10.1016/j.geoderma.2007.07.007; Yin Y, 2017, J HAZARD MATER, V327, P64, DOI 10.1016/j.jhazmat.2016.12.044; Zhang YX, 2009, ATMOS ENVIRON, V43, P812, DOI 10.1016/j.atmosenv.2008.10.050	24	2	2	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196439	10.1371/journal.pone.0196439	http://dx.doi.org/10.1371/journal.pone.0196439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689089	Green Published, gold			2022-12-26	WOS:000430678800055
J	Chen, YJ; Wang, JS; Hsu, CC; Lin, PJ; Tsai, FC; Wen, MS; Kuo, CT; Huang, SC				Chen, Yu-Jen; Wang, Jong-Shyan; Hsu, Chih-Chin; Lin, Pyng-Jing; Tsai, Feng-Chun; Wen, Ming-Shien; Kuo, Chi-Tai; Huang, Shu-Chun			Cerebral desaturation in heart failure: Potential prognostic value and physiologic basis	PLOS ONE			English	Article							INFRARED SPECTROSCOPY NIRS; ARTERY BLOOD VELOCITY; CARBON-DIOXIDE; EXERCISE; FLOW; OXYGENATION; HEMODYNAMICS; ASSOCIATION; CAPACITY; ANEMIA	Cerebral tissue oxygen saturation (SctO(2)) reflects cerebral perfusion and tissue oxygen consumption, which decline in some patients with heart failure with reduced ejection fraction (HFrEF) or stroke, especially during exercise. Its physiologic basis and clinical significance remain unclear. We aimed to investigate the association of SctO(2) with oxygen transport physiology and known prognostic factors during both rest and exercise in patients with HFrEF or stroke. Thirty-four HFrEF patients, 26 stroke patients, and 17 healthy controls performed an incremental cardiopulmonary exercise test using a bicycle ergometer. Integrated near-infrared spectroscopy and automatic gas analysis were used to measure cerebral tissue oxygenation and cardiac and ventilatory parameters. We found that SctO(2) (rest; peak) were significantly lower in the HFrEF (66.3 +/- 13.3%; 63.4 +/- 13.8%,) than in the stroke (72.1 +/- 4.2%; 72.7 +/- 4.5%) and control (73.1 +/- 2.8%; 72 +/- 3.2%) groups. In the HFrEF group, SctO(2) at rest (SctO(2rest)) and peak SctO(2) (SctO(2peak)) were linearly correlated with brain natriuretic peptide (BNP), peak oxygen consumption ((V) over dotO(2peak)), and oxygen uptake efficiency slope (r between -0.561 and 0.677, p < 0.001). Stepwise linear regression showed that SctO(2rest) was determined by partial pressure of end-tidal carbon dioxide at rest (PETCO2rest), hemoglobin, and mean arterial pressure at rest (MAPrest) (adjusted R = 0.681, p < 0.05), while SctO(2peak) was mainly affected by peak carbon dioxide production ((V) over dotO(2peak)) (adjusted R = 0.653, p < 0.05) in patients with HFrEF. In conclusion, the study delineates the relationship of cerebral saturation and parameters associated with oxygen delivery. Moreover, SctO(2peak) and SctO(2rest) are correlated with some well-recognized prognostic factors in HFrEF, suggesting its potential prognostic value.	[Chen, Yu-Jen; Huang, Shu-Chun] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Linkou, Taiwan; [Wang, Jong-Shyan] Chang Gung Univ, Hlth Aging Res Ctr, Grad Inst Rehabil Sci, Med Coll, Taoyuan, Taiwan; [Hsu, Chih-Chin] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Keelung, Taiwan; [Lin, Pyng-Jing; Tsai, Feng-Chun] Chang Gung Mem Hosp, Div Thorac & Cardiovasc Surg, Linkou, Taiwan; [Wen, Ming-Shien; Kuo, Chi-Tai] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Cardiovasc Div, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, SC (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Linkou, Taiwan.	doc.sc.huang@gmail.com			Chang Gung Medical Research Program [CMRPG3G0601]; Ministry of Science and Technology, ROC [NMRPG3E6091/2]	Chang Gung Medical Research Program; Ministry of Science and Technology, ROC	The authors would like to thank the Chang Gung Medical Research Program (CMRPG3G0601) and Ministry of Science and Technology, ROC (NMRPG3E6091/2) for the financial support.	Alba AC, 2016, J CARD FAIL, V22, P492, DOI 10.1016/j.cardfail.2016.01.012; Alosco Michael L, 2013, J Neurol Sci, V328, P51, DOI 10.1016/j.jns.2013.02.015; Arena R, 2007, INT J CARDIOL, V117, P103, DOI 10.1016/j.ijcard.2006.04.058; BHAVANISHANKAR K, 1992, CAN J ANAESTH, V39, P617, DOI 10.1007/BF03008330; Brassard P, 2016, CAN J CARDIOL, V32, P475, DOI 10.1016/j.cjca.2015.12.021; Cattadori G, 2017, EUR J INTERN MED, V37, P56, DOI 10.1016/j.ejim.2016.09.011; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P951, DOI 10.1016/S0735-1097(98)00679-2; Ezeugwu VE, 2013, PHYSIOTHER RES INT, V18, P212, DOI 10.1002/pri.1547; Ferdinand Phillip, 2016, Exp Transl Stroke Med, V8, P9; Fischer GW, 2008, SEMIN CARDIOTHORAC V, V12, P60, DOI 10.1177/1089253208316443; Fraser KS, 2015, JACC-HEART FAIL, V3, P168, DOI 10.1016/j.jchf.2014.07.017; Fu TC, 2016, AM J PHYS MED REHAB, V95, P15, DOI 10.1097/PHM.0000000000000312; Fu TC, 2013, INT J CARDIOL, V167, P41, DOI 10.1016/j.ijcard.2011.11.086; Fu TC, 2011, AM J PHYSIOL-HEART C, V300, pH1545, DOI 10.1152/ajpheart.00867.2010; GELMERS HJ, 1987, AM J CARDIOL, V59, pB173, DOI 10.1016/0002-9149(87)90098-1; Greenberg S, 2017, ANESTH ANALG, V124, P356, DOI 10.1213/ANE.0000000000001290; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Gruhn N, 2001, STROKE, V32, P2530, DOI 10.1161/hs1101.098360; HARPER AM, 1965, J NEUROL NEUROSUR PS, V28, P449, DOI 10.1136/jnnp.28.5.449; Heil B, 2015, CLEV CLIN J MED, V82, pS28, DOI 10.3949/ccjm.82.s2.05; Hellstrom G, 1996, CARDIOL ELDER, V4, P191; HERHOLZ K, 1987, J NEUROL, V234, P9, DOI 10.1007/BF00314001; Hoiland RL, 2016, AM J PHYSIOL-REG I, V310, pR398, DOI 10.1152/ajpregu.00270.2015; Hu XM, 2017, CIRC RES, V120, P449, DOI 10.1161/CIRCRESAHA.116.308427; Ide K, 2000, ACTA PHYSIOL SCAND, V170, P33; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jones S, 2016, ARTERY RES, V16, P25, DOI 10.1016/j.artres.2016.09.001; Karlman Wasserman JEH, 2011, PRINCIPLES EXERCISE; Koike A, 2008, CIRC J, V72, P1852, DOI 10.1253/circj.CJ-08-0376; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Mancini DM, 2003, KIDNEY INT, V64, pS48, DOI 10.1046/j.1523-1755.64.s87.8.x; McSwain SD, 2010, RESP CARE, V55, P288; Medicine DRJKEGLMMACoS, 2018, ACSMS GUIDELINES EXE; Mezzani A, 2009, EUR J CARDIOV PREV R, V16, P249, DOI 10.1097/HJR.0b013e32832914c8; Myers J, 2015, CURR PROB CARDIOLOGY, V40, P322, DOI 10.1016/j.cpcardiol.2015.01.009; Nielsen HB, 1999, AM J PHYSIOL-HEART C, V277, pH1045, DOI 10.1152/ajpheart.1999.277.3.H1045; Oliveira MF, 2016, RESP PHYSIOL NEUROBI, V221, P41, DOI 10.1016/j.resp.2015.10.005; PILOTE L, 1989, CIRCULATION, V80, P1636, DOI 10.1161/01.CIR.80.6.1636; Pott F, 1997, ACTA PHYSIOL SCAND, V160, P251, DOI 10.1046/j.1365-201X.1997.00144.x; Rifai Luay, 2012, Congest Heart Fail, V18, P85, DOI 10.1111/j.1751-7133.2011.00284.x; Robertson AD, 2015, EXP BRAIN RES, V233, P2467, DOI 10.1007/s00221-015-4317-6; Rosen SD, 2004, EUR HEART J, V25, P952, DOI 10.1016/j.ehj.2004.03.025; Scheeren TWL, 2012, J CLIN MONIT COMPUT, V26, P279, DOI 10.1007/s10877-012-9348-y; Seifert T, 2009, ACTA PHYSIOL, V196, P295, DOI 10.1111/j.1748-1716.2008.01946.x; Shen YQ, 2015, EXP THER MED, V9, P1407, DOI 10.3892/etm.2015.2267; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; VARAT MA, 1972, AM HEART J, V83, P415, DOI 10.1016/0002-8703(72)90445-0; Vogels Raymond L C, 2008, Congest Heart Fail, V14, P61, DOI 10.1111/j.1751-7133.2008.07365.x; Wahba RWM, 1996, CAN J ANAESTH, V43, P862, DOI 10.1007/BF03013040; Wahr JA, 1996, J CARDIOTHOR VASC AN, V10, P406, DOI 10.1016/S1053-0770(96)80107-8; Wang JS, 2013, INT J CARDIOL, V167, P1289, DOI 10.1016/j.ijcard.2012.03.170; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1161/CIR.0000000000000509, 10.1016/j.jacc.2017.04.025]	55	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196299	10.1371/journal.pone.0196299	http://dx.doi.org/10.1371/journal.pone.0196299			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689105	gold, Green Submitted, Green Published			2022-12-26	WOS:000430678800040
J	Ayllon, T; Camara, DCP; Morone, FC; Goncalves, LD; de Barros, FSM; Brasil, P; Carvalho, MS; Honorio, NA				Ayllon, Tania; Portela Camara, Daniel Cardoso; Morone, Fernanda Cristina; Goncalves, Larissa da Silva; Monteiro de Barros, Fabio Saito; Brasil, Patricia; Carvalho, Marilia Sa; Honorio, Nildimar Alves			Dispersion and oviposition of Aedes albopictus in a Brazilian slum: Initial evidence of Asian tiger mosquito domiciliation in urban environments	PLOS ONE			English	Article							RIO-DE-JANEIRO; VECTOR COMPETENCE; AEGYPTI; CULICIDAE; DIPTERA; COMPETITION; DENGUE; FEVER; COEXISTENCE; RESISTANCE	Aedes albopictus, originally considered as a secondary vector for arbovirus transmission, especially in areas where this species co-exist with Aedes aegypti, has been described in most regions of the world. Dispersion and domiciliation of Ae. albopictus in a complex of densely urbanized slums in Rio de Janeiro, Southeastern Brazil, was evidenced. In this study, we tested the hypotheses that 1) Ae. albopictus distribution in urban slums is negatively related to distance from vegetation, and 2) these vectors have taken on a domestic life style with a portion of the population feeding, ovipositing, and resting indoors. To do this, we developed an integrated surveillance proposal, aiming to detect the presence and abundance of Aedes mosquitoes. The study, based on a febrile syndrome surveillance system in a cohort of infants living in the slum complex, was performed on a weekly basis between February 2014 and April 2017. A total of 8,418 adult mosquitoes (3,052 Ae. aegypti, 44 Ae. albopictus, 16 Ae. scapularis, 4 Ae. fluviatilis and 5,302 Culex quinquefasciatus) were collected by direct aspiration and 46,047 Aedes spp. eggs were collected by oviposition traps. The Asian tiger mosquito, Ae. albopictus, was aspirated in its adult form (n = 44), and immature forms of this species (n = 12) were identified from the eggs collected by the ovitraps. In most collection sites, co-occurrence of Ae. aegypti and Ae. albopictus was observed. Key-sites, such as junkyards, thrift stores, factories, tire repair shops and garages, had the higher abundance of Ae. albopictus, followed by schools and households. We collected Ae. albopictus at up to 400 meters to the nearest vegetation cover. The log transformed (n+1) number of females Ae. albopictus captured at each collection point was inversely related to the distance to the nearest vegetation border. These results show that Ae. albopictus, a competent vector for important arboviruses and more commonly found in areas with higher vegetation coverage, is present and spread in neglected and densely urbanized areas, being collected at a long distance from the typical encounter areas for this species. Besides, as Ae. albopictus can easily move between sylvatic and urban environment, the entomological monitoring of Ae. albopictus should be an integral part of mosquito surveillance and control. Finally, key sites, characterized by high human influx and presence of potential Aedes breeding sites, should be included in entomological monitoring.	[Ayllon, Tania; Brasil, Patricia] Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil; [Ayllon, Tania; Portela Camara, Daniel Cardoso; Morone, Fernanda Cristina; Goncalves, Larissa da Silva; Honorio, Nildimar Alves] Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores Nosmove, Rio De Janeiro, Brazil; [Portela Camara, Daniel Cardoso; Honorio, Nildimar Alves] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil; [Monteiro de Barros, Fabio Saito] Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil; [Carvalho, Marilia Sa] Fiocruz MS, Programa Computacao Cient PROCC, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz	Ayllon, T (corresponding author), Fiocruz MS, Inst Nacl Infectol Evandro Chagas, Lab Doencas Febris Agudas, Rio De Janeiro, Brazil.; Ayllon, T; Honorio, NA (corresponding author), Fiocruz MS, Nucleo Operac Sentinela Mosquitos Vetores Nosmove, Rio De Janeiro, Brazil.; Honorio, NA (corresponding author), Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, Brazil.	tasainat@gmail.com; honorio@ioc.fiocruz.br	Santiago, Tania Ayllon/B-2543-2019; Brasil, Patricia/P-3536-2014; CARVALHO, MARILIA/AAD-8283-2020; Câmara, Daniel C. P./S-3504-2018	Santiago, Tania Ayllon/0000-0002-1195-5078; CARVALHO, MARILIA/0000-0002-9566-0284; Câmara, Daniel C. P./0000-0002-5439-4477; Brasil, Patricia/0000-0001-9555-7976	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [157464/2015-6]; Programa Estrategico de Apoio a Pesquisa em Saude-PAPES VI [407744/2012-6]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [E-26 010.001610/2016]; Fundo Nacional de Saude-FNS [TED 90/2016]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Estrategico de Apoio a Pesquisa em Saude-PAPES VI; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundo Nacional de Saude-FNS	This work was supported by grants from: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (grant nr. 157464/2015-6), Programa Estrategico de Apoio a Pesquisa em Saude-PAPES VI (grant nr. 407744/2012-6), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ (grant nr. E-26 010.001610/2016) and Fundo Nacional de Saude-FNS (grant nr. TED 90/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007; Bargielowski IE, 2016, INSECT SCI, V23, P162, DOI 10.1111/1744-7917.12291; Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075; Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; CONNOR M. E., 1923, American Journal of Tropical Medicine, V3, P9; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013; de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105; dos Reis IC, 2010, ACTA TROP, V114, P37, DOI 10.1016/j.actatropica.2010.01.001; Favoretto S., 2016, BIORXIV, DOI [10.1101/049395049395, DOI 10.1101/049395]; Lagrotta MT, 2008, CAD SAUDE PUBLICA, V24, P70, DOI 10.1590/S0102-311X2008000100007; FONTENILLE D, 1989, J AM MOSQUITO CONTR, V5, P219; Foratini OP., 2004, ECOLOGIA EPIDEMIOLOG; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; Honorio NA, 2017, BIOL INVASIONS, P1; Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003; Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811; Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4; Juliano SA, 1998, ECOLOGY, V79, P255, DOI 10.1890/0012-9658(1998)079[0255:SIARAM]2.0.CO;2; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Lourenco-de-Oliveira R, 2004, J VECTOR ECOL, V29, P94; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Camara DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157120; RCore Team, 2020, R LANG ENV STAT COMP; Reisen WK, 2010, ANNU REV ENTOMOL, V55, P461, DOI 10.1146/annurev-ento-112408-085419; RSTudio Team, 2012, RSTUDIO RELEASES SHI; Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058; TABACHNICK W J, 1991, American Entomologist, V37, P14; Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007; Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755	39	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195014	10.1371/journal.pone.0195014	http://dx.doi.org/10.1371/journal.pone.0195014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684029	Green Published, gold, Green Submitted			2022-12-26	WOS:000430660600010
J	Cross, M; Biberacher, S; Park, SY; Rajan, S; Korhonen, P; Gasser, RB; Kim, JS; Coster, MJ; Hofmann, A				Cross, Megan; Biberacher, Sonja; Park, Suk-Youl; Rajan, Siji; Korhonen, Pasi; Gasser, Robin B.; Kim, Jeong-Sun; Coster, Mark J.; Hofmann, Andreas			Trehalose 6-phosphate phosphatases of Pseudomonas aeruginosa	FASEB JOURNAL			English	Article						drug discovery; enzyme activity; halo-acid dehydrogenase; multidrug resistance; protein structure-function	HORIZONTAL GENE-TRANSFER; CRYSTAL-STRUCTURE; BURKHOLDERIA-PSEUDOMALLEI; GENOMIC ISLANDS; ACTIVE-SITE; ENZYME; TREHALOSE-6-PHOSPHATE; VIRULENCE; COMPLEX; PATHOGENICITY	The opportunistic bacterium Pseudomonas aeruginosa has been recognized as an important pathogen of clinical relevance and is a leading cause of hospital-acquired infections. The presence of a glycolytic enzyme in Pseudomonas, which is known to be inhibited by trehalose 6-phosphate (T6P) in other organisms, suggests that these bacteria may be vulnerable to the detrimental effects of intracellular T6P accumulation. In the present study, we explored the structural and functional properties of trehalose 6-phosphate phosphatase (TPP) in P. aeruginosa in support of future target-based drug discovery. A survey of genomes revealed the existence of 2 TPP genes with either chromosomal or extrachromosomal location. Both TPPs were produced as recombinant proteins, and characterization of their enzymatic properties confirmed specific, magnesium-dependent catalytic hydrolysis of T6P. The 3-dimensional crystal structure of the chromosomal TPP revealed a protein dimer arising through -sheet expansion of the individual monomers, which possess the overall fold of halo-acid dehydrogenases.Cross, M., Biberacher, S., Park, S.-Y., Rajan, S., Korhonen, P., Gasser, R. B., Kim, J.-S., Coster, M. J., Hofmann, A. Trehalose 6-phosphate phosphatases of Pseudomonas aeruginosa.	[Cross, Megan; Biberacher, Sonja; Rajan, Siji; Coster, Mark J.; Hofmann, Andreas] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Biberacher, Sonja] Friedrich Alexander Univ, Dept Biol, Erlangen, Germany; [Park, Suk-Youl] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang, Gyeongbuk, South Korea; [Korhonen, Pasi; Gasser, Robin B.; Hofmann, Andreas] Univ Melbourne, Melbourne Vet Sch, Dept Vet Biosci, Parkville, Vic, Australia; [Kim, Jeong-Sun] Chonnam Natl Univ, Dept Chem, Gwangju, South Korea; [Hofmann, Andreas] Queensland Trop Hlth Alliance, Smithfield, RI, Australia	Griffith University; University of Erlangen Nuremberg; Pohang University of Science & Technology (POSTECH); University of Melbourne; Chonnam National University	Hofmann, A (corresponding author), Griffith Univ, N75 Don Young Rd, Nathan, Qld 4111, Australia.	a.hofmann@griffith.edu.au	Hofmann, Andreas/M-9870-2019; Gasser, Robin/ABH-6185-2020	Hofmann, Andreas/0000-0003-4408-5467; Gasser, Robin/0000-0002-4423-1690; Cross, Megan/0000-0001-7512-7223; Korhonen, Pasi/0000-0002-9957-4674; Rajan, Siji/0000-0002-2142-0042	Australian Research Council; Rebecca L. Cooper Medical Research Foundation; Chonnam National University [2015-0597]; German Academic Exchange Service through DAAD RISE scholarship; German Academic Exchange Service through DAAD PROMOS scholarship	Australian Research Council(Australian Research Council); Rebecca L. Cooper Medical Research Foundation; Chonnam National University; German Academic Exchange Service through DAAD RISE scholarship; German Academic Exchange Service through DAAD PROMOS scholarship	Research in the investigators' laboratories was funded by the Australian Research Council (to A.H. and R.B.G.), the Rebecca L. Cooper Medical Research Foundation (to A.H.), and the Chonnam National University (2015-0597, to J.-S.K.). The Equity Trustees Ph.D. Scholarship and the Australian Government Research Training Program Scholarship (to M.C.), as well as support by the German Academic Exchange Service through DAAD RISE and PROMOS scholarships (to S.B.) are gratefully acknowledged. Mass spectrometric analysis was undertaken at the Australian Proteome Analysis Facility, and the infrastructure was provided by the Australian Government through the National Collaborative Research Infrastructure Strategy. The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bhatt VD, 2012, J APPL MICROBIOL, V112, P639, DOI 10.1111/j.1365-2672.2012.05244.x; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CAMPBELL JJ, 1962, J BACTERIOL, V83, P1155, DOI 10.1128/JB.83.5.1155-1160.1962; Claridge C. A., 1953, THESIS; Cross M, 2017, EMERG TOP LIFE SCI, V1, P675, DOI 10.1042/ETLS20170106; Cross M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02220-2; Cross M, 2017, FASEB J, V31, P920, DOI 10.1096/fj.201601149R; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deroover S, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow036; Di Nardo G, 2015, J BIOL CHEM, V290, P1186, DOI 10.1074/jbc.M114.595108; Djonovic S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003217; Eastmond PJ, 2002, PLANT J, V29, P225, DOI 10.1046/j.1365-313x.2002.01220.x; Eberl L, 2004, INT J MED MICROBIOL, V294, P123, DOI 10.1016/j.ijmm.2004.06.022; Edavana VK, 2004, ARCH BIOCHEM BIOPHYS, V426, P250, DOI 10.1016/j.abb.2004.02.014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farelli JD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004245; Gaballa A, 1997, APPL ENVIRON MICROB, V63, P4340, DOI 10.1128/AEM.63.11.4340-4345.1997; Guo FB, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0986-6; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller P., 1982, MINERALOGICAL RECORD, V13, P155; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; Korte J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006043; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Kuser P, 2008, PROTEINS, V72, P731, DOI 10.1002/prot.21956; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; LAPP D, 1971, J BIOL CHEM, V246, P4567; Leitner G, 2007, VET IMMUNOL IMMUNOP, V119, P198, DOI 10.1016/j.vetimm.2007.05.007; Liu CL, 2017, EUR J MED CHEM, V128, P274, DOI 10.1016/j.ejmech.2017.02.001; Matthijs S, 2000, RES MICROBIOL, V151, P845, DOI 10.1016/S0923-2508(00)01151-7; MATULA M, 1971, J BACTERIOL, V107, P217, DOI 10.1128/JB.107.1.217-222.1971; MCDOUGALL J, 1993, FEMS MICROBIOL LETT, V107, P25, DOI 10.1111/j.1574-6968.1993.tb05998.x; Moore Nicholas M, 2011, Clin Lab Sci, V24, P47; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Nunes C, 2013, PLANT PHYSIOL BIOCH, V63, P89, DOI 10.1016/j.plaphy.2012.11.011; Nzula S, 2000, FEMS IMMUNOL MED MIC, V28, P307, DOI 10.1111/j.1574-695X.2000.tb01491.x; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pannu NS, 2003, ACTA CRYSTALLOGR D, V59, P1801, DOI 10.1107/S090744490301936X; Park HC, 2007, LETT APPL MICROBIOL, V44, P50, DOI 10.1111/j.1472-765X.2006.02036.x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Puttikamonkul S, 2010, MOL MICROBIOL, V77, P891, DOI 10.1111/j.1365-2958.2010.07254.x; Qiu X, 2009, GENOME DYNAM, V6, P126, DOI 10.1159/000235767; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reinders A, 1997, MOL MICROBIOL, V24, P687, DOI 10.1046/j.1365-2958.1997.3861749.x; Roder A, 2005, FEMS MICROBIOL LETT, V243, P219, DOI 10.1016/j.femsle.2004.12.005; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwarz S, 2017, VIRULENCE, V8, P5, DOI 10.1080/21505594.2016.1216295; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SIMOPOULOS TT, 1994, BIOCHEMISTRY-US, V33, P10375, DOI 10.1021/bi00200a018; Stratton JR, 2001, BIOCHEMISTRY-US, V40, P10411, DOI 10.1021/bi015542n; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; TARDIF G, 1982, ANTIMICROB AGENTS CH, V22, P142, DOI 10.1128/AAC.22.1.142; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vanaporn M, 2017, VIRULENCE, V8, P30, DOI 10.1080/21505594.2016.1199316; Wang CK, 2012, BIOINFORMATICS, V28, P1026, DOI 10.1093/bioinformatics/bts035; Weaver VB, 2004, J BACTERIOL, V186, P2376, DOI 10.1128/JB.186.8.2376-2384.2004; Weeratunga S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-201; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Zeidler S, 2017, ENVIRON MICROBIOL, V19, P5088, DOI 10.1111/1462-2920.13987; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	84	9	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5470	5482		10.1096/fj.201800500R	http://dx.doi.org/10.1096/fj.201800500R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29688811	Green Submitted, Bronze			2022-12-26	WOS:000447972500023
J	Liu, Q; Goss, DJ				Liu, Qiao; Goss, Dixie J.			The 3 mRNA I-shaped structure of maize necrotic streak virus binds to eukaryotic translation factors for eIF4F-mediated translation initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant virus; RNA-protein interaction; RNA virus; RNA structure; eukaryotic translation initiation; I-shaped RNA structure; kissing loop; maize necrotic streak virus; RNA UTR; viral protein translation	CAP-INDEPENDENT TRANSLATION; PLANT VIRAL RNAS; FACTOR 4G EIF4G; WHEAT-GERM; FAMILY TOMBUSVIRIDAE; HELICASE ACTIVITY; PROTEIN; ENHANCERS; EIFISO4F; COMPLEX	Unlike the mRNAs of their eukaryotic hosts, many RNAs of viruses lack a 5 m(7)GpppN cap and the 3 polyadenosine tail, and yet they are translated efficiently. Plant RNA viruses, in particular, have complex structures within their mRNA UTRs that allow them to bypass some cellular translation control steps. In the 3 UTR of maize necrotic streak virus (MNeSV), an I-shaped RNA structure (ISS) has been shown to bind eukaryotic initiation factor (eIF)4F and to mediate viral translation initiation. A 5-3 RNA kissing-loop interaction is required for optimal translation. However, the details of how the 3 ISS mediates translation initiation are not well understood. Here, we studied the binding of the 3 ISS with eIFs. The eIF4A-eIF4B complex was found to increase binding affinity of eIF4F with the 3 ISS by 4-fold (from K-D = 173 +/- 34 nm to K-D = 48 +/- 11 nm). Pre-steady-state analysis indicated that the eIF4A-eIF4B complex increased the RNA association rate and decreased the dissociation rate in an ATP-independent manner. Furthermore, our findings suggest that eIF4F could promote binding of the 3 ISS with the MNeSV 5UTR, enhancing the long-distance kissing-loop interaction. However, the association of the 5UTR with the 3 ISS-eIF4F complex did not increase 40S ribosomal subunit binding affinity. These quantitative results suggest a stepwise model in which the first committed step is eIF4F binding to the 3 ISS, followed by an interaction with the 5UTR and subsequent 40S ribosomal subunit binding.	[Liu, Qiao; Goss, Dixie J.] CUNY, Biochem Program, Grad Ctr, New York, NY 10065 USA; [Liu, Qiao; Goss, Dixie J.] CUNY, Chem Grad Program, Grad Ctr, New York, NY 10065 USA; [Liu, Qiao; Goss, Dixie J.] CUNY Hunter Coll, Dept Chem & Biochem, New York, NY 10065 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY)	Goss, DJ (corresponding author), CUNY Hunter Coll, Dept Chem & Biochem, New York, NY 10065 USA.	dgoss@hunter.cuny.edu		Goss, Dixie/0000-0002-8500-0629	National Science Foundation [MCB 1513737]; Direct For Biological Sciences [1513737] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB 1513737 (to D.J.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Banerjee B, 2014, J BIOL CHEM, V289, P4286, DOI 10.1074/jbc.M113.530329; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; BROWNING KS, 1989, J BIOL CHEM, V264, P8491; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; Cheng SJ, 2013, TRANSLATION, V1, DOI 10.4161/trla.24038; De Stradis A, 2005, J PLANT PATHOL, V87, P213; Gao F, 2012, J VIROL, V86, P9828, DOI 10.1128/JVI.00677-12; GOSS DJ, 1988, BIOCHEMISTRY-US, V27, P3610, DOI 10.1021/bi00410a012; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Khan MA, 2005, BIOCHEMISTRY-US, V44, P4510, DOI 10.1021/bi047298g; Khan MA, 2008, BBA-GENE REGUL MECH, V1779, P622, DOI 10.1016/j.bbagrm.2008.07.004; Khan MA, 2014, NUCLEIC ACIDS RES, V42, P6567, DOI 10.1093/nar/gku248; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P369; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Louie R, 2000, PLANT DIS, V84, P1133, DOI 10.1094/PDIS.2000.84.10.1133; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; Miller WA, 2007, BIOCHEM SOC T, V35, P1629, DOI 10.1042/BST0351629; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Nicholson BL, 2013, J VIROL, V87, P1872, DOI 10.1128/JVI.02711-12; Nicholson BL, 2011, CURR OPIN VIROL, V1, P373, DOI 10.1016/j.coviro.2011.10.002; Nicholson BL, 2010, RNA, V16, P1402, DOI 10.1261/rna.2135210; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; RAY BK, 1985, J BIOL CHEM, V260, P7651; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Scheets K, 2006, VIROLOGY, V350, P171, DOI 10.1016/j.virol.2006.02.004; Sharma Sohani Das, 2015, J Biol Chem, V290, P11268, DOI 10.1074/jbc.M115.645002; Simon AE, 2013, ANNU REV MICROBIOL, V67, P21, DOI 10.1146/annurev-micro-092412-155609; Stuart G, 2004, ARCH VIROL, V149, P1595, DOI 10.1007/s00705-004-0298-7; Yumak H, 2010, BBA-GENE REGUL MECH, V1799, P653, DOI 10.1016/j.bbagrm.2010.08.003; Zhao P, 2017, J BIOL CHEM, V292, P5921, DOI [10.1074/jbc.M116.764902, 10.1074/jbc.m116.764902]; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	5	5	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9486	9495		10.1074/jbc.RA118.003377	http://dx.doi.org/10.1074/jbc.RA118.003377			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29700118	hybrid, Green Published			2022-12-26	WOS:000435441400031
J	Lyman, M; Lieuw, V; Richardson, R; Timmer, A; Stewart, C; Granger, S; Woods, R; Silacci, M; Grabulovski, D; Newman, R				Lyman, Michael; Lieuw, Vincent; Richardson, Robyn; Timmer, Anjuli; Stewart, Christine; Granger, Steve; Woods, Richard; Silacci, Michela; Grabulovski, Dragan; Newman, Roland			A bispecific antibody that targets IL-6 receptor and IL-17A for the potential therapy of patients with autoimmune and inflammatory diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; antibody engineering; autoimmune disease; cytokine; inflammation	MODIFYING ANTIRHEUMATIC DRUGS; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; IMMUNE-RESPONSES; NECROSIS-FACTOR; ANCHOR DRUG; TOCILIZUMAB; METHOTREXATE; TRIAL; INTERLEUKIN-17A	Despite the success of current biological therapeutics for rheumatoid arthritis, these therapies, targeting individual cytokines or pathways, produce beneficial responses in only about half of patients. Therefore, better therapeutics are needed. IL-6 and IL-17A are proinflammatory cytokines in many autoimmune and inflammatory diseases, and several therapeutics have been developed to specifically inhibit them. However, targeting both of these cytokines with a bispecific therapeutic agent could account for their nonoverlapping proinflammatory functions and for the fact that IL-6 and IL-17A act in a positive feedback loop. Here, we present the development of MT-6194, a bispecific antibody targeting both IL-6R and IL-17A that was developed with the FynomAb technology. We also present data from mouse inflammatory disease experiments, indicating that simultaneous inhibition of both IL-6 and IL-17A yields enhanced efficacy compared with inhibition of each cytokine alone.	[Lyman, Michael; Lieuw, Vincent; Richardson, Robyn; Timmer, Anjuli; Stewart, Christine; Granger, Steve; Newman, Roland] Tanabe Res Labs USA Inc, 4540 Towne Ctr Ct, San Diego, CA 92121 USA; [Woods, Richard; Silacci, Michela; Grabulovski, Dragan] Covagen AG, Wagistr 25, CH-8952 Schlieren, Switzerland; [Lyman, Michael] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Richardson, Robyn] Neurocrine Biosci, 12780 El Camino Real, San Diego, CA 92130 USA; [Timmer, Anjuli] NantKwest Inc, 3530 John Hopkins Ct, San Diego, CA 92121 USA; [Granger, Steve] Salimetrics LLC, 5962 La Pl Ct,Ste 275, Carlsbad, CA 92008 USA; [Grabulovski, Dragan] Grabulovski Consulting Serv, Riedhofstr 57, CH-8049 Zurich, Switzerland	Salk Institute; Neurocrine Biosciences	Newman, R (corresponding author), Tanabe Res Labs USA Inc, 4540 Towne Ctr Ct, San Diego, CA 92121 USA.	rnewman@trlusa.com						Aletaha D, 2002, RHEUMATOLOGY, V41, P1367, DOI 10.1093/rheumatology/41.12.1367; Ben-Horin S, 2011, ALIMENT PHARM THER, V33, P987, DOI 10.1111/j.1365-2036.2011.04612.x; Brack S, 2014, MOL CANCER THER, V13, P2030, DOI 10.1158/1535-7163.MCT-14-0046-T; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; Grabulovski D, 2007, J BIOL CHEM, V282, P3196, DOI 10.1074/jbc.M609211200; Hyrich KL, 2009, RHEUMATOLOGY, V48, P1323, DOI 10.1093/rheumatology/kep242; Ito H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3238; Kieseier BC, 2013, JAMA NEUROL, V70, P390, DOI 10.1001/jamaneurol.2013.668; Kirkham BW, 2014, IMMUNOLOGY, V141, P133, DOI 10.1111/imm.12142; Nascimento MSL, 2015, J INFECT DIS, V211, P1015, DOI 10.1093/infdis/jiu531; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lubberts E, 2015, NAT REV RHEUMATOL, V11, P415, DOI 10.1038/nrrheum.2015.53; Matsuyama M, 2007, INTERNAL MED, V46, P771, DOI 10.2169/internalmedicine.46.6262; Mihara M, 2002, IMMUNOL LETT, V84, P223, DOI 10.1016/S0165-2478(02)00201-8; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Orlow S. J., 2015, DERMATOLOGY TIMES; Pieper J, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-34; Pincus T, 2003, CLIN EXP RHEUMATOL, V21, pS179; Ragab AA, 2002, AM J PHYSIOL-CELL PH, V283, pC679, DOI 10.1152/ajpcell.00421.2001; Raychaudhuri SP, 2013, CLIN REV ALLERG IMMU, V44, P183, DOI 10.1007/s12016-012-8307-1; Rubbert-Roth A, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2666; Salvarani C, 2012, CLIN EXP RHEUMATOL, V30, pS90; Sato Kojiro, 2008, Allergol Int, V57, P109, DOI 10.2332/allergolint.R-07-158; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Sheridan C, 2016, NAT BIOTECHNOL, V34, P1215, DOI 10.1038/nbt1216-1215; Sigaux J, 2017, JOINT BONE SPINE, V84, P39, DOI 10.1016/j.jbspin.2016.04.013; Silacci M, 2016, MABS-AUSTIN, V8, P141, DOI 10.1080/19420862.2015.1093266; Sokka T, 2002, J RHEUMATOL, V29, P2521; SWAAK AJG, 1989, RHEUMATOL INT, V8, P263, DOI 10.1007/BF00270982; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Teitsma XM, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1108-9; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wuellner U, 2015, ANTIBODIES, V4, P426, DOI 10.3390/antib4040426; Yoshida Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698313; Zhang Y, 2013, INT IMMUNOPHARMACOL, V15, P199, DOI 10.1016/j.intimp.2012.12.010	38	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9326	9334		10.1074/jbc.M117.818559	http://dx.doi.org/10.1074/jbc.M117.818559			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29678878	Green Published, hybrid			2022-12-26	WOS:000435441400018
J	Gonzalez-Munoz, N; Sterck, F; Torres-Ruiz, JM; Petit, G; Cochard, H; von Arx, G; Lintunen, A; Caldeira, MC; Capdeville, G; Copini, P; Gebauer, R; Gronlund, L; Holtta, T; Lobo-do-Vales, R; Peltoniemi, M; Stritih, A; Urban, J; Delzon, S				Gonzalez-Munoz, N.; Sterck, F.; Torres-Ruiz, J. M.; Petit, G.; Cochard, H.; von Arx, G.; Lintunen, A.; Caldeira, M. C.; Capdeville, G.; Copini, P.; Gebauer, R.; Gronlund, L.; Holtta, T.; Lobo-do-Vales, R.; Peltoniemi, M.; Stritih, A.; Urban, J.; Delzon, S.			Quantifying in situ phenotypic variability in the hydraulic properties of four tree species across their distribution range in Europe	PLOS ONE			English	Article							DROUGHT-INDUCED MORTALITY; CLIMATE-CHANGE IMPACTS; CAVITATION RESISTANCE; XYLEM EMBOLISM; SCOTS PINE; STAND DENSITY; PLANT-GROWTH; VULNERABILITY; POPULATIONS; PLASTICITY	Many studies have reported that hydraulic properties vary considerably between tree species, but little is known about their intraspecific variation and, therefore, their capacity to adapt to a warmer and drier climate. Here, we quantify phenotypic divergence and clinal variation for embolism resistance, hydraulic conductivity and branch growth, in four tree species, two angiosperms (Betula pendula, Populus tremula) and two conifers (Picea abies, Pinus sylvestris), across their latitudinal distribution in Europe. Growth and hydraulic efficiency varied widely within species and between populations. The variability of embolism resistance was in general weaker than that of growth and hydraulic efficiency, and very low for all species but Populus tremula. In addition, no and weak support for a safety vs. efficiency trade-off was observed for the angiosperm and conifer species, respectively. The limited variability of embolism resistance observed here for all species except Populus tremula, suggests that forest populations will unlikely be able to adapt hydraulically to drier conditions through the evolution of embolism resistance.	[Gonzalez-Munoz, N.; Torres-Ruiz, J. M.; Capdeville, G.; Delzon, S.] Univ Bordeaux, BIOGECO, INRA, Pessac, France; [Sterck, F.; Copini, P.] Wageningen Univ & Res, Forest Ecol & Forest Management Grp, Wageningen, Netherlands; [Petit, G.] Univ Padua, Dep TeSAF, Legnaro, PD, Italy; [Cochard, H.] Univ Clermont Auvergne, PIAF, INRA, Clermont Ferrand, France; [von Arx, G.] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [von Arx, G.] Inst Environm Sci, Climat Change & Climate Impacts, Geneva, Switzerland; [Lintunen, A.; Gronlund, L.; Holtta, T.] Univ Helsinki, Dept Forest Sci, Helsinki, Finland; [Caldeira, M. C.; Lobo-do-Vales, R.] Univ Lisbon, Sch Agr, Forest Res Ctr, Lisbon, Portugal; [Copini, P.] Wageningen Environm Res Alterra, Wageningen, Netherlands; [Gebauer, R.; Urban, J.] Mendel Univ Brno, Dept Forest Bot Dendrol & Geobiocoenol, Zemedelska 3, Brno, Czech Republic; [Peltoniemi, M.] Nat Resources Inst Finland Luke, Latokartanonkaari 9, Helsinki, Finland; [Stritih, A.] Swiss Fed Inst Technol, Planning Landscape & Urban Syst, Zurich, Switzerland	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Wageningen University & Research; University of Padua; INRAE; Universite Clermont Auvergne (UCA); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Helsinki; Universidade de Lisboa; Forest Research Centre; Wageningen University & Research; Mendel University in Brno; Natural Resources Institute Finland (Luke); Swiss Federal Institutes of Technology Domain; ETH Zurich	Gonzalez-Munoz, N (corresponding author), Univ Bordeaux, BIOGECO, INRA, Pessac, France.	noelia.gonzalezm@gmail.com	Lobo-do-Vale, Raquel/D-4570-2013; Caldeira, Maria/D-4107-2013; Delzon, Sylvain/R-9538-2018; Lintunen, Anna/D-5942-2015; von Arx, Georg/E-1785-2012; Urban, Josef/A-8754-2013; Torres-Ruiz, José Manuel/I-6587-2012; Cochard, Hervé/P-7406-2015	Lobo-do-Vale, Raquel/0000-0003-4566-5420; Caldeira, Maria/0000-0002-3586-8526; Delzon, Sylvain/0000-0003-3442-1711; Lintunen, Anna/0000-0002-1077-0784; von Arx, Georg/0000-0002-8566-4599; Urban, Josef/0000-0003-1730-947X; Torres-Ruiz, José Manuel/0000-0003-1367-7056; Cochard, Hervé/0000-0002-2727-7072; Gebauer, Roman/0000-0001-5661-7585; Peltoniemi, Mikko/0000-0003-2028-6969; Stritih, Ana/0000-0001-5323-8176; Petit, Giai/0000-0002-6546-7141; Holtta, Teemu/0000-0001-7677-7156; Copini, Paul/0000-0002-5547-2609	COST (European Cooperation in Science and Technology); French National Agency for Research [ANR-10-EQPX-16]; Cluster of Excellence COTE [ANR-10-LABX-45]; Agreenskills+ Fellowship Programme; EU's Seventh Framework Programme [FP7-26719]; Swiss State Secretariat for Education, Research and Innovation SERI [SBFI C14.0104]; Portuguese Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/86938/2012]; Ministry of Education, Sports and Youth of the Czech Republic [COST-LD13017]; EU Life Programme [LIFE12 ENV/FI/000409]; FCT [UID/AGR/00239/2013]	COST (European Cooperation in Science and Technology)(European Cooperation in Science and Technology (COST)); French National Agency for Research(French National Research Agency (ANR)); Cluster of Excellence COTE; Agreenskills+ Fellowship Programme; EU's Seventh Framework Programme(European Commission); Swiss State Secretariat for Education, Research and Innovation SERI; Portuguese Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Ministry of Education, Sports and Youth of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); EU Life Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This article is based on work from COST Action FP1106 STReESS, supported by COST (European Cooperation in Science and Technology). This study was funded in part by the "Investments for the Future" programme (grant no. ANR-10-EQPX-16, XYLOFOREST) from the French National Agency for Research and the Cluster of Excellence COTE (ANR-10-LABX-45, within the DEFI project) to SD. NGM was supported by the Agreenskills+ Fellowship Programme, which has received funding from the EU's Seventh Framework Programme under grant agreement No. FP7-26719 (Agreenskills+ contract). GvA was supported by a grant from the Swiss State Secretariat for Education, Research and Innovation SERI (SBFI C14.0104). RLdV was funded by a postdoctoral fellowship from the Portuguese Fundacao para a Ciencia e a Tecnologia (FCT; SFRH/BPD/86938/2012). RG and JU were supported by the Ministry of Education, Sports and Youth of the Czech Republic (COST-LD13017). MP was supported by EU Life Programme (LIFE12 ENV/FI/000409). Forest Research Centre (CEF, School of Agriculture, University of Lisbon) is a research unit funded by FCT (UID/AGR/00239/2013).	Ahmad HB, 2017, PHYSL PLANT IN PRESS; Alberto F, 2011, J EVOLUTION BIOL, V24, P1442, DOI 10.1111/j.1420-9101.2011.02277.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2016, P NATL ACAD SCI USA, V113, P5024, DOI 10.1073/pnas.1525678113; Anderegg WRL, 2015, NAT GEOSCI, V8, P367, DOI [10.1038/ngeo2400, 10.1038/NGEO2400]; Anderegg WRL, 2015, NEW PHYTOL, V205, P1008, DOI 10.1111/nph.12907; Benito-Garzon M, 2013, GLOBAL ECOL BIOGEOGR, V22, P1141, DOI 10.1111/geb.12075; Bouche PS, 2014, J EXP BOT, V65, P4419, DOI 10.1093/jxb/eru218; Bresson CC, 2011, TREE PHYSIOL, V31, P1164, DOI 10.1093/treephys/tpr084; Brodribb TJ, 2009, PLANT PHYSIOL, V149, P575, DOI 10.1104/pp.108.129783; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Choat B, 2008, NEW PHYTOL, V177, P608, DOI 10.1111/j.1469-8137.2007.02317.x; Choat B, 2012, NATURE, V491, P752, DOI 10.1038/nature11688; Christman MA, 2010, PLANT CELL ENVIRON, V33, P431, DOI 10.1111/j.1365-3040.2009.02094.x; Cochard H, 2005, PHYSIOL PLANTARUM, V124, P410, DOI 10.1111/j.1399-3054.2005.00526.x; Cochard H, 2002, PLANT CELL ENVIRON, V25, P815, DOI 10.1046/j.1365-3040.2002.00863.x; Corcuera L, 2011, TREES-STRUCT FUNCT, V25, P1033, DOI 10.1007/s00468-011-0578-2; Cornwell WK, 2007, FUNCT ECOL, V21, P1063, DOI 10.1111/j.1365-2435.2007.01323.x; Delzon S, 2004, PLANT CELL ENVIRON, V27, P1077, DOI 10.1111/j.1365-3040.2004.01213.x; Delzon S, 2014, NEW PHYTOL, V203, P355, DOI 10.1111/nph.12798; Delzon S, 2010, PLANT CELL ENVIRON, V33, P2101, DOI 10.1111/j.1365-3040.2010.02208.x; Gleason SM, 2016, NEW PHYTOL, V209, P123, DOI 10.1111/nph.13646; Hajek P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00791; Hatfield JL, 2015, WEATHER CLIM EXTREME, V10, P4, DOI 10.1016/j.wace.2015.08.001; Heres AM, 2014, FUNCT PLANT BIOL, V41, P244, DOI 10.1071/FP13067; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Lamy JB, 2014, NEW PHYTOL, V201, P874, DOI 10.1111/nph.12556; Lamy JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023476; Lens F, 2011, NEW PHYTOL, V190, P709, DOI 10.1111/j.1469-8137.2010.03518.x; Lexer C, 2005, MOL ECOL, V14, P1045, DOI 10.1111/j.1365-294X.2005.02469.x; Lexer C, 2009, TAXON, V58, P349, DOI 10.1002/tax.582003; Li S, 2016, IAWA J, V37, P152, DOI 10.1163/22941932-20160128; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lipiec J, 2013, INT AGROPHYS, V27, P463, DOI 10.2478/intag-2013-0017; Maherali H, 2000, TREE PHYSIOL, V20, P859; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Makinen H, 1999, CAN J FOREST RES, V29, P1216, DOI 10.1139/cjfr-29-8-1216; Makinen H, 2002, TREES-STRUCT FUNCT, V16, P346, DOI 10.1007/s00468-002-0162-x; Makinen H, 2001, SCAND J FOREST RES, V16, P354, DOI 10.1080/02827580152496740; Martinez-Vilalta J, 2002, FOREST ECOL MANAG, V161, P247, DOI 10.1016/S0378-1127(01)00495-9; Martinez-Vilalta J, 2009, NEW PHYTOL, V184, P353, DOI 10.1111/j.1469-8137.2009.02954.x; Mencuccini M, 1997, J EXP BOT, V48, P1323, DOI 10.1093/jxb/48.6.1323; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Pammenter NW, 1998, TREE PHYSIOL, V18, P589, DOI 10.1093/treephys/18.8-9.589; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Petit G, 2008, NEW PHYTOL, V177, P653, DOI 10.1111/j.1469-8137.2007.02291.x; Pittermann J, 2010, PLANT PHYSIOL, V153, P1919, DOI 10.1104/pp.110.158824; R Core Team, 2016, R FDN STAT COMP; Salmon Y, 2015, PLANT CELL ENVIRON, V38, P2575, DOI 10.1111/pce.12572; Schuldt B, 2016, NEW PHYTOL, V210, P443, DOI 10.1111/nph.13798; Sperry JS, 2006, AM J BOT, V93, P1490, DOI 10.3732/ajb.93.10.1490; SPERRY JS, 1990, PLANT CELL ENVIRON, V13, P427, DOI 10.1111/j.1365-3040.1990.tb01319.x; Sperry JS, 2005, PLANT CELL ENVIRON, V28, P456, DOI 10.1111/j.1365-3040.2005.01287.x; Stojnic S, 2017, TREE PHYSL IN PRESS; Torres-Ruiz JM, 2017, NEW PHYTOL, V215, P489, DOI 10.1111/nph.14589; Torres-Ruiz JM, 2017, TREE PHYSIOL, V37, P755, DOI 10.1093/treephys/tpx013; Tyree M. T., 2002, SPR S WOOD; Urli M, 2013, TREE PHYSIOL, V33, P672, DOI 10.1093/treephys/tpt030; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Vander Willigen C, 1998, TREE PHYSIOL, V18, P595; Weiskittel AR, 2007, FOREST ECOL MANAG, V251, P182, DOI 10.1016/j.foreco.2007.06.007; Wortemann R, 2011, TREE PHYSIOL, V31, P1175, DOI 10.1093/treephys/tpr101; YANG SD, 1993, TREE PHYSIOL, V12, P231, DOI 10.1093/treephys/12.3.231; Zimmermann N.E., 2001, FINAL REPORT MLP CLI	66	18	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196075	10.1371/journal.pone.0196075	http://dx.doi.org/10.1371/journal.pone.0196075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715289	Green Published, gold			2022-12-26	WOS:000431281100009
J	Macedo, E; Cerda, J; Hingorani, S; Hou, JY; Bagga, A; Burdmann, EA; Rocco, VM; Mehta, LR				Macedo, Etienne; Cerda, Jorge; Hingorani, Sangeeta; Hou, Jiayi; Bagga, Arvind; Burdmann, Emmanuel Almeida; Rocco, Michael, V; Mehta, Ravindra L.			Recognition and management of acute kidney injury in children: The ISN 0by25 Global Snapshot study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INTERNATIONAL SOCIETY; DEVELOPING-COUNTRY; MORTALITY; DIALYSIS; EPIDEMIOLOGY; ASSOCIATION; OLIGURIA; AKI	Background In low and middle-income countries, reliable data on the epidemiology of childhood acute kidney injury (AKI) is lacking. The Global Snapshot, conducted by the ISN "0by25" AKI initiative, was a world-wide cross-sectional, observational study to evaluate AKI in hospitalized patients. Here we report the pediatric results of this study. Patients and methods We prospectively collected data on children who met the Kidney Disease Improving Global Outcomes AKI criteria during a 10-week window in late 2014. AKI risk factors, etiological factors, management and outcomes were recorded using standardized forms and protocols. Countries were classified according to their 2014 gross national income (GNI) per person into high-income countries (HIC), upper-middle income countries (UMIC) and low and low-middle income countries (LLMIC). Need for renal replacement therapy, mortality, and renal recovery were assessed 7 days after AKI diagnosis or at hospital discharge, whichever came first. Results 92 centers from 41 countries collected data on 354 pediatric AKI patients; 53% of the children developed AKI while hospitalized and 47% in the community. The most common etiological factors for AKI differed across GNI categories as well as between patients with community-acquired vs. hospital-acquired AKI. Children from HIC were younger, and larger proportion of AKI in this group were due to post-surgical complications vs. other etiologies when compared to other income categories. In patients with hypotension as the cause of AKI, the adjusted risk of death was almost 10-fold higher compared to patients without hypotension as an etiological factor for AKI development. Mortality was similar within AKI stages in HIC and UMIC. In LLMIC, patients with the highest AKI level of severity had higher mortality than patients in higher income categories. Patients from LLMIC and UMIC had a 57-fold and 11 fold higher adjusted risk of death, respectively, compared to patients from HIC. Conclusion In resource-limited countries, pediatric AKI-associated mortality is disproportionately higher when compared to high-resource areas, especially among patients with more severe AKI.	[Macedo, Etienne; Mehta, Ravindra L.] Univ Calif San Diego, Dept Med, Div Nephrol, San Diego, CA 92103 USA; [Cerda, Jorge] Albany Med Coll, Dept Med, Div Nephrol, Albany, NY 12208 USA; [Hingorani, Sangeeta] Univ Washington, Dept Pediat, Seattle Childrens Hosp, Div Nephrol, Seattle, WA 98195 USA; [Hou, Jiayi] Univ Calif San Diego, Altman Clin & Translat Res Inst, San Diego, CA 92103 USA; [Bagga, Arvind] All India Inst Med Sci, Div Pediat Nephrol, New Delhi, India; [Burdmann, Emmanuel Almeida] Univ Sao Paulo, Med Sch, Div Nephrol, LIM 12, Sao Paulo, Brazil; [Rocco, Michael, V] Wake Forest Sch Med, Sect Nephrol, Dept Internal Med, Winston Salem, NC USA	University of California System; University of California San Diego; Albany Medical College; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; All India Institute of Medical Sciences (AIIMS) New Delhi; Universidade de Sao Paulo; Wake Forest University	Macedo, E (corresponding author), Univ Calif San Diego, Dept Med, Div Nephrol, San Diego, CA 92103 USA.	emmacedo@ucsd.edu	Burdmann, Emmanuel/B-7023-2009; Burdmann, Emmanuel/AAY-1966-2020; Macedo, Etienne/D-4659-2012	Burdmann, Emmanuel/0000-0002-7644-8579; Macedo, Etienne/0000-0002-3669-6519	International Society of Nephrology (ISN); Astute Medical (San Diego, CA, USA); Danone Nutricia Research (Palaiseau, France); Bellco (Mirandola, Italy); National Institutes of Health of CTSA funding [UL1TR001442]; UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research [NIH P30-DK079337]	International Society of Nephrology (ISN); Astute Medical (San Diego, CA, USA); Danone Nutricia Research (Palaiseau, France); Bellco (Mirandola, Italy); National Institutes of Health of CTSA funding; UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research	The International Society of Nephrology (ISN) provided funding through unrestricted grants for the study, gave logistic support for this study, and holds all copyrights on the data obtained through this study. Further support to the study has been provided through unrestricted grants from Astute Medical (San Diego, CA, USA), Danone Nutricia Research (Palaiseau, France) and Bellco (Mirandola, Italy). The grants were given to ISN and none of the authors received any direct payments from any of the entities. The project was partially supported by the National Institutes of Health, Grant UL1TR001442 of CTSA funding. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We also acknowledge support from the UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research (NIH P30-DK079337) for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Further support to the study has been provided through unrestricted grants from Astute Medical (San Diego, CA, USA), Danone Nutricia Research (Palaiseau, France) and Bellco (Mirandola, Italy). The grants were given to ISN and none of the authors received any direct payments from any of the entities. The project was partially supported by the National Institutes of Health, Grant UL1TR001442 of CTSA funding. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We also acknowledge support from the UAB-UCSD O'Brien Core Center for Acute Kidney Injury Research (NIH P30-DK079337) for this project. We thank all the providers for their involvement in data acquisition and International Society for Nephrology staff Luisa Strani, Louise Fox, and Luca Segantini, and the coordinating centre personnel Marcela Zhou-Huang, Susan Calleran, Wes Vetter, and Sean Patno for their support. Participating providers and centers are listed in the Si Acknowledgments.	Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Basu RK, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0016-6; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bouchard J, 2015, CLIN J AM SOC NEPHRO, V10, P1324, DOI 10.2215/CJN.04360514; Cerda A J MS, 2017, KIDNEY INT REPORTS; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; Cerda J, 2008, NAT CLIN PRACT NEPHR, V4, P138, DOI 10.1038/ncpneph0722; Cerda J, 2017, KIDNEY INT REP, V2, P530, DOI 10.1016/j.ekir.2017.04.009; Cerda J, 2011, KIDNEY INT, V80, P699, DOI 10.1038/ki.2011.177; Davenport GC, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4286576; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Imani PD, 2013, PEDIATR NEPHROL, V28, P2199, DOI 10.1007/s00467-013-2544-2; Jha V, 1997, J Assoc Physicians India, VSuppl 2, P18; Jha V, 2013, NAT REV NEPHROL, V9, P278, DOI 10.1038/nrneph.2013.36; Kaddourah A, 2016, N ENGL J MED; Kateera F, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0973-z; Kohli HS, 2007, RENAL FAILURE, V29, P463, DOI 10.1080/08860220701260651; Kolhe NV, 2015, KIDNEY INT, V88, P1161, DOI 10.1038/ki.2015.234; Krishnamurthy S, 2013, INDIAN J CRIT CARE M, V17, P207, DOI 10.4103/0972-5229.118412; Krishnamurthy S, 2013, INDIAN J PEDIATR, V80, P183, DOI 10.1007/s12098-012-0791-z; Kwenti TE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004673; Lameire N, 2016, PEDIAT NEPHROL; Langford S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004195; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Macedo E, 2017, ASN RENAL WEEK, P416; Macedo E, 2011, KIDNEY INT, V80, P760, DOI 10.1038/ki.2011.150; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2016, LANCET, V387, P2017, DOI 10.1016/S0140-6736(16)30240-9; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Mehta RL, 2016, LANCET; Mishra OP, 2012, PERITON DIALYSIS INT, V32, P431, DOI 10.3747/pdi.2012.00118; Naicker S, 2008, SEMIN NEPHROL, V28, P348, DOI 10.1016/j.semnephrol.2008.04.003; Naing C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003205; Odetunde Odutola Israel, 2014, ScientificWorldJournal, V2014, P903151, DOI 10.1155/2014/903151; Ogunlesi T, 2009, INDIAN J PEDIATR, V76, P293, DOI 10.1007/s12098-009-0055-8; Olowu WA, 2004, KIDNEY INT, V66, P1541, DOI 10.1111/j.1523-1755.2004.00918.x; Olowu WA, 2016, LANCET GLOB HEALTH, V4, pE242, DOI 10.1016/S2214-109X(15)00322-8; Remuzzi G, 2013, LANCET, V382, P2041, DOI 10.1016/S0140-6736(13)62193-5; Roberts DJ, 2016, HEMATOL ONCOL CLIN N, V30, P233, DOI 10.1016/j.hoc.2015.11.001; Sanchez-Pinto LN, 2015, PEDIATR CRIT CARE ME, V16, P703, DOI 10.1097/PCC.0000000000000461; Susantitaphong P, 2013, CLIN J AM S IN PRESS; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Tette EMA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150387; Thakar CV, 2007, AM J KIDNEY DIS, V50, P703, DOI 10.1053/j.ajkd.2007.07.021; Zappitelli M, 2007, PEDIATR NEPHROL, V22, P272, DOI 10.1007/s00467-006-0322-0	45	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196586	10.1371/journal.pone.0196586	http://dx.doi.org/10.1371/journal.pone.0196586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715307	Green Submitted, gold, Green Published			2022-12-26	WOS:000431281100033
J	Awad, SF; Chemaitelly, H; Abu-Raddad, LJ				Awad, Susanne F.; Chemaitelly, Hiam; Abu-Raddad, Laith J.			Temporal evolution of HIV sero-discordancy patterns among stable couples in sub-Saharan Africa	PLOS ONE			English	Article							TRANSMISSION; INFECTIONS; PREVENTION; EPIDEMIC; BEHAVIOR; RISK; SEX	Introduction Objective was to examine the temporal variation of HIV sero-discordancy in select representative countries (Kenya, Lesotho, Mali, Niger, Tanzania, and Zimbabwe) in sub-Saharan Africa at different HIV epidemic scales. A sero-discordant couple is defined as a stable couple (SC) in which one partner is HIV-positive while the other is HIV-negative. Methods A deterministic compartmental mathematical model was constructed to describe HIV transmission dynamics. The model was pair-based, that is explicitly modeling formation of SCs and infection dynamics in both SCs and in single individuals. The model accommodated for different forms of infection statuses in SCs. Using population-based nationally-representative epidemiologic and demographic input data, historical (1980-2014) and future (2015-2030) trends of sero-discordancy and other demographic and epidemiologic indicators were projected throughout HIV epidemic phases. Results As the epidemics emerged, about 90% of SCs affected by HIV were sero-discordant. This proportion declined to 45%-88% at epidemic peak and stabilized as the epidemics started their natural decline. The largest reductions in sero-discordancy were in high HlV-prevalence countries. As the epidemics further declined with antiretroviral therapy (ART) scale-up, the proportion of sero-discordant couples among HIV-affected couples was projected to increase to 70%-92% by 2030. The proportion of sero-discordant couples among all SCs increased as the epidemics emerged and evolved, then peaked at 2%-20% as the epidemics peaked, and then declined as the epidemics declined to reach 0.3%-16% by 2030. Conclusions Sero-discordancy patterns varied with the evolution of the epidemics, and were affected by both epidemic phase and scale. The largest variations were found in high HIV-prevalence countries. The fraction of stable couples that are sero-discordant, as opposed to being sero-concordant positive, was projected to increase with ART scale-up and further HIV incidence decline over the coming two decades. These findings inform strategic planning and resource allocation for interventions among sero-discordant couples.	[Awad, Susanne F.; Chemaitelly, Hiam; Abu-Raddad, Laith J.] Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar; [Awad, Susanne F.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY 10021 USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; St Georges University London; Cornell University	Abu-Raddad, LJ (corresponding author), Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar.; Abu-Raddad, LJ (corresponding author), Cornell Univ, Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY 10021 USA.	lja2002@qatar-med.cornell.edu	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Chemaitelly, Hiam/0000-0002-8756-6968	NPRP from the Qatar National Research Fund (a member of Qatar Foundation) [6-681-3-173]	NPRP from the Qatar National Research Fund (a member of Qatar Foundation)	This publication was made possible by NPRP grant number 6-681-3-173 from the Qatar National Research Fund (a member of Qatar Foundation). The findings achieved herein are solely the responsibility of the authors.	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; [Anonymous], DEM HLTH SURV; Awad SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145729; Awad SF, 2014, EPIDEMICS-NETH, V8, P9, DOI 10.1016/j.epidem.2014.06.001; Bellan SE, 2013, LANCET, V381, P1561, DOI 10.1016/S0140-6736(12)61960-6; Chemaitelly H, 2016, EPIDEMIOL INFECT, V144, P90, DOI 10.1017/S0950268815000758; CHEMAITELLY H, 2011, 18 C RETR OPP INF BO; Chemaitelly H, 2014, EPIDEMICS-NETH, V6, P1, DOI 10.1016/j.epidem.2013.11.001; Chemaitelly H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18765; Chemaitelly H, 2013, SEX TRANSM INFECT, V89, P138, DOI 10.1136/sextrans-2012-050651; Chemaitelly H, 2013, AIDS, V27, P251, DOI 10.1097/QAD.0b013e32835ad459; Chemaitelly H, 2012, SEX TRANSM INFECT, V88, P51, DOI 10.1136/sextrans-2011-050114; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cuadros DF, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13090865; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Granich R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131353; Guthrie BL, 2007, CURR HIV RES, V5, P416, DOI 10.2174/157016207781023992; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Matovu JKB, 2010, CURR HIV RES, V8, P430, DOI 10.2174/157016210793499303; Muessig KE, 2014, CURR HIV-AIDS REP, V11, P434, DOI 10.1007/s11904-014-0225-9; Omori R, 2016, INT J INFECT DIS, V44, P1, DOI 10.1016/j.ijid.2016.01.005; Omori R, 2015, SEX TRANSM INFECT, V91, P451, DOI 10.1136/sextrans-2014-051925; Shelton JD, 2010, LANCET, V375, P964, DOI 10.1016/S0140-6736(10)60416-3; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; The MathWorks Inc.MATLAB, 2015, LANG TECHN COMP 8 5; UNAIDS, 2011, GLOB HIV AIDS RESP E; UNAIDS, 2014, HIV EST 1990 2014; UNAIDS. AIDSinfo, 2015, COV PEOPL REC ART; World Health Organization, 2012, GUID OR PREEXP PROPH	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196613	10.1371/journal.pone.0196613	http://dx.doi.org/10.1371/journal.pone.0196613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708995	Green Published, gold, Green Submitted			2022-12-26	WOS:000431130100042
J	Gama, ADS; de Paula, M; da Silva, RRV; Ferreira, WS; de Medeiros, PM				Sena Gama, Aline Dourado; de Paula, Marcelo; Vasconcelos da Silva, Rafael Ricardo; Ferreira Junior, Washington Soares; de Medeiros, Patricia Muniz			Exotic species as models to understand biocultural adaptation: Challenges to mainstream views of human-nature relations	PLOS ONE			English	Article							LOCAL ECOLOGICAL KNOWLEDGE; COST-BENEFIT-ANALYSIS; MAPUCHE COMMUNITY; GENETIC-VARIATION; MEDICINAL-PLANTS; TEHUACAN VALLEY; CLIMATE-CHANGE; EVOLUTION; DOMESTICATION; ENVIRONMENTS	A central argument in the research on traditional knowledge, which persists in the scientific literature, is that the entrance of exotic plants in local medical systems is directly associated with acculturation. However, this logic has put an end for a long period to efforts to understand why such species have so successfully entered socio-ecological systems or even their real role in such systems. This study provides evidence that (1) in some socio-environmental contexts, exotic medicinal species usually confer greater adaptive advantages to local populations, and (2) despite their general importance, exotic species only excel in medical systems when cost-benefit ratio is favorable to them. Thus, in order to avoid the loss of knowledge about native plants and to ensure biocultural conservation, it is necessary to create strategies to amplify the advantages of these species.	[Sena Gama, Aline Dourado; de Paula, Marcelo] Univ Fed Oeste Bahia, Programa Posgrad Ciencias Ambientais, Estr Barrocao, Barreiras, BA, Brazil; [Vasconcelos da Silva, Rafael Ricardo; de Medeiros, Patricia Muniz] Univ Fed Alagoas, Ctr Ciencias Agr, Rio Largo, Alagoas, Brazil; [Ferreira Junior, Washington Soares] Univ Pernambuco, Campus Petrolina, Petrolina, PE, Brazil	Universidade Federal do Oeste da Bahia; Universidade Federal de Alagoas; Universidade de Pernambuco (UPE)	de Medeiros, PM (corresponding author), Univ Fed Alagoas, Ctr Ciencias Agr, Rio Largo, Alagoas, Brazil.	patricia.medeiros@ceca.ufal.br	Júnior, Washington Soares Ferreira/F-8600-2018; de Medeiros, Patricia Muniz/H-7198-2012; da Silva, Rafael Ricardo Vasconcelos/AAS-2412-2020	Júnior, Washington Soares Ferreira/0000-0002-3128-0514; de Medeiros, Patricia Muniz/0000-0002-3835-5232; da Silva, Rafael Ricardo Vasconcelos/0000-0003-4296-0117	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [441550/2014-2, 302786/2016-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (proc. 441550/2014-2 and proc. 302786/2016-3), http://www.cnpq.br/.; The authors thank the community of Morrao de Cima for the reception and willingness to participate in the study. The authors also thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the research grant (proc. 441550/2014-2) and productivity grant (proc. 302786/2016-3) given to P.M.M.	Albuquerque Ulysses Paulino, 2015, EVOLUTIONARY ETHNOBI; Alencar NL, 2014, REV BRAS FARMACOGN, V24, P506, DOI 10.1016/j.bjp.2014.09.003; Alencar NL, 2010, ECON BOT, V64, P68, DOI 10.1007/s12231-009-9104-5; Alexiades MN., 1996, SELECTED GUIDELINES; Atallah DG, 2016, INT J DISAST RISK RE, V19, P92, DOI 10.1016/j.ijdrr.2016.08.027; Barton L, 2016, ARCHAEOL RES ASIA, V5, P4, DOI 10.1016/j.ara.2016.01.001; BEGOSSI A, 1993, INTERCIENCIA, V18, P121; Bennett BC, 2000, ECON BOT, V54, P90, DOI 10.1007/BF02866603; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Blanco J, 2016, J ARID ENVIRON, V127, P30, DOI 10.1016/j.jaridenv.2015.10.021; Casas A, 1997, ECON BOT, V51, P279, DOI 10.1007/BF02862097; Chou CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107869; de Albuquerque UP, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-30; de Medeiros PM, 2015, J ETHNOPHARMACOL, V159, P43, DOI 10.1016/j.jep.2014.11.001; de Medeiros PM, 2013, ETHNOBIOL CONSERV, V2, DOI 10.15451/ec2013-8-2.3-1-05; Estomba D, 2006, J ETHNOPHARMACOL, V103, P109, DOI 10.1016/j.jep.2005.07.015; Ferreira Junior WS., 2015, EVOLUTIONARY ETHNOBI, P105, DOI DOI 10.1007/978-3-319-19917-7; GUIMARAES M. P., 2016, THESIS; HAWKES K, 1982, AM ETHNOL, V9, P379, DOI 10.1525/ae.1982.9.2.02a00100; Hu Y, 2007, BIOMED CHROMATOGR, V21, P967, DOI 10.1002/bmc.841; IBGE, 2015, CID I BRAS GEOGR EST; JOHNS T, 1990, ORIGINS HUMAN DIET M; Kameda T, 2002, EVOL HUM BEHAV, V23, P373, DOI 10.1016/S1090-5138(02)00101-0; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; Kormondy Edward John, 1998, FUNDAMENTALS HUMAN E; Ladio AH, 2004, BIODIVERS CONSERV, V13, P1153, DOI 10.1023/B:BIOC.0000018150.79156.50; Ladio AH, 2003, BIODIVERS CONSERV, V12, P937, DOI 10.1023/A:1022873725432; Levine J, 2015, ECOL ECON, V114, P22, DOI 10.1016/j.ecolecon.2015.03.010; Linstadter A, 2013, J ARID ENVIRON, V95, P30, DOI 10.1016/j.jaridenv.2013.03.008; Medeiros P. M., 2015, EVOLUTIONARY ETHNOBI, P7; MEDEIROS P. V. Q., 2012, THESIS; Moro MF, 2012, ACTA BOT BRAS, V26, P991, DOI 10.1590/S0102-33062012000400029; Orlove B, 2005, ENVIRON SCI POLICY, V8, P589, DOI 10.1016/j.envsci.2005.06.009; Otero-Arnaiz A, 2005, MOL ECOL, V14, P1603, DOI 10.1111/j.1365-294X.2005.02494.x; Pavlovic A, 2015, ANN BOT-LONDON, V115, P1075, DOI 10.1093/aob/mcv050; Peroni N, 2007, GENET RESOUR CROP EV, V54, P1333, DOI 10.1007/s10722-006-9116-2; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI 10.1007/BF02862204; REYER HU, 1984, ANIM BEHAV, V32, P1163, DOI 10.1016/S0003-3472(84)80233-X; ROUGHGARDEN J, 1975, ECOLOGY, V56, P1201, DOI 10.2307/1936160; Goncalves PHS, 2016, ECOL APPL, V26, P2238, DOI 10.1002/eap.1364; Saslis-Lagoudakis CH, 2012, P NATL ACAD SCI USA, V109, P15835, DOI 10.1073/pnas.1202242109; Schluter M, 2017, ECOL ECON, V131, P21, DOI 10.1016/j.ecolecon.2016.08.008; Sieber SS, 2011, J AGR ENVIRON ETHIC, V24, P511, DOI 10.1007/s10806-010-9277-z; Sih A, 2001, ANIM BEHAV, V61, P379, DOI 10.1006/anbe.2000.1592; SMITH EA, 1983, CURR ANTHROPOL, V24, P625, DOI 10.1086/203066; Winterhalder B, 2000, EVOL ANTHROPOL, V9, P51; Worm B, 2016, TRENDS ECOL EVOL, V31, P600, DOI 10.1016/j.tree.2016.05.008; Wu Xiaoxu, 2016, Environ Int, V86, P14, DOI 10.1016/j.envint.2015.09.007; Yang ST, 2011, PLANTA MED, V77, P865, DOI 10.1055/s-0030-1250601	49	16	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196091	10.1371/journal.pone.0196091	http://dx.doi.org/10.1371/journal.pone.0196091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE3RI	29708981	gold, Green Published, Green Submitted			2022-12-26	WOS:000431130100014
J	Breunig, CT; Durovic, T; Neuner, AM; Baumann, V; Wiesbeck, MF; Koferle, A; Gotz, M; Ninkovic, J; Stricker, SH				Breunig, Christopher T.; Durovic, Tamara; Neuner, Andrea M.; Baumann, Valentin; Wiesbeck, Maximilian F.; Koeferle, Anna; Goetz, Magdalena; Ninkovic, Jovica; Stricker, Stefan H.			One step generation of customizable gRNA vectors for multiplex CRISPR approaches through string assembly gRNA cloning (STAgR)	PLOS ONE			English	Article							GENOME; SYSTEM; GENES; CELLS	Novel applications based on the bacterial CRISPR system make genetic, genomic, transcriptional and epigenomic engineering widely accessible for the first time. A significant advantage of CRISPR over previous methods is its tremendous adaptability due to its bipartite nature. Cas9 or its engineered variants define the molecular effect, while short gRNAs determine the targeting sites. A majority of CRISPR approaches depend on the simultaneous delivery of multiple gRNAs into single cells, either as an essential precondition, to increase responsive cell populations or to enhance phenotypic outcomes. Despite these requirements, methods allowing the efficient generation and delivery of multiple gRNA expression units into single cells are still sparse. Here we present STAgR (String assembly gRNA cloning), a single step gRNA multiplexing system, that obtains its advantages by employing the N20 targeting sequences as necessary homologies for Gibson assembly. We show that STAgR allows reliable and cost-effective generation of vectors with high numbers of gRNAs enabling multiplexed CRISPR approaches. Moreover, STAgR is easily customizable, as vector backbones as well as gRNA structures, numbers and promoters can be freely chosen and combined. Finally, we demonstrate STAgR's widespread functionality, its efficiency in multi-targeting approaches, using it for both, genome and transcriptome editing, as well as applying it in vitro and in vivo.	[Breunig, Christopher T.; Neuner, Andrea M.; Baumann, Valentin; Wiesbeck, Maximilian F.; Koeferle, Anna; Stricker, Stefan H.] Ludwig Maximilians Univ Munchen, Munich Ctr Neurosci, MCN Jr Res Grp, BioMed Ctr, Planegg Martinsried, Germany; [Breunig, Christopher T.; Stricker, Stefan H.] Helmholtz Zentrum, German Res Ctr Environm Hlth, Inst Stem Cell Res, Epigenet Engn, Planegg Martinsried, Germany; [Durovic, Tamara; Baumann, Valentin] Ludwig Maximilians Univ Munchen, Grad Sch System Neurosci, Munich, Germany; [Durovic, Tamara; Ninkovic, Jovica] Helmholtz Zentrum, German Res Ctr Environm Hlth, Inst Stem Cell Res, Neurogenesis & Regenerat, Neuherberg, Germany; [Goetz, Magdalena] Helmholtz Zentrum, German Res Ctr Environm Hlth, Inst Stem Cell Res, Neural Stem cells, Neuherberg, Germany; [Goetz, Magdalena; Ninkovic, Jovica] Ludwig Maximilians Univ Munchen, BioMed Ctr, Physiol Genom, Planegg Martinsried, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Stricker, SH (corresponding author), Ludwig Maximilians Univ Munchen, Munich Ctr Neurosci, MCN Jr Res Grp, BioMed Ctr, Planegg Martinsried, Germany.; Stricker, SH (corresponding author), Helmholtz Zentrum, German Res Ctr Environm Hlth, Inst Stem Cell Res, Epigenet Engn, Planegg Martinsried, Germany.	stricker@biologie.uni-muenchen.de	Stricker, Stefan H/A-4930-2015; Ninkovic, Jovica/AAH-5220-2019	Stricker, Stefan H/0000-0002-5488-8530; Ninkovic, Jovica/0000-0002-4381-0041; Koferle, Anna/0000-0003-1601-7774	Deutsche Forschungsgemeinschaft [STR 1385/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	CB, AN, VB, MW, AK and SHS were supported by Deutsche Forschungsgemeinschaft (STR 1385/1-1) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balboa D, 2015, STEM CELL REP, V5, P448, DOI 10.1016/j.stemcr.2015.08.001; Barbosa JS, 2016, NAT PROTOC, V11, P1360, DOI 10.1038/nprot.2016.077; Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729; Black JB, 2016, CELL STEM CELL, V19, P406, DOI 10.1016/j.stem.2016.07.001; Chakraborty S, 2014, STEM CELL REP, V3, P940, DOI 10.1016/j.stemcr.2014.09.013; Chavez A, 2015, NAT METHODS, V12, P326, DOI [10.1038/nmeth.3312, 10.1038/NMETH.3312]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Ferreira R, 2018, ACS SYNTH BIOL, V7, P10, DOI 10.1021/acssynbio.7b00259; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Jiang JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep21918; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/nmeth.4108, 10.1038/NMETH.4108]; Kizil C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027395; Koeferle A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0185-8; Koferle A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3268-z; Koferle A, J VISUALIZE IN PRESS; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Ledford H, 2016, NATURE, V531, P156, DOI 10.1038/531156a; Lekomtsev S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3084-5; Maeder ML, 2013, NAT METHODS, V10, P977, DOI [10.1038/NMETH.2598, 10.1038/nmeth.2598]; Port F, 2016, NAT METHODS, V13, P852, DOI 10.1038/nmeth.3972; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Stricker SH, 2017, NAT REV GENET, V18, P51, DOI 10.1038/nrg.2016.138; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17517; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396	34	22	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196015	10.1371/journal.pone.0196015	http://dx.doi.org/10.1371/journal.pone.0196015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702666	Green Published, gold			2022-12-26	WOS:000431013300014
J	Aoki, T; Yamada, A; Nagata, N; Niikura, R; Hirata, Y; Koike, K				Aoki, Tomonori; Yamada, Atsuo; Nagata, Naoyoshi; Niikura, Ryota; Hirata, Yoshihiro; Koike, Kazuhiko			External validation of the NOBLADS score, a risk scoring system for severe acute lower gastrointestinal bleeding	PLOS ONE			English	Article							DIVERTICULAR HEMORRHAGE; EARLY PREDICTORS; COLONOSCOPY; MORTALITY; JAPAN; TRIAGE	Background We aimed to evaluate the generalizability of NOBLADS, a severe lower gastrointestinal bleeding (LGIB) prediction model which we had previously derived when working at a different institution, using an external validation cohort. NOBLADS comprises the following factors: non-steroidal anti-inflammatory drug use, no diarrhea, no abdominal tenderness, blood pressure <= 100 mmHg, antiplatelet drug use, albumin < 3.0 g/dL, disease score >= 2, and syncope. Methods We retrospectively analyzed 511 patients emergently hospitalized for acute LGIB at the University of Tokyo Hospital, from January 2009 to August 2016. The areas under the receiver operating characteristic curves (ROCs-AUCs) for severe bleeding (continuous and/or recurrent bleeding) were compared between the original derivation cohort and the external validation cohort. Results Severe LGIB occurred in 44% of patients. Several clinical factors were significantly different between the external and derivation cohorts (p < 0.05), including background, laboratory data, NOBLADS scores, and diagnosis. The NOBLADS score predicted the severity of LGIB with an AUC value of 0.74 in the external validation cohort and one of 0.77 in the derivation cohort. In the external validation cohort, the score predicted the risk for blood transfusion need (AUC, 0.71), but was not adequate for predicting intervention need (AUC, 0.54). The in-hospital mortality rate was higher in patients with a score >= 5 than in those with a score < 5 (AUC, 0.83). Conclusions Although the external validation cohort clinically differed from the derivation cohort in many ways, we confirmed the moderately high generalizability of NOBLADS, a clinical risk score for severe LGIB. Appropriate triage using this score may support early decision-making in various hospitals.	[Aoki, Tomonori; Yamada, Atsuo; Niikura, Ryota; Hirata, Yoshihiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Nagata, Naoyoshi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan	University of Tokyo; National Center for Global Health & Medicine - Japan	Yamada, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	yamada-a@umin.ac.jp			JSPS KAKENHI [15K08964]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the JSPS KAKENHI (Grant Number 15K08964) to AY. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2016, CLIN GASTROENTEROL H; Blatchford O, 2000, LANCET, V356, P1318, DOI 10.1016/S0140-6736(00)02816-6; Chan FKL, 2010, J RHEUMATOL, V37, P167, DOI 10.3899/jrheum.090168; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chong V, 2016, INT J SURG, V25, P19, DOI 10.1016/j.ijsu.2015.11.003; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; KOLLEF MH, 1995, CRIT CARE MED, V23, P1048, DOI 10.1097/00003246-199506000-00009; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Longstreth GF, 2002, AM J GASTROENTEROL, V97, P203; Miyamoto M, 2012, J GASTROEN HEPATOL, V27, P372, DOI 10.1111/j.1440-1746.2011.06878.x; Nagata N, 2016, CLIN GASTROENTEROL H, V14, P558, DOI 10.1016/j.cgh.2015.10.011; Nagata N, 2014, INT J COLORECTAL DIS, V29, P379, DOI 10.1007/s00384-013-1808-4; Newman J, 2012, COLORECTAL DIS, V14, P1020, DOI 10.1111/j.1463-1318.2011.02824.x; Niikura R, 2015, J GASTROENTEROL, V50, P533, DOI 10.1007/s00535-014-0994-3; Oakland K, 2017, LANCET GASTROENTEROL, V2, P635, DOI 10.1016/S2468-1253(17)30150-4; Sengupta N, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2016.12.009; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Strate LL, 2005, AM J GASTROENTEROL, V100, P1821, DOI 10.1111/j.1572-0241.2005.41755.x; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Strate LL, 2016, AM J GASTROENTEROL; Velayos FS, 2004, CLIN GASTROENTEROL H, V2, P485, DOI 10.1016/S1542-3565(04)00167-3	23	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196514	10.1371/journal.pone.0196514	http://dx.doi.org/10.1371/journal.pone.0196514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698506	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600090
J	Lin, C; Tsai, CH; Chen, PY; Wu, CY; Chang, YL; Yang, YL; Chen, YL				Lin, Chih; Tsai, Chia-Hsin; Chen, Pi-Yu; Wu, Chia-Yen; Chang, Ya-Lin; Yang, Yu-Liang; Chen, Ying-Lien			Biological control of potato common scab by Bacillus amyloliquefaciens Ba01	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; STREPTOMYCES-SCABIES; PLANT-GROWTH; FUNCTIONAL-CHARACTERIZATION; GENE CLUSTERS; STRAIN; BIOSYNTHESIS; BIOCONTROL; DISEASE; PATHOGENICITY	Potato common scab, which is caused by soil-borne Streptomyces species, is a severe plant disease that results in a significant reduction in the economic value of potatoes worldwide. Due to the lack of efficacious pesticides, crop rotations, and resistant potato cultivars against the disease, we investigated whether biological control can serve as an alternative approach. In this study, multiple Bacillus species were isolated from healthy potato tubers, and Bacillus amyloliquefaciens Ba01 was chosen for further analyses based on its potency against the potato common scab pathogen Streptomyces scabies. Ba01 inhibited the growth and sporulation of S. scabies and secreted secondary metabolites such as surfactin, iturin A, and fengycin with potential activity against S. scabies as determined by imaging mass spectrometry. In pot assays, the disease severity of potato common scab decreased from 55.6 +/- 11.1% (inoculated with S. scabies only) to 4.2 +/- 1.4% (inoculated with S. scabies and Ba01). In the field trial, the disease severity of potato common scab was reduced from 14.4 +/- 2.9% (naturally occurring) to 5.6 +/- 1.1% after Ba01 treatment, representing evidence that Bacillus species control potato common scab in nature.	[Lin, Chih; Wu, Chia-Yen; Chang, Ya-Lin; Chen, Ying-Lien] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei, Taiwan; [Tsai, Chia-Hsin] Agr Res Inst Taiwan, Dept Plant Pathol, Taichung, Taiwan; [Chen, Pi-Yu; Yang, Yu-Liang] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan	National Taiwan University; Agricultural Research Institute of Taiwan; Academia Sinica - Taiwan	Chen, YL (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei, Taiwan.	ychen28@ntu.edu.tw		Chen, Ying-Lien/0000-0002-1966-470X	Bureau of Animal and Plant Health Inspection and Quarantine [104AS-10.7.3-BQ-B1(5), 105AS-10.6.3-BQ-B1, 106AS-9.5.3.-BQ-B3(3)]; Ministry of Science & Technology in Taiwan [102-230-B-002-041-MY2, 104-2320-B-002-063-MY3, 106-2923-B-002-001-MY3]	Bureau of Animal and Plant Health Inspection and Quarantine; Ministry of Science & Technology in Taiwan	We are grateful to Ms. Shang-Jie Yu for assistance with scanning electron microscopy, Mr. Rong Su for providing the potato field for the trial, Dr. Chih-Hung Huang for providing Streptomyces coelicolor A3(2) strain and Cecelia Wall for language edits. This work is financially supported by 104AS-10.7.3-BQ-B1(5), 105AS-10.6.3-BQ-B1, and 106AS-9.5.3.-BQ-B3(3) from the Bureau of Animal and Plant Health Inspection and Quarantine, and 102-230-B-002-041-MY2, 104-2320-B-002-063-MY3, and 106-2923-B-002-001-MY3 from the Ministry of Science & Technology in Taiwan.	Correa DBA, 2015, EUR J PLANT PATHOL, V142, P1, DOI 10.1007/s10658-014-0584-5; Arseneault T, 2016, PHYTOPATHOLOGY, V106, P963, DOI 10.1094/PHYTO-01-16-0019-R; Arseneault T, 2015, PHYTOPATHOLOGY, V105, P1311, DOI 10.1094/PHYTO-12-14-0358-R; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bignell DRD, 2014, J APPL MICROBIOL, V116, P223, DOI 10.1111/jam.12369; Bignell DRD, 2010, MOL PLANT MICROBE IN, V23, P161, DOI 10.1094/MPMI-23-2-0161; Chen XH, 2009, J BIOTECHNOL, V140, P27, DOI 10.1016/j.jbiotec.2008.10.011; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen XH, 2009, J MOL MICROB BIOTECH, V16, P14, DOI 10.1159/000142891; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; Chowdhury SP, 2015, MOL PLANT MICROBE IN, V28, P984, DOI 10.1094/MPMI-03-15-0066-R; Chowdhury SP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00780; Dees MW, 2012, POTATO RES, V55, P249, DOI 10.1007/s11540-012-9206-9; Eckwall EC, 1997, J IND MICROBIOL BIOT, V19, P220, DOI 10.1038/sj.jim.2900455; Garcia-Gutierrez L, 2013, MICROB BIOTECHNOL, V6, P264, DOI 10.1111/1751-7915.12028; Han JS, 2005, J APPL MICROBIOL, V99, P213, DOI 10.1111/j.1365-2672.2005.02614.x; Hiltunen LH, 2009, J APPL MICROBIOL, V106, P199, DOI 10.1111/j.1365-2672.2008.03992.x; Huguet-Tapia JC, 2016, APPL ENVIRON MICROB, V82, P2146, DOI 10.1128/AEM.03504-15; King RR, 2009, PHYTOCHEMISTRY, V70, P833, DOI 10.1016/j.phytochem.2009.04.013; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lambert DH, 2007, INT J SYST EVOL MICR, V57, P2447, DOI 10.1099/ijs.0.65275-0; Larkin RP, 2011, PHYTOPATHOLOGY, V101, P58, DOI 10.1094/PHYTO-04-10-0100; Lin C., 2017, Journal of Plant Medicine, V59, P31, DOI 10.6716/JPM.201709_59(3).0004; LORIA R, 1995, PHYTOPATHOLOGY, V85, P537, DOI 10.1094/Phyto-85-537; Loria R, 2006, ANNU REV PHYTOPATHOL, V44, P469, DOI 10.1146/annurev.phyto.44.032905.091147; Meng QX, 2012, J APPL MICROBIOL, V113, P1165, DOI 10.1111/j.1365-2672.2012.05420.x; Schneider K, 2007, J NAT PROD, V70, P1417, DOI 10.1021/np070070k; Shih CJ, 2014, NAT PROD REP, V31, P739, DOI 10.1039/c3np70091g; Singh S., 2013, ISRN MICROBIOL, P1, DOI [10.1155/2013/728134, DOI 10.1155/2013/728134]; St-Onge R, 2008, SYST APPL MICROBIOL, V31, P474, DOI 10.1016/j.syapm.2008.09.002; St-Onge R, 2011, FEMS MICROBIOL ECOL, V75, P173, DOI 10.1111/j.1574-6941.2010.00992.x; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Wanner LA, 2014, J APPL MICROBIOL, V116, P123, DOI 10.1111/jam.12336; Wanner LA, 2006, PHYTOPATHOLOGY, V96, P1363, DOI 10.1094/PHYTO-96-1363; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wilson CR, 1999, J PHYTOPATHOL, V147, P13, DOI 10.1111/j.1439-0434.1999.tb03801.x; Yuan J, 2013, J AGR FOOD CHEM, V61, P3774, DOI 10.1021/jf400038z; Zhang YC, 2016, MOL PLANT MICROBE IN, V29, P640, DOI 10.1094/MPMI-04-16-0068-R	42	29	36	15	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196520	10.1371/journal.pone.0196520	http://dx.doi.org/10.1371/journal.pone.0196520			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698535	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600093
J	Mendes, CB; Norenburg, JL; Solferini, VN; Andrade, SCS				Mendes, Cecili B.; Norenburg, Jon L.; Solferini, Vera N.; Andrade, Sonia C. S.			Hidden diversity: Phylogeography of genus Ototyphlonemertes Diesing, 1863 (Ototyphlonemertidae: Hoplonemertea) reveals cryptic species and high diversity in Chilean populations	PLOS ONE			English	Article							NEUTRALITY TESTS; SOUTH-AFRICA; DISPERSAL; MEIOFAUNA; NEMERTEA; COSMOPOLITAN; GASTROTRICHA; SOFTWARE; INVERTEBRATES; COLONIZATION	Ototyphlonemertes is a cosmopolitan genus of meiofaunal nemerteans. Their morphological characters are insufficient to reliably identify and delimit species. Consequently, some of the species are considered cosmopolitan despite anticipated low dispersion capability of the adults and a short planktonic larval phase. Indeed, recent studies show that some species actually comprise cryptic species, and populations are connected by stochastic events of long-distance dispersion. Based solely on morphological traits, a Lactea and a Pallida morph of Ototyphlonemertes are recognized here from collections at eight and five locations respectively along the Chilean coast. To assess the phylogeographic patterns of their populations, two mitochondrial markers (COI and COX3) of 162 specimens of Lactea and 25 of Pallida were sequenced. Final sequences are 605bp and 362bp for COI and COX3, respectively. Results from phylogenetic and haplotype network analyses suggest that the Lactea morph comprises up to three independent evolutionary units (one with only COX3 sequences). A COI gene tree including other previously published Ototyphlonemertes sequences groups the Chilean Lactea with other Lactea, while the Chilean Pallida is grouped with other Pallida. Different structuring and gene flow patterns found for the four groups support the hypothesis that these are four independent evolutionary entities with different ecological, dispersal and demographical characteristics.	[Mendes, Cecili B.; Andrade, Sonia C. S.] IB USP, Lab Diversidade Genom, Dept Genet & Biol Evolut, Sao Paulo, SP, Brazil; [Norenburg, Jon L.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Solferini, Vera N.] IB UNICAMP, Lab Diversidade Genet, Dept Genet Evolucao Microbiol & Imunol, Campinas, SP, Brazil	Smithsonian Institution; Smithsonian National Museum of Natural History; Universidade Estadual de Campinas	Mendes, CB; Andrade, SCS (corresponding author), IB USP, Lab Diversidade Genom, Dept Genet & Biol Evolut, Sao Paulo, SP, Brazil.	cecilimendes@gmail.com; soniacsandrade@ib.usp.br	Mendes, Cecili/AAH-8523-2020; Andrade, Sonia/GLS-1234-2022; UNICAMP, CCES -/J-7787-2015; Solferini, Vera/E-9121-2012; Andrade, Sonia CS/F-8267-2014; Norenburg, Jon/K-3481-2015	Mendes, Cecili/0000-0002-9041-1270; Andrade, Sonia/0000-0002-1302-5261; Solferini, Vera/0000-0001-6582-1449; Andrade, Sonia CS/0000-0002-1302-5261; Norenburg, Jon/0000-0001-7776-1527	National Science Foundation [DEB-9712463]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2016/20005-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1629710]	National Science Foundation(National Science Foundation (NSF)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by the following institutions: National Science Foundation Grant DEB-9712463 to JLN, funding the fieldwork and lab work; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br), through the grant No 2016/20005-5, funding CBM's PhD scholarship; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br), through the grant No 1629710, funding the first months of CBM's PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksic JM, 2010, PLANT SYST EVOL, V285, P1, DOI 10.1007/s00606-009-0250-0; Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade SCS, 2011, MAR BIOL, V158, P2109, DOI 10.1007/s00227-011-1718-3; ARMONIES W, 1994, HELGOLANDER MEERESUN, V48, P299, DOI 10.1007/BF02367043; Beerli Peter, 2009, V17, P42; Bik HM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-389; Boeckner MJ, 2009, HYDROBIOLOGIA, V624, P91, DOI 10.1007/s10750-008-9669-5; BRATTSTROM H, 1983, SARSIA, V68, P289, DOI 10.1080/00364827.1983.10420583; Broitman BR, 2011, REV CHIL HIST NAT, V84, P143, DOI 10.4067/S0716-078X2011000100011; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Casu M, 2004, MAR BIOL, V145, P669, DOI 10.1007/s00227-004-1367-x; CHERNYSHEV AV, 2000, RUSSIAN J MARINE BIO, V26, P48, DOI DOI 10.1007/BF02759495; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Commito JA, 2002, J EXP MAR BIOL ECOL, V268, P237, DOI 10.1016/S0022-0981(01)00386-0; CORREA DIVA DINIZ, 1949, COMUNIC ZOOL MUS HIST NAT MONTEVIDEO, V3, P1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Envall M, 1998, ZOOL J LINN SOC-LOND, V123, P105, DOI 10.1006/zjls.1996.0130; Envall M, 2001, HYDROBIOLOGIA, V456, P145, DOI 10.1023/A:1013029310452; Envall M, 1996, J ZOOL, V238, P253, DOI 10.1111/j.1469-7998.1996.tb05393.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FLEEGER JW, 1995, J MAR RES, V53, P609, DOI 10.1357/0022240953213070; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; GIERE O, 1993, MEIOBENTHOLOGY MICRO; Guizien K, 2006, MAR ECOL PROG SER, V311, P47, DOI 10.3354/meps311047; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; HERMANS CO, 1983, OCEANOGR MAR BIOL, V21, P283; Hoffmann A., 1997, MARINE FLORA CENTRAL; Hormazabal S, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001956; Hudson RR, 2000, GENETICS, V155, P2011; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jorger KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-245; Johansson ML, 2015, MOL ECOL, V24, P4866, DOI 10.1111/mec.13371; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kieneke A, 2012, MOL ECOL, V21, P1239, DOI 10.1111/j.1365-294X.2011.05421.x; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Landers Stephen C., 2012, Gulf of Mexico Science, V30, P20; Leasi F, 2016, MOL ECOL, V25, P1381, DOI 10.1111/mec.13568; Leasi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104385; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macfarlane CBA, 2013, ECOLOGY, V94, P250, DOI 10.1890/12-1049.1; MANTEL N, 1967, CANCER RES, V27, P209; Marincovic L., 1973, SCI B NAT HIST MUSEU, V16, P1; MCINTYRE AD, 1968, J ZOOL, V156, P377, DOI 10.1111/j.1469-7998.1968.tb04360.x; MCLACHLAN A, 1977, ZOOL AFR, V12, P279, DOI 10.1080/00445096.1977.11447576; Mock H, 1975, INTERSTITIELLE FAUNA; Montecinos A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-97; MURRELL MC, 1989, CONT SHELF RES, V9, P1049, DOI 10.1016/0278-4343(89)90057-5; Navarrete SA, 2005, P NATL ACAD SCI USA, V102, P18046, DOI 10.1073/pnas.0509119102; Nei M., 1987, MOL EVOLUTIONARY GEN; Packmor J, 2016, MAR BIODIVERS, V46, P861, DOI 10.1007/s12526-016-0448-7; Poulin E, 2002, LIMNOL OCEANOGR, V47, P1248, DOI 10.4319/lo.2002.47.4.1248; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Sanchez R, 2011, MAR ECOL PROG SER, V434, P121, DOI 10.3354/meps09184; Schmidt H, 2000, ZOOL SCR, V29, P17, DOI 10.1046/j.1463-6409.2000.00026.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Strub P.T., 1998, SEA; SUN B, 1994, MAR ECOL PROG SER, V110, P167, DOI 10.3354/meps110167; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; TEMPLETON AR, 1992, GENETICS, V132, P619; Thiel M, 2005, OCEANOGR MAR BIOL, V42, P181, DOI DOI 10.1201/9780203507810.CH6; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Thollesson M, 2000, MOL PHYLOGENET EVOL, V16, P161, DOI 10.1006/mpev.2000.0789; Todaro MA, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.142.2036; Todaro MA, 1996, MAR BIOL, V125, P735, DOI 10.1007/BF00349256; Tulchinsky AY, 2012, MAR BIOL, V159, P661, DOI 10.1007/s00227-011-1844-y; Turbeville JM, 2007, MOL PHYLOGENET EVOL, V43, P1056, DOI 10.1016/j.ympev.2006.10.025; TYLER S, 1980, ZOOMORPHOLOGIE, V95, P1, DOI 10.1007/BF01342230; van Soosten C, 1998, MAR BIOL, V131, P659, DOI 10.1007/s002270050358; Varela AI, 2012, REV CHIL HIST NAT, V85, P495, DOI 10.4067/S0716-078X2012000400011; Westheide W, 2003, MAR BIOL, V142, P637, DOI 10.1007/s00227-002-0960-0; Westheide W, 2003, HELGOLAND MAR RES, V57, P1, DOI 10.1007/s10152-002-0114-2; Westheide W, 2001, J ZOOL SYST EVOL RES, V39, P103; Wieters EA, 2009, LIMNOL OCEANOGR, V54, P1060, DOI 10.4319/lo.2009.54.4.1060; Zakas C, 2009, MAR ECOL PROG SER, V394, P165, DOI 10.3354/meps08265; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	85	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195833	10.1371/journal.pone.0195833	http://dx.doi.org/10.1371/journal.pone.0195833			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698411	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600019
J	Rowlands, MA; Mondesire-Crump, I; Levin, A; Mauguen, A; Francis, JH; Dunkel, IJ; Brodie, SE; Gobin, YP; Abramson, DH				Rowlands, Megan A.; Mondesire-Crump, Ijah; Levin, Ariana; Mauguen, Audrey; Francis, Jasmine H.; Dunkel, Ira J.; Brodie, Scott E.; Gobin, Y. Pierre; Abramson, David H.			Total retinal detachments due to retinoblastoma: Outcomes following intra-arterial chemotherapy/ophthalmic artery chemosurgery	PLOS ONE			English	Article							MANAGEMENT; EYES	Purpose To report on the rate and timing of retinal reattachment and outcomes for retinoblastoma children who have total retinal detachments at presentation to our center and were treated with intra-arterial chemotherapy (ophthalmic artery chemosurgery, OAC). Patients and methods Single-center retrospective review of retinoblastoma patients who presented with total retinal detachments and were subsequently treated with OAC at MSKCC between May 2006 and July 2016. Endpoints were retinal detachment resolution, visual function, ERG amplitude, ocular survival, and patient survival from metastases. Results 87 eyes of 84 retinoblastoma patients were included. Using a survival multistate model, by 36 months of follow-up, there was a 54% cumulative probability of complete retinal reattachment and a 76% probability of partial reattachment. 24% of eyes that completely reattached received only OAC without any prior or adjuvant treatments. Eyes that completely reattached were significantly more likely to have been diagnosed at a younger age (p<0.0001) and to have greater initial ERG values (p=0.006). At final follow-up, 14% of eyes had gained at least 25 mu V of ERG activity, and 8.0% had achieved hand motion vision or better, including one to 20/60. 13% of eyes were enucleated. No patient died from metastatic disease, and only one developed metastases. Conclusion OAC can successfully treat previously considered "non-salvageable" retinoblastoma eyes with total retinal detachments, promote retinal reattachment in the majority of eyes, and preserve ocular and patient survival.	[Rowlands, Megan A.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Mondesire-Crump, Ijah; Levin, Ariana; Francis, Jasmine H.; Gobin, Y. Pierre; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Mauguen, Audrey] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA; [Francis, Jasmine H.; Abramson, David H.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Dunkel, Ira J.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Brodie, Scott E.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Dept Radiol Neurosurg & Neurol, Weill Cornell Med Coll, Intervent Neuroradiol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Icahn School of Medicine at Mount Sinai; Cornell University; NewYork-Presbyterian Hospital	Rowlands, MA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	Megan.A.Rowlands@gmail.com		Francis, Jasmine/0000-0002-7637-3108	NIH/NCI Cancer Center Support Grant [P30 CA008748]; Fund for Ophthalmic Knowledge, Inc.	NIH/NCI Cancer Center Support Grant; Fund for Ophthalmic Knowledge, Inc.	This work was supported in part by grants from the NIH/NCI Cancer Center Support Grant P30 CA008748 and The Fund for Ophthalmic Knowledge, Inc.	Abdelhakim AH, 2017, BRIT J OPHTHALMOL, V101, P623, DOI 10.1136/bjophthalmol-2016-308591; Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146582; Abramson DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145436; Abramson DH, 2014, ANNU REV MED, V65, P171, DOI 10.1146/annurev-med-061312-123455; Brodie SE, 2012, BRIT J OPHTHALMOL, V96, P877, DOI 10.1136/bjophthalmol-2011-301248; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Grigorovski N, 2014, INT J OPHTHALMOL-CHI, V7, P726, DOI 10.3980/j.issn.2222-3959.2014.04.26; Madreperla SA, 2000, RETINA-J RET VIT DIS, V20, P28, DOI 10.1097/00006982-200001000-00005; Materin MA, 2013, J NEUROINTERV SURG, V5, pE42, DOI [10.1136/neurintsurg-2012-010508.rep, 10.1136/neurintsurg-2012-010316]; Palioura S, 2012, PEDIATR BLOOD CANCER, V59, P859, DOI 10.1002/pbc.24170; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; REESE AB, 1958, ARCH OPHTHALMOL-CHIC, V60, P897; REESE AB, 1955, ARCH OPHTHALMOL-CHIC, V53, P505; Reese AB, 1976, TUMORS OF THE EYE; Shields CL, 2012, RETINA-J RET VIT DIS, V32, P799, DOI 10.1097/IAE.0b013e31823d8e1e; Shields CL, 2006, OPHTHALMOLOGY, V113, P2276, DOI 10.1016/j.ophtha.2006.06.018	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195395	10.1371/journal.pone.0195395	http://dx.doi.org/10.1371/journal.pone.0195395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698399	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600009
J	Booth, DT; Dunstan, A				Booth, David Terrington; Dunstan, Andrew			A preliminary investigation into the early embryo death syndrome (EEDS) at the world's largest green turtle rookery	PLOS ONE			English	Article							OLIVE RIDLEY TURTLE; CARETTA-CARETTA; INCUBATION-TEMPERATURE; LEPIDOCHELYS-OLIVACEA; DERMOCHELYS-CORIACEA; OXYGEN-CONTENT; GAS-EXCHANGE; NESTS; HATCHLINGS; MORTALITY	Raine Island hosts the largest nesting aggregation of green turtles in the world, but nest emergence success and hence recruitment of hatchlings off the beach appear to have significantly declined since the 1990s. Nests destroyed by subsequent nesting turtles, and nest failure due to flooding account for most of the nest failure, but many nests still have poor hatch success even when undisturbed and flood-free. In undisturbed, flood-free nests that experience high mortality, embryos typically die at a very early stage of development, a phenomenon we term early embryo death syndrome (EEDS). Previous research indicates that EEDS is correlated with the number of females nesting at Raine Island during a nesting season. Here, we monitor nest temperature and oxygen (PO2) and carbon dioxide (PCO2) partial pressures during the first week after nest construction to discover if they are associated with EEDS. Our investigation found that the proportion of early embryo death was greatest in two nests that experienced the highest nest temperature, lowest PO2 and highest PCO2 during the first week of incubation suggesting that these variables either by themselves or in combination may be the underlying cause of EEDS. These two nests were located adjacent to maturing nests, so the high temperature and more extreme PO(2)s and PCO(2)s are most likely to be caused by the combined metabolism of embryos in the mature nests. Although this conclusion is based on just two nests and needs to be substantiated in future studies, it would appear that the laying of new nests in the close location to mature nests could be a significant cause of hatch failure at high density nesting sea turtle rookeries around the world.	[Booth, David Terrington] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Dunstan, Andrew] Queensland Govt Dept Natl Pk Sports & Racing, Brisbane, Qld, Australia	University of Queensland	Booth, DT (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	d.booth@uq.edu.au	Booth, David/A-7184-2012	Booth, David/0000-0002-3801-0488	Raine Island Recovery Project; BHP; Queensland Government; Great Barrier Reef Marine Park Authority; Great Barrier Reef Foundation	Raine Island Recovery Project; BHP; Queensland Government; Great Barrier Reef Marine Park Authority; Great Barrier Reef Foundation	Funded by Raine Island Recovery Project, a collaboration with BHP, the Queensland Government, the Great Barrier Reef Marine Park Authority, the Wuthathi Nation and Kemer Kemer Meriam Nation (Ugar, Mer, Erub), Traditional Owners and the Great Barrier Reef Foundation.	ACKERMAN RA, 1977, RESP PHYSIOL, V31, P19, DOI 10.1016/0034-5687(77)90062-7; Bell BA, 2004, BIOL CONSERV, V115, P131, DOI 10.1016/S0006-3207(03)00102-2; Bezy VS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118579; Booth DT, 2013, MAR BIOL, V160, P127, DOI 10.1007/s00227-012-2070-y; Chen CL, 2010, J COMP PHYSIOL B, V180, P1045, DOI 10.1007/s00360-010-0479-5; Cheng IJ, 2015, J EXP MAR BIOL ECOL, V471, P104, DOI 10.1016/j.jembe.2015.05.013; Clusella Trullas S, 2007, J ZOOL, V272, P367, DOI 10.1111/j.1469-7998.2006.00277.x; Cornclius SE., 1986, SEA TURTLES SANTA RO; Dunstan AJ, 2017, RAINE ISLAND RECOVER; Hays GC, 2017, P ROY SOC B, V284; Honarvar S, 2008, OECOLOGIA, V157, P221, DOI 10.1007/s00442-008-1065-3; Honarvar S, 2011, J EXP MAR BIOL ECOL, V409, P339, DOI 10.1016/j.jembe.2011.09.015; Howard R, 2014, ENDANGER SPECIES RES, V26, P75, DOI 10.3354/esr00636; Kobayashi S, 2017, J EXP MAR BIOL ECOL, V486, P274, DOI 10.1016/j.jembe.2016.10.020; Laloe JO, 2017, GLOBAL CHANGE BIOL, V23, P4922, DOI 10.1111/gcb.13765; Limpus CJ, 2003, MEM QUEENSLAND MUS, V49, P339; MALONEY JE, 1990, COPEIA, P378, DOI 10.2307/1446343; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; Maulany RI, 2012, COPEIA, P738, DOI 10.1643/CH-12-088; Mazaris AD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600730; Miller J.D., 1985, Biology of Reptilia, V14, P269; Miller NA, 2008, COPEIA, P882, DOI 10.1643/CP-07-256; Rafferty AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021038; Ralph CR, 2005, AUST J ZOOL, V53, P289, DOI 10.1071/ZO04062; SEYMOUR RS, 1986, J COMP PHYSIOL B, V156, P773, DOI 10.1007/BF00694250; Sim EL, 2015, BIOL OPEN, V4, P685, DOI 10.1242/bio.20148995; Suss JS, 2012, INTEGR COMP BIOL, V52, pE335; Valverde Roldan A., 2010, Endangered Species Research, V12, P77, DOI 10.3354/esr00296; Wallace BP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P423, DOI 10.1086/420951; Williamson SA, 2017, PHYSIOL BIOCHEM ZOOL, V90, P523, DOI 10.1086/692630	30	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195462	10.1371/journal.pone.0195462	http://dx.doi.org/10.1371/journal.pone.0195462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694365	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400029
J	Blazquez, R; Sanchez-Margallo, FM; Alvarez, V; Matilla, E; Hernandez, N; Marinaro, F; Gomez-Serrano, M; Jorge, I; Casado, JG; Macias-Garcia, B				Blazquez, Rebeca; Miguel Sanchez-Margallo, Francisco; Alvarez, Veronica; Matilla, Elvira; Hernandez, Nuria; Marinaro, Federica; Gomez-Serrano, Maria; Jorge, Inmaculada; Casado, Javier G.; Macias-Garcia, Beatriz			Murine embryos exposed to human endometrial MSCs-derived extracellular vesicles exhibit higher VEGF/PDGF AA release, increased blastomere count and hatching rates	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; IN-VITRO; CULTURE-MEDIUM; MOUSE EMBRYO; AVIAN EMBRYO; IMPLANTATION; EXOSOMES; ANGIOGENESIS; PDGF	Endometrial Mesenchymal Stromal Cells (endMSCs) are multipotent cells with immunomodulatory and pro-regenerative activity which is mainly mediated by a paracrine effect. The exosomes released by MSCs have become a promising therapeutic tool for the treatment of immune-mediated diseases. More specifically, extracellular vesicles derived from endMSCs (EV-endMSCs) have demonstrated a cardioprotective effect through the release of anti-apoptotic and pro-angiogenic factors. Here we hypothesize that EV-endMSCs may be used as a co-adjuvant to improve in vitro fertilization outcomes and embryo quality. Firstly, endMSCs and EV-endMSCs were isolated and phenotypically characterized for in vitro assays. Then, in vitro studies were performed on murine embryos co-cultured with EV-endMSCs at different concentrations. Our results firstly demonstrated a significant increase on the total blastomere count of expanded murine blastocysts. Moreover, EV-endMSCs triggered the release of pro-angiogenic molecules from embryos demonstrating an EV-endMSCs concentration-dependent increase of VEGF and PDGF-AA. The release of VEGF and PDGF-AA by the embryos may indicate that the beneficial effect of EV-endMSCs could be mediating not only an increase in the blastocyst's total cell number, but also may promote endometrial angiogenesis, vascularization, differentiation and tissue remodeling. In summary, these results could be relevant for assisted reproduction being the first report describing the beneficial effect of human EV-endMSCs on embryo development.	[Blazquez, Rebeca; Miguel Sanchez-Margallo, Francisco; Alvarez, Veronica; Marinaro, Federica; Casado, Javier G.] Jesus Uson Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain; [Blazquez, Rebeca; Miguel Sanchez-Margallo, Francisco; Jorge, Inmaculada; Casado, Javier G.] GIBER Enfermedades Cardiovasc, Madrid, Spain; [Matilla, Elvira; Hernandez, Nuria; Macias-Garcia, Beatriz] Jesus Uson Minimally Invas Surg Ctr, Assisted Reprod Unit, Caceres, Spain; [Gomez-Serrano, Maria; Jorge, Inmaculada] CNIC, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Casado, JG (corresponding author), Jesus Uson Minimally Invas Surg Ctr, Stem Cell Therapy Unit, Caceres, Spain.; Casado, JG (corresponding author), GIBER Enfermedades Cardiovasc, Madrid, Spain.	jgarcia@ccmijesususon.com	García, Javier/AAH-1330-2020; Hernández, Nuria/AAJ-3293-2020; Pérez, Verónica Álvarez/AAP-1021-2020; Marinaro, Federica/L-3745-2019; G Casado, Javier/ABE-9043-2021; Sánchez Margallo, Francisco Miguel Miguel/I-5605-2019; Blázquez, Rebeca/Q-2588-2019; B, Macias-Garcia/H-7301-2013; Gómez-Serrano, María/AAZ-3953-2021; Blazquez, Rebeca/D-9523-2017; Marinaro, Federica/T-4724-2017; Garcia, Javier/X-4319-2018	Pérez, Verónica Álvarez/0000-0002-7319-6089; Marinaro, Federica/0000-0001-5965-7718; Sánchez Margallo, Francisco Miguel Miguel/0000-0003-2138-988X; Blázquez, Rebeca/0000-0002-1149-8305; B, Macias-Garcia/0000-0001-5331-9793; Gómez-Serrano, María/0000-0002-9669-091X; Blazquez, Rebeca/0000-0002-1149-8305; Marinaro, Federica/0000-0001-5965-7718; Jorge, Inmaculada/0000-0001-8645-9477; G Casado, Javier/0000-0001-6797-7287; Hernandez, Nuria/0000-0002-6812-1189; Matilla, Elvira/0000-0001-6639-3300	CIBER-CV [CB16/11/00494]; Junta de Extremadura (Ayuda a grupos catalogados de la Junta de Extremadura) [GR15175]; Junta de Extremadura - FEDER/FSE [TA13042, 1616168]; FEDER/FSE [IB16159]; Instituto de Salud Carlos III - FEDER/FSE [CP17/00021]; Spanish Ministry of Economy, Industry and Competitiveness [IJCI-2014-19428]	CIBER-CV; Junta de Extremadura (Ayuda a grupos catalogados de la Junta de Extremadura); Junta de Extremadura - FEDER/FSE; FEDER/FSE(European Social Fund (ESF)European Commission); Instituto de Salud Carlos III - FEDER/FSE(Instituto de Salud Carlos III); Spanish Ministry of Economy, Industry and Competitiveness	This work was supported in part by CIBER-CV (CB16/11/00494). One grant from Junta de Extremadura (Ayuda a grupos catalogados de la Junta de Extremadura, GR15175). Two grants from Junta de Extremadura to JGC (TA13042 and 1616168 co-financed by FEDER/FSE). One grant to B-MC (IB16159 co-financed by FEDER/FSE). One grant "Miguel Servet I" from Instituto de Salud Carlos III to JGC (CP17/00021 co-financed by FEDER/FSE). One grant "Juan de la Cierva" to B-MC from Spanish Ministry of Economy, Industry and Competitiveness (IJCI-2014-19428). The funders had no role in study designs, data collection and analysis, decision to publish or preparation of the manuscript.	Achen MG, 1997, GROWTH FACTORS, V15, P69, DOI 10.3109/08977199709002113; Alcayaga-Miranda F, 2016, ONCOTARGET, V7, P44462, DOI 10.18632/oncotarget.9852; Altmae S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10098-3; Alvarez V, 2015, ACTA BIOQUIM CLIN L, V49, P311; Artini PG, 2008, GYNECOL ENDOCRINOL, V24, P184, DOI 10.1080/09513590801893117; Artus J, 2013, STEM CELLS, V31, P1932, DOI 10.1002/stem.1442; Balaban B, 2011, HUM REPROD, V26, pI24; Baranao RI, 1997, AM J REPROD IMMUNOL, V37, P191; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Burke J, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0112-7; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Cerkiene Z, 2010, MEDICINA-LITHUANIA, V46, P233, DOI 10.3390/medicina46040032; Chaouat G, 2007, J ASSIST REPROD GEN, V24, P491, DOI 10.1007/s10815-007-9142-9; Chen L, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-016-0453-6; Cui W, 2018, ADV ANAT EMBRYOL CEL, V229, P31, DOI 10.1007/978-3-319-63187-5_4; Daughtry BL, 2016, CELL TISSUE RES, V363, P201, DOI 10.1007/s00441-015-2305-6; DUBAND JL, 1990, CELL DIFFER DEV, V30, P55, DOI 10.1016/0922-3371(90)90074-7; Elsheikh E, 2011, INT J MOL MED, V27, P221, DOI 10.3892/ijmm.2010.570; FLAMME I, 1995, DEV BIOL, V171, P399, DOI 10.1006/dbio.1995.1291; Fresco VM, 2016, J BIOL CHEM, V291, P18730, DOI 10.1074/jbc.M115.702761; Gabrielsen A, 2006, REPROD BIOMED ONLINE, V12, P70, DOI 10.1016/S1472-6483(10)60983-2; GORDON JW, 1993, FERTIL STERIL, V59, P1296; Goyal P, 2013, MOL HUM REPROD, V19, P528, DOI 10.1093/molehr/gat023; Greening DW, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134890; Gu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070112; Han J, 2010, ENDOCRINOLOGY, V151, P1732, DOI 10.1210/en.2009-0845; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Homer H, 2017, PLACENTA, V54, P89, DOI 10.1016/j.placenta.2016.12.011; Hu Y, 2018, THERANOSTICS, V8, P169, DOI 10.7150/thno.21234; Johnson MH, 2009, ANNU REV CELL DEV BI, V25, P483, DOI 10.1146/annurev.cellbio.042308.113348; Khoury M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00205; Kim HJ, 2017, CLIN EXP REPROD MED, V44, P193, DOI 10.5653/cerm.2017.44.4.193; Komaki M, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0660-9; Lahav-Baratz S, 2004, FERTIL STERIL, V82, P1029, DOI 10.1016/j.fertnstert.2004.06.026; Li R, 2012, J HAZARD MATER, V241, P231, DOI 10.1016/j.jhazmat.2012.09.038; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Liu XL, 2017, INT J BIOL SCI, V13, P232, DOI 10.7150/ijbs.16951; Lombardo G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25689; Lopera-Vasquez R, 2017, REPRODUCTION, V153, P461, DOI 10.1530/REP-16-0384; Lopera-Vasquez R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148083; Marcho C, 2015, REPRODUCTION, V150, pR109, DOI 10.1530/REP-15-0180; Mehta Bindu N, 2013, J Hum Reprod Sci, V6, P140, DOI 10.4103/0974-1208.117171; Mellisho EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178306; Montag M, 2000, BIOL REPROD, V62, P1738, DOI 10.1095/biolreprod62.6.1738; Moreno R, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3615729; Mutlu L, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126771; NASRESFAHANI MH, 1992, J REPROD FERTIL, V96, P41, DOI 10.1530/jrf.0.0960041; Park Sung Baek, 2014, Clin Exp Reprod Med, V41, P68, DOI 10.5653/cerm.2014.41.2.68; Qu PX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174535; Rani S, 2015, MOL THER, V23, P812, DOI 10.1038/mt.2015.44; RAPPOLEE DA, 1988, SCIENCE, V241, P1823, DOI 10.1126/science.3175624; REPONEN P, 1995, DEV DYNAM, V202, P388, DOI 10.1002/aja.1002020408; Robertson SA, 2011, AM J REPROD IMMUNOL, V66, P2, DOI 10.1111/j.1600-0897.2011.01039.x; Salamonsen LA, 2016, AM J REPROD IMMUNOL, V75, P218, DOI 10.1111/aji.12450; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tribulo P, 2018, J DAIRY SCI, V101, P690, DOI 10.3168/jds.2017-13221; TSUIKI A, 1989, AM J OBSTET GYNECOL, V160, P724, DOI 10.1016/S0002-9378(89)80068-7; Uder C, 2018, CYTOM PART A, V93A, P32, DOI 10.1002/cyto.a.23239; Volarevic V, 2014, STEM CELLS, V32, P2818, DOI 10.1002/stem.1818; Wang H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-207; Wang LF, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00651; Xu JS, 2000, FERTIL STERIL, V74, P1215, DOI 10.1016/S0015-0282(00)01618-6; Zemel'ko V I, 2013, Tsitologiia, V55, P101; Zhang J, 2001, CHINESE SCI BULL, V46, P409, DOI 10.1007/BF03183277; Zhou WH, 2016, J ASSIST REPROD GEN, V33, P39, DOI 10.1007/s10815-015-0627-7; Ziebe S, 2013, FERTIL STERIL, V99, P1600, DOI 10.1016/j.fertnstert.2012.12.043; ZOLTI M, 1991, FERTIL STERIL, V56, P265	69	22	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196080	10.1371/journal.pone.0196080	http://dx.doi.org/10.1371/journal.pone.0196080			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684038	Green Published, gold, Green Submitted			2022-12-26	WOS:000430660600036
J	de Visser, HM; Mastbergen, SC; Ravipati, S; Welsing, PMJ; Pinto, FC; Lafeber, FPJG; Chapman, V; Barrett, DA; Weinans, H				de Visser, H. M.; Mastbergen, S. C.; Ravipati, S.; Welsing, P. M. J.; Pinto, F. C.; Lafeber, F. P. J. G.; Chapman, V.; Barrett, D. A.; Weinans, H.			Local and systemic inflammatory lipid profiling in a rat model of osteoarthritis with metabolic dysregulation	PLOS ONE			English	Article							SYMPTOMATIC KNEE OSTEOARTHRITIS; LOW-GRADE INFLAMMATION; SYNOVIAL-FLUID; LINOLENIC ACID; MEDIATORS; ROLES; EICOSANOIDS; MACROPHAGES; INHIBITION; PLASMA	Objective Bioactive oxidised lipids (oxylipins) are important signalling mediators, capable of modulating the inflammatory state of the joint and anticipated to be of importance in joint homeostasis and status of osteoarthritis. The aim of this study was to quantify oxylipin levels in plasma and synovial fluid from rats with experimentally induced osteoarthritis to investigate the potential role of oxylipins as a marker in the disease process of early osteoarthritis. Design Forty rats were randomly allocated to a standard or high-fat diet group. After 12 weeks, local cartilage damage was induced in one knee joint in 14 rats of each diet group. The remaining 6 rats per group served as controls. At week 24, samples were collected. Oxylipin levels were quantified by liquid chromatography-mass spectrometry. Results Overall, 31 lipid-derived inflammatory mediators were detected in fasted plasma and synovial fluid. Principal component analysis identified four distinct clusters associated with histopathological changes. Diet induced differences were evident for 13 individual plasma oxylipins, as well as 5,6-EET in synovial fluid. Surgical-model induced differences were evident for three oxylipins in synovial fluid (15-HETE, 8,9-DHET and 17R-ResolvinD1) with a different response in lipid concentrations for synovial fluid and plasma. Conclusions We demonstrate the quantification of oxidised lipids in rat plasma and synovial fluid in a model of early experimental osteoarthritis. Oxylipins in the synovial fluid that were altered as consequence of the surgically induced osteoarthritis were not represented in the plasma. Our findings suggest differential roles of the oxylipins in the local versus peripheral compartment.	[de Visser, H. M.; Weinans, H.] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [de Visser, H. M.; Mastbergen, S. C.; Welsing, P. M. J.; Lafeber, F. P. J. G.; Weinans, H.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Ravipati, S.; Lafeber, F. P. J. G.; Barrett, D. A.] Univ Nottingham, Sch Pharm, Nottingham, England; [Ravipati, S.; Chapman, V.] Univ Nottingham, Sch Life Sci, Nottingham, England; [Chapman, V.] Univ Nottingham, Arthrit Res UK Pain Ctr, Sch Life Sci, Nottingham, England; [Weinans, H.] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Nottingham; University of Nottingham; University of Nottingham; Delft University of Technology	Mastbergen, SC (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	s.mastbergen@umcutrecht.nl	Barrett, David/C-9922-2011	Barrett, David/0000-0001-6900-9474; Chapman, Victoria/0000-0002-7969-2788; Weinans, Harrie/0000-0002-2275-6170	European Union Seventh Framework Programme [305815]; Dutch Arthritis Foundation [LLP-22]	European Union Seventh Framework Programme(European Commission); Dutch Arthritis Foundation	The research leading to these results has received partial funding from the European Union Seventh Framework Programme (FP7/2007-2013, https://cordis.europa.eu/project/rcn/105314_en.html) under grant agreement no305815 to HW. The study was also supported by the Dutch Arthritis Foundation (LLP-22, https://home.reumafonds.nl/) to HW. Funding sources had no role in study design, collection, analysis or interpretation of the data, writing of the manuscript or in the decision to submit the manuscript for publication.; "The research leading to these results has received partial funding from the European Union Seventh Framework Programme (FP7/2007-2013, https://cordis.europa.eu/project/rcn/105314_en.html) under grant agreement no305815. The study was also supported by the Dutch Arthritis Foundation (LLP-22, https://home.reumafonds.nl/). Funding sources had no role in study design, collection, analysis or interpretation of the data, writing of the manuscript or in the decision to submit the manuscript for publication." There was no additional external funding received for this study.	Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; Attur M, 2015, ARTHRITIS RHEUMATOL, V67, P2905, DOI 10.1002/art.39279; Berenbaum F, 2017, ARTHRITIS RHEUMATOL, V69, P9, DOI 10.1002/art.39842; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Brand-Schieber E, 2000, J PHYSIOL PHARMACOL, V51, P655; Burdge G, 2004, CURR OPIN CLIN NUTR, V7, P137, DOI 10.1097/00075197-200403000-00006; Collins KH, 2016, J ORTHOP RES, V34, P1010, DOI 10.1002/jor.23103; Cuppen BVJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163087; de Visser HM, 2017, OSTEOARTHR CARTILAGE, V25, pS263, DOI 10.1016/j.joca.2017.02.444; de Visser HM, 2018, J ORTHOP RES, V36, P881, DOI 10.1002/jor.23712; de Visser HM, 2017, J ORTHOP RES, V35, P496, DOI 10.1002/jor.23299; Eisinger K, 2014, EXP MOL PATHOL, V97, P37, DOI 10.1016/j.yexmp.2014.05.002; Futami I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045517; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Guma M, 2016, NAT REV RHEUMATOL, V12, P269, DOI 10.1038/nrrheum.2016.1; Hanif A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162147; Hao CM, 2007, KIDNEY INT, V71, P1105, DOI 10.1038/sj.ki.5002192; Hao CM, 2007, SEMIN NEPHROL, V27, P338, DOI 10.1016/j.semnephrol.2007.02.008; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Huang H, 2006, EXP BIOL MED, V231, P1744, DOI 10.1177/153537020623101112; Huang J, 2016, ARTHRITIS RHEUMATOL, DOI [10.1002/art.s12248-013-9454-x, DOI 10.1002/ART.S12248-013-9454-X]; Huebner JL, 2002, OSTEOARTHR CARTILAGE, V10, P758, DOI 10.1053/joca.2002.0821; Jones PH, 2006, TEX HEART I J, V33, P180; Klein-Wieringa IR, 2013, J IMMUNOL, V191, P1356, DOI 10.4049/jimmunol.1203074; Kosinska MK, 2016, OSTEOARTHR CARTILAGE, V24, P1470, DOI 10.1016/j.joca.2016.03.017; Kosinska MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091769; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Kronke G, 2009, AUTOIMMUNITY, V42, P383, DOI 10.1080/08916930902832488; Lai YS, 2015, J AGR FOOD CHEM, V63, P7873, DOI 10.1021/acs.jafc.5b02830; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; Li J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00187; Loeser RF, 2013, OSTEOARTHR CARTILAGE, V21, P1436, DOI 10.1016/j.joca.2013.05.020; Lotz M, 2013, ANN RHEUM DIS, V72, P1756, DOI 10.1136/annrheumdis-2013-203726; Martel-Pelletier J, 2003, SEMIN ARTHRITIS RHEU, V33, P155, DOI 10.1016/S0049-0172(03)00134-3; Mickiewicz B, 2015, J ORTHOP RES, V33, P1631, DOI 10.1002/jor.22949; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Oresic M, 2008, TRENDS BIOTECHNOL, V26, P647, DOI 10.1016/j.tibtech.2008.09.001; Pokreisz P, 2006, HYPERTENSION, V47, P762, DOI 10.1161/01.HYP.0000208299.62535.58; Pontes-Arruda A, 2006, CRIT CARE MED, V34, P2325, DOI 10.1097/01.CCM.0000234033.65657.B6; Richardson D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2401; Robinson WH, 2016, NAT REV RHEUMATOL, V12, P580, DOI 10.1038/nrrheum.2016.136; Rocha PN, 2003, SPRINGER SEMIN IMMUN, V25, P215, DOI 10.1007/s00281-003-0132-4; Scanzello CR, 2009, OSTEOARTHR CARTILAGE, V17, P1040, DOI 10.1016/j.joca.2009.02.011; Scanzello CR, 2015, ARTHRITIS RHEUMATOL, V67, P2797, DOI 10.1002/art.39304; Seifer DR, 2008, OSTEOARTHR CARTILAGE, V16, P1532, DOI 10.1016/j.joca.2008.04.013; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Sisignano M, 2012, J NEUROSCI, V32, P6364, DOI 10.1523/JNEUROSCI.5793-11.2012; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Tang HF, 2014, J IMMUNOL, V193, P3769, DOI 10.4049/jimmunol.1400942; Teeple E, 2013, AAPS J, V15, P438, DOI 10.1208/s12248-013-9454-x; Tessaro FHG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/568408; Wong A, 2014, J LIPID RES, V55, P1902, DOI 10.1194/jlr.M048694; Wu CL, 2017, SCI REP-UK, V7, DOI 10.1038/srep44315; Yang T, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-151; Zhang WD, 2015, J RHEUMATOL, V42, P859, DOI 10.3899/jrheum.141252; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	59	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196308	10.1371/journal.pone.0196308	http://dx.doi.org/10.1371/journal.pone.0196308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684084	Green Published, gold			2022-12-26	WOS:000430660600052
J	Kostrikis, LG; Hezka, J; Stylianou, DC; Kostaki, E; Andreou, M; Kousiappa, L; Paraskevis, D; Demetriades, L				Kostrikis, Leondios G.; Hezka, Johana; Stylianou, Dora C.; Kostaki, Evangelia; Andreou, Maria; Kousiappa, Loanna; Paraskevis, Dimitrios; Demetriades, Loannis			HIV-1 transmission networks across Cyprus (2010-2012)	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; GENETIC-ANALYSIS; TYPE-1 STRAINS; INFECTION; SEQUENCES; RECOMBINANT; PREVALENCE; THERAPY; EUROPE	A molecular epidemiology study of HIV-1 infection was conducted in one hundred diagnosed and untreated HIV-1-infected patients in Cyprus between 2010 and 2012, representing 65.4% of all the reported HIV-1 infections in Cyprus in this three-year period, using a previously defined enrolment strategy. Eighty-two patients were newly diagnosed (genotypic drug resistance testing within six months from diagnosis), and eighteen patients were HIV-1 diagnosed for a longer period or the diagnosis date was unknown. Phylogenetic trees of the po/sequences obtained in this study with reference sequences indicated that subtypes B and A1 were the most common subtypes present and accounted for 41.0 and 19.0% respectively, followed by sub-type C (7.0%), F1 (8.0%), CRF02_AG (4.0%), A2 (2.0%), other circulating recombinant forms (CRFs) (7.0%) and unknown recombinant forms (URFs) (12%). Most of the newly-diagnosed study subjects were Cypriots (63%), males (78%) with median age 39 (Interquartile Range, IQR 33-48) reporting having sex with other men (MSM) (51%). A high rate of clustered transmission of subtype B drug-sensitive strains to reverse transcriptase and protease inhibitors was observed among MSM, twenty-eight out of forty-one MSM study subjects (68.0%) infected were implicated in five transmission clusters, two of which are sub-subtype Al and three of which are subtype B strains. The two largest MSM subtype B clusters included nine and eight Cypriot men, respectively, living in all major cities in Cyprus. There were only three newly diagnosed patients with transmitted drug resistant HIV-1 strains, one study subject from the United Kingdom infected with subtype B strain and one from Romania with sub-subtype A2 strain, both with PI drug resistance mutation M46L and one from Greece with sub-subtype A1 with non-nucleoside reverse transcriptase inhibitors (NNRTI) drug resistance mutation K103N.	[Kostrikis, Leondios G.; Hezka, Johana; Stylianou, Dora C.; Andreou, Maria; Kousiappa, Loanna] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Kostaki, Evangelia; Paraskevis, Dimitrios] Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece; [Demetriades, Loannis] Larnaca Gen Hosp, AIDS Clin, Larnax, Cyprus	University of Cyprus; National & Kapodistrian University of Athens	Kostrikis, LG (corresponding author), Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus.	lkostrik@ucy.ac.cy	Kostaki, Evangelia Georgia/AAE-7014-2021; Stylianou, Dora/AAT-1074-2020; Paraskevis, Dimitrios/H-5835-2019; KOSTRIKIS, LEONDIOS G/A-5330-2016	Kostaki, Evangelia Georgia/0000-0002-3346-0930; Stylianou, Dora/0000-0003-4167-1380; Paraskevis, Dimitrios/0000-0001-6167-7152; KOSTRIKIS, LEONDIOS G/0000-0002-5340-7109; Kousiappa, Ioanna/0000-0002-7491-5946				Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Antoniadou ZA, 2014, AIDS RES HUM RETROV, V30, P225, DOI [10.1089/AID.2013.0166, 10.1089/aid.2013.0166]; Bannister WP, 2008, JAIDS-J ACQ IMM DEF, V48, P324, DOI 10.1097/QAI.0b013e31817ae5c0; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; KOSTRIKIS LG, 1995, J VIROL, V69, P6122, DOI 10.1128/JVI.69.10.6122-6130.1995; Kousiappa I, 2009, AIDS RES HUM RETROV, V25, P23, DOI 10.1089/aid.2008.0168; Kousiappa I, 2011, AIDS RES HUM RETROV, V27, P1183, DOI [10.1089/aid.2011.0060, 10.1089/AID.2011.0060]; Kousiappa I, 2009, AIDS RES HUM RETROV, V25, P727, DOI 10.1089/aid.2008.0239; Kuritzkes DR, 2008, J INFECT DIS, V197, P867, DOI 10.1086/528802; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Pillay D, 2006, AIDS, V20, P21, DOI 10.1097/01.aids.0000196172.35056.b7; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9	21	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195660	10.1371/journal.pone.0195660	http://dx.doi.org/10.1371/journal.pone.0195660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684083	Green Submitted, Green Published, gold			2022-12-26	WOS:000430660600021
J	Sainohira, M; Yamashita, T; Terasaki, H; Sonoda, S; Miyata, K; Murakami, Y; Ikeda, Y; Morimoto, T; Endo, T; Fujikado, T; Kamo, J; Sakamoto, T				Sainohira, Mayumi; Yamashita, Takehiro; Terasaki, Hiroto; Sonoda, Shozo; Miyata, Kazunori; Murakami, Yusuke; Ikeda, Yasuhiro; Morimoto, Takeshi; Endo, Takao; Fujikado, Takashi; Kamo, Junko; Sakamoto, Taiji			Quantitative analyses of factors related to anxiety and depression in patients with retinitis pigmentosa	PLOS ONE			English	Article							QUALITY-OF-LIFE; VISUAL FUNCTION QUESTIONNAIRE; HOSPITAL ANXIETY; MENTAL-HEALTH; GENE-THERAPY; VISION; PEOPLE; SCALE; MODEL	The purpose of this study is to determine the factors related to anxiety and depression in patients with retinitis pigmentosa (RP). The status of anxiety and depression was determined in RP patients with the Hospital Anxiety and Depression Scale (HADS) questionnaire which consisted of subscales for HADS-anxiety (HADS-A) and HADS-depression (HADS-D). The vision-specific quality of life (VSQOL) was assessed with the National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ25). The correlations between the HADS-A or HADS-D scores and vision-related clinical parameters such as the best-corrected visual acuity (BCVA), Functional Acuity Score, Functional Field Score, Functional Vision Score, the NEI-VFQ25 subscale score were determined. The socioeconomic status, such as the work status and membership in the RP society, was investigated to determine the factors related to the HADS-A and HADS-D scores. One hundred and twelve RP patients (46 men and 66 women) with mean age of 60.7 +/- 15.4 (standard deviation) years were studied. The HADS-A score was not significantly correlated with any visual functions but was significantly correlated with the general health condition (r = -0.34, P<0.001) and the role limitation (r = -0.20, P= 0.03) of the NEI-VFQ25 subscale. The HADS-D score was significantly correlated with all the visual functions (r = -0.38 to 0.29, P<0.001), the NEI-VFQ25 subscale score (r = -0.58 to -0.33, P<0.001) by Spearman's correlations. The HADS-A score was significantly higher in the members of the RP society than in non-members (P = 0.013). The mean HADS-D score of employed individuals was significantly lower than that of unemployed ones (P= 0.001) by the Mann-Whitney U test. The results indicate that visual function impairments and vision-related quality of life are associated with a depressive state, and the general health condition is related to anxiety in RP patients. Being employed may be strongly correlated with the degree of depression in RP patients.	[Sainohira, Mayumi; Yamashita, Takehiro; Terasaki, Hiroto; Sonoda, Shozo; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan; [Sainohira, Mayumi; Miyata, Kazunori] Miyata Eye Hosp, Miyazaki, Japan; [Murakami, Yusuke; Ikeda, Yasuhiro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan; [Morimoto, Takeshi; Fujikado, Takashi] Osaka Univ, Grad Sch Med, Dept Appl Visual Sci, Osaka, Japan; [Endo, Takao] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Osaka, Japan; [Kamo, Junko] Kofu Kyoritsu Hosp, Dept Ophthalmol, Yamanashi, Japan	Kagoshima University; Kyushu University; Osaka University; Osaka University	Sakamoto, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp			JSPS KAKENHI [15H04996]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI grant (15H04996). This study was registered with the University Hospital Medical Network-clinical trials registry (No. UMIN000018444). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Augustin A, 2007, INVEST OPHTH VIS SCI, V48, P1498, DOI 10.1167/iovs.06-0761; Azoulay L, 2015, OPHTHALMIC RES, V54, P78, DOI 10.1159/000435886; Bertelsen M, 2015, ACTA OPHTHALMOL, V93, P134, DOI 10.1111/aos.12467; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Chaumet-Riffaud AE, 2017, AM J OPHTHALMOL, V177, P169, DOI 10.1016/j.ajo.2017.02.016; Cure Research, STAT COUNTR RET PIGM; Dawson SR, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-78; Evans JR, 2007, OPHTHALMOLOGY, V114, P283, DOI 10.1016/j.ophtha.2006.10.006; Fuhr P., 2003, VIS, V5, P137, DOI [10.1080/1388235039048690, DOI 10.1080/1388235039048690]; Fujikado T, 2016, INVEST OPHTH VIS SCI, V57, P6147, DOI 10.1167/iovs.16-20367; Hahm BJ, 2008, BRIT J OPHTHALMOL, V92, P650, DOI 10.1136/bjo.2007.127092; Hayman KJ, 2007, OPTOMETRY VISION SCI, V84, P1024, DOI 10.1097/OPX.0b013e318157a6b1; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Ikeda Y, 2015, JPN J OPHTHALMOL, V59, P43, DOI 10.1007/s10384-014-0354-0; Kim S, 2013, OPTOMETRY VISION SCI, V90, P488, DOI 10.1097/OPX.0b013e31828dee0a; Levinson JD, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/6950642; Li Y, 2014, MOL THER, V22, P1688, DOI 10.1038/mt.2014.100; Mabuchi F, 2012, BRIT J OPHTHALMOL, V96, P821, DOI 10.1136/bjophthalmol-2011-300910; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Michalakis S, 2014, ADV EXP MED BIOL, V801, P733, DOI 10.1007/978-1-4614-3209-8_92; Moschos M, 2015, EUR J OPHTHALMOL, V25, P459, DOI 10.5301/ejo.5000590; Owsley C, 2004, OPHTHALMOLOGY, V111, P2259, DOI 10.1016/j.ophtha.2004.06.026; SNAITH RP, 1986, BMJ-BRIT MED J, V292, P344, DOI DOI 10.1136/BMJ.292.6516.344; Sugawara T, 2010, EYE, V24, P535, DOI 10.1038/eye.2009.176; Suzukamo Yoshimi, 2005, Health Qual Life Outcomes, V3, P65, DOI 10.1186/1477-7525-3-65; Tran BK, 2017, KLIN MONATSBL AUGENH, V234, P538, DOI 10.1055/s-0042-121660; Vaidya A, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-49; Yoshida T, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-45; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	30	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195983	10.1371/journal.pone.0195983	http://dx.doi.org/10.1371/journal.pone.0195983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684094	Green Submitted, Green Published, gold			2022-12-26	WOS:000430660600028
J	Chen, A; Sceneay, J; Godde, N; Kinwel, T; Ham, S; Thompson, EW; Humbert, PO; Moller, A				Chen, Anna; Sceneay, Jaclyn; Godde, Nathan; Kinwel, Tanja; Ham, Sunyoung; Thompson, Erik W.; Humbert, Patrick O.; Moller, Andreas			Intermittent hypoxia induces a metastatic phenotype in breast cancer	ONCOGENE			English	Article							SUPPRESSOR-CELLS; SIGNALING PATHWAYS; GENE-EXPRESSION; DOWN-REGULATION; TUMOR-CELLS; MECHANISMS; ANGIOGENESIS; PROGRESSION; AUTOPHAGY; PROMOTES	Hypoxia arises frequently in solid tumors and is a poor prognostic factor as it promotes tumor cell proliferation, invasion, angiogenesis, therapy resistance, and metastasis. Notably, there are two described forms of hypoxia present in a growing tumor: chronic hypoxia, caused by abnormal tumor vasculature, and intermittent hypoxia, caused by transient perfusion facilitated by tumor-supplying blood vessels. Here, we demonstrate that intermittent hypoxia, but not chronic hypoxia, endows breast cancer cells with greater metastatic potential. Using an immunocompetent and syngeneic murine model of breast cancer, we show that intermittent hypoxia enhances metastatic seeding and outgrowth in lungs in vivo. Furthermore, exposing mammary tumor cells to intermittent hypoxia promoted clonal diversity, upregulated metastasis-associated gene expression, induced a pro-tumorigenic secretory profile, increased stem-like cell marker expression, and gave rise to tumor-initiating cells at a relatively higher frequency. This work demonstrates that intermittent hypoxia, but not chronic hypoxia, induces a number of genetic, molecular, biochemical, and cellular changes that facilitate tumor cell survival, colonization, and the creation of a permissive microenvironment and thus enhances metastatic growth.	[Chen, Anna; Godde, Nathan; Kinwel, Tanja; Humbert, Patrick O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, St Andrews Pl, Melbourne, Vic 3002, Australia; [Chen, Anna; Kinwel, Tanja; Humbert, Patrick O.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Chen, Anna; Sceneay, Jaclyn; Ham, Sunyoung; Moller, Andreas] QIMR Berghofer Med Res Inst, Tumour Microenvironm Lab, Brisbane, Qld 4006, Australia; [Godde, Nathan; Kinwel, Tanja; Humbert, Patrick O.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Godde, Nathan; Humbert, Patrick O.] Univ Melbourne, Sir Peter MaCallum Dept Oncol, Parkville, Vic 3010, Australia; [Godde, Nathan] CSIRO, Australian Anim Hlth Lab, Pathol & Pathogenesis Grp, Diagnost Surveillance & Response, Geelong, Vic 3220, Australia; [Thompson, Erik W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4000, Australia; [Thompson, Erik W.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4000, Australia; [Thompson, Erik W.] Univ Melbourne, St Vincents Hosp, Dept Surg, East Melbourne 3002, Australia; [Humbert, Patrick O.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Sceneay, Jaclyn] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Peter Maccallum Cancer Center; University of Melbourne; QIMR Berghofer Medical Research Institute; La Trobe University; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Melbourne; University of Melbourne; Harvard University; Brigham & Women's Hospital	Humbert, PO (corresponding author), Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, St Andrews Pl, Melbourne, Vic 3002, Australia.; Humbert, PO (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia.; Moller, A (corresponding author), QIMR Berghofer Med Res Inst, Tumour Microenvironm Lab, Brisbane, Qld 4006, Australia.; Humbert, PO (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia.; Humbert, PO (corresponding author), Univ Melbourne, Sir Peter MaCallum Dept Oncol, Parkville, Vic 3010, Australia.; Humbert, PO (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.	p.humbert@latrobe.edu.au; andreas.moller@qimrberghofer.edu.au	Möller, Andreas/O-1063-2015; Humbert, Patrick O/L-4264-2016; Thompson, Erik/GPK-2067-2022; Thompson, Erik W/A-1425-2009	Möller, Andreas/0000-0002-8618-6998; Humbert, Patrick O/0000-0002-1366-6691; Thompson, Erik/0000-0002-9723-4924; Thompson, Erik W/0000-0002-9723-4924; Godde, Nathan/0000-0002-3413-407X	National Health and Medical Research Council of Australia [APP1068510, APP1079133]; Cancer Council Queensland [APP1045620]; National Breast Cancer Foundation (Australia) [ECF-11-09, NC-13-26]; APA scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); National Breast Cancer Foundation (Australia); APA scholarship	The authors thank Carmen Yong for help with flow cytometry and IV injections, and the groups of POH and AM for proof-reading the manuscript. This work was supported by funding from a project grant from the National Health and Medical Research Council of Australia (APP1068510 to AM). POH was supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia (APP1079133). AM was supported by Cancer Council Queensland (APP1045620), and National Breast Cancer Foundation (Australia) fellowship and grant (ECF-11-09, NC-13-26). AC was supported by an APA scholarship.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Alqawi O, 2007, FREE RADICAL RES, V41, P788, DOI 10.1080/10715760701361531; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bayer C, 2012, STRAHLENTHER ONKOL, V188, P616, DOI 10.1007/s00066-012-0085-4; Bhaskara VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030905; Boidot R, 2014, ONCOTARGET, V5, P6947, DOI 10.18632/oncotarget.2285; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Cairns RA, 2004, CANCER RES, V64, P2054, DOI 10.1158/0008-5472.CAN-03-3196; Cairns RA, 2001, CANCER RES, V61, P8903; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chan N, 2008, CANCER RES, V68, P605, DOI 10.1158/0008-5472.CAN-07-5472; Chen A, 2015, ONCOTARGET, V6, P862, DOI 10.18632/oncotarget.2696; Cooper C, 2004, CLIN CANCER RES, V10, P8720, DOI 10.1158/1078-0432.CCR-04-1235; Daneau G, 2010, CLIN CANCER RES, V16, P410, DOI 10.1158/1078-0432.CCR-09-0583; Fang YY, 2015, CELL BIOL INT, V39, P891, DOI 10.1002/cbin.10463; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gupta R, 2011, INT J ONCOL, V38, P733, DOI 10.3892/ijo.2010.883; Gutsche K, 2016, FREE RADICAL BIO MED, V101, P129, DOI 10.1016/j.freeradbiomed.2016.10.002; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hsieh CH, 2012, MOL IMAGING BIOL, V14, P489, DOI 10.1007/s11307-011-0516-0; Hsieh CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023945; Hsieh CH, 2010, ONCOL REP, V24, P1629, DOI 10.3892/or_00001027; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hussein D, 2006, MOL CANCER THER, V5, P2241, DOI 10.1158/1535-7163.MCT-06-0145; Kalliomaki TM, 2009, CANCER LETT, V282, P98, DOI 10.1016/j.canlet.2009.03.009; Kamat CD, 2007, CANCER LETT, V249, P209, DOI 10.1016/j.canlet.2006.08.017; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Liu YL, 2010, J CELL BIOCHEM, V111, P554, DOI 10.1002/jcb.22739; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Ma J, 2012, TUMOR BIOL, V33, P1983, DOI 10.1007/s13277-012-0458-4; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Miao ZF, 2014, TUMOR BIOL, V35, P6801, DOI 10.1007/s13277-014-1928-7; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moller A, 2009, ONCOGENE, V28, P289, DOI 10.1038/onc.2008.382; Mujcic H, 2013, CLIN CANCER RES, V19, P6126, DOI 10.1158/1078-0432.CCR-13-0526; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Rofstad EK, 2010, INT J CANCER, V127, P1535, DOI 10.1002/ijc.25176; Rouschop KMA, 2009, RADIOTHER ONCOL, V92, P411, DOI 10.1016/j.radonc.2009.06.029; Sceneay J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066388; Sceneay J, 2012, CANCER RES, V72, P3906, DOI 10.1158/0008-5472.CAN-11-3873; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Toffoli S, 2008, FEBS J, V275, P2991, DOI 10.1111/j.1742-4658.2008.06454.x; Wong CSF, 2012, CANCER RES, V72, P1694, DOI 10.1158/0008-5472.CAN-11-3310; Zhu HT, 2014, ONCOL REP, V32, P935, DOI 10.3892/or.2014.3298; Zolzer F, 2002, INT J RADIAT ONCOL, V54, P910, DOI 10.1016/S0360-3016(02)02963-2	60	72	73	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 2	2018	37	31					4214	4225		10.1038/s41388-018-0259-3	http://dx.doi.org/10.1038/s41388-018-0259-3			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP1HN	29713057				2022-12-26	WOS:000440566100002
J	Lee, HK; Lee, EW; Seo, J; Jeong, M; Lee, SH; Kim, SY; Jho, EH; Choi, CH; Chung, JY; Song, J				Lee, Hae-Kyung; Lee, Eun-Woo; Seo, Jinho; Jeong, Manhyung; Lee, Seon-Hyeong; Kim, Soo-Youl; Jho, Eek-Hoon; Choi, Chel Hun; Chung, Joon-Yong; Song, Jaewhan			Ubiquitylation and degradation of adenomatous polyposis coli by MKRN1 enhances Wnt/beta-catenin signaling	ONCOGENE			English	Article							TUMOR-SUPPRESSOR APC; BETA-CATENIN; WNT PATHWAY; COLORECTAL-CANCER; PLASMA-MEMBRANE; WILMS-TUMOR; GENE; AXIN; PHOSPHORYLATION; UBIQUITIN	The adenomatous polyposis coli (APC) protein has a tumor-suppressor function by acting as a negative regulator of the Wnt signaling pathway. While its role as a tumor suppressor is well-defined, the post-translational modifications that regulate APC stability are not fully understood. Here we showed that MKRN1, an E3 ligase, could directly interact with and ubiquitylate APC, promoting its proteasomal degradation. In contrast, an E3 ligase-defective MKRN1 mutant was no longer capable of regulating APC, indicating that its E3 ligase activity is required for APC regulation by MKRN1. Strengthening these results, MKRN1 ablation resulted in reduced beta-catenin activity and decreased expression of Wnt target genes. The ability of the Wnt-dependent pathway to induce cancer cell proliferation, migration, and invasion was impaired by MKRN1 depletion, but restored by simultaneous APC knockdown. Taken together, these results demonstrate that MKRN1 functions as a novel E3 ligase of APC that positively regulates Wnt/beta-catenin-mediated biological processes.	[Lee, Hae-Kyung; Seo, Jinho; Jeong, Manhyung; Song, Jaewhan] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, 50 Yonsei Ro, Seoul 03722, South Korea; [Lee, Eun-Woo] KRIBB, Metab Regulat Res Ctr, Daejeon 34141, South Korea; [Lee, Seon-Hyeong; Kim, Soo-Youl] Natl Canc Ctr, Div Canc Biol, Tumor Microenvironm Res Branch, Goyang 10408, Gyeonggi Do, South Korea; [Jho, Eek-Hoon] Univ Seoul, Dept Life Sci, 90 Jeonnong Dong, Seoul 02592, South Korea; [Choi, Chel Hun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Obstet & Gynecol, Seoul 135710, South Korea; [Chung, Joon-Yong] NCI, Expt Pathol Lab, Lab Pathol, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Cancer Center - Korea (NCC); University of Seoul; Sungkyunkwan University (SKKU); Samsung Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Song, J (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, 50 Yonsei Ro, Seoul 03722, South Korea.	jso678@yonsei.ac.kr	Chung, Joon-Yong/J-9177-2017; Lee, Eun-Woo/AAP-9603-2020	Chung, Joon-Yong/0000-0001-5041-5982; Song, Jaewhan/0000-0001-8152-9210; Lee, Hae-Kyung/0000-0001-6076-481X; Lee, Eun-Woo/0000-0002-5156-0003; Jho, Eek-hoon/0000-0003-2414-6234	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2015R1A3A2066581]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	We thank Prof. KY Choi (Yonsei University) for providing L929, L929-hWnt3a, and HEK293-TOP-FLASH stable cell lines. This research was supported by a grant from the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning (NRF-2015R1A3A2066581) to J Song.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bastakoty D, 2016, FASEB J, V30, P3271, DOI 10.1096/fj.201600502R; Berndt JD, 2013, SCIENCE, V339, P1388, DOI 10.1126/science.1236641; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blagodatski Artem, 2014, Mol Cell Ther, V2, P28, DOI 10.1186/2052-8426-2-28; Bol GM, 2010, HISTOPATHOLOGY, V57, P363, DOI 10.1111/j.1365-2559.2010.03642.x; Cassar PA, 2015, EMBO REP, V16, P1334, DOI 10.15252/embr.201540974; Choi J, 2004, J BIOL CHEM, V279, P49188, DOI 10.1074/jbc.M404655200; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Gao CX, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-13; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; Tran H, 2012, J BIOL CHEM, V287, P28552, DOI 10.1074/jbc.M112.387878; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kim JH, 2014, CELL DEATH DIFFER, V21, P594, DOI 10.1038/cdd.2013.181; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kim W, 2013, ONCOGENE, V32, P3390, DOI 10.1038/onc.2012.373; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Ko A, 2012, JNCI-J NATL CANCER I, V104, P1660, DOI 10.1093/jnci/djs424; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Lee EW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1981; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Morishita EC, 2011, STRUCTURE, V19, P1496, DOI 10.1016/j.str.2011.07.013; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Nusse R, 2015, NATURE, V519, P163, DOI 10.1038/nature14208; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; Valkenburg KC, 2013, CHIN J CANCER, V32, P380, DOI 10.5732/cjc.012.10218; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Zhang ZY, 2012, CELL RES, V22, P372, DOI 10.1038/cr.2011.119; Zimmerman ZF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008086	68	12	13	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 2	2018	37	31					4273	4286		10.1038/s41388-018-0267-3	http://dx.doi.org/10.1038/s41388-018-0267-3			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP1HN	29713058				2022-12-26	WOS:000440566100006
J	Aboudehen, K; Farahani, S; Kanchwala, M; Chan, SC; Avdulov, S; Mickelson, A; Lee, D; Gearhart, MD; Patel, V; Xing, C; Igarashi, P				Aboudehen, Karam; Farahani, Shayan; Kanchwala, Mohammed; Chan, Siu Chiu; Avdulov, Svetlana; Mickelson, Alan; Lee, Dayeon; Gearhart, Micah D.; Patel, Vishal; Xing, Chao; Igarashi, Peter			Long noncoding RNA Hoxb3os is dysregulated in autosomal dominant polycystic kidney disease and regulates mTOR signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; long noncoding RNA (long ncRNA; lncRNA); mTOR complex (mTORC); CRISPR; Cas; epithelial cell	CYST FORMATION; CELL-PROLIFERATION; MAMMALIAN TARGET; GENE; CANCER; INACTIVATION; ACTIVATION; MALAT-1; PATHWAY; PROTEIN	Autosomal dominant polycystic kidney disease (ADPKD) is a debilitating disease that is characterized by the accumulation of numerous fluid-filled cysts in the kidney. ADPKD is primarily caused by mutations in two genes, PKD1 and PKD2. Long noncoding RNAs (lncRNA), defined by a length >200 nucleotides and absence of a long ORF, have recently emerged as epigenetic regulators of development and disease; however, their involvement in PKD has not been explored previously. Here, we performed deep RNA-Seq to identify lncRNAs that are dysregulated in two orthologous mouse models of ADPKD (kidney-specific Pkd1 and Pkd2 mutant mice). We identified a kidney-specific, evolutionarily conserved lncRNA called Hoxb3os that was down-regulated in cystic kidneys from Pkd1 and Pkd2 mutant mice. The human ortholog HOXB3-AS1 was down-regulated in cystic kidneys from ADPKD patients. Hoxb3os was highly expressed in renal tubules in adult WT mice, whereas its expression was lost in the cyst epithelium of mutant mice. To investigate the function of Hoxb3os, we utilized CRISPR/Cas9 to knock out its expression in mIMCD3 cells. Deletion of Hoxb3os resulted in increased phosphorylation of mTOR and its downstream targets, including p70 S6 kinase, ribosomal protein S6, and the translation repressor 4E-BP1. Consistent with activation of mTORC1 signaling, Hoxb3os mutant cells displayed increased mitochondrial respiration. The Hoxb3os mutant phenotype was partially rescued upon re-expression of Hoxb3os in knockout cells. These findings identify Hoxb3os as a novel lncRNA that is down-regulated in ADPKD and regulates mTOR signaling and mitochondrial respiration.	[Aboudehen, Karam; Farahani, Shayan; Chan, Siu Chiu; Avdulov, Svetlana; Mickelson, Alan; Lee, Dayeon; Igarashi, Peter] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Gearhart, Micah D.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Kanchwala, Mohammed; Xing, Chao] UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Xing, Chao] UT Southwestern Med Ctr, Dept Clin Sci, Dallas, TX 75390 USA; [Xing, Chao] UT Southwestern Med Ctr, Dept Bioinformat, Dallas, TX 75390 USA; [Patel, Vishal] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Aboudehen, K (corresponding author), 420 Delaware St SE,MMC 605, Minneapolis, MN 55455 USA.	karam@umn.edu	Patel, Vishal/GMW-7076-2022	Patel, Vishal/0000-0003-2875-4659; Xing, Chao/0000-0002-1838-0502; Farahani, Shayan/0000-0002-1656-5183; aboudehen, karam/0000-0003-4975-464X; Gearhart, Micah/0000-0002-9873-1930; Kanchwala, Mohammed/0000-0001-6035-2970	National Institutes of Health [R37DK042921, UL1TR001105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102572, R37DK042921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grants R37DK042921 (to P. I.) and UL1TR001105 (to C. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguiari G, 2004, FASEB J, V18, P884, DOI 10.1096/fj.03-0687fje; Audrezet MP, 2016, J AM SOC NEPHROL, V27, P722, DOI 10.1681/ASN.2014101051; Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Birkenmeier K, 2016, INT J CANCER, V138, P2231, DOI 10.1002/ijc.29934; Boca M, 2006, J AM SOC NEPHROL, V17, P637, DOI 10.1681/ASN.2005050534; Braun WE, 2014, CLIN J AM SOC NEPHRO, V9, P881, DOI 10.2215/CJN.02650313; Cornec-Le Gall E, 2018, J AM SOC NEPHROL, V29, P13, DOI 10.1681/ASN.2017050483; De Kumar B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501402; Emmrich S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-171; Fatima Roshan, 2015, Mol Cell Ther, V3, P5, DOI 10.1186/s40591-015-0042-6; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Grantham J. J., 1985, PROBL DIAGN MAN POL; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Harris PC, 2002, GENEREVIEWS; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hessels D, 2009, NAT REV UROL, V6, P255, DOI 10.1038/nrurol.2009.40; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Igarashi P, 2007, J AM SOC NEPHROL, V18, P1371, DOI 10.1681/ASN.2007030299; IGLESIAS CG, 1983, AM J KIDNEY DIS, V2, P630; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; Kuntz EM, 2017, NAT MED, V23, P1234, DOI 10.1038/nm.4399; Kurbegovic A, 2014, MOL CELL BIOL, V34, P3341, DOI 10.1128/MCB.00687-14; Li LJ, 2013, CELL REP, V5, P3, DOI 10.1016/j.celrep.2013.09.003; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Long JY, 2016, J CLIN INVEST, V126, P4205, DOI 10.1172/JCI87927; Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Parasramka MA, 2016, PHARMACOL THERAPEUT, V161, P67, DOI 10.1016/j.pharmthera.2016.03.004; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Patel V, 2009, CURR OPIN NEPHROL HY, V18, P99, DOI 10.1097/MNH.0b013e3283262ab0; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Qian P, 2016, CELL STEM CELL, V18, P1, DOI DOI 10.1016/j.stem.2015.11.001; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Wang F, 2015, ONCOTARGET, V6, P1; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang X, 2018, J CELL BIOCHEM, V119, P1567, DOI 10.1002/jcb.26317; Warner G, 2016, J AM SOC NEPHROL, V27, P1437, DOI 10.1681/ASN.2015020132; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Ying L, 2012, MOL BIOSYST, V8, P2289, DOI 10.1039/c2mb25070e	53	25	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9388	9398		10.1074/jbc.RA118.001723	http://dx.doi.org/10.1074/jbc.RA118.001723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29716997	Green Published, hybrid			2022-12-26	WOS:000435441400023
J	Zuo, XL; Rong, BW; Li, L; Lv, RT; Lan, F; Tong, MH				Zuo, Xiaoli; Rong, Bowen; Li, Li; Lv, Ruitu; Lan, Fei; Tong, Ming-Han			The histone methyltransferase SETD2 is required for expression of acrosin-binding protein 1 and protamines and essential for spermiogenesis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						spermatogenesis; histone modification; histone methylation; testis; reproduction; acrosome biogenesis; histone-to-protamine transition; Setd2; spermiogenesis	GERM-CELL APOPTOSIS; LIFE-HISTORY; ZONA-PELLUCIDA; METHYLATION; SPERM; CYCLE; SPERMATOGENESIS; WAVE; DIFFERENTIATION; DEFICIENCY	Spermatogenesis is precisely controlled by complex gene expression programs and involves epigenetic reprogramming, including histone modification and DNA methylation. SET domain-containing 2 (SETD2) is the predominant histone methyltransferase catalyzing the trimethylation of histone H3 lysine 36 (H3K36me3) and plays key roles in embryonic stem cell differentiation and somatic cell development. However, its role in male germ cell development remains elusive. Here, we demonstrate an essential role of Setd2 for spermiogenesis, the final stage of spermatogenesis. Using RNA-seq, we found that, in postnatal mouse testes, Setd2 mRNA levels dramatically increase in 14-day-old mice. Using a germ cell-specific Setd2 knockout mouse model, we also found that targeted Setd2 knockout in germ cells causes aberrant spermiogenesis with acrosomal malformation before step 8 of the round-spermatid stage, resulting in complete infertility. Furthermore, we noted that the Setd2 deficiency results in complete loss of H3K36me3 and significantly decreases expression of thousands of genes, including those encoding acrosin-binding protein 1 (Acrbp1) and protamines, required for spermatogenesis. Our findings thus reveal a previously unappreciated role of the SETD2-dependent H3K36me3 modification in spermiogenesis and provide clues to the molecular mechanisms in epigenetic disorders underlying male infertility.	[Zuo, Xiaoli; Tong, Ming-Han] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Key Lab Mol Androl,State Key Lab Mol Bio, Shanghai 200031, Peoples R China; [Rong, Bowen; Lv, Ruitu; Lan, Fei] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Shanghai Minist Educ,Key Lab Epigenet, Liver Canc Inst,Zhongshan Hosp,Minist Educ, Shanghai 200032, Peoples R China; [Rong, Bowen; Lv, Ruitu; Lan, Fei] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Li, Li] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji Med Clin Stem Cell Res Ctr 10, Ren Ji Hosp,Sch Biomed Engn, Shanghai 200001, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; Fudan University; Shanghai Jiao Tong University	Lan, F (corresponding author), Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Shanghai Minist Educ,Key Lab Epigenet, Liver Canc Inst,Zhongshan Hosp,Minist Educ, Shanghai 200032, Peoples R China.; Lan, F (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Tong, MH (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	fei_lan@fudan.edu.cn; minghan@sibcb.ac.cn	Lyu, Ruitu/ABG-1437-2021; Lyu, Ruitu/ABU-6220-2022	Lyu, Ruitu/0000-0003-4597-1604; Lyu, Ruitu/0000-0003-4597-1604; tong, ming han/0000-0002-1967-5927; Li, Li/0000-0003-2342-3658	National Natural Science Foundation of China [31671553, 31371303, 81772938]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]; Ministry of Science and Technology of China [2014CB943101]; National Key Research and Development Program of China [2016YFC1000600]; Science and Technology Commission of Shanghai Municipality [17JC1420102, 16140902100, 18140902700]; Shanghai Institutes for Biological Sciences foundation; State Key Development Program [2014CB943103, 2016YFA0101800]; Science and Technology Commission of Shanghai Municipality Major Project [2017SHZDZX01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key Research and Development Program of China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Institutes for Biological Sciences foundation; State Key Development Program; Science and Technology Commission of Shanghai Municipality Major Project	This work was supported by National Natural Science Foundation of China Grant 31671553, Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19000000, Ministry of Science and Technology of China Grant 2014CB943101, National Key Research and Development Program of China Grant 2016YFC1000600, Science and Technology Commission of Shanghai Municipality Grant 17JC1420102, and the Shanghai Institutes for Biological Sciences foundation (to M.-H. T.); State Key Development Program Grants 2014CB943103 and 2016YFA0101800, National Natural Science Foundation of China Grant 31371303, and Science and Technology Commission of Shanghai Municipality Major Project 2017SHZDZX01 (to F. L.); and National Natural Science Foundation of China Grant 81772938 and Science and Technology Commission of Shanghai Municipality Grants 16140902100 and 18140902700 (to L. L.). The authors declare that they have no conflicts of interest with the contents of this article.	An J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.171; Aviles M, 1997, HISTOCHEM J, V29, P583, DOI 10.1023/A:1026432211012; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/ng0501-82; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; de Mateo S, 2014, SEMIN CELL DEV BIOL, V29, P84, DOI 10.1016/j.semcdb.2014.04.021; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dhar S, 2012, J BIOL CHEM, V287, P6387, DOI 10.1074/jbc.M111.288167; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gaucher J, 2012, EMBO J, V31, P3809, DOI 10.1038/emboj.2012.233; Gaysinskaya V, 2014, CYTOM PART A, V85A, P556, DOI 10.1002/cyto.a.22463; Griswold MD, 2016, PHYSIOL REV, V96, P1, DOI 10.1152/physrev.00013.2015; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P409, DOI 10.1002/jemt.20786; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P364, DOI 10.1002/jemt.20785; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P320, DOI 10.1002/jemt.20784; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P279, DOI 10.1002/jemt.20787; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Iwamori N, 2016, P NATL ACAD SCI USA, V113, pE5408, DOI 10.1073/pnas.1611995113; Iwamori N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072689; Kanemori Y, 2016, P NATL ACAD SCI USA, V113, pE3696, DOI 10.1073/pnas.1522333113; Kim S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030062; Lambrot R, 2015, FASEB J, V29, P4402, DOI 10.1096/fj.14-267328; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Legrand JMD, 2018, SEMIN CELL DEV BIOL, V79, P80, DOI 10.1016/j.semcdb.2017.10.006; Lin Z, 2017, CELL RES, V27, P1216, DOI 10.1038/cr.2017.117; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; McClusky LM, 2009, J MOL HISTOL, V40, P287, DOI 10.1007/s10735-009-9240-3; MORTIMER D, 1987, J REPROD FERTIL, V81, P127; Mu WP, 2014, GENE DEV, V28, P2056, DOI 10.1101/gad.246124.114; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Powers NR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006146; Rathke C, 2014, BBA-GENE REGUL MECH, V1839, P155, DOI 10.1016/j.bbagrm.2013.08.004; Stewart KR, 2016, EPIGENOMICS-UK, V8, P1399, DOI 10.2217/epi-2016-0056; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Wang Yu, 2015, INT J MECHATRONICS A, V5, pl, DOI DOI 10.1021/ACS.NAN0LETT.5B00964; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230; Yabuta Y, 2011, J CELL BIOL, V192, P781, DOI 10.1083/jcb.201009043; Yan W, 2010, J BIOL CHEM, V285, P31418, DOI 10.1074/jbc.M110.116418; Yang KF, 2012, MOL CELL BIOL, V32, P216, DOI 10.1128/MCB.06158-11; Yuan HR, 2017, J CLIN INVEST, V127, P3381, DOI 10.1172/JCI94292; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188; Zhang YL, 2014, CELL REP, V8, P1989, DOI 10.1016/j.celrep.2014.08.031; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626	56	30	31	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9188	9197		10.1074/jbc.RA118.002851	http://dx.doi.org/10.1074/jbc.RA118.002851			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29716999	Green Published, hybrid			2022-12-26	WOS:000435441400005
J	Tang, YZ; Romano, FB; Brena, M; Heuck, AP				Tang, Yuzhou; Romano, Fabian B.; Brena, Mariana; Heuck, Alejandro P.			The Pseudomonas aeruginosa type III secretion translocator PopB assists the insertion of the PopD translocator into host cell membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING ACTIVITY; MOLECULAR ARCHITECTURE; PERFRINGOLYSIN O; FLUORESCENCE; SYSTEM; DOMAIN; CHOLESTEROL; REGULATOR; EFFECTORS; REVEALS	Many Gram-negative bacterial pathogens use a type III secretion system to infect eukaryotic cells. The injection of bacterial toxins or protein effectors via this system is accomplished through a plasma membrane channel formed by two bacterial proteins, termed translocators, whose assembly and membraneinsertion mechanisms are currently unclear. Here, using purified proteins we demonstrate that the translocators PopB and PopD in Pseudomonas aeruginosa assemble heterodimers in membranes, leading to stably inserted hetero-complexes. Using site-directed fluorescence labeling with an environment-sensitive probe, we found that hydrophobic segments inPopDanchor the translocator to the membrane, but without adopting a typical transmembrane orientation. A fluorescence dual-quenching assay revealed that the presence of PopB changes the conformation adopted by PopD segments in membranes. Furthermore, analysis of PopD's interaction with human cell membranes revealed that PopD adopts a distinctive conformation when PopB is present. An N-terminal region of PopD is only exposed to the host cytosol when PopB is present. We conclude that PopB assists with the proper insertion of PopD in cell membranes, required for the formation of a functional translocon and host infection.	[Tang, Yuzhou; Romano, Fabian B.; Brena, Mariana; Heuck, Alejandro P.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Heuck, Alejandro P.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Heuck, AP (corresponding author), 710 N Pleasant St,LGRT 1228, Amherst, MA 01003 USA.	heuck@umass.edu	Romano-Chernac, Fabian B./K-9396-2019	Heuck, Alejandro/0000-0002-7786-3109; Monopoli, Kathryn/0000-0002-8615-4849	National Institutes of Health [GM097414]; National Research Service Award from the National Institutes of Health [T32 GM08515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097414, T32GM008515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM097414 (to A. P. H). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Research Service Award T32 GM08515 from the National Institutes of Health.	Alder NN, 2008, CELL, V134, P439, DOI 10.1016/j.cell.2008.06.007; Anantharajah A, 2016, TRENDS PHARMACOL SCI, V37, P734, DOI 10.1016/j.tips.2016.05.011; Armentrout EI, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005530; Boens N, 2007, ANAL CHEM, V79, P2137, DOI 10.1021/ac062160k; Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Chatterjee A, 2015, J BIOL CHEM, V290, P25579, DOI 10.1074/jbc.M115.648204; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20; Dortet L, 2018, NAT MICROBIOL, V3, P378, DOI 10.1038/s41564-018-0109-7; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Garcia JT, 2006, INFECT IMMUN, V74, P5645, DOI 10.1128/IAI.00690-06; Ghatak C, 2015, TOXINS, V7, P1303, DOI 10.3390/toxins7041303; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Heuck AP, 2002, CELL BIOCHEM BIOPHYS, V36, P89, DOI 10.1385/CBB:36:1:89; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Howell HA, 2013, MBIO, V4, DOI 10.1128/mBio.00032-13; Hu B, 2017, CELL, V168, P1065, DOI 10.1016/j.cell.2017.02.022; Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Jameson DM, 2003, METHOD ENZYMOL, V360, P1; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Johnson BB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14002-x; Kaufman MR, 2000, MICROBIOL-UK, V146, P2531, DOI 10.1099/00221287-146-10-2531; Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792; Kurnikov IV, 2013, J MOL BIOL, V425, P2752, DOI 10.1016/j.jmb.2013.04.030; Ladokhin AS, 2013, TOXINS, V5, P1362, DOI 10.3390/toxins5081362; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Mounier J, 2012, CELL HOST MICROBE, V12, P381, DOI 10.1016/j.chom.2012.07.010; Ohlendieck K, 1996, Methods Mol Biol, V59, P293; Perier A, 2007, J BIOL CHEM, V282, P24239, DOI 10.1074/jbc.M703392200; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Reinhart G D, 1991, J Fluoresc, V1, P153, DOI 10.1007/BF00865362; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Romano FB, 2016, J BIOL CHEM, V291, P6304, DOI 10.1074/jbc.M115.681031; Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x; Savinov SN, 2017, TOXINS, V9, DOI 10.3390/toxins9120381; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Senerovic L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.124; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Tomalka AG, 2012, MOL MICROBIOL, V86, P1464, DOI 10.1111/mmi.12069; Urbanowski ML, 2007, INFECT IMMUN, V75, P4432, DOI 10.1128/IAI.00664-07; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Vargas-Uribe M, 2013, BIOCHEMISTRY-US, V52, P7901, DOI 10.1021/bi400926k	51	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8982	8993		10.1074/jbc.RA118.002766	http://dx.doi.org/10.1074/jbc.RA118.002766			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29685888	Green Published, hybrid			2022-12-26	WOS:000434941900021
J	Chan, BKK; Xu, G; Kim, HK; Park, JH; Kim, W				Chan, Benny K. K.; Xu, Guang; Kim, Hyun Kyong; Park, Jin-Ho; Kim, Won			Living with marginal coral communities: Diversity and host-specificity in coral-associated barnacles in the northern coral distribution limit of the East China Sea	PLOS ONE			English	Article							CIRRIPEDIA PYRGOMATIDAE; BIODIVERSITY; EVOLUTION; KOREA	Corals and their associated fauna are extremely diverse in tropical waters and form major reefs. In the high-latitude temperate zone, corals living near their distribution limit are considered marginal communities because they are particularly extremely sensitive to environmental and climatic changes. In this study, we examined the diversity and host usage of coral-associated barnacles on Jeju Island, Korea, the northern coral distribution limit in the East China Sea. In this study, only three coral-associated barnacles D from two genera in two subfamilies D were collected. The Pyrgomatinid barnacles Cantellius arcuatus and Cantellius cf. euspinulosum were found only on the corals Montipora millepora and Alveopora japonica, respectively. The Megatrematinid barnacle Pyrgomina oulastreae, relatively a generalist, was found on Psammocora spp. (both profundacella and albopicta) and Oulastrea crispata corals. The host usage of these three barnacles does not overlap. DNA barcode sequences of the C. arcuatus specimens collected in the present study matched those collected in Kochi in Japan, Taiwan, Malaysia and Papua New Guinea, suggesting that this species has a wide geographical distribution. C. arcuatus covers a wider host range in Taiwan waters, inhabiting Montipora spp. and Porites spp., which suggests that the host specificity of coral-associated barnacles varies with host availability. C. cf. euspinulosum probably has a very narrow distribution and host usage. The sequences of C. cf. euspinulosum on Jeju Island do not match those of any known sequences of Cantellius barnacles in the Indo-Pacific region. P. oulastreae probably prefers cold water because it has been reported in temperate regions. Coral-associated barnacles in marginal communities have considerably lower diversity than their subtropical and tropical counterparts. When host availability is limited, marginal coral-associated barnacles exhibit higher host specificity than those in subtropical and tropical reef systems.	[Chan, Benny K. K.] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Xu, Guang; Kim, Hyun Kyong; Park, Jin-Ho; Kim, Won] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea	Academia Sinica - Taiwan; Seoul National University (SNU)	Kim, W (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	wonkim@plaza.snu.ac.kr	PARK, JINHO/AAF-3608-2021	PARK, JINHO/0000-0001-6522-744X	Senior Investigator Award, Academia Sinica, Taiwan [23161050500]; Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea [20170431]; National Institute of Biological Resources (NIBR) - Ministry of Environment (MOE) of the Republic of Korea [NIBR201701201]; Academia Sinica	Senior Investigator Award, Academia Sinica, Taiwan; Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea; National Institute of Biological Resources (NIBR) - Ministry of Environment (MOE) of the Republic of Korea; Academia Sinica(Academia Sinica - Taiwan)	This study is supported from the Senior Investigator Award, Academia Sinica, Taiwan (23161050500) and a grant from Marine Biotechnology Program (20170431) funded by the Ministry of Oceans and Fisheries, Korea, and the National Institute of Biological Resources (NIBR), funded by the Ministry of Environment (MOE) of the Republic of Korea (NIBR201701201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BKKC would like to acknowledge the Senior Investigator Award from Academia Sinica. Thanks to Noah Last (Academia Sinica) for editing the English of the present article.	Achituv Y, 1996, B MAR SCI, V58, P856; Achituv Y, 1997, MAR BIOL, V130, P243; Achituv Y, 2009, ZOOTAXA, P15, DOI 10.11646/zootaxa.2022.1.2; Asami K, 1997, SESSILE ORGANISMS, V14, P9, DOI [10.4282/sosj.14.9, DOI 10.4282/S0SJ.14.9, DOI 10.4282/SOSJ.14.9]; Blackall LL, 2015, MOL ECOL, V24, P5330, DOI 10.1111/mec.13400; BROCH HJALMAR, 1931, VIDENSK MEDDEL DANSK NATURHIST FOR KOBENHAVN, V91, P1; Chan BKK, 2008, J ZOOL, V275, P294, DOI 10.1111/j.1469-7998.2008.00441.x; Chan BKK, 2014, J NAT HIST, V48, P1503, DOI 10.1080/00222933.2014.896488; Chan BKK, 2013, J CRUSTACEAN BIOL, V33, P392, DOI 10.1163/1937240X-00002134; Chan BNKK, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.719.12471; Chan BKK, 2013, CRUSTACEAN FAUNA TAI, VII, P367; Chan BKK, 2013, CRUSTACEAN FAUNA TAI, VII, P1; Chen HN, 2014, BIOFOULING, V30, P1067, DOI 10.1080/08927014.2014.967232; Choi Eunae, 2014, Animal Systematics Evolution and Diversity, V30, P183, DOI 10.5635/ASED.2014.30.3.183; Dai CF, 2009, SCLERACTINIA TAIWAN; Darwin CR, 1854, MONOGRAPH SUBCLASS C, P1; De Palmas S, 2015, CORAL REEFS, V34, P919, DOI 10.1007/s00338-015-1286-y; Denis V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054330; Foster B.A., 1980, P 1 INT MAR BIOL WOR; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim IH, 2011, VERTEBRATE FAUNA KOR, V21, P105; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ministry of Justice of the Republic of Kazakhstan, 2004, COMP INS PLANT GROW, P1; Ogawa K, 1990, NANKI BIOL SOC, V32, P73; Rosell NC, 1981, ZOOLOGIE, V91, P278; ROSS A, 1973, Transactions of the San Diego Society of Natural History, V17, P137; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stella JS, 2011, OCEANOGR MAR BIOL, V49, P43; Sugihara K, 2014, ECOL RES MONOGR, P111, DOI 10.1007/978-4-431-54783-9_6; Tsang LM, 2014, MOL PHYLOGENET EVOL, V77, P11, DOI 10.1016/j.ympev.2014.03.002; Tsang LM, 2009, MOL ECOL, V18, P1463, DOI 10.1111/j.1365-294X.2009.04090.x; Utinomi H., 1962, Publications of the Seto Marine Biological Laboratory, V10, P211; Veron J.E.N., 2000, AUST I MAR SCI, V1-3, P382	33	10	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196309	10.1371/journal.pone.0196309	http://dx.doi.org/10.1371/journal.pone.0196309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715264	gold, Green Submitted, Green Published			2022-12-26	WOS:000431281100016
J	Hamilton, KA; Wang, Y; Raefsky, SM; Berkowitz, S; Spangler, R; Suire, CN; Camandola, S; Lipsky, RH; Mattson, MP				Hamilton, Kelly A.; Wang, Yue; Raefsky, Sophia M.; Berkowitz, Sean; Spangler, Ryan; Suire, Caitlin N.; Camandola, Simonetta; Lipsky, Robert H.; Mattson, Mark P.			Mice lacking the transcriptional regulator Bhlhe40 have enhanced neuronal excitability and impaired synaptic plasticity in the hippocampus	PLOS ONE			English	Article							AMYLOID-BETA; EPILEPSY; GENE; DISEASE; STRA13; MODEL; DEC1; SUPPRESSION; EXPRESSION; CURRENTS	Bhlhe40 is a transcription factor that is highly expressed in the hippocampus; however, its role in neuronal function is not well understood. Here, we used Bhlhe40 null mice on a congenic C57Bl6/J background (Bhlhe40 KO) to investigate the impact of Bhlhe40 on neuronal excitability and synaptic plasticity in the hippocampus. Bhlhe40 KO CA1 neurons had increased miniature excitatory post-synaptic current amplitude and decreased inhibitory post-synaptic current amplitude, indicating CA1 neuronal hyperexcitability. Increased CA1 neuronal excitability was not associated with increased seizure severity as Bhlhe40 KO relative to +/+ (WT) control mice injected with the convulsant kainic acid. However, significant reductions in long term potentiation and long term depression at CA1 synapses were observed in Bhlhe40 KO mice, indicating impaired hippocampal synaptic plasticity. Behavioral testing for spatial learning and memory on the Morris Water Maze (MWM) revealed that while Bhlhe40 KO mice performed similarly to WT controls initially, when the hidden platform was moved to the opposite quadrant Bhlhe40 KO mice showed impairments in relearning, consistent with decreased hippocampal synaptic plasticity. To investigate possible mechanisms for increased neuronal excitability and decreased synaptic plasticity, a whole genome mRNA expression profile of Bhlhe40 KO hippocampus was performed followed by a chromatin immunoprecipitation sequencing (ChIP-Seq) screen of the validated candidate genes for Bhlhe40 protein-DNA interactions consistent with transcriptional regulation. Of the validated genes identified from mRNA expression analysis, insulin degrading enzyme (Ide) had the most significantly altered expression in hippocampus and was significantly downregulated on the RNA and protein levels; although Bhlhe40 did not occupy the Ide gene by ChIP-Seq. Together, these findings support a role for Bhlhe40 in regulating neuronal excitability and synaptic plasticity in the hippocampus and that indirect regulation of Ide transcription may be involved in these phenotypes.	[Hamilton, Kelly A.; Wang, Yue; Raefsky, Sophia M.; Berkowitz, Sean; Spangler, Ryan; Suire, Caitlin N.; Camandola, Simonetta; Mattson, Mark P.] NIA, Lab Neurosci, Baltimore, MD 21224 USA; [Hamilton, Kelly A.; Lipsky, Robert H.] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Lipsky, Robert H.] Inova Hlth Syst, Dept Neurosci, Falls Church, VA 22042 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); George Mason University; Inova Health System	Lipsky, RH (corresponding author), Inova Hlth Syst, Dept Neurosci, Falls Church, VA 22042 USA.	Robert.Lipsky@inova.org		Berkowitz, Sean/0000-0002-9763-7192; Lipsky, Robert/0000-0001-7753-1473; Suire, Caitlin/0000-0001-5224-1330	intramural budget for the National Institute on Aging; George Mason University [222865]	intramural budget for the National Institute on Aging; George Mason University	Research funding support was provided by the intramural budget for the National Institute on Aging and by George Mason University grant no. 222865 to RHL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah JM, 2012, MALAYS J MED SCI, V19, P1; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Cho CH, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00055; Collins B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001959; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; El-Hayek YH, 2011, EXP NEUROL, V231, P295, DOI 10.1016/j.expneurol.2011.07.003; Fisahn A, 2005, J PHYSIOL-LONDON, V562, P65, DOI 10.1113/jphysiol.2004.077388; Frank MG, 2014, TRENDS NEUROSCI, V37, P491, DOI 10.1016/j.tins.2014.06.005; Georgiev D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043904; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Jiang XY, 2008, J NEUROSCI, V28, P1118, DOI 10.1523/JNEUROSCI.2262-07.2008; Kato Y, 2014, CURR TOP DEV BIOL, V110, P339, DOI 10.1016/B978-0-12-405943-6.00010-5; Klugmann M, 2006, MOL CELL NEUROSCI, V31, P303, DOI 10.1016/j.mcn.2005.09.019; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Liu HT, 1999, P NATL ACAD SCI USA, V96, P12096, DOI 10.1073/pnas.96.21.12096; Lu CB, 2002, NEUROMOL MED, V1, P69; Mathis DM, 2011, JOVE-J VIS EXP, DOI 10.3791/2330; Mohajeri MH, 2004, GENES BRAIN BEHAV, V3, P228, DOI 10.1111/j.1601-1848.2004.00073.x; O'Donnell KC, 2014, DIS MODEL MECH, V7, P571, DOI 10.1242/dmm.013185; O'Neill HC, 2013, PHARMACOL BIOCHEM BE, V103, P603, DOI 10.1016/j.pbb.2012.10.014; Ow JR, 2014, CURR TOP DEV BIOL, V110, P317, DOI 10.1016/B978-0-12-405943-6.00009-9; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Qian YJ, 2012, CELL CYCLE, V11, P3525, DOI 10.4161/cc.21962; Qian YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086328; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Rossner MJ, 1997, MOL CELL NEUROSCI, V9, P460, DOI 10.1006/mcne.1997.0640; Sakagami H, 2005, EUR J NEUROSCI, V22, P2697, DOI 10.1111/j.1460-9568.2005.04463.x; Scharfman Helen E, 2005, Epilepsy Curr, V5, P83, DOI 10.1111/j.1535-7511.2005.05312.x; Schutte SS, 2016, J NEUROPHYSIOL, V115, P1755, DOI 10.1152/jn.00824.2015; Shahmoradi A, 2015, P NATL ACAD SCI USA, V112, pE3582, DOI 10.1073/pnas.1423989112; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Stengel R, 2012, J BIOL CHEM, V287, P35565, DOI 10.1074/jbc.M112.363978; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Takeuchi T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0288; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104450; Wang Y, 2009, NEUROBIOL AGING, V30, P1061, DOI 10.1016/j.neurobiolaging.2007.10.009; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang JM, 2011, CELL, V145, P284, DOI 10.1016/j.cell.2011.03.016; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196223	10.1371/journal.pone.0196223	http://dx.doi.org/10.1371/journal.pone.0196223			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715265	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100014
J	Khan, A; Junaid, M; Kaushik, AC; Ali, A; Ali, SS; Mehmoodl, A; Wei, DQ				Khan, Abbas; Junaid, Muhammad; Kaushik, Aman Chandra; Ali, Arif; Ali, Syed Shujait; Mehmoodl, Aamir; Wei, Dong-Qing			Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches	PLOS ONE			English	Article							T-CELL EPITOPES; HUMAN-PAPILLOMAVIRUS TYPE-16; FAST INTERACTION REFINEMENT; HPV-16 E6; PREDICTION; VIRUS; E7; TRANSFORMATION; FLEXIBILITY; SUFFICIENT	High-risk human papillomaviruses (hrHPVs) are the most prevalent viruses in human diseases including cervical cancers. Expression of E6 protein has already been reported in cervical cancer cases, excluding normal tissues. Continuous expression of E6 protein is making it ideal to develop therapeutic vaccines against hrHPVs infection and cervical cancer. Therefore, we carried out a meta-analysis of multiple hrHPVs to predict the most potential prophylactic peptide vaccines. In this study, immunoinformatics approach was employed to predict antigenic epitopes of hrHPVs E6 proteins restricted to 12 Human HLAs to aid the development of peptide vaccines against hrHPVs. Conformational B-cell and CTL epitopes were predicted for hrHPVs E6 proteins using ElliPro and NetCTL. The potential of the predicted peptides were tested and validated by using systems biology approach considering experimental concentration. We also investigated the binding interactions of the antigenic CTL epitopes by using docking. The stability of the resulting peptide-MHC I complexes was further studied by molecular dynamics simulations. The simulation results highlighted the regions from 46-62 and 65-76 that could be the first choice for the development of prophylactic peptide vaccines against hrHPVs. To overcome the worldwide distribution, the predicted epitopes restricted to different HLAs could cover most of the vaccination and would help to explore the possibility of these epitopes for adaptive immunotherapy against HPVs infections.	[Khan, Abbas; Junaid, Muhammad; Kaushik, Aman Chandra; Ali, Arif; Mehmoodl, Aamir; Wei, Dong-Qing] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China; [Khan, Abbas; Junaid, Muhammad; Kaushik, Aman Chandra; Ali, Arif; Mehmoodl, Aamir; Wei, Dong-Qing] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai, Peoples R China; [Ali, Syed Shujait] Univ Swat, Ctr Biotechnol & Microbiol, Khyber Pakhtunkhwa, Pakistan	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Swat	Wei, DQ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China.; Wei, DQ (corresponding author), Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai, Peoples R China.	dqwei@sjtu.edu.cn	Khan, Abbas/AAF-2409-2020; Ali, syed shujait/AAF-7661-2021; Junaid, Dr. Muhammad/ABF-9669-2021	Ali, Syed Shujait/0000-0002-6277-2335	Key Research Area Grant from the Ministry of Science and Technology of China [2016YFA0501703]; State Key Lab on Microbial Metabolism at Shanghai Jiaotong University; Joint Research Funds for Medical and Engineering & Scientific Research at Shanghai Jiaotong University; Center for High Performance Computing, Shanghai Jiao Tong University	Key Research Area Grant from the Ministry of Science and Technology of China; State Key Lab on Microbial Metabolism at Shanghai Jiaotong University; Joint Research Funds for Medical and Engineering & Scientific Research at Shanghai Jiaotong University; Center for High Performance Computing, Shanghai Jiao Tong University	Dong-Qing Wei is supported by the Key Research Area Grant 2016YFA0501703 from the Ministry of Science and Technology of China and also grants from the State Key Lab on Microbial Metabolism, and Joint Research Funds for Medical and Engineering & Scientific Research at Shanghai Jiaotong University.; The simulations in this work were supported by Center for High Performance Computing, Shanghai Jiao Tong University.	Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; BEDELL MA, 1987, J VIROL, V61, P3635, DOI 10.1128/JVI.61.11.3635-3640.1987; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Brusic V, 2004, METHODS, V34, P436, DOI 10.1016/j.ymeth.2004.06.006; Brusic Vladimir, 2005, Expert Rev Clin Immunol, V1, P145, DOI 10.1586/1744666X.1.1.145; Case DA, 2014, AMBER 14; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chiou SS, 2012, J GEN VIROL, V93, P1185, DOI 10.1099/vir.0.040238-0; Cohen T, 2010, INFECTIOUS DISEASE INFORMATICS, P223, DOI 10.1007/978-1-4419-1327-2_11; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deliloglu S. I., PEPARATION SYNTHETIC; Dell C, 2001, CELL MOL LIFE SCI, V58, P1923, DOI 10.1007/PL00000827; DOEBERITZ MV, 1988, CANCER RES, V48, P3780; DOEBERITZ MV, 1991, P NATL ACAD SCI USA, V88, P1411, DOI 10.1073/pnas.88.4.1411; Duhovny D., 2002, EFFICIENT UNBOUND DO, P185, DOI DOI 10.1007/3-540-45784-4_14; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; Greenwood B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0433; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; HUDSON JB, 1990, J VIROL, V64, P519, DOI 10.1128/JVI.64.2.519-526.1990; Hung CF, 2008, EXPERT OPIN BIOL TH, V8, P421, DOI [10.1517/14712598.8.4.421, 10.1517/14712598.8.4.421 ]; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KAST WM, 1994, J IMMUNOL, V152, P3904; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Kingsford CL, 2005, BIOINFORMATICS, V21, P1028, DOI 10.1093/bioinformatics/bti144; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kotturi MF, 2007, J VIROL, V81, P4928, DOI 10.1128/JVI.02632-06; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAIMINS LA, 1993, INFECT AGENT DIS, V2, P74; Lamiable A., 2016, NUCLEIC ACIDS RES; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liu ZY, 2016, SEX HEALTH, V13, P10, DOI 10.1071/SH15089; Longuet M, 1996, J CLIN MICROBIOL, V34, P1859, DOI 10.1128/JCM.34.7.1859-1862.1996; LOWY DR, 1994, P NATL ACAD SCI USA, V91, P2436, DOI 10.1073/pnas.91.7.2436; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; MATLASHEWSKI G, 1987, EMBO J, V6, P1741, DOI 10.1002/j.1460-2075.1987.tb02426.x; Maupetit J, 2007, PROTEINS, V69, P394, DOI 10.1002/prot.21505; Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313; Mould D, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.14; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Muderspach L, 2000, CLIN CANCER RES, V6, P3406; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; MUNGER K, 1989, J VIROL, V63, P4417; Nair DT, 2002, J IMMUNOL, V168, P2371, DOI 10.4049/jimmunol.168.5.2371; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schiller JT, 2004, NAT REV MICROBIOL, V2, P343, DOI 10.1038/nrmicro867; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Schwarz E, 1985, STRUCTURE TRANSCRIPT; Wagner JG, 1985, NEW SIMPLE METHOD PR; Wise-Draper TM, 2008, FRONT BIOSCI-LANDMRK, V13, P1003, DOI 10.2741/2739; Yao YF, 2013, VACCINE, V31, P2289, DOI 10.1016/j.vaccine.2013.02.065; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	71	59	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196484	10.1371/journal.pone.0196484	http://dx.doi.org/10.1371/journal.pone.0196484			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715318	Green Published, gold			2022-12-26	WOS:000431281100025
J	Wen, YM; Ng, CJ; Seak, CJ; Chien, CY; Chen, KF; Lin, JR; Chang, CJ				Wen, Yi-Ming; Ng, Chip-Jin; Seak, Chen-June; Chien, Cheng-Yu; Chen, Kuan-Fu; Lin, Jr-Rung; Chang, Chee-Jen			One-year survival rate and healthcare costs after cardiac arrest in Taiwan, 2006-2012	PLOS ONE			English	Article							RESUSCITATION OUTCOMES; VALIDATION; RESIDENCE; PLACE; LIFE; EXPENDITURES; ASSOCIATION	Objectives The annual increase in costs and the quality of life of survivors of cardiac arrest are major concerns. This study used National Health Insurance Research Database (NHIRD) of Taiwan to evaluate the 1-year survival rate and the annual healthcare costs of survivors after cardiac arrest. Methods This retrospective, fixed-cohort study conducted from 2006 to 2012, involved 2 million individuals randomly selected from the NHIRD of Taiwan. Adult patients at least 18 years old who were diagnosed with cardiac arrest were enrolled. Survival was followed up for 1 year. Results In total, 2,256 patients were enrolled. The survivor cohort accounted for 4% (89/2256) of the study population. There were no significant differences in the demographic characteristics of the survival and non-survival cohorts, with the exceptions of gender (male: survival vs. non-survival, 50.6% vs. 64.5%, p = 0.007), diabetes mellitus (49.4% vs. 35.8%, p = 0.009), and acute coronary syndrome (44.9% vs. 31.9%, p = 0.010). Only 38 (1.7%) patients survived for > 1 year. The mean re-admission to hospital during the 1-year follow up was 73.5 (SD: 110.2) days. The mean healthcare cost during the 1-year follow up was $12,953. Factors associated with total healthcare costs during the 1-year follow up were as follows: city or county of residence, being widowed, and Chronic Obstructive Pulmonary Disease (city or county of residence, beta: -23,604, p < 0.001; being widowed, beta: 25,588, p = 0.049; COPD, beta: 14,438, p = 0.024). Conclusions There was a great burden of the annual healthcare costs of survivors of cardiac arrest. Socioeconomic status and comorbidity were major confounders of costs. The outcome measures of cardiac arrest should extend beyond the death, and encompass destitution. These findings add to our knowledge of the health economics and indicate future research about healthcare of cardiac arrest survivors.	[Wen, Yi-Ming] Tao Yuan Gen Hosp, Prehosp Care Div, Dept Emergency Med, Tao Yuan, Taiwan; [Wen, Yi-Ming; Ng, Chip-Jin; Seak, Chen-June] Chang Gung Mem Hosp, Dept Emergency Med, Linkou, Taiwan; [Wen, Yi-Ming; Ng, Chip-Jin; Seak, Chen-June] Chang Gung Univ, Coll Med, Linkou, Taiwan; [Wen, Yi-Ming] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Chien, Cheng-Yu] Ton Yen Gen Hosp, Dept Emergency Med, Zhubei City, Hsinchu County, Taiwan; [Chen, Kuan-Fu] Chang Gung Mem Hosp, Dept Emergency Med, Keelung, Taiwan; [Chen, Kuan-Fu] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Chen, Kuan-Fu; Lin, Jr-Rung; Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Tao Yuan, Taiwan; [Chen, Kuan-Fu; Lin, Jr-Rung; Chang, Chee-Jen] Chang Gung Univ, Grad Inst Clin Med, Tao Yuan, Taiwan; [Lin, Jr-Rung] Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan; [Lin, Jr-Rung] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Res Serv Ctr Hlth Informat, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Dept Cardiovasc Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Chang, CJ (corresponding author), Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Tao Yuan, Taiwan.; Chang, CJ (corresponding author), Chang Gung Univ, Grad Inst Clin Med, Tao Yuan, Taiwan.; Chang, CJ (corresponding author), Chang Gung Univ, Res Serv Ctr Hlth Informat, Tao Yuan, Taiwan.; Chang, CJ (corresponding author), Chang Gung Univ, Dept Cardiovasc Med, Tao Yuan, Taiwan.	cjchang@mail.cgu.edu.tw		Chen, Kuan-Fu/0000-0001-7287-9497; Lin, Jr-Rung/0000-0002-8522-6601; SEAK, CHEN-JUNE/0000-0003-0984-8385	Chang Gung Memorial Hospital, Linkou, Taiwan [CIRPD1D0031]	Chang Gung Memorial Hospital, Linkou, Taiwan(Chang Gung Memorial Hospital)	This study was funded by the Chang Gung Memorial Hospital, Linkou, Taiwan (CIRPD1D0031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094295; Bikdeli B, 2014, CIRC-CARDIOVASC QUAL, V7, P749, DOI 10.1161/CIRCOUTCOMES.113.000911; Chan CL, 2013, HEALTH POLICY, V110, P271, DOI 10.1016/j.healthpol.2012.12.003; Chan PS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002924; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheung M, 2001, CJEM, V3, P19; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; EDGREN E, 1994, LANCET, V343, P1055, DOI 10.1016/S0140-6736(94)90179-1; Elliott VJ, 2011, RESUSCITATION, V82, P247, DOI 10.1016/j.resuscitation.2010.10.030; Fukuda T, 2013, RESUSCITATION, V84, P964, DOI 10.1016/j.resuscitation.2013.02.019; Ginsberg GM, 2015, RESUSCITATION, V86, P54, DOI 10.1016/j.resuscitation.2014.10.024; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Graf J, 2008, CRIT CARE, V12, DOI 10.1186/cc6963; GRAY WA, 1991, NEW ENGL J MED, V325, P1393, DOI 10.1056/NEJM199111143252001; Johnson AM, 2014, LUNG CANCER, V83, P401, DOI 10.1016/j.lungcan.2014.01.008; Lee B, 2014, ONCOLOGIST, V19, P283, DOI 10.1634/theoncologist.2013-0343; Low LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167413; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; McGarry K, 2005, J GERONTOL B-PSYCHOL, V60, pS160, DOI 10.1093/geronb/60.3.S160; Merchant RM, 2012, MED CARE, V50, P124, DOI 10.1097/MLR.0b013e31822d5d17; Naess AC, 2004, RESUSCITATION, V60, P57, DOI 10.1016/S0300-9572(03)00262-4; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Ong MEH, 2015, RESUSCITATION, V96, P100, DOI 10.1016/j.resuscitation.2015.07.026; Rolden HJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115478; Suchard JR, 1999, J EMERG MED, V17, P801, DOI 10.1016/S0736-4679(99)00086-4; van Walraven Carl, 2012, Open Med, V6, pe80; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Wachelder EM, 2009, RESUSCITATION, V80, P517, DOI 10.1016/j.resuscitation.2009.01.020; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196687	10.1371/journal.pone.0196687	http://dx.doi.org/10.1371/journal.pone.0196687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715272	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281100045
J	Kurita, K; Lachs, MS; Adelman, RD; Siegler, EL; Reid, MC; Prigerson, HG				Kurita, Keiko; Lachs, Mark S.; Adelman, Ronald D.; Siegler, Eugenia L.; Reid, M. Cary; Prigerson, Holly G.			Mild cognitive dysfunction of caregivers and its association with care recipients' end-of-life plans and preferences	PLOS ONE			English	Article							SPOUSAL CAREGIVERS; OLDER-ADULTS; CANCER; HEALTH; FAMILY; PATIENT; DECLINE; STRESS; DEATH	Little is known about the association between cognitive dysfunction among informal caregivers and patients' plans and preferences for patients' end of life care. We report on the frequency of cognitive dysfunction among both patients and caregivers and examine associations between caregivers' cognitive screening scores and end of life plans and preferences of patients with advanced cancer. The current sample was derived from a National Cancer Institute- and National Institute of Mental Health-funded study of patients with distant metastasis who had disease progression on at least first-line chemotherapy, and their informal caregivers (n = 550 pairs). The Pfeiffer Short Portable Mental Status, a validated cognitive screen, was administered to patients and caregivers. Patients were interviewed about their end of life plans and preferences. Logistic regression models regressed patients' advance care planning and treatment preferences on caregivers' cognitive screen scores. Patients' cognitive screen scores were included as covariates. Most caregivers (55%) were spouses. Almost 30% of patients scored worse on the cognitive screen than their caregivers and 12% of caregivers scored worse than the patients. For each additional error that caregivers made on the cognitive screen, patients were more likely (AOR = 1.59, p = 0.002) to report that they preferred that everything possible be done to keep them alive and were less likely (AOR = 0.75, p = 0.04) to have a living will or a health care proxy/durable power of attorney. Worse caregiver cognitive screening scores were associated with higher likelihood of patients' reporting that they wanted everything done to save their lives and a lower likelihood of having a living will or other type of advanced care plan. Future studies should confirm these findings in other populations and determine the mechanisms that may underlie the identified relationships.	[Kurita, Keiko; Prigerson, Holly G.] Weill Cornell Med, Ctr Res End Of Life Care, New York, NY USA; [Kurita, Keiko; Lachs, Mark S.; Adelman, Ronald D.; Siegler, Eugenia L.; Reid, M. Cary; Prigerson, Holly G.] Weill Cornell Med, Dept Med, Div Geriatr & Palliat Med, New York, NY USA	Cornell University; Cornell University	Prigerson, HG (corresponding author), Weill Cornell Med, Ctr Res End Of Life Care, New York, NY USA.; Prigerson, HG (corresponding author), Weill Cornell Med, Dept Med, Div Geriatr & Palliat Med, New York, NY USA.	hgp2001@med.cornell.edu	Prigerson, Holly/GWV-3283-2022; Prigerson, Holly/L-3800-2019	Prigerson, Holly/0000-0002-7075-4268; Siegler, Eugenia/0000-0001-9449-5873	National Cancer Institute [R01 CA106370, R35 CA197730, CA218313]; National Institute of Mental Health [R01 MH63892]; National Institute on Aging [T32 AG049666, P30 AG022845, K24 AG053462]; Howard and Phyllis Schwartz Philanthropic Fund; Independent Grant for Learning and Change from Pfizer Inc [28540451]; Gilead Sciences [IN-US-311-4182]; Fan Fox and Leslie R. Samuels Foundation; NATIONAL CANCER INSTITUTE [R35CA197730] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard and Phyllis Schwartz Philanthropic Fund; Independent Grant for Learning and Change from Pfizer Inc; Gilead Sciences(Gilead Sciences); Fan Fox and Leslie R. Samuels Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by a grant from the National Cancer Institute (R01 CA106370, awarded to Dr. Prigerson) and from the National Institute of Mental Health (R01 MH63892, awarded to Dr. Prigerson). Dr. Kurita is supported by a grant from the National Institute on Aging (T32 AG049666). Dr. Prigerson is supported by grants from the National Cancer Institute (R35 CA197730, CA218313). Dr. Reid is supported by grants from the National Institute on Aging (P30 AG022845 and K24 AG053462), the Howard and Phyllis Schwartz Philanthropic Fund, and an Independent Grant for Learning and Change from Pfizer Inc (28540451). Dr. Siegler is an investigator on an investigator initiated research grant from Gilead Sciences [IN-US-311-4182] and receives support from the Fan Fox and Leslie R. Samuels Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucher L, 1996, J AM GERIATR SOC, V44, P828, DOI 10.1111/j.1532-5415.1996.tb03742.x; Braun UK, 2008, J GEN INTERN MED, V23, P267, DOI 10.1007/s11606-007-0487-7; Brazil K, 2003, AGING MENT HEALTH, V7, P376, DOI 10.1080/1360786031000150649; Caswell LW, 2003, EXP AGING RES, V29, P303, DOI 10.1080/03610730303721; Chen P, 2013, TOP STROKE REHABIL, V20, P369, DOI 10.1310/tsr2004-369; Correa MS, 2015, NEUROSCIENCE, V286, P371, DOI 10.1016/j.neuroscience.2014.11.052; de Vugt ME, 2006, AGE AGEING, V35, P160, DOI 10.1093/ageing/afj044; Gao X, 2013, J PAIN SYMPTOM MANAG, V45, P650, DOI 10.1016/j.jpainsymman.2012.03.003; Garlo K, 2010, J AM GERIATR SOC, V58, P2315, DOI 10.1111/j.1532-5415.2010.03177.x; Janelsins MC, 2011, SEMIN ONCOL, V38, P431, DOI 10.1053/j.seminoncol.2011.03.014; Kreling B, 2006, PSYCHO-ONCOLOGY, V15, P1065, DOI 10.1002/pon.1042; Kurita K, 2018, J PALLIAT MED, V21, P536, DOI 10.1089/jpm.2017.0385; Lavela SL, 2010, CHRONIC ILLN, V6, P67, DOI 10.1177/1742395309356943; Nielsen MK, 2017, PSYCHO-ONCOLOGY, V26, P2048, DOI 10.1002/pon.4416; Oken BS, 2011, J GERIATR PSYCH NEUR, V24, P191, DOI 10.1177/0891988711422524; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Schafer C, 2006, SUPPORT CARE CANCER, V14, P952, DOI 10.1007/s00520-006-0025-x; Sklenarova H, 2015, CANCER-AM CANCER SOC, V121, P1513, DOI 10.1002/cncr.29223; Tomarken A, 2008, PSYCHO-ONCOLOGY, V17, P105, DOI 10.1002/pon.1188; Vitaliano PP, 2011, J AM GERIATR SOC, V59, P900, DOI 10.1111/j.1532-5415.2011.03368.x; Vitaliano PP, 2009, GERONTOLOGIST, V49, P12, DOI 10.1093/geront/gnp004; Wolff JL, 2016, JAMA INTERN MED, V176, P372, DOI 10.1001/jamainternmed.2015.7664; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	23	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196147	10.1371/journal.pone.0196147	http://dx.doi.org/10.1371/journal.pone.0196147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE3RI	29708996	Green Published, gold, Green Submitted			2022-12-26	WOS:000431130100017
J	Messner, M; Ghadge, SK; Goetsch, V; Wimmer, A; Dorler, J; Polzl, G; Zaruba, MM				Messner, Moritz; Ghadge, Santhosh Kumar; Goetsch, Valentina; Wimmer, Andreas; Doerler, Jakob; Poelz, Gerhard; Zaruba, Marc-Michael			Upregulation of the aging related LMNA splice variant progerin in dilated cardiomyopathy	PLOS ONE			English	Article							HEART-FAILURE; PRELAMIN; LAMINS; MUTATIONS; ACCUMULATION; INSIGHTS	Background Mutations in the LMNA gene are a common cause (6-8%) of dilated cardiomyopathy (DCM) leading to heart failure, a growing health care problem worldwide. The premature aging disease Hutchinson-Gilford syndrome (HGPS) is also caused by defined mutations in the LMNA gene resulting in activation of a cryptic splice donor site leading to a defective truncated prelamin A protein called progerin. Low levels of progerin are expressed in healthy individuals associated with ageing. Here, we aimed to address the role of progerin in dilated cardiomyopathy. Methods and results mRNA expression of progerin was analyzed in heart tissue of DCM (n = 15) and non-failing hearts (n = 10) as control and in blood samples from patients with DCM (n = 56) and healthy controls (n = 10). Sequencing confirmed the expression of progerin mRNA in the human heart. Progerin mRNA levels derived from DCM hearts were significantly upregulated compared to controls (1.27 +/- 0.42 vs. 0.81 +/- 0.24; p = 0.005). In contrast, progerin mRNA levels in whole blood cells were not significantly different in DCM patients compared to controls. Linear regression analyses revealed that progerin mRNA in the heart is significantly negatively correlated to ejection fraction (r = -0.567, p = 0.003) and positively correlated to left ventricular enddiastolic diameter (r = 0.551, p = 0.004) but not with age of the heart per se. Progerin mRNA levels were not influenced by inflammation in DCM hearts. Immunohistochemistry and Immunofluorescence analysis confirmed increased expression of progerin protein in cell nuclei of DCM hearts associated with increased TUNEL+apoptotic cells. Conclusion Our data suggest that progerin is upregulated in human DCM hearts and strongly correlates with left ventricular remodeling. Progerin might be involved in progression of heart failure and myocardial aging.	[Messner, Moritz; Ghadge, Santhosh Kumar; Goetsch, Valentina; Wimmer, Andreas; Doerler, Jakob; Poelz, Gerhard; Zaruba, Marc-Michael] Med Univ Innsbruck, Dept Internal Med Cardiol & Angiol 3, Innsbruck, Tirol, Austria	Medical University of Innsbruck	Zaruba, MM (corresponding author), Med Univ Innsbruck, Dept Internal Med Cardiol & Angiol 3, Innsbruck, Tirol, Austria.	Marc-Michael.Zaruba@i-med.ac.at	Zaruba, Marc-Michael/AAI-8571-2020; Messner, Moritz/CAG-1593-2022	Zaruba, Marc-Michael/0000-0003-1074-5463; Messner, Moritz/0000-0003-3250-4353	Austrian Science Fund [FWF P 28817-B28]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF P 28817-B28). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola M, 2014, CURR OPIN CELL BIOL, V28, P61, DOI 10.1016/j.ceb.2014.03.003; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Brayson D, 2017, NUCLEUS-PHILA, V8, P17, DOI 10.1080/19491034.2016.1260798; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3; Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346; Davies BSJ, 2010, HUM MOL GENET, V19, P2682, DOI 10.1093/hmg/ddq158; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Frustaci A, 2009, EUR HEART J, V30, P1995, DOI 10.1093/eurheartj/ehp249; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gruenbaum Y, 2015, ANNU REV BIOCHEM, V84, P131, DOI 10.1146/annurev-biochem-060614-034115; Guo XX, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2015.11.011; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hilton BA, 2017, FASEB J, V31, P3882, DOI 10.1096/fj.201700014R; Lee JM, 2016, J CLIN INVEST, V126, P1592, DOI 10.1172/JCI85908; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Osmanagic-Myers S, 2015, GENE DEV, V29, P225, DOI 10.1101/gad.255968.114; Parks SB, 2008, AM HEART J, V156, P161, DOI 10.1016/j.ahj.2008.01.026; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Rodriguez SA, 2016, AGING CELL, V15, P267, DOI 10.1111/acel.12433; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4; SINENSKY M, 1994, J CELL SCI, V107, P61; Tesson F, 2014, CARDIOL J, V21, P331, DOI 10.5603/CJ.a2014.0037; ULAS J, 1986, NEUROCHEM INT, V9, P255, DOI 10.1016/0197-0186(86)90061-6; Vidak S, 2016, HISTOCHEM CELL BIOL, V145, P401, DOI 10.1007/s00418-016-1411-1; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196739	10.1371/journal.pone.0196739	http://dx.doi.org/10.1371/journal.pone.0196739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702688	Green Published, gold, Green Submitted			2022-12-26	WOS:000431013300046
J	Ali, HI; Platat, C; El Mesmoudi, N; El Sadig, M; Tewfik, I				Ali, Habiba I.; Platat, Carine; El Mesmoudi, Najoua; El Sadig, Mohamed; Tewfik, Ihab			Evaluation of a photographic food atlas as a tool for quantifying food portion size in the United Arab Emirates	PLOS ONE			English	Article							VALIDITY; VALIDATION; AGREEMENT	Although, United Arab Emirates (UAE) has one of the highest prevalence of overweight, obesity and type 2 diabetes in the world, however, validated dietary assessment aids to estimate food intake of individuals and populations in the UAE are currently lacking. We conducted two observational studies to evaluate the accuracy of a photographic food atlas which was developed as a tool for food portion size estimation in the UAE. The UAE Food Atlas presents eight portion sizes for each food. Study 1 involved portion size estimations of 13 food items consumed during the previous day. Study 2 involved portion size estimations of nine food items immediately after consumption. Differences between the food portion sizes estimated from the photographs and the weighed food portions (estimation error), as well as the percentage differences relative to the weighed food portion for each tested food item were calculated. Four of the evaluated food items were underestimated (by -8.9% to -18.4%), while nine were overestimated (by 9.5% to 90.9%) in Study 1. Moreover, there were significant differences between estimated and eaten food portions for eight food items (P<0.05). In Study 2, one food item was underestimated (-8.1%) while eight were overestimated (range 2.52% to 82.1%). Furthermore, there were significant differences between estimated and eaten food portions (P<0.05) for six food items. The limits of agreement between the estimated and consumed food portion size were wide indicating a large variability in food portion estimation errors. These reported findings highlight the need for further developments of the UAE Food Atlas to improve the accuracy of food portion size intake estimations in dietary assessments. Additionally, recalling food portions from the previous day did not seem to increase food portion estimation errors in this study.	[Ali, Habiba I.; Platat, Carine; El Mesmoudi, Najoua] United Arab Emirates Univ, Nutr & Hlth Dept, Coll Food & Agr, Al Ain, U Arab Emirates; [El Sadig, Mohamed] United Arab Emirates Univ, Inst Publ Heath, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Tewfik, Ihab] Univ Westminster, Div Food Nutr & Publ Hlth, London, England; [Tewfik, Ihab] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	United Arab Emirates University; United Arab Emirates University; University of Westminster; Harvard University; Harvard T.H. Chan School of Public Health	Ali, HI (corresponding author), United Arab Emirates Univ, Nutr & Hlth Dept, Coll Food & Agr, Al Ain, U Arab Emirates.	habAli@uaeu.ac.ae	Ali, Habiba/ABE-7828-2020; Elsadig, Mohamed/AAX-7935-2020	Ali, Habiba/0000-0003-2685-1244; Elsadig, Mohamed/0000-0001-5795-8189	United Arab Emirates University [31R059]	United Arab Emirates University	This work was supported by the United Arab Emirates University (http://www.uaeu.ac.ae/en/); (Grant No. 31R059). HIA received the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADFCA, 2014, PHOT ATL FOOD PORT E; Al Marzooqi HM, 2015, J FOOD COMPOS ANAL, V43, P140, DOI 10.1016/j.jfca.2015.05.008; [Anonymous], 1995, MEASURING FOOD INTAK, P215, DOI DOI 10.1080/10640266.2011.584818; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Frobisher C, 2003, J HUM NUTR DIET, V16, P181, DOI 10.1046/j.1365-277X.2003.00434.x; HAAD, 2015, HLTH AUTH ABU DHAB S; Harris-Fry H, 2016, PUBLIC HEALTH NUTR, V19, P2495, DOI 10.1017/S1368980016000537; Hernandez T, 2006, J FOOD COMPOS ANAL, V19, pS14, DOI 10.1016/j.jfca.2006.02.010; HOWAT PM, 1994, J AM DIET ASSOC, V94, P169, DOI 10.1016/0002-8223(94)90242-9; HUDSON GJ, 1995, BRIT J NUTR, V73, P551, DOI 10.1079/BJN19950058; Huybregts L, 2008, PUBLIC HEALTH NUTR, V11, P581, DOI 10.1017/S1368980007000870; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Korkalo L, 2013, PUBLIC HEALTH NUTR, V16, P1558, DOI 10.1017/S1368980012003655; Kretsch MJ, 1999, J AM DIET ASSOC, V99, P300, DOI 10.1016/S0002-8223(99)00078-4; Kuwait Institute for Scientific Research (KISR), 2010, GUID COLL FOOD DAT; LUCAS F, 1995, J HUM NUTR DIET, V8, P65, DOI 10.1111/j.1365-277X.1995.tb00296.x; Michael Nelson, 1997, FOOD PORTION SIZES P; Millen AE, 2006, AM J EPIDEMIOL, V163, P279, DOI 10.1093/aje/kwj031; NELSON M, 1994, BRIT J NUTR, V72, P649, DOI 10.1079/BJN19940069; Nelson M, 1996, BRIT J NUTR, V76, P31, DOI 10.1079/BJN19960007; Ng SW, 2011, OBES REV, V12, P1, DOI 10.1111/j.1467-789X.2010.00750.x; Robinson F, 1997, J HUM NUTR DIET, V10, P117, DOI 10.1046/j.1365-277X.1997.00043.x; Subar AF, 2010, J AM DIET ASSOC, V110, P55, DOI 10.1016/j.jada.2009.10.007; Thompson FE, 2013, NUTR PREVENTION TREA, P5, DOI DOI 10.1016/B978-0-12-391884-0.00001-9; Tueni M, 2012, PUBLIC HEALTH NUTR, V15, P1023, DOI 10.1017/S1368980012000171; Turconi G, 2005, EUR J CLIN NUTR, V59, P923, DOI 10.1038/sj.ejcn.1602162; Venter CS, 2000, J HUM NUTR DIET, V13, P205, DOI [10.1046/j.1365-277x.2000.00228.x, 10.1046/j.1365-277X.2000.00228.x]	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196389	10.1371/journal.pone.0196389	http://dx.doi.org/10.1371/journal.pone.0196389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698434	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000431007600071
J	Haubruck, P; Ober, J; Heller, R; Miska, M; Schmidmaier, G; Tanner, MC				Haubruck, Patrick; Ober, Julian; Heller, Raban; Miska, Matthias; Schmidmaier, Gerhard; Tanner, Michael C.			Complications and risk management in the use of the reaming-irrigator-aspirator (RIA) system: RIA is a safe and reliable method in harvesting autologous bone graft	PLOS ONE			English	Article							DONOR SITE MORBIDITY; ILIAC CREST; INTRAMEDULLARY PRESSURE; CASE SERIES; GROWTH-FACTORS; FRACTURES; EXPERIENCE; INCREASE; FEMUR; CELLS	Background Autologous bone grafting (ABG) remains the gold standard for augmentation of bone defects. The RIA system has become more prevalent, but evidence regarding risk management and complications remain scarce. This study presents the risk management and complications associated with RIA in the largest single-center case series to date. Methods All records, operative notes, lab data and radiographs of patients receiving a RIA procedure at Heidelberg's University Hospital between 01/01/2010 and 31/12/2016 were reviewed. Multivariate logistic regression models adjusting for clinically relevant covariates were used to examine the respective relevance regarding the presence and absence of prolonged postoperative pain (PPP). Results A total of 341 RIA procedures on 306 patients were performed at our level-1 trauma center. The femur was the main donor site (98.53%; N = 336) whereas only in 1.47% (N = 5) the tibia was utilized. A total of 11 patients showed a relevant loss of hemoglobin requiring blood transfusion. A total of 22 patients suffered from PPP directly associated with the RIA procedure resulting in prevalence of 6.45%. The 6 major complications in our study were of diverse origin and all intraoperative complications took place in the early phase of the RIA procedure in our center (2010 +/- 2013). Our data revealed influence of sex (p = 0.0459) and age (p = 0.0596) on the criterion PPP. The favored model including sex and age resulted in an AUC of 66.2% (CI: 55.5%-76.9%). Conclusion Perioperative blood loss remains a prevalent complication during RIA reaming. In addition, PPP occurs with a prevalence of 6.45%. This study showed a complication rate of 1.76%, emphasizing RIA A s overall safety and furthermore highlighting the need for vigilance in its application and prior extensive hands-on training of surgeons.	[Haubruck, Patrick; Ober, Julian; Heller, Raban; Miska, Matthias; Schmidmaier, Gerhard; Tanner, Michael C.] Heidelberg Univ Hosp, HTRG, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Trauma & Reconstruct Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Haubruck, P (corresponding author), Heidelberg Univ Hosp, HTRG, Ctr Orthoped Trauma Surg & Spinal Cord Injury, Trauma & Reconstruct Surg, Heidelberg, Germany.	patrick.haubruck@med.uni-heidelberg.de	Heller, Raban/P-4152-2019; Haubruck, Patrick/U-4442-2019; Tanner, Michael/AAC-8900-2020	Heller, Raban/0000-0001-8006-9742; Haubruck, Patrick/0000-0002-7045-0387; Tanner, Michael/0000-0003-0243-8113; Ober, Julian/0000-0003-2746-3702				[Anonymous], 2015, BLOOD TRANSFUSION; BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012; Belthur MV, 2008, CLIN ORTHOP RELAT R, V466, P2973, DOI 10.1007/s11999-008-0538-3; Bhandari M, 2000, J ORTHOP TRAUMA, V14, P2, DOI 10.1097/00005131-200001000-00002; Blum B, 2004, ORTHOPEDICS, V27, pS161; BONIVER J, 1992, LEUKEMIA, V6, pS83; Calori GM, 2014, INJURY, V45, pS116, DOI 10.1016/j.injury.2014.10.034; Conway JD, 2010, ORTHOP CLIN N AM, V41, P75, DOI 10.1016/j.ocl.2009.07.006; Cox G, 2011, INT ORTHOP, V35, P951, DOI 10.1007/s00264-010-1189-z; Dawson J, 2014, J ORTHOP TRAUMA, V28, P584, DOI 10.1097/BOT.0000000000000086; De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465; Dimitriou R, 2011, INJURY, V42, pS3, DOI 10.1016/j.injury.2011.06.015; Finkemeier CG, 2010, ORTHOP CLIN N AM, V41, P99, DOI 10.1016/j.ocl.2009.07.007; Giannoudis PV, 2009, INJURY, V40, P1231, DOI 10.1016/j.injury.2009.07.070; Green J, 2010, INJURY, V41, pS24, DOI 10.1016/S0020-1383(10)70005-X; Hammer TO, 2007, J BONE JOINT SURG BR, V89B, P1534, DOI 10.1302/0301-620X.89B11.18994; Han FC, 2015, INJURY, V46, P2042, DOI 10.1016/j.injury.2015.07.027; Hannouche D, 2001, J BONE JOINT SURG BR, V83B, P157, DOI 10.1302/0301-620X.83B2.12106; Henrich D, 2010, INJURY, V41, pS62, DOI 10.1016/S0020-1383(10)70012-7; Higgins TE, 2007, J ORTHOP TRAUMA, V21, P192, DOI 10.1097/BOT.0b013e318038d952; Hoegel F, 2004, J TRAUMA, V56, P363, DOI 10.1097/01.TA.0000047811.13196.02; Husebye EE, 2006, INJURY, V37, P935, DOI 10.1016/j.injury.2006.06.119; Joist A, 2004, J TRAUMA, V57, P146, DOI 10.1097/01.TA.0000100379.54339.0E; Kanakaris NK, 2011, INJURY, V42, pS28, DOI 10.1016/S0020-1383(11)70009-2; Lowe JA, 2010, J ORTHOP TRAUMA, V24, P46, DOI 10.1097/BOT.0b013e31819c0ccb; McCall TA, 2010, ORTHOP CLIN N AM, V41, P63, DOI 10.1016/j.ocl.2009.08.002; Moghaddam A, 2017, SPINAL CORD, V55, P8, DOI 10.1038/sc.2016.104; Moghaddam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159764; OLERUD S, 1986, ORTHOPEDICS, V9, P1204; Pape HC, 2010, J ORTHOP TRAUMA, V24, pS36, DOI 10.1097/BOT.0b013e3181cec4a1; Pape HC, 2005, J BONE JOINT SURG AM, V87A, P2515, DOI 10.2106/JBJS.D.02024; Porter RM, 2009, J ORTHOP RES, V27, P42, DOI 10.1002/jor.20715; Quintero AJ, 2010, J ORTHOP TRAUMA, V24, P42, DOI 10.1097/BOT.0b013e3181b2b4eb; Qvick LM, 2013, INJURY, V44, P1263, DOI 10.1016/j.injury.2013.06.008; RHINELANDER FW, 1979, CLIN ORTHOP RELAT R, P74; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schmidmaier G, 2006, BONE, V39, P1156, DOI 10.1016/j.bone.2006.05.023; Schult M, 2006, J ORTHOP RES, V24, P1186, DOI 10.1002/jor.20106; Steuber TD, 2016, ANN PHARMACOTHER, V50, P578, DOI 10.1177/1060028016647977; Stinner DJ, 2014, ORTHOP CLIN N AM, V45, P33, DOI 10.1016/j.ocl.2013.09.001; STURMER KM, 1993, INJURY, V24, pS7, DOI 10.1016/0020-1383(93)90002-N; Team RC, 2015, R LANG ENV STAT COMP; TORNETTA P, 1995, J TRAUMA, V38, P213, DOI 10.1097/00005373-199502000-00011; Tosounidis TH, 2016, EUR J TRAUMA EMERG S, V42, P417, DOI 10.1007/s00068-016-0700-7; van der Bel R, 2014, INJURY, V45, P2060, DOI 10.1016/j.injury.2014.10.009; WENDA K, 1993, INJURY, V24, pS73, DOI 10.1016/0020-1383(93)90011-T; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002	48	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196051	10.1371/journal.pone.0196051	http://dx.doi.org/10.1371/journal.pone.0196051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698513	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600031
J	Maritz, MF; Ray, RM; Bick, AJ; Tomasicchio, M; Woodland, JG; Govender, Y; Avenant, C; Hapgood, JP				Maritz, Michelle F.; Ray, Roslyn M.; Bick, Alexis J.; Tomasicchio, Michele; Woodland, John G.; Govender, Yashini; Avenant, Chanel; Hapgood, Janet P.			Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels	PLOS ONE			English	Article							HORMONAL CONTRACEPTIVE METHODS; CHEMOKINE RECEPTOR; GENE-EXPRESSION; IN-VITRO; T-CELLS; PROGESTINS; WOMEN; INFECTION; ACQUISITION; THERAPY	High usage of progestin-only injectable contraceptives, which include the intramuscular injectables depo-medroxyprogesterone acetate (DMPA-IM, Depo-Provera) and norethisterone (NET) enanthate (NET-EN or Nur-Isterate), correlates worldwide with areas of high HIV-1 prevalence. Epidemiological data show a significant association between usage of DMPA-IM and increased HIV-1 acquisition but no such association from limited data for NET-EN. Whether MPA and NET have similar effects on HIV-1 acquisition and pathogenesis, and the relationship between these effects and the dose of MPA, are critical issues for women's health and access to suitable and safe contraceptives. We show for the first time that MPA, unlike NET, significantly increases HIV-1 replication in peripheral blood mononuclear cells (PBMCs) and a cervical cell line model. The results provide novel evidence for a biological mechanism whereby MPA, acting via the glucocorticoid receptor (GR), increases HIV-1 replication by at least in part increasing expression of the CCR5 HIV-1 coreceptor on target T-lymphocytes. MPA, unlike NET, also increases activation of T-cells and increases the CD4/CD8 ratio, suggesting that multiple mechanisms are involved in the MPA response. Our data offer strong support for different biological mechanisms for MPA versus NET, due to their differential GR activity. The dose-dependence of the MPA response suggests that significant effects are observed within the range of peak serum levels of progestins in DMPA-IM but not NET-EN users. Dose-response results further suggest that effects of contraceptives containing MPA on HIV-1 acquisition and disease progression may be critically dependent on dose, time after injection and intrinsic factors that affect serum concentrations in women.	[Maritz, Michelle F.; Ray, Roslyn M.; Bick, Alexis J.; Woodland, John G.; Govender, Yashini; Avenant, Chanel; Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, Cape Town, South Africa; [Tomasicchio, Michele] Univ Cape Town, Ctr Lung Infect & Immun, Div Pulmonol, Cape Town, South Africa; [Tomasicchio, Michele] Univ Cape Town, UCT Lung Inst, Dept Med, Cape Town, South Africa; [Hapgood, Janet P.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Ray, Roslyn M.] City Of Hope, Beckman Res Inst, Ctr Gene Therapy, Duarte, CA USA; [Govender, Yashini] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA USA	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; City of Hope; Beckman Research Institute of City of Hope; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hapgood, JP (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, Cape Town, South Africa.; Hapgood, JP (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa.	Janet.Hapgood@uct.ac.za	Hapgood, Janet P/P-2549-2018; Ray, Roslyn/AAB-2898-2019; Woodland, John/AAH-9423-2020	Hapgood, Janet P/0000-0002-4414-4861; Tomasicchio, Michele/0000-0003-2421-7215; Maritz, Michelle Frances/0000-0001-6345-4446; Woodland, John/0000-0001-6273-5596	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD083026]	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant to JH (R01HD083026) from the EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT (http://grants.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africander D, 2013, BIOCHEM BIOPH RES CO, V433, P305, DOI 10.1016/j.bbrc.2013.02.086; Africander D, 2011, STEROIDS, V76, P636, DOI 10.1016/j.steroids.2011.03.001; Africander DJ, 2014, J STEROID BIOCHEM, V143, P404, DOI 10.1016/j.jsbmb.2014.05.007; Avenant C, 2010, BIOCHEMISTRY-US, V49, P972, DOI 10.1021/bi901956s; Butler AR, 2013, AIDS, V27, P105, DOI 10.1097/QAD.0b013e32835a5a52; Byrne EH, 2016, LANCET INFECT DIS, V16, P441, DOI 10.1016/S1473-3099(15)00429-6; Calla NEQ, 2015, HUM REPROD, V30, P1169, DOI 10.1093/humrep/dev035; Dogan E, 2005, RENAL FAILURE, V27, P421, DOI 10.1081/JDI-200065342; ECHO, 2016, THE EVIDENCE FOR CON; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Eszterhas SK, 2011, INFECT DIS REP, V3, P52, DOI [10.4081/idr.2011.e11, 10.1081/idr2011.e11]; FOTHERBY K, 1980, FERTIL STERIL, V34, P131; Govender Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096497; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hapgood JP, 2014, J STEROID BIOCHEM, V142, P39, DOI 10.1016/j.jsbmb.2013.08.001; Hapgood JP, 2014, AM J REPROD IMMUNOL, V71, P505, DOI 10.1111/aji.12214; Hapgood JP, 2004, TRENDS PHARMACOL SCI, V25, P554, DOI 10.1016/j.tips.2004.09.005; Hapgood JP, 2017, BIOLOGICAL MECHANISM; Heffron R, 2013, AIDS, V27, P261, DOI 10.1097/QAD.0b013e32835ad473; Huijbregts RPH, 2014, CONTRACEPTION, V90, P123, DOI 10.1016/j.contraception.2014.02.006; Huijbregts RPH, 2013, ENDOCRINOLOGY, V154, P1282, DOI 10.1210/en.2012-1850; Iyer SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178193; Jain J, 2004, CONTRACEPTION, V70, P11, DOI 10.1016/j.contraception.2004.01.011; Kleynhans L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024639; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Koubovec D, 2004, MOL CELL ENDOCRINOL, V221, P75, DOI 10.1016/j.mce.2004.03.006; Louw-du Toit R, 2014, J BIOL CHEM, V289, P31136, DOI 10.1074/jbc.M114.587311; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips SJ, 2016, CONTRACEPTION, V93, P11, DOI 10.1016/j.contraception.2015.10.002; Phillips SJ, 2013, AIDS, V27, P787, DOI 10.1097/QAD.0b013e32835bb672; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Polis CB, 2017, CONTRACEPTION; Polis CB, 2016, AIDS, V30, P2665, DOI 10.1097/QAD.0000000000001228; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Prakash M, 2002, J REPROD IMMUNOL, V54, P117, DOI 10.1016/S0165-0378(01)00125-5; Ralph LJ, 2015, CURR OPIN OBSTET GYN, V27, P487, DOI 10.1097/GCO.0000000000000228; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Sales KJ, 2014, MOL HUM REPROD, V20, P1144, DOI 10.1093/molehr/gau063; Sampah MES, 2015, AIDS, V29, P1137, DOI 10.1097/QAD.0000000000000681; SANG GW, 1981, CONTRACEPTION, V24, P15, DOI 10.1016/0010-7824(81)90065-2; Sciaranghella G, 2015, J INFECT DIS, V212, P1397, DOI 10.1093/infdis/jiv233; Sridama Vitaya, 1992, Journal of the Medical Association of Thailand, V75, P479; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Stanczyk FZ, 2003, STEROIDS, V68, P879, DOI 10.1016/j.steroids.2003.08.003; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Tasker Carley, 2017, Immunohorizons, V1, P223, DOI 10.4049/immunohorizons.1700047; Toll YC, 2004, CLIN THER, V26, P1845, DOI 10.1016/j.clinthera.2004.11.013; Tomasicchio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062895; Vassiliadou N, 1999, J IMMUNOL, V162, P7510; Verhoog NJD, 2011, J BIOL CHEM, V286, P19297, DOI 10.1074/jbc.M110.193672; World Health Organization, 2017, HORMONAL CONTRACEPTI	55	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196043	10.1371/journal.pone.0196043	http://dx.doi.org/10.1371/journal.pone.0196043			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698514	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000431007600030
J	Rubio, L; Sioli, JM; Gaitan, MJ; Martin-de-las-Heras, S				Rubio, Leticia; Manuel Sioli, Jose; Jesus Gaitan, Maria; Martin-de-las-Heras, Stella			Dental color measurement to predict DNA concentration in incinerated teeth for human identification	PLOS ONE			English	Article							HIGH-TEMPERATURES; PULP; REMAINS; HEAT	Teeth exposed to thermal stress can shed light on the identification of incinerated individuals and on the circumstances of the fire. Changes in the color of burned teeth can provide information on structural changes and the temperature of exposure. The objective of this study was to correlate color modifications with the concentration of human DNA in teeth burned at different temperatures. Spectrophotometry was used to measure the color of 40 teeth heated at temperatures of 100, 200, and 400 degrees C for 60 min. DNA was extracted by phenol-chloroform extraction and quantified by real-time quantitative PCR using the Quantifier human DNA quantification kit. Preliminary results indicated an association of higher temperature with changes in colorimetric variables and a decrease in DNA concentrations. A significant positive correlation was found between luminosity values and DNA concentration (r = 0.4727, p = 0.0128) and between chromaticity a* values and DNA concentration (r = 0.4154, p = 0.0250). Spectrophotometry analysis of the color of burned teeth may predict the feasibility of extracting human DNA for identification purposes.	[Rubio, Leticia; Manuel Sioli, Jose; Jesus Gaitan, Maria] Univ Malaga, Dept Forens Med, Malaga, Spain; [Martin-de-las-Heras, Stella] Univ Granada, Dept Forens Med & Forens Dent, Granada, Spain	Universidad de Malaga; University of Granada	Rubio, L (corresponding author), Univ Malaga, Dept Forens Med, Malaga, Spain.; Martin-de-las-Heras, S (corresponding author), Univ Granada, Dept Forens Med & Forens Dent, Granada, Spain.	lorubio@uma.es; stella@ugr.es	Martin-de-las-Heras, Stella/Q-9271-2018; Lamia, Leticia Olga Rubio/ABD-6146-2020	Martin-de-las-Heras, Stella/0000-0002-1554-951X; Lamia, Leticia Olga Rubio/0000-0002-8233-624X; Gaitan-Arroyo, Maria Jesus/0000-0002-8832-6368	University of Malaga [PPIT.UMA.B1.2017/24]	University of Malaga	This work was supported by the University of Malaga (PPIT.UMA.B1.2017/24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the University of Malaga (PPIT.UMA.B1.2017/24).	Alonso A, 2005, CROAT MED J, V46, P540; [Anonymous], 1993, STANDARD TEST METHOD; [Anonymous], 2006, QUANT KITS US MAN; CIE, 1986, COLORIMETRY; Ellingham STD, 2016, J FORENSIC SCI, V61, P153, DOI 10.1111/1556-4029.12855; Fereira JL, 2008, FORENSIC SCI INT, V178, P119, DOI 10.1016/j.forsciint.2007.12.009; Garcia AA, 1996, INT J LEGAL MED, V109, P125, DOI 10.1007/BF01369671; Garriga JA, 2016, SCI JUSTICE, V56, P437, DOI 10.1016/j.scijus.2016.06.006; Giardina E, 2011, NANOMEDICINE-UK, V6, P257, DOI [10.2217/nnm.10.160, 10.2217/NNM.10.160]; Higgins D, 2013, SCI JUSTICE, V53, P433, DOI 10.1016/j.scijus.2013.06.001; Karkhanis S, 2009, J Forensic Odontostomatol, V27, P9; Makhlouf F, 2011, LEGAL MED-TOKYO, V13, P98, DOI 10.1016/j.legalmed.2010.11.007; Manjunath BC, 2011, J FORENSIC LEG MED, V18, P191, DOI 10.1016/j.jflm.2011.02.005; Martin-de las Heras S, 2003, FORENSIC SCI INT, V132, P57, DOI 10.1016/S0379-0738(02)00454-1; Martin-de-las-Heras S, 2016, AUS J FORENSIC SCI, V50, P82; Moreno S, 2009, J FORENSIC DENT SCI, V1, P17, DOI DOI 10.4103/0974-2948.50883; Muller M, 1998, J Forensic Odontostomatol, V16, P1; Myers SL, 1999, J FORENSIC SCI, V44, P805; Paul S, 2002, J DENT RES, V81, P578, DOI 10.1177/154405910208100815; Rees KA, 2010, J FORENSIC SCI, V55, P410, DOI 10.1111/j.1556-4029.2009.01286.x; Rubio L, 2015, FORENSIC SCI INT, V252, DOI 10.1016/j.forsciint.2015.04.033; Rubio L, 2013, ACTA ODONTOL SCAND, V71, P638, DOI 10.3109/00016357.2012.700068; Rubio L, 2009, J FORENSIC SCI, V54, P1411, DOI 10.1111/j.1556-4029.2009.01159.x; Savio C, 2006, FORENSIC SCI INT, V158, P108, DOI 10.1016/j.forsciint.2005.05.003; Sudoyo H, 2008, FORENSIC SCI INT-GEN, V2, P231, DOI 10.1016/j.fsigen.2007.12.007; SWEET DJ, 1995, J FORENSIC SCI, V40, P310; Tsuchimochi T, 2002, AM J FOREN MED PATH, V23, P268, DOI 10.1097/00000433-200209000-00013; Yamada Y, 1997, J Forensic Odontostomatol, V15, P13	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196305	10.1371/journal.pone.0196305	http://dx.doi.org/10.1371/journal.pone.0196305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698524	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600060
J	Sethi, SK; Bansal, SB; Khare, A; Dhaliwal, M; Raghunathan, V; Wadhwani, N; Nandwani, A; Yadav, DK; Mahapatra, AK; Raina, R				Sethi, Sidharth Kumar; Bansal, Shyam B.; Khare, Anshika; Dhaliwal, Maninder; Raghunathan, Veena; Wadhwani, Nikita; Nandwani, Ashish; Yadav, Dinesh Kumar; Mahapatra, Amit Kumar; Raina, Rupesh			Heparin free dialysis in critically sick children using sustained low efficiency dialysis (SLEDD-f): A new hybrid therapy for dialysis in developing world	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; RENAL REPLACEMENT THERAPY; PERITONEAL-DIALYSIS; HEMODIALYSIS; OUTCOMES; ALPHA; ICU	Background In critically sick adults, sustained low efficiency dialysis [SLED] appears to be better tolerated hemodynamically and outcomes seem to be comparable to CRRT. However, there is paucity of data in critically sick children. In children, two recent studies from Taiwan (n = 11) and India (n = 68) showed benefits of SLED in critically sick children. Aims and objectives The objective of the study was to look at the feasibility and tolerability of sustained low efficiency daily dialysis-filtration [SLEDD-f] in critically sick pediatric patients. Material and methods Design: Retrospective study Inclusion criteria: All pediatric patients who had undergone heparin free SLEDD-f from January 2012 to October 2017. Measurements: Data collected included demographic details, vital signs, PRISM III at admission, ventilator parameters (where applicable), number of inotropes, blood gas and electrolytes before, during, and on conclusion of SLED therapy. Technical information was gathered regarding SLEDD-f prescription and complications. Results Between 2012-2017, a total of 242 sessions of SLEDD-f were performed on 70 patients, out of which 40 children survived. The median age of patients in years was 12 (range 0.8-17 years), and the median weight was 39 kg (range 8.5-66 kg). The mean PRISM score at admission was 8.77 +/- 7.22. SLEDD-f sessions were well tolerated, with marked improvement in fluid status and acidosis. Premature terminations had to be done in 23 (9.5%) of the sessions. There were 21 sessions (8.6%) terminated due to hypotension and 2 sessions (0.8%) terminated due to circuit clotting. Post-SLEDD-f hypocalcemia occurred in 15 sessions (6.2%), post-SLEDD-f hypophosphatemia occurred in 1 session (0.4%), and post-SLEDD-f hypokalemia occurred in 17 sessions (7.0%). Conclusions This study is the largest compiled data on pediatric SLEDD-f use in critically ill patients. Our study confirms the feasibility of heparin free SLEDD-f in a larger pediatric population, and even in children weighing <20 kg on inotropic support.	[Sethi, Sidharth Kumar; Bansal, Shyam B.; Wadhwani, Nikita; Nandwani, Ashish; Yadav, Dinesh Kumar; Mahapatra, Amit Kumar] Medanta, Kidney Inst, Gurgaon, Haryana, India; [Khare, Anshika] Northeast Ohio Med Univ, Rootstown, OH USA; [Dhaliwal, Maninder; Raghunathan, Veena] Medanta, Pediat Crit Care, Gurgaon, Haryana, India; [Raina, Rupesh] Akron Childrens Hosp, Pediat Nephrol, Akron, OH 44308 USA	Northeast Ohio Medical University (NEOMED); Akron Children's Hospital	Raina, R (corresponding author), Akron Childrens Hosp, Pediat Nephrol, Akron, OH 44308 USA.	RRaina@akronchildrens.org	raina, rupesh/AAE-6660-2020	Sethi, Sidharth/0000-0002-1516-3393				Bagga A, 2007, PEDIATR NEPHROL, V22, P1655, DOI 10.1007/s00467-007-0565-4; Basu RK, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/785392; Berbece AN, 2006, KIDNEY INT, V70, P963, DOI 10.1038/sj.ki.5001700; BUNCHMAN TE, 1994, PEDIATR NEPHROL, V8, P96, DOI 10.1007/BF00868282; Callegari JG, 2012, KIDNEY INT, V81, P331, DOI 10.1038/ki.2011.408; Cullis B, 2014, PERITON DIALYSIS INT, V34, P494, DOI 10.3747/pdi.2013.00222; Fiaccadori E, 2013, CLIN J AM SOC NEPHRO, V8, P1670, DOI 10.2215/CJN.00510113; Fieghen HE, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-32; Finkelstein FO, 2014, PERITON DIALYSIS INT, V34, P478, DOI 10.3747/pdi.2014.00041; Goldstein B, 2006, PEDIATR CRIT CARE ME, V7, P200, DOI 10.1097/01.PCC.0000217470.68764.36; Goldstein SL, 2005, KIDNEY INT, V67, P653, DOI 10.1111/j.1523-1755.2005.67121.x; Kielstein JT, 2010, J NEPHROL, V23, P494; Lee CY, 2012, PEDIATR NEPHROL, V27, P2301, DOI 10.1007/s00467-012-2254-1; Legrand M, 2013, INTENS CARE MED, V39, P101, DOI 10.1007/s00134-012-2706-x; Lonnemann G, 1999, KIDNEY INT, V56, pS84, DOI 10.1046/j.1523-1755.56.s72.8.x; Marshall MR, 2004, NEPHROL DIAL TRANSPL, V19, P877, DOI 10.1093/ndt/gfg625; Marshall MR, 2001, KIDNEY INT, V60, P777, DOI 10.1046/j.1523-1755.2001.060002777.x; Paganini EP, 1996, AM J KIDNEY DIS, V28, pS81, DOI 10.1016/S0272-6386(96)90084-0; Ponce D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126436; Ponce D, 2012, CLIN J AM SOC NEPHRO, V7, P887, DOI 10.2215/CJN.11131111; Raina R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178233; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Ronco C, 1998, NEPHROL DIAL TRANSPL, V13, P79, DOI 10.1093/ndt/13.suppl_6.79; Santiago MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8172; Schetz M, 1999, KIDNEY INT, V56, pS88, DOI 10.1046/j.1523-1755.56.s72.12.x; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; Sethi SK, 2018, HEMODIAL INT, V22, P228, DOI 10.1111/hdi.12605; Sinha R, 2018, PEDIATR NEPHROL, V33, P1283, DOI 10.1007/s00467-017-3732-2; Sutherland SM, 2012, PEDIATR NEPHROL, V27, P2007, DOI 10.1007/s00467-011-2080-x; Sutherland SM, 2010, AM J KIDNEY DIS, V55, P316, DOI 10.1053/j.ajkd.2009.10.048; Zhang L, 2015, AM J KIDNEY DIS, V66, P322, DOI 10.1053/j.ajkd.2015.02.328	31	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195536	10.1371/journal.pone.0195536	http://dx.doi.org/10.1371/journal.pone.0195536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698409	Green Submitted, Green Published, gold			2022-12-26	WOS:000431007600011
J	Ye, LY; Liu, SR; Xie, F; Zhao, LL; Wu, XP				Ye, Liyun; Liu, Shengrong; Xie, Fan; Zhao, Lili; Wu, Xiaoping			Enhanced production of polysaccharides and triterpenoids in Ganoderma lucidum fruit bodies on induction with signal transduction during the fruiting stage	PLOS ONE			English	Article							MEDICINAL MUSHROOM; SUBMERGED CULTURE; SALICYLIC-ACID; CORDYCEPS-MILITARIS; BIOACTIVE COMPOUNDS; SYNTHASE GENE; BIOSYNTHESIS; FERMENTATION; FUNGUS; CELLS	Ganoderma lucidum is a medicinal mushroom that has been widely used in East Asia for the treatment of various diseases. The pharmacological activity of this fungus is primarily attributable to the polysaccharides and triterpenoids. In this study, to obtain the fruit bodies with improved content of active constituents, we examined the effect of salicylic acid (SA) and calcium ion on the biosynthesis of polysaccharides and triterpenoids by spraying the chemicals during the fruiting. To explore the underlying mechanisms for the variation, the transcripts of related genes involved in the polysaccharide and triterpenoid biosynthesis were measured. Results showed that Ca2+ had no effect on production of polysaccharides and triterpenoids, whereas SA increased triterpenoid content by 23.32%, compared to the control, but it had little influence on polysaccharide production. Interestingly, the combined induction increased polysaccharide and triterpenoid content by 9.02% and 13.61%, respectively, compared to the control. Under Ca2+ induction, the transcript of ugp gene in the polysaccharide biosynthetic pathway up-regulated in all three stages (mycelium, primordium, and fruit body), while pgm and gls gave no response in the mycelium and primordium stages, and up-regulated in the fruit body stage. Differently, six key triterpenoid biosynthetic genes including hmgr, hmgs, mvd, fps, sqs, and ls did not respond to the induction. In the case of SA and combined induction, pgm and ugp were up-regulated in all three stages, while gls showed an increased expression in the primordium stage and no response in other stages. The six triterpenoid biosynthetic genes were up-regulated in all three stages. The present study provides a useful approach to producing G. lucidum fruit bodies with high polysaccharide and triterpenoid content. This is important to the G. lucidum industry.	[Ye, Liyun; Xie, Fan; Zhao, Lili; Wu, Xiaoping] Fujian Agr & Forestry Univ, Mycol Res Ctr, Fuzhou, Fujian, Peoples R China; [Liu, Shengrong] Ningde Normal Univ, Coll Life Sci, Ningde, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Ningde Normal University	Wu, XP (corresponding author), Fujian Agr & Forestry Univ, Mycol Res Ctr, Fuzhou, Fujian, Peoples R China.	fjwxp@126.com			Special Fund for Scientific and Technological Innovation of Fujian Agriculture and Forestry University [KFA17539A]; Program of JUNCAO Industry Collaborative Innovation of Fujian Department of Education [JCXTGG06]	Special Fund for Scientific and Technological Innovation of Fujian Agriculture and Forestry University; Program of JUNCAO Industry Collaborative Innovation of Fujian Department of Education	This work was supported by the Special Fund for Scientific and Technological Innovation of Fujian Agriculture and Forestry University (No. KFA17539A) and the Program of JUNCAO Industry Collaborative Innovation of Fujian Department of Education (No. JCXTGG06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao PF, 2017, INT J MED MUSHROOMS, V19, P65, DOI [10.1615/IntJMedMushrooms.v19.i1.70, 10.1615/intjmedmushrooms.v19.i1.70]; Chang MY, 2006, ENZYME MICROB TECH, V38, P407, DOI 10.1016/j.enzmictec.2005.06.011; Chen NH, 2009, PROCESS BIOCHEM, V44, P928, DOI 10.1016/j.procbio.2009.03.018; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Chen TQ, 2014, J TAIWAN INST CHEM E, V45, P57, DOI 10.1016/j.jtice.2013.05.010; Chen Y, 2007, J FOOD ENG, V81, P162, DOI 10.1016/j.jfoodeng.2006.10.018; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; Dong JZ, 2013, J FOOD BIOCHEM, V37, P578, DOI 10.1111/jfbc.12009; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Feng J, 2016, APPL BIOCHEM BIOTECH, V180, P740, DOI 10.1007/s12010-016-2129-1; Feng YL, 2010, BIOCHEM ENG J, V49, P104, DOI 10.1016/j.bej.2009.12.002; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; Guo B, 2007, ENVIRON POLLUT, V147, P743, DOI 10.1016/j.envpol.2006.09.007; JONG SC, 1992, ADV APPL MICROBIOL, V37, P101, DOI 10.1016/S0065-2164(08)70253-3; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Khan MIR, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26374; Kim KC, 2007, CANCER LETT, V246, P210, DOI 10.1016/j.canlet.2006.02.014; Kozarski M, 2011, FOOD CHEM, V129, P1667, DOI 10.1016/j.foodchem.2011.06.029; Li HJ, 2016, BIOPROC BIOSYST ENG, V39, P75, DOI 10.1007/s00449-015-1491-7; Liang CX, 2010, APPL MICROBIOL BIOT, V86, P1367, DOI 10.1007/s00253-009-2415-8; Lin QY, 2017, J SCI FOOD AGR, V97, P3476, DOI 10.1002/jsfa.8097; Liu SR, 2017, SCI HORTIC-AMSTERDAM, V216, P58, DOI 10.1016/j.scienta.2016.12.016; MIZUNO T, 1995, FOOD REV INT, V11, P151, DOI 10.1080/87559129509541025; Ren A, 2014, BIOTECHNOL LETT, V36, P2529, DOI 10.1007/s10529-014-1636-9; Ren A, 2013, WORLD J MICROB BIOT, V29, P523, DOI 10.1007/s11274-012-1206-z; Ren A, 2010, BIORESOURCE TECHNOL, V101, P6785, DOI 10.1016/j.biortech.2010.03.118; Ren XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087578; Roth-Bejerano N., 2004, Mycoscience, V45, P30, DOI 10.1007/s10267-003-0156-6; Royse DJ, 2003, BIORESOURCE TECHNOL, V90, P225, DOI 10.1016/S0960-8524(03)00119-6; Ruan W., 2012, BIOMED PREV NUTR, V2, P203, DOI [10.1016/j.bionut.2012.03.004, DOI 10.1016/j.bionut.2012.03.004]; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Sa-Correia I, 2002, J IND MICROBIOL BIOT, V29, P170, DOI 10.1038/sj.jim.7000266; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; Shi LA, 2010, APPL MICROBIOL BIOT, V88, P1243, DOI 10.1007/s00253-010-2871-1; Sudheer S, 2016, POSTHARVEST BIOL TEC, V117, P81, DOI 10.1016/j.postharvbio.2016.01.014; Tang W, 2006, LIFE SCI, V80, P205, DOI 10.1016/j.lfs.2006.09.001; Tang YJ, 2010, BIOTECHNOL PROGR, V26, P417, DOI 10.1002/btpr.352; Tang YJ, 2002, BIOTECHNOL LETT, V24, P1023, DOI 10.1023/A:1015677313598; Wu WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095359; Xu JW, 2015, BIOPROC BIOSYST ENG, V38, P399, DOI 10.1007/s00449-014-1279-1; Xu JW, 2010, APPL MICROBIOL BIOT, V85, P941, DOI 10.1007/s00253-009-2106-5; Xu YN, 2012, BIOTECHNOL ADV, V30, P1301, DOI 10.1016/j.biotechadv.2011.10.001; Yang FC, 1998, PROCESS BIOCHEM, V33, P547, DOI 10.1016/S0032-9592(98)00023-5; Zhang W, 2008, BIOTECHNOL PROGR, V24, P1249, DOI 10.1002/btpr.36; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106; Zhou JS, 2014, BIOCHEM ENG J, V90, P178, DOI 10.1016/j.bej.2014.06.008	46	22	29	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196287	10.1371/journal.pone.0196287	http://dx.doi.org/10.1371/journal.pone.0196287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694432	gold, Green Published, Green Submitted			2022-12-26	WOS:000430802400079
J	Borges, PF; Garcia-Montoya, E; Perez-Lozano, P; Jo, E; Minarro, M; Manich, A; Sune-Negre, JM				Florez Borges, Paloma; Garcia-Montoya, Encarna; Perez-Lozano, Pilar; Jo, Enric; Minarro, Montserrat; Manich, Albert; Maria Sune-Negre, Josep			The role of SeDeM for characterizing the active substance and polyvinyilpyrrolidone eliminating metastable forms in an oral lyophilizate-A preformulation study	PLOS ONE			English	Article							DOSAGE FORMS; DIAGRAM; FORMULATION; PRODUCTS; DESIGN; IMPACT; TABLET; STATE	A preformulation study of an oral lyophilisate with cetirizine dihydrochloride (CTZ) as active ingredient, mannitol and PVP K30 as bulking agents is presented. CTZ shown a humidity content of 0.150% and a spontaneous hygroscopicity of 0.200% (both determined by SeDeM diagram), demonstrating an adequate stability behavior in solid form. A design of experiments (DoE) performed with both mannitol and PVP K30, followed by a simple factorial design (3(2)) has determined the optimum combination of excipients and CTZ, and showed that a higher proportion of PVP K30 was able to prevent metastable forms generated by mannitol.	[Florez Borges, Paloma; Garcia-Montoya, Encarna; Perez-Lozano, Pilar; Minarro, Montserrat; Maria Sune-Negre, Josep] Univ Barcelona, Fac Pharm, Pharm & Pharmaceut Technol Dept, Barcelona, Spain; [Florez Borges, Paloma; Jo, Enric] Reig Jofre Grp, St Joan Despi, Spain; [Manich, Albert] CSIC, IQAC, Inst Adv Chem Catalonia, Barcelona, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC)	Borges, PF (corresponding author), Univ Barcelona, Fac Pharm, Pharm & Pharmaceut Technol Dept, Barcelona, Spain.; Borges, PF (corresponding author), Reig Jofre Grp, St Joan Despi, Spain.	pflorezb@gmail.com	Miñarro, Montserrat/R-5543-2019; MANICH, ALBERT/K-2673-2017; Lozano, Pilar Perez/W-7485-2018; Garcia_Montoya, Encarna/C-5787-2015	MANICH, ALBERT/0000-0002-9835-2850; Garcia_Montoya, Encarna/0000-0003-1576-5586; Minarro, Montserrat/0000-0002-6795-2685	University of Barcelona	University of Barcelona	The author received no specific funding for the work. The author (myself) received no specific funding for the work, nor grant. All the fees and tuition of the University of Barcelona were paid with my salary working in Reig Jofre. I did my PhD thesis part time, which helped me accomplish both work and PhD thesis. The funder provided support in the form of salaries for authors PFB and EJ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'Authors contributions' section.	Ahmed IS, 2007, EUR J PHARM SCI, V32, P58, DOI 10.1016/j.ejps.2007.05.114; AlHusban F, 2010, EUR J PHARM BIOPHARM, V75, P254, DOI 10.1016/j.ejpb.2010.03.012; Atkins PC, 1997, J ALLERGY CLIN IMMUN, V99, P806, DOI 10.1016/S0091-6749(97)80015-2; Baird JA, 2012, ADV DRUG DELIVER REV, V64, P396, DOI 10.1016/j.addr.2011.07.009; Chandrasekhar R, 2009, EUR J PHARM BIOPHARM, V72, P119, DOI 10.1016/j.ejpb.2008.11.011; Corveleyn S, 1997, INT J PHARM, V152, P215, DOI 10.1016/S0378-5173(97)00092-6; Craig DQM, 1999, INT J PHARM, V179, P179, DOI 10.1016/S0378-5173(98)00338-X; Diaz JEA, 2012, EUR J PHARM BIOPHARM, V80, P638, DOI DOI 10.1016/J.EJPB.2011.12.012; Aguilar-Diaz JE, 2009, EUR J PHARM BIOPHARM, V73, P414, DOI 10.1016/j.ejpb.2009.07.001; EMA, 2015, ICH GUID Q8 R2 PHARM; Florez Borges P., 2016, THESIS; Florez Borges P, 2015, EUR PHARM C AUG 25 2; Borges PF, 2014, DARU, V22, DOI 10.1186/s40199-014-0082-5; Imamura K, 2008, J PHARM SCI-US, V97, P1301, DOI 10.1002/jps.21066; Jennings TA., 1999, INTRO BASIC PRINCIPL, p1 ; Kadajji VG, 2011, POLYMERS-BASEL, V3, P1972, DOI 10.3390/polym3041972; Kasper JC, 2011, EUR J PHARM BIOPHARM, V78, P248, DOI 10.1016/j.ejpb.2011.03.010; Kawakami K, 2012, ADV DRUG DELIVER REV, V64, P480, DOI 10.1016/j.addr.2011.10.009; Kim AI, 1998, J PHARM SCI, V87, P931, DOI 10.1021/js980001d; Kollidon Buhler V., 2008, POLYVYNYLPYRROLIDONE, p17 ; Komarow HD, 2008, AM J MED, V121, P379, DOI 10.1016/j.amjmed.2007.10.039; Meister E, 2009, AAPS PHARMSCITECH, V10, P582, DOI 10.1208/s12249-009-9245-y; Mizumoto T, 2005, INT J PHARMACEUT, V306, P83, DOI 10.1016/j.ijpharm.2005.09.009; Nabors LO, 2012, ALTERNATIVE SWEETENE, P333; Ortonne JP, 2012, EUR J INTERN MED, V23, P26, DOI 10.1016/j.ejim.2011.09.008; Perez Lozano P, 2010, FABRICACION CONTROL, p662 ; Perez P, 2006, EUR J PHARM BIOPHARM, V64, P351, DOI 10.1016/j.ejpb.2006.06.008; Rowe R.C., 2009, HDB PHARM EXCIPIENTS, VSixth; Sammour OA, 2006, AAPS PHARMSCITECH, V7, pE167; Seager H, 1998, J PHARM PHARMACOL, V50, P375, DOI 10.1111/j.2042-7158.1998.tb06876.x; Simons FER, 2004, NEW ENGL J MED, V351, P2203, DOI 10.1056/NEJMra033121; Sune-Negre J, 2005, CIENC TECNOL PHARM, V15, P125; Sune-Negre JM, 2011, SEDEM DIAGRAM NEW EX, p17 ; Sune-Negre JM, 2008, EUR J PHARM BIOPHARM, V69, P1029, DOI 10.1016/j.ejpb.2008.01.020; Sune-Negre JM, 2011, EUR J PHARM BIOPHARM, V79, P464, DOI 10.1016/j.ejpb.2011.04.002; Tong HHY, 2011, INT J PHARMACEUT, V404, P148, DOI 10.1016/j.ijpharm.2010.11.027; Ursino MG, 2011, REGUL TOXICOL PHARM, V60, P93, DOI 10.1016/j.yrtph.2011.02.010; Walsh GM, 2001, DRUGS, V61, P207, DOI 10.2165/00003495-200161020-00006	38	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196049	10.1371/journal.pone.0196049	http://dx.doi.org/10.1371/journal.pone.0196049			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689061	Green Published, gold, Green Submitted			2022-12-26	WOS:000430678800023
J	zu Ermgassen, EKHJ; Kelly, M; Bladon, E; Salemdeeb, R; Balmford, A				zu Ermgassen, Erasmus K. H. J.; Kelly, Moira; Bladon, Eleanor; Salemdeeb, Ramy; Balmford, Andrew			Support amongst UK pig farmers and agricultural stakeholders for the use of food losses in animal feed	PLOS ONE			English	Article							WASTE; ECOFEED	While food losses (foods which were intended for human consumption, but which ultimately are not directly eaten by people) have been included in animal feed for millennia, the practice is all but banned in the European Union. Amid recent calls to promote a circular economy, we conducted a survey of pig farmers (n = 82) and other agricultural stakeholders (n = 81) at a UK agricultural trade fair on their attitudes toward the use of food losses in pig feed, and the potential relegalisation of swill (the use of cooked food losses as feed). While most respondents found the use of feeds containing animal by-products or with the potential for intra-species recycling (i.e. pigs eating pork products) to be less acceptable than feeds without, we found strong support (>75%) for the relegalisation of swill among both pig farmers and other stakeholders. We fit multi-hierarchical Bayesian models to understand people's position on the relegalisation of swill, finding that respondents who were concerned about disease control and the perception of the pork industry supported relegalisation less, while people who were concerned with farm financial performance and efficiency or who thought that swill would benefit the environment and reduce trade-deficits, were more supportive. Our results provide a baseline estimate of support amongst the large-scale pig industry for the relegalisation of swill, and suggest that proponents for its relegalisation must address concerns about disease control and the consumer acceptance of swill-fed pork.	[zu Ermgassen, Erasmus K. H. J.; Balmford, Andrew] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Kelly, Moira] Univ Ghent, Wildlife Populat Hlth Grp, Ghent, Belgium; [Bladon, Eleanor] Univ Cambridge, Dept Zool, Cambridge, England; [Salemdeeb, Ramy] Univ Cambridge, Dept Engn, Cambridge, England	University of Cambridge; Ghent University; University of Cambridge; University of Cambridge	zu Ermgassen, EKHJ (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England.	erasmus.zu.ermgassen@gmail.com	; Salemdeeb, Ramy/J-4411-2016	Balmford, Andrew/0000-0002-0144-3589; Salemdeeb, Ramy/0000-0002-3252-1084; Kelly, Moira/0000-0003-4372-700X; zu Ermgassen, Erasmus Klaus Helge Justus/0000-0002-9168-6057; Bladon, Eleanor/0000-0002-0466-0335	BBSRC [BB/J014540/1]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	E.K.H.J.zE is funded by BBSRC grant BB/J014540/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkin A, 2014, ASSESSMENT RISK MANA, P127; [Anonymous], 2017, PROC UND GET INS FEE; BPPF, 2017, BRIT PIG POULTR FAIR; Brancoli P, 2017, RESOUR CONSERV RECY, V118, P39, DOI 10.1016/j.resconrec.2016.11.024; Danby G., 2015, PIG SWILL BAN SLEDGE; Ermgassen EKHJZ, 2016, FOOD POLICY, V58, P35, DOI 10.1016/j.foodpol.2015.11.001; Eurostat database, 2014, AGR STAT; Fairlie S, 2017, FARMING POLICY BREXI; Fairlie S., 2010, MEAT BENIGN EXTRAVAG; FAO, 2014, DEF FRAM FOOD LOSS; FERA, 2012, FO0218 FERA; Gachango FG, 2017, AQUACULTURE, V479, P265, DOI 10.1016/j.aquaculture.2017.04.029; McElreath R., 2016, RETHINKING R PACKAGE; McElreath R, 2016, TEXT STAT SCI, pXI; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Papargyropoulou E, 2014, J CLEAN PROD, V76, P106, DOI 10.1016/j.jclepro.2014.04.020; R Core Team, 2013, R VERS 3 0 1 R LANG; Revelle W, 2017, PACKAGE PSYCH; Salemdeeb R, 2017, J CLEAN PROD, V140, P871, DOI 10.1016/j.jclepro.2016.05.049; Sasaki K, 2011, ANIM SCI J, V82, P175, DOI 10.1111/j.1740-0929.2010.00817.x; Scudamore JM, 2002, ORIGIN UK FOOT MOUTH; Stenmarck A., 2016, ESTIMATES EUROPEAN F, DOI [10.13140/RG.2.1.4658.4721, DOI 10.13140/RG.2.1.4658.4721]; Stuart T., 2009, WASTE UNCOVERING GLO; Sugiura K, 2009, VET ITAL, V45, P397; Vandermeersch T, 2014, RESOUR CONSERV RECY, V87, P57, DOI 10.1016/j.resconrec.2014.03.008; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Verbeke W, 2015, ANIM FEED SCI TECH, V204, P72, DOI 10.1016/j.anifeedsci.2015.04.001	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196288	10.1371/journal.pone.0196288	http://dx.doi.org/10.1371/journal.pone.0196288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689078	Green Submitted, gold, Green Published			2022-12-26	WOS:000430678800038
J	Cao, HH; Zhang, ZF; Wang, XF; Liu, TX				Cao, He-He; Zhang, Zhan-Feng; Wang, Xiao-Feng; Liu, Tong-Xian			Nutrition versus defense: Why & IT;Myzus persicae & IT; (green peach aphid) prefers and performs better on young leaves of cabbage	PLOS ONE			English	Article							MYZUS-PERSICAE; AMINO-ACIDS; PLANT; BRASSICA; RESISTANCE; PHYSIOLOGY; NITROGEN; GENE	Plant leaves of different ages differ in nutrients and toxic metabolites and thus exhibit various resistance levels against insect herbivores. However, little is known about the influence of leaf ontogeny on plant resistance to phloem-feeding insects. In this study, we found that the green peach aphid, Myzus persicae, preferred to settle on young cabbage leaves compared with mature or old leaves, although young leaves contained the highest concentration of glucosinolates. Furthermore, aphids feeding on young leaves had higher levels of glucosinolates in their body, but aphids performed better on young leaves in terms of body weight and population growth. Phloem sap of young leaves had higher amino acid:sugar molar ratio than mature leaves, and aphids feeding on young leaves showed two times longer phloem feeding time and five times more honeydew excretion than on other leaves. These results indicate that aphids acquired the highest amount of nutrients and defensive metabolites when feeding on young cabbage leaves that are strong natural plant sinks. Accordingly, we propose that aphids generally prefer to obtain more nutrition rather than avoiding host plant defense, and total amount of nutrition that aphids could obtain is significantly influenced by leaf ontogeny or source-sink status of feeding sites.	[Cao, He-He; Zhang, Zhan-Feng; Liu, Tong-Xian] Northwest A&F Univ, Coll Plant Protect, Key Lab Northwest Loess Plateau Crop Pest Managem, Minist Agr, Yangling, Shaanxi, Peoples R China; [Cao, He-He; Wang, Xiao-Feng] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Liu, TX (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Northwest Loess Plateau Crop Pest Managem, Minist Agr, Yangling, Shaanxi, Peoples R China.	txliu@nwsuaf.edu.cn		Zhang, Zhanfeng/0000-0003-3393-0696; Liu, Tong-Xian/0000-0002-7686-0686	Ministry of Science and Technology, China [2013CB127600]; Natural Science Foundation of China [31272089]	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of Ministry of Science and Technology, China (973 Program, 2013CB127600) (TXL), Natural Science Foundation of China (31272089) (TXL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUCLAIR JL, 1963, ANNU REV ENTOMOL, V8, P439, DOI 10.1146/annurev.en.08.010163.002255; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Cao HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21954; Cao HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091768; Cibils-Stewart X, 2015, ENTOMOL EXP APPL, V156, P149, DOI 10.1111/eea.12325; Cole RA, 1997, ENTOMOL EXP APPL, V85, P121, DOI 10.1023/A:1003049105464; Divol F, 2007, PLANT CELL ENVIRON, V30, P187, DOI 10.1111/j.1365-3040.2006.01618.x; Douglas AE, 2003, ADV INSECT PHYSIOL, V31, P73, DOI 10.1016/S0065-2806(03)31002-1; DREYER DL, 1987, PLANT CELL ENVIRON, V10, P353; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gabrys B, 2002, ENTOMOL EXP APPL, V104, P89, DOI 10.1023/A:1021274218915; Girousse C, 2005, PLANT PHYSIOL, V137, P1474, DOI 10.1104/pp.104.057430; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Gould GG, 2007, ENVIRON ENTOMOL, V36, P1212, DOI 10.1603/0046-225X(2007)36[1212:VIECPD]2.0.CO;2; HODGSON CJ, 1978, ECOL ENTOMOL, V3, P289, DOI 10.1111/j.1365-2311.1978.tb00929.x; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Hunt EJ, 2006, MOL ECOL, V15, P4203, DOI 10.1111/j.1365-294X.2006.03090.x; Hunt E, 2010, J EXP BOT, V61, P55, DOI 10.1093/jxb/erp274; Kim JH, 2008, PLANT J, V54, P1015, DOI 10.1111/j.1365-313X.2008.03476.x; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Kohler A, 2015, PLANT CELL ENVIRON, V38, P1081, DOI 10.1111/pce.12464; Lambdon PW, 2003, AGR ECOSYST ENVIRON, V97, P205, DOI 10.1016/S0167-8809(03)00036-7; LARSON KC, 1991, OECOLOGIA, V88, P15, DOI 10.1007/BF00328398; Mathers TC, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1145-3; Munch E, 1930, STOFFBEWEGUNEN PFLAN, V15, P488; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Pfalz M, 2009, PLANT CELL, V21, P985, DOI 10.1105/tpc.108.063115; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; PRADO E, 1994, ENTOMOL EXP APPL, V72, P157, DOI 10.1007/BF02383550; Rochfort SJ, 2008, PHYTOCHEMISTRY, V69, P1671, DOI 10.1016/j.phytochem.2008.02.010; Sarria E, 2009, COMPUT ELECTRON AGR, V67, P35, DOI 10.1016/j.compag.2009.02.006; Schuman MC, 2016, ANNU REV ENTOMOL, V61, P373, DOI 10.1146/annurev-ento-010715-023851; Thiele B, 2008, ANAL BIOANAL CHEM, V391, P2663, DOI 10.1007/s00216-008-2167-9; Will T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00336; Wool D, 2004, ANNU REV ENTOMOL, V49, P175, DOI 10.1146/annurev.ento.49.061802.123236; Zust T, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.206, 10.1038/nplants.2015.206]	36	15	15	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196219	10.1371/journal.pone.0196219	http://dx.doi.org/10.1371/journal.pone.0196219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684073	gold, Green Published, Green Submitted			2022-12-26	WOS:000430660600043
J	Rejmankova, E; Sirova, D; Castle, ST; Barta, J; Carpenter, H				Rejmankova, Eliska; Sirova, Dagmara; Castle, Stephanie T.; Barta, Jiri; Carpenter, Heather			Heterotrophic N-2-fixation contributes to nitrogen economy of a common wetland sedge, Schoenoplectus californicus	PLOS ONE			English	Article							N-2 FIXATION; PLANT; PHOSPHORUS; BACTERIA; GRASS; ACCUMULATION; MACROPHYTES; SUGARCANE; GROWTH; RHIZOSPHERE	A survey of the ecological variability within 52 populations of Schoenoplectus californicus (C.A. Mey.) Sojak across its distributional range revealed that it is commonly found in nitrogen (N) limited areas, but rarely in phosphorus limited soils. We explored the hypothesis that S. californicus supplements its nitrogen demand by bacterial N-2-fixation processes associated with its roots and rhizomes. We estimated N-2-fixation of diazotrophs associated with plant rhizomes and roots from several locations throughout the species' range and conducted an experiment growing plants in zero, low, and high N additions. Nitrogenase activity in rhizomes and roots was measured using the acetylene reduction assay. The presence of diazotrophs was verified by the detection of the nifHgene. Nitrogenase activity was restricted to rhizomes and roots and it was two orders of magnitude higher in the latter plant organs (81 and 2032 nmol C2H4 g DW-1 d(-1), respectively). Correspondingly, 40x more nifH gene copies were found on roots compared to rhizomes. The proportion of the nifHgene copies in total bacterial DNA was positively correlated with the nitrogenase activity. In the experiment, the contribution of fixed N to the plant N content ranged from 13.8% to 32.5% among clones from different locations. These are relatively high values for a non-cultivated plant and justify future research on the link between N-fixing bacteria and S. californicus production.	[Rejmankova, Eliska; Castle, Stephanie T.; Carpenter, Heather] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Sirova, Dagmara] CAS, Biol Ctr, Inst Hydrobiol, Ceske Budejovice, Czech Republic; [Barta, Jiri] Univ South Bohemia, Ceske Budejovice, Czech Republic	University of California System; University of California Davis; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Rejmankova, E (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA.	erejmankova@uodavis.edu	Sirova, Dagmara/AAC-9401-2021	Sirova, Dagmara/0000-0003-1662-3045; Barta, Jiri/0000-0002-7319-303X; Castle, Stephanie/0000-0002-8441-1573; Rejmankova, Eliska/0000-0001-7539-0232	USAID [AID-520-A-12-00001]	USAID(United States Agency for International Development (USAID))	The study was partly funded by USAID grant No. AID-520-A-12-00001 "United for Lake Atitlan" to Eliska Rejmankova.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Asis CA, 2003, SOIL SCI PLANT NUTR, V49, P915, DOI 10.1080/00380768.2003.10410356; Bedford BL, 1999, ECOLOGY, V80, P2151, DOI 10.1890/0012-9658(1999)080[2151:PINAAP]2.0.CO;2; Boddey RM, 2003, PLANT SOIL, V252, P139, DOI 10.1023/A:1024152126541; BODDEY RM, 1986, PLANT SOIL, V95, P109, DOI 10.1007/BF02378857; BODDEY RM, 1995, PLANT SOIL, V174, P195, DOI 10.1007/BF00032247; Burgmann H, 2005, ENVIRON MICROBIOL, V7, P1711, DOI 10.1111/j.1462-2920.2005.00818.x; Carpenter HM, 2009, THESIS U CALIFORNIA; Dakora FD, 2000, PLANT CELL ENVIRON, V23, P943, DOI 10.1046/j.1365-3040.2000.00610.x; Dalton DA, 2004, FEMS MICROBIOL ECOL, V49, P469, DOI 10.1016/j.femsec.2004.04.010; de Morais RF, 2012, PLANT SOIL, V356, P23, DOI 10.1007/s11104-011-0944-2; Dejoux C, 1992, LAKE TITCACA SYNTHES; DeLuca TH, 2002, NATURE, V419, P917, DOI 10.1038/nature01051; ECKARDT NA, 1988, CAN J BOT, V66, P2419, DOI 10.1139/b88-328; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; Gaby JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042149; Gyaneshwar P, 2002, NEW PHYTOL, V154, P131, DOI 10.1046/j.1469-8137.2002.00371.x; Haiyambo DH, 2015, CURR MICROBIOL, V71, P566, DOI 10.1007/s00284-015-0886-7; Hedin LO, 2002, ANNU REV ECOL EVOL S, V40, P613; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; James EK, 2012, PLANT SOIL, V356, P1, DOI 10.1007/s11104-012-1317-1; Jurelevicius D, 2010, J MICROBIOL BIOTECHN, V20, P862, DOI 10.4014/jmb.0910.10012; Keymer DP, 2014, GCB BIOENERGY, V6, P577, DOI 10.1111/gcbb.12095; Knoth JL, 2014, NEW PHYTOL, V201, P599, DOI 10.1111/nph.12536; Malik KA, 1997, PLANT SOIL, V194, P37, DOI 10.1023/A:1004295714181; McNamara AE, 2000, FRESHWATER BIOL, V43, P649, DOI 10.1046/j.1365-2427.2000.00537.x; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; MWAURA FB, 1992, HYDROBIOLOGIA, V232, P23, DOI 10.1007/BF00014608; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Prakamhang J, 2009, APPL SOIL ECOL, V42, P141, DOI 10.1016/j.apsoil.2009.02.008; Reed SC, 2013, BIOGEOCHEMISTRY, V114, P135, DOI 10.1007/s10533-013-9835-3; Reed SC, 2011, ANNU REV ECOL EVOL S, V42, P489, DOI 10.1146/annurev-ecolsys-102710-145034; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Reis VM, 2001, AUST J PLANT PHYSIOL, V28, P837, DOI 10.1071/PP01079; Rejmankova E, 2005, NEW PHYTOL, V167, P471, DOI 10.1111/j.1469-8137.2005.01449.x; Rejmankova E, 2008, PLANT SOIL, V313, P141, DOI 10.1007/s11104-008-9687-0; Ritchie ME, 2016, PEDOBIOLOGIA, V59, P233, DOI 10.1016/j.pedobi.2016.09.001; Rondon XJ, 2003, ECON BOT, V57, P35, DOI 10.1663/0013-0001(2003)057[0035:EIOCSC]2.0.CO;2; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Rout ME, 2009, PLANT SOIL, V315, P163, DOI 10.1007/s11104-008-9740-z; Santi C, 2013, ANN BOT-LONDON, V111, P743, DOI 10.1093/aob/mct048; Santruckova H, 2010, BIOGEOCHEMISTRY, V101, P295, DOI 10.1007/s10533-010-9479-5; SHEARER G, 1986, AUST J PLANT PHYSIOL, V13, P699, DOI 10.1071/PP9860699; Sokal RR, 1995, BIOMETRY; STAL LJ, 1988, METHOD ENZYMOL, V167, P474; Taule C, 2012, PLANT SOIL, V356, P35, DOI 10.1007/s11104-011-1023-4; Terakado-Tonooka J, 2013, PLANT SOIL, V367, P639, DOI 10.1007/s11104-012-1495-x; Thullen JS, 2008, ECOL ENG, V32, P281, DOI 10.1016/j.ecoleng.2007.12.003; Ticconi CA, 2004, TRENDS PLANT SCI, V9, P548, DOI 10.1016/j.tplants.2004.09.003; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Vance CP, 2003, NEW PHYTOL, V157, P423, DOI 10.1046/j.1469-8137.2003.00695.x; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; WEIER KL, 1995, SOIL BIOL BIOCHEM, V27, P441, DOI 10.1016/0038-0717(95)98616-V; Wickstrom CE, 1997, AQUAT BOT, V59, P157, DOI 10.1016/S0304-3770(97)00053-3; Wurzburger N, 2016, ECOL LETT, V19, P62, DOI 10.1111/ele.12543; Zehr JP, 2007, BIOL NITROGEN CYCLE, P452	58	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195570	10.1371/journal.pone.0195570	http://dx.doi.org/10.1371/journal.pone.0195570			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684035	Green Published, gold			2022-12-26	WOS:000430660600016
J	Nguyen, TK; Hong, MG; Chang, PS; Lee, BH; Yoo, SH				Tien-Kieu Nguyen; Hong, Moon-Gi; Chang, Pahn-Shick; Lee, Byung-Hoo; Yoo, Sang-Ho			Biochemical properties of L-arabinose isomerase from & IT;Clostridium hylemonae & IT; to produce D-tagatose as a functional sweetener	PLOS ONE			English	Article							D-GALACTOSE; LACTOBACILLUS-PLANTARUM; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CLONING; BIOCONVERSION; EXPRESSION; STRAIN; STEAROTHERMOPHILUS; PURIFICATION	D-Tagatose has gained substantial interest due to its potential functionalities as a sucrose substitute. In this study, the gene araA, encoding L-arabinose isomerase (L-Al) from Clostridium hylemonae (DSM 15053), was cloned and expressed in Escherichia coli BL21 (DE3). This gene consists of 1,506 nucleotides and encodes a protein of 501 amino acid residues with a calculated molecular mass of 56,554 Da. Since L-Al was expressed as an intracellular inclusion body, this enzyme was solubilized with guanidine hydrochloride, refolded, and activated with a descending concentration gradient of urea. The purified enzyme exhibited the greatest activity at 50 degrees C, pH 7-7.5, and required 1 mM of Mg2+ as a cofactor. Notably, the catalytic efficiency (3.69 mM(-1) sec(-1)) of L-Al from C. hylemonae on galactose was significantly greater than that of other previously reported enzymes. The bioconversion yield of D-tagatose using the C. hylemonae L-arabinose isomerase at 60 degrees C reached approximately 46% from 10 mM of D-galactose after 2 h. From these results, it is suggested that the L-arabinose isomerase from C. hylemonae could be utilized as a potential enzyme for D-tagatose production due to its high conversion yield at an industrially competitive temperature.	[Tien-Kieu Nguyen; Yoo, Sang-Ho] Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea; [Tien-Kieu Nguyen; Yoo, Sang-Ho] Sejong Univ, Carbohydrate Bioprod Res Ctr, Seoul, South Korea; [Hong, Moon-Gi; Lee, Byung-Hoo] Gachon Univ, Coll BioNano Technol, Dept Food Sci & Biotechnol, Seongnam, South Korea; [Chang, Pahn-Shick] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Chang, Pahn-Shick] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Chang, Pahn-Shick] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Sejong University; Sejong University; Gachon University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Yoo, SH (corresponding author), Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea.; Yoo, SH (corresponding author), Sejong Univ, Carbohydrate Bioprod Res Ctr, Seoul, South Korea.; Lee, BH (corresponding author), Gachon Univ, Coll BioNano Technol, Dept Food Sci & Biotechnol, Seongnam, South Korea.	blee@gachon-ac.kr; shyoo@sejong.ac.kr	Yoo, Sang-Ho/AAI-4446-2020	NGUYEN, TIEN/0000-0001-5224-2157; Yoo, Sang-Ho/0000-0002-7258-5090	Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [115035-03-2-HD020]	Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work received support from the High Value-added Food Technology Development Program (Project number: 115035-03-2-HD020), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea to SHY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LM, 2009, INT J FOOD SCI TECH, V44, P815, DOI 10.1111/j.1365-2621.2009.01909.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buemann B, 2000, BRIT J NUTR, V84, P227; CHEETHAM PSJ, 1993, ENZYME MICROB TECH, V15, P105, DOI 10.1016/0141-0229(93)90032-W; Cheon J, 2009, FOOD BIOTECHNOL, V23, P8, DOI 10.1080/08905430802671873; Chouayekh H, 2007, FEMS MICROBIOL LETT, V277, P260, DOI 10.1111/j.1574-6968.2007.00961.x; Dobbs CM, 2010, FOOD RES INT, V43, P382, DOI 10.1016/j.foodres.2009.10.010; Dong GQ, 1997, APPL ENVIRON MICROB, V63, P3569, DOI 10.1128/AEM.63.9.3569-3576.1997; Donner TW, 1999, DIABETES OBES METAB, V1, P285, DOI 10.1046/j.1463-1326.1999.00039.x; Espinosa I, 2010, EXPERT OPIN INV DRUG, V19, P285, DOI 10.1517/13543780903501521; Fan C, 2014, J MOL CATAL B-ENZYM, V102, P120, DOI 10.1016/j.molcatb.2014.02.001; Hung XG, 2014, BIOCHEM ENG J, V83, P121, DOI 10.1016/j.bej.2013.04.026; Kim BC, 2002, FEMS MICROBIOL LETT, V212, P121, DOI 10.1016/S0378-1097(02)00715-2; Kim HJ, 2005, J BIOTECHNOL, V120, P162, DOI 10.1016/j.jbiotec.2005.06.004; Kim JW, 2003, BIOTECHNOL LETT, V25, P963, DOI 10.1023/A:1024069813839; Kim P, 2004, APPL MICROBIOL BIOT, V65, P243, DOI 10.1007/s00122-004-1665-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DW, 2005, ARCH BIOCHEM BIOPHYS, V434, P333, DOI 10.1016/j.abb.2004.11.004; Lee DW, 2004, APPL ENVIRON MICROB, V70, P1397, DOI 10.1128/AEM.70.3.1397-1404.2004; Lee SJ, 2005, APPL ENVIRON MICROB, V71, P7888, DOI 10.1128/AEM.71.12.7888-7896.2005; Levin Gilbert V., 2002, Journal of Medicinal Food, V5, P23, DOI 10.1089/109662002753723197; Li YJ, 2011, EXTREMOPHILES, V15, P441, DOI 10.1007/s00792-011-0375-2; Lu Y, 2008, DIABETES OBES METAB, V10, P109, DOI 10.1111/j.1463-1326.2007.00799.x; Luecke KJ, 2010, J FOOD SCI, V75, pC346, DOI 10.1111/j.1750-3841.2010.01601.x; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Moore MC, 2006, CURR OPIN INVESTIG D, V7, P924; Oh DK, 2007, APPL MICROBIOL BIOT, V76, P1, DOI 10.1007/s00253-007-0981-1; Oh DK, 2001, BIOTECHNOL LETT, V23, P1859, DOI 10.1023/A:1012730522288; Prabhu P, 2008, APPL MICROBIOL BIOT, V81, P283, DOI 10.1007/s00253-008-1652-6; Rhimi M, 2006, BBA-GEN SUBJECTS, V1760, P191, DOI 10.1016/j.bbagen.2005.11.007; Roh HJ, 2000, BIOTECHNOL APPL BIOC, V31, P1, DOI 10.1042/BA19990065; Roh HJ, 2000, BIOTECHNOL LETT, V22, P197, DOI 10.1023/A:1005689030717; Seo DH, 2008, CARBOHYDRATE ACTIVE, P125, DOI [10.1533/9781845695750.1.125, DOI 10.1533/9781845695750.1.125]; Staudigl P, 2014, J AGR FOOD CHEM, V62, P1617, DOI 10.1021/jf404785m; Xu Z, 2014, APPL MICROBIOL BIOT, V98, P8869, DOI 10.1007/s00253-014-6073-0; Yoon SH, 2003, WORLD J MICROB BIOT, V19, P47, DOI 10.1023/A:1022575601492; Zhan YJ, 2014, J AGR FOOD CHEM, V62, P2412, DOI 10.1021/jf4042485	37	15	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196099	10.1371/journal.pone.0196099	http://dx.doi.org/10.1371/journal.pone.0196099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684065	Green Submitted, Green Published, gold			2022-12-26	WOS:000430660600037
J	Manechini, JRV; da Costa, JB; Pereira, BT; Carlini-Garcia, LA; Xavier, MA; Landell, MGD; Pinto, LR				Vieira Manechini, Joao Ricardo; da Costa, Juliana Borges; Pereira, Bruna Turcatto; Carlini-Garcia, Luciana Aparecida; Xavier, Mauro Alexandre; de Andrade Landell, Marcos Guimaraes; Pinto, Luciana Rossini			Unraveling the genetic structure of Brazilian commercial sugarcane cultivars through microsatellite markers	PLOS ONE			English	Article							SACCHARUM-SPONTANEUM L.; POPULATION-STRUCTURE; SSR MARKERS; DIVERSITY; SEQUENCE; AFLP; DNA; SPP.; RAPD; PCR	The Brazilian sugarcane industry plays an important role in the worldwide supply of sugar and ethanol. Investigation into the genetic structure of current commercial cultivars and comparisons to the main ancestor species allow sugarcane breeding programs to better manage crosses and germplasm banks as well as to promote its rational use. In the present study, the genetic structure of a group of Brazilian cultivars currently grown by commercial producers was assessed through microsatellite markers and contrasted with a group of basic germplasm mainly composed of Saccharum officinarum and S. spontaneum accessions. A total of 285 alleles was obtained by a set of 12 SSRs primer pairs that taken together were able to efficiently distinguish and capture the genetic variability of sugarcane commercial cultivars and basic germplasm accessions allowing its application in a fast and cost-effective way for routine cultivar identification and management of sugarcane germplasm banks. Allelic distribution revealed that 97.6% of the cultivar alleles were found in the basic germplasm while 42% of the basic germplasm alleles were absent in cultivars. Of the absent alleles, 3% was exclusive to S. officinarum, 33% to S. spontaneum and 19% to other species/exotic hybrids. We found strong genetic differentiation between the Brazilian commercial cultivars and the two main species (S. officinarum: (Phi)over-cap(ST) = 0.211 and S. spontaneum: (Phi)over-cap(ST) = 0.216, P<0.001), and significant contribution of the latter in the genetic variability of commercial cultivars. Average dissimilarity within cultivars was 1.2 and 1.4 times lower than that within S. officinarum and S. spontaneum. Genetic divergence found between cultivars and S. spontaneum accessions has practical applications for energy cane breeding programs as the choice of more divergent parents will maximize the frequency of transgressive individuals in the progeny.	[Vieira Manechini, Joao Ricardo; Pinto, Luciana Rossini] Univ Estadual Paulista Julio de Mesquite Filho, FCAV, Dept Genet & Melhoramento Plantas, Jaboticabal, SP, Brazil; [Vieira Manechini, Joao Ricardo; da Costa, Juliana Borges; Pereira, Bruna Turcatto; Xavier, Mauro Alexandre; de Andrade Landell, Marcos Guimaraes; Pinto, Luciana Rossini] IAC, Ctr Cana, Ribeirao Preto, SP, Brazil; [Carlini-Garcia, Luciana Aparecida] APTA, Polo Reg Ctr Sul, Piracicaba, SP, Brazil	Universidade Estadual Paulista; Instituto Agronomico de Campinas (IAC)	Pinto, LR (corresponding author), Univ Estadual Paulista Julio de Mesquite Filho, FCAV, Dept Genet & Melhoramento Plantas, Jaboticabal, SP, Brazil.; Pinto, LR (corresponding author), IAC, Ctr Cana, Ribeirao Preto, SP, Brazil.	lurossini@iac.sp.gov.br	da Silva, Luciana Rossini Pinto Machado/AAT-6921-2021	da Silva, Luciana Rossini Pinto Machado/0000-0002-7369-7609; Manechini, Joao Ricardo Vieira/0000-0002-6450-2355	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/22500-5, 2008/57908-6]; INCT/Bioetanol CNPq [574002/2008-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/22500-5, 2008/57908-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCT/Bioetanol CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by the following institutions and/or grant programs: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/) grants: 2013/22500-5 and 2008/57908-6; INCT/Bioetanol CNPq (http://inct.cnpq.br/web/inct-bioetanol) no574002/2008-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants: 2013/22500-5; 2008/57908-6) and INCT/Bioetanol CNPq no574002/2008-1. J.R.V Manechini received Master fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Aitken K, 2005, THEOR APPL GENET, V110, P789, DOI 10.1007/s00122-004-1813-7; Aitken K., 2010, Genetics, genomics and breeding of sugarcane, P19; Aitken KS, 2006, AUST J AGR RES, V57, P1167, DOI 10.1071/AR05391; Aljanabi SM, 1999, PLANT MOL BIOL REP, V17, P281, DOI 10.1023/A:1007692929505; Alwala S., 2010, Genetics, genomics and breeding of sugarcane, P69; ARCENEAUX G., 1967, Proc. 12th Congr. int. Soc. Sugar Cane Technol., Puerto Rico, 1965., P844; Berding N., 2004, SUGARCANE, P20; Berding N, 1998, SUGARCANE IMPROVEMEN, P143; Vieira MLC, 2016, GENET MOL BIOL, V39, P312, DOI 10.1590/1678-4685-GMB-2016-0027; CONAB, 2017, AC SAFR BRAS CAN DE; Cordeiro GM, 2003, PLANT SCI, V165, P181, DOI 10.1016/S0168-9452(03)00157-2; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; Costa M. L. M. da, 2011, American Journal of Plant Sciences, V2, P425, DOI 10.4236/ajps.2011.23048; CTC, 2017, VAR CTC; D'Hont A, 1998, GENOME, V41, P221, DOI 10.1139/gen-41-2-221; da Silva JAG, 2001, GENET MOL BIOL, V24, P155, DOI 10.1590/S1415-47572001000100021; Dal-Bianco M, 2012, CURR OPIN BIOTECH, V23, P265, DOI 10.1016/j.copbio.2011.09.002; Daniels J, 1998, SUGARCANE IMPROVEMEN, P7; dos Santos JM, 2012, IND CROP PROD, V40, P145, DOI 10.1016/j.indcrop.2012.03.005; Earl D, 2010, CONSERV GENET RESOUR, V4, P359; Edme SJ, 2006, HEREDITY, V97, P366, DOI 10.1038/sj.hdy.6800888; Efron B., 1994, INTRO BOOTSTRAP; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Everitt B., 1982, INTRO NUMERICAL TAXO; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faulks LK, 2017, AQUAT CONSERV, V27, P39, DOI 10.1002/aqc.2684; Frankham R, 2002, FOREST ECOL MANAG, DOI [10.1016/j.foreco.2003.12.001, DOI 10.1016/J.FORECO.2003.12.001]; Garcia AAF, 2004, GENET MOL BIOL, V27, P579, DOI 10.1590/S1415-47572004000400019; GRIVET L, 2004, ETHNOBOTANY RES APPL, V2, P9, DOI DOI 10.17348/era.2.0.9-17; HALLDEN C, 1994, THEOR APPL GENET, V88, P123, DOI 10.1007/BF00222404; Harvey M, 1996, EUPHYTICA, V89, P257, DOI 10.1007/BF00034614; Hemaprabha G, 2005, SUGAR TECH, V7, P9, DOI DOI 10.1007/BF02942521; Pocovi MI, 2015, CHIL J AGR RES, V75, P152, DOI 10.4067/S0718-58392015000200003; Jannoo N, 1999, THEOR APPL GENET, V99, P171, DOI 10.1007/s001220051222; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; JESWIET J., 1928, REC TRAV BOT NEERL, V25a, P185; Jordan DR, 1998, EUPHYTICA, V102, P1, DOI 10.1023/A:1018311908636; Kemp S J, 2002, PIC CALCULATOR; Kopelman N, 2012, CLUMPAK PROGRAM IDEN; Lima MLA, 2002, THEOR APPL GENET, V104, P30, DOI 10.1007/s001220200003; Liu XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151524; Maccheroni W., 2009, Sugar Cane International, V27, P47; Manly B.F.J., 1994, MULTIVARIATE STAT ME; Marconi Thiago G, 2011, BMC Res Notes, V4, P264, DOI 10.1186/1756-0500-4-264; Matsuoka S, 2014, ADV BOT, V2014, P1, DOI [10.1155/2014/597275, DOI 10.1155/2014/597275]; Ming R, 2006, PL BRED RE, V27, P15; Mutsaers H, 2007, PEASANTS FARMERS SCI, DOI [10.1007/978-1-4020-6166-0, DOI 10.1007/978-1-4020-6166-0]; Nayak SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110856; Oliveira KM, 2007, MOL BREEDING, V20, P189, DOI 10.1007/s11032-007-9082-1; Oliveira KM, 2009, CHARACTERIZATION NEW, V209, P191, DOI [10.1139/G08105, DOI 10.1139/G08105]; Palhares AC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-51; Pan Y. B., 2010, American Journal of Plant Sciences, V1, P87, DOI 10.4236/ajps.2010.12011; Pan Y. B., 2007, Sugar Tech, V9, P176; Pan Y. B., 2006, Sugar Tech, V8, P246, DOI 10.1007/BF02943564; Pan YB, 2004, GENET RESOUR CROP EV, V51, P895, DOI 10.1007/s10722-005-1933-1; Pan YB, 2003, MAYDICA, V48, P319; Pan YB, 2000, GENETICA, V108, P285, DOI 10.1023/A:1004191625603; Parida SK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-251; Pinto LR, 2006, PLANT BREEDING, V125, P378, DOI 10.1111/j.1439-0523.2006.01227.x; Pinto LR, 2004, GENOME, V47, P795, DOI [10.1139/g04-055, 10.1139/G04-055]; Powell W, 1996, COMP RFLP RAPD AFLP, P225; Prevost A, 1999, THEOR APPL GENET, V98, P107, DOI 10.1007/s001220051046; Pritchard JK, 2000, GENETICS, V155, P945; Ramdoyal K., 2002, P307, DOI 10.1079/9780851995229.0307; Roach BT, 1969, CYTOLOGICAL STUDIES; RStudio Team, 2018, RSTUDIOINTEGRATED DE; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Scordia D, 2010, BIORESOURCE TECHNOL, V101, P5358, DOI 10.1016/j.biortech.2010.02.036; Silva D. C., 2012, African Journal of Biotechnology, V11, P4722; Silva JA, 2017, SUGAR TECH, V19, P229, DOI [10.1007/s12355-017-0510-1, DOI 10.1007/S12355-017-0510-1]; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Stevenson GC, 1965, GENETICS BREEDING SU, DOI [10.1017/S0014479700021682, DOI 10.1017/S0014479700021682]; Tena E, 2016, ADV AGR, DOI [10.1155/2016/8909506, DOI 10.1155/2016/8909506]; TIVANG JG, 1994, THEOR APPL GENET, V89, P259, DOI 10.1007/BF00225151; UNICA, 2016, HIST PROD MOAG; Urashima AS, 2017, J PHYTOPATHOL, V165, P414, DOI 10.1111/jph.12575; Varshney RK, 2007, PLANT SCI, V173, P638, DOI 10.1016/j.plantsci.2007.08.010; Wright S., 1978, EVOLUTION GENETICS P; You Q, 2016, SUGAR TECH, V18, P380, DOI 10.1007/s12355-015-0395-9; You Q, 2013, SCI WORLD J, DOI 10.1155/2013/613062	82	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195623	10.1371/journal.pone.0195623	http://dx.doi.org/10.1371/journal.pone.0195623			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684082	Green Published, Green Submitted, gold			2022-12-26	WOS:000430660600020
J	Madhav, A; Andres, A; Duong, F; Mishra, R; Haldar, S; Liu, ZQ; Angara, B; Gottlieb, R; Zumsteg, ZS; Bhowmick, NA				Madhav, Anisha; Andres, Allen; Duong, Frank; Mishra, Rajeev; Haldar, Subhash; Liu, Zhenqiu; Angara, Bryan; Gottlieb, Roberta; Zumsteg, Zachary S.; Bhowmick, Neil A.			Antagonizing CD105 enhances radiation sensitivity in prostate cancer	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; CELLS IN-VITRO; ENDOGLIN CD105; TGF-BETA; PANCREATIC-CANCER; ENERGY-METABOLISM; GASTRIC-CANCER; PHASE-I; THERAPY; RADIOSENSITIVITY	Radiation therapy is the primary intervention for nearly half of the patients with localized advanced prostate cancer and standard of care for recurrent disease following surgery. The development of radiation-resistant disease is an obstacle for nearly 30-50% of patients undergoing radiotherapy. A better understanding of mechanisms that lead to radiation resistance could aid in the development of sensitizing agents to improve outcome. Here we identified a radiation-resistance pathway mediated by CD105, downstream of BMP and TGF-beta signaling. Antagonizing CD 105-dependent BMP signaling with a partially humanized monoclonal antibody, TRC105, resulted in a significant reduction in clonogenicity when combined with irradiation. In trying to better understand the mechanism for the radio-sensitization, we found that radiation-induced CD 105/ BMP signaling was sufficient and necessary for the upregulation of sirtuin 1 (SIRT1) in contributing to p53 stabilization and PGC-1 alpha activation. Combining TRC105 with irradiation delayed DNA damage repair compared to irradiation alone. However, in the absence of p53 function, combining TRC105 and radiation resulted in no reduction in clonogenicity compared to radiation alone, despite similar reduction of DNA damage repair observed in p53-intact cells. This suggested DNA damage repair was not the sole determinant of CD 105 radio-resistance. As cancer cells undergo an energy deficit following irradiation, due to the demands of DNA and organelle repair, we examined SIRT1's role on p53 and PGC-1 alpha with respect to glycolysis and mitochondrial biogenesis, respectively. Consequently, blocking the CD105-SIRT1 axis was found to deplete the ATP stores of irradiated cells and cause G2 cell cycle arrest. Xenograft models supported these findings that combining TRC105 with irradiation significantly reduces tumor size over irradiation alone (p value = 10(-9)). We identified a novel synthetic lethality strategy of combining radiation and CD 105 targeting to address the DNA repair and metabolic addiction induced by irradiation in p53-functional prostate cancers.	[Madhav, Anisha; Andres, Allen; Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Duong, Frank; Mishra, Rajeev; Haldar, Subhash; Liu, Zhenqiu; Angara, Bryan; Gottlieb, Roberta; Bhowmick, Neil A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Zumsteg, Zachary S.] Cedars Sinai Med Ctr, Dept Radiat Oncol, Los Angeles, CA 90048 USA; [Bhowmick, Neil A.] Greater Los Angeles Vet Adm, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Bhowmick, NA (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA.; Bhowmick, NA (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.; Bhowmick, NA (corresponding author), Greater Los Angeles Vet Adm, Los Angeles, CA 90048 USA.	bhowmickn@cshs.org	Mishra, Rajeev/AEX-2208-2022; Bhowmick, Neil/AAA-7302-2019	Mishra, Rajeev/0000-0002-7411-4022; Bhowmick, Neil/0000-0001-8747-5989; Haldar, Subhash/0000-0002-1230-1770; Gottlieb, Roberta/0000-0002-1432-006X	Department of Defense [PC161016]; Department of Veterans Affairs [I01BX0011040]; National Cancer Institute (NIH) [CA108646, CA098912]; NATIONAL CANCER INSTITUTE [P01CA098912, R01CA108646] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001040] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Department of Veterans Affairs(US Department of Veterans Affairs); National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the Department of Defense (PC161016 to AM), Department of Veterans Affairs (I01BX0011040 to NAB), and the National Cancer Institute (NIH, CA108646 and CA098912 to NAB). The metabolic analysis was possible because of help from the Cedars-Sinai Medical Center Metabolism and Mitochondrial Research Core. We also thank Tracon Pharmaceuticals for providing the CD105 antagonist, TRC105.	Andres AM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89303; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Bouquet F, 2011, CLIN CANCER RES, V17, P6754, DOI 10.1158/1078-0432.CCR-11-0544; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chen L, 2016, CELL CYCLE, V15, P840, DOI 10.1080/15384101.2016.1151582; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Ewan KB, 2002, CANCER RES, V62, P5627; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Hardee ME, 2012, CANCER RES, V72, P4119, DOI 10.1158/0008-5472.CAN-12-0546; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; Jonker L, 2014, MICROCIRCULATION, V21, P93, DOI 10.1111/micc.12099; Jung-Hynes B, 2009, J BIOL CHEM, V284, P3823, DOI 10.1074/jbc.M807869200; Karzai FH, 2015, BJU INT, V116, P546, DOI 10.1111/bju.12986; Koyama Y, 2010, EXP THER MED, V1, P627, DOI 10.3892/etm_00000098; Kumar S, 2014, ONCOGENE, V33, P3970, DOI 10.1038/onc.2013.386; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Miao ZF, 2016, HUM PATHOL, V51, P114, DOI 10.1016/j.humpath.2015.12.023; Moeller BJ, 2004, CELL CYCLE, V3, P1107; Moon DH, 2017, UROL ONCOL-SEMIN ORI, V35, P59, DOI 10.1016/j.urolonc.2016.06.002; Morris WJ, 2017, INT J RADIAT ONCOL, V98, P275, DOI 10.1016/j.ijrobp.2016.11.026; Munoz-Fontela C, 2011, CELL CYCLE, V10, P3701, DOI 10.4161/cc.10.21.17899; Pal K, 2014, MOL CANCER THER, V13, P2264, DOI 10.1158/1535-7163.MCT-14-0291; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Romero D, 2010, CARCINOGENESIS, V31, P359, DOI 10.1093/carcin/bgp217; Rosen LS, 2012, CLIN CANCER RES, V18, P4820, DOI 10.1158/1078-0432.CCR-12-0098; Rukstalis Daniel B, 2002, Rev Urol, V4 Suppl 2, pS12; Sanchez-Elsner T, 2002, J BIOL CHEM, V277, P43799, DOI 10.1074/jbc.M207160200; Shipley WU, 2017, NEW ENGL J MED, V376, P417, DOI 10.1056/NEJMoa1607529; Smith SJ, 2012, ACTA NEUROPATHOL, V124, P99, DOI 10.1007/s00401-012-0952-1; Vo MN, 2010, BREAST CANCER RES TR, V119, P767, DOI 10.1007/s10549-008-0261-5; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Winter Jordan M, 2006, HPB (Oxford), V8, P324, DOI 10.1080/13651820600804203; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Yamoah K, 2015, INT J RADIAT ONCOL, V93, P737, DOI 10.1016/j.ijrobp.2015.07.2284; YOUNG VR, 1977, CANCER RES, V37, P2336; Zhang J, 2015, CANCER LETT, V363, P108, DOI 10.1016/j.canlet.2015.04.015; Zhong J, 2013, RADIOTHER ONCOL, V106, P390, DOI 10.1016/j.radonc.2013.02.013; Ziebarth AJ, 2013, CLIN CANCER RES, V19, P170, DOI 10.1158/1078-0432.CCR-12-1045; Zumsteg ZS, 2016, CLIN CANCER RES, V22, P2009, DOI 10.1158/1078-0432.CCR-15-2245; Zumsteg ZS, 2015, J UROLOGY, V194, P1624, DOI 10.1016/j.juro.2015.06.100	46	15	15	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 9	2018	37	32					4385	4397		10.1038/s41388-018-0278-0	http://dx.doi.org/10.1038/s41388-018-0278-0			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GP8FA	29717261	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000441144300004
J	Ge, JF; Burnier, L; Adamopoulou, M; Kwa, MQ; Schaks, M; Rottner, K; Brakebusch, C				Ge, Jianfeng; Burnier, Laurent; Adamopoulou, Maria; Kwa, Mei Qi; Schaks, Matthias; Rottner, Klemens; Brakebusch, Cord			RhoA, Rac1, and Cdc42 differentially regulate SMA and collagen I expression in mesenchymal stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arp2; 3 complex; cell differentiation; cell signaling; cytoskeleton; GTPase; molecular cell biology; p38; Rac (Rac GTPase); SMAD transcription factor; stem cells; mesenchymal stem cell; MRTFa; myofibroblast; Rho GTPase; TGF; SMA	C-JUN; MYOFIBROBLAST; FIBROSIS; GTPASES; INDUCTION; BINDING	Mesenchymal stem cells (MSC) are suggested to be important progenitors of myofibroblasts in fibrosis. To understand the role of Rho GTPase signaling in TGF-induced myofibroblast differentiation of MSC, we generated a novel MSC line and its descendants lacking functional Rho GTPases and Rho GTPase signaling components. Unexpectedly, our data revealed that Rho GTPase signaling is required for TGF-induced expression of -smooth muscle actin (SMA) but not of collagen I 1 (col1a1). Whereas loss of RhoA and Cdc42 reduced SMA expression, ablation of the Rac1 gene had the opposite effect. Although actin polymerization and MRTFa were crucial for TGF-induced SMA expression, neither Arp2/3-dependent actin polymerization nor cofilin-dependent severing and depolymerization of F-actin were required. Instead, F-actin levels were dependent on cell contraction, and TGF-induced actin polymerization correlated with increased cell contraction mediated by RhoA and Cdc42. Finally, we observed impaired collagen I secretion in MSC lacking RhoA or Cdc42. These data give novel molecular insights into the role of Rho GTPases in TGF signaling and have implications for our understanding of MSC function in fibrosis.	[Ge, Jianfeng; Burnier, Laurent; Adamopoulou, Maria; Kwa, Mei Qi; Brakebusch, Cord] Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark; [Schaks, Matthias; Rottner, Klemens] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Spielmannstr 8, D-38106 Braunschweig, Germany; [Schaks, Matthias; Rottner, Klemens] Helmholtz Ctr Infect Res, Dept Cell Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany	University of Copenhagen; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Brakebusch, C (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	cord.brakebusch@bric.ku.dk	Burnier, Laurent P/E-5807-2011; Rottner, Klemens/AAE-5030-2020	Burnier, Laurent P/0000-0001-7767-0334; Kwa, Mei Qi/0000-0001-8890-3391; Brakebusch, Cord/0000-0002-9342-1634; Rottner, Klemens/0000-0003-4244-4198	Novo Nordisk Foundation; Deutsche Forschungsgemeinschaft [GRK2223/1]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Novo Nordisk Foundation (to L. B.) and Grant GRK2223/1 from the Deutsche Forschungsgemeinschaft (to K. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Desai VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086865; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Hayakawa K, 2011, J CELL BIOL, V195, P721, DOI 10.1083/jcb.201102039; Hinz B, 2016, EXP EYE RES, V142, P56, DOI 10.1016/j.exer.2015.07.009; Kanellos G, 2016, J CELL SCI, V129, P3211, DOI 10.1242/jcs.187849; Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111; Knipe RS, 2015, PHARMACOL REV, V67, P103, DOI 10.1124/pr.114.009381; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Lengfeld J, 2012, MOL BIOL CELL, V23, P1955, DOI 10.1091/mbc.E11-06-0531; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Luchsinger LL, 2011, J BIOL CHEM, V286, P44116, DOI 10.1074/jbc.M111.276931; Ma FY, 2007, J AM SOC NEPHROL, V18, P472, DOI 10.1681/ASN.2006060604; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Nanthakumar CB, 2015, NAT REV DRUG DISCOV, V14, P693, DOI 10.1038/nrd4592; Ni JX, 2013, FREE RADICAL BIO MED, V61, P26, DOI 10.1016/j.freeradbiomed.2013.03.012; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rosenbloom J, 2017, METHODS MOL BIOL, V1627, P1, DOI 10.1007/978-1-4939-7113-8_1; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Tsochatzis EA, 2014, HEPATOLOGY, V60, P832, DOI 10.1002/hep.27296; Tsuchida K, 2003, KIDNEY INT, V63, P2000, DOI 10.1046/j.1523-1755.2003.00009.x; Unbekandt M, 2014, J MOL MED, V92, P217, DOI 10.1007/s00109-014-1133-6; Verrecchia F, 2001, ONCOGENE, V20, P2205, DOI 10.1038/sj.onc.1204347; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Xu SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126015; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	36	14	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9358	9369		10.1074/jbc.RA117.001113	http://dx.doi.org/10.1074/jbc.RA117.001113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29700112	Green Published, hybrid			2022-12-26	WOS:000435441400021
J	Nagarajan, D; Sukumaran, S; Deka, G; Krishnamurthy, K; Atreya, HS; Chandra, N				Nagarajan, Deepesh; Sukumaran, Sujeesh; Deka, Geeta; Krishnamurthy, Kiran; Atreya, Hanudatta S.; Chandra, Nagasuma			Design of a heme-binding peptide motif adopting a beta-hairpin conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein design; computational biology; heme; protein folding; protein motif; structural biology	DE-NOVO DESIGN; 4-HELIX BUNDLE; COMBINATORIAL LIBRARIES; COMPUTATIONAL DESIGN; ENZYMATIC-ACTIVITY; PROTEIN DESIGN; HIGH-AFFINITY; HEMEPROTEIN; HELICHROME; STABILITY	Heme-binding proteins constitute a large family of catalytic and transport proteins. Their widespread presence as globins and as essential oxygen and electron transporters, along with their diverse enzymatic functions, have made them targets for protein design. Most previously reported designs involved the use of -helical scaffolds, and natural peptides also exhibit a strong preference for these scaffolds. However, the reason for this preference is not well-understood, in part because alternative protein designs, such as those with -sheets or hairpins, are challenging to perform. Here, we report the computational design and experimental validation of a water-soluble heme-binding peptide, Pincer-1, composed of predominantly -scaffold secondary structures. Such heme-binding proteins are rarely observed in nature, and by designing such a scaffold, we simultaneously increase the known fold space of heme-binding proteins and expand the limits of computational design methods. For a -scaffold, two tryptophan zipper -hairpins sandwiching a heme molecule were linked through an N-terminal cysteine disulfide bond. -Hairpin orientations and residue selection were performed computationally. Heme binding was confirmed through absorbance experiments and surface plasmon resonance experiments (K-D = 730 +/- 160 nm). CD and NMR experiments validated the -hairpin topology of the designed peptide. Our results indicate that a helical scaffold is not essential for heme binding and reveal the first designed water-soluble, heme-binding -hairpin peptide. This peptide could help expand the search for and design space to cytoplasmic heme-binding proteins.	[Nagarajan, Deepesh; Chandra, Nagasuma] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Sukumaran, Sujeesh; Krishnamurthy, Kiran; Atreya, Hanudatta S.] Indian Inst Sci, NMR Res Ctr, Bangalore 560012, Karnataka, India; [Sukumaran, Sujeesh] Indian Inst Sci, Solid State & Struct Chem Unit, Bangalore 560012, Karnataka, India; [Deka, Geeta] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Chandra, N (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	nchandra@iisc.ac.in		Nagarajan, Deepesh/0000-0001-8468-9834; Chandra, Nagasuma/0000-0002-9939-8439	Department of Biotechnology (India)	Department of Biotechnology (India)(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology (India). The authors declare that they have no conflicts of interest with the contents of this article.	Anand Praveen, 2014, F1000Res, V3, P214, DOI 10.12688/f1000research.5165.1; Anderson JLR, 2014, CHEM SCI, V5, P507, DOI [10.1039/c3sc52019f, 10.1039/C3SC52019F]; Cherry JR, 1999, NAT BIOTECHNOL, V17, P379, DOI 10.1038/7939; CHOMA CT, 1994, J AM CHEM SOC, V116, P856, DOI 10.1021/ja00082a005; Cochran AG, 2001, P NATL ACAD SCI USA, V98, P5578, DOI 10.1073/pnas.091100898; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Copeland WB, 2012, METAB ENG, V14, P270, DOI 10.1016/j.ymben.2012.03.001; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; D'Souza A, 2016, CHEM SCI, V7, P2563, DOI 10.1039/c5sc04108b; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Discher BM, 2005, BIOCHEMISTRY-US, V44, P12329, DOI 10.1021/bi050695m; Dunbar JB, 2013, J CHEM INF MODEL, V53, P1842, DOI [10.1021/ci400161J, 10.1021/ci4000486]; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Eriksen DT, 2014, J STRUCT BIOL, V185, P234, DOI 10.1016/j.jsb.2013.03.011; Faiella M, 2012, CHEM-EUR J, V18, P15960, DOI 10.1002/chem.201201404; Farid TA, 2013, NAT CHEM BIOL, V9, P826, DOI [10.1038/NCHEMBIO.1362, 10.1038/nchembio.1362]; GRAY JC, 1992, PHOTOSYNTH RES, V34, P359, DOI 10.1007/BF00029811; Hanson EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012830; Huang PS, 2016, NAT CHEM BIOL, V12, P29, DOI [10.1038/NCHEMBIO.1966, 10.1038/nchembio.1966]; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Huang SS, 2004, P NATL ACAD SCI USA, V101, P5536, DOI 10.1073/pnas.0306676101; Isogai Y, 1999, BIOCHEMISTRY-US, V38, P7431, DOI 10.1021/bi983006y; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; Korendovych IV, 2010, J AM CHEM SOC, V132, P15516, DOI 10.1021/ja107487b; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/NCHEMBIO.970, 10.1038/nchembio.970]; Lin YW, 2013, CHEM-ASIAN J, V8, P2534, DOI 10.1002/asia.201300291; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Mahajan M, 2014, CHEMBIOCHEM, V15, P1257, DOI 10.1002/cbic.201402142; Malisi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052505; Moffet DA, 2003, BIOPHYS CHEM, V105, P231, DOI 10.1016/S0301-4622(03)00072-3; Moretti R, 2016, METHODS MOL BIOL, V1414, P47, DOI 10.1007/978-1-4939-3569-7_4; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nagarajan D, 2018, J BIOL CHEM, V293, P3492, DOI [10.1074/jbc.M117.805499, 10.1074/jbc.m117.805499]; Nagarajan D, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0047-4; Nanda V, 2010, NAT CHEM, V2, P15, DOI [10.1038/NCHEM.473, 10.1038/nchem.473]; Ouberai M, 2011, CHEM SCI, V2, P1293, DOI 10.1039/c1sc00016k; Paoli M, 1999, NAT STRUCT BIOL, V6, P926; Patel SC, 2009, PROTEIN SCI, V18, P1388, DOI 10.1002/pro.147; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; Rojas NRL, 1997, PROTEIN SCI, V6, P2512; Rosenblatt MM, 2003, P NATL ACAD SCI USA, V100, P13140, DOI 10.1073/pnas.2231273100; Rufo CM, 2014, NAT CHEM, V6, P303, DOI [10.1038/NCHEM.1894, 10.1038/nchem.1894]; SASAKI T, 1990, BIOPOLYMERS, V29, P79, DOI 10.1002/bip.360290112; SASAKI T, 1989, J AM CHEM SOC, V111, P380, DOI 10.1021/ja00183a065; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Venkatraman J, 2001, CHEM REV, V101, P3131, DOI 10.1021/cr000053z; Voet D., 2006, FUNDAMENTALS BIOCH L, P838; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	59	5	5	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9412	9422		10.1074/jbc.RA118.001768	http://dx.doi.org/10.1074/jbc.RA118.001768			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29695501	Green Published, hybrid			2022-12-26	WOS:000435441400025
J	Cutts, BB; Greenlee, AJ; Prochaska, NK; Chantrill, CV; Contractor, AB; Wilhoit, JM; Abts, N; Hornik, K				Cutts, Bethany B.; Greenlee, Andrew J.; Prochaska, Natalie K.; Chantrill, Carolina V.; Contractor, Annie B.; Wilhoit, Juliana M.; Abts, Nancy; Hornik, Kaitlyn			Is a clean river fun for all? Recognizing social vulnerability in watershed planning	PLOS ONE			English	Article							ENVIRONMENTAL GENTRIFICATION; PARTICIPATION; MANAGEMENT; COMMUNITY; POVERTY; RISK; COLLABORATION; NEOLIBERALISM; DISASTERS; CAPACITY	Watershed planning can lead to policy innovation and action toward environmental protection. However, groups often suffer from low engagement with communities that experience disparate impacts from flooding and water pollution. This can limit the capacity of watershed efforts to dismantle pernicious forms of social inequality. As a result, the benefits of environmental changes often flow to more empowered residents, short-changing the power of watershed-based planning as a tool to transform ecological, economic, and social relationships. The objectives of this paper are to assess whether the worldview of watershed planning actors are sufficiently attuned to local patterns of social vulnerability and whether locally significant patterns of social vulnerability can be adequately differentiated using conventional data sources. Drawing from 35 in-depth interviews with watershed planners and community stakeholders in the Milwaukee River Basin (WI, USA), we identify five unique definitions of social vulnerability. Watershed planners in our sample articulate a narrower range of social vulnerability definitions than other participants. All five definitions emphasize spatial and demographic characteristics consistent with existing ways of measuring social vulnerability. However, existing measures do not adequately differentiate among the spatio-temporal dynamics used to distinguish definitions. In response, we develop two new social vulnerability measures. The combination of interviews and demographic analyses in this study provides an assessment technique that can help watershed planners (a) understand the limits of their own conceptualization of social vulnerability and (b) acknowledge the importance of place-based vulnerabilities that may otherwise be obscured. We conclude by discussing how our methods can be a useful tool for identifying opportunities to disrupt social vulnerability in a watershed by evaluating how issue frames, outreach messages, and engagement tactics. The approach allows watershed planners to shift their own culture in order to consider socially vulnerable populations comprehensively.	[Cutts, Bethany B.; Hornik, Kaitlyn] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Greenlee, Andrew J.; Prochaska, Natalie K.; Chantrill, Carolina V.; Contractor, Annie B.; Wilhoit, Juliana M.; Abts, Nancy] Univ Illinois, Dept Urban & Reg Planning, Urbana, IL USA; [Cutts, Bethany B.] North Carolina State Univ, Dept Pk Recreat & Tourism Management, Raleigh, NC 27695 USA; [Cutts, Bethany B.] North Carolina State Univ, Ctr Geospatial Analyt, Raleigh, NC 27695 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Cutts, BB (corresponding author), Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA.; Cutts, BB (corresponding author), North Carolina State Univ, Dept Pk Recreat & Tourism Management, Raleigh, NC 27695 USA.; Cutts, BB (corresponding author), North Carolina State Univ, Ctr Geospatial Analyt, Raleigh, NC 27695 USA.	bbcutts@ncsu.edu	Cutts, Bethany/L-2757-2019	Cutts, Bethany/0000-0001-7879-526X; Greenlee, Andrew/0000-0002-2790-673X; Prochaska, Natalie/0000-0001-9156-5469	Illinois-Indiana Sea Grant [NM 40AR4170095]; University of Illinois Urbana-Champaign Graduate College Focal Point Initiative "Focal Point: Urban Environmental Equity"	Illinois-Indiana Sea Grant; University of Illinois Urbana-Champaign Graduate College Focal Point Initiative "Focal Point: Urban Environmental Equity"	BC, AG were awarded funding from Illinois-Indiana Sea Grant, grant no. NM 40AR4170095 and the University of Illinois Urbana-Champaign Graduate College Focal Point Initiative "Focal Point: Urban Environmental Equity". Funding supported partial salary for KH and NS and travel for BC, AJ, NP, AC, CC, JW, NS, and KH. The funder (Illinois-Indiana Sea Grant) aided in initial contacts with watershed planning groups in the study area. Key personnel! helped to validate interpretations of interview responses along with the research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2003, ENCY RES METHODS SOC, P978; Abson DJ, 2012, APPL GEOGR, V35, P515, DOI 10.1016/j.apgeog.2012.08.004; Agyeman J, 2016, ANNU REV ENV RESOUR, V41, P321, DOI 10.1146/annurev-environ-110615-090052; Albrecht DE, 2000, RURAL SOCIOL, V65, P87, DOI 10.1111/j.1549-0831.2000.tb00344.x; [Anonymous], 2005, SWIMMING UPSTREAM CO, DOI DOI 10.7551/MITPRESS/6577.001.0001; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Bell MP, 2007, ACAD MANAGE PERSPECT, V21, P21, DOI 10.5465/AMP.2007.27895336; Birkmann J, 2006, MEASURING UNMEASURAB, DOI [10.1111/jfr3.12018, DOI 10.1111/JFR3.12018]; Bolin B., 2018, HDB DISASTER RES, P181, DOI [10.1007/978-3-319-63254-4_10, DOI 10.1007/978-3-319-63254-4_10]; Bonnell JE, 2007, SOC NATUR RESOUR, V20, P153, DOI 10.1080/08941920601052412; Boone C. G, 2012, URBANIZATION SUSTAIN, V3; Burton C., 2008, Natural Hazards Review, V9, P136, DOI 10.1061/(ASCE)1527-6988(2008)9:3(136); Carr G, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011662; Center for Disease Control, 2014, SOC VULN IND MAPP DA; Chakraborty J., 2005, NAT HAZARDS REV, V6, P23, DOI [10.1061/(ASCE)1527-6988(2005)6:1(23), DOI 10.1061/(ASCE)1527-6988(2005)6:1(23)]; Cohen A, 2012, ENVIRON PLANN A, V44, P2207, DOI 10.1068/a44265; Cutter SL, 2013, J FLOOD RISK MANAG, V6, P332, DOI 10.1111/jfr3.12018; Cutter S.L., 2013, MEASURING VULNERABIL, P304; Cutter SL, 2006, ENVIRONMENT, V48, P8, DOI 10.3200/ENVT.48.2.8-20; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; Cutter SL, 2010, J HOMEL SECUR EMERG, V7; Cutts BB, 2013, WATER POLICY, V15, P61, DOI 10.2166/wp.2012.059; Donner W, 2008, SOC FORCES, V87, P1089; Duram LA, 1999, SOC NATUR RESOUR, V12, P455, DOI 10.1080/089419299279533; Edelenbos J, 2015, CURR OPIN ENV SUST, V12, P25, DOI 10.1016/j.cosust.2014.08.009; EPA, 2013, WAT CENTR WIK MILW W; Finch C, 2010, POPUL ENVIRON, V31, P179, DOI 10.1007/s11111-009-0099-8; Foster KA, 2011, SOC WORK RES, V35, P25, DOI 10.1093/swr/35.1.25; GALSTER GC, 1995, HOUS POLICY DEBATE, V6, P7, DOI 10.1080/10511482.1995.9521180; Genskow KD, 2009, ENVIRON MANAGE, V43, P411, DOI 10.1007/s00267-008-9236-x; Geolytics, 2012, NEIGHB CHANG DAT; Gurda John, 1999, MAKING MILWAUKEE; Hall B.M., 2016, GEOGRAPHICAL B, V57, P77; Hornik K, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13100979; Imperial M, 2005, ADMIN SOC, V37, P281, DOI 10.1177/0095399705276111; Jargowsky PA, 1997, POVERTY PLACE GHETTO, DOI [10.7758/9781610443081, DOI 10.7758/9781610443081]; Jargowsky Paul, 1991, URBAN UNDER, V235, P251; Jones PD, 2012, OAH MAG HIST, V26, P17, DOI [10.1093/oahmag/oar050, DOI 10.1093/OAHMAG/OAR050]; Kanter RM, 2013, MILWAUKEE A MAKING W; Kauneckis D., 2007, INT J ORG THEORY BEH, V10, P503, DOI DOI 10.1108/IJOTB-10-04-2007-B004; Klanicnik F, 2010, CIVIL ENG, P64; Koehler B, 2008, ENVIRON MANAGE, V41, P143, DOI 10.1007/s00267-007-9040-z; Koontz TM, 2004, POLICY SCI, V37, P185, DOI 10.1023/B:OLIC.0000048532.94150.07; Koontz TM, 2013, ENVIRON MANAGE, V51, P571, DOI 10.1007/s00267-012-0008-2; Leach WD, 2001, J WATER RES PL-ASCE, V127, P378, DOI 10.1061/(ASCE)0733-9496(2001)127:6(378); Mendenhall R., 2013, J AFR AM STUD, V17, P74, DOI [10.1007/s12111-012-9220-7, DOI 10.1007/S12111-012-9220-7]; Miller T, 2015, CURR OPIN ENV SUST, V17, P30, DOI 10.1016/j.cosust.2015.08.008; Moore EA, 2003, SOC NATUR RESOUR, V16, P451, DOI 10.1080/08941920309182; Oulahen G, 2015, ANN ASSOC AM GEOGR, V105, P473, DOI 10.1080/00045608.2015.1012634; Palamar C, 2010, NAT CULT, V5, P277, DOI 10.3167/nc.2010.050304; Paveglio TB, 2016, ENVIRON MANAGE, V58, P534, DOI 10.1007/s00267-016-0719-x; Pearsall H, 2012, LOCAL ENVIRON, V17, P1013, DOI 10.1080/13549839.2012.714762; Pearsall H, 2010, LOCAL ENVIRON, V15, P569, DOI 10.1080/13549839.2010.487528; Pearsall H, 2010, ENVIRON PLANN C, V28, P872, DOI 10.1068/c08126; Preston BL, 2013, GLOBAL ENVIRON CHANG, V23, P719, DOI 10.1016/j.gloenvcha.2013.02.009; Preston BL, 2011, SUSTAIN SCI, V6, P177, DOI 10.1007/s11625-011-0129-1; Prokopy LS, 2014, SOC NATUR RESOUR, V27, P1177, DOI 10.1080/08941920.2014.918230; Reed MS, 2009, J ENVIRON MANAGE, V90, P1933, DOI 10.1016/j.jenvman.2009.01.001; Reid M, 2013, SOCIOL COMPASS, V7, P984, DOI 10.1111/soc4.12080; River Alliance of Wisconsin, 2015, MILW RIV BAS PARTN, P1; Rongerude J, 2016, NEW HORIZON ENV POLI, P317; Rufat S, 2015, INT J DISAST RISK RE, V14, P470, DOI 10.1016/j.ijdrr.2015.09.013; Sampson RJ, 2008, DEMOGRAPHY, V45, P1, DOI 10.1353/dem.2008.0012; Schmidtlein MC, 2008, RISK ANAL, V28, P1099, DOI 10.1111/j.1539-6924.2008.01072.x; SEWRPC Southeastern Wisconsin Regional Planning Commission, 1979, 30 SEWRPC; Shilling FM, 2009, ENVIRON SCI POLICY, V12, P694, DOI 10.1016/j.envsci.2009.03.003; Sievert LN, 2006, HUMANE METROPOLIS PE, P141; Snyder AR, 2004, RURAL SOCIOL, V69, P127, DOI 10.1526/003601104322919937; STARRELS ME, 1994, J FAM ISSUES, V15, P590, DOI 10.1177/019251394015004005; Tate E, 2013, ANN ASSOC AM GEOGR, V103, P526, DOI 10.1080/00045608.2012.700616; Tate E, 2012, NAT HAZARDS, V63, P325, DOI 10.1007/s11069-012-0152-2; Toke A NA, 2014, EARTHS FUTURE, P440; Warren RF, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1174; Wei F, 2015, ENVIRON PLANN A, V47, P50, DOI 10.1068/a46278; Yoon DK, 2012, NAT HAZARDS, V63, P823, DOI 10.1007/s11069-012-0189-2; Zahran S, 2008, URBAN AFF REV, V43, P447, DOI 10.1177/1078087407304688; Zimmerman J, 2008, CITIES, V25, P230, DOI 10.1016/j.cities.2008.04.006	78	5	5	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196416	10.1371/journal.pone.0196416	http://dx.doi.org/10.1371/journal.pone.0196416			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE5RZ	29715285	gold, Green Published			2022-12-26	WOS:000431281100020
J	Fisher, KA; Cahill, LM; Broyles, S; Rorke, M; Robinson, WT				Fisher, Kiva Ariani; Cahill, Laura Michele; Broyles, Stephanie; Rorke, Marion; Robinson, William Thomas			Knowledge of hepatitis C status moderates the relationship between history of drug treatment and sterile syringe use	PLOS ONE			English	Article							RISK BEHAVIORS; INJECT DRUGS; HIDDEN POPULATIONS; VIRUS; PEOPLE; INFECTION; ASSOCIATION; PREVENTION; EQUIPMENT; AWARENESS	High-risk injection related behavior including use of non-sterile syringes is associated with negative health outcomes among people who inject drugs (PWID). Drug treatment programs have been reported to curb hepatitis C (HCV) transmission. This study aims to assess the role of drug treatment programs and knowledge of HCV status, and how they influence current injection-related risk. Data were collected in 2012 by the New Orleans arm of the CDC funded National HIV Behavioral Surveillance. Respondent driven sampling was used to recruit a sample of PWID. The analytic sample consisted of 473 participants. Univariate, bivariate, and linear regression analyses were performed. Findings indicated that history of drug treatment is associated with sterile syringe use among PWID. Further, knowledge of HCV status modifies the relationship between history of drug treatment and sterile syringe use in this sample. These findings highlight the importance of scaling up prevention efforts by expanding testing, counselling, and treatment for HCV among PWID who enter drug treatment facilities.	[Fisher, Kiva Ariani; Cahill, Laura Michele; Broyles, Stephanie; Robinson, William Thomas] LSUHSC Sch Publ Hlth, Behav & Community Hlth Sci, New Orleans, LA 70112 USA; [Broyles, Stephanie] Pennington Biomed Res Ctr, Contextual Risk Factors, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Rorke, Marion] Dept Publ Hlth & Environm, Community Hlth Div, Denver, CO USA; [Robinson, William Thomas] Louisiana Off Publ Hlth, STD HIV Program, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Colorado Department of Public Health & Environment	Fisher, KA (corresponding author), LSUHSC Sch Publ Hlth, Behav & Community Hlth Sci, New Orleans, LA 70112 USA.	kfish6@lsuhsc.edu	Broyles, Stephanie/C-8647-2011	Broyles, Stephanie/0000-0003-3168-0056	Centers for Disease Control and Prevention (CDC) for National HIV Behavioral Surveillance [5U1B/PS003252]	Centers for Disease Control and Prevention (CDC) for National HIV Behavioral Surveillance(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The authors would like to acknowledge support through the Centers for Disease Control and Prevention (CDC) for National HIV Behavioral Surveillance cooperative agreement number 5U1B/PS003252.	Ball J.C., 2012, EFFECTIVENESS METHAD; Booth RE, 2011, AIDS BEHAV, V15, P30, DOI 10.1007/s10461-010-9751-7; Burt RD, 2009, DRUG ALCOHOL DEPEN, V105, P215, DOI 10.1016/j.drugalcdep.2009.07.005; CDC, 2015, HEP C FAQS HLTH PROF; Centers for Disease Control and Prevention, 2014, NAT HIV BEH SURV ROU; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Cox J, 2009, SUBST USE MISUSE, V44, P548, DOI 10.1080/10826080802544349; Dutra L, 2008, AM J PSYCHIAT, V165, P179, DOI 10.1176/appi.ajp.2007.06111851; Echevarria D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135901; Fox JM, 2015, TROP MED INT HEALTH, V20, P638, DOI 10.1111/tmi.12465; Gallagher KM, 2007, PUBLIC HEALTH REP, V122, P32, DOI 10.1177/00333549071220S106; Grady BP, 2013, CLIN INFECT DIS, V57, pS105, DOI 10.1093/cid/cit301; Groves RM, 2011, SURVEY METHODOLOGY; Guardino V., 2010, Morbidity and Mortality Weekly Report, V59, P1488; Hagan H, 2006, PUBLIC HEALTH REP, V121, P710, DOI 10.1177/003335490612100611; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hickman M, 2017, ADDICTION, V112, P201, DOI 10.1111/add.13521; Korthuis PT, 2012, ADDICT BEHAV, V37, P552, DOI 10.1016/j.addbeh.2011.12.001; Kwiatkowski CF, 2002, ADDICTION, V97, P1289, DOI 10.1046/j.1360-0443.2002.00208.x; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; Magill M, 2009, J STUD ALCOHOL DRUGS, V70, P516, DOI 10.15288/jsad.2009.70.516; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Naji L, 2016, SUBST ABUS-RES TREAT, V10, P9, DOI 10.4137/SART.S37030; National Institute on Drug Abuse, PRINC DRUG ADD TREAT; National Institute on Drug Abuse (NIDA), 2018, PRINC DRUG ADD TREAT, VThird; Pollack H, 2004, MONOGRAPHS, P345; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Smith BD, 2013, J INFECT DIS, V208, P1934, DOI 10.1093/infdis/jit520; Spelman T, 2015, J EPIDEMIOL COMMUN H, V69, P745, DOI 10.1136/jech-2014-205224; Tsui JI, 2014, JAMA INTERN MED, V174, P1974, DOI 10.1001/jamainternmed.2014.5416	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196157	10.1371/journal.pone.0196157	http://dx.doi.org/10.1371/journal.pone.0196157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1YS	29702681	Green Published, gold, Green Submitted			2022-12-26	WOS:000431013300021
J	Hansson, SF; Zhou, AX; Vachet, P; Eriksson, JW; Pereira, MJ; Skrtic, S; Wallin, HJ; Ericsson-Dahlstrand, A; Karlsson, D; Ahnmark, A; Winzell, MS; Magnone, MC; Davidsson, P				Hansson, Sara F.; Zhou, Alex-Xianghua; Vachet, Pauline; Eriksson, Jan W.; Pereira, Maria J.; Skrtic, Stanko; Wallin, Helen Jongsma; Ericsson-Dahlstrand, Anders; Karlsson, Daniel; Ahnmark, Andrea; Winzell, Maria Sorhede; Magnone, Maria Chiara; Davidsson, Pia			Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction	PLOS ONE			English	Article							PANCREATIC BETA-CELL; INSULIN-SECRETION; CA2+-BINDING PROTEIN; EXPRESSION; APOPTOSIS; BINDING; IDENTIFICATION; CONTRIBUTES; FREQUENCY; MELLITUS	Beta cell dysfunction accompanies and drives the progression of type 2 diabetes mellitus (T2D), but there are few clinical biomarkers available to assess islet cell stress in humans. Secretagogin, a protein enriched in pancreatic islets, demonstrates protective effects on beta cell function in animals. However, its potential as a circulating biomarker released from human beta cells and islets has not been studied. In this study primary human islets, beta cells and plasma samples were used to explore secretion and expression of secretagogin in relation to the T2D pathology. Secretagogin was abundantly and specifically expressed and secreted from human islets. Furthermore, T2D patients had an elevated plasma level of secretagogin compared with matched healthy controls, which was confirmed in plasma of diabetic mice transplanted with human islets. Additionally, the plasma secretagogin level of the human cohort had an inverse correlation to clinical assessments of beta cell function. To explore the mechanism of secretagogin release in vitro, human beta cells (EndoC-[beta H1) were exposed to elevated glucose or cellular stress-inducing agents. Secretagogin was not released in parallel with glucose stimulated insulin release, but was markedly elevated in response to endoplasmic reticulum stressors and cytokines. These findings indicate that secretagogin is a potential novel biomarker, reflecting stress and islet cell dysfunction in T2D patients.	[Hansson, Sara F.; Zhou, Alex-Xianghua; Vachet, Pauline; Magnone, Maria Chiara; Davidsson, Pia] AstraZeneca, IMED Biotech Unit, Translat Sci Cardiovasc Renal & Metab, Gothenburg, Sweden; [Eriksson, Jan W.; Pereira, Maria J.] Uppsala Univ, Dept Med Sci, Clin Diabet & Metab, Uppsala, Sweden; [Skrtic, Stanko] AstraZeneca, IMED Biotech Unit, Early Clin Dev, Translat Med Unit CVRM, Gothenburg, Sweden; [Skrtic, Stanko] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Wallin, Helen Jongsma; Ericsson-Dahlstrand, Anders] Offspring Biosci, Sodertalje, Sweden; [Karlsson, Daniel; Ahnmark, Andrea; Winzell, Maria Sorhede] AstraZeneca, IMED Biotech Unit, Biosci Cardiovasc Renal & Metab, Gothenburg, Sweden	AstraZeneca; Uppsala University; AstraZeneca; University of Gothenburg; AstraZeneca	Hansson, SF (corresponding author), AstraZeneca, IMED Biotech Unit, Translat Sci Cardiovasc Renal & Metab, Gothenburg, Sweden.	sara.hansson@astrazeneca.com	Pereira, Maria J/B-7947-2017; Eriksson, Jan/AAB-5820-2021	Pereira, Maria/0000-0001-5498-3899	AstraZeneca RD; EXODIAB (Excellence of Diabetes Research in Sweden); Swedish Diabetes Foundation; ALF grants; AstraZeneca	AstraZeneca RD(AstraZeneca); EXODIAB (Excellence of Diabetes Research in Sweden); Swedish Diabetes Foundation; ALF grants; AstraZeneca(AstraZeneca)	Funding: The clinical studies were supported by grants from AstraZeneca R&D, EXODIAB (Excellence of Diabetes Research in Sweden), the Swedish Diabetes Foundation and ALF grants. JWE has research grant or consultancy for AstraZeneca, Bristol-Myers-Squibb, Merck Sharpe & Dohme and NovoNordisk. Authors with affiliation AstraZeneca are employed by AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We confirm that the funder AstraZeneca provided support in the form of salaries for authors [SFH, AZ, SS, MCM, DK, AA, MSW, PD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; The clinical studies were supported by grants from AstraZeneca R&D, EXODIAB (Excellence of Diabetes Research in Sweden), the Swedish Diabetes Foundation and ALF grants. JWE has research grant or consultancy for AstraZeneca, Bristol-Myers-Squibb, Merck Sharpe & Dohme, and NovoNordisk.	Bai YF, 2014, ONCOTARGET, V5, P7760, DOI 10.18632/oncotarget.2305; Bauer MC, 2011, MOL BIOSYST, V7, P2196, DOI 10.1039/c0mb00349b; Bazwinsky-Wutschke I, 2010, HISTOCHEM CELL BIOL, V134, P115, DOI 10.1007/s00418-010-0721-y; Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1; Brandhorst H, 2009, TRANSPLANTATION, V87, P370, DOI 10.1097/TP.0b013e31819499f0; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cras-Meneur C, 2004, DIABETOLOGIA, V47, P284, DOI 10.1007/s00125-003-1300-8; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Ehses Jan A., 2009, Archives of Physiology and Biochemistry, V115, P240, DOI 10.1080/13813450903025879; Fiorina P, 1998, AM J HYPERTENS, V11, P1100, DOI 10.1016/S0895-7061(98)00125-3; Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Flint MS, 2005, J NEUROIMMUNOL, V167, P34, DOI 10.1016/j.jneuroim.2005.06.012; Gartner W, 2007, AM J PHYSIOL-ENDOC M, V293, pE347, DOI 10.1152/ajpendo.00055.2007; Gartner W, 2001, CEREB CORTEX, V11, P1161, DOI 10.1093/cercor/11.12.1161; GORLOV IP, 1986, GENETIKA+, V22, P1019; Hasegawa K, 2013, FASEB J, V27, P2301, DOI 10.1096/fj.12-226092; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Ilhan A, 2011, HUM PATHOL, V42, P641, DOI 10.1016/j.humpath.2010.10.004; Ilhan-Mutlu A, 2013, NEUROSURG REV, V36, P45, DOI 10.1007/s10143-012-0401-6; Karaca M, 2009, DIABETES METAB, V35, P77, DOI 10.1016/j.diabet.2008.09.007; Khandelwal R, 2017, BIOCHEMISTRY-US, V56, P411, DOI 10.1021/acs.biochem.6b00761; Kim DS, 2010, J PROTEOME RES, V9, P3710, DOI 10.1021/pr100236r; Kobayashi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151927; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lim S, 2008, MOL CELLS, V25, P390; Maj M, 2010, J ENDOCRINOL, V205, P25, DOI 10.1677/JOE-09-0341; Malenczyk K, 2017, EMBO J, V36, P2107, DOI 10.15252/embj.201695347; Malvandi AM, 2010, STRESS, V13, P276, DOI 10.3109/10253890903296710; Montaner J, 2011, J INTERN MED, V270, P166, DOI 10.1111/j.1365-2796.2010.02329.x; Neutzsky-Wulff AV, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-214; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pereira MJ, 2016, METABOLISM, V65, P1768, DOI 10.1016/j.metabol.2016.09.008; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Romanov RA, 2015, EMBO J, V34, P36, DOI 10.15252/embj.201488977; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Skovhus KV, 2006, SCAND J IMMUNOL, V64, P639, DOI 10.1111/j.1365-3083.2006.01854.x; Solini A, 2015, J AM SOC NEPHROL, V26, P1007, DOI 10.1681/ASN.2014070721; Sparre T, 2002, DIABETOLOGIA, V45, P1550, DOI 10.1007/s00125-002-0953-z; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang SY, 2016, BIOCHEM J, V473, P1791, DOI 10.1042/BCJ20160137	47	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0196601	10.1371/journal.pone.0196601	http://dx.doi.org/10.1371/journal.pone.0196601			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1YS	29702679	Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300043
J	Martinez-Martinez, V; Gomez-Gill, J; Machado, ML; Pinto, FAC				Martinez-Martinez, Victor; Gomez-Gill, Jaime; Machado, Marley L.; Pinto, Francisco A. C.			Leaf and canopy reflectance spectrometry applied to the estimation of angular leaf spot disease severity of common bean crops	PLOS ONE			English	Article							NEAR-INFRARED-SPECTROSCOPY; HYPERSPECTRAL REFLECTANCE; PHASEOLUS-VULGARIS; REGRESSION; WHEAT; CLASSIFICATION; VARIABLES; LEGUMES; INDEXES; BIOMASS	This study is aimed at (i) estimating the angular leaf spot (ALS) disease severity in common beans crops in Brazil, caused by the fungus Pseudocercospora griseola, employing leaf and canopy spectral reflectance data, (ii) evaluating the informative spectral regions in the detection, and (iii) comparing the estimation accuracy when the reflectance or the first derivative reflectance (FDR) is employed. Three data sets of useful spectral reflectance measurements in the 440 to 850 nm range were employed; measurements were taken over the leaves and canopy of bean crops with different levels of disease. A system based in Principal Component Analysis (PCA) and Artificial Neural Networks (ANN) was developed to estimate the disease severity from leaf and canopy hyperspectral reflectance spectra. Levels of disease to be taken as true reference were determined from the proportion of the total leaf surface covered by necrotic lesions on RGB images. When estimating ALS disease severity in bean crops by using hyperspectral reflectance spectrometry, this study suggests that (i) successful estimations with coefficients of determination up to 0.87 can be achieved if the spectra is acquired by the spectroradiometer in contact with the leaves, (ii) unsuccessful estimations are obtained when the spectra are acquired by the spectroradiometer from one or more meters above the crop, (iii) the red to near-infrared spectral region (630 +/- 850 nm) offers the same precision in the estimation as the blue to near-infrared spectral region (440 +/- 850), and (iv) neither significant improvements nor significant detriments are achieved when the input data to the estimation processing system are the FDR spectra, instead of the reflectance spectra.	[Martinez-Martinez, Victor; Gomez-Gill, Jaime] Univ Valladolid, Dept Signal Theory Commun & Telemat Engn, Valladolid, Spain; [Machado, Marley L.] Empresa Pesquisa Agr Minas Gerais, Dept Pesquisa, Belo Horizonte, MG, Brazil; [Pinto, Francisco A. C.] Univ Fed Vicosa, Dept Agr Engn, Vicosa, MG, Brazil	Universidad de Valladolid; Universidade Federal de Vicosa	Martinez-Martinez, V (corresponding author), Univ Valladolid, Dept Signal Theory Commun & Telemat Engn, Valladolid, Spain.	vmarmar@ribera.tel.uva.es	Gomez-Gil, Jaime/L-7620-2014; Martínez-Martínez, Víctor/R-5049-2019	Gomez-Gil, Jaime/0000-0003-3333-0148; Martínez-Martínez, Víctor/0000-0002-3730-7407; Pinto, Francisco/0000-0002-8279-9535; Pinto, Francisco/0000-0003-3000-9084	FAPEMIG (Minas Gerais State Foundation for Research Development); CNPq; "Formacion de Personal Investigador" program grant; Universidad de Valladolid from Spain; Banco Santander	FAPEMIG (Minas Gerais State Foundation for Research Development)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); "Formacion de Personal Investigador" program grant; Universidad de Valladolid from Spain; Banco Santander	Authors of the article want to thank the financial support provided by FAPEMIG (Minas Gerais State Foundation for Research Development, http://www.fapemig.br) and CNPq Brazilian agencies (http://cnpq.br), that helped to conduct the field experiments of the article. The first author's work was made possible thanks to a "Formacion de Personal Investigador" program grant. This program was financed by the Universidad de Valladolid (www.uva.es), from Spain, and cofinanced by Banco Santander (www.bancosantander.es). Moreover, the collaboration among the authors was possible thanks to a grant program entitled "Becas Iberoamerica. Jovenes Profesores e Investigadores. Santander Universidades" (https://www.agora-santander.com), financed by Banco Santander. The first and second author were each awarded a grant under this program in 2014, and it financed their stay at the Universidade Federal de Vicosa (MG, Brazil) while the ALS estimation method was implemented and evaluated.	Achwartz HFSJ.R., 2005, COMPENDIUM BEAN DIS; Ashourloo D, 2014, REMOTE SENS-BASEL, V6, P4723, DOI 10.3390/rs6064723; Bauriegel E, 2011, COMPUT ELECTRON AGR, V75, P304, DOI 10.1016/j.compag.2010.12.006; Bazzano LA, 2011, NUTR METAB CARDIOVAS, V21, P94, DOI 10.1016/j.numecd.2009.08.012; Blackburn GA, 2007, J EXP BOT, V58, P855, DOI 10.1093/jxb/erl123; Bock CH, 2010, CRIT REV PLANT SCI, V29, P59, DOI 10.1080/07352681003617285; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Campbell J.B., 2011, INTRO REMOTE SENSING; Campbell JB, 2007, INTRO REMOTE SENSING, P447; Dammer KH, 2011, CROP PROT, V30, P420, DOI 10.1016/j.cropro.2010.12.015; Darmadi-Blackberry I, 2004, ASIA PAC J CLIN NUTR, V13, P217; de Jesus WC, 2001, PHYTOPATHOLOGY, V91, P1045, DOI 10.1094/PHYTO.2001.91.11.1045; DeFries RS, 2000, REMOTE SENS ENVIRON, V74, P503, DOI 10.1016/S0034-4257(00)00142-5; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Deschasaux M, 2014, J NUTR, V144, P504, DOI 10.3945/jn.113.189670; Di Cui, 2009, Sensing and Instrumentation for Food Quality and Safety, V3, P49, DOI 10.1007/s11694-009-9070-8; Dutta S, 2014, J INDIAN SOC REMOTE, V42, P353, DOI 10.1007/s12524-013-0325-9; Gazala IFS, 2013, INDIAN J VIROL, V24, P242, DOI 10.1007/s13337-013-0161-0; Gnyp ML, 2014, FIELD CROP RES, V155, P42, DOI 10.1016/j.fcr.2013.09.023; HAGEDORN D. J., 1986, HDB BEAN DIS; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; Konduru T, 2015, J FOOD ENG, V160, P19, DOI 10.1016/j.jfoodeng.2015.03.025; Liu ZY, 2010, COMPUT ELECTRON AGR, V72, P99, DOI 10.1016/j.compag.2010.03.003; Liu Zhan-yu, 2007, Journal of Zhejiang University-Science B, V8, P738, DOI 10.1631/jzus.2007.B0738; MALTHUS TJ, 1993, REMOTE SENS ENVIRON, V45, P107, DOI 10.1016/0034-4257(93)90086-D; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Messina V, 2014, AM J CLIN NUTR, V100, p437S, DOI 10.3945/ajcn.113.071472; Monteiro ST, 2007, ISPRS J PHOTOGRAMM, V62, P2, DOI 10.1016/j.isprsjprs.2006.12.002; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; Muhammed HH, 2003, BIOSYST ENG, V86, P125, DOI 10.1016/S1537-5110(03)00090-4; Nutter FW, 2006, EUR J PLANT PATHOL, V115, P95, DOI 10.1007/s10658-005-1230-z; Penuelas J, VISIBLE NEAR INFRARE, V3, P151, DOI [10.1016/S1360-1385(98)01213-8, DOI 10.1016/S1360-1385(98)01213-8]; Pietrzykowski E, 2006, FOREST PATHOL, V36, P334, DOI 10.1111/j.1439-0329.2006.00459.x; Ponzoni FJ, 2000, SENSORIAMENTO REMOTO, P157; Prabhakar M, 2013, CROP PROT, V45, P132, DOI 10.1016/j.cropro.2012.12.003; PRICE TV, 1990, CRIT REV PLANT SCI, V9, P235, DOI 10.1080/07352689009382289; Rumpf T, 2010, COMPUT ELECTRON AGR, V74, P91, DOI 10.1016/j.compag.2010.06.009; Rundquist DC, 1996, PHOTOGRAMM ENG REM S, V62, P195; Sankaran S, 2011, COMPUT ELECTRON AGR, V77, P127, DOI 10.1016/j.compag.2011.03.004; SCHWARTZ HF, 1981, PLANT DIS, V65, P494, DOI 10.1094/PD-65-494; Singh SP, 2010, CROP SCI, V50, P2199, DOI 10.2135/cropsci2009.03.0163; Teofilo RF, 2009, J CHEMOMETR, V23, P32, DOI 10.1002/cem.1192; Tharanathan RN, 2003, TRENDS FOOD SCI TECH, V14, P507, DOI 10.1016/j.tifs.2003.07.002; Thompson MD, 2012, CARCINOGENESIS, V33, P226, DOI 10.1093/carcin/bgr247; Wortmann C.S., 1998, ATLAS COMMON BEAN PH; Wu D, 2008, T ASABE, V51, P1133, DOI 10.13031/2013.24504; Xiao Qingfu, 2005, Urban Ecosystems, V8, P349, DOI 10.1007/s11252-005-4867-7; Yang CC, 2003, AGR SYST, V76, P1101, DOI 10.1016/S0308-521X(02)00051-3; Yi QX, 2008, J ZHEJIANG UNIV-SC B, V9, P378, DOI 10.1631/jzus.B0730019; Zhang H, 2011, ACTA PHYSIOL PLANT, V33, P2461, DOI 10.1007/s11738-011-0790-0; Zhang M., 2003, INT J APPL EARTH OBS, V4, P295, DOI 10.1016/S0303-2434(03)00008-4; Zhang Minghua, 2005, Precision Agriculture, V6, P489, DOI 10.1007/s11119-005-5640-x	52	9	9	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196072	10.1371/journal.pone.0196072	http://dx.doi.org/10.1371/journal.pone.0196072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698420	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600034
J	Robinson, RC; Poulsen, NA; Barile, D				Robinson, Randall C.; Poulsen, Nina Aagaard; Barile, Daniela			Multiplexed bovine milk oligosaccharide analysis with aminoxy tandem mass tags	PLOS ONE			English	Article							N-LINKED GLYCANS; PERFORMANCE LIQUID-CHROMATOGRAPHY; LC-MS/MS; RELATIVE QUANTIFICATION; DANISH JERSEY; SPECTROMETRY; HOLSTEIN; QUANTITATION; CONSUMPTION; MICROBIOTA	Milk oligosaccharides (OS) are a key factor that influences the infant gut microbial composition, and their importance in promoting healthy infant development and disease prevention is becoming increasingly apparent. Investigating the structures, properties, and sources of these compounds requires a host of complementary analytical techniques. Relative compound quantification by mass spectral analysis of isobarically labeled samples is a relatively new technique that has been used mainly in the proteomics field. Glycomics applications have so far focused on analysis of protein-linked glycans, while analysis of free milk OS has previously been conducted only on analytical standards. In this paper, we extend the use of isobaric glycan tags to the analysis of bovine milk OS by presenting a method for separation of labeled OS on a porous graphitized carbon liquid chromatographic column with subsequent analysis by quadrupole time-of-flight tandem mass spectrometry. Abundances for 15 OS extracted from mature bovine milk were measured, with replicate injections providing coefficients of variation below 15% for most OS. Isobaric labeling improved ionization efficiency for low-abundance, high-molecular weight fucosylated OS, which are known to exist in bovine milk but have been only sporadically reported in the literature. We compared the abundances of four fucosylated OS in milk from Holstein and Jersey cattle and found that three of the compounds were more abundant in Jersey milk, which is in general agreement with a previous study. This novel method represents an advancement in our ability to characterize milk OS and provides the advantages associated with isobaric labeling, including reduced instrumental analysis time and increased analyte ionization efficiency. This improved ability to measure differences in bioactive OS abundances in large datasets will facilitate exploration of OS from all food sources for the purpose of developing health-guiding products for infants, immune-compromised elderly, and the population at large.	[Robinson, Randall C.; Barile, Daniela] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Poulsen, Nina Aagaard] Aarhus Univ, Dept Food Sci, Tjele, Denmark; [Barile, Daniela] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA	University of California System; University of California Davis; Aarhus University; University of California System; University of California Davis	Barile, D (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.; Barile, D (corresponding author), Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA.	dbarile@ucdavis.edu	barile, daniela/AAA-3892-2020; Robinson, Randall/A-2617-2019	barile, daniela/0000-0002-3889-1596; Poulsen, Nina/0000-0001-9983-9663; Robinson, Randall/0000-0002-4227-5745	National Institutes of Health [R01AT007079, R01AT008759]; USDA:NIFA Hatch project [232719]; Arla Food Ingredients; National Center for Complementary & Integrative Health [R01AT007079, R01AT008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA:NIFA Hatch project; Arla Food Ingredients; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Barile Lab acknowledges funding from National Institutes of Health awards R01AT007079 and R01AT008759 (www.nih.gov), USDA:NIFA Hatch project 232719 (nifa.usda.gov), and Arla Food Ingredients. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldredge DL, 2013, GLYCOBIOLOGY, V23, P664, DOI 10.1093/glycob/cwt007; Alley WR, 2010, ANAL CHEM, V82, P5095, DOI 10.1021/ac100131e; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Atwood JA, 2008, J PROTEOME RES, V7, P367, DOI 10.1021/pr070476i; Bao YW, 2013, ANAL BIOCHEM, V433, P28, DOI 10.1016/j.ab.2012.10.003; Barile D, 2010, J DAIRY SCI, V93, P3940, DOI 10.3168/jds.2010-3156; Barile D, 2009, INT DAIRY J, V19, P524, DOI 10.1016/j.idairyj.2009.03.008; Bertino E, 2008, INT J IMMUNOPATH PH, V21, P381, DOI 10.1177/039463200802100216; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Cohen JL, 2017, INT DAIRY J, V66, P68, DOI 10.1016/j.idairyj.2016.10.016; Coppa GV, 2006, PEDIATR RES, V59, P377, DOI 10.1203/01.pdr.0000200805.45593.17; Dallas DC, 2014, FOOD RES INT; Fong B, 2011, J AGR FOOD CHEM, V59, P9788, DOI 10.1021/jf202035m; Hahne H, 2012, ANAL CHEM, V84, P3716, DOI 10.1021/ac300197c; Halim A, 2014, J PROTEOME RES, V13, P6024, DOI 10.1021/pr500898r; Harvey DJ, 2011, J CHROMATOGR B, V879, P1196, DOI 10.1016/j.jchromb.2010.11.010; Hong QT, 2013, ANAL CHEM, V85, P8585, DOI 10.1021/ac4009995; Jantscher-Krenn E, 2012, GUT, V61, P1417, DOI 10.1136/gutjnl-2011-301404; Johnson KL, 2004, J AM SOC MASS SPECTR, V15, P437, DOI 10.1016/j.jasms.2003.11.016; Kang P, 2007, ANAL CHEM, V79, P6064, DOI 10.1021/ac062098r; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Locascio RG, 2007, J AGR FOOD CHEM, V55, P8914, DOI 10.1021/jf0710480; Marino K, 2011, GLYCOBIOLOGY, V21, P1317, DOI 10.1093/glycob/cwr067; Mehra R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096040; Meitei N. S., 2015, J PROTEOMICS; Meng R, 2011, J PROTEOMICS, V75, P366, DOI 10.1016/j.jprot.2011.07.030; Meyrand M, 2013, SMALL RUMINANT RES, V113, P411, DOI 10.1016/j.smallrumres.2013.03.014; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Newburg DS, 2000, J PEDIATR GASTR NUTR, V30, pS8, DOI 10.1097/00005176-200000002-00003; Ninonuevo M, 2005, ELECTROPHORESIS, V26, P3641, DOI 10.1002/elps.200500246; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Oursel S, 2017, J CHROMATOGR B, V1071, P49, DOI 10.1016/j.jchromb.2017.03.028; Poulsen NA, 2012, J DAIRY SCI, V95, P6362, DOI 10.3168/jds.2012-5820; Rauniyar N, 2013, J PROTEOME RES, V12, P1031, DOI 10.1021/pr3008896; Redding Alyssa M., 2006, Briefings in Functional Genomics & Proteomics, V5, P133, DOI 10.1093/bfgp/ell025; Ruiz-Moyano S, 2013, APPL ENVIRON MICROB, V79, P6040, DOI 10.1128/AEM.01843-13; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Sundekilde UK, 2012, J AGR FOOD CHEM, V60, P6188, DOI 10.1021/jf300015j; Tao N, 2008, J DAIRY SCI, V91, P3768, DOI 10.3168/jds.2008-1305; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Walker SH, 2011, ANAL CHEM, V83, P6738, DOI 10.1021/ac201376q; Werner T, 2012, ANAL CHEM, V84, P7188, DOI 10.1021/ac301553x; Wickramasinghe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018895; Wu S, 2012, ANAL CHEM, V84, P7456, DOI 10.1021/ac301398h; Wu SA, 2011, J PROTEOME RES, V10, P856, DOI 10.1021/pr101006u; Xia BY, 2009, ANAL BIOCHEM, V387, P162, DOI 10.1016/j.ab.2009.01.028; Xu G, 2017, J NUTR, V147, P117, DOI 10.3945/jn.116.238279; Yu ZT, 2013, GLYCOBIOLOGY, V23, P1281, DOI 10.1093/glycob/cwt065; Zhong XF, 2015, ANAL CHEM, V87, P6527, DOI 10.1021/acs.analchem.5b01835; Zhou SY, 2017, ANAL BIOANAL CHEM, V409, P453, DOI 10.1007/s00216-016-9996-8; Zhou SY, 2016, ANAL CHEM, V88, P7515, DOI 10.1021/acs.analchem.6b00465; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107	53	18	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196513	10.1371/journal.pone.0196513	http://dx.doi.org/10.1371/journal.pone.0196513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698512	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600089
J	Roosenboom, J; Lee, MK; Hecht, JT; Heike, CL; Wehby, GL; Christensen, K; Feingold, E; Marazita, ML; Maga, AM; Shaffer, JR; Weinberg, SM				Roosenboom, Jasmien; Lee, Myoung Keun; Hecht, Jacqueline T.; Heike, Carrie L.; Wehby, George L.; Christensen, Kaare; Feingold, Eleanor; Marazita, Mary L.; Maga, A. Murat; Shaffer, John R.; Weinberg, Seth M.			Mapping genetic variants for cranial vault shape in humans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NEMO-LIKE KINASE; CRANIOSYNOSTOSIS; LOCI; MUTATIONS; SKULL	The shape of the cranial vault, a region comprising interlocking flat bones surrounding the cerebral cortex, varies considerably in humans. Strongly influenced by brain size and shape, cranial vault morphology has both clinical and evolutionary relevance. However, little is known about the genetic basis of normal vault shape in humans. We performed a genome-wide association study (GWAS) on three vault measures (maximum cranial width [MCW], maximum cranial length [MCL], and cephalic index [CI]) in a sample of 4419 healthy individuals of European ancestry. All measures were adjusted by sex, age, and body size, then tested for association with genetic variants spanning the genome. GWAS results for the two cohorts were combined via meta-analysis. Significant associations were observed at two loci: 15p11.2 (lead SNP rs2924767, p = 2.107 x 10(-8)) forMCW and 17q11.2 (lead SNP rs72841279, p = 5.29 x 10(-9)) for MCL. Additionally, 32 suggestive loci (p < 5x10(-6)) were observed. Several candidate genes were located in these loci, such as NLK, MEF2A, SOX9 and SOX11. Genome-wide linkage analysis of cranial vault shape in mice (N = 433) was performed to follow-up the associated candidate loci identified in the human GWAS. Two loci, 17q11.2 (c11. loc44 in mice) and 17q25.1 (c11. loc74 in mice), associated with cranial vault size in humans, were also linked with cranial vault size in mice (LOD scores: 3.37 and 3.79 respectively). These results provide further insight into genetic pathways and mechanisms underlying normal variation in human craniofacial morphology.	[Roosenboom, Jasmien; Lee, Myoung Keun; Marazita, Mary L.; Shaffer, John R.; Weinberg, Seth M.] Univ Pittsburgh, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15260 USA; [Hecht, Jacqueline T.] Univ Texas McGovern Med Ctr, Dept Pediat, Houston, TX USA; [Heike, Carrie L.; Maga, A. Murat] Univ Washington, Dept Pediat, Seattle Childrens Craniofacial Ctr, Seattle, WA 98195 USA; [Wehby, George L.] Univ Iowa, Dept Hlth Management & Policy, Iowa City, IA USA; [Christensen, Kaare] Univ Southern Denmark, Inst Publ Hlth, Dept Epidemiol, Odense, Denmark; [Feingold, Eleanor; Marazita, Mary L.; Shaffer, John R.; Weinberg, Seth M.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; [Maga, A. Murat] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA USA; [Weinberg, Seth M.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Iowa; University of Southern Denmark; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Seattle Children's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weinberg, SM (corresponding author), Univ Pittsburgh, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15260 USA.; Weinberg, SM (corresponding author), Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA.; Weinberg, SM (corresponding author), Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA.	smwst46@pitt.edu	Christensen, Kaare/C-2360-2009; Heike, Carrie/ABA-4852-2021	Christensen, Kaare/0000-0002-5429-5292; Heike, Carrie/0000-0003-2178-7730; Weinberg, Seth/0000-0001-9467-4556; Roosenboom, Jasmien/0000-0001-5558-4291; Maga, A. Murat/0000-0002-7921-9018; Shaffer, John/0000-0003-1897-1131	National Institute for Dental and Craniofacial Research [U01- DE020078, R01-DE027023, R01-DE016148]; Centers for Disease Control [R01-DD000295]; National Human Genome Research Institute [X01-HG007821, X01-HG007485]; University of Washington from the National Institute for Dental and Craniofacial Research [HHSN268201200008I]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016148, R01DE027023] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of Washington from the National Institute for Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The National Institute for Dental and Craniofacial Research (http://www.nidcr.nih.gov/) provided funding through the following grants: U01- DE020078 (SMW, MLM); R01-DE027023 (SMW, JRS); R01-DE016148 (MLM, SMW). The Centers for Disease Control (https://www.cdc.gov/) provided funding through the following grant: R01-DD000295 (GLW). Funding for genotyping of the 3DFN cohort was provided by the National Human Genome Research Institute (https://www.genome.gov/): X01-HG007821 (MLM, SMW, EF). Funding for genotyping of the OFC cohort was provided by the National Human Genome Research Institute (https://www.genome.gov/): X01-HG007485 (MLM). Funding for initial genomic data cleaning by the University of Washington was provided by contract #HHSN268201200008I from the National Institute for Dental and Craniofacial Research (http://www.nidcr.nih.gov/) awarded to the Center for Inherited Disease Research (CIDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HHH, 2016, NAT NEUROSCI, V19, P1569, DOI 10.1038/nn.4398; Bhagavatula MRK, 2004, HUM MOL GENET, V13, P3181, DOI 10.1093/hmg/ddh329; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Brand NJ, 1997, INT J BIOCHEM CELL B, V29, P1467, DOI 10.1016/S1357-2725(97)00084-8; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; CHURCHILL GA, 1994, GENETICS, V138, P963; Coussens AK, 2005, GENOMICS, V85, P563, DOI 10.1016/j.ygeno.2005.02.002; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Eppig JT, 2017, METHODS MOL BIOL, V1488, P47, DOI 10.1007/978-1-4939-6427-7_3; Gomez-Valdes JA, 2013, AM J HUM BIOL, V25, P12, DOI 10.1002/ajhb.22331; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hoshino H, 2007, MOL BIOL CELL, V18, P1143, DOI 10.1091/mbc.E06-08-0733; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huckert M, 2015, HUM MOL GENET, V24, P3038, DOI 10.1093/hmg/ddv053; Ishitani T, 2013, CELL SIGNAL, V25, P190, DOI 10.1016/j.cellsig.2012.09.017; Justice CM, 2012, NAT GENET, V44, P1360, DOI 10.1038/ng.2463; Katz DC, 2017, P NATL ACAD SCI USA, V114, P9050, DOI 10.1073/pnas.1702586114; Kolar JC, 1997, AM J PHYS ANTHROPOL, V103, P341, DOI 10.1002/(SICI)1096-8644(199707)103:3<341::AID-AJPA4>3.0.CO;2-T; Koli K, 2008, BONE, V43, P679, DOI 10.1016/j.bone.2008.06.016; Koyabu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4625; Lattanzi W, 2017, AM J MED GENET A, V173, P1406, DOI 10.1002/ajmg.a.38159; Leslie E. J., 2016, HUM MOL GENET, V25; Maga AM, 2017, J ANAT, V231, P433, DOI 10.1111/joa.12645; Maga AM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00092; Martinez-Abadias N, 2009, J ANAT, V214, P19, DOI 10.1111/j.1469-7580.2008.01015.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richtsmeier JT, 2013, ACTA NEUROPATHOL, V125, P469, DOI 10.1007/s00401-013-1104-y; Riley JW, 1949, AM SOCIOL REV, V14, P557, DOI 10.2307/2087216; Sahar DE, 2005, DEV BIOL, V280, P344, DOI 10.1016/j.ydbio.2005.01.022; Satoh K, 2007, MOL CELL BIOL, V27, P7623, DOI 10.1128/MCB.01481-07; Shaffer JR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006149; Sparks CS, 2002, P NATL ACAD SCI USA, V99, P14636, DOI 10.1073/pnas.222389599; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; Twigg SRF, 2015, AM J HUM GENET, V97, P359, DOI 10.1016/j.ajhg.2015.07.006; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weinberg SM, 2016, CLEFT PALATE-CRAN J, V53, pE185, DOI 10.1597/15-199; Weinberg SM, 2006, CLEFT PALATE-CRAN J, V43, P7, DOI 10.1597/04-122R1.1	38	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196148	10.1371/journal.pone.0196148	http://dx.doi.org/10.1371/journal.pone.0196148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698431	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600040
J	Selepe, MM; Ceccobelli, S; Lasagna, E; Kunene, NW				Selepe, Mokhethi Matthews; Ceccobelli, Simone; Lasagna, Emiliano; Kunene, Nokuthula Winfred			Genetic structure of South African Nguni (Zulu) sheep populations reveals admixture with exotic breeds	PLOS ONE			English	Article							COMPUTER-PROGRAM; INDIGENOUS SHEEP; DIVERSITY; DIFFERENTIATION; DOMESTICATION; CONSERVATION; RAREFACTION; BOTTLENECK; PATTERNS; TESTS	The population of Zulu sheep is reported to have declined by 7.4% between 2007 and 2011 due to crossbreeding. There is insufficient information on the genetic diversity of the Zulu sheep populations in the different area of KwaZulu Natal where they are reared. The study investigated genetic variation and genetic structure within and among eight Zulu sheep populations using 26 microsatellite markers. In addition, Damara, Dorper and South African Merino breeds were included to assess the genetic relationship between these breeds and the Zulu sheep. The results showed that there is considerable genetic diversity among the Zulu sheep populations (expected heterozygosity ranging from 0.57 to 0.69) and the level of inbreeding was not remarkable. The structure analysis results revealed that Makhathini Research Station and UNIZULU research station share common genetic structure, while three populations (Nongoma, Ulundi and Nquthu) had some admixture with the exotic Dorper breed. Thus, there is a need for sustainable breeding and conservation programmes to control the gene flow, in order to stop possible genetic dilution of the Zulu sheep.	[Selepe, Mokhethi Matthews; Kunene, Nokuthula Winfred] Univ Zululand, Dept Agr, Kwa Dlangezwa, South Africa; [Ceccobelli, Simone; Lasagna, Emiliano] Univ Perugia, Dept Agr Food & Environm Sci, Perugia, Italy	University of Zululand; University of Perugia	Lasagna, E (corresponding author), Univ Perugia, Dept Agr Food & Environm Sci, Perugia, Italy.	emiliano.lasagna@unipg.it	Emiliano, Lasagna/I-9304-2019; Ceccobelli, Simone/AAZ-9332-2020	Ceccobelli, Simone/0000-0002-0416-5748; Lasagna, Emiliano/0000-0003-2725-2921	Italian Ministry of Foreign Affairs; Nation Research Foundation	Italian Ministry of Foreign Affairs(Ministry of Foreign Affairs and International Cooperation (Italy)); Nation Research Foundation	This research was financially supported by Italian Ministry of Foreign Affairs (to EL) and Nation Research Foundation (to NWK) - "Executive programme of scientific and technological cooperation between the Italian republic and the republic of South Africa for the years 2014-2017 Projects for the exchange of researchers". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaviezor B. O., 2013, J ANIM PROD ADV, V3, P35; Agaviezor BO, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-38; Al-Atiyat RM, 2014, ELECTRON J BIOTECHN, V17, P168, DOI 10.1016/j.ejbt.2014.04.002; BELKHIR K, 2000, 9060 CNRS UPR U MONT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buduram P., 2004, THESIS; Ceccobelli S, 2015, SMALL RUMINANT RES, V123, P62, DOI 10.1016/j.smallrumres.2014.09.009; Cloete SWP, 2000, SMALL RUMINANT RES, V36, P119, DOI 10.1016/S0921-4488(99)00156-X; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Cornuet JM, 1996, GENETICS, V144, P2001; DEGEN AA, 1992, J AGR SCI, V119, P419, DOI 10.1017/S0021859600012260; Department Agriculture Forestry and Fisheries - South Africa (DAFF), 2015, PROF S AFR WOOL MARK; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Dobney K, 2006, J ZOOL, V269, P261, DOI 10.1111/j.1469-7998.2006.00042.x; Du Toit DJ, 2008, INDIGENOUS LIVESTOCK; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Elbeltagy AR, 2015, SMALL RUMINANT RES, V132, P137, DOI 10.1016/j.smallrumres.2015.10.020; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2015, 2 REP STAT WORLDS AN, P3; Food and Agricultural Organization of the United Nations Standing Committee, 2004, SEC GUID DEV NAT FAR; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Gaouar SBS, 2016, SMALL RUMINANT RES, V144, P23, DOI 10.1016/j.smallrumres.2016.07.021; Gaouar SBS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122667; Ghazy A., 2013, Research in Zoology, V3, P1; Gorkhali N. A., 2015, Tropical Agricultural Research, V26, P632; Gornas N, 2011, SMALL RUMINANT RES, V95, P27, DOI 10.1016/j.smallrumres.2010.08.009; Hlophe S.R., 2011, GENETIC VARIATION 6; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kdidi S, 2015, SMALL RUMINANT RES, V131, P64, DOI 10.1016/j.smallrumres.2015.08.012; Kevorkian SEM, 2010, ROM BIOTECH LETT, V15, P5059; Kunene N, 2007, S AFR J ANIM SCI, V37, P11; Kunene NW, 2009, SMALL RUMINANT RES, V84, P100, DOI 10.1016/j.smallrumres.2009.06.012; Kunene N. W., 2006, Livestock Research for Rural Development, V18, P113; Kunene NW, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3083; Loukovitis D, 2016, SMALL RUMINANT RES, V136, P238, DOI 10.1016/j.smallrumres.2016.02.008; Mavule B. S., 2013, Scientific Research and Essays, V8, P1226; Mavule BS, 2016, SMALL RUMINANT RES, V140, P50, DOI 10.1016/j.smallrumres.2016.06.001; Mavule BS., 2012, THESIS; Mukhongo DM, 2014, J LIVEST SCI, V5, P65; Othman OE, 2016, SMALL RUMINANT RES, V144, P346, DOI 10.1016/j.smallrumres.2016.10.020; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park S.D.E., 2001, THESIS; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pleurdeau D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040340; Pollott G, 2009, SHEEP GOATS DIVERSE, P9; Pritchard JK, 2000, GENETICS, V155, P945; Qwabe SO, 2013, TROP ANIM HEALTH PRO, V45, P511, DOI 10.1007/s11250-012-0250-x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay K, 2000, LANDRACE BREEDS S AF, P112; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sadr K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134215; Sharma R, 2016, META GENE, V8, P14, DOI 10.1016/j.mgene.2016.01.002; Shirley E., 2008, THE ZULU; Soma P, 2012, SMALL RUMINANT RES, V103, P112, DOI 10.1016/j.smallrumres.2011.09.041; Taberlet P, 2008, MOL ECOL, V17, P275, DOI 10.1111/j.1365-294X.2007.03475.x; Wei CaiHong, 2015, BMC Genomics, V16; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang J, 2016, MOL BIOL EVOL, V33, P2576, DOI 10.1093/molbev/msw129; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zhao YX, 2017, MOL BIOL EVOL, V34, P2380, DOI 10.1093/molbev/msx181	66	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196276	10.1371/journal.pone.0196276	http://dx.doi.org/10.1371/journal.pone.0196276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698497	Green Published, Green Submitted, gold			2022-12-26	WOS:000431007600056
J	Wang, YH; Wang, MQ; Li, Y; Wu, AP; Huang, JY				Wang, Yanhong; Wang, Minqiang; Li, Yan; Wu, Aiping; Huang, Juying			Effects of arbuscular mycorrhizal fungi on growth and nitrogen uptake of Chrysanthemum morifolium under salt stress	PLOS ONE			English	Article							MINERAL-NUTRITION; SALINE SOILS; TOMATO; PLANTS; ONION; ALLEVIATION; PHOSPHORUS; TOLERANCE; ROOTS; ACCUMULATION	Soil salinity is a common and serious environmental problem worldwide. Arbuscular mycorrhizal fungi (AMF) are considered as bio-ameliorators of soil salinity tolerance in plants. However, few studies have addressed the possible benefits of AMF inoculation for medicinal plants under saline conditions. In this study, we examined the effects of colonization with two AMF, Funneliformis mosseae and Diversispora versiformis, alone and in combination, on the growth and nutrient uptake of the medicinal plant Chrysanthemum morifolium (Hangbaiju) in a greenhouse salt stress experiment. After 6 weeks of a non-saline pretreatment, Hangbaiju plants with and without AMF were grown for five months under salinity levels that were achieved using 0, 50 and 200 mM NaCl. Root length, shoot and root dry weight, total dry weight, and root N concentration were higher in the mycorrhizal plants than in the non-mycorrhizal plants under conditions of moderate salinity, especially with D. versiformis colonization. As salinity increased, mycorrhizal colonization and mycorrhizal dependence decreased. The enhancement of root N uptake is probably the main mechanism underlying salt tolerance in mycorrhizal plants. These results suggest that the symbiotic associations between the fungus D. versiformis and C. morifolium plants may be useful in biotechnological practice.	[Wang, Yanhong; Wang, Minqiang; Li, Yan] Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China; [Wu, Aiping] Hunan Agr Univ, Hunan Prov Key Lab Rural Ecosyst Hlth Dongting La, Changsha, Hunan, Peoples R China; [Huang, Juying] Ningxia Univ, Inst Environm Engn, Ningxia, Peoples R China	Zhejiang A&F University; Hunan Agricultural University; Ningxia University	Wang, YH (corresponding author), Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China.	wangyh313@126.com	Wu, Aiping/AAU-8710-2020		National Natural Science Foundation of China [31400366, 41730638, 31360111]; Open Foundation of the Key Laboratory of Hangzhou City for Ecosystem Protection and Restoration [ECR-2017-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of the Key Laboratory of Hangzhou City for Ecosystem Protection and Restoration	This work was financially supported by the National Natural Science Foundation of China (No. 31400366; No. 41730638; No. 31360111) and Open Foundation of the Key Laboratory of Hangzhou City for Ecosystem Protection and Restoration (ECR-2017-01). YHW, YL, HJY and YHW received the fundings, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by the National Natural Science Foundation of China (No. 31400366; No. 41730638; No. 31360111) and the Open Foundation of the Key Laboratory of Hangzhou City for Ecosystem Protection and Restoration (ECR-2017-01). The valuable suggestions by Dr. Qingsong Shao are greatly appreciated.	Al-Karaki GN, 2001, J PLANT NUTR, V24, P1311, DOI 10.1081/PLN-100106983; Al-Karaki GN, 2000, MYCORRHIZA, V10, P51, DOI 10.1007/s005720000055; Allen SE, 1989, CHEM ANAL ECOLOGICAL, P46; Balliu A, 2015, SUSTAINABILITY-BASEL, V7, P15967, DOI 10.3390/su71215799; BIERMANN B, 1981, NEW PHYTOL, V87, P63, DOI 10.1111/j.1469-8137.1981.tb01690.x; BOLAN NS, 1991, PLANT SOIL, V134, P189, DOI 10.1007/BF00012037; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Cantrell IC, 2001, PLANT SOIL, V233, P269, DOI 10.1023/A:1010564013601; Chandrasekaran M, 2014, MYCORRHIZA, V24, P611, DOI 10.1007/s00572-014-0582-7; Colla G, 2008, BIOL FERT SOILS, V44, P501, DOI 10.1007/s00374-007-0232-8; Dodd IC, 2012, J EXP BOT, V63, P3415, DOI 10.1093/jxb/ers033; DUKE ER, 1986, NEW PHYTOL, V104, P583, DOI 10.1111/j.1469-8137.1986.tb00658.x; Evelin H, 2012, MYCORRHIZA, V22, P203, DOI 10.1007/s00572-011-0392-0; Evelin H, 2009, ANN BOT-LONDON, V104, P1263, DOI 10.1093/aob/mcp251; Feng G, 2002, MYCORRHIZA, V12, P185, DOI 10.1007/s00572-002-0170-0; Fester T, 2011, CRIT REV PLANT SCI, V30, P459, DOI 10.1080/07352689.2011.605741; Garg N, 2011, J PLANT GROWTH REGUL, V30, P490, DOI 10.1007/s00344-011-9211-2; Giri B, 2004, MYCORRHIZA, V14, P307, DOI 10.1007/s00572-003-0274-1; Giri B, 2003, BIOL FERT SOILS, V38, P170, DOI 10.1007/s00374-003-0636-z; Guan ZhiYong, 2010, Scientia Agricultura Sinica, V43, P4063; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hajiboland R, 2010, PLANT SOIL, V331, P313, DOI 10.1007/s11104-009-0255-z; Hajiboland R, 2009, ACTA AGR SCAND B-S P, V59, P295, DOI 10.1080/09064710802154714; HIRREL MC, 1980, SOIL SCI SOC AM J, V44, P654, DOI 10.2136/sssaj1980.03615995004400030046x; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Huang Lu-Qi, 2007, Zhongguo Zhong Yao Za Zhi, V32, P277; Huang SL, 2010, GUANGDONG AGR SCI, P71; JUNIPER S, 1993, MYCORRHIZA, V4, P45, DOI 10.1007/BF00204058; KHAN AG, 1974, J GEN MICROBIOL, V81, P7, DOI 10.1099/00221287-81-1-7; Li Y, 2017, JIANGXI AGR, P56; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; McNamara NP, 2003, APPL SOIL ECOL, V24, P117, DOI 10.1016/S0929-1393(03)00073-8; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; OJALA JC, 1983, AGRON J, V75, P255, DOI 10.2134/agronj1983.00021962007500020023x; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Porras-Soriano A, 2009, J PLANT PHYSIOL, V166, P1350, DOI 10.1016/j.jplph.2009.02.010; POSS JA, 1985, PLANT SOIL, V88, P307, DOI 10.1007/BF02197488; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; Ruiz-Lozano JM, 2000, MYCORRHIZA, V10, P137, DOI 10.1007/s005720000075; RuizLozano JM, 1996, PHYSIOL PLANTARUM, V98, P767, DOI 10.1111/j.1399-3054.1996.tb06683.x; Shao Qingsong, 2011, Zhongguo Zhong Yao Za Zhi, V36, P3233; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Szabolcs I., 1994, HDB PLANT CROP STRES; Turkmen O, 2008, AFR J BIOTECHNOL, V7, P392; Veiga RSL, 2013, PLANT CELL ENVIRON, V36, P1926, DOI 10.1111/pce.12102; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Wilson GWT, 1998, AM J BOT, V85, P1732, DOI 10.2307/2446507; Wu Xiang, 2012, Journal of Northeast Forestry University, V40, P44; [张龙 Zhang Long], 2013, [核农学报, Journal of Nuclear Agricultural Sciences], V27, P1553; Zhang P, 2015, JIANGSU AGR SCI, V43, P234; Zheng CZ, 1993, FLORA OF ZHEJIANG, P271	51	57	64	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196408	10.1371/journal.pone.0196408	http://dx.doi.org/10.1371/journal.pone.0196408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698448	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600075
J	Viviani, DA; Bottjer, D; Letelier, RM; Church, MJ				Viviani, Donn A.; Boettjer, Daniela; Letelier, Ricardo M.; Church, Matthew J.			The influence of abrupt increases in seawater pCO(2) on plankton productivity in the subtropical North Pacific Ocean	PLOS ONE			English	Article							TRANSPARENT EXOPOLYMER PARTICLES; DISSOLVED INORGANIC CARBON; CO2 CONCENTRATION; PROTEIN-SYNTHESIS; ELEMENTAL RATIOS; ORGANIC-CARBON; ELEVATED CO2; SEA-WATER; ACIDIFICATION; DYNAMICS	We conducted a series of experiments to examine short-term (2-5 days) effects of abrupt increases in the partial pressure of carbon dioxide (pCO(2)) in seawater on rates of primary and bacterial production at Station ALOHA (22 degrees 45'N, 158 degrees W) in the North Pacific Subtropical Gyre (NPSG). The majority of experiments (8 of 10 total) displayed no response in rates of primary production (measured by C-14-bicarbonate assimilation; C-14-PP) under elevated pCO(2) (similar to 1100 mu atm) compared to ambient pCO(2) (similar to 387 mu atm). In 2 of 10 experiments, rates of C-14-PP decreased significantly (similar to 43%) under elevated pCO(2) treatments relative to controls. Similarly, no significant differences between treatments were observed in 6 of 7 experiments where bacterial production was measured via incorporation of H-3-leucine (H-3-Leu), while in 1 experiment, rates of H-3-Leu incorporation measured in the dark (H-3-LeuDark) increased more than 2-fold under high pCO(2) conditions. We also examined photoperiodlength, depth-dependent (0-125 m) responses in rates of C-14-PP and H-3-Leu incorporation to abrupt pCO(2) increases (to similar to 750 mu atm). In the majority of these depth-resolved experiments (4 of 5 total), rates of C-14-PP demonstrated no consistent response to elevated pCO(2). In 2 of 5 depth-resolved experiments, rates of H-3-LeuDark incorporation were lower (10% to 15%) under elevated pCO(2) compared to controls. Our results revealed that rates of C-14-PP and bacterial production in this persistently oligotrophic habitat generally demonstrated no or weak responses to abrupt changes in pCO(2). We postulate that any effects caused by changes in pCO(2) may be masked or outweighed by the role that nutrient availability and temperature play in controlling metabolism in this ecosystem.	[Viviani, Donn A.; Boettjer, Daniela; Church, Matthew J.] Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Viviani, Donn A.; Letelier, Ricardo M.; Church, Matthew J.] Univ Hawaii Manoa, Daniel K Inouye Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA; [Letelier, Ricardo M.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Boettjer, Daniela] Univ Hawaii Manoa, Ctr Teaching Excellence, Honolulu, HI 96822 USA; [Church, Matthew J.] Univ Montana, Flathead Lake Biol Stn, Poison, MT USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Oregon State University; University of Hawaii System; University of Hawaii Manoa; University of Montana System; University of Montana	Viviani, DA (corresponding author), Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA.; Viviani, DA (corresponding author), Univ Hawaii Manoa, Daniel K Inouye Ctr Microbial Oceanog Res & Educ, Honolulu, HI 96822 USA.	viviani@hawaii.edu	Letelier, Ricardo/A-6953-2009; Viviani, Donn/M-1037-2019	Letelier, Ricardo/0000-0003-3376-4026; Viviani, Donn/0000-0002-7195-3672	National Science Foundation [OCE-0850827, 1260164]; Center for Microbial Oceanography: Research and Education (CMORE; NSF) [EF04-24599]; Hawaii Ocean Time-series (HOT; NSF) [OCE-09-26766]	National Science Foundation(National Science Foundation (NSF)); Center for Microbial Oceanography: Research and Education (CMORE; NSF); Hawaii Ocean Time-series (HOT; NSF)	Funding for this study was derived from the National Science Foundation (https://www.nsf.gov/), under grants OCE-0850827 (MJC and RML) and 1260164 (MJC). Additional support was provided by the Center for Microbial Oceanography: Research and Education (CMORE; NSF grant EF04-24599) and Hawaii Ocean Time-series (HOT; NSF grant OCE-09-26766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger M, 2003, PHOTOSYNTH RES, V77, P83, DOI 10.1023/A:1025821717773; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Beman JM, 2011, P NATL ACAD SCI USA, V108, P208, DOI 10.1073/pnas.1011053108; Bjorkman KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01401; Bottjer D, 2014, GLOBAL BIOGEOCHEM CY, V28, P601, DOI 10.1002/2013GB004690; Church MJ, 2006, AQUAT MICROB ECOL, V45, P41, DOI 10.3354/ame045041; Church MJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003418; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Dickson A.G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dore JE, 1996, DEEP-SEA RES PT II, V43, P385, DOI 10.1016/0967-0645(95)00105-0; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Egge JK, 2009, BIOGEOSCIENCES, V6, P877, DOI 10.5194/bg-6-877-2009; Endres S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099228; Engel A, 2013, BIOGEOSCIENCES, V10, P1291, DOI 10.5194/bg-10-1291-2013; Engel A, 2002, J PLANKTON RES, V24, P49, DOI 10.1093/plankt/24.1.49; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; GARSIDE C, 1982, MAR CHEM, V11, P159, DOI 10.1016/0304-4203(82)90039-1; Gattuso J.-P., 2015, SEACARB SEAWATER CAR; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Grossart HP, 2006, LIMNOL OCEANOGR, V51, P1, DOI 10.4319/lo.2006.51.1.0001; Hein M, 1997, NATURE, V388, P526, DOI 10.1038/41457; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Hu CM, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007395; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Karl DM, 1998, LIMNOL OCEANOGR, V43, P1270, DOI 10.4319/lo.1998.43.6.1270; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105, DOI 10.4319/lo.1992.37.1.0105; Kim JM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047346; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Krause E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047035; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Letelier RM, 1996, DEEP-SEA RES PT II, V43, P467, DOI 10.1016/0967-0645(96)00006-9; Li BL, 2011, MAR ECOL PROG SER, V440, P27, DOI 10.3354/meps09345; Liu JW, 2010, AQUAT MICROB ECOL, V61, P291, DOI 10.3354/ame01446; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; Lomas MW, 2012, AQUAT MICROB ECOL, V66, P211, DOI 10.3354/ame01576; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; MacGilchrist GA, 2014, BIOGEOSCIENCES, V11, P3695, DOI 10.5194/bg-11-3695-2014; Maranon E, 2016, LIMNOL OCEANOGR, V61, P1345, DOI 10.1002/lno.10295; PEREZ FF, 1987, MAR CHEM, V21, P161, DOI 10.1016/0304-4203(87)90036-3; Piontek J, 2013, BIOGEOSCIENCES, V10, P297, DOI 10.5194/bg-10-297-2013; Piontek J, 2010, BIOGEOSCIENCES, V7, P1615, DOI 10.5194/bg-7-1615-2010; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Raven JA, 1997, BIOGEOCHEMISTRY, V39, P139, DOI 10.1023/A:1005855528289; Richier S, 2014, BIOGEOSCIENCES, V11, P4733, DOI 10.5194/bg-11-4733-2014; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rii YM, 2016, MAR ECOL PROG SER, V562, P1, DOI 10.3354/meps11954; Riser SC, 2008, NATURE, V451, P323, DOI 10.1038/nature06441; Rivkin RB, 2001, SCIENCE, V291, P2398, DOI 10.1126/science.291.5512.2398; Shi DL, 2012, P NATL ACAD SCI USA, V109, pE3094, DOI 10.1073/pnas.1216012109; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P744, DOI 10.4319/lo.2000.45.3.0744; Tortell PD, 2002, MAR ECOL PROG SER, V236, P37, DOI 10.3354/meps236037; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; UPPSTROM LR, 1974, DEEP-SEA RES, V21, P161, DOI 10.1016/0011-7471(74)90074-6; Winn CD, 1998, MAR CHEM, V60, P33, DOI 10.1016/S0304-4203(97)00085-6; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Yamada N, 2010, J OCEANOGR, V66, P233, DOI 10.1007/s10872-010-0021-0; Yoshimura T, 2010, J EXP MAR BIOL ECOL, V395, P191, DOI 10.1016/j.jembe.2010.09.001; Zark M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500531; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124	67	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0193405	10.1371/journal.pone.0193405	http://dx.doi.org/10.1371/journal.pone.0193405			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694353	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400003
J	Wagner, L; Rahne, T; Plontke, SK; Heidekruger, N				Wagner, Luise; Rahne, Torsten; Plontke, Stefan K.; Heidekruger, Nico			Mismatch negativity reflects asymmetric pre-attentive harmonic interval discrimination	PLOS ONE			English	Article							ABSTRACT REGULARITIES; BRAIN; MMN; LISTENERS; PARADIGM; PITCH	Objective Western music is based on intervals; thus, interval discrimination is important for distinguishing the character of melodies or tracking melodies in polyphonic music. In this study the encoding of intervals in simultaneously presented sound is studied. Study design In an electrophysiological experiment in 15 normal-hearing non-musicians, major thirds or fifths were presented in a controlled oddball paradigm. Harmonic intervals were created by simultaneously presented sinusoidals with randomized root frequency. Mismatch negativity (MMN) responses were measured with an EEG recording. The discrimination index was calculated in a psychoacoustic experiment. Results A clear MMN response was found for the major third but not for the fifth. The neural generators were located within the auditory cortices. Psychoacoustically, no evidence was found that the subjects were able to detect the deviants. Conclusions We conclude that pre-attentive discrimination of harmonic interval size is, in principle, possible in listeners without musical training although simultaneous presentation makes it harder to distinguish compared to non-overlapping intervals. Furthermore we see a difference in the response to infrequent dissonant stimuli in consonant standard stimuli compared to the opposite, rare consonant stimuli in dissonant standard stimuli.	[Wagner, Luise; Rahne, Torsten; Plontke, Stefan K.; Heidekruger, Nico] Martin Luther Univ Halle Wittenberg, Dept Otorhinolaryngol Head & Neck Surg, Univ Hosp Halle Seale, Halle, Seale, Germany	Martin Luther University Halle Wittenberg	Wagner, L (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Otorhinolaryngol Head & Neck Surg, Univ Hosp Halle Seale, Halle, Seale, Germany.	luise.wagner@uk-halle.de	Rahne, Torsten/AAD-1369-2021					ATTNEAVE F, 1971, AM J PSYCHOL, V84, P147, DOI 10.2307/1421351; Brattico E, 2003, ANN NY ACAD SCI, V999, P158, DOI 10.1196/annals.1284.019; Brattico E, 2009, J COGNITIVE NEUROSCI, V21, P2230, DOI 10.1162/jocn.2008.21144; Deutsch D, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P1; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gfeller K, 2016, EUR ANN OTORHINOLARY, V133, pS50, DOI 10.1016/j.anorl.2016.01.010; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Lappe C, 2011, PLOS ONE, V6; Looi Valerie, 2012, Seminars in Hearing, V33, P307, DOI 10.1055/s-0032-1329222; Luo X, 2014, J ACOUST SOC AM, V136, P1831, DOI 10.1121/1.4894738; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1980, Prog Brain Res, V54, P343, DOI 10.1016/S0079-6123(08)61645-3; Paavilainen P, 2007, NEUROREPORT, V18, P159, DOI 10.1097/WNR.0b013e328010e2ac; Paavilainen P, 2013, INT J PSYCHOPHYSIOL, V88, P109, DOI 10.1016/j.ijpsycho.2013.03.015; Putkinen V, 2014, NEUROBIOL LEARN MEM, V110, P8, DOI 10.1016/j.nlm.2014.01.007; Russo FA, 2005, PSYCHON B REV, V12, P1068, DOI 10.3758/BF03206445; Ruusuvirta TT, 2012, NEUROREPORT, V23, P220, DOI 10.1097/WNR.0b013e32834fe71d; SAARINEN J, 1992, NEUROREPORT, V3, P1149, DOI 10.1097/00001756-199212000-00030; Schellenberg EG, 1996, J ACOUST SOC AM, V100, P3321, DOI 10.1121/1.417355; Timm J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00189; van Zuijen TL, 2006, J COGNITIVE NEUROSCI, V18, P1292, DOI 10.1162/jocn.2006.18.8.1292; Virtala P, 2011, NEUROSCI LETT, V487, P406, DOI 10.1016/j.neulet.2010.10.066; Vuust P, 2011, CORTEX, V47, P1091, DOI 10.1016/j.cortex.2011.04.026; Yu XD, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/469508	26	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196176	10.1371/journal.pone.0196176	http://dx.doi.org/10.1371/journal.pone.0196176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	29694384	Green Published, Green Submitted, gold			2022-12-26	WOS:000430802400071
J	Garrett, NJ; Osman, F; Maharaj, B; Naicker, N; Gibbs, A; Norman, E; Samsunder, N; Ngobese, H; Mitchev, N; Singh, R; Karim, SSA; Kharsany, ABM; Mlisana, K; Rompalo, A; Mindel, A				Garrett, Nigel J.; Osman, Farzana; Maharaj, Bhavna; Naicker, Nivashnee; Gibbs, Andrew; Norman, Emily; Samsunder, Natasha; Ngobese, Hope; Mitchev, Nireshni; Singh, Ravesh; Karim, Salim S. Abdool; Kharsany, Ayesha B. M.; Mlisana, Koleka; Rompalo, Anne; Mindel, Adrian			Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low-and middle-income countries	PLOS ONE			English	Article							DELIVERED PARTNER MEDICATION; OF-CARE TESTS; SOUTH-AFRICA; TRICHOMONAS-VAGINALIS; NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; PREGNANT-WOMEN; RISK-FACTORS; DISEASES; TRANSMISSION	Introduction In light of the limited impact the syndromic management approach has had on the global sexually transmitted infection (STI) epidemic, we assessed a care model comprising pointof- care (POC) STI testing, immediate treatment, and expedited partner therapy (EPT) among a cohort of young women at high HIV risk in South Africa. Methods and findings HIV negative women presenting for STI care underwent POC testing for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV), and swabs were sent for NG culture and susceptibility testing. Results were available within 2 hours and women with STIs were immediately treated and offered EPT packs, including medication, condoms, and information for sexual partners. An EPT questionnaire was administered after one week, and women retested for STIs after 6 and 12 weeks. 267 women, median age 23 (IQR 21-26), were recruited and 88.4% (236/267) reported genital symptoms. STI prevalence was CT 18.4% (95% CI 13.7-23.0), NG 5.2% (95% CI 2.6-7.9) and TV 3.0% (95% CI 1.0-5.0). After 12 weeks, all but one NG and two CT infections were cleared. No cephalosporin- resistant NG was detected. Of 63/267 women (23.6%) diagnosed with STIs, 98.4% (62/63) were offered and 87.1% (54/62) accepted EPT. At one week 88.9% (48/54) stated that their partner had taken the medication. No allergic reactions or social harms were reported. Of 51 women completing 6-week follow up, detection rates were lower amongst women receiving EPT (2.2%, 1/46) compared to those who did not (40.0%, 2/5), p = 0.023. During focus group discussions women supported the care model, because they received a rapid, specific diagnosis, and could facilitate their partners' treatment. Conclusions POC STI testing and EPT were acceptable to young South African women and their partners, and could play an important role in reducing STI reinfection rates and HIV risk. Larger studies should evaluate the feasibility and cost-effectiveness of implementing this strategy at population level.	[Garrett, Nigel J.; Osman, Farzana; Maharaj, Bhavna; Naicker, Nivashnee; Norman, Emily; Samsunder, Natasha; Karim, Salim S. Abdool; Kharsany, Ayesha B. M.; Mindel, Adrian] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Garrett, Nigel J.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Gibbs, Andrew] South African Med Res Council, Durban, South Africa; [Norman, Emily; Karim, Salim S. Abdool] Columbia Univ, Dept Epidemiol, New York, NY USA; [Ngobese, Hope] Prince Cyril Zulu Communicable Dis Ctr, Durban, South Africa; [Mitchev, Nireshni; Singh, Ravesh; Mlisana, Koleka] Univ KwaZulu Natal, Dept Microbiol, Durban, South Africa; [Singh, Ravesh; Mlisana, Koleka] Natl Hlth Lab Serv, Durban, South Africa; [Rompalo, Anne] Johns Hopkins Univ, Baltimore, MD USA	University of Kwazulu Natal; South African Medical Research Council; Columbia University; National Institute for Communicable Diseases (NICD); University of Kwazulu Natal; Johns Hopkins University	Garrett, NJ (corresponding author), Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.; Garrett, NJ (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.	nigel.garrett@caprisa.org	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019; Mitchev, Nireshni/AGQ-3804-2022; Mlisana, Koleka/N-6204-2013	Karim, Salim Abdool/0000-0002-4986-2133; Mitchev, Nireshni/0000-0002-0221-0808; Garrett, Nigel/0000-0002-4530-234X; Mlisana, Koleka/0000-0002-8436-3268; Maharaj, Bhavna/0000-0003-1935-4637; Gibbs, Andrew/0000-0003-2812-5377	United States - South African Program for Collaborative Biomedical Research grant through the South African Medical Research Council; National Institute of Health [AI116759]	United States - South African Program for Collaborative Biomedical Research grant through the South African Medical Research Council; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by a United States - South African Program for Collaborative Biomedical Research grant through the South African Medical Research Council and the National Institute of Health (AI116759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2016, PEDIATR INFECT DIS J, V35, P894, DOI 10.1097/INF.0000000000001199; Atkinson LM, 2016, INT J STD AIDS, V27, P650, DOI 10.1177/0956462415591414; Bosu WK, 1999, TROP MED INT HEALTH, V4, P114, DOI 10.1046/j.1365-3156.1999.00360.x; Centre for Disease Control and Prevention, 2015, SEXUALLY; Department for Business Innovation & Skills, 2015, SPORT FUT NEW STRAT; Department of Health of South Africa, 2010, GAUT HLTH INF MAN RE; Garrett NJ, 2017, SEX TRANSM INFECT, V93, P4, DOI 10.1136/sextrans-2016-052581; Gaydos CA, 2017, SEX TRANSM INFECT, V93, pS31, DOI 10.1136/sextrans-2016-053063; Gaydos CA, 2013, J CLIN MICROBIOL, V51, P1666, DOI 10.1128/JCM.03461-12; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; Guy RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-485; Hawkes S, 1999, LANCET, V354, P1776, DOI 10.1016/S0140-6736(99)02463-0; Hegazy MM, 2012, DIAGN MICR INFEC DIS, V74, P49, DOI 10.1016/j.diagmicrobio.2012.05.003; Huppert JS, 2011, SEX TRANSM INFECT, V87, P494, DOI 10.1136/sextrans-2011-050037; Huppert JS, 2010, SEX TRANSM INFECT, V86, P514, DOI 10.1136/sti.2009.042168; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kharsany ABM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-231; Kissinger Patricia, 2011, Curr Infect Dis Rep, V13, P188, DOI 10.1007/s11908-010-0159-3; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Mayanja Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155383; Nguyen M, 2016, SEX TRANSM DIS, V43, P296, DOI 10.1097/OLQ.0000000000000436; Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298; Naidoo S, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-31; Nathan B, 2015, INT J STD AIDS, V26, P251, DOI 10.1177/0956462414534833; Nuwaha F, 2001, SEX TRANSM DIS, V28, P105, DOI 10.1097/00007435-200102000-00008; PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233; Ramjee G, 2005, JAIDS-J ACQ IMM DEF, V39, P333, DOI 10.1097/01.qai.0000144445.44518.ea; Romoren M, 2007, SEX TRANSM INFECT, V83, P558, DOI 10.1136/sti.2007.026930; Shiely F, 2010, SEX TRANSM DIS, V37, P602, DOI 10.1097/OLQ.0b013e3181e1a296; Shisana O, 2014, S AFRICAN NATL HIV P; STAMM WE, 1988, JAMA-J AM MED ASSOC, V260, P1429, DOI 10.1001/jama.260.10.1429; UNAIDS, 2016, AIDS BY THE NUMB; van der Helm JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032122; Vuylsteke B, 2004, SEX TRANSM INFECT, V80, P333, DOI 10.1136/sti.2004.009407; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; White RG, 2008, SEX TRANSM INFECT, V84, P528, DOI 10.1136/sti.2008.032011; Wolday D, 2004, SEX TRANSM INFECT, V80, P392, DOI 10.1136/sti.2003.005660; Young T, 2007, INT J STD AIDS, V18, P338, DOI 10.1258/095646207780749781	40	51	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196209	10.1371/journal.pone.0196209	http://dx.doi.org/10.1371/journal.pone.0196209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689080	Green Submitted, Green Published, gold			2022-12-26	WOS:000430678800032
J	Wasitthankasem, R; Vichaiwattana, P; Siripon, N; Posuwan, N; Auphimail, C; Klinfueng, S; Thanetkongtong, N; Vuthitanachot, V; Saiyatha, S; Thongmai, C; Sochoo, S; Pongsuwan, N; Poovorawan, K; Tangkijvanich, P; Poovorawan, Y				Wasitthankasem, Rujipat; Vichaiwattana, Preeyaporn; Siripon, Nipaporn; Posuwan, Nawarat; Auphimail, Chompoonut; Klinfueng, Sirapa; Thanetkongtong, Napha; Vuthitanachot, Viboonsak; Saiyatha, Supapith; Thongmai, Chaiwat; Sochoo, Saowakon; Pongsuwan, Natnada; Poovorawan, Kittiyod; Tangkijvanich, Pisit; Poovorawan, Yong			Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; HEPATOCELLULAR-CARCINOMA; RISK	The prevalence of hepatitis C virus (HCV) infection has been decreasing globally, but the growing effects of HCV-related morbidity and mortality remain of concern. Advances in curative medicine, involving direct-acting antivirals (DAAs), have led many countries to aim to eradicate HCV. Information on epidemiology and disease burden is essential for national policy development. Thus, this study aimed to determine the HCV-related hepatic disease burden in areas of Thailand with high and average HCV prevalence in order to extrapolate the viral burden across Thailand. Patients previously diagnosed as positive for anti-HCV antibodies were recruited to assess chronic HCV infection (CHC) status, liver function, HCV-RNA level and hepatic fibrosis. The number of patients eligible for Universal Health Coverage (UC) scheme and the approximately required expenditure on interferon (IFN)based treatment were estimated. In areas of both high (12%) and average (2%) HCV viremic prevalence, over half of the patients (52.2% to 62.5%) had advanced liver fibrosis (F3 and F4). A striking percentage of patients with F4 (38.9%) were found in the high-prevalence area, while comparable proportions of advanced liver fibrosis presented in the two areas and disease burden peaked at 50 +/- 59 years. Under the current UC program treatment scenario, 78 +/- 83% of CHC patients with stage F2 +/- F4 fibrosis were eligible for treatment. The estimated expenditure required for overall CHC treatment across the whole country was 1,240 million USD at this current status, but the declining cost of generic DAA-based therapy may reduce the requirement to <90 million USD. This study provides information on the estimated number of CHC patients, liver disease burden and expenditure requirements for Thailand. To eliminate HCV by 2030, proactive government strategies raising public health to minimize transmission and emphasizing targeted screen-and-treatment programs, novel therapeutic guideline development for decentralizing treatment, and effective budget allocation are urgently needed.	[Wasitthankasem, Rujipat; Vichaiwattana, Preeyaporn; Siripon, Nipaporn; Posuwan, Nawarat; Auphimail, Chompoonut; Klinfueng, Sirapa; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand; [Thanetkongtong, Napha; Vuthitanachot, Viboonsak] Chumpare Hosp, Khon Kaen, Thailand; [Saiyatha, Supapith; Thongmai, Chaiwat] Phetchabun Prov Publ Hlth Off, Mueang Phetchabun, Phetchabun, Thailand; [Sochoo, Saowakon; Pongsuwan, Natnada] Lomkao Crown Prince Hosp, Lom Kao, Phetchabun, Thailand; [Poovorawan, Kittiyod] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Dept Biochem, Ctr Excellence Hepatitis & Liver Canc, Fac Med, Bangkok, Thailand	Chulalongkorn University; Mahidol University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Kittiyod/0000-0001-7016-7605	National Science and Technology Development Agency [P-15-5004]; National Research University Project, Office of Higher Education Commission [NRU-59-002-HR]; Thailand Research Fund [RTA5980008]; Ratchadaphiseksomphot Endowment Fund for Postdoctoral Fellowship; Center of Excellence in Clinical Virology, Chulalongkorn University [GCE58-014-30-004]; King Chulalongkorn Memorial Hospital	National Science and Technology Development Agency; National Research University Project, Office of Higher Education Commission; Thailand Research Fund(Thailand Research Fund (TRF)); Ratchadaphiseksomphot Endowment Fund for Postdoctoral Fellowship; Center of Excellence in Clinical Virology, Chulalongkorn University(Chulalongkorn University); King Chulalongkorn Memorial Hospital(Chulalongkorn University)	This work was supported by the Research Chair Grant from the National Science and Technology Development Agency (P-15-5004) to YP, the National Research University Project, Office of Higher Education Commission (NRU-59-002-HR) to YP, Thailand Research Fund (RTA5980008) to PT, Ratchadaphiseksomphot Endowment Fund for Postdoctoral Fellowship to RW, the Center of Excellence in Clinical Virology, Chulalongkorn University (GCE58-014-30-004) and King Chulalongkorn Memorial Hospital to YP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Capileno YA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175562; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chimparlee N, 2011, SE ASIAN J TROP MED, V42, P609; Committee of Preventive and Control Development on Viral Hepatitis Ministry of Public Health, 2017, THAIL NAT STRAT VIR, P2017; D'Ambrosio R, 2015, INT J MOL SCI, V16, P19698, DOI 10.3390/ijms160819698; Dalgard O, 2003, SCAND J GASTROENTERO, V38, P864, DOI 10.1080/00365520310004542; Falade-Nwulia O, 2017, ANN INTERN MED, V166, P637, DOI [10.7326/m16-2575, 10.7326/M16-2575]; Freiman JM, 2016, ANN INTERN MED, V165, P345, DOI 10.7326/M16-0065; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hajarizadeh B, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.37234; Julicher P, 2018, J MED ECON, V21, P1, DOI 10.1080/13696998.2017.1369983; Kattakuzhy S, 2017, ANN INTERN MED, V167, P311, DOI [10.7326/M17-0118, 10.7326/m17-0118]; Kileng H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2722-0; Mauss S, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0856-y; Miller MM, 2017, AM J HEALTH-SYST PH, V74, P1045, DOI 10.2146/ajhp60632; Nebehay S., 2017, HEPATITIS DRUGS MORE; Poovorawan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163095; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Tangkijvanich P, 2012, J VIRAL HEPATITIS, V19, P423, DOI 10.1111/j.1365-2893.2011.01566.x; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Toyoda H, 2015, J GASTROEN HEPATOL, V30, P1183, DOI 10.1111/jgh.12915; Wait S, 2016, LANCET GASTROENTEROL, V1, P248, DOI 10.1016/S2468-1253(16)30031-0; Wasitthankasem R, 2017, PEERJ, V5, DOI 10.7717/peerj.4008; Wasitthankasem R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177022; Wasitthankasem R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149362; WHO, 2017, GLOBAL HEPATITIS REP	29	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0196301	10.1371/journal.pone.0196301	http://dx.doi.org/10.1371/journal.pone.0196301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689073	Green Submitted, gold, Green Published			2022-12-26	WOS:000430678800041
J	McKinley, BA; Olson, SN; Ritter, KB; Herb, DW; Karien, SD; Lu, FH; Ralph, J; Rooney, WL; Mullet, JE				McKinley, Brian A.; Olson, Sara N.; Ritter, Kimberley B.; Herb, Dustin W.; Karien, Steven D.; Lu, Fachuang; Ralph, John; Rooney, William L.; Mullet, John E.			Variation in energy sorghum hybrid TX08001 biomass composition and lignin chemistry during development under irrigated and non-irrigated field conditions	PLOS ONE			English	Article							SWEET SORGHUM; SUCROSE ACCUMULATION; AERENCHYMA FORMATION; GENETIC MODEL; DFRC METHOD; YIELD; MAIZE; FEEDSTOCK; SUGARCANE; STABILITY	This study was conducted to document the extent and basis of compositional variation of shoot biomass of the energy Sorghum bicolor hybrid TX08001 during development under field conditions. TX08001 is capable of accumulating similar to 40 Mg/ha of dry biomass under good growing conditions and this genotype allocates similar to 80% of its shoot biomass to stems. After 150 days of growth TX08001 stems had a fresh/dry weight ratio of similar to 3:1 and soluble biomass accounted for similar to 30% of stem biomass. A panel of diverse energy sorghum genotypes varied similar to 6-fold in the ratio of stem structural to soluble biomass after 150 days of growth. Near-infrared spectroscopic analysis (NIRS) showed that TX08001 leaves accumulated higher levels of protein, water extractives and ash compared to stems, which have higher sugar, cellulose, and lignin contents. TX08001 stem sucrose content varied during development, whereas the composition of TX08001 stem cell walls, which consisted of similar to 45-49% cellulose, similar to 27-30% xylan, and similar to 15-18% lignin, remained constant after 90 days post emergence until the end of the growing season (180 days). TX08001 and Della stem syringyl (S)/guaiacyl (G) (0.53-0.58) and ferulic acid (FA)/para-coumaric acid (pCA) ratios were similar whereas ratios of pCA/(S+G) differed between these genotypes. Additionally, an analysis of irrigated versus non-irrigated TX08001 revealed that non-irrigated hybrids exhibited a 50% reduction in total cell wall biomass, an similar to 2-fold increase in stem sugars, and an similar to 25% increase in water extractives relative to irrigated hybrids. This study provides a baseline of information to help guide further optimization of energy sorghum composition for various end-uses.	[McKinley, Brian A.; Olson, Sara N.; Ritter, Kimberley B.; Mullet, John E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [McKinley, Brian A.; Karien, Steven D.; Lu, Fachuang; Ralph, John; Mullet, John E.] Great Lakes Bioenergy Res Ctr, Dept Energy, Madison, WI 53706 USA; [Herb, Dustin W.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Karien, Steven D.; Lu, Fachuang; Ralph, John] Univ Wisconsin, Wisconsin Energy Inst, Dept Biochem, Madison, WI USA; [Rooney, William L.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; United States Department of Energy (DOE); Oregon State University; University of Wisconsin System; University of Wisconsin Madison; Texas A&M University System; Texas A&M University College Station	Mullet, JE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.; Mullet, JE (corresponding author), Great Lakes Bioenergy Res Ctr, Dept Energy, Madison, WI 53706 USA.	jmullet@tamu.edu	Ralph, John/C-3161-2009; Lu, Fachuang/K-6487-2019	Ralph, John/0000-0002-6093-4521; Mckinley, Brian/0000-0001-7105-9649	Great Lakes Bioenergy Research Center [BER DOE-DE-SC0006930, DE-SC0018409]; Perry Adkisson Chair in Agricultural Biology of Texas AM University; US Department of Energy, the Office of Science [BER DOE-DE-SC0006930, DE-SC0018409]; Perry Adkisson Chair	Great Lakes Bioenergy Research Center; Perry Adkisson Chair in Agricultural Biology of Texas AM University; US Department of Energy, the Office of Science(United States Department of Energy (DOE)); Perry Adkisson Chair	This research was funded by the Great Lakes Bioenergy Research Center (https://www.glbrc.org/) (BER DOE-DE-SC0006930 and DE-SC0018409) and by the Perry Adkisson Chair in Agricultural Biology of Texas A&M University awarded to John Mullet. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Susan Hall for help with the collection of the plant materials used in these analyses and Sarah Liu for preparing the samples for NMR analysis. We would also like to thank Leo Hoffmann Jr. for help with statistical analysis of NIRS. This research funded by the US Department of Energy, the Office of Science (BER DOE-DE-SC0006930 and DE-SC0018409) and the Perry Adkisson Chair (J.E.M.).	Arundale RA, 2015, BIOENERG RES, V8, P1636, DOI 10.1007/s12155-015-9613-2; Beck P, 2013, GRASSL SCI, V59, P52, DOI 10.1111/grs.12007; Bennett AS, 2009, BIORESOURCE TECHNOL, V100, P1595, DOI 10.1016/j.biortech.2008.09.023; Brenton ZW, 2016, GENETICS, V204, P21, DOI 10.1534/genetics.115.183947; Bruinsma J., 2009, RESOURCE OUTLOOK 205; Burks PS, 2013, AGRON J, V105, P263, DOI 10.2134/agronj2012.0317; Byrt CS, 2011, J INTEGR PLANT BIOL, V53, P120, DOI 10.1111/j.1744-7909.2010.01023.x; Carpita NC, 1996, ANNU REV PLANT PHYS, V47, P445, DOI 10.1146/annurev.arplant.47.1.445; Chen SF, 2007, J AGR FOOD CHEM, V55, P5912, DOI 10.1021/jf0700327; Dale BE, 2012, BIOTECHNOL PROGR, V28, P893, DOI 10.1002/btpr.1575; Dale BE, 2009, BIOFUEL BIOPROD BIOR, V3, P219, DOI 10.1002/bbb.132; del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n; Gill JR, 2014, BIOENERG RES, V7, P1026, DOI 10.1007/s12155-014-9445-5; Gnansounou E, 2010, BIORESOURCE TECHNOL, V101, P4980, DOI 10.1016/j.biortech.2010.02.009; Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f; Gutjahr S, 2013, FUNCT PLANT BIOL, V40, P355, DOI 10.1071/FP12177; HoffmannThoma G, 1996, PHYSIOL PLANTARUM, V97, P277, DOI 10.1034/j.1399-3054.1996.970210.x; Karlen SD, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600393; Kenney KL, 2013, BIOFUELS-UK, V4, P111, DOI [10.4155/BFS.12.83, 10.4155/bfs.12.83]; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; Kulamarva AG, 2009, INT J FOOD PROP, V12, P55, DOI 10.1080/10942910802252148; Kumar V, 2014, J EXP BOT SOC EXPT B, V66; Lan W, 2015, PLANT PHYSIOL, V167, P1284, DOI 10.1104/pp.114.253757; Li X, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-27; Lingle SE, 2012, BIOENERG RES, V5, P168, DOI 10.1007/s12155-011-9153-3; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Lu FC, 1997, J AGR FOOD CHEM, V45, P4655, DOI 10.1021/jf970539p; Lu FC, 1997, J AGR FOOD CHEM, V45, P2590, DOI 10.1021/jf970258h; Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064; Alonso DM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603301; McBee GG., 1983, SORGHUM ROOT STALK R, P119; McCann MC, 2015, J EXP BOT, V66, P4109, DOI 10.1093/jxb/erv267; McKinley B, 2016, PLANT J, V88, P662, DOI 10.1111/tpj.13269; Mullet J, 2014, J EXP BOT, V65, P3479, DOI 10.1093/jxb/eru229; National Cooperative Soil Survey, 2007, OFF SER DESCR BELK S; Olson SN, 2013, BIOMASS BIOENERG, V56, P307, DOI 10.1016/j.biombioe.2013.04.028; Olson SN, 2012, BIOFUEL BIOPROD BIOR, V6, P640, DOI 10.1002/bbb.1357; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Perlack D, 2011, AGR BIOSYST ENG TECH; RALPH J, 1998, LIGNIN LIGNAN BIOSYN, P209, DOI DOI 10.1021/BK-1998-0697.CH016; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Ranum P, 2014, ANN NY ACAD SCI, V1312, P105, DOI 10.1111/nyas.12396; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Rinaldi R, 2016, ANGEW CHEM INT EDIT, V55, P8164, DOI 10.1002/anie.201510351; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Rooney WL, 1999, CROP SCI, V39, P397, DOI 10.2135/cropsci1999.0011183X0039000200016x; Sanjuan R, 2001, HOLZ ROH WERKST, V59, P447, DOI 10.1007/s001070100236; Sattler SE, 2012, BIOENERG RES, V5, P855, DOI 10.1007/s12155-012-9197-z; SCHMITT MR, 1981, J EXP BOT, V32, P459, DOI 10.1093/jxb/32.3.459; Scully ED, 2016, J INTEGR PLANT BIOL, V58, P136, DOI 10.1111/jipb.12375; Shahandeh H, 2016, AIMS ENERGY, V4, P633, DOI 10.3934/energy.2016.4.633; Shuai L, 2016, SCIENCE, V354, P329, DOI 10.1126/science.aaf7810; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; Sluiter A., 2005, NREL LAB ANAL PROCED; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Stefaniak TR, 2012, CROP SCI, V52, P1949, DOI 10.2135/cropsci2011.10.0534; Steffens B, 2011, NEW PHYTOL, V190, P369, DOI 10.1111/j.1469-8137.2010.03496.x; Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059; Takahashi H, 2015, ANN BOT-LONDON, V115, P879, DOI 10.1093/aob/mcv018; van der Weijde T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00107; Vermerris W, 2011, J INTEGR PLANT BIOL, V53, P105, DOI 10.1111/j.1744-7909.2010.01020.x; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Weinberg ZG, 2011, GRASSL SCI, V57, P46, DOI 10.1111/j.1744-697X.2010.00207.x; Wilkerson CG, 2014, SCIENCE, V344, P90, DOI 10.1126/science.1250161; Wolfrum E, 2013, MULTIVARIATE CALIBRA; Wu E, 2014, IN VITRO CELL DEV-PL, V50, P9, DOI 10.1007/s11627-013-9583-z	66	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0195863	10.1371/journal.pone.0195863	http://dx.doi.org/10.1371/journal.pone.0195863			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684037	Green Published, Green Submitted, gold			2022-12-26	WOS:000430660600023
J	Abdullah, CS; Jin, ZQ				Abdullah, Chowdhury S.; Jin, Zhu-Qiu			Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice	FASEB JOURNAL			English	Article						CD4(+) T lymphocytes; regulatory T cells; diabetic cardiomyopathy; myocardial fibrosis	MYOCARDIAL-INFARCTION; SPHINGOSINE 1-PHOSPHATE; HEART-FAILURE; CARDIOMYOPATHY; LYMPHOCYTES; MECHANISMS; ACTIVATION; SPHINGOSINE-1-PHOSPHATE; DIFFERENTIATION; INFLAMMATION	Infiltration of T cells is associated with patients who have diabetes at an increased risk of heart attack. T-cell sphingosine 1-phosphate receptor 1 (S1P(1))-mediated signaling directs T-lymphocyte trafficking. Effects of T-cell S1P(1) activation on cardiac fibrosis in a murine diabetic model remain to be explored. For this purpose, conditional T-cell S1P(1) knockout (TS1P(1)KO) mice generated by crossing S1pr(1)(loxP/loxP) mice with Lck-Cre mice were used in a model of streptozotocin-induced diabetic cardiomyopathy. The TS1P(1)KO mice exhibited sustained deficiency of both CD4(+) and CD8(+) T cells in the blood. The TS1P(1)KO vehicle control mouse hearts featured an altered phenotype characterized by increased myocardial fibrosis and reduced cardiac contractility under normal levels of glucose. Compared with littermate diabetic mice, TS1P(1)KO diabetic mice had improved cardiac function and alleviated cardiac fibrosis detected after 11 wk of diabetic induction. Our results indicate that T-cell S1P(1) signaling activation plays a dual role in the pathogenesis of cardiac fibrosis with respect to the levels of glucose: T-cell S1P(1) activation exerts antifibrotic effects in normoglycemia but exacerbates fibrosis under hyperglycemia.Abdullah, C. S., Jin, Z.-Q. Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice.	[Abdullah, Chowdhury S.] South Dakota State Univ, Coll Pharm, Dept Pharmaceut Sci, Brookings, SD 57007 USA; [Jin, Zhu-Qiu] Calif Northstate Univ, Dept Pharmaceut & Biomed Sci, Coll Pharm, 9700 West Taron Dr, Elk Grove, CA 95757 USA; [Abdullah, Chowdhury S.] Louisiana State Univ, Dept Pathol, Hlth Sci Ctr, Shreveport, LA 71105 USA	South Dakota State University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jin, ZQ (corresponding author), Calif Northstate Univ, Dept Pharmaceut & Biomed Sci, Coll Pharm, 9700 West Taron Dr, Elk Grove, CA 95757 USA.	zhuqiu.jin@cnsu.edu	Abdullah, Chowdhury S/AAJ-9373-2020; Jin, Zhuqiu/ABB-1444-2020	Abdullah, Chowdhury S/0000-0001-5771-220X; Jin, Zhuqiu/0000-0001-9856-7790	Rollins Juhnke Research Fund (College of Pharmacy, South Dakota State University); Faculty Development Fund (College of Pharmacy, California Northstate University)	Rollins Juhnke Research Fund (College of Pharmacy, South Dakota State University); Faculty Development Fund (College of Pharmacy, California Northstate University)	This research was supported by the Rollins Juhnke Research Fund (College of Pharmacy, South Dakota State University) and the Faculty Development Fund (College of Pharmacy, California Northstate University) to Z.-Q.J. The authors declare no conflicts of interest.	Abdullah CS, 2016, INT IMMUNOPHARMACOL, V39, P251, DOI 10.1016/j.intimp.2016.07.027; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Bansal SS, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003688; Becher PM, 2013, INT J MOL MED, V32, P158, DOI 10.3892/ijmm.2013.1368; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Boveda-Ruiz D, 2013, IMMUNOBIOLOGY, V218, P245, DOI 10.1016/j.imbio.2012.05.020; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Camm J, 2014, AM HEART J, V168, P632, DOI 10.1016/j.ahj.2014.06.028; Dong C, 2010, CELL MOL IMMUNOL, V7, P163, DOI 10.1038/cmi.2010.23; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Huwiler A, 2008, BIOCHEM PHARMACOL, V75, P1893, DOI 10.1016/j.bcp.2007.12.018; Jia GH, 2018, CIRC RES, V122, P624, DOI 10.1161/CIRCRESAHA.117.311586; Jin ZQ, 2004, CIRCULATION, V110, P1980, DOI 10.1161/01.CIR.0000143632.06471.93; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Laroumanie F, 2014, CIRCULATION, V129, P2111, DOI 10.1161/CIRCULATIONAHA.113.007101; Li Z, 2014, BRIT J PHARMACOL, V171, P2913, DOI 10.1111/bph.12621; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Lu J, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-105; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Nevers T, 2015, CIRC-HEART FAIL, V8, P776, DOI 10.1161/CIRCHEARTFAILURE.115.002225; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Russo I, 2016, J MOL CELL CARDIOL, V90, P84, DOI 10.1016/j.yjmcc.2015.12.011; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wang LJ, 2005, CIRC RES, V97, P891, DOI 10.1161/01.RES.0000187469.82595.15; Wang WG, 2004, FASEB J, V18, P1043, DOI 10.1096/fj.04-1555fje; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Westermann D, 2007, BASIC RES CARDIOL, V102, P500, DOI 10.1007/s00395-007-0673-0; Zhen Y, 2012, CELL MOL IMMUNOL, V9, P75, DOI 10.1038/cmi.2011.37; Zouggari Y, 2013, NAT MED, V19, P1273, DOI 10.1038/nm.3284	39	14	14	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5426	5435		10.1096/fj.201800231R	http://dx.doi.org/10.1096/fj.201800231R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29698062	Bronze			2022-12-26	WOS:000447972500019
J	Li, W; Ji, ML; Lin, YD; Miao, Y; Chen, SM; Li, H				Li, Wenli; Ji, Meiling; Lin, Yandie; Miao, Yi; Chen, Simin; Li, Hao			DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21	FASEB JOURNAL			English	Article						decidualization; liver; reactive oxygen species; insulin	GROWTH-FACTOR 21; PHOSPHOENOLPYRUVATE CARBOXYKINASE; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; ADIPOSE-TISSUE; GENES; IDENTIFICATION; PROGESTERONE; SENSITIVITY	Decidual protein induced by progesterone (DEPP/DEPP1/C10ORF10) is induced by denying access to food and reduced by refeeding in insulin-sensitive organs in vivo. The negative regulation of DEPP by insulin is also proven in several cell lines. However, the functions of DEPP in insulin-sensitive organs remain unknown. In the present study, we investigated the impact of DEPP on hepatic energy metabolism and addressed the underlying mechanisms. The metabolic effects of DEPP were investigated in mice with adenovirus-mediated hepatic overexpression. Liver triglyceride (TG), glycogen, and serum metabolites were detected by biochemical assays. Energy homeostasis was measured by indirect calorimetry. Quantitative PCR was used to examine expression of genes involved in fatty acid oxidation, ketogenesis, lipogenesis, and gluconeogenesis. To evaluate the role of fibroblast growth factor 21 (FGF21) mediating the metabolic effects of DEPP, FGF21 antibody was administrated intraperitoneally to mice at 24 h after the delivery of adenovirus, and the metabolic alterations were examined. Reactive oxygen species (ROS) levels were measured by catalase activity assay, live cell fluorescence, or quantitative PCR. Effects of DEPP on the phenotype of db/db mice were also assessed. Acute hepatic overexpression of DEPP significantly reduced serum glucose and TG levels, dramatically elevated -hydroxybutyrate levels, and improved glucose clearance. Compared with controls, DEPP overexpression reduced food intake, the energy expenditure rate, and the respiratory quotient. DEPP overexpression significantly increased fatty acid oxidation and ketogenesis but suppressed lipid synthesis and gluconeogenesis. Investigations of the underlying mechanisms revealed that DEPP regulates energy metabolism by inducing oxidative stress. With the impairment of the ROS scavenging system and promotion of ROS formation, DEPP overexpression leads to ROS accumulation. FGF21 is upregulated in response to oxidative stress and mediates the effects of DEPP on fatty acid oxidation, ketogenesis, and lipid synthesis but not gluconeogenesis, as evidenced by the fact that the FGF21 antibody dramatically suppressed a DEPP-induced increase of fatty acid oxidation and ketogenesis, reversed the reduction of lipid synthesis, but did not change the suppression of gluconeogenesis. Moreover, overexpression of DEPP in db/db mice led to a marked reduction in body weight and serum glucose levels and significantly improved insulin sensitivity. Hepatic overexpression of DEPP in mice promotes fatty acid oxidation and ketogenesis and suppresses lipogenesis and gluconeogenesis, which is partly mediated by FGF21 induced by elevated cellular ROS levels.Li, W., Ji, M., Lin, Y., Miao, Y., Chen, S., Li, H. DEPP/DEPP1/C10ORF10 regulates hepatic glucose and fat metabolism partly via ROS-induced FGF21.	[Li, Wenli; Ji, Meiling; Lin, Yandie; Miao, Yi; Chen, Simin; Li, Hao] Nanjing Med Univ, Key Lab Targeted Intervent Cardiovasc Dis, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Dept Pathophysiol, Nanjing, Jiangsu, Peoples R China; [Li, Wenli] Binzhou Peoples Hosp, Binzhou, Peoples R China	Nanjing Medical University	Li, H (corresponding author), Nanjing Med Univ, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	haoli@njmu.edu.cn	Miao, Yi/AAE-9123-2020		National Natural Science Foundation of China [81270944, 81070678]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81270944 and 81070678; to H.L.). H.L. is an associate fellow at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. The authors declare no conflicts of interest.	Gomez-Samano MA, 2017, REDOX BIOL, V11, P335, DOI 10.1016/j.redox.2016.12.024; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chen SM, 2011, FEBS LETT, V585, P1796, DOI 10.1016/j.febslet.2011.04.024; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Gomez-Valades AG, 2008, DIABETES, V57, P2199, DOI 10.2337/db07-1087; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Kim HT, 2006, CANCER RES, V66, P12009, DOI 10.1158/0008-5472.CAN-05-2515; Kornmann B, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e51; Kuroda Y, 2010, HORM METAB RES, V42, P173, DOI 10.1055/s-0029-1241841; Lu Y, 2010, CHINESE MED J-PEKING, V123, P3417, DOI 10.3760/cma.j.issn.0366-6999.2010.23.008; Ragel BT, 2007, NEUROSURG REV, V30, P181, DOI 10.1007/s10143-007-0070-z; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Salcher S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0661-4; Salcher S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-224; Shin DH, 2005, DEV DYNAM, V233, P1589, DOI 10.1002/dvdy.20479; Stepp MW, 2014, BBA-MOL CELL RES, V1843, P1076, DOI 10.1016/j.bbamcr.2014.02.003; Viollet B, 2011, HANDB EXP PHARMACOL, V203, P303, DOI 10.1007/978-3-642-17214-4_13; WANG K, 1995, SHOCK, V3, P204, DOI 10.1097/00024382-199503000-00008; Watanabe H, 2005, MOL HUM REPROD, V11, P471, DOI 10.1093/molehr/gah186; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Yabuta N, 2006, NUCLEIC ACIDS RES, V34, P4878, DOI 10.1093/nar/gkl651	24	7	7	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5459	5469		10.1096/fj.201800357R	http://dx.doi.org/10.1096/fj.201800357R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29702025	Bronze			2022-12-26	WOS:000447972500022
J	De, P; McNeil, M; Xia, M; Boot, CM; Hesser, DC; Denef, K; Rithner, C; Sours, T; Dobos, KM; Hoft, D; Chatterjee, D				De, Prithwiraj; McNeil, Michael; Xia, Mei; Boot, Claudia M.; Hesser, Danny C.; Denef, Karolien; Rithner, Christopher; Sours, Tyler; Dobos, Karen M.; Hoft, Daniel; Chatterjee, Delphi			Structural determinants in a glucose-containing lipopolysaccharide from Mycobacterium tuberculosis critical for inducing a subset of protective T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tuberculosis; vaccine; analytical chemistry; carbohydrate chemistry; carbohydrate function; T cells; lipoglycan; structural analysis	ADAPTIVE IMMUNE-RESPONSE; MASS-SPECTROMETRY; METHYLGLUCOSE LIPOPOLYSACCHARIDE; ELECTROSPRAY-IONIZATION; REVISED STRUCTURE; M. TUBERCULOSIS; CALMETTE-GUERIN; BIOSYNTHESIS; POLYSACCHARIDES; PURIFICATION	Mycobacteria synthesize intracellular, 6-O-methylglucose-containing lipopolysaccharides (mGLPs) proposed to modulate bacterial fatty acid metabolism. Recently, it has been shown that Mycobacterium tuberculosis mGLP specifically induces a specific subset of protective (92) T cells. Mild base treatment, which removes all the base-labile groups, reduces the specific activity of mGLP required for induction of these T cells, suggesting that acylation of the saccharide moieties is required for (92) T-cell activation. On the basis of this premise, we used analytical LC/MS and NMR methods to identify and locate the acyl functions on the mGLP saccharides. We found that mGLP is heterogeneous with respect to acyl functions and contains acetyl, isobutyryl, succinyl, and octanoyl groups and that all acylations in mGLP, except for succinyl and octanoyl residues, reside on the glucosyl residues immediately following the terminal 3-O-methylglucose. Our analyses also indicated that the octanoyl residue resides at position 2 of an internal glucose toward the reducing end. LC/MS analysis of the residual product obtained by digesting the mGLP with pancreatic -amylase revealed that the product is an oligosaccharide terminated by -(14)-linked 6-O-methyl-d-glucosyl residues. This oligosaccharide retained none of the acyl groups, except for the octanoyl group, and was unable to induce protective (92) T cells. This observation confirmed that mGLP induces (92) T cells and indicated that the acylated glucosyl residues at the nonreducing terminus of mGLP are required for this activity.	[De, Prithwiraj; McNeil, Michael; Hesser, Danny C.; Dobos, Karen M.; Chatterjee, Delphi] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Boot, Claudia M.; Denef, Karolien; Rithner, Christopher; Sours, Tyler] Colorado State Univ, Cent Instrument Facil, Dept Chem, Ft Collins, CO 80523 USA; [Xia, Mei; Hoft, Daniel] St Louis Univ, Dept Internal Med, St Louis, MO 63104 USA	Colorado State University; Colorado State University; Saint Louis University	Chatterjee, D (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Delphi.chatterjee@colostate.edu	Boot, Claudia M/C-8622-2013; McNeil, Michael/G-3325-2019; De, Prithwiraj/S-1199-2019; Dobos, Karen/D-1170-2017	Boot, Claudia M/0000-0002-1487-242X; De, Prithwiraj/0000-0003-4499-2147; Dobos, Karen/0000-0001-7115-8524	National Institutes of Health [2R01AI048391-09]; Bill and Melinda Gates Foundation [OPP1118659]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 2R01AI048391-09 (to D. H.) and Bill and Melinda Gates Foundation Grant OPP1118659 (to D. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abate G, 2016, INFECT IMMUN, V84, P580, DOI 10.1128/IAI.01262-15; Alalouf O, 2011, J BIOL CHEM, V286, P41993, DOI 10.1074/jbc.M111.301051; ANET FAL, 1992, J AM CHEM SOC, V114, P411, DOI 10.1021/ja00028a004; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Chatterjee D, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P147; Chen CY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003501; Chen ZW, 2016, CURR OPIN IMMUNOL, V42, P105, DOI 10.1016/j.coi.2016.06.005; Chen ZW, 2013, CELL MOL IMMUNOL, V10, P1, DOI 10.1038/cmi.2012.73; Chen ZW, 2013, CELL MOL IMMUNOL, V10, P58, DOI 10.1038/cmi.2012.46; Chen ZW, 2003, MICROBES INFECT, V5, P491, DOI 10.1016/S1286-4579(03)00074-1; Chen ZW, 2003, TRENDS IMMUNOL, V24, P213, DOI 10.1016/S1471-4906(03)00032-2; DELL A, 1983, CARBOHYD RES, V120, P95, DOI 10.1016/0008-6215(83)88010-0; Dinadayala P, 2004, J BIOL CHEM, V279, P12369, DOI 10.1074/jbc.M308908200; FORSBERG LS, 1982, J BIOL CHEM, V257, P3555; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gest P, 2008, ACTA CRYSTALLOGR F, V64, P1121, DOI 10.1107/S1744309108032892; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; HILL RE, 1987, J BIOL CHEM, V262, P7463; HINDSGAUL O, 1984, BIOCHEMISTRY-US, V23, P577, DOI 10.1021/bi00298a028; Hopper JTS, 2012, ANAL BIOCHEM, V421, P788, DOI 10.1016/j.ab.2011.10.034; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P466, DOI 10.1016/j.jasms.2006.10.012; Jackson M, 2009, J BIOL CHEM, V284, P1949, DOI 10.1074/jbc.R800047200; KAMISANGO K, 1987, J BIOL CHEM, V262, P4580; Kaur D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005447; LEE YC, 1964, J BIOL CHEM, V239, P3602; LEE YC, 1966, J BIOL CHEM, V241, P1899; Maranha A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13610; Matwiejuk M, 2011, CHEM COMMUN, V47, P8379, DOI 10.1039/c1cc11690h; Meng XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep35261; Nunes-Costa D, 2017, GLYCOBIOLOGY, V27, P213, DOI 10.1093/glycob/cww132; POMMIER MT, 1986, J GEN MICROBIOL, V132, P2433; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; SAWYER DT, 1966, ANAL CHEM, V38, P192, DOI 10.1021/ac60234a011; Shen L, 2004, J INFECT DIS, V190, P1438, DOI 10.1086/423939; Shen Y, 2002, SCIENCE, V295, P2255, DOI 10.1126/science.1068819; SMITH WL, 1973, J BIOL CHEM, V248, P7118; Spencer CT, 2008, J IMMUNOL, V181, P4471, DOI 10.4049/jimmunol.181.7.4471; Spencer CT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003119; Stadthagen G, 2007, J BIOL CHEM, V282, P27270, DOI 10.1074/jbc.M702676200; TUFFAL G, 1995, J CARBOHYD CHEM, V14, P631, DOI 10.1080/07328309508005364; Tuffal G, 1998, GLYCOBIOLOGY, V8, P675, DOI 10.1093/glycob/8.7.675; Usui T., 2014, J AGR BIOL CHEM, V39, P1071; Worku S, 2003, INFECT IMMUN, V71, P1763, DOI 10.1128/IAI.71.4.1763-1773.2003; Xia M, 2016, INFECT IMMUN, V84, P2449, DOI 10.1128/IAI.01322-15; YABUSAKI KK, 1979, J BIOL CHEM, V254, P2314; Zhang ZQ, 2009, CURR ANAL CHEM, V5, P225, DOI 10.2174/157341109788680291	47	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9706	9717		10.1074/jbc.RA118.002582	http://dx.doi.org/10.1074/jbc.RA118.002582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29716995	hybrid, Green Published			2022-12-26	WOS:000436102300015
J	Speer, EM; Dowling, DJ; Xu, JJ; Ozog, LS; Mathew, JA; Chander, A; Yin, DL; Levy, O				Speer, Esther M.; Dowling, David J.; Xu, Jianjin; Ozog, Lukasz S.; Mathew, Jaime A.; Chander, Avinash; Yin, Donglei; Levy, Ofer			Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro	PLOS ONE			English	Article							LOW-DOSE HYDROCORTISONE; TOLL-LIKE RECEPTORS; PRETERM INFANTS; DENDRITIC CELLS; INNATE IMMUNITY; NEURODEVELOPMENTAL OUTCOMES; BASIC MECHANISMS; HUMAN-LEUKOCYTES; ACTIVATION; MONOCYTES	Introduction Neonatal inflammation, mediated in part through Toll-like receptor (TLR) and inflammasome signaling, contributes to adverse outcomes including organ injury. Pentoxifylline (PTX), a phosphodiesterase inhibitor which potently suppresses cytokine production in newborn cord blood, is a candidate neonatal anti-inflammatory agent. We hypothesized that combinations of PTX with other anti-inflammatory agents, the steroid dexamethasone (DEX) or the macrolide azithromycin (AZI), may exert broader, more profound and/or synergistic anti-inflammatory activity towards neonatal TLR-and inflammasome-mediated cytokine production. Methods Whole newborn and adult blood was treated with PTX (50-200 mu M), DEX (10(-10)-10(-7) M), or AZI (2.5-20 mu M), alone or combined, and cultured with lipopolysaccharide (LPS) (TLR4 agonist), R848 (TLR7/8 agonist) or LPS/adenosine triphosphate (ATP) (inflammasome induction). Supernatant and intracellular cytokines, signaling molecules and mRNA were measured by multiplex assay, flow cytometry and real-time PCR. Drug interactions were assessed based on Loewe's additivity. Results PTX, DEX and AZI inhibited TLR-and/or inflammasome-mediated cytokine production in newborn and adult blood, whether added before, simultaneously or after TLR stimulation. PTX preferentially inhibited pro-inflammatory cytokines especially TNF. DEX inhibited IL-10 in newborn, and TNF, IL-1 beta, IL-6 and interferon-alpha in newborn and adult blood. AZI inhibited R848-induced TNF, IL-1 beta, IL-6 and IL-10, and LPS-induced IL-1 beta and IL-10. (PTX+DEX) synergistically decreased LPS-and LPS/ATP-induced TNF, IL-1 beta, and IL-6, and R848-induced IL-1 beta and interferon-a, while (PTX+AZI) synergistically decreased induction of TNF, IL-1 beta, and IL-6. Synergistic inhibition of TNF production by (PTX+DEX) was especially pronounced in newborn vs. adult blood and was accompanied by reduction of TNF mRNA and enhancement of IL10 mRNA. Conclusions Age, agent, and specific drug-drug combinations exert distinct anti-inflammatory effects towards TLR-and/or inflammasome-mediated cytokine production in human newborn blood in vitro. Synergistic combinations of PTX, DEX and AZI may offer benefit for prevention and/or treatment of neonatal inflammatory conditions while potentially limiting drug exposure and toxicity.	[Speer, Esther M.; Ozog, Lukasz S.; Mathew, Jaime A.; Chander, Avinash] SUNY Stony Brook, Dept Pediat, Div Neonatol, Sch Med, Stony Brook, NY 11794 USA; [Dowling, David J.; Levy, Ofer] Boston Childrens Hosp, Div Infect Dis, Dept Med, Boston, MA USA; [Dowling, David J.; Levy, Ofer] Harvard Med Sch, Boston, MA USA; [Xu, Jianjin] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY USA; [Levy, Ofer] Boston Childrens Hosp, Precis Vaccine Program, Boston, MA USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Boston Children's Hospital	Speer, EM (corresponding author), SUNY Stony Brook, Dept Pediat, Div Neonatol, Sch Med, Stony Brook, NY 11794 USA.	esther.speer@stonybrookmedicine.edu	Speer, Esther/AFU-2182-2022	Dowling, David/0000-0003-1095-6156; Levy, Ofer/0000-0002-5859-1945	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Infant Immunity grant [R01A1100135-01]; NIAID Adjuvant Discovery Program [HHSN272201400052C]; Biostatistical Consulting Core at the School of Medicine, Stony Brook University; Department of Pediatrics Intramural Grant Program, Stony Brook, NY; Stony Brook Children's Hospital, Stony Brook, NY; Stony Brook University School of Medicine, Stony Brook, NY	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Infant Immunity grant; NIAID Adjuvant Discovery Program; Biostatistical Consulting Core at the School of Medicine, Stony Brook University; Department of Pediatrics Intramural Grant Program, Stony Brook, NY; Stony Brook Children's Hospital, Stony Brook, NY; Stony Brook University School of Medicine, Stony Brook, NY	This study in ES's laboratory was financially supported by the Department of Pediatrics Intramural Grant Program, Stony Brook Children's Hospital and Stony Brook University School of Medicine, Stony Brook, NY. OL is supported by U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Infant Immunity grant R01A1100135-01 and its administrative supplements as well as a NIAID Adjuvant Discovery Program Contract No. HHSN272201400052C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Jie Yang, Department of Family, Population, and Preventive Medicine, Stony Brook University School of Medicine, for providing expert advice regarding statistical analysis, and Todd Rueb, Flow Cytometry Core Facility, Stony Brook University School of Medicine, for assistance with flow cytometry experiments and their interpretation. We thank members of the Levy Laboratory at Boston Children's Hospital for their technical assistance with LAL experiments. Finally, we acknowledge the biostatistical consultation and support provided by the Biostatistical Consulting Core at the School of Medicine, Stony Brook University.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Aghai ZH, 2007, PEDIATR RES, V62, P483, DOI 10.1203/PDR.0b013e318142582d; Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Battersby AJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00309; Baud O, 2017, JAMA-J AM MED ASSOC, V317, P1329, DOI 10.1001/jama.2017.2692; Baud O, 2016, LANCET, V387, P1827, DOI 10.1016/S0140-6736(16)00202-6; Belderbos ME, 2013, PEDIAT ALLERG IMM-UK, V24, P102, DOI 10.1111/pai.12023; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Bi D, 2015, J INFECT DIS, V212, P1480, DOI 10.1093/infdis/jiv231; Bosnar M, 2013, INT IMMUNOPHARMACOL, V15, P498, DOI 10.1016/j.intimp.2013.02.011; Broering R, 2011, INT IMMUNOL, V23, P537, DOI 10.1093/intimm/dxr048; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Cavaillon JM, 2014, CRIT CARE, V18, DOI 10.1186/cc13787; Chan B, 1996, BIOTHERAPY, V9, P221, DOI 10.1007/BF02620735; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Cornette L, 2004, Semin Fetal Neonatal Med, V9, P459, DOI 10.1016/j.siny.2004.08.004; Dowling DJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91020; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Doyle LW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub5; Doyle LW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001145.pub4; Du Pont-Thibodeau Genevieve, 2014, F1000Prime Rep, V6, P67, DOI 10.12703/P6-67; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Fan LC, 2017, AM J PHYSIOL-LUNG C, V313, pL677, DOI 10.1152/ajplung.00123.2017; Funk JO, 1995, INT J IMMUNOPHARMACO, V17, P1007, DOI 10.1016/0192-0561(95)00096-8; Gibson SJ, 2002, CELL IMMUNOL, V218, P74, DOI 10.1016/S0008-8749(02)00517-8; Grimaldi D, 2014, MED MALADIES INFECT, V44, P455, DOI 10.1016/j.medmal.2014.07.017; Gualdoni GA, 2015, SCI REP-UK, V5, DOI 10.1038/srep12016; Hagberg H, 2002, CURR OPIN INFECT DIS, V15, P301, DOI 10.1097/00001432-200206000-00014; Halliday HL, 2017, NEONATOLOGY, V111, P415, DOI 10.1159/000458460; HAN J, 1990, J EXP MED, V172, P391, DOI 10.1084/jem.172.1.391; Harbron C, 2010, STAT MED, V29, P1746, DOI 10.1002/sim.3916; Harris Emma, 2010, Paediatr Drugs, V12, P301, DOI 10.2165/11532600-000000000-00000; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Johnson Steven C, 2016, Top Antivir Med, V23, P161; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kalay S, 2013, PEDIATR NEUROL, V49, P319, DOI 10.1016/j.pediatrneurol.2013.05.011; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kuban KCK, 2014, J CHILD NEUROL, V29, P1692, DOI 10.1177/0883073813513335; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lim G, 2015, PEDIATR NEONATOL, V56, P261, DOI 10.1016/j.pedneo.2014.11.006; Lugo RA, 1996, EUR J CLIN PHARMACOL, V49, P477, DOI 10.1007/s002280050053; Mallard C, 2009, CLIN PERINATOL, V36, P763, DOI 10.1016/j.clp.2009.07.009; Merchan LM, 2015, ANTIMICROB AGENTS CH, V59, P570, DOI 10.1128/AAC.03951-14; Michel O, 2000, HNO, V48, P182, DOI 10.1007/s001060050030; Moller DR, 1997, IMMUNOLOGY, V91, P197, DOI 10.1046/j.1365-2567.1997.00246.x; Page-Sharp M, 2017, J PHARMACEUT BIOMED, V146, P302, DOI 10.1016/j.jpba.2017.08.030; Pammi M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004205.pub3; Pestana EA, 2010, EARLY, RAPID AND SENSITIVE VETERINARY MOLECULAR DIAGNOSTICS - REAL TIME PCR APPLICATIONS, P247, DOI 10.1007/978-90-481-3132-7_7; Pettengill MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00457; Philbin VJ, 2007, BIOCHEM SOC T, V35, P1485, DOI 10.1042/BST0351485; Philbin VJ, 2012, J ALLERGY CLIN IMMUN, V130, P195, DOI 10.1016/j.jaci.2012.02.042; Redondo ACC, 2014, J PEDIAT-BRAZIL, V90, P472, DOI 10.1016/j.jped.2013.12.012; Rettig L, 2010, BLOOD, V115, P4533, DOI 10.1182/blood-2009-11-247817; SAS Institute Inc, 2016, SAS STAT 14 2 US GUI; Schuller SS, 2017, PEDIATR RES, V82, P215, DOI 10.1038/pr.2017.41; Schulzke SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010018.pub2; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Shabaan A, 2015, PEDIATR INFECT DIS J, V34, pE143, DOI 10.1097/INF.0000000000000698; SIMONE JV, 1979, CANCER RES, V39, P4301; Sittel C, 2000, AM J OTOL, V21, P425, DOI 10.1016/S0196-0709(00)80055-1; Speer EM, 2017, PEDIATR RES, V81, P806, DOI 10.1038/pr.2017.6; Strunk T, 2014, LANCET INFECT DIS, V14, P751, DOI 10.1016/S1473-3099(14)70710-8; Strunk T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010111; Szymura-Oleksiak J., 1997, PHARM SCI, V3, P367; Tarnow-Mordi W, 2010, CLIN PERINATOL, V37, P481, DOI 10.1016/j.clp.2009.12.002; Travadi J, 2006, PEDIATR RES, V60, P185, DOI 10.1203/01.pdr.0000228325.24945.ac; Turhan AH, 2012, EXP LUNG RES, V38, P250, DOI 10.3109/01902148.2012.676704; van Haren SD, 2016, J IMMUNOL, V197, P4413, DOI 10.4049/jimmunol.1600282; VANFURTH AM, 1995, CLIN DIAGN LAB IMMUN, V2, P689, DOI 10.1128/CDLI.2.6.689-692.1995; VANFURTH AM, 1994, PEDIATR RES, V35, P725, DOI 10.1203/00006450-199406000-00020; Vrancic M, 2012, BRIT J PHARMACOL, V165, P1348, DOI 10.1111/j.1476-5381.2011.01576.x; Xie X, 2011, OCUL IMMUNOL INFLAMM, V19, P275, DOI 10.3109/09273948.2011.569110	74	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196352	10.1371/journal.pone.0196352	http://dx.doi.org/10.1371/journal.pone.0196352			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715306	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100019
J	Zhang, JX; Zhang, LL; Xu, YC; Jiang, SS; Sheo, YY				Zhang, Jingxiao; Zhang, Lilei; Xu, Yangcheng; Jiang, Shanshan; Sheo, Yueyue			Deciphering the binding behavior of flavonoids to the cyclin dependent kinase 6/cyclin D complex	PLOS ONE			English	Article							CELL-CYCLE; INHIBITOR; CDK6; EFFICIENT; AFFINITY; INSIGHT; DOCKING; DRUGS; STATE	Flavonoids, a class of natural compounds with variable phenolic structures, have been found to possess anti-cancer activities by modulating different enzymes and receptors like CDK6. To understand the binding behavior of flavonoids that inhibit the active CDK6, molecular dynamics (MD) simulations were performed on six inhibitors, chrysin (M01), fisetin (M03), galangin (M04), genistein (M05), quercetin (M06) and kaempferol (M07), complexed with CDK6/cyclin D. For all six flavonoids, the 3'-OH and 4'-OH of B-ring were found to be favorable for hydrogen bond formation, but the 3-OH on the C-ring and 5-OH on the A-ring were unfavorable, which were confirmed by the MD simulation results of the test molecule, 3', 4', 7-trihydroxyflavone (M15). The binding efficiencies of flavonoids against the CDK6/cyclin D complex were mainly through the electrostatic (especially the H-bond force) and vdW interactions with residues ILE19, VAL27, ALA41, GLU61, PHE98, GLN103, ASP163 and LEU152. The order of binding affinities of these flavonoids toward the CDK6/cyclin D was M03 > M01 > M07 > M15 > M06 > M05 > M04. It is anticipated that the binding features of flavonoid inhibitors studied in the present work may provide valuable insights for the development of CDK6 inhibitors.	[Zhang, Jingxiao; Zhang, Lilei; Xu, Yangcheng; Jiang, Shanshan; Sheo, Yueyue] Hubei Univ Nationalities, Coll Chem & Environm Engn, Enshi, Hubei, Peoples R China; [Zhang, Jingxiao; Zhang, Lilei] Luoyang Normal Univ, Coll Chem & Chem Engn, Luoyang, Henan, Peoples R China	Hubei Minzu University; Luoyang Normal University	Zhang, LL (corresponding author), Hubei Univ Nationalities, Coll Chem & Environm Engn, Enshi, Hubei, Peoples R China.; Zhang, LL (corresponding author), Luoyang Normal Univ, Coll Chem & Chem Engn, Luoyang, Henan, Peoples R China.	zhanglilei@outlook.com		zhang, lilei/0000-0003-0798-1991	Scientific Research Project of Hubei Education Department [B2016095]	Scientific Research Project of Hubei Education Department	This work was supported by the Scientific Research Project of Hubei Education Department (No.B2016095).	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Amin KM, 2010, EUR J MED CHEM, V45, P2117, DOI 10.1016/j.ejmech.2009.12.078; Bai QF, 2016, SCI REP-UK, V6, DOI 10.1038/srep21763; Bai QF, 2014, PHYS CHEM CHEM PHYS, V16, P24332, DOI 10.1039/c4cp03331k; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Contreras-Garcia J, 2011, J CHEM THEORY COMPUT, V7, P625, DOI 10.1021/ct100641a; Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9; Cui FC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125848; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vivo M, 2011, FUTURE MED CHEM, V3, P1551, DOI [10.4155/FMC.11.113, 10.4155/fmc.11.113]; Dickler MN, 2017, CLIN CANCER RES, V23, P5218, DOI 10.1158/1078-0432.CCR-17-0754; Fry DW, 2001, J BIOL CHEM, V276, P16617, DOI 10.1074/jbc.M008867200; Gray N, 1999, CURR MED CHEM, V6, P859; Grotewold Erich, 2006, P1; Guan SS, 2016, J BIOMOL STRUCT DYN, V34, P15, DOI 10.1080/07391102.2015.1007167; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang X., 2014, BLOOD, V124, P3440; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Infante JR, 2016, CLIN CANCER RES, V22, P1; Jalili S, 2009, COLLOID SURFACE A, V352, P99, DOI 10.1016/j.colsurfa.2009.10.007; Johnson ER, 2010, J AM CHEM SOC, V132, P6498, DOI 10.1021/ja100936w; Kawasaki Y, 2016, CELL REP, V16, P2554, DOI 10.1016/j.celrep.2016.08.015; Khuntawee W, 2012, J CHEM INF MODEL, V52, P76, DOI 10.1021/ci200304v; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lazarevic B, 2011, NUTR CANCER, V63, P889, DOI 10.1080/01635581.2011.582221; Li HL, 2017, INT J CLIN EXP PATHO, V10, P9614; Li Y, 2015, INT J MOL SCI, V16, P9314, DOI 10.3390/ijms16059314; Li ZH, 2014, J MED CHEM, V57, P3430, DOI 10.1021/jm500118j; Lin TS, 2009, J CLIN ONCOL, V27, P6012, DOI 10.1200/JCO.2009.22.6944; Liu XY, 2015, INT J MOL SCI, V16, P3148, DOI 10.3390/ijms16023148; Lu HS, 2005, J MED CHEM, V48, P737, DOI 10.1021/jm049353p; Lu J, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0194-5; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mariaule G, 2014, MOLECULES, V19, P14366, DOI 10.3390/molecules190914366; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Platania CBM, 2015, FRONT PHARMACOL, V6, DOI [10.3389/tphar.7015.00248, 10.3389/fphar.2015.00248]; Ravishankar D, 2013, INT J BIOCHEM CELL B, V45, P2821, DOI 10.1016/j.biocel.2013.10.004; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Tadesse S, 2015, CELL CYCLE, V14, P3220, DOI 10.1080/15384101.2015.1084445; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wu P, 2013, J CHEM THEORY COMPUT, V9, P2226, DOI 10.1021/ct4001087; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7	46	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196651	10.1371/journal.pone.0196651	http://dx.doi.org/10.1371/journal.pone.0196651			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715320	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100040
J	Cervero, M; Torres, R; Agud, JL; Alcazar, V; Jusdado, JJ; Garcia-Lacalle, C; Moreno, S				Cervero, Miguel; Torres, Rafael; Luis Agud, Jose; Alcazar, Victoria; Jose Jusdado, Juan; Garcia-Lacalle, Concepcion; Moreno, Santiago			Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ABACAVIR-LAMIVUDINE; TENOFOVIR; EMTRICITABINE; OSTEOPOROSIS; OSTEOPENIA; INHIBITORS; FRACTURES; MASS	Objectives Several studies have involved antiretroviral therapy in the pathogenesis of low bone mineral density (BMD), while others have not confirmed this association. In this study we analyze the impact of HIV status, traditional risk factors and antiretroviral therapy in BMD in an HIV-infected population living in Madrid. Material and methods We performed a cross-sectional analysis of 107 individuals infected with HIV and exposed to antiretroviral treatment to estimate the prevalence of decreased BMD. Bone mineral density of lumbar spine and femoral neck was measured by dual-energy X-ray absorptiometry. In a multivariate analysis variables related with HIV status, antiretroviral drugs and traditional risk factors were included. Results Low BMD was diagnosed in 63 participants (58.9%), including osteoporosis in 11 (10%). At least one cause of osteoporosis was identified in 43 patients (40%), with a deficiency of vitamin D in 86 (89%) and secondary hyperparathyroidism in 30 (28%). In multivariate analysis, increasing age, a treatment based on boosted PI and tenofovir DF, and previous exposure to tenofovir were identified as independent risk factors for a decreased BMD in both lumbar spine and femoral neck. Conclusions We have confirmed a high prevalence of reduced BMD, which is favoured by ritonavir-boosted PI and TDF. Bone safety should continue to be evaluated in clinical trials and cohort studies in order to demonstrate that the new drugs offer additional advantages regarding the impact on BMD.	[Cervero, Miguel; Torres, Rafael; Luis Agud, Jose; Jose Jusdado, Juan] Severo Ochoa Univ Hosp, Dept Internal Med, Madrid, Spain; [Alcazar, Victoria] Severo Ochoa Univ Hosp, Dept Endocrinol, Madrid, Spain; [Garcia-Lacalle, Concepcion] Severo Ochoa Univ Hosp, Dept Biochem, Madrid, Spain; [Moreno, Santiago] Univ Alcala de Henares, Ramon y Cajal Hosp, Dept Infect Dis, IRYCIS, Madrid, Spain	Severo Ochoa University Hospital; Severo Ochoa University Hospital; Severo Ochoa University Hospital; Universidad de Alcala	Cervero, M (corresponding author), Severo Ochoa Univ Hosp, Dept Internal Med, Madrid, Spain.	miguel.cervero@salud.madrid.org			Foundation Universidad Alfonso X el Sabio	Foundation Universidad Alfonso X el Sabio	Foundation Universidad Alfonso X el Sabio has provided financial support for the project leading to this publication.	Bonjoch A, 2010, AIDS, V24, P2827, DOI 10.1097/QAD.0b013e328340a28d; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Carr A, 2015, HIV MED, V16, P137, DOI 10.1111/hiv.12242; Casado JL, 2014, OSTEOPOROSIS INT, V25, P1071, DOI 10.1007/s00198-013-2506-3; Castilla V, 2003, REV CLIN ESP, V203, P170, DOI 10.1157/13045536; Cazanave C, 2008, AIDS, V22, P395, DOI 10.1097/QAD.0b013e3282f423dd; Cervero M, 2012, AIDS RES HUM RETROV, V28, P763, DOI [10.1089/AID.2011.0244, 10.1089/aid.2011.0244]; Cihlar T, 2007, ANTIVIR THER, V12, P267; Cotter AG, 2014, AIDS, V28, P2051, DOI 10.1097/QAD.0000000000000353; Curran A, 2012, AIDS, V26, P475, DOI 10.1097/QAD.0b013e32834f3507; Romero MJGD, 2011, REV OSTEOPOR METAB M, V3, P53; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Garg MK, 2014, CLIN ENDOCRINOL, V80, P41, DOI 10.1111/cen.12248; Grant PM, 2016, J INFECT DIS, V214, P607, DOI 10.1093/infdis/jiw204; Hansen AB, 2011, HIV MED, V12, P157, DOI 10.1111/j.1468-1293.2010.00864.x; Hansen ABE, 2012, AIDS, V26, P285, DOI 10.1097/QAD.0b013e32834ed8a7; Jimenez B, 2017, PEDIATR INFECT DIS J, V36, P578, DOI 10.1097/INF.0000000000001506; Knobel H, 2001, AIDS, V15, P807, DOI 10.1097/00002030-200104130-00022; Kooij KW, 2015, J INFECT DIS, V211, P539, DOI 10.1093/infdis/jiu499; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; Martinez E, 2009, JAIDS-J ACQ IMM DEF, V51, P290, DOI 10.1097/QAI.0b013e3181aa12d5; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Moore AL, 2001, AIDS, V15, P1731, DOI 10.1097/00002030-200109070-00019; Mulligan K, 2012, CLIN INFECT DIS, V55, P461, DOI 10.1093/cid/cis455; Shiau S, 2013, AIDS, V27, P1949, DOI 10.1097/QAD.0b013e328361d241; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Stone B, 2010, ARCH BIOCHEM BIOPHYS, V503, P66, DOI 10.1016/j.abb.2010.07.029; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; Thomas J, 2003, JAIDS-J ACQ IMM DEF, V33, P281, DOI 10.1097/00126334-200307010-00001	31	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196201	10.1371/journal.pone.0196201	http://dx.doi.org/10.1371/journal.pone.0196201			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709013	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100021
J	Bowden, B; John, A; Trefan, L; Morgan, J; Farewel, D; Fone, D				Bowden, Bethan; John, Ann; Trefan, Laszlo; Morgan, Jennifer; Farewel, Daniel; Fone, David			Risk of suicide following an alcohol-related emergency hospital admission: An electronic cohort study of 2.8 million people	PLOS ONE			English	Article							ASSOCIATION; DISORDERS; BEHAVIOR	Objective Alcohol misuse is a well-known risk factor for suicide however, the relationship between alcohol-related hospital admission and subsequent risk of death from suicide is unknown. We aimed to determine the risk of death from suicide following emergency admission to hospital with an alcohol-related cause. Methods We established an electronic cohort study of all 2,803,457 residents of Wales, UK, aged from 10 to under 100 years on 1 January 2006 with six years' follow-up. The outcome event was death from suicide defined as intentional self-harm (ICD-10 X 60-84) or undetermined intent (Y10-34). The main exposure was an alcohol-related admission defined as a 'wholly attributable' ICD-10 alcohol code in the admission record. Admissions were coded for the presence or absence of co-existing psychiatric morbidity. The analysis was by Cox regression with adjustments for confounding variables within the dataset. Results During the study follow-up period, there were 15,546,355 person years at risk with 28,425 alcohol-related emergency admissions and 1562 suicides. 125 suicides followed an admission (144.6 per 100,000 person years), of which 11 (9%) occurred within 4 weeks of discharge. The overall adjusted hazard ratio (HR) for suicide following admission was 26.8 (95% confidence interval (CI) 18.8 to 38.3), in men HR 9.83 (95% CI 7.91 to 12.2) and women HR 28.5 (95% CI 19.9 to 41.0). The risk of suicide remained substantial in subjects without known co-existing psychiatric morbidity: HR men 8.11 (95% CI 6.30 to 10.4) and women HR 24.0 (95% CI 15.5 to 37.3). The analysis was limited by the absence in datasets of potentially important confounding variables and the lack of information on alcohol-related harm and psychiatric morbidity in subjects not admitted to hospital. Conclusion Emergency alcohol-related hospital admission is associated with an increased risk of suicide. Identifying individuals in hospital provides an opportunity for psychosocial assessment and suicide prevention of a targeted at-risk group before their discharge to the community.	[Bowden, Bethan; John, Ann] Publ Hlth Wales NHS Trust, Swansea, W Glam, Wales; [Bowden, Bethan; John, Ann] Swansea Univ Med Sch, Inst Life Sci 2, Swansea, W Glam, Wales; [Trefan, Laszlo; Morgan, Jennifer; Farewel, Daniel; Fone, David] Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales	Swansea University; Cardiff University	Farewel, D (corresponding author), Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales.	farewelld@cardiff.ac.uk		Fone, David/0000-0002-6476-4881; Farewell, Daniel/0000-0002-8871-1653	Public Health Research programme [PHR 09/3007/02]	Public Health Research programme	This project uses a dataset funded by the Public Health Research programme (PHR 09/3007/02) to David Fone. Further information available at: http://www.nets.nihr.ac.uk/projects/phr/09300702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford D, 2006, Ir Med J, V99, P80; Beghi M, 2013, NEUROPSYCH DIS TREAT, V9, P1725, DOI 10.2147/NDT.S40213; Blakely TA, 2003, J EPIDEMIOL COMMUN H, V57, P594, DOI 10.1136/jech.57.8.594; Cherpitel CJ, 2004, ALCOHOL CLIN EXP RES, V28, p18S, DOI 10.1097/01.ALC.0000127411.61634.14; Darvishi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126870; Flensborg-Madsen T, 2009, PSYCHIAT RES, V167, P123, DOI 10.1016/j.psychres.2008.01.008; Fone D., 2016, PUBLIC HLTH RES, V4; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gunnarsdottir AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006327; Gunnell D, 2013, PSYCHOL MED, V43, P1415, DOI 10.1017/S0033291712002401; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; Inskip HM, 1998, BRIT J PSYCHIAT, V172, P35, DOI 10.1192/bjp.172.1.35; John A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006780; Juurlink DN, 2004, ARCH INTERN MED, V164, P1179, DOI 10.1001/archinte.164.11.1179; Kaplan MS, 2014, ANN EPIDEMIOL, V24, P588, DOI 10.1016/j.annepidem.2014.05.008; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Malone D, 2005, POSTGRAD MED J, V81, P161, DOI 10.1136/pgmj.2004.024703; Miller IW, 2017, JAMA PSYCHIAT, V74, P563, DOI 10.1001/jamapsychiatry.2017.0678; National Institute of Clinical Excellence, 2011, ALC US DIS DIAGN ASS; Office for National Statistics, 2004, RUR URB DEF ENGL WAL; Office for National Statistics, 2016, STAT B; Office for National Statistics, WHAT AR TOP CAUS DEA; Office for National Statistics, 2015, MORT STAT MET; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859; Welsh Government, WELSH IND MULT DEPR; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS11, DOI 10.1016/j.drugalcdep.2004.08.003; World Health Organisation, 2014, REC PER CAP 15 CONS; World Health Organization, INT CLASS DIS ICD; Wyllie C, 2012, MEN SUICIDE SOC	31	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0194772	10.1371/journal.pone.0194772	http://dx.doi.org/10.1371/journal.pone.0194772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1YS	29702655	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000431013300003
J	Chen, M; Ma, YL; Chen, HC; Dai, J; Dong, LJ; Yang, CJ; Li, YF; Luo, HB; Zhang, RZ; Jin, XM; Yang, L; Cheung, AKL; Jia, MH; Song, ZZ				Chen, Min; Ma, Yanling; Chen, Huichao; Dai, Jie; Dong, Lijuan; Yang, Chaojun; Li, Youfang; Luo, Hongbing; Zhang, Renzhong; Jin, Xiaomei; Yang, Li; Cheung, Allen Ka Loon; Jia, Manhong; Song, Zhizhong			HIV-1 genetic transmission networks among men who have sex with men in Kunming, China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RECONSTRUCTION; EPIDEMIOLOGY; INDIVIDUALS; EVOLUTION	Background Yunnan has the greatest share of reported human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) cases in China. In recent years, HIV prevalence and incidence remained stubbornly high in men who have sex with men (MSM). To follow the dynamics of the HIV-1 epidemic among MSM, HIV-1 genetic characteristics and genetic transmission networks were investigated. Methods Blood samples from 190 newly diagnosed HIV-1 cases among MSM were continuously collected at fixed sites from January 2013 to December 2015 in Kunming City, Yunnan Province. Partial gag, pol and env genes were sequenced and used for phylogenetic and genotypic drug resistance analyses. The genetic characteristics of the predominant HIV-1 strains were analyzed by the Bayesian Markov Chain Monte Carlo (MCMC) method. The genetic transmission networks were identified with a genetic distance of 0.03 substitutions/site and 90% bootstrap support. Results Among the 190 HIV-1 positive MSM reported during 2013 +/- 2105, various genotypes were identified, including CRF01_AE (45.3%), CRF07_BC (35.8%), unique recombinant forms (URFs) (11.6%), CRF08_BC (3.2%), CRF55_01B (2.1%), subtype B (1.6%) and CRF59_01B (0.5%). The effective population sizes (EPS) for CRF01_AE and CRF07_BC increased exponentially from approximately 2001 +/- 2010 and 2005 +/- 2009, respectively. Genetic transmission networks were constructed with 308 pol sequences from MSM diagnosed during 2010 +/- 2015. Of the 308 MSM, 109 (35.4%) were identified in 38 distinct clusters. Having multiple male partners was associated with a high probability of identification in the genetic transmission networks. Of the 38 clusters, 27 (71.1%) contained individuals diagnosed in different years. Of the 109 individuals in the networks, 26 (23.9%) had >= 2 potential transmission partners (>= 2 links). The proportion of MSM with >= 2 links was higher among those diagnosed from 2010-2012. The constituent ratios of their potential transmission partners by areas showed no significant difference among MSM from Kunming, other cities in Yunnan and other provinces. Additionally, surveillance drug resistance mutations (SDRMs) were identified in 5% of individuals. Conclusion This study revealed the various HIV-a genotypes circulating among MSM in Kunming. MSM with more partners were more easily detected in transmission networks, and early-diagnosed MSM remained active in transmission networks. These findings suggested that the routine interventions should be combined with HIV testing and linkage to care and early anti-retroviral therapy among HIV-positive MSM.	[Chen, Min; Ma, Yanling; Chen, Huichao; Dai, Jie; Dong, Lijuan; Yang, Chaojun; Li, Youfang; Luo, Hongbing; Zhang, Renzhong; Jin, Xiaomei; Yang, Li; Jia, Manhong; Song, Zhizhong] Yunnan Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Kunming, Yunnan, Peoples R China; [Cheung, Allen Ka Loon] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, AIDS Inst, Hong Kong, Hong Kong, Peoples R China; [Cheung, Allen Ka Loon] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Jia, MH; Song, ZZ (corresponding author), Yunnan Ctr Dis Control & Prevent, Inst AIDS STD Control & Prevent, Kunming, Yunnan, Peoples R China.	jiamanhong@hotmail.com; songzhizhong@yncdc.cn	MA, YAN/HHN-2912-2022	Cheung, Allen/0000-0001-8989-0537	National Natural Science Foundation of China [81560327]; research project for Yunnan science and technology plan [2015FB200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); research project for Yunnan science and technology plan	This work was supported by the National Natural Science Foundation of China (81560327) and the research project for Yunnan science and technology plan (2015FB200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALFE P, 1990, J VIROL, V64, P6221, DOI 10.1128/JVI.64.12.6221-6233.1990; Beyrer C, 2016, LANCET, V388, P198, DOI 10.1016/S0140-6736(16)30781-4; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; BURGER H, 1991, P NATL ACAD SCI USA, V88, P11236, DOI 10.1073/pnas.88.24.11236; Chen MQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109214; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Feng Yibing, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P752; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Han XX, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00050-12; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Li XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34729; Liu JX, 2006, AIDS BEHAV, V10, pS25, DOI 10.1007/s10461-006-9123-5; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Mehta SR, 2012, J INFECT DIS, V205, P1529, DOI 10.1093/infdis/jis231; Mi GD, 2016, CLIN INFECT DIS, V62, P1443, DOI 10.1093/cid/ciw167; National Health and Family Planning Commission of the People's Republic of China, 2015, 2015 CHIN AIDS RESP; NCAIDS NCSTD China CDC, CHIN J AIDS STD, V22, P69; Oster AM, 2015, JAIDS-J ACQ IMM DEF, V70, P444, DOI 10.1097/QAI.0000000000000809; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Rose R, 2017, AIDS RES HUM RETROV, V33, P211, DOI [10.1089/aid.2016.0205, 10.1089/AID.2016.0205]; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang SY, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1904-5; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Wertheim JO, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006000; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; Whiteside YO, 2015, AIDS, V29, P2517, DOI 10.1097/QAD.0000000000000852; Zhang XJ, 2017, INT J STD AIDS, V28, P1115, DOI 10.1177/0956462416688818; Zhang ZM, 2017, ARCH VIROL, V162, P3329, DOI 10.1007/s00705-017-3485-z	35	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196548	10.1371/journal.pone.0196548	http://dx.doi.org/10.1371/journal.pone.0196548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698467	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600098
J	Choi, HG; Bang, W; Park, B; Sim, S; Tae, K; Song, CM				Choi, Hyo Geun; Bang, Woojin; Park, Bumjung; Sim, Songyong; Tae, Kyung; Song, Chang Myeon			Lack of evidence that nephrolithiasis increases the risk of sialolithiasis: A longitudinal follow-up study using a national sample cohort	PLOS ONE			English	Article							KIDNEY-STONES; SALIVARY STONES; POPULATION; MANAGEMENT; CALCULI; PATHOGENESIS; PREVALENCE; DIAGNOSIS; ETIOLOGY; DISEASES	Objective The objective of this study was to evaluate the risk of sialolithiasis in nephrolithiasis patients. Methods Using data from the national cohort study from the Korean Health Insurance Review and Assessment Service, we selected 24,038 patients with nephrolithiasis. The control group consisted of 96,152 participants without nephrolithiasis who were matched 1: 4 by age, sex, income, region of residence, diabetes, hypertension, and dyslipidemia. The incidence of sialolithiasis in the two groups was compared, with a follow-up period of up to 12 years. The crude and adjusted hazard ratio (HR) of nephrolithiasis to sialolithiasis was analyzed with a Cox-proportional hazard regression model. Results The rates of sialolithiasis in the nephrolithiasis group and the control group were not significantly different (0.08% vs. 0.1%, P = 0.447). The crude and adjusted hazard ratios of nephrolithiasis to sialolithiasis were not statistically significant (crude HR = 0.82, 95% confidence interval [CI] = 0.50-1.35, P = 0.448; adjusted HR = 0.81, 95% CI = 0.49-1.33, P = 0.399). Subgroup analyses according to age and sex also failed to reveal statistical significance. Conclusion There is no evidence of an increased risk of sialolithiasis associated with nephrolithiasis. We suggest that routine evaluation for sialolithiasis in all patients with nephrolithiasis is not necessary.	[Choi, Hyo Geun; Park, Bumjung] Hallym Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Anyang, South Korea; [Bang, Woojin] Hallym Univ, Sacred Heart Hosp, Dept Urol, Anyang, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea; [Tae, Kyung; Song, Chang Myeon] Hanyang Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea	Hallym University; Hallym University; Hallym University; Hanyang University	Song, CM (corresponding author), Hanyang Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	cmsong@hanyang.ac.kr	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549; Song, Chang Myeon/0000-0001-5267-0135	Hanyang University (HY)	Hanyang University (HY)	This work was supported by the research fund of Hanyang University (HY-2017) to Chang Myeon Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the research fund of Hanyang University (HY-2017). The manuscript was edited for English language, grammar, punctuation, spelling, and overall style by the highly qualified native English-speaking editor at Industry-University Cooperation Foundation, Hanyang University (Certificate 02-13-782).	Acar B, 2008, WORLD J UROL, V26, P627, DOI 10.1007/s00345-008-0331-7; Alelign T, 2018, ADV UROL, V2018, DOI 10.1155/2018/3068365; EMAMIAN SA, 1993, ACTA RADIOL, V34, P482; EPIVATIANOS A, 1989, ARCH ORAL BIOL, V34, P261, DOI 10.1016/0003-9969(89)90066-6; Escudier MP, 1999, BRIT DENT J, V186, P463, DOI 10.1038/sj.bdj.4800141a; Frassetto L, 2011, AM FAM PHYSICIAN, V84, P1234; Gianfrancesco F, 2003, AM J HUM GENET, V72, P1479, DOI 10.1086/375628; Harrison John D, 2009, Otolaryngol Clin North Am, V42, P927, DOI 10.1016/j.otc.2009.08.012; Hung SH, 2016, LARYNGOSCOPE, V126, P847, DOI 10.1002/lary.25360; Huoh KC, 2011, OTOLARYNG HEAD NECK, V145, P935, DOI 10.1177/0194599811415489; IRO H, 1992, LANCET, V339, P1333, DOI 10.1016/0140-6736(92)91968-E; Kim J, 2013, INT J CHRONIC OBSTR, V8, P561, DOI 10.2147/COPD.S48577; Koch M, 2005, OTOLARYNG HEAD NECK, V133, P863, DOI 10.1016/j.otohns.2005.08.005; Kraaij S, 2015, OR SURG OR MED OR PA, V119, P539, DOI 10.1016/j.oooo.2015.01.010; LUSTMANN J, 1981, J DENT RES, V60, P1386, DOI 10.1177/00220345810600080101; LUSTMANN J, 1990, INT J ORAL MAX SURG, V19, P135, DOI 10.1016/S0901-5027(05)80127-4; Marchal F, 2003, ARCH OTOLARYNGOL, V129, P951, DOI 10.1001/archotol.129.9.951; Nancollas G H, 1994, Adv Dent Res, V8, P307; OSHIBUCHI M, 1991, J GASTROEN HEPATOL, V6, P165, DOI 10.1111/j.1440-1746.1991.tb01459.x; PAK CYC, 1991, AM J KIDNEY DIS, V18, P624, DOI 10.1016/S0272-6386(12)80602-0; PAK CYC, 1980, AM J MED, V69, P19, DOI 10.1016/0002-9343(80)90495-7; Paterson JR, 2001, J CLIN PATHOL, V54, P412, DOI 10.1136/jcp.54.5.412; PERROTTA RJ, 1978, ARCH OTOLARYNGOL, V104, P469; Qi SR, 2005, LARYNGOSCOPE, V115, P541, DOI 10.1097/01.mlg.0000157832.23380.df; RICE DH, 1984, WESTERN J MED, V140, P238; Romero Victoriano, 2010, Rev Urol, V12, pe86; Sakhaee K, 2012, J CLIN ENDOCR METAB, V97, P1847, DOI 10.1210/jc.2011-3492; Schroder S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007385; Schroder SA, 2017, EUR ARCH OTO-RHINO-L, V274, P1975, DOI 10.1007/s00405-016-4437-z; Sherman JA, 2000, BRIT J ORAL MAX SURG, V38, P50, DOI 10.1054/bjom.1999.0074; Sigismund PE, 2015, LARYNGOSCOPE, V125, P1879, DOI 10.1002/lary.25377; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Stamatiou K N, 2006, Rural Remote Health, V6, P610; Teymoortash A, 2002, ACTA OTO-LARYNGOL, V122, P210, DOI 10.1080/00016480252814252; Thorleifsson G, 2009, NAT GENET, V41, P926, DOI 10.1038/ng.404; Trinchieri A, 2000, EUR UROL, V37, P23, DOI 10.1159/000020094; Waseem BAZ, 2005, INT J PEDIATR OTORHI, V69, P691, DOI 10.1016/j.ijporl.2004.11.015; Wu CC, 2016, ACTA OTO-LARYNGOL, V136, P497, DOI 10.3109/00016489.2015.1129068; Zenk J, 1999, HNO, V47, P963, DOI 10.1007/s001060050476	39	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196659	10.1371/journal.pone.0196659	http://dx.doi.org/10.1371/journal.pone.0196659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698468	gold, Green Submitted, Green Published			2022-12-26	WOS:000431007600114
J	Libois, A; Hallin, M; Crucitti, T; Delforge, M; De Wit, S				Libois, Agnes; Hallin, Marie; Crucitti, Tania; Delforge, Marc; De Wit, Stephane			Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: An observational, cross-sectional study	PLOS ONE			English	Article							2016 EUROPEAN GUIDELINE; NONGONOCOCCAL URETHRITIS; MACROLIDE RESISTANCE; ASSAY; INFECTIONS; URINE	Background Mycoplasma genitalium (MG) is a cause of urethritis. While resistance to azithromycin is increasing, routine detection of MG is not performed in Belgium, where its prevalence is unknown. The aim of this study is to determine prevalence of MG in men with urethritis. Method and findings An "in-house" amplification assay detecting MG was performed on urine of men with complaints of urethritis who consulted the emergency unit or the Sexually Transmitted Infection clinic of our public hospital in Brussels. Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) were tested on the same sample. A total of 187 men were tested. Prevalence of MG was 9% (95% Confidence Interval: 5 to 13.2%). CT was detected in 20%, NG in 22% and 56% of samples were negative for these three pathogens. Neither age, ethnic origin, sexual orientation nor HIV infection were associated with MG urethritis. Conclusion M. genitalium was identified in 9% of men with complaints of urethritis indicating that amplification assay detecting MG should be implemented in routine testing for those patients.	[Libois, Agnes; Delforge, Marc; De Wit, Stephane] Univ Libre Bruxelles, CHU St Pierre, Dept Infect Dis, Brussels, Belgium; [Hallin, Marie] Lab Hosp Univ Bruxelles, Ctr Mol Diagnost, Brussels, Belgium; [Crucitti, Tania] ITM, Dept Clin Sci, Antwerp, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institute of Tropical Medicine (ITM)	Libois, A (corresponding author), Univ Libre Bruxelles, CHU St Pierre, Dept Infect Dis, Brussels, Belgium.	agnes_Jibois@stpierre-bru.be	Crucitti, Tania/AAH-1902-2021; Libois, Agnès/AAQ-2077-2021; Crucitti, Tania/AAB-9967-2019; Crucitti, Tania/AEQ-9792-2022	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; LIBOIS, Agnes/0000-0002-6078-878X	Association d'Aide a la Recherche Medicale Andre Vesale	Association d'Aide a la Recherche Medicale Andre Vesale	This work was supported by Association d'Aide a la Recherche Medicale Andre Vesale - www.associationvesale.be (Bourse de la Loterie Nationale Juin 2012, no grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann L, 2018, SEX TRANSM INFECT, V94, P254, DOI 10.1136/sextrans-2017-053384; Coorevits L, 2018, J GLOB ANTIMICROB RE, V12, P149, DOI 10.1016/j.jgar.2017.09.018; Gottesman T, 2017, INT J STD AIDS, V28, P127, DOI 10.1177/0956462416630675; Horner PJ, 2016, INT J STD AIDS, V27, P928, DOI 10.1177/0956462416648585; Jensen JS, 2016, J EUR ACAD DERMATOL, V30, P1650, DOI 10.1111/jdv.13849; Le Roy C, 2017, J CLIN MICROBIOL, V55, P3194, DOI 10.1128/JCM.00579-17; Le Roy C, 2016, EMERG INFECT DIS, V22, P1677, DOI 10.3201/eid2209.160446; Lun A, 1999, CLIN CHEM, V45, P1879; Manhart LE, 2015, CLIN INFECT DIS, V61, pS802, DOI 10.1093/cid/civ785; Muller EE, 2012, J MICROBIOL METH, V88, P311, DOI 10.1016/j.mimet.2011.12.017; Murray GL, 2017, EMERG INFECT DIS, V23, P809, DOI 10.3201/eid2305.161745; Pitt R, 2018, SEX TRANSM INFECT, V94, P565, DOI 10.1136/sextrans-2017-053366; Pond MJ, 2014, CLIN INFECT DIS, V58, P631, DOI 10.1093/cid/cit752; Salado-Rasmussen K, 2014, CLIN INFECT DIS, V59, P24, DOI 10.1093/cid/ciu217; Ursi D, 2016, EUR J CLIN MICROBIOL, V35, P1159, DOI 10.1007/s10096-016-2646-4; van der Veer C, 2016, SEX TRANSM INFECT, V92, P83, DOI 10.1136/sextrans-2015-052118; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	17	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196217	10.1371/journal.pone.0196217	http://dx.doi.org/10.1371/journal.pone.0196217			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698421	gold, Green Published, Green Submitted			2022-12-26	WOS:000431007600046
J	de Guevara, CML; Fernandez-Serrano, MJ; del Paso, GAR; Duschek, S				Munoz Ladron de Guevara, Cristina; Jose Fernandez-Serrano, Maria; Reyes del Paso, Gustavo A.; Duschek, Stefan			Executive function impairments in fibromyalgia syndrome: Relevance of clinical variables and body mass index	PLOS ONE			English	Article							COGNITIVE FUNCTION; INTEROCEPTIVE AWARENESS; DECISION-MAKING; MEMORY FUNCTION; SELF-REGULATION; PAIN; PERFORMANCE; DOPAMINE; IMPACT; INHIBITION	Background Several investigations suggest the presence of deterioration of executive function in fibro-myalgia syndrome (FMS). The study quantified executive functions in patients with FMS. A wide array of functions was assessed, including updating, shifting and inhibition, as well as decision making and mental planning. Moreover, clinical variables were investigated as possible mediators of executive dysfunction, including pain severity, psychiatric comorbidity, medication and body mass index (BMI). Methods Fifty-two FMS patients and 32 healthy controls completed a battery of 14 neuropsychological tests. Clinical interviews were conducted and the McGill Pain Questionnaire, Beck Depression Inventory, State-Trait Anxiety Inventory, Fatigue Severity Scale and Oviedo Quality of Sleep Questionnaire were presented. Results Patients performed poorer than controls on the Letter Number Sequencing, Arithmetic and Similarities subtests of the Wechsler Adult Intelligence Scale, the Spatial Span subtest of the Wechsler Memory Scale, an N-back task, a verbal fluency task, the Ruff Figural Fluency Test, the Inhibition score of the Stroop Test, the Inhibition and Shifting scores of the Five Digits Test, the Key Search Test and the Zoo Map Task. Moreover, patients exhibited less steep learning curves on the Iowa Gambling Task. Among clinical variables, BMI and pain severity explained the largest proportion of performance variance. Conclusions This study demonstrated impairments in executive functions of updating, shifting inhibition, decision making and planning in FMS. While the mediating role of pain in cognitive impairments in FMS had been previously established, the influence of BMI is a novel finding. Overweight and obesity should be considered by FMS researchers, and in the treatment of the condition.	[Munoz Ladron de Guevara, Cristina; Jose Fernandez-Serrano, Maria; Reyes del Paso, Gustavo A.] Univ Jaen, Dept Psychol, Jaen, Spain; [Duschek, Stefan] UMIT Univ Hlth Sci Med Informat & Technol, Hall In Tirol, Austria	Universidad de Jaen; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH	del Paso, GAR (corresponding author), Univ Jaen, Dept Psychol, Jaen, Spain.	greyes@ujaen.es	Serrano, M Josefa Fernández/V-3124-2019; Fernandez-Serrano, Maria Jose/AGA-6711-2022; Reyes del Paso, Gustavo A./G-4179-2011; Muñoz Ladrón de Guevara, Cristina/AEJ-4678-2022	Serrano, M Josefa Fernández/0000-0002-6158-237X; Reyes del Paso, Gustavo A./0000-0002-2188-8673; Muñoz Ladrón de Guevara, Cristina/0000-0002-9172-7058	European Regional Development Fund (ERDF) [PSI2015-69235P]; Spanish Ministry of Economy and Competitiveness	European Regional Development Fund (ERDF)(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was supported by a grant from the Spanish Ministry of Economy and Competitiveness, co-financed by European Regional Development Fund (ERDF) (Project PSI2015-69235P).	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Arnold LM, 2008, PATIENT EDUC COUNS, V73, P114, DOI 10.1016/j.pec.2008.06.005; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; Bennett RM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2783; Bobes J., 2000, PSICOTHEMA, V12, P107; Bulbena A., 2000, MEDICI N 150 NICA PS; Burgmer M, 2009, NEUROIMAGE, V44, P502, DOI 10.1016/j.neuroimage.2008.09.008; Castaneda AE, 2008, J AFFECT DISORDERS, V106, P1, DOI 10.1016/j.jad.2007.06.006; Cockshell SJ, 2013, NEUROPSYCHOLOGY, V27, P230, DOI 10.1037/a0032084; Cvejic E, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0577-9; Damasio A, 2000, FEELING WHAT HAPPENS; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Delis DC, 2001, DELIS KAPLAN EXECUTI; Dick B, 2002, ARTHRIT RHEUM-ARTHR, V47, P639, DOI 10.1002/art.10800; Dick BD, 2008, PAIN, V139, P610, DOI 10.1016/j.pain.2008.06.017; Duschek S, 2017, BEHAV MED, V43, P100, DOI 10.1080/08964289.2015.1094442; Duschek S, 2015, J INDIVID DIFFER, V36, P110, DOI 10.1027/1614-0001/a000165; Duschek S, 2013, BEHAV MED, V39, P11, DOI 10.1080/08964289.2012.708684; Ehlers DK, 2017, BREAST CANCER RES TR, V165, P699, DOI 10.1007/s10549-017-4363-9; Elliott R, 2003, BRIT MED BULL, V65, P49, DOI 10.1093/bmb/65.1.49; Fanning J, 2017, J BEHAV MED, V40, P332, DOI 10.1007/s10865-016-9788-9; First M.B., 1999, ENTREVISTA 150 NICA; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Gameiro F, 2017, PSICOTHEMA, V29, P61, DOI 10.7334/psicothema2016.202; Gelonch O, 2016, COMPR PSYCHIAT, V66, P113, DOI 10.1016/j.comppsych.2016.01.002; Glass JM, 2011, J PAIN, V12, P1219, DOI 10.1016/j.jpain.2011.06.007; Glass JM, 2005, J PSYCHOSOM RES, V58, P263, DOI 10.1016/j.jpsychores.2004.09.004; Grace GM, 1999, J CLIN EXP NEUROPSYC, V21, P477, DOI 10.1076/jcen.21.4.477.876; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Gracely RH, 2011, BEST PRACT RES CL RH, V25, P271, DOI 10.1016/j.berh.2011.02.003; Grant DA, 1993, WISCONSIN CARD SORTI; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Gunstad J, 2007, COMPR PSYCHIAT, V48, P57, DOI 10.1016/j.comppsych.2006.05.001; Hauser W, 2010, EUR J PAIN, V14, P5, DOI 10.1016/j.ejpain.2009.01.006; Hair JF, 2002, MARKETING RES PRACTI; Harker KT, 2011, PSYCHOL HEALTH, V26, P915, DOI 10.1080/08870446.2010.525639; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Helmes E, 2017, J WOMEN AGING, V29, P376, DOI 10.1080/08952841.2016.1256736; Henriksen M, 2009, ARTHRIT RHEUM-ARTHR, V61, P732, DOI 10.1002/art.24512; Hirshorn EA, 2006, NEUROPSYCHOLOGIA, V44, P2547, DOI 10.1016/j.neuropsychologia.2006.03.035; Hoffmann A, 2017, BRAIN COGNITION, V118, P108, DOI 10.1016/j.bandc.2017.08.003; Johnson-Greene D, 2013, CLIN NEUROPSYCHOL, V27, P148, DOI 10.1080/13854046.2012.733732; Jonides J, 1997, STUD COGNIT, P243; Kaplan GB, 2006, NEURAL NETWORKS, V19, P375, DOI 10.1016/j.neunet.2005.08.015; Katz RS, 2004, JCR-J CLIN RHEUMATOL, V10, P53, DOI 10.1097/01.rhu.0000120895.20623.9f; Kim CH, 2012, ARTHRIT CARE RES, V64, P222, DOI 10.1002/acr.20653; Krawczyk DC, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00062; Lazaro C., 1994, EUR J PSYCHOL ASSESS, V10, P145; Leavitt F, 2002, JCR-J CLIN RHEUMATOL, V8, P77, DOI 10.1097/00124743-200204000-00003; Leavitt F, 2008, JCR-J CLIN RHEUMATOL, V14, P214, DOI 10.1097/RHU.0b013e31817a2472; Lee PL, 2014, INT J AGING HUM DEV, V79, P263, DOI 10.1177/0091415015574190; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lorenz J, 1997, PAIN, V73, P369, DOI 10.1016/S0304-3959(97)00123-1; Mitchell RLC, 2007, NEUROPSYCHOLOGIA, V45, P617, DOI 10.1016/j.neuropsychologia.2006.06.030; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Montoro CI, 2015, NEUROPSYCHOLOGY, V29, P173, DOI 10.1037/neu0000138; Montoya P, 2005, PSYCHOSOM MED, V67, P957, DOI 10.1097/01.psy.0000188401.55394.18; Montoya P, 2006, ARTHRITIS RHEUM-US, V54, P1995, DOI 10.1002/art.21910; Morrison RG, 2004, J COGNITIVE NEUROSCI, V16, P260, DOI 10.1162/089892904322984553; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Okifuji A, 2009, CLIN RHEUMATOL, V28, P475, DOI 10.1007/s10067-009-1094-2; Park DC, 2001, ARTHRITIS RHEUM, V44, P2125, DOI 10.1002/1529-0131(200109)44:9<2125::AID-ART365>3.0.CO;2-1; Patel VP, 2017, MULT SCLER RELAT DIS, V11, P40, DOI 10.1016/j.msard.2016.11.012; Paul RH, 2002, J CLIN NEUROSCI, V9, P243, DOI 10.1054/jocn.2001.1016; Penrod JR, 2004, J RHEUMATOL, V31, P1391; Qavam SE, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0211-9; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Restivo MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176898; Rey A, 1964, LEXAMEN CLINIQUE PSY; del Paso GAR, 2012, EUR J PAIN, V16, P421, DOI 10.1002/j.1532-2149.2011.00032.x; del Paso GAR, 2015, J CLIN EXP NEUROPSYC, V37, P414, DOI 10.1080/13803395.2015.1023265; Robertson I. H., 1994, TEST EVERYDAY ATTENT; Rooks DS, 2007, CURR OPIN RHEUMATOL, V19, P111; Ruff R. M., 1996, RUFF FIGURAL FLUENCY; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Salvucci DD, 2001, COGNITIVE SCI, V25, P67, DOI 10.1207/s15516709cog2501_4; Sanz J., 2003, ANAL MODIF CONDUCT, P239, DOI DOI 10.6018/ANALESPS.29.1.130532; Schaefer C, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-71; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Sedo M, 2007, TEST CINCO DIGITOS; Sephton SE, 2003, HEALTH PSYCHOL, V22, P592, DOI 10.1037/0278-6133.22.6.592; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Soriano-Maldonado A, 2016, J SPORT SCI, V34, P1731, DOI 10.1080/02640414.2015.1136069; Spielberger C.D., 1986, CUESTIONARIO ANSIEDA, V2nd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tassain V, 2003, PAIN, V104, P389, DOI 10.1016/S0304-3959(03)00047-2; Veldhuijzen DS, 2012, J PAIN, V13, P507, DOI 10.1016/j.jpain.2012.02.011; Verdejo-Garcia A, 2009, ARCH CLIN NEUROPSYCH, V24, P113, DOI 10.1093/arclin/acp014; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Walitt B, 2008, RHEUMATOL INT, V28, P561, DOI 10.1007/s00296-007-0487-2; Walteros C, 2011, J PSYCHOSOM RES, V70, P294, DOI 10.1016/j.jpsychores.2010.07.013; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Watter S, 2001, PSYCHOPHYSIOLOGY, V38, P998, DOI 10.1111/1469-8986.3860998; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; Weiss S, 2013, BEHAV MED, V39, P146, DOI 10.1080/08964289.2013.818932; Werner NS, 2009, INT J PSYCHOPHYSIOL, V74, P259, DOI 10.1016/j.ijpsycho.2009.09.010; Williams DA, 2011, J MUSCULOSKELET PAIN, V19, P66, DOI 10.3109/10582452.2011.558989; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Wood PB, 2004, MED HYPOTHESES, V62, P420, DOI 10.1016/j.mehy.2003.10.013; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Yunus MB, 2002, SCAND J RHEUMATOL, V31, P27, DOI 10.1080/030097402317255336; Zhang T, 2015, INT J PSYCHOPHYSIOL, V96, P155, DOI 10.1016/j.ijpsycho.2015.04.010	110	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196329	10.1371/journal.pone.0196329	http://dx.doi.org/10.1371/journal.pone.0196329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD8ZI	29694417	gold, Green Published, Green Submitted			2022-12-26	WOS:000430802400083
J	Su, YB; Li, TH; Huang, CC; Tsai, HC; Huang, SF; Hsieh, YC; Yang, YY; Huang, YH; Hou, MC; Lin, HC				Su, Yen-Bo; Li, Tzu-Hao; Huang, Chia-Chang; Tsai, Hung-Cheng; Huang, Shiang-Fen; Hsieh, Yun-Cheng; Yang, Ying-Ying; Huang, Yi-Hsiang; Hou, Ming-Chih; Lin, Han-Chieh			Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; VITAMIN-D DEFICIENCY; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; TNF-ALPHA; D-RECEPTOR; ADIPOSE-TISSUE; PERMEABILITY; EXPRESSION; D-3	Vitamin D deficiency and up-regulated TNF alpha-related signals are reported to be involved in abnormalities including intestinal hyper-permeability, bacterial translocation, systemic/portal endotoxemia, intestinal/adipose tissue/hepatic inflammation, and hepatic steatosis in nonalcoholic steatohepatitis (NASH). This study aims to explore the molecular mechanisms and effects of chronic calcitriol [1,25-(OH)(2)D-3, hormonal form of vitamin D] on gut-adipose tissue-liver axis abnormalities using a high-fat diet (HFD)-fed rat model of NASH. In HFD-fed obese rats on a 10-week calcitriol (0.3 pg/kg/TIW) or vehicle treatment (NASH-vit. D and NASH-V rats) reigme, various in vivo and in vitro experiments were undertaken. Through anti-INF alpha-TNFR1-NF kappa B signaling effects, chronic calcitriol treatment significantly restored plasma calcitriol levels and significantly improved vitamin D receptor (VDR) expression in monocytes and the small intestine of NASH-vit. D rats. Significantly, plasma and portal endotoxin/INF alpha levels, bacterial translocation to mesenteric lymph nodes, plasma DX4000-FITC, fecal albumin-assessed intestinal hyper-permeability, over-expression of TNF alpha-related immune profiles in monocytes, inflammation of intestinal/mesenteric adipose tissue (MAT)/liver and hepatic steatosis were improved by chronic calcitriol treatment of NASH rats. Additionally, in vitro experiments with acute calcitriol co-incubation reversed NASH-V rat monocyte supernatant/TNF alpha-induced monolayer barrier dysfunction in caco-2 cells, cytokine release from MAT-derived adipocytes, and triglyceride synthesis by lean-V rat hepatocytes. Using in vivo and in vitro experiments, our study reported calcitriol signaling in the gut as well as in adipose tissue. Meanwhile, our study suggests that restoration of systemic and intestinal vitamin D deficiency using by chronic vitamin D treatment effectively reduces TNF alpha-mediated immunological abnormalities associated with the gut-adipose tissue-liver axis and hepatic steatosis in NASH rats.	[Su, Yen-Bo; Huang, Chia-Chang; Tsai, Hung-Cheng; Yang, Ying-Ying] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Su, Yen-Bo; Li, Tzu-Hao; Huang, Chia-Chang; Tsai, Hung-Cheng; Huang, Shiang-Fen; Hsieh, Yun-Cheng; Yang, Ying-Ying; Huang, Yi-Hsiang; Hou, Ming-Chih; Lin, Han-Chieh] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan; [Li, Tzu-Hao] Taipei Vet Gen Hosp, Div Allergy & Immunol, Taipei, Taiwan; [Li, Tzu-Hao; Huang, Chia-Chang; Yang, Ying-Ying] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei, Taiwan; [Li, Tzu-Hao] Taichung Vet Gen Hosp, Chia Yi Branch, Chiayi, Taiwan; [Huang, Shiang-Fen] Taipei Vet Gen Hosp, Div Infect, Taipei, Taiwan; [Hsieh, Yun-Cheng; Yang, Ying-Ying; Huang, Yi-Hsiang; Hou, Ming-Chih; Lin, Han-Chieh] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Yang, Ying-Ying] Taipei Vet Gen Hosp, Div Gen Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Yang, YY (corresponding author), Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.; Yang, YY; Lin, HC (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan.; Yang, YY (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei, Taiwan.; Yang, YY; Lin, HC (corresponding author), Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan.; Yang, YY (corresponding author), Taipei Vet Gen Hosp, Div Gen Med, Taipei, Taiwan.	yangyy@vghtpe.gov.tw; hclin@vghtpe.gov.tw	Lin, Han/GRF-1081-2022; Huang, Shiang-Fen/ABA-5375-2021	Huang, Shiang-Fen/0000-0003-0390-9108; Huang, Shiang-Fen/0000-0002-6685-8259; Huang, Chia-Chang/0000-0002-1313-4628; Yang, Ying-Ying/0000-0002-7719-0397	National Science Council [NSC-102-2314-B-010-036-MY3]; Taipei Veterans General Hospital;  [V106EA-007];  [VGHUST105-GI-2-2]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); ; 	We especially thank Yun-Ru Wang, Fan-Yi Jhan, Che-Jui Chang and Yen-Ling Lin for their excellent technical supports. This work was entirely supported by research grants NSC-102-2314-B-010-036-MY3 and from the National Science Council, and V106EA-007, VGHUST105-GI-2-2 and by the Taipei Veterans General Hospital.	Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Brandl K, 2015, EXPERT REV GASTROENT, V9, P1069, DOI 10.1586/17474124.2015.1057122; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cantorna MT, 2010, P NUTR SOC, V69, P286, DOI 10.1017/S0029665110001722; Chang E, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040338; Chen YZ, 2014, INFLAMM BOWEL DIS, V20, P1910, DOI 10.1097/MIB.0000000000000158; Cohen ML, 2001, KIDNEY INT, V59, P69, DOI 10.1046/j.1523-1755.2001.00467.x; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Devin A, 2001, MOL CELL BIOL, V21, P3986, DOI 10.1128/MCB.21.12.3986-3994.2001; Ding C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061707; Drori A, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0688-4; Duarte MS, 2012, J METABOLIC SYND, V1, P4, DOI [10.4172/2167-0943.1000112, DOI 10.4172/2167-0943.1000112]; FEINGOLD KR, 1987, J CLIN INVEST, V80, P184, DOI 10.1172/JCI113046; Feng YJ, 2013, J PHYSIOL-LONDON, V591, P3709, DOI 10.1113/jphysiol.2013.253518; Froicu M, 2003, MOL ENDOCRINOL, V17, P2386, DOI 10.1210/me.2003-0281; Gabele E, 2011, J HEPATOL, V55, P1391, DOI 10.1016/j.jhep.2011.02.035; Gao D, 2013, INT J OBESITY, V37, P357, DOI 10.1038/ijo.2012.53; Garcia-Alvarez M, 2016, AIDS, V30, P1069, DOI 10.1097/QAD.0000000000001007; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; GRUNFELD C, 1991, METABOLISM, V40, P894, DOI 10.1016/0026-0495(91)90062-2; Han H, 2015, NUTR METAB CARDIOVAS, V25, P556, DOI 10.1016/j.numecd.2015.02.011; Jiang TT, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030126; Jiang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08096; Kang EJ, 2015, INT J MOL MED, V36, P1151, DOI 10.3892/ijmm.2015.2300; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Leppkes M, 2014, INT IMMUNOL, V26, P509, DOI 10.1093/intimm/dxu051; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Li YC, 2015, J STEROID BIOCHEM, V148, P179, DOI 10.1016/j.jsbmb.2015.01.011; Liu H, 2011, CYTOKINE, V56, P581, DOI 10.1016/j.cyto.2011.08.023; Liu LN, 2016, EXP THER MED, V11, P2284, DOI 10.3892/etm.2016.3242; Liu XJ, 2015, ENDOCRINOLOGY, V156, P2103, DOI 10.1210/en.2014-2037; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Manna P, 2017, ARCH BIOCHEM BIOPHYS, V615, P22, DOI 10.1016/j.abb.2017.01.002; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; MULLER K, 1992, CYTOKINE, V4, P506, DOI 10.1016/1043-4666(92)90012-G; Nakano T, 2011, J HEPATOL, V55, P415, DOI 10.1016/j.jhep.2010.11.028; Nelson JE, 2016, AM J GASTROENTEROL, V111, P852, DOI 10.1038/ajg.2016.51; Peterson CA, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-10; Poniachik J, 2006, CYTOKINE, V33, P252, DOI 10.1016/j.cyto.2006.02.006; Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Targher G, 2007, NUTR METAB CARDIOVAS, V17, P517, DOI 10.1016/j.numecd.2006.04.002; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Unno N, 1996, AM J PHYSIOL-GASTR L, V270, pG1010, DOI 10.1152/ajpgi.1996.270.6.G1010; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824, DOI 10.1128/IAI.67.8.3824-3829.1999; Vida M, 2015, DIS MODEL MECH, V8, P721, DOI 10.1242/dmm.019166; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086117; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206; Zhao P, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-1	55	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0194867	10.1371/journal.pone.0194867	http://dx.doi.org/10.1371/journal.pone.0194867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684027	Green Published, gold, Green Submitted			2022-12-26	WOS:000430660600008
J	Uechi, E; Okada, M; Fushimi, K				Uechi, Eishi; Okada, Masato; Fushimi, Kiyohide			Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database	PLOS ONE			English	Article							ANCA-ASSOCIATED VASCULITIS; DIFFUSE ALVEOLAR HEMORRHAGE; MICROSCOPIC POLYANGIITIS; RESPIRATORY-FAILURE; JAPAN; SCORE; GLOMERULONEPHRITIS; GRANULOMATOSIS; NOMENCLATURE; MANAGEMENT	Background & para;& para;Secondary pulmonary hemorrhage increases the risk of mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV); plasma exchange therapy may improve outcomes in these patients. We conducted a retrospective cohort study to investigate the effect of plasma exchange therapy on short-term prognoses in patients with pulmonary hemorrhage secondary to AAV.& para;& para;Methods & para;& para;This study utilized the Diagnosis Procedure Combination database, which is a nationwide inpatient database in Japan. We checked the abstract data and medical actions and identified the patients with pulmonary hemorrhage secondary to AAV who required proactive treatment between 2009 and 2014. To compare the in-hospital mortality, we performed propensity score matching between the plasma exchange and non-plasma exchange groups at a ratio of 1:1.& para;& para;Results & para;& para;Of the 52,932 patients with AAV, 940 developed pulmonary hemorrhage as a complication. A total of 249 patients from 194 hospitals were eligible for the study. Propensity score matching at a ratio of 1:1 was performed, and 59 pairs were formed (plasma exchange group, n = 59; non-plasma exchange group, n = 59). A statistically significant difference was found in the all-cause in-hospital mortality between the plasma exchange and non-plasma exchange groups (35.6% vs. 54.2%; p = 0041; risk difference, -18.6; 95% confidence interval (CI), -35.4% to -0.67%).& para;& para;Conclusion & para;& para;Thus, plasma exchange therapy was associated with improved in-hospital mortality in patients with pulmonary hemorrhage secondary to AAV.	[Uechi, Eishi; Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch, Dept Hlth Policy & Informat, Bunkyo Ku, Tokyo, Japan; [Uechi, Eishi] Tomishiro Cent Hosp, Div Rheumatol, Tomigusuku, Okinawa, Japan; [Okada, Masato] St Lukes Int Univ, St Lukes Int Hosp, Immunorheumatol Ctr, Chuo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); St. Luke's International Hospital	Fushimi, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Hlth Policy & Informat, Bunkyo Ku, Tokyo, Japan.	kfushimi.hci@tmd.ac.jp		Fushimi, Kiyohide/0000-0002-1894-0290	Ministry of Health, Labour, and Welfare, Japan [H28-Seisaku-Shitei-009]	Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	KF had a Grant-in-Aid for Research on Policy Planning and Evaluation from the Ministry of Health, Labour, and Welfare, Japan (H28-Seisaku-Shitei-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso S, 2016, CRIT CARE MED, V44, P1974, DOI 10.1097/CCM.0000000000001828; Buttgereit F, 2002, ANN RHEUM DIS, V61, P718, DOI 10.1136/ard.61.8.718; Cartin-Ceba R, 2016, ARTHRITIS RHEUMATOL, V68, P1467, DOI 10.1002/art.39562; CASIAN AL, 2010, NDT PLUS S3, V3, P278; Chen M, 2009, AM J MED SCI, V337, P411, DOI 10.1097/MAJ.0b013e3181928d24; Chikuda H, 2012, J BONE JOINT SURG AM, V94A, P433, DOI 10.2106/JBJS.K.00183; Fujimoto S, 2011, RHEUMATOLOGY, V50, P1916, DOI 10.1093/rheumatology/ker205; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Guillevin L, 2011, MEDICINE, V90, P19, DOI 10.1097/MD.0b013e318205a4c6; Hasegawa W, 2015, ALLERGY, V70, P585, DOI 10.1111/all.12597; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; HAWORTH SJ, 1985, BMJ-BRIT MED J, V290, P1775, DOI 10.1136/bmj.290.6484.1775; Hogan SL, 1996, J AM SOC NEPHROL, V7, P23; Hruskova Z, 2013, SCAND J RHEUMATOL, V42, P211, DOI 10.3109/03009742.2012.754939; Isogai T, 2017, J CARDIOL, V69, P287, DOI 10.1016/j.jjcc.2016.05.008; Isogai T, 2016, INT J CARDIOL, V222, P163, DOI 10.1016/j.ijcard.2016.07.159; Iwagami M, 2014, CRIT CARE MED, V42, P1187, DOI 10.1097/CCM.0000000000000150; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kallenberg CGM, 2014, NAT REV RHEUMATOL, V10, P484, DOI 10.1038/nrrheum.2014.104; Klemmer PJ, 2003, AM J KIDNEY DIS, V42, P1149, DOI 10.1053/j.ajkd.2003.08.015; Kostianovsky A, 2012, CLIN EXP RHEUMATOL, V30, pS77; Lauque D, 2000, MEDICINE, V79, P222, DOI 10.1097/00005792-200007000-00003; Lin Y, 2009, JCR-J CLIN RHEUMATOL, V15, P341, DOI 10.1097/RHU.0b013e3181b59581; Nakatani H, 2003, HEALTH POLICY, V64, P377, DOI 10.1016/S0168-8510(02)00199-9; Ntatsaki E, 2014, RHEUMATOLOGY, V53, P2306, DOI 10.1093/rheumatology/ket445; Ravindran V, 2010, RHEUMATOLOGY, V49, P1410, DOI 10.1093/rheumatology/keq061; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; terMaaten JC, 1996, CHEST, V110, P357, DOI 10.1378/chest.110.2.357; Tesar V, 1998, BLOOD PURIFICAT, V16, P72, DOI 10.1159/000014316; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Yates M, 2016, ANN RHEUM DIS, V75, P1583, DOI 10.1136/annrheumdis-2016-209133	32	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196009	10.1371/journal.pone.0196009	http://dx.doi.org/10.1371/journal.pone.0196009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684034	gold, Green Submitted, Green Published			2022-12-26	WOS:000430660600030
J	Chang, JW; Kuo, WH; Lin, CM; Chen, WL; Chan, SH; Chiu, MF; Chang, IS; Jiang, SS; Tsai, FY; Chen, CH; Huang, PH; Chang, KJ; Lin, KT; Lin, SC; Wang, MY; Uen, YH; Tu, CW; Hou, MF; Tsai, SF; Shen, CY; Tung, SL; Wang, LH				Chang, Jer-Wei; Kuo, Wen-Hung; Lin, Chiao-Mei; Chen, Wen-Ling; Chan, Shih-Hsuan; Chiu, Meng-Fan; Chang, I-Shou; Jiang, Shih-Sheng; Tsai, Fang-Yu; Chen, Chung-Hsing; Huang, Pei-Hsin; Chang, King-Jen; Lin, Kai-Ti; Lin, Sheng-Chieh; Wang, Ming-Yang; Uen, Yih-Huei; Tu, Chi-Wen; Hou, Ming-Feng; Tsai, Shih-Feng; Shen, Chen-Yang; Tung, Shiao-Lin; Wang, Lu-Hai			Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway	ONCOGENE			English	Article							YOUNG AGE; PROTEIN; ACTIN; DIAGNOSIS; PROGNOSIS; PATTERNS; IDENTIFICATION; PROGRESSION; ABNORMALITY; FEATURES	The early onset breast cancer patients (age <= 40) often display higher incidence of axillary lymph node metastasis, and poorer five-year survival than the late-onset patients. To identify the genes and molecules associated with poor prognosis of early onset breast cancer, we examined gene expression profiles from paired breast normal/tumor tissues, and coupled with Gene Ontology and public data base analysis. Our data showed that the expression of GAS7b gene was lower in the early onset breast cancer patients as compared to the elder patients. We found that GAS7 was associated with CYFIP1 and WAVE2 complex to suppress breast cancer metastasis via blocking CYFIP1 and Rac1 protein interaction, actin polymerization, and beta 1-integrin/FAK/Src signaling. We further demonstrated that p53 directly regulated GAS7 gene expression, which was inversely correlated with p53 mutations in breast cancer specimens. Our study uncover a novel regulatory mechanism of p53 in early onset breast cancer progression through GAS7-CYFIP1-mediated signaling pathways.	[Chang, Jer-Wei; Lin, Chiao-Mei; Chen, Wen-Ling; Chan, Shih-Hsuan; Chiu, Meng-Fan; Tsai, Shih-Feng; Wang, Lu-Hai] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Kuo, Wen-Hung; Chang, King-Jen; Wang, Ming-Yang] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Chan, Shih-Hsuan] Natl Tsing Hua Univ, Inst Mol Med, Coll Life Sci, Hsinchu, Taiwan; [Chan, Shih-Hsuan] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan; [Chang, I-Shou; Jiang, Shih-Sheng; Tsai, Fang-Yu; Chen, Chung-Hsing] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Huang, Pei-Hsin] Natl Taiwan Univ, Dept Pathol, Coll Med, Taipei, Taiwan; [Chang, King-Jen] Taiwan Adventist Hosp, Taipei, Taiwan; [Lin, Kai-Ti] Natl Tsing Hua Univ, Inst Biotechnol, Coll Life Sci, Hsinchu, Taiwan; [Lin, Sheng-Chieh; Wang, Lu-Hai] China Med Univ, Coll Chinese Med, Taichung, Taiwan; [Uen, Yih-Huei] Asia Univ Hosp, Dept Surg, Taichung, Taiwan; [Tu, Chi-Wen] Ditmanson Med Fdn, Dept Gen Surg, Chia Yi Christian Hosp, Chiayi, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Dept Surg, Coll Med, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Municipal Hsiaokang Hosp, Dept Surg, Kaohsiung, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ Hosp, Div Breast Surg, Kaohsiung, Taiwan; [Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Tung, Shiao-Lin] Ton Yen Gen Hosp, Dept Hematol & Oncol, Hsinchu, Taiwan	National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; China Medical University Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; National Tsing Hua University; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Academia Sinica - Taiwan	Wang, LH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan.; Wang, LH (corresponding author), China Med Univ, Coll Chinese Med, Taichung, Taiwan.	luhaiwang@mail.cmu.edu.tw	Jiang, Shih Sheng/J-9671-2019; Chan, Shih-Hsuan/AAD-4317-2021; Shen, CY/F-6271-2010; Chan, Shih-Hsuan/AAW-6857-2020; Lin, Kai-Ti/B-3840-2016	Jiang, Shih Sheng/0000-0003-1909-437X; Lin, Kai-Ti/0000-0001-8656-5755; KUO, WEN-HUNG/0000-0002-9881-4605; Tung, Shiao-Lin/0000-0002-6241-6293; Chen, Chung-Hsing/0000-0002-1205-7368; Hou, Ming-Feng/0000-0001-6030-9702; Chan, Shih-Hsuan/0000-0002-8703-5139; Chang, King jen/0000-0001-9811-3422	Advance Medical Plan from Ministry of Health and Welfare, Taiwan [107-0324-01-19-03];  [CA-105-SP-01];  [MOHW105-TDU-B-212-112017]	Advance Medical Plan from Ministry of Health and Welfare, Taiwan; ; 	This work was supported by grants (CA-105-SP-01 and MOHW105-TDU-B-212-112017) and Advance Medical Plan (107-0324-01-19-03) from Ministry of Health and Welfare, Taiwan.	ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Anders CK, 2011, J CLIN ONCOL, V29, pE18, DOI 10.1200/JCO.2010.28.9199; Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; BONNIER P, 1995, INT J CANCER, V62, P138, DOI 10.1002/ijc.2910620205; BRENNER DG, 1989, P NATL ACAD SCI USA, V86, P5517, DOI 10.1073/pnas.86.14.5517; Chan SH, 2014, ONCOGENE, V33, P4496, DOI 10.1038/onc.2014.10; Chao CCK, 2005, J NEUROSCI RES, V81, P153, DOI 10.1002/jnr.20552; Chen FM, 2004, CANCER LETT, V207, P59, DOI 10.1016/j.canlet.2003.12.005; Cheng SH, 2000, BREAST CANCER RES TR, V63, P213, DOI 10.1023/A:1006468514396; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DELAROCHEFORDIERE A, 1993, LANCET, V341, P1039, DOI 10.1016/0140-6736(93)92407-K; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hu JH, 2011, J CELL SCI, V124, P1739, DOI 10.1242/jcs.078014; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Jong YJ, 2004, CANCER GENET CYTOGEN, V148, P55, DOI 10.1016/S0165-4608(03)00205-X; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kuo WH, 2006, BREAST CANCER RES TR, V99, P221, DOI 10.1007/s10549-006-9194-z; Kurisu S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-226; Lin KT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6917; Lin KT, 2012, CANCER RES, V72, P3000, DOI 10.1158/0008-5472.CAN-11-2502; Liu SX, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0144-2; Lortie K, 2005, BRAIN RES, V1036, P27, DOI 10.1016/j.brainres.2004.12.024; Lou MA, 1997, BRIT J CANCER, V75, P746, DOI 10.1038/bjc.1997.132; Melhem-Bertrandt A, 2012, CANCER-AM CANCER SOC, V118, P908, DOI 10.1002/cncr.26377; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; Saengsawang W, 2012, CURR BIOL, V22, P494, DOI 10.1016/j.cub.2012.01.038; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; She BR, 2002, EXP CELL RES, V273, P34, DOI 10.1006/excr.2001.5435; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Tseng RC, 2008, LUNG CANCER, V59, P332, DOI 10.1016/j.lungcan.2007.08.038; Tseng RC, 2015, ONCOTARGET, V6, P44207, DOI 10.18632/oncotarget.6229; Xu GW, 2005, INT J CANCER, V116, P187, DOI 10.1002/ijc.21071; Yan C, 2003, EMBO J, V22, P3602, DOI 10.1093/emboj/cdg350; You JJ, 2010, J BIOL CHEM, V285, P11652, DOI 10.1074/jbc.M109.051094; Zhou P, 2004, CANCER-AM CANCER SOC, V101, P1264, DOI 10.1002/cncr.20523	42	23	23	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 26	2018	37	30					4137	4150		10.1038/s41388-018-0253-9	http://dx.doi.org/10.1038/s41388-018-0253-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GO2YI	29706651	Green Published, hybrid			2022-12-26	WOS:000439847000007
J	Toosi, BM; El Zawily, A; Truitt, L; Shannon, M; Allonby, O; Babu, M; DeCoteau, J; Mousseau, D; Ali, M; Freywald, T; Gall, A; Vizeacoumar, FS; Kirzinger, MW; Geyer, CR; Anderson, DH; Kim, T; Welm, AL; Siegel, P; Vizeacoumar, FJ; Kusalik, A; Freywald, A				Toosi, Behzad M.; El Zawily, Amr; Truitt, Luke; Shannon, Matthew; Allonby, Odette; Babu, Mohan; DeCoteau, John; Mousseau, Darrell; Ali, Mohsin; Freywald, Tanya; Gall, Amanda; Vizeacoumar, Frederick S.; Kirzinger, Morgan W.; Geyer, C. Ronald; Anderson, Deborah H.; Kim, TaeHyung; Welm, Alana L.; Siegel, Peter; Vizeacoumar, Franco J.; Kusalik, Anthony; Freywald, Andrew			EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours	ONCOGENE			English	Article							RECEPTOR TYROSINE KINASE; MAMMARY STEM-CELLS; METASTATIC COLONIZATION; CARCINOMA CELLS; EXPRESSION; IDENTIFICATION; HETEROGENEITY; TRANSITION; MECHANISMS; PLASTICITY	Triple-negative breast cancer (TNBC) tumours that lack expression of oestrogen, and progesterone receptors, and do not overexpress the HER2 receptor represent the most aggressive breast cancer subtype, which is characterised by the resistance to therapy in frequently relapsing tumours and a high rate of patient mortality. This is likely due to the resistance of slowly proliferating tumour-initiating cells (TICs), and understanding molecular mechanisms that control TICs behaviour is crucial for the development of effective therapeutic approaches. Here, we present our novel findings, indicating that an intrinsically catalytically inactive member of the Eph group of receptor tyrosine kinases, EPHB6, partially suppresses the epithelial-mesenchymal transition in TNBC cells, while also promoting expansion of TICs. Our work reveals that EPHB6 interacts with the GRB2 adapter protein and that its effect on enhancing cell proliferation is mediated by the activation of the RAS-ERK pathway, which allows it to elevate the expression of the TIC-related transcription factor, OCT4. Consistent with this, suppression of either ERK or OCT4 activities blocks EPHB6-induced pro-proliferative responses. In line with its ability to trigger propagation of TICs, EPHB6 accelerates tumour growth, potentiates tumour initiation and increases TIC populations in xenograft models of TNBC. Remarkably, EPHB6 also suppresses tumour drug resistance to DNA-damaging therapy, probably by forcing TICs into a more proliferative, drug-sensitive state. In agreement, patients with higher EPHB6 expression in their tumours have a better chance for recurrence-free survival. These observations describe an entirely new mechanism that governs TNBC and suggest that it may be beneficial to enhance EPHB6 action concurrent with applying a conventional DNA-damaging treatment, as it would decrease drug resistance and improve tumour elimination.	[Toosi, Behzad M.; El Zawily, Amr; Truitt, Luke; Allonby, Odette; DeCoteau, John; Ali, Mohsin; Freywald, Tanya; Vizeacoumar, Frederick S.; Geyer, C. Ronald; Freywald, Andrew] Univ Saskatchewan, Coll Med, Dept Pathol & Lab Med, Royal Univ Hosp, Room 2841,103 Hosp Dr, Saskatoon, SK S7N 0W8, Canada; [El Zawily, Amr] Damanhour Univ, Fac Sci, Damanhour 22516, Egypt; [Shannon, Matthew; Kirzinger, Morgan W.; Kusalik, Anthony] Univ Saskatchewan, Dept Comp Sci, 176 Thorvaldsen Bldg,110 Sci Pl, Saskatoon, SK S7N 5C9, Canada; [Babu, Mohan] Univ Regina, Dept Chem & Biochem, Fac Sci, Res & Innovat Ctr, Room 232, Regina, SK S4S 0A2, Canada; [Mousseau, Darrell] Univ Saskatchewan, Dept Psychiat, Coll Med, Cell Signaling Lab, GB41 Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada; [Gall, Amanda] Univ Saskatchewan, Dept Biochem, Coll Med, Room 2D01 Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada; [Anderson, Deborah H.; Vizeacoumar, Franco J.] Univ Saskatchewan, Saskatchewan Canc Agcy, 4D30-2 Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada; [Kim, TaeHyung] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Kim, TaeHyung] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3E1, Canada; [Welm, Alana L.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, 2000 Circle Hope, Salt Lake City, UT 84112 USA; [Siegel, Peter] McGill Univ, Goodman Canc Res Ctr, 1160 Pine Ave West, Montreal, PQ H3A 1A3, Canada	University of Saskatchewan; Egyptian Knowledge Bank (EKB); Damanhour University; University of Saskatchewan; University of Regina; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Toronto; University of Toronto; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; McGill University	Freywald, A (corresponding author), Univ Saskatchewan, Coll Med, Dept Pathol & Lab Med, Royal Univ Hosp, Room 2841,103 Hosp Dr, Saskatoon, SK S7N 0W8, Canada.; Kusalik, A (corresponding author), Univ Saskatchewan, Dept Comp Sci, 176 Thorvaldsen Bldg,110 Sci Pl, Saskatoon, SK S7N 5C9, Canada.	kusalik@cs.usask.ca; andrew.freywald@usask.ca	Vizeacoumar, Franco/GLS-7161-2022; Mohan, Babu P./I-7362-2019; Ali, Mohsin/GRY-0476-2022	Vizeacoumar, Frederick/0000-0002-4676-2911	Canadian Breast Cancer Foundation (CBCF) [C7003]	Canadian Breast Cancer Foundation (CBCF)	We thank Chelsea Cunningham for her help with qPCR experiments and Farhad Maleki for assistance with cluster validity analysis. This work was supported by Canadian Breast Cancer Foundation (CBCF) grant # C7003.	Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bailey CM, 2014, MOL CANCER RES, V12, P1303, DOI 10.1158/1541-7786.MCR-13-0673; Beltran AS, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3019; Bhushan L, 2014, CANCER GENOM PROTEOM, V11, P239; Brantley-Sieders DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024426; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Brooks MD, 2015, CELL STEM CELL, V17, P260, DOI 10.1016/j.stem.2015.08.014; Charafe-Jauffret E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-202; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen J, 2015, CYTOKINE GROWTH F R, V26, P1, DOI 10.1016/j.cytogfr.2014.05.001; Denkert C, 2017, LANCET, V389, P2430, DOI 10.1016/S0140-6736(16)32454-0; DeRose Yoko S, 2013, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1423s60; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; DeVeale B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003957; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Duggal Rohit, 2013, J Stem Cells, V8, P135, DOI jsc.2014.8.3/4.135; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; El Zawily AM, 2016, ONCOTARGET, V7, P77865, DOI 10.18632/oncotarget.12838; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Fox BP, 2006, BIOCHEM BIOPH RES CO, V340, P268, DOI 10.1016/j.bbrc.2005.11.174; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Fox BP, 2009, ONCOGENE, V23, P23; Funasaka T, 2009, CANCER RES, V69, P5349, DOI 10.1158/0008-5472.CAN-09-0488; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gu Y, 2016, J CLIN PATHOL, V69, P448, DOI 10.1136/jclinpath-2015-203160; Hafner C, 2003, INT J ONCOL, V23, P1553; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kleffel S, 2013, ADV EXP MED BIOL, V734, P145, DOI 10.1007/978-1-4614-1445-2_8; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kurpios NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058151; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Liersch-Lohn B, 2016, INT J CANCER, V138, P1220, DOI 10.1002/ijc.29865; Lisabeth EM, 2013, COLD SPRING HARB PER, V5; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Mateo-Lozano S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43702; Mayer IA, 2014, CLIN CANCER RES, V20, P782, DOI 10.1158/1078-0432.CCR-13-0583; Mohamed ER, 2015, ONCOL LETT, V9, P1672, DOI 10.3892/ol.2015.2925; Morrison BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049752; Muller-Tidow C, 2005, CANCER RES, V65, P1778, DOI 10.1158/0008-5472.CAN-04-3388; Mustacchi G, 2015, DRUG DES DEV THER, V9, P4303, DOI 10.2147/DDDT.S86105; Nishi M, 2014, ONCOGENE, V33, P643, DOI 10.1038/onc.2012.614; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Stankic M, 2013, CELL REP, V5, P1228, DOI 10.1016/j.celrep.2013.11.014; Stratford AL, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001535; Sultan AS, 2008, CANCER SCI, V99, P272, DOI 10.1111/j.1349-7006.2007.00685.x; Tang XX, 1999, CLIN CANCER RES, V5, P1491; Tang XX, 2000, MED PEDIATR ONCOL, V35, P656, DOI 10.1002/1096-911X(20001201)35:6<656::AID-MPO37>3.0.CO;2-A; Truitt L, 2011, BIOCHEM CELL BIOL, V89, P115, DOI [10.1139/O10-145, 10.1139/o10-145]; Truitt L, 2010, CANCER RES, V70, P1141, DOI 10.1158/0008-5472.CAN-09-1710; Vizeacoumar FJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.54; Yu J, 2010, CLIN CANCER RES, V16, P2275, DOI 10.1158/1078-0432.CCR-09-2000; Yu J, 2009, INT J ONCOL, V35, P175, DOI 10.3892/ijo_00000326	64	19	20	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 26	2018	37	30					4073	4093		10.1038/s41388-018-0228-x	http://dx.doi.org/10.1038/s41388-018-0228-x			21	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GO2YI	29700392	Green Published, hybrid			2022-12-26	WOS:000439847000003
J	Zhang, YY; Tabataba, H; Liu, XY; Wang, JY; Yan, XG; Farrelly, M; Jiang, CC; Guo, ST; Liu, T; Kao, HY; Thorne, RF; Zhang, XD; Jin, L				Zhang, Yuan Yuan; Tabataba, Hessam; Liu, Xiao Ying; Wang, Jia Yu; Yan, Xu Guang; Farrelly, Margaret; Jiang, Chen Chen; Guo, Su Tang; Liu, Tao; Kao, Hung-Ying; Thorne, Rick F.; Zhang, Xu Dong; Jin, Lei			ACTN4 regulates the stability of RIPK1 in melanoma	ONCOGENE			English	Article							ALPHA-ACTININ 4; NF-KAPPA-B; COPY NUMBER INCREASE; GENE AMPLIFICATION; CELL MOTILITY; STAGE-I; CANCER; KINASE; CROSSROADS; ALPHA-ACTININ-4	The actin crosslinking protein alpha-actinin-4 (ACTN4) is emerging as an important contributor to the pathogenesis of cancer. This has largely been attributed to its role in regulating cytoskeleton organization and its involvement in transcriptional regulation of gene expression. Here we report a novel function of ACTN4 as a scaffold necessary for stabilization of receptor-interacting protein kinase 1 (RIPK1) that we have recently found to be an oncogenic driver in melanoma. ACTN4 bound to RIPK1 and cellular inhibitor of apoptosis protein 1 (cIAP1) with its actin-binding domain at the N-terminus and the CaM-like domain at the C-terminus, respectively. This facilitated the physical association between RIPK1 and cIAP1 and was critical for stabilization of RIPK1 that in turn activated NF-kappa B. Functional investigations showed that silencing of ACTN4 suppressed melanoma cell proliferation and retarded melanoma xenograft growth. In contrast, overexpression of ACTN4 promoted melanocyte and melanoma cell proliferation and moreover, prompted melanocyte anchorage-independent growth. Of note, the expression of ACTN4 was transcriptionally activated by NF-kappa B. Taken together, our findings identify ACTN4 as an oncogenic regulator through driving a feedforward signaling axis of ACTN4-RIPK1-NF-kappa B, with potential implications for targeting ACTN4 in the treatment of melanoma.	[Zhang, Yuan Yuan; Liu, Xiao Ying; Jiang, Chen Chen; Jin, Lei] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Tabataba, Hessam; Wang, Jia Yu; Yan, Xu Guang; Farrelly, Margaret; Guo, Su Tang; Zhang, Xu Dong] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Liu, Xiao Ying] Anhui Med Univ, Sch Life Sci, Hefei 230000, Anhui, Peoples R China; [Jiang, Chen Chen; Zhang, Xu Dong; Jin, Lei] Hunter Med Res Inst, Canc Res Program, New Lambton, NSW 2305, Australia; [Guo, Su Tang] Shanxi Canc Hosp & Inst, Dept Mol Biol, Taiyuan 030013, Shanxi, Peoples R China; [Liu, Tao] Univ New South Wales, Childrens Canc Inst Australia Med Res, Sydney, NSW 2750, Australia; [Kao, Hung-Ying] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Thorne, Rick F.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle; Anhui Medical University; Hunter Medical Research Institute; University of Newcastle; Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; Case Western Reserve University; University of Newcastle	Jin, L (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia.; Zhang, XD (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.; Zhang, XD; Jin, L (corresponding author), Hunter Med Res Inst, Canc Res Program, New Lambton, NSW 2305, Australia.	Xu.Zhang@newcastle.edu.au; Lei.Jin@newcastle.edu.au	ZHANG, YUANYUAN/Q-3332-2019; Jin, Lei/J-1896-2019; Liu, Tao/A-3922-2015; Wang, jiayu/ABB-6772-2020; Jin, Lei/K-2315-2019; zhang, xian/GYA-0290-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022	ZHANG, YUANYUAN/0000-0001-5851-5128; Jin, Lei/0000-0001-7187-9671; Tabatabaee, Hessam/0000-0001-8912-1746; Zhang, Xu Dong/0000-0001-9457-8003; Liu, Tao/0000-0001-6244-7316; Thorne, Rick/0000-0001-7882-7081	National Health and Medical Research Council (NHMRC) [APP1083496, APP1099947]; Natural Science Foundation of China (NSFC) [81772908]; Cancer Institute NSW Fellowships	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Cancer Institute NSW Fellowships	This work was supported by the National Health and Medical Research Council (NHMRC) (APP1083496 and APP1099947) and the Natural Science Foundation of China (NSFC) (81772908). L.J. and C.C.J. are recipients of Cancer Institute NSW Fellowships.	Agarwal N, 2013, ONCOGENE, V32, P462, DOI 10.1038/onc.2012.69; Aksenova V, 2013, ONCOTARGET, V4, P362, DOI 10.18632/oncotarget.901; Babakov V N, 2004, Tsitologiia, V46, P1064; Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blackwell K, 2013, MOL CELL BIOL, V33, P1901, DOI 10.1128/MCB.01416-12; Broderick MJF, 2002, J STRUCT BIOL, V137, P184, DOI 10.1006/jsbi.2002.4465; Carragher NO, 2001, J BIOL CHEM, V276, P4270, DOI 10.1074/jbc.M008972200; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Ding ZY, 2006, P NATL ACAD SCI USA, V103, P15014, DOI 10.1073/pnas.0606917103; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Dong L, 2014, ONCOGENE, V33, P4756, DOI 10.1038/onc.2013.420; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao YF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1295-9; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0031-0; Hsu KS, 2013, VITAM HORM, V93, P323, DOI 10.1016/B978-0-12-416673-8.00005-8; Hu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.441; Jin L, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1035690; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Kakuya T, 2017, INT J ORAL MAX SURG, V46, P968, DOI 10.1016/j.ijom.2017.03.001; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; Liu XY, 2015, CANCER RES, V75, P1736, DOI 10.1158/0008-5472.CAN-14-2199; Luan Q, 2015, AUTOPHAGY, V11, P975, DOI 10.1080/15548627.2015.1049800; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Noro R, 2013, ANN ONCOL, V24, P2594, DOI 10.1093/annonc/mdt293; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Oikonomou KG, 2011, AUTOIMMUN REV, V10, P389, DOI 10.1016/j.autrev.2010.12.009; Shao HS, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.579185; Shao HS, 2013, INT J BIOCHEM CELL B, V45, P1051, DOI 10.1016/j.biocel.2013.02.015; Shao HS, 2010, J BIOL CHEM, V285, P2591, DOI 10.1074/jbc.M109.035790; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Tay KH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.79; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Watabe Y, 2014, CANCER MED-US, V3, P613, DOI 10.1002/cam4.214; Watanabe T, 2015, BRIT J CANCER, V112, P704, DOI 10.1038/bjc.2014.623; Yamamoto S, 2012, HISTOPATHOLOGY, V60, P1073, DOI 10.1111/j.1365-2559.2011.04163.x; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Ye Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2489; Zhao X, 2015, J BIOL CHEM, V290, P338, DOI 10.1074/jbc.M114.597260	48	16	16	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 19	2018	37	29					4033	4045		10.1038/s41388-018-0260-x	http://dx.doi.org/10.1038/s41388-018-0260-x			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GN5LP	29706658				2022-12-26	WOS:000439101300009
J	Agwa, AJ; Peigneur, S; Chow, CY; Lawrence, N; Craik, DJ; Tytgat, J; King, GF; Henriques, ST; Schroeder, CI				Agwa, Akello J.; Peigneur, Steve; Chow, Chun Yuen; Lawrence, Nicole; Craik, David J.; Tytgat, Jan; King, Glenn F.; Henriques, Sonia Troeira; Schroeder, Christina I.			Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; TARANTULA TOXINS; ION-CHANNEL; HAINANTOXIN-IV; MOLECULAR-BASIS; PEPTIDE TOXIN; DOMAIN-II; PROTX-II; SENSOR; BINDING	Gating modifier toxins (GMTs) are venom-derived peptides isolated from spiders and other venomous creatures and modulate activity of disease-relevant voltage-gated ion channels and are therefore being pursued as therapeutic leads. The amphipathic surface profile of GMTs has prompted the proposal that some GMTs simultaneously bind to the cell membrane and voltage-gated ion channels in a trimolecular complex. Here, we examined whether there is a relationship among spider GMT amphipathicity, membrane binding, and potency or selectivity for voltage-gated sodium (Na-V) channels. We used NMR spectroscopy and in silico calculations to examine the structures and physicochemical properties of a panel of nine GMTs and deployed surface plasmon resonance to measure GMT affinity for lipids putatively found in proximity to Na-V channels. Electrophysiology was used to quantify GMT activity on Na(V)1.7, an ion channel linked to chronic pain. Selectivity of the peptides was further examined against a panel of Na-V channel subtypes. We show that GMTs adsorb to the outer leaflet of anionic lipid bilayers through electrostatic interactions. We did not observe a direct correlation between GMT amphipathicity and affinity for lipid bilayers. Furthermore, GMT-lipid bilayer interactions did not correlate with potency or selectivity for Na(V)s. We therefore propose that increased membrane binding is unlikely to improve subtype selectivity and that the conserved amphipathic GMT surface profile is an adaptation that facilitates simultaneous modulation of multiple Na(V)s.	[Agwa, Akello J.; Chow, Chun Yuen; Lawrence, Nicole; Craik, David J.; King, Glenn F.; Henriques, Sonia Troeira; Schroeder, Christina I.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Peigneur, Steve; Tytgat, Jan] Univ Leuven KU Leuven, Lab Toxicol & Pharmacol, B-3000 Leuven, Belgium	University of Queensland; KU Leuven	Schroeder, CI (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	c.schroeder@imb.uq.edu.au	Chow, Chun Yuen/C-7941-2017; Lawrence, Nicole/A-5573-2017; Craik, David/B-1695-2010; Chow, Chun Yuen/AAS-2223-2020; Agwa, Akello/N-8633-2019; Schroeder, Christina/K-2042-2014; Troeira Henriques, Sonia/J-3500-2016	Chow, Chun Yuen/0000-0003-2861-5843; Lawrence, Nicole/0000-0002-9013-1770; Craik, David/0000-0003-0007-6796; Chow, Chun Yuen/0000-0003-2861-5843; Agwa, Akello/0000-0001-9295-5071; Schroeder, Christina/0000-0002-6737-6374; Peigneur, Steve/0000-0003-0504-5702; Tytgat, Jan/0000-0003-1778-6022; Troeira Henriques, Sonia/0000-0001-9564-9651; King, Glenn/0000-0002-2308-2200	Australian National Health and Medical Research Council [APP1080405, APP1072113, APP1044414]; Australian Research Council (ARC) [FT160100055, FT150100398]; Australian Laureate fellowship [FL150100146]; Central Europe Leuven Strategic Alliance Grant [CELSA/17/047-BOF/ISP]; University of Queensland International Postgraduate Scholarships	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Australian Laureate fellowship; Central Europe Leuven Strategic Alliance Grant; University of Queensland International Postgraduate Scholarships	This work was supported by Australian National Health and Medical Research Council Project Grant APP1080405 (to C. I. S. and S. T. H.) and Program Grant APP1072113 and Principal Research Fellowship APP1044414 (to G. F. K.); Australian Research Council (ARC) Future Fellowships FT160100055 (to C. I. S.) and FT150100398 (to S. T. H.) and Australian Laureate fellowship FL150100146 (to D. J. C.); Central Europe Leuven Strategic Alliance Grant CELSA/17/047-BOF/ISP (to J. T.); and University of Queensland International Postgraduate Scholarships (to A. J. A. and C. Y. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agwa AJ, 2017, NEUROPHARMACOLOGY, V127, P32, DOI 10.1016/j.neuropharm.2017.04.004; Agwa AJ, 2017, TOXINS, V9, DOI 10.3390/toxins9080248; Agwa AJ, 2017, BBA-BIOMEMBRANES, V1859, P835, DOI 10.1016/j.bbamem.2017.01.020; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Cai TF, 2015, PEPTIDES, V68, P148, DOI 10.1016/j.peptides.2014.09.005; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Deplazes E, 2016, BBA-BIOMEMBRANES, V1858, P872, DOI 10.1016/j.bbamem.2016.02.002; Deuis JR, 2016, J BIOL CHEM, V291, P11829, DOI 10.1074/jbc.M116.721662; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gui JH, 2014, CURR BIOL, V24, P473, DOI 10.1016/j.cub.2014.01.013; Henriques ST, 2016, J BIOL CHEM, V291, P17049, DOI 10.1074/jbc.M116.729095; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Jung HH, 2010, BIOPHYS J, V99, P638, DOI 10.1016/j.bpj.2010.04.061; Kalia J, 2015, J MOL BIOL, V427, P158, DOI 10.1016/j.jmb.2014.07.027; King GF, 2014, ACS CHEM NEUROSCI, V5, P749, DOI 10.1021/cn500171p; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, P277, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4_8]; Lau CHY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34333; Lee CW, 2004, BIOCHEMISTRY-US, V43, P890, DOI 10.1021/bi0353373; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Lewis RJ, 2015, RSC DRUG DISCOV, V39, P297; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; Liu Y, 2012, J PEPT SCI, V18, P643, DOI 10.1002/psc.2451; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Marvin L, 1999, EUR J BIOCHEM, V265, P572, DOI 10.1046/j.1432-1327.1999.00726.x; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Minassian NA, 2013, J BIOL CHEM, V288, P22707, DOI 10.1074/jbc.M113.461392; Murray JK, 2015, J MED CHEM, V58, P2299, DOI 10.1021/jm501765v; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; Ostrow KL, 2003, TOXICON, V42, P263, DOI 10.1016/S0041-0101(03)00141-7; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Peigneur S, 2015, NEUROPHARMACOLOGY, V95, P269, DOI 10.1016/j.neuropharm.2015.03.027; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posokhov YO, 2007, BIOPHYS J, V93, pL20, DOI 10.1529/biophysj.107.112375; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Salari A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23894; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200	63	29	29	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9041	9052		10.1074/jbc.RA118.002553	http://dx.doi.org/10.1074/jbc.RA118.002553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29703751	hybrid, Green Published			2022-12-26	WOS:000434941900026
J	Dong, K; Guo, X; Chen, WP; Hsu, AC; Shao, Q; Chen, JF; Chen, SY				Dong, Kun; Guo, Xia; Chen, Weiping; Hsu, Amanda C.; Shao, Qiang; Chen, Jian-Fu; Chen, Shi-You			Mesenchyme homeobox 1 mediates transforming growth factor-beta (TGF-beta)-induced smooth muscle cell differentiation from mouse mesenchymal progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; smooth muscle; cell differentiation; transforming growth factor beta (TGF-); SMAD transcription factor; mesenchyme homeobox 1 (Meox1); SMAD family member 3 (Smad3)	SERUM RESPONSE FACTOR; NEURAL CREST CELLS; DIVISION CYCLE 7; TGF-BETA; GENE-EXPRESSION; SMAD PROTEINS; SYSTEM; TRANSCRIPTION; PHOSPHATASES; RECRUITMENT	Differentiation of smooth muscle cells (SMCs) is critical for proper vasculogenesis and angiogenesis. However, the molecular mechanisms controlling SMC differentiation are not completely understood. During embryogenesis, the transcription factor mesenchyme homeobox 1 (Meox1) is expressed in the early developing somite, which is one of the origins of SMCs. In the present study, we identified Meox1 as a positive regulator of SMC differentiation. We found that transforming growth factor- (TGF-) induces Meox1 expression in the initial phase of SMC differentiation of pluripotent murine C3H10T1/2 cells. shRNA-mediated Meox1 knockdown suppressed TGF--induced expression of SMC early markers, whereas Meox1 overexpression increased expression of these markers. Mechanistically, Meox1 promoted SMAD family member 3 (Smad3) nuclear retention during the early stage of TGF- stimulation because Meox1 inhibited protein phosphatase Mg2+/Mn2+-dependent 1A (PPM1A) and thereby prevented PPM1A-mediated Smad3 dephosphorylation. Meox1 appears to promote PPM1A degradation, leading to sustained Smad3 phosphorylation, thus allowing Smad3 to stimulate SMC gene transcription. In vivo, Meox1 knockdown in mouse embryos impaired SMC marker expression in the descending aorta of neonatal mice, indicating that Meox1 is essential for SMC differentiation during embryonic development. In summary, the transcriptional regulator Meox1 controls TGF--induced SMC differentiation from mesenchymal progenitor cells by preventing PPM1A-mediated Smad3 dephosphorylation, thereby supporting SMC gene expression.	[Dong, Kun; Guo, Xia; Hsu, Amanda C.; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Chen, Weiping] NIDDK, Genom Core Lab, NIH, Bethesda, MD 20892 USA; [Shao, Qiang; Chen, Jian-Fu] Univ Southern Calif, Ostrow Sch Dent USC, Los Angeles, CA 90089 USA	University System of Georgia; University of Georgia; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Southern California	Chen, SY (corresponding author), 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu	Chen, Wei/GZK-7348-2022; Shao, Eric Qiang/I-1359-2019	Shao, Eric Qiang/0000-0001-5307-8264	National Institutes of Health [HL119053, HL123302, HL135854]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123302, R01HL119053, R01HL135854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL119053, HL123302, and HL135854 (to S. Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Buckley SMK, 2008, MOL THER, V16, P819, DOI 10.1038/mt.2008.26; CANDIA AF, 1992, DEVELOPMENT, V116, P1123; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Chen SY, 2003, NUCLEIC ACIDS RES, V31, P1302, DOI 10.1093/nar/gkg224; Douville JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029099; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Kirilenko P, 2011, MOL CELL BIOL, V31, P1301, DOI 10.1128/MCB.00705-10; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Li FM, 2007, J BIOL CHEM, V282, P10133, DOI 10.1074/jbc.C600225200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mack CP, 2005, J THROMB HAEMOST, V3, P1976, DOI 10.1111/j.1538-7836.2005.01316.x; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Majesky MW, 2011, CIRC RES, V108, P365, DOI 10.1161/CIRCRESAHA.110.223800; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Nguyen PD, 2014, NATURE, V512, P314, DOI 10.1038/nature13678; Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768; Shi N, 2013, J BIOL CHEM, V288, P34336, DOI 10.1074/jbc.M113.498238; Shi N, 2012, J BIOL CHEM, V287, P6860, DOI 10.1074/jbc.M111.306209; Shi XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093995; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Wu B, 2018, INT J CARDIOL, V251, P82, DOI 10.1016/j.ijcard.2017.10.098; Xie WB, 2013, CIRC RES, V113, pE76, DOI 10.1161/CIRCRESAHA.113.301921; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747	35	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8712	8719		10.1074/jbc.RA118.002350	http://dx.doi.org/10.1074/jbc.RA118.002350			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29678882	Green Published, hybrid			2022-12-26	WOS:000434205700033
J	Eidson, EL; Mock, KE; Bentz, BJ				Eidson, Erika L.; Mock, Karen E.; Bentz, Barbara J.			Low offspring survival in mountain pine beetle infesting the resistant Great Basin bristlecone pine supports the preference-performance hypothesis	PLOS ONE			English	Article							PONDEROSAE HOPKINS COLEOPTERA; DENDROCTONUS-PONDEROSAE; WHITEBARK-PINE; BROOD PRODUCTION; LODGEPOLE PINE; LIMBER PINE; SCOLYTIDAE; RANGE; BARK; CURCULIONIDAE	The preference-performance hypothesis states that ovipositing phytophagous insects will select host plants that are well-suited for their offspring and avoid host plants that do not support offspring performance (survival, development and fitness). The mountain pine beetle (Dendroctonus ponderosae), a native insect herbivore in western North America, can successfully attack and reproduce in most species of Pinus throughout its native range. However, mountain pine beetles avoid attacking Great Basin bristlecone pine (Pinus longaeva), despite recent climate-driven increases in mountain pine beetle populations at the high elevations where Great Basin bristlecone pine grows. Low preference for a potential host plant species may not persist if the plant supports favorable insect offspring performance, and Great Basin bristlecone pine suitability for mountain pine beetle offspring performance is unclear. We infested cut bolts of Great Basin bristlecone pine and two susceptible host tree species, limber (P. flexilis) and lodgepole (P. contorta) pines with adult mountain pine beetles and compared offspring performance. To investigate the potential for variation in offspring performance among mountain pine beetles from different areas, we tested beetles from geographically-separated populations within and outside the current range of Great Basin bristlecone pine. Although mountain pine beetles constructed galleries and laid viable eggs in all three tree species, extremely few offspring emerged from Great Basin bristlecone pine, regardless of the beetle population. Our observed low offspring performance in Great Basin bristlecone pine corresponds with previously documented low mountain pine beetle attack preference. A low preference-low performance relationship suggests that Great Basin bristlecone pine resistance to mountain pine beetle is likely to be retained through climate-driven high-elevation mountain pine beetle outbreaks.	[Eidson, Erika L.; Mock, Karen E.] Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA; [Mock, Karen E.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Bentz, Barbara J.] US Forest Serv, USDA, Rocky Mt Res Stn, Logan, UT USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); United States Forest Service	Eidson, EL (corresponding author), Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA.	eidson.erika@gmail.com			United States Forest Service National Forest Health Monitoring Program [WC-EM-F-14-1]; National Institute of Food and Agriculture National Needs Fellowship Program [UTAE-2010-03313]	United States Forest Service National Forest Health Monitoring Program; National Institute of Food and Agriculture National Needs Fellowship Program	This work was supported by United States Forest Service National Forest Health Monitoring Program, grant number: WC-EM-F-14-1, https://www.fs.fed.us/foresthealth/protecting-forest/forest-health-monitoring/, recipient: BJB; National Institute of Food and Agriculture National Needs Fellowship Program, grant number: UTAE-2010-03313, https://nifa.usda.gov/funding-opportunity/food-and-agricultural-sciences-national-needs-graduate-and-postgraduate, recipients: KEM and BJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMAN GD, 1982, ENVIRON ENTOMOL, V11, P590, DOI 10.1093/ee/11.3.590; [Anonymous], [No title captured]; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bentz BJ, 2017, NEW PHYTOL, V213, P611, DOI 10.1111/nph.14191; Bentz BJ, 2016, FORESTRY, V89, P271, DOI 10.1093/forestry/cpv054; Bentz BJ, 2015, AGR FOREST ENTOMOL, V17, P421, DOI 10.1111/afe.12124; Bentz BJ, 2001, CAN ENTOMOL, V133, P375, DOI 10.4039/Ent133375-3; Bracewell RR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01761-4; Bracewell RR, 2011, EVOLUTION, V65, P961, DOI 10.1111/j.1558-5646.2010.01201.x; Buotte PC, 2016, ECOL APPL, V26, P2505, DOI 10.1002/eap.1396; Carrillo-Gavilan A, 2015, J BIOGEOGR, V42, P684, DOI 10.1111/jbi.12444; Cerezke HF, 1995, CAN ENTOMOL, V127, P955, DOI 10.4039/Ent127955-6; Cleaver CM, 2015, FOREST ECOL MANAG, V358, P139, DOI 10.1016/j.foreco.2015.09.010; Cohen Michael P., 1998, GARDEN BRISTLECONES; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Dooley EM, 2015, FOREST SCI, V61, P235, DOI 10.5849/forsci.14-014; Eidson EL, 2017, FOREST ECOL MANAG, V402, P12, DOI 10.1016/j.foreco.2017.06.034; Esch ED, 2016, CAN J FOREST RES, V46, P557, DOI 10.1139/cjfr-2015-0351; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Furniss Malcolm M., 2003, American Entomologist, V49, P198; FURNISS MM, 1969, J ECON ENTOMOL, V62, P518, DOI 10.1093/jee/62.2.518; Graf M, 2012, CAN ENTOMOL, V144, P467, DOI 10.4039/tce.2012.38; Gray CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135752; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Hamrick JL, 1979, TOPICS PLANT POPULAT, P84, DOI [10.1007/978-1-349-04627-0_5, DOI 10.1007/978-1-349-04627-0_5]; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Janz N, 2001, EVOLUTION, V55, P783, DOI 10.1554/0014-3820(2001)055[0783:EDOHPS]2.0.CO;2; KAROWE DN, 1990, EVOLUTION, V44, P1637, DOI 10.1111/j.1558-5646.1990.tb03852.x; LANGOR DW, 1990, EVOLUTION, V44, P609, DOI [10.2307/2409438, 10.1111/j.1558-5646.1990.tb05941.x]; LANIER GN, 1968, ANN ENTOMOL SOC AM, V61, P517, DOI 10.1093/aesa/61.2.517; Lanner R.M., 2007, BRISTLECONE BOOK NAT; Lieutier F, 2002, MECHANISMS AND DEPLOYMENT OF RESISTANCE IN TREES TO INSECTS, P31, DOI 10.1007/0-306-47596-0_2; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Logan JA, 1999, ENVIRON ENTOMOL, V28, P924, DOI 10.1093/ee/28.6.924; LYON R. L., 1958, CANADIAN ENT, V90, P582; Macfarlane WW, 2013, ECOL APPL, V23, P421, DOI 10.1890/11-1982.1; Mason SC, 2015, BIOL J LINN SOC, V115, P586, DOI 10.1111/bij.12574; McKee FR, 2015, CAN ENTOMOL, V147, P39, DOI 10.4039/tce.2014.22; Mitton JB, 2000, MOL ECOL, V9, P91, DOI 10.1046/j.1365-294x.2000.00840.x; Morales-Jimenez J, 2012, MICROB ECOL, V64, P268, DOI 10.1007/s00248-011-9999-0; Perkins DL, 1996, CAN J FOREST RES, V26, P2123, DOI 10.1139/x26-241; Raffa K.F., 2015, BARK BEETLES BIOL EC, P1, DOI [10.1016/B978-0-12-417156-5.00014-9, DOI 10.1016/B978-0-12-417156-5.00001-0, 10.1016/B978-0-12-417156-5.00001-0]; Raffa KF, 2014, J CHEM ECOL, V40, P1, DOI 10.1007/s10886-013-0368-y; Reid ML, 2017, J CHEM ECOL, V43, P351, DOI 10.1007/s10886-017-0824-1; Rosenberger DW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176269; Safranyik L., 2006, The mountain pine beetle: a synthesis of biology, management and impacts on lodgepole pine; SAFRANYIK L, 1976, CAN ENTOMOL, V108, P209, DOI 10.4039/Ent108209-2; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; WASSERMAN SS, 1981, EVOLUTION, V35, P605, DOI 10.1111/j.1558-5646.1981.tb04923.x; Weed AS, 2015, LANDSCAPE ECOL, V30, P1075, DOI 10.1007/s10980-015-0170-z; WIKLUND C, 1975, OECOLOGIA, V18, P185, DOI 10.1007/BF00345421	52	12	12	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196732	10.1371/journal.pone.0196732	http://dx.doi.org/10.1371/journal.pone.0196732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715269	Green Submitted, gold, Green Published			2022-12-26	WOS:000431281100050
J	Medina-Mirapeix, F; Bernabeu-Mora, R; Sanchez-Martinez, MP; Montilla-Herrador, J; Bernabeu-Mora, M; Escolar-Reina, P				Medina-Mirapeix, Francesc; Bernabeu-Mora, Roberto; Piedad Sanchez-Martinez, Ma; Montilla-Herrador, Joaquina; Bernabeu-Mora, Myriam; Escolar-Reina, Pilar			Mobility limitations related to reduced pulmonary function among aging people with chronic obstructive pulmonary disease	PLOS ONE			English	Article							PHYSICAL PERFORMANCE BATTERY; HAND-HELD DYNAMOMETRY; RETEST RELIABILITY; MUSCLE STRENGTH; CEREBRAL-PALSY; DISABILITY; COPD; ADULTS; GRIP	Background Chronic obstructive pulmonary disease (COPD) is a major cause of disability. We aimed to analyse the impact of reduced pulmonary function on non-respiratory impairments and mobility activity limitations in an elderly population with COPD and to elucidate which specific limitations on mobility are related to reduced pulmonary function Methods Cross-sectional study of 110 patients with COPD, recruited from public and university hospital. The effect of impaired pulmonary function on the risk of non-respiratory impairments and mobility limitations was analysed using validated measures, including: the 6-Minute Walk Test (6MWT), skeletal muscle strength, the Short Physical Performance Battery (SPPB), and self-reported mobility questionnaire. Multivariate analysis was used to control for confounders such as age, sex, height, education, and cigarette smoking. Results Greater impairment of pulmonary function was associated with less distance walked during the 6MWT, poorer SPPB scores, and greater risk of self-reported mobility limitations (p<0.05). Lower forced expiratory volume in 1 s was also associated with a greater risk of limitations in carrying items under 10 pounds (4.54 kg), walking alone up and down a flight of stairs, and walking two or three neighbourhood blocks. There was no clear statistical relationship between pulmonary function impairment and skeletal muscle strength. Conclusions Impaired pulmonary function was associated with the 6MWT score and limitations on performance-based and self-reported mobility activities, but not with skeletal muscle strength among elderly COPD patients.	[Medina-Mirapeix, Francesc; Bernabeu-Mora, Roberto; Piedad Sanchez-Martinez, Ma; Montilla-Herrador, Joaquina; Escolar-Reina, Pilar] Univ Murcia, Dept Phys Therapy, Murcia, Spain; [Bernabeu-Mora, Roberto] Hosp Gen Univ JM Morales Meseguer, Dept Pneumol, Murcia, Spain; [Bernabeu-Mora, Myriam] Hosp Vega Baja de Orihuela, Dept Internal Med, Alicante, Spain	University of Murcia; Meseguer General University Hospital Morales	Bernabeu-Mora, R (corresponding author), Univ Murcia, Dept Phys Therapy, Murcia, Spain.; Bernabeu-Mora, R (corresponding author), Hosp Gen Univ JM Morales Meseguer, Dept Pneumol, Murcia, Spain.	rbernabeumora@hotmail.com		MONTILLA-HERRADOR, JOAQUINA/0000-0003-1581-3621; Sanchez Martinez/0000-0002-6750-8269	AstraZeneca Pharmaceutical Spain, S.A.	AstraZeneca Pharmaceutical Spain, S.A.	AstraZeneca Pharmaceutical Spain, S.A. funded manuscript translation from a first version in spanish language, but had no role in study design, data collection and analysis, decision to publish or writing of the manuscript.	Bernabeu-Mora R, 2015, INT J CHRONIC OBSTR, V10, P2619, DOI 10.2147/COPD.S94377; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Damiano DL, 1998, ARCH PHYS MED REHAB, V79, P119, DOI 10.1016/S0003-9993(98)90287-8; Eisner MD, 2008, AM J MED, V121, P789, DOI 10.1016/j.amjmed.2008.04.030; Eisner MD, 2008, AM J EPIDEMIOL, V167, P1090, DOI 10.1093/aje/kwn025; Eisner MD, 2011, THORAX, V66, P108, DOI 10.1136/thx.2010.137661; Falter LB, 2003, DISABIL REHABIL, V25, P795, DOI 10.1080/0963828031000093495; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2015, GLOBAL STRATEGY DIAG; Guralnik J.M., ASSESSING PHYS PERFO; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Haraguchi Mizuha, 2016, BMC Res Notes, V9, P7, DOI 10.1186/s13104-015-1810-8; HOSMER DW, 1989, APPL LOGISTIC REGRES; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; MATHIOWETZ V, 1984, J HAND SURG-AM, V9A, P222, DOI 10.1016/S0363-5023(84)80146-X; Medina-Mirapeix F, 2016, ARCH PHYS MED REHAB, V97, P2002, DOI 10.1016/j.apmr.2016.05.004; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; O'Shea SD, 2007, ARCH PHYS MED REHAB, V88, P32, DOI 10.1016/j.apmr.2006.10.002; Park JH, 2016, EXP GERONTOL, V85, P48, DOI 10.1016/j.exger.2016.09.018; Sternfeld B, 2002, AM J EPIDEMIOL, V156, P110, DOI 10.1093/aje/kwf023; Taylor NF, 2004, ARCH PHYS MED REHAB, V85, P77, DOI 10.1016/S0003-9993(03)00379-4; WADSWORTH CT, 1992, J ORTHOP SPORT PHYS, V16, P74, DOI 10.2519/jospt.1992.16.2.74; WHO, 2002, WHOEIPGPECAS013; Yohannes AM, 2014, CHEST, V145, P200, DOI 10.1378/chest.13-1703	28	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196152	10.1371/journal.pone.0196152	http://dx.doi.org/10.1371/journal.pone.0196152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715295	Green Published, Green Submitted, gold			2022-12-26	WOS:000431281100012
J	Takashi, Y; Koga, M; Matsuzawa, Y; Saito, J; Omura, M; Nishikawa, T				Takashi, Yuichi; Koga, Minae; Matsuzawa, Yoko; Saito, Jun; Omura, Masao; Nishikawa, Tetsuo			Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HUMAN ENDOTHELIAL-CELLS; REGULATES TISSUE FACTOR; LONG PENTRAXIN; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASES; ARTERIAL DISTENSIBILITY; VASCULAR INFLAMMATION; CLOTTING ACTIVATION; DIABETES-MELLITUS	Pentraxin 3 (PTX3) is reported to be a vascular inflammation marker providing prognostic information of vasculopathy. Until today, however, the effect of aldosterone or oxidative stress on the regulation of PTX3 is unknown. In present study, we investigated to find regulative factors, especially aldosterone and oxidative stress, on PTX3. Serum PTX3 levels were measured in 75 patients (45 male and 30 women, aged 55.1 +/- 13.4 year-old (mean +/- SD)) with various endocrine disorders including 47 with diabetes, 24 with primary aldosteronism (PA). All participants were free from cardio vascular diseases and diabetic retinopathy. Serum PTX3 level was significantly lower in patients with PA than without PA and was significantly higher in patients with diabetes than without diabetes. PTX3 was significantly correlated with glycated hemoglobin (HbA1c), urinary albumin excretion (UAE) and plasma aldosterone concentration (PAC) (r = 0.431, P<0.001; r = 0.313, P = 0.009; r = -0.375, P = 0.004). A stepwise multiple regression analysis chose HbA1c and UAE as independent determinants of PTX3 (beta = 0.282, P<0.001; beta = 0.783, P<0.001). On the other hand, PTX3 was not significantly correlated with HbA1c and UAE but significantly negatively correlated with PAC in patients with diabetes. Therefore, it might be suggested that PTX3 is positively regulated by chronic hyperglycemia but negatively regulated by aldosterone, and is associated with urinary albumin excretion as a micro vasculopathy.	[Takashi, Yuichi; Koga, Minae; Matsuzawa, Yoko; Saito, Jun; Omura, Masao; Nishikawa, Tetsuo] Yokohama Rosai Hosp, Endocrinol & Diabet Ctr, Yokohama, Kanagawa, Japan; [Takashi, Yuichi] Tokushima Univ, Inst Adv Med Sci, Diabet Therapeut & Res Ctr, Tokushima, Japan	Yokohama Rosai Hospital; Tokushima University	Nishikawa, T (corresponding author), Yokohama Rosai Hosp, Endocrinol & Diabet Ctr, Yokohama, Kanagawa, Japan.	tetsuon@yokohamah.johas.go.jp						Abu Seman N, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/298019; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Aydogdu A, 2012, GYNECOL ENDOCRINOL, V28, P722, DOI 10.3109/09513590.2011.652719; Bonacina F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/725102; Dagna L, 2011, ANN INTERN MED, V155, P425, DOI 10.7326/0003-4819-155-7-201110040-00005; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gkaliagkousi E, 2018, J AM SOC HYPERTENS, V12, P50, DOI 10.1016/j.jash.2017.12.001; Gustin C, 2008, ARTERIOSCL THROM VAS, V28, P491, DOI 10.1161/ATVBAHA.107.158642; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Jylhava J, 2011, CLIN EXP IMMUNOL, V164, P211, DOI 10.1111/j.1365-2249.2011.04354.x; Katakami N, 2013, DIABETES RES CLIN PR, V99, P185, DOI 10.1016/j.diabres.2012.11.020; Kizilgul M, 2017, ENDOCR PRACT, V23, P662, DOI 10.4158/EP161713.OR; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Lekva T, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0345-1; Miyaki A, 2014, AM J MED SCI, V347, P228, DOI 10.1097/MAJ.0b013e31828341af; Miyaki A, 2013, AM J HYPERTENS, V26, P1250, DOI 10.1093/ajh/hpt103; Miyaki A, 2010, J ATHEROSCLER THROMB, V17, P278, DOI 10.5551/jat.2741; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Napoleone E, 2004, J LEUKOCYTE BIOL, V76, P203, DOI 10.1189/jlb.1003528; Napoleone E, 2002, ARTERIOSCL THROM VAS, V22, P782, DOI 10.1161/01.ATV.0000012282.39306.64; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Oe H, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0242-z; Ohbayashi H, 2009, J ATHEROSCLER THROMB, V16, P490, DOI 10.5551/jat.No613; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Petramala L, 2014, J HYPERTENS, V32, P2022, DOI 10.1097/HJH.0000000000000284; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Soeki T, 2011, J CARDIOL, V58, P151, DOI 10.1016/j.jjcc.2011.04.005; Suliman ME, 2008, CLIN J AM SOC NEPHRO, V3, P976, DOI 10.2215/CJN.03960907; Tomandlova M, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/159051; Tsurutani Y, 2017, CURR THER RES CLIN E, V84, P26, DOI 10.1016/j.curtheres.2016.12.002; Weiss EP, 2017, ENDOCRINE, V55, P162, DOI 10.1007/s12020-016-1093-4; Yano Y, 2010, J GERONTOL A-BIOL, V65, P547, DOI 10.1093/gerona/glq030; Yilmaz MI, 2009, CLIN J AM SOC NEPHRO, V4, P535, DOI 10.2215/CJN.04330808; Yuan YG, 2015, LAB INVEST, V95, P1374, DOI 10.1038/labinvest.2015.118; Zanetti M, 2009, CLIN EXP MED, V9, P243, DOI 10.1007/s10238-009-0039-z	41	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196526	10.1371/journal.pone.0196526	http://dx.doi.org/10.1371/journal.pone.0196526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715313	Green Submitted, gold, Green Published			2022-12-26	WOS:000431281100030
J	Zhang, YC; Dong, FH; Liu, ZX; Guo, JS; Zhang, J; Fang, J				Zhang, Yuchen; Dong, Feihong; Liu, Zhengxin; Guo, Jinsong; Zhang, Jue; Fang, Jing			Nanosecond pulsed electric fields promoting the proliferation of porcine iliac endothelial cells: An in vitro study	PLOS ONE			English	Article							SIROLIMUS-ELUTING STENT; NITRIC-OXIDE; CANCER; EXPOSURE	Currently, nanosecond pulsed electric fields (nsPEFs) with short pulse duration and non-thermal effects have various potential applications in medicine and biology, especially in tumor ablation. Additionally, there are a few investigations on its proliferative effects in the normal cell. Clinically, proliferation of endothelial cells can perhaps accelerate the stent endothelialization and reduce the risk of acute thrombosis. To explore the feasibility using nsPEFs to induce proliferation of endothelial cells, in this study, porcine iliac endothelial (PIEC) cell line was cultured and tested by CCK-8 assay after nsPEFs treatment. The results reflected that nsPEFs with low field strength (100ns, 5 kV/cm, 10 pulses) had a significant proliferative effect with an increase in the PIEC cell growth of 16% after a 48 hour' post-treatment. To further understand the mechanism of cell proliferation, intracellular Ca2+ concentration was measured through fluo-4 AM and reactive oxygen species assay was applied to estimate the level of intracellular reactive oxygen species (ROS). Finally, the total nitric oxide assay for NO production in the cultured medium was evaluated. An enhanced concentration of intracellular Ca2+ and ROS were observed, while the concentration of extracellular NO also increased after nsPEFs treatment. Such experimental results demonstrated that nsPEFs with appropriate pulse parameters could effectively enhance cell proliferation on PIEC cells, and the cell proliferation associated strongly with the changes of intracellular Ca2+ concertation, ROS and NO production induced by nsPEFs treatment. This in vitro preliminary study indicates that as a novel physical doping, the nsPEFs have potential in stimulating endothelial cells to accelerate stent endothelialization.	[Zhang, Yuchen] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China; [Dong, Feihong; Liu, Zhengxin; Zhang, Jue; Fang, Jing] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China; [Guo, Jinsong; Zhang, Jue; Fang, Jing] Peking Univ, Coll Engn, Beijing, Peoples R China	Capital Medical University; Peking University; Peking University	Zhang, J (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China.; Zhang, J (corresponding author), Peking Univ, Coll Engn, Beijing, Peoples R China.	zhangjue@pku.edu.cn	Zhang, Yuchen/GYI-8858-2022; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Guo, Jinsong/0000-0002-7379-4708; LIU, Zhengxin/0000-0003-4520-291X; Dong, Feihong/0000-0003-2930-4406	Peking University Biomed-X Foundation	Peking University Biomed-X Foundation(Peking University)	This project was supported by Peking University Biomed-X Foundation.	Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048; Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005; Beier HT, 2012, BIOCHEM BIOPH RES CO, V423, P863, DOI 10.1016/j.bbrc.2012.06.055; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bian WJ, 2013, CHEM ENG J, V219, P385, DOI 10.1016/j.cej.2012.12.074; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Choi DH, 2016, COLLOID SURFACE B, V141, P602, DOI 10.1016/j.colsurfb.2016.01.028; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Guo JS, 2017, BIOELECTROCHEMISTRY, V113, P35, DOI 10.1016/j.bioelechem.2016.09.002; Guo JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25949; Hargrave B, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12461; Kolb JF, 2006, BIOELECTROMAGNETICS, V27, P172, DOI 10.1002/bem.20185; Kulbacka J, 2015, PHOTODIAGN PHOTODYN, V12, P621, DOI 10.1016/j.pdpdt.2015.11.002; Li HG, 2009, CURR PHARM DESIGN, V15, P3133, DOI 10.2174/138161209789058002; Luo DL, 2008, CELL CALCIUM, V43, P165, DOI 10.1016/j.ceca.2007.04.017; Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Nuccitelli R, 2013, BIOCHEM BIOPH RES CO, V435, P580, DOI 10.1016/j.bbrc.2013.05.014; Orban C, 2016, CYTOM PART A, V89A, P472, DOI 10.1002/cyto.a.22838; Pakhomov AG, 2015, BBA-BIOMEMBRANES, V1848, P958, DOI 10.1016/j.bbamem.2014.12.026; Pakhomova ON, 2012, ARCH BIOCHEM BIOPHYS, V527, P55, DOI 10.1016/j.abb.2012.08.004; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Scarlett SS, 2009, BBA-BIOMEMBRANES, V1788, P1168, DOI 10.1016/j.bbamem.2009.02.006; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; Shirota T, 2003, BIOMATERIALS, V24, P2295, DOI 10.1016/S0142-9612(03)00042-5; Steuer A, 2016, BIOELECTROCHEMISTRY, V112, P33, DOI 10.1016/j.bioelechem.2016.07.003; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Su B, 2015, PLASMA PROCESS POLYM, V12, P372, DOI 10.1002/ppap.201400131; Takahashi S, 2007, CIRC J, V71, P226, DOI 10.1253/circj.71.226; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Wu S, 2014, CANCER LETT, V343, P268, DOI 10.1016/j.canlet.2013.09.032; Wu X, 2016, ACS APPL MATER INTER, V8, P7578, DOI 10.1021/acsami.6b00152; Yao CG, 2009, IEEE T DIELECT EL IN, V16, P1259, DOI 10.1109/TDEI.2009.5293936; Zhang K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05836	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2018	13	5							e0196688	10.1371/journal.pone.0196688	http://dx.doi.org/10.1371/journal.pone.0196688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE5RZ	29715270	Green Submitted, Green Published, gold			2022-12-26	WOS:000431281100046
J	Sanchez-Garcia, AB; Ibanez, S; Cano, A; Acosta, M; Perez-Perez, JM				Bel Sanchez-Garcia, Ana; Ibanez, Sergio; Cano, Antonio; Acosta, Manuel; Manuel Perez-Perez, Jose			A comprehensive phylogeny of auxin homeostasis genes involved in adventitious root formation in carnation stem cuttings	PLOS ONE			English	Article							INTEGRATIVE GENOMICS VIEWER; PLANT DEVELOPMENT; ARABIDOPSIS-THALIANA; INDOLE-3-ACETIC-ACID METHYLTRANSFERASE; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR-CLONING; PIN PROTEINS; GH3 FAMILY; BIOSYNTHESIS; EVOLUTION	Understanding the functional basis of auxin homeostasis requires knowledge about auxin biosynthesis, auxin transport and auxin catabolism genes, which is not always directly available despite the recent whole-genome sequencing of many plant species. Through sequence homology searches and phylogenetic analyses on a selection of 11 plant species with high-quality genome annotation, we identified the putative gene homologs involved in auxin biosynthesis, auxin catabolism and auxin transport pathways in carnation (Dianthus caryophyllus L.). To deepen our knowledge of the regulatory events underlying auxin-mediated adventitious root formation in carnation stem cuttings, we used RNA-sequencing data to confirm the expression profiles of some auxin homeostasis genes during the rooting of two carnation cultivars with different rooting behaviors. We also confirmed the presence of several auxin-related metabolites in the stem cutting tissues. Our findings offer a comprehensive overview of auxin homeostasis genes in carnation and provide a solid foundation for further experiments investigating the role of auxin homeostasis in the regulation of adventitious root formation in carnation.	[Bel Sanchez-Garcia, Ana; Ibanez, Sergio; Manuel Perez-Perez, Jose] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain; [Cano, Antonio; Acosta, Manuel] Univ Murcia, Dept Biol Vegetal Fisiol Vegetal, Murcia, Spain	Universidad Miguel Hernandez de Elche; University of Murcia	Perez-Perez, JM (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Elche, Spain.	jmperez@umn.es	Ibáñez, Sergio/N-6856-2019; Cano, Antonio/B-8723-2008; Acosta, Manuel/A-2127-2008; Perez-Perez, Jose Manuel/B-4247-2011	Ibáñez, Sergio/0000-0002-1505-6010; Cano, Antonio/0000-0001-8555-5053; Acosta, Manuel/0000-0003-0611-6672; Perez-Perez, Jose Manuel/0000-0003-2848-4919; Sanchez-Garcia, Ana Belen/0000-0002-1315-8400	Ministerio de Economia y Competitividad (MINECO) of Spain; FEDER Funds of the European Commission [AGL2012-33610, BIO2015-64255-R]	Ministerio de Economia y Competitividad (MINECO) of Spain; FEDER Funds of the European Commission	This work was supported by the Ministerio de Economia y Competitividad (MINECO) of Spain and by FEDER Funds of the European Commission (grants no. AGL2012-33610 and BIO2015-64255-R) to JMPP.	Agullo-Anton MA, 2014, PHYSIOL PLANTARUM, V150, P446, DOI 10.1111/ppl.12114; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bellini C, 2014, ANNU REV PLANT BIOL, V65, P639, DOI 10.1146/annurev-arplant-050213-035645; Bennett T, 2015, TRENDS PLANT SCI, V20, P498, DOI 10.1016/j.tplants.2015.05.005; Bennett T, 2014, MOL BIOL EVOL, V31, P2042, DOI 10.1093/molbev/msu147; Birlanga V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133123; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Cho M, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22990; Dong CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149917; Enders TA, 2015, AM J BOT, V102, P180, DOI 10.3732/ajb.1400285; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110896; Forestan C, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00016; Garrido G, 2002, PHYSIOL PLANTARUM, V114, P303, DOI 10.1034/j.1399-3054.2002.1140217.x; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Jackson RG, 2001, J BIOL CHEM, V276, P4350, DOI 10.1074/jbc.M006185200; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Jin SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061705; Kasahara H, 2016, BIOSCI BIOTECH BIOCH, V80, P34, DOI 10.1080/09168451.2015.1086259; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Krecek P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-249; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lane TS, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0277-6; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li LC, 2008, PLANT CELL REP, V27, P575, DOI 10.1007/s00299-007-0458-9; Li WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101051; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Ljung K, 2013, DEVELOPMENT, V140, P943, DOI 10.1242/dev.086363; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Mellor N, 2016, P NATL ACAD SCI USA, V113, P11022, DOI 10.1073/pnas.1604458113; Pacurar DI, 2014, PHYSIOL PLANTARUM, V151, P83, DOI 10.1111/ppl.12171; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Peer WA, 2013, J EXP BOT, V64, P2629, DOI 10.1093/jxb/ert152; Peer WA, 2011, MOL PLANT, V4, P487, DOI 10.1093/mp/ssr034; Pencik A, 2013, PLANT CELL, V25, P3858, DOI 10.1105/tpc.113.114421; Peret B, 2012, PLANT CELL, V24, P2874, DOI 10.1105/tpc.112.097766; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Pollmann S, 2003, PHYTOCHEMISTRY, V62, P293, DOI 10.1016/S0031-9422(02)00563-0; Pollmann S, 2006, PLANTA, V224, P1241, DOI 10.1007/s00425-006-0304-2; Porco S, 2016, P NATL ACAD SCI USA, V113, P11016, DOI 10.1073/pnas.1604375113; Qin GJ, 2005, PLANT CELL, V17, P2693, DOI 10.1105/tpc.105.034959; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sanchez-Parra Beatriz, 2014, Plants-Basel, V3, P324, DOI 10.3390/plants3030324; Sheela VL, 2008, FLOWERS TRADE, P95; Shen CJ, 2010, FEBS J, V277, P2954, DOI 10.1111/j.1742-4658.2010.07706.x; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Sugawara S, 2009, P NATL ACAD SCI USA, V106, P5430, DOI 10.1073/pnas.0811226106; Swarup R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00225; Tanaka K, 2014, PLANT CELL PHYSIOL, V55, P218, DOI 10.1093/pcp/pct173; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Villacorta-Martin C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2003-5; Villanova J, 2017, PLANT GROWTH REGUL, V81, P511, DOI 10.1007/s10725-016-0228-1; Wang JR, 2009, MOL PLANT, V2, P823, DOI 10.1093/mp/ssp023; Wendel JF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0908-1; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Xu M, 2005, PLANT CELL PHYSIOL, V46, P1674, DOI 10.1093/pcp/pci183; Yagi M, 2014, DNA RES, V21, P231, DOI 10.1093/dnares/dst053; Yue RQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118751; Zhang J, 2016, P NATL ACAD SCI USA, V113, P11010, DOI 10.1073/pnas.1604769113; Zhao N, 2008, PLANT PHYSIOL, V146, P455, DOI 10.1104/pp.107.110049; Zhao N, 2007, PHYTOCHEMISTRY, V68, P1537, DOI 10.1016/j.phytochem.2007.03.041; Zhao Yunde, 2014, Arabidopsis Book, V12, pe0173, DOI 10.1199/tab.0173; Zhao ZG, 2013, DEV CELL, V27, P113, DOI 10.1016/j.devcel.2013.09.005	74	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196663	10.1371/journal.pone.0196663	http://dx.doi.org/10.1371/journal.pone.0196663			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709027	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100051
J	Lim, T; Cappelle, J; Hoem, T; Furey, N				Lim, Thona; Cappelle, Julien; Hoem, Thavry; Furey, Neil			Insectivorous bat reproduction and human cave visitation in Cambodia: A perfect conservation storm?	PLOS ONE			English	Article							SEASONALITY; ABUNDANCE; KARST	Cave roosting bats represent an important component of Southeast Asian bat diversity and are vulnerable to human disturbance during critical reproductive periods (pregnancy, lactation and weaning). Because dramatic growth of cave tourism in recent decades has raised concerns about impacts on cave bats in the region, we assessed the reproductive phenology of two insectivorous species (Hipposideros larvatus sensu lato and Taphozous melanopogon) at three caves in Cambodia for 23 months in 2014-2016 and evaluated human visitation to these sites between 2007 and 2014. Despite the differing foraging strategies employed by the two taxa, the temporal consistency observed in proportions of pregnant, lactating and juvenile bats indicates that their major birth peaks coincide with the time of greatest cave visitation annually, particularly for domestic visitors and namely during the Cambodian new year in April. They also reflect rainfall patterns and correspond with the reproductive phenology of insectivorous cave bats in Vietnam. These findings were predictable because 1) insect biomass and thus food availability for insectivorous bats are optimal for ensuring survival of young following this period, and 2) the Khmer new year is the most significant month for religious ceremonies and thus domestic cave visitation nationally, due to the abundance of Buddhist shrines and temples in Cambodian caves. While the impact of visitor disturbance on bat population recruitment cannot be empirically assessed due to lack of historical data, it is nonetheless likely to have been considerable and raises a conservation concern. Further, because growing evidence suggests that insectivorous cave bats exhibit reproductive synchrony across continental Southeast Asia where countless cave shrines are heavily frequented during April in Theravada Buddhist countries (e.g., Myanmar, Thailand, Cambodia and Laos), our results may have wider applicability in the region. We consequently advocate for increased emphasis on sustainable cave management practices in Cambodia and further investigations to determine whether our findings present a broader concern for cave bat conservation in Southeast Asia.	[Lim, Thona; Hoem, Thavry; Furey, Neil] Royal Univ Phnom Penh, Ctr Biodivers Conservat, Phnom Penh, Cambodia; [Cappelle, Julien; Hoem, Thavry] Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia; [Cappelle, Julien] CIRAD ES, UPR AGIRs, Montpellier, France; [Furey, Neil] Fauna & Flora Int, Phnom Penh, Cambodia; [Furey, Neil] Harrison Inst, Canterbury, Kent, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; CIRAD	Lim, T; Furey, N (corresponding author), Royal Univ Phnom Penh, Ctr Biodivers Conservat, Phnom Penh, Cambodia.; Furey, N (corresponding author), Fauna & Flora Int, Phnom Penh, Cambodia.; Furey, N (corresponding author), Harrison Inst, Canterbury, Kent, England.	lim.thona@yahoo.com; neil.m.furey@gmail.com		Cappelle, Julien/0000-0001-7668-1971; Lim, Thona/0000-0003-4044-2236	Southeast Asian Bat Research & Conservation Unit (USA National Science Foundation) [1051363]; US Agency for International Development (Helping Address Rural Vulnerabilities and Ecosystem STability Recovery Program) [AID-442-C-11-00001]; Columbus Zoo and Aquarium Conservation Fund (USA); European Commission Innovate program (ComAcross project) [DCI-ASIE/2013/315-047]; Aviesan Sud and Fondation Total (SouthEast Asia Encephalitis project)	Southeast Asian Bat Research & Conservation Unit (USA National Science Foundation); US Agency for International Development (Helping Address Rural Vulnerabilities and Ecosystem STability Recovery Program)(United States Agency for International Development (USAID)); Columbus Zoo and Aquarium Conservation Fund (USA); European Commission Innovate program (ComAcross project); Aviesan Sud and Fondation Total (SouthEast Asia Encephalitis project)	This study was supported by the Southeast Asian Bat Research & Conservation Unit (USA National Science Foundation, grant no. 1051363), US Agency for International Development (Helping Address Rural Vulnerabilities and Ecosystem STability Recovery Program, prime contract #AID-442-C-11-00001), Columbus Zoo and Aquarium Conservation Fund (USA), European Commission Innovate program (ComAcross project, grant no. DCI-ASIE/2013/315-047) and Aviesan Sud and Fondation Total (SouthEast Asia Encephalitis project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades Gary W.J., 1999, Memoirs of the Hong Kong Natural History Society, V22, P81; [Anonymous], 1992, J MAMMAL, V73, P707; Anthony E.L.P., 1988, P47; Aye Nu Nu, 2006, THESIS; Barclay RMR, 2003, BAT ECOLOGY, P209; Bates P, 2008, IUCN RED LIST THREAT, V1, P1; Bates PJJ, 1997, BATS INDIAN SUBCONTI; Cambodian Ministry of Tourism, 2012, TOUR STAT REP 2011, V1, P1; Cambodian Ministry of Tourism, 2016, TOUR STAT REP YEAR 2, V1, P1; Cardiff SG, 2012, ACTA CHIROPTEROL, V14, P479, DOI 10.3161/150811012X661783; Chuan G.K., 2005, PHYS GEOGRAPHY SE AS, P80; CIA, 2016, WORLD FACTBOOK; Csorba G, 2008, IUCN RED LIST THREAT, V1, P1; Cumming GS, 1997, OECOLOGIA, V111, P309, DOI 10.1007/s004420050240; DENNEBORG M., 2002, GERMAN SPELEOLOGICAL; FRANCIS C. M., 2008, GUIDE MAMMALS SE ASI; FRITH CB, 1985, AUST J ECOL, V10, P237, DOI 10.1111/j.1442-9993.1985.tb00886.x; Furey N. M. T., 2016, BERLINER HOHLENKUNDL, P82; Furey NM, 2016, BIOTROPICA, V48, P545, DOI 10.1111/btp.12322; Furey Neil M., 2016, P463; Furey NM, 2011, ACTA CHIROPTEROL, V13, P341, DOI 10.3161/150811011X624811; Furman A, 2012, ORYX, V46, P330, DOI 10.1017/S0030605312000518; GOULD E, 1978, BIOTROPICA, V10, P75, DOI 10.2307/2388113; HAPPOLD DCD, 1990, J ZOOL, V222, P557, DOI 10.1111/j.1469-7998.1990.tb06014.x; Hays J., 2013, FACTS DETAILS, V1, P1; Hildreth-Werker V, 2006, CAVE CONSERVATION RE; Juberthie C, 2000, ECOSY WORLD, V30, P691; Kai KH, 2002, J TROP ECOL, V18, P637, DOI 10.1017/S0266467402002419; KINGSTON T, 2006, BATS KRAU WILDLIFE R; KRUSKOP S. V., 2015, LYNX, V46, P29; Kruskop S.V., 2013, BATS VIETNAM CHECKLI; KURTA A, 1989, PHYSIOL ZOOL, V62, P804, DOI 10.1086/physzool.62.3.30157928; Laumanns M., 2016, INT SPELEOLOGICAL PR; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Lim Tae Yun, 2016, THESIS; Luo JH, 2013, ORYX, V47, P526, DOI 10.1017/S0030605311001505; Mann SL, 2002, J WILDLIFE MANAGE, V66, P618, DOI 10.2307/3803128; MCCRACKEN G F, 1989, NSS Bulletin, V51, P47; McWilliam A. N., 1982, THESIS; MCWILLIAM AN, 1988, J ZOOL, V215, P433, DOI 10.1111/j.1469-7998.1988.tb02850.x; Medellin RA, 2017, BIOL CONSERV, V211, P45, DOI 10.1016/j.biocon.2017.01.012; MITCHELL-JONES A. J., 2007, PROTECTING MANAGING; Nguyen TS, 2016, J THREAT TAXA, V8, P8953; Niu H, 2007, ANIM CONSERV, V10, P470, DOI 10.1111/j.1469-1795.2007.00136.x; Nurul-Ain E, 2017, BIOTROPICA, DOI [10.1111/btp.12464, DOI 10.1111/BTP.12464]; Olson C.R., 2011, NW NATURALIST, V92, P224; Racey P.A., 1987, Symposia of the Zoological Society of London, P107; Racey P.A., 2009, ECOLOGICAL BEHAV MET, P249; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; Sidisunthorn Pindar, 2006, CAVES NO THAILAND; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sponsel L., 2015, CHANGING WORLD RELIG, P503; Sponsel L, 2016, ENCY PSYCHOL RELIG, P214; Sponsel L, 2016, ENCY HIST SCI TECHNO, P768; Sponsel Leslie E, 2004, THIS SACRED EARTH RE, P134; Stihler Craig W., 1993, Bat Research News, V34, P130; Suyanto A, 2007, ACTA CHIROPTEROL, V9, P67, DOI 10.3161/1733-5329(2007)9[67:BOTSLK]2.0.CO;2; Tun K. M. M, 2015, J TROP BIOL CONSERV, V12, P35; Tuttle Merlin D., 2013, P363; Vermeulen J., 1999, BIODIVERSITY CULTURA; Zhang LB, 2009, ORYX, V43, P179, DOI 10.1017/S0030605309432022	61	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196554	10.1371/journal.pone.0196554	http://dx.doi.org/10.1371/journal.pone.0196554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29709036	Green Published, Green Submitted, gold			2022-12-26	WOS:000431130100038
J	Wu, TW; Liu, CC; Hung, CL; Yen, CH; Wu, YJ; Wang, LY; Yeh, HI				Wu, Tzu-Wei; Liu, Chun-Chieh; Hung, Chung-Lieh; Yen, Chih-Hsien; Wu, Yih-Jer; Wang, Li-Yu; Yeh, Hung-I			Genetic profiling of young and aged endothelial progenitor cells in hypoxia	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; INDUCIBLE FACTOR-I; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; RISK-FACTORS; TELOMERE LENGTH; QUALITY-CONTROL; STEM-CELLS; ALL-CAUSE	Age is a major risk factor for diseases caused by ischemic hypoxia, such as stroke and coronary artery disease. Endothelial progenitor cells (EPCs) are the major cells respond to ischemic hypoxia through angiogenesis and vascular remodeling. However, the effect of aging on EPCs and their responses to hypoxia are not well understood. CD34(+) EPCs were isolated from healthy volunteers and aged by replicative senescence, which was to passage cells until their doubling time was twice as long as the original cells. Young and aged CD34(+) EPCs were exposed to a hypoxic environment (1% oxygen for 48hrs) and their gene expression profiles were evaluated using gene expression array. Gene array results were confirmed using quantitative polymerase chain reaction, Western blotting, and BALB/c female athymic nude mice hindlimb ischemia model. We identified 115 differentially expressed genes in young CD34(+) EPCs, 54 differentially expressed genes in aged CD34(+) EPCs, and 25 common genes between normoxia and hypoxia groups. Among them, the expression of solute carrier family 2 (facilitated glucose transporter), member 1 (SLC2A1) increased the most by hypoxia in young cells. Gene set enrichment analysis indicated the pathways affected by aging and hypoxia most, including genes "response to oxygen levels" in young EPCs and genes involved "chondroitin sulfate metabolic process" in aged cells. Our study results indicate the key factors that contribute to the effects of aging on response to hypoxia in CD34(+) EPCs. With the potential applications of EPCs in cardiovascular and other diseases, our study also provides insight on the impact of ex vivo expansion might have on EPCs.	[Wu, Tzu-Wei; Wu, Yih-Jer; Wang, Li-Yu; Yeh, Hung-I] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Liu, Chun-Chieh; Hung, Chung-Lieh; Yen, Chih-Hsien; Wu, Yih-Jer; Yeh, Hung-I] Mackay Mem Hosp, Sect Cardiol, Dept Internal Med, Taipei, Taiwan	Mackay Medical College; Mackay Memorial Hospital	Wu, TW (corresponding author), Mackay Med Coll, Dept Med, New Taipei, Taiwan.	tzuweiwu@mmc.edu.tw			Ministry of Science and Technology, the Executive Yuan, Taiwan [MOST 105-2314-B-715-004-MY2, MOST 102-2632-B-715-001-MY3, MOST 106-2632-B-715-001]	Ministry of Science and Technology, the Executive Yuan, Taiwan	This study was supported by grants from the Ministry of Science and Technology, the Executive Yuan, Taiwan (MOST 105-2314-B-715-004-MY2 to TW, MOST 102-2632-B-715-001-MY3 to HY and MOST 106-2632-B-715-001 to YW (https://www.most.gov.tw/). The funders played no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Bonora E, 2003, DIABETES CARE, V26, P1251, DOI 10.2337/diacare.26.4.1251; Bosch-Marce M, 2007, CIRC RES, V101, P1310, DOI 10.1161/CIRCRESAHA.107.153346; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Cas AD, 2013, NUTR METAB CARDIOVAS, V23, P272, DOI 10.1016/j.numecd.2011.04.005; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Charles ST, 2010, ANNU REV PSYCHOL, V61, P383, DOI 10.1146/annurev.psych.093008.100448; Chen YJ, 2009, AUTOPHAGY, V5, P173, DOI 10.4161/auto.5.2.7360; Chien KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003435; Collins TC, 2009, CIRCULATION, V119, P2305, DOI 10.1161/CIRCULATIONAHA.108.820993; Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Huang CY, 2010, CHINESE J PHYSIOL, V53, P299, DOI 10.4077/CJP.2010.AMK063; Huang SC, 2009, J MED VIROL, V81, P1241, DOI 10.1002/jmv.21502; Hung CL, 2012, INT J GERONTOL, V6, P122, DOI 10.1016/j.ijge.2012.05.014; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; Jurasz P, 2011, ANGIOGENESIS, V14, P199, DOI 10.1007/s10456-011-9204-6; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Kinnaird T, 2004, CIRC RES, V95, P354, DOI 10.1161/01.RES.0000137878.26174.66; Koskinen J, 2009, CIRCULATION, V120, P229, DOI 10.1161/CIRCULATIONAHA.108.845065; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Kuper H, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4265; Kushner EJ, 2009, CLIN CHEM LAB MED, V47, P47, DOI 10.1515/CCLM.2009.016; Lee SD, 2006, INT J CARDIOL, V108, P376, DOI 10.1016/j.ijcard.2005.05.046; Li H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-188; Li W, 2008, CEREBROVASC DIS, V25, P539, DOI 10.1159/000131672; Lin CC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-484; Lin HF, 2009, ATHEROSCLEROSIS; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Martin-Rendon E, 2007, STEM CELLS, V25, P1003, DOI 10.1634/stemcells.2006-0398; Medina RJ, 2013, STEM CELLS, V31, P1657, DOI 10.1002/stem.1414; Milicevic Z, 2008, DIABETES CARE, V31, pS155, DOI 10.2337/dc08-s240; Mobasheri A, 2005, HISTOL HISTOPATHOL, V20, P1327, DOI 10.14670/HH-20.1327; Murray CD, 1926, P NATL ACAD SCI USA, V12, P299, DOI 10.1073/pnas.12.5.299; Pierson D J, 2000, Respir Care, V45, P39; Pierson DJ, 2000, RESP CARE, V45, P51; Pitts Kelly R., 2008, Journal of Pharmacological and Toxicological Methods, V57, P42, DOI 10.1016/j.vascn.2007.09.001; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Tian XL, 2014, J GENET GENOMICS, V41, P485, DOI 10.1016/j.jgg.2014.08.001; Tracy K, 2007, MOL CELL BIOL, V27, P6229, DOI 10.1128/MCB.02246-06; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; Wang HH, 2013, ANGIOGENESIS, V16, P553, DOI 10.1007/s10456-013-9335-z; Wang JJ, 2007, EUR HEART J, V28, P857, DOI 10.1093/eurheartj/ehl524; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weng YJ, 2010, MOL CELL BIOCHEM, V345, P241, DOI 10.1007/s11010-010-0578-3; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wu SY, 2011, NEOPLASIA, V13, P1171, DOI 10.1593/neo.11888; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yang Z, 2010, CLIN EXP HYPERTENS, V32, P444, DOI 10.3109/10641961003686435; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zhao YH, 2013, CNS NEUROSCI THER, V19, P67, DOI 10.1111/cns.12040	74	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2018	13	4							e0196572	10.1371/journal.pone.0196572	http://dx.doi.org/10.1371/journal.pone.0196572			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3RI	29708992	gold, Green Submitted, Green Published			2022-12-26	WOS:000431130100039
J	van Soest, A; Saha, UR				van Soest, Arthur; Saha, Unnati Rani			Relationships between infant mortality, birth spacing and fertility in Matlab, Bangladesh	PLOS ONE			English	Article							CHILD-MORTALITY; NEONATAL-MORTALITY; GENDER PREFERENCE; CONTRACEPTIVE USE; RURAL BANGLADESH; STATE DEPENDENCE; DEATH; SURVIVAL; SIBLINGS; INTERVAL	Although research on the fertility response to childhood mortality is widespread in demographic literature, very few studies focused on the two-way causal relationships between infant mortality and fertility. Understanding the nature of such relationships is important in order to design effective policies to reduce child mortality and improve family planning. In this study, we use dynamic panel data techniques to analyse the causal effects of infant mortality on birth intervals and fertility, as well as the causal effects of birth intervals on mortality in rural Bangladesh, accounting for unobserved heterogeneity and reverse causality. Simulations based upon the estimated model show whether (and to what extent) mortality and fertility can be reduced by breaking the causal links between short birth intervals and infant mortality. We find a replacement effect of infant mortality on total fertility of about 0.54 children for each infant death in the comparison area with standard health services. Eliminating the replacement effect would lengthen birth intervals and reduce the total number of births, resulting in a fall in mortality by 2.45 children per 1000 live births. These effects are much smaller in the treatment area with extensive health services and information on family planning, where infant mortality is smaller, birth intervals are longer, and total fertility is lower. In both areas, we find evidence of boy preference in family planning.	[van Soest, Arthur; Saha, Unnati Rani] Tilburg Univ, Tilburg Sch Econ & Management, Dept Econometr & Operat Res, Le Tilburg, Netherlands	Tilburg University	Saha, UR (corresponding author), Tilburg Univ, Tilburg Sch Econ & Management, Dept Econometr & Operat Res, Le Tilburg, Netherlands.	unnati.saha01@gmail.com	van Soest, A/AGL-3772-2022	van Soest, A/0000-0002-4765-8382; Saha, Unnati Rani/0000-0002-4019-9697				Alam N, 1998, J BIOSOC SCI, V30, P333, DOI 10.1017/S0021932098003332; Arulampalam W, 2006, J ROY STAT SOC A STA, V169, P829, DOI 10.1111/j.1467-985X.2006.00425.x; BENPORATH Y, 1976, J POLIT ECON, V84, pS163, DOI 10.1086/260537; Bhalotra S, 2008, J ECONOMETRICS, V143, P274, DOI 10.1016/j.jeconom.2007.10.005; BHATIA S, 1983, STUD FAMILY PLANN, V14, P20, DOI 10.2307/1966265; Chowdhury AKM, 1976, POPULATION STUDIES, V30, P263; CHOWDHURY MK, 1990, POPUL DEV REV, V16, P749, DOI 10.2307/1972966; CLELAND JG, 1984, POP STUD-J DEMOG, V38, P401, DOI 10.1080/00324728.1984.10410300; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; CURTIS SL, 1993, DEMOGRAPHY, V30, P33, DOI 10.2307/2061861; D'souza S, 1981, Rural Demogr, V8, P29; DaVanzo J, 1993, MATERNAL DEPLETION C; DaVanzo J, 2008, POP STUD-J DEMOG, V62, P131, DOI 10.1080/00324720802022089; Hale L, 2009, J POPUL RES, V26, P3, DOI 10.1007/s12546-008-9003-0; ICDDR B: Centre for Health and Population Research Dhaka Bangladesh, 2006, 93 ICDDR B CTR HLTH; Joshi S, 2013, DEMOGRAPHY, V50, P149, DOI 10.1007/s13524-012-0172-2; KOENIG MA, 1990, DEMOGRAPHY, V27, P251, DOI 10.2307/2061452; MILLER JE, 1992, DEMOGRAPHY, V29, P305, DOI 10.2307/2061733; Moffitt R, 2005, DEMOGRAPHY, V42, P91, DOI 10.1353/dem.2005.0006; National Institute of Population Research and Training (NIPORT) Mitra and Associates ORC Macro, 2004, BANGL DEM HLTH SURV; Nyarko P, 2003, A0308 SOC STAT RES C; OLSEN RJ, 1980, DEMOGRAPHY, V17, P429, DOI 10.2307/2061155; Olsen RJ, 1988, RES POPUL ECOL, V6, P111; Omariba DWR, 2008, DEMOGR RES, V18, P311; PRESTON SH, 1975, POPUL DEV REV, V1, P189, DOI 10.2307/1972220; PRITCHETT LH, 1994, POPUL DEV REV, V20, P1, DOI 10.2307/2137629; RAHMAN M, 1993, DEMOGRAPHY, V30, P315, DOI 10.2307/2061643; RAHMAN M, 1992, STUD FAMILY PLANN, V23, P229, DOI 10.2307/1966885; Saha UR, 2013, STUD FAMILY PLANN, V44, P45, DOI 10.1111/j.1728-4465.2013.00343.x; Saha UR, 2011, POP STUD-J DEMOG, V65, P273, DOI 10.1080/00324728.2011.602100; SANTOW G, 1984, POP STUD-J DEMOG, V38, P241, DOI 10.2307/2174075; Scrimshaw NS, 1996, NUTR TODAY, V31, P55; STEER RA, 1992, J CLIN EPIDEMIOL, V45, P1093, DOI 10.1016/0895-4356(92)90149-H; SUFIAN AJM, 1989, J BIOSOC SCI, V21, P207, DOI 10.1017/S0021932000017892; TRUSSELL J, 1982, HEALTH POLICY EDUC, V3, P1, DOI 10.1016/0165-2281(82)90022-4; TRUSSELL J, 1983, DEMOGRAPHY, V20, P391, DOI 10.2307/2061250; VANGINNE.JK, 1974, STUD FAMILY PLANN, V5, P201, DOI 10.2307/1965371; VANGINNEKEN J, 1998, SPECIAL PUBLICATION, V72; WHO, 2015, UN SUST DEV SUMM SUS; Wolpin K.I, 1997, HDB POPULATION FAMIL, V1, P483; Wolpin KI., 1998, DEATH BIRTH MORTALIT; ZENGER E, 1993, DEMOGRAPHY, V30, P477, DOI 10.2307/2061652; Zhang J, 1990, J Popul Econ, V3, P303; ZIMMER BG, 1979, SOC BIOL, V26, P161, DOI 10.1080/19485565.1979.9988374	44	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2018	13	4							e0195940	10.1371/journal.pone.0195940	http://dx.doi.org/10.1371/journal.pone.0195940			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1YS	29702692	Green Published, gold, Green Submitted			2022-12-26	WOS:000431013300009
J	Robazza, C; Izzicupo, P; D'Amico, MA; Ghinassi, B; Crippa, MC; Di Cecco, V; Ruiz, MC; Bortoli, L; Di Baldassarre, A				Robazza, Claudio; Izzicupo, Pascal; D'Amico, Maria Angela; Ghinassi, Barbara; Crippa, Maria Chiara; Di Cecco, Vincenzo; Ruiz, Montse C.; Bortoli, Laura; Baldassarre, Angela Di			Psychophysiological responses of junior orienteers under competitive pressure	PLOS ONE			English	Article							WORKING-MEMORY; CARDIOVASCULAR INDEXES; BIOPSYCHOSOCIAL MODEL; ATHLETIC PERFORMANCE; ATTENTIONAL CONTROL; CHROMOGRANIN-A; CHALLENGE; THREAT; PLAYERS; STRESS	The purpose of the study was to examine psychobiosocial states, cognitive functions, endocrine responses (i.e., salivary cortisol and chromogranin A), and performance under competitive pressure in orienteering athletes. The study was grounded in the individual zones of optimal functioning (IZOF) and biopsychosocial models. Fourteen junior orienteering athletes (7 girls and 7 boys), ranging in age from 15 to 20 years (M = 16.93, SD = 1.77) took part in a two-day competitive event. To enhance competitive pressure, emphasis was placed on the importance of the competition and race outcome. Psychophysiological and performance data were collected at several points before, during, and after the races. Results showed that an increase in cortisol levels was associated with competitive pressure and reflected in higher perceived exertion (day 1, r = .32; day 2, r = .46), higher intensity of dysfunctional states (day 1, r = .59; day 2, r = .55), lower intensity of functional states (day 1, r = -.36; day 2, r = -.33), and decay in memory (day 1, r = -.27; day 2, r = -.35), visual attention (day 1, r = -.56; day 2, r = -.35), and attention/mental flexibility (day 1, r = .16; day 2, r = .26) tasks. The second day we observed better performance times, lower intensity of dysfunctional states, lower cortisol levels, improved visual attention and attention/mental flexibility (p < .050). Across the two competition days, chromogranin A levels were higher (p < .050) on the most difficult loops of the race in terms of both physical and psychological demands. Findings suggest emotional, cognitive, psychophysiological, and performance variables to be related and to jointly change across different levels of cognitive and physical load. Overall results are discussed in light of the IZOF and biopsychosocial models. The procedure adopted in the study also supports the feasibility of including additional cognitive load for possible practical applications.	[Robazza, Claudio; Izzicupo, Pascal; D'Amico, Maria Angela; Ghinassi, Barbara; Bortoli, Laura; Baldassarre, Angela Di] G dAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, Chieti, Italy; [Crippa, Maria Chiara] Sacro Cuore Catholic Univ Milan, Serv Educ & Learning Psychol, SPAEE, Milan, Italy; [Di Cecco, Vincenzo] Italian Federat Orienteering Sports, FISO, Trento, Italy; [Ruiz, Montse C.] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland	G d'Annunzio University of Chieti-Pescara; Catholic University of the Sacred Heart; University of Jyvaskyla	Robazza, C (corresponding author), G dAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, Chieti, Italy.	c.robazza@unich.it	Ruiz, Montse/F-4500-2016; IZZICUPO, PASCAL/K-9699-2018; Di Baldassarre, Angela/D-5402-2014; Ghinassi, Barbara/AAJ-9147-2020; Robazza, Claudio/AAS-1152-2020	Ruiz, Montse/0000-0002-1116-206X; IZZICUPO, PASCAL/0000-0001-6944-8995; Di Baldassarre, Angela/0000-0002-4473-4909; Ghinassi, Barbara/0000-0002-3529-2790; Robazza, Claudio/0000-0002-3639-1539	Italian Olympic Committee of Abruzzo Region (CONI, Comitato Regionale Abruzzo)	Italian Olympic Committee of Abruzzo Region (CONI, Comitato Regionale Abruzzo)	This research was funded by a grant from the Italian Olympic Committee of Abruzzo Region (CONI, Comitato Regionale Abruzzo), http://abruzzo.coni.it/abruzzo.html.	Alesi M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01627; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Bertollo M, 2013, APPL PSYCHOPHYS BIOF, V38, P91, DOI 10.1007/s10484-013-9211-z; Blascovich J, 2004, J EXP SOC PSYCHOL, V40, P683, DOI 10.1016/j.jesp.2003.10.007; Blascovich J, 1996, ADV EXP SOC PSYCHOL, V28, P1, DOI 10.1016/S0065-2601(08)60235-X; Blascovich J, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P431; Bocanegra OL, 2012, EUR J APPL PHYSIOL, V112, P3195, DOI 10.1007/s00421-011-2294-4; Borg G, 2001, INT J SPORT PSYCHOL, V32, P110; Borg G., 1998, BORGS PERCEIVED EXER; Bourdon PC, 2017, INT J SPORT PHYSIOL, V12, P161, DOI 10.1123/IJSPP.2017-0208; Cumming SJD, 2017, SPORT PSYCHOL, V31, P217, DOI 10.1123/tsp.2016-0087; Cunniffe B, 2015, INT J SPORT PHYSIOL, V10, P687, DOI 10.1123/ijspp.2014-0370; D'amico MA, 2014, ENDOCR CONNECT, V3, pR45, DOI 10.1530/EC-14-0027; Demetriou A, 2014, INTELLIGENCE, V46, P107, DOI 10.1016/j.intell.2014.05.013; Di Corrado D, 2014, MOL MED REP, V9, P2441, DOI 10.3892/mmr.2014.2115; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Eccles DW, 2015, J SPORT SCI, V33, P609, DOI 10.1080/02640414.2014.951953; Englert C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00314; Filaire E, 2009, PSYCHONEUROENDOCRINO, V34, P150, DOI 10.1016/j.psyneuen.2008.08.022; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Furley P, 2016, J APPL RES MEM COGN, V5, P415, DOI 10.1016/j.jarmac.2016.05.001; Gallina S, 2011, CLIN ENDOCRINOL, V75, P747, DOI 10.1111/j.1365-2265.2011.04143.x; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Hallahan M, 1996, BEHAV RES THER, V34, P489, DOI 10.1016/0005-7967(95)00082-8; Hanin Y.L., 2012, HDB SPORT PSYCHOL, P31, DOI [10.1002/9781118270011.ch2, DOI 10.1002/9781118270011.CH2]; Harrison TL, 2015, MEM COGNITION, V43, P389, DOI 10.3758/s13421-014-0473-3; Jamieson JP, 2017, HANDBOOK OF COMPETENCE AND MOTIVATION, 2 EDITION, P175; Jones M., 2009, INT REV SPORT EXER P, V2, P161, DOI [DOI 10.1080/17509840902829331, 10.1080/17509840902829331]; Laborde S., 2016, PERFORMANCE PSYCHOL, P275, DOI [10.1016/B978-0-12-803377-7.00017-X, DOI 10.1016/B978-0-12-803377-7.00017-X]; Lautenbach F., 2016, PERFORMANCE PSYCHOL, P315, DOI [10.1016/B978-0-12-803377-7.00019-3, DOI 10.1016/B978-0-12-803377-7.00019-3, DOI 10.1016/B978-0-12-803377-7.00019]; Lautenbach F, 2015, INT J PSYCHOPHYSIOL, V98, P167, DOI 10.1016/j.ijpsycho.2015.10.002; Lazarus R.S., 1999, STRESS EMOTION NEW S; Mertler CraigA., 2017, ADV MULTIVARIATE STA, V6; Moore LJ, 2012, PSYCHOPHYSIOLOGY, V49, P1417, DOI 10.1111/j.1469-8986.2012.01449.x; Robazza C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167448; Robazza C, 2012, PSYCHOL SPORT EXERC, V13, P509, DOI 10.1016/j.psychsport.2012.02.011; Ruiz MC, 2017, INT J SPORT EXERC PS, V15, P41, DOI [10.1080/1612197x.2015.1041545, 10.1080/1612197X.2015.1041545]; Ruiz MC, 2016, SPORT PSYCHOL, V30, P201, DOI 10.1123/tsp.2015-0035; Salvador A, 2009, NEUROSCI BIOBEHAV R, V33, P160, DOI 10.1016/j.neubiorev.2008.09.005; Seery MD, 2011, NEUROSCI BIOBEHAV R, V35, P1603, DOI 10.1016/j.neubiorev.2011.03.003; Strauss E, 2006, COMPENDIUM NEUROPSYC; Turner MJ, 2014, INT J PSYCHOPHYSIOL, V94, P9, DOI 10.1016/j.ijpsycho.2014.07.004; Verma J., 2016, SPORTS RES ANAL SOLU; Vine SJ, 2013, J EXP PSYCHOL-APPL, V19, P185, DOI 10.1037/a0034106	45	11	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0196273	10.1371/journal.pone.0196273	http://dx.doi.org/10.1371/journal.pone.0196273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GE1WN	29698498	Green Published, gold, Green Submitted			2022-12-26	WOS:000431007600055
J	Waaijenborg, S; Korobko, O; van Dijk, KW; Lips, M; Hankemeier, T; Wilderjans, TF; Smilde, AK; Westerhuis, JA				Waaijenborg, Sandra; Korobko, Oksana; van Dijk, Ko Willems; Lips, Mirjam; Hankemeier, Thomas; Wilderjans, Tom F.; Smilde, Age K.; Westerhuis, Johan A.			Fusing metabolomics data sets with heterogeneous measurement errors	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; DISCRIMINANT-ANALYSIS; COMPONENT ANALYSIS; AMINO-ACIDS; MODELS; CLASSIFICATION; TRANSFORMATION; PROTEOMICS; SUBJECT	Combining different metabolomics platforms can contribute significantly to the discovery of complementary processes expressed under different conditions. However, analysing the fused data might be hampered by the difference in their quality. In metabolomics data, one often observes that measurement errors increase with increasing measurement level and that different platforms have different measurement error variance. In this paper we compare three different approaches to correct for the measurement error heterogeneity, by transformation of the raw data, by weighted filtering before modelling and by a modelling approach using a weighted sum of residuals. For an illustration of these different approaches we analyse data from healthy obese and diabetic obese individuals, obtained from two metabolomics platforms. Concluding, the filtering and modelling approaches that both estimate a model of the measurement error did not outperform the data transformation approaches for this application. This is probably due to the limited difference in measurement error and the fact that estimation of measurement error models is unstable due to the small number of repeats available. A transformation of the data improves the classification of the two groups.	[Waaijenborg, Sandra; Korobko, Oksana; Smilde, Age K.; Westerhuis, Johan A.] Univ Amsterdam, Swammerdam Inst Life Sci, Biosyst Data Anal, Amsterdam, Netherlands; [van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Lips, Mirjam] Leiden Univ, Med Ctr, Dept Endocrinol & Metab, Leiden, Netherlands; [Hankemeier, Thomas] Leiden Amsterdam Ctr Drug Res, Div Analyt Biosci, Leiden, Netherlands; [Wilderjans, Tom F.] Leiden Univ, Inst Psychol, Methodol & Stat Unit, Leiden, Netherlands; [Wilderjans, Tom F.] Katholieke Univ Leuven, Res Grp Quantitat Psychol & Individual Difference, Leuven, Belgium; [Westerhuis, Johan A.] North West Univ, Dept Stat, Potchefstroom, South Africa	University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; KU Leuven; North West University - South Africa	Westerhuis, JA (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Biosyst Data Anal, Amsterdam, Netherlands.; Westerhuis, JA (corresponding author), North West Univ, Dept Stat, Potchefstroom, South Africa.	J.A.Westerhuis@uva.nl	van Dijk, Ko Willems/A-1798-2008; Hankemeier, Thomas/V-5407-2019; van Dijk, Ko Willems/AAT-4681-2021; Wilderjans, Tom/AAC-5066-2019	van Dijk, Ko Willems/0000-0002-2172-7394; Hankemeier, Thomas/0000-0001-7871-2073; van Dijk, Ko Willems/0000-0002-2172-7394; Wilderjans, Tom/0000-0002-1677-4938; Smilde, Age/0000-0002-3052-4644	STATegra [306000]	STATegra	SW, OK, TH, JAW and AKS acknowledge funding from STATegra, a project from the Seventh Framework Program [FP7/2007-2013] under grant agreement No 306000. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bro R, 2002, J CHEMOMETR, V16, P387, DOI 10.1002/cem.734; Christin C, 2013, MOL CELL PROTEOMICS, V12, P263, DOI 10.1074/mcp.M112.022566; Durbin B, 2003, BIOINFORMATICS, V19, P1360, DOI 10.1093/bioinformatics/btg178; Durbin B P, 2002, Bioinformatics, V18 Suppl 1, pS105; Hoefsloot HCJ, 2008, STAT APPL GENET MOL, V7; Hoefsloot HCJ, 2006, J CHEMOMETR, V20, P120, DOI 10.1002/cem.996; HOOGERBRUGGE R, 1983, ANAL CHEM, V55, P1710, DOI 10.1021/ac00261a016; Lips MA, 2014, DIABETES CARE, V37, P3150, DOI 10.2337/dc14-0195; Lutz U, 2006, ANAL CHEM, V78, P4564, DOI 10.1021/ac0522299; Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234; Parsons HM, 2009, ANALYST, V134, P478, DOI 10.1039/b808986h; Purohit PV, 2004, OMICS, V8, P118, DOI 10.1089/1536231041388348; ROCKE DM, 1995, TECHNOMETRICS, V37, P176, DOI 10.2307/1269619; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Ten Berge JMF., 1992, STAT APPL, V4, P377; Thalacker-Mercer AE, 2014, DIABETES, V63, P791, DOI 10.2337/db13-0396; Timmerman ME, 2006, BRIT J MATH STAT PSY, V59, P301, DOI 10.1348/000711005X67599; Timmerman ME, 2003, PSYCHOMETRIKA, V68, P105, DOI 10.1007/BF02296656; Van Batenburg MF, 2011, ANAL CHEM, V83, P3267, DOI 10.1021/ac102374c; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van den Berg RA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-340; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; Van Deun K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-448; Westerhuis JA, 1998, J CHEMOMETR, V12, P301, DOI 10.1002/(SICI)1099-128X(199809/10)12:5<301::AID-CEM515>3.0.CO;2-S; Wilderjans TF, 2011, BRIT J MATH STAT PSY, V64, P277, DOI 10.1348/000711010X513263	26	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2018	13	4							e0195939	10.1371/journal.pone.0195939	http://dx.doi.org/10.1371/journal.pone.0195939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE1WN	29698490	Green Published, gold			2022-12-26	WOS:000431007600024
J	Myte, R; Gylling, B; Haggstrom, J; Schneede, J; Lofgren-Burstrom, A; Huyghe, JR; Hallmans, G; Meyer, K; Johansson, I; Ueland, PM; Palmqvist, R; Van Guelpen, B				Myte, Robin; Gylling, Bjorn; Haggstrom, Jenny; Schneede, Jorn; Lofgren-Burstrom, Anna; Huyghe, Jeroen R.; Hallmans, Goran; Meyer, Klaus; Johansson, Ingegerd; Ueland, Per Magne; Palmqvist, Richard; Van Guelpen, Bethany			One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status	PLOS ONE			English	Article							FOLIC-ACID FORTIFICATION; LOW FOLATE LEVELS; B-VITAMINS; MOLECULAR SUBTYPES; COLON-CANCER; PLASMA; DISEASE; TUMOR; HOMOCYSTEINE; COMPONENTS	Disturbances in one-carbon metabolism, intracellular reactions involved in nucleotide synthesis and methylation, likely increase the risk of colorectal cancer (CRC). However, results have been inconsistent. To explore whether this inconsistency could be explained by intertumoral heterogeneity, we evaluated a comprehensive panel of one-carbon metabolism biomarkers and some single nucleotide polymorphisms (SNPs) in relation to the risk of molecular subtypes of CRC defined by mutations in the KRAS and BRAF oncogenes. This nested case-control study included 488 CRC cases and 947 matched controls from two population-based cohorts in the Northern Sweden Health and Disease Study. We analyzed 14 biomarkers and 17 SNPs in prediagnostic blood and determined KRAS and BRAF mutation status in tumor tissue. In a multivariate network analysis, no variable displayed a strong association with the risk of specific CRC subtypes. A non-synonymous SNP in the CTH gene, rs1021737, had a stronger association compared with other variables. In subsequent univariate analyses, participants with variant rs1021737 genotype had a decreased risk of KRAS-mutated CRC (OR per allele = 0.72, 95% CI = 0.50, 1.05), and an increased risk of BRAF-mutated CRC (OR per allele = 1.56, 95% CI = 1.07, 2.30), with weak evidence for heterogeneity (P-heterogeneity = 0.01). This subtype-specific SNP association was not replicated in a case-case analysis of 533 CRC cases from The Cancer Genome Atlas (P = 0.85). In conclusion, we found no support for clear subtype-specific roles of one-carbon metabolism biomarkers and SNPs in CRC development, making differences in CRC molecular subtype distributions an unlikely explanation for the varying results on the role of one-carbon metabolism in CRC development across previous studies. Further investigation of the CTH gene in colorectal carcinogenesis with regards to KRAS and BRAF mutations or other molecular characteristics of the tumor may be warranted.	[Myte, Robin; Van Guelpen, Bethany] Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden; [Gylling, Bjorn; Lofgren-Burstrom, Anna; Palmqvist, Richard] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden; [Haggstrom, Jenny] Umea Univ, Umea Sch Business & Econ, Dept Stat, Umea, Sweden; [Schneede, Jorn] Umea Univ, Dept Clin Pharmacol Pharmacol & Clin Neurosci, Umea, Sweden; [Huyghe, Jeroen R.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Hallmans, Goran] Umea Univ, Dept Biobank Res Publ Hlth & Clin Med, Umea, Sweden; [Meyer, Klaus] Bevital AS, Bergen, Norway; [Johansson, Ingegerd] Umea Univ, Dept Odontol, Cariol, Umea, Sweden; [Ueland, Per Magne] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Ueland, Per Magne] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway	Umea University; Umea University; Umea University; Umea University; Fred Hutchinson Cancer Center; Umea University; Umea University; University of Bergen; University of Bergen; Haukeland University Hospital	Myte, R (corresponding author), Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden.	robin.myte@umu.se	Ueland, Per M/C-7340-2013; Van Guelpen, Bethany/J-8159-2015	Van Guelpen, Bethany/0000-0002-9692-101X; Ueland, Per Magne/0000-0002-1903-0571	Swedish Council for Working Life and Social Research [2007-0925]; Swedish Cancer Society [2012/0501, 2014/780]; Swedish Research Council [K2012-55X-21100-04-3]; Faculty of Medicine at Umea University; Cancer Research Foundation in Northern Sweden [AMP 15-761, AMP 16-798, AMP 15-768]; Umea University [VLL-493531, VLL-400931]; Vasterbotten County Council [VLL-493531, VLL-400931]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Faculty of Medicine at Umea University; Cancer Research Foundation in Northern Sweden; Umea University; Vasterbotten County Council	This work was supported by Swedish Council for Working Life and Social Research (grant number 2007-0925 to IJ), Swedish Cancer Society (grant numbers 2012/0501 to RP and 2014/780 to BVG), the Swedish Research Council (grant number K2012-55X-21100-04-3 to RP), the Faculty of Medicine at Umea University, the Cancer Research Foundation in Northern Sweden (grant numbers AMP 15-761 and AMP 16-798 to BG, and AMP 15-768 to RM), and through the regional agreement between Umea University and Vasterbotten County Council on cooperation in the field of Medicine, Odontology and Health (grant numbers VLL-493531 and VLL-400931 to IJ). The funders provided support in the form of salaries for authors or costs of analyses (RM, BG, IJ, RP, BVG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The same was true for Bevital AS, who is the employer of KM. Bevital AS is 100% owned by a private non-profit organization. The specific roles of the authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Eklof V, 2013, BRIT J CANCER, V108, P2153, DOI 10.1038/bjc.2013.212; Eussen SJPM, 2013, BRIT J NUTR, V110, P363, DOI 10.1017/S0007114512004990; Fan K, 2014, CELL SIGNAL, V26, P2801, DOI 10.1016/j.cellsig.2014.08.023; Figueiredo JC, 2013, MOL NUTR FOOD RES, V57, P607, DOI 10.1002/mnfr.201200278; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gonsalves WI, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju106; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Gylling B, 2014, CANCER EPIDEM BIOMAR, V23, P2136, DOI 10.1158/1055-9965.EPI-13-1352; Hustad S, 2012, CLIN CHEM, V58, P402, DOI 10.1373/clinchem.2011.174490; Inamura K, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv363; Jennings BA, 2015, CANCER LETT, V356, P224, DOI 10.1016/j.canlet.2014.02.024; Johansson I, 2010, EUR J CLIN NUTR, V64, P905, DOI 10.1038/ejcn.2010.80; Kalmbach RD, 2008, AM J CLIN NUTR, V88, P763, DOI 10.1093/ajcn/88.3.763; Keum N, 2014, AM J PREV MED, V46, pS65, DOI 10.1016/j.amepre.2013.10.025; Kudryavtseva AV, 2016, ONCOTARGET, V7, P53959, DOI 10.18632/oncotarget.9796; Le Marchand L, 2009, CANCER EPIDEM BIOMAR, V18, P2195, DOI 10.1158/1055-9965.EPI-09-0141; Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1197, DOI 10.1158/1055-9965.EPI-08-1001; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Liu L, 2018, EUR J EPIDEMIOL, V33, P381, DOI 10.1007/s10654-017-0346-8; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Mason JB, 2011, BIOFACTORS, V37, P253, DOI 10.1002/biof.174; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Meyer K, 2009, CLIN CHEM, V55, P139, DOI 10.1373/clinchem.2008.115378; Midttun O, 2014, J NUTR, V144, P784, DOI 10.3945/jn.113.189738; Miller JW, 2013, AM J CLIN NUTR, V97, P827, DOI 10.3945/ajcn.112.049932; Morkel M, 2015, ONCOTARGET, V6, P20785, DOI 10.18632/oncotarget.4750; Myte R, 2017, SCI REP-UK, V7, DOI 10.1038/srep43434; Myte R, 2016, EPIDEMIOLOGY, V27, P787, DOI 10.1097/EDE.0000000000000529; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; Nilsson SE, 2009, SCAND J CLIN LAB INV, V69, P562, DOI 10.1080/00365510902814646; Nishihara R, 2013, JAMA-J AM MED ASSOC, V309, P2563, DOI 10.1001/jama.2013.6599; Norberg M, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19166; Norberg M, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.4643; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/ERM.12.46, 10.1586/erm.12.46]; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Phillips CM, 2017, CANCER RES, V77, P5741, DOI 10.1158/0008-5472.CAN-16-3480; Richiardi L, 2017, EUR J EPIDEMIOL, V32, P353, DOI 10.1007/s10654-017-0253-z; Rodin A, 2006, BIOINFORMATICS, V22, P1, DOI 10.1093/bioinformatics/bti813; Rosty C, 2013, MODERN PATHOL, V26, P825, DOI 10.1038/modpathol.2012.240; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Schumacher FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8138; Scutari M, 2013, ARTIF INTELL MED, V57, P207, DOI 10.1016/j.artmed.2012.12.006; Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035; Sorbye H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131046; Su CW, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-6; Sucher R, 2010, CANCER LETT, V287, P13, DOI 10.1016/j.canlet.2009.05.008; Szabo C, 2016, NAT REV DRUG DISCOV, V15, P185, DOI 10.1038/nrd.2015.1; Szabo C, 2013, P NATL ACAD SCI USA, V110, P12474, DOI 10.1073/pnas.1306241110; Van Guelpen B, 2006, GUT, V55, DOI 10.1136/gut.2005.085480; Van Guelpen B, 2010, CANCER CAUSE CONTROL, V21, P557, DOI 10.1007/s10552-009-9484-y; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; Wang J, 2004, CLIN GENET, V65, P483, DOI 10.1111/j.1399-0004.2004.00250.x; Wang ML, 2016, STAT MED, V35, P782, DOI 10.1002/sim.6793; Weinstein SJ, 2008, CANCER EPIDEM BIOMAR, V17, P3233, DOI 10.1158/1055-9965.EPI-08-0459	59	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0196233	10.1371/journal.pone.0196233	http://dx.doi.org/10.1371/journal.pone.0196233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694444	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400077
J	Schmautz, C; Hillreiner, M; Ballweg, I; Pfaffl, MW; Kliem, H				Schmautz, Christiane; Hillreiner, Maria; Ballweg, Ines; Pfaffl, Michael W.; Kliem, Heike			Stimulated enrichment of Clostridium difficile specific IgA in mature cow's milk	PLOS ONE			English	Article							DAIRY-CATTLE; IMMUNE COMPONENTS; BOVINE COLOSTRUM; MAMMARY-GLAND; WHEY-PROTEIN; PREVENTION; DISEASE; IMMUNIZATION; CONCENTRATE; DIARRHEA	Cow milk products enriched with Clostridium difficile (C. diff.) specific IgA are possible alternative therapeutics against C. diff. associated diarrhea. A persistently high level of C. diff. specific IgA in mature milk triggered by continuous immunizations of dairy cows against C. diff. was hypothesized. Nine Brown Swiss cows were repeatedly vaccinated against C. diff. and divided into low responder (LR) and high responder (HR) cows, as measured by their production of anti-C. diff. specific IgA in milk (threshold: 8.0 mu g anti-C. diff. specific IgA/mL on average). Total and C. diff. specific IgA were quantified in bovine milk and blood using a sandwich ELISA. Important milk production factors were analyzed per lactation stage. Milk yield, milk fats and proteins were significantly different (P < 0.05) in the early lactation stage when the treated with the untreated cows (n = 30) were compared. In contrast to the "before treatment control" values, the HR's milk anti-C. diff. IgA was approximately 80% higher at any lactation stage, and the HR's total milk IgA increased up to 72% in the late lactation stage. The LR's total milk IgA differed from the baseline by roughly 47% only in the late lactation stage. The total and specific IgA contents in milk were more influenced by the anti-C. diff. immunizations than in blood. The correlations between anti-C. diff. specific IgA, total IgA and the main production factors in milk were classified as weak (I r I < 0.5), except for the close relation of anti-C. diff. specific IgA and total IgA (r = 0.69). To conclude, a sustainable C. diff. specific IgA enrichment in milk can be achieved by continuous immunization of dairy cows, provided a potent and well-formulated anti-C. diff. vaccine is given to dairy cows preselected due to their proven anti-C. diff. receptivity.	[Schmautz, Christiane; Hillreiner, Maria; Ballweg, Ines; Pfaffl, Michael W.; Kliem, Heike] Tech Univ Munich, Chair Anim Physiol & Immunol, Freising Weihenstephan, Germany	Technical University of Munich	Kliem, H (corresponding author), Tech Univ Munich, Chair Anim Physiol & Immunol, Freising Weihenstephan, Germany.	heike.kliem@wzw.tum.de	Pfaffl, Michael/G-6622-2013	Pfaffl, Michael/0000-0002-3192-1019	Biosys UK Ltd.; MucoVax GmbH; VFMF association (Vereinigung zur Forderung der Milchwissenschaftlichen Forschung an der Technischen Universitat MOnchen e.V.", Freising, Germany); German Research Foundation (DFG); Technical University of Munich (TUM)	Biosys UK Ltd.; MucoVax GmbH; VFMF association (Vereinigung zur Forderung der Milchwissenschaftlichen Forschung an der Technischen Universitat MOnchen e.V.", Freising, Germany); German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM)	This study was funded by Biosys UK Ltd., the successor company of the MucoVax GmbH, and the VFMF association (Vereinigung zur Forderung der Milchwissenschaftlichen Forschung an der Technischen Universitat MOnchen e.V.", Freising, Germany). Biosys UK Ltd. provided financial support for the research materials. The VFMF association granted the stipend for the author CS. In the framework of the Open Access Publishing Program, the German Research Foundation (DFG) and the Technical University of Munich (TUM) subsidize this work. The funders had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT JG, 1994, CLIN INFECT DIS, V18, pS265, DOI 10.1093/clinids/18.Supplement_4.S265; BUTCHER KR, 1967, J DAIRY SCI, V50, P185, DOI 10.3168/jds.S0022-0302(67)87386-7; DEVERYPOCIUS JE, 1983, J DAIRY SCI, V66, P221, DOI 10.3168/jds.S0022-0302(83)81780-9; Fischer B, 2002, VET ZOOTECH-LITH, V19, P41; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Giannasca PJ, 2004, VACCINE, V22, P848, DOI 10.1016/j.vaccine.2003.11.030; Gingerich DA, 2005, REGUL TOXICOL PHARM, V41, P102, DOI 10.1016/j.yrtph.2004.10.002; GUIDRY AJ, 1980, VET IMMUNOL IMMUNOP, V1, P329, DOI 10.1016/0165-2427(80)90012-4; HILPERT H, 1987, J INFECT DIS, V156, P158, DOI 10.1093/infdis/156.1.158; Keel MK, 2006, VET PATHOL, V43, P225, DOI 10.1354/vp.43-3-225; Kelly CP, 1997, ANTIMICROB AGENTS CH, V41, P236, DOI 10.1128/AAC.41.2.236; Kelly Gregory S, 2003, Altern Med Rev, V8, P378; Korhonen H, 2000, BRIT J NUTR, V84, pS135; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; LARSON BL, 1980, J DAIRY SCI, V63, P665, DOI 10.3168/jds.S0022-0302(80)82988-2; LeBlanc SJ, 2006, J DAIRY SCI, V89, P1267, DOI 10.3168/jds.S0022-0302(06)72195-6; Lun S, 2007, REPROD DOMEST ANIM, V42, P126, DOI 10.1111/j.1439-0531.2006.00741.x; Marnila P, 2002, ENCY DAIRY SCI, P1950; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Mehra R, 2006, INT DAIRY J, V16, P1262, DOI 10.1016/j.idairyj.2006.06.003; MULLER LD, 1981, J DAIRY SCI, V64, P1727, DOI 10.3168/jds.S0022-0302(81)82754-3; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Numan SC, 2007, GUT, V56, P888, DOI 10.1136/gut.2006.119016; PETERSEN W E, 1955, J Lancet, V75, P494; Reilly RM, 1997, CLIN PHARMACOKINET, V32, P313, DOI 10.2165/00003088-199732040-00004; SARWAR M, 1964, CAN J COMP MED VET S, V28, P183; SCHUTZ MM, 1990, J DAIRY SCI, V73, P484, DOI 10.3168/jds.S0022-0302(90)78696-1; Sedgmen BJ, 2004, IMMUNOL CELL BIOL, V82, P10, DOI 10.1111/j.1440-1711.2004.01214.x; SHOOK GE, 1989, J DAIRY SCI, V72, P1349, DOI 10.3168/jds.S0022-0302(89)79242-0; Steele J, 2013, HUM VACC IMMUNOTHER, V9, P1565, DOI 10.4161/hv.24078; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; Stubbe H, 2000, J IMMUNOL, V164, P1952, DOI 10.4049/jimmunol.164.4.1952; van Dissel JT, 2005, J MED MICROBIOL, V54, P197, DOI 10.1099/jmm.0.45773-0; Wheeler TT, 2007, J MAMMARY GLAND BIOL, V12, P237, DOI 10.1007/s10911-007-9051-7; Young KWH, 2007, REGUL TOXICOL PHARM, V47, P317, DOI 10.1016/j.yrtph.2006.12.001; Zhao S, 2014, HUM VACC IMMUNOTHER, V10, P3522, DOI 10.4161/21645515.2014.980193	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2018	13	4							e0195275	10.1371/journal.pone.0195275	http://dx.doi.org/10.1371/journal.pone.0195275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD8ZI	29694363	Green Published, gold, Green Submitted			2022-12-26	WOS:000430802400026
J	Yang, M; Zhang, JF; Su, S; Qin, B; Kang, LH; Zhu, RR; Guan, HJ				Yang, Mei; Zhang, Junfang; Su, Shu; Qin, Bai; Kang, Lihua; Zhu, Rongrong; Guan, Huaijin			Allelic interaction effects of DNA damage and repair genes on the predisposition to age-related cataract	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; BREAST-CANCER; LOGISTIC-REGRESSION; CORTICAL CATARACT; RECQ HELICASES; ASSOCIATION; POLYMORPHISMS; POPULATION; RISK; EYE	Purpose Age-related cataract (ARC) is a leading cause of visual impairment and blindness worldwide. DNA damage and malfunction of DNA repair are believed to contribute to the pathogenesis of ARC. Aside from increasing age, the risk factors for ARC appear to be rather complex, and one or more gene variations could play critical roles in the diverse processes of ARC progression. This study aimed to investigate the combined effects of different genetic variants on ARC risk. Methods A cohort of 789 ARC patients and 531 normal controls from the Jiangsu Eye Study was included in this study. Genotyping of 18 single-nucleotide polymorphisms (SNPs) in 4 DNA damage/repair genes was performed using TaqMan SNP assays. SNP-SNP interactions were analyzed via multifactor dimensionality reduction (MDR), classification and regression tree (CART) and genetic risk score (GRS) analyses. Results Based on single-locus analyses of the 18 SNPs examined, WRN-rs11574311 (T>C) was associated with ARC risk. However, in MDR, the gene-gene interaction among the five SNPs (WRN-rs4733220 (G>A), WRN-rs1801195 (T>G), OGG1-rs2072668 (G>C) and OGG1-rs2304277 (A>G)) on ARC risk was significant (OR = 5.03, 95% CI: 3.54 similar to 7.13). CART analyses also revealed that the combination of five SNPs above was the best polymorphic signature for discriminating between the cases and the controls. The overall odds ratio for CART ranged from 4.56 to 7.90 showing an incremental risk for ARC. This result indicated that these critical SNPs participate in complex interactions. The GRS results showed an increased risk for ARC among individuals with the SNPs in this polymorphic signature. Conclusion The use of multifactorial analysis (or an integrated approach) rather than a single methodology could be an improved strategy for identifying complex gene interactions. The multifactorial approach used in this study has the potential to identify complex biological relationships among ARC-related genes and processes. This approach will lead to the discovery of novel biological information, ultimately improving ARC risk management.	[Yang, Mei; Zhang, Junfang; Su, Shu; Qin, Bai; Kang, Lihua; Zhu, Rongrong; Guan, Huaijin] Nantong Univ, Affiliated Hosp, Eye Inst, Nantong, Jiangsu, Peoples R China	Nantong University	Guan, HJ (corresponding author), Nantong Univ, Affiliated Hosp, Eye Inst, Nantong, Jiangsu, Peoples R China.	guanhjeye@163.com			National Natural Science Foundation of China [81270987, 81470616]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by The National Natural Science Foundation of China (No.81270987, No.81470616), http://www.nsfc.gov.cn/.	Baas DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013786; Briollais L, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-22; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Carayol J, 2010, STAT MED, V29, P2359, DOI 10.1002/sim.4006; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Ding SL, 2009, CARCINOGENESIS, V30, P43, DOI 10.1093/carcin/bgn233; Ehrenberg M, 2010, MOL VIS, V16, P1771; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Frank B, 2010, CARCINOGENESIS, V31, P442, DOI 10.1093/carcin/bgp293; Garcia-Magarinos M, 2009, ANN HUM GENET, V73, P360, DOI 10.1111/j.1469-1809.2009.00511.x; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hirai M, 2005, DIABETES RES CLIN PR, V69, P287, DOI 10.1016/j.diabres.2005.01.012; Jiang ZX, 2012, MOL VIS, V18, P1247; KLEIMAN NJ, 1990, MUTAT RES, V240, P35, DOI 10.1016/0165-1218(90)90006-N; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P546; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; LI WC, 1995, J CELL BIOL, V130, P169, DOI 10.1083/jcb.130.1.169; Mahmoud AAH, 2002, AM J MED GENET, V111, P81, DOI 10.1002/ajmg.10492; Manne Mamata, 2012, Oman J Ophthalmol, V5, P32, DOI 10.4103/0974-620X.94764; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Opresko PL, 2008, MECH AGEING DEV, V129, P79, DOI 10.1016/j.mad.2007.10.007; Ottonello S, 2000, OPHTHALMOLOGICA, V214, P78, DOI 10.1159/000027474; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Su S, 2013, INVEST OPHTH VIS SCI, V54, P1201, DOI 10.1167/iovs.12-10940; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Tuo JS, 2006, P NATL ACAD SCI USA, V103, P9256, DOI 10.1073/pnas.0603485103; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Wang YB, 2011, DNA REPAIR, V10, P416, DOI 10.1016/j.dnarep.2011.01.009; Ye L, 1997, AM J MED GENET, V68, P494, DOI 10.1002/(SICI)1096-8628(19970211)68:4<494::AID-AJMG30>3.0.CO;2-L; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023	36	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2018	13	4							e0184478	10.1371/journal.pone.0184478	http://dx.doi.org/10.1371/journal.pone.0184478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7GN	29689049	gold, Green Submitted, Green Published			2022-12-26	WOS:000430678800001
J	Dabas, Y; Mohan, A; Xess, I				Dabas, Yubhisha; Mohan, Anant; Xess, Immaculata			Serum galactomannan antigen as a prognostic and diagnostic marker for invasive aspergillosis in heterogeneous medicine ICU patient population	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PULMONARY ASPERGILLOSIS; RISK-FACTORS; BRONCHOALVEOLAR LAVAGE; RESPIRATORY-TRACT; PIPERACILLIN; INFECTIONS; DISEASE	Objective & para;& para;This study was conducted to get a complete clinical and mycological picture of invasive aspergillosis (IA) in respiratory medicine ICU of a tertiary care hospital.& para;& para;Patients & para;& para;From the cohort of 235 patients only one had proven IA. Based on AspICU algorithm, 21 had putative IA (8.9%), 12 were colonised (5.1%).& para;& para;Results & para;& para;Adjusting the confounding factors, significant risk factors for IA were chronic obstructive pulmonary disease (COPD), temperature of >= 38 degrees C, pneumonia and acute respiratory distress syndrome (ARDS). The best predictor of IA was AspICU algorithm (AUC, 1) followed by serum galactomannan antigen (GM) cut-off (>= 1.24) calculated based on AspICU algorithm (AUC, 0.822). For 37% of patients, IA diagnoses was made earlier with serum GM than radiology. There were 70/235 (29.8%) deaths within 30 days of enrolment in the study. Aspergillus culture positivity (34/235, 14.5%) was associated with very high mortality (27/34, 79.4%), (p<0.05). The best predictor of mortality was GM cut-off (>= 1.24) calculated based on AspICU algorithm (AUC, 0.835).& para;& para;Conclusion & para;& para;This study imparts the focus on relatively underestimated Aspergillus infections prevalent in ICUs. The AspICU algorithm was found to be useful over others for IA diagnosis. The prognostic usefulness of serum GM antigen detection test highlighted overlooking the same may not be rewarding for the outcome of IA suspected ICU subpopulation.	[Dabas, Yubhisha; Xess, Immaculata] All India Inst Med Sci, Dept Microbiol, New Delhi, India; [Mohan, Anant] All India Inst Med Sci, Dept Pulm Med & Sleep Disorders, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Xess, I (corresponding author), All India Inst Med Sci, Dept Microbiol, New Delhi, India.	immaculataxess@gmail.com			Indian Council of Medical Research (ICMR) [80/896/2014-ECD-I]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	The authors are grateful to the patients and their relatives for providing the consent for the study. Yubhisha Dabas received senior research fellowship (SRF) awarded by Indian Council of Medical Research (ICMR) (80/896/2014-ECD-I).	Aubry A, 2006, J CLIN MICROBIOL, V44, P389, DOI 10.1128/JCM.44.2.389-394.2006; Bassetti M, 2017, INTENS CARE MED, V43, P1225, DOI 10.1007/s00134-017-4731-2; Blot SI, 2012, AM J RESP CRIT CARE, V186, P56, DOI 10.1164/rccm.201111-1978OC; Chai LYA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090176; Clemons KV, 2009, MED MYCOL, V47, pS132, DOI 10.1080/13693780802213340; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dutkiewicz Radek, 2010, Proc Am Thorac Soc, V7, P204, DOI 10.1513/pats.200906-050AL; Eigl S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0905-x; Fujitani S, 2009, RESP CARE, V54, P1453; Gangneux J-P, 2010, Rev Mal Respir, V27, pe34, DOI 10.1016/j.rmr.2010.01.004; Garnacho-Montero J, 2005, CRIT CARE, V9, pR191, DOI 10.1186/cc3488; Gerlinger MP, 2012, MED MALADIES INFECT, V42, P10, DOI 10.1016/j.medmal.2011.10.018; Ghosh I, 2013, INDIAN J MED PAEDIAT, V34, P74, DOI [10.4103/0971-, 10.4103/0971-5851.116181]; Guinea J, 2010, CLIN MICROBIOL INFEC, V16, P870, DOI 10.1111/j.1469-0691.2009.03015.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Khasawneh F, 2006, J CRIT CARE, V21, P322, DOI 10.1016/j.jcrc.2006.03.006; Ko JH, 2015, EUR J CLIN MICROBIOL, V34, P1437, DOI 10.1007/s10096-015-2370-5; Kousha M, 2011, EUR RESPIR REV, V20, P156, DOI 10.1183/09059180.00001011; Lugosi M, 2014, J INFECTION, V69, P284, DOI 10.1016/j.jinf.2014.04.010; McClenny N, 2005, MED MYCOL, V43, pS125, DOI 10.1080/13693780500052222; Meersseman W, 2004, AM J RESP CRIT CARE, V170, P621, DOI 10.1164/rccm.200401-093OC; Meersseman W, 2008, AM J RESP CRIT CARE, V177, P27, DOI 10.1164/rccm.200704-606OC; Metan G, 2010, INFECTION, V38, P217, DOI 10.1007/s15010-010-0003-6; Mikulska M, 2012, J ANTIMICROB CHEMOTH, V67, P1746, DOI 10.1093/jac/dks111; Murthy S, 2012, CRIT CARE, V16, DOI 10.1186/cc11140; Pashley CH, 2012, MED MYCOL, V50, P433, DOI 10.3109/13693786.2011.615762; Schroeder M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1326-1; Sulahian A, 2003, NEW ENGL J MED, V349, P2366, DOI 10.1056/NEJM200312113492424; Taccone FS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0722-7; van Paassen J, 2016, EUROSURVEILLANCE, V21, P16, DOI 10.2807/1560-7917.ES.2016.21.30.30300; Vandewoude K, 2004, ACTA CLIN BELG, V59, P251, DOI 10.1179/acb.2004.037; Vandewoude KH, 2006, CRIT CARE, V10, DOI 10.1186/cc4823; Vergidis P, 2014, J CLIN MICROBIOL, V52, P2199, DOI 10.1128/JCM.00285-14	33	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196196	10.1371/journal.pone.0196196	http://dx.doi.org/10.1371/journal.pone.0196196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684057	Green Published, gold, Green Submitted			2022-12-26	WOS:000430660600042
J	Schmuck, B; Sandgren, M; Hard, T				Schmuck, Benjamin; Sandgren, Mats; Hard, Torleif			The kinetics of TEM1 antibiotic degrading enzymes that are displayed on Ure2 protein nanofibrils in a flow reactor	PLOS ONE			English	Article							BETA-LACTAMASE; RESISTANT BACTERIA; CHEMICAL-ANALYSIS; PRION FILAMENTS; AMYLOID FIBRILS; IMMOBILIZATION; STRATEGIES; DOMAIN	Enzymatic functionalization of cross-beta structured protein nanofibrils has hitherto resulted in a severe reduction of the catalytic efficiency of high turnover biocatalysts. It has been speculated that steric restrictions and mass transport pose limits on the attached enzymes, but detailed kinetics analyzing this have not yet been reported. For a more comprehensive understanding, we studied protein nanofibrils endowed with TEM1, a beta-lactamase from Escherichia coll. The packing density of TEM1 along the fibrils was controlled by co-fibrillation; in other words, the N-terminal ureidosuccinate transporter Ure2(1-80) from Saccharomyces cerevisiae was simultaneously aggregated with the chimeric proteins TEM1-Ure2(1-80). The mature fibrils were trapped in a column, and the rate of ampicillin hydrolysis was recorded using a continuous substrate flow. The turnover rate was plotted as a function of substrate molecules available per enzyme per second, which demonstrated that an elevated substrate availability counteracts mass transport limitations. To analyze this data set, we derived a kinetic model, which makes it possible to easily characterize and compare enzymes packed in columns. The functional TEM1 nanofibrils possess 80% of the catalytic turnover rate compared to free TEM1 in solution. Altogether, we have created protein nanofibrils that can effectively hydrolyze beta-lactam antibiotic contaminations and provided a groundwork strategy for other highly functional enzymatic nanofibrils.	[Schmuck, Benjamin; Sandgren, Mats; Hard, Torleif] Swedish Univ Agr Sci SLU, Dept Mol Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences	Hard, T (corresponding author), Swedish Univ Agr Sci SLU, Dept Mol Sci, Uppsala, Sweden.	torleif.hard@slu.se		Sandgren, Mats/0000-0002-2358-4534; Schmuck, Benjamin/0000-0003-4021-6458	Svenska Forskningsradet Formas [942-2015-945]	Svenska Forskningsradet Formas(Swedish Research Council Formas)	This work was supported by a grant from Svenska Forskningsradet Formas (http://www.formas.se; grant number: 942-2015-945) to Torleif Hard and Mats Sandgren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mayah Ameel M R, 2012, Enzyme Res, V2012, P459190, DOI 10.1155/2012/459190; Ansari SA, 2012, BIOTECHNOL ADV, V30, P512, DOI 10.1016/j.biotechadv.2011.09.005; Barbosa O, 2015, BIOTECHNOL ADV, V33, P435, DOI 10.1016/j.biotechadv.2015.03.006; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Beijer K, 2017, CHEMOSPHERE, V176, P342, DOI 10.1016/j.chemosphere.2017.02.127; BLAEDEL WJ, 1972, ANAL CHEM, V44, P2030, DOI 10.1021/ac60320a021; Brena B, 2013, METHODS MOL BIOL, V1051, P15, DOI 10.1007/978-1-62703-550-7_2; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; Cantu C, 1998, J BIOL CHEM, V273, P26603, DOI 10.1074/jbc.273.41.26603; Cantu C, 1997, J BIOL CHEM, V272, P29144, DOI 10.1074/jbc.272.46.29144; DAKA JN, 1988, BIOTECHNOL BIOENG, V32, P213, DOI 10.1002/bit.260320211; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; DiCosimo R, 2013, CHEM SOC REV, V42, P6437, DOI 10.1039/c3cs35506c; Hauser CAE, 2014, CHEM SOC REV, V43, P5326, DOI 10.1039/c4cs00082j; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; KATCHALSKIKATZIR E, 1993, TRENDS BIOTECHNOL, V11, P471, DOI 10.1016/0167-7799(93)90080-S; LILLY MD, 1966, BIOCHEM J, V100, P718, DOI 10.1042/bj1000718; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; MANSFELD J, 1987, BIOTECHNOL BIOENG, V29, P72, DOI 10.1002/bit.260290111; Matosevic S, 2011, J BIOTECHNOL, V155, P320, DOI 10.1016/j.jbiotec.2011.07.017; Michaelis L, 1913, BIOCHEM Z, V49, P333; MOVVA NR, 1980, J BIOL CHEM, V255, P27; Rohatgi A, 2017, WEBPLOTDIGITIZER; Schmuck B, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600672; Seong GH, 2003, ANAL CHEM, V75, P3161, DOI 10.1021/ac034155b; Sideraki V, 2001, P NATL ACAD SCI USA, V98, P283, DOI 10.1073/pnas.011454198; Tang SS, 2014, ADV DRUG DELIVER REV, V78, P3, DOI 10.1016/j.addr.2014.08.003; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; Urban PL, 2006, BIOTECHNOL ADV, V24, P42, DOI 10.1016/j.biotechadv.2005.06.001; Wong LS, 2009, CHEM REV, V109, P4025, DOI 10.1021/cr8004668; Yu Y, 2011, BIOCHEM J, V434, P143, DOI 10.1042/BJ20101895; Zhou XM, 2015, ACS NANO, V9, P5772, DOI 10.1021/acsnano.5b00061; Zhou XM, 2014, CHEMCATCHEM, V6, P1961, DOI 10.1002/cctc.201402125	35	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2018	13	4							e0196250	10.1371/journal.pone.0196250	http://dx.doi.org/10.1371/journal.pone.0196250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD7AK	29684061	Green Published, Green Submitted, gold			2022-12-26	WOS:000430660600048
J	Zhang, JS; Basso, B; Price, RF; Putman, G; Shuai, GY				Zhang, Jinshui; Basso, Bruno; Price, Richard F.; Putman, Gregory; Shuai, Guanyuan			Estimating plant distance in maize using Unmanned Aerial Vehicle (UAV)	PLOS ONE			English	Article							VEGETATION INDEXES; HOUGH TRANSFORM; AUTOMATED CROP; GRAIN-YIELD; VISION; CORN; VARIABILITY; ROWS	Distance between rows and plants are essential parameters that affect the final grain yield in row crops. This paper presents the results of research intended to develop a novel method to quantify the distance between maize plants at field scale using an Unmanned Aerial Vehicle (UAV). Using this method, we can recognize maize plants as objects and calculate the distance between plants. We initially developed our method by training an algorithm in an indoor facility with plastic corn plants. Then, the method was scaled up and tested in a farmer's field with maize plant spacing that exhibited natural variation. The results of this study demonstrate that it is possible to precisely quantify the distance between maize plants. We found that accuracy of the measurement of the distance between maize plants depended on the height above ground level at which UAV imagery was taken. This study provides an innovative approach to quantify plant-to-plant variability and, thereby final crop yield estimates.	[Zhang, Jinshui] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing, Peoples R China; [Zhang, Jinshui; Basso, Bruno; Price, Richard F.; Putman, Gregory; Shuai, Guanyuan] Michigan State Univ, Dept Earth & Environm Sci, E Lansing, MI 48824 USA; [Basso, Bruno] Michigan State Univ, WK Kellogg Biol Stn, E Lansing, MI 48824 USA; [Basso, Bruno] Queensland Univ Technol, Inst Future Environm & Sci, Brisbane, Qld, Australia; [Basso, Bruno] Queensland Univ Technol, Engn Fac, Brisbane, Qld, Australia	Beijing Normal University; Michigan State University; Michigan State University; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Basso, B (corresponding author), Michigan State Univ, Dept Earth & Environm Sci, E Lansing, MI 48824 USA.; Basso, B (corresponding author), Michigan State Univ, WK Kellogg Biol Stn, E Lansing, MI 48824 USA.; Basso, B (corresponding author), Queensland Univ Technol, Inst Future Environm & Sci, Brisbane, Qld, Australia.; Basso, B (corresponding author), Queensland Univ Technol, Engn Fac, Brisbane, Qld, Australia.	basso@msu.edu	Basso, Bruno/AAF-1271-2019	Basso, Bruno/0000-0003-2090-4616	USDANIFA [2015-68007-23133]; NSF [1313677]	USDANIFA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF))	This research was supported by the USDANIFA grant # 2015-68007-23133, and NSF grant # 1313677. Both grants were awarded to Bruno Basso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker T, 2008, COMPUT ELECTRON AGR, V60, P87, DOI 10.1016/j.compag.2007.07.006; Basso B., 2007, GUIDELINES AGROMETEO; Cammarano D, 2014, REMOTE SENS-BASEL, V6, P2827, DOI 10.3390/rs6042827; Candiago S, 2015, REMOTE SENS-BASEL, V7, P4026, DOI 10.3390/rs70404026; Coulter JA, 2011, AGRON J, V103, P577, DOI 10.2134/agronj2010.0405; Diaz-Varela RA, 2015, REMOTE SENS-BASEL, V7, P4213, DOI 10.3390/rs70404213; Gnadinger F, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9060544; Hague T, 2006, PRECIS AGRIC, V7, P21, DOI 10.1007/s11119-005-6787-1; Ji RH, 2011, MATH COMPUT MODEL, V54, P1016, DOI 10.1016/j.mcm.2010.11.030; Jiang GQ, 2016, COMPUT ELECTRON AGR, V123, P211, DOI 10.1016/j.compag.2016.02.002; Jin J, 2009, J FIELD ROBOT, V26, P591, DOI 10.1002/rob.20293; Kise M, 2005, BIOSYST ENG, V90, P357, DOI 10.1016/j.biosystemseng.2004.12.008; Kovacs P, 2014, AGRON J, V106, P1746, DOI 10.2134/agronj14.0173; Leemans V, 2006, BIOSYST ENG, V94, P325, DOI 10.1016/j.biosystemseng.2006.03.014; Marchant J. A., 1995, Real-Time Imaging, V1, P363, DOI 10.1006/rtim.1995.1036; Martin KL, 2005, AGRON J, V97, P1603, DOI 10.2134/agronj2005.0129; Matese A, 2015, REMOTE SENS-BASEL, V7, P2971, DOI 10.3390/rs70302971; Meyer GE, 2008, COMPUT ELECTRON AGR, V63, P282, DOI 10.1016/j.compag.2008.03.009; MULDOON JF, 1981, CAN J PLANT SCI, V61, P887, DOI 10.4141/cjps81-132; Pla F, 1997, IMAGE VISION COMPUT, V15, P465, DOI 10.1016/S0262-8856(96)01147-X; Reid JF, 1986, AM SOC AGR ENG; Sogaard HT, 2003, COMPUT ELECTRON AGR, V38, P141, DOI 10.1016/S0168-1699(02)00140-0; Torres-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058210; WOEBBECKE DM, 1995, T ASAE, V38, P259, DOI 10.13031/2013.27838; Woli KP, 2014, AGRON J, V106, P1523, DOI 10.2134/agronj14.0054; XU L, 1990, PATTERN RECOGN LETT, V11, P331, DOI 10.1016/0167-8655(90)90042-Z	26	12	12	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195223	10.1371/journal.pone.0195223	http://dx.doi.org/10.1371/journal.pone.0195223			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677204	gold, Green Published, Green Submitted			2022-12-26	WOS:000430638900009
